Citrus Sinensis ID: 001974
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 988 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.975 | 0.954 | 0.458 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.960 | 0.920 | 0.437 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.971 | 0.936 | 0.452 | 0.0 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.899 | 0.757 | 0.351 | 1e-138 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.848 | 0.855 | 0.364 | 1e-131 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.909 | 0.719 | 0.339 | 1e-131 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.913 | 0.721 | 0.321 | 1e-128 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.938 | 0.841 | 0.308 | 1e-119 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.923 | 0.811 | 0.316 | 1e-117 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.892 | 0.739 | 0.326 | 1e-117 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 828 bits (2139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/990 (45%), Positives = 634/990 (64%), Gaps = 26/990 (2%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
++ D + +L+SWN S C WKG+TCG +++RVT L L L G +SP IGNLSFL +
Sbjct: 36 VSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSL 95
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L N G IP+E G+L RLE L + N L G IP L CSRL L L N+L GS+P
Sbjct: 96 DLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVP 155
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL L QL + NN+ G +P +GNLT LE ++L+ N G IP+ + QL ++ SL
Sbjct: 156 SELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSL 215
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
L ANN SG+ PP++YNLS L + N F G L P LG+ LP+L F + N+F+GSI
Sbjct: 216 QLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSI 275
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P +LSN S LE + +N+ +G + FG + NL + N+LGS S ++ F+ SL N
Sbjct: 276 PTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTN 334
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C+ L TL N+L G LP SIANLS +L L + + GSIP IGNL+ L +L +
Sbjct: 335 CTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQ 394
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N +G +P +GKL NL + L+ N+LSG IP+ +GN+++L L L+NN G++P+ LG
Sbjct: 395 NMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLG 454
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ L L + +N LNGTIP EI + L L+++ N L+GS+P IG L+ L ++
Sbjct: 455 NCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGALQNLGTLSLG 513
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSG++P LG C +E +++ GN F+G IP L L V +DLS N+LSG IP++
Sbjct: 514 DNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYF 572
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC-TEKNSRN 599
S LEYLNLSFN+LEG+VP KG+F N + +S+ G N LCGGI QL C ++ S
Sbjct: 573 ASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVV 632
Query: 600 QKISQRLKAIISTLSAVLGIVMVFFLC---FCWF-KRRRGPSKQQPSRPILRKALQKVSY 655
+K S RLK ++ +S + ++++ F+ W KR++ P+ L +K+SY
Sbjct: 633 KKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISY 692
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALK 715
L AT+GFSS++++G GSFG+VYK + +VA+KV N+QR GA KSF+AEC++LK
Sbjct: 693 GDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLK 752
Query: 716 NIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
+IRHRNLVK++T+CSSIDFQGN+F+AL+YEFM NGSL+ WLHP+ V +++ + LTL
Sbjct: 753 DIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV--EEIHRPSRTLTL 810
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR---QEV 832
L+R+NIAIDVAS +DYLH HC EP+ HCDLKP NVLLD+D+ AHV DFGLAR+ E
Sbjct: 811 LERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE 870
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
S Q S GVRGTIGYAAPEYG+G + S NGD+YS+GILLLEM TGK+PT+ +F G+
Sbjct: 871 SFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFT 930
Query: 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952
L++Y ++AL + ++DIVD +++ LR +EC + +G+ C
Sbjct: 931 LNSYTKSALPERILDIVDESILH----------IGLRVGF--PVVECLTMVFEVGLRCCE 978
Query: 953 ESPQDRMSITNVVHELQSVKNALLEAWNCT 982
ESP +R++ + VV EL S++ +A T
Sbjct: 979 ESPMNRLATSIVVKELISIRERFFKASRTT 1008
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/987 (43%), Positives = 597/987 (60%), Gaps = 38/987 (3%)
Query: 9 ILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSI 68
+L SWN S FC W G+TCG R RV LNL L+G +SP IGNLSFLR +NL +NS
Sbjct: 50 VLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF 109
Query: 69 QGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLY 128
IP++ GRLFRL+ L +S N L G IP++LS CSRL+ + L N L +P E SL
Sbjct: 110 GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169
Query: 129 KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNL 188
KL L + +NNLTG P +GNLTSL+ + A N G IP+ + +L ++ + N+
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229
Query: 189 SGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNA 248
SG PP++YN+S L + S+ N F G+L G LP+LR + N F+G+IP +L+N
Sbjct: 230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289
Query: 249 SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTL 308
S LE + N SG + ++FG ++NL + + N+LG+ S + F+ ++ANC+ L L
Sbjct: 290 SSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYL 349
Query: 309 IFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTI 368
N+L G LP SIANLS L +L + N + G+IP IGNLV L L + N +G +
Sbjct: 350 DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409
Query: 369 PKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAI 428
P GKL NL+ + LY N +SGEIPS GN++ L +L LN+NS G IP LG + L
Sbjct: 410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469
Query: 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L + N LNGTIP+EI + L+ ++L+ N L G P ++G L+ L S N LSG+
Sbjct: 470 LWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLE 547
+P +G C +E ++M+GN F G+IP +S L ++ +D S NNLSG IP++L L SL
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587
Query: 548 YLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNS--RNQKISQR 605
LNLS N EG VPT GVF N + +SV G +CGG+ E+QL C + S + + +S R
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647
Query: 606 LKAIISTLSAVLGIVMVFFLC-FCWFKRRRGPSKQQPSRPILRKAL----QKVSYESLFK 660
K + + ++++ + CWF +R+ + P L +KVSYE L
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720
AT FSST+LIG G+FG+V+KG + +VA+KV NL +HGA+KSF+AEC+ K IRHR
Sbjct: 708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
NLVK+IT CSS+D +GNDF+ALVYEFM GSL+ WL + + + V + LT +++N
Sbjct: 768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLER--VNDHSRSLTPAEKLN 825
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV---SNLTQ 837
IAIDVASA++YLH HC +PV HCD+KP N+LLD+D+ AHV DFGLA++ + S L Q
Sbjct: 826 IAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQ 885
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897
S GVRGTIGYAAPEYG+G + S GD+YS+GILLLEM +GKKPTD F GD NLH+Y
Sbjct: 886 FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT 945
Query: 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957
++ L N E ++++G+ CS E P+D
Sbjct: 946 KSILSGCT-----------------------SSGGSNAIDEGLRLVLQVGIKCSEEYPRD 982
Query: 958 RMSITNVVHELQSVKNALLEAWNCTGE 984
RM V EL S+++ + E
Sbjct: 983 RMRTDEAVRELISIRSKFFSSKTTITE 1009
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/987 (45%), Positives = 614/987 (62%), Gaps = 27/987 (2%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
++ + +L SWNDS C W G+ CGL+HRRVT ++L L+G +SP++GNLSFLR +
Sbjct: 51 VSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSL 110
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL +N G IP E G LFRL+ L +S+N G IP LS CS L+ L L N L +P
Sbjct: 111 NLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVP 170
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
EF SL KL L++ RNNLTG P +GNLTSL+ + N G IP + +LK++
Sbjct: 171 LEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFF 230
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
+ N +G+ PP IYNLS L S+ N F G+L P G LP+L++ + N F+G+I
Sbjct: 231 RIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTI 290
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P +LSN S L ++ N +GK+ ++FG ++NL + N+LG+ S ++ F+ +L N
Sbjct: 291 PETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTN 350
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
CS L+ L NKL G LP IANLS QL L + N + GSIP GIGNLV L L +G
Sbjct: 351 CSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGE 410
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N TG +P +G+L L + LY N LSGEIPSSLGN+S L+ L L NNS G IPS LG
Sbjct: 411 NLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLG 470
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
S L L+L N LNG+IP E+ L L LN++ N LVG + IG LK+L +VS
Sbjct: 471 SCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALDVS 529
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSG+IP L C LE + ++GN F G IP + L + +DLS+NNLSG IP+++
Sbjct: 530 YNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYM 588
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCT-EKNSRN 599
+ S L+ LNLS N+ +G VPT+GVF N S +SV G LCGGIP LQL C+ E R+
Sbjct: 589 ANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRH 648
Query: 600 QKISQRLKAIISTLSAVLGIVMVFFLCFCWFKR-----RRGPSKQQPSRPILRKALQKVS 654
+ + + +S + A L ++ + + CW+K R ++ S ++ +K+S
Sbjct: 649 SSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKIS 708
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKAL 714
Y+ L+K T GFSS++LIG G+FG+V+KG VAIKV NL + GA+KSF+AEC+AL
Sbjct: 709 YDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEAL 768
Query: 715 KNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
IRHRNLVK++T CSS DF+GNDF+ALVYEFM NG+L+ WLHPD + ++ + L
Sbjct: 769 GGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI--EETGNPSRTLG 826
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
L R+NIAIDVASA+ YLH +C P+ HCD+KP N+LLD D+ AHV DFGLA++ +
Sbjct: 827 LFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR 886
Query: 835 LT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
T Q S GVRGTIGYAAPEYG+G S GD+YS+GI+LLE+ TGK+PT+ +F L
Sbjct: 887 DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGL 946
Query: 892 NLHNYARTALLD-HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVAC 950
LH++ ++AL +DI D ++ R A+ +EC + R+GV+C
Sbjct: 947 TLHSFTKSALQKRQALDITDETIL------------RGAYAQHFNMVECLTLVFRVGVSC 994
Query: 951 SVESPQDRMSITNVVHELQSVKNALLE 977
S ESP +R+S+ + +L S++ +
Sbjct: 995 SEESPVNRISMAEAISKLVSIRESFFR 1021
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1266), Expect = e-138, Method: Compositional matrix adjust.
Identities = 349/994 (35%), Positives = 537/994 (54%), Gaps = 105/994 (10%)
Query: 44 LSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYC 103
L+GS+ IG L+ L +++L N + G+IPR+FG L L++L L++N L G+IPA + C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 104 SRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA 163
S L L L N+L G IP E +L +L+ L + +N LT IP + LT L + L+ N
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 164 FGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLT 223
G I +G L+ L+ L L +NN +G P SI NL L +V N G LP LGL
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 224 LPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYN 283
L +LR H N +G IP S+SN + L+ ++ N +G++ FG M NL++ ++ N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRN 441
Query: 284 NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS 343
+ +GE + F NCSNL TL A N L G L I L +L+ L ++ N L G
Sbjct: 442 HF-TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQ-KLRILQVSYNSLTGP 494
Query: 344 IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILS 403
IP IGNL L L + N FTG IP+EM L L+G+ +Y N L G IP + ++ +LS
Sbjct: 495 IPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLS 554
Query: 404 ELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463
L L+NN SG IP+ L+ L L L N NG+IP + +L+ L N+ +++ N L G
Sbjct: 555 VLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLL-NTFDISDNLLTG 613
Query: 464 SIPTK-IGNLKYLRVF-NVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
+IP + + +LK ++++ N S+N L+G IP +LG ++EI + N F GSIP SL + +
Sbjct: 614 TIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACK 673
Query: 522 AV-------------------------------------------------LAIDLSRNN 532
V +++DLS NN
Sbjct: 674 NVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNN 733
Query: 533 LSGLIPKFLEDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPK 591
L+G IP+ L +LS L++L L+ N+L+G VP GVF NI+ + G LCG L+
Sbjct: 734 LTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK--P 791
Query: 592 CTEKNSRNQKISQRLKAII----STLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILR 647
CT K ++ S+R + I+ S + +L +++V L C K ++ + + S P L
Sbjct: 792 CTIKQ-KSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLD 850
Query: 648 KALQKVSYE--SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-- 703
AL+ +E L +ATD F+S ++IG S +VYKG +DGT++A+KV NL+ A
Sbjct: 851 SALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAES 909
Query: 704 SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ 763
K F E K L ++HRNLVK++ ++ KALV FM NG+LE+ +H A P
Sbjct: 910 DKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPI 965
Query: 764 KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823
+LL++I++ + +AS IDYLH P++HCDLKP N+LLD+D +AHV DF
Sbjct: 966 G---------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDF 1016
Query: 824 GLARV---RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
G AR+ R++ S T + + GTIGY APE+ +V+T D++S+GI+++E++T +
Sbjct: 1017 GTARILGFREDGS--TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQ 1074
Query: 881 KPTDVMFEG--DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE 938
+PT + E D+ L ++ + +V + D+E D+ + +A IE
Sbjct: 1075 RPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL---DMELGDSIVSLKQEEA-----IE 1126
Query: 939 CPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972
+++ + C+ P+DR + ++ L ++
Sbjct: 1127 ---DFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1210), Expect = e-131, Method: Compositional matrix adjust.
Identities = 333/914 (36%), Positives = 480/914 (52%), Gaps = 76/914 (8%)
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNL-TSLESISLAANAFGGNIPN 170
GR+ L G I +L L L + RN G IPP IG+L +L+ +SL+ N GNIP
Sbjct: 75 GRD-LGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQ 133
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIY---NLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227
LG L L L LG+N L+G IP ++ + S L + N G +P + L L
Sbjct: 134 ELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKEL 193
Query: 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL-SVNFGGMKNLSYFNVAYNNLG 286
R + N +G++P SLSN++ L++++ N SG+L S M L + ++YN+
Sbjct: 194 RFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFV 253
Query: 287 S--GESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSI 344
S ++ F SLAN S+L+ L A N L G + S+ +LS L + + N++HGSI
Sbjct: 254 SHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSI 313
Query: 345 PSGIG------------------------NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380
P I L L R+ + N TG IP E+G + L
Sbjct: 314 PPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGL 373
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTI 440
+ + N LSG IP S GNLS L LLL N LSG +P LG L IL L N L GTI
Sbjct: 374 LDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTI 433
Query: 441 PEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYL 499
P E+ NL L LNL+ NHL G IP ++ + + ++SSN LSG+IP QLG C L
Sbjct: 434 PVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIAL 493
Query: 500 EEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI-PKFLEDLSLEYLNLSFNDLEG 558
E + + N F ++PSSL L + +D+S N L+G I P F + +L++LN SFN L G
Sbjct: 494 EHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSG 553
Query: 559 EVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIIST-LSAVL 617
V KG F+ ++ S G + LCG I +Q C +K+ + L ++I+T + V
Sbjct: 554 NVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPVLCVF 611
Query: 618 GIVMV----FFLCFCWFKRR--RGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLI 671
G +V F + + KQ + P ++SY+ L AT GF+++ LI
Sbjct: 612 GYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP----KYPRISYQQLIAATGGFNASSLI 667
Query: 672 GMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCS 730
G G FG VYKG ++ T VA+KV + + S SF EC+ LK RHRNL+++IT+CS
Sbjct: 668 GSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCS 726
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F ALV M NGSLE L+P K+ L L+Q +NI DVA I
Sbjct: 727 K-----PGFNALVLPLMPNGSLERHLYPGEYSSKN-------LDLIQLVNICSDVAEGIA 774
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ---EVSNLTQSCSVG----- 842
YLHH+ V+HCDLKP N+LLD++M A V DFG++R+ Q E + S S G
Sbjct: 775 YLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGL 834
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902
+ G++GY APEYG+G ST+GD+YS+G+LLLE+V+G++PTDV+ +LH + ++
Sbjct: 835 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKS--- 891
Query: 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962
H D ++ I+ + W K + E + M+ +G+ C+ +P R +
Sbjct: 892 -HYPDSLEGIIEQALSRWKPQGKPEKCEKLWR---EVILEMIELGLVCTQYNPSTRPDML 947
Query: 963 NVVHELQSVKNALL 976
+V HE+ +K L
Sbjct: 948 DVAHEMGRLKEYLF 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1205), Expect = e-131, Method: Compositional matrix adjust.
Identities = 337/993 (33%), Positives = 491/993 (49%), Gaps = 94/993 (9%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREF-GRLFRLEALFLSDNDL 92
+ L+L + L+G + N+S L ++ L NN + G +P+ LE L LS L
Sbjct: 289 LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
GEIP LS C L L L N L GSIP F L +L L + N L G + P I NLT
Sbjct: 349 SGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLT 408
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
+L+ + L N G +P + L++L+ L L N SG IP I N + L + N F
Sbjct: 409 NLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHF 468
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
G +PPS+G L L L + N G +P SL N +L ++ DN SG + +FG +
Sbjct: 469 EGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFL 527
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQN 332
K L + YNN S + + +SL + NL + + N+L G + H + S L +
Sbjct: 528 KGLEQL-MLYNN-----SLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYL-S 579
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
+T+N IP +GN L RL +G NQ TG IP +GK++ L + + N L+G I
Sbjct: 580 FDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTI 639
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA------------------------I 428
P L L+ + LNNN LSG IP LG L QL +
Sbjct: 640 PLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLV 699
Query: 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L L N LNG+IP+EI NL L N LNL +N GS+P +G L L +S N+L+GE
Sbjct: 700 LSLDGNSLNGSIPQEIGNLGAL-NVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGE 758
Query: 489 IPSQLGLCSYLEE-IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SL 546
IP ++G L+ + + N F G IPS++ +L + +DLS N L+G +P + D+ SL
Sbjct: 759 IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSL 818
Query: 547 EYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC--TEKNSRNQKISQ 604
YLN+SFN+L G++ K F+ S G LCG L +C N++ Q +S
Sbjct: 819 GYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSA 872
Query: 605 RLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSK----------------QQPSRPILRK 648
R IIS +SA+ I ++ + +FK+R K Q +P+ R
Sbjct: 873 RSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRN 932
Query: 649 ALQK--VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS 706
K + +E + +AT S +IG G G VYK + T+ K+ ++KS
Sbjct: 933 GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS 992
Query: 707 FLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV 766
F E K L IRHR+LVK++ CSS + L+YE+M NGS+ +WLH D + +
Sbjct: 993 FSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHED---KPVL 1046
Query: 767 EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
E + + L R+ IA+ +A ++YLHH C P++H D+K NVLLD++M AH+GDFGLA
Sbjct: 1047 EKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLA 1106
Query: 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886
+V E + + + GY APEY + + D+YS GI+L+E+VTGK PTD +
Sbjct: 1107 KVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSV 1166
Query: 887 FEGDLNLHNYARTAL------LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECP 940
F ++++ + T L D +ID L+ ED
Sbjct: 1167 FGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEED-------------------AA 1207
Query: 941 ISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973
++ I + C+ SPQ+R S L V N
Sbjct: 1208 CQVLEIALQCTKTSPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-128, Method: Compositional matrix adjust.
Identities = 335/1041 (32%), Positives = 505/1041 (48%), Gaps = 138/1041 (13%)
Query: 30 RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSD 89
R + + LNL SG + +G+L ++ +NL+ N +QG IP+ L L+ L LS
Sbjct: 238 RLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSS 297
Query: 90 NDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSL-YKLKQLAMQRNNLTGGIPPFI 148
N+L G I ++L L L +N+L GS+P S LKQL + L+G IP I
Sbjct: 298 NNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEI 357
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
N SL+ + L+ N G IP+SL QL EL +L L N+L G + SI NL+ L F++
Sbjct: 358 SNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLY 417
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN 268
N G +P +G L L + ++ N FSG +P+ + N ++L+ I+ N SG++ +
Sbjct: 418 HNNLEGKVPKEIGF-LGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSS 476
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA---- 324
G +K+L+ ++ N L + SL NC + + A N+L G++P S
Sbjct: 477 IGRLKDLTRLHLRENELVG------NIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTA 530
Query: 325 -------------NLSDQLQNLI-----------------------------MTSNQLHG 342
NL D L NL +T N G
Sbjct: 531 LELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEG 590
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
IP +G L RL +G NQFTG IP+ GK+ L + + N LSG IP LG L
Sbjct: 591 DIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKL 650
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLA----------------------ILHLFENG--LNG 438
+ + LNNN LSGVIP+ LG L L IL LF +G LNG
Sbjct: 651 THIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNG 710
Query: 439 TIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSY 498
+IP+EI NL L N+LNL N L G +P+ IG L L +S N L+GEIP ++G
Sbjct: 711 SIPQEIGNLQAL-NALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQD 769
Query: 499 LEE-IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDL 556
L+ + + N F G IPS++S+L + ++DLS N L G +P + D+ SL YLNLS+N+L
Sbjct: 770 LQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNL 829
Query: 557 EGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK-ISQRLKAIISTLSA 615
EG++ K F+ + G LCG L C S+NQ+ +S + IIS +S+
Sbjct: 830 EGKL--KKQFSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVIISAISS 883
Query: 616 VLGIVMVFFLCFCWFKRRRGPSKQ-------------QPSRPILRK--ALQKVSYESLFK 660
+ I ++ + +FK+ K+ P+ A + ++ + +
Sbjct: 884 LAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIME 943
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720
AT + +IG G G VYK TI K+ ++KSF E K L IRHR
Sbjct: 944 ATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHR 1003
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+LVK++ CSS + + L+YE+M NGS+ +WLH + +K + L R+
Sbjct: 1004 HLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKK-----EVLGWETRLK 1055
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
IA+ +A ++YLH+ C P++H D+K NVLLD+++ AH+GDFGLA++ + +
Sbjct: 1056 IALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESN 1115
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
G+ GY APEY + + D+YS GI+L+E+VTGK PT+ MF+ + ++ + T
Sbjct: 1116 TMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETV 1175
Query: 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKI--------ECPISMVRIGVACSV 952
L D R+ I+ ++ E ++ I + C+
Sbjct: 1176 L-------------------DTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTK 1216
Query: 953 ESPQDRMSITNVVHELQSVKN 973
PQ+R S L +V N
Sbjct: 1217 SYPQERPSSRQASEYLLNVFN 1237
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 333/1080 (30%), Positives = 511/1080 (47%), Gaps = 153/1080 (14%)
Query: 4 HDPQGILNSWND-SGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREIN 62
+D G L SWN + C W GI C R VT ++L LSG+LSP I L LR++N
Sbjct: 39 NDSNGYLASWNQLDSNPCNWTGIACT-HLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLN 97
Query: 63 LMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPF 122
+ N I G IP++ LE L L N G IP L+ L L+L N L GSIP
Sbjct: 98 VSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPR 157
Query: 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLG 182
+ +L L++L + NNLTG IPP + L L I N F G IP+ + + LK LG
Sbjct: 158 QIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLG 217
Query: 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS-- 240
L N L G +P + L L + + +N+ G +PPS+G + L + +H N+F+GS
Sbjct: 218 LAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG-NISRLEVLALHENYFTGSIP 276
Query: 241 ----------------------IPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYF 278
IP + N I+ +N +G + FG + NL
Sbjct: 277 REIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLL 336
Query: 279 ------------------------NVAYNNLGSGESDEMSFMNSLANC------------ 302
+++ N L E+ F+ L +
Sbjct: 337 HLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIP 396
Query: 303 ------SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTS---NQLHGSIPSGIGNLVG 353
SN L +AN L G +P + Q LI+ S N+L G+IP +
Sbjct: 397 PLIGFYSNFSVLDMSANSLSGPIPAHFC----RFQTLILLSLGSNKLSGNIPRDLKTCKS 452
Query: 354 LYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS 413
L +L +G NQ TG++P E+ LQNL + L+ N LSG I + LG L L L L NN+ +
Sbjct: 453 LTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFT 512
Query: 414 GVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLK 473
G IP +G+L ++ ++ N L G IP+E+ + + L+L+ N G I ++G L
Sbjct: 513 GEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQR-LDLSGNKFSGYIAQELGQLV 571
Query: 474 YLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAV-LAIDLSRNN 532
YL + +S N L+GEIP G + L E+ + GN +IP L L ++ +++++S NN
Sbjct: 572 YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNN 631
Query: 533 LSGLIPK-----------FLED--------------LSLEYLNLSFNDLEGEVPTKGVFA 567
LSG IP +L D +SL N+S N+L G VP VF
Sbjct: 632 LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQ 691
Query: 568 NISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKI---SQRLKAIISTLSAVLGIVMVFF 624
+ + AG + LC P +S+ + SQR K + T + + ++ F
Sbjct: 692 RMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITF 751
Query: 625 LCFCWFKRRRGPS---KQQPSRPILRKAL----QKVSYESLFKATDGFSSTHLIGMGSFG 677
L CW +RR P+ + ++P + + + +Y+ L AT FS ++G G+ G
Sbjct: 752 LGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACG 811
Query: 678 SVYKGAFDQDGTIVAIKVFNLQRHGASK--SFLAECKALKNIRHRNLVKVITSCSSIDFQ 735
+VYK G ++A+K N + GAS SF AE L IRHRN+VK+ C +
Sbjct: 812 TVYKAEMS-GGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFC----YH 866
Query: 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH 795
N L+YE+M+ GSL L +K+ ++ R IA+ A + YLHH
Sbjct: 867 QNS-NLLLYEYMSKGSLGEQLQRG---EKNCLLDWNA-----RYRIALGAAEGLCYLHHD 917
Query: 796 CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV-GVRGTIGYAAPEY 854
C+ ++H D+K N+LLD AHVGDFGLA+ + +L+ S S+ V G+ GY APEY
Sbjct: 918 CRPQIVHRDIKSNNILLDERFQAHVGDFGLAK----LIDLSYSKSMSAVAGSYGYIAPEY 973
Query: 855 GLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV--IDIVDPI 912
+V+ DIYS+G++LLE++TGK P + +G +L N+ R ++ + + I++ D
Sbjct: 974 AYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPTIEMFDAR 1032
Query: 913 LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972
L D +K+ + + + +++I + C+ SP R ++ VV + +
Sbjct: 1033 L-------DTNDKRTVHEMSL---------VLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 425 bits (1092), Expect = e-117, Method: Compositional matrix adjust.
Identities = 344/1086 (31%), Positives = 507/1086 (46%), Gaps = 174/1086 (16%)
Query: 10 LNSWNDSGHF-CEWKGITCGLRHRR-------VTVLNLRSKGLSGSLSPYIGNLSFLREI 61
L++WN C W G+ C + VT L+L S LSG +SP IG L L +
Sbjct: 55 LHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYL 114
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL N++ G+IPRE G +LE +FL++N G IP ++ S+L + NKL G +P
Sbjct: 115 NLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLP 174
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E LY L++L NNLTG +P +GNL L + N F GNIP +G+ LK L
Sbjct: 175 EEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLL 234
Query: 182 GLG------------------------ANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLP 217
GL N SG IP I NL+ L ++ N G +P
Sbjct: 235 GLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIP 294
Query: 218 PSLG--LTLPHLRLFQ---------------------VHHNFFSGSIPISLSNASKLEFI 254
+G +L L L+Q N SG IP+ LS S+L +
Sbjct: 295 SEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLL 354
Query: 255 EALDNSFSGKLSVNFGGMKNLSYFNVAYN-----------NLGSGESDEMSFMNSLANC- 302
N +G + ++NL+ +++ N NL S ++ F NSL+
Sbjct: 355 YLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQL-FHNSLSGVI 413
Query: 303 -------SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMT---SNQLHGSIPSGIGNLV 352
S L + F+ N+L G +P I Q NLI+ SN++ G+IP G+
Sbjct: 414 PQGLGLYSPLWVVDFSENQLSGKIPPFIC----QQSNLILLNLGSNRIFGNIPPGVLRCK 469
Query: 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412
L +L + GN+ TG P E+ KL NL + L N+ SG +P +G L L L N
Sbjct: 470 SLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQF 529
Query: 413 SGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNL 472
S +P+ + L L ++ N L G IP EI N L L+L+RN +GS+P ++G+L
Sbjct: 530 SSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQR-LDLSRNSFIGSLPPELGSL 588
Query: 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSL--------------- 517
L + +S N SG IP +G ++L E+ M GN F GSIP L
Sbjct: 589 HQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYN 648
Query: 518 ----------SSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVF 566
+L ++ + L+ N+LSG IP E+L SL N S+N+L G++P +F
Sbjct: 649 DFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIF 708
Query: 567 ANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKA--------------IIST 612
N++ S G LCGG L C +S IS LKA +I
Sbjct: 709 QNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISS-LKAGSARRGRIIIIVSSVIGG 763
Query: 613 LSAVLGIVMVFFL-----CFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSS 667
+S +L ++V FL + + P Q+ + K ++ + + + +AT GF
Sbjct: 764 ISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPK--ERFTVKDILEATKGFHD 821
Query: 668 THLIGMGSFGSVYKGAFDQDGTIVAIKV------FNLQRHGASKSFLAECKALKNIRHRN 721
++++G G+ G+VYK TI K+ N + SF AE L IRHRN
Sbjct: 822 SYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRN 881
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V++ + C QG++ L+YE+M+ GSL LH D R I
Sbjct: 882 IVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWP---------TRFAI 929
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A+ A + YLHH C+ ++H D+K N+L+D + AHVGDFGLA+V L++S S
Sbjct: 930 ALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID--MPLSKSVS- 986
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901
V G+ GY APEY +V+ DIYS+G++LLE++TGK P + +G +L + R +
Sbjct: 987 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DLATWTRNHI 1045
Query: 902 LDHVI--DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959
DH + +I+DP L VED N I++ +I V C+ SP DR
Sbjct: 1046 RDHSLTSEILDPYL-TKVEDDVILNHM--------------ITVTKIAVLCTKSSPSDRP 1090
Query: 960 SITNVV 965
++ VV
Sbjct: 1091 TMREVV 1096
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-117, Method: Compositional matrix adjust.
Identities = 323/989 (32%), Positives = 496/989 (50%), Gaps = 107/989 (10%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
+++LNL S L G + P +GN L+ + L NS+ G +P E + L N L
Sbjct: 260 LSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEI-PLLTFSAERNQLS 318
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
G +P+ + L L L N+ G IP E LK L++ N L+G IP + S
Sbjct: 319 GSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGS 378
Query: 154 LESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
LE+I L+ N G I L L L N ++G IP ++ L L+A + N F
Sbjct: 379 LEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMA-LDLDSNNFT 437
Query: 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMK 273
G +P SL + +L F +N G +P + NA+ L+ + DN +G++ G +
Sbjct: 438 GEIPKSLWKST-NLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLT 496
Query: 274 NLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNL 333
+LS N+ N E L +C++L TL +N L+G +P I L+ QLQ L
Sbjct: 497 SLSVLNLNANMFQGKIPVE------LGDCTSLTTLDLGSNNLQGQIPDKITALA-QLQCL 549
Query: 334 IMTSNQLHGSIPSG---------IGNLVGLYRLG---MGGNQFTGTIPKEMGKLQNLEGM 381
+++ N L GSIPS + +L L G + N+ +G IP+E+G+ L +
Sbjct: 550 VLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEI 609
Query: 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIP 441
L +N LSGEIP+SL L+ L+ L L+ N+L+G IP +G+ +L L+L N LNG IP
Sbjct: 610 SLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIP 669
Query: 442 EEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE 501
E F L LNL +N L G +P +GNLK L ++S NNLSGE+ S+L L
Sbjct: 670 ES-FGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVG 728
Query: 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEV 560
+Y+ N F G IPS L +L + +D+S N LSG IP + L +LE+LNL+ N+L GEV
Sbjct: 729 LYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEV 788
Query: 561 PTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIISTLSAVLGI- 619
P+ GV + S+ ++G LCG + S + +L++ +LG
Sbjct: 789 PSDGVCQDPSKALLSGNKELCGRV----------VGSDCKIEGTKLRSAWGIAGLMLGFT 838
Query: 620 VMVFFLCFC---W-----FKRRRGPSKQQPSR-------------------------PIL 646
++VF F W K+R P + + SR +
Sbjct: 839 IIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMF 898
Query: 647 RKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS 706
+ L KV + +ATD FS ++IG G FG+VYK + T VA+K + + ++
Sbjct: 899 EQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKT-VAVKKLSEAKTQGNRE 957
Query: 707 FLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV 766
F+AE + L ++H NLV ++ CS ++ K LVYE+M NGSL++WL ++
Sbjct: 958 FMAEMETLGKVKHPNLVSLLGYCSF-----SEEKLLVYEYMVNGSLDHWL-------RNQ 1005
Query: 767 EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
++ L +R+ IA+ A + +LHH ++H D+K N+LLD D V DFGLA
Sbjct: 1006 TGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLA 1065
Query: 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886
R+ +S S + GT GY PEYG + +T GD+YS+G++LLE+VTGK+PT
Sbjct: 1066 RL---ISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPD 1122
Query: 887 F---EGDLNLHNYARTAL-LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPIS 942
F EG NL +A + +D++DP+L++ A +LR
Sbjct: 1123 FKESEGG-NLVGWAIQKINQGKAVDVIDPLLVS-----VALKNSQLR------------- 1163
Query: 943 MVRIGVACSVESPQDRMSITNVVHELQSV 971
+++I + C E+P R ++ +V+ L+ +
Sbjct: 1164 LLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 988 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.933 | 0.547 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.982 | 0.509 | 0.546 | 0.0 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.969 | 0.941 | 0.546 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.968 | 0.932 | 0.548 | 0.0 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.957 | 0.980 | 0.536 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.977 | 0.942 | 0.529 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.982 | 0.944 | 0.520 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.981 | 0.938 | 0.522 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.978 | 0.946 | 0.510 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.966 | 0.944 | 0.520 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/983 (54%), Positives = 684/983 (69%), Gaps = 12/983 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I DP GI SWNDS HFC W G+TCG RH+RV LNL S L GSLSP IGNL+FL +
Sbjct: 51 ITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGSLSPSIGNLTFLTGL 110
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL N+ G+IP+E GRL RL AL L++N GEIPANLS CS L LG N L+G IP
Sbjct: 111 NLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIP 170
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
S K+ ++ + NNLTG +P +GNLTS++S+S A N G+IP +LGQL+ L+ +
Sbjct: 171 SWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFM 230
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
GLG N SGIIP S+YN+S L FS+P N+ +GSLP L TLP+L++ + +N F+GS+
Sbjct: 231 GLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSL 290
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P SLSNAS L + ++F+GK+S++FGGM NL +A N LG GE+D++SF+NSL
Sbjct: 291 PSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMK 350
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C L+ L + ++ G LP+SIANLS QL L + +NQL G+IP GIGNLV L L +
Sbjct: 351 CRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILAN 410
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N FTG+IP +G LQ L + L NQLSG IPSSLGN++ L L L NN LSG IPS G
Sbjct: 411 NDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFG 470
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+L L L L N LNGTIPE++ +L L+ SLNLARN L G +P+++ LK L +VS
Sbjct: 471 NLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVS 530
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSGEIP LG C LE ++M GNFF GSIP S SLR +L +DLSRNNLSG IP+FL
Sbjct: 531 ENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFL 590
Query: 542 EDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK 601
+ LSL LNLSFN+ EG++PTKGVF N + SVAG N+LCGGIPEL LP C + +
Sbjct: 591 QQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGE 650
Query: 602 ISQRLKAIISTLSAVLGIVMVFFLCFCWFKRR--RGPSKQQPSRPILRKALQKVSYESLF 659
+ LK +I L+ LG+V++ L RR R PS+ S + + VSY+ LF
Sbjct: 651 SKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASS---KDLILNVSYDGLF 707
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH 719
KAT GFSS +LIG G FGSVYKG QD T+VA+KV L + GA KSF AEC+AL+NIRH
Sbjct: 708 KATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRH 767
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
RNLVKV+T+CSS+D+QGNDFKALVYEFM NGSLENWLHP P + ++ ++ L+L QR+
Sbjct: 768 RNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDV-LRILSLPQRL 826
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV---SNLT 836
NIAIDVASA+DYLHHHC +P++HCDLKP N+LLDNDM AHVGDFGLAR E S+ +
Sbjct: 827 NIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPS 886
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
QS S+G++GTIGYAAPEYG+G++VS GD YSYGILLLEM TGK+PT+ MF LNLHN+
Sbjct: 887 QSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNF 946
Query: 897 ARTALLDHVIDIVDPILIND---VEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953
+ AL + + DI+DP ++ E+ A + L K EC IS++RIGV+CS+E
Sbjct: 947 VKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLE 1006
Query: 954 SPQDRMSITNVVHELQSVKNALL 976
SP++RM+IT + ELQ ++ LL
Sbjct: 1007 SPRERMAITEAIKELQLIRKILL 1029
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2626), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/983 (54%), Positives = 683/983 (69%), Gaps = 12/983 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I DP GI SWNDS HFC W G+TCG RH+RV LNL S L GSLSP IGNL+FL +
Sbjct: 82 ITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGL 141
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL N+ G+IP+E GRL RL AL L++N GEIPANLS CS L LG N L+G IP
Sbjct: 142 NLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIP 201
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
S K+ ++ + NNLTG +P +GNLTS++S+S A N G+IP +LGQL+ L+ +
Sbjct: 202 SWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFM 261
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
GLG N SGIIP S+YN+S L FS+P N+ +GSLP L TLP+L++ + +N F+G +
Sbjct: 262 GLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPL 321
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P SLSNAS L + ++F+GK+S++FGGM NL +A N LG GE+D++SF+NSL
Sbjct: 322 PSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMK 381
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C L+ L + ++ G LP+SIANLS QL L + +NQL G+IP GIGNLV L L +
Sbjct: 382 CRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILAN 441
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N FTG+IP +G LQ L + L NQLSG IPSSLGN++ L L L NN LSG IPS G
Sbjct: 442 NDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFG 501
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+L L L L N LNGTIPE++ +L L+ SLNLARN L G +P+++ LK L +VS
Sbjct: 502 NLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVS 561
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSGEIP LG C LE ++M GNFF GSIP S SLR +L +DLSRNNLSG IP+FL
Sbjct: 562 ENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFL 621
Query: 542 EDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK 601
+ LSL LNLSFN+ EG++PTKGVF N + SVAG N+LCGGIPEL LP C + +
Sbjct: 622 QQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGE 681
Query: 602 ISQRLKAIISTLSAVLGIVMVFFLCFCWFKRR--RGPSKQQPSRPILRKALQKVSYESLF 659
+ LK +I L+ LG+V++ L RR R PS+ S + + VSY+ LF
Sbjct: 682 SKRGLKLMIGLLTGFLGLVLIMSLLVINRLRRVKREPSQTSASS---KDLILNVSYDGLF 738
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH 719
KAT GFSS +LIG G FGSVYKG QD T+VA+KV L + GA KSF AEC+AL+NIRH
Sbjct: 739 KATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRH 798
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
RNLVKV+T+CSS+D+QGNDFKALVYEFM NGSLENWLHP P + ++ ++ L+L QR+
Sbjct: 799 RNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDV-LRILSLPQRL 857
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV---SNLT 836
NIAIDVASA+DYLHHHC +P++HCDLKP N+LLDNDM AHVGDFGLAR E S+ +
Sbjct: 858 NIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPS 917
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
QS S+G++GTIGYAAPEYG+G++VS GD YSYGILLLEM TGK+PT+ MF LNLHN+
Sbjct: 918 QSSSIGLKGTIGYAAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNF 977
Query: 897 ARTALLDHVIDIVDPILIND---VEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953
+ AL + + DI+DP ++ E+ A + L K EC IS++RIGV+CS+E
Sbjct: 978 VKMALPERIADIIDPFFLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLE 1037
Query: 954 SPQDRMSITNVVHELQSVKNALL 976
SP++RM+IT + ELQ ++ LL
Sbjct: 1038 SPRERMAITEAIKELQLIRKILL 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2595), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/983 (54%), Positives = 697/983 (70%), Gaps = 25/983 (2%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I HDPQ I SWNDS HFC+W+G+ CG RH RVTVL L S GL GS+SP +GNLSFL +
Sbjct: 50 IIHDPQNIFGSWNDSLHFCQWQGVRCGRRHERVTVLKLESSGLVGSISPALGNLSFLWGL 109
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L NN++QG+IP GRLFRL+ L L++N VGEIP NLS+CS+L L L N L+G IP
Sbjct: 110 DLSNNTLQGKIPDGLGRLFRLQILVLNNNSFVGEIPGNLSHCSKLDYLGLASNNLVGKIP 169
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL KL++L + +NNL+G IPPFIGNLTSL SIS AAN F G IP++LGQLK L+SL
Sbjct: 170 AELVSLSKLEKLVIHKNNLSGAIPPFIGNLTSLNSISAAANNFQGRIPDTLGQLKNLESL 229
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
GLG N LSG IP IYNLS L+ S+ NQ G LP +G++LP+L+ Q+ N FSGSI
Sbjct: 230 GLGTNFLSGTIPLPIYNLSTLSILSLSENQLQGYLPSDIGVSLPNLQYIQIRANQFSGSI 289
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P+S+SN+S L+ +EA DNSFSGKLSVNFGG+K+L+ ++++N +GSGE E+SF++SL N
Sbjct: 290 PLSISNSSNLQVLEAGDNSFSGKLSVNFGGLKHLAVVSLSFNKMGSGEPGELSFLDSLIN 349
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C++L + N G LP+S+ NLS L L + NQL G I SGIGNL+ L LG+
Sbjct: 350 CTSLYAIDIVGNHFEGMLPNSLGNLSTGLTFLGLGQNQLFGGIHSGIGNLINLNTLGLEF 409
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
NQ +G IP ++GKL+ L+ L N+LSG IPSS+GNL++L E L N L G IPS +G
Sbjct: 410 NQLSGPIPLDIGKLRMLQRFSLSYNRLSGHIPSSIGNLTLLLEFDLQGNQLQGTIPSSIG 469
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ ++L +LHL N L+G P+E+F ++ LS SL+L++N+ GS+P++IG+LK L NVS
Sbjct: 470 NCQKLLLLHLSRNNLSGNAPKELFAISSLSVSLDLSQNYFNGSLPSEIGSLKSLAKLNVS 529
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N SGEIPS L C+ LE +YM+ NFF GSIPSS S+LR + +DLS NNLSG IPKFL
Sbjct: 530 YNEFSGEIPSTLASCTSLEYLYMQHNFFQGSIPSSFSTLRGIQKLDLSHNNLSGQIPKFL 589
Query: 542 EDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK 601
+ +L LNLSFND EGEVPTKG F N + ISV G +LCGGI EL+LPKC K S+ K
Sbjct: 590 DTFALLTLNLSFNDFEGEVPTKGAFGNATAISVDGNKKLCGGISELKLPKCNFKKSKKWK 649
Query: 602 ISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFKA 661
I L +++ LG+ +V F+ +R+R K+Q S L++ L KVSYE L KA
Sbjct: 650 IPLWLILLLTIACGFLGVAVVSFVLLYLSRRKR---KEQSSELSLKEPLPKVSYEMLLKA 706
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN 721
T+GFSS +LIG G FGSVY+G DQD T+VAIKV NLQ GASKSF+AEC+AL+N+RHRN
Sbjct: 707 TNGFSSDNLIGEGGFGSVYRGILDQDDTVVAIKVLNLQTRGASKSFVAECEALRNVRHRN 766
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGS---LENWLHPDAVPQKDVEIEIQKLTLLQR 778
L+K+ITSCSS+DFQGN+FKALVYEFM NGS LE WL+ L LLQR
Sbjct: 767 LLKIITSCSSVDFQGNEFKALVYEFMPNGSLEILEKWLYSHNY----------FLDLLQR 816
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+NI IDVASA++YLHH V+HCDLKP N+LLD +M+AHV DFG+A++ E ++TQ+
Sbjct: 817 LNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDENMVAHVSDFGIAKLLGEGHSITQT 876
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
++ T+GY APEYGLGS+VS GDIYSYGI LLEM+T K+PTD MFEG LNLH +AR
Sbjct: 877 MTL---ATVGYMAPEYGLGSQVSIYGDIYSYGIPLLEMITRKRPTDNMFEGTLNLHGFAR 933
Query: 899 TALLDHVIDIVDPILIN--DVEDWDATNKQRLRQAKINGKI----ECPISMVRIGVACSV 952
AL + V++IVDP L++ +V+ +N +G+I EC S+++IG++CS
Sbjct: 934 MALPEQVLNIVDPSLLSSGNVKAGRMSNTSLENPTSSSGEIGTLVECVTSLIQIGLSCSR 993
Query: 953 ESPQDRMSITNVVHELQSVKNAL 975
E P+DR+ I + + EL S++ L
Sbjct: 994 ELPRDRLEINHAITELCSIRKIL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2564), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/977 (54%), Positives = 683/977 (69%), Gaps = 20/977 (2%)
Query: 4 HDPQG-ILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREIN 62
DP L+SWNDS FC W GITCG RH RV ++NL + L+G+LSPY+GN+SFLREI
Sbjct: 45 QDPHSNTLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGTLSPYVGNISFLREIR 104
Query: 63 LMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPF 122
L NN+I GEIP E GRL RL L L++N + G+IPANLS CS L L++ RNKL G IP
Sbjct: 105 LANNTIHGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLAELYIDRNKLGGEIPT 164
Query: 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLG 182
E L KL L+ ++NNL G IP IGNLTSLES+SL N G IP+SLG+LK L SL
Sbjct: 165 ELGFLSKLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGTIPDSLGRLKRLTSLL 224
Query: 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIP 242
LG N LSG IPPS+YNLSL+ F + N F GSLP +LGL+ PHL+ + N FSG IP
Sbjct: 225 LGENKLSGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHLQWLALWQNQFSGPIP 284
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
SL+NAS+L+ + NS +GK+ FG + +LS + NNLG+G DEM+F+ SL NC
Sbjct: 285 GSLTNASELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGTGGDDEMAFLASLTNC 344
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
S L+ + N+L G+LP ++ NLS + ++ N + G IPSGIGNLV L L M N
Sbjct: 345 SMLKVVSINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSGIGNLVNLTFLYMDRN 404
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
FTG IP G L+ LE L+ N+LSG+IPSSLGNLS+LS L L++N L IP+ LG
Sbjct: 405 HFTGEIPTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYLDDNKLKDTIPASLGG 464
Query: 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
K L L L LNG+IPE++F + + SLNL+ N GS+P+ IG+LK L +VS
Sbjct: 465 CKNLVSLGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPSTIGSLKGLSELDVSW 524
Query: 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLE 542
N LSGEIP+ G C+ LE ++M NFF GSIPSS SSLR + +DLS NNLSG +P FL
Sbjct: 525 NMLSGEIPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDLSCNNLSGQLPNFLV 584
Query: 543 DLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKI 602
+ LNLS+N+ EGEVP KGVF N S +SV G ++LCGGI EL LP+C K + K+
Sbjct: 585 TIPFISLNLSYNNFEGEVPRKGVFTNESAVSVVGNDKLCGGILELHLPECPNKEPKKTKM 644
Query: 603 S--QRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFK 660
S Q L A I+ A++G + V FCWFK++R K+ S +L+++ ++SYE LFK
Sbjct: 645 SHLQYLLA-ITIPCALVGAITVSSFLFCWFKKKR---KEHSSDTLLKESFPQISYERLFK 700
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720
ATDGFS+T+LIG+GSF SVYKG D+DGT+VAIKV NLQR GASKSF EC+AL+NIRHR
Sbjct: 701 ATDGFSTTNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFKDECEALRNIRHR 760
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI-EIQKLTLLQRI 779
NLVK+ITSCSSIDFQGN+FKALVYE+M GSLE WLHP D +I ++Q+ LL+RI
Sbjct: 761 NLVKIITSCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQQINQVQRPNLLERI 820
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT-QS 838
NIAIDVA+A+DYLHHHC P++HCD+KP N+LLD DMI H+GDFGLAR+ QE S + +S
Sbjct: 821 NIAIDVAAALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGLARIFQEFSEPSLES 880
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
S G++GT GYAAPEYG G EVS +GD+YSYGILLLEM+TGK+P D FE LNLH +A+
Sbjct: 881 SSAGIKGTTGYAAPEYGQGREVSIDGDVYSYGILLLEMMTGKRPIDDTFEKGLNLHMFAK 940
Query: 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958
AL DHVI+I DP+L+++ +A + + EC S+V+IGVACS++SP+DR
Sbjct: 941 MALPDHVIEITDPVLLSERHLENAASME-----------ECLTSLVKIGVACSMDSPRDR 989
Query: 959 MSITNVVHELQSVKNAL 975
M ++ VV EL V++
Sbjct: 990 MDMSRVVRELLMVRDTF 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/957 (53%), Positives = 677/957 (70%), Gaps = 11/957 (1%)
Query: 24 GITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLE 83
G+ CG RH+RVT+L+L+S+ L GS+SP+IGNLSFLR + L N EIP E G L RL+
Sbjct: 1 GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60
Query: 84 ALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGG 143
LFLS+N L GEIPANLS CS+L +++G N+L+G IP E SL KL+ L + N+L+GG
Sbjct: 61 MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
IP GNL+SLE +S N G IP SL QL L + L AN LSG IPPS+ NLS L
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180
Query: 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263
F+V N HG+LP +LG+TLP+L+ + N F+GSIP+SLSNAS LE+ N+ +G
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240
Query: 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI 323
K+ + ++ L +F+V NNLG+GE +++ F++SL N SNL L N G LP SI
Sbjct: 241 KVP-SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESI 299
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
N S +L L++ N++ GSIP+GIGNLV L RL M NQ +G+IP ++GKLQNL + L
Sbjct: 300 GNWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLML 359
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEE 443
N+LSG +PSSLGNL L +L+L N G IPS LG + L L L N L+GTIP +
Sbjct: 360 IKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQ 419
Query: 444 IFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIY 503
+ +L+ LS SL+++ N L G++P ++GNLK L V +VS+N LSG IPS +G C+ LE +
Sbjct: 420 VVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLS 479
Query: 504 MRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTK 563
M+GNFF GSIPSS SSLR + +DLS NNLSG IP+FL+D+ + +NLS+ND EG +PT+
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTE 539
Query: 564 GVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIISTLSAVLGIVMVF 623
GVF N+S S+ G ++LCGGIPE QLPKC + + + +S LK II+T+S +L I V
Sbjct: 540 GVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVL 599
Query: 624 -FLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKG 682
FL F W ++++G +P+ K+L KVSY+SL +ATDGFSS++LIG+GSFGSVYKG
Sbjct: 600 SFLIFLWLRKKKG----EPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKG 655
Query: 683 AFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742
D DGT +A+KV NL R GASKSF+AEC+AL+NIRHRNLVKV+T+CS +D+QGNDFKA+
Sbjct: 656 ILDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAV 715
Query: 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLH 802
VYEFM NGSLE WLHP + +KL LQR+NIAIDVA A+DYLHH CQ P++H
Sbjct: 716 VYEFMVNGSLEQWLHPTPT-TAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVH 774
Query: 803 CDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSE 859
CDLKP NVLLD +M HVGDFG+A+ E + QS S+G+RGTIGYAAPEYG+GSE
Sbjct: 775 CDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSE 834
Query: 860 VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVED 919
VST+GD+YS+GILLLEM TGK+PT+ MF+ LN+HN+ +TA+ + V +I DP+L+ + +
Sbjct: 835 VSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLLQEGVE 894
Query: 920 WDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALL 976
D T QR R A + EC IS+ IG+ACS E P++R +IT+ EL SV++ L
Sbjct: 895 MDNTTSQR-RMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRDIFL 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/981 (52%), Positives = 676/981 (68%), Gaps = 15/981 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I +DP G+L+SWN+S HFC+W G+ CG RHRRV ++L S L GSLSP+IGNLSFLR +
Sbjct: 46 ITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGSLSPHIGNLSFLRIL 105
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
L NN IP+E G LFRL L L +N G+IP N+S+CS L IL L N L G +P
Sbjct: 106 KLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLLILSLSGNNLTGKLP 165
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL KL+ Q N L GGIP GNL+++ I A N G IPNS+GQLK LKS
Sbjct: 166 IELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQGGIPNSIGQLKSLKSF 225
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
G NN++G+IPPSIYNLS L F+VP NQ HG+LPP LGLTLP+L + + N FSGSI
Sbjct: 226 SFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPNLEILLMSFNRFSGSI 285
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P + SNAS + IE +N+ +G++ + + L + V N LG+G D++SF+ LAN
Sbjct: 286 PPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDVNYLGNGNDDDLSFLPPLAN 344
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
++L L N G LP I+N S+ L+ + NQ+ GSIPSGIGNL+GL LG+
Sbjct: 345 KTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPSGIGNLIGLDTLGLEM 404
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
NQ TG IP +GKLQNL + L N++SG IPSS+GN++ L E+ L+ N+L G IPS LG
Sbjct: 405 NQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLG 464
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ + L ILHL +N L+G+IP+E+ ++ S L L+ N L GS+P ++G L L FN+S
Sbjct: 465 NCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLPLEVGKLANLGYFNLS 524
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSGEIP LG C LE +YM GN F G IP SLSSLRA+ ++LS NNLSG IPKFL
Sbjct: 525 HNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFL 584
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQ 600
+L L L+LSFN+LEGEVP +G+FA S S+ G +LCGG+P+L L +CT K SR
Sbjct: 585 AELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGMPQLNLSRCTSKKSRKL 644
Query: 601 KISQRLKAIISTLSAVLGIVMVF-FLCFCWFKRRRG-PSKQQPSRPILRKALQKVSYESL 658
K S +LK II+ +GI++V ++ F + K ++ P+ P Q+V+YE L
Sbjct: 645 KSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKSRPASGSP----WESTFQRVAYEDL 700
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR 718
+AT+GFS +LIG GSFGSVYKG DG VA+KVFNL R GASKSF+AEC AL NIR
Sbjct: 701 LQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIR 760
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
HRNLVKV+T+CS IDFQGNDFKALVYEFM NGSLE WLHP + D + L+LLQR
Sbjct: 761 HRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQI--SDEAHRRRDLSLLQR 818
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---L 835
+NIAIDVASA+DYLH+HCQ ++HCDLKP NVLLD D+ AHVGDFGLAR+ + S+ L
Sbjct: 819 LNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCL 878
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
Q+ S+G++GTIGYAAPEYGLGSEVS GD+YSYGILLLE+ TG++PTD +F+ LNLHN
Sbjct: 879 DQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHN 938
Query: 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955
+A+TAL V +++DP+L+ + E+ +R+ + I +EC ++V++GVACS E P
Sbjct: 939 FAKTALPISVAEVLDPVLVTEAEETSGDASRRM--SHIGNHMECLAAIVKVGVACSAEFP 996
Query: 956 QDRMSITNVVHELQSVKNALL 976
++RM I++V EL+ +++ LL
Sbjct: 997 RERMEISSVAVELRRIRHILL 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2502), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/985 (52%), Positives = 670/985 (68%), Gaps = 14/985 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I DP IL+SWN+S HFC+W GITCG RH+RV ++L S LSGSL+ +IGNLSFLR +
Sbjct: 46 ITDDPLHILSSWNESLHFCKWSGITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVL 105
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL NNS+ IP+E GRLFRL L L N GEIP N+SYCS L L LGRN L G +P
Sbjct: 106 NLQNNSLSHYIPQEIGRLFRLRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLP 165
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL KL+ + N LTG I P NL+SLE I N F G IPNS+GQLK L++
Sbjct: 166 AELKSLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTF 225
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
LG +N SG+IPPSI+NLS L SVP NQ HG+LPP LG +LP L + +++ N FSGSI
Sbjct: 226 SLGGSNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSI 285
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P ++SNAS L ++ N+F+GK+ + + NLSY + NNLG+GE D++SF+ +LAN
Sbjct: 286 PPTISNASNLVALDVSQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLAN 344
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
+NL L N L G LP ++N S +L ++ N++ G IPS I NL+ L LG
Sbjct: 345 NTNLEILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFER 404
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N+ TG+IP +GKL+NL + L DN +SG IPSSLGN++ LS + L N+L G IPS LG
Sbjct: 405 NELTGSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLG 464
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ +Q+ ++ L N L+GTIP+E+ ++ LS SL+L+ N GS+P ++G L L +VS
Sbjct: 465 NCQQMLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVS 524
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSGEIP LG C+ LE +Y++GN F G+IP SLSSLR + ++LS NNL+G IP F
Sbjct: 525 KNKLSGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFF 584
Query: 542 EDL-SLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQ 600
+ SLE L+LS+ND EGEVP +GVF N S S++G LCGGIPE+ LP+CT S
Sbjct: 585 AEFKSLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKP 644
Query: 601 KISQRLKAII--STLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESL 658
K S +L+ II + V +++ L FC K R+ S I QKVSY++L
Sbjct: 645 KTSHKLRLIIVVACCGVVGVLLLTSALLFCCLKMRKNKEASGSSLDIF---FQKVSYQNL 701
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR 718
KATDGFSS +LIG GSFGSVYKG D TI+A+KV NLQ GAS+SF+ EC+AL N+R
Sbjct: 702 LKATDGFSSANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVR 761
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
HRNLVKV+T+CSS DF+ NDFKALVYE+M NGSLE WLHP P +D I L+L++R
Sbjct: 762 HRNLVKVLTACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRI--LSLIER 819
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-VRQEVSNLTQ 837
++I+IDVASA+DYLH+ CQ PV+HCDLKP N+LLD+DM AHVGDFGLAR + + +
Sbjct: 820 LSISIDVASALDYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSP 879
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897
S S+G+RGT+GYAAPEYG+GS+VST GD+Y+YGILLLE+ TGKKPTD MF+ LNLH A
Sbjct: 880 SSSIGIRGTVGYAAPEYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILA 939
Query: 898 RTALLDHVIDIVDP-ILINDVEDWDA---TNKQRLRQAKINGKIECPISMVRIGVACSVE 953
+ A+ D + DP +LI + E A + R+ + + C S+++IGV CS E
Sbjct: 940 KMAMPDRLALAADPFLLITEDEGTSASATSASHRITCIARDKVLGCLNSILKIGVDCSAE 999
Query: 954 SPQDRMSITNVVHELQSVKNALLEA 978
SP+DRM I++V +EL ++N LLE
Sbjct: 1000 SPRDRMDISDVANELVRIRNILLET 1024
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/986 (52%), Positives = 695/986 (70%), Gaps = 16/986 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I DP G+++SWNDS HFC W GI CG H+RV LNL GL GSLSP IGN+SFLR I
Sbjct: 49 IKLDPLGLMSSWNDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSLSPQIGNMSFLRGI 108
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L N GEIP+E GRL RL+ + S+N GEIPANLS CS L +L LG NKL G IP
Sbjct: 109 SLEQNYFHGEIPQEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLMLRLGFNKLTGQIP 168
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
++ SL KL+++ + NNL G +P +GN++S+ S+SL+ N F G+IP++LG+LK L L
Sbjct: 169 YQLGSLQKLERVQLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRLKTLNFL 228
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
GLG NNLSG+IPP+I+NLS L F++P NQ HG+LP LGLTLP+L++ + HNFFSG +
Sbjct: 229 GLGLNNLSGMIPPTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPL 288
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P+S+SNAS L ++ +D S K++++FGG+ NL ++ N LG GE+D++SF++SL
Sbjct: 289 PVSISNASNLLELD-IDTSNFTKVTIDFGGLPNLWSLALSSNPLGKGEADDLSFIDSLTK 347
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C NLR L + + G +P SI NLS QL L + NQL GSIP+ I NL+ L L +
Sbjct: 348 CRNLRLLDLSNSHFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLAELTVEK 407
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N +G+IP +G L+ L+ + L +N+LSG IPSSLGN++ L E L N + G IPS G
Sbjct: 408 NYLSGSIPSVLGNLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGSIPSSFG 467
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+LK L L L +N L+GTIP+E+ L+ L+ SLNLA+N L G +P + NL L +VS
Sbjct: 468 NLKYLQNLDLSQNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVS 527
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N L G+IPS LG C LE+++M+GNFF G+IP S SSLR + +DLSRNNLSG IP+FL
Sbjct: 528 ENKLYGQIPSSLGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFL 587
Query: 542 EDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK 601
+ L+L LNLSFN EGEVP +G F N + IS++G RLCGGIP+L+LP+C S+N K
Sbjct: 588 KRLALISLNLSFNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGK 647
Query: 602 ISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPIL---RKALQKVSYESL 658
S+R+K +I+ L+ +L V+VF + R R ++Q L ++ L KVSY +L
Sbjct: 648 TSRRVKLMIAILTPLL--VLVFVMSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNL 705
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR 718
KAT GFSS +LIG GSFGSVY+G D + T+VA+KV +++ KSF+AEC+ LKNIR
Sbjct: 706 HKATAGFSSANLIGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIR 765
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-VEIEIQKLTLLQ 777
HRNLVK++T+CSS+DFQGNDFKALVYEFM NG+LE+WLH + P+ + + +++ L+ Q
Sbjct: 766 HRNLVKILTACSSVDFQGNDFKALVYEFMPNGTLESWLH--SFPRTNGINEDLKILSFHQ 823
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV---SN 834
R+NIAIDVA+A++YLH+ C +PV+HCDLKP NVLLDNDM AHVGDFGLAR +E S+
Sbjct: 824 RLNIAIDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFIEEAINPSH 883
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
+S SVG++GT+GYAAPEYG+GS+ S NGD+YSYGILLLEM TGK+PTD MF L+LH
Sbjct: 884 RNESSSVGLKGTVGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRPTDDMFHDGLDLH 943
Query: 895 NYARTALLDHVIDIVDPILINDVEDWDATN---KQRLR-QAKINGKIECPISMVRIGVAC 950
N+ +TAL D + ++VDP+ + E + + R R Q K + E I+++RIG+AC
Sbjct: 944 NFVKTALPDQISEVVDPLFVTGGEGDEEETGHLENRTRGQIKKDQMQESLIAILRIGIAC 1003
Query: 951 SVESPQDRMSITNVVHELQSVKNALL 976
SVES +R ++ +V+ ELQ+V+ L
Sbjct: 1004 SVESINERKNVKDVLTELQNVRRFFL 1029
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 953 bits (2463), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/979 (51%), Positives = 663/979 (67%), Gaps = 12/979 (1%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
I DP G L+SWN+S FC+W G+TCG RH+RV L+L S L GSLSP+IGNLSFLR +
Sbjct: 46 ITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHSYQLVGSLSPHIGNLSFLRIL 105
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
NL NNS+ IP+E GRLFRLE L L +N G IPAN+S C+ L IL R L G +P
Sbjct: 106 NLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANISRCANLRILDFSRGNLTGKLP 165
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E L KL+ L ++ NN G IP GNL+++ +I + N G+IPN GQLK LK L
Sbjct: 166 AELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKIL 225
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
LGANNLSG+IPPSI+NLS L S P NQ +GSLP +LGLTLP+L++F +H N F G I
Sbjct: 226 SLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLI 285
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLA- 300
P + SNAS L + N+F+GK+ +L V NNLG GE+++++F+ LA
Sbjct: 286 PATFSNASNLLSFQIGSNNFNGKVPP-LSSSHDLQVLGVGDNNLGKGENNDLNFVYPLAN 344
Query: 301 NCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360
N ++L L + N G LP ++N S +L + NQ+ GSIP+ IGNL+ L LG+
Sbjct: 345 NMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLE 404
Query: 361 GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
NQ TG IP MGKLQ L + L N++SG IPSS+GN++ L + + N+L G IP L
Sbjct: 405 TNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSL 464
Query: 421 GSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNV 480
G+ ++L L L +N L+G IP+E+ ++ LS L L+ N L GS+P ++ L L +V
Sbjct: 465 GNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDV 524
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540
S N SGEIP LG C LE +++ NF G IP +LSSLRA+ ++LS NNL+G IP+F
Sbjct: 525 SKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEF 584
Query: 541 LEDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRN 599
LED LE LNLSFND EGEVP +G F N S IS+ G +LCGGIP+L L +C N
Sbjct: 585 LEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTN 644
Query: 600 QKISQRLKAIISTLSAVLGIVMV--FFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYES 657
K +L II ++ LG++++ F L +C+ K++ P+ QPS L + +V+YE
Sbjct: 645 SKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDKPAASQPS---LETSFPRVAYED 701
Query: 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI 717
L ATDGFSS +LIG GSFGSV+KG D +VA+KV NL R GASKSF+AEC+ALK+I
Sbjct: 702 LLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASKSFMAECEALKSI 761
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
RHRNLVK++T+CSSIDFQGNDFKALVYEFM NG+LE WLHP V D + L L+
Sbjct: 762 RHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHP--VQTSDEANGPKALDLMH 819
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
R+NIAI +ASA++YLHH CQ P++HCDLKP N+LLD +M AHVGDFGLAR E SN Q
Sbjct: 820 RLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLARFHSEASN--Q 877
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897
+ SVG++GTIGYAAPEYG+G +VST GD+YSYGILLLEM TGK+P D MF+ LNLH+YA
Sbjct: 878 TSSVGLKGTIGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYA 937
Query: 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957
+ AL D ++++VDP+L+ ++ +++++ + + C ++++++GVACSVE P++
Sbjct: 938 KMALPDRIVEVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRE 997
Query: 958 RMSITNVVHELQSVKNALL 976
RM I +VV EL +K+ LL
Sbjct: 998 RMDIGDVVTELNRIKDTLL 1016
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/976 (52%), Positives = 651/976 (66%), Gaps = 21/976 (2%)
Query: 5 DPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLM 64
DP L+SWN S HFC+W G+ CG RH+R+ LNL+S L+G+LSP+IGNLSFLR +NL
Sbjct: 47 DPLDALSSWNASTHFCKWSGVICGHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLE 106
Query: 65 NNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEF 124
N +IP+E GRLFRL+ L L +N GEIP N+S CS L +L LG N L G IP +
Sbjct: 107 GNYFSRDIPQELGRLFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQL 166
Query: 125 FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLG 184
SL KL +Q NNL G IP GNL+S+++ N G IP SLG LK LK +
Sbjct: 167 GSLSKLGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVA 226
Query: 185 ANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPIS 244
N+LSG IP SI N+S LA S+ +NQ HGSLPP LGL LP+L ++ N +G IP +
Sbjct: 227 ENDLSGTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPAT 286
Query: 245 LSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSN 304
LSNASK+ ++ N+ +GK+ + + +L V +N+LG+GE D++SF+ +LAN +N
Sbjct: 287 LSNASKIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTN 345
Query: 305 LRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQF 364
L +L N G LP ++N S L+ + NQ+HGSIP+ IGNL+ L L + NQ
Sbjct: 346 LESLGINDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQL 405
Query: 365 TGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLK 424
G IP +GKLQNL + L +N++SG IPSSLGN++ L E+ N+L G IP+ LG+
Sbjct: 406 HGIIPSSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWH 465
Query: 425 QLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNN 484
+L IL L +N L+G IP+E+ ++ LS L L N L GS+P+++G L L VS N
Sbjct: 466 KLLILDLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNR 525
Query: 485 LSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL 544
LSGEIP L C LE + + GNFF G +P LSSLRA+ + LS NNLSG IP+FL+D
Sbjct: 526 LSGEIPKSLDSCKSLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDF 584
Query: 545 S-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKIS 603
LE L+LS+ND EGEVP +GVF N SRISV G +LCGGIP+L LPKCT K
Sbjct: 585 KLLETLDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSH 644
Query: 604 QRLKAIISTLSAVLGIV-MVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFKAT 662
+L II+ LGIV M FL F K + P+ S P + Q+++Y+ L +AT
Sbjct: 645 TKLILIIAIPCGFLGIVLMTSFLLFYSRKTKDEPA----SGPSWESSFQRLTYQDLLQAT 700
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
DGFSS++L+G G+FGSVY+G DG +VA+KV NL R GASKSF+AEC AL NIRHRNL
Sbjct: 701 DGFSSSNLVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNL 760
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
VKVIT+CSS DFQGNDFKALVYEFM NGSLE WLHP V DV E + L L+QR+NIA
Sbjct: 761 VKVITACSSNDFQGNDFKALVYEFMVNGSLEEWLHP--VHISDVTPETRNLDLVQRLNIA 818
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSC 839
IDVASA+DYLH+HCQ PV+HCDLKP NVLL +DM A VGDFGLAR E SN +S
Sbjct: 819 IDVASALDYLHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEASNQLPADESS 878
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899
SVG++GTIGYAAPEYG+GSEVST GD+YSYGILLLEM TG++PTD MF+ NLHNYA+
Sbjct: 879 SVGLKGTIGYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKM 938
Query: 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959
L D+V++ VDP L E + ++ +EC +S++++G+ACS E P +RM
Sbjct: 939 VLPDNVLEFVDPTLREHEEMNHNDDSHKV--------MECMVSIIKVGLACSAELPGERM 990
Query: 960 SITNVVHELQSVKNAL 975
I NVV EL ++ L
Sbjct: 991 GIANVVVELHRIREML 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 988 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.960 | 0.925 | 0.472 | 6.4e-218 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.975 | 0.954 | 0.443 | 8.7e-214 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.964 | 0.944 | 0.437 | 9.2e-210 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.963 | 0.941 | 0.430 | 5.2e-207 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.959 | 0.924 | 0.443 | 7.7e-206 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.949 | 0.909 | 0.426 | 1.8e-199 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.721 | 0.876 | 0.422 | 2.3e-142 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.899 | 0.757 | 0.334 | 1.2e-122 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.857 | 0.753 | 0.316 | 3.2e-119 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.867 | 0.874 | 0.348 | 1.1e-117 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 2105 (746.1 bits), Expect = 6.4e-218, P = 6.4e-218
Identities = 462/978 (47%), Positives = 604/978 (61%)
Query: 10 LNSWNDSGH--FCEWKGITCGLRHRR----VTVLNLRSKGLSGSLSPYIGNLSFLREINL 63
L SWN SGH C W G+ CG R RR V L LRS LSG +SP +GNLSFLRE++L
Sbjct: 51 LASWNTSGHGQHCTWVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDL 110
Query: 64 MNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFE 123
+N + GEIP E RL RL+ L LSDN + G IPA + C++LT L L N+L G IP E
Sbjct: 111 GDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPRE 170
Query: 124 F-FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLG 182
SL L L + +N L+G IP +GNLTSL+ L+ N G IP+SLGQL L ++
Sbjct: 171 IGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMN 230
Query: 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSIP 242
LG NNLSG+IP SI+NLS L FSV N+ + + N F G IP
Sbjct: 231 LGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIP 290
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
S++NAS L I+ N FSG ++ FG ++NL+ + N + E D+ F++ L NC
Sbjct: 291 ASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNC 350
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
S L+TL N L G LP+S +NLS L L + N++ GSIP IGNL+GL L + N
Sbjct: 351 SKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNN 410
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLGS 422
F G++P +G+L+NL + Y+N LSG IP G IP L +
Sbjct: 411 NFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSN 470
Query: 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
L L L L N L+G IP E+FN+ LS +N+++N+L GSIP +IG+LK L F+ S
Sbjct: 471 LTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAES 530
Query: 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLE 542
N LSG+IP+ LG C L +Y++ N GSIPS+L L+ + +DLS NNLSG IP L
Sbjct: 531 NRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLA 590
Query: 543 DLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQK 601
D++ L LNLSFN GEVPT G FA S IS+ G +LCGGIP+L LP+C N+K
Sbjct: 591 DITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPL-LENRK 649
Query: 602 ISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESLFKA 661
L +S L+A L I+ +L W KR + K PSR + K VSY L KA
Sbjct: 650 HFPVLPISVS-LAAALAILSSLYLLITWHKRTK---KGAPSRTSM-KGHPLVSYSQLVKA 704
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFD-QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720
TDGF+ T+L+G GSFGSVYKG + QD VA+KV L+ A KSF AEC+AL+N+RHR
Sbjct: 705 TDGFAPTNLLGSGSFGSVYKGKLNIQDH--VAVKVLKLENPKALKSFTAECEALRNMRHR 762
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
NLVK++T CSSID +GNDFKA+VY+FM NGSLE+W+HP+ Q D + L L +R+
Sbjct: 763 NLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQ----RHLNLHRRVT 818
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ--S 838
I +DVA A+DYLH H EPV+HCD+K NVLLD+DM+AHVGDFGLAR+ + ++L Q +
Sbjct: 819 ILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQST 878
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
S+G GTIGYAAPEYG+G ST+GDIYSYGIL+LE+VTGK+PTD F DL L Y
Sbjct: 879 SSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVE 938
Query: 899 TALLDHVIDIVDPILINDVEDW-DATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957
L V D+VD LI D E+W ++TN R+ EC + ++R+G++CS E P
Sbjct: 939 LGLHGRVTDVVDTKLILDSENWLNSTNNSPCRRIT-----ECIVWLLRLGLSCSQELPSS 993
Query: 958 RMSITNVVHELQSVKNAL 975
R +++ EL ++K L
Sbjct: 994 RTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2066 (732.3 bits), Expect = 8.7e-214, P = 8.7e-214
Identities = 439/990 (44%), Positives = 611/990 (61%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
++ D + +L+SWN S C WKG+TCG +++RVT L L L G +SP IGNLSFL +
Sbjct: 36 VSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSL 95
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L N G IP+E G+L RLE L + N L G IP L CSRL L L N+L GS+P
Sbjct: 96 DLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVP 155
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL L QL + NN+ G +P +GNLT LE ++L+ N G IP+ + QL ++ SL
Sbjct: 156 SELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSL 215
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSI 241
L ANN SG+ PP++YNLS L + N F F + N+F+GSI
Sbjct: 216 QLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSI 275
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P +LSN S LE + +N+ +G + FG + NL + N+LGS S ++ F+ SL N
Sbjct: 276 PTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTN 334
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C+ L TL N+L G LP SIANLS +L L + + GSIP IGNL+ L +L +
Sbjct: 335 CTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQ 394
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLG 421
N +G +P +GKL NL + L+ N+LSG IP G++P+ LG
Sbjct: 395 NMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLG 454
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ L L + +N LNGTIP EI + L L+++ N L+GS+P IG L+ L ++
Sbjct: 455 NCSHLLELWIGDNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGALQNLGTLSLG 513
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
N LSG++P LG C +E +++ GN F+G IP L L V +DLS N+LSG IP++
Sbjct: 514 DNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYF 572
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC-TEKNSRN 599
S LEYLNLSFN+LEG+VP KG+F N + +S+ G N LCGGI QL C ++ S
Sbjct: 573 ASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVV 632
Query: 600 QKISQRLKAIISTLSAVLGIVMVFFLC---FCWF-KRRRGPSKQQPSRPILRKALQKVSY 655
+K S RLK ++ +S + ++++ F+ W KR++ P+ L +K+SY
Sbjct: 633 KKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISY 692
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALK 715
L AT+GFSS++++G GSFG+VYK + +VA+KV N+QR GA KSF+AEC++LK
Sbjct: 693 GDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLK 752
Query: 716 NIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
+IRHRNLVK++T+CSSIDFQGN+F+AL+YEFM NGSL+ WLHP+ V +++ + LTL
Sbjct: 753 DIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV--EEIHRPSRTLTL 810
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR---QEV 832
L+R+NIAIDVAS +DYLH HC EP+ HCDLKP NVLLD+D+ AHV DFGLAR+ E
Sbjct: 811 LERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE 870
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
S Q S GVRGTIGYAAPEYG+G + S NGD+YS+GILLLEM TGK+PT+ +F G+
Sbjct: 871 SFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFT 930
Query: 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952
L++Y ++AL + ++DIVD +++ LR +EC + +G+ C
Sbjct: 931 LNSYTKSALPERILDIVDESILHI----------GLRVGF--PVVECLTMVFEVGLRCCE 978
Query: 953 ESPQDRMSITNVVHELQSVKNALLEAWNCT 982
ESP +R++ + VV EL S++ +A T
Sbjct: 979 ESPMNRLATSIVVKELISIRERFFKASRTT 1008
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2028 (719.0 bits), Expect = 9.2e-210, P = 9.2e-210
Identities = 429/980 (43%), Positives = 601/980 (61%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
++ + L++WN+S C WK + CG +H+RVT L+L L G +SP IGNLSFL +
Sbjct: 36 VSESKRDALSAWNNSFPLCSWKWVRCGRKHKRVTRLDLGGLQLGGVISPSIGNLSFLIYL 95
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L NNS G IP+E G LFRL+ L + N L GEIPA+LS CSRL L L N L +P
Sbjct: 96 DLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVP 155
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL KL L + N+L G P FI NLTSL ++L N G IP+ + L ++ SL
Sbjct: 156 SELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSL 215
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSI 241
L NN SG+ PP+ YNLS L N + N F +H NF +G+I
Sbjct: 216 TLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAI 275
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P +L+N S LE N +G +S NFG ++NL Y +A N+LGS +++F+++L N
Sbjct: 276 PTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTN 335
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
CS+L L + N+L GALP SI N+S +L L + N ++GSIP IGNL+GL L +
Sbjct: 336 CSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLAD 395
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLG 421
N TG +P +G L L + L+ N+ SGEIP G++P LG
Sbjct: 396 NLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLG 455
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ L + N LNGTIP+EI + L + LN+ N L GS+P IG L+ L +
Sbjct: 456 DCSHMLDLQIGYNKLNGTIPKEIMQIPTLVH-LNMESNSLSGSLPNDIGRLQNLVELLLG 514
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
+NNLSG +P LG C +E IY++ N F G+IP + L V +DLS NNLSG I ++
Sbjct: 515 NNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYF 573
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEK----N 596
E+ S LEYLNLS N+ EG VPT+G+F N + +SV G LCG I EL+L C +
Sbjct: 574 ENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVE 633
Query: 597 SRNQKISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKAL-QKVSY 655
+R+ + +++ +S A+L +++F + WFK+R+ K S P + +K+SY
Sbjct: 634 TRHPSLLKKVAIGVSVGIALL--LLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSY 691
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALK 715
L ATDGFSS++++G GSFG+V+K + IVA+KV N+QR GA KSF+AEC++LK
Sbjct: 692 GDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLK 751
Query: 716 NIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
+IRHRNLVK++T+C+SIDFQGN+F+AL+YEFM NGSL+ WLHP+ V +++ + LTL
Sbjct: 752 DIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEV--EEIHRPSRTLTL 809
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR---QEV 832
L+R+NIAIDVAS +DYLH HC EP+ HCDLKP N+LLD+D+ AHV DFGLAR+ +
Sbjct: 810 LERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQE 869
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
S Q S GVRGTIGYAAPEYG+G + S +GD+YS+G+L+LEM TGK+PT+ +F G+
Sbjct: 870 SFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFT 929
Query: 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952
L++Y + AL + V+DI D +++ LR +EC ++ +G+ C
Sbjct: 930 LNSYTKAALPERVLDIADKSILHS----------GLRVGF--PVLECLKGILDVGLRCCE 977
Query: 953 ESPQDRMSITNVVHELQSVK 972
ESP +R++ + EL S++
Sbjct: 978 ESPLNRLATSEAAKELISIR 997
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2002 (709.8 bits), Expect = 5.2e-207, P = 5.2e-207
Identities = 423/983 (43%), Positives = 607/983 (61%)
Query: 2 IAHDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREI 61
++ + +L+SWN+S C WK +TCG +H+RVT LNL L G +SP IGN+SFL +
Sbjct: 36 VSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGIVSPSIGNVSFLISL 95
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+L +N+ G IPRE G LFRLE L+++ N L G IPA LS CSRL L L N L +P
Sbjct: 96 DLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVP 155
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
E SL KL L + RNNL G +P +GNLTSL+S+ N G +P+ L +L ++ L
Sbjct: 156 SELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGL 215
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSI 241
GL N G+ PP+IYNLS L + + + F R + N G+I
Sbjct: 216 GLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAI 275
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
P +LSN S L+ N +G + NFG + +L Y +++ N LGS ++ F++SL N
Sbjct: 276 PTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTN 335
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361
C++L+ L +L GALP SIAN+S +L +L + N GSIP IGNL+GL RL +G
Sbjct: 336 CTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGK 395
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLG 421
N TG +P +GKL L + LY N++SGEIP G++P LG
Sbjct: 396 NMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLG 455
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+ L + N LNGTIP+EI + L N L++ N L GS+P IG+L+ L ++
Sbjct: 456 KCSHMLDLRIGYNKLNGTIPKEIMQIPTLVN-LSMEGNSLSGSLPNDIGSLQNLVKLSLE 514
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
+N SG +P LG C +E+++++GN F G+IP+ + L V +DLS N+LSG IP++
Sbjct: 515 NNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN-IRGLMGVRRVDLSNNDLSGSIPEYF 573
Query: 542 EDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC-TEKNSRN 599
+ S LEYLNLS N+ G+VP+KG F N + + V G LCGGI +L+L C ++
Sbjct: 574 ANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVE 633
Query: 600 QKISQRLK--AIISTLS-AVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQ----K 652
K S LK AI+ ++ A+L ++++ + CWF++RR K Q + ++ L+ K
Sbjct: 634 TKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRR---KNQQTNNLVPSKLEIFHEK 690
Query: 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK 712
+SY L AT+GFSS++++G GSFG+V+K + IVA+KV N+QR GA KSF+AEC+
Sbjct: 691 ISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECE 750
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+LK+ RHRNLVK++T+C+S DFQGN+F+AL+YE++ NGS++ WLHP+ V +++ +
Sbjct: 751 SLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEV--EEIRRPPRT 808
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR--- 829
LTLL+R+NI IDVAS +DYLH HC EP+ HCDLKP NVLL++D+ AHV DFGLAR+
Sbjct: 809 LTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKF 868
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
+ S L Q S GVRGTIGYAAPEYG+G + S +GD+YS+G+LLLEM TGK+PTD +F G
Sbjct: 869 DKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGG 928
Query: 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVA 949
+L LH+Y + AL + V +I D +++ + R A EC ++ +G+
Sbjct: 929 NLTLHSYTKLALPEKVFEIADKAILH------IGLRVGFRTA------ECLTLVLEVGLR 976
Query: 950 CSVESPQDRMSITNVVHELQSVK 972
C E P +R++ + V EL S++
Sbjct: 977 CCEEYPTNRLATSEVAKELISIR 999
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1991 (705.9 bits), Expect = 7.7e-206, P = 7.7e-206
Identities = 434/979 (44%), Positives = 590/979 (60%)
Query: 9 ILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSI 68
+L SWNDS C W G+ CGL+HRRVT ++L L+G +SP++GNLSFLR +NL +N
Sbjct: 58 VLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFF 117
Query: 69 QGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLY 128
G IP E G LFRL+ L +S+N G IP LS CS L+ L L N L +P EF SL
Sbjct: 118 HGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLS 177
Query: 129 KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNL 188
KL L++ RNNLTG P +GNLTSL+ + N G IP + +LK++ + N
Sbjct: 178 KLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKF 237
Query: 189 SGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSIPISLSNA 248
+G+ PP IYNLS L S+ N F ++ + N F+G+IP +LSN
Sbjct: 238 NGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNI 297
Query: 249 SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTL 308
S L ++ N +GK+ ++FG ++NL + N+LG+ S ++ F+ +L NCS L+ L
Sbjct: 298 SSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYL 357
Query: 309 IFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTI 368
NKL G LP IANLS QL L + N + GSIP GIGNLV L L +G N TG +
Sbjct: 358 NVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKL 417
Query: 369 PKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLGSLKQLAI 428
P +G+L L + LY N LSGEIP G IPS LGS L
Sbjct: 418 PPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLD 477
Query: 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L+L N LNG+IP E+ L L LN++ N LVG + IG LK+L +VS N LSG+
Sbjct: 478 LNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQ 536
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LE 547
IP L C LE + ++GN F G IP + L + +DLS+NNLSG IP+++ + S L+
Sbjct: 537 IPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQ 595
Query: 548 YLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLK 607
LNLS N+ +G VPT+GVF N S +SV G LCGGIP LQL C+ + R S R K
Sbjct: 596 NLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHS-SVR-K 653
Query: 608 AIISTLSAVLGIVMVFFLC---FCWFKRR----RGPSKQQP-SRPILRKALQKVSYESLF 659
I +SAV+ +++ LC CW+K R R + + S ++ +K+SY+ L+
Sbjct: 654 IITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELY 713
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH 719
K T GFSS++LIG G+FG+V+KG VAIKV NL + GA+KSF+AEC+AL IRH
Sbjct: 714 KTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRH 773
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
RNLVK++T CSS DF+GNDF+ALVYEFM NG+L+ WLHPD + ++ + L L R+
Sbjct: 774 RNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI--EETGNPSRTLGLFARL 831
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT--- 836
NIAIDVASA+ YLH +C P+ HCD+KP N+LLD D+ AHV DFGLA++ + T
Sbjct: 832 NIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHI 891
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
Q S GVRGTIGYAAPEYG+G S GD+YS+GI+LLE+ TGK+PT+ +F L LH++
Sbjct: 892 QFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSF 951
Query: 897 ARTALLDH-VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955
++AL +DI D ++ R A+ +EC + R+GV+CS ESP
Sbjct: 952 TKSALQKRQALDITDETIL------------RGAYAQHFNMVECLTLVFRVGVSCSEESP 999
Query: 956 QDRMSITNVVHELQSVKNA 974
+R+S+ + +L S++ +
Sbjct: 1000 VNRISMAEAISKLVSIRES 1018
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1931 (684.8 bits), Expect = 1.8e-199, P = 1.8e-199
Identities = 416/976 (42%), Positives = 580/976 (59%)
Query: 9 ILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSI 68
+L SWN S FC W G+TCG R RV LNL L+G +SP IGNLSFLR +NL +NS
Sbjct: 50 VLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF 109
Query: 69 QGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLY 128
IP++ GRLFRL+ L +S N L G IP++LS CSRL+ + L N L +P E SL
Sbjct: 110 GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169
Query: 129 KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNL 188
KL L + +NNLTG P +GNLTSL+ + A N G IP+ + +L ++ + N+
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229
Query: 189 SGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSIPISLSNA 248
SG PP++YN+S L + S+ N F R + N F+G+IP +L+N
Sbjct: 230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289
Query: 249 SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTL 308
S LE + N SG + ++FG ++NL + + N+LG+ S + F+ ++ANC+ L L
Sbjct: 290 SSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYL 349
Query: 309 IFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTI 368
N+L G LP SIANLS L +L + N + G+IP IGNLV L L + N +G +
Sbjct: 350 DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409
Query: 369 PKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLGSLKQLAI 428
P GKL NL+ + LY N +SGEIP G IP LG + L
Sbjct: 410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469
Query: 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L + N LNGTIP+EI + L+ ++L+ N L G P ++G L+ L S N LSG+
Sbjct: 470 LWMDTNRLNGTIPQEILQIPSLAY-IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLE 547
+P +G C +E ++M+GN F G+IP +S L ++ +D S NNLSG IP++L L SL
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587
Query: 548 YLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC-TEKNSRNQK-ISQR 605
LNLS N EG VPT GVF N + +SV G +CGG+ E+QL C + + R +K +S R
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647
Query: 606 LKAIISTLSAVLGIVMVFFLC-FCWFKRRRGPSKQQPSRPILRKAL----QKVSYESLFK 660
K + + ++++ + CWF +R+ + P L +KVSYE L
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHS 707
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720
AT FSST+LIG G+FG+V+KG + +VA+KV NL +HGA+KSF+AEC+ K IRHR
Sbjct: 708 ATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHR 767
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
NLVK+IT CSS+D +GNDF+ALVYEFM GSL+ WL + + + V + LT +++N
Sbjct: 768 NLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLER--VNDHSRSLTPAEKLN 825
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV---SNLTQ 837
IAIDVASA++YLH HC +PV HCD+KP N+LLD+D+ AHV DFGLA++ + S L Q
Sbjct: 826 IAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQ 885
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897
S GVRGTIGYAAPEYG+G + S GD+YS+GILLLEM +GKKPTD F GD NLH+Y
Sbjct: 886 FSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYT 945
Query: 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957
++ +++ +N I+ + ++++G+ CS E P+D
Sbjct: 946 KS-------------ILSGCTSSGGSNA-------IDEGLRL---VLQVGIKCSEEYPRD 982
Query: 958 RMSITNVVHELQSVKN 973
RM V EL S+++
Sbjct: 983 RMRTDEAVRELISIRS 998
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1392 (495.1 bits), Expect = 2.3e-142, P = 2.3e-142
Identities = 307/726 (42%), Positives = 423/726 (58%)
Query: 60 EINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGS 119
++ L ++++ G I G L L L LSDN L G+IP LS SRL L L N L G
Sbjct: 82 KLRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGE 141
Query: 120 IPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELK 179
IP +L L L + N L+G IP +G LT L ++LA N G+IP+S GQL+ L
Sbjct: 142 IPAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLS 201
Query: 180 SLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSG 239
L L NNLSG IP I+N+S L F V N+ + +++N F G
Sbjct: 202 FLSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHG 261
Query: 240 SIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299
IP S+ NAS + NSFSG + G M+NL + + E+++ FM +L
Sbjct: 262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321
Query: 300 ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGM 359
NCSNL+ + K G LP S++NLS L +L + N++ GS+P IGNLV L L +
Sbjct: 322 TNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL 381
Query: 360 GGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSC 419
N TG++P KL+NL + + +N+L G +P G IPS
Sbjct: 382 ANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPST 441
Query: 420 LGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFN 479
LG+L +L ++L N G IP EIF++ LS L+++ N+L GSIP +IG LK + F+
Sbjct: 442 LGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFH 501
Query: 480 VSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK 539
SN LSGE PS +G C L+ ++++ NF +GSIP +L+ L+ + +DLS NNLSG IP
Sbjct: 502 ADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPM 561
Query: 540 FLEDLSLEY-LNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSR 598
L D+ L + LNLSFN GEVPT GVFAN S I + G +CGGIPEL LP C+ K+ +
Sbjct: 562 SLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRK 621
Query: 599 NQKISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESL 658
+K L ++ L + L + + ++ KRR+ K+ P+ ++ ++Y+ L
Sbjct: 622 KKKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRK---KEVPATTSMQ-GHPMITYKQL 677
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFD-QDGTI---VAIKVFNLQRHGASKSFLAECKAL 714
KATDGFSS+HL+G GSFGSVYKG FD QDG I VA++V L+ A KSF AEC+ L
Sbjct: 678 VKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETL 737
Query: 715 KNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
+N RHRNLVK++T CSSID +GNDFKA+VY+FM NGSLE+WLHP+ Q E + LT
Sbjct: 738 RNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQA----EQRHLT 793
Query: 775 LLQRIN 780
L QR++
Sbjct: 794 LHQRVS 799
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1206 (429.6 bits), Expect = 1.2e-122, P = 1.2e-122
Identities = 316/946 (33%), Positives = 490/946 (51%)
Query: 44 LSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYC 103
L G + IGN S L ++ L +N + G+IP E G L +L+AL + N L IP++L
Sbjct: 252 LEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRL 311
Query: 104 SRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA 163
++LT L L N L+G I E L L+ L + NN TG P I NL +L +++ N
Sbjct: 312 TQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNN 371
Query: 164 FGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXXXXX 223
G +P LG L L++L N L+G IP SI N + L + NQ
Sbjct: 372 ISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM 431
Query: 224 XXXXRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYN 283
+ N F+G IP + N S LE + DN+ +G L G ++ L V+YN
Sbjct: 432 NLT--FISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYN 489
Query: 284 NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS 343
+L +G + N +L L +N G +P ++NL+ LQ L M SN L G
Sbjct: 490 SL-TGP-----IPREIGNLKDLNILYLHSNGFTGRIPREMSNLT-LLQGLRMYSNDLEGP 542
Query: 344 IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXX 403
IP + ++ L L + N+F+G IP KL++L + L N+ +G IP
Sbjct: 543 IPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLN 602
Query: 404 XXXXXXXXXXGVIPS-CLGSLKQLAILHLFENGL-NGTIPEEIFNLTYLSNSLNLARNHL 461
G IP L SLK + + F N L GTIP+E+ L + ++L+ N
Sbjct: 603 TFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE-IDLSNNLF 661
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL--GLCSYLEEIYMRGNFFHGSIPSSLSS 519
GSIP + K + + S NNLSG IP ++ G+ + + + N F G IP S +
Sbjct: 662 SGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGM-DMIISLNLSRNSFSGEIPQSFGN 720
Query: 520 LRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFN 578
+ ++++DLS NNL+G IP+ L +LS L++L L+ N+L+G VP GVF NI+ + G
Sbjct: 721 MTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNT 780
Query: 579 RLCGGIPELQLPKCTEKNSRNQKISQRLKAII----STLSAVLGIVMVFFLCFCWFKRRR 634
LCG L+ P CT K ++ S+R + I+ S + +L +++V L C K ++
Sbjct: 781 DLCGSKKPLK-P-CTIKQ-KSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKK 837
Query: 635 GPSKQQPSRPILRKALQKVSYE--SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVA 692
+ + S P L AL+ +E L +ATD F+S ++IG S +VYKG + DGT++A
Sbjct: 838 IENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE-DGTVIA 896
Query: 693 IKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG 750
+KV NL+ A K F E K L ++HRNLVK++ ++ KALV FM NG
Sbjct: 897 VKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENG 952
Query: 751 SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
+LE+ +H A P +LL++I++ + +AS IDYLH P++HCDLKP N+
Sbjct: 953 NLEDTIHGSAAPIG---------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANI 1003
Query: 811 LLDNDMIAHVGDFGLARVR--QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYS 868
LLD+D +AHV DFG AR+ +E + T S S GTIGY APE+ +V+T D++S
Sbjct: 1004 LLDSDRVAHVSDFGTARILGFREDGSTTASTSA-FEGTIGYLAPEFAYMRKVTTKADVFS 1062
Query: 869 YGILLLEMVTGKKPTDVMFEG--DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQ 926
+GI+++E++T ++PT + E D+ L ++ + +V + D+E D+
Sbjct: 1063 FGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVL---DMELGDSIVSL 1119
Query: 927 RLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972
+ +A IE +++ + C+ P+DR + ++ L ++
Sbjct: 1120 KQEEA-----IE---DFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1029 (367.3 bits), Expect = 3.2e-119, Sum P(2) = 3.2e-119
Identities = 287/907 (31%), Positives = 436/907 (48%)
Query: 41 SKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL 100
+ L+G L +GNL+ L N G IP E G+ L+ L L+ N + GE+P +
Sbjct: 190 TNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEI 249
Query: 101 SYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLA 160
+L + L +NK G IP + +L L+ LA+ N+L G IP IGN+ SL+ + L
Sbjct: 250 GMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLY 309
Query: 161 ANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFXXXXXXXX 220
N G IP LG+L ++ + N LSG IP + +S L + +N+
Sbjct: 310 QNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNEL 369
Query: 221 XXXXXXXRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNV 280
+L + N +G IP N + + ++ NS SG + G L +
Sbjct: 370 SKLRNLAKL-DLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDF 428
Query: 281 AYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQL 340
+ N L SG+ + SNL L +N++ G +P + LQ L + N+L
Sbjct: 429 SENQL-SGKIPPF-----ICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQ-LRVVGNRL 481
Query: 341 HGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPXXXXXXX 400
G P+ + LV L + + N+F+G +P E+G Q L+ + L NQ S +P
Sbjct: 482 TGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLS 541
Query: 401 XXXXXXXXXXXXXGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNH 460
G IPS + + K L L L N G++P E+ +L L L L+ N
Sbjct: 542 NLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLE-ILRLSENR 600
Query: 461 LVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE-EIYMRGNFFHGSIPSSLSS 519
G+IP IGNL +L + N SG IP QLGL S L+ + + N F G IP + +
Sbjct: 601 FSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGN 660
Query: 520 LRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVAGFN 578
L ++ + L+ N+LSG IP E+LS L N S+N+L G++P +F N++ S G
Sbjct: 661 LHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNK 720
Query: 579 RLCGGIPELQLPKCTEKNSRNQKISQRLKA-------IISTLSAVLGIVMVFFLCFCWFK 631
LCGG L C +S IS LKA II +S+V+G + + +
Sbjct: 721 GLCGG----HLRSCDPSHSSWPHISS-LKAGSARRGRIIIIVSSVIGGISLLLIAIVVHF 775
Query: 632 RRRGPSKQQP----SRPILRKA------LQKVSYESLFKATDGFSSTHLIGMGSFGSVYK 681
R P P +++ ++ + + + +AT GF ++++G G+ G+VYK
Sbjct: 776 LRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYK 835
Query: 682 GAFDQDGTIVAIKVFNLQRHG-------ASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734
G +A+K R G SF AE L IRHRN+V++ + C
Sbjct: 836 AVMPS-GKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYH--- 891
Query: 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH 794
QG++ L+YE+M+ GSL LH D R IA+ A + YLHH
Sbjct: 892 QGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPT---------RFAIALGAAEGLAYLHH 942
Query: 795 HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEY 854
C+ ++H D+K N+L+D + AHVGDFGLA+V L++S S V G+ GY APEY
Sbjct: 943 DCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID--MPLSKSVSA-VAGSYGYIAPEY 999
Query: 855 GLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVI--DIVDPI 912
+V+ DIYS+G++LLE++TGK P + +G +L + R + DH + +I+DP
Sbjct: 1000 AYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DLATWTRNHIRDHSLTSEILDPY 1058
Query: 913 LINDVED 919
L VED
Sbjct: 1059 LTK-VED 1064
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 322/924 (34%), Positives = 479/924 (51%)
Query: 85 LFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYK-LKQLAMQRNNLTGG 143
L +S DL GEI +++ + LT+L L RN +G IP E SL++ LKQL++ N L G
Sbjct: 71 LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGN 130
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSL---GQLKELKSLGLGANNLSGIIPPSIY-NL 199
IP +G L L + L +N G+IP L G L+ + L N+L+G IP + + +L
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHL 190
Query: 200 SLLANFSVPRNQFXXXXXXXXXXXXXXXRLFQVHHNFFSGSIPIS-LSNASKLEFIEALD 258
L + N+ + + N SG +P +S +L+F+
Sbjct: 191 KELRFLLLWSNKLTGTVPSSLSNSTNL-KWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249
Query: 259 NSF-SGKLSVN----FGGMKN---LSYFNVAYNNLGSGESDEMSFMNSLANCS-NLRTLI 309
N F S + N F + N L +A N+LG GE +S+ + S NL +
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLG-GE-----ITSSVRHLSVNLVQIH 303
Query: 310 FAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIP 369
N++ G++P I+NL + L L ++SN L G IP + L L R+ + N TG IP
Sbjct: 304 LDQNRIHGSIPPEISNLLN-LTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIP 362
Query: 370 KEMGKLQNLEGMGLYDNQLSGEIPXXXXXXXXXXXXXXXXXXXXGVIPSCLGSLKQLAIL 429
E+G + L + + N LSG IP G +P LG L IL
Sbjct: 363 MELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEIL 422
Query: 430 HLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L N L GTIP E+ NL L LNL+ NHL G IP ++ + + ++SSN LSG+
Sbjct: 423 DLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGK 482
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIP-KFLEDLSLE 547
IP QLG C LE + + N F ++PSSL L + +D+S N L+G IP F + +L+
Sbjct: 483 IPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLK 542
Query: 548 YLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLK 607
+LN SFN L G V KG F+ ++ S G + LCG I +Q C +K+ + L
Sbjct: 543 HLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPSVLLPVLL 600
Query: 608 AIIST-LSAVLGIVMVFFLCF-----CWFKRR-RGPSKQQPSRPILRKALQKVSYESLFK 660
++I+T + V G +V F + K KQ + P ++SY+ L
Sbjct: 601 SLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP----KYPRISYQQLIA 656
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRH 719
AT GF+++ LIG G FG VYKG ++ T VA+KV + + S SF EC+ LK RH
Sbjct: 657 ATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRH 715
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
RNL+++IT+CS G F ALV M NGSLE L+P K+++ L+Q +
Sbjct: 716 RNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPGEYSSKNLD-------LIQLV 763
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ---EVSNLT 836
NI DVA I YLHH+ V+HCDLKP N+LLD++M A V DFG++R+ Q E +
Sbjct: 764 NICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTD 823
Query: 837 QSCSVG-----VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
S S G + G++GY APEYG+G ST+GD+YS+G+LLLE+V+G++PTDV+
Sbjct: 824 DSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGS 883
Query: 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACS 951
+LH + ++ H D ++ I+ + W K + K+ ++ + M+ +G+ C+
Sbjct: 884 SLHEFMKS----HYPDSLEGIIEQALSRWKPQGKPE-KCEKLWREVI--LEMIELGLVCT 936
Query: 952 VESPQDRMSITNVVHELQSVKNAL 975
+P R + +V HE+ +K L
Sbjct: 937 QYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4585 | 0.9757 | 0.9544 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 988 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-121 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 393 bits (1010), Expect = e-121
Identities = 310/982 (31%), Positives = 471/982 (47%), Gaps = 86/982 (8%)
Query: 4 HDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINL 63
+DP L++WN S C W+GITC RV ++L K +SG +S I L +++ INL
Sbjct: 42 NDPLKYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100
Query: 64 MNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPF 122
NN + G IP + F L L LS+N+ G IP L L L N L G IP
Sbjct: 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPN 158
Query: 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLG 182
+ S LK L + N L G IP + NLTSLE ++LA+N G IP LGQ+K LK +
Sbjct: 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218
Query: 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIP 242
LG NNLSG IP I L+ L + + N G +P SLG L +L+ ++ N SG IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIP 277
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
S+ + KL ++ DNS SG++ ++NL ++ NN +G+ +L +
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF-TGKIPV-----ALTSL 331
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQ--LQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360
L+ L +NK G +P NL L L +++N L G IP G+ + L++L +
Sbjct: 332 PRLQVLQLWSNKFSGEIP---KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 361 GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
N G IPK +G ++L + L DN SGE+PS L ++ L ++NN+L G I S
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 421 GSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNV 480
+ L +L L N G +P+ F L N L+L+RN G++P K+G+L L +
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDS-FGSKRLEN-LDLSRNQFSGAVPRKLGSLSELMQLKL 506
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540
S N LSGEIP +L C L + + N G IP+S S + + +DLS+N LSG IPK
Sbjct: 507 SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566
Query: 541 LEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRN 599
L ++ SL +N+S N L G +P+ G F I+ +VAG LCGG LP C R
Sbjct: 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC----KRV 622
Query: 600 QKISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQ----KVSY 655
+K I TL A L + +V F F + + R ++ LQ KVS
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAF-GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSK 681
Query: 656 ESLFKATDGFSST---HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK 712
D SS ++I G G+ YKG ++G +K N + S +A+
Sbjct: 682 S--ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD-- 736
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+ ++H N+VK+I C S L++E++ +L L +
Sbjct: 737 -MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVL--------------RN 776
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L+ +R IAI +A A+ +LH C V+ +L P +++D H+
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----------R 825
Query: 833 SNLTQSCSVGVRGTI--GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+L + I Y APE +++ DIY +G++L+E++TGK P D F
Sbjct: 826 LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885
Query: 891 LNLHNYARTALLDHVIDI-VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVA 949
++ +AR D +D+ +DP + DV + N+ + + ++ + +
Sbjct: 886 GSIVEWARYCYSDCHLDMWIDPSIRGDV----SVNQNEI------------VEVMNLALH 929
Query: 950 CSVESPQDRMSITNVVHELQSV 971
C+ P R +V+ L+S
Sbjct: 930 CTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 76/248 (30%), Positives = 108/248 (43%), Gaps = 29/248 (11%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITS 728
+G GSFG VY + G +VAIKV ++ + L E K LK ++H N+V++
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
F+ D LV E+ G L + L + +L+ + + SA
Sbjct: 66 -----FEDEDKLYLVMEYCEGGDLFDLLK-----------KRGRLSEDEARFYLRQILSA 109
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YLH ++H DLKP N+LLD D + DFGLAR LT GT
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPE 161
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
Y APE LG DI+S G++L E++TGK P F GD L +
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFP 217
Query: 909 VDPILIND 916
I+
Sbjct: 218 PPEWDISP 225
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G G FG+VY + G VAIK+ + + L E + LK + H N+VK+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
+ LV E+ GSL++ L KL+ + + I + + +
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKDLLKE----------NEGKLSEDEILRILLQILEGL 105
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+YLH + ++H DLKP N+LLD+D + DFGL+++ +L ++ GT
Sbjct: 106 EYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI----VGTPA 158
Query: 849 YAAPEYGLG-SEVSTNGDIYSYGILLLEM 876
Y APE LG S DI+S G++L E+
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
+G GSFG+VYK G IVA+K+ + ++ E + L+ + H N+V++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
F+ D LV E+ G L ++L L+ + IA+ +
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRG-----------GPLSEDEAKKIALQILRG 110
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YLH + ++H DLKP N+LLD + + + DFGLA+ + S GT
Sbjct: 111 LEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL----LKSSSSLTTFVGTPW 163
Query: 849 YAAPE-YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907
Y APE G+ D++S G++L E++TGK P F G+ L
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRR------ 213
Query: 908 IVDPILINDVEDWD 921
I+ P L D W
Sbjct: 214 ILGPPLEFDEPKWS 227
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 671 IGMGSFGSVYKG----AFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG VYKG + T VA+K + FL E +K + H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ C+ QG +V E+M G L ++L + +KLTL + +A+ +
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLR-----KHG-----EKLTLKDLLQMALQI 111
Query: 786 ASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS--CSVG 842
A ++YL + +H DL N L+ +++ + DFGL+R E + +
Sbjct: 112 AKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
++ APE + ++ D++S+G+LL E+ T G++P
Sbjct: 168 IKWM----APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVI 726
L+G GSFGSVY G ++A+K L ++ E + L +++H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S + + + E+++ GSL + L E I+K T +
Sbjct: 66 GSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGKLP---EPVIRKYT--------RQIL 111
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ YLH + ++H D+K N+L+D+D + + DFG A+ T + VRGT
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG--DIETGEGTGSVRGT 166
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ APE G E DI+S G ++EM TGK P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 70/307 (22%), Positives = 135/307 (43%), Gaps = 64/307 (20%)
Query: 671 IGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNL 722
+G G+FG VYKG G VA+K + AS + FL E + ++ + H N+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
VK++ C+ + +V E+M G L ++L + ++L+L ++ A
Sbjct: 64 VKLLGVCTE---EEPLM--IVMEYMPGGDLLDYLR---------KNRPKELSLSDLLSFA 109
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ +A ++YL +H DL N L+ +++ + DFGL+R ++ + G
Sbjct: 110 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKG 163
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901
+ I + APE + ++ D++S+G+LL E+ T G++P Y
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-------------YP---- 206
Query: 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961
+ + ++ ++ RL + CP + ++ + C E P+DR +
Sbjct: 207 -----GMSNAEVLEYLK-----KGYRLPKPP-----NCPPELYKLMLQCWAEDPEDRPTF 251
Query: 962 TNVVHEL 968
+ +V L
Sbjct: 252 SELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 65/307 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTI----VAIKVFNLQRHGAS----KSFLAECKALKNIRHRNL 722
+G G+FG VYKG G VA+K + AS + FL E + ++ + H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
VK++ C+ + + +V E+M G L ++L KL+L ++ A
Sbjct: 64 VKLLGVCTE---EEPLY--IVMEYMEGGDLLSYLR----------KNRPKLSLSDLLSFA 108
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ +A ++YL +H DL N L+ +++ + DFGL+R ++ + G
Sbjct: 109 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRG 162
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901
+ I + APE + ++ D++S+G+LL E+ T G++P Y +
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-------------YPGMSN 209
Query: 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961
+ ++ ++ N RL Q CP + + + C E P+DR +
Sbjct: 210 EE---------VLEYLK-----NGYRLPQPP-----NCPPELYDLMLQCWAEDPEDRPTF 250
Query: 962 TNVVHEL 968
+ +V L
Sbjct: 251 SELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 671 IGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLV 723
+G G+FG VYKG T VA+K + AS+ FL E + +K + H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+++ C+ + + LV E+M G L ++L E L+L ++ AI
Sbjct: 60 RLLGVCTE---EEPLY--LVLEYMEGGDLLDYLR--KSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+A ++YL +H DL N L+ D++ + DFGL+R
Sbjct: 113 QIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-------DVYDDDYYR 162
Query: 844 RGTIG-----YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ T G + APE ++ D++S+G+LL E+ T G P
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G FG VYK + G VAIKV L+ + + E + LK +H N+VK S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS-- 65
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ D +V EF + GSL++ L + Q E +I + ++ ++
Sbjct: 66 ---YLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAY--------VCKELLKGLE 112
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR-GTIGY 849
YLH + ++H D+K N+LL +D + DFGL+ + L+ + + GT +
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLS------AQLSDTKARNTMVGTPYW 163
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE G DI+S GI +E+ GK P
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVIT 727
IG GSFG VY DG + +K +L + L E K LK + H N++K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR-------IN 780
S F+ +V E+ G L +I+K + ++
Sbjct: 67 S-----FEEKGKLCIVMEYADGGDLSQ--------------KIKKQKKEGKPFPEEQILD 107
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ + A+ YLH +LH D+KP N+ L ++ + +GDFG+++V +L ++
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y +PE + DI+S G +L E+ T K P FEG+
Sbjct: 165 ----GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 71/218 (32%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V G D G VA+K L+ A+++FLAE + +RH NLV+++
Sbjct: 13 TIGKGEFGDVMLG--DYRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLL-- 66
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ QGN +V E+M GSL ++L +TL Q++ A+DV
Sbjct: 67 --GVVLQGNPL-YIVTEYMAKGSLVDYLRSR---------GRAVITLAQQLGFALDVCEG 114
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR---VRQEVSNLTQSCSVGVRG 845
++YL ++ +H DL NVL+ D++A V DFGLA+ Q+ L
Sbjct: 115 MEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL---------- 161
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + APE + ST D++S+GILL E+ + G+ P
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA----LKNIRHRNLVKV 725
LIG G+FG VYKG + G VAIK +L + L LKN++H N+VK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISL--EKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP-DAVPQKDVEIEIQKLTLLQRINIAID 784
I S + +D ++ E+ NGSL + P+ V + + +
Sbjct: 65 IGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ------------ 107
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
V + YLH ++ V+H D+K N+L D + + DFG+A +VS S V
Sbjct: 108 VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----VV 160
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + APE S ST DI+S G ++E++TG P
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G GSFG V G + A+KV + + + L E L I H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN------- 780
+ FQ + LV E+ G L + L +
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGEL--------------------FSHLSKEGRFSEERA 95
Query: 781 --IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
A ++ A++YLH +++ DLKP N+LLD D + DFGLA+ E+S+
Sbjct: 96 RFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSR 149
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT Y APE LG D +S G+LL EM+TGK P
Sbjct: 150 TN-TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 30/223 (13%)
Query: 666 SSTHL---IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHR 720
S L +G G FG V+ G ++ T VA+K + G ++FL E + +K +RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHD 61
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
LV++ CS + +V E+M+ GSL ++L E +KL L Q ++
Sbjct: 62 KLVQLYAVCS----EEEPI-YIVTEYMSKGSLLDFLKSG---------EGKKLRLPQLVD 107
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+A +A + YL +H DL N+L+ +++ + DFGLAR+ + + +
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAR 161
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + I + APE + D++S+GILL E+VT G+ P
Sbjct: 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 73/215 (33%), Positives = 111/215 (51%), Gaps = 27/215 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--ASKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V++G ++ + T VA+K + G K FLAE + +K +RH L+++
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ + +V E M GSL +L A + L L Q I++A VAS
Sbjct: 70 CTL-----EEPIYIVTELMKYGSLLEYLQGGAG---------RALKLPQLIDMAAQVASG 115
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ YL +H DL NVL+ + I V DFGLARV +E ++ ++ G + I
Sbjct: 116 MAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE--DIYEA-REGAKFPIK 169
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE L + S D++S+GILL E+VT G+ P
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 70/223 (31%), Positives = 109/223 (48%), Gaps = 29/223 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRH-RNLVKV 725
+G GSFG VY +D +VA+KV + + + FL E + L ++ H N+VK+
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
FQ LV E++ GSLE+ L L+ + + I +
Sbjct: 64 YDF-----FQDEGSLYLVMEYVDGGSLEDLLKKI--------GRKGPLSESEALFILAQI 110
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQE--VSNLTQSCSVG 842
SA++YLH ++H D+KP N+LLD + + + DFGLA++ + ++ +
Sbjct: 111 LSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
Query: 843 VRGTIGYAAPEYGLGSE---VSTNGDIYSYGILLLEMVTGKKP 882
GT GY APE LG S++ DI+S GI L E++TG P
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVI 726
+ IG G+FG VY G ++A+K +Q K E K L+ ++H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 727 TSCSSIDFQGNDFKALVYEFM---TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
++ VY FM + G+LE L I +++ +
Sbjct: 64 --YYGVEVHREK----VYIFMEYCSGGTLEELLE---------HGRILDEHVIRVY--TL 106
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ + YLH H ++H D+KP N+ LD++ + +GDFG A + + +
Sbjct: 107 QLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 844 RGTIGYAAPEYGLGSEVSTNG---DIYSYGILLLEMVTGKKP 882
GT Y APE G + +G DI+S G ++LEM TGK+P
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 74/234 (31%), Positives = 109/234 (46%), Gaps = 40/234 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFD-QDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHRN 721
+ +G G++G VYK A D + G IVA+K L + G + L E LK ++H N
Sbjct: 1 YEKLEKLGEGTYGVVYK-ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPN 59
Query: 722 LVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
+VK VI + + LV+E+ L+ +L + + K + Q
Sbjct: 60 IVKLLDVIHTERKL--------YLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQL 107
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-VRQEVSNLTQ 837
+ + Y H H +LH DLKP N+L++ D + + DFGLAR + T
Sbjct: 108 LR-------GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157
Query: 838 SCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
V T+ Y APE LGS+ ST DI+S G + EM+TGK +F GD
Sbjct: 158 E-VV----TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK----PLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 70/223 (31%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V++G + ++ VAIK+ + F E +ALK +RH++L+ + CS
Sbjct: 14 LGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ ++ E M GSL +L P E Q L + I++A VA +
Sbjct: 73 -----VGEPVYIITELMEKGSLLAFL---RSP------EGQVLPVASLIDMACQVAEGMA 118
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
YL ++ +H DL N+L+ D++ V DFGLAR+ +E L+ + + T
Sbjct: 119 YLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---- 171
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLN 892
APE ST D++S+GILL EM T G+ P + G N
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP----YPGMNN 210
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVK---V 725
IG G++G VYK + G +VA+K ++ + G + + E K L+ +RH N+V+ +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 726 ITSCSSIDFQGNDFKALVYEFMT---NGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+TS +G+ + +V+E+M G L+ P+ K T Q
Sbjct: 67 VTSKG----KGSIY--MVFEYMDHDLTGLLD---SPE-----------VKFTESQIKCYM 106
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ + YLH + +LH D+K N+L++ND + + DFGLAR + ++ +
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--ADYTNR 161
Query: 843 VRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGK 880
V T+ Y PE LG+ D++S G +L E+ GK
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 75/304 (24%), Positives = 137/304 (45%), Gaps = 54/304 (17%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
H +G G +G VY+G + + VA+K + + FL E +K I+H NLV+++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ + F ++ EFMT G+L ++L ++ E+ + LL +A ++SA
Sbjct: 71 CT----REPPF-YIITEFMTYGNLLDYL------RECNRQEVNAVVLLY---MATQISSA 116
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL ++ +H DL N L+ + + V DFGL+R+ T + G + I
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIK 170
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVID 907
+ APE ++ S D++++G+LL E+ T G P + G L V +
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPG----------IDLSQVYE 216
Query: 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967
+++ + R + G CP + + AC +P DR S +
Sbjct: 217 LLE---------------KGYRMERPEG---CPPKVYELMRACWQWNPSDRPSFAEIHQA 258
Query: 968 LQSV 971
+++
Sbjct: 259 FETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVIT 727
IG G+FG V + A+K N Q+ G+ ++ L E + L+ + H LV +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL-- 65
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ-KLTLLQRINIAIDVA 786
S FQ + LV + + G L H + QK E Q K ++
Sbjct: 66 -WYS--FQDEENMYLVVDLLLGGDLR--YH---LSQKVKFSEEQVKF-------WICEIV 110
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
A++YLH ++H D+KP N+LLD H+ DF +A + T + GT
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-----GT 162
Query: 847 IGYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GY APE G V D +S G+ E + GK+P
Sbjct: 163 PGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTI-VAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVIT 727
+G G FG V+ G + G I VAIK+ R GA F+ E K + + H NLV++
Sbjct: 12 LGSGQFGVVHLGKWR--GKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
C+ Q F +V E+M NG L N+L +K LL + DV
Sbjct: 67 VCTK---QRPIF--IVTEYMANGCLLNYLRE----RKGKL---GTEWLLD---MCSDVCE 111
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
A++YL + +H DL N L+ D + V DFGLAR V + + S G + +
Sbjct: 112 AMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTKFPV 165
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
+A PE S S+ D++S+G+L+ E+ + GK P +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 86/313 (27%), Positives = 142/313 (45%), Gaps = 60/313 (19%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVF-NLQRHGASKSFLAECKALKNIRHRNLVK 724
+G G+FG V+ G + D +VA+K + A K F E + L N +H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQRINI 781
C+ +G D +V+E+M +G L +L PDA K + + +LTL Q + I
Sbjct: 73 FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A+ +AS + YL + +H DL N L+ D++ +GDFG++R ++ +
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYY 178
Query: 842 GVRGT----IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896
V G I + PE + + +T D++S+G++L E+ T GK+P + L N
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP---WYG----LSN- 230
Query: 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956
+ VI+ + QR R CP + I + C PQ
Sbjct: 231 ------EEVIECIT----------QGRLLQRPR--------TCPSEVYDIMLGCWKRDPQ 266
Query: 957 DRMSITNVVHELQ 969
R++I ++ LQ
Sbjct: 267 QRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRNLV 723
++G GS G VYK G I A+K ++ R K L E K L++ +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR----KQLLRELKTLRSCESPYVV 62
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPD-AVPQKDVEIEIQKLTLLQRINIA 782
K C ++ + ++V E+M GSL + L +P+ + IA
Sbjct: 63 K----CYGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIPEPVLAY------------IA 105
Query: 783 IDVASAIDYLH--HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ +DYLH H ++H D+KP N+L+++ + DFG+++V + N C+
Sbjct: 106 RQILKGLDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKV---LENTLDQCN 158
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
V GT+ Y +PE G S DI+S G+ LLE GK P
Sbjct: 159 TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 36/216 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G FG+V +G + G VA+K N++ +++FL E + + H+NLV+++
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL---G 66
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPD---AVPQKDVEIEIQKLTLLQRINIAIDVAS 787
I G +V E M+ G+L N+L V ++Q + ++DVA
Sbjct: 67 VILHNG---LYIVMELMSKGNLVNFLRTRGRALVS------------VIQLLQFSLDVAE 111
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
++YL + ++H DL N+L+ D +A V DFGLARV + + + +
Sbjct: 112 GMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS-------KLPV 161
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE + S+ D++SYG+LL E+ + G+ P
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFL-AECKALKNIRHRNLVK---- 724
IG GSFG+V K DG I+ K + K L +E L+ ++H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 725 -VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ S ++ +V E+ G L + QK + E + + I
Sbjct: 68 IIDRSNQTL--------YIVMEYCEGGDLAQLI------QKCKK-ERKYIEEEFIWRILT 112
Query: 784 DVASAIDYLHH--HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ A+ H+ VLH DLKP N+ LD + +GDFGLA++ S+ ++
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y +PE DI+S G L+ E+ P
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 41/225 (18%)
Query: 671 IGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLV 723
IG G FG V +G + VAIK + G+S FL E + H N++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 724 K---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+ V+T + ++ E+M NGSL+ +L + D K T+ Q +
Sbjct: 69 RLEGVVTKSRPV--------MIITEYMENGSLDKFLR-----END-----GKFTVGQLVG 110
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL--TQS 838
+ +AS + YL +H DL N+L++++++ V DFGL+R ++ T+
Sbjct: 111 MLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE-MVTGKKP 882
+ +R T APE + ++ D++S+GI++ E M G++P
Sbjct: 168 GKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 41/234 (17%)
Query: 670 LIGMGSFGSVYKGAFDQ-DGTIVAIKVFN---LQRHGASKSFLAECKAL-KNIRHRNLVK 724
+IG GSF +V A ++ AIK+ + L + K E + L + H ++K
Sbjct: 8 IIGEGSFSTVVL-AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + FQ + V E+ NG L ++ D + + A +
Sbjct: 67 LYYT-----FQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKC-TR--------FYAAE 110
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ A++YLH + ++H DLKP N+LLD DM + DFG A+V S+ +
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 845 ----------------GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y +PE + D+++ G ++ +M+TGK P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIK--VFNLQRHGASKSFLAECKALKNIR---HRNLVK 724
IG G++G+VYK G VA+K L G S L E LK + H N+V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
++ C LV+E + + L +L P+ + E K ++
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIK-------DLMRQ 115
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ +D+LH H ++H DLKP N+L+ +D + DFGLAR+ LT S V
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT-SVVV--- 168
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
T+ Y APE L S +T D++S G + E+
Sbjct: 169 -TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V G D G VA+K ++ +++FLAE + +RH NLV+++
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
++ +G + +V E+M GSL ++L + + ++DV A
Sbjct: 68 I--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGD---------CLLKFSLDVCEA 114
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL + +H DL NVL+ D +A V DFGL + E S+ + + V+ T
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT-- 166
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE + ST D++S+GILL E+ + G+ P
Sbjct: 167 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 29/221 (13%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
+ + IG G+ G VYK G VAIK L++ + + E +K+ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI-EIQKLTLLQRINIAI 783
S + D +V E+M GSL D + Q V + E Q + + +
Sbjct: 80 YYDS-----YLVGDELWVVMEYMDGGSLT-----DIITQNFVRMNEPQIAYVCREVL--- 126
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS--V 841
++YLH + V+H D+K N+LL D + DFG A + LT+ S
Sbjct: 127 ---QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFA------AQLTKEKSKRN 174
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
V GT + APE + DI+S GI+ +EM G+ P
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 38/222 (17%)
Query: 671 IGMGSFGSV----YKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVK 724
+G G FG V ++G +D VAIK+ + G+ F+ E K + + H LV+
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK-LTLLQRINIAI 783
+ C+ Q + +V E+M+NG L N+L E K Q + +
Sbjct: 64 LYGVCTK---QRPIY--IVTEYMSNGCLLNYLR-----------EHGKRFQPSQLLEMCK 107
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
DV + YL +H DL N L+D+ V DFGL+R V + + SVG
Sbjct: 108 DVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGS 161
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
+ + ++ PE L S+ S+ D++++G+L+ E+ + GK P +
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 24/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V+ G ++ + T VA+K + +SFL E + +K +RH LV++ S
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+V E+M+ GSL ++L KD E + L L +++A VA+ +
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL-------KDGEG--RALKLPNLVDMAAQVAAGMA 116
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
Y+ + +H DL+ N+L+ + ++ + DFGLAR+ + + + G + I +
Sbjct: 117 YIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWT 170
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE L + D++S+GILL E+VT G+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 77/236 (32%), Positives = 117/236 (49%), Gaps = 42/236 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNL 722
++ IG G++G VYKG + G IVA+K L+ G + + E LK ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ-KDVEIEIQKLTLLQRINI 781
V + + Q + L++EF++ L+ +L D++P+ + ++ E+ K L Q
Sbjct: 62 VCLQ----DVLMQESRL-YLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQ---- 109
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ I + H VLH DLKP N+L+DN + + DFGLAR + +
Sbjct: 110 ---ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR----------AFGI 153
Query: 842 GVRG------TIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
VR T+ Y APE LGS ST DI+S G + EM T KKP +F GD
Sbjct: 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 74/236 (31%), Positives = 110/236 (46%), Gaps = 43/236 (18%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHRNL 722
F IG G++G VYK G +VA+K L + G + + E LK + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 723 VKVITSCSSIDFQGNDFKA-LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
VK++ D + K LV+EF+ + L+ ++ DA P + + + K L Q +
Sbjct: 62 VKLL------DVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQ- 111
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ + H H VLH DLKP N+L++ + + DFGLAR + V
Sbjct: 112 ------GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR----------AFGV 152
Query: 842 GVRG------TIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
VR T+ Y APE LG + ST DI+S G + EMVT + +F GD
Sbjct: 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 76/232 (32%), Positives = 111/232 (47%), Gaps = 47/232 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVK---V 725
IG G++G VYK G IVA+K L+ G + + E LK + H N+V+ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ S + + LV+EF+ + L+ ++ D+ P ++ + K L Q +
Sbjct: 67 VHSENKL--------YLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLL------ 109
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
I Y H H VLH DLKP N+L+D + + DFGLAR + V VR
Sbjct: 110 -QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR----------AFGVPVRT 155
Query: 846 ------TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y APE LGS + ST DI+S G + EMV ++P +F GD
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP---LFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V+ G ++ T VAIK + ++FL E + +K +RH LV++ S
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+V E+M+ GSL ++L + + L L Q +++A +AS +
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 116
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
Y+ + +H DL+ N+L+ +++ V DFGLAR+ + + + G + I +
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 170
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE L + D++S+GILL E+ T G+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 79/312 (25%), Positives = 137/312 (43%), Gaps = 56/312 (17%)
Query: 671 IGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG V+ +QD +VA+K A + F E + L ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDA-VPQKDVEIEIQKLTLLQRINI 781
C+ +V+E+M +G L +L PDA + ++ +LTL Q + I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A +AS + YL +H DL N L+ ++ +GDFG++R ++ + T V
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYS-TDYYRV 180
Query: 842 GVRGT--IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898
G R I + PE L + +T DI+S+G++L E+ T GK+P + +
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP----------WYQLSN 230
Query: 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958
T ++ + T + L + + CP + I C PQ R
Sbjct: 231 TEAIECI-----------------TQGRELERPR-----TCPPEVYAIMQGCWQREPQQR 268
Query: 959 MSITNVVHELQS 970
M I ++ LQ+
Sbjct: 269 MVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITS 728
IG G++G VYK G IVAIK L+ G K+ L E K LK + H N++K++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ D LV+EFM + Q+ + + K L Q +
Sbjct: 65 --DVFRHKGDL-YLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQ-------LLQG 110
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVGVRGTI 847
+ + H H +LH DLKP N+L++ + + + DFGLAR V T T
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TR 162
Query: 848 GYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGK 880
Y APE LG + ST DI+S G + E+++ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 60/301 (19%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V+ G + + VAIK R GA + F+ E + + + H LV++
Sbjct: 12 IGSGQFGLVWLGYW-LEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ LV+EFM +G L ++L Q+ + + TLL + +DV
Sbjct: 68 CTE-----RSPICLVFEFMEHGCLSDYLRA----QRG---KFSQETLLG---MCLDVCEG 112
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ YL V+H DL N L+ + + V DFG+ R V + + S G + +
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVK 166
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVID 907
+++PE S+ S+ D++S+G+L+ E+ + GK P + ++
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---------------- 210
Query: 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967
VE +A RL + ++ S+ + C E P+DR S + ++H+
Sbjct: 211 ---------VETINAGF--RLYKPRL-----ASQSVYELMQHCWKERPEDRPSFSLLLHQ 254
Query: 968 L 968
L
Sbjct: 255 L 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V+ G ++ T VAIK ++FL E + +K +RH LV + S
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+V EFM GSL ++L E + + L L Q +++A +A +
Sbjct: 72 EEPIY------IVTEFMGKGSLLDFLK---------EGDGKYLKLPQLVDMAAQIADGMA 116
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
Y+ + +H DL+ N+L+ ++++ + DFGLAR+ + + + G + I +
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWT 170
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE L + D++S+GILL E+VT G+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 671 IGMGSFGSVYKGAFD--QDGT--IVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVKV 725
+G G FG V +D D T VA+K N +S F E + L+ + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
C G L+ E++ +GSL ++L +D ++ L + + + +
Sbjct: 72 KGVCEK---PGGRSLRLIMEYLPSGSLRDYLQR----HRD------QINLKRLLLFSSQI 118
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE------VSNLTQSC 839
+DYL + +H DL N+L++++ + + DFGLA+V E V +S
Sbjct: 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES- 174
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
I + APE S+ S+ D++S+G+ L E+ T
Sbjct: 175 ------PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 38/226 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDG---TIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRN 721
+IG G FG V +G G VAIK QR + FL+E + H N
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPN 66
Query: 722 LVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
++ V+T + ++ EFM NG+L+++L Q D + T++Q
Sbjct: 67 IIHLEGVVTKSRPV--------MIITEFMENGALDSFLR-----QND-----GQFTVIQL 108
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE-VSNLTQ 837
+ + +A+ + YL + +H DL N+L++++++ V DFGL+R ++ S+ T
Sbjct: 109 VGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE-MVTGKKP 882
+ S+G + I + APE + ++ D++SYGI++ E M G++P
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 66/220 (30%), Positives = 111/220 (50%), Gaps = 38/220 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVK---VI 726
+G G FG V+ G + T VAIK +L++ S FLAE +K ++H LV+ V+
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
T + ++ E+M NGSL ++L E KLT+ + I++A +A
Sbjct: 71 T---------QEPIYIITEYMENGSLVDFLKTP---------EGIKLTINKLIDMAAQIA 112
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ ++ ++ +H DL+ N+L+ + + DFGLAR+ ++ + G +
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE---GAKFP 166
Query: 847 IGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
I + APE YG + D++S+GILL E+VT G+ P
Sbjct: 167 IKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-KSFLAECKALKNIRHRNLVKVITSC 729
IG+G+ VY + VAIK +L++ S E +A+ H N+VK TS
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
F D LV +++ GSL + + + P + E T+L+ +V +
Sbjct: 68 ----FVVGDELWLVMPYLSGGSLLD-IMKSSYP-RGGLDEAIIATVLK------EVLKGL 115
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS--CSVGVR--- 844
+YLH + Q +H D+K GN+LL D + DFG++ ++L + VR
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVS------ASLADGGDRTRKVRKTF 166
Query: 845 -GTIGYAAPE-----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + APE +G + DI+S+GI +E+ TG P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
I G++G V+ G I AIKV + R L E L + +VK+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
S FQG LV E++ G L + L +DV RI IA ++
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----------ARIYIA-EIVL 104
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV----RQEVSNLTQSCSVGV 843
A++YLH + ++H DLKP N+L+D++ + DFGL++V RQ N + +
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE LG S D +S G +L E + G P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 44/232 (18%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G GS+GSVYK + G +VAIKV ++ + + E LK +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVK----- 62
Query: 730 SSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI-- 783
+ G+ FK +V E+ GS+ D+ ++I TL + IA
Sbjct: 63 ----YYGSYFKNTDLWIVMEYCGAGSV-----------SDI-MKITNKTLTEE-EIAAIL 105
Query: 784 -DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
++YLH + +H D+K GN+LL+ + A + DFG V ++++ T +
Sbjct: 106 YQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTD-TMAKRNT 158
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK------KPTDVMFE 888
V GT + APE + DI+S GI +EM GK P +F
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRNLVK 724
L+G GSFGSVY+G DG A+K +L A K E L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 725 VITSCSSIDFQGNDFKALVY-EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ + D ++ E + GSL L +
Sbjct: 67 YLGTEREED------NLYIFLELVPGGSLAKLLK-----------KYGSFPEPVIRLYTR 109
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ ++YLH +H D+K N+L+D + + + DFG+A+ E S +S
Sbjct: 110 QILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSF---- 161
Query: 844 RGTIGYAAPE-------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+G+ + APE YGL + DI+S G +LEM TGK P
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK---VIT 727
+G G FG V+ G + + T VA+K ++FL E +K ++H LV+ V+T
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
I ++ E+M GSL ++L D E K+ L + I+ + +A
Sbjct: 72 KEEPI--------YIITEYMAKGSLLDFLKSD---------EGGKVLLPKLIDFSAQIAE 114
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+ Y+ ++ +H DL+ NVL+ ++ + DFGLARV + + + G + I
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKFPI 168
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891
+ APE + D++S+GILL E+VT GK P M D+
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-17
Identities = 73/231 (31%), Positives = 103/231 (44%), Gaps = 49/231 (21%)
Query: 668 THLIGMGSFGSVYKGAFD-QDGTIVAIK----VFNLQRHGASKSFLAECKALKNIRHRNL 722
IG G++G V A D + G VAIK VF+ K L E K L+++RH N+
Sbjct: 5 LKPIGSGAYGVVCS-AVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHENI 61
Query: 723 VK---VITSCSSIDFQGNDFKALVYEFM-TNGSLENWLHPDAVPQKDVEIEIQKLT--LL 776
+ ++ S DF ND +V E M T+ L + PQ + IQ +L
Sbjct: 62 IGLLDILRPPSPEDF--NDV-YIVTELMETD--LHKVIKS---PQPLTDDHIQYFLYQIL 113
Query: 777 QRINIAIDVASAIDYLH--HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ---- 830
+ YLH + V+H DLKP N+L++++ + DFGLAR
Sbjct: 114 ----------RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGK 880
E LT+ V T Y APE L S T DI+S G + E++T K
Sbjct: 159 EKGFLTE----YV-VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 82/319 (25%), Positives = 140/319 (43%), Gaps = 61/319 (19%)
Query: 671 IGMGSFGSV-----YKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG V Y + +D +VA+K A K F E + L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQK--LTLLQRIN 780
C D +V+E+M +G L +L PDA+ D + K L L Q ++
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
IA +AS + YL + +H DL N L+ +++ +GDFG++R ++ +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDY 178
Query: 841 VGVRG----TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895
V G I + PE + + +T D++S+G++L E+ T GK+P L N
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-------FQLSN 231
Query: 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955
VI+ + T + L + ++ CP + I + C P
Sbjct: 232 -------TEVIECI-------------TQGRVLERPRV-----CPKEVYDIMLGCWQREP 266
Query: 956 QDRMSITNVVHELQSVKNA 974
Q R++I + L ++ A
Sbjct: 267 QQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 45/226 (19%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRN-- 721
+G G++ VYK + G IVAIK L G + + L E K L+ ++H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 722 -LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ----KLTLL 776
L+ V S+I+ LV+EFM LE + KD I + K +L
Sbjct: 66 GLLDVFGHKSNIN--------LVFEFM-ETDLEKVI-------KDKSIVLTPADIKSYML 109
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS-NL 835
+ ++YLH + +LH DLKP N+L+ +D + + DFGLA R S N
Sbjct: 110 MTLR-------GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA--RSFGSPNR 157
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGK 880
+ V T Y APE G+ G D++S G + E++
Sbjct: 158 KMTHQV---VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIK-----VFNLQRHGASKSFLAECKALKNIRHRNLVK 724
IG G+FG VYKG + T VA+K + + + FL E + LK H N+VK
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLK----RKFLQEAEILKQYDHPNIVK 56
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+I C +V E + GSL +L +LT+ + + +++D
Sbjct: 57 LIGVCVQ-----KQPIYIVMELVPGGSLLTFLRKKK----------NRLTVKKLLQMSLD 101
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
A+ ++YL +H DL N L+ + + + DFG++R E + S G++
Sbjct: 102 AAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLK 155
Query: 845 GT-IGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVTG 879
I + APE YG ++ D++SYGILL E +
Sbjct: 156 QIPIKWTAPEALNYG---RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 71/252 (28%), Positives = 108/252 (42%), Gaps = 44/252 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV--FNLQRHGASKSFLAECKALKNIRHRNL 722
F + IG G++G VY+ G IVA+K + +R G S L E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 723 V---KVIT--SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
V +V+ SI F LV E+ L + L D +P E +++ L L
Sbjct: 69 VELKEVVVGKHLDSI------F--LVMEYCEQ-DLASLL--DNMPTPFSESQVKCLML-- 115
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
+ + YLH + ++H DLK N+LL + + DFGLAR +
Sbjct: 116 ------QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
V T+ Y APE LG T D+++ G +L E++ K + G +
Sbjct: 167 PKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK----PLLPGKSEIE-- 216
Query: 897 ARTALLDHVIDI 908
LD +I +
Sbjct: 217 ----QLDLIIQL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G GSFG VY+G + T VAIK N AS FL E +K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 722 LVKVITSCSSIDFQGNDFKALV-YEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQ 777
+V+++ S G LV E M G L+++L P+A + TL +
Sbjct: 71 VVRLLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP----PTLQK 120
Query: 778 RINIAIDVASAIDYLH--HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
I +A ++A + YL H DL N ++ D+ +GDFG+ R E ++
Sbjct: 121 FIQMAAEIADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTRDIYE-TDY 174
Query: 836 TQSCSVG---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
+ G VR + APE +T D++S+G++L EM T
Sbjct: 175 YRKGGKGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVK---VI 726
+G G++ +VYKG G IVA+K +L G + + E +K ++H N+V+ VI
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + + LV+E+M + L+ ++ H ++ LL+
Sbjct: 68 HTENKL--------MLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK------- 111
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
I + H + VLH DLKP N+L++ + DFGLAR N + V
Sbjct: 112 ---GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--- 162
Query: 845 GTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGK 880
T+ Y AP+ LGS ST+ DI+S G ++ EM+TG+
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 75/241 (31%), Positives = 107/241 (44%), Gaps = 48/241 (19%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHR 720
D + IG G++G VYK +A+K L++ G + + E LK ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 721 NLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
N+V+ V+ S + LV+E++ L+ H D+ P + K L Q
Sbjct: 62 NIVRLQDVVHSEKRL--------YLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA-HVGDFGLARVRQEVSNLT 836
+ I Y H H VLH DLKP N+L+D A + DFGLAR
Sbjct: 111 -------ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR--------- 151
Query: 837 QSCSVGVRG------TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
+ + VR T+ Y APE LGS ST DI+S G + EMV +KP +F G
Sbjct: 152 -AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP---LFPG 206
Query: 890 D 890
D
Sbjct: 207 D 207
|
Length = 294 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 24/223 (10%)
Query: 671 IGMGSFGSV-----YKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG V Y +QD +VA+K A K F E + L N++H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQRINIA 782
C D +V+E+M +G L +L PDAV + + LT Q ++IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIA 126
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+A+ + YL + +H DL N L+ +++ +GDFG++R +V + T VG
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYS-TDYYRVG 179
Query: 843 VRGT--IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
I + PE + + +T D++S G++L E+ T GK+P
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK--VFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G+FG V+K + IVA+K + ++ G + L E K L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 729 CSSIDFQGNDFKA---LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
C + N +K LV+EF + L L V EI+ LL
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL--------- 129
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ + Y+H + +LH D+K N+L+ D I + DFGLAR N +
Sbjct: 130 -NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 846 TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVT 878
T+ Y PE LG + D++ G ++ EM T
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
IG G+ G V+K + G VA+K L+R G L E KAL+ +H +VK++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ G+ F LV E+M L L + P + +++ LL+
Sbjct: 66 --DVFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK----------G 111
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ Y+H ++H DLKP N+L+ D + + DFGLAR+ E S V R
Sbjct: 112 VAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR---W 165
Query: 849 YAAPEYGLGSEVSTNG-DIYSYGILLLEMVTG 879
Y APE G+ G D+++ G + E++ G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 75/255 (29%), Positives = 118/255 (46%), Gaps = 36/255 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIR---HRNLVKV 725
IG+G++G+VYK G VA+K +Q G S + E LK + H N+V++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ C++ LV+E + + L +L D VP + E K + Q +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL--DKVPPPGLPAETIKDLMRQFL------ 118
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+D+LH +C ++H DLKP N+L+ + + DFGLAR+ LT V
Sbjct: 119 -RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP-----VVV 169
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905
T+ Y APE L S +T D++S G + EM +KP +F G+ + D +
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN---------SEADQL 216
Query: 906 IDIVDPILINDVEDW 920
I D I + +DW
Sbjct: 217 GKIFDLIGLPPEDDW 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 73/233 (31%), Positives = 114/233 (48%), Gaps = 41/233 (17%)
Query: 670 LIGMGSFGSVYKG-AFDQDG-----TIVAIKVFNLQRHGAS----KSFLAECKALKNIRH 719
+G G+FG VY+G A D G VA+K R GA+ K FL E + N H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
N+VK++ C N+ + ++ E M G L ++L DA ++ LTL + +
Sbjct: 59 PNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLR-DARVER---FGPPLLTLKELL 109
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL-----DNDMIAHVGDFGLARVRQEVSN 834
+I +DVA YL Q +H DL N L+ D D + +GDFGLAR +
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR------D 160
Query: 835 LTQSCSVGVRG----TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ +S G + + APE L + +T D++S+G+L+ E++T G++P
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/220 (29%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVIT 727
+G GSFG V G A+K+ + + + L E + L++IRH LV +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
S FQ + LV E++ G L + L + + A V
Sbjct: 69 S-----FQDDSNLYLVMEYVPGGELFSHLR-----------KSGRFPEPVARFYAAQVVL 112
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVRGT 846
A++YLH +++ DLKP N+LLD+D + DFG A+ V T + C GT
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR---VKGRTYTLC-----GT 161
Query: 847 IGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE G G V D ++ GIL+ EM+ G P
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 74/316 (23%), Positives = 133/316 (42%), Gaps = 63/316 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDGTI---VAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVK 724
++G G FGSV +G QD VA+K L H S + FL+E +K+ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 725 VITSCSSIDFQGNDFKAL-----VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
+I C F+ + + + + FM +G L ++L + ++ +Q L
Sbjct: 66 LIGVC----FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--- 118
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
+D+A ++YL +H DL N +L DM V DFGL++ Q
Sbjct: 119 --MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 840 SVGVRGTIGYAAPEYGLGSEVST-NGDIYSYGILLLEMVT-GKKPTDVMFEGDLN--LHN 895
+ + + A E L V T D++++G+ + E+ T G+ P + G N +++
Sbjct: 174 I--AKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGQTP----YPGVENHEIYD 226
Query: 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955
Y R + RL+Q + +C + + +C P
Sbjct: 227 YLR-------------------------HGNRLKQPE-----DCLDELYDLMYSCWRADP 256
Query: 956 QDRMSITNVVHELQSV 971
+DR + T + L+++
Sbjct: 257 KDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTI---VAIKVF-NLQRHGASKSFLAECKALKNIRHRNLVKVI 726
+G G+FGSV KG + VA+K K FL E + + H +V++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C +G LV E G L +L +K EI + L L A VA
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYL------KKRREIPVSDLKEL-----AHQVA 105
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ YL + +H DL NVLL N A + DFG++R S+ ++ + G R
Sbjct: 106 MGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG-RWP 161
Query: 847 IGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + APE YG + S+ D++SYG+ L E + G KP
Sbjct: 162 LKWYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 65/239 (27%), Positives = 102/239 (42%), Gaps = 31/239 (12%)
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVA---IKVFNLQRHGASKSFLAECKALKNIR 718
F IG G F VYK DG +VA +++F + A + L E LK +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
H N++K + S F N+ +V E G L + + QK + +R
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIK---------HFKKQKRLIPER 106
Query: 779 I--NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
+ + SA++++H ++H D+KP NV + + +GD GL R +
Sbjct: 107 TIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD-LNLH 894
S + GT Y +PE + + DI+S G LL EM + P F GD +NL+
Sbjct: 164 HS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNI 717
F D + +G GS+ +VYKG +G +VA+KV LQ G + + E LK +
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 718 RHRNLV---KVITSCSSIDFQGNDFKALVYEFMTNGSLE------NWLHPDAVPQKDVEI 768
+H N+V +I + ++ LV+E++ + LHP+ V
Sbjct: 61 KHANIVLLHDIIHTKETL--------TLVFEYVHTDLCQYMDKHPGGLHPENV------- 105
Query: 769 EIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828
KL L Q + + Y+H Q +LH DLKP N+L+ + + DFGLAR
Sbjct: 106 ---KLFLFQLLR-------GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARA 152
Query: 829 RQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTG 879
+ S+ + V T+ Y P+ LGS E ST D++ G + +EM+ G
Sbjct: 153 KSVPSHTYSNEVV----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 75/256 (29%), Positives = 115/256 (44%), Gaps = 37/256 (14%)
Query: 671 IGMGSFGSVYKGA-FDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIR---HRNLVK 724
IG G++G V+K G VA+K +Q G S + E L+++ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ C+ LV+E + + L +L D VP+ V E K + Q
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQ------- 118
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ +D+LH H V+H DLKP N+L+ + + DFGLAR+ Q V
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVV 170
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
T+ Y APE L S +T D++S G + EM +KP +F G + +D
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGSSD---------VDQ 217
Query: 905 VIDIVDPILINDVEDW 920
+ I+D I + EDW
Sbjct: 218 LGKILDVIGLPGEEDW 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 670 LIGMGSFGSVYKGAF-DQDGTIVAIKVFNL----------QRHGASKSFLAECKALK-NI 717
+G G+FG VYK + ++A+K N+ +R + ++E +K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
RH N+V+ + F ND +V + + L H +++ +K +++
Sbjct: 67 RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIW--- 116
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
NI + + A+ YLH ++ ++H DL P N++L D + DFGLA+ +Q S LT
Sbjct: 117 --NIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
V GTI Y+ PE D++++G +L +M T + P
Sbjct: 173 -----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 48/225 (21%)
Query: 671 IGMGSFGSV----YKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLV 723
+G G FG V Y A D G +VA+K Q++ + + E LK + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHENIV 69
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K CS QG L+ E++ GSL ++L P+ KL L Q + A
Sbjct: 70 KYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL-----PK-------HKLNLAQLLLFAQ 114
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA----------RVRQEVS 833
+ + YLH + +H DL NVLLDND + +GDFGLA RVR++
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
+ + + A E ++ S D++S+G+ L E++T
Sbjct: 172 S-----------PVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL------QRHGASKSFLAECKALKNI 717
F +G GS+GSVYK D A+K +L +R A + E + L ++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA----VNEIRILASV 56
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
H N++ + +D GN +V E+ G L + +K + +
Sbjct: 57 NHPNIISY--KEAFLD--GNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQE------- 104
Query: 778 RI-NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
I I I + + LH ++ +LH DLK N+LL + + +GD G+++V L
Sbjct: 105 -IWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV------LK 154
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
++ + GT Y APE G S DI+S G LL EM T P FE
Sbjct: 155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL----------QRHGASKSFLAECKAL 714
+ LIG G++G+VY+G G +VA+K+ NL QR A L++ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA---LLSQ---L 56
Query: 715 KNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
+ + N+ K S +G ++ E+ GS+ + + +K + + I+++
Sbjct: 57 RQSQPPNITKYYGSY----LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL 111
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
+ A+ Y+H V+H D+K N+L+ N + DFG+A + + S+
Sbjct: 112 V------------ALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156
Query: 835 LTQSCSVGVRGTIGYAAPEYGL-GSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT + APE G T DI+S GI + EM TG P
Sbjct: 157 KRST----FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 43/228 (18%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK----------SFLAECKAL 714
F+ IG GSFG VYK + +VAIKV +L+ ++ FL++C++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE---EAEDEIEDIQQEIQFLSQCRSP 59
Query: 715 KNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
+ K S F ++ E+ GS + L P + + +
Sbjct: 60 ------YITKYYGS-----FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF------ 102
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
I +V ++YLH +E +H D+K N+LL + + DFG V ++++
Sbjct: 103 ------ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTS 150
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ V GT + APE S DI+S GI +E+ G+ P
Sbjct: 151 TMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAEC----KALKNIRHRNLVKVI 726
IG GSFG V+K D + A+K +L ++ E + L + +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLS--KMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S F +V E+ NG L L Q+ + L Q I +
Sbjct: 66 ES-----FLDKGKLNIVMEYAENGDLHKLLKM----QRG-----RPLPEDQVWRFFIQIL 111
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ +LH + +LH D+K N+ LD +GD G+A++ + +N + + GT
Sbjct: 112 LGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT----IVGT 164
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
Y +PE + D+++ G++L E TGK P D +G L
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 44/228 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDG---TIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRN 721
+IG G FG V++G G VAIK QR + FL+E + H N
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR----QDFLSEASIMGQFSHHN 67
Query: 722 LVK---VITSCSSIDFQGNDFK--ALVYEFMTNGSLENWLHPDAVPQKDVEIE-IQKLTL 775
+++ V+T FK ++ E+M NG+L+ +L D E Q + +
Sbjct: 68 IIRLEGVVTK----------FKPAMIITEYMENGALDKYLR-----DHDGEFSSYQLVGM 112
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
L+ I + S ++Y+H DL N+L+++++ V DFGL+RV ++
Sbjct: 113 LRGIAAGMKYLSDMNYVHR---------DLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
T + S G + I + APE + ++ D++S+GI++ E+++ G++P
Sbjct: 164 TYTTS-GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVKVITSC 729
+G G+ G V K G I+A+K L+ + A K L E L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
+ D ++ E+M GSL+ L K+V+ I + L + IA+ V +
Sbjct: 69 ----YNNGDI-SICMEYMDGGSLDKIL-------KEVQGRIPERILGK---IAVAVLKGL 113
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGY 849
YLH + ++H D+KP N+L+++ + DFG++ L S + GT Y
Sbjct: 114 TYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG------QLVNSLAKTFVGTSSY 165
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE G++ S DI+S G+ L+E+ TG+ P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 75/239 (31%), Positives = 111/239 (46%), Gaps = 58/239 (24%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK-VF-------NLQRHGASKSFLAECKALKNIRHRNL 722
+G G++G V+K + +VA+K +F + QR FL E L + H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE---LGD--HPNI 69
Query: 723 VKVITSCSSIDFQGNDFKA-------LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
VK++ N KA LV+E+M E LH AV + ++ ++ K
Sbjct: 70 VKLL----------NVIKAENDKDIYLVFEYM-----ETDLH--AVIRANILEDVHK--- 109
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
I + A+ Y+H V+H DLKP N+LL++D + DFGLAR +S L
Sbjct: 110 ---RYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR---SLSEL 160
Query: 836 TQSCSVGVR----GTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEG 889
++ V T Y APE LGS T G D++S G +L EM+ GK +F G
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP----LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNI-RHRNLVKV 725
+IG G+FG V K +DG + + ++ + + + F E + L + H N++ +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKLTLLQRIN 780
+ +C + + L E+ +G+L ++L V + D I L+ Q ++
Sbjct: 74 LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A DVA +DYL Q+ +H DL N+L+ + +A + DFGL+R ++
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------- 175
Query: 841 VGVRGTIG-----YAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
V V+ T+G + A E S +TN D++SYG+LL E+V+
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV--ITS 728
+G G FG V+ +++ T VA+K +FLAE +K ++H LVK+ + +
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
I ++ EFM GSL ++L D E K L + I+ + +A
Sbjct: 72 KEPI--------YIITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEG 114
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ ++ Q +H DL+ N+L+ ++ + DFGLARV ++ + G + I
Sbjct: 115 MAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE---GAKFPIK 168
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE + D++S+GILL+E+VT G+ P
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNIRHRNLVKV 725
++G G++G V K G IVAIK F + K+ L E K L+ +RH N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ +G + LV+E++ LE +A P + + + + Q +
Sbjct: 66 KEAFRR---KGRLY--LVFEYVERTLLELL---EASP-GGLPPDAVRSYIWQLLQ----- 111
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
AI Y H H ++H D+KP N+L+ + + DFG AR + + V R
Sbjct: 112 --AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR- 165
Query: 846 TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
Y APE +G D+++ G ++ E++ G+ +F GD
Sbjct: 166 --WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP----LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 42/226 (18%)
Query: 674 GSFGSVYKGAFDQDGTIVAIK--VFNLQRHGASKSFLAECKALKNIRHRNLVKV--ITSC 729
G++G VY+ + G IVA+K ++ G + L E L ++H N+V V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 730 SSID--FQGNDFKALVYEFMTN---GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
S++D + +V E++ + +E P E++ L+ ++
Sbjct: 76 SNLDKIY-------MVMEYVEHDLKSLMETMKQPFLQS------EVK--CLMLQL----- 115
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
S + +LH + +LH DLK N+LL+N I + DFGLA R+ S L + V
Sbjct: 116 -LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLA--REYGSPLKPYTQLVV- 168
Query: 845 GTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
T+ Y APE LG E ST D++S G + E++T KKP +F G
Sbjct: 169 -TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKP---LFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 44/228 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDG---TIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRN 721
+IG G FG V G G VAIK QR + FL+E + H N
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR----RDFLSEASIMGQFDHPN 66
Query: 722 LVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
++ V+T + +V E+M NGSL+ +L + D + T++Q
Sbjct: 67 IIHLEGVVTKSKPV--------MIVTEYMENGSLDAFLR-----KHD-----GQFTVIQL 108
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ---EVSNL 835
+ + +AS + YL +H DL N+L++++++ V DFGL+RV + E +
Sbjct: 109 VGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE-MVTGKKP 882
T+ + +R T APE + ++ D++SYGI++ E M G++P
Sbjct: 166 TRGGKIPIRWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 671 IGMGSFGSVYKGAFDQDG----TIVAIKVF-NLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG+VYKG + +G VAIKV A+K L E + ++ H ++V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ C S Q L+ + M G L +++ ++ + I LL N + +
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYV-------RNHKDNIGSQYLL---NWCVQI 118
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV--RQEVSNLTQSCSVGV 843
A + YL ++H DL NVL+ + DFGLA++ E + + G
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGG 171
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
+ I + A E L + D++SYG+ + E++T G KP +
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 34/226 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNIRHRNLVKVI 726
L+G GS+G V K + G IVAIK F L+ K + E + LK +RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLH-PDAVPQKDVEIEIQKLTLLQRINIAIDV 785
F+ LV+EF+ + L++ P+ + + V + L Q +
Sbjct: 67 EV-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV-----RKYLFQILR----- 111
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
I++ H H ++H D+KP N+L+ + + DFG AR ++ + + V
Sbjct: 112 --GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART---LAAPGEVYTDYV-A 162
Query: 846 TIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T Y APE +G ++ DI++ G L+ EM+TG + +F GD
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIRHRNLVKVITS 728
L+G G+FG V+KG +D T VA+K K FL+E + LK H N+VK+I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ +V E + G ++L +KD +L Q + A+D A+
Sbjct: 61 CTQ-----RQPIYIVMELVPGGDFLSFLR----KKKD------ELKTKQLVKFALDAAAG 105
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ YL + +H DL N L+ + + + DFG++ RQE + S + + I
Sbjct: 106 MAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMS--RQEDDGIYSSSGLK-QIPIK 159
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLE 875
+ APE S+ D++SYGILL E
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK---VFNLQRHGASKSFLAECKALKNIRHRNLVKVIT 727
IG G F VY+ DG VA+K +F+L A + E LK + H N++K
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI--NIAIDV 785
S F ++ +V E G L + + QK + ++ + +
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSRMIK---------HFKKQKRLIPEKTVWKYFVQL 115
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
SA++++H V+H D+KP NV + + +GD GL R + S + G
Sbjct: 116 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVG 168
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD-LNLHNYAR 898
T Y +PE + + DI+S G LL EM + P F GD +NL++ +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 65/264 (24%), Positives = 99/264 (37%), Gaps = 50/264 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
I G+FGSVY G AIKV KS + + N++ + +I S
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIAKNQVTNVKAERAIMMIQGES 56
Query: 731 SI------DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR---INI 781
FQ D+ LV E++ G D I+ L L
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGG--------------DCASLIKTLGGLPEDWAKQY 102
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+V ++ LH Q ++H D+KP N+L+D + DFGL+R E
Sbjct: 103 IAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----- 154
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE----GDLN 892
GT Y APE LG D +S G ++ E + G P D +F+ +N
Sbjct: 155 ---GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN 211
Query: 893 LHNYARTALLDHVIDIVDPILIND 916
+ +D+++ +L D
Sbjct: 212 WPEEVKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF-----LAECKALKNI-RHRNLVK 724
+G G+FGSVY + G +VAIK S+ L E K+L+ + H N+VK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ F+ ND V+E+M G+L L D + E I+ +I
Sbjct: 63 LKEV-----FRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIR--------SIIYQ 107
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSCSV 841
+ + ++H H H DLKP N+L+ + + DFGLAR E+ + T S
Sbjct: 108 ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVS- 160
Query: 842 GVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGK 880
T Y APE L S S+ DI++ G ++ E+ T +
Sbjct: 161 ----TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 69/251 (27%), Positives = 99/251 (39%), Gaps = 53/251 (21%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRH 719
D F +IG G+FG V+ G + A+KV + + AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLLQR 778
+VK+ S FQ + LV E+M G L N L D P++ I +L L
Sbjct: 61 PWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL--- 112
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLA---------- 826
A+D +H + +H D+KP N+L+D D H+ DFGL
Sbjct: 113 ---------ALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDRE 158
Query: 827 RVRQEVSNLTQSCSVGVR---------------GTIGYAAPEYGLGSEVSTNGDIYSYGI 871
+ NL +V VR GT Y APE G+ D +S G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 872 LLLEMVTGKKP 882
+L EM+ G P
Sbjct: 219 ILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 65/234 (27%), Positives = 116/234 (49%), Gaps = 45/234 (19%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNI 717
F A + + +G GS+ +VYKG +G +VA+KV +++ G + + E LK +
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 718 RHRNLV---KVITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQK 772
+H N+V +I + ++ F V+E+M + L ++ HP + +V +
Sbjct: 61 KHANIVLLHDIIHTKETLTF--------VFEYM-HTDLAQYMIQHPGGLHPYNV-----R 106
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG-----DFGLAR 827
L + Q + + Y+H + +LH DLKP N+L I+++G DFGLAR
Sbjct: 107 LFMFQLLR-------GLAYIHG---QHILHRDLKPQNLL-----ISYLGELKLADFGLAR 151
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGK 880
+ + + T S V T+ Y P+ LG+ + S+ DI+ G + +EM+ G+
Sbjct: 152 AKS-IPSQTYSSEV---VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 69/233 (29%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRNLVKV 725
IG GSFG +Y D IK +L + ASK E L ++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA--- 782
S FQ N +V E+ G L I Q+ L I
Sbjct: 65 FAS-----FQENGRLFIVMEYCDGGDLMK------------RINRQRGVLFSEDQILSWF 107
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ ++ + ++H +LH D+K N+ L N M+A +GDFG+AR + L +C
Sbjct: 108 VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV- 163
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
GT Y +PE + DI+S G +L E+ T K P FEG+ NLH
Sbjct: 164 ---GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLH 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 83/327 (25%), Positives = 141/327 (43%), Gaps = 62/327 (18%)
Query: 665 FSSTHLI-----GMGSFGSVYKGAFD--QDGT--IVAIKVFNLQRHGAS--KSFLAECKA 713
F HL G G+FGSV +D QD T +VA+K LQ A + F E +
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEI 58
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVE-IEIQK 772
LK+++H N+VK C S G LV E++ GSL ++L QK E ++ +K
Sbjct: 59 LKSLQHDNIVKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYL------QKHRERLDHRK 109
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV---R 829
L L A + ++YL + +H DL N+L++++ +GDFGL +V
Sbjct: 110 LLLY-----ASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT----GKKPTDV 885
+E + + I + APE S+ S D++S+G++L E+ T P
Sbjct: 162 KEYYKVREPG----ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE 217
Query: 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVR 945
+ ++ ++ H+I+++ N RL CP +
Sbjct: 218 FMR--MMGNDKQGQMIVYHLIELLK-------------NNGRLPAPP-----GCPAEIYA 257
Query: 946 IGVACSVESPQDRMSITNVVHELQSVK 972
I C P R S + + ++++++
Sbjct: 258 IMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 35/228 (15%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNI 717
F + + +G GS+ +VYKG G +VA+K L+ GA + + E LK++
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL 60
Query: 718 RHRNLV---KVITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQK 772
+H N+V +I + ++ LV+E++ + L+ ++ + +V +
Sbjct: 61 KHANIVTLHDIIHTKKTL--------TLVFEYL-DTDLKQYMDDCGGGLSMHNV-----R 106
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L L Q + + Y H VLH DLKP N+L+ + DFGLAR + V
Sbjct: 107 LFLFQLLR-------GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKS-V 155
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTG 879
+ T S V T+ Y P+ LGS E ST+ D++ G + EM TG
Sbjct: 156 PSKTYSNEV---VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-14
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKV-FNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
IG G+ G+VYK G + A+KV + + E + L+++ H N+VK C
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----C 137
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
+ + + L+ EFM GSLE D DV A + S I
Sbjct: 138 HDMFDHNGEIQVLL-EFMDGGSLEGTHIADEQFLADV---------------ARQILSGI 181
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS---CSVGVRGT 846
YLH + ++H D+KP N+L+++ + DFG++R+ L Q+ C+ V GT
Sbjct: 182 AYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI------LAQTMDPCNSSV-GT 231
Query: 847 IGYAAPEYGLGSEVSTN----------GDIYSYGILLLEMVTGKKPTDVMFEGD 890
I Y +PE ++T+ GDI+S G+ +LE G+ P V +GD
Sbjct: 232 IAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 671 IGMGSFGSV----YKGAFDQDGTIVAIKVFNLQRHGASKSFL-AECKALKNIRHRNLVKV 725
+G G FG V Y D G VA+K + G + L E + L+N+ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
C+ + GN K L+ EF+ +GSL+ +L P+ K+ L Q++ A+ +
Sbjct: 72 KGICT--EDGGNGIK-LIMEFLPSGSLKEYL-----PRN-----KNKINLKQQLKYAVQI 118
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+DYL +H DL NVL++++ +GDFGL + E + +
Sbjct: 119 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDLDS 174
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
+ + APE + S+ D++S+G+ L E++T
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 39/232 (16%)
Query: 671 IGMGSFGS--VYKGAFDQDGTIVAIKVFNLQRHGASKSFLA--ECKALKNIRHRNLVKVI 726
+G G+FG +Y+ +D ++V K NL R + A E L ++H N++
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR---INIAI 783
F ++ + E+ G+L K V QK L + +
Sbjct: 66 NH-----FMDDNTLLIEMEYANGGTLY---------DKIVR---QKGQLFEEEMVLWYLF 108
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ SA+ Y+H + +LH D+K N+ L + +GDFG++++ ++ ++
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV--- 162
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD--LNL 893
GT Y +PE G + + DI++ G +L E++T K+ F+ LNL
Sbjct: 163 -GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDATNPLNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 35/81 (43%), Positives = 53/81 (65%)
Query: 116 LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQL 175
L G IP + L L+ + + N++ G IPP +G++TSLE + L+ N+F G+IP SLGQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 176 KELKSLGLGANNLSGIIPPSI 196
L+ L L N+LSG +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 31/87 (35%), Positives = 54/87 (62%), Gaps = 1/87 (1%)
Query: 315 LRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK 374
LRG +P+ I+ L LQ++ ++ N + G+IP +G++ L L + N F G+IP+ +G+
Sbjct: 430 LRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 375 LQNLEGMGLYDNQLSGEIPSSLGNLSI 401
L +L + L N LSG +P++LG +
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G++G VYK G +VAIKV L+ + E LK RH N+V S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE-IQKLTLLQRINIAIDVASAI 789
+ D +V E+ GSL++ P +++I + + TL +
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK-----------GL 114
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR----G 845
YLH + +H D+K N+LL D + DFG++ + LT ++ R G
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS------AQLTA--TIAKRKSFIG 163
Query: 846 TIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
T + APE + V G DI++ GI +E+ + P MF +LH
Sbjct: 164 TPYWMAPEV---AAVERKGGYDGKCDIWALGITAIELAELQPP---MF----DLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 32/226 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V+ G + + VAIK N GA + F+ E K + + H LV++
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ Q + +V EFM NG L N+L Q+ ++ L +++ DV
Sbjct: 68 CTQ---QKPLY--IVTEFMENGCLLNYLR-----QRQGKLSKDML-----LSMCQDVCEG 112
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL + +H DL N L+ + + V DFG+ R V + + S G + +
Sbjct: 113 MEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY---VLDDEYTSSSGAKFPVK 166
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNL 893
++ PE S+ S+ D++S+G+L+ E+ T GK P FE N
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 65/242 (26%), Positives = 100/242 (41%), Gaps = 44/242 (18%)
Query: 654 SYESLFKATDG---FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSF 707
LF D F+ IG GSFG+VY + +VAIK + Q + +
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 708 LAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQ 763
+ E + L+ +RH N +I+++G + LV E+ GS + L P
Sbjct: 63 IKEVRFLQQLRHPN---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPL 112
Query: 764 KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823
++VEI I + YLH H + +H D+K GN+LL + DF
Sbjct: 113 QEVEIAA----------ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADF 159
Query: 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNG--DIYSYGILLLEMVTGK 880
G A + ++ GT + APE L E +G D++S GI +E+ K
Sbjct: 160 GSASLVSPANSFV--------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 881 KP 882
P
Sbjct: 212 PP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNL-----QRH-----GASKSFLAECKALKNIRH 719
LIG G++G VY G ++A+K L RH K+ +E + LK++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
N+V+ + ++ ++ E++ GS+ + L ++ + + L
Sbjct: 68 LNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---- 118
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
+ YLH + +LH DLK N+L+D D I + DFG+++ ++ + Q+
Sbjct: 119 -------EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 840 SVGVRGTIGYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S ++G++ + APE Y G S DI+S G ++LEM G++P
Sbjct: 169 S--MQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 31/218 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G G FG V G + A K + L++ + L E K L+ + R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQRINIAID 784
+ F+ D LV M G L+ ++ P+ I A
Sbjct: 57 -SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARA------------IFYAAQ 103
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ +++LH Q +++ DLKP NVLLD+ + D GLA V G
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA 155
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT GY APE G + D ++ G L EM+ G+ P
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKAL-KNIRHRNLVKVI 726
IG GSFG V DG A+KV + + K +AE L KN++H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI-AIDV 785
S FQ D V +++ G L + H ++ ++ R A ++
Sbjct: 63 YS-----FQTADKLYFVLDYVNGGEL--FFH----------LQRERSFPEPRARFYAAEI 105
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVR 844
ASA+ YLH +++ DLKP N+LLD+ + DFGL + E S T + C
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC----- 157
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFEGDLN 892
GT Y APE D + G +L EM+ G P T M++ LN
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 54/180 (30%), Positives = 77/180 (42%), Gaps = 31/180 (17%)
Query: 454 LNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSI 513
L L L G IP I L++L+ N+S N++ G IP LG + LE + + N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 514 PSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRIS 573
P SL L ++ ++L+ N+LSG +P L L + +F D G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG--------------- 527
Query: 574 VAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIISTLSAVLGIVMVFFLCFCWFKRR 633
LC GIP L C S KI + + + CW+KRR
Sbjct: 528 ------LC-GIP--GLRACGPHLSVGAKIGI-------AFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 1/94 (1%)
Query: 401 ILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNH 460
+ L L+N L G IP+ + L+ L ++L N + G IP + ++T L L+L+ N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNS 477
Query: 461 LVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLG 494
GSIP +G L LR+ N++ N+LSG +P+ LG
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 30/226 (13%)
Query: 669 HLIGMGSFGSVYKG-AFDQDG----TIVAIKVFNLQRHGAS-KSFLAECKALKNI-RHRN 721
+G G+FG V K A D + VA+K+ ++E + +K I +H+N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH------PDAVPQKDVEIEIQKLTL 775
++ ++ C+ +G + +V E+ +G+L ++L A P E + LT
Sbjct: 78 IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE-ETLTQ 131
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
++ A VA +++L + +H DL NVL+ D + + DFGLAR ++ ++
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHI 185
Query: 836 T--QSCSVGVRGTIGYAAPEYGLGSEVSTN-GDIYSYGILLLEMVT 878
+ + G R + + APE L V T+ D++S+G+LL E+ T
Sbjct: 186 DYYRKTTNG-RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 69/244 (28%), Positives = 111/244 (45%), Gaps = 39/244 (15%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHR 720
D F IG G++G VYK G +VA+K L ++ G + + E K L+ + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 721 NLVK----VITSCSSIDF---QGNDFKALVYEFMTN---GSLENWLHPDAVPQKDVEIEI 770
N+V V ++DF +G + LV+E+M + G LE+
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLES---------------- 108
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
L +I + ++ L++ ++ LH D+K N+LL+N + DFGLAR+
Sbjct: 109 -GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEG 889
+ + V T+ Y PE LG E D++S G +L E+ T KKP +F+
Sbjct: 168 SEESRPYTNKV---ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP---IFQA 220
Query: 890 DLNL 893
+ L
Sbjct: 221 NQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
F+ IG GSFG V+KG ++ +VAIK+ +L+ AE +++I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 725 VITSCSS---IDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
V++ C S + G+ K ++ E++ GS + L P + E Q T+L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 108
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
++ +DYLH E +H D+K NVLL + DFG+A + TQ
Sbjct: 109 ------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD----TQ 155
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + APE S + DI+S GI +E+ G+ P
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK--VFNLQRHGASKSFLAECKALKNIRHRNLVK---- 724
+G G+FG VYK + G +VA+K + + ++ G + L E K LK ++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 725 VITSCSSIDFQGNDFKALVYEFMT---NGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+ + +V +M +G LEN P + K +LQ
Sbjct: 76 AVERPDKSKRKRGSV-YMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQ---- 123
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCS 840
+ I+YLH + +LH D+K N+L+DN I + DFGLAR N
Sbjct: 124 ---LLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 841 VGVRG------TIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGK 880
G R T Y PE LG +T DI+ G + EM T +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 36/227 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNL--------QRHGASKSFLA-ECKALKNIRHR 720
LIG GSFGSVY G G ++A+K L R + LA E LK ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP-DAVPQKDVEIEIQKLTLLQRI 779
N+V+ + S D + E++ GS+ L+ A + V
Sbjct: 67 NIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVR------------ 109
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
N + ++YLH ++H D+K N+L+DN + DFG+++ + +N +
Sbjct: 110 NFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE--ANSLSTK 164
Query: 840 SVGVR----GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ G R G++ + APE + + DI+S G L++EM+TGK P
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 38/221 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
IG G++G+V+K + IVA+K L G S L E LK ++H+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65
Query: 729 CSSIDFQGNDFK-ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
D +D K LV+E+ + L+ + D+ D++ EI K + Q +
Sbjct: 66 ----DVLHSDKKLTLVFEY-CDQDLKKYF--DSC-NGDIDPEIVKSFMFQLLK------- 110
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-----VRQEVSNLTQSCSVG 842
+ + H H VLH DLKP N+L++ + + DFGLAR VR + +
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------ 161
Query: 843 VRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKP 882
T+ Y P+ G+++ ST+ D++S G + E+ +P
Sbjct: 162 ---TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVK---VI 726
+G G++ +V+KG +VA+K L+ GA + + E LKN++H N+V +I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + LV+E++ + L+ +L ++I LL+
Sbjct: 73 HTERCL--------TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR--------- 114
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ Y H +LH DLKP N+L++ + DFGLAR + V T S V T
Sbjct: 115 -GLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKS-VPTKTYSNEV---VT 166
Query: 847 IGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
+ Y P+ LGS E ST D++ G +L EM TG+ MF G
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP----MFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 31/230 (13%)
Query: 671 IGMGSFGSVYKG---AFDQD----GTIVAIKVFNLQRHGASKSF---LAECKALKNI-RH 719
+G G FG V D+D VA+K+ L+ K ++E + +K I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKLT 774
+N++ ++ +C+ Q LV E+ + G+L +L P D + ++LT
Sbjct: 78 KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
++ A VA ++YL + +H DL NVL+ D + + DFGLAR +V N
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---DVHN 186
Query: 835 LT-QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + R + + APE + D++S+G+LL E+ T G P
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-13
Identities = 40/110 (36%), Positives = 58/110 (52%)
Query: 357 LGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVI 416
LG+ G IP ++ KL++L+ + L N + G IP SLG+++ L L L+ NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 417 PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP 466
P LG L L IL+L N L+G +P + S N N + IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
F+ IG GSFG V+KG ++ +VAIK+ +L+ AE +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 725 VITSCSS---IDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
V++ C S + G+ K ++ E++ GS + L E Q T+L+
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD------EFQIATMLK 108
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
I +DYLH E +H D+K NVLL + DFG+A + TQ
Sbjct: 109 EI------LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQ 155
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886
GT + APE S + DI+S GI +E+ G+ P M
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
++G G++G VY +AIK + + E ++HRN+V+ + S
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
S N F + E + GSL L P KD E I T + +
Sbjct: 75 SE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK--------QILEGL 121
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDN-DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
YLH ++H D+K NVL++ + + DFG ++ ++ T++ GT+
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET----FTGTLQ 174
Query: 849 YAAPEY------GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE G G+ DI+S G ++EM TGK P
Sbjct: 175 YMAPEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 30/222 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLA---ECKALKNIRHRNLV 723
++G G++G+VY G +Q G ++A+K L A K + E LK+++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP-DAVPQKDVEIEIQKLTLLQRINIA 782
+ + +C N ++ EF+ GS+ + L+ +P E K T
Sbjct: 66 QYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLP----EPVFCKYTK------- 109
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS-NLTQSCSV 841
+ + YLH++C V+H D+K NV+L + I + DFG AR V + T S +
Sbjct: 110 -QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 842 -GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT + APE S DI+S G + EM TGK P
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGAS-----KSFLAECKALKNIRHRNLV 723
L+G G+FG VY +D D G +A+K + E + LKN++H +V
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ C D + F E+M GS+++ L + V +K T
Sbjct: 68 QYY-GCLRDDETLSIF----MEYMPGGSVKDQLKAYGALTETV---TRKYTR-------- 111
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ ++YLH + ++H D+K N+L D+ +GDFG ++ Q + + + V
Sbjct: 112 QILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-SSGTGMKSV 167
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + +PE G D++S G ++EM+T K P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK----SFLAECKALKNIRHR 720
+ ++G G+FG V+ D +V IK + +K + EC+ LK + H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLSHP 59
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N+++ + F + +V E+ G+L ++ +R N
Sbjct: 60 NIIEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQ-------------------KRCN 95
Query: 781 IAIDVASAIDY-------LHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEV 832
+D + + + LHH + +LH DLK N+LLD + M+ +GDFG++++
Sbjct: 96 SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-- 153
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
++S + V GT Y +PE G + DI++ G +L E+ + K+ +
Sbjct: 154 ---SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 41/229 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK----VFNLQRHGASKSFLAECKALKNIRHRNLVKV- 725
IG G+FG V+ +DG VA+K VF Q + K E K L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 726 -ITSCSSIDFQGNDFKAL--VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
I ID F+ + V E M + LH V + + + K+ L Q
Sbjct: 66 DILQPPHIDP----FEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQ----- 111
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ--EVSNLTQSCS 840
+ + YLH +LH D+KPGN+L++++ + + DFGLARV + E ++TQ
Sbjct: 112 --ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFE 888
T Y APE +GS T+ DI+S G + E++ + ++F+
Sbjct: 167 -----TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNI-RHRNLVKV 725
+IG G+FG V + +DG + + L+ + + F E + L + H N++ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ-----KLTLLQRIN 780
+ +C + + + E+ G+L ++L V + D + LT Q +
Sbjct: 69 LGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A DVA+ + YL ++ +H DL NVL+ ++ + + DFGL+R +
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---------- 170
Query: 841 VGVRGTIG-----YAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
V V+ T+G + A E S +T D++S+G+LL E+V+
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
F+ IG GSFG VYKG ++ +VAIK+ +L+ AE +++I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54
Query: 725 VITSCSS---IDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
V++ C S + G+ K ++ E++ GS + L P P ++ I T+L+
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIA----TILR 108
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
I +DYLH E +H D+K NVLL + DFG+A + TQ
Sbjct: 109 EI------LKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD----TQ 155
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + APE S DI+S GI +E+ G+ P
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 29/222 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTI----VAIKVFNLQRHG--ASKSFLAECKALKNIRHRNLV 723
++G G+FG+VYKG + +G VAIK+ N + G A+ F+ E + ++ H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+++ C S Q LV + M +G L +++H KD I Q L +N +
Sbjct: 73 RLLGVCLSPTIQ------LVTQLMPHGCLLDYVH----EHKD-NIGSQLL-----LNWCV 116
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+A + YL + ++H DL NVL+ + + DFGLAR+ + + + + G
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGG 171
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
+ I + A E + + D++SYG+ + E++T G KP D
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 45/108 (41%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 378 LEGMGLYDNQ-LSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL 436
++G+GL DNQ L G IP+ + L L + L+ NS+ G IP LGS+ L +L L N
Sbjct: 420 IDGLGL-DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 437 NGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLR-VFNVSSN 483
NG+IPE + LT L LNL N L G +P +G R FN + N
Sbjct: 479 NGSIPESLGQLTSL-RILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 39/104 (37%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 22 WKGITCGL----RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFG 77
W G C + L L ++GL G + I L L+ INL NSI+G IP G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 78 RLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
+ LE L LS N G IP +L + L IL L N L G +P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 38/87 (43%), Positives = 49/87 (56%), Gaps = 1/87 (1%)
Query: 338 NQ-LHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
NQ L G IP+ I L L + + GN G IP +G + +LE + L N +G IP SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSL 423
G L+ L L LN NSLSG +P+ LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF---LAECKALKNIRHRNLVKVIT 727
+G G FG V G + A K N +R K + + E + L + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
+ FQ LV M G L ++ +V+ E + + S
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLRYHIY-------NVDEENPGFPEPRACFYTAQIIS 108
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+++LH Q +++ DLKP NVLLDND + D GLA ++ + T+ G GT
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK----GYAGTP 161
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
G+ APE G E + D ++ G+ L EM+ + P
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 671 IGMGSFGSVYKG-AFDQDG----TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G G FG V K AF G T VA+K+ + AS S L+E LK + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH------PDAV-------PQKDVEI 768
++K+ +CS + L+ E+ GSL ++L P +
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 769 EIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR- 827
+ + LT+ I+ A ++ + YL + ++H DL NVL+ + DFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
V +E S + +S R + + A E +T D++S+G+LL E+VT G P
Sbjct: 177 VYEEDSYVKRSKG---RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 37/228 (16%)
Query: 671 IGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRN 721
IG G+FG V++ + T+VA+K+ + AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQK------ 772
+VK++ C+ G L++E+M G L +L P A +
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 773 --LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--V 828
L+ +++ IA VA+ + YL + +H DL N L+ +M+ + DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 829 RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
+ +++ ++ +R + PE + +T D+++YG++L E+
Sbjct: 182 SADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVKVITSC 729
IG G+FG V+ G D T VA+K K+ FL E + LK H N+V++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
+ Q +V E + G +L E +L + + I + + A+ +
Sbjct: 63 T----QKQPI-YIVMELVQGGDFLTFL----------RTEGPRLKVKELIQMVENAAAGM 107
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT-IG 848
+YL +H DL N L+ + + DFG++R E + + + G++ +
Sbjct: 108 EYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVK 161
Query: 849 YAAPE---YGLGSEVSTNGDIYSYGILLLE 875
+ APE YG S+ D++S+GILL E
Sbjct: 162 WTAPEALNYG---RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSFLAECKALKNIRHRN 721
F H IG GSFG+VY +VA+K + Q + + + E K L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 722 LVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
+I+++G K LV E+ GS + L P ++VEI LQ
Sbjct: 83 ---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
+ YLH H ++H D+K GN+LL + DFG A ++
Sbjct: 133 ----------GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV- 178
Query: 838 SCSVGVRGTIGYAAPEYGLG-SEVSTNG--DIYSYGILLLEMVTGKKP 882
GT + APE L E +G D++S GI +E+ K P
Sbjct: 179 -------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG GS G V G VA+K +L++ + E +++ +H N+V++ +S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ D +V EF+ G+L D V + E Q + + V A+
Sbjct: 85 ---YLVGDELWVVMEFLEGGALT-----DIVTHTRMNEE-------QIATVCLAVLKALS 129
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGTIGY 849
+LH V+H D+K ++LL +D + DFG A+V +EV + GT +
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYW 181
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE T DI+S GI+++EMV G+ P
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 48/223 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVF-----NLQRHGASKSFLAECKALKNIRHRNLVKV 725
IG GS+G V+K + G IVAIK F + K L E + LK ++H NLV +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIALREIRMLKQLKHPNLVNL 65
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQRINIAI 783
I F+ LV+E+ + ++ N L +P VP E I+K+
Sbjct: 66 IEV-----FRRKRKLHLVFEYCDH-TVLNELEKNPRGVP----EHLIKKIIW-------- 107
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS-- 840
A+++ H H+C +H D+KP N+L+ + DFG AR+ LT
Sbjct: 108 QTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI------LTGPGDDY 157
Query: 841 ---VGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTG 879
V R Y APE +G ++ D+++ G + E++TG
Sbjct: 158 TDYVATR---WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 34/223 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDG--TI-VAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVK- 724
+G GSFG V +G + G I VA+K + FL E + ++ H NL++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 725 --VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI-NI 781
V+ + + +V E GSL + L DA+ L+ + +
Sbjct: 62 YGVVLTHPLM---------MVTELAPLGSLLDRLRKDALGH----------FLISTLCDY 102
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-VRQEVSNLTQSCS 840
A+ +A+ + YL + +H DL N+LL +D +GDFGL R + Q +
Sbjct: 103 AVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ V + APE S D++ +G+ L EM T G++P
Sbjct: 160 LKV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 31/215 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVK---VI 726
+G G++ +VYKG +VA+K L+ GA + + E LK+++H N+V +I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ S+ LV+E++ + L+ +L + + KL L Q +
Sbjct: 74 HTEKSL--------TLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLR------ 115
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
++Y H + VLH DLKP N+L++ + DFGLAR + + T S V T
Sbjct: 116 -GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEV---VT 167
Query: 847 IGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGK 880
+ Y P+ LGS + ST D++ G + EM TG+
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G+G FG V A+K + G + +E + L+ H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL-TLLQRINIAIDVA 786
+ F+ + ++ E+ G L L + R IA V
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGELWTILR-----------DRGLFDEYTARFYIAC-VV 103
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
A +YLH+ +++ DLKP N+LLD++ + DFG A+ + C GT
Sbjct: 104 LAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GT 155
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE L + D +S GILL E++TG+ P
Sbjct: 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G+ G+VY G VAIK NLQ+ + + E ++ +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI---DVAS 787
+ D +V E++ GSL DV E T + IA +
Sbjct: 85 ---YLVGDELWVVMEYLAGGSL-----------TDVVTE----TCMDEGQIAAVCRECLQ 126
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGT 846
A+++LH V+H D+K N+LL D + DFG A++ E QS + GT
Sbjct: 127 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGT 178
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ APE DI+S GI+ +EMV G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 671 IGMGSFGSVYKGAFDQDG-----TIVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVK 724
+G G+FG VYKG T VAIK + F E + + +++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLLQRI 779
++ C+ +++E++ +G L +L H D + E L +
Sbjct: 73 LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 780 NIAIDVASAIDYL--HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-------VRQ 830
+IAI +A+ ++YL HH H DL N L+ + + DFGL+R R
Sbjct: 128 HIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
+ +L + VR + PE L + +T DI+S+G++L E+
Sbjct: 183 QSKSL-----LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 52/222 (23%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS------KSFLAECKALKNIRHRNLV 723
+G G+F S Y+ + GT++A+K R+ +S ++ E + + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ + + F V E+M GS+ + L ++ V I N
Sbjct: 67 R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVII-----------NYTE 110
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ + YLH + ++H D+K N+L+D+ + DFG A + + T +
Sbjct: 111 QLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA--RLAAKGTGAGEFQ 165
Query: 843 --VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GTI + APE G + + D++S G +++EM T K P
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 71/285 (24%), Positives = 112/285 (39%), Gaps = 52/285 (18%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRN 721
+ +G G+ GSV K G I A+K + K L E + K+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 722 LVKVITSC-----SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+VK + SSI + E+ GSL D++ +K ++K
Sbjct: 61 IVKYYGAFLDESSSSI--------GIAMEYCEGGSL------DSIYKK-----VKKRG-- 99
Query: 777 QRIN------IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
RI IA V + YLH ++H D+KP N+LL + DFG
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG------ 150
Query: 831 EVS-NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
VS L S + GT Y APE G S D++S G+ LLE+ + P F
Sbjct: 151 -VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPP 205
Query: 890 DLNLHNYARTALLDHVIDIVDPILINDVED---WDATNKQRLRQA 931
+ LL +++++ +P L ++ + W K ++Q
Sbjct: 206 E-GEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQC 249
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-11
Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 15/241 (6%)
Query: 319 LPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNL 378
+P I L L+ L ++ N++ S+PS + NL L L + N + +PK + L NL
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188
Query: 379 EGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438
+ L N++S ++P + LS L EL L+NNS+ + S L +LK L+ L L N L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246
Query: 439 TI--PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLC 496
+ NL L S N S + +G+L LR ++S N+LS +P L
Sbjct: 247 LPESIGNLSNLETLDLSNNQ------ISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 497 SYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDL 556
LE + N L +L ++ N + SL L N L
Sbjct: 301 LLLELL---LNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNAL 357
Query: 557 E 557
+
Sbjct: 358 D 358
|
Length = 394 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA--LKNIRHRNLVKVITS 728
+G GS+G V DG IK NL+ + AE +A L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 729 CSSIDFQGND-FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL---QRINIAID 784
++G D +V F G L + L QK LL Q + +
Sbjct: 68 -----WEGEDGLLYIVMGFCEGGDLYHKLKE------------QKGKLLPENQVVEWFVQ 110
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+A A+ YLH ++ +LH DLK NV L I VGD G+ARV + ++ + +
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST----LI 163
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
GT Y +PE + D+++ G + EM T K
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 42/238 (17%)
Query: 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTI----VAIKVFNLQRHGASKSFLA---E 710
+ K T+ L+G G FG+V+KG + +G VAIK +Q ++F
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDH 59
Query: 711 CKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI 770
A+ ++ H +V+++ C Q LV + GSL D V Q ++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLL-----DHVRQHRDSLDP 108
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-- 828
Q+L +N + +A + YL H ++H +L N+LL +D I + DFG+A +
Sbjct: 109 QRL-----LNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160
Query: 829 ---RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
++ + + I + A E L + D++SYG+ + EM++ G +P
Sbjct: 161 PDDKKYFYS-------EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 671 IGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIRHRNLVK 724
+G GSFG VY+G D+ T VAIK N + FL E +K ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
++ S QG ++ E MT G L+++L P+ + +L + I +A +
Sbjct: 74 LLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+A + YL+ + +H DL N ++ D +GDFG+ R E T G +
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGK 180
Query: 845 G--TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
G + + +PE +T D++S+G++L E+ T
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 39/241 (16%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHR 720
D + IG G++G VYK G +VA+K L+ G + L E L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 721 N-LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQ 777
+V+++ + G LV+E++ + L+ ++ + + I+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGDFGLARVRQEVSNLT 836
+A + H H V+H DLKP N+L+D + + D GL R
Sbjct: 120 LKGVA--------HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR--------- 159
Query: 837 QSCSVGVRG------TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
+ S+ V+ T+ Y APE LGS ST DI+S G + EM + +F G
Sbjct: 160 -AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP----LFPG 214
Query: 890 D 890
D
Sbjct: 215 D 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/238 (27%), Positives = 102/238 (42%), Gaps = 28/238 (11%)
Query: 646 LRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK 705
R ALQ V + S IG GS G V G VA+K +L++ +
Sbjct: 7 FRAALQLVVSPG--DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE 64
Query: 706 SFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD 765
E +++ H N+V + S + D +V EF+ G+L D V
Sbjct: 65 LLFNEVVIMRDYHHENVVDMYNS-----YLVGDELWVVMEFLEGGALT-----DIVTHTR 114
Query: 766 VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825
+ E Q + + V A+ YLH + V+H D+K ++LL +D + DFG
Sbjct: 115 MNEE-------QIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGF 164
Query: 826 -ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
A+V +EV + GT + APE T DI+S GI+++EM+ G+ P
Sbjct: 165 CAQVSKEVPKRKS-----LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G+FG VYK + G A K+ ++ + F+ E L +H N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---- 68
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F N L+ EF G+L++ + +E+E + LT Q + + A++
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIM---------LELE-RGLTEPQIRYVCRQMLEALN 117
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG----LARVRQEVSNLTQSCSVGVRGT 846
+LH H V+H DLK GN+LL D + DFG Q+ GT
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--------GT 166
Query: 847 IGYAAPEYGLGSEVSTN-----GDIYSYGILLLEMVTGKKP 882
+ APE N DI+S GI L+E+ + P
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 17/225 (7%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRHGAS--KSFLAECKALKNIRH 719
F+ ++G G FGSV + + VA+K+ +S + FL E +K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 720 RNLVKVI-TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
N++K+I S S ++ FM +G L +L + ++ + +Q L
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ ID+AS ++YL + +H DL N +L+ +M V DFGL++ Q
Sbjct: 116 VRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
C+ + + + A E + +T+ D++++G+ + E++T G+ P
Sbjct: 173 CASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 62/314 (19%)
Query: 670 LIGMGSFGSVYKGAF-DQDG--TIVAIKVFN-LQRHGASKSFLAECKALKNIRHRNLVKV 725
+IG G FG VY G D DG A+K N + + FL E +K+ H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ C + +G+ +V +M +G L N++ E T+ I + V
Sbjct: 62 LGIC--LPSEGSPL--VVLPYMKHGDLRNFIRS----------ETHNPTVKDLIGFGLQV 107
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A ++YL + +H DL N +LD V DFGLAR + + G +
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDH 904
+ + A E + +T D++S+G+LL E++T G P Y
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-------------YP------- 204
Query: 905 VIDIVDPILINDVEDWDATN----KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960
DV+ +D T +RL Q + CP + + ++C P+ R +
Sbjct: 205 -----------DVDSFDITVYLLQGRRLLQPEY-----CPDPLYEVMLSCWHPKPEMRPT 248
Query: 961 ITNVVHELQSVKNA 974
+ +V ++ + +
Sbjct: 249 FSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIK---VFNLQRHGASKSFLAECKALKNIRHRNLVKVIT 727
IG G F VY+ D VA+K +F + A + + E LK + H N++K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI--NIAIDV 785
S F ++ +V E G L Q + QK + +R + +
Sbjct: 70 S-----FIEDNELNIVLELADAGDLS---------QMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
SA++++H V+H D+KP NV + + +GD GL R + S + G
Sbjct: 116 CSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVG 168
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD-LNL 893
T Y +PE + + DI+S G LL EM + P F GD +NL
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG GS G V G VA+K+ +L++ + E +++ +H+N+V++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
G + L+ EF+ G+L D V Q +L Q + V A+
Sbjct: 88 ---LVGEELWVLM-EFLQGGALT-----DIVSQT-------RLNEEQIATVCESVLQALC 131
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGTIGY 849
YLH + V+H D+K ++LL D + DFG A++ ++V + GT +
Sbjct: 132 YLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYW 183
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE + T DI+S GI+++EMV G+ P
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 69/228 (30%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 671 IGMGSFGSVYKGAFDQD-GTIVAIKVFN--LQRHGASKSFLAECKALKNIRHRN---LVK 724
+G G++G V AFD G VAIK + Q +K E + LK++ H N L+
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 725 VITSCSSI-DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
V T SS+ DFQ D LV M L N ++ QKL+ +
Sbjct: 82 VFTPASSLEDFQ--DV-YLVTHLM-GADLNNI------------VKCQKLSDDHIQFLVY 125
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ + Y+H ++H DLKP N+ ++ D + DFGLA R +T G
Sbjct: 126 QILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA--RHTDDEMT-----GY 175
Query: 844 RGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGD 890
T Y APE L DI+S G ++ E++TGK +F G
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK----TLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF--NLQRHGASKSFLAECKALKNIRHRNL 722
F ++G G++G V K + IVAIK F + + ++ L E K L+ ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLLQRINI 781
V++ + F+ LV+E++ LE P+ VP + V I +L
Sbjct: 63 VELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI------- 110
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
AI + H + ++H D+KP N+L+ ++ + + DFG AR E SN + V
Sbjct: 111 -----KAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
R Y +PE LG+ D++S G +L E+ G+
Sbjct: 163 ATR---WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 73/231 (31%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA----ECKALKNIRHRN---LV 723
+G G++G+V + G VAIK L R S+ F E + LK+++H N L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
V T S+D + +DF LV FM + H +K E IQ L
Sbjct: 81 DVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVY-------- 125
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ + Y+H ++H DLKPGN+ ++ D + DFGLA RQ S +T G
Sbjct: 126 QMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA--RQTDSEMT-----GY 175
Query: 844 RGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
T Y APE L + DI+S G ++ EM+TGK +F+G +L
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP----LFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG GS G V G +VA+K +L++ + E +++ +H N+V++ S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ D +V EF+ G+L D V + E Q + + V A+
Sbjct: 86 ---YLVGDELWVVMEFLEGGALT-----DIVTHTRMNEE-------QIAAVCLAVLKALS 130
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGTIGY 849
LH + V+H D+K ++LL +D + DFG A+V +EV + GT +
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYW 182
Query: 850 AAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE G EV DI+S GI+++EMV G+ P
Sbjct: 183 MAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-11
Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 1/89 (1%)
Query: 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
L L GL G IP +I L +L S+NL+ N + G+IP +G++ L V ++S N+ +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHL-QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSL 517
IP LG + L + + GN G +P++L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 55/218 (25%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVKVI 726
+G G FGSV +G +QD +I+ + V ++ ++S FL+E +K H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 727 TSC-SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
C +++ +G ++ FM +G L ++L + + Q L + D+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-----VKFMTDI 121
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
AS ++YL + +H DL N +L+ +M V DFGL++ Q +
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI--AKM 176
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + A E +T D++S+G+ + E+ T G+ P
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 671 IGMGSFGSVYKGAFD--QDGTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLVKV 725
IG G++G VYK +DG AIK F Q G S+S E L+ ++H N+V +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 726 ITSCSS---------IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+ D+ +D ++ + ++P V K L
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV-------SIPPSMV-----KSLLW 115
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH----VGDFGLARVRQEV 832
Q +N + YLH VLH DLKP N+L+ + +GD GLAR+
Sbjct: 116 QILN-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVT 878
V TI Y APE LG+ T DI++ G + E++T
Sbjct: 166 LKPLAD-LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 6e-11
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G+ G+VY G VAIK NLQ+ + + E ++ ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ D +V E++ GSL + + + + + + + A+D
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------VCRECLQALD 129
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGTIGY 849
+LH + V+H D+K N+LL D + DFG A++ E QS + GT +
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYW 181
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE DI+S GI+ +EMV G+ P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 54/230 (23%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF-NLQRHGASKS----FLAECKALKNI 717
D + + L+ G+FG ++ G + +VF + AS+ L E L +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI---QKLT 774
H+N++ ++ C + + ++Y +M G+L+ +L Q+ E Q L+
Sbjct: 66 SHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFL------QQCRLGEANNPQALS 115
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
Q +++AI +A + YLH V+H D+ N ++D ++ + D L+R ++
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSR---DLFP 169
Query: 835 LTQSC-SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ C + + A E + E S+ D++S+G+LL E++T G+ P
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 52/230 (22%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G+FG VY+ I A+KV + K +A+ + I RN I +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILVRT 50
Query: 731 SID-----------FQGNDFKALVYEFMTNGSLENWLHPDA-VPQKDVEIEIQKLTLLQR 778
+D FQ + LV ++M+ G L L + + + I +L L
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL--- 107
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
A+++LH + +++ DLKP N+LLD + DFGL++ + T +
Sbjct: 108 ---------ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155
Query: 839 -CSVGVRGTIGYAAPEY-----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
C GT Y APE G V D +S G+L+ EM G P
Sbjct: 156 FC-----GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 73/234 (31%), Positives = 107/234 (45%), Gaps = 42/234 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF----LAECKALKNIRHR 720
++S +G G++GSV + G VAIK L R S+ F E LK+++H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 721 N---LVKVITSCSSID-FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
N L+ V TS S D FQ DF LV +M + HP + E ++Q L
Sbjct: 75 NVIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQTDLQKIMGHPLS------EDKVQYLVY- 124
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
+ + Y+H ++H DLKPGN+ ++ D + DFGLA R + +T
Sbjct: 125 -------QMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMT 172
Query: 837 QSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
G T Y APE L + DI+S G ++ EM+TGK +F+G
Sbjct: 173 -----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 68/234 (29%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKAL-KNIRHRNLVKV 725
+IG GSFG V DG+ A+KV + + +AE L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI-AID 784
S FQ + V +++ G L + H ++ ++ L R A +
Sbjct: 62 HYS-----FQTAEKLYFVLDYVNGGEL--FFH----------LQRERCFLEPRARFYAAE 104
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGV 843
VASAI YLH +++ DLKP N+LLD+ + DFGL + E T + C
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---- 157
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFEGDLN 892
GT Y APE D + G +L EM+ G P M++ L+
Sbjct: 158 -GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-11
Identities = 64/242 (26%), Positives = 96/242 (39%), Gaps = 49/242 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKV-------FNLQRHGASKSFLAECKALKNIRHRNL 722
LIG G G VY VA+K L + K FL E K ++ H +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHPGI 64
Query: 723 VKVITSCSSID--------FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
V V + CS D +G K+L L++ +++ K++ +
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSL---------LKSVWQKESLS-KELAEKTSVGA 114
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
L I + + I+Y+H + VLH DLKP N+LL + D+G A ++
Sbjct: 115 FLS---IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 835 LTQSCSVGVR--------------GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
V R GT Y APE LG S + DIY+ G++L +M+T
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228
Query: 881 KP 882
P
Sbjct: 229 FP 230
|
Length = 932 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 71/259 (27%), Positives = 107/259 (41%), Gaps = 51/259 (19%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSFLAECKALKNIRHRN 721
FS IG GSFG+VY ++ +VAIK + Q + + + E + L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 722 LVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
+I ++G + LV E+ GS + L P ++VEI LQ
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
+ YLH H ++H D+K GN+LL + +GDFG A + +
Sbjct: 127 ----------GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV- 172
Query: 838 SCSVGVRGTIGYAAPEYGLG-SEVSTNG--DIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
GT + APE L E +G D++S GI +E+ K P L
Sbjct: 173 -------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LF 215
Query: 895 NYARTALLDHVIDIVDPIL 913
N + L H+ P L
Sbjct: 216 NMNAMSALYHIAQNESPAL 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G+ G+V+ G VAIK NLQ+ + + E +K +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI---DVAS 787
F D +V E++ GSL DV E T + IA +
Sbjct: 85 ---FLVGDELFVVMEYLAGGSL-----------TDVVTE----TCMDEAQIAAVCRECLQ 126
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGT 846
A+++LH + V+H D+K NVLL D + DFG A++ E QS + GT
Sbjct: 127 ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGT 178
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ APE DI+S GI+ +EMV G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 671 IGMGSFGSVYKG---AFDQDG----TIVAIKVFNLQRHGASKSF---LAECKALKNI-RH 719
+G G FG V D++ T VA+K+ L+ K ++E + +K I +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL------------HPDAVPQKDVE 767
+N++ ++ +C+ Q +V E+ + G+L +L +P VP+
Sbjct: 84 KNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE---- 134
Query: 768 IEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827
++L+ ++ A VA ++YL + +H DL NVL+ D + + DFGLAR
Sbjct: 135 ---EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ ++ + R + + APE + D++S+G+LL E+ T G P
Sbjct: 189 DIHHIDYYKKTTN--GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVF-NLQRHGASKSFLAECK 712
+ K T+ F ++G G+FG+VYKG + +G VAIK A+K L E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+ ++ + ++ +++ C + Q L+ + M G L D V + I Q
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 110
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L +N + +A ++YL + ++H DL NVL+ + DFGLA++
Sbjct: 111 L-----LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-- 160
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
++ + + G + I + A E L + D++SYG+ + E++T G KP D
Sbjct: 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 69/244 (28%), Positives = 102/244 (41%), Gaps = 41/244 (16%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV----FNLQRHGASKSFLAEC 711
+S F + + IG G+ G V G VAIK F H +K E
Sbjct: 9 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYREL 66
Query: 712 KALKNIRHRN---LVKVITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDV 766
+K + H+N L+ V T S++ +F+ LV E M + V Q D+
Sbjct: 67 VLMKLVNHKNIIGLLNVFTPQKSLE----EFQDVYLVMELMDANLCQ-------VIQMDL 115
Query: 767 EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
+ E L Q + I +LH ++H DLKP N+++ +D + DFGLA
Sbjct: 116 DHERMSYLLYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
Query: 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886
R ++ + V R Y APE LG N DI+S G ++ EM+ G V+
Sbjct: 166 RTAG--TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VL 216
Query: 887 FEGD 890
F G
Sbjct: 217 FPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 31/230 (13%)
Query: 671 IGMGSFGSVYKG-AF-------DQDGTIVAIKVFNLQRHGASKSF---LAECKALKNI-R 718
+G G FG V + A+ DQ T VA+K+ L+ + K ++E + +K I +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVT-VAVKM--LKDNATDKDLADLISEMELMKLIGK 76
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK-----L 773
H+N++ ++ C+ Q +V E+ G+L +L P D +I K L
Sbjct: 77 HKNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833
+ ++ A VA ++YL +H DL NVL+ D + + DFGLAR ++
Sbjct: 132 SFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI- 187
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + S G R + + APE + D++S+GIL+ E+ T G P
Sbjct: 188 DYYKKTSNG-RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 38/228 (16%)
Query: 670 LIGMGSFGSVY--KGAFDQD-GTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLV 723
++G GSFG V+ + D G + A+KV L+ ++ + E L + H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAV-PQKDVEIEIQKLTLLQRINIA 782
K+ + FQ L+ +F+ G L L + + ++DV+ + +L L
Sbjct: 62 KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------- 109
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSV 841
A+D+LH +++ DLKP N+LLD + + DFGL++ + S C
Sbjct: 110 -----ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-- 159
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
GT+ Y APE + + D +S+G+L+ EM+TG P F+G
Sbjct: 160 ---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 33/231 (14%)
Query: 671 IGMGSFGSVYKG---AFDQD----GTIVAIKVFNLQRHGASKSF---LAECKALKNI-RH 719
+G G FG V D+D VA+K+ L+ K ++E + +K I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKLT 774
+N++ ++ +C+ Q +V E+ + G+L +L P + +I +++T
Sbjct: 81 KNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
++ VA ++YL + +H DL NVL+ + + + DFGLAR +V+N
Sbjct: 136 FKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR---DVNN 189
Query: 835 LT--QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + + G R + + APE + D++S+G+L+ E+ T G P
Sbjct: 190 IDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNI-RHRNLVKV 725
+IG G+FG V K +DG + + ++ + + + F E + L + H N++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ-----KLTLLQRIN 780
+ +C + + L E+ +G+L ++L V + D I L+ Q ++
Sbjct: 62 LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A DVA +DYL Q+ +H DL N+L+ + +A + DFGL+R ++
Sbjct: 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------- 163
Query: 841 VGVRGTIG-----YAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
V V+ T+G + A E S +TN D++SYG+LL E+V+
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 35/245 (14%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK----VFNLQRHGASKSFLAECKAL 714
F + IG G++G V + G VAIK F++ +K L E K L
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKIL 58
Query: 715 KNIRHRNLVKVITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
++ +H N++ + G DFK +V + M E+ LH + + E +
Sbjct: 59 RHFKHDNIIAIRDILRP---PGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIR 110
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L Q + + Y+H V+H DLKP N+L++ D +GDFG+AR
Sbjct: 111 YFLYQ-------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL--S 158
Query: 833 SNLTQSCSVGVR--GTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
S+ T+ T Y APE L E +T D++S G + EM+ G++ +F G
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ---LFPG 214
Query: 890 DLNLH 894
+H
Sbjct: 215 KNYVH 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 665 FSSTHL-----IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-KSFLAECKALKNIR 718
F++ L IG G+FG+V K GTI+A+K K L + + R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58
Query: 719 HRNLVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
+ ++ F G F+ + E M SL+ + K V E+ K
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELMDI-SLDKFY-------KYVY-EVLKSV 103
Query: 775 LLQRI--NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
+ + I IA+ A++YL + ++H D+KP N+LLD + + DFG++ Q V
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG--QLV 159
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG--------DIYSYGILLLEMVTGKKP 882
++ ++ G R Y APE + + D++S GI L E+ TGK P
Sbjct: 160 DSIAKTRDAGCRP---YMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 62/220 (28%), Positives = 86/220 (39%), Gaps = 39/220 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVIT 727
+G GSFG V G AIK + + + E L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
S FQ + + EF+ G L L DV K ++
Sbjct: 86 S-----FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV----AKF-------YHAELVL 129
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA-RVRQEVSNLTQSCSVGVRGT 846
A +YLH + +++ DLKP N+LLDN V DFG A +V L C GT
Sbjct: 130 AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---C-----GT 178
Query: 847 IGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE G G V D ++ G+LL E + G P
Sbjct: 179 PEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVK---VI 726
+G G++ +V+KG +VA+K L+ GA + + E LK+++H N+V ++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ S+ LV+E++ + L+ ++ + + K+ L Q +
Sbjct: 74 HTDKSL--------TLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQ-------IL 114
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ Y H + VLH DLKP N+L++ + DFGLAR + V T S V T
Sbjct: 115 RGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-VPTKTYSNEV---VT 167
Query: 847 IGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGK 880
+ Y P+ LG SE ST D++ G + EM +G+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 31/223 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVK 724
++G G+FG+VYKG + DG VAIKV A+K L E + + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQRINIA 782
++ C + Q LV + M G L +++ + D + +D+ +N
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL------------LNWC 115
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ +A + YL + ++H DL NVL+ + + DFGLAR+ + T+ + G
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADG 170
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884
+ I + A E L + D++SYG+ + E++T G KP D
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/220 (30%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKAL-KNIRHRNLVK 724
+IG GSFG V DG A+KV L R K +AE L KN++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAERNVLLKNVKHPFLVG 60
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPD-AVPQKDVEIEIQKLTLLQRINIAI 783
+ S FQ + V +F+ G L L + + P+
Sbjct: 61 LHYS-----FQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA------------ 103
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVG 842
++ASA+ YLH +++ DLKP N+LLD+ + DFGL + S+ T + C
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--- 157
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE D + G +L EM+ G P
Sbjct: 158 --GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G+FG VYK + G + A KV + + + ++ E L + H N+VK++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ N+ L+ EF G++ DAV +E+E + LT Q + A++
Sbjct: 72 ---YYENNLWILI-EFCAGGAV------DAVM---LELE-RPLTEPQIRVVCKQTLEALN 117
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
YLH + ++H DLK GN+L D + DFG++ S GT +
Sbjct: 118 YLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPYWM 170
Query: 851 APEYGLGSEVSTN------GDIYSYGILLLEMVTGKKP 882
APE + E S + D++S GI L+EM + P
Sbjct: 171 APEVVM-CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRH 719
D +G G+FG V+ A+KV + R + E + LK + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
++++ + D F ++ E++ G L ++L + + +
Sbjct: 61 PFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLR-----------NSGRFSNSTGL 104
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS- 838
A ++ A++YLH +++ DLKP N+LLD + + DFG A+ ++ + T +
Sbjct: 105 FYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWTL 158
Query: 839 CSVGVRGTIGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
C GT Y APE G V D ++ GIL+ EM+ G P
Sbjct: 159 C-----GTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIK--VFNLQRHGASKSFLAECKA 713
++F+ T+ + +GMG+FG V A DQ G VAIK + +K E K
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCS-ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKL 62
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL 773
LK++RH N++ S S I + V E + LH + + +E + +
Sbjct: 63 LKHLRHENII----SLSDIFISPLEDIYFVTELLGTD-----LH-RLLTSRPLEKQFIQY 112
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833
L Q + + Y+H V+H DLKP N+L++ + + DFGLAR++
Sbjct: 113 FLYQ-------ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD--P 160
Query: 834 NLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGK 880
+T G T Y APE L EV DI+S G + EM+ GK
Sbjct: 161 QMT-----GYVSTRYYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 52/244 (21%)
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RH 719
T F +IG G++G VYK + G +VAIK+ ++ + E L+ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62
Query: 720 RNLVKVITSCSSIDFQGNDFKA----------LVYEFMTNGSLENWLHPDAVPQKDVEIE 769
N+ F G K LV E GS+ D V K + +
Sbjct: 63 PNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLV--KGLRKK 106
Query: 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG--DFGLAR 827
++L I + + YLH + V+H D+K N+LL + A V DFG++
Sbjct: 107 GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSA 161
Query: 828 VRQEVSNLTQSCSVGVRGT-IG---YAAPE-----YGLGSEVSTNGDIYSYGILLLEMVT 878
++ + ++G R T IG + APE + D++S GI +E+
Sbjct: 162 ---QLDS-----TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213
Query: 879 GKKP 882
GK P
Sbjct: 214 GKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 53/239 (22%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSF------------LAECKALKN 716
+G G++G V K G IVAIK + + +K L E K +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
I+H N++ ++ + DF LV + M L +K V+ +I +LT
Sbjct: 77 IKHENIMGLVDV-----YVEGDFINLVMDIM-ASDL----------KKVVDRKI-RLTES 119
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR------VRQ 830
Q I + + + ++ LH +H DL P N+ +++ I + DFGLAR
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 831 EVSNLTQSCS--------VGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGK 880
+S V T+ Y APE +G+E D++S G + E++TGK
Sbjct: 177 TLSKDETMQRREEMTSKVV----TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 56/226 (24%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVF------NLQRHGASKSFLAECKALKNIRHRNLVK 724
+G G+ G+VYK I+A+KV LQ+ S+ ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE-----------------LE 51
Query: 725 VITSCSS---IDFQGNDFK----ALVYEFMTNGSLE-NWLHPDAVPQKDVEIEIQKLTLL 776
++ C S I F G F ++ EFM GSL+ P+ V L
Sbjct: 52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHV--------------L 97
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
RI +A V + YL +LH D+KP N+L++ + DFG++ L
Sbjct: 98 GRIAVA--VVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST------QLV 146
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S + GT Y APE G + + D++S GI +E+ G+ P
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK---SFLAECKALKNIRHRNLVKVIT 727
IG G FG V G + + + V L+ FL E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 728 SC-SSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLLQRINI 781
C SI + LV EF G L+N+L + QKDV LQR+
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV---------LQRM-- 105
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR-QEVSNLTQSCS 840
A +VAS + +LH Q +H DL N L D+ +GD+GLA + E +T+ C
Sbjct: 106 ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 841 VGVRGTIGYAAPEYG-------LGSEVSTNGDIYSYGILLLEMVT 878
+ + APE L + + +I+S G+ + E+ T
Sbjct: 163 A---VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G+ G+VY G VAI+ NLQ+ + + E ++ ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ D +V E++ GSL + + + + + + + A++
Sbjct: 86 ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------VCRECLQALE 130
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-ARVRQEVSNLTQSCSVGVRGTIGY 849
+LH + V+H D+K N+LL D + DFG A++ E S + + GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-----MVGTPYW 182
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
APE DI+S GI+ +EM+ G+ P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-10
Identities = 38/103 (36%), Positives = 53/103 (51%)
Query: 133 LAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192
L + L G IP I L L+SI+L+ N+ GNIP SLG + L+ L L N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
P S+ L+ L ++ N G +P +LG L H F N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 39/259 (15%)
Query: 671 IGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G GS G V+ A D D VA+K L + K L E K ++ + H N+VKV
Sbjct: 13 LGCGSNGLVFS-AVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPD---AVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + E + ++ ++ D + Q + E +L + Q +
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------ 125
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLAR-VRQEVSN---LTQSCSV 841
+ Y+H VLH DLKP NV ++ D++ +GDFGLAR V S+ L++
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180
Query: 842 GVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
T Y +P L T D+++ G + EM+TGK +F G H
Sbjct: 181 ----TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGA---HE----- 224
Query: 901 LLDHVIDIVDPILINDVED 919
L+ + I++ + + ED
Sbjct: 225 -LEQMQLILESVPVVREED 242
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 76/318 (23%), Positives = 122/318 (38%), Gaps = 74/318 (23%)
Query: 671 IGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVK 724
+G G+FG VY+G + D VA+K +S FL E + H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLLQRI 779
+I + F+ + ++ E M G L+++L P+ LT+ +
Sbjct: 74 LI----GVSFERLP-RFILLELMAGGDLKSFLRENRPRPERPSS---------LTMKDLL 119
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DMIAHVGDFGLAR--VRQEVSN 834
A DVA YL + +H D+ N LL +A + DFG+AR R
Sbjct: 120 FCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 835 LTQSCSVGVRGT--IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891
G R I + PE L ++ D++S+G+LL E+ + G P
Sbjct: 177 ------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP------- 223
Query: 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACS 951
N V++ V T RL K CP + RI C
Sbjct: 224 GRTN-------QEVMEFV-------------TGGGRLDPPK-----GCPGPVYRIMTDCW 258
Query: 952 VESPQDRMSITNVVHELQ 969
+P+DR + ++ +Q
Sbjct: 259 QHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
D F +G G+ G V+K + G I+A K+ +L+ A++N R L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 723 VKVITSCSS---IDFQGNDFK----ALVYEFMTNGSLENWLHPDA-VPQKDVEIEIQKLT 774
+V+ C+S + F G + ++ E M GSL+ L +P++
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------- 103
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
+L +++IA V + YL + ++H D+KP N+L+++ + DFG++
Sbjct: 104 ILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQ 153
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
L S + GT Y +PE G+ S DI+S G+ L+EM G+ P
Sbjct: 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 182 GLGANN--LSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSG 239
GLG +N L G IP I L L + ++ N G++PPSLG ++ L + + +N F+G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNG 480
Query: 240 SIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271
SIP SL + L + NS SG++ GG
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGASKS-FLAECKALKNIRHRNLVKV-- 725
+IG GS+G V G VAIK + ++ H + + L E K L+ +RH ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 726 ITSCSSIDFQGNDFKAL--VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
I S +FK + V+E M E+ LH D+ E + L Q +
Sbjct: 67 IMLPPS----RREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR--- 114
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
A+ Y+H V H DLKP N+L + D + DFGLARV T
Sbjct: 115 ----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN-DTPTAIFWTDY 166
Query: 844 RGTIGYAAPEY--GLGSEVSTNGDIYSYGILLLEMVTGK 880
T Y APE S+ + DI+S G + E++TGK
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 670 LIGMGSFGSVYKGAF-DQDGTI--VAIKVFNLQRHGASKS-FLAECKALKNIRHRNLVKV 725
IG G FG VY+G + + VA+K + + FL E ++ H ++VK+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
I + + +V E G L ++L ++ L L I + +
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYL----------QVNKYSLDLASLILYSYQL 116
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
++A+ YL + +H D+ NVL+ + +GDFGL+R ++ S S +
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK---GKL 170
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLE-MVTGKKP 882
I + APE ++ D++ +G+ + E ++ G KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS---FLAECKALKNIRHRN 721
F ++G G FG V G + A K +R K L E + L+ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V + + ++ D LV M G L+ H + + E + +
Sbjct: 62 VVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEG-------RAVFY 107
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A ++ ++ LH QE +++ DLKP N+LLD+ + D GLA E +
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK----- 159
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
G GT+GY APE + + D ++ G LL EM+ G+ P
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 7e-10
Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 41/228 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSFLAECKALKNIRHRN 721
F+ IG GSFG+VY + +VAIK + Q + + + E K L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 722 LVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
SI+++G + LV E+ GS + L P ++VEI LQ
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
+ YLH H ++H D+K GN+LL + DFG A + ++
Sbjct: 137 ----------GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV- 182
Query: 838 SCSVGVRGTIGYAAPEYGLG-SEVSTNG--DIYSYGILLLEMVTGKKP 882
GT + APE L E +G D++S GI +E+ K P
Sbjct: 183 -------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA--ECKALKNIRHRNLVKVITS 728
IG GSFG +DG IK N+ + + + E L N++H N+V+ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA---IDV 785
F+ N +V ++ G L +I Q+ L I + +
Sbjct: 68 -----FEENGNLYIVMDYCEGGDLYK------------KINAQRGVLFPEDQILDWFVQI 110
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A+ ++H +LH D+K N+ L D +GDFG+ARV L ++C G
Sbjct: 111 CLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI----G 163
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
T Y +PE + DI++ G +L EM T K
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 64/234 (27%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 664 GFSSTHLIGMGSFGSVYKGAFDQ--DGTIVAIK----VFNLQRHGASKSFLAECKALKNI 717
+ +G G++G V + + VAIK VF+ + +K L E K L++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHF 58
Query: 718 R-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
R H+N+ + I F GN + +YE + L + P D + +L
Sbjct: 59 RGHKNITCLYDM--DIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQIL 115
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
+ Y+H VLH DLKPGN+L++ D + DFGLAR E
Sbjct: 116 ----------CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 837 QSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
T Y APE L + D++S G +L E++ G+KP +F+G
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP---VFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 671 IGMGSFGSVYKGAF--DQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIRHRNLVKVIT 727
+G G+FG V KG + + VAIKV + + + + E + + + + +V++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
C + LV E + G L +L +KD EI + + L V+
Sbjct: 63 VCEAEALM------LVMEMASGGPLNKFL----SGKKD-EITVSNVVELMH-----QVSM 106
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+ YL + +H DL NVLL N A + DFGL++ + ++ S G + +
Sbjct: 107 GMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPL 162
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886
+ APE + S+ D++SYGI + E + G+KP M
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR----HGASKSFLAECKALKNIRHR 720
F ++G G FG V G + A K +R G S + L E + L+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQ 60
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+V + + ++ D LV M G L+ ++ P + E + +
Sbjct: 61 FVVNLAYA-----YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---------RALF 106
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A ++ ++ LH +E ++ DLKP N+LLD+ + D GLA V+ +
Sbjct: 107 YAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIR--- 159
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
G GT+GY APE + + D + G L+ EM+ G+ P
Sbjct: 160 -GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA---SKSFLAECKALKNIRHRNLVKVIT 727
IG G FG V G + T + V L+ + FL E + ++++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 728 SCSS-IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C+ + LV EF G L+ +L + E+ T LQR+ A ++A
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRS----CRKAELMTPDPTTLQRM--ACEIA 110
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ +LH + +H DL N LL D+ +GD+GL+ + + + V
Sbjct: 111 LGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--P 165
Query: 847 IGYAAPEYGLGSEVSTN---------GDIYSYGILLLEMVT-GKKP 882
+ + APE L EV N +++S G+ + E+ G +P
Sbjct: 166 LRWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 56/234 (23%), Positives = 87/234 (37%), Gaps = 49/234 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKV 725
++G GSFG V + A+KV LQ + + E + L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-ECTMTEKRVLALAGKHPFLTQ 60
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ SC FQ D V E++ G L + + + A ++
Sbjct: 61 LHSC----FQTKDRLFFVMEYVNGGDLMFHIQ-----------RSGRFDEPRARFYAAEI 105
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR- 844
+ +LH +++ DLK NVLLD++ + DFG+ C G+
Sbjct: 106 VLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGM-------------CKEGILG 149
Query: 845 --------GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE D ++ G+LL EM+ G+ P FEGD
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 665 FSSTHLI---GMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHR 720
F HL G+ F FD +VA+K+ A FL E K + +++
Sbjct: 18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP 77
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE------IQKLT 774
N+++++ C S +D ++ E+M NG L +L Q+++E I ++
Sbjct: 78 NIIRLLGVCVS-----DDPLCMITEYMENGDLNQFL-----SQREIESTFTHANNIPSVS 127
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
+ + +A+ +AS + YL +H DL N L+ N + DFG++R N
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR------N 178
Query: 835 LTQSCSVGVRG----TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
L ++G I + A E L + +T D++++G+ L EM T
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 71/241 (29%), Positives = 109/241 (45%), Gaps = 37/241 (15%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIKVFN--LQRHGASKSFLAECK 712
+S F + IG G+ G V AFD G VA+K + Q +K E
Sbjct: 14 DSTFTVLKRYQQLKPIGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV 72
Query: 713 ALKNIRHRN---LVKVITSCSSID-FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI 768
LK + H+N L+ V T S++ FQ LV E M + +L +H +E+
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQD---VYLVMELM-DANLCQVIH--------MEL 120
Query: 769 EIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828
+ ++++ L + I +LH ++H DLKP N+++ +D + DFGLAR
Sbjct: 121 DHERMSYL-----LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172
Query: 829 RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888
+N + V R Y APE LG N DI+S G ++ E+V G V+F+
Sbjct: 173 --ACTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVKGS----VIFQ 223
Query: 889 G 889
G
Sbjct: 224 G 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF---LAECKALKNIRHRNLVKVI 726
L+G G+FG V G A+K+ + A L E + LKN RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S FQ D V E++ G L L + V +D + ++
Sbjct: 62 YS-----FQTKDRLCFVMEYVNGGELFFHLSRERVFSED-----------RTRFYGAEIV 105
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR-QEVSNLTQSCSVGVRG 845
SA+DYLH +++ DLK N++LD D + DFGL + + + + C G
Sbjct: 106 SALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-----G 157
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T Y APE ++ D + G+++ EM+ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G G FG V G + A K + L++ K L E + L+ + +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
+ F+ LV M G L+ H V ++ +E+E + I+ + +
Sbjct: 61 A-----FESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEME-------RVIHYSAQITC 106
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
I +LH +++ D+KP NVLLD+ + D GLA ++ +TQ GT
Sbjct: 107 GILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-----GTN 158
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GY APE S D ++ G + EMV G+ P
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGT--IVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
+G G+FG+V KG + + VA+K+ + + L E ++ + + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C + + LV E G L +L QK+ + + +T L V+
Sbjct: 63 GICEAESWM------LVMELAELGPLNKFL------QKNKHVTEKNITELVH-----QVS 105
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ YL +H DL NVLL A + DFGL++ N ++ + G +
Sbjct: 106 MGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWP 161
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891
+ + APE + S+ D++S+G+L+ E + G+KP M ++
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G+FG VYK + G + A KV + + ++ E + L H +VK++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK-LTLLQRINIAIDVASAI 789
F + ++ EF G++ DA + +E+ + LT Q I + A+
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAV------DA-----IMLELDRGLTEPQIQVICRQMLEAL 123
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGY 849
YLH ++H DLK GNVLL D + DFG++ + V L + S GT +
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDS--FIGTPYW 176
Query: 850 AAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKP 882
APE + + DI+S GI L+EM + P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKV--FNLQRHGASKSFLA-EC--KALKNIRHRNLV 723
L+G G+FG VY +D D G +A+K F+ + SK A EC + LKN+ H +V
Sbjct: 9 LLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ D ++ E M GS+++ L ++V + + L
Sbjct: 68 QYYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-------- 116
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ YLH + ++H D+K N+L D+ +GDFG ++ Q + L+ + V
Sbjct: 117 ---EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-LSGTGMKSV 169
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + +PE G DI+S G ++EM+T K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKN------IRHRNLV 723
++G GSFG V+ AIK L++ EC ++ H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ---KLTLLQRIN 780
+ + FQ + V E++ G D+ IQ K L +
Sbjct: 60 HLYCT-----FQTKENLFFVMEYLNGG--------------DLMFHIQSCHKFDLPRATF 100
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A ++ + +LH + +++ DLK N+LLD D + DFG+ + + + ++C+
Sbjct: 101 YAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCT 155
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE LG + +T+ D +S+G+LL EM+ G+ P
Sbjct: 156 FC--GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 70/324 (21%), Positives = 135/324 (41%), Gaps = 72/324 (22%)
Query: 665 FSSTHL-----IGMGSFGSVY----KGAFDQDG-TIVAIKVFNLQRHGASKS-FLAECKA 713
F ++L +G G FG V+ KG ++ G T+V +K + +S F E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL 773
+ + H+N+V+++ C + ++ E+ G L+ +L A KD +++ L
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLR--ATKSKDEKLKPPPL 114
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--VRQE 831
+ Q++ + +A +D+L + +H DL N L+ + V L++ E
Sbjct: 115 STKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
Query: 832 VSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890
L + + +R + APE + ST D++S+G+L+ E+ T G+ P F G
Sbjct: 172 YYKLRNAL-IPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----FYG- 221
Query: 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE------CPISMV 944
++++ L + + GK+E CP +
Sbjct: 222 -------------------------------LSDEEVLNRLQ-AGKLELPVPEGCPSRLY 249
Query: 945 RIGVACSVESPQDRMSITNVVHEL 968
++ C +P+DR S + +V L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 39/129 (30%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CS 840
A ++ A+++LH + +++ DLK NVLLD D + D+G+ + + T + C
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC- 157
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG-DLNLHNYART 899
GT Y APE G E + D ++ G+L+ EM+ G+ P D++ + D+N +Y
Sbjct: 158 ----GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 900 ALLDHVIDI 908
+L+ I I
Sbjct: 214 VILEKPIRI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKV--FNLQRHGASKSFLA-EC--KALKNIRHRNLV 723
L+G G+FG VY +D D G +A K F+ + SK A EC + LKN++H +V
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ + + + E+M GS+++ L + V + + L
Sbjct: 68 QYY---GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-------- 116
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ YLH + ++H D+K N+L D+ +GDFG ++ Q + ++ + V
Sbjct: 117 ---EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC-MSGTGIRSV 169
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + +PE G D++S G ++EM+T K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGASKSFLAECKALKNI 717
F + + IG G++G V G VAIK + + + L E K L+
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 718 RHRNLVKVITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT- 774
+H N++ ++ F+ F +V E M E L+ I+ Q L+
Sbjct: 61 KHENIIGILDIIRPPSFE--SFNDVYIVQELM-----ETDLYK--------LIKTQHLSN 105
Query: 775 ------LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828
L Q + + Y+H VLH DLKP N+LL+ + + DFGLAR+
Sbjct: 106 DHIQYFLYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
Query: 829 RQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGK 880
+ T + V T Y APE L S + DI+S G +L EM++ +
Sbjct: 156 ADPEHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 671 IGMGSFGSVYKG-AF----DQDGTIVAIKVFNLQRHGASK-SFLAECKALKNI-RHRNLV 723
+G G+FG V + A+ VA+K+ H + + + ++E K + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
++ +C+ G ++ E+ G L N+L +++ + ++ L ++ +
Sbjct: 103 NLLGACTI---GGPIL--VITEYCCYGDLLNFLRR----KRESFLTLEDL-----LSFSY 148
Query: 784 DVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
VA + +L +C +H DL NVLL + I + DFGLAR SN
Sbjct: 149 QVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV------ 198
Query: 843 VRGT----IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
V+G + + APE + D++SYGILL E+ +
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-09
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 31/206 (15%)
Query: 686 QDGTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742
G VAIK+ + F E + H N+V ++ S +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFA 56
Query: 743 VYEFMTNGSLENWLHPDAV--PQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPV 800
V+E++ +L L D + + +Q L D L + +
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGRLMLQVL----------------DALACAHNQGI 100
Query: 801 LHCDLKPGNVLL---DNDMIAHVGDFGLARV---RQEVSNLTQSCSVGVRGTIGYAAPEY 854
+H DLKP N+++ A V DFG+ + ++ T + + V GT Y APE
Sbjct: 101 VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ 160
Query: 855 GLGSEVSTNGDIYSYGILLLEMVTGK 880
G V+ N D+Y++G++ LE +TG+
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNL 722
++G G FG + +G VAI R G S + FLAE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 723 VK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
V+ VIT +++ +V E+M+NG+L+++L +L Q +
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHE----------GQLVAGQLM 110
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG-LARVRQEVSNLTQS 838
+ +AS + YL + +H L VL+++D++ + F L + E T
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT-- 165
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE-MVTGKKP 882
+ + + +AAPE S+ D++S+GI++ E M G++P
Sbjct: 166 --MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 51/232 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G G +G V+ G IVA+K L + + L E L + LVK++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI------ 781
+ FQ +++ L E++ G TLL + +
Sbjct: 69 A-----FQDDEYLYLAMEYVPGGDFR--------------------TLLNNLGVLSEDHA 103
Query: 782 ---AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
++ A+D LH + +H DLKP N L+D + DFGL++ + S
Sbjct: 104 RFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS 157
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
V G+ Y APE G D +S G +L E + G P F G
Sbjct: 158 ----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGS 201
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF---LAECKALKNIRHRNLVKVI 726
L+G G+FG V G A+K+ + A L E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S FQ +D V E+ G L L + V +D + ++
Sbjct: 62 YS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGAEIV 105
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR-QEVSNLTQSCSVGVRG 845
SA+DYLH ++ V++ DLK N++LD D + DFGL + ++ + + C G
Sbjct: 106 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-----G 158
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T Y APE ++ D + G+++ EM+ G+ P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 36/234 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKAL-KNIRHRNLVKV 725
+IG GSFG V + A+KV + + K ++E L KN++H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI-AID 784
S FQ D V +++ G L + H ++ ++ L R A +
Sbjct: 62 HFS-----FQTADKLYFVLDYINGGEL--FYH----------LQRERCFLEPRARFYAAE 104
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGV 843
+ASA+ YLH +++ DLKP N+LLD+ + DFGL + E + T + C
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---- 157
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFEGDLN 892
GT Y APE D + G +L EM+ G P T M++ LN
Sbjct: 158 -GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 60/230 (26%), Positives = 92/230 (40%), Gaps = 35/230 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKV 725
++G GSFG V + AIKV LQ + + E + L +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCT-MTEKRILALAAKHPFLTA 60
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN---IA 782
+ C FQ D V E++ G D+ +IQ+ A
Sbjct: 61 LHCC----FQTKDRLFFVMEYVNGG--------------DLMFQIQRSRKFDEPRSRFYA 102
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSV 841
+V A+ +LH H V++ DLK N+LLD + + DFG+ + T + C
Sbjct: 103 AEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-- 157
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
GT Y APE E + D ++ G+L+ EM+ G+ P + E DL
Sbjct: 158 ---GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 66/256 (25%), Positives = 101/256 (39%), Gaps = 43/256 (16%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAF-DQDGT 689
K++ S ++P R K+ YE F+ +G GSFG V + ++D
Sbjct: 11 KKKDSDSTKEPKRK------NKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFP 57
Query: 690 IVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEF 746
VAIK F + + +E K L I H V + S F+ + LV EF
Sbjct: 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS-----FKDESYLYLVLEF 112
Query: 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806
+ G +L + DV A + +YL +++ DLK
Sbjct: 113 VIGGEFFTFLRRNKRFPNDVGC-----------FYAAQIVLIFEYLQ---SLNIVYRDLK 158
Query: 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDI 866
P N+LLD D + DFG A+V + + + GT Y APE L D
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEYIAPEILLNVGHGKAADW 211
Query: 867 YSYGILLLEMVTGKKP 882
++ GI + E++ G P
Sbjct: 212 WTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 38/235 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKV 725
++G GSFG V + G + A+KV LQ + + E + L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQ 60
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI---A 782
+ C FQ D V EF+ G D+ IQK A
Sbjct: 61 LYCC----FQTPDRLFFVMEFVNGG--------------DLMFHIQKSRRFDEARARFYA 102
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
++ SA+ +LH + +++ DLK NVLLD++ + DFG+ ++ + N + +
Sbjct: 103 AEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFC 157
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFEGDLN 892
GT Y APE + D ++ G+LL EM+ G P D +FE LN
Sbjct: 158 --GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
D F +G G+ G V K G I+A K+ +L+ A++N R L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 723 VKVITSCSS---IDFQGNDFK----ALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLT 774
+V+ C+S + F G + ++ E M GSL+ L +P++
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE---------- 103
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
+L +++IA V + YL Q ++H D+KP N+L+++ + DFG++
Sbjct: 104 ILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQ 153
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
L S + GT Y +PE G+ S DI+S G+ L+E+ G+ P
Sbjct: 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 50/258 (19%), Positives = 105/258 (40%), Gaps = 39/258 (15%)
Query: 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLV 723
G++ + GS G V+ V +K+ G + L E L+N+ H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120
Query: 724 KVITSCSSIDFQG---NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
++ + S + + +Y ++T S + L + Q +
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-------------------RPLPIDQALI 161
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
I + + YLH ++H D+K N+ +++ +GD G A+ +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAF 213
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
+G+ GT+ APE + ++ DI+S GI+L EM+ P+ + + Y ++
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSC 271
Query: 901 LLDHVIDIVDPILINDVE 918
H++ I+ + ++ E
Sbjct: 272 -HSHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 35/229 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKV 725
L+G G+FG V G A+K+ + + + + L E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLTAL 60
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
S FQ +D V E+ G L L + V +D R A ++
Sbjct: 61 KYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSED----------RARFYGA-EI 104
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVR 844
SA+ YLH V++ DLK N++LD D + DFGL + ++ C
Sbjct: 105 VSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----- 156
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
GT Y APE ++ D + G+++ EM+ G+ P + +FE
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKV--FNLQRHGASKSFLA-EC--KALKNIRHRNLV 723
L+G G+FG VY +D D G +A+K F+ SK A EC + LKN+RH +V
Sbjct: 9 LLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ C D + V E+M GS+++ L ++V + L
Sbjct: 68 QYY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQIL-------- 116
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ YLH + ++H D+K N+L D+ +GDFG ++ Q + ++ + V
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC-MSGTGIKSV 169
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT + +PE G D++S ++EM+T K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH 793
FQ + V E++ G L + + + A ++ + +LH
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQ-----------SSGRFDEARARFYAAEIICGLQFLH 113
Query: 794 HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVRGTIGYAAP 852
++ +++ DLK NVLLD D + DFG+ + + C GT Y AP
Sbjct: 114 ---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-----GTPDYIAP 165
Query: 853 EYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
E G + + + D +S+G+LL EM+ G+ P F G+
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 41/244 (16%)
Query: 670 LIGMGSFGSVY---KGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI----RHRNL 722
++G G +G V+ K G I A+KV ++ A KA +NI +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V +I + FQ L+ E+++ G L L + + +D L I++A
Sbjct: 63 VDLIYA-----FQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISLA 112
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSV 841
++ +LH Q+ +++ DLKP N+LLD + DFGL + +T + C
Sbjct: 113 LE------HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-- 161
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG---------KKPTDVMFEGDLN 892
GTI Y APE + S D +S G L+ +M+TG KK D + +G LN
Sbjct: 162 ---GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 893 LHNY 896
L Y
Sbjct: 219 LPPY 222
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFD-QDGTIVAIKVFN--LQRHGASKSFLAECK 712
+++++ + + + +G G++GSV AFD + G VA+K + Q +K E +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVC-AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 68
Query: 713 ALKNIRHRN---LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE 769
LK+++H N L+ V T S++ + ND LV M L N ++
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNI------------VK 113
Query: 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829
QKLT + + + Y+H ++H DLKP N+ ++ D + DFGLAR
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 168
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGK 880
T G T Y APE L + DI+S G ++ E++TG+
Sbjct: 169 -----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV---- 725
+IG G FG VY G + A+K + +R K E AL +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCP 57
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAV-PQKDVEIEIQKLTLLQRINIAID 784
C + F D + + M G L L V +K++ A +
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF------------YATE 105
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ ++++H+ V++ DLKP N+LLD + D GLA + S SV
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV--- 156
Query: 845 GTIGYAAPE-YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT GY APE G+ ++ D +S G +L +++ G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 25/221 (11%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS---FLAECKALKNIRHRN 721
F ++G G FG V G + A K +R K L E + L+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V + + ++ D LV M G L+ ++ P D + + I
Sbjct: 62 VVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIFY 107
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A ++ ++ L +E +++ DLKP N+LLD+ + D GLA E +
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR----- 159
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
G GT+GY APE + + + D + G L+ EM+ G+ P
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 671 IGMGSFGSVYKG-AFD----QDGTIVAIKVFNLQRHGASK-SFLAECKALKNIRHRNLVK 724
+G GSFG VY+G A D + T VA+K N + FL E +K ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQRINI 781
++ S +V E M +G L+++L P+A TL + I +
Sbjct: 74 LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP----TLQEMIQM 124
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A ++A + YL+ + +H DL N ++ +D +GDFG+ R E T
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRK 177
Query: 842 GVRG--TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
G +G + + APE +T+ D++S+G++L E+ +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G G+ GSV K GT++A KV ++ + K L E + + R +V +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
F + + EFM GSL D + +K I ++ L IA+ V +
Sbjct: 72 ----FLNENNICMCMEFMDCGSL------DRIYKKGGPIPVEILG-----KIAVAVVEGL 116
Query: 790 DYLH--HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
YL+ H ++H D+KP N+L+++ + DFG V E+ N VG T
Sbjct: 117 TYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFG---VSGELINSIADTFVG---TS 166
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y +PE G + + D++S GI ++E+ GK P
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 38/228 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKV----FNLQRHGASKSFLAECK---ALKNIRHRNLV 723
+G G FG V + + G + AIK + R +S + E + + RH LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-ESLMCEKRIFETANSERHPFLV 65
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ +C FQ D V E+ G L +H D + + + A
Sbjct: 66 NLF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------------RAVFYAA 108
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVG 842
V + YLH + +++ DLK N+LLD + + DFGL + + T + C
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC--- 162
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE + + D + G+L+ EM+ G+ P F GD
Sbjct: 163 --GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 65/244 (26%), Positives = 93/244 (38%), Gaps = 60/244 (24%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G++G V + VAIK +K L E K L+++ H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 729 CSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
F +VYE M T L +I +
Sbjct: 73 MPPP--HREAFNDVYIVYELMD-------------------------TDLHQI-----IR 100
Query: 787 SAIDYLHHHCQ---------------EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831
S+ HCQ VLH DLKP N+LL+ + + DFGLAR E
Sbjct: 101 SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160
Query: 832 VSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ V T Y APE L SE +T D++S G + E++ G+KP +F G
Sbjct: 161 KGDFMTEYVV----TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKP---LFPGK 212
Query: 891 LNLH 894
+H
Sbjct: 213 DYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 38/249 (15%)
Query: 648 KALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF 707
++L + +L F ++G G++G VYKG + G + AIKV ++ +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEI 59
Query: 708 LAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA-LVYEFMTNGSLENWLHPDAVPQKD 765
E LK HRN+ + G+D + LV EF GS+ +
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL---------- 109
Query: 766 VEIEIQKLTLLQRINIAI---DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822
++ K L+ IA ++ + +LH H V+H D+K NVLL + + D
Sbjct: 110 --VKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVD 164
Query: 823 FGLARVRQEVSNLTQSCSVGVR----GTIGYAAPEY-----GLGSEVSTNGDIYSYGILL 873
FG++ + L + +VG R GT + APE + DI+S GI
Sbjct: 165 FGVS------AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216
Query: 874 LEMVTGKKP 882
+EM G P
Sbjct: 217 IEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVKVI 726
IG GSFG V + I A+K + H S+S LAE L + +V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S FQ + LV F+ G L + L Q++ ++ + R A ++
Sbjct: 60 FS-----FQSPEKLYLVLAFINGGELFHHL------QREGRFDLSR----ARFYTA-ELL 103
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVRG 845
A++ LH + V++ DLKP N+LLD + DFGL ++ + + T + C G
Sbjct: 104 CALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-----G 155
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T Y APE LG + D ++ G+LL EM+TG P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 58/242 (23%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 665 FSSTHLIGMGSFGSVY---KGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNI 717
F ++G G++G V+ K + G + A+KV +Q+ ++ E + L++I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLL 776
R + + FQ + L+ +++ G L L + +++V+I ++ L
Sbjct: 62 RQSPFLVTLHYA----FQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL- 116
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--VRQEVSN 834
A+++LH + +++ D+K N+LLD++ + DFGL++ EV
Sbjct: 117 -----------ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNG--DIYSYGILLLEMVTGKKPTDVMFEGDLN 892
C GTI Y AP+ G + + D +S G+L+ E++TG P V +G+ N
Sbjct: 163 AYSFC-----GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKN 215
Query: 893 LH 894
Sbjct: 216 SQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 41/229 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR----HGASKSFLAECKALKNIRHR 720
F ++G G FG V G + A K +R G + + L E + L+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+V + + ++ D LV M G L+ ++ P D E + +
Sbjct: 61 FVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---------RAVF 106
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA-------RVRQEVS 833
A ++ ++ LH +E +++ DLKP N+LLD+ + D GLA +R V
Sbjct: 107 YAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV- 162
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT+GY APE + + D + G L+ EM+ GK P
Sbjct: 163 -----------GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-08
Identities = 76/247 (30%), Positives = 111/247 (44%), Gaps = 17/247 (6%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS- 153
+ NL L L L N+L +I E L L L + NN+T IPP IG L S
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKSN 141
Query: 154 LESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
L+ + L+ N ++P+ L L LK+L L N+LS +P + NLS L N + N+
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMK 273
LPP + L L L + +N + SLSN L +E L N+ L + G +
Sbjct: 200 -DLPPEIEL-LSALEELDLSNNSII-ELLSSLSNLKNLSGLE-LSNNKLEDLPESIGNLS 255
Query: 274 NLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNL 333
NL +++ N + S ++SL + +NLR L + N L ALP L L
Sbjct: 256 NLETLDLSNNQI--------SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
Query: 334 IMTSNQL 340
+
Sbjct: 308 NLLLTLK 314
|
Length = 394 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK-ALKNIRHRNLVKVITSC 729
+G G+ G V K G I+A K+ +L E K A++N R L KV+ C
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHL-----------EIKPAIRNQIIREL-KVLHEC 56
Query: 730 SS---IDFQGNDFK----ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+S + F G + ++ E M GSL D V +K I +L +I+IA
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEN---ILGKISIA 107
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
V + YL + ++H D+KP N+L+++ + DFG++ L S +
Sbjct: 108 --VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANS 157
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y +PE G+ + DI+S G+ L+EM G+ P
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAEC----KALKNIRHRNLVKV 725
++G GSFG V G A+K L++ EC K + + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ---KLTLLQRINIA 782
C+ FQ + V EF+ G D+ IQ + L + A
Sbjct: 60 HLYCT---FQTKEHLFFVMEFLNGG--------------DLMFHIQDKGRFDLYRATFYA 102
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSV 841
++ + +LH + +++ DLK NV+LD D + DFG+ + N + C
Sbjct: 103 AEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-- 157
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE G + + + D +S+G+LL EM+ G+ P F GD
Sbjct: 158 ---GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G++GSVYK G +A+K L+ L E K + I +++ S
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--------LDESKFNQIIMELDILHKAVSPY 60
Query: 731 SIDFQGNDF-KALVY---EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+DF G F + VY E+M GSL D + V E +L+RI A V
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL------DKLYAGGVATEGIPEDVLRRITYA--VV 112
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ +L + ++H D+KP NVL++ + + DFG++ NL S + G
Sbjct: 113 KGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGC 164
Query: 847 IGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKP 882
Y APE + N D++S G+ +LEM G+ P
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 57/250 (22%), Positives = 114/250 (45%), Gaps = 44/250 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK---SFLAECKALKNIRHRNLVKVIT 727
IG G FG V D + + V L+ + +SK FL + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 728 SC-SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C +I + LV+E+ G L+++L + +++ ++ LLQR+ A ++A
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQL-----LLLQRM--ACEIA 109
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL--ARVRQEVSNLTQSCSVGVR 844
+ + ++H H LH DL N L +D+ VGD+G+ +R +++ V +R
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 845 GTIGYAAPEYG-------LGSEVSTNGDIYSYGILLLEMV-TGKKPTDVMFEGDLNLHNY 896
+ APE + +E + ++++ G+ L E+ +P +
Sbjct: 167 ----WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP----------YSHL 212
Query: 897 ARTALLDHVI 906
+ +L+HVI
Sbjct: 213 SDREVLNHVI 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 30/219 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV---- 725
+IG G FG VY G + A+K + +R K E AL +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCP 57
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAV-PQKDVEIEIQKLTLLQRINIAID 784
C S F D + + + M G L L V + ++ A +
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF------------YAAE 105
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ ++++H+ V++ DLKP N+LLD + D GLA + S SV
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV--- 156
Query: 845 GTIGYAAPE-YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT GY APE G ++ D +S G +L +++ G P
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-08
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 671 IGMGSFGSVYKGAFD-QDGTIVAIKVFN--LQRHGASKSFLAECKALKNIRHRN---LVK 724
+G G++GSV A+D + VA+K + Q ++ E + LK+++H N L+
Sbjct: 23 VGSGAYGSV-CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 725 VITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V T +SI+ +F LV M L N + + + V+ I +L
Sbjct: 82 VFTPATSIE----NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLL-------- 128
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ Y+H ++H DLKP NV ++ D + DFGLA RQ +T G
Sbjct: 129 ----RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADDEMT-----G 174
Query: 843 VRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T Y APE L + DI+S G ++ E++ GK +F G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK----ALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 27/233 (11%)
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKN--IRH 719
F ++G GSFG V + AIK+ L++ + EC ++ +
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
++ +T S FQ D V E++ G L + ++ K Q +
Sbjct: 57 QDKPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQ-----------QVGKFKEPQAV 104
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS- 838
A +++ + +LH + +++ DLK NV+LD++ + DFG+ + T++
Sbjct: 105 FYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
C GT Y APE + D ++YG+LL EM+ G+ P D E +L
Sbjct: 162 C-----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGT----IVAIKVF----NLQRHGASKSFLAECKALKNIRHRNL 722
+G +FG +YKG G +VAIK N Q+ G F E + + H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQK-LTLL 776
V ++ + +++E++ G L +L H D D + ++ L
Sbjct: 70 VCLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-VRQEVSNL 835
++IAI +A+ ++YL H +H DL N+L+ + + D GL+R +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
Q S+ I + PE + + S++ DI+S+G++L E+ + G +P
Sbjct: 182 VQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF---LAECKALKNIRHRNLVKVI 726
L+G G+FG V G A+K+ + A + E + L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ FQ +D V E+ G L L + V ++ R A ++
Sbjct: 62 YA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEE----------RARFYGA-EIV 105
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSCSVGV 843
SA++YLH V++ D+K N++LD D + DFGL ++ +S+ + C
Sbjct: 106 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFC---- 156
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE ++ D + G+++ EM+ G+ P
Sbjct: 157 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-07
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 792 LHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR--GTIGY 849
+HH + ++H D+K N+LL ++ + +GDFG +++ T S VG GT Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVGRTFCGTPYY 211
Query: 850 AAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
APE S D++S G+LL E++T K+P D
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 37/252 (14%)
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV---FNLQRHGASKSFLAECKALKN 716
KA D + +IG G+FG V + A+K+ F + + S F E +
Sbjct: 41 KAED-YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+V++ + FQ + + +V E+M G L N + VP+K + ++ L
Sbjct: 100 ANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL- 153
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
A+D +H ++H D+KP N+LLD + DFG E +
Sbjct: 154 -----------ALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV- 198
Query: 837 QSCSVGVRGTIGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
C V GT Y +PE G D +S G+ L EM+ G P F D
Sbjct: 199 -RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP----FYADSL 252
Query: 893 LHNYARTALLDH 904
+ Y++ ++DH
Sbjct: 253 VGTYSK--IMDH 262
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 74/283 (26%), Positives = 112/283 (39%), Gaps = 53/283 (18%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIR 718
D F +IG G+FG V I A+K+ N L+R AE + R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR--------AETACFREER 52
Query: 719 HRNLVKVITSCSSID-----FQGNDFKALVYEFMTNGSLENWLHP--DAVPQKDVEIEIQ 771
+ V V C I FQ ++ LV ++ G L L D +P+ I
Sbjct: 53 N---VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA 109
Query: 772 KLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831
++ L AI +H Q +H D+KP NVLLD + + DFG +
Sbjct: 110 EMVL------------AIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154
Query: 832 VSNLTQSCSVGVRGTIGYAAPEY------GLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885
+ S +V GT Y +PE G+G + D +S G+ + EM+ G+ P
Sbjct: 155 DGTVQSSVAV---GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP--- 207
Query: 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRL 928
F + + Y + +++H P I DV + QRL
Sbjct: 208 -FYAESLVETYGK--IMNHEERFQFPSHITDVSEEAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 29/222 (13%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHR 720
+ A +VA+KV R AS + FL E K L +
Sbjct: 27 DGLQDFSEKAFAENDNADA----PVLVAVKVL---RPDASDNAREDFLKEVKILSRLSDP 79
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N+ +++ C+ + ++ E+M NG L +L + + L+ +
Sbjct: 80 NIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY 134
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+A +AS + YL +H DL N L+ + + DFG++R NL S
Sbjct: 135 MATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR------NLYSSDY 185
Query: 841 VGVRGT----IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
V+G I + A E L + +T D++++G+ L E++T
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 65/229 (28%), Positives = 95/229 (41%), Gaps = 32/229 (13%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLV 723
F L+G G++G VYKG + G + AIKV ++ + E LK HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66
Query: 724 KVITSCSSIDFQGNDFKA-LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+ + G D + LV EF GS+ + I+ K L+ IA
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------------IKNTKGNTLKEEWIA 114
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ L H Q V+H D+K NVLL + + DFG++ + L + +VG
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS------AQLDR--TVG 166
Query: 843 VR----GTIGYAAPEYGLGSE-----VSTNGDIYSYGILLLEMVTGKKP 882
R GT + APE E D++S GI +EM G P
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 7/161 (4%)
Query: 52 IGNLSFLREINLMNNSIQGEIPREFGRL-FRLEALFLSDNDLVGEIPANLSYCSRLTILF 110
+ L+ L ++L NN+I +IP G L L+ L LSDN + +P+ L L L
Sbjct: 112 LLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLD 169
Query: 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPN 170
L N L +P +L L L + N ++ +PP I L++LE + L+ N + +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN-SIIELLS 226
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
SL LK L L L +NN +P SI NLS L + NQ
Sbjct: 227 SLSNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 35/116 (30%), Positives = 63/116 (54%), Gaps = 16/116 (13%)
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
IA+ + A++YLH + V+H D+KP NVL++ + + DFG++ V ++ ++
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTID 163
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNG-----DIYSYGILLLEMVTGKKPTD---VMFE 888
G + Y APE + E++ G D++S GI ++E+ TG+ P D F+
Sbjct: 164 AGCKP---YMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 36/128 (28%), Positives = 66/128 (51%), Gaps = 10/128 (7%)
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+++ A++YLH + +++ DLK NVLLD++ + D+G+ + + T +
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--- 157
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG---DLNLHNYARTA 900
GT Y APE G + + D ++ G+L+ EM+ G+ P D++ D N +Y
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216
Query: 901 LLDHVIDI 908
+L+ I I
Sbjct: 217 ILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 57/251 (22%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSV---YKGAFDQDGTIVAIKVFN--LQRHGASKSFLAE 710
+S F + + IG G+ G V Y +++ VAIK + Q +K E
Sbjct: 17 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRE 73
Query: 711 CKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI-- 768
+K + H+N++ L+ F SLE + +DV I
Sbjct: 74 LVLMKCVNHKNII-----------------GLLNVFTPQKSLEEF--------QDVYIVM 108
Query: 769 EIQKLTLLQRINIAID----------VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818
E+ L Q I + +D + I +LH ++H DLKP N+++ +D
Sbjct: 109 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
+ DFGLAR +T T Y APE LG N DI+S G ++ EM+
Sbjct: 166 KILDFGLARTAGTSFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 879 GKKPTDVMFEG 889
G V+F G
Sbjct: 221 GG----VLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 68/234 (29%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIR 718
D F +IG G+FG V G + A+K+ N L+R + F E L N
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR-AETACFREERDVLVNGD 59
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP--DAVPQKDVEIEIQKLTLL 776
R IT+ FQ + LV ++ G L L D +P+ + ++ L
Sbjct: 60 RR----WITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL- 113
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSN 834
AID +H Q +H D+KP NVLL D H+ DFG + +R
Sbjct: 114 -----------AIDSVH---QLGYVHRDIKPDNVLL--DKNGHIRLADFG-SCLRLLADG 156
Query: 835 LTQSCSVGVRGTIGYAAPEY------GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
QS +V V GT Y +PE G G D +S G+ + EM+ G+ P
Sbjct: 157 TVQS-NVAV-GTPDYISPEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 66/251 (26%), Positives = 102/251 (40%), Gaps = 57/251 (22%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSV---YKGAFDQDGTIVAIKVFN--LQRHGASKSFLAE 710
+S F + + IG G+ G V Y D++ VAIK + Q +K E
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRE 66
Query: 711 CKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI-- 768
+K + H+N++ +L+ F SLE + +DV +
Sbjct: 67 LVLMKCVNHKNII-----------------SLLNVFTPQKSLEEF--------QDVYLVM 101
Query: 769 EIQKLTLLQRINIAID----------VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818
E+ L Q I + +D + I +LH ++H DLKP N+++ +D
Sbjct: 102 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158
Query: 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
+ DFGLAR +T T Y APE LG N DI+S G ++ EMV
Sbjct: 159 KILDFGLARTAGTSFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 879 GKKPTDVMFEG 889
K ++F G
Sbjct: 214 HK----ILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 39/242 (16%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALK 715
ESL TD + IG G++G VYK +DG++ A+K+ + + AE L+
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQ 73
Query: 716 NI-RHRNLVKVITSCSSIDFQGNDFKA---------LVYEFMTNGSLENWLHPDAVPQKD 765
++ H N+VK F G +KA LV E GS+ + K
Sbjct: 74 SLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSVTELV-------KG 117
Query: 766 VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825
+ I Q+ L I+ + A+ L H ++H D+K N+LL + + DFG+
Sbjct: 118 LLICGQR---LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEY-----GLGSEVSTNGDIYSYGILLLEMVTGK 880
+ + + L ++ SV GT + APE D++S GI +E+ G
Sbjct: 175 S-AQLTSTRLRRNTSV---GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 881 KP 882
P
Sbjct: 231 PP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 36/131 (27%), Positives = 67/131 (51%), Gaps = 12/131 (9%)
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CS 840
+ +++ A+++LH + +++ DLK NVLLD + + D+G+ + + T + C
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC- 157
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMF---EGDLNLHNYA 897
GT Y APE G + + D ++ G+L+ EM+ G+ P D++ D N +Y
Sbjct: 158 ----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 898 RTALLDHVIDI 908
+L+ I I
Sbjct: 214 FQVILEKQIRI 224
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 65/247 (26%), Positives = 94/247 (38%), Gaps = 57/247 (23%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKV---FNLQRHGASKSFLAECKALKNIRHRNLVKVI 726
L+G G G V+ G + A+KV + + K L E + L + H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S FQ + LV ++ G L L P K + E+ + A +V
Sbjct: 68 AS-----FQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARF-------YAAEVL 113
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLA------------------ 826
A++YLH +++ DLKP N+LL H+ DF L+
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 827 --RVRQEVSNLTQSCSVGVR-----GTIGYAAPE----YGLGSEVSTNGDIYSYGILLLE 875
+ + T S R GT Y APE G GS V D ++ GILL E
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224
Query: 876 MVTGKKP 882
M+ G P
Sbjct: 225 MLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 665 FSSTHLIGMGSFGSVY---KGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNI 717
F ++G G++G V+ K G + A+KV +Q+ ++ E + L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 718 RHRN-LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTL 775
R LV + + FQ + L+ +++ G L L + + +V + I ++ L
Sbjct: 62 RRCPFLVTLHYA-----FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVL 116
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--VRQEVS 833
A+D+LH Q +++ D+K N+LLD++ + DFGL++ + +E
Sbjct: 117 ------------ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG--DIYSYGILLLEMVTGKKP 882
C GTI Y APE G + D +S G+L E++TG P
Sbjct: 162 RAYSFC-----GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 671 IGMGSFGSVY----KGAFDQDGTIV--AIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
+G GSFG+VY K A ++ V I V L + ++ E + L + H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDHPAIVK 66
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
S F D ++ E+ L+ L ++++ + L+ Q I
Sbjct: 67 FHAS-----FLERDAFCIITEYCEGRDLDCKL-------EELKHTGKTLSENQVCEWFIQ 114
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV- 843
+ + Y+H Q +LH DLK N+ L N+++ +GDFG++R+ L SC +
Sbjct: 115 LLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRL------LMGSCDLATT 164
Query: 844 -RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
GT Y +PE + DI+S G +L EM
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 43/251 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGT--IVAIKVFN---LQRHGASKSFLAECKALKNIRH 719
F+ ++G GSFG V ++ GT + AIK+ + + + + E + L
Sbjct: 2 FNFLMVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL--- 776
+ + SC FQ D V E++ G D+ IQ++
Sbjct: 60 PPFLTQLHSC----FQTMDRLYFVMEYVNGG--------------DLMYHIQQVGKFKEP 101
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
+ A ++A + +LH + +++ DLK NV+LD + + DFG+ + T
Sbjct: 102 HAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158
Query: 837 QS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
++ C GT Y APE + D +++G+LL EM+ G+ P D E +L
Sbjct: 159 RTFC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---- 209
Query: 896 YARTALLDHVI 906
++++H +
Sbjct: 210 --FQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 651 QKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAE 710
+ + ++S +D + IG G++G V+K ++G+ A+K+ + H + AE
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAE 64
Query: 711 CKALKNIR-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE 769
LK + H N+VK D + D LV E GS+ + V+
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL----------VKGF 114
Query: 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829
+++ ++ IA + A+ L H +H D+K N+LL + + DFG++ +
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS-AQ 173
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEY-----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ L ++ SV GT + APE L S D++S GI +E+ G P
Sbjct: 174 LTSTRLRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 59/257 (22%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
D F S +IG G+FG V G I A+K+ K+ + E + + +IR
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 723 VKVITSCSSI-----DFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLL 776
+ V + + FQ L+ EF+ G + L D + ++ + I + L
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL- 112
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL------ARVRQ 830
AID +H Q +H D+KP N+LLD + DFGL A +
Sbjct: 113 -----------AIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158
Query: 831 EVSNLTQS-------------------------CSVGVRGTIGYAAPEYGLGSEVSTNGD 865
NLT + + GT Y APE + + + D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 866 IYSYGILLLEMVTGKKP 882
+S G+++ EM+ G P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 35/232 (15%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
+ F IG G++G VYK G + AIKV L+ E +K+ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V S + D + EF GSL++ H L+ Q ++
Sbjct: 69 VAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTG-----------PLSESQIAYVS 112
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ + YLH + +H D+K N+LL ++ + DFG++ Q + + + S
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKS-- 165
Query: 843 VRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKPTDVMFE 888
GT + APE + V G DI++ GI +E+ + P MF+
Sbjct: 166 FIGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 53/232 (22%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 671 IGMGSFGSVY-----------KGAFDQDGT-----IVAIKVFNLQRHGASKS----FLAE 710
+G G FG V+ F D + +VA+K+ R A+K+ FL E
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML---REDANKNARNDFLKE 69
Query: 711 CKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI 770
K + ++ N+++++ C + +D ++ E+M NG L +L + + ++
Sbjct: 70 IKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
++ I +A +AS + YL +H DL N L+ + + DFG++R
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--- 178
Query: 831 EVSNLTQSCSVGVRG----TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
NL ++G I + + E L + +T D++++G+ L E++T
Sbjct: 179 ---NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
+ + + + I V AI YLH + ++H D+K N+ +++ +GDFG A
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
++ + G GTI APE DI+S GI+L EM T D +FE D
Sbjct: 234 DI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 39/267 (14%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRH 719
+ F +IG G+FG V + A+K+ N + + + F E L N +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP--DAVPQKDVEIEIQKLTLLQ 777
+ IT+ FQ + LV ++ G L L D +P+ ++ + L +
Sbjct: 61 ----QWITTLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-----DMARFYLAE 110
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
+ IAID + Y+H D+KP N+L+D + + DFG E +
Sbjct: 111 MV-IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160
Query: 838 SCSVGVRGTIGYAAPEYGLGSE-----VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
S +V GT Y +PE E D +S G+ + EM+ G+ P F +
Sbjct: 161 SVAV---GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP----FYAESL 213
Query: 893 LHNYARTALLDHVIDIVDPILINDVED 919
+ Y + +++H P + DV +
Sbjct: 214 VETYGK--IMNHKERFQFPAQVTDVSE 238
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 29/178 (16%)
Query: 708 LAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQK 764
LA C ++H + DF+ +D L+ E+ + G L + + +P +
Sbjct: 119 LAACDHFGIVKHFD-----------DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167
Query: 765 DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824
+ E+ + L +I +A+D +H ++H DLK N+ L I +GDFG
Sbjct: 168 EYEVGL----LFYQIVLALD------EVHSRK---MMHRDLKSANIFLMPTGIIKLGDFG 214
Query: 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
++ Q +++ + GT Y APE S D++S G++L E++T +P
Sbjct: 215 FSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 67/270 (24%)
Query: 671 IGMGSFGSVYKG-AFDQDGT----IVAIKVFNL-QRHGASKSFLAECKALKNI-RHRNLV 723
+G G+FG V + AF + + VA+K+ K+ + E K L +I H N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH-----------PDAVPQKDVEIEIQK 772
++ +C+ G +V E+ G+L N+L ++ + E +K
Sbjct: 75 NLLGACTK---PGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 773 ---------------------------------------LTLLQRINIAIDVASAIDYLH 793
LTL I+ + VA +++L
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL- 189
Query: 794 HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE 853
+H DL N+LL + + + DFGLAR + + + R + + APE
Sbjct: 190 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD--ARLPLKWMAPE 245
Query: 854 YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+T D++S+G+LL E+ + G P
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 33/231 (14%)
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV---FNLQRHGASKSFLAECKALKN 716
KA D F +IG G+FG V + A+K+ F + + S F E ++
Sbjct: 41 KAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE----RD 95
Query: 717 IR-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
I H N ++ + FQ + + +V E+M G L N + +P+K ++ L
Sbjct: 96 IMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL 153
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
A+D +H +H D+KP N+LLD + DFG ++ + + +
Sbjct: 154 ------------ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGM 197
Query: 836 TQSCSVGVRGTIGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ C V GT Y +PE G D +S G+ L EM+ G P
Sbjct: 198 VR-CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVK 724
+G FG VYKG A + VAIK + G + F E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLLQRI 779
++ + ++++ + ++ L +L H D D + L +
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--VRQEVSNLTQ 837
+I +A+ +++L H V+H DL NVL+ + + + D GL R + L
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + +R + +PE + + S + DI+SYG++L E+ + G +P
Sbjct: 185 NSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 61/235 (25%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
IG G+ G VYK F + G ++A+K ++R G + E K R L+ +
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK--QMRRTGNKE----ENK-------RILMDLDVVL 68
Query: 730 SSIDFQGNDFKALVY---EFMTNGSLENWLHPDAVPQKDVEIEIQKLT-----LLQRIN- 780
S +D +V F+T+ DV I ++ ++ LL+RI
Sbjct: 69 KS-----HDCPYIVKCYGYFITD--------------SDVFICMELMSTCLDKLLKRIQG 109
Query: 781 ---------IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831
+ + + A+ YL + V+H D+KP N+LLD + DFG++ +
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167
Query: 832 VSNLTQSCSVGVRGTIGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T+S G Y APE + D++S GI L+E+ TG+ P
Sbjct: 168 SKAKTRSA-----GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 31/230 (13%)
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV---FNLQRHGASKSFLAECKALKN 716
KA D + +IG G+FG V + A+K+ F + + S F E +
Sbjct: 41 KAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+V++ + FQ + + +V E+M G L N + VP+K ++ L
Sbjct: 100 ANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL- 153
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
A+D ++ ++H D+KP N+LLD + DFG ++ +
Sbjct: 154 -----ALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMV 198
Query: 837 QSCSVGVRGTIGYAAPEY----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ C V GT Y +PE G D +S G+ L EM+ G P
Sbjct: 199 R-CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 16/104 (15%)
Query: 785 VASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
VA +D+L +C +H D+ NVLL + +A + DFGLAR SN V
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV------V 270
Query: 844 RGT----IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+G + + APE + D++SYGILL E+ + GK P
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 5/103 (4%)
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L L Q +A + SAIDY+H E ++H D+K NVL++ +GDFG A +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR-- 311
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE 875
+ + G+ GT+ APE G + + DI+S G+++ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 51/234 (21%)
Query: 710 ECKALKNIRHRNLVKVITSCSSIDF-----QGNDFKALVYEFMTNGSLENWLHPDAVPQK 764
E AL + H N++K+ S Q DF +Y FM + + + W K
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W--------K 261
Query: 765 DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824
D + L Q I + A++Y+H + ++H D+K N+ L+ D +GDFG
Sbjct: 262 DRPL------LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT------ 878
A ++ G GT+ +PE G DI+S G++LL+M++
Sbjct: 313 TA---MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369
Query: 879 ---GKKP-------------TDVMF-EGDLNLHNYARTALLDHVIDIVDPILIN 915
G KP D F + L +Y +A +DH V P++ N
Sbjct: 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 26/72 (36%), Positives = 40/72 (55%), Gaps = 2/72 (2%)
Query: 29 LRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88
LRH + +NL + G++ P +G+++ L ++L NS G IP G+L L L L+
Sbjct: 441 LRH--LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498
Query: 89 DNDLVGEIPANL 100
N L G +PA L
Sbjct: 499 GNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 45/243 (18%)
Query: 665 FSSTHLIGMGSFGSVY---KGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNI 717
F ++G G++G V+ K G + A+KV +Q+ + E L+++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP-DAVPQKDVEIEIQKLTLL 776
R + + FQ L+ ++++ G + L+ D + +V ++ L
Sbjct: 62 RQSPFLVTLHYA----FQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL- 116
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR--VRQEVSN 834
A+++LH + +++ D+K N+LLD++ + DFGL++ + +E
Sbjct: 117 -----------ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
Query: 835 LTQSCSVGVRGTIGYAAPEY-----GLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
C GTI Y APE G G V D +S GIL+ E++TG P EG
Sbjct: 163 TYSFC-----GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP--FTLEG 211
Query: 890 DLN 892
+ N
Sbjct: 212 ERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G++G VYK G + A+K+ L+ E +K +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ + + E+ GSL++ H L+ LQ + + +
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLA 120
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS--VGVRGTIG 848
YLH + +H D+K N+LL ++ + DFG+A + +T + + GT
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA------AKITATIAKRKSFIGTPY 171
Query: 849 YAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKPTDVMFE 888
+ APE + V NG DI++ GI +E+ + P MF+
Sbjct: 172 WMAPEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP---MFD 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 43/235 (18%)
Query: 670 LIGMGSFGSVYKGAFDQDGTI---VAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVI 726
LIG G FG VY+ D I K+ NL+ +++ + E NI + + +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDIDKIALW 74
Query: 727 TSCSSIDFQG-------NDFK--ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
+ +ID G FK + Y F+ LE + K ++ + +KL
Sbjct: 75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL---LEKLVENTKEIFKRIKCKNKKLIK-- 129
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA----------R 827
NI D+ + ++Y+H H + H D+KP N+++D + ++ D+G+A
Sbjct: 130 --NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIE 184
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+E +L RGT+ YA + G+ V+ GD+ S G +L+ K P
Sbjct: 185 YSKEQKDLH-------RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-06
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLVKVIT 727
I G+FG VY G + + A+KV ++ AE AL + +V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
S Q + LV E++ G +++ LH D E+ ++ ++ +VA
Sbjct: 72 S-----LQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEEMAVKYIS---------EVAL 115
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828
A+DYLH H ++H DLKP N+L+ N+ + DFGL++V
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 5/108 (4%)
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
+ LT L ++ VA +++L + +H DL NVLL I + DFGLAR
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
SN S + + + APE + +T D++SYGILL E+ +
Sbjct: 289 HDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 39/207 (18%)
Query: 690 IVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745
+VA+K+ R A+K+ FL E K L ++ N+++++ C D ++ E
Sbjct: 48 LVAVKIL---RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITE 99
Query: 746 FMTNGSLENWLH-----------PDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH 794
+M NG L +L DAVP I +LL ++A+ +AS + YL
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL---HVALQIASGMKYL-- 154
Query: 795 HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG----TIGYA 850
+H DL N L+ ++ + DFG++R NL ++G I +
Sbjct: 155 -SSLNFVHRDLATRNCLVGENLTIKIADFGMSR------NLYAGDYYRIQGRAVLPIRWM 207
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMV 877
A E L + +T D++++G+ L E++
Sbjct: 208 AWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 61/257 (23%), Positives = 101/257 (39%), Gaps = 59/257 (22%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRN 721
+ F S +IG G+FG V G + A+K+ K+ + E + + +IR R+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53
Query: 722 LVKVITSCSSI----DFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLL 776
++ S + FQ L+ EF+ G + L D + +++ + I + L
Sbjct: 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL- 112
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL------ARVRQ 830
AID +H Q +H D+KP N+LLD+ + DFGL A +
Sbjct: 113 -----------AIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158
Query: 831 EVSNLTQS-------------------------CSVGVRGTIGYAAPEYGLGSEVSTNGD 865
NL S + GT Y APE + + + D
Sbjct: 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 866 IYSYGILLLEMVTGKKP 882
+S G+++ EM+ G P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIR-HRNLVKVI-- 726
IG G+F V K + G AIK + + L E +AL+ + H N++++I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 727 -----TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
T ++ F+ D +YE + + P +P+K V K + Q +
Sbjct: 67 LFDRKTGRLALVFELMDMN--LYELI-----KGRKRP--LPEKRV-----KSYMYQLL-- 110
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
++D++H + + H D+KP N+L+ +D++ + DFG R T+ S
Sbjct: 111 -----KSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS- 160
Query: 842 GVRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVT 878
T Y APE L T+G DI++ G + E+++
Sbjct: 161 ----TRWYRAPECLL-----TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 28/217 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITS 728
++G GSFG A+K L + A + E L ++H N+V S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR---INIAIDV 785
F+ + +V E+ G L QK I++Q+ L + + +
Sbjct: 67 -----FEADGHLYIVMEYCDGGDLM---------QK---IKLQRGKLFPEDTILQWFVQM 109
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ ++H ++ VLH D+K N+ L + +GDFG AR+ S +C+ G
Sbjct: 110 CLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACT--YVG 162
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T Y PE + DI+S G +L E+ T K P
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A ++ A+D LH +E ++ DL P N+LLD G L +
Sbjct: 91 AAEMVVALDALH---REGIVCRDLNPNNILLD-----DRGHIQLTYFSRWSEVEDSCDGE 142
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
V Y APE G SE + D +S G +L E++TGK
Sbjct: 143 AVENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 7/177 (3%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL 87
GL + L+L + SL + NL L+ ++L N + ++P+ L L L L
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193
Query: 88 SDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147
S N + ++P + S L L L N ++ + +L L L + N L +P
Sbjct: 194 SGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250
Query: 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLAN 204
IGNL++LE++ L+ N + +SLG L L+ L L N+LS +P L LL
Sbjct: 251 IGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)
Query: 772 KLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI-AHVGDFGLARVRQ 830
KL+ + I + A++ LH H ++H D+K NVL D ++ D+GL ++
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T SC GT+ Y +PE G + D ++ G+L E++TGK P + +
Sbjct: 162 -----TPSCY---DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
Query: 891 LNL 893
L+L
Sbjct: 214 LDL 216
|
Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 46/173 (26%), Positives = 69/173 (39%), Gaps = 22/173 (12%)
Query: 710 ECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE 769
E LK I HR ++ +I + +K+ V M + + + D
Sbjct: 136 EIDILKTISHRAIINLIHAYR--------WKSTVCMVMPKYKCDLFTYVDRS-------- 179
Query: 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829
L L Q I I + A+ YLH ++H D+K N+ LD A +GDFG A +
Sbjct: 180 -GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG-AACK 234
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ T C G GT+ +PE DI+S G++L EM
Sbjct: 235 LDAHPDTPQC-YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 64/266 (24%), Positives = 106/266 (39%), Gaps = 69/266 (25%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI----RHR 720
F +G+G+FG V + A+K ++ +++ +A KA ++I +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEADNE 61
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLLQRI 779
+VK+ S FQ D V +++ G + + L + P+ I +LTL
Sbjct: 62 WVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL---- 112
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL-------------- 825
AI+ +H + +H D+KP N+L+D D + DFGL
Sbjct: 113 --------AIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161
Query: 826 --ARVRQ---EVSNL---TQSCSVGVR---------------------GTIGYAAPEYGL 856
+ +RQ E S+L +C G R GT Y APE L
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 857 GSEVSTNGDIYSYGILLLEMVTGKKP 882
+ D +S G++L EM+ G+ P
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 60/265 (22%), Positives = 105/265 (39%), Gaps = 67/265 (25%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI----RHR 720
F +G+G+FG V + A+K ++ ++ +A KA ++I +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEADNE 61
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+V++ S FQ D V +++ G + + L + +D L R
Sbjct: 62 WVVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED----------LARFY 106
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA-------------- 826
IA ++ A++ +H + +H D+KP N+L+D D + DFGL
Sbjct: 107 IA-ELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 827 --RVRQEVSNLT------QSCSVGVR---------------------GTIGYAAPEYGLG 857
VRQ+ + + +C G R GT Y APE L
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 858 SEVSTNGDIYSYGILLLEMVTGKKP 882
+ + D +S G++L EM+ G+ P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 73/276 (26%)
Query: 671 IGMGSFGSVYKG-AFDQDGT----IVAIKVFNL-QRHGASKSFLAECKALKNI-RHRNLV 723
+G G+FG V + AF D T VA+K+ H ++ ++E K L +I H N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHP---DAVPQK--------------DV 766
++ +C+ G +V EF G+L N+L + VP K D+
Sbjct: 75 NLLGACTK---PGGPLMVIV-EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130
Query: 767 EIEIQK---------------------------------------LTLLQRINIAIDVAS 787
++++ LTL I + VA
Sbjct: 131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAK 190
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+++L +H DL N+LL + + + DFGLAR + + + R +
Sbjct: 191 GMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD--ARLPL 245
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE + D++S+G+LL E+ + G P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 41/235 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAEC-----KALKNIRH 719
F+ ++G GSFG V + AIK+ L++ + EC + L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR- 778
+ + SC FQ D V E++ G D+ +IQ++ +
Sbjct: 60 PPFLTQLHSC----FQTMDRLYFVMEYVNGG--------------DLMYQIQQVGRFKEP 101
Query: 779 --INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
+ A ++A + +LH + +++ DLK NV+LD++ + DFG+ + T
Sbjct: 102 HAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158
Query: 837 QS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
++ C GT Y APE + D +++G+LL EM+ G+ P FEG+
Sbjct: 159 KTFC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-05
Identities = 63/231 (27%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 375 LQNLEGMGLYDNQL--SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432
L L + L S + +L NL L L LN N L I L L L L L
Sbjct: 66 LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLD 124
Query: 433 ENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492
N + IP I L L+L+ N + S+P+ + NL L+ ++S N+LS
Sbjct: 125 NNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS------ 176
Query: 493 LGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNL 551
+P LS+L + +DLS N +S +P +E LS LE L+L
Sbjct: 177 -------------------DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 552 SFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEK--NSRNQ 600
S N + + + N+S + ++ N+L + E S NQ
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSN-NKLEDLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 63/233 (27%), Positives = 89/233 (38%), Gaps = 38/233 (16%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK--SFLAECKALKNIRHR 720
F L+G G FG V G I A+KV A + SF E ++I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILSI 57
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQR 778
+ I FQ D LV E+ G L + L + D + + + +L L
Sbjct: 58 SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL--- 113
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
AI +H Q +H D+KP NVL+D + DFG A + LT +
Sbjct: 114 ---------AIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSA------ARLTAN 155
Query: 839 CSVGVR---GTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKP 882
V + GT Y APE G D +S G++ EM+ G+ P
Sbjct: 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 6e-05
Identities = 56/237 (23%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V+ + K + + + + E ++ ++H+N+V+ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ + N ++ EF G L + QK ++ K+ ++I + A
Sbjct: 81 FLN---KANQKLYILMEFCDAGDLSRNI------QKCYKM-FGKIEEHAIVDITRQLLHA 130
Query: 789 IDYLHHHCQEP----VLHCDLKPGNVLLDNDM-----------------IAHVGDFGLAR 827
+ Y H+ P VLH DLKP N+ L + IA +GDFGL++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTN--GDIYSYGILLLEMVTGKKP 882
+ ++ SC GT Y +PE L S + D+++ G ++ E+ +GK P
Sbjct: 191 -NIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 63/267 (23%), Positives = 100/267 (37%), Gaps = 76/267 (28%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRN 721
D F S +IG G+FG V G I A+K KS + E + + ++R R+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERD 53
Query: 722 L---------VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+ VK+ S FQ ++ L+ E++ G + L ++K
Sbjct: 54 ILAEADNPWVVKLYYS-----FQDENYLYLIMEYLPGGDMMTLL-------------MKK 95
Query: 773 LTLLQ---RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL---- 825
T + R IA + AID +H +H D+KP N+LLD + DFGL
Sbjct: 96 DTFTEEETRFYIA-ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
Query: 826 --ARVRQEVSNLTQSCSVGVR----------------------------GTIGYAAPEYG 855
+ + L+ + GT Y APE
Sbjct: 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF 211
Query: 856 LGSEVSTNGDIYSYGILLLEMVTGKKP 882
L + + D +S G+++ EM+ G P
Sbjct: 212 LQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-05
Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 19/152 (12%)
Query: 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK-----LTLLQRINIAIDVASAIDYLHHH 795
+ Y T + + +DV EI + L ++ + VA + +L
Sbjct: 174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL--- 230
Query: 796 CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT----IGYAA 851
+ +H DL N+LL + I + DFGLAR + SN V+G + + A
Sbjct: 231 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV------VKGNARLPVKWMA 284
Query: 852 PEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
PE + D++SYGILL E+ + G P
Sbjct: 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 18/62 (29%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 768 IEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL-HCDLKPGNVLLDNDMIAHVGDFGLA 826
+ +++ ++ +IA +A + LH VL H DL PGN+L+D+ I + D+ A
Sbjct: 78 ETLDEVSEEEKEDIAEQLAELLAKLHQL-PLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
Query: 827 RV 828
Sbjct: 137 GY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
++IG GSFG VY+ VAIK ++ L +KN+ H N++ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 729 CSSIDFQGND---FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ F+ N+ F +V EF+ ++ ++ A + + + KL Q +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ-------L 179
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
A+ Y+H + + H DLKP N+L+D N + DFG A+ + L SV
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLAGQRSVSYI 231
Query: 845 GTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTG 879
+ Y APE LG+ +T+ D++S G ++ EM+ G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 54/238 (22%), Positives = 82/238 (34%), Gaps = 58/238 (24%)
Query: 670 LIGMGSFG--SVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHRNLVKV 725
LIG V+ T+VA+K NL K E + ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWL---HPDAVPQKDVEIEIQKLTLLQRINIA 782
+TS F + +V M GS E+ L P+ +P E+ I I
Sbjct: 65 VTS-----FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP----ELAIA--------FIL 107
Query: 783 IDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
DV +A+DY+H +H +K ++LL D + S L S S+
Sbjct: 108 KDVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVL------------SGLRYSVSM 151
Query: 842 GVRGTIGYAAPEYGLGSEVSTN-----------------GDIYSYGILLLEMVTGKKP 882
G ++ S + DIYS GI E+ G P
Sbjct: 152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 5/106 (4%)
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L+ + + + VA+ +++L + +H DL NVL+ + + DFGLAR
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
SN S + + + APE + +T D++S+GILL E+ T
Sbjct: 293 SNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 46/269 (17%)
Query: 671 IGMGSFGSVYK-----GAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLV-- 723
+G G++G VYK G D+D A+K ++ G S S E L+ ++H N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRD---YALK--QIEGTGISMSACREIALLRELKHPNVISL 63
Query: 724 -KVITSCSS------IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
KV S + D+ +D ++ + + + P +P+ V+ +LL
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK---PVQLPRGMVK------SLL 114
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI----AHVGDFGLARV-RQE 831
+I I YLH + VLH DLKP N+L+ + + D G AR+
Sbjct: 115 YQI------LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 832 VSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGD 890
+ L V V T Y APE LG+ T DI++ G + E++T +P + D
Sbjct: 166 LKPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222
Query: 891 LNLHNYARTALLDHVIDIVDPILINDVED 919
+ N LD + +++ D ED
Sbjct: 223 IKTSNPYHHDQLDRIFNVMGFPADKDWED 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN- 721
+ F + +IG G+FG V G I A+K L+ K LA KA +++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 722 ---LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
+V + S FQ + L+ EF+ G L L +DV R
Sbjct: 60 SPWVVSLYYS-----FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----------TR 104
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
+A + AI+ +H + +H D+KP N+L+D + DFGL+
Sbjct: 105 FYMA-ECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTI---VAIKVFNLQRHGASKSFLAECKALKNIRHRNLV---K 724
+G G++G VYK A +DG A+K ++ G S S E L+ ++H N++ K
Sbjct: 9 VGRGTYGHVYK-AKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 725 VITSCSS------IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
V S S D+ +D ++ + + + P +P+ V+ +LL +
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK---PMQLPRSMVK------SLLYQ 116
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI----AHVGDFGLARV-RQEVS 833
I I YLH + VLH DLKP N+L+ + + D G AR+ +
Sbjct: 117 I------LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGDLN 892
L V V T Y APE LG+ T DI++ G + E++T +P + D+
Sbjct: 168 PLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIK 224
Query: 893 LHNYARTALLDHVIDIVDPILINDVED 919
N LD + ++ D ED
Sbjct: 225 TSNPFHHDQLDRIFSVMGFPADKDWED 251
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 39/150 (26%), Positives = 57/150 (38%), Gaps = 51/150 (34%)
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA--------- 826
L R IA ++ AI+ +H + +H D+KP N+L+D D + DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 827 ----------------------------------RVRQEVSNLTQSCSVGVRGTIGYAAP 852
R RQ L S + GT Y AP
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS----LVGTPNYIAP 213
Query: 853 EYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
E L + + D +S G++L EM+ G+ P
Sbjct: 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 4e-04
Identities = 13/27 (48%), Positives = 16/27 (59%), Gaps = 1/27 (3%)
Query: 2 IAHDPQGILNSWNDS-GHFCEWKGITC 27
+ DP G L+SWN S C W G+TC
Sbjct: 15 LNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 36/218 (16%)
Query: 678 SVYKGAFDQDGTIVAIKVFNLQRHGASK---SFLAECKALKNIRHRNLVKV----ITSCS 730
S+YKG F+ V I+ F G E K L+ I N++K+ I
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ +L+ E+ T G L L D E + L+ ++++AID +
Sbjct: 93 DLPRL-----SLILEYCTRGYLREVL--------DKE---KDLSFKTKLDMAIDCCKGLY 136
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
L+ + +P + +L + L+ + + GL + S + Y
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL-------EKILSSPPFKNVNFMVYF 187
Query: 851 APEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886
+ + SE + DIYS G++L E+ TGK P + +
Sbjct: 188 SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 34/122 (27%), Positives = 59/122 (48%), Gaps = 6/122 (4%)
Query: 762 PQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821
PQ+ ++ LT+ I + VA +++L +H DL N+LL + + +
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKIC 216
Query: 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GK 880
DFGLAR + + + S R + + APE +T D++S+G+LL E+ + G
Sbjct: 217 DFGLARDIYKDPDYVRKGS--ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274
Query: 881 KP 882
P
Sbjct: 275 SP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 70/262 (26%), Positives = 109/262 (41%), Gaps = 77/262 (29%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALK-NIRHRN 721
+ F + LI G++G+VY L RH ++ A K K N+ RN
Sbjct: 1 EDFETIKLISNGAYGAVY-----------------LVRHKETRQRFAMKKINKQNLILRN 43
Query: 722 LV-KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH----PDAVPQKDVEIEIQKLTLL 776
+ +V + F N F ++ S E H + V D TLL
Sbjct: 44 QIQQVFVERDILTFAENPFVVSMF-----CSFETKRHLCMVMEYVEGGDCA------TLL 92
Query: 777 QRIN-IAIDVAS--------AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG--DFGL 825
+ I + +D+A A++YLH++ ++H DLKP N+L+ + + H+ DFGL
Sbjct: 93 KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITS--MGHIKLTDFGL 147
Query: 826 ARVRQEVSNLTQSCSVG-------------VRGTIGYAAPEY----GLGSEVSTNGDIYS 868
+++ + +LT + G V GT Y APE G G V D ++
Sbjct: 148 SKI--GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWA 201
Query: 869 YGILLLEMVTGKKPTDVMFEGD 890
GI+L E + G P F GD
Sbjct: 202 MGIILYEFLVGCVP----FFGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 988 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-114 Score=1091.64 Aligned_cols=903 Identities=32% Similarity=0.503 Sum_probs=766.3
Q ss_pred cCCccccCCCCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccC-CCCCC
Q 001974 4 HDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFG-RLFRL 82 (988)
Q Consensus 4 ~~~~~~~~~w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L 82 (988)
.||.+.+++|..+.+||.|.||+|+. .++|+.|||++|++++.+++++..+++|++|+|++|++++.+|..+. .+++|
T Consensus 42 ~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L 120 (968)
T PLN00113 42 NDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSL 120 (968)
T ss_pred CCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCC
Confidence 47999999999888999999999985 56899999999999999999999999999999999999988887654 99999
Q ss_pred cEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeecccc
Q 001974 83 EALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAAN 162 (988)
Q Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (988)
++|+|++|.+++.+|. +.+++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+|..|.++++|++|+|++|
T Consensus 121 ~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n 198 (968)
T PLN00113 121 RYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASN 198 (968)
T ss_pred CEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCC
Confidence 9999999999988885 56899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccC
Q 001974 163 AFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIP 242 (988)
Q Consensus 163 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p 242 (988)
.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|++++|.+.+.+|..+. .+++|+.|++++|++++.+|
T Consensus 199 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p 277 (968)
T PLN00113 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIP 277 (968)
T ss_pred CCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCc
Confidence 99999999999999999999999999999999999999999999999999988887654 79999999999999999999
Q ss_pred cccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCch
Q 001974 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHS 322 (988)
Q Consensus 243 ~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 322 (988)
..+.++++|+.|++++|.+.+..|..+.++++|+.|++++|.++...+. .+..+++|++|++++|++++.+|..
T Consensus 278 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~------~~~~l~~L~~L~L~~n~l~~~~p~~ 351 (968)
T PLN00113 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV------ALTSLPRLQVLQLWSNKFSGEIPKN 351 (968)
T ss_pred hhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh------hHhcCCCCCEEECcCCCCcCcCChH
Confidence 9999999999999999999999999999999999999999999865543 5678999999999999999999998
Q ss_pred hhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCC
Q 001974 323 IANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402 (988)
Q Consensus 323 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 402 (988)
+..+. +|+.|++++|++.+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+|..|..+++|
T Consensus 352 l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L 430 (968)
T PLN00113 352 LGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLV 430 (968)
T ss_pred HhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCC
Confidence 88875 79999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCC
Q 001974 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482 (988)
Q Consensus 403 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~ 482 (988)
+.|+|++|.+++.+|..+..+++|+.|++++|++.|.+|..+ ..+.+ +.|++++|++++.+|..+.++++|+.|+|++
T Consensus 431 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 508 (968)
T PLN00113 431 YFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508 (968)
T ss_pred CEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcC
Confidence 999999999999999999999999999999999998888765 45677 8999999999999999999999999999999
Q ss_pred cccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCC
Q 001974 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 483 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p 561 (988)
|++++.+|..++.+++|+.|+|++|.++|.+|..|..+++|+.|||++|+++|.+|.. ..+.+|++|++++|+++|.+|
T Consensus 509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 9999999999999999999999999999999999999999999999999999999886 677789999999999999999
Q ss_pred CCcccCcccccccccccccCCCCCCCCCCcccccCCCcccccchhhhhhhhhHHHHHHHHHHHhhhhhccccCCC-CCC-
Q 001974 562 TKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIISTLSAVLGIVMVFFLCFCWFKRRRGP-SKQ- 639 (988)
Q Consensus 562 ~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~- 639 (988)
..+++.++...++.||+.+||..+....+.|..... .. ....++++++++++.+++++++++ ++++|++. .++
T Consensus 589 ~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 663 (968)
T PLN00113 589 STGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TP--SWWFYITCTLGAFLVLALVAFGFV-FIRGRNNLELKRV 663 (968)
T ss_pred CcchhcccChhhhcCCccccCCccccCCCCCccccc--cc--eeeeehhHHHHHHHHHHHHHHHHH-HHHhhhccccccc
Confidence 999999999999999999999876555566643211 11 111122222222222222222222 22222211 111
Q ss_pred C-CChhHH-----HhhccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHH
Q 001974 640 Q-PSRPIL-----RKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA 713 (988)
Q Consensus 640 ~-~~~~~~-----~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~ 713 (988)
. ...... .+....++++++ ...|...+.||+|+||.||+|++..+++.||||+++.... ....|+++
T Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~ 736 (968)
T PLN00113 664 ENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIAD 736 (968)
T ss_pred ccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHH
Confidence 0 000000 011122333333 3457788899999999999999988999999999864322 22356889
Q ss_pred HHhcCCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH
Q 001974 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH 793 (988)
Q Consensus 714 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 793 (988)
+++++||||++++++|.. ++..++||||+++|+|.++++ .++|.++.+|+.|||+|++|||
T Consensus 737 l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~--------------~l~~~~~~~i~~~ia~~L~yLH 797 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR--------------NLSWERRRKIAIGIAKALRFLH 797 (968)
T ss_pred HhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh--------------cCCHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999754 367899999999999999984 4788999999999999999999
Q ss_pred cCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHH
Q 001974 794 HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILL 873 (988)
Q Consensus 794 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl 873 (988)
+.+.++|+||||||+||+++.++.+++. ||.+...... ....++..|+|||++.+..++.++|||||||++
T Consensus 798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl 868 (968)
T PLN00113 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--------TKCFISSAYVAPETRETKDITEKSDIYGFGLIL 868 (968)
T ss_pred cCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--------CCccccccccCcccccCCCCCcccchhhHHHHH
Confidence 7666799999999999999999988875 6655432111 123578999999999999999999999999999
Q ss_pred HHHHhCCCCCCccccCCcchHHHHHHHHhhh-hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccC
Q 001974 874 LEMVTGKKPTDVMFEGDLNLHNYARTALLDH-VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952 (988)
Q Consensus 874 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 952 (988)
|||+||+.||+...........|++....+. ...++|+.+..... ...+...++.+++.+||+
T Consensus 869 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~~Cl~ 932 (968)
T PLN00113 869 IELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----------------VNQNEIVEVMNLALHCTA 932 (968)
T ss_pred HHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----------------ccHHHHHHHHHHHHhhCc
Confidence 9999999999765555556666665443322 33344444322110 112344568899999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHh
Q 001974 953 ESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 953 ~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.||++||||+|++++|+++.+.-
T Consensus 933 ~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 933 TDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CCchhCcCHHHHHHHHHHhhccc
Confidence 99999999999999999986643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-61 Score=610.00 Aligned_cols=516 Identities=33% Similarity=0.514 Sum_probs=485.4
Q ss_pred CcEEEEEcCCCCCccccccccc-CCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceee
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIG-NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (988)
..++.|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+.+.+|..|+.+++|++|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 5789999999999999998766 999999999999999988885 5689999999999999999999999999999999
Q ss_pred cCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC
Q 001974 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 111 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 190 (988)
|++|.+.+..|..|.++++|++|+|++|.+++.+|..|+++++|++|+|++|.+.+.+|..|+++++|++|+|++|++++
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 250 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCccccccc
Q 001974 191 IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFG 270 (988)
Q Consensus 191 ~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~ 270 (988)
.+|..+.++++|+.|++++|++.+.+|..+. .+++|+.|++++|.+++.+|..+.++++|+.|++++|.+.+..|..+.
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 329 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHh
Confidence 9999999999999999999999988887765 799999999999999999999999999999999999999999999999
Q ss_pred CCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccC
Q 001974 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350 (988)
Q Consensus 271 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 350 (988)
.+++|+.|++++|.+.+..+. .+..+++|+.|++++|++++.+|..+.... .|+.|++++|++.+.+|..+..
T Consensus 330 ~l~~L~~L~L~~n~l~~~~p~------~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~ 402 (968)
T PLN00113 330 SLPRLQVLQLWSNKFSGEIPK------NLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-NLFKLILFSNSLEGEIPKSLGA 402 (968)
T ss_pred cCCCCCEEECcCCCCcCcCCh------HHhCCCCCcEEECCCCeeEeeCChhHhCcC-CCCEEECcCCEecccCCHHHhC
Confidence 999999999999999765443 567889999999999999999999988865 7999999999999999999999
Q ss_pred CCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceee
Q 001974 351 LVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILH 430 (988)
Q Consensus 351 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (988)
+++|+.|++++|++++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+. .++|+.|+
T Consensus 403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ 481 (968)
T PLN00113 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLD 481 (968)
T ss_pred CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999998764 58999999
Q ss_pred cCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcccc
Q 001974 431 LFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510 (988)
Q Consensus 431 l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 510 (988)
+++|++++.+|..+.+++.| +.|+|++|++++.+|..+..+++|++|+|++|.++|.+|..|+.+++|+.|+|++|+++
T Consensus 482 ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 560 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560 (968)
T ss_pred CcCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence 99999999999999999999 99999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCc-Cccc
Q 001974 511 GSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFND-LEGE 559 (988)
Q Consensus 511 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~-l~~~ 559 (988)
|.+|..+..+..|+.||+++|+++|.+|.......+....+.+|. +.|.
T Consensus 561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 610 (968)
T PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610 (968)
T ss_pred ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCC
Confidence 999999999999999999999999999987655556666677776 4443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=419.80 Aligned_cols=289 Identities=38% Similarity=0.691 Sum_probs=244.3
Q ss_pred hccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEee
Q 001974 649 ALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728 (988)
Q Consensus 649 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 728 (988)
....|+++++..+|++|...+.||+|+||.||+|... +|+.||||++........++|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 5677999999999999999999999999999999996 669999998865443214669999999999999999999999
Q ss_pred cccccccCCC-ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 729 CSSIDFQGND-FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 729 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
|.+. + +.++|||||++|+|.++++..... +++|.++.+||.++|+||+|||+.+.++||||||||
T Consensus 140 C~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~---------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs 205 (361)
T KOG1187|consen 140 CLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGE---------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS 205 (361)
T ss_pred EecC-----CceEEEEEEccCCCCHHHHhCCCCCC---------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence 9764 4 589999999999999999876521 689999999999999999999999888999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccc-cccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQE-VSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
+|||+|+++++||+|||+|+.... ...... ...||.+|+|||++..+..+.|+|||||||++.|++||+.|.+..
T Consensus 206 sNILLD~~~~aKlsDFGLa~~~~~~~~~~~~----~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 206 SNILLDEDFNAKLSDFGLAKLGPEGDTSVST----TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred HHeeECCCCCEEccCccCcccCCccccceee----ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 999999999999999999965443 111111 006999999999999999999999999999999999999998865
Q ss_pred c-cCCcchHHHHHHHHhh-hhhhhhcccccc-CcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 887 F-EGDLNLHNYARTALLD-HVIDIVDPILIN-DVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 887 ~-~~~~~~~~~~~~~~~~-~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
. .++..+..|+...+.+ .+.+++|+.+.. ..... +....+..++.+|++.+|++||+|.|
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~-----------------~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE-----------------KEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChH-----------------HHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 5 3445588888887777 488999998763 22110 23345789999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 964 VVHELQSVKN 973 (988)
Q Consensus 964 vl~~L~~i~~ 973 (988)
|+++|+.+..
T Consensus 345 Vv~~L~~~~~ 354 (361)
T KOG1187|consen 345 VVKELEGILS 354 (361)
T ss_pred HHHHHHhhcc
Confidence 9999966543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=379.12 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=208.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC-ceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND-FKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~ 741 (988)
+.+.+..||+|..|+||+++++.+++.+|+|++... +....+++.+|++++++.+||+||.+||+|.. +. ...
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEE
Confidence 345678999999999999999999999999999543 34455789999999999999999999999643 35 599
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
|+||||++|+|++++...+ ++++...-+|+.++++||.|||+. .+||||||||+|||++..|++|||
T Consensus 155 I~mEYMDgGSLd~~~k~~g-----------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG-----------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eehhhcCCCCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 9999999999999997653 689999999999999999999963 299999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.++..... ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+....+.....
T Consensus 222 DFGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~--- 292 (364)
T KOG0581|consen 222 DFGVSGILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC--- 292 (364)
T ss_pred cccccHHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH---
Confidence 99999876554 233467999999999999999999999999999999999999998754221111111111
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhcccc-chhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKI-ECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+++ .+.+..+. .+++++++++..|+++||.+|||++|+++.
T Consensus 293 -----~Iv~-------------------~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 -----AIVD-------------------EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -----HHhc-------------------CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 11112233 378899999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=396.53 Aligned_cols=262 Identities=32% Similarity=0.517 Sum_probs=212.7
Q ss_pred CCCCceeccccceeEEEEEECCCCeE-EEEEEeeccccch--hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTI-VAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
....+.+|+|+||+||+|.+ .|+. ||||++....... .++|.+|+.+|.+++|||||+++|+|... ....+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceE
Confidence 34456699999999999999 5666 9999997543222 46899999999999999999999998754 12689
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEeccCCCCCeeeCCCC-cEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP-VLHCDLKPGNVLLDNDM-IAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~k 819 (988)
+||||+++|+|.++++.... ..+++..++.||.|||+||.|||+. + ||||||||+|||++.++ ++|
T Consensus 117 iVtEy~~~GsL~~~l~~~~~---------~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~K 184 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRK---------RKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLK 184 (362)
T ss_pred EEEEeCCCCcHHHHHhhccc---------CCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEE
Confidence 99999999999999987411 4799999999999999999999998 7 99999999999999997 999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccC--CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL--GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|+|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+||+.||...... +.+
T Consensus 185 I~DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-----~~~ 255 (362)
T KOG0192|consen 185 IADFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-----QVA 255 (362)
T ss_pred ECCCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-----HHH
Confidence 99999998665432 1112256999999999999 569999999999999999999999998754221 111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
..... ....+..+..+++.+..+|.+||+.||+.||++.+++..|+.+......
T Consensus 256 ~~v~~--------------------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 256 SAVVV--------------------------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHh--------------------------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11110 1111122335889999999999999999999999999999999887765
Q ss_pred hc
Q 001974 978 AW 979 (988)
Q Consensus 978 ~~ 979 (988)
..
T Consensus 310 ~~ 311 (362)
T KOG0192|consen 310 AG 311 (362)
T ss_pred cC
Confidence 33
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=389.75 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=213.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+.+..++.||+|.||.||.|.+. ....||+|.++.. ....++|.+|+++|++++|++||+++|+|... +.++|
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyI 278 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYI 278 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEE
Confidence 33456789999999999999995 4458999999754 33457899999999999999999999998753 57999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
|||||+.|+|.+|++.... ..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|
T Consensus 279 VtE~m~~GsLl~yLr~~~~---------~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREG---------GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred EEEecccCcHHHHhhhcCC---------CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcc
Confidence 9999999999999987322 4688899999999999999999999 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||+|+...+.. .....+..-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+... +
T Consensus 347 FGLAr~~~d~~---Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----e------ 412 (468)
T KOG0197|consen 347 FGLARLIGDDE---YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----E------ 412 (468)
T ss_pred cccccccCCCc---eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----H------
Confidence 99999443322 222333446789999999999999999999999999999999 99998743211 1
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+.+.++ +......+..||+++.++|..||+.+|++|||++.+...++++...
T Consensus 413 ---v~~~le------------------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 413 ---VLELLE------------------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---HHHHHh------------------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 111111 2223345668999999999999999999999999999999888653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=386.55 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=213.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeec---cccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+|...+.||+|||+.||.+++..+|+.||+|++.. ......+.+.+||++.++++|||||+++++ |++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 569999999999999999999988999999999964 245566789999999999999999999999 566799
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
+|||.|+|+.++|..+++..+ ++++.+++.+++||+.||.|||+. +|+|||||-.|+|++++.++|
T Consensus 93 VYivLELC~~~sL~el~Krrk-----------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK-----------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC-----------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEE
Confidence 999999999999999998543 799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|......... ..+..||+.|.|||++.....+..+||||+||++|-|++|++||+.. .
T Consensus 159 IgDFGLAt~le~~~Er----k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~------- 222 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGER----KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----T------- 222 (592)
T ss_pred ecccceeeeecCcccc----cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----h-------
Confidence 9999999987754322 22356999999999999999999999999999999999999999731 0
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.+.. .+++......+.....+..+||.++|+.||.+|||+++|++.
T Consensus 223 -----vkety----------------~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 223 -----VKETY----------------NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----HHHHH----------------HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11100 112222223344667788999999999999999999999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=369.63 Aligned_cols=201 Identities=32% Similarity=0.548 Sum_probs=180.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
...+|+..+.||+|+||+||+|+++.++..||||.+... .....+.+..|+.+++.++|||||++++++. .++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCC
Confidence 346799999999999999999999999999999999755 3445577899999999999999999999965 458
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND--- 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 815 (988)
..++|||||.||||.+|++..+ .+++..++.++.|||.||++||++ +||||||||.|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~-----------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~ 148 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG-----------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARN 148 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCC
Confidence 9999999999999999998764 689999999999999999999999 99999999999999765
Q ss_pred ---CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 816 ---MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 816 ---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
-.+||+|||+|+......... ...|++.|||||+++..+|+.|+|+||.|+++|++++|+.||+.
T Consensus 149 ~~~~~LKIADFGfAR~L~~~~~a~-----tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 149 DTSPVLKIADFGFARFLQPGSMAE-----TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCCceEEecccchhhhCCchhHHH-----HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 468999999999887544333 35699999999999999999999999999999999999999973
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=371.50 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=203.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-------chhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-------GASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++..... .......+|+++|++++|||||+++++ |
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence 4568889999999999999999999999999999964321 122346799999999999999999999 4
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
+.++..||||||++||+|.+++-.++ .+.+.....+++|++.|+.|||++ ||+||||||+|||+..
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk-----------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANK-----------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSN 311 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhcc-----------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEecc
Confidence 55688899999999999999997665 567777789999999999999999 9999999999999976
Q ss_pred C---CcEEEeeecccccccccccccceeccccccccccccCcccCCCCC---CCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 815 D---MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV---STNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 815 ~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+ ..+||+|||+|+......... +..||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.....
T Consensus 312 ~~e~~llKItDFGlAK~~g~~sfm~-----TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGEGSFMK-----TLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred CCcceEEEecccchhhccccceehh-----hhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 5 789999999999876544333 3569999999999987543 3478999999999999999999975433
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... . .+++. ...+...+..| .++.++..++|.+||..||++|||++|+++.
T Consensus 387 ~~s-l--------~eQI~---~G~y~f~p~~w----------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 387 DPS-L--------KEQIL---KGRYAFGPLQW----------------DRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Ccc-H--------HHHHh---cCcccccChhh----------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 211 1 11110 01111111122 2567788999999999999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=355.33 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=207.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.+|++.++||+|+||+||+++...+|..||.|.++.. +....++...|+.++++++|||||+++++.. .++....
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence 4578889999999999999999999999999998733 3344567899999999999999999998532 2233448
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeCCCCcE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~ 818 (988)
.||||||.+|+|...++..+.. .+.+++..+|+++.|++.||.++|++- ++ |+||||||.||+++.+|.+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~q-------kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQ-------KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhc-------cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCce
Confidence 9999999999999998765432 257999999999999999999999942 24 8999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++.+..... .....+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||... ++.....
T Consensus 168 KLGDfGL~r~l~s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~ 238 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK 238 (375)
T ss_pred eeccchhHhHhcchhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH
Confidence 9999999998766433 334568999999999999999999999999999999999999998631 2222221
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccc-cchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGK-IECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
+... .+... .+ .-++..+..||..|+..||+.||+.-.++..+..
T Consensus 239 KI~q------------gd~~~---------------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIEQ------------GDYPP---------------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHc------------CCCCC---------------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1110 01100 01 1356678999999999999999996555554443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=388.72 Aligned_cols=475 Identities=25% Similarity=0.349 Sum_probs=366.9
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
..+.+++++|.++ .+.+.+.++..|.+|++++|++. ..|.+++++.+++.|+.++|.+. ++|..++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3577889999988 67778889999999999999998 78889999999999999999999 899999999999999999
Q ss_pred cccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCcc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 192 (988)
+|.+. ..|..++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|+++...|+.+. ++.|++||...|-++ .+
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tl 198 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TL 198 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cC
Confidence 99998 88888999999999999999998 6788888999999999999999955554444 999999999999998 78
Q ss_pred chhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCC
Q 001974 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272 (988)
Q Consensus 193 ~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l 272 (988)
|..++++.+|..|+|.+|+|. ++| -|.++..|+.|+++.|+|+-...+..+++.++.+||+.+|++. ..|+.+.-+
T Consensus 199 P~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL 274 (565)
T KOG0472|consen 199 PPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL 274 (565)
T ss_pred ChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence 889999999999999999998 888 3457888999999999998443344568999999999999998 456678888
Q ss_pred ccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhh-----hccccccE----EEccCCcc---
Q 001974 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA-----NLSDQLQN----LIMTSNQL--- 340 (988)
Q Consensus 273 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-----~~~~~L~~----L~L~~N~l--- 340 (988)
++|.+||+|+|.|++.+. +++++ +|+.|.+.+|.++ .+-..+. ...+.|+. =-++.-+-
T Consensus 275 rsL~rLDlSNN~is~Lp~-------sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 275 RSLERLDLSNNDISSLPY-------SLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred hhhhhhcccCCccccCCc-------ccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 999999999999987654 57788 8999999999886 3222221 11112221 01111100
Q ss_pred -----ccCCCccccCCCcceEEEeeCccCCCccCcccCCCCc---cCeEecccccCCCCCCCCCCCCCCCC-EEEccccc
Q 001974 341 -----HGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQN---LEGMGLYDNQLSGEIPSSLGNLSILS-ELLLNNNS 411 (988)
Q Consensus 341 -----~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~ 411 (988)
..........+.+.+.|++++-+++ .+|+....... ....+++.|++. ++|..+..+..+. .+.+++|.
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 0011122344567788888888887 66665433322 677888888887 7777777776654 34455555
Q ss_pred cccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCc
Q 001974 412 LSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPS 491 (988)
Q Consensus 412 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 491 (988)
++ .+|..++.+++|..|+|++|-+. .+|.+++.+..+ +.||+|+|+|. .+|..+..+..|+.+-.++|++...-|+
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L-q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL-QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS 499 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhh-heecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence 54 77888888888888888888887 788888888776 78888888887 7787777777777777777888744444
Q ss_pred ccccCCCCcEEEecCccccccCCccccCccccCeeecCCCccc
Q 001974 492 QLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS 534 (988)
Q Consensus 492 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 534 (988)
.+.+|.+|..|||.+|.+. .+|..+++|.+|+.|+|++|.|.
T Consensus 500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 4778888888888888887 77778888888888888888777
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=395.39 Aligned_cols=270 Identities=25% Similarity=0.435 Sum_probs=219.6
Q ss_pred hCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
..+....+.||+|+||+||+|+.. ++...||||.++..... ..++|++|++++..++|||||+++|+|...
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--- 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG--- 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---
Confidence 345566789999999999999874 23467999999877665 678999999999999999999999998754
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhH----hhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE----IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
+..++|+|||..|||.+|++....... .... ..+++..+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 562 --~P~~MvFEYm~~GDL~eFLra~sP~a~-~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 562 --DPLCMVFEYMDHGDLHEFLRARSPKAD-KLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred --CeeEEEEEecccccHHHHHHhhCCccc-cccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 889999999999999999986543211 1111 24599999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
|.++..|||+|||+++..-..+.+.. .....-+.+|||||.+..++||++||||||||+|||+++ |+.||......
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~--~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~- 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKV--RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ- 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcc--cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-
Confidence 99999999999999996544332221 112335789999999999999999999999999999999 99998643222
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
++.+.+. .....+.+..||.++++||..||+..|++||+++||-.+|++
T Consensus 713 -------------EVIe~i~------------------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 713 -------------EVIECIR------------------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred -------------HHHHHHH------------------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 1111110 111245667899999999999999999999999999999998
Q ss_pred HHHH
Q 001974 971 VKNA 974 (988)
Q Consensus 971 i~~~ 974 (988)
..++
T Consensus 762 ~~~~ 765 (774)
T KOG1026|consen 762 WAQA 765 (774)
T ss_pred HHhc
Confidence 7654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=357.04 Aligned_cols=243 Identities=29% Similarity=0.401 Sum_probs=203.8
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
..++|++.++||+|+||+||+++.+.+++.+|+|++++.. ....+...+|..++.+++||+||+++.. |+++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 4578999999999999999999999999999999997442 2345678899999999999999999987 6778
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..|+|+||+.||.|..++.+.+ .+++..++-++.+|+.||.|||++ +||||||||+|||+|++|+
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg-----------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GH 163 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG-----------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGH 163 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC-----------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCc
Confidence 99999999999999999998764 689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
++|+|||+++..-..... +.++.||+.|||||++.+..|+.++|.||+|+++|||++|.+||... +...+.
T Consensus 164 i~LtDFgL~k~~~~~~~~----t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~ 234 (357)
T KOG0598|consen 164 IKLTDFGLCKEDLKDGDA----TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMY 234 (357)
T ss_pred EEEeccccchhcccCCCc----cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHH
Confidence 999999999854443222 23367999999999999999999999999999999999999998632 111111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccc-hhHHHHHHhhcccCcCCCCCC
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE-CPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RP 959 (988)
...... +...+.. .+.+..+++.++++.||++|.
T Consensus 235 ~~I~~~----------------------------k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 DKILKG----------------------------KLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHhcC----------------------------cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111 1111222 566789999999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=388.87 Aligned_cols=259 Identities=25% Similarity=0.476 Sum_probs=218.0
Q ss_pred CCCCCceeccccceeEEEEEECCCC---eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...+.++||.|.||.||+|+.+..| ..||||.++.... ....+|+.|+.||.+++||||+++.|+... ...
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence 3467789999999999999997666 4699999986544 445789999999999999999999999654 488
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.+||+|||++|+|+.|++.+. .++++.+...+.++||.||.||.++ ++|||||.++|||++.+..+|
T Consensus 705 vMIiTEyMENGsLDsFLR~~D----------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCK 771 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND----------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCK 771 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC----------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEE
Confidence 999999999999999999876 3689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
++|||+++.+++.... .....+-.-+.+|.|||.+..++++.+|||||||+|+||.++ |..||-.+...+
T Consensus 772 VsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------- 842 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------- 842 (996)
T ss_pred eccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--------
Confidence 9999999988665532 222333445789999999999999999999999999999988 999975432210
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
+... .-+.-.+..+++||..+.+||..||++|-.+||.+++|+..|+++-.
T Consensus 843 ------VIka------------------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 843 ------VIKA------------------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ------HHHH------------------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1000 01122345678999999999999999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=345.47 Aligned_cols=270 Identities=24% Similarity=0.334 Sum_probs=204.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
+.|+...++|+|+||+||+++++.+|+.||||.+... ++...+-.++|++++++++|+|+|.++++|. .....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 4688889999999999999999999999999999633 2334467899999999999999999999955 45889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+|||+..-|. -+.... ..++...+.+++.|++.|+.|+|++ ++|||||||+|||++.+|.+||
T Consensus 77 hLVFE~~dhTvL~-eLe~~p----------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKL 142 (396)
T KOG0593|consen 77 HLVFEYCDHTVLH-ELERYP----------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKL 142 (396)
T ss_pred EEEeeecchHHHH-HHHhcc----------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEe
Confidence 9999999654444 444333 3678889999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
||||+|+........ .+..+.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+.|... .|.+....++.
T Consensus 143 CDFGFAR~L~~pgd~----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~k 216 (396)
T KOG0593|consen 143 CDFGFARTLSAPGDN----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRK 216 (396)
T ss_pred ccchhhHhhcCCcch----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHH
Confidence 999999988743221 223568999999999888 78999999999999999999999987632 22222222233
Q ss_pred HHhhh---hhhhhcc--cc----ccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDH---VIDIVDP--IL----INDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~---~~~~~d~--~l----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.+- -..++.. .+ .+.+++ ..+.....+....-+.++++.|++.||++|++.+|++.
T Consensus 217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~---------~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEH---------PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHcccCHHHHHHhccCCceeeeecCCCCC---------ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22221 1111111 11 011111 00111112244456889999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.00 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=215.3
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDF 734 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 734 (988)
.+...+|...+.||+|+|++|++|+.+.+++.||||++.+. +....+.+..|-.+|.+| .||.|++++.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 34557799999999999999999999999999999998633 233446678899999999 89999999987 6
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
++...+|+|+||+++|+|.++|++.+ .+++..++.++.+|+.||+|||++ |||||||||+|||+|+
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~G-----------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~ 209 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYG-----------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDK 209 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhC-----------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcC
Confidence 77799999999999999999998764 689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccccccc---------cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 815 DMIAHVGDFGLARVRQEVSNL---------TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+|++||+|||.|+.+.+.... .......++||..|.+||++.....++.+|+|||||++|.|+.|++||..
T Consensus 210 dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 210 DGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred CCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 999999999999987654322 11111457899999999999999999999999999999999999999874
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
..+ + .+. +++.......+...|+.+.+|+.+.|..||.+|+|+++|.
T Consensus 290 ~Ne----y------liF-----------------------qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 290 ANE----Y------LIF-----------------------QKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred ccH----H------HHH-----------------------HHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 211 1 111 1222223344557788899999999999999999998887
Q ss_pred HH
Q 001974 966 HE 967 (988)
Q Consensus 966 ~~ 967 (988)
+.
T Consensus 337 ~H 338 (604)
T KOG0592|consen 337 AH 338 (604)
T ss_pred hC
Confidence 64
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=374.48 Aligned_cols=270 Identities=29% Similarity=0.473 Sum_probs=213.5
Q ss_pred CHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 654 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
+.++++...+.+.+.+.||+|+||+||+|.|- | .||||++..... +..+.|++|+..+++-+|.||+-+.|||..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 33555556666778899999999999999995 3 499999986543 345789999999999999999999999865
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
. ...||+.+|+|-+|+.+++... .++...+.+.||+|||+||.|||.+ +|||||||..||+
T Consensus 460 p------~~AIiTqwCeGsSLY~hlHv~e----------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIF 520 (678)
T KOG0193|consen 460 P------PLAIITQWCEGSSLYTHLHVQE----------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIF 520 (678)
T ss_pred C------ceeeeehhccCchhhhhccchh----------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceE
Confidence 3 3499999999999999998665 4789999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+.++++|||+|||++......... .......|...|||||++.. .+|++++||||||+|+|||+||..||.. ..
T Consensus 521 l~~~~kVkIgDFGLatvk~~w~g~--~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~ 597 (678)
T KOG0193|consen 521 LHEDLKVKIGDFGLATVKTRWSGE--QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN 597 (678)
T ss_pred EccCCcEEEecccceeeeeeeccc--cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC
Confidence 999999999999999864433111 11122347889999999875 4799999999999999999999999972 22
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
.+..+-..-+. .+..+. ......|+.++.+|+..||..+|++||.+.+|+..|
T Consensus 598 ~dqIifmVGrG------------~l~pd~---------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 598 RDQIIFMVGRG------------YLMPDL---------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred hhheEEEeccc------------ccCccc---------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHH
Confidence 21111000000 000010 011237889999999999999999999999999999
Q ss_pred HHHHHHh
Q 001974 969 QSVKNAL 975 (988)
Q Consensus 969 ~~i~~~~ 975 (988)
+++....
T Consensus 651 ~~l~~~~ 657 (678)
T KOG0193|consen 651 EELLPSL 657 (678)
T ss_pred HHhhhcc
Confidence 9887653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=379.55 Aligned_cols=459 Identities=27% Similarity=0.389 Sum_probs=388.2
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeec
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (988)
.-.+++++++|+++ ..|++++.+..++.|+.++|++. ++|+.++.+.+|..|+++.|.+. ..|+.++.+-.|..|+.
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 46789999999999 88999999999999999999999 89999999999999999999999 99999999999999999
Q ss_pred CcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCc
Q 001974 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 112 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 191 (988)
.+|+|+ ..|+.+..+.+|..|++.+|+++. .|...-+++.|++||...|-++ .+|..++++.+|+.|+|.+|+|. .
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~ 220 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-F 220 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-c
Confidence 999998 899999999999999999999995 4444555999999999999998 78889999999999999999999 6
Q ss_pred cchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccC
Q 001974 192 IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271 (988)
Q Consensus 192 ~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~ 271 (988)
.| +|.+++.|++|+++.|+|. .+|...+.++++|..|||++|+++ ..|+.+.-+.+|++||+++|.|++ .|..+++
T Consensus 221 lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgn 296 (565)
T KOG0472|consen 221 LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGN 296 (565)
T ss_pred CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCccccc
Confidence 67 9999999999999999999 999999999999999999999999 789999999999999999999995 5666999
Q ss_pred CccccEEecccccCCCCCCCchhhhcccccCCCCcE----EEeecc---c-CCCCCCch-hh--hccccccEEEccCCcc
Q 001974 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRT----LIFAAN---K-LRGALPHS-IA--NLSDQLQNLIMTSNQL 340 (988)
Q Consensus 272 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~----L~Ls~N---~-l~~~~p~~-~~--~~~~~L~~L~L~~N~l 340 (988)
+ .|+.|.+.+|.+.++..+-..... -.-++.|+. =-++.- . -.+..|.+ +. ...-+.+.|+++.-++
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii~~gT-~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql 374 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREIISKGT-QEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL 374 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHHcccH-HHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence 9 999999999998755432111000 000011111 000000 0 00111111 11 1112578888998888
Q ss_pred ccCCCccccCCCc---ceEEEeeCccCCCccCcccCCCCccC-eEecccccCCCCCCCCCCCCCCCCEEEcccccccccc
Q 001974 341 HGSIPSGIGNLVG---LYRLGMGGNQFTGTIPKEMGKLQNLE-GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVI 416 (988)
Q Consensus 341 ~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 416 (988)
+ .+|+..+.-.+ .+..+++.|++. ++|..+..+..+. .+.+++|.++ .+|..++.+++|..|+|++|-+. .+
T Consensus 375 t-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~L 450 (565)
T KOG0472|consen 375 T-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DL 450 (565)
T ss_pred c-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hc
Confidence 8 67777666555 889999999999 8898888887664 5666677766 88888999999999999999998 78
Q ss_pred ccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccC
Q 001974 417 PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLC 496 (988)
Q Consensus 417 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 496 (988)
|..++.+..|+.|+++.|+|. .+|+++..+..+ +.+-.++|++...-|+.+.++.+|+.|||.+|.+. .+|+.+++|
T Consensus 451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l-Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnm 527 (565)
T KOG0472|consen 451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL-ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNM 527 (565)
T ss_pred chhhhhhhhhheecccccccc-cchHHHhhHHHH-HHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccc
Confidence 999999999999999999998 999999888887 88888889998555666999999999999999999 899999999
Q ss_pred CCCcEEEecCcccc
Q 001974 497 SYLEEIYMRGNFFH 510 (988)
Q Consensus 497 ~~L~~L~L~~N~l~ 510 (988)
.+|++|+|++|.|.
T Consensus 528 tnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 528 TNLRHLELDGNPFR 541 (565)
T ss_pred cceeEEEecCCccC
Confidence 99999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.63 Aligned_cols=270 Identities=22% Similarity=0.310 Sum_probs=212.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhH-HHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|.++++||.|.||.||+|+.+.+|+.||||.++..-....+ .-.+|+..++++. ||||+++.+++.+. +..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cce
Confidence 46789999999999999999999999999999999754433322 3468999999997 99999999996543 238
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||| ..+|++.++... +.+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+|
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~----------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iK 150 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRN----------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIK 150 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcC----------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeE
Confidence 99999999 789999998774 4899999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+||.......++. .+.|.+|+|||++.. +-|+.+.||||+|||++|+.+-++.|....+-|
T Consensus 151 iaDFGLARev~SkpPYTe-----YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-------- 217 (538)
T KOG0661|consen 151 IADFGLAREVRSKPPYTE-----YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-------- 217 (538)
T ss_pred ecccccccccccCCCcch-----hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--------
Confidence 999999998877665554 468999999998654 678999999999999999999999876432221
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHH--HHhhhhhc--------cccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQ--RLRQAKIN--------GKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
++..+.+-...++...|.....- .+....+. -...++.+..++|.+|+++||.+||||+|.++.
T Consensus 218 -----qi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 218 -----QIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred -----HHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 12222222222333333331110 00000000 013477889999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.09 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=207.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.++...+.||+|+||+||++...++|+..|||.+...+....+.+.+|+.+|++++|||||+++|..... +. ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-eeeEe
Confidence 4577789999999999999999988999999998765433357789999999999999999999974322 11 36899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcEEEe
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIAHVG 821 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 821 (988)
.|||+++|+|.+++...+. ++++..++.+++||++||+|||++ |||||||||+|||++. ++.+||+
T Consensus 94 ~mEy~~~GsL~~~~~~~g~----------~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG----------KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred eeeccCCCcHHHHHHHcCC----------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence 9999999999999987652 589999999999999999999998 9999999999999999 7999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++..... ...........||+.|||||++..+ ....++||||+||++.||+||++||..... ...+.-..
T Consensus 161 DFG~a~~~~~~-~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~~~i 235 (313)
T KOG0198|consen 161 DFGLAKKLESK-GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEALLLI 235 (313)
T ss_pred cCccccccccc-cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHHHHH
Confidence 99999876641 1111223346799999999999963 344599999999999999999999874300 00100000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
... ...+..+...+.+..+++.+|++.||++||||+++++.-...
T Consensus 236 g~~--------------------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 236 GRE--------------------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred hcc--------------------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 000 001122345777899999999999999999999999875443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=369.66 Aligned_cols=392 Identities=20% Similarity=0.235 Sum_probs=305.2
Q ss_pred cEEEEEcCCCCCcccccccccCC--CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceee
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNL--SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (988)
....||+++++++..--..+..+ +.-+.|||++|+|..+-+..|.++++|+.+++.+|.++ .+|.......+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 44566777777664322333322 23467999999999888888999999999999999999 8898777788899999
Q ss_pred cCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC
Q 001974 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 111 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 190 (988)
|.+|.|+.+-..++.-++.|+.|||+.|.|+.+.-..|..-.++++|+|++|+|+......|..+.+|..|.|+.|+|+.
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 99999998888888899999999999999986666678887889999999999998888889999999999999999997
Q ss_pred ccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCccccccc
Q 001974 191 IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFG 270 (988)
Q Consensus 191 ~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~ 270 (988)
..+.+|++|++|+.|+|..|+|. .+....|.++++|+.|.|..|.+...--..|-.+.+++.|+|+.|+++.+...++.
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lf 290 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLF 290 (873)
T ss_pred cCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccc
Confidence 77788888999999999999887 66667788888888888888888876667777888888888888888888788888
Q ss_pred CCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccC
Q 001974 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350 (988)
Q Consensus 271 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 350 (988)
+++.|+.|+||+|.|..+..+.. +-+++|++|+|+.|+|+..-+..+..+ .+|++|.|++|.+...-...|..
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~W------sftqkL~~LdLs~N~i~~l~~~sf~~L-~~Le~LnLs~Nsi~~l~e~af~~ 363 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSW------SFTQKLKELDLSSNRITRLDEGSFRVL-SQLEELNLSHNSIDHLAEGAFVG 363 (873)
T ss_pred ccchhhhhccchhhhheeecchh------hhcccceeEeccccccccCChhHHHHH-HHhhhhcccccchHHHHhhHHHH
Confidence 88888888888888877766633 345677777888777774444444444 36777777777777666667777
Q ss_pred CCcceEEEeeCccCCCccCc---ccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccc
Q 001974 351 LVGLYRLGMGGNQFTGTIPK---EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427 (988)
Q Consensus 351 l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 427 (988)
+.+|+.|||++|.|+..+.+ .|.+|++|+.|+|.+|+|..+.-.+|.++..|++|+|.+|.|..+-|.+|..+ .|+
T Consensus 364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk 442 (873)
T KOG4194|consen 364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK 442 (873)
T ss_pred hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence 77777777777777755443 46677777777777777775555677777777777777777777777777777 677
Q ss_pred eeecCCC
Q 001974 428 ILHLFEN 434 (988)
Q Consensus 428 ~L~l~~N 434 (988)
+|.++.-
T Consensus 443 ~Lv~nSs 449 (873)
T KOG4194|consen 443 ELVMNSS 449 (873)
T ss_pred hhhhccc
Confidence 7766543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=370.24 Aligned_cols=386 Identities=23% Similarity=0.243 Sum_probs=353.7
Q ss_pred CCCCCceeeeeEEeCC--------------CCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCC
Q 001974 15 DSGHFCEWKGITCGLR--------------HRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLF 80 (988)
Q Consensus 15 ~~~~~c~~~~v~c~~~--------------~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 80 (988)
+.++.|.-+-.+|+.. +..+..||+++|++..+-+..|.++++|++++|..|.++ .+|...+...
T Consensus 47 pa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sg 125 (873)
T KOG4194|consen 47 PATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESG 125 (873)
T ss_pred CCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccccccc
Confidence 5677788888899852 357888999999999899999999999999999999999 8998888888
Q ss_pred CCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeecc
Q 001974 81 RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLA 160 (988)
Q Consensus 81 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 160 (988)
+|+.|+|.+|.|+..-..+++.++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+....+.|.++.+|..|.|+
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLs 205 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLS 205 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecc
Confidence 99999999999998888899999999999999999997777788888999999999999998889999999999999999
Q ss_pred ccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccc
Q 001974 161 ANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS 240 (988)
Q Consensus 161 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 240 (988)
.|+++..++.+|.+|++|+.|+|..|+|.-+.--+|.+|++|+.|.|..|.|. .+.+++|.++.+++.|+|+.|+++..
T Consensus 206 rNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~v 284 (873)
T KOG4194|consen 206 RNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAV 284 (873)
T ss_pred cCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhh
Confidence 99999888899999999999999999999555789999999999999999999 99999999999999999999999988
Q ss_pred cCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCC
Q 001974 241 IPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320 (988)
Q Consensus 241 ~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 320 (988)
-..++-+++.|+.|++|+|.|..+.+....-.++|+.|+|++|+|+...+. +|..+..|++|.|++|.++ .+.
T Consensus 285 n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~------sf~~L~~Le~LnLs~Nsi~-~l~ 357 (873)
T KOG4194|consen 285 NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG------SFRVLSQLEELNLSHNSID-HLA 357 (873)
T ss_pred hcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChh------HHHHHHHhhhhcccccchH-HHH
Confidence 889999999999999999999999999999999999999999999998877 6778899999999999999 566
Q ss_pred chhhhccccccEEEccCCccccCCCc---cccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCC
Q 001974 321 HSIANLSDQLQNLIMTSNQLHGSIPS---GIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLG 397 (988)
Q Consensus 321 ~~~~~~~~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 397 (988)
+..+...++|++|||++|.|...+.+ .|..|++|+.|+|.+|+|..+.-.+|.++.+|+.|||.+|-|-.+-|.+|.
T Consensus 358 e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe 437 (873)
T KOG4194|consen 358 EGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFE 437 (873)
T ss_pred hhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccc
Confidence 65555566899999999999876654 577899999999999999966667999999999999999999999999999
Q ss_pred CCCCCCEEEcccc
Q 001974 398 NLSILSELLLNNN 410 (988)
Q Consensus 398 ~l~~L~~L~L~~N 410 (988)
.+ .|++|.+..-
T Consensus 438 ~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 438 PM-ELKELVMNSS 449 (873)
T ss_pred cc-hhhhhhhccc
Confidence 99 8999877543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=326.00 Aligned_cols=269 Identities=23% Similarity=0.376 Sum_probs=211.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|...+++|+|.||.||+|++.++|+.||||.++... ++......+|++.++.++|+||+.++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 46888999999999999999999999999999997442 3345678999999999999999999999 5566889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
.+|+||| ..+|...++... ..++..++..++.++++|++|+|++ .|+||||||.|+|++++|.+||
T Consensus 77 ~lVfEfm-~tdLe~vIkd~~----------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKi 142 (318)
T KOG0659|consen 77 SLVFEFM-PTDLEVVIKDKN----------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKI 142 (318)
T ss_pred EEEEEec-cccHHHHhcccc----------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEe
Confidence 9999999 679999998766 3789999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+|+.+......... .+-|..|+|||.+.+ ..|+..+||||.||++.||+-|.+-|. ++.++.+....
T Consensus 143 ADFGLAr~f~~p~~~~~~----~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp----G~sDidQL~~I 214 (318)
T KOG0659|consen 143 ADFGLARFFGSPNRIQTH----QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP----GDSDIDQLSKI 214 (318)
T ss_pred ecccchhccCCCCccccc----ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC----CCchHHHHHHH
Confidence 999999987765433222 367999999999887 578999999999999999999987754 33333333221
Q ss_pred HHhhhhhhhhccccccCcchhhhhhH------HH-Hhhhhhc-cccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNK------QR-LRQAKIN-GKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~------~~-~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.-...+..+.|+.... .. .+.+... .-..+.....+++.+|+.+||.+|+|++|++++
T Consensus 215 ---------f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 215 ---------FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ---------HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11112222222321111 00 1111111 123455667999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.39 Aligned_cols=272 Identities=26% Similarity=0.356 Sum_probs=211.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+.|+.+++||+|.||.||+|++..+|+.||+|.++.+. .+......+||.+|+++.||||+++.+..... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 345777899999999999999999999999999997554 55567889999999999999999999987653 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
+|+|+||| .-||.-++..... .+++.++..+++|++.||+|+|++ +|+|||||.+|||||.+|.+|
T Consensus 193 iYlVFeYM-dhDL~GLl~~p~v----------kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LK 258 (560)
T KOG0600|consen 193 IYLVFEYM-DHDLSGLLSSPGV----------KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLK 258 (560)
T ss_pred EEEEEecc-cchhhhhhcCCCc----------ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEE
Confidence 99999999 5688888876553 799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+|+++....... .+..+.|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.|+.. .++.+.
T Consensus 259 iaDFGLAr~y~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~----tEveQl-- 329 (560)
T KOG0600|consen 259 IADFGLARFYTPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR----TEVEQL-- 329 (560)
T ss_pred eccccceeeccCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc----cHHHHH--
Confidence 99999999776654322 2345689999999998885 7999999999999999999999997632 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhH---------HHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNK---------QRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..++.-+.......|....- ...+....+.....+....+|+..+|..||.+|.||.++++
T Consensus 330 -------~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 330 -------HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred -------HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111112222220000 00011111113356778899999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.01 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=209.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch-hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..+.|+..+.||.|..++||+|+....++.||||++..++... .+.+.+|+..|+.++||||++++.. |..+..
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSE 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEecce
Confidence 3567999999999999999999999999999999998654433 4789999999999999999999988 445689
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|+||.||.+|++.+.++.... ..+.+..+..|.+++++||.|||.+ |.||||||+.||||+++|.+|
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~---------~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYP---------DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHcc---------ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEE
Confidence 9999999999999999976543 3588999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|+|||.+.................+||+.|||||+++. ..|+.|+||||||++..|+.+|..||...-+. +..
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-----kvL 241 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-----KVL 241 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-----HHH
Confidence 99999887554433222222256789999999999544 57999999999999999999999998743211 111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...+........ .-.. +. .........+.+++..|+++||++||||+++++.
T Consensus 242 l~tLqn~pp~~~--t~~~---~~-------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 242 LLTLQNDPPTLL--TSGL---DK-------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHhcCCCCCcc--cccC---Ch-------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111111110000 0000 00 0111344578999999999999999999999853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=358.40 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=213.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
...|...++||+|+.|.||.|....+++.||||++........+-+.+|+.+|+..+|+|||.+++.+. .++..|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeE
Confidence 346788899999999999999999999999999998877777788999999999999999999999854 348899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|||||+||+|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+
T Consensus 347 VVMEym~ggsLTDvVt~~------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKlt 411 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLT 411 (550)
T ss_pred EEEeecCCCchhhhhhcc------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEe
Confidence 999999999999998764 489999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++..+..... .....+||+.|||||++....|++|.||||||++++||+-|.+||-. +..+.+.....
T Consensus 412 DFGFcaqi~~~~~----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa- 482 (550)
T KOG0578|consen 412 DFGFCAQISEEQS----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIA- 482 (550)
T ss_pred eeeeeeccccccC----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHh-
Confidence 9999987766443 23346899999999999999999999999999999999999999752 11111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. . ..+.+..+....+.+.+++.+||+.||++||+|+|+++.
T Consensus 483 -~--------n----------------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 483 -T--------N----------------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -h--------c----------------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0 0 011223344677889999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=387.15 Aligned_cols=269 Identities=25% Similarity=0.435 Sum_probs=217.8
Q ss_pred CCCCCCceeccccceeEEEEEECCC-C----eEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQD-G----TIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
+..+..+.||+|+||.||.|+.... | ..||+|.++.. +.....+|.+|..+|++++|||||+++|+|.+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----- 766 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----- 766 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----
Confidence 4456678999999999999998532 2 24899988644 44566899999999999999999999999865
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....+|++|||++|+|..|+++.+..... ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++..
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~----~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQ----PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERR 839 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCC----CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccC
Confidence 47889999999999999999987543221 24789999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+|+.......+.... ...-+..|||||.+..+.++.|+|||||||++||++| |..||......+
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~--~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~----- 912 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHG--EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE----- 912 (1025)
T ss_pred cEEEcccchhHhhhhchheeccC--ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-----
Confidence 99999999999544333222211 1234579999999999999999999999999999999 999987431110
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. ......+.....+..||..++++|.+||+.+|++||++.++++.+.++.+..
T Consensus 913 --------------------------v-~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 --------------------------V-LLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --------------------------H-HHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 0 0011122344556789999999999999999999999999999999997765
Q ss_pred hh
Q 001974 976 LE 977 (988)
Q Consensus 976 ~~ 977 (988)
..
T Consensus 966 ~~ 967 (1025)
T KOG1095|consen 966 LG 967 (1025)
T ss_pred cc
Confidence 54
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=357.09 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=203.9
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
...+-||.|+.|.||+|+. .++.||||.++.- -..+|+.|++++||||+.+.|+|... ..+|||||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 4468899999999999999 6889999987522 23578999999999999999999765 77899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
||+.|-|++.++... +++......|.++||.||.|||.+ .|||||||+-||||+.+..+||+|||.
T Consensus 193 fCa~GqL~~VLka~~-----------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGR-----------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ccccccHHHHHhccC-----------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence 999999999998764 688889999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
++...+... ...+.||..|||||++...+.+.|+||||||||||||+||..||....... .+
T Consensus 259 S~e~~~~ST-----kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----II-------- 320 (904)
T KOG4721|consen 259 SKELSDKST-----KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----II-------- 320 (904)
T ss_pred hHhhhhhhh-----hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eE--------
Confidence 987655432 234679999999999999999999999999999999999999987431110 00
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
|.. .-....+.-+..||+.+.-|+++||+..|..||++.+++..|+-...
T Consensus 321 --------------wGV----GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 321 --------------WGV----GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred --------------Eec----cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 000 00011223356899999999999999999999999999998865443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=353.33 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=208.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... ...+.+.+|++++++++||||+.++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 578899999999999999999999999999999965433 334678999999999999999999999 5566999
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+||+.| +|..++...+ .++++.+..|+.|++.||.|||+. +|.|||+||.||+++..|++|+
T Consensus 77 ~vVte~a~g-~L~~il~~d~-----------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Kl 141 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG-----------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKL 141 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceee
Confidence 999999955 9999998764 799999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
||||+|+.... .......+.||+.|||||...+.+|+..+|.||+||++||+++|++||-.. .+.+.+...
T Consensus 142 cdFg~Ar~m~~----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I 212 (808)
T KOG0597|consen 142 CDFGLARAMST----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSI 212 (808)
T ss_pred chhhhhhhccc----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHH
Confidence 99999986544 233344567999999999999999999999999999999999999997521 111111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ++..| +......+..++...+.+||.+|.|..+++..
T Consensus 213 ~~-------------d~v~~---------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 213 LK-------------DPVKP---------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hc-------------CCCCC---------------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11 11111 23566778999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.78 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=207.9
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc----cc-chhHHHHHHHHHHHhcC-CCCceEEEeeccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ----RH-GASKSFLAECKALKNIR-HRNLVKVITSCSSID 733 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 733 (988)
....+|.+.+.||+|+||+|+.|.+..+++.||+|++... .. ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 3456899999999999999999999999999999987543 11 23456778999999998 999999999954
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.....++||||+.+|+|.+++... .++.+.++..+++|++.|++|+|++ ||+||||||+||+++
T Consensus 91 --t~~~~~ivmEy~~gGdL~~~i~~~-----------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld 154 (370)
T KOG0583|consen 91 --TPTKIYIVMEYCSGGDLFDYIVNK-----------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLD 154 (370)
T ss_pred --cCCeEEEEEEecCCccHHHHHHHc-----------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEec
Confidence 447799999999999999999873 3789999999999999999999999 999999999999999
Q ss_pred CC-CcEEEeeeccccccc-ccccccceeccccccccccccCcccCCCC-CC-CccchHHHHHHHHHHHhCCCCCCccccC
Q 001974 814 ND-MIAHVGDFGLARVRQ-EVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VS-TNGDIYSYGILLLEMVTGKKPTDVMFEG 889 (988)
Q Consensus 814 ~~-~~~kL~DfG~a~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~vl~elltg~~p~~~~~~~ 889 (988)
.+ +++||+|||++.... .... .....||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.
T Consensus 155 ~~~~~~Kl~DFG~s~~~~~~~~~-----l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---- 225 (370)
T KOG0583|consen 155 GNEGNLKLSDFGLSAISPGEDGL-----LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---- 225 (370)
T ss_pred CCCCCEEEeccccccccCCCCCc-----ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC----
Confidence 99 999999999998763 2222 22356999999999999977 85 789999999999999999999984
Q ss_pred CcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccch-hHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIEC-PISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
.+....... +.......+..+ ..++.+++.+|+..||.+|+|+.||+ .-
T Consensus 226 -~~~~~l~~k----------------------------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h 275 (370)
T KOG0583|consen 226 -SNVPNLYRK----------------------------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EH 275 (370)
T ss_pred -ccHHHHHHH----------------------------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hC
Confidence 111111111 111112223334 67789999999999999999999999 44
Q ss_pred HHHH
Q 001974 969 QSVK 972 (988)
Q Consensus 969 ~~i~ 972 (988)
.-++
T Consensus 276 ~w~~ 279 (370)
T KOG0583|consen 276 PWFQ 279 (370)
T ss_pred hhhc
Confidence 4343
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=322.35 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=201.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|+..+.||.|+||.|.+++.+.+|..+|+|+++...- ...+...+|..+++.+.||+++++++.+ .+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 4578899999999999999999999999999999975433 3345678899999999999999999984 4558
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++||.|..++++.+ ++++..++.+|.||+.|++|||+. +|++||+||+|||+|.+|.+
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~-----------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG-----------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC-----------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcE
Confidence 9999999999999999998764 799999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+|+..... +.+..||+.|+|||+++..++..++|.|||||++|||+.|.+||....+ .+
T Consensus 184 KitDFGFAK~v~~r-------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~--- 248 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQ--- 248 (355)
T ss_pred EEEeccceEEecCc-------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HH---
Confidence 99999999876542 2235699999999999999999999999999999999999999863211 11
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 958 (988)
+.+. +-..+...+.-...++.+|+...++.|-.+|
T Consensus 249 --iY~K-----------------------I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 249 --IYEK-----------------------ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --HHHH-----------------------HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1111 1112223344566778999999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=355.14 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=212.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.-|...+.||+|+.|.|-+|++..+|+.+|||++.... ......+.+|+-+|+-+.||||+++|++ +++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence 34778899999999999999999999999999996542 2234568899999999999999999999 556699
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
+|+|.||+++|.|.+++...+ ++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++|
T Consensus 87 lylvlEyv~gGELFdylv~kG-----------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG-----------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 999999999999999997765 799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCC-CccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS-TNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+|..-.+..-..+. .|.+.|.|||++.+.+|. .++||||.|||+|.|+||+.||+ |+++.....
T Consensus 153 IADFGMAsLe~~gklLeTS-----CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----DdNir~LLl 222 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLLETS-----CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----DDNIRVLLL 222 (786)
T ss_pred eeccceeecccCCcccccc-----CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----CccHHHHHH
Confidence 9999999876655544444 499999999999999984 78999999999999999999998 333333322
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
+. +....+.+..++.+.++|+.+|+..||++|.|++||++.-
T Consensus 223 KV----------------------------~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 223 KV----------------------------QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HH----------------------------HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 21 2222233457888999999999999999999999998763
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.16 Aligned_cols=289 Identities=25% Similarity=0.282 Sum_probs=214.7
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEee--ccccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.+.....|...+.||+|+||.|+.|.++.+|+.||+|.+. .......++..+|+++++.++|+||+.+++.+......
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445667777899999999999999999999999999986 44555668889999999999999999999998764344
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.-...|+|+|+| +.+|...++... .++...+..++.||++||.|+|+. +|+|||+||+|++++.+
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~-----------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~ 161 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQ-----------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD 161 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCc-----------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC
Confidence 557789999999 789999998653 589999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
..+||+|||+|+..... ......+..+.|.+|+|||++.. ..|+.+.||||.||++.||++|++-|... ..+.
T Consensus 162 c~lKI~DFGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~----d~v~ 235 (359)
T KOG0660|consen 162 CDLKICDFGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK----DYVH 235 (359)
T ss_pred CCEEeccccceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC----chHH
Confidence 99999999999987653 12222345678999999998765 68999999999999999999999987632 1111
Q ss_pred HH--HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NY--ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~--~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+. ....+...-.+.+...-......+-......-+.+....-+...+...+|+.+||..||.+|+|++|+++.
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 11111110000000000000000000000000111111123566778999999999999999999998764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.58 Aligned_cols=275 Identities=19% Similarity=0.255 Sum_probs=219.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.+|+|||+.||+++.-.+++.+|+|++.....+..+..++|++..++++||||+++++++....-+....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45678999999999999999999998899999999998777777889999999999999999999999987653445567
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|++++|+..|+|.+.+......+ ..+++.++++|+.+|++||++||+. .++++||||||.||++++++.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg-------~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKG-------NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcC-------CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceE
Confidence 899999999999999997765432 3689999999999999999999998 34699999999999999999999
Q ss_pred Eeeecccccccccccccc-----eeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 820 VGDFGLARVRQEVSNLTQ-----SCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+.|||.++...-.-.... ........|..|+|||.+. +...++++|||||||++|+|+.|..||+...+...
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999975432111000 0011234789999999875 45678999999999999999999999986544322
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.+.-. +... +........++..+.++++.|++.||.+||++.+++..++++
T Consensus 250 SlaLA-----------v~n~------------------q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 250 SLALA-----------VQNA------------------QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eEEEe-----------eecc------------------ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21110 0000 001111224778899999999999999999999999998875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=343.75 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=205.5
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
...++|+.++.||+|+||.||+|+.+.+|..+|+|++++. .....+.+..|-.+|....+|.||++|.. |++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecC
Confidence 3567899999999999999999999999999999999744 33455778899999999999999999988 677
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.+++|+||||++||++..++.... .+++..++.++.+++.|++.+|+. |+|||||||+|+|||..|
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~-----------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~G 278 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD-----------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKG 278 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC-----------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCC
Confidence 899999999999999999998765 799999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccc---------------------cccc-----ce-----------------eccccccccccccCc
Q 001974 817 IAHVGDFGLARVRQEV---------------------SNLT-----QS-----------------CSVGVRGTIGYAAPE 853 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~---------------------~~~~-----~~-----------------~~~~~~gt~~y~aPE 853 (988)
++||+|||++.-.... .... .. .....+|||.|||||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 9999999998632210 0000 00 112357999999999
Q ss_pred ccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhh
Q 001974 854 YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKI 933 (988)
Q Consensus 854 ~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~ 933 (988)
++.+..|+..+|.||+|||+|||+.|.+||..... ..-| +.... |.. .-..
T Consensus 359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp----~~T~-rkI~n-----------------wr~-------~l~f 409 (550)
T KOG0605|consen 359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP----QETY-RKIVN-----------------WRE-------TLKF 409 (550)
T ss_pred HHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHH-HHHHH-----------------Hhh-------hccC
Confidence 99999999999999999999999999999863211 1111 11100 100 0001
Q ss_pred ccccchhHHHHHHhhcccCcCCCCCCC---HHHHHH
Q 001974 934 NGKIECPISMVRIGVACSVESPQDRMS---ITNVVH 966 (988)
Q Consensus 934 ~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 966 (988)
.....+.++..+||.+|+. ||++|.- ++||.+
T Consensus 410 P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 410 PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 1123455788999999999 9999964 555543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.94 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=207.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
...|+..+.||+|+||.||+|.+..+++.||+|++..+. ....++.++|+.++..++++||.++|+.+ -.+..+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-----l~g~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-----LKGTKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-----eecccH
Confidence 345778899999999999999999999999999998553 34467899999999999999999999984 445889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
+++||||.||++.+.++... .+.+..+..|++++..|+.|||++ +.+|||||+.||++..+|.+|+
T Consensus 87 wiiMey~~gGsv~~lL~~~~-----------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl 152 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGN-----------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKL 152 (467)
T ss_pred HHHHHHhcCcchhhhhccCC-----------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEE
Confidence 99999999999999998764 346777788999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+......... ...++||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+..
T Consensus 153 ~DfgVa~ql~~~~~r----r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------- 218 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKR----RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------- 218 (467)
T ss_pred Eecceeeeeechhhc----cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------
Confidence 999999876554322 245789999999999999899999999999999999999999986432210
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.-.+.+... +.....+.+.+.+++..|+.+||+.||||.++++.
T Consensus 219 ----vlflIpk~~P------------------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 219 ----VLFLIPKSAP------------------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ----EEEeccCCCC------------------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0000000000 01112566779999999999999999999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=359.64 Aligned_cols=273 Identities=24% Similarity=0.397 Sum_probs=207.8
Q ss_pred hhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
+.++|++.++||+|+||.||+|.+. .+++.||+|+++.... ...+.+.+|+.+++++ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 4578999999999999999999852 3456899999864332 3346789999999999 89999999998743
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCch------------------------------------------------
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKD------------------------------------------------ 765 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------ 765 (988)
.+...++||||+++|+|.+++.........
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 235689999999999999998754211000
Q ss_pred ---hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccc
Q 001974 766 ---VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842 (988)
Q Consensus 766 ---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~ 842 (988)
......++++.++..++.||++||+|||+. +|+||||||+||++++++.+||+|||+++.......... ...
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--~~~ 235 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGS 235 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhc--ccC
Confidence 000123588899999999999999999998 999999999999999999999999999986533221111 112
Q ss_pred cccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhh
Q 001974 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWD 921 (988)
Q Consensus 843 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 921 (988)
..++..|+|||++.+..++.++|||||||++|||++ |..||......+ ... . .+.. .
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~-~----~~~~---~---------- 293 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFC-Q----RLKD---G---------- 293 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHH-H----HHhc---C----------
Confidence 346788999999999999999999999999999997 999986421110 000 0 0000 0
Q ss_pred hhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 922 ATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
.....+..+++++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 294 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 294 ---------TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0001123466789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.24 Aligned_cols=272 Identities=22% Similarity=0.275 Sum_probs=207.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+.|+.+++|++|+||.||+|+++.+++.||+|+++.+.. +-.-...+||.++.+.+|||||.+-.+.... .-+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence 3568889999999999999999999999999999985543 3334678999999999999999999887654 3466
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
+|+||||| .-||...+.... +++...++.-++.|+++|++|||.. .|+||||||+|+|+.+.|.+|
T Consensus 152 iy~VMe~~-EhDLksl~d~m~----------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lK 217 (419)
T KOG0663|consen 152 IYIVMEYV-EHDLKSLMETMK----------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILK 217 (419)
T ss_pred eeeeHHHH-HhhHHHHHHhcc----------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEE
Confidence 99999999 569999987765 5799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+|+.++..... .+..+-|..|+|||.+.+ ..|+++.|+||+|||+.||+++++.|....+ +.+.
T Consensus 218 iaDFGLAR~ygsp~k~----~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl-- 287 (419)
T KOG0663|consen 218 IADFGLAREYGSPLKP----YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQL-- 287 (419)
T ss_pred ecccchhhhhcCCccc----CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHH--
Confidence 9999999988765322 223567999999999887 4689999999999999999999998764322 2111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHH---------hhhhh--cccc-chhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRL---------RQAKI--NGKI-ECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~---------~~~~~--~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..++.-...+....|+....-.. +.... .... .....-.+++..++.+||++|.||+|.++
T Consensus 288 -------~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 288 -------DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred -------HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111111122222211111000 00000 0011 14466789999999999999999999875
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 361 h 361 (419)
T KOG0663|consen 361 H 361 (419)
T ss_pred c
Confidence 3
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.36 Aligned_cols=265 Identities=23% Similarity=0.366 Sum_probs=211.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch-hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.+...+.++||+|-||.|.+++.. .+..||||.++..+... ..+|.+|+++|.+++||||++++|+|... +.+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 345677899999999999999985 46999999998765544 48999999999999999999999999754 889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+|||++|+|.+|+.++..+. ........|+.|||.||+||.+. ++||||+.++|+|+|.++++||
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt---------~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKi 678 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT---------AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKI 678 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc---------cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEe
Confidence 99999999999999998775421 24445677999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh--CCCCCCccccCCcchHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT--GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~~~~~~~~~~~~~~~ 898 (988)
+|||+++.+-..+.+ ......+-+.+|||||.+..++++.++|||+||+++||+++ ...||....++
T Consensus 679 adfgmsR~lysg~yy--~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------- 747 (807)
T KOG1094|consen 679 ADFGMSRNLYSGDYY--RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------- 747 (807)
T ss_pred cCcccccccccCCce--eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---------
Confidence 999999955443322 12223456789999999999999999999999999999876 77887643221
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..-+...++++.-- ++.-+..+.-||.++.++|.+||..|-++||+++++...|++.
T Consensus 748 -~vven~~~~~~~~~---------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 748 -QVVENAGEFFRDQG---------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -HHHHhhhhhcCCCC---------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111122221100 1112334567999999999999999999999999999988764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.25 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=200.1
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--------------cchhHHHHHHHHHHHhcCCCCceEE
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--------------HGASKSFLAECKALKNIRHRNLVKV 725 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~~ 725 (988)
+..++|++.+.||+|.||.|-+|++..+++.||+|++.... ....+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999999999999999995321 1122578999999999999999999
Q ss_pred EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 726 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
+++..+ ...+.+|||+|||..|.+...-... ..+++.++++|+.+++.||+|||.+ +||||||
T Consensus 174 iEvLDD---P~s~~~YlVley~s~G~v~w~p~d~-----------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 174 IEVLDD---PESDKLYLVLEYCSKGEVKWCPPDK-----------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred EEeecC---cccCceEEEEEeccCCccccCCCCc-----------ccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 998654 3558899999999888775332211 1389999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccc-cceeccccccccccccCcccCCCC----CCCccchHHHHHHHHHHHhCC
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNL-TQSCSVGVRGTIGYAAPEYGLGSE----VSTNGDIYSYGILLLEMVTGK 880 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~ 880 (988)
||+|+|++++|++||+|||.+......... ....-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 999999999999999999999865332111 111122367999999999987732 356889999999999999999
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||-..+. + +-...++...+. .....+....+.+||.++|.+||++|.+
T Consensus 317 ~PF~~~~~----~---------~l~~KIvn~pL~------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~ 365 (576)
T KOG0585|consen 317 LPFFDDFE----L---------ELFDKIVNDPLE------------------FPENPEINEDLKDLIKRLLEKDPEQRIT 365 (576)
T ss_pred CCcccchH----H---------HHHHHHhcCccc------------------CCCcccccHHHHHHHHHHhhcChhheee
Confidence 99852111 0 001111111110 0111245667899999999999999999
Q ss_pred HHHHHHHH
Q 001974 961 ITNVVHEL 968 (988)
Q Consensus 961 ~~evl~~L 968 (988)
..||....
T Consensus 366 l~~ik~Hp 373 (576)
T KOG0585|consen 366 LPDIKLHP 373 (576)
T ss_pred hhhheecc
Confidence 99987654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=354.64 Aligned_cols=268 Identities=22% Similarity=0.388 Sum_probs=214.2
Q ss_pred HHHHhhCCCCCCceeccccceeEEEEEECCCCe---E-EEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeec
Q 001974 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGT---I-VAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSC 729 (988)
Q Consensus 657 ~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 729 (988)
.++...++....++||+|+||.||+|+.+..+. . ||||..+.. ......++.+|+++|++++|||||++||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455666677999999999999999965422 3 899998742 245567899999999999999999999997
Q ss_pred ccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCC
Q 001974 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGN 809 (988)
Q Consensus 730 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 809 (988)
.. ...+++|||+|.||+|.+|++... ..++..+...++.+.|.||+|||++ ++|||||.++|
T Consensus 231 ~~-----~~Pl~ivmEl~~gGsL~~~L~k~~----------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARN 292 (474)
T KOG0194|consen 231 VL-----EEPLMLVMELCNGGSLDDYLKKNK----------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARN 292 (474)
T ss_pred cC-----CCccEEEEEecCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHH
Confidence 54 488999999999999999998876 2589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcccc
Q 001974 810 VLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFE 888 (988)
Q Consensus 810 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 888 (988)
+|++.++.+||+|||+++.......... ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.....
T Consensus 293 cL~~~~~~vKISDFGLs~~~~~~~~~~~----~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGSQYVMKKF----LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred heecCCCeEEeCccccccCCcceeeccc----cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 9999999999999999986542111110 1135689999999999999999999999999999999 8999874321
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
. .+ ...+. . .......+...|.++..++.+||..+|++||+|.++.+.+
T Consensus 369 ~------~v----~~kI~---~------------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 369 Y------EV----KAKIV---K------------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred H------HH----HHHHH---h------------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 1 01 11110 0 0001122336788899999999999999999999999999
Q ss_pred HHHHHHhhh
Q 001974 969 QSVKNALLE 977 (988)
Q Consensus 969 ~~i~~~~~~ 977 (988)
+.+......
T Consensus 418 ~~~~~~~~~ 426 (474)
T KOG0194|consen 418 EALEKKKEA 426 (474)
T ss_pred HHHHhcccc
Confidence 999776553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=335.18 Aligned_cols=277 Identities=25% Similarity=0.330 Sum_probs=204.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHh--cCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKN--IRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
......+.+|+|+||.||+|+. +++.||||++... ..+.|..|-++.+. ++|+||++++++-...+.. ...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 3345568899999999999999 6799999999643 34677788777765 4899999999985544222 4578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEeccCCCCCeeeCC
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH------CQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~ 814 (988)
++|+||.+.|+|.+|+..+ .++|.+..+|+..+++||+|||+. .+++|+|||||++||||.+
T Consensus 284 wLVt~fh~kGsL~dyL~~n------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~ 351 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN 351 (534)
T ss_pred eEEeeeccCCcHHHHHHhc------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence 9999999999999999875 589999999999999999999975 4678999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCC------CCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE------VSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
|+++.|+|||+|..+..... .....+.+||.+|||||++.+.. .-.+.||||+|.|+|||+++..-++. .
T Consensus 352 DlTccIaDFGLAl~~~p~~~--~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~--~ 427 (534)
T KOG3653|consen 352 DLTCCIADFGLALRLEPGKP--QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP--G 427 (534)
T ss_pred CCcEEeeccceeEEecCCCC--CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC--C
Confidence 99999999999998875433 33345578999999999987742 22468999999999999997654421 0
Q ss_pred CCcchHHHHHHHHhh-----hhhh-hhccccccC-cchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 889 GDLNLHNYARTALLD-----HVID-IVDPILIND-VEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~-----~~~~-~~d~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.-.++..-....+.. ++.+ ++.++..+. +..|.. -.....+.+.+..||..||+.|.|+
T Consensus 428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~--------------h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 428 PVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK--------------HAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred CCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc--------------CccHHHHHHHHHHHcCCchhhhhhh
Confidence 001111111111111 1111 011111111 111211 1345668999999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 001974 962 TNVVHELQSVKNAL 975 (988)
Q Consensus 962 ~evl~~L~~i~~~~ 975 (988)
.-+-+++.++..-.
T Consensus 494 ~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 494 GCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHHhccC
Confidence 99999999886543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.85 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=201.0
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccch---hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA---SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+. .......++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEEE
Confidence 6799999999999998 78999999997543322 46788999999999999999999987542 123457899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++.... .+++.....++.|++.|++|||+. .+++||||||+||++++++.+||+|||+
T Consensus 103 y~~~g~L~~~l~~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 103 YCTRGYLREVLDKEK-----------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred eCCCCcHHHHHhhCC-----------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccch
Confidence 999999999997643 578899999999999999999973 2788999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 170 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~ 237 (283)
T PHA02988 170 EKILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINK 237 (283)
T ss_pred Hhhhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhc
Confidence 98653321 12347899999999876 6889999999999999999999999874211 1111100000
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
......+..++.++.+++.+||+.||++|||++|+++.|+.++.
T Consensus 238 --------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 --------------------------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --------------------------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00011123577889999999999999999999999999998754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.16 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=210.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+.++|++.+.||+|.||.||.|+.++++-.||+|++... ......++.+|+++-+.++||||+++|+++ .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 356799999999999999999999999999999998533 223446899999999999999999999994 456
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...|+++||..+|.+...++.... .++++.....++.|+|.|+.|+|.. +|+||||||+|+|++..+.
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~---------~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~ 162 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM---------KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGE 162 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc---------ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCC
Confidence 899999999999999999985543 3678888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
.||+|||.+....... .....||..|.|||...+..++..+|+|++|++.||++.|.+||.....+ .
T Consensus 163 lkiAdfGwsV~~p~~k------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-e------ 229 (281)
T KOG0580|consen 163 LKIADFGWSVHAPSNK------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-E------ 229 (281)
T ss_pred eeccCCCceeecCCCC------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-H------
Confidence 9999999997544221 12345999999999999999999999999999999999999998743211 0
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.-+++.......+..++.+..++|.+|+..+|.+|.+..|+++.
T Consensus 230 --------------------------tYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 230 --------------------------TYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------------------------HHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 01122222233345677889999999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.77 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=215.6
Q ss_pred CCCCceeccccceeEEEEEECCC--C--eEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQD--G--TIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+..+.||+|-||.||+|.+... | -.||||..+.+ ..+..+.|.+|..+|++++||||++++|+|.+ ..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QP 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cc
Confidence 44557899999999999998432 2 25899998763 44556889999999999999999999999875 57
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.+||||.++.|.|+.|++..+ ..++......++.||+.||+|||+. ++|||||.++|||+.....+|
T Consensus 465 ~WivmEL~~~GELr~yLq~nk----------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK----------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeEEEecccchhHHHHHHhcc----------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence 899999999999999998876 3688889999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++..+....+... ...-+..|||||.+.-..++.++|||-|||++||++. |..||......|.-
T Consensus 532 LaDFGLSR~~ed~~yYkaS---~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------ 602 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS---RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------ 602 (974)
T ss_pred ecccchhhhccccchhhcc---ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------
Confidence 9999999988776544333 2335778999999999999999999999999999988 99999754333210
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+..+ ....+..+..||+.++.|+.+||++||.+||.+.|+...|+++..+
T Consensus 603 ----------------~~iE----------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 603 ----------------GHIE----------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred ----------------EEec----------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 0000 1223456778999999999999999999999999999999998763
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=342.42 Aligned_cols=264 Identities=27% Similarity=0.461 Sum_probs=220.3
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
+.++....+....++||-|.||.||.|.|++..-.||||.++ ++....++|..|+.+|+.++|||+|+++|+|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E--- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence 445555556677889999999999999999999999999997 4455678999999999999999999999999753
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
..+|||+|||.+|+|.+|+++... +.++....+.+|.||+.||+||..+ ++|||||.++|+|+.++
T Consensus 336 --pPFYIiTEfM~yGNLLdYLRecnr---------~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 336 --PPFYIITEFMCYGNLLDYLRECNR---------SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 401 (1157)
T ss_pred --CCeEEEEecccCccHHHHHHHhch---------hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhcccccc
Confidence 678999999999999999988753 4567778899999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
..+|++|||+++..... ++....+..-++.|.|||-+....++.|+|||+|||+|||+.| |-.||... ++
T Consensus 402 hiVKvADFGLsRlMtgD---TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dl- 472 (1157)
T KOG4278|consen 402 HIVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DL- 472 (1157)
T ss_pred ceEEeeccchhhhhcCC---ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cH-
Confidence 99999999999976543 2223334456789999999999999999999999999999999 99998743 11
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.++.+.+..-+.- ..+..||+.+++||..||++.|.+||+++|+.+.++.+.
T Consensus 473 --------SqVY~LLEkgyRM------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 473 --------SQVYGLLEKGYRM------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------HHHHHHHhccccc------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1122222222211 234589999999999999999999999999999997753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.80 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=200.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+..+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|++++++++|++|+++++++. .++..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence 3778899999999999999998899999999986432 222346788999999999999999999854 44789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN---------PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999988754321 2578999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 144 ~Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~-- 214 (285)
T cd05631 144 SDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVD-- 214 (285)
T ss_pred eeCCCcEEcCCCCe-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHH--
Confidence 99999976533221 123458999999999999999999999999999999999999987422110 000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 967 (988)
.. ........+...+.++.+|+.+||+.||++||+ ++|+++.
T Consensus 215 --~~-----------------------~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 215 --RR-----------------------VKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --HH-----------------------hhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 000111122346678999999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=351.93 Aligned_cols=286 Identities=22% Similarity=0.250 Sum_probs=202.3
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|++++++++||||+++++++...........+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999989999999998632 223345688999999999999999999987544333335689
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+ +++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 lv~e~~-~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-----------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEc
Confidence 999999 578998886542 588999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|||+++......... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 146 Dfg~~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~ 222 (338)
T cd07859 146 DFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITD 222 (338)
T ss_pred cCccccccccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHH
Confidence 999997543222111 11123468999999999876 6789999999999999999999999863211 000011111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......+................................++.+.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000000000000000000000000001112456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=327.35 Aligned_cols=282 Identities=23% Similarity=0.300 Sum_probs=204.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.|+..+++|.|+||.||+|....+++.||||..-.+.. .-.+|+.+|+++.|||||++..++....-.+.-...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46678999999999999999999999999998754332 23479999999999999999988776532223356689
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-CcEEEee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGD 822 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~D 822 (988)
|||| ..+|.++++..... .++++...++-++.||.+||+|||+. +|+||||||.|+|+|.+ |.+||||
T Consensus 101 leym-P~tL~~~~r~~~~~-------~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 101 LEYM-PETLYRVIRHYTRA-------NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred HHhc-hHHHHHHHHHHhhc-------CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEecc
Confidence 9999 46999888753211 14688888999999999999999998 99999999999999976 8999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH--HH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA--RT 899 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--~~ 899 (988)
||.|+......... ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.. +....+.+ -.
T Consensus 170 FGSAK~L~~~epni-----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik 240 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNI-----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIK 240 (364)
T ss_pred CCcceeeccCCCce-----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHH
Confidence 99999876654332 24578999999998885 699999999999999999999998763 22222221 11
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhh-hhh-ccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQ-AKI-NGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSVKN 973 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 973 (988)
.+...-.+-+..+-.... + .....+.. ... -.....+++..+++.++++++|.+|.++.|++.. .+++++
T Consensus 241 ~lG~Pt~e~I~~mn~~y~-~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 241 VLGTPTREDIKSMNPNYT-E---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HhCCCCHHHHhhcCcccc-c---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111111111111111000 0 00000011 100 1234678889999999999999999999999853 455443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.85 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=200.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47899999999999999999999899999999986432 22345688999999999999999999874 44578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG-----------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence 999999999999999986543 588899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++...... ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 142 l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~ 209 (291)
T cd05612 142 LTDFGFAKKLRDRT-------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK 209 (291)
T ss_pred EEecCcchhccCCc-------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 99999998653311 124589999999999998999999999999999999999999863211 011100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 967 (988)
.. ......+...+..+.+++.+||+.||.+||+ ++|+++.
T Consensus 210 i~----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 IL----------------------------AGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HH----------------------------hCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 0011112245667899999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.55 Aligned_cols=273 Identities=23% Similarity=0.369 Sum_probs=209.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc--CCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI--RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..+....+.||+|.||+||+|.| .|+.||||+|...+ .+...+|.++++.+ +|+||+.+++.-... -..-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEE
Confidence 45677889999999999999999 79999999996433 35666777777765 999999999873221 112245
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEeccCCCCCeeeCC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH-----CQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~ 814 (988)
.++|++|.+.|||.||+... .++....++++..+|.||++||.. .+|.|.|||||+.||||..
T Consensus 284 LwLvTdYHe~GSL~DyL~r~------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred EEEeeecccCCcHHHHHhhc------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 78999999999999999864 588899999999999999999953 4688999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhC---------
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTG--------- 879 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg--------- 879 (988)
++++.|+|+|+|.................+||.+|||||++... ..-..+||||||.|+||+...
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 99999999999987766543333344456899999999997653 122468999999999998763
Q ss_pred -CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC
Q 001974 880 -KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958 (988)
Q Consensus 880 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 958 (988)
+.||....+.|..+.+......-++.... -+..| ...++...+.++|+.||..+|..|
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~-------ipnrW--------------~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPN-------IPNRW--------------KSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCC-------CCccc--------------ccCHHHHHHHHHHHHhhcCCchhh
Confidence 35676666666555443322211111111 11122 123456678999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 001974 959 MSITNVVHELQSVKN 973 (988)
Q Consensus 959 Ps~~evl~~L~~i~~ 973 (988)
-||-.+.+.|.++.+
T Consensus 491 ltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 491 LTALRIKKTLAKLSN 505 (513)
T ss_pred hHHHHHHHHHHHHhc
Confidence 999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.00 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|...++||+|+||+|++|+.+.+++.+|||++++.. ....+..+.|.+++... +||.++.++.+ |+.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 4567999999999999999999999999999999998543 34567788899888877 69999999998 677
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.++.++||||+.||++..+.+. +.+++..+.-+|..|+.||+|||++ +||+||||-+|||+|.+|
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEG 505 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccC
Confidence 7999999999999996555443 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++..-... ..+.++.||+.|||||++.+..|+.++|.|||||++|||+.|..||....+
T Consensus 506 h~kiADFGlcKe~m~~g----~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------- 573 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQG----DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------- 573 (694)
T ss_pred cEEecccccccccCCCC----CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------
Confidence 99999999998543222 123456799999999999999999999999999999999999999873211
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.+++|..+.++ ..++..++.+...++++++..+|++|--+
T Consensus 574 ---------ee~FdsI~~d~----------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 ---------EEVFDSIVNDE----------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------HHHHHHHhcCC----------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12222222222 12345677889999999999999999755
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=376.19 Aligned_cols=482 Identities=26% Similarity=0.321 Sum_probs=343.3
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
+|++...++ .||..+..-..+..|+++.|-+-..+-+...+..+|+.||+++|++. ..|..+..+.+|+.|.++.|-|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 455666666 66766666666888888888776322233344555888888888888 7888888888888888888888
Q ss_pred cCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhh
Q 001974 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSI 196 (988)
Q Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 196 (988)
. ..|.+..++.+|++|.|.+|++. ..|..+..+.+|+.|+++.|++. .+|..+..++.++.+..++|.-....
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l---- 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL---- 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh----
Confidence 7 77778888888888888888887 77888888888888888888887 77778888888888888888222122
Q ss_pred ccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCcccc
Q 001974 197 YNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLS 276 (988)
Q Consensus 197 ~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~ 276 (988)
+... ++.+++..|.+.+.++..+. .+.+ .|+|++|.+. --.+.++.+|+.|....|++..... .-++|+
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----~g~~l~ 222 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----SGPSLT 222 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----cCcchh
Confidence 2222 77778888887776666554 2333 4888888776 2345667777888888877764332 246778
Q ss_pred EEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceE
Q 001974 277 YFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYR 356 (988)
Q Consensus 277 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 356 (988)
.|+.++|.++..... ..-.+|+++++++|+++ .+|+++.... +|+.+...+|++. .+|..+..+++|+.
T Consensus 223 ~L~a~~n~l~~~~~~--------p~p~nl~~~dis~n~l~-~lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 223 ALYADHNPLTTLDVH--------PVPLNLQYLDISHNNLS-NLPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLVS 291 (1081)
T ss_pred eeeeccCcceeeccc--------cccccceeeecchhhhh-cchHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHHH
Confidence 888888877743332 22356788888888887 6677776665 6888888888885 77777888888888
Q ss_pred EEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCC-CCCC-CCCEEEccccccccccccccccccccceeecCCC
Q 001974 357 LGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL-GNLS-ILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434 (988)
Q Consensus 357 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 434 (988)
|.+.+|.+. -+|....++++|++|+|..|+|. .+|+.+ .-+. .|..|+.+.|++.....-.=..++.|+.|++.+|
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 888888887 66777777888888888888887 555533 2222 2666777777776322111224566788888888
Q ss_pred CCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCC
Q 001974 435 GLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIP 514 (988)
Q Consensus 435 ~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 514 (988)
.++...-+-+-+...| +.|+|++|++.......+.++..|+.|+||+|+++ .+|..+..+..|+.|...+|+|. ..|
T Consensus 370 ~Ltd~c~p~l~~~~hL-KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHL-KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred cccccchhhhccccce-eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 8876666666677777 78888888887444455677888888888888888 77888888888888888888887 677
Q ss_pred ccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCc
Q 001974 515 SSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFND 555 (988)
Q Consensus 515 ~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~ 555 (988)
.+..+++|+.+|+|.|+|+...-.. ...++|++|||++|.
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 7788888888888888887544332 333678888888886
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.55 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=211.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc-
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF- 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~- 739 (988)
++|+.++.+|+|+||.++.++++.+++.||+|.+..... ...+...+|+.++++++|||||.+.+.+. .++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~-----~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE-----EDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh-----cCCce
Confidence 579999999999999999999999999999999975443 33357889999999999999999999853 3455
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.+|||+|++||++.+.+.+.+. .-+++..+++|+.|++.|+.|||+. +|+|||||+.||+++.++.||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~---------~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKG---------VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhh---------ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCcee
Confidence 9999999999999999987652 3688999999999999999999988 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ ....+||+.||.||.+.+.+|..|+||||+||++|||++-+++|... +....+..
T Consensus 147 LgDfGlaK~l~~~~~~----a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~k 217 (426)
T KOG0589|consen 147 LGDFGLAKILNPEDSL----ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILK 217 (426)
T ss_pred ecchhhhhhcCCchhh----hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHH
Confidence 9999999987765422 23467999999999999999999999999999999999999998732 11111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. +......+..+..++..++..|++.+|+.||++.+++.+
T Consensus 218 i~---------------------------~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 IN---------------------------RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Hh---------------------------hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 111112233566789999999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.61 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=213.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccC--CC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQG--ND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~--~~ 738 (988)
..++++.+.|.+|||+.||.|++...|..||+|++-..+....+.+.+|+++|++|+ |+|||.+++.+....... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 445778899999999999999998777999999998777778889999999999995 999999999433221122 25
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
+++|.||||++|.|-+++..... ..+++.++++|+.|+++|+++||.. +++|||||||.+|||++.++..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq---------~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ---------TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh---------ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence 67899999999999999975432 3699999999999999999999996 6789999999999999999999
Q ss_pred EEeeecccccccccccccce-----eccccccccccccCccc---CCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 819 HVGDFGLARVRQEVSNLTQS-----CSVGVRGTIGYAAPEYG---LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
||||||.|.-.-........ .......|+.|+|||++ .+.+.++|+||||+||+||.|+....||+....-
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l- 264 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL- 264 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence 99999999743322211100 01123479999999975 4678899999999999999999999999843111
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
.+++..+. ......+...+.+||..||+.||.+||++.+|+..+.+
T Consensus 265 ----------------aIlng~Y~------------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 ----------------AILNGNYS------------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ----------------eEEecccc------------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 11111110 01113577889999999999999999999999999999
Q ss_pred HHHH
Q 001974 971 VKNA 974 (988)
Q Consensus 971 i~~~ 974 (988)
+...
T Consensus 311 l~~~ 314 (738)
T KOG1989|consen 311 LANK 314 (738)
T ss_pred HhcC
Confidence 8765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.81 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=207.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch---hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA---SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+|++.+.||+|.||.|-+|.....|+.||||.++...-.. .-.+.+|+++|..++||||+.+|++ |++.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence 46888899999999999999998899999999997554333 3457899999999999999999999 667799
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
+.|||||..+|.|++|+.+.+ .+++.++..+++||..|+.|+|.+ ++||||||-+|||+|.++++|
T Consensus 128 IvivMEYaS~GeLYDYiSer~-----------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERG-----------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred EEEEEEecCCccHHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 999999999999999998764 799999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||++-.+.......+ +.|++-|.+||++.+.+| ++.+|.||+||+||-++.|..||+.. +....++
T Consensus 194 IADFGLSNly~~~kfLqT-----FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvr 263 (668)
T KOG0611|consen 194 IADFGLSNLYADKKFLQT-----FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVR 263 (668)
T ss_pred eeccchhhhhccccHHHH-----hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHH
Confidence 999999988766544443 459999999999999988 57899999999999999999999842 1111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
..-. +. -..++.|....-||++|+..+|++|.|+.||....
T Consensus 264 QIs~------------Ga-----------------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 264 QISR------------GA-----------------YREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred Hhhc------------cc-----------------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1000 00 01224556677899999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=347.57 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=200.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 357899999999999999999999899999999986432 233457889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG-----------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCE
Confidence 8999999999999999987543 578888999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ....
T Consensus 158 kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~-~~~~- 224 (329)
T PTZ00263 158 KVTDFGFAKKVPDRT-------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----P-FRIY- 224 (329)
T ss_pred EEeeccCceEcCCCc-------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----H-HHHH-
Confidence 999999998653321 12358999999999999999999999999999999999999985311 0 0000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 967 (988)
+.+.+ .....+..++..+.+++.+||+.||++||+ ++|+++.
T Consensus 225 ----~~i~~-----------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 ----EKILA-----------------------GRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----HHHhc-----------------------CCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00000 001112235567899999999999999997 5777643
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.35 Aligned_cols=281 Identities=25% Similarity=0.337 Sum_probs=211.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCC-ceEEEeeccccc-ccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRN-LVKVITSCSSID-FQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~~ 738 (988)
..|+.+++||+|+||+||+|+.+.+|+.||+|.++.... +......+|+.+++.++|+| |+++++++.... +....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 446677889999999999999999999999999985543 45678899999999999999 999999976531 12234
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++|+||+ .-+|..++....... +.++...++.++.||+.||+|||++ +|+||||||.||+|+++|.+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~l 159 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVL 159 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcE
Confidence 788999999 789999998765321 2466688999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+|+...-... .....++|..|+|||++.+. .|+...||||+||+++||+++++-|....+ .
T Consensus 160 KlaDFGlAra~~ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~---- 227 (323)
T KOG0594|consen 160 KLADFGLARAFSIPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----I---- 227 (323)
T ss_pred eeeccchHHHhcCCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----H----
Confidence 9999999996543222 23345689999999999886 789999999999999999999988764322 1
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHH---hhhh-------hccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRL---RQAK-------INGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~---~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
++...++.-...+....|+....-.- .... ............+++.+|++++|++|.|++.++..
T Consensus 228 -----~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 228 -----DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred -----HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11222222222222333322211000 0000 00011222467899999999999999999999876
Q ss_pred --HHHH
Q 001974 968 --LQSV 971 (988)
Q Consensus 968 --L~~i 971 (988)
++.+
T Consensus 303 ~yf~~~ 308 (323)
T KOG0594|consen 303 PYFSEL 308 (323)
T ss_pred hhhccc
Confidence 5444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=374.35 Aligned_cols=484 Identities=26% Similarity=0.358 Sum_probs=414.4
Q ss_pred EEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccccc
Q 001974 60 EINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNN 139 (988)
Q Consensus 60 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 139 (988)
.+|++..+++ .+|.-+..-..++.|+++.|.+....-....+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 4788889998 88888777777999999999888433333445556999999999998 899999999999999999999
Q ss_pred ccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCc
Q 001974 140 LTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPS 219 (988)
Q Consensus 140 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~ 219 (988)
|. ..|....++.+|++|.|.+|++. ..|..+..+++|++|+++.|++. .+|..+..++.++.+..++|.....++.
T Consensus 80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~- 155 (1081)
T KOG0618|consen 80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ- 155 (1081)
T ss_pred Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc-
Confidence 99 78889999999999999999998 89999999999999999999999 8899999999999999999933223332
Q ss_pred ccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhccc
Q 001974 220 LGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299 (988)
Q Consensus 220 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l 299 (988)
..++.+++..|.+.+.++..+.++.. .|||.+|.+. ...+..+.+|+.+....|++.....
T Consensus 156 -----~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~--------- 216 (1081)
T KOG0618|consen 156 -----TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI--------- 216 (1081)
T ss_pred -----ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe---------
Confidence 23899999999999999998888887 8999999997 3456778999999999999976543
Q ss_pred ccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccC
Q 001974 300 ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLE 379 (988)
Q Consensus 300 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 379 (988)
..++|+.|+.++|.++...+.. .+..|+++++++|+++ .+|++++.+.+|+.|++.+|+++ .+|..+..+++|+
T Consensus 217 -~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~ 290 (1081)
T KOG0618|consen 217 -SGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLV 290 (1081)
T ss_pred -cCcchheeeeccCcceeecccc---ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHH
Confidence 3578999999999998433332 3457999999999999 67799999999999999999997 8999999999999
Q ss_pred eEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccc-cceeecCCCCCCccCchhhh-hhcccccceecc
Q 001974 380 GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQ-LAILHLFENGLNGTIPEEIF-NLTYLSNSLNLA 457 (988)
Q Consensus 380 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~-~l~~l~~~L~ls 457 (988)
.|.+.+|++. -+|.....++.|++|+|..|+|....+..|.-+.. |..|+.+.|++. ..|..-. ....| +.|.+.
T Consensus 291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~L-q~Lyla 367 (1081)
T KOG0618|consen 291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAAL-QELYLA 367 (1081)
T ss_pred HHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHH-HHHHHh
Confidence 9999999999 78888899999999999999999444434444433 889999999998 6664322 34445 899999
Q ss_pred cccccCCCccccccccccceeecCCcccccccC-cccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCc
Q 001974 458 RNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIP-SQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536 (988)
Q Consensus 458 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 536 (988)
+|.++...-+.+.+.+.|+.|+|++|+|. .+| ..+.++..|++|+||+|+|+ .+|+++..+++|++|..-+|+|...
T Consensus 368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f 445 (1081)
T KOG0618|consen 368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF 445 (1081)
T ss_pred cCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec
Confidence 99999888788999999999999999999 555 56789999999999999999 8999999999999999999999976
Q ss_pred CcccccCCCCcEEeCCCCcCcc-cCCCCcccCccccccccccccc
Q 001974 537 IPKFLEDLSLEYLNLSFNDLEG-EVPTKGVFANISRISVAGFNRL 580 (988)
Q Consensus 537 ~p~~~~~~~L~~l~l~~N~l~~-~~p~~~~~~~~~~~~~~~n~~l 580 (988)
| ....++.|+.+|||.|+|+. .+|....+++++-+.+.||.++
T Consensus 446 P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 446 P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 6 77888999999999999985 5555555578888889998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=345.17 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=195.8
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|++..+|+.||+|+++... ......+.+|+.++++++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999899999999997432 23345678899999999999999999885 44578999999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 76 YANGGELFFHLSRER-----------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred CCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999986543 588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... +..........
T Consensus 142 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~--- 209 (323)
T cd05571 142 CKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILM--- 209 (323)
T ss_pred CcccccCCC----cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHHc---
Confidence 875322111 112345899999999999999999999999999999999999998631 11111100000
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
.....+...+.++.+++.+||+.||++|| ++.++++
T Consensus 210 -------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 210 -------------------------EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00112235677899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.33 Aligned_cols=273 Identities=25% Similarity=0.335 Sum_probs=200.3
Q ss_pred CCCCCCceeccccceeEEEEEECC-CCeEEEEEEeeccc--cchhHHHHHHHHHHHhc---CCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQR--HGASKSFLAECKALKNI---RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 736 (988)
++|++.+.||+|+||.||+|++.. +++.||+|+++... ......+.+|+.+++.+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 46889999986432 22234566787777766 6999999999986443445
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||++ ++|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 147 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCC
Confidence 567899999995 799998865432 2578999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++...... ......|++.|+|||++.+..++.++|||||||++|||++|++||...... .....
T Consensus 148 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~ 220 (290)
T cd07862 148 QIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGK 220 (290)
T ss_pred CEEEccccceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHH
Confidence 99999999997654321 122345899999999998889999999999999999999999998742111 10000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhH---HH----HhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNK---QR----LRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. ++........+|..... .. ............+..+.+++.+|++.||++|||+.|+++
T Consensus 221 i-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 221 I-----------LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred H-----------HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00000001111111000 00 000000111246677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.20 Aligned_cols=257 Identities=21% Similarity=0.381 Sum_probs=203.3
Q ss_pred hCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++.... .....+.+|+.++++++||||+++++++. .+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 356889999999999999999874 3467899999875432 33457889999999999999999999854 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~ 145 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE----------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLV 145 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCc
Confidence 78999999999999999987543 2688999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+|++|||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ..
T Consensus 146 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----~~ 217 (266)
T cd05064 146 CKISGFRRLQEDKSEAIY---TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----DV 217 (266)
T ss_pred EEECCCcccccccccchh---cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HH
Confidence 999999987653221111 1112235678999999999999999999999999999875 99998632110 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.. .+. +. .....+..+|..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 218 ~~-----~~~---~~-------------------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IK-----AVE---DG-------------------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HH-----HHH---CC-------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 000 00 00112235778899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.39 Aligned_cols=273 Identities=21% Similarity=0.365 Sum_probs=203.0
Q ss_pred hCCCCCCceeccccceeEEEEEECC----------------CCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ----------------DGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVK 724 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 724 (988)
.++|++.++||+|+||.||+|.+.. ++..||+|+++.... ....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578999999999999999998632 344799999875432 23457899999999999999999
Q ss_pred EEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchh--------hhHhhcCCHHHHHHHHHHHHHHHHHHHcCC
Q 001974 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV--------EIEIQKLTLLQRINIAIDVASAIDYLHHHC 796 (988)
Q Consensus 725 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 796 (988)
+++++.. .+..++||||+++|+|.+++.......... ......+++.++..++.||+.||+|||+.
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999643 467899999999999999986533211100 01113578899999999999999999998
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHH
Q 001974 797 QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876 (988)
Q Consensus 797 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el 876 (988)
+|+||||||+||++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 111223457899999999888999999999999999999
Q ss_pred Hh--CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC
Q 001974 877 VT--GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 877 lt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
++ +..||...... .....+........ .......+..++..+.+++.+||+.|
T Consensus 234 ~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 234 LMLCKEQPYGELTDE--QVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred HHccCCCCCCcCCHH--HHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHccCC
Confidence 87 55666532111 11111100000000 00001123357788999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 001974 955 PQDRMSITNVVHELQ 969 (988)
Q Consensus 955 P~~RPs~~evl~~L~ 969 (988)
|++|||+.||.+.|+
T Consensus 289 p~~RPs~~~i~~~l~ 303 (304)
T cd05096 289 CRERPSFSDIHAFLT 303 (304)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=340.11 Aligned_cols=279 Identities=25% Similarity=0.349 Sum_probs=199.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.+++.++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 5789999999999999999999998999999999864432 23356788999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+ .++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 79 ~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 144 (303)
T cd07869 79 TLVFEYV-HTDLCQYMDKHP----------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKL 144 (303)
T ss_pred EEEEECC-CcCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999 578888876543 2578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+......
T Consensus 145 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 220 (303)
T cd07869 145 ADFGLARAKSVPSH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220 (303)
T ss_pred CCCCcceeccCCCc----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence 99999875432211 1122457899999998865 457889999999999999999999987432111001000000
Q ss_pred HHhhhhhhhhc---cccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVD---PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......+... .........+........... ......+..+.+++.+|++.||++|||++|+++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 221 -LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQA--WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred -hCCCChhhccchhhccccccccccccCCccHHHH--hhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 000000000000000000000 011124567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=341.55 Aligned_cols=281 Identities=20% Similarity=0.294 Sum_probs=206.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..++..||+|+++.... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 4689999999999999999999999999999999875432 33467899999999999999999999854 34789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl 145 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK-----------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKL 145 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEE
Confidence 99999999999999986543 578899999999999999999985 26999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+.......
T Consensus 146 ~Dfg~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~ 217 (331)
T cd06649 146 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRP 217 (331)
T ss_pred ccCcccccccccc------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhccc
Confidence 9999987553321 12345899999999999999999999999999999999999998632111 111111000
Q ss_pred Hhhhhh---hhhccccc--------cCcchhhhh-hHHHHh---hh-hhc-cccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 901 LLDHVI---DIVDPILI--------NDVEDWDAT-NKQRLR---QA-KIN-GKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 901 ~~~~~~---~~~d~~l~--------~~~~~~~~~-~~~~~~---~~-~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
..+... ....+... ......... ...... .. ... ....++.++.+++.+||+.||++|||++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e 297 (331)
T cd06649 218 VVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 297 (331)
T ss_pred ccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHH
Confidence 000000 00000000 000000000 000000 00 000 01235678999999999999999999999
Q ss_pred HHHHH
Q 001974 964 VVHEL 968 (988)
Q Consensus 964 vl~~L 968 (988)
+++.-
T Consensus 298 ll~h~ 302 (331)
T cd06649 298 LMNHT 302 (331)
T ss_pred HhcCh
Confidence 98763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=308.33 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=202.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+.|++-+.||+|.|+.||++.+..+|+.+|+|++... .....+++.+|+++.+.++||||+++.+. +.....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 46788889999999999999999999999999998532 23356789999999999999999999988 455688
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
.++|+|+|.|++|..-+-.. .-+++..+-.+++||++||.|+|.. +|||||+||+|+++.. .-
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R-----------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred eEEEEecccchHHHHHHHHH-----------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCC
Confidence 99999999999997555322 3578889999999999999999999 9999999999999953 33
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
-+||+|||+|...... ....+.+||++|||||++...+|+..+|||+.||++|-++.|.+||.....
T Consensus 151 ~vKL~~FGvAi~l~~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------- 217 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------- 217 (355)
T ss_pred ceeecccceEEEeCCc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------
Confidence 6999999999987632 223457899999999999999999999999999999999999999863110
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+.+++.. ....-+.+.| ..+.++..+|+.+|+..||++|.|+.|.++
T Consensus 218 --~rlye~I~~---g~yd~~~~~w----------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 218 --HRLYEQIKA---GAYDYPSPEW----------------DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --HHHHHHHhc---cccCCCCccc----------------CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111122111 0111111222 356778899999999999999999998774
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=347.74 Aligned_cols=272 Identities=24% Similarity=0.361 Sum_probs=205.9
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
...++|++.+.||+|+||.||+|++... +..||+|+++... ....+.+.+|+++++.+ +|+||++++++|..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~- 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH- 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-
Confidence 3456799999999999999999986433 3579999997443 23345688999999999 89999999998643
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCC-------------------------------------------------
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQ------------------------------------------------- 763 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------- 763 (988)
++..++||||+++|+|.+++.......
T Consensus 114 ----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 114 ----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred ----CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 478899999999999999986432100
Q ss_pred ----------chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccc
Q 001974 764 ----------KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833 (988)
Q Consensus 764 ----------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 833 (988)
........++++.++++|+.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 00000113578899999999999999999998 99999999999999999999999999997654322
Q ss_pred cccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhhccc
Q 001974 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPI 912 (988)
Q Consensus 834 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 912 (988)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+... ....
T Consensus 267 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~------------~~~~ 331 (374)
T cd05106 267 NY--VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM------------VKRG 331 (374)
T ss_pred ce--eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHH------------HHcc
Confidence 11 11112235678999999998899999999999999999997 999986432110 00000 0000
Q ss_pred cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 913 LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 913 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
. ....+...++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 332 ~------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 Y------------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred c------------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 00111235678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.81 Aligned_cols=276 Identities=22% Similarity=0.269 Sum_probs=200.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 46999999999999999999999899999999987432 233467889999999999999999998853 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl 141 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-----------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKL 141 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEE
Confidence 9999999887776554322 2588899999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++......... ......|+..|+|||++.+..++.++||||+||++|||++|+.||......+ .... ....
T Consensus 142 ~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~ 216 (287)
T cd07848 142 CDFGFARNLSEGSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFT-IQKV 216 (287)
T ss_pred eeccCcccccccccc---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHh
Confidence 999999865432211 1123458999999999999899999999999999999999999986421111 0000 0000
Q ss_pred Hhh----hhhhh-hccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLD----HVIDI-VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~----~~~~~-~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ..... .++.... ..+... ..............+.++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 217 LGPLPAEQMKLFYSNPRFHG--LRFPAV--NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hCCCCHHHHHhhhccchhcc--cccCcc--cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000 0000000 000000 00000000111235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.09 Aligned_cols=278 Identities=23% Similarity=0.315 Sum_probs=200.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.++||+|+||.||+|+...+++.||+|+++.... .....+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence 3579999999999999999999998999999999874432 23456789999999999999999999853 44778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl 144 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCG----------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKL 144 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999996 59998886543 2578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...... ........
T Consensus 145 ~DfG~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~ 218 (288)
T cd07871 145 ADFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFR 218 (288)
T ss_pred CcCcceeeccCCCc----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999975432211 1123457899999998865 56899999999999999999999998632111 00000100
Q ss_pred HHhhhhhhhhccccccCcchhhhhh-HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATN-KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.......+...... ..+.+.... ...............+.+..+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 219 LLGTPTEETWPGIT--SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HhCCCChHHhhccc--cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01000001000000 000000000 000000001112245667899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=345.50 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=204.3
Q ss_pred hCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||.||+|++ ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 45789999999999999999975 3356789999986433 23346788999999999 89999999999644
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCch-------------------------------------------------
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKD------------------------------------------------- 765 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------- 765 (988)
++..++||||+++|+|.+++.........
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 47789999999999999999654311000
Q ss_pred ---------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 766 ---------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 766 ---------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
.......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 000112578999999999999999999998 99999999999999999999999999998654
Q ss_pred ccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhh
Q 001974 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIV 909 (988)
Q Consensus 831 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (988)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ..... +...
T Consensus 266 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~----~~~~----- 333 (375)
T cd05104 266 NDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM----IKEG----- 333 (375)
T ss_pred Cccccc--ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH----HHhC-----
Confidence 332211 1112235678999999999999999999999999999998 888886421110 00000 0000
Q ss_pred ccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 910 DPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 910 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. ....+...+.++.+++.+||+.||++|||++||++.|++.
T Consensus 334 ---~------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 ---Y------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---c------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0011123567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.08 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=202.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++..++||||+++++++. .++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 36899999999999999999999889999999997432 233456889999999999999999999854 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG-----------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEE
Confidence 999999999999999996543 578899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 142 L~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~ 209 (333)
T cd05600 142 LTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETWEN 209 (333)
T ss_pred EEeCcCCccccc-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHHHH
Confidence 999999975533 122346899999999999999999999999999999999999998632111 11000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .. ....... . .+ ......++.++.+++.+||..+|++||+++|+++.
T Consensus 210 i-~~-~~~~~~~---~---~~------------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 210 L-KY-WKETLQR---P---VY------------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred H-Hh-ccccccC---C---CC------------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 00 0000000 0 00 00012456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=339.54 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=194.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|+...+|+.||+|+++... ......+.+|+++++.++||||+++++++. .++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999899999999997432 233456778999999999999999998854 4578999999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 76 YANGGELFFHLSRER-----------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred CCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHH
Confidence 999999998886543 588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 142 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~--- 209 (323)
T cd05595 142 CKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILM--- 209 (323)
T ss_pred hccccCCCC----ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc---
Confidence 874322111 11234589999999999999999999999999999999999999863211 000000000
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
.....+..+++++.+++.+||+.||++|| ++.++++
T Consensus 210 -------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 210 -------------------------EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00112235677899999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.25 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=199.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC-eEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG-TIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+++++.++||||+++++++. ++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence 456999999999999999999876554 68999998643 2233457889999999999999999999954 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ 169 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK-----------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGF 169 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCC
Confidence 78999999999999999987543 588899999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 170 ikL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~ 237 (340)
T PTZ00426 170 IKMTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIY 237 (340)
T ss_pred EEEecCCCCeecCCC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHH
Confidence 999999999865321 1224589999999999998899999999999999999999999863210 0000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
..+. ......+...+..+.+++.+|++.||++|+ +++|+++.
T Consensus 238 -----~~i~-----------------------~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 238 -----QKIL-----------------------EGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----HHHh-----------------------cCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0000 000111234566789999999999999995 88888764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.19 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=193.0
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||.||+|++..+++.||+|+++.. .......+.+|+.++++++||||+++++++. .++..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 69999999999999989999999998643 2233456788999999999999999998854 457899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 76 ~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 76 NGGELFHHLQREG-----------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred CCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 9999999986543 588999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...........
T Consensus 142 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~----- 207 (312)
T cd05585 142 LNMKDDD----KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQ----- 207 (312)
T ss_pred cCccCCC----ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHc-----
Confidence 5322211 122346899999999999999999999999999999999999998632 11111111000
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC---HHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS---ITNVVH 966 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 966 (988)
.....+...++++.+++.+||+.||++||+ +.|+++
T Consensus 208 -----------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 208 -----------------------EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -----------------------CCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 011122356678999999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=343.40 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=194.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|+..+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+++++.++|+||+++++++ ..++..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 346677899999999999999988999999999864432 3346788999999999999999999985 3457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+
T Consensus 149 lv~e~~~~~~L~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~ 210 (353)
T PLN00034 149 VLLEFMDGGSLEGTH---------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA 210 (353)
T ss_pred EEEecCCCCcccccc---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence 999999999986532 345667888999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|||+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+...
T Consensus 211 DfG~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~ 284 (353)
T PLN00034 211 DFGVSRILAQTMD----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASL 284 (353)
T ss_pred ccccceecccccc----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHH
Confidence 9999986543211 1123468999999998743 23456899999999999999999998732111 11111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... .........++.++.+++.+||+.||++|||+.|+++.
T Consensus 285 ~~~~~~---------------------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 285 MCAICM---------------------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHhc---------------------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110000 00011223567789999999999999999999999874
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.16 Aligned_cols=387 Identities=26% Similarity=0.404 Sum_probs=267.5
Q ss_pred CCCCCCEEEcCCCccc-ccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccc
Q 001974 54 NLSFLREINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQ 132 (988)
Q Consensus 54 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 132 (988)
-|+..+-.|+++|.++ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-+++..|+.|+.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs 82 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS 82 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence 3455666666666666 356666666666666666666666 55555555555555555555554 44455555555555
Q ss_pred cccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCC
Q 001974 133 LAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212 (988)
Q Consensus 133 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i 212 (988)
+.+.+|++.. .-+|..+.+|..|+.||||+|++. ..|..+....++-.|+||+|+|
T Consensus 83 v~~R~N~LKn-----------------------sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 83 VIVRDNNLKN-----------------------SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred Hhhhcccccc-----------------------CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 5555555541 124555556666666666666666 5566666666666666666666
Q ss_pred CCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCc
Q 001974 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292 (988)
Q Consensus 213 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 292 (988)
. +||..+|.+++.|-.||||+|++... |.....+..|++|+|++|.+.
T Consensus 139 e-tIPn~lfinLtDLLfLDLS~NrLe~L-------------------------PPQ~RRL~~LqtL~Ls~NPL~------ 186 (1255)
T KOG0444|consen 139 E-TIPNSLFINLTDLLFLDLSNNRLEML-------------------------PPQIRRLSMLQTLKLSNNPLN------ 186 (1255)
T ss_pred c-cCCchHHHhhHhHhhhccccchhhhc-------------------------CHHHHHHhhhhhhhcCCChhh------
Confidence 6 77777776666666666666655521 112222333333333333331
Q ss_pred hhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCC-CccCcc
Q 001974 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFT-GTIPKE 371 (988)
Q Consensus 293 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~ 371 (988)
..--..+..|++|..|++++.+=+ ..+|.+
T Consensus 187 -------------------------------------------------hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts 217 (1255)
T KOG0444|consen 187 -------------------------------------------------HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS 217 (1255)
T ss_pred -------------------------------------------------HHHHhcCccchhhhhhhcccccchhhcCCCc
Confidence 111112334566667777765443 357888
Q ss_pred cCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccc
Q 001974 372 MGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLS 451 (988)
Q Consensus 372 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~ 451 (988)
+..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+ .+....+...+|+.|+||+|+++ .+|..++.+++|
T Consensus 218 ld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL- 293 (1255)
T KOG0444|consen 218 LDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL- 293 (1255)
T ss_pred hhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH-
Confidence 888888888888888888 78888888888888888888888 56666778888999999999998 889999999988
Q ss_pred cceeccccccc-CCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCC
Q 001974 452 NSLNLARNHLV-GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR 530 (988)
Q Consensus 452 ~~L~ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 530 (988)
+.|.+.+|+++ .-+|..++.|.+|+++..++|.+. .+|+.++.|..|+.|.|++|+|. .+|+.+.-|+.|+.|||.+
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 88888888876 247999999999999999999999 89999999999999999999999 8999999999999999999
Q ss_pred CcccCcCcccccC-CCCcEEeCCC
Q 001974 531 NNLSGLIPKFLED-LSLEYLNLSF 553 (988)
Q Consensus 531 N~l~~~~p~~~~~-~~L~~l~l~~ 553 (988)
|.=-.-+|+...- .+|+.-++..
T Consensus 372 NpnLVMPPKP~da~~~lefYNIDF 395 (1255)
T KOG0444|consen 372 NPNLVMPPKPNDARKKLEFYNIDF 395 (1255)
T ss_pred CcCccCCCCcchhhhcceeeecce
Confidence 9876667665322 3566655443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=339.00 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=196.0
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|++..+++.||+|++.... ......+.+|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46899999999999999899999999997432 23345788899999999999999999884 44588999999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 y~~~g~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 76 YVNGGELFFHLSRER-----------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred CCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcC
Confidence 999999998886543 588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 142 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~--- 209 (328)
T cd05593 142 CKEGITDAA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILM--- 209 (328)
T ss_pred CccCCCccc----ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhcc---
Confidence 875322111 1123458999999999999999999999999999999999999986321 1111100000
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
.....+...+.++.+++.+||+.||++|| ++.|+++.
T Consensus 210 -------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 -------------------------EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -------------------------CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00111234667889999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.84 Aligned_cols=260 Identities=23% Similarity=0.407 Sum_probs=205.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCe----EEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
..+|+..+.||+|+||.||+|++..+++ .||+|+++... ....+++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----
Confidence 3569999999999999999999865555 38999986433 3445678899999999999999999999753
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++
T Consensus 81 -~~~~~v~e~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~ 146 (316)
T cd05108 81 -STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQ 146 (316)
T ss_pred -CCceeeeecCCCCCHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCC
Confidence 34679999999999999987653 2578889999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... ...+..++..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~ 219 (316)
T cd05108 147 HVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE 219 (316)
T ss_pred cEEEccccccccccCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence 99999999998654332211 1112234678999999999999999999999999999998 9999863211 01
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.. ...... .....+..++.++.+++.+||+.+|++||++.+++..+.++...
T Consensus 220 ~~---------~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 220 IS---------SILEKG------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HH---------HHHhCC------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00 000000 00111234667789999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=338.97 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=205.3
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeecc
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMT 748 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 748 (988)
-+||+|.||+||.|++..+...+|||.+...+....+-+..|+..-+.++|.|||+++|.|.+ +++.-|.||.++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCC
Confidence 379999999999999999999999999987777777889999999999999999999999654 478899999999
Q ss_pred ccchhhhcCCCCCCCchhhhHhhcC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC-CCCcEEEeeecc
Q 001974 749 NGSLENWLHPDAVPQKDVEIEIQKL--TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGL 825 (988)
Q Consensus 749 ~gsL~~~l~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~ 825 (988)
||+|.++++..-. ++ .+..+-.+.+||++||.|||+. .|||||||-+||+|+ -.|.+||+|||.
T Consensus 656 GGSLSsLLrskWG----------PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGT 722 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG----------PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGT 722 (1226)
T ss_pred CCcHHHHHHhccC----------CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccccc
Confidence 9999999986643 44 6778888999999999999999 999999999999995 678999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
++...... .++.++.||..|||||++..+ .|+.++|||||||++.||.||++||.........
T Consensus 723 sKRLAgin----P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----------- 787 (1226)
T KOG4279|consen 723 SKRLAGIN----PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----------- 787 (1226)
T ss_pred chhhccCC----ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----------
Confidence 98776543 344557799999999999875 5889999999999999999999998754222100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+ .+..+....+..+.+...+...+|.+|+.+||.+||+|++++..
T Consensus 788 ----M---------------FkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 788 ----M---------------FKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ----h---------------hhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 0 00111112223455677788999999999999999999999853
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.18 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=167.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++||||+++++++. .+...+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence 467999999999999999999999999999999753 245678999999999999999999854 457889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+|++ +++|.+++.... .+++.+++.++.||+.||+|||+. +||||||||+||+++.++.+||+
T Consensus 160 lv~e~~-~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~ 224 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR-----------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLG 224 (391)
T ss_pred EEEecC-CCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEE
Confidence 999999 578988886542 578999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 225 DFG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 225 DFGAACFPVDINA---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred eCCcccccccccc---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999975332211 11223569999999999999999999999999999999999998864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.87 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=205.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.+|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|++++++++||||+++++++.. ++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence 4578889999999999999999888999999998643 3345678999999999999999999998643 477899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|
T Consensus 80 v~e~~~~~~L~~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d 147 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNR---------QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 147 (263)
T ss_pred EEEeCCCCcHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCC
Confidence 9999999999999865432 3578899999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||... ........
T Consensus 148 f~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~-- 217 (263)
T cd05052 148 FGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYEL-- 217 (263)
T ss_pred Ccccccccccee---eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH--
Confidence 999986543221 11112234668999999998899999999999999999998 99997532 11111000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
+.. . .....+..++.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus 218 ---~~~----~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 ---LEK----G------------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HHC----C------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000 0 01112235678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.80 Aligned_cols=251 Identities=31% Similarity=0.531 Sum_probs=193.6
Q ss_pred CCceeccccceeEEEEEEC----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 667 STHLIGMGSFGSVYKGAFD----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+.||.|.||.||+|.+. ..+..|+||+++.... ...+.+.+|++.+++++||||++++|+|.. .+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 4578999999999999997 3457899999965433 336789999999999999999999999763 36689
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++..... ..+++.++..|+.||+.||+|||+. +++||||+++||++++++.+||+
T Consensus 78 lv~e~~~~g~L~~~L~~~~~---------~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~ 145 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK---------EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLS 145 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT---------TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEE
T ss_pred cccccccccccccccccccc---------ccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 99999999999999987621 3689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||++......... ...........|+|||.+.+..++.++||||||+++||+++ |+.||..... .......
T Consensus 146 ~f~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~ 218 (259)
T PF07714_consen 146 DFGLSRPISEKSKY--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKL 218 (259)
T ss_dssp STTTGEETTTSSSE--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHH
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccc
Confidence 99999866322111 22223447789999999998889999999999999999999 7888763311 1111110
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
. .......+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 219 -~--------------------------~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -K--------------------------QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -H--------------------------TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -c--------------------------ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0 0011122335788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.16 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
+|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++. .++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4788999999999999999998899999999986432 122345778999999999999999999854 44789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN---------PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEE
Confidence 999999999999988864321 2588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++........ .....|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....
T Consensus 144 ~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--~~~~~---- 212 (285)
T cd05605 144 SDLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--VKREE---- 212 (285)
T ss_pred eeCCCceecCCCCc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh--hHHHH----
Confidence 99999976533221 12245899999999999889999999999999999999999998632110 00000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
+...+ .......+...+..+.+++.+||+.||++|| +++++++.
T Consensus 213 ~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRV-----------------------KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHh-----------------------hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00000 0001111234667789999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=300.01 Aligned_cols=253 Identities=21% Similarity=0.378 Sum_probs=204.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc--------hhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--------ASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
-+.|+..+.+|.|..++|.++.++.+|..+|+|++...... ..+.-.+|+.+++++ .||+|+.+.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 35688889999999999999999999999999999633221 124567899999998 89999999999
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
++.+...++|+|.|+.|.|.+|+...- .+++.+..+|++|+.+|++|||.. +|||||+||+|||+
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLts~V-----------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILl 156 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLTSKV-----------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILL 156 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhhhhe-----------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheee
Confidence 455688899999999999999997653 789999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCC------CCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG------SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
|++.++||+|||+|+....+..... ..||++|.|||.+.. ..|+..+|+||.||++|.++.|.+||-.-
T Consensus 157 ddn~~i~isDFGFa~~l~~GekLre-----lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLEPGEKLRE-----LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred ccccceEEeccceeeccCCchhHHH-----hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 9999999999999998877665544 459999999998653 46888999999999999999999997421
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+..+...+. ...+.-..++| .++.....+||.+|++.||.+|.|++|+++
T Consensus 232 ----------kQmlMLR~Im---eGkyqF~speW----------------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 ----------KQMLMLRMIM---EGKYQFRSPEW----------------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ----------HHHHHHHHHH---hcccccCCcch----------------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0000111111 11111112233 256677899999999999999999999986
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 283 H 283 (411)
T KOG0599|consen 283 H 283 (411)
T ss_pred C
Confidence 4
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.52 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=199.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||.||+|+++ ++..+|+|.+.... ....++.+|++++++++||||+++++++. .++..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 46888999999999999999986 56789999876332 33467889999999999999999999864 3477899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 77 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d 143 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ----------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSD 143 (256)
T ss_pred EEEcCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECC
Confidence 999999999999987543 2578899999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 144 ~g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~-- 213 (256)
T cd05114 144 FGMTRYVLDDEYT---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEM-- 213 (256)
T ss_pred CCCccccCCCcee---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH--
Confidence 9999765332211 1122345678999999988889999999999999999999 8999863210 011100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
+.. ......+...+.++.+++.+||+.+|++||+++|+++.|
T Consensus 214 ---i~~----------------------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 214 ---ISR----------------------GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---HHC----------------------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000 000011223456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.15 Aligned_cols=273 Identities=23% Similarity=0.378 Sum_probs=207.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECC-----CCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
+.++|++.+.||+|+||.||+|.... +++.||+|+++... ....+.+..|+.++.++ +|+||++++++|..
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-- 82 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-- 82 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec--
Confidence 34679999999999999999997532 35789999986432 22345678899999999 89999999998753
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCC--------------------------------------------------
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQ-------------------------------------------------- 763 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 763 (988)
.+...+++|||+++++|.+++.......
T Consensus 83 --~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 83 --PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred --CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3467889999999999999986432100
Q ss_pred chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceecccc
Q 001974 764 KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843 (988)
Q Consensus 764 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 843 (988)
........++++..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++......... .....
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--~~~~~ 235 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGDA 235 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--hccCC
Confidence 00111124789999999999999999999998 99999999999999999999999999998654322111 11123
Q ss_pred ccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhh
Q 001974 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDA 922 (988)
Q Consensus 844 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 922 (988)
.++..|+|||++.+..++.++|||||||++|||++ |..||......+ . .. ..+....
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~---~~-~~~~~~~----------------- 293 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E---FC-RRLKEGT----------------- 293 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H---HH-HHHhccC-----------------
Confidence 46778999999999999999999999999999998 999986421110 0 00 0000000
Q ss_pred hhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 923 TNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 923 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
....+...++++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 294 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 ---------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001122456779999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.26 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=193.3
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHH---HhcCCCCceEEEeecccccccCCC
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKAL---KNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
|++.+.||+|+||.||+|++..+++.||||+++... ....+.+..|++++ +.++||||+++++++. .++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 677899999999999999999899999999997432 22335566676655 4568999999999853 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|..++... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD------------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcE
Confidence 899999999999999887542 588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 141 kL~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----~~~~~ 211 (324)
T cd05589 141 KIADFGLCKEGMGFGD----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----EEVFD 211 (324)
T ss_pred EeCcccCCccCCCCCC----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 9999999874322111 12234689999999999999999999999999999999999999863211 01100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
. + .......+..++..+.+++.+||+.||++|| ++.++++
T Consensus 212 ~-----i-----------------------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 S-----I-----------------------VNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred H-----H-----------------------HhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0 0001112234677889999999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.74 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=173.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.++||+|+||.||+|++..++..||+|+++... ......+.+|++++++++||||+++++++.. ++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 468999999999999999999999899999999987542 2334678999999999999999999999653 4789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+||++++++.+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL 145 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG-----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL 145 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEE
Confidence 99999999999999986542 578888999999999999999974 27999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+|||++....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 ~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 146 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred eeCCcchhhhhhc------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999987543221 1224589999999999998899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.44 Aligned_cols=266 Identities=23% Similarity=0.421 Sum_probs=205.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCC-----eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDG-----TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
++|++.+.||+|+||.||+|.....+ +.||+|.++.... .....+.+|++++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 46889999999999999999986444 6799999864432 33457889999999999999999999854 3
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.+..+++|||+++++|.+++......... .......+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 47789999999999999999754321100 000113588999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
+++++.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ- 233 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 999999999999999754332211 11122346788999999998899999999999999999998 99998632111
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
... ..+. . ......+..++.++.+++.+||+.||++||+++||++.|++
T Consensus 234 ----~~~-----~~i~----~------------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ----EVI-----EMIR----S------------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHH-----HHHH----c------------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 000 0000 0 00011234678899999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.17 Aligned_cols=258 Identities=30% Similarity=0.504 Sum_probs=209.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+..+|++.+.||+|+||.||+|.+.. ++.||+|++..........+..|+.+++.++|+||+++++++. ..+.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCC
Confidence 345678999999999999999999975 8999999997665545678999999999999999999999854 3477
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+|
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~k 144 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEG---------QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCK 144 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEE
Confidence 8999999999999999976432 3578999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||.+......... .....++..|+|||...+..++.++||||||+++|+|++ |+.||...... ....
T Consensus 145 l~d~g~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-----~~~~ 215 (261)
T cd05148 145 VADFGLARLIKEDVYL----SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-----EVYD 215 (261)
T ss_pred EccccchhhcCCcccc----ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHH
Confidence 9999999765432111 112346778999999988899999999999999999998 89998632110 0000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. +.. . .....+..+++++.+++.+||+.||++|||++++++.|+.+
T Consensus 216 ~-----~~~----~------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 Q-----ITA----G------------------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred H-----HHh----C------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 000 0 00112236678899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=357.98 Aligned_cols=274 Identities=24% Similarity=0.309 Sum_probs=207.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.++||+|+||.||+|++..+|+.||+|+++... ....+++.+|++++++++||||+++++++.. ++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 57999999999999999999999899999999986432 2234578999999999999999999998643 478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++||+|.+++.................++..++.++.||++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998642211100011123567888999999999999999998 999999999999999999999
Q ss_pred Eeeecccccccccccc--------------cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 820 VGDFGLARVRQEVSNL--------------TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
|+|||+++........ .........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999865211100 00011224699999999999999999999999999999999999999864
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-CHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-SITNV 964 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ev 964 (988)
..... ... .... .++ .. .....++|+.+.+++.+|++.||++|| +++++
T Consensus 234 ~~~~k-----i~~---~~~i---~~P------~~-------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 234 KKGRK-----ISY---RDVI---LSP------IE-------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cchhh-----hhh---hhhc---cCh------hh-------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11100 000 0000 000 00 001125677899999999999999995 67778
Q ss_pred HHHHHHHHHH
Q 001974 965 VHELQSVKNA 974 (988)
Q Consensus 965 l~~L~~i~~~ 974 (988)
.+.|+...+.
T Consensus 284 l~~Le~~lq~ 293 (932)
T PRK13184 284 KQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHhc
Confidence 8888877554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.43 Aligned_cols=258 Identities=24% Similarity=0.443 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||+||+|++... ...||+|+++.... ....++.+|+.++++++||||+++++++. .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 46799999999999999999998643 45799999864432 33467889999999999999999999854 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~ 144 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND----------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLV 144 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCC
Confidence 77899999999999999987543 2688999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~ 217 (266)
T cd05033 145 CKVSDFGLSRRLEDSEAT--YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DV 217 (266)
T ss_pred EEECccchhhcccccccc--eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HH
Confidence 999999999876421111 11112335678999999998899999999999999999998 99997532110 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
...+.. . .....+..++..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 218 -----~~~~~~---~-------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 -----IKAVED---G-------------------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----HHHHHc---C-------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 0 00011235677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.43 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=197.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+.++.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++. +++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5888999999999999999999999999999996432 233457889999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME-----------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEE
Confidence 99999999999999986543 578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccc-------------------------------------------cceeccccccccccccCcccCC
Q 001974 821 GDFGLARVRQEVSNL-------------------------------------------TQSCSVGVRGTIGYAAPEYGLG 857 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~ 857 (988)
+|||+++........ .........||+.|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 999997643110000 0000123469999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhcccc
Q 001974 858 SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKI 937 (988)
Q Consensus 858 ~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~ 937 (988)
..++.++|||||||++|||++|+.||...... ..... +...... .......
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~-----i~~~~~~-------------------~~~~~~~ 273 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT-----ETQLK-----VINWENT-------------------LHIPPQV 273 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHH-----HHHHH-----HHccccc-------------------cCCCCCC
Confidence 89999999999999999999999998632111 00000 0000000 0001112
Q ss_pred chhHHHHHHhhc--ccCcCCCCCCCHHHHHHH
Q 001974 938 ECPISMVRIGVA--CSVESPQDRMSITNVVHE 967 (988)
Q Consensus 938 ~~~~~l~~li~~--cl~~dP~~RPs~~evl~~ 967 (988)
.+++++.+++.+ |+..+|..||+++|+++.
T Consensus 274 ~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 274 KLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 356778899988 556667779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.64 Aligned_cols=275 Identities=24% Similarity=0.386 Sum_probs=206.1
Q ss_pred CCCCCCceeccccceeEEEEEE----CCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.+.||+|+||.||+|.. ..+++.||+|.++.......+.+.+|++++++++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 5788999999999999999984 356889999998766555567889999999999999999999986532 345
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~ 147 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR----------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRV 147 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeE
Confidence 6899999999999999986543 2578999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++.......... ......++..|+|||++.+..++.++|||||||++|||++|..|+..... . +..
T Consensus 148 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~---~~~ 220 (284)
T cd05081 148 KIGDFGLTKVLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA---E---FMR 220 (284)
T ss_pred EECCCcccccccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch---h---hhh
Confidence 9999999986543322111 11112244569999999988899999999999999999998777532110 0 000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHH-hhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRL-RQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. ..... .... ......+.+ ..........++.++.+++.+||+.+|++|||++|+++.|+++
T Consensus 221 ~-~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 221 M-MGNDK--------QGQM--IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred h-ccccc--------cccc--chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 00000 0000 000000000 0011122345778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=351.29 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=202.5
Q ss_pred CCCCCceeccccceeEEEEEECCC-CeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.|.+.+.||+|++|.||+|....+ ++.||+|.+..........+..|+.+++.++||||+++++++. .++..++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 488999999999999999998777 7889999876555555567888999999999999999999964 3478999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++|+|.+++...... ..++++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 143 v~E~~~gg~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE-------HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEe
Confidence 99999999999887542110 13588999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..........
T Consensus 213 Fgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~ 285 (478)
T PTZ00267 213 FGFSKQYSDSVS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLY 285 (478)
T ss_pred CcCceecCCccc--cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh
Confidence 999986543221 111223468999999999999999999999999999999999999986321 1111111000
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.. ...+..++.++.+++.+||+.||++||++++++.
T Consensus 286 ------------~~~---------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 ------------GKY---------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------------CCC---------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 0112245677999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=337.74 Aligned_cols=243 Identities=24% Similarity=0.299 Sum_probs=194.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|++..+|+.||+|+++... ......+..|+++++.++||||+++++++ ..++..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999899999999997432 22345678899999999999999999884 44578999999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
|+++|+|.+++.... .+++.++..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 76 YANGGELFFHLSRER-----------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred CCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence 999999998886543 58899999999999999999997 6 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~i~--- 209 (325)
T cd05594 142 LCKEGIKDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELIL--- 209 (325)
T ss_pred CCeecCCCCc----ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHHHh---
Confidence 9874322111 11224589999999999999999999999999999999999999863210 01100000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
......+...++++.+++.+||+.||++|+ +++++++.
T Consensus 210 -------------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 -------------------------MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -------------------------cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 000111234667899999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.40 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=192.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCC-CCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRH-RNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 739 (988)
+|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|++++..+.| ++|+++++++ ...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 488899999999999999999989999999999743 22344667889999999966 4577888774 34578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG-----------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEE
Confidence 999999999999999886543 578899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++........ ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .....
T Consensus 142 L~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~- 211 (324)
T cd05587 142 IADFGMCKENIFGGK----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQ- 211 (324)
T ss_pred EeecCcceecCCCCC----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH-
Confidence 999999864321111 11234589999999999999999999999999999999999999863211 00000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.+. ......+...+.++.+++.+||+.||++|+++
T Consensus 212 ----~i~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 212 ----SIM-----------------------EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----HHH-----------------------cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 00011123456778999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=343.94 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=200.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+.+++.++||||+++++++. .++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence 47999999999999999999999899999999997432 233456788999999999999999999854 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD-----------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEE
Confidence 999999999999999986543 588999999999999999999998 999999999999999999999
Q ss_pred Eeeecccccccccccccc----------------------------------eeccccccccccccCcccCCCCCCCccc
Q 001974 820 VGDFGLARVRQEVSNLTQ----------------------------------SCSVGVRGTIGYAAPEYGLGSEVSTNGD 865 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sD 865 (988)
|+|||++........... ......+||+.|+|||++.+..++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 999999875432110000 0011245899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHH
Q 001974 866 IYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVR 945 (988)
Q Consensus 866 vwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 945 (988)
||||||++|||++|..||..... ...... +..+... + ........++++.+
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~-----~~~~~~-----i~~~~~~-~------------------~~~~~~~~s~~~~~ 272 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNP-----QETYRK-----IINWKET-L------------------QFPDEVPLSPEAKD 272 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCH-----HHHHHH-----HHcCCCc-c------------------CCCCCCCCCHHHHH
Confidence 99999999999999999863211 110000 0000000 0 00011135677899
Q ss_pred HhhcccCcCCCCCCC---HHHHHHH
Q 001974 946 IGVACSVESPQDRMS---ITNVVHE 967 (988)
Q Consensus 946 li~~cl~~dP~~RPs---~~evl~~ 967 (988)
++.+|+. +|.+|++ ++|+++.
T Consensus 273 li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 273 LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999996 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.24 Aligned_cols=204 Identities=26% Similarity=0.353 Sum_probs=174.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+...+++.||+|+++... ......+..|+.++.+++|+||+++++++ .++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47899999999999999999999899999999996432 22335678899999999999999999985 44578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD-----------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEE
Confidence 999999999999999987543 688999999999999999999998 999999999999999999999
Q ss_pred Eeeeccccccccccccc-------------------------------ceeccccccccccccCcccCCCCCCCccchHH
Q 001974 820 VGDFGLARVRQEVSNLT-------------------------------QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYS 868 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvws 868 (988)
|+|||+++......... ........||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 99999987543211000 00012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCc
Q 001974 869 YGILLLEMVTGKKPTDV 885 (988)
Q Consensus 869 lG~vl~elltg~~p~~~ 885 (988)
|||++|||++|+.||..
T Consensus 222 lGvil~ell~G~~Pf~~ 238 (363)
T cd05628 222 LGVIMYEMLIGYPPFCS 238 (363)
T ss_pred hHHHHHHHHhCCCCCCC
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=350.53 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=206.6
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc-
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ- 735 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 735 (988)
....++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+..+..++|+|++++.+.+...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345579999999999999999999998899999999986442 23345688899999999999999988765432111
Q ss_pred --CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 736 --GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 736 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.....++||||+++|+|.+++....... ..+++..+..++.|++.||.|||+. +|+||||||+||+++
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~-------~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTN-------RTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC 177 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence 1123689999999999999986532211 3688999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ..
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~ 250 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NM 250 (496)
T ss_pred CCCCEEEEecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CH
Confidence 9999999999999865432111 1122346899999999999999999999999999999999999998632 11
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......... . ....+..+++++.+++.+||+.||++||++.++++.
T Consensus 251 ~~~~~~~~~~------------~---------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTLAG------------R---------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHhcC------------C---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111000 0 001123567789999999999999999999999864
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.10 Aligned_cols=238 Identities=24% Similarity=0.323 Sum_probs=190.4
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|+++.+++.||+|+++.. .....+.+..|..++... +||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 4699999999999999989999999998743 223445677888888877 799999999985 4457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 Ey~~~g~L~~~i~~~~-----------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 76 EFVNGGDLMFHIQKSR-----------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred cCCCCchHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence 9999999999886543 588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~-- 210 (320)
T cd05590 142 MCKEGIFNGK----TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILN-- 210 (320)
T ss_pred CCeecCcCCC----cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhc--
Confidence 9875322111 12234589999999999999999999999999999999999999863211 111110000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
.....+...+.++.+++.+|++.||++||++.
T Consensus 211 --------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 211 --------------------------DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --------------------------CCCCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 00011223567789999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=314.79 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=207.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
|.++.+||+|+||.||+|.++.+|..||+|.+..+ ...+++.+|+.+|+++..|+||++||.+.. ....+|||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEeeh
Confidence 66788999999999999999999999999998654 345889999999999999999999998543 37789999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
|||..|+..+.++... +++++.++..+.+..++||+|||.. .-||||||+.|||++.+|.+||+|||
T Consensus 108 EYCGAGSiSDI~R~R~----------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR----------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG 174 (502)
T ss_pred hhcCCCcHHHHHHHhc----------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence 9999999999998765 4899999999999999999999998 88999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
.|..+.+.. .....+.||+.|||||++..-.|..++||||+|++..||..|++||....+...-+
T Consensus 175 VAGQLTDTM----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------- 239 (502)
T KOG0574|consen 175 VAGQLTDTM----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------- 239 (502)
T ss_pred ccchhhhhH----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----------
Confidence 998765432 22335689999999999999999999999999999999999999987543321000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
++ ...+ .+....+.....++.+++++|+.+.|++|.||.++++.
T Consensus 240 ---MI----PT~P------------PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 ---MI----PTKP------------PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---ec----cCCC------------CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 00 0000 01112234556789999999999999999999998753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.45 Aligned_cols=242 Identities=21% Similarity=0.328 Sum_probs=190.2
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999899999999997432 22334556677777655 899999999884 3457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~gg~L~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 76 EYLNGGDLMFHIQSSG-----------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred cCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence 9999999999886543 588899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 142 ~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~----- 207 (316)
T cd05592 142 MCKENMNGE----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDS----- 207 (316)
T ss_pred CCeECCCCC----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHH-----
Confidence 997543221 112234589999999999999999999999999999999999999863211 111100
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH-HHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT-NVVH 966 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 966 (988)
+.. .....+..++.++.+++.+||+.||++||++. ++++
T Consensus 208 i~~-----------------------~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 208 ILN-----------------------DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHc-----------------------CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 000 00111224567789999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=327.09 Aligned_cols=271 Identities=25% Similarity=0.393 Sum_probs=203.9
Q ss_pred CCCCceeccccceeEEEEEE----CCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
|...+.||+|+||+||++.. ..+++.||+|+++.... .....+.+|++++++++||||+++++++... ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence 38889999999999988653 34678999999875432 3456788999999999999999999986532 3456
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++... .+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~------------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~ 147 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH------------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVK 147 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEE
Confidence 89999999999999998542 589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++......... .......++..|+|||.+.+..++.++||||||+++|||+||+.||................
T Consensus 148 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 148 IGDFGLAKAVPEGHEYY-RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred EeecccccccCCcchhh-ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 99999998654322111 11112235677999999988889999999999999999999999976422110000000000
Q ss_pred HH-hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 900 AL-LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 900 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.. .....+..+ .......+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 227 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 QMTVVRLIELLE------------------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccchhhhhhhhh------------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 000000000 00111223457789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.08 Aligned_cols=270 Identities=25% Similarity=0.407 Sum_probs=208.9
Q ss_pred CCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|.+.+.||+|+||.||++... .++..||+|.++.......+.+.+|++++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 56888999999999999999852 345679999987655555678999999999999999999999964 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch--hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD--VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+..++||||+++++|.+++......... .......+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 7889999999999999999754321100 000113589999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----- 229 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----- 229 (288)
T ss_pred CcEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999985533221 111112335778999999998899999999999999999999 89997632111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
..... +.. .. ....+..++.++.+++.+||+.||.+|||+.|+.+.|+++.++
T Consensus 230 ~~~~~-----i~~---~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIEC-----ITQ---GR-------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHH-----HHc---CC-------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00000 000 00 0011124567899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=342.67 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=203.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+..|++++..++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 47999999999999999999999899999999997432 23446788999999999999999999884 45588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD-----------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence 999999999999999987542 588999999999999999999998 999999999999999999999
Q ss_pred Eeeeccccccccccc-------------------------ccceeccccccccccccCcccCCCCCCCccchHHHHHHHH
Q 001974 820 VGDFGLARVRQEVSN-------------------------LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLL 874 (988)
Q Consensus 820 L~DfG~a~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ 874 (988)
|+|||++........ ..........||+.|+|||++.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 999999986543320 0001122346899999999999999999999999999999
Q ss_pred HHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC
Q 001974 875 EMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 875 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
||++|+.||..... ..... .+..+... ........+++++.+++.+|+. |
T Consensus 222 ell~g~~Pf~~~~~-----~~~~~-----~i~~~~~~-------------------~~~p~~~~~~~~~~~li~~ll~-d 271 (350)
T cd05573 222 EMLYGFPPFYSDTL-----QETYN-----KIINWKES-------------------LRFPPDPPVSPEAIDLICRLLC-D 271 (350)
T ss_pred hhccCCCCCCCCCH-----HHHHH-----HHhccCCc-------------------ccCCCCCCCCHHHHHHHHHHcc-C
Confidence 99999999864211 00000 01000000 0001112357789999999997 9
Q ss_pred CCCCCC-HHHHHHH
Q 001974 955 PQDRMS-ITNVVHE 967 (988)
Q Consensus 955 P~~RPs-~~evl~~ 967 (988)
|++||+ ++|+++.
T Consensus 272 p~~R~~s~~~ll~h 285 (350)
T cd05573 272 PEDRLGSFEEIKSH 285 (350)
T ss_pred hhhcCCCHHHHhcC
Confidence 999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=322.93 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=201.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe----EEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|++.+.||+|+||+||+|.+..+++ .|++|.+..... ....++..|+.++++++||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 568889999999999999999976666 477777753322 23356778888999999999999999853 2
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++++||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~ 147 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR----------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSI 147 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCc
Confidence 45689999999999999997543 3688999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||.++........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... .
T Consensus 148 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~ 219 (279)
T cd05111 148 VQIADFGVADLLYPDDKK--YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH------E 219 (279)
T ss_pred EEEcCCccceeccCCCcc--cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 999999999865332211 11122446788999999998899999999999999999998 99998632110 0
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
. .+.+... .....+..++..+.+++.+||..||++|||+.|+++.|..+.+.
T Consensus 220 ~--------~~~~~~~------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 220 V--------PDLLEKG------------------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred H--------HHHHHCC------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0 0000000 00011223566788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=333.08 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=192.9
Q ss_pred CceeccccceeEEEEEEC---CCCeEEEEEEeeccc----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 668 THLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++.||+|+||.||+|+.. .+++.||+|+++... ......+..|+.+++.++||||+++++++. .++..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence 368999999999999873 467899999987432 223356788999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 141 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-----------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKL 141 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 99999999999999986543 577888999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 142 ~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~- 211 (323)
T cd05584 142 TDFGLCKESIHEGT----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDK- 211 (323)
T ss_pred eeCcCCeecccCCC----cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHH-
Confidence 99999874322211 1123458999999999999889999999999999999999999986321 0011100
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
+.. .....+..+++++.+++.+||+.||++|| +++++++
T Consensus 212 -------~~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 212 -------ILK--------------------GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------HHc--------------------CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 000 01112234567889999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.00 Aligned_cols=253 Identities=20% Similarity=0.261 Sum_probs=196.5
Q ss_pred CCCCCceeccccceeEEEEEEC---CCCeEEEEEEeecc----ccchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQ----RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
+|++.+.||+|+||.||+|+.. .+++.||+|+++.. .....+.+..|+.+++.+ +||+|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4888999999999999998873 46889999998642 222345678899999999 599999999884 4
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~ 141 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD-----------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE 141 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC
Confidence 4578999999999999999986543 588999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++........ ......||..|+|||++.+. .++.++|||||||++|||+||+.||....... ...
T Consensus 142 ~~~kl~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~ 217 (332)
T cd05614 142 GHVVLTDFGLSKEFLSEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQS 217 (332)
T ss_pred CCEEEeeCcCCccccccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHH
Confidence 99999999999754332211 11234689999999998865 47889999999999999999999986322111 000
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
... . .+ .......+...+..+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~-~----~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 EVS-R----RI-----------------------LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHH-H----HH-----------------------hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 0 00 0001112234667789999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.67 Aligned_cols=266 Identities=27% Similarity=0.472 Sum_probs=205.9
Q ss_pred hCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|.+.+.||+|+||.||+|.+. .+++.||+|.++..... ..+.+.+|++++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 356888999999999999999874 23578999998754433 45789999999999999999999999643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchh---hhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDV---EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+...++||||+++++|.+++.......... ......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 478999999999999999997653211110 11124688999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-- 231 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-- 231 (280)
T ss_pred cCCCeEEECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999999754332211 11112345788999999999999999999999999999999 99997532111
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
..... +. .. .....+..++..+.+++.+||+.||++||++.||++.|+
T Consensus 232 ---~~~~~-----~~---~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 ---EVIEC-----IT---QG-------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHHHH-----HH---cC-------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000 00 00 000112246778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.65 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=203.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++. .++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCc
Confidence 3467899999999999999999975 67789999876433 23578899999999999999999998854 44778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 144 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEG---------GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 144 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEE
Confidence 999999999999999865432 3578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.++....... .......++..|+|||++....++.++|||||||++|+|+| |+.||...... . ...
T Consensus 145 ~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~-~~~ 215 (261)
T cd05072 145 ADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----D-VMS 215 (261)
T ss_pred CCCccceecCCCce---eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----H-HHH
Confidence 99999986543221 11122345778999999988889999999999999999998 99998632110 0 000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
.+.... .......++.++.+++.+||+.+|++||+++++.+.|++
T Consensus 216 ----~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 216 ----ALQRGY----------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----HHHcCC----------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000000 001122467789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.07 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=193.2
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|.+++..+ +||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 46899999999999999889999999987432 23345677888888876 8999999999854 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 E~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 76 EYVNGGDLMFQIQRSR-----------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred eCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence 9999999998886543 578899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
++........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----~~~~~~i~~-- 210 (321)
T cd05591 142 MCKEGILNGV----TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----DDLFESILH-- 210 (321)
T ss_pred cceecccCCc----cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----HHHHHHHHc--
Confidence 9875322211 11234589999999999999999999999999999999999999863211 011100000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-------CHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-------SITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 967 (988)
.....+..++.++.+++.+||+.||++|| +++++++.
T Consensus 211 --------------------------~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 211 --------------------------DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --------------------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00011223567789999999999999999 77777644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.78 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=205.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+.|+.++.||+|.-|+||+++...++..+|+|++..... ....+...|-+||+.++||.++.+|+. |+.++.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 456778999999999999999998889999999975432 334567789999999999999999998 566799
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|+|||||+||+|....+++.. +.+++..++.++.+++.||+|||-. |||.|||||+||||.++|++.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~---------~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG---------KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC---------CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence 9999999999999999887664 4799999999999999999999999 999999999999999999999
Q ss_pred Eeeecccccccccc---------------------------------c-------------------ccceecccccccc
Q 001974 820 VGDFGLARVRQEVS---------------------------------N-------------------LTQSCSVGVRGTI 847 (988)
Q Consensus 820 L~DfG~a~~~~~~~---------------------------------~-------------------~~~~~~~~~~gt~ 847 (988)
|+||.++....... . .....+..++||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 99999886432100 0 0001123467999
Q ss_pred ccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHH
Q 001974 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQR 927 (988)
Q Consensus 848 ~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 927 (988)
.|.|||++.+...+.++|.|+|||++|||+.|..||......+ -....+.+.
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----Tl~NIv~~~----------------------- 351 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----TLRNIVGQP----------------------- 351 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----hHHHHhcCC-----------------------
Confidence 9999999999999999999999999999999999987432211 111111111
Q ss_pred HhhhhhccccchhHHHHHHhhcccCcCCCCCCC----HHHHHH
Q 001974 928 LRQAKINGKIECPISMVRIGVACSVESPQDRMS----ITNVVH 966 (988)
Q Consensus 928 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 966 (988)
.........+..+.+||++.|.+||++|.. |+||.+
T Consensus 352 ---l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 352 ---LKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ---CcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 011112255677999999999999999988 777754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=327.55 Aligned_cols=279 Identities=24% Similarity=0.277 Sum_probs=199.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhc---CCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNI---RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|++.+.||+|+||+||+|++..+++.||+|.++... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999986432 22234566777777665 799999999987654334456
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 7899999996 689888865432 2588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++....... .....|+..|+|||++.+..++.++||||+||++|||++|++||...... ..+.....
T Consensus 148 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~ 221 (288)
T cd07863 148 KLADFGLARIYSCQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFD 221 (288)
T ss_pred EECccCccccccCccc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHH
Confidence 9999999986543221 12245789999999999989999999999999999999999998532111 00100000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....................+.. ............++.++.+++.+|++.||++|||+.|++.
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 222 -LIGLPPEDDWPRDVTLPRGAFSP----RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred -HhCCCChhhCcccccccccccCC----CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000000000000000 0000001112356677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=325.53 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=193.9
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||+||++++..+++.||+|.+..... ...+.+..|++++++++|+||+++.+++. .+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence 6999999999999998999999999864322 22356778999999999999999998853 447799999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++|+|.+++....... ..+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||.+.
T Consensus 76 ~~g~L~~~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 76 NGGDLRYHIYNVDEEN-------PGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred CCCCHHHHHHhccccC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccce
Confidence 9999998875322111 3689999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ....+
T Consensus 146 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~-----~~~~~-- 213 (280)
T cd05608 146 ELKDGQS----KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKE-----LKQRI-- 213 (280)
T ss_pred ecCCCCc----cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHH-----HHHhh--
Confidence 6543221 1223468999999999999999999999999999999999999986321110 0000 00000
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
. ......+..++..+.+++.+||+.||++|| +++++++.
T Consensus 214 -~--------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 -L--------------------NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -c--------------------ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0 000112235677899999999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=337.90 Aligned_cols=272 Identities=25% Similarity=0.364 Sum_probs=206.9
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeecccc-chhHHHHHHHHHHHhcC-CCCceEEEeecccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQRH-GASKSFLAECKALKNIR-HRNLVKVITSCSSI 732 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 732 (988)
...++|++.+.||+|+||.||+|++... +..||||+++.... ...+.+.+|+++++++. ||||++++++|..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 3457899999999999999999987432 34799999964332 33467899999999995 9999999999643
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCch-----------------------------------------------
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD----------------------------------------------- 765 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------- 765 (988)
.+..++||||+++|+|.+++.........
T Consensus 113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 47899999999999999988653210000
Q ss_pred --------------------------------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 766 --------------------------------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 766 --------------------------------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
.......+++.++..++.||+.||+|||+. +|+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence 000013588899999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||++++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999999999865432211 11122346788999999999899999999999999999997 99998643
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...+. ....+... .....+..++.++.+++.+||+.||++||++.++.+
T Consensus 344 ~~~~~---------~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 344 IVDST---------FYNKIKSG----------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred chhHH---------HHHHHhcC----------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 11100 00000000 001112356788999999999999999999999999
Q ss_pred HHHHHH
Q 001974 967 ELQSVK 972 (988)
Q Consensus 967 ~L~~i~ 972 (988)
.|+++.
T Consensus 393 ~l~~l~ 398 (400)
T cd05105 393 IVESLL 398 (400)
T ss_pred HHHHHc
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=323.29 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=206.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|+...+++.||+|.++... ......+.+|+++++.++||||+++++++.. .+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 57899999999999999999998899999999876322 2334568899999999999999999998543 478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++|+||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ-------KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEE
Confidence 89999999999999888532211 12578889999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+...
T Consensus 147 l~d~g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~ 219 (267)
T cd08228 147 LGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQK 219 (267)
T ss_pred ECccccceeccchhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHH
Confidence 999999886543221 11123588899999999888899999999999999999999999753211 11111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
+.....+. ......+..+.+++.+||+.+|++||+++++++.++.++
T Consensus 220 -----~~~~~~~~---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 -----IEQCDYPP---------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----HhcCCCCC---------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000000 001135567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=333.58 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=191.5
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|+.++.++ +||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 4799999999999999989999999999743 223345677888888877 8999999999854 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 E~~~~~~L~~~~~~~~-----------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 76 EYVNGGDLMFHMQRQR-----------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred eCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999998886542 688999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc---chHHHHHHHH
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL---NLHNYARTAL 901 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~---~~~~~~~~~~ 901 (988)
+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+. ....+....+
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i 217 (329)
T cd05618 142 MCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217 (329)
T ss_pred ccccccCCCC----ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH
Confidence 9875322111 11234689999999999999999999999999999999999999964221110 1111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.......+...+.++.+++.+||+.||++||++
T Consensus 218 ---------------------------~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 218 ---------------------------LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---------------------------hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 011111233456778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.13 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=194.8
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++.++ +||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence 46899999999999999899999999997432 22345678899999998 7999999999854 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... ++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~g~L~~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 76 EFVSGGDLMFHMQRQR-----------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred eCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence 9999999998886442 689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC---cchHHHHHHHH
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD---LNLHNYARTAL 901 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~---~~~~~~~~~~~ 901 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....+....+
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 217 (329)
T cd05588 142 MCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217 (329)
T ss_pred cccccccCCC----ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH
Confidence 9874221111 1123468999999999999999999999999999999999999997422111 01111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC------HHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS------ITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 966 (988)
.......+..++.++.+++.+||+.||++||+ ++|+++
T Consensus 218 ---------------------------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 218 ---------------------------LEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---------------------------HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 01111123346677899999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=326.02 Aligned_cols=272 Identities=24% Similarity=0.375 Sum_probs=207.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe--EEEEEEeecc-ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT--IVAIKVFNLQ-RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.+.||+|+||.||+|....++. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.. .+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence 578999999999999999999876664 4788887632 233446789999999999 79999999998543 46
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
..++||||+++++|.+++......... .......+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 789999999999999999754321100 000113588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLN 892 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 892 (988)
+++.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---- 224 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK-----KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---- 224 (297)
T ss_pred CCCeEEECCcCCCccccceec-----cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 999999999999864322111 111123567999999988889999999999999999998 9999863211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
...... +. . ......+..++.++.+++.+||+.+|.+||+++++++.|+++.
T Consensus 225 -~~~~~~-----~~----~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 -AELYEK-----LP----Q------------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -HHHHHH-----Hh----c------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111100 00 0 0000112346778999999999999999999999999999998
Q ss_pred HHhhhhc
Q 001974 973 NALLEAW 979 (988)
Q Consensus 973 ~~~~~~~ 979 (988)
++....+
T Consensus 277 ~~~~~~~ 283 (297)
T cd05089 277 EARKAYV 283 (297)
T ss_pred Hhhcccc
Confidence 8765533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=331.55 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=207.8
Q ss_pred CCCCceeccccceeEEEEEECCCC---eEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
....++||+|.||.|++|.|+..+ -.||||.++..... ...+|.+|+.+|.+++|+|++++||+..+ ...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence 345578999999999999996433 25999999866554 56899999999999999999999999643 567
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
.+|||.++.|+|.+.++.... ..+-......++.|||.||.||.++ ++||||+.++|+++-....+||
T Consensus 186 mMV~ELaplGSLldrLrka~~---------~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI 253 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKK---------AILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKI 253 (1039)
T ss_pred hHHhhhcccchHHHHHhhccc---------cceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeee
Confidence 899999999999999987322 3677888999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+.+-+........ ......-...|+|||.+....++.++|||+|||++|||+| |..||......
T Consensus 254 ~DFGLmRaLg~ned~Yv-m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------- 322 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYV-MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------- 322 (1039)
T ss_pred ecccceeccCCCCcceE-ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------
Confidence 99999998776554332 2222345789999999999999999999999999999999 99998642111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
++.+.+| ....+..+..|++.++++++.||...|++|||+.+|.+.+-
T Consensus 323 ----qIL~~iD------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 323 ----QILKNID------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----HHHHhcc------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1122222 12234456689999999999999999999999999985543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.99 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=190.9
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|++..+++.||+|+++... ....+.+..|..++... +||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999899999999997532 23345567788888765 9999999999854 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ey~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 76 EYLNGGDLMFHIQSCH-----------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred eCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence 9999999999986542 578889999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||..|+|||++.+..++.++||||+||++|||++|+.||.... .......
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~----- 207 (316)
T cd05619 142 MCKENMLGDA----KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQS----- 207 (316)
T ss_pred cceECCCCCC----ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHH-----
Confidence 9874322111 1123458999999999999999999999999999999999999986321 1111000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH-HHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT-NVVH 966 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 966 (988)
+. ......+...+.++.+++.+||+.||++||++. ++.+
T Consensus 208 i~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 208 IR-----------------------MDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HH-----------------------hCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 00 000011123556789999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.73 Aligned_cols=242 Identities=21% Similarity=0.293 Sum_probs=192.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..++..+ +|++|+++++++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 4888999999999999999999899999999987432 22334567788888877 6899999988853 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG-----------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEE
Confidence 999999999999999886543 578899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .....
T Consensus 142 L~DfG~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~- 211 (323)
T cd05616 142 IADFGMCKENMWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ- 211 (323)
T ss_pred EccCCCceecCCCCC----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHH-
Confidence 999999975322111 11234589999999999999999999999999999999999999863211 00100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.+. ......+...+.++.+++.+|++.||++|+++
T Consensus 212 ----~i~-----------------------~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 212 ----SIM-----------------------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----HHH-----------------------hCCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 000 00111223466778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=319.57 Aligned_cols=256 Identities=32% Similarity=0.500 Sum_probs=203.8
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|+.++++++||||+++++++. ..+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence 3467899999999999999999975 56789999986443 23567899999999999999999999854 34778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l 144 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAG---------RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKV 144 (261)
T ss_pred eeeeecccCCcHHHHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEE
Confidence 999999999999999965431 3588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ....+...+..|+|||+..+..++.++||||||+++|||++ |+.||...... ...
T Consensus 145 ~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~-- 214 (261)
T cd05068 145 ADFGLARVIKEDIY---EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVL-- 214 (261)
T ss_pred CCcceEEEccCCcc---cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHH--
Confidence 99999986643211 11112223468999999999899999999999999999999 99998632100 000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
..+. .. .....+..++..+.+++.+|++.+|++||++.++++.|++
T Consensus 215 ---~~~~----~~------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 215 ---QQVD----QG------------------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---HHHH----cC------------------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000 00 0001123466789999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.26 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=208.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.-|...+.||+|.|+.|-+|++.-+|+.||||++..... .....+.+|++.|+-++|||||++|++ +......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence 457888999999999999999999999999999975433 334578899999999999999999999 4455889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC-CCCcEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 819 (988)
|+|+|.-.+|+|.+|+-+.. ..+.+.-+.+++.||+.|+.|+|.. .+|||||||+||.+- .-|-+|
T Consensus 93 yLiLELGD~GDl~DyImKHe----------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHE----------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred EEEEEecCCchHHHHHHhhh----------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceE
Confidence 99999999999999997765 4789999999999999999999998 999999999998875 568999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCC-CccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS-TNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|.|||++-.+.+.....+.| |+..|.|||++.+..|+ +++||||+||+||-+++|++||+...+.+
T Consensus 160 LTDFGFSNkf~PG~kL~TsC-----GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------- 226 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKLTTSC-----GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------- 226 (864)
T ss_pred eeeccccccCCCcchhhccc-----chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------
Confidence 99999998887766665544 99999999999999886 67899999999999999999998543321
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.-+.|..+ ..+.....++.+||..|+..||++|.+.+||+.
T Consensus 227 -----TLTmImDCKY--------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 -----TLTMIMDCKY--------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----hhhhhhcccc--------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112222221 123346678999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.64 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=212.0
Q ss_pred CCCceeccccceeEEEEEECCCCe----EEEEEEeec-cccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNL-QRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
...++||+|+||+||+|.|-..|+ +||+|++.. .......++..|+.+|.+++|||+++++|+|... ..
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence 346899999999999999966665 689998863 3344568899999999999999999999998753 37
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
.||++|++.|+|.+|++..+ ..+.....+.|..|||+||.|||++ ++|||||.++||||.+...+||
T Consensus 773 qlvtq~mP~G~LlDyvr~hr----------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvki 839 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR----------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKI 839 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh----------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEE
Confidence 89999999999999998866 3788889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
.|||+|+......... ...+..-.+.|||=|.+....|+.++|||||||++||++| |..||+....+
T Consensus 840 tdfgla~ll~~d~~ey--~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---------- 907 (1177)
T KOG1025|consen 840 TDFGLAKLLAPDEKEY--SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---------- 907 (1177)
T ss_pred EecchhhccCcccccc--cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----------
Confidence 9999999876544322 2223345788999999999999999999999999999999 99998754221
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
++.+.+.. ..+++.++.|+.++..++.+||..|++.||+++++..++.++...
T Consensus 908 ----eI~dlle~------------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 908 ----EIPDLLEK------------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----HhhHHHhc------------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11111110 112345668999999999999999999999999999999987654
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.67 Aligned_cols=241 Identities=22% Similarity=0.313 Sum_probs=190.8
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|+++.+|+.||+|+++... ....+....|..++... +||||+++++++ ..++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997432 23345667788888765 899999999985 3457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 E~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 76 EFLNGGDLMFHIQDKG-----------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence 9999999999886542 578899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..... +.
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~-----~~ 207 (316)
T cd05620 142 MCKENVFGDN----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELF-----ES 207 (316)
T ss_pred CCeecccCCC----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHH-----HH
Confidence 9874322111 1223468999999999999999999999999999999999999986321 00100 00
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH-HHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT-NVV 965 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 965 (988)
+. ......+..++.++.+++.+||+.||++||++. +++
T Consensus 208 ~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 208 IR-----------------------VDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HH-----------------------hCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 000111223566789999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=322.92 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=192.5
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||.||+++.+.+|+.||+|.+.... ......+..|++++++++||||+++++++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999899999999986322 12234566799999999999999999884 3457899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 76 ~g~~L~~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 76 NGGDLKYHIYNVGE---------RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred CCCCHHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeee
Confidence 99999988854331 3578899999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||...... .........
T Consensus 144 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~-------- 209 (277)
T cd05607 144 ELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRR-------- 209 (277)
T ss_pred ecCCCce-----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHH--------
Confidence 6543221 12245899999999999988999999999999999999999998632111 000000000
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... ......++.++.+++.+||+.||++||+++|+++.
T Consensus 210 ~~~~~~-------------------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 210 TLEDEV-------------------KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred hhcccc-------------------ccccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 000000 00011356778999999999999999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=335.70 Aligned_cols=203 Identities=26% Similarity=0.302 Sum_probs=169.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999999889999999998633 2334467889999999999999999999865331 1222
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++ +++.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh-------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCC
Confidence 45799999995 56666553 2467888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 162 ~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 162 LKILDFGLARTACTNFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred EEEecCCCccccccCcc-----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999975432211 1224589999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=341.72 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=197.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+...+++.||+|++.... ....+.+.+|++++++++||||+++++++. +++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence 47899999999999999999999999999999986432 223456888999999999999999999854 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD-----------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence 999999999999999986543 578889999999999999999998 999999999999999999999
Q ss_pred Eeeecccccccccccc------------c-------------------------------ceeccccccccccccCcccC
Q 001974 820 VGDFGLARVRQEVSNL------------T-------------------------------QSCSVGVRGTIGYAAPEYGL 856 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~------------~-------------------------------~~~~~~~~gt~~y~aPE~~~ 856 (988)
|+|||+++........ . ........||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 9999999633211000 0 00001246999999999999
Q ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccc
Q 001974 857 GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGK 936 (988)
Q Consensus 857 ~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~ 936 (988)
+..++.++|||||||++|||++|+.||..... . .... .+..+.... .....
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~-~~~~-----~i~~~~~~~-------------------~~p~~ 272 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENS----H-ETYR-----KIINWRETL-------------------YFPDD 272 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCH----H-HHHH-----HHHccCCcc-------------------CCCCC
Confidence 99999999999999999999999999863211 0 0000 000000000 00011
Q ss_pred cchhHHHHHHhhcccCcCCCCC---CCHHHHHHH
Q 001974 937 IECPISMVRIGVACSVESPQDR---MSITNVVHE 967 (988)
Q Consensus 937 ~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 967 (988)
..++.++.+++.+|+. +|.+| +++.|+++.
T Consensus 273 ~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 273 IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 1355678999999997 77765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.60 Aligned_cols=253 Identities=21% Similarity=0.245 Sum_probs=200.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|+.+++.++|+||+++++++. +++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence 46899999999999999999999999999999997432 234456889999999999999999998853 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE----------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEE
Confidence 999999999999999997653 2688999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccC------CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL------GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 143 L~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----- 214 (330)
T cd05601 143 LADFGSAARLTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----- 214 (330)
T ss_pred eccCCCCeECCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----
Confidence 9999999865433221 112245899999999986 45678999999999999999999999863211
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... .+..... . .........+.++.+++.+|++ +|++|||++++++
T Consensus 215 ~~~~~-----~i~~~~~-~------------------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 215 AKTYN-----NIMNFQR-F------------------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHH-----HHHcCCC-c------------------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 01110 0000000 0 0001112456778999999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.21 Aligned_cols=242 Identities=20% Similarity=0.293 Sum_probs=193.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|.+..+++.||+|+++... ......+..|.++++.+ +||||+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999899999999997432 23345677888898888 7999999999854 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|..++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 76 e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 76 EYVNGGDLMFHIQRSG-----------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred cCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence 9999999998886543 589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.... .......
T Consensus 142 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~----- 207 (318)
T cd05570 142 MCKEGILGGV----TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQS----- 207 (318)
T ss_pred CCeecCcCCC----cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHH-----
Confidence 9874322111 1122458999999999999999999999999999999999999986321 0111000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH-----HHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI-----TNVVH 966 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 966 (988)
+. ......+..++.++.+++.+||+.||++||++ .++++
T Consensus 208 i~-----------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 IL-----------------------EDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HH-----------------------cCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00 00011123466788999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.03 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=200.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++ .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4567999999999999999999999899999999986422 22335578899999999999999999884 445
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCC
Confidence 7899999999999999998542 467888899999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCC----CCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS----EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .
T Consensus 181 ~kL~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~ 252 (370)
T cd05596 181 LKLADFGTCMKMDANGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----L 252 (370)
T ss_pred EEEEeccceeeccCCCcc---cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----H
Confidence 999999999765432211 11234689999999998653 47889999999999999999999986321 1
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVHE 967 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 967 (988)
.... ..+ .+.... ........++.++.+++.+|++.+|++ |||++|+++.
T Consensus 253 ~~~~-----~~i---~~~~~~----------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 VGTY-----SKI---MDHKNS----------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHH-----HHH---HcCCCc----------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 000 000000 000111245778999999999999998 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.82 Aligned_cols=272 Identities=22% Similarity=0.392 Sum_probs=208.2
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
....++|++.+.||+|+||.||+|.+... ...||+|++.... ......+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34456789999999999999999998533 3789999987432 23345688999999999 89999999998643
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhh-----hHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVE-----IEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
++..++||||+++|+|.+++........... .....+++..++.++.|++.||+|||+. +|+|||||
T Consensus 88 -----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlk 159 (293)
T cd05053 88 -----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLA 159 (293)
T ss_pred -----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccc
Confidence 4778999999999999999975431110000 1124789999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||++++++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceec--cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 9999999999999999999986544221111 112235678999999988899999999999999999998 9998753
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.. ....... +. .......+..++..+.+++.+||..||++|||+.|++
T Consensus 238 ~~-----~~~~~~~-----~~----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil 285 (293)
T cd05053 238 IP-----VEELFKL-----LK----------------------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285 (293)
T ss_pred CC-----HHHHHHH-----HH----------------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 21 1010000 00 0001112335677899999999999999999999999
Q ss_pred HHHHHHH
Q 001974 966 HELQSVK 972 (988)
Q Consensus 966 ~~L~~i~ 972 (988)
+.|+++.
T Consensus 286 ~~l~~~~ 292 (293)
T cd05053 286 EDLDRML 292 (293)
T ss_pred HHHHHhh
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.11 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=197.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++.+ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 36899999999999999999999899999999986432 22345688999999999999999999985 45588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ik 141 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK 141 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEE
Confidence 999999999999999996543 578888999999999999999998 999999999999999999999
Q ss_pred Eeeeccccccccccc---------------------------------------ccceeccccccccccccCcccCCCCC
Q 001974 820 VGDFGLARVRQEVSN---------------------------------------LTQSCSVGVRGTIGYAAPEYGLGSEV 860 (988)
Q Consensus 820 L~DfG~a~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~ 860 (988)
|+|||+|........ ..........||+.|+|||++.+..+
T Consensus 142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 221 (376)
T cd05598 142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221 (376)
T ss_pred EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC
Confidence 999999853211000 00000113469999999999999999
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchh
Q 001974 861 STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECP 940 (988)
Q Consensus 861 ~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 940 (988)
+.++|||||||++|||++|+.||...... ..... +..+. .. ........++
T Consensus 222 ~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~-----i~~~~-~~------------------~~~~~~~~~s 272 (376)
T cd05598 222 TQLCDWWSVGVILYEMLVGQPPFLADTPA-----ETQLK-----VINWE-TT------------------LHIPSQAKLS 272 (376)
T ss_pred CcceeeeeccceeeehhhCCCCCCCCCHH-----HHHHH-----HhccC-cc------------------ccCCCCCCCC
Confidence 99999999999999999999998642111 00000 00000 00 0001112456
Q ss_pred HHHHHHhhcccCcCCCCCC---CHHHHHHH
Q 001974 941 ISMVRIGVACSVESPQDRM---SITNVVHE 967 (988)
Q Consensus 941 ~~l~~li~~cl~~dP~~RP---s~~evl~~ 967 (988)
.++.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 273 ~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 273 REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 67888998876 5999999 88988865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.83 Aligned_cols=265 Identities=25% Similarity=0.411 Sum_probs=203.2
Q ss_pred CCCCceeccccceeEEEEEECCC---CeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCC
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGND 738 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 738 (988)
|.+.+.||+|+||.||+|....+ +..||+|+++.... .....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999998643 37899999874432 234578999999999999999999998754321 2234
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|..++........ ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGL-----PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCC-----cccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeE
Confidence 57999999999999999854332111 13688999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 153 kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~ 225 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIY 225 (273)
T ss_pred EECCccceeeccccccccc--cccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence 9999999986543322111 111235678999999988899999999999999999999 88887532110 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
+.+. +. .....+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 226 -----~~~~---~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 -----DYLR---HG-------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----HHHH---cC-------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 00 00112235677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=324.32 Aligned_cols=266 Identities=23% Similarity=0.378 Sum_probs=202.6
Q ss_pred hhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
..++|++.+.||+|+||.||+|.+. ..++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 5678999999999999999999864 235679999985432 233456889999999999999999999854
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.+...++||||+++++|.+++........ .......+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEME-NNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 154 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCcccc-ccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC
Confidence 44788999999999999999865332110 000113468889999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcch
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNL 893 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 893 (988)
++.++|+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----- 227 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----- 227 (277)
T ss_pred CCCEEECCCCCccccCCcceeec--CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 99999999999875433221111 111235778999999998899999999999999999999 7888753211
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
........ .. .....+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 228 ~~~~~~~~--------~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 EQVLRFVM--------EG-------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHH--------cC-------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 01110000 00 000112346778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.14 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=196.4
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||++++++|.. ....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 46899999999999998899999999876432 2334678999999999999999999999643 47789999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 142 (252)
T cd05084 76 QGGDFLTFLRTEG----------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSR 142 (252)
T ss_pred cCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCc
Confidence 9999999986543 2578999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVI 906 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 906 (988)
......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 143 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~ 206 (252)
T cd05084 143 EEEDGVYAS--TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTR 206 (252)
T ss_pred ccccccccc--cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHH
Confidence 543211100 0011123567999999999899999999999999999998 88887532110 000
Q ss_pred hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 907 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
..+... .....+..++..+.+++.+||+.+|++|||+.|+.+.|+
T Consensus 207 ~~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 207 EAIEQG------------------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHcC------------------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000000 001112346778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=324.44 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=197.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
|.-.+.||.|+||.||.|++..+.+.||||.+.... .+.-.++.+|++.+.+++|||++.+-|++. .+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchHH
Confidence 445688999999999999999999999999996433 233468999999999999999999999854 447889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||| -|+-.+++.-.+ +++.+.++..|+.+.+.||+|||+. +.||||||+.|||+++.|.|||+
T Consensus 103 LVMEYC-lGSAsDlleVhk----------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHH-hccHHHHHHHHh----------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence 999999 678888875443 5789999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||.|....+. ..++|||.|||||++. .+.|+-++||||+|++..|+...++|+-.+.. + .+-
T Consensus 169 DFGSAsi~~PA--------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----M--SAL 234 (948)
T KOG0577|consen 169 DFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----M--SAL 234 (948)
T ss_pred cccchhhcCch--------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----H--HHH
Confidence 99999865442 2367999999999865 47899999999999999999999999643210 0 011
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+.+ --.|.+. .. +....+.+++..|+++-|.+|||.+++++
T Consensus 235 YHIAQ----NesPtLq--s~-------------------eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 235 YHIAQ----NESPTLQ--SN-------------------EWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHh----cCCCCCC--Cc-------------------hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111 1111111 12 34567899999999999999999998774
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.32 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=201.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++. .++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 357999999999999999999998899999999997555445567889999999999999999999864 347889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||+|+||++++++.+||+
T Consensus 83 iv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~ 148 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLA 148 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEC
Confidence 9999999999999886432 578899999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||......+.
T Consensus 149 dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------- 217 (267)
T cd06646 149 DFGVAAKITATIA----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------- 217 (267)
T ss_pred cCccceeeccccc----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------
Confidence 9999986532211 112245888999999874 34578899999999999999999999753211100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
...+..... ...........+.++.+++.+||+.+|++|||++++++.+
T Consensus 218 ------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 ------LFLMSKSNF---------------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ------heeeecCCC---------------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000000 0000011124567899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.53 Aligned_cols=265 Identities=24% Similarity=0.398 Sum_probs=201.8
Q ss_pred CCCCceeccccceeEEEEEECCCCe--EEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGT--IVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 739 (988)
|.+.+.||+|+||.||+|++..+++ .||+|.++.. .....+.+..|+.+++.++|+||++++++|..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999976665 6999988643 23345678899999999999999999998754311 12235
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++........ ...+++..+..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDC-----PQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCC-----cccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEE
Confidence 7899999999999988743321110 13588999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++......... ......+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ...
T Consensus 153 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~- 224 (272)
T cd05075 153 VADFGLSKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EIY- 224 (272)
T ss_pred ECCCCcccccCccccee--cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH-
Confidence 99999998654322111 1112235678999999999999999999999999999999 88888632110 000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
+.+.. ......+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 225 ----~~~~~----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 ----DYLRQ----------------------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HHHHc----------------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 000111235667799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.79 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=204.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCe----EEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|+..++||+|+||+||+|++..+++ .||+|+++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4578899999999999999999876665 48999986433 2334678899999999999999999998643
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~ 146 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK----------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPN 146 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence 44679999999999999987543 2588999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... ......++..|+|||...+..++.++|||||||++|||++ |..||+..... ..
T Consensus 147 ~~kL~dfG~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~-- 220 (279)
T cd05109 147 HVKITDFGLARLLDIDETEY--HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EI-- 220 (279)
T ss_pred cEEECCCCceeeccccccee--ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH--
Confidence 99999999998664322111 1112235678999999998899999999999999999998 99998632110 00
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
...+... .....+..++.++.+++.+||+.||++||++.|+++.++++...
T Consensus 221 ----------~~~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 221 ----------PDLLEKG------------------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----------HHHHHCC------------------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0000000 00111234667899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.22 Aligned_cols=203 Identities=23% Similarity=0.318 Sum_probs=171.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+.+++||+|+||+||+|+...+++.||+|++.... ......+.+|++++++++||||+++++++. +++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5889999999999999999999899999999986432 233457889999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG-----------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999986543 578888999999999999999998 9999999999999999999999
Q ss_pred eeeccccccccccc-------------------------------------------ccceeccccccccccccCcccCC
Q 001974 821 GDFGLARVRQEVSN-------------------------------------------LTQSCSVGVRGTIGYAAPEYGLG 857 (988)
Q Consensus 821 ~DfG~a~~~~~~~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~ 857 (988)
+|||+++....... ..........||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999753211000 00000123468999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 858 SEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 858 ~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
..++.++||||+||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.70 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=196.4
Q ss_pred eeccccceeEEEEEE--CCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 670 LIGMGSFGSVYKGAF--DQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
.||+|+||.||+|.+ ..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++. ++..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999975 45678999999864432 23467899999999999999999999853 256789999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++++|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.
T Consensus 76 ~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~ 141 (257)
T cd05116 76 LAELGPLNKFLQKNK-----------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGL 141 (257)
T ss_pred cCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcc
Confidence 999999999986432 578899999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
++.......... ......++..|+|||.+....++.++|||||||++|||++ |+.||...... ...
T Consensus 142 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~------- 208 (257)
T cd05116 142 SKALGADENYYK-AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EVT------- 208 (257)
T ss_pred ccccCCCCCeee-ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-------
Confidence 986543322111 1112234678999999988889999999999999999998 99998632111 000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
+.+... .....+..++.++.+++.+||+.||++||++++|++.|++.
T Consensus 209 --~~i~~~------------------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 209 --QMIESG------------------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --HHHHCC------------------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 000000 00112235778899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.59 Aligned_cols=270 Identities=25% Similarity=0.420 Sum_probs=208.8
Q ss_pred CCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.+|.+.+.||+|+||.||+|++. .++..|++|.++.......+.+.+|++++++++|+||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 45788899999999999999863 245679999987655555578999999999999999999999964 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+..++||||+++++|.+++......... .......+++..++.++.||+.|++|||++ +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 7789999999999999999754321100 000113589999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 232 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-- 232 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999754432211 11122346788999999999999999999999999999999 99997532111
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..... ... .. ....+..++..+.+++.+||+.||++|||+++|+++|+++
T Consensus 233 ---~~~~~-~~~-------~~-------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 233 ---EVIEC-ITQ-------GR-------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ---HHHHH-HhC-------CC-------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 00000 000 00 0011224567899999999999999999999999999999
Q ss_pred HHH
Q 001974 972 KNA 974 (988)
Q Consensus 972 ~~~ 974 (988)
.+.
T Consensus 283 ~~~ 285 (291)
T cd05094 283 GKA 285 (291)
T ss_pred Hhh
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=337.14 Aligned_cols=257 Identities=21% Similarity=0.274 Sum_probs=199.1
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
....++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----Q 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence 34457899999999999999999999989999999998632 222345678899999999999999999984 4
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++++
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~ 178 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKH 178 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCC
Confidence 458899999999999999998542 467888999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC----CCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS----EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+.+||+|||+|......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---- 251 (370)
T cd05621 179 GHLKLADFGTCMKMDETGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---- 251 (370)
T ss_pred CCEEEEecccceecccCCce---ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC----
Confidence 99999999999865432211 11234699999999998754 37889999999999999999999986321
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVHE 967 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 967 (988)
...... .+.+..... ........+..+.+++.+|+..+|.+ ||+++|+++.
T Consensus 252 -~~~~~~--------~i~~~~~~~----------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 252 -LVGTYS--------KIMDHKNSL----------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -HHHHHH--------HHHhCCccc----------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111110 011100000 00111245667889999999865544 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.46 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=200.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||.||+|.. .|+.||+|.++.. ...+.+.+|+.++++++|+|++++++++. ..+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 4688999999999999999987 5788999998643 23467899999999999999999998753 33467899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 78 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGR---------SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred EEECCCCCcHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecC
Confidence 9999999999999875432 2478899999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||++........ ...++..|+|||++.+..++.++|||||||++|||++ |+.||... ........
T Consensus 146 fg~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~-- 211 (256)
T cd05082 146 FGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR-- 211 (256)
T ss_pred CccceeccccCC-------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHH--
Confidence 999875433211 1234668999999998889999999999999999998 99997632 11111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
+. .. ........+++.+.+++.+||+.+|++|||++++++.|+++
T Consensus 212 ---~~----~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 ---VE----KG------------------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---Hh----cC------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 00 00011235678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.13 Aligned_cols=259 Identities=23% Similarity=0.453 Sum_probs=203.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCe---EEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|+..+.||+|+||.||+|....+++ .||+|.++... ....+.+.+|++++++++|||++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 4568889999999999999999865554 79999986442 334567889999999999999999999964 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~ 145 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD----------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLE 145 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCc
Confidence 77899999999999999986543 2588999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||++........... .......+..|+|||++.+..++.++|||||||++||+++ |+.||...... ..
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~ 219 (268)
T cd05063 146 CKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EV 219 (268)
T ss_pred EEECCCccceecccccccce-eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HH
Confidence 99999999976543222111 1111223567999999988889999999999999999998 99998532110 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. ..+.. . ........++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 220 ~-----~~i~~---~-------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 220 M-----KAIND---G-------------------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred H-----HHHhc---C-------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00000 0 00111235677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.93 Aligned_cols=204 Identities=25% Similarity=0.279 Sum_probs=170.9
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQG 736 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 736 (988)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3467899999999999999999999889999999998643 2233467888999999999999999999865331 123
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||++ +++.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~ 156 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHh-------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCC
Confidence 346799999995 56766653 2478888999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 157 TLKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CEEEeeCcccccCCCccc-----cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999986543221 1224589999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.71 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=195.8
Q ss_pred eeccccceeEEEEEEC--CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEee
Q 001974 670 LIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
.||+|+||.||+|.+. ..+..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 4899999999999874 3456799999865432 234568999999999999999999998632 467999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccc
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 826 (988)
+++++|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~ 142 (257)
T cd05115 76 ASGGPLNKFLSGKK----------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS 142 (257)
T ss_pred CCCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcc
Confidence 99999999986543 2688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
........... ......++..|+|||++.+..++.++|||||||++||+++ |..||...... ...
T Consensus 143 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~-------- 208 (257)
T cd05115 143 KALGADDSYYK-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----EVM-------- 208 (257)
T ss_pred ccccCCcccee-ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH--------
Confidence 75443222111 1111224578999999988889999999999999999996 99998643111 000
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..+... .....+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 209 -~~~~~~------------------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 209 -SFIEQG------------------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HHHHCC------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 000000 00112235678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.70 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=199.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||.||.|.+. .+..||+|.++... .....+.+|+.++++++||||+++++++.. .+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 46888999999999999999885 45569999886432 234678999999999999999999999643 366899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 77 v~e~~~~~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d 143 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG----------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD 143 (256)
T ss_pred EEEcCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECC
Confidence 999999999999986543 2578999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.++....... .......++..|+|||...+..++.++|||||||++|||++ |+.||...... ...
T Consensus 144 ~g~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~---- 211 (256)
T cd05113 144 FGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETV---- 211 (256)
T ss_pred CccceecCCCce---eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHH----
Confidence 999875533221 11122346678999999988889999999999999999999 99998632110 000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
..+... .....+...+..+.+++.+||+.+|.+||++.++++.++
T Consensus 212 -~~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 -EKVSQG----------------------LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -HHHhcC----------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000000 000111234677899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.42 Aligned_cols=271 Identities=25% Similarity=0.406 Sum_probs=204.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeE--EEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTI--VAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+..++.. +|+|.++... ......+.+|++++.++ +||||+++++++. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 35688899999999999999998767754 5777765322 23345788999999999 8999999999954 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchh-----hhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDV-----EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+..++||||+++++|.+++........+. ......+++.+++.++.|++.|++|||+. +++||||||+||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 77899999999999999997543211000 00113588999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
++++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 229 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 229 (303)
T ss_pred cCCCcEEeCccccCcccchhhh-----cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---
Confidence 9999999999999864221110 111224668999999988889999999999999999998 9999853211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..... .+.. . .....+..++.++.+++.+||+.+|++||++++++..++++
T Consensus 230 --~~~~~-----~~~~---~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 230 --AELYE-----KLPQ---G-------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HHHHH-----HHhc---C-------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 0000 0 00011224567789999999999999999999999999988
Q ss_pred HHHhhh
Q 001974 972 KNALLE 977 (988)
Q Consensus 972 ~~~~~~ 977 (988)
.+.-..
T Consensus 281 ~~~~~~ 286 (303)
T cd05088 281 LEERKT 286 (303)
T ss_pred HHhhhh
Confidence 665443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.00 Aligned_cols=254 Identities=28% Similarity=0.513 Sum_probs=201.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.++||+|+||.||+|.+. ++..||+|.++.... ..+.+.+|+.++++++|++++++++++. ....+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence 457899999999999999999876 667799999875433 3467899999999999999999998853 24578
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~ 144 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG---------RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIA 144 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeC
Confidence 99999999999999875431 3578999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.+......... ......++..|+|||+..+..++.++||||||+++|||++ |..||..... ......
T Consensus 145 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~- 215 (260)
T cd05070 145 DFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQ- 215 (260)
T ss_pred CceeeeeccCcccc---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH-
Confidence 99999765432211 1112235678999999988889999999999999999999 8999863211 000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
+ ... .....+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 216 ----~----~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ----V----ERG------------------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----H----HcC------------------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 000 0011123566789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=342.30 Aligned_cols=285 Identities=22% Similarity=0.276 Sum_probs=198.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc---CC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ---GN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++....+. ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999998899999999885322 3345799999999999999998876433221 22
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM- 816 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 816 (988)
...++||||++ +++.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~-------~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARN-------NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCC
Confidence 34679999995 5777666432110 13688999999999999999999998 999999999999999664
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... ..+..
T Consensus 209 ~vkL~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~ 282 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVR 282 (440)
T ss_pred ceeeeccccchhccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence 799999999986543221 122458999999999876 46899999999999999999999998632111 00111
Q ss_pred HHHHHHhhhhhh---hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHH
Q 001974 896 YARTALLDHVID---IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQS 970 (988)
Q Consensus 896 ~~~~~~~~~~~~---~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 970 (988)
... .......+ ...+.... ..+.......+. ...+...+.++.+++.+||+.||.+|||+.|+++. ++.
T Consensus 283 i~~-~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~l~---~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 283 IIQ-VLGTPTEDQLKEMNPNYAD--IKFPDVKPKDLK---KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHH-HhCCCCHHHHHHhchhhhc--ccCCccCchhHH---HHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 100 00000000 00000000 000000000000 11123467789999999999999999999999854 444
Q ss_pred HH
Q 001974 971 VK 972 (988)
Q Consensus 971 i~ 972 (988)
+.
T Consensus 357 ~~ 358 (440)
T PTZ00036 357 LR 358 (440)
T ss_pred hh
Confidence 44
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.77 Aligned_cols=251 Identities=28% Similarity=0.433 Sum_probs=199.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|++++++++||||+++++++. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence 45888999999999999999986 56789999986332 23457889999999999999999999854 3477899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 77 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d 143 (256)
T cd05059 77 VTEYMANGCLLNYLRERK----------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143 (256)
T ss_pred EEecCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECC
Confidence 999999999999987543 2578999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...
T Consensus 144 fg~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~---- 211 (256)
T cd05059 144 FGLARYVLDDQYT---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVV---- 211 (256)
T ss_pred cccceeccccccc---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHH----
Confidence 9999765332111 1112234568999999998899999999999999999999 89998632111 000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
..+... .....+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus 212 -~~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 -ESVSAG----------------------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -HHHHcC----------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000000 00112234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=331.22 Aligned_cols=238 Identities=27% Similarity=0.346 Sum_probs=187.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHH-HHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|++..+|+.||+|++.... ......+..|.. +++.++||||+++++++. .++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 47999999999999999999999999986432 122334555554 467789999999998853 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 76 DYVNGGELFFHLQRER-----------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred cCCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence 9999999999886543 578889999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.........
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~--- 209 (323)
T cd05575 142 LCKEGIEHSK----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNIL--- 209 (323)
T ss_pred CCcccccCCC----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHH---
Confidence 9874322111 122345899999999999999999999999999999999999998632 1111111000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
. .........+.++.+++.+|++.||++||++.
T Consensus 210 -----~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 210 -----N--------------------KPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----c--------------------CCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 00111224577899999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.52 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=198.5
Q ss_pred ceeccccceeEEEEEECCCC---eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
++||+|+||.||+|.+...+ ..||+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 47999999999999875544 7899999874433 24567899999999999999999999853 25679999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 75 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~ 140 (257)
T cd05060 75 ELAPLGPLLKYLKKRR-----------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFG 140 (257)
T ss_pred EeCCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccc
Confidence 9999999999997543 578999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
.++......... .......++..|+|||...+..++.++|||||||++|||++ |..||..... ....... ..
T Consensus 141 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~ 213 (257)
T cd05060 141 MSRALGAGSDYY-RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ES 213 (257)
T ss_pred ccceeecCCccc-ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----Hc
Confidence 998654332211 11111224568999999998899999999999999999998 9999864211 0111100 00
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
. .....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 214 --------~------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 --------G------------------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --------C------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 001122356778999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.81 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=192.2
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
+|+..+.||+|+||+||+|++..+|+.||+|+++... ....+.+..|..+++.+. |++|+++++++ ...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 4778899999999999999999899999999987432 233456778889988885 57788888874 34578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++++++.+|
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~-----------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG-----------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence 999999999999999986543 688999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......
T Consensus 142 L~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~ 212 (323)
T cd05615 142 IADFGMCKEHMVDGV----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQS 212 (323)
T ss_pred EeccccccccCCCCc----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 999999875322111 12234589999999999998999999999999999999999999863211 001000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
+. ......+...+.++.+++.+|++.+|++|++.
T Consensus 213 -----i~-----------------------~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 -----IM-----------------------EHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----HH-----------------------hCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00 00011123456678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.01 Aligned_cols=262 Identities=24% Similarity=0.325 Sum_probs=207.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|....+|+.||+|.++.. .....+.+.+|++++++++|+|++++++++. .++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5799999999999999999999889999999988632 2233567889999999999999999999854 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++....... ..+++.+++.++.|++.|++|||+. +|+||||+|+||+++.++.++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQK-------RLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccC-------CCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEE
Confidence 899999999999999986432111 3578999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||.+......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .........
T Consensus 147 l~d~~~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~ 219 (267)
T cd08224 147 LGDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK 219 (267)
T ss_pred EeccceeeeccCCCcc----cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh
Confidence 9999998754332111 122357889999999998889999999999999999999999975321 111111100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
+.. ..... ......+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus 220 -----~~~---~~~~~------------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 -----IEK---CDYPP------------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----hhc---CCCCC------------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 00000 001145667899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.19 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=201.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-----chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-----GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|+..+.||+|++|.||.|....+++.||+|.+..... ...+.+.+|++++++++||||+++++++. .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 578999999999999999999988999999999864321 12356888999999999999999999954 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~ 142 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-----------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGN 142 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 78999999999999999886542 578889999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
++|+|||.++......... .......++..|+|||++.+..++.++||||+|+++|||++|+.||..... .....
T Consensus 143 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~ 217 (263)
T cd06625 143 VKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIF 217 (263)
T ss_pred EEEeecccceecccccccc-ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHH
Confidence 9999999997654322111 111223478899999999998899999999999999999999999863210 00000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .... ......+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 218 -~--------~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 -K--------IATQ------------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -H--------Hhcc------------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 0000 00011223566789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.98 Aligned_cols=256 Identities=23% Similarity=0.431 Sum_probs=194.7
Q ss_pred ceeccccceeEEEEEECC---CCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|.+.. .+..||+|.+... .....+.+.+|+.+++.++||||+++++++.. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998742 3457999988532 23345678899999999999999999997643 235678999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+.+++|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||
T Consensus 77 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg 143 (262)
T cd05058 77 PYMKHGDLRNFIRSET----------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG 143 (262)
T ss_pred ecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence 9999999999997543 2456778889999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhC-CCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG-KKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
+++.................++..|+|||++.+..++.++|||||||++|||++| .+||... ........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~---- 214 (262)
T cd05058 144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVY---- 214 (262)
T ss_pred ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH----
Confidence 9975433211111111223467789999999888999999999999999999995 5555421 10011100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
+. .. .....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 215 -~~---~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 -LL---QG-------------------RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -Hh---cC-------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00 00 0001122456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.29 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=198.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++++++|++|+++.+++. .++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 3677889999999999999999899999999986432 222345788999999999999999998853 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl 143 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGN---------PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred EEEEEeccCccHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEE
Confidence 999999999999988864321 2589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++........ .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ...
T Consensus 144 ~Dfg~~~~~~~~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~----~~~ 212 (285)
T cd05632 144 SDLGLAVKIPEGES-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--K----REE 212 (285)
T ss_pred ecCCcceecCCCCc-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--H----HHH
Confidence 99999975433211 122458999999999998899999999999999999999999986321100 0 000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 967 (988)
+...+. ..........+.++.+++.+||+.||++||+ +.++++.
T Consensus 213 ~~~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 213 VDRRVL-----------------------ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHhhh-----------------------ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 000000 0001112345677899999999999999999 6676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.32 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=203.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECC-----CCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
..++|.+.+.||+|++|.||+|.+.. .+..||+|.+..... .....+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 34678999999999999999999976 678899998864432 234578999999999999999999998543
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.+..++||||+++++|.+++........ ....+++.++..++.||+.|++|||+. +++||||||+||+++.
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~ 151 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPE----RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTC 151 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEec
Confidence 3677999999999999999976542111 012589999999999999999999998 9999999999999986
Q ss_pred CC---cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 815 DM---IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 815 ~~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
++ .+||+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~- 228 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ- 228 (277)
T ss_pred cCCCcceEeccCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 54 69999999998653322111 1111234568999999999999999999999999999997 99998632110
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
... +.+... .....+..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 229 ----~~~---------~~~~~~------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ----EVM---------EFVTGG------------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHH---------HHHHcC------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 000000 001123356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.52 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=201.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+|++.+.||+|+||.||++++..+++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++. .++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 478899999999999999999989999999998643 2334567889999999999999999999854 4578999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++++|
T Consensus 76 v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~d 143 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRG---------KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGD 143 (255)
T ss_pred EEeeCCCCcHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcc
Confidence 9999999999998864332 2578889999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||.+......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||... ...........
T Consensus 144 fg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~ 214 (255)
T cd08219 144 FGSARLLTSPGAY----ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQ 214 (255)
T ss_pred cCcceeecccccc----cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhc
Confidence 9999765432211 12345888999999999888999999999999999999999998631 11111110000
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ....+..++..+.+++.+||+.||++|||+.|++.+
T Consensus 215 ~~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GS---------------------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC---------------------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 000112355678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.72 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=203.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++.+.. +...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence 4579999999999999999999988999999999976655556788999999999999999999998543 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 94 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~ 158 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (296)
T ss_pred EeecccCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEC
Confidence 999999999999998532 468889999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.. ..
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~-~~ 229 (296)
T cd06654 159 DFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYL-IA 229 (296)
T ss_pred ccccchhcccccc----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHH-Hh
Confidence 9999875433211 111235889999999999888999999999999999999999998632111 00000 00
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .....+...+..+.+++.+||..||++||++.|+++.
T Consensus 230 -------~~~~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 -------TNGT------------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -------cCCC------------------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000 0001122456678999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.42 Aligned_cols=239 Identities=24% Similarity=0.319 Sum_probs=190.8
Q ss_pred ceeccccceeEEEEEE---CCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 669 HLIGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
+.||+|+||.||+++. ..+|+.||+|+++.... .....+..|++++++++||||+++++++. .++..++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 6799999999999886 35789999999974322 22345778999999999999999999854 45789999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 77 ~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV-----------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred EcCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeec
Confidence 99999999999986542 589999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
|+++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 143 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~---- 209 (318)
T cd05582 143 GLSKESIDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTM---- 209 (318)
T ss_pred cCCcccCCCCC----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHH----
Confidence 99875433211 12234689999999999988899999999999999999999999863210 000000
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
+. ......+...+..+.+++.+||+.||++||++.+
T Consensus 210 -i~-----------------------~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 210 -IL-----------------------KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -HH-----------------------cCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 0011112345677899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=329.10 Aligned_cols=195 Identities=28% Similarity=0.413 Sum_probs=171.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-C-----CCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-H-----RNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 737 (988)
+|++.+.||+|+||.|.+|.+.++++.||||+++... ....+...|+.+|..++ | -|+|++++++ ...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----ccc
Confidence 7899999999999999999999999999999997443 34567788999999996 4 3899999994 456
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM- 816 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 816 (988)
++.|||+|.+ ..+|+++++.+.. ..++...++.++.||+.||.+||+. +|||+||||+|||+.+.+
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f---------~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKF---------RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKR 327 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCc
Confidence 9999999999 7899999998875 4689999999999999999999998 999999999999996543
Q ss_pred -cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 817 -IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 817 -~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
.+||+|||.|........ ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.
T Consensus 328 ~~vKVIDFGSSc~~~q~vy-------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY-------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred CceeEEecccccccCCcce-------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 799999999987554322 3457889999999999999999999999999999999988765
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.31 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=199.1
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+..+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++|++++++++.+. .++..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 37788999999999999999999999999999864322 22345778999999999999999999854 34789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l 143 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE---------AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRI 143 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999998854321 2588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++........ .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ... .
T Consensus 144 ~Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~-~---- 212 (285)
T cd05630 144 SDLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE-E---- 212 (285)
T ss_pred eeccceeecCCCcc-----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH-H----
Confidence 99999875432221 112358999999999999999999999999999999999999987421110 000 0
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
.....+. ........+++++.+++.+||+.||++||| ++|+++
T Consensus 213 ----~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 213 ----VERLVKE-------------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----HHhhhhh-------------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0000000 000112245677899999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.71 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=202.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|++|.||+|.+..+++.|++|.+... .....+.+.+|++++++++|||++++++++. .++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 478889999999999999999989999999998643 2344567889999999999999999999854 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~ 143 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG---------RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIG 143 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEc
Confidence 99999999999999875421 3688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||+++........ .....|+..|+|||+..+..++.++|||||||++|||++|+.||..... ......
T Consensus 144 df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~-- 212 (256)
T cd08529 144 DLGVAKLLSDNTNF----ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILK-- 212 (256)
T ss_pred ccccceeccCccch----hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--
Confidence 99998865443211 1223578899999999999999999999999999999999999863211 000000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.. . ........++.++.+++.+||+.+|++||++.++++.
T Consensus 213 ---~~~---~-------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 ---IIR---G-------------------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---HHc---C-------------------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 0 0001112456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.76 Aligned_cols=277 Identities=22% Similarity=0.319 Sum_probs=199.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|.+.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 679999999999999999999988999999999874432 23356788999999999999999999854 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 146 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCG----------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLA 146 (309)
T ss_pred EEEeCCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 9999995 58888876543 2578889999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++....... ......++..|+|||++.+ ..++.++||||+||++|||+||+.||...... +........
T Consensus 147 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~ 220 (309)
T cd07872 147 DFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRL 220 (309)
T ss_pred ccccceecCCCcc----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence 9999975432211 1112357899999998765 56889999999999999999999998642111 111111110
Q ss_pred Hhhhhhhhhcccccc-CcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILIN-DVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......+........ ...++.. ..............++.++.+++.+|++.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKNYNF--PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hCCCCHHHHhhhcchhhhhhhhc--CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000 0000000 000000001112346778899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=334.17 Aligned_cols=273 Identities=22% Similarity=0.268 Sum_probs=199.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++||||+++++++...........+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999889999999998632 223346788999999999999999999987644222223789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 lv~e~~~-~~l~~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~ 145 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKIC 145 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEec
Confidence 9999994 6888877543 2688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++........ ......++..|+|||++.+. .++.++||||+||++|||++|+.||...... .........
T Consensus 146 Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~ 220 (372)
T cd07853 146 DFGLARVEEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDL 220 (372)
T ss_pred cccceeecccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHH
Confidence 99999865332211 11223578999999998774 5789999999999999999999998642111 000000000
Q ss_pred HhhhhhhhhccccccCcchhhhhh----HHHH--------hhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATN----KQRL--------RQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~----~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... ...++.... .... ...........++++.+++.+||+.||++|||+.|+++.
T Consensus 221 ~g~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 221 LGTP-----------SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred cCCC-----------CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000000 0000 000001122456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.44 Aligned_cols=268 Identities=24% Similarity=0.386 Sum_probs=204.7
Q ss_pred CCCCCceeccccceeEEEEEECC-----CCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+|++.+.||+|+||.||+|+... ....||+|.+..... .....+.+|+.+++.++||||+++++.+.. +
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 47888999999999999998742 235789998864432 334678899999999999999999998643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch-------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD-------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCD 804 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 804 (988)
+..++|+||+++++|.+++......... .......+++..++.++.|++.||+|||+. +++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 6789999999999999998653221100 001124688999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 001974 805 LKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPT 883 (988)
Q Consensus 805 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~ 883 (988)
|||+||++++++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK--RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhc--ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999975533221111 112335678999999988889999999999999999999 99998
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
..... .. +.+...... ....+..++.++.+++.+||+.+|++||+++|
T Consensus 231 ~~~~~-----~~---------~~~~~~~~~------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 231 PGIAP-----ER---------LFNLLKTGY------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred CCCCH-----HH---------HHHHHhCCC------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 63211 00 001111000 00112346678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 964 VVHELQSVKN 973 (988)
Q Consensus 964 vl~~L~~i~~ 973 (988)
+++.|+++..
T Consensus 279 i~~~l~~~~~ 288 (290)
T cd05045 279 ISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHh
Confidence 9999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.84 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=201.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.++||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|++++++++||||+++++++. .+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence 45799999999999999999998644 5699999874332 3467899999999999999999998742 25578
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~ 144 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 144 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEec
Confidence 99999999999999975321 2578899999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.++........ ......++..|+|||+..+..++.++|||||||++|||+| |+.||...... ...
T Consensus 145 dfg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~--- 213 (262)
T cd05071 145 DFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVL--- 213 (262)
T ss_pred cCCceeeccccccc---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHH---
Confidence 99999765432211 1112346778999999988899999999999999999999 88887632110 000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..+.. . .......+++..+.+++.+|++.||++||+++++++.|++.
T Consensus 214 --~~~~~---~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 --DQVER---G-------------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --HHHhc---C-------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00000 0 00011235677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.16 Aligned_cols=284 Identities=20% Similarity=0.228 Sum_probs=200.8
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc-c
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-Q 735 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 735 (988)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345688999999999999999999998899999999986432 2233567789999999999999999988653211 2
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.....++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~ 154 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC------------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED 154 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC
Confidence 234578999998 8899888753 2588999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.
T Consensus 155 ~~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~ 226 (343)
T cd07878 155 CELRILDFGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLK 226 (343)
T ss_pred CCEEEcCCccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHH
Confidence 99999999999865332 123458999999999877 56889999999999999999999998632110 0000
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... ........+............+...................++.+.+++.+|++.||++|||++|+++.
T Consensus 227 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 227 RIM-EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHH-HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000000000000000000000000000000011345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.51 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+.+.+|+.++++++|+||+++++++.. .+..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence 45789999999999999999988 588999999975543 45788999999999999999999998543 47889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~ 144 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR---------AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVS 144 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEc
Confidence 99999999999999865432 2589999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.++....... ....+..|+|||++.+..++.++||||||+++||+++ |..||...... .
T Consensus 145 d~g~~~~~~~~~~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~----- 207 (256)
T cd05039 145 DFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D----- 207 (256)
T ss_pred ccccccccccccc-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----H-----
Confidence 9999986532211 1235678999999998899999999999999999998 99998632110 0
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
....+.. . .....+..+++++.+++.+||..+|++|||++|++++|+.+
T Consensus 208 ~~~~~~~----~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 VVPHVEK----G------------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHhc----C------------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0000000 0 00011234678899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.34 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=206.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|+...+++.||||.+.... .....++.+|+.+++.++||||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 46888999999999999999998899999999876432 223457889999999999999999999854 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++...... ...+++..++.++.||+.|++|||+. +++|+||||+||+++.++.++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-------KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 89999999999999988642211 13589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ......
T Consensus 147 l~dfg~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~- 218 (267)
T cd08229 147 LGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCK- 218 (267)
T ss_pred ECcchhhhccccCCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhh-
Confidence 999999876543221 112245888999999998888999999999999999999999998532111 101000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.+.....+. ......+.++.+++.+||+.||++|||+++|++.++++.
T Consensus 219 ----~~~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 ----KIEQCDYPP---------------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhhcCCCCC---------------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000000000 001235678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.00 Aligned_cols=203 Identities=25% Similarity=0.281 Sum_probs=170.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... +...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999999989999999998643 2334467889999999999999999998865331 2233
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++ +++.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence 56799999995 57776663 2467888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+||+|||+++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 165 ~kL~DfG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 165 LKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred EEEEeCCCccccCCCCc-----ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 99999999986543221 1224589999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.32 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=198.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 46888999999999999999998899999999986442 3334678899999999999999999999654 47789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+
T Consensus 76 lv~e~~~~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~ 137 (279)
T cd06619 76 ICTEFMDGGSLDVYR---------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLC 137 (279)
T ss_pred EEEecCCCCChHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEe
Confidence 999999999997552 467788899999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+..... ...
T Consensus 138 dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~ 208 (279)
T cd06619 138 DFGVSTQLVNSI------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---LQL 208 (279)
T ss_pred eCCcceeccccc------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---HHH
Confidence 999997543321 12245899999999999989999999999999999999999998753322111000 000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ...+.. .. .......++++.+++.+||+.+|++||+++|+++.
T Consensus 209 ~~---~~~~~~----~~--------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQ---CIVDED----PP--------------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HH---HHhccC----CC--------------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000000 00 00012355678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.78 Aligned_cols=274 Identities=23% Similarity=0.378 Sum_probs=205.9
Q ss_pred hhCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++... ......+.+|+.++.++ +||||++++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 346799999999999999999985 2467899999997533 23345788999999999 78999999998743
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCc-------------------------------------------------
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQK------------------------------------------------- 764 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------- 764 (988)
.+...++||||+++|+|.+++........
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 23567899999999999999865321000
Q ss_pred -------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccc
Q 001974 765 -------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837 (988)
Q Consensus 765 -------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~ 837 (988)
........+++.++..++.||++||+|||+. +|+||||||+||++++++.+||+|||++...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 0001123578899999999999999999998 999999999999999999999999999976533221111
Q ss_pred eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccC
Q 001974 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILIND 916 (988)
Q Consensus 838 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 916 (988)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. .......
T Consensus 238 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~-~~~~~~~------------ 298 (343)
T cd05103 238 --KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EF-CRRLKEG------------ 298 (343)
T ss_pred --cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HH-HHHHhcc------------
Confidence 112235678999999988899999999999999999997 999986421110 00 0000000
Q ss_pred cchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 917 VEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.....+...++++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 299 --------------~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 299 --------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00011123456789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.38 Aligned_cols=266 Identities=22% Similarity=0.382 Sum_probs=202.4
Q ss_pred CCCCCCceeccccceeEEEEEEC----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|++.+.||+|+||.||+|.+. ..++.||+|.++.... .....+.+|++++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 46788899999999999999852 3567899999864332 33367889999999999999999999854 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCC------chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQ------KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
+..++||||+++++|.+++....... .........+++.++..++.|++.||+|||+. +++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 77899999999999999985432100 00001123578999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-- 232 (283)
T ss_pred EcCCCcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 999999999999999765332211 11122345778999999988889999999999999999999 9989753210
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
... .+.++.. .....+..++.++.+++.+||+.||++||++.++.+.|.+
T Consensus 233 ---~~~---------~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ---QEV---------IEMVRKR------------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHH---------HHHHHcC------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000 0000000 0011223567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=333.22 Aligned_cols=272 Identities=22% Similarity=0.337 Sum_probs=206.1
Q ss_pred HhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcC-CCCceEEEeecccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQR-HGASKSFLAECKALKNIR-HRNLVKVITSCSSI 732 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 732 (988)
...++|.+.+.||+|+||.||+|++. ..++.||+|+++... ....+.+.+|++++.++. ||||++++++|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~- 112 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK- 112 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence 34456888999999999999999863 345689999997442 223457889999999996 9999999999654
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCc------------------------------------------------
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQK------------------------------------------------ 764 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------ 764 (988)
.+..++||||+++|+|.++++.......
T Consensus 113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 3678999999999999999975432000
Q ss_pred ---------------------------------------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 765 ---------------------------------------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 765 ---------------------------------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
........+++.+++.++.||+.||+|||+. +++||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence 0000112478888999999999999999998 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~ 884 (988)
||+||++++++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYIS--KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceeccccccccc--CCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999986433221111 112346788999999998889999999999999999998 888976
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.....+ ... ..+... .....+..++.++.+++.+||..+|++||+++||
T Consensus 344 ~~~~~~-----~~~--------~~~~~~------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 344 ELPMNE-----QFY--------NAIKRG------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred CCCchH-----HHH--------HHHHcC------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 321110 000 000000 0011223467789999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 965 VHELQSVK 972 (988)
Q Consensus 965 l~~L~~i~ 972 (988)
++.|+++.
T Consensus 393 l~~L~~~~ 400 (401)
T cd05107 393 VHLVGDLL 400 (401)
T ss_pred HHHHHHHh
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.89 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=192.4
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|+...+++.||+|+++... ....+.+..|+.++.++ +||+|+++++++. ..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 47999999999999999899999999997432 23345678899999888 6999999999853 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 76 EYVNGGDLMFHMQRQR-----------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred eCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence 9999999998886442 689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccC-CcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG-DLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~ 903 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.....
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-- 215 (327)
T cd05617 142 MCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-- 215 (327)
T ss_pred cceeccCCCC----ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--
Confidence 9874322111 112346899999999999999999999999999999999999999643221 111111111100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
.......+...+..+.+++.+||+.||++|+++.
T Consensus 216 -------------------------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 216 -------------------------LEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -------------------------HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0011112334567789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.07 Aligned_cols=259 Identities=22% Similarity=0.379 Sum_probs=205.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 35688899999999999999987533 3468999886544 3445688999999999999999999998643
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~ 145 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK----------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDC 145 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCC
Confidence 45689999999999999997543 2578999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||...... ..
T Consensus 146 ~~l~d~g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~ 217 (270)
T cd05056 146 VKLGDFGLSRYLEDESYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DV 217 (270)
T ss_pred eEEccCceeeeccccccee---cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HH
Confidence 9999999997654432111 112234568999999988889999999999999999986 99998633111 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
... +. .......+..++.++.+++.+|+..+|++|||+.++++.|+++..+
T Consensus 218 ~~~-----~~----------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 IGR-----IE----------------------NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHH-----HH----------------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 00 0001112335678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=330.06 Aligned_cols=242 Identities=25% Similarity=0.304 Sum_probs=188.8
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHH-HHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. .++..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 46999999999999999899999999986432 122234444444 567789999999998853 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 76 DYINGGELFYHLQRER-----------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred eCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence 9999999999986543 577888899999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........
T Consensus 142 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~--- 209 (325)
T cd05602 142 LCKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNIL--- 209 (325)
T ss_pred CCcccccCCC----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHH---
Confidence 9975322111 12234689999999999999999999999999999999999999863211 11100000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. .........+..+.+++.+|++.||.+||++.+.+.
T Consensus 210 -----~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 210 -----N--------------------KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -----h--------------------CCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 001112356778999999999999999999885443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.30 Aligned_cols=274 Identities=23% Similarity=0.375 Sum_probs=205.0
Q ss_pred CCCCCCceeccccceeEEEEEE----CCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.-|++.+.||+|+||.||+|.+ ..+++.||+|.++... ....+.+.+|++++++++|||++++++++... ++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3478899999999999999985 3467899999987443 33446789999999999999999999986532 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 147 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 147 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCC
Confidence 56899999999999999986543 2578999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++........ ........++..|+|||++.+..++.++|||||||++|||+|++.|+....... ....
T Consensus 148 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~ 223 (284)
T cd05079 148 VKIGDFGLTKAIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMI 223 (284)
T ss_pred EEECCCccccccccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhc
Confidence 999999999865433221 111123446778999999988889999999999999999999887643211100 0000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHh-hhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLR-QAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.+...... .. ....... ......+..++.++.+++.+||+.+|++|||++|+++.++++
T Consensus 224 ------------~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 224 ------------GPTHGQMT--VT-RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ------------cccccccc--HH-HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 00 0000000 001112335778899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.82 Aligned_cols=259 Identities=24% Similarity=0.461 Sum_probs=203.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC---eEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++..++ ..||+|.++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 357889999999999999999885443 379999886432 233467899999999999999999999854 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 144 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD----------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLV 144 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCe
Confidence 78899999999999999997543 2578999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
++|+|||++.......... .......++..|+|||++.+..++.++||||||+++||+++ |..||...... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~ 218 (267)
T cd05066 145 CKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DV 218 (267)
T ss_pred EEeCCCCccccccccccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HH
Confidence 9999999998654332111 11112234568999999998899999999999999999887 99997632110 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. ..+.+ . ........++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 219 ~-----~~~~~---~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 219 I-----KAIEE---G-------------------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred H-----HHHhC---C-------------------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00000 0 00011235677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.52 Aligned_cols=259 Identities=24% Similarity=0.470 Sum_probs=203.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe---EEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.+|++.+.||+|+||.||+|++..+++ .||+|+++.. ......++..|+.++++++||||+++++++. .+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence 357889999999999999999876654 6999998644 2334568999999999999999999999853 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~ 145 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcE
Confidence 7899999999999999987543 2578999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccc-eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQ-SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
||+|||.+........... ....+...+..|+|||++.+..++.++|||||||++||+++ |..||..... ...
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~ 220 (269)
T cd05065 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDV 220 (269)
T ss_pred EECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHH
Confidence 9999999876543221111 11111112457999999999999999999999999999987 9999853211 000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
... +... .....+.+++..+.+++.+||+.+|++||++++++..|+++
T Consensus 221 ~~~-----i~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INA-----IEQD----------------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHH-----HHcC----------------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0000 00111235677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.72 Aligned_cols=273 Identities=21% Similarity=0.351 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECC----------------CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ----------------DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVK 724 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 724 (988)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++... .....++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986532 34579999987443 233467899999999999999999
Q ss_pred EEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecc
Q 001974 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCD 804 (988)
Q Consensus 725 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 804 (988)
+++++. .++..++||||+++++|.+++................+++.++..++.|++.|++|||+. +++|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 999854 346789999999999999999765432221122224588899999999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh--CCCC
Q 001974 805 LKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT--GKKP 882 (988)
Q Consensus 805 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p 882 (988)
|||+||++++++.++|+|||+++......... ......++..|+|||...++.++.++|||||||++|||++ |..|
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999997553322111 1112234678999999888889999999999999999998 6778
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|...... ..... ......... .......+..++..+.+++.+||+.||++||++.
T Consensus 234 ~~~~~~~-----~~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 234 YSQLSDE-----QVIEN-----TGEFFRDQG---------------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred ccccChH-----HHHHH-----HHHHHhhcc---------------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 7532111 11100 000000000 0000112235678899999999999999999999
Q ss_pred HHHHHHH
Q 001974 963 NVVHELQ 969 (988)
Q Consensus 963 evl~~L~ 969 (988)
||++.|+
T Consensus 289 ~i~~~l~ 295 (296)
T cd05095 289 EIHATLL 295 (296)
T ss_pred HHHHHHh
Confidence 9999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.09 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=200.5
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
.++....++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--- 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 344556689999999999999999999999999999999986322 22335678899999999999999999885
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
..++..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 113 --~~~~~~~lv~Ey~~gg~L~~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll 175 (371)
T cd05622 113 --QDDRYLYMVMEYMPGGDLVNLMSNY------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 175 (371)
T ss_pred --EcCCEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEE
Confidence 3457899999999999999998643 467888899999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC----CCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS----EVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-- 250 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-- 250 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcc---cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--
Confidence 99999999999999865432211 11234699999999998754 3788999999999999999999998631
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVH 966 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 966 (988)
........ +...... ........++..+.+++.+|+..+|.+ ||+++|+++
T Consensus 251 ---~~~~~~~~-----i~~~~~~-------------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 251 ---SLVGTYSK-----IMNHKNS-------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred ---CHHHHHHH-----HHcCCCc-------------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 11111100 0000000 000111246677899999999844433 789999887
Q ss_pred HH
Q 001974 967 EL 968 (988)
Q Consensus 967 ~L 968 (988)
..
T Consensus 304 h~ 305 (371)
T cd05622 304 HL 305 (371)
T ss_pred Cc
Confidence 53
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.44 Aligned_cols=265 Identities=26% Similarity=0.434 Sum_probs=204.2
Q ss_pred CCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.+|...++||+|+||.||+|... .++..||+|.++.........+.+|+++++.++|+||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 46788899999999999999752 356789999987655555678999999999999999999999854 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
+..++||||+++++|.+++......... .......+++..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 6789999999999999999754321100 000113588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLN 892 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 892 (988)
+++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |++||......
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 231 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--- 231 (280)
T ss_pred CCCCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---
Confidence 999999999999975433211 111122335788999999999999999999999999999998 99997532111
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
..... + .. ......+..+++.+.+++.+||+.||++||+++||++.|+
T Consensus 232 --~~~~~-----~---~~-------------------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 --EAIEC-----I---TQ-------------------GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHHHH-----H---Hc-------------------CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 0 00 0001122356788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.41 Aligned_cols=276 Identities=21% Similarity=0.249 Sum_probs=203.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|++++++++||||+++++++. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 46899999999999999999999899999999986442 233456889999999999999999999864 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+. .+++||||||+||++++++.+||+
T Consensus 76 lv~ey~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~ 142 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG-----------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 142 (308)
T ss_pred EEeeccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEc
Confidence 9999999999999996542 578889999999999999999973 289999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ......
T Consensus 143 dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~---- 210 (308)
T cd06615 143 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMF---- 210 (308)
T ss_pred cCCCcccccccc------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhh----
Confidence 999987543221 12345889999999998888999999999999999999999998632111 111100
Q ss_pred hhhhhhhhcc------ccc-cC-cc--hhhhhhHHHHhhhhhccc-cchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 902 LDHVIDIVDP------ILI-ND-VE--DWDATNKQRLRQAKINGK-IECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 902 ~~~~~~~~d~------~l~-~~-~~--~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
........++ ... .+ .. .+...............+ ..++.++.+++.+||+.||++|||++|+++.-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000000000 000 00 00 000000000000111111 12567899999999999999999999998874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.85 Aligned_cols=242 Identities=26% Similarity=0.318 Sum_probs=188.9
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHH-HHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||+||+|++..+|+.||+|++.... ......+..|.. +++.++||||+++++++. .++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 46899999999999999899999999986432 223344555555 467789999999998853 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 76 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 76 DFVNGGELFFHLQRER-----------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred cCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence 9999999998886542 688999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +..........
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~~-- 210 (325)
T cd05604 142 LCKEGIAQSD----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNILH-- 210 (325)
T ss_pred CcccCCCCCC----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHHc--
Confidence 9874322111 112345899999999999999999999999999999999999998632 11111111000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. ........+.++.+++.+|++.+|++||++++.++
T Consensus 211 ------~--------------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 211 ------K--------------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ------C--------------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 0 00112245667889999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.40 Aligned_cols=270 Identities=22% Similarity=0.382 Sum_probs=209.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECC----CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ----DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
..++|++.+.||+|+||.||+|.+.. .+..|++|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 45789999999999999999999864 26789999886432 2335678899999999999999999998643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.+...++++||+++++|.+++......... ....+++.+++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~ 153 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEAN---NPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCC
Confidence 346789999999999999998654321100 113689999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||..... .
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~ 226 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----F 226 (280)
T ss_pred CcEEECCCCCcccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----H
Confidence 99999999999855332211 11112346778999999998889999999999999999999 9999863211 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.+.. .+.. . ........+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 227 ~~~~-----~~~~----~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 227 EMAA-----YLKD----G------------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHH-----HHHc----C------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1100 0000 0 00011234677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.55 Aligned_cols=259 Identities=24% Similarity=0.308 Sum_probs=202.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc-CC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ-GN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~ 737 (988)
.+.+.|++.+.||+|+||.||+|....+++.||+|++.... .....+..|+.+++++ +|+||+++++++...... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677999999999999999999999899999999987543 3346788999999998 799999999997653221 13
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG---------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCC
Confidence 568999999999999999875331 3588999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
++|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 150 ~~l~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--- 222 (272)
T cd06637 150 VKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--- 222 (272)
T ss_pred EEEccCCCceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---
Confidence 99999999976533211 122345889999999986 345788999999999999999999998532110
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... ......+ ......++.++.+++.+||..||.+|||+.|+++
T Consensus 223 -~~~~~------~~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 -RALFL------IPRNPAP---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHHHH------HhcCCCC---------------------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 0000000 0011245667899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.56 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=206.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc---hhHHHHHHHHHHHhcC-CCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG---ASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 736 (988)
..+.|++.+.||+|.||.||+++.+.+|+.+|+|++...... ..+.+.+|+.+|+++. ||||+.+++++ ++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 346788999999999999999999999999999999755443 3468999999999997 99999999994 45
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND- 815 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~- 815 (988)
....++|||++.||.|.+.+... .+++.++..++.|++.|+.|||+. ||||||+||+|+|+...
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD 172 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence 58999999999999999998643 288999999999999999999998 99999999999999643
Q ss_pred ---CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 816 ---MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 816 ---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+.+|++|||+|....... .....+||+.|+|||++....|+.++||||+||++|.|++|.+||.......
T Consensus 173 ~~~~~ik~~DFGla~~~~~~~-----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-- 245 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKPGE-----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-- 245 (382)
T ss_pred CCCCcEEEeeCCCceEccCCc-----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--
Confidence 579999999999776522 2334679999999999999999999999999999999999999986422111
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .+......-..+.| ..+...+.+++..|+..||.+|+|++++++
T Consensus 246 --~~~---------~i~~~~~~f~~~~w----------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 246 --IFL---------AILRGDFDFTSEPW----------------DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred --HHH---------HHHcCCCCCCCCCc----------------cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111 11111111111222 246778899999999999999999999998
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.05 Aligned_cols=275 Identities=19% Similarity=0.252 Sum_probs=196.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
...+|++.+.||+|+||.||+|++..+++.||+|+... .....|+.++++++||||+++++++.. +...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCee
Confidence 34579999999999999999999988899999998532 223569999999999999999998643 4778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+ .++|.+++.... ..+++.++..|+.||+.||+|||++ +||||||||+||+++.++.+||
T Consensus 133 ~lv~e~~-~~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl 198 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKRS----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198 (357)
T ss_pred EEEEEcc-CCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999 578888886543 3689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC-CCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-TDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-~~~~~~~~~~~~~~~~~ 899 (988)
+|||.++....... ..+..||..|+|||++.+..++.++|||||||++|||+++..| |................
T Consensus 199 ~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~ 273 (357)
T PHA03209 199 GDLGAAQFPVVAPA-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273 (357)
T ss_pred ecCccccccccCcc-----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHH
Confidence 99999975332211 1234589999999999999999999999999999999995554 33221111111111111
Q ss_pred HHhhhhhhh--hccccccCcchhhhhhHHHHh----------hhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDI--VDPILINDVEDWDATNKQRLR----------QAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+.+.+... ....+..+... ........ .........++....++|.+||+.||++||||.|+++.
T Consensus 274 ~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 274 HLLKIISTLKVHPEEFPRDPGS--RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHHHhccChhhcCCCCcc--HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 111111000 00000000000 00000000 00000112456677889999999999999999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.61 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=202.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.++||+|+||.||+|... +++.||+|.+.... ....++.+|+.++++++|+||+++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPI 75 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCc
Confidence 3467899999999999999999975 67889999986433 33468899999999999999999998742 2568
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l 143 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEG---------IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI 143 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEE
Confidence 999999999999999865432 3678899999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ .......++..|+|||++.+..++.++||||||+++||+++ |+.||...... .....
T Consensus 144 ~dfg~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~ 215 (260)
T cd05067 144 ADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EVIQN 215 (260)
T ss_pred ccCcceeecCCCCc---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HHHHH
Confidence 99999976542211 11122345778999999998889999999999999999999 99998632110 00000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
+.. . .....+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 216 -----~~~----~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 -----LER----G------------------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----HHc----C------------------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000 0 0001122456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=320.03 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=203.1
Q ss_pred hCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 35689999999999999999985 2345689999987443 23346789999999999 89999999998643
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.+..++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 111 --~~~~~lv~e~~~~~~L~~~i~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 176 (302)
T cd05055 111 --GGPILVITEYCCYGDLLNFLRRKRE---------SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH 176 (302)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC
Confidence 4678999999999999999965431 1378999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcch
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNL 893 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 893 (988)
++.++++|||+++........ .......++..|+|||.+.+..++.++||||+||++|||++ |..||......+
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--- 251 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--- 251 (302)
T ss_pred CCeEEECCCcccccccCCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---
Confidence 999999999999865432211 11122346788999999999899999999999999999998 999986321110
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. . ...++... ....+...+.++.+++.+||+.+|++|||+.|+++.|++.
T Consensus 252 -~-~--------~~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -K-F--------YKLIKEGY------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -H-H--------HHHHHcCC------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0 00000000 0011123466799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=350.73 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=201.1
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+..|+.++++++||||+++++++... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence 344578999999999999999999999999999999986432 23346788999999999999999999986432 3
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC----CCCeEeccCCCCCeee
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC----QEPVLHCDLKPGNVLL 812 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlkp~NIll 812 (988)
...+++||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+.. ..+||||||||+|||+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~-------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM-------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 46789999999999999998643211 136899999999999999999999852 1259999999999999
Q ss_pred CC-----------------CCcEEEeeecccccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHH
Q 001974 813 DN-----------------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILL 873 (988)
Q Consensus 813 ~~-----------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl 873 (988)
+. .+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL 233 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence 64 23589999999986533221 123468999999999864 4588999999999999
Q ss_pred HHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCc
Q 001974 874 LEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953 (988)
Q Consensus 874 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 953 (988)
|||+||+.||... ......... +... + .......+.++.+||..||+.
T Consensus 234 YELLTGk~PF~~~----~~~~qli~~-----lk~~--p---------------------~lpi~~~S~eL~dLI~~~L~~ 281 (1021)
T PTZ00266 234 YELCSGKTPFHKA----NNFSQLISE-----LKRG--P---------------------DLPIKGKSKELNILIKNLLNL 281 (1021)
T ss_pred HHHHHCCCCCCcC----CcHHHHHHH-----HhcC--C---------------------CCCcCCCCHHHHHHHHHHhcC
Confidence 9999999998632 111111110 0000 0 000113467799999999999
Q ss_pred CCCCCCCHHHHHH
Q 001974 954 SPQDRMSITNVVH 966 (988)
Q Consensus 954 dP~~RPs~~evl~ 966 (988)
+|.+||++.|++.
T Consensus 282 dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 282 SAKERPSALQCLG 294 (1021)
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=319.91 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=204.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.+|++.+.||.|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++|||++++++++. .++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 46999999999999999999998899999999997665555678899999999999999999999854 3478999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
|+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 94 v~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~d 158 (296)
T cd06655 94 VMEYLAGGSLTDVVTET------------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTD 158 (296)
T ss_pred EEEecCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999988532 578999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||++......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .... . ..
T Consensus 159 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~-~-~~ 228 (296)
T cd06655 159 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALY-L-IA 228 (296)
T ss_pred Cccchhccccccc----CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH-H-HH
Confidence 9998765432211 12235788999999999888999999999999999999999998642111 0000 0 00
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. .......+..+++.+.+++.+||..||++||++.++++.
T Consensus 229 ~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 229 TN------------------------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred hc------------------------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 000011223567789999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=334.42 Aligned_cols=204 Identities=27% Similarity=0.356 Sum_probs=173.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|+..+.||+|+||.||+|+...+++.||+|+++... ......+..|+.++..++||+|+++++++ .+++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46889999999999999999999899999999996432 23345788899999999999999999984 45588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD-----------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence 999999999999999986543 588999999999999999999998 999999999999999999999
Q ss_pred Eeeecccccccccccc-------------------------------cceeccccccccccccCcccCCCCCCCccchHH
Q 001974 820 VGDFGLARVRQEVSNL-------------------------------TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYS 868 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvws 868 (988)
|+|||++......... .........||+.|+|||++.+..++.++||||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 9999998754321100 000012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCc
Q 001974 869 YGILLLEMVTGKKPTDV 885 (988)
Q Consensus 869 lG~vl~elltg~~p~~~ 885 (988)
|||++|||++|+.||..
T Consensus 222 lGvilyel~tG~~Pf~~ 238 (360)
T cd05627 222 LGVIMYEMLIGYPPFCS 238 (360)
T ss_pred ccceeeecccCCCCCCC
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=322.08 Aligned_cols=277 Identities=22% Similarity=0.422 Sum_probs=209.4
Q ss_pred hhCCCCCCceeccccceeEEEEEEC-------CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD-------QDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++|.+.+.||+|+||.||+|+.. .....||+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467889999999999999999863 234579999987432 23345788999999999 69999999998643
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
++..++||||+++|+|.+++......... .......+++.++..++.|++.||+|||++ +++|||||
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlk 161 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLA 161 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 46789999999999999999764321100 001123689999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||++++++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999986543221111 111124567999999998899999999999999999999 8888753
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.. ....... +.. ......+..++.++.+++.+||+.+|++|||+.|++
T Consensus 240 ~~-----~~~~~~~-----~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 287 (314)
T cd05099 240 IP-----VEELFKL-----LRE----------------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLV 287 (314)
T ss_pred CC-----HHHHHHH-----HHc----------------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 21 1011000 000 000112235677899999999999999999999999
Q ss_pred HHHHHHHHHhhhhc
Q 001974 966 HELQSVKNALLEAW 979 (988)
Q Consensus 966 ~~L~~i~~~~~~~~ 979 (988)
+.|+++.....+.+
T Consensus 288 ~~l~~~~~~~~~~~ 301 (314)
T cd05099 288 EALDKVLAAVSEEY 301 (314)
T ss_pred HHHHHHHHHhcCCc
Confidence 99999987655543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=320.81 Aligned_cols=272 Identities=20% Similarity=0.405 Sum_probs=207.7
Q ss_pred hhCCCCCCceeccccceeEEEEEEC-------CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD-------QDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++|++.+.||+|+||.||+|++. .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 4567889999999999999999752 234579999986432 23346788999999999 8999999999864
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchh-----hhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-----EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.....++||||+++|+|.+++.......... ......+++.++..++.||+.||+|||+. +++|||||
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 3477899999999999999997643211100 01123688999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||++++++.+||+|||.++......... ......++..|+|||++.+..++.++||||||+++||+++ |..||..
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999998654322111 1112335678999999998889999999999999999998 7888752
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
. ......... ... .....+..++..+.+++.+||+.+|++|||+.|++
T Consensus 243 ~-----~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 243 I-----PVEELFKLL-KEG--------------------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred C-----CHHHHHHHH-HcC--------------------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 2 111111100 000 00011235677899999999999999999999999
Q ss_pred HHHHHHHHH
Q 001974 966 HELQSVKNA 974 (988)
Q Consensus 966 ~~L~~i~~~ 974 (988)
+.|+++.+-
T Consensus 291 ~~l~~~~~~ 299 (304)
T cd05101 291 EDLDRILTL 299 (304)
T ss_pred HHHHHHHHh
Confidence 999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.59 Aligned_cols=238 Identities=26% Similarity=0.333 Sum_probs=186.4
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHH-HHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++. +.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 47999999999999999899999999986432 122344555554 577889999999998853 457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|..++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 76 DYVNGGELFFHLQRER-----------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred cCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence 9999999998886432 578888999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +.......
T Consensus 142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~----- 207 (321)
T cd05603 142 LCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDN----- 207 (321)
T ss_pred CCccCCCCCC----ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHH-----
Confidence 9875322111 122345899999999999989999999999999999999999998632 11111100
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
+ .. .....+...+.++.+++.+|++.||++||++.
T Consensus 208 i---~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 208 I---LH--------------------KPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred H---hc--------------------CCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 00 00111224566789999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.20 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=200.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++. .++..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence 46888899999999999999998899999999997665555567889999999999999999999854 4478899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG-----------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred EEeccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence 999999999999986543 588999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
||.+........ ......|+..|+|||++. ...++.++||||+||++|||++|+.||....... ... .
T Consensus 150 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~~-~ 220 (267)
T cd06645 150 FGVSAQITATIA----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALF-L 220 (267)
T ss_pred ceeeeEccCccc----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hHH-h
Confidence 999875432211 112345899999999874 4568899999999999999999999975321110 000 0
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. ......+ ........++..+.+++.+||+.+|++||+++++++
T Consensus 221 ~----~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 221 M----TKSNFQP-------------------PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred h----hccCCCC-------------------CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 0000000 000111235567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.55 Aligned_cols=269 Identities=20% Similarity=0.260 Sum_probs=207.4
Q ss_pred CHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 654 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
.++.+..+.++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556667899999999999999999999999899999999876432 2346688899999999 799999999987654
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
....++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili 157 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-------GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILL 157 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-------CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEE
Confidence 345567899999999999999987532111 13578889999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
++++.+||+|||+++....... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CCCCCEEEccCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999976543211 1122458999999998753 457889999999999999999999986321
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ..... ......+ ....+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~----~~~~~------~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PM----RALFK------IPRNPPP--------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh----HHHhh------ccccCCC--------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 10 00000 0000000 000111245678999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=319.39 Aligned_cols=265 Identities=21% Similarity=0.327 Sum_probs=201.9
Q ss_pred CCCCCceeccccceeEEEEEECC-----CCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+|++.+.||+|+||.||+|.+.. .++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----E 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 47778999999999999998743 357899999874433 234568899999999999999999999643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCC-----chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQ-----KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
...++++||+++++|.+++....... .........+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 67899999999999999985332100 00011123588899999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
++++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred cCCCceEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 99999999999998765332211 11122346789999999988889999999999999999998 8888753211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
...... +. +.. ....+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 233 --~~~~~~-----i~---~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --QDVIEM-----IR---NRQ-------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHH-----HH---cCC-------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111110 00 000 001123578889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=321.82 Aligned_cols=271 Identities=22% Similarity=0.409 Sum_probs=206.6
Q ss_pred hCCCCCCceeccccceeEEEEEECC-------CCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
.++|.+.+.||+|+||.||+|++.. ++..||+|.++... ......+..|+.+++++ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4679999999999999999998742 23579999987542 23345788899999999 89999999999643
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCc-----hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-----DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
.+..++||||+++|+|.+++........ ........+++.+++.++.|++.||+|||+. +++||||||
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 4678999999999999999976432110 0001123589999999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||+++.++.+||+|||.++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhc--cccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999875543211111 111224568999999998889999999999999999998 88887521
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........ +.. ......+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 247 -----~~~~~~~~---------~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 247 -----PVEELFKL---------LKE------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred -----CHHHHHHH---------HHc------------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 11111110 000 0001122356778999999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 967 ELQSVKNA 974 (988)
Q Consensus 967 ~L~~i~~~ 974 (988)
.|+++.+.
T Consensus 295 ~l~~~~~~ 302 (307)
T cd05098 295 DLDRILAL 302 (307)
T ss_pred HHHHHHHH
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=342.85 Aligned_cols=202 Identities=22% Similarity=0.339 Sum_probs=166.1
Q ss_pred HHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCC------CCceEEEeecc
Q 001974 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH------RNLVKVITSCS 730 (988)
Q Consensus 657 ~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 730 (988)
++....++|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999998899999999986432 233456678888777754 45888888764
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCC
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGN 809 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~N 809 (988)
. ...+.++|||++ +++|.+++.... .+++.++..|+.||+.||+|||+ . +||||||||+|
T Consensus 202 ~----~~~~~~iv~~~~-g~~l~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~N 262 (467)
T PTZ00284 202 N----ETGHMCIVMPKY-GPCLLDWIMKHG-----------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPEN 262 (467)
T ss_pred c----CCceEEEEEecc-CCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 3 236789999998 888988886442 68899999999999999999997 5 99999999999
Q ss_pred eeeCCCC----------------cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHH
Q 001974 810 VLLDNDM----------------IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILL 873 (988)
Q Consensus 810 Ill~~~~----------------~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl 873 (988)
||++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++
T Consensus 263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred EEEecCCcccccccccccCCCCceEEECCCCccccCccc-------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 9998765 4999999988643221 1235689999999999999999999999999999
Q ss_pred HHHHhCCCCCCc
Q 001974 874 LEMVTGKKPTDV 885 (988)
Q Consensus 874 ~elltg~~p~~~ 885 (988)
|||++|+.||+.
T Consensus 336 ~elltG~~pf~~ 347 (467)
T PTZ00284 336 YELYTGKLLYDT 347 (467)
T ss_pred HHHHhCCCCCCC
Confidence 999999999964
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.51 Aligned_cols=269 Identities=23% Similarity=0.370 Sum_probs=202.8
Q ss_pred HhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeeccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSID 733 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 733 (988)
...++|++.+.||+|+||.||+|..+ ..+..||+|.++.... .....+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 35678999999999999999999764 2355899998763322 23346788999999999999999999854
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.++..++||||+++|+|.+++........ ........++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~ 153 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAE-NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA 153 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhccccc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEc
Confidence 34678999999999999999965321100 000112457788899999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLN 892 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 892 (988)
+++.++|+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---- 227 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---- 227 (288)
T ss_pred CCCcEEECcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999985433221111 111235678999999998899999999999999999999 7888753211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
...... ..+. .....+..++..+.+++.+||+.||++|||+.|+++.+++.
T Consensus 228 -~~~~~~--------~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 -EQVLKF--------VMDG-------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -HHHHHH--------HHcC-------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 010000 0000 00111234567899999999999999999999999888775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=317.55 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=199.0
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
|++.+.||+|+||.||+|++..++..+++|.+........+.+.+|+++++.++|||++++++++.. ++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 6778899999999999999998899999999876555556788999999999999999999998643 47889999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|..++.... .++++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 82 e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg 148 (282)
T cd06643 82 EFCAGGAVDAVMLELE----------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG 148 (282)
T ss_pred EecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence 9999999998876432 3689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
++........ ......++..|+|||++. +..++.++|||||||++|||++|++||...... .....
T Consensus 149 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~ 219 (282)
T cd06643 149 VSAKNTRTIQ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLK 219 (282)
T ss_pred cccccccccc----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHH
Confidence 9875432211 112345889999999974 345788999999999999999999998632110 00000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .....+ ....+..++.++.+++.+||+.||.+||+++++++.
T Consensus 220 ~-----~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 220 I-----AKSEPP--------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred H-----hhcCCC--------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 001122456779999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=319.76 Aligned_cols=261 Identities=25% Similarity=0.422 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCe----EEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|+..+.||+|+||.||+|++..+++ .||+|.+..... .....+.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence 4568889999999999999999876665 578888764332 223468899999999999999999998743
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
...++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 81 -~~~~~v~e~~~~g~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~ 146 (303)
T cd05110 81 -PTIQLVTQLMPHGCLLDYVHEHK----------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPN 146 (303)
T ss_pred -CCceeeehhcCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCC
Confidence 34579999999999999987543 2578889999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++||+++ |+.||...... .
T Consensus 147 ~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-----~ 219 (303)
T cd05110 147 HVKITDFGLARLLEGDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-----E 219 (303)
T ss_pred ceEEccccccccccCcccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 9999999999865432211 11122345778999999998899999999999999999998 89998632110 0
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. . +.+... .....+..++..+.+++.+||..+|++||+++++++.++++.+..
T Consensus 220 ~-~--------~~~~~~------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 220 I-P--------DLLEKG------------------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred H-H--------HHHHCC------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 0 000000 000112235667899999999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.60 Aligned_cols=274 Identities=24% Similarity=0.411 Sum_probs=208.2
Q ss_pred CCCCCCceeccccceeEEEEEECC----CCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQ----DGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+.|+..+.||+|+||.||+|++.. +++.||+|+++..... ..+.+.+|+++++.++||||+++++++... .+
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 457788999999999999999743 4789999999755443 457899999999999999999999986532 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~ 147 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR----------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDL 147 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCC
Confidence 67899999999999999997543 2589999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
++|+|||.+......... ........++..|+|||...+..++.++||||||+++|||++|+.|+..............
T Consensus 148 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 226 (284)
T cd05038 148 VKISDFGLAKVLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226 (284)
T ss_pred EEEcccccccccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence 999999999876532221 1111122356679999999888999999999999999999999999754221110000000
Q ss_pred HH-HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 898 RT-ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 898 ~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.. .....+.+.+. .......+..++.++.+++.+||+.+|++|||+.||+++|+++
T Consensus 227 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 227 QGQMIVTRLLELLK------------------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccHHHHHHHHH------------------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 00000000000 0001112335678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.01 Aligned_cols=240 Identities=20% Similarity=0.328 Sum_probs=186.7
Q ss_pred ceeccccceeEEEEEECCC------------CeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 669 HLIGMGSFGSVYKGAFDQD------------GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
+.||+|+||.||+|..... ...||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 4689999999999986322 23589998876555555678899999999999999999999653
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+...++||||+++++|..++.... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS----------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREG 142 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCC
Confidence 367799999999999999886543 2588999999999999999999998 999999999999998766
Q ss_pred c-------EEEeeecccccccccccccceeccccccccccccCcccC-CCCCCCccchHHHHHHHHHHH-hCCCCCCccc
Q 001974 817 I-------AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-GSEVSTNGDIYSYGILLLEMV-TGKKPTDVMF 887 (988)
Q Consensus 817 ~-------~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~ell-tg~~p~~~~~ 887 (988)
. ++++|||.+...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||....
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred ccCCCCceeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4 899999998654321 1234788999999887 467899999999999999998 5888865321
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ... ..... ........+.++.+++.+||+.||++||++.+|++.
T Consensus 215 ~~-----~~~---------~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 215 LA-----EKE---------RFYEG--------------------QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hh-----HHH---------HHHhc--------------------CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 000 00000 000111234578999999999999999999999987
Q ss_pred H
Q 001974 968 L 968 (988)
Q Consensus 968 L 968 (988)
+
T Consensus 261 ~ 261 (262)
T cd05077 261 I 261 (262)
T ss_pred c
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=318.29 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=201.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++. .+...+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEE
Confidence 367999999999999999999999889999999997666666678899999999999999999999854 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 86 lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD----------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred EEEecCCCCcHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEc
Confidence 9999999999988875433 2588999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|||.+........ ......++..|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 153 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~ 223 (292)
T cd06644 153 DFGVSAKNVKTLQ----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRV 223 (292)
T ss_pred cCccceecccccc----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHH
Confidence 9999875332211 112245788999999975 34578899999999999999999999853211 000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ......+ ....+..++.++.+++.+||+.+|++||+++|+++
T Consensus 224 ~~~-----~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 LLK-----IAKSEPP--------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHH-----HhcCCCc--------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0000000 00112245667899999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.53 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|.+..+++.+|+|++........+.+.+|++++++++||||+++++++. .++..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEE
Confidence 367999999999999999999998889999999998665556678999999999999999999999853 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
++|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 77 l~~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~ 143 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR----------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLA 143 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEEC
Confidence 9999999999999986542 2688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC---CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS---EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||.+........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ...
T Consensus 144 d~g~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-----~~~ 214 (262)
T cd06613 144 DFGVSAQLTATIA----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-----ALF 214 (262)
T ss_pred ccccchhhhhhhh----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHH
Confidence 9999976543211 11224578899999998876 88999999999999999999999986321110 000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... . ..+ .........+.++.+++.+||..+|++|||+.+++.
T Consensus 215 ~~~~~---~-~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 LISKS---N-FPP-------------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHhc---c-CCC-------------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0 000 000111234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=312.46 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=199.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|++|.||+|.+. .+..||+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 56889999999999999999986 44569999876433 23467889999999999999999998753 255789
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|
T Consensus 78 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~d 145 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDG---------KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIAD 145 (260)
T ss_pred EEEcCCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECC
Confidence 9999999999999975431 2578899999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+......... ......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ...
T Consensus 146 fg~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~---- 213 (260)
T cd05069 146 FGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVL---- 213 (260)
T ss_pred CccceEccCCccc---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH----
Confidence 9999765332211 1112346778999999988899999999999999999999 89998632110 000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
..+.... ....+...+..+.+++.+||+.||++||+++++++.|++
T Consensus 214 -~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 -EQVERGY----------------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -HHHHcCC----------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000000 001122466789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.75 Aligned_cols=273 Identities=22% Similarity=0.361 Sum_probs=201.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCC--------------CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD--------------GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVI 726 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~ 726 (988)
.++|++.+.||+|+||.||+|+.... ...||+|.++... ......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999987432 2358999986542 23345789999999999999999999
Q ss_pred eecccccccCCCceEEEEeeccccchhhhcCCCCCCC-chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ-KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 727 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
+++. .++..++||||+++++|.+++....... .........+++..++.++.|++.||+|||+. +++||||
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9964 3478899999999999999986532110 00000112468889999999999999999998 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh--CCCCC
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT--GKKPT 883 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~ 883 (988)
||+||++++++.+||+|||++........ ........++..|+|||+..+..++.++|||||||++|||++ |..||
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999975433221 111122345778999999988889999999999999999998 56676
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
...... ..... .....+... .......+..+|..+.+++.+||+.||++|||+++
T Consensus 234 ~~~~~~-----~~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 234 SLLSDE-----QVIEN-----TGEFFRNQG---------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred cccChH-----HHHHH-----HHHhhhhcc---------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 532111 00000 000000000 00001112346778999999999999999999999
Q ss_pred HHHHHH
Q 001974 964 VVHELQ 969 (988)
Q Consensus 964 vl~~L~ 969 (988)
|++.|+
T Consensus 289 i~~~l~ 294 (295)
T cd05097 289 IHHFLR 294 (295)
T ss_pred HHHHHh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.01 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=203.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.......+.+..|++++++++||||+++++++. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 467999999999999999999998889999999998666556678999999999999999999999854 347889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... ..+++.+++.++.|++.||.|||+. +|+||||+|+||+++.++.++|+
T Consensus 79 lv~e~~~~~~L~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~ 145 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE----------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLA 145 (280)
T ss_pred EEeeccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEc
Confidence 9999999999999986543 3589999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|||.+......... .....++..|+|||.+. ...++.++||||||+++|||++|+.||..... ...
T Consensus 146 d~g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~ 216 (280)
T cd06611 146 DFGVSAKNKSTLQK----RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRV 216 (280)
T ss_pred cCccchhhcccccc----cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHH
Confidence 99998754332211 12245889999999874 34577899999999999999999999863211 000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... +.....+ ....+..++.++.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~-----~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLK-----ILKSEPP--------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHH-----HhcCCCC--------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0000000 001122456778999999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.54 Aligned_cols=273 Identities=22% Similarity=0.361 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC----------------eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG----------------TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVK 724 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 724 (988)
.++|++.+.||+|+||.||+|.+...+ ..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999875433 5689999875432 34567889999999999999999
Q ss_pred EEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecc
Q 001974 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCD 804 (988)
Q Consensus 725 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 804 (988)
+++++. .++..++||||+++++|.+++................+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999864 347889999999999999998765421111011113689999999999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh--CCCC
Q 001974 805 LKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT--GKKP 882 (988)
Q Consensus 805 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p 882 (988)
|||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 9999999999999999999998754332211 11122346788999999988889999999999999999998 6677
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|...... ... .......... . .......+..++.++.+++.+||+.||++|||+.
T Consensus 234 ~~~~~~~--~~~--------~~~~~~~~~~---~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 288 (296)
T cd05051 234 YEHLTDQ--QVI--------ENAGHFFRDD---G------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288 (296)
T ss_pred CCCcChH--HHH--------HHHHhccccc---c------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence 6532110 000 0000000000 0 0000111234667899999999999999999999
Q ss_pred HHHHHHH
Q 001974 963 NVVHELQ 969 (988)
Q Consensus 963 evl~~L~ 969 (988)
|+++.|+
T Consensus 289 el~~~L~ 295 (296)
T cd05051 289 EIHLFLQ 295 (296)
T ss_pred HHHHHhc
Confidence 9999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=313.74 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=196.6
Q ss_pred ceeccccceeEEEEEECCCCe--EEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGT--IVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|++..++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 468999999999999977765 46888876432 33446788999999999 89999999999653 46789999
Q ss_pred eeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 745 EFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
||+++|+|.+++......... .......+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999754321100 001113578999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||.... ......
T Consensus 153 l~dfgl~~~~~~~~~-----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~~~ 222 (270)
T cd05047 153 IADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYE 222 (270)
T ss_pred ECCCCCccccchhhh-----ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHHHH
Confidence 999999863221110 111224567999999988889999999999999999997 999985321 001100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
. + ... .....+..++.++.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus 223 ~-----~----~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 K-----L----PQG------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred H-----H----hCC------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0 000 000112245677899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=316.59 Aligned_cols=265 Identities=25% Similarity=0.400 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 46788999999999999999998643 3789999986432 233457889999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.+...++||||+++++|.+++......... ......+++..++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~ 155 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAEN-NPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED 155 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC
Confidence 347889999999999999999654321100 00113578899999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... .
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~ 228 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----E 228 (277)
T ss_pred CCEEECCcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----H
Confidence 99999999999755432211 11122346789999999988889999999999999999998 9999753111 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.... .+. +. .....+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 229 ~~~~-----~~~---~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 EVLK-----FVI---DG-------------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHH-----HHh---cC-------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000 000 00 001122345778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.13 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=200.2
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+.+++.+.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NG 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CC
Confidence 3455666677899999999999999988899999999876655566789999999999999999999998643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-C
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL--TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-D 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~ 815 (988)
..++|+||+++++|.+++.... ..+ ++..+..++.||+.|++|||+. +|+||||||+||+++. +
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~ 145 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW----------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYS 145 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc----------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCC
Confidence 8899999999999999987542 133 7788889999999999999998 9999999999999976 6
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
+.++|+|||.+........ ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........
T Consensus 146 ~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-- 219 (268)
T cd06624 146 GVVKISDFGTSKRLAGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-- 219 (268)
T ss_pred CeEEEecchhheecccCCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--
Confidence 7999999999875533211 11123478999999998664 378899999999999999999999863211100
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+.. .. .......+..+++++.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~-----~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 220 AMFKV-----GM-----------------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hHhhh-----hh-----------------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000 00 00001112346677899999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.94 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=196.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|+...+++.||+|++... .....+.+.+|+.++..++|+||+++++++. .++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 4799999999999999999999989999999998642 2233456888999999999999999999854 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEE
Confidence 999999999999999986532 2588899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
|+|||++.......... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...
T Consensus 143 l~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~ 214 (331)
T cd05597 143 LADFGSCLRLLADGTVQ---SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV 214 (331)
T ss_pred EEECCceeecCCCCCcc---ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHH
Confidence 99999987544322111 112358999999999863 45788999999999999999999998632 111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCC--CCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ--DRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 967 (988)
.......... ... ........++.++.+++.+|+..+++ .||+++++++.
T Consensus 215 ~~~~~i~~~~------~~~-----------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 215 ETYGKIMNHK------EHF-----------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHcCC------Ccc-----------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111100000 000 00011123677789999998765443 37899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.84 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=205.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe----EEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.+|++.+.||+|+||.||+|.++.+|+ .||+|..+.... .....+.+|+.++++++||||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 568889999999999999999876654 589998864432 334678899999999999999999998643
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++|+|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK----------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH 147 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCe
Confidence 67899999999999999997654 2588999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||.++......... ......++..|+|||.+....++.++||||||+++||+++ |+.||..... ...
T Consensus 148 ~kL~dfg~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~ 220 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEI 220 (279)
T ss_pred EEECCCcccccccCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHH
Confidence 9999999998654322211 1112224678999999988889999999999999999999 9999864211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
... +.. ......+..++..+.+++.+||..||++||++.++++.|+++.+.
T Consensus 221 ~~~-----~~~----------------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 221 PDL-----LEK----------------------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHH-----HhC----------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 100 000 000111224556789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.05 Aligned_cols=364 Identities=24% Similarity=0.372 Sum_probs=243.0
Q ss_pred CcEEEEEcCCCCCc-ccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceee
Q 001974 32 RRVTVLNLRSKGLS-GSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 32 ~~v~~l~l~~~~~~-~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (988)
+-|+..|+++|.++ +..|.+...++.++.|-|...++. .+|+.++.+.+|++|.+++|++. .+-+.++.|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 45788899999998 678999999999999999999999 89999999999999999999999 8888999999999999
Q ss_pred cCcccccC-CCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccccccccc
Q 001974 111 LGRNKLMG-SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 111 L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 189 (988)
+.+|++.. -+|..+..|..|..|+|++|+++ ..|..+..-+++-+|+||+|+|..++...|.+|+.|-.||||+|++.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 99999974 46888999999999999999999 78999999999999999999999555566789999999999999999
Q ss_pred CccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccc
Q 001974 190 GIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNF 269 (988)
Q Consensus 190 ~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~ 269 (988)
.+|..+..+..|+.|+|++|.+.. ..-.-.-.+++|..|.+++.+-+ ..-+|..+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~h-fQLrQLPsmtsL~vLhms~TqRT-----------------------l~N~Ptsl 218 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNH-FQLRQLPSMTSLSVLHMSNTQRT-----------------------LDNIPTSL 218 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhH-HHHhcCccchhhhhhhcccccch-----------------------hhcCCCch
Confidence 778888888888888888887651 00000002333444444433322 11223333
Q ss_pred cCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCcccc
Q 001974 270 GGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIG 349 (988)
Q Consensus 270 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~ 349 (988)
..+.+|..+|+|.| .+. .+|+.+..+. +|+.|+||+|+|+ .+.-..+
T Consensus 219 d~l~NL~dvDlS~N------------------------------~Lp-~vPecly~l~-~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSEN------------------------------NLP-IVPECLYKLR-NLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred hhhhhhhhcccccc------------------------------CCC-cchHHHhhhh-hhheeccCcCcee-eeeccHH
Confidence 33333333333333 333 3444444443 3444444444444 3333334
Q ss_pred CCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCC-CCCCCCCCCCCCCEEEccccccccccccccccccccce
Q 001974 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG-EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAI 428 (988)
Q Consensus 350 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 428 (988)
...+|..|+||+|+++ .+|+.+++++.|+.|++.+|+++- -+|+.++.+.+|+.+..++|.+. ..|+.++.|..|+.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 4444555555555554 455555555555555555555431 24444555555555555555554 44555555555555
Q ss_pred eecCCCCCCccCchhhhhhcccccceeccccc
Q 001974 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNH 460 (988)
Q Consensus 429 L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~ 460 (988)
|.|+.|++. ++|+.+.-++.+ +.||+..|.
T Consensus 344 L~L~~NrLi-TLPeaIHlL~~l-~vLDlreNp 373 (1255)
T KOG0444|consen 344 LKLDHNRLI-TLPEAIHLLPDL-KVLDLRENP 373 (1255)
T ss_pred hccccccee-echhhhhhcCCc-ceeeccCCc
Confidence 555555554 455555444444 445554443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=319.85 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=203.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++++. .++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence 367999999999999999999998899999999997655555677889999999999999999999864 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+
T Consensus 93 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~ 157 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (297)
T ss_pred EeecccCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEC
Confidence 999999999999998542 468889999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+......... .....+++.|+|||.+.+..++.++|||||||++|++++|+.||.........
T Consensus 158 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--------- 224 (297)
T cd06656 158 DFGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------- 224 (297)
T ss_pred cCccceEccCCccC----cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---------
Confidence 99998754332211 11235788999999999988999999999999999999999998632111000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ... ......+...+..+.+++.+||+.+|++||+++++++
T Consensus 225 ----~~~~----~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 ----YLIA----TNG-------------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----eeec----cCC-------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000 0000112245677899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=318.04 Aligned_cols=270 Identities=23% Similarity=0.260 Sum_probs=207.4
Q ss_pred cCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 653 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
+.++++..+.++|++.+.||+|+||.||+|....+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556667889999999999999999999998899999999986432 2346678899999999 89999999999865
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.+....+..++||||+++++|.++++..... ...+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nil 160 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC-------GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNIL 160 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEE
Confidence 4333446789999999999999988642211 13688999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-----CCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-----EVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
+++++.+||+|||.+......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 161 i~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 161 LTTEGGVKLVDFGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EcCCCCEEEeecccchhccccccc----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999998765432211 1224578899999987643 3688999999999999999999998632
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ..... +.....+ ....+...+..+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~-----~~~~~-----~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 237 HPV-----KTLFK-----IPRNPPP--------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cHH-----HHHHH-----HhcCCCC--------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 00000 0000000 00111234567899999999999999999999986
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 287 ~ 287 (291)
T cd06639 287 H 287 (291)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=312.26 Aligned_cols=256 Identities=27% Similarity=0.498 Sum_probs=204.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|+||+++++++. .+...
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCce
Confidence 4578999999999999999999985 66789999987433 34467999999999999999999999854 34778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~---------~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l 144 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEG---------KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKI 144 (261)
T ss_pred EEEEeccCCCCHHHHHhcccc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999976432 3588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.++...... ........++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... .....
T Consensus 145 ~d~g~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~- 215 (261)
T cd05034 145 ADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLE- 215 (261)
T ss_pred Cccccceeccchh---hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH-
Confidence 9999997654311 111112235678999999998889999999999999999999 9999853210 00000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
.+... .....+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 216 ----~~~~~----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 216 ----QVERG----------------------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----HHHcC----------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00000 0001123457789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=331.12 Aligned_cols=278 Identities=20% Similarity=0.226 Sum_probs=197.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|+||+++++++.. ++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 457999999999999999999999899999999642 2345689999999999999999998543 47789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|||++ .++|.+++.... ..+++.+++.|+.||+.||+|||+. +||||||||+|||++.++.+||+
T Consensus 237 lv~e~~-~~~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~ 302 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL----------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLG 302 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEc
Confidence 999999 578988886433 2689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccC--CcchHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG--DLNLHNYART 899 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~--~~~~~~~~~~ 899 (988)
|||+++....... ........||..|+|||++.+..++.++|||||||++|||++|..|+-..... ...+......
T Consensus 303 DFGla~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~ 380 (461)
T PHA03211 303 DFGAACFARGSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380 (461)
T ss_pred ccCCceecccccc--cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHH
Confidence 9999986543221 11122356999999999999999999999999999999999988764322111 1111111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHh---hhh-----hccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLR---QAK-----INGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+... ....+.........+......+.. ... ..........+.+|+.+||+.||++|||++|+++.
T Consensus 381 ~i~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 381 IIRQA-QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHhh-ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11110 000000000000000000000000 000 00011234568899999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.68 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=197.9
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhH--HHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK--SFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++++.||+|+||+||+|....+++.||+|++......... ...+|+.++++++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 56789999999999999999999999999999865443322 34569999999999999999999543 588899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++... ..+++.+++.++.|+++||+|||+. +|+||||||+||++++++.++|+|
T Consensus 76 v~~~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~D 141 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN-----------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLID 141 (260)
T ss_dssp EEEEETTEBHHHHHHHH-----------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESS
T ss_pred ccccccccccccccccc-----------ccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999998722 3689999999999999999999999 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccC-CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+...... ........++..|+|||++. +..++.++||||+|+++|+|++|..||...... +.........
T Consensus 142 fg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~ 215 (260)
T PF00069_consen 142 FGSSVKLSEN----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKIL 215 (260)
T ss_dssp GTTTEESTST----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHH
T ss_pred cccccccccc----ccccccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcc
Confidence 9999754111 11122345899999999998 788999999999999999999999998743000 0001111000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ........+.++.+++.+||+.||++||++.++++
T Consensus 216 ~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 216 KRPLPS------------------------SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTHHHH------------------------HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccc------------------------cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000122367999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=321.48 Aligned_cols=207 Identities=24% Similarity=0.310 Sum_probs=163.2
Q ss_pred CceeccccceeEEEEEEC--CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 668 THLIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
.++||+|+||+||+|+++ .+++.||+|.++.. .....+.+|+.++++++||||+++++++... .+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 468999999999999975 36688999998643 2335678999999999999999999986432 3466899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee----CCCCcEEEe
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVG 821 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~ 821 (988)
|+ +++|.+++......... .....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred cc-CCCHHHHHHhccccccc--CCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99 56888887543221100 0113588999999999999999999998 99999999999999 456799999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
|||+++........ ........||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 155 DfG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 155 DMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ecCceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99999865432211 111223568999999999877 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.70 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=202.7
Q ss_pred ceeccccceeEEEEEECCC---CeEEEEEEeeccccch-hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|.+... +..||+|+++...... .+.+.+|++.++.++|+|++++++++.. +...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999999765 8899999997554333 5788999999999999999999998643 57899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++....... .......+++.+++.++.|++.|++|||+. +++||||+|+||++++++.+||+|||
T Consensus 76 e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg 150 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF--PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFG 150 (262)
T ss_pred EeccCCcHHHHHhhccccc--cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccc
Confidence 9999999999997752110 000013689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
.+........ ........++..|+|||.+....++.++||||+|+++|||++ |..||..... .....
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~----- 218 (262)
T cd00192 151 LSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLE----- 218 (262)
T ss_pred cccccccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-----
Confidence 9986654321 111223457889999999988889999999999999999999 6999874311 01100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.+.. ......+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 219 ~~~~----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRK----------------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHc----------------------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 0011123356788999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.35 Aligned_cols=278 Identities=22% Similarity=0.317 Sum_probs=200.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++||||+++++++. .++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 357999999999999999999998899999999987443 233456788999999999999999999954 44789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 145 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCG----------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKL 145 (301)
T ss_pred EEEEeccc-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEE
Confidence 99999995 68988886543 2578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 146 ~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~ 219 (301)
T cd07873 146 ADFGLARAKSIPTK----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFR 219 (301)
T ss_pred CcCcchhccCCCCC----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999975432211 1122347889999998765 45788999999999999999999998632111 00011100
Q ss_pred HHhhhhhhhhccccccCcchhhhhh-HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATN-KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
................ ..+.... ..............+++.+.+++.+|++.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 220 ILGTPTEETWPGILSN--EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HcCCCChhhchhhhcc--ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000000 0000000 000000000112356778899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.32 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=199.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc---------hhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG---------ASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 477889999999999999999888999999988643221 1256888999999999999999999854
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
..+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~ 141 (267)
T cd06628 77 -DADHLNIFLEYVPGGSVAALLNNYG-----------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDN 141 (267)
T ss_pred -eCCccEEEEEecCCCCHHHHHHhcc-----------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcC
Confidence 3478899999999999999996543 578889999999999999999998 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccc--ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 815 DMIAHVGDFGLARVRQEVSNLT--QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
++.++|+|||.++......... ........|+..|+|||.+.+..++.++||||+||++|+|++|+.||.....
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---- 217 (267)
T cd06628 142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---- 217 (267)
T ss_pred CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----
Confidence 9999999999998664321110 1111123478899999999988899999999999999999999999863211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .. .+.... ....+...+..+.+++.+||+.||++||++.|+++
T Consensus 218 ~~~-~~-----~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 218 LQA-IF-----KIGENA----------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHH-HH-----HHhccC----------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 00 000000 01112346778999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.84 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=194.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
++||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 46899999999999875 788999999864432 223468899999999999999999998643 36789999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... ..+++..+..++.|++.||.|+|+. +++||||||+||++++++.+||+|||++.
T Consensus 75 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 141 (250)
T cd05085 75 PGGDFLSFLRKKK----------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR 141 (250)
T ss_pred CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccce
Confidence 9999999986543 2578899999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVI 906 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 906 (988)
....... .......++..|+|||++.+..++.++||||||+++||+++ |..||...... .. .......
T Consensus 142 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~-~~~~~~~-- 210 (250)
T cd05085 142 QEDDGIY---SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QA-REQVEKG-- 210 (250)
T ss_pred ecccccc---ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HH-HHHHHcC--
Confidence 5432211 11111234678999999998899999999999999999998 99998632110 00 0000000
Q ss_pred hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 907 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.....+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 211 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 ------------------------YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ------------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001112356778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.27 Aligned_cols=278 Identities=27% Similarity=0.332 Sum_probs=198.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|++|.||+|+...+++.||+|+++... ....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4788999999999999999998899999999986432 223467889999999999999999999954 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++ ++|.+++...... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 143 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG--------QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLA 143 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC--------CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEEC
Confidence 9999996 6888888653311 2588999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+. .......
T Consensus 144 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~- 217 (285)
T cd07861 144 DFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRI- 217 (285)
T ss_pred cccceeecCCCcc----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHH-
Confidence 9999975432211 11123468899999987654 578899999999999999999999863211100 0000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........... .....++..................+++++.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 218 LGTPTEDVWPG--VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hCCCChhhhhc--chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 00000000000000000001112246778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=325.85 Aligned_cols=287 Identities=21% Similarity=0.247 Sum_probs=203.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.. .......+.+|+.++++++|+||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999999989999999998643 23344678889999999999999999998766555555678
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+||++ +++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~lv~e~~~-~~l~~~~~~~------------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl 147 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ------------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKI 147 (336)
T ss_pred EEEehhcc-cCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence 99999995 6888777532 588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||++........... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... .........
T Consensus 148 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~ 224 (336)
T cd07849 148 CDFGLARIADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILG 224 (336)
T ss_pred CcccceeeccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 99999976543222111 1123458899999998654 5688999999999999999999999863210 000000000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......+..+.........+...................+.++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000000000000000000000000000112346778999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.30 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=200.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 5889999999999999999998889999999986432 2334578899999999999999999987432 234678
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+
T Consensus 77 lv~e~~~~~~l~~~l~~~~~---------~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~ 144 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG---------KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVG 144 (257)
T ss_pred EEecccCCCcHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEe
Confidence 99999999999999875321 3588999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++........ ......+++.|+|||+..+..++.++||||+|+++|+|++|+.||... +.........
T Consensus 145 df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~~ 215 (257)
T cd08223 145 DLGIARVLENQCD----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRII 215 (257)
T ss_pred cccceEEecccCC----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHH
Confidence 9999976543221 122345789999999999999999999999999999999999998631 1111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. .. ...+...++++.+++.+||+.+|++||++.++++.
T Consensus 216 ~~--------~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EG--------KL-------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hc--------CC-------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00 01122456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=311.18 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=202.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|+..+.||+|+||.||+|.+..+++.||+|.++.... .+++.+|++++++++||||+++++++. .+...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEE
Confidence 3679999999999999999999988899999999865432 678999999999999999999999854 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+++||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 75 l~~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~ 141 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN----------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLA 141 (256)
T ss_pred EEEecCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEc
Confidence 9999999999999986543 3689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 142 dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~--- 209 (256)
T cd06612 142 DFGVSGQLTDTMA----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IF--- 209 (256)
T ss_pred ccccchhcccCcc----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hh---
Confidence 9999986544321 11123478899999999988999999999999999999999999864211100 00
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.. ... .....+..++.++.+++.+||+.||++|||+.|+++
T Consensus 210 --~~~~----~~~----------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 --MIPN----KPP----------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --hhcc----CCC----------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 000 000111235567899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.28 Aligned_cols=240 Identities=22% Similarity=0.352 Sum_probs=185.3
Q ss_pred eeccccceeEEEEEECCC------------------------CeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEE
Q 001974 670 LIGMGSFGSVYKGAFDQD------------------------GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 725 (988)
.||+|+||.||+|....+ ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 689999999999985321 23589999875544455678889999999999999999
Q ss_pred EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 726 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
+++|.. +...++||||+++|+|..++.... ..+++..+..++.||++||+|||++ +|+||||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dl 143 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK----------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNV 143 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCC
Confidence 999754 367899999999999999986543 3578889999999999999999998 9999999
Q ss_pred CCCCeeeCCCC-------cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHH
Q 001974 806 KPGNVLLDNDM-------IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMV 877 (988)
Q Consensus 806 kp~NIll~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~ell 877 (988)
||+||+++..+ .+|++|||.+....... ...++..|+|||.+.+ ..++.++|||||||++||++
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~--------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE--------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCcccccccccc--------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999997643 48999999886432211 1246788999998865 56899999999999999995
Q ss_pred -hCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCC
Q 001974 878 -TGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956 (988)
Q Consensus 878 -tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 956 (988)
+|+.||......+ ...+ ... ....+......+.+++.+||+.+|+
T Consensus 216 ~~g~~p~~~~~~~~--~~~~------------~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 216 FDGEVPLKERTPSE--KERF------------YEK--------------------KHRLPEPSCKELATLISQCLTYEPT 261 (274)
T ss_pred hCCCCCccccChHH--HHHH------------HHh--------------------ccCCCCCCChHHHHHHHHHcccChh
Confidence 6999976321110 0000 000 0001112335688999999999999
Q ss_pred CCCCHHHHHHHHH
Q 001974 957 DRMSITNVVHELQ 969 (988)
Q Consensus 957 ~RPs~~evl~~L~ 969 (988)
+|||++++++.|+
T Consensus 262 ~Rps~~~il~~L~ 274 (274)
T cd05076 262 QRPSFRTILRDLT 274 (274)
T ss_pred hCcCHHHHHHhhC
Confidence 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.06 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=203.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|+||.||.++...+++.|++|.+.... ....+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 5888999999999999999999899999999986442 344567889999999999999999999954 447899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~ 143 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG---------QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLG 143 (256)
T ss_pred EEEEecCCCcHHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEEC
Confidence 99999999999999975431 3578999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+........ ......++..|+|||+..+..++.++||||||+++|||++|..||.... .........
T Consensus 144 d~~~~~~~~~~~~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~ 214 (256)
T cd08221 144 DFGISKILGSEYS----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIV 214 (256)
T ss_pred cCcceEEcccccc----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHH
Confidence 9999976543221 1223458999999999988889999999999999999999999986321 111111000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... ......++.++.+++.+||+.+|++||+++|+++.
T Consensus 215 --------~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 215 --------QGNY-------------------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --------cCCC-------------------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0000 00112456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.84 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=198.4
Q ss_pred ceeccccceeEEEEEECC-CC--eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQ-DG--TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|++|.||+|.+.. .+ ..||+|.++.... ...+.+.+|+.++++++||||+++++++. . ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999864 33 3699999976555 55678999999999999999999999853 2 6789999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 75 e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg 142 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL---------GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG 142 (257)
T ss_pred EecCCCcHHHHHHhccc---------ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccc
Confidence 99999999999876431 2578999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
+++........ ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... +.....
T Consensus 143 ~~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~--- 213 (257)
T cd05040 143 LMRALPQNEDH-YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKI--- 213 (257)
T ss_pred ccccccccccc-eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH---
Confidence 99876442221 111122447789999999998899999999999999999999 99998632111 110000
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.. . ......+...|..+.+++.+||+.+|++|||++|+++.|.
T Consensus 214 --~~---~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 214 --DK---E------------------GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --Hh---c------------------CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00 0 0000112246778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.93 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=196.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.+|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++... .+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 46899999999999999999998899999999986432 12335688899999999999999999986431 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-----------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGN 144 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 66789999999999999986542 578888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++......... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 145 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----~~~~ 218 (266)
T cd06651 145 VKLGDFGASKRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----MAAI 218 (266)
T ss_pred EEEccCCCccccccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----HHHH
Confidence 9999999987543321111 111224578899999999998899999999999999999999999863211 0000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ....... ...+...++.+.+++ +||..+|++||+++|+++
T Consensus 219 ~~----~~~~~~~----------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FK----IATQPTN----------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HH----HhcCCCC----------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 0000000 011123455677787 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.45 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=203.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence 56888899999999999999998889999999986443 3345678999999999999999999999643 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... .+++..+..++.+++.|+.|||+. .+++||||+|+||++++++.++|+
T Consensus 80 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~ 146 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG-----------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLC 146 (284)
T ss_pred EEEecCCCCCHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEc
Confidence 9999999999999886532 578999999999999999999973 289999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++....... .....|+..|+|||++.+..++.++|||||||++|++++|+.||......+.. ......+
T Consensus 147 d~gl~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~--~~~~~~~ 218 (284)
T cd06620 147 DFGVSGELINSI------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG--QDDPMGI 218 (284)
T ss_pred cCCcccchhhhc------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh--hhhhhHH
Confidence 999986542211 11245899999999998889999999999999999999999999753322110 0000000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.+........ .... .....++.++.+++.+||+.||++|||+.|+++...
T Consensus 219 ~~~~~~~~~~----~~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 219 LDLLQQIVQE----PPPR--------------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHhhc----cCCC--------------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000000000 0000 001136678999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.59 Aligned_cols=276 Identities=23% Similarity=0.309 Sum_probs=200.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|+..+.||+|++|.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++|||++++++++. .+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 46899999999999999999998889999999986432 223456889999999999999999999854 44788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++++.+..+..... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l 141 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR-----------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKL 141 (286)
T ss_pred EEEEeccCccHHHHHHhCCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEE
Confidence 99999999988888765432 588999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||++......... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ .......
T Consensus 142 ~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~ 215 (286)
T cd07847 142 CDFGFARILTGPGDD----YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRK 215 (286)
T ss_pred CccccceecCCCccc----ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH
Confidence 999999865443211 112347889999999876 557899999999999999999999986432111 0000111
Q ss_pred HHhhhh---hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHV---IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~---~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.....+ .+..+..... .......... ...........+..+.+++.+||+.||++||++.|++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 216 TLGDLIPRHQQIFSTNQFF--KGLSIPEPET-REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhCCCChHHhhhccccccc--ccccCCCccc-ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 100000 0000000000 0000000000 00000011235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.90 Aligned_cols=255 Identities=21% Similarity=0.281 Sum_probs=199.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.++++++||||+++++++. .++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 4688999999999999999999889999999998654 2233467889999999999999999999854 357899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|..++..... ...+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~ 145 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA--------TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLC 145 (286)
T ss_pred EEEeecCCCCHHHHHHhccc--------cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999865321 13689999999999999999999963 289999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
|||.+....... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .
T Consensus 146 dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~ 214 (286)
T cd06622 146 DFGVSGNLVASL------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----N 214 (286)
T ss_pred ecCCcccccCCc------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----h
Confidence 999987543221 1123478899999998654 3478999999999999999999998632110 0
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ..+....+. .....+..++.++.+++.+||+.+|++||+++++++.
T Consensus 215 ~~-----~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 IF-----AQLSAIVDG-------------------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HH-----HHHHHHhhc-------------------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00 000000000 0011223467788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.26 Aligned_cols=266 Identities=24% Similarity=0.293 Sum_probs=206.0
Q ss_pred cCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 653 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
.+..++..+.+.|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345556667788999999999999999999998899999999986543 2345688899999998 79999999998753
Q ss_pred ccc-cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 732 IDF-QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 732 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
... ......++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||+|+||
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~ni 152 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---------NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV 152 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence 211 234678999999999999999865432 2577888999999999999999998 999999999999
Q ss_pred eeCCCCcEEEeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
++++++.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 999999999999999875432211 112345889999999875 34678899999999999999999999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
..... . ......... .......++.++.+++.+||+.||.+||++.|++
T Consensus 229 ~~~~~----~---------~~~~~~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 229 MHPMR----A---------LFLIPRNPP------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred cCHHh----h---------hhhHhhCCC------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 21100 0 000000000 0001124677899999999999999999999987
Q ss_pred H
Q 001974 966 H 966 (988)
Q Consensus 966 ~ 966 (988)
+
T Consensus 278 ~ 278 (282)
T cd06636 278 K 278 (282)
T ss_pred c
Confidence 5
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.44 Aligned_cols=267 Identities=24% Similarity=0.408 Sum_probs=203.2
Q ss_pred hCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++.... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467999999999999999999874 2578899999864432 334678899999999999999999998643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCch-----------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecc
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKD-----------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCD 804 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 804 (988)
++..++||||+++++|.+++......... .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 46789999999999999999754321000 001113578899999999999999999998 999999
Q ss_pred CCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCC
Q 001974 805 LKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPT 883 (988)
Q Consensus 805 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~ 883 (988)
|||+||++++++.++|+|||.+.......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcccc--ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987543322111 1112235678999999998899999999999999999998 88887
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
..... ...... ..+.. ....+..++.++.+++.+||+.||++|||+.|
T Consensus 234 ~~~~~-----~~~~~~--------~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 234 YGMAH-----EEVIYY--------VRDGN-------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred CCCCH-----HHHHHH--------HhcCC-------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 52211 011100 00000 00112246778999999999999999999999
Q ss_pred HHHHHHH
Q 001974 964 VVHELQS 970 (988)
Q Consensus 964 vl~~L~~ 970 (988)
+++.|++
T Consensus 282 l~~~l~~ 288 (288)
T cd05050 282 INRILQR 288 (288)
T ss_pred HHHHhhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.89 Aligned_cols=271 Identities=23% Similarity=0.412 Sum_probs=206.5
Q ss_pred hCCCCCCceeccccceeEEEEEECC-------CCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
..+|++.+.||+|+||.||+|++.. .+..||+|.++... ....+.+.+|+++++++ +||||++++++|..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 3468999999999999999998642 22368999886432 23346789999999999 89999999999643
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
++..++||||+++|+|.+++......... .......+++.++..++.|++.||+|||+. +++||||||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 46789999999999999999754321100 011224688999999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||++++++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccc--cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999998654322111 1112234568999999999999999999999999999998 88887532
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.......... . . .....+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 241 -----~~~~~~~~~~-~-------~-------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 241 -----PVEELFKLLK-E-------G-------------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred -----CHHHHHHHHH-c-------C-------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1111111100 0 0 000112356678999999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 967 ELQSVKNA 974 (988)
Q Consensus 967 ~L~~i~~~ 974 (988)
.|+++...
T Consensus 289 ~l~~~~~~ 296 (334)
T cd05100 289 DLDRVLTV 296 (334)
T ss_pred HHHHHhhh
Confidence 99998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.75 Aligned_cols=284 Identities=18% Similarity=0.213 Sum_probs=198.3
Q ss_pred CCceeccc--cceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 667 STHLIGMG--SFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 667 ~~~~lg~G--~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+.++||+| +|++||++..+.+|+.||+|+++... ....+.+.+|+++++.++||||+++++++.. ++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 46789999 68899999999999999999987542 2334567789999999999999999999643 478899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 77 v~e~~~~~~l~~~~~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~ 144 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFM---------DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 144 (327)
T ss_pred EEeccCCCcHHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcc
Confidence 9999999999999865321 2578999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccc---cceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 823 FGLARVRQEVSNL---TQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 823 fG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|+.+......... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~ 219 (327)
T cd08227 145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-----ML 219 (327)
T ss_pred cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-----HH
Confidence 9875433211110 0001112346788999999876 468899999999999999999999997432111 01
Q ss_pred HHHHhhhhhhhhcccc------------c-cC--cchhhhhh---HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 898 RTALLDHVIDIVDPIL------------I-ND--VEDWDATN---KQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l------------~-~~--~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
.......+....+... . .+ ..++.... ...............++++.+++.+||+.||++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 220 LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred HHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 0111111110000000 0 00 00000000 00000000011223567899999999999999999
Q ss_pred CHHHHHHH--HHHHH
Q 001974 960 SITNVVHE--LQSVK 972 (988)
Q Consensus 960 s~~evl~~--L~~i~ 972 (988)
|++|+++. +++++
T Consensus 300 t~~ell~~p~f~~~~ 314 (327)
T cd08227 300 SASTLLNHSFFKQIK 314 (327)
T ss_pred CHHHHhcChhhhhcc
Confidence 99999873 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.27 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=196.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|+.++..++|++|+++++++ .+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 4799999999999999999999989999999998642 222335578899999999999999999985 34588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEE
Confidence 999999999999999997532 2578889999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
|+|||++.......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..
T Consensus 143 l~DfG~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~ 214 (331)
T cd05624 143 LADFGSCLKMNQDGTVQ---SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LV 214 (331)
T ss_pred EEeccceeeccCCCcee---eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HH
Confidence 99999997654322111 122458999999999875 467889999999999999999999986321 11
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 967 (988)
.......... ... ........++.++.+++.+|+..++++ |++++++++.
T Consensus 215 ~~~~~i~~~~------~~~-----------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ETYGKIMNHE------ERF-----------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHcCC------Ccc-----------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1110000000 000 000111245678899999999876654 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.60 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=201.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||.|++|.||+|++..+++.||+|++.... ......+.+|+++++.++|+||+++++++. ++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence 46888999999999999999999899999999987543 334567889999999999999999999854 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||+++++|.+++... ++++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+
T Consensus 76 ~v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~ 140 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLA 140 (274)
T ss_pred EEEEeeCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEc
Confidence 999999999999998643 578899999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.++....... ......++..|+|||++.+..++.++||||||+++|||+||+.||...... ...
T Consensus 141 d~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~---- 207 (274)
T cd06609 141 DFGVSGQLTSTMS----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVL---- 207 (274)
T ss_pred ccccceeeccccc----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHH----
Confidence 9999987654321 122345788999999999888999999999999999999999998632110 000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccc-hhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE-CPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..+.....+ ..... ++.++.+++.+||..||++|||++++++.
T Consensus 208 -~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 208 -FLIPKNNPP----------------------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -HHhhhcCCC----------------------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000000000 00111 56678999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.88 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=201.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||++....+|+.||+|.+.... ....+++.+|+.++++++||||+++++++ ...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5888999999999999999999899999999986432 23346789999999999999999999985 4457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~ 143 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRG---------VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLG 143 (256)
T ss_pred EEEecCCCCcHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999865432 2578889999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+......... .....|+..|+|||+..+..++.++|||||||++|+|++|+.||... ..........
T Consensus 144 d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~ 214 (256)
T cd08218 144 DFGIARVLNSTVEL----ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKII 214 (256)
T ss_pred eccceeecCcchhh----hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHh
Confidence 99999765432211 11234788999999999888999999999999999999999998631 1111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. +. ....+...+.++.+++.+||+.+|++||++.||++
T Consensus 215 ~------------~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 215 R------------GS---------------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred c------------CC---------------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 00 00112346678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=322.85 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=196.8
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEee----ccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
...+||+|+|-+||+|.+..+|..||--.++ .......++|..|+.+|+.++||||+++|+++.+. .....-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeee
Confidence 4468999999999999998888888743332 22334457899999999999999999999997654 2356789
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcEEEe
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIAHVG 821 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 821 (988)
|+|.+..|+|+.|.++.+ +++...++.|++||++||.|||++ .|+|||||||-+||||+. .|.|||+
T Consensus 121 iTEL~TSGtLr~Y~kk~~-----------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR-----------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred eeecccCCcHHHHHHHhc-----------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence 999999999999998765 688889999999999999999997 679999999999999975 5899999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|+|+|+....... ..++|||.|||||... ..|+..+||||||+++.||+|+..||...... .+..++..
T Consensus 189 DLGLAtl~r~s~a------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKKV~ 257 (632)
T KOG0584|consen 189 DLGLATLLRKSHA------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKKVT 257 (632)
T ss_pred chhHHHHhhcccc------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHHHH
Confidence 9999997655332 2367999999999876 78999999999999999999999998754222 12222221
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...-.+.+.+ --.++++++|.+|+.. .++|||+.|+++.
T Consensus 258 SGiKP~sl~k--------------------------V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 258 SGIKPAALSK--------------------------VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCCHHHhhc--------------------------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1110000000 1124689999999999 9999999999863
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.45 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=209.9
Q ss_pred hccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEE
Q 001974 649 ALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKV 725 (988)
Q Consensus 649 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~ 725 (988)
..+....+-.....+.|+.-++||+||||.||-++.+.+|+.+|.|.+... .........+|-.++.+++.+.||.+
T Consensus 171 FlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 171 FLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred HHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 334444444444567789999999999999999999999999999988533 22334567899999999999999998
Q ss_pred EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 726 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
-.+ |+..+..|+|+..|.||+|.-+|...+. ..+++..++.+|.+|+.||++||.. +||.||+
T Consensus 251 aYA-----feTkd~LClVLtlMNGGDLkfHiyn~g~---------~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDL 313 (591)
T KOG0986|consen 251 AYA-----FETKDALCLVLTLMNGGDLKFHIYNHGN---------PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDL 313 (591)
T ss_pred eee-----ecCCCceEEEEEeecCCceeEEeeccCC---------CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccC
Confidence 766 5566999999999999999999987664 3689999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+|||+|+.|+++|+|.|+|..+....... +.+||.+|||||++.+..|+...|.||+||++|||+.|+.||..
T Consensus 314 KPeNILLDd~GhvRISDLGLAvei~~g~~~~-----~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 314 KPENILLDDHGHVRISDLGLAVEIPEGKPIR-----GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred ChhheeeccCCCeEeeccceEEecCCCCccc-----cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999999999999999999999776654332 34799999999999999999999999999999999999999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
-.+. ...+ -+|.+...+.. ..+...+++..++....|+.||++|-..
T Consensus 389 ~KeK----------vk~e----Evdrr~~~~~~---------------ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 389 RKEK----------VKRE----EVDRRTLEDPE---------------EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhh----------hhHH----HHHHHHhcchh---------------hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2111 1111 11222222221 2233566788999999999999999643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.40 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=196.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.++||+|+||+||+++.+.+++.||+|++... .......+..|+.++..++|++|+++++++. +++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 4789999999999999999999989999999998632 1223345788999999999999999999854 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 999999999999999997533 2578889999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||... ...
T Consensus 143 L~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~ 214 (332)
T cd05623 143 LADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV 214 (332)
T ss_pred EeecchheecccCCcc---eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHH
Confidence 9999998754332211 112245899999999986 346789999999999999999999998632 111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 967 (988)
.......... . . .........++.++.+++.+|+..+|++ |++++|+++.
T Consensus 215 ~~~~~i~~~~--------~-----~----------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ETYGKIMNHK--------E-----R----------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHhCCC--------c-----c----------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111100000 0 0 0000111246778899999988665444 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=320.56 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=203.1
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
-|+++..||.|+||.||+|+.+.++-..|.|++.....+..++++-|++|+..+.||+||++++.+. .++..+|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEE
Confidence 3566788999999999999999888888999998888888899999999999999999999999843 45889999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
.|||.||..+..+-.-. +.+++.++..+++|++.||.|||+. +|||||||+.|||++-+|.++|+||
T Consensus 108 iEFC~GGAVDaimlEL~----------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG----------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred EeecCCchHhHHHHHhc----------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence 99999999998886654 4799999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|.+....... .....+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|...... ....-
T Consensus 175 GVSAKn~~t~----qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVll 245 (1187)
T KOG0579|consen 175 GVSAKNKSTR----QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLL 245 (1187)
T ss_pred cccccchhHH----hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHHH
Confidence 9886533321 1223467999999999864 46899999999999999999999999653211 11110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. +... +|..... +......+.+++.+|+..+|..||+++++++
T Consensus 246 K-----iaKS-ePPTLlq-------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 246 K-----IAKS-EPPTLLQ-------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred H-----Hhhc-CCCcccC-------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 0 0000 1111111 2234456889999999999999999999874
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.90 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=199.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..+|++.+.||+|+||.||+|.+. .++.+|+|.++... ....++.+|++++++++|||++++++++. .....+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPIC 75 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceE
Confidence 356888999999999999999885 57789999886432 23467899999999999999999999854 346789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~ 142 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR----------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVS 142 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEEC
Confidence 9999999999999986543 2578899999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 143 d~g~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~-- 212 (256)
T cd05112 143 DFGMTRFVLDDQY---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVE-- 212 (256)
T ss_pred CCcceeecccCcc---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHH--
Confidence 9999875433211 11112335678999999998899999999999999999998 9999863211 01110
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.+.+. .....+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 213 ---~~~~~----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 213 ---TINAG----------------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---HHhCC----------------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00000 000011234677999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=327.28 Aligned_cols=274 Identities=21% Similarity=0.208 Sum_probs=197.5
Q ss_pred hCCCCCCceeccccceeEEEEEEC--CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..+|++.+.||+|+||.||+|... ..++.||+|.+... +...+|++++++++||||+++++++. ....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence 357999999999999999999764 34678999987532 34568999999999999999998853 4478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++|||++ +++|.+++... ..+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRS-----------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred EEEEehhc-CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEE
Confidence 89999999 57888888433 3689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC--cchHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD--LNLHNYA 897 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~--~~~~~~~ 897 (988)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....
T Consensus 226 l~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~ 303 (392)
T PHA03207 226 LGDFGAACKLDAHPDT--PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303 (392)
T ss_pred EccCccccccCccccc--ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence 9999999765443221 11224569999999999999999999999999999999999999986432211 0011110
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHh-------hhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLR-------QAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .......+. ................. .+........+.++.+++.+||..||++|||+.|++..
T Consensus 304 ~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 304 R-CMQVHPLEF----PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred H-HhccCcccc----CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000000000 00000000000000000 00000012345678899999999999999999999875
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.31 Aligned_cols=247 Identities=28% Similarity=0.504 Sum_probs=197.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4688999999999999999975 78889999986432 34678899999999999999999998642 34689
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 76 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~D 143 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR---------ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSD 143 (254)
T ss_pred EEECCCCCCHHHHHHhcCc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECC
Confidence 9999999999999975432 2578889999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+....... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.... .......
T Consensus 144 fg~~~~~~~~~-------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~-- 209 (254)
T cd05083 144 FGLARVGSMGV-------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKEC-- 209 (254)
T ss_pred CccceeccccC-------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHH--
Confidence 99987543211 11234578999999988899999999999999999998 999986321 1111000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
+ .... .......++.++.+++.+||+.+|++||+++++++.|++
T Consensus 210 ---~----~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 ---V----EKGY------------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---H----hCCC------------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 0000 001122467789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.94 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=201.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|.+. .+..||+|.++... ...+.+.+|++++++++|+||+++++++. . ...
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~ 75 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPI 75 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCe
Confidence 4568999999999999999999875 66779999886432 23467889999999999999999998853 2 567
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l 143 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEG---------SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI 143 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCc---------cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence 999999999999999975432 2578889999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ .......++..|+|||++....++.++|||||||++|+++| |+.||...... ....
T Consensus 144 ~d~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~- 214 (260)
T cd05073 144 ADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR- 214 (260)
T ss_pred CCCcceeeccCCCc---ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHH-
Confidence 99999976543211 11122345678999999998889999999999999999999 99998632110 0000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
.+... .........+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 215 ~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 215 ALERG--------------------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHhCC--------------------------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00000 0001123466789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.46 Aligned_cols=270 Identities=24% Similarity=0.319 Sum_probs=196.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|+||.||+|++..+|+.||+|+++... ......+.+|++++++++||||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4888899999999999999999899999999986432 22335678899999999999999999984 4457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||++ ++|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 76 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~ 141 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCN----------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLA 141 (284)
T ss_pred EEEecCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEEC
Confidence 9999995 68888775432 2589999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++....... ......++..|+|||++.+. .++.++|||||||++|||+||..|+.........+... ...
T Consensus 142 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~ 216 (284)
T cd07839 142 DFGLARAFGIPVR----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI-FRL 216 (284)
T ss_pred ccchhhccCCCCC----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH-HHH
Confidence 9999975433211 11223578899999998764 46899999999999999999998864321111111000 000
Q ss_pred Hhhh-------hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDH-------VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~-------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... +....+.. ....+.. ...........+.++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~---~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 217 LGTPTEESWPGVSKLPDYK---PYPMYPA------TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hCCCChHHhHHhhhccccc---ccCCCCC------cchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000000 0000000 00001112346678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.15 Aligned_cols=288 Identities=20% Similarity=0.246 Sum_probs=205.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|....+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 478999999999999999999999899999999986432 233466788999999999999999998865432 34467
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~lv~e~~-~~~l~~~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 83 VYVVMDLM-ESDLHHIIHSDQ-----------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred EEEEEehh-hhhHHHHhccCC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence 89999999 579999886543 589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||++..................++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~ 225 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLIL 225 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHH
Confidence 99999997654332222222223468899999998765 56889999999999999999999998632110 0111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
........+..+.............................+.++.+++.+||+.+|++||++++++..
T Consensus 226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111111111000000000000000000000000112457889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=309.93 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=200.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+|+..+.||+|++|.||+|....+++.||+|++..... ...+.+.+|++++++++|+||+++++++. .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 47888999999999999999988999999999864331 23467889999999999999999999954 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM- 816 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 816 (988)
+..++||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++||||+|+||+++.++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG-----------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence 78899999999999999986432 578899999999999999999998 999999999999998776
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||.+..................++..|+|||.+.+..++.++||||+|+++|+|++|..||...... .....
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~ 219 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLAL 219 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHH
Confidence 6999999999766443211111222345789999999998888999999999999999999999998632111 00000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ...... .....+...++++.+++.+|+..+|++||++.|+++
T Consensus 220 ~~--------~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 IF--------KIASAT------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HH--------HHhccC------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 000000 000112245677899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.64 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=196.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|++.+.||+|+||.||.|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 57889999999999999999998899999999885322 12245788899999999999999999985432 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... .+++..+.+++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG-----------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGN 144 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCC
Confidence 56789999999999999986432 478888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
++|+|||.++........ ........++..|+|||.+.+..++.++|||||||++|||++|+.||.... .....
T Consensus 145 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~- 218 (265)
T cd06652 145 VKLGDFGASKRLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAI- 218 (265)
T ss_pred EEECcCcccccccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHH-
Confidence 999999999865332111 111122458889999999988889999999999999999999999986320 00000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ...... ...+...+..+.+++.+|+. +|++||+++|+++
T Consensus 219 ~~~----~~~~~~----------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 FKI----ATQPTN----------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHH----hcCCCC----------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000 000000 01122345568899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=307.30 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=189.5
Q ss_pred ceeccccceeEEEEEEC--CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|.+. .++..+|+|.++.... .....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 46899999999999874 2446799998865432 233578889999999999999999998644 367899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++........ ...++..+..++.|++.|++|||+. +++||||||+||+++.++++||+|||.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~ 146 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAEL------MTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGL 146 (269)
T ss_pred CCCCCcHHHHHHHhhhccc------ccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccc
Confidence 9999999999865432110 2456778889999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCC-------CCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-------EVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
++........ .......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ . .
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~---~ 219 (269)
T cd05087 147 SHNKYKEDYY--VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--V---L 219 (269)
T ss_pred cccccCccee--ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--H---H
Confidence 9754322211 111224477889999987642 35789999999999999997 999986432111 0 0
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
............++ ......+..+.+++.+|| .+|++|||++||++.|+
T Consensus 220 ~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 220 TYTVREQQLKLPKP----------------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHhhcccCCCCCC----------------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000000000 111234566889999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.21 Aligned_cols=249 Identities=21% Similarity=0.355 Sum_probs=199.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 5888999999999999999998899999999986432 23456788999999999999999999884 3457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-CcEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 820 (988)
+||||+++++|.+++..... ..+++..+..++.|++.|++|||++ +++||||+|+||+++++ +.+||
T Consensus 76 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l 143 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN---------SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKI 143 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999975431 2578999999999999999999998 99999999999999855 46899
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ........
T Consensus 144 ~d~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~~~~ 213 (256)
T cd08220 144 GDFGISKILSSKSK-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALVLKI 213 (256)
T ss_pred ccCCCceecCCCcc-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHHHHH
Confidence 99999986543221 122457889999999998889999999999999999999999986321 11111100
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ......+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 214 ~~---------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 214 MS---------------------------GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred Hh---------------------------cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 0000112245677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=290.55 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=204.5
Q ss_pred hhCCCCCC-ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSST-HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
.+++|.+. ++||-|-.|.|..+.++.+|+.+|+|++.. ....++|++.--.. .|||||.+++++... +.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 35566554 579999999999999999999999999852 24556788765544 799999999998765 77788
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---C
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---D 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~ 815 (988)
...+|||.|+||.|...+...+. +.+++.++-.|++||+.|+.|||+. +|.||||||+|+|.+. +
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~---------~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD---------QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc---------ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 88999999999999999987764 5799999999999999999999999 9999999999999965 4
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
-.+||+|||+|+.........+ ...|+.|.|||++...+|+...|+||+||++|-|++|.+||...... .+..
T Consensus 201 a~lKLtDfGFAK~t~~~~~L~T-----Pc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aisp 273 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEPGDLMT-----PCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISP 273 (400)
T ss_pred cceEecccccccccCCCccccC-----CcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCCh
Confidence 4799999999997665443333 34799999999999999999999999999999999999998643221 1111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
-.+..+...-.+ -..++|+ .++++..++|+.+|..+|.+|.|+.|+++
T Consensus 274 gMk~rI~~gqy~-------FP~pEWs----------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 GMKRRIRTGQYE-------FPEPEWS----------------CVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHhHhhccCcc-------CCChhHh----------------HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111111111 1112332 46677899999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.99 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=188.3
Q ss_pred ceeccccceeEEEEEECC--CCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQ--DGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|.... ....+|+|.+..... .....+.+|+..++.++||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence 368999999999997632 345788888754332 234568899999999999999999998643 477899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++........ ...++..+..++.||+.|++|||+. +|+||||||+||++++++++||+|||+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVA------QMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred eCCCCcHHHHHHhcccccc------ccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccc
Confidence 9999999999976542111 2356778899999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-------SEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
++.......... .....++..|+|||++.. ..++.++|||||||++|||++ |..||....+. ...
T Consensus 147 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~ 219 (269)
T cd05042 147 ALEQYPEDYYIT--KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVL 219 (269)
T ss_pred ccccccchheec--cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHH
Confidence 875332211111 122346778999998643 456889999999999999999 78887632111 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
............+ ......++..+.+++..|| .||++|||++||++.|.
T Consensus 220 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 220 KQVVREQDIKLPK----------------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHhhccCccCCC----------------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111110000000 0112346677889999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.99 Aligned_cols=205 Identities=24% Similarity=0.314 Sum_probs=161.7
Q ss_pred ceeccccceeEEEEEECC--CCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEee
Q 001974 669 HLIGMGSFGSVYKGAFDQ--DGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
.+||+|+||.||+|+... +++.||+|.++... ....+.+|++++++++||||+++++++.. ..+...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence 689999999999999753 55789999886432 33567899999999999999999998653 234678999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee----CCCCcEEEee
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVGD 822 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 822 (988)
+ +++|.+++......... .....+++..++.++.||+.||+|||+. +|+||||||+||++ ++++.+||+|
T Consensus 82 ~-~~~l~~~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 82 A-EHDLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred e-CCcHHHHHHhhhccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9 46888777533211100 0113588999999999999999999998 99999999999999 5667999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+++........ ........||..|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 156 fG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 156 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9999865432211 111223468999999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.99 Aligned_cols=241 Identities=21% Similarity=0.335 Sum_probs=187.7
Q ss_pred ceeccccceeEEEEEECCCCe-------EEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGT-------IVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+.||+|+||.||+|.....+. .||+|.+........+.+.+|+.+++.++||||+++++++.. ++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 468999999999999865443 488888865544555678899999999999999999999643 46789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc----
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI---- 817 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 817 (988)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~ 142 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK----------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTG 142 (258)
T ss_pred EEEecCCCCcHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccC
Confidence 9999999999999997654 2578889999999999999999998 9999999999999987765
Q ss_pred ----EEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCC-CCCCccccCCc
Q 001974 818 ----AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGK-KPTDVMFEGDL 891 (988)
Q Consensus 818 ----~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~ 891 (988)
++++|||.+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||.....
T Consensus 143 ~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--- 211 (258)
T cd05078 143 NPPFIKLSDPGISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--- 211 (258)
T ss_pred CCceEEecccccccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---
Confidence 699999988654321 123478899999998874 5789999999999999999985 55432100
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
..... .. . .....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 212 --~~~~~------~~---~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 --QKKLQ------FY---E--------------------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHHH------HH---H--------------------ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 0 000111233456899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.09 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=199.3
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++. .+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 4666788999999999999998889999999986433 334467889999999999999999999854 4578999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|
T Consensus 80 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 80 IMEYLGGGSALDLLKPG------------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEEccCCCcHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence 99999999999998542 578889999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||++........ ......++..|+|||++.+..++.++|||||||++|||++|+.||....... . .
T Consensus 145 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~---~----- 210 (277)
T cd06642 145 FGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--V---L----- 210 (277)
T ss_pred ccccccccCcch----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--H---H-----
Confidence 999976543221 1112357889999999999889999999999999999999999976321110 0 0
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..+ .... .......++.++.+++.+||+.+|++||++.|+++.
T Consensus 211 ~~~----~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 FLI----PKNS------------------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhh----hcCC------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 0000 001112456778999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.84 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=196.2
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
++||+|+||.||+|.+.. ++.||+|.++..... ..+.+.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 478999999999999976 999999998754433 4567899999999999999999999854 347889999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||.+.
T Consensus 75 ~~~~l~~~l~~~~----------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~ 141 (251)
T cd05041 75 PGGSLLTFLRKKK----------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR 141 (251)
T ss_pred CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccc
Confidence 9999999986543 2578889999999999999999998 99999999999999999999999999997
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVI 906 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 906 (988)
........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ... ..+
T Consensus 142 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----~~~-----~~~- 208 (251)
T cd05041 142 EEEGGIYT--VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----QTR-----ERI- 208 (251)
T ss_pred cccCCcce--eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----HHH-----HHH-
Confidence 65421111 11111224567999999988899999999999999999999 88887532111 000 000
Q ss_pred hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 907 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
... .....+...+.++.+++.+||..+|++|||+.|+++.|+
T Consensus 209 ---~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 209 ---ESG------------------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---hcC------------------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000 000112346778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.50 Aligned_cols=241 Identities=24% Similarity=0.287 Sum_probs=184.2
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhc---CCCCceEEEeecccccccCCCceEEEE
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNI---RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
||+|+||+||+|++..+++.||+|++..... .....+..|..++... +||||+++++++ ..++..++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999999998999999999864321 1223455666676655 699999999884 4457899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 76 DYMSGGELFWHLQKEG-----------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred cCCCCChHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence 9999999998886543 688999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
+++....... ......||..|+|||++.+. .++.++||||+||++|||++|+.||... ............
T Consensus 142 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~~i~~~ 212 (330)
T cd05586 142 LSKANLTDNK----TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYRNIAFG 212 (330)
T ss_pred cCcCCCCCCC----CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHHHHHcC
Confidence 9875322211 11234589999999998764 4789999999999999999999998632 111111100000
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC----HHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS----ITNVVH 966 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 966 (988)
. ..+ .....+.++.+++.+||+.||++||+ +.|+++
T Consensus 213 ~------~~~---------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 K------VRF---------------------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C------CCC---------------------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 000 01134667899999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=305.76 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=201.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc--hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|...+.||+|+||.||+|....+++.||+|+++..... ..+.+..|+.++++++|+||+++++++. ..+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 588899999999999999999889999999999755443 5678999999999999999999999853 447889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~ 141 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR-----------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLG 141 (264)
T ss_pred EEEecCCCCcHHHHHhhcC-----------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence 9999999999999987542 478888999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCC---CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE---VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||.+..................++..|+|||++.+.. ++.++||||||+++||+++|+.||...... .. ...
T Consensus 142 d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~-~~~ 217 (264)
T cd06626 142 DFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQ-IMF 217 (264)
T ss_pred ccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HH-HHH
Confidence 99999876543322111112345788999999988766 889999999999999999999998632110 00 000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. +.....+. ......++..+.+++.+||+.+|++||++.|++.
T Consensus 218 ~-----~~~~~~~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 218 H-----VGAGHKPP--------------------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred H-----HhcCCCCC--------------------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 00000000 0011234677899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.57 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=202.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|+..+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.. +...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 46888899999999999999999899999999987543 2344678899999999999999999998543 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
+|+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++||||||+||++++++.++|
T Consensus 76 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l 142 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ----------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKL 142 (265)
T ss_pred EEEEecCCCcHHHHHHHcc----------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999987543 267888999999999999999999 7 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.................
T Consensus 143 ~d~g~~~~~~~~~~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 216 (265)
T cd06605 143 CDFGVSGQLVNSLAK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216 (265)
T ss_pred eecccchhhHHHHhh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH
Confidence 999998755332111 14578899999999999999999999999999999999999864322111111111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccc-hhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE-CPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... .....+.. ++.++.+++.+||..||++|||+.|+++.
T Consensus 217 ~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 217 VNE---------------------------PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcC---------------------------CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 00001111 56779999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=309.07 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=200.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
..|+..+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.++++++||||+++++++. ++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence 35778899999999999999998889999999987443 334567889999999999999999999864 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++... ++++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++
T Consensus 79 lv~e~~~~~~L~~~i~~~------------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~ 143 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG------------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLA 143 (277)
T ss_pred EEEecCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEc
Confidence 999999999999998642 477888999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++........ ......++..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 144 dfg~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~---- 210 (277)
T cd06640 144 DFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VL---- 210 (277)
T ss_pred ccccceeccCCcc----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hh----
Confidence 9999976543221 1122357889999999988889999999999999999999999986321110 00
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... . .......++..+.+++.+||+.+|++||+++|+++.
T Consensus 211 -----~~~~~~---~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 -----FLIPKN---N---------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----hhhhcC---C---------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000000 0 001122456778999999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.49 Aligned_cols=280 Identities=25% Similarity=0.362 Sum_probs=197.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++++|.+.+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.+++.++|+||+++++++. .++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 45789999999999999999999988999999999864432 23356789999999999999999999854 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+. +++.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP----------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEE
Confidence 899999994 77777765432 2467888899999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.||+........+... .
T Consensus 144 l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~ 218 (291)
T cd07870 144 LADFGLARAKSIPSQT----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI-W 218 (291)
T ss_pred EeccccccccCCCCCC----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-H
Confidence 9999999754322111 1123478899999998764 57889999999999999999999987432110000000 0
Q ss_pred HHHhhhhhhhhc--cccccCcchhh-hhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVD--PILINDVEDWD-ATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d--~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
............ .........+. ........ ........+..+.+++.+|+..||++|||+.|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 219 TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLR--VVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHcCCCChhhhhhhhhcccccchhccccCCcchh--hhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00000000000 00000000 00111123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=305.20 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=199.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|+..+.||+|++|.||+|....+++.||+|.+.... ....+.+.+|+++++.++|+||+++++++. .+.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4778899999999999999998889999999986433 124467889999999999999999999854 447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~ 141 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-----------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVV 141 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 8899999999999999986542 578889999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.+....... ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||...... ...
T Consensus 142 kl~d~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~ 211 (258)
T cd06632 142 KLADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAV 211 (258)
T ss_pred EEccCccceeccccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHH
Confidence 999999987654322 122345889999999987766 899999999999999999999998643210 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ......+..++..+.+++.+||+.+|++||++.++++
T Consensus 212 ~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 212 FKIGRS--------------------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHhc--------------------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 0000112245677899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.38 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=199.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 46889999999999999999999899999999986432 233467889999999999999999999853 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+|
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG-----------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence 999999999999999986543 688999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... .......
T Consensus 142 l~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~ 209 (290)
T cd05580 142 ITDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEK 209 (290)
T ss_pred EeeCCCccccCCC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence 9999999865432 122358899999999988888999999999999999999999986321 0000000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
+ . ......+...+..+.+++.+||+.||++|| +++|+++
T Consensus 210 -----~---~--------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 210 -----I---L--------------------EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -----H---h--------------------cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 0 000111223467789999999999999998 6677663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.79 Aligned_cols=201 Identities=28% Similarity=0.455 Sum_probs=168.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|++|.||+|..+.+++.||+|.+..... .....+.+|++++++++|+||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 3679999999999999999999988999999999864332 23355778999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ ++|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 144 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCG----------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKL 144 (291)
T ss_pred EEEEecCC-CCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEE
Confidence 99999996 59999886543 2578899999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+|||.++....... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 145 ~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 145 ADFGLARAKSVPSK----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CccccccccCCCCc----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999875432111 1112246789999998875 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.90 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=198.3
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|++++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 4788999999999999999874 788999998864321 123568889999999999999999999643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ++++..+..++.|++.||+|||+. +|+|+||+|+||++++++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~ 140 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG-----------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGI 140 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCe
Confidence 78999999999999999986542 578889999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccc--cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 818 AHVGDFGLARVRQEVSNL--TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
++|+|||.+......... .........++..|+|||++.+..++.++|||||||++|+|++|+.||...... ..
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~ 216 (265)
T cd06631 141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AA 216 (265)
T ss_pred EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HH
Confidence 999999999764321111 111122345889999999999888999999999999999999999998632110 00
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... .. .. ......+..++.++.+++.+||+.+|++||++.|+++
T Consensus 217 ~~~~--~~--~~----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 MFYI--GA--HR----------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHh--hh--cc----------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00 00 0000112346677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.08 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=198.4
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
|.....||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++|+||+++++.+. .++..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 444577999999999999998889999999987655555677899999999999999999999854 447889999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++... .+++.++..++.||+.|++|||+. +|+||||||+||++++++.++|+|||
T Consensus 99 e~~~~~~L~~~~~~~------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 99 EFLEGGALTDIVTHT------------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred eCCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence 999999999988532 478889999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
++........ ......|+..|+|||...+..++.++||||||+++|||++|+.||..... . .... .
T Consensus 164 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~-~~~~-----~ 229 (292)
T cd06658 164 FCAQVSKEVP----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----L-QAMR-----R 229 (292)
T ss_pred chhhcccccc----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H-HHHH-----H
Confidence 9875432211 11224588999999999888899999999999999999999999863110 0 0000 0
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.....+.. ......+..+.+++.+||..||++|||++|+++.
T Consensus 230 ~~~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 230 IRDNLPPRV--------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHhcCCCcc--------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000000000 0112345678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.01 Aligned_cols=263 Identities=20% Similarity=0.360 Sum_probs=202.6
Q ss_pred CCCCCCceeccccceeEEEEEECC-----CCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
++|+..+.||+|+||.||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence 578899999999999999999753 3467999988654433 45679999999999999999999998643
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.+..++||||+++++|.+++......... .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~--~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEK--LKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQR 154 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccc--ccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCC
Confidence 46789999999999999999755421100 0012589999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||...... .
T Consensus 155 ~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~ 226 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----E 226 (275)
T ss_pred cEEEcccccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----H
Confidence 999999999874432211 11122346778999999988888999999999999999999 88887532110 1
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
......... . ....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 227 ~~~~~~~~~--------~------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQAGK--------L------------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHcCC--------c------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000000 0 00112356778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.00 Aligned_cols=268 Identities=25% Similarity=0.361 Sum_probs=199.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++. .++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 468899999999999999999988899999999864322 23467889999999999999999999854 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++++++.++..... .+++.+++.++.||+.||+|||+. +++||||+|+||++++++.++|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l 141 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN-----------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKL 141 (286)
T ss_pred EEEEecCCccHHHHHHhccC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEE
Confidence 99999999999988765432 578999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|++||.... ....+...
T Consensus 142 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~----~~~~~~~~ 213 (286)
T cd07846 142 CDFGFARTLAAPGE----VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS----DIDQLYHI 213 (286)
T ss_pred EeeeeeeeccCCcc----ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc----hHHHHHHH
Confidence 99999876533221 1122457889999999875 457889999999999999999999985321 11111110
Q ss_pred H--Hh---hhhhhhhc------cccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 A--LL---DHVIDIVD------PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~--~~---~~~~~~~d------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. .. .......+ ......... ..........++..+.+++.+||+.+|++||+++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE---------IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccC---------cchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00 00000000 000000000 00000112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.17 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=205.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+.++.+++|+|++++++++. .++..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 368899999999999999999998899999999875543 44578999999999999999999999854 348899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
+||||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|
T Consensus 76 lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l 141 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-----------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKI 141 (264)
T ss_pred EEEEecCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEE
Confidence 999999999999999654 268899999999999999999999 8 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+.......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .........
T Consensus 142 ~df~~~~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~ 215 (264)
T cd06623 142 ADFGISKVLENTLDQC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAI 215 (264)
T ss_pred ccCccceecccCCCcc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHH
Confidence 9999998654322211 1235788999999999999999999999999999999999998643220 111111100
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccc-hhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE-CPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. . ......... ++..+.+++.+||+.+|++||++.|+++.
T Consensus 216 ~--------~-------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 C--------D-------------------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred h--------c-------------------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0 000111223 67789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=308.42 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=202.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|+..+.||.|++|.||+|.+..+++.||+|++..... .....+.+|++++++++||||+++++++... .++..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 468889999999999999999988999999999874432 3456789999999999999999999987532 345789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~ 147 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR-------GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLC 147 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEe
Confidence 999999999999886532110 13578889999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++........ ....++..|+|||.+.+..++.++||||+||++|+|++|+.||+...............
T Consensus 148 dfg~~~~~~~~~~------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-- 219 (287)
T cd06621 148 DFGVSGELVNSLA------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-- 219 (287)
T ss_pred ecccccccccccc------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH--
Confidence 9999875432211 12347889999999999899999999999999999999999987432211111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.....+.+... .......++.+.+++.+||+.+|++|||+.|+++.
T Consensus 220 ---~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 220 ---IVNMPNPELKDE----------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---HhcCCchhhccC----------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000000000000 00011345678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.87 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=199.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+++++.++||||+++++.+. .++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 46889999999999999999999899999999986443 223456789999999999999999999854 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG-----------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEE
Confidence 899999999999999996543 578899999999999999999998 999999999999999999999
Q ss_pred Eeeeccccccccccc-----------ccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 820 VGDFGLARVRQEVSN-----------LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 820 L~DfG~a~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
|+|||+++....... ..........++..|+|||.+.+..++.++|||||||++||+++|..||...
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-- 219 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-- 219 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--
Confidence 999999864211100 0001111235788999999998888999999999999999999999998521
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
.............. .. ......++.++.+++.+||+.||++||++.++.+.+
T Consensus 220 ---~~~~~~~~~~~~~~---~~----------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 220 ---TPEELFGQVISDDI---EW----------------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ---CHHHHHHHHHhccc---CC----------------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11111110000000 00 001114677799999999999999999976555554
Q ss_pred HH
Q 001974 969 QS 970 (988)
Q Consensus 969 ~~ 970 (988)
+.
T Consensus 272 ~~ 273 (305)
T cd05609 272 QH 273 (305)
T ss_pred hC
Confidence 43
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=303.97 Aligned_cols=252 Identities=26% Similarity=0.504 Sum_probs=200.6
Q ss_pred CCCCceeccccceeEEEEEECCCC----eEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+++.+.||+|+||.||+|++...+ ..||+|+++..... ..+.+..|+++++.++|+||+++++++.. .+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence 456789999999999999997665 88999999755433 56789999999999999999999998643 378
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.+++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~ 143 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP---------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh---------ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEE
Confidence 8999999999999999875431 1289999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||.+............ ...++..|+|||.+.+..++.++||||+|+++|+|++ |..||... .......
T Consensus 144 l~dfg~~~~~~~~~~~~~~---~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~ 215 (258)
T smart00219 144 ISDFGLSRDLYDDDYYKKK---GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLE 215 (258)
T ss_pred EcccCCceecccccccccc---cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence 9999999866543221111 1236789999999988889999999999999999998 88887531 1011110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
..... .....+..++.++.+++.+|+..||++|||+.|+++.|
T Consensus 216 ~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKG---------------------------YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcC---------------------------CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00000 00111224677899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=314.67 Aligned_cols=256 Identities=24% Similarity=0.322 Sum_probs=200.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc---hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG---ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|+..+.||+|++|.||+|....+++.||+|.+...... ..+.+..|+++++.++|+||+++++.+. .++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 4688899999999999999999888999999999754322 3457889999999999999999999853 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG---------KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIM 143 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC---------CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEE
Confidence 9999999999999999875431 3688899999999999999999998 999999999999999999999
Q ss_pred Eeeecccccccccccccc-------------------------eeccccccccccccCcccCCCCCCCccchHHHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQ-------------------------SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLL 874 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ 874 (988)
|+|||++........... .......|+..|+|||++.+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 999999875433211100 0111245888999999999988999999999999999
Q ss_pred HHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC
Q 001974 875 EMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 875 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
+|++|+.||...... ..+ ..+.+... ........+.++.+++.+||+.|
T Consensus 224 ~l~~g~~pf~~~~~~----~~~---------~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~ 272 (316)
T cd05574 224 EMLYGTTPFKGSNRD----ETF---------SNILKKEV------------------TFPGSPPVSSSARDLIRKLLVKD 272 (316)
T ss_pred HHhhCCCCCCCCchH----HHH---------HHHhcCCc------------------cCCCccccCHHHHHHHHHHccCC
Confidence 999999998632111 000 00000000 00111125778999999999999
Q ss_pred CCCCCC----HHHHHH
Q 001974 955 PQDRMS----ITNVVH 966 (988)
Q Consensus 955 P~~RPs----~~evl~ 966 (988)
|++||| ++|+++
T Consensus 273 p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 273 PSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HhHCCCchhhHHHHHc
Confidence 999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=310.04 Aligned_cols=262 Identities=21% Similarity=0.304 Sum_probs=203.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccc-cCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDF-QGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 737 (988)
.++++|++.+.||+|++|.||+|.++.+++.|++|++..... ..+.+.+|+.+++++ .|+||+++++++..... ..+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999988899999999875433 346789999999999 79999999999765422 235
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-------GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCe
Confidence 6689999999999999988643210 13688999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+||+|||.+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 152 ~~l~d~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--- 224 (275)
T cd06608 152 VKLVDFGVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--- 224 (275)
T ss_pred EEECCCccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---
Confidence 99999999875433221 1122458899999998754 34678999999999999999999998632110
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .+ +.....+ ........+.++.+++.+||..||++|||+.|+++
T Consensus 225 --~~~----~~-~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 --RAL----FK-IPRNPPP--------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --HHH----HH-hhccCCC--------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 00 0000000 00111235667899999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.93 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=202.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||.|+||.||+|.+..+++.||+|+++... ....+.+..|++++++++||||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4888999999999999999999899999999986432 2334578889999999999999999987543 2346679
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEeccCCCCCeeeCCCC
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH-----HHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++|||+++++|.+++...... ..++++..++.++.||+.||+||| +. +++||||+|+||++++++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~ 147 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE-------RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANN 147 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc-------ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCC
Confidence 999999999999998653211 136899999999999999999999 66 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....
T Consensus 148 ~~kl~d~g~~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~ 218 (265)
T cd08217 148 NVKLGDFGLAKILGHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQL 218 (265)
T ss_pred CEEEecccccccccCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHH
Confidence 9999999999876543211 122458899999999999889999999999999999999999986321 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. .+.. .. ....+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 219 ~~-----~~~~---~~-------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 219 AS-----KIKE---GK-------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HH-----HHhc---CC-------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 10 0000 00 001122456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.82 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=198.7
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
|+....||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++|||++++++++. .++..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEE
Confidence 444568999999999999998889999999997655555677889999999999999999999854 347899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||
T Consensus 98 e~~~~~~L~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg 162 (297)
T cd06659 98 EFLQGGALTDIVSQ------------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG 162 (297)
T ss_pred ecCCCCCHHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence 99999999988743 2578899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ... ...
T Consensus 163 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~-~~~----- 228 (297)
T cd06659 163 FCAQISKDVP----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQA-MKR----- 228 (297)
T ss_pred hHhhcccccc----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH-HHH-----
Confidence 9875433211 11224588999999999988899999999999999999999999863211 000 000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+..... .........+..+.+++.+||+.+|++||+++|+++.
T Consensus 229 ~~~~~~--------------------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 229 LRDSPP--------------------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HhccCC--------------------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 0001112456678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.54 Aligned_cols=265 Identities=22% Similarity=0.383 Sum_probs=199.9
Q ss_pred CCCCceeccccceeEEEEEECC---CCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc-CCC
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ-GND 738 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 738 (988)
|.+.+.||+|+||.||+|.+.. +++.||+|+++... ....+++.+|++++++++||||+++++++...... ...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5678899999999999998643 56899999986432 23456788999999999999999999986543111 112
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++++||+++|+|.+++........ ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEE-----PFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCE
Confidence 34789999999999988753321111 02578889999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.++.......... .....++..|++||.+....++.++|||||||++|||++ |++||..... ....
T Consensus 153 kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~ 225 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQ--GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIY 225 (273)
T ss_pred EECcccccccccCCcceec--CCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHH
Confidence 9999999986543221111 112235678999999998889999999999999999999 8888753211 0000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. .+.. . .....+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 226 ~-----~~~~---~-------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 N-----YLIK---G-------------------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H-----HHHc---C-------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 0 00011224667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.99 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=193.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEee--ccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
...|++.+.||+||.+.||++... +.+.||+|.+. ..+.....-|.+|+..|.++ .|.+|+++++|- ..++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence 346899999999999999999885 55667777654 22334456799999999999 699999999994 3468
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..|+||||- ..+|..+++.... .+....++.+..|++.|+.++|.+ ||||.||||.|+++- .|.+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~----------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~L 498 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKS----------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRL 498 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccC----------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeE
Confidence 999999997 7899999987653 223237888999999999999999 999999999999987 4799
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCC-----------CCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-----------EVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
||+|||+|....... +.......+||+.||+||.+... +.+.++||||+||++|+|+.|+.||....
T Consensus 499 KLIDFGIA~aI~~DT--TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 499 KLIDFGIANAIQPDT--TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred EeeeechhcccCccc--cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 999999998765532 22233456899999999987643 25678999999999999999999987421
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. ....+..+.||.-.-.+.+ ..-..++.++|+.||+.||++|||..|+++.
T Consensus 577 n------------~~aKl~aI~~P~~~Iefp~-----------------~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 N------------QIAKLHAITDPNHEIEFPD-----------------IPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H------------HHHHHHhhcCCCccccccC-----------------CCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 1112233333311111110 0112238999999999999999999999853
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=318.12 Aligned_cols=291 Identities=22% Similarity=0.237 Sum_probs=206.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|.+.+.||+|+||+||+|++..+++.||+|.++.. .......+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999999989999999998642 2233456778999999999999999999876442233356
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++|+||+ +++|.+++.... ++++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~k 148 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQ-----------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLK 148 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence 89999999 578988886543 688999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||++........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ........
T Consensus 149 L~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~ 222 (337)
T cd07858 149 ICDFGLARTTSEKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQLKLIT 222 (337)
T ss_pred ECcCccccccCCCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHH
Confidence 999999986543221 1122357889999998765 4688999999999999999999999863210 00000011
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSVKN 973 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 973 (988)
........+..+.........+..................+++++.+++.+||+.+|++|||++|+++. ++.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000000000000000000000000000000001123567889999999999999999999999977 655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=289.92 Aligned_cols=287 Identities=22% Similarity=0.272 Sum_probs=209.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC----eEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
...|+.+..||+|.||.||+|..+++. +.+|+|.++.+. .+......+|+..++.++|||++.+..++...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 456899999999999999999664332 368999997442 34457788999999999999999999886542
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+...++++||.+ -+|...++..+.... +.++...+..|+.||+.|+.|||+. =|+||||||.|||+..+
T Consensus 100 -d~~v~l~fdYAE-hDL~~II~fHr~~~~------~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 100 -DKKVWLLFDYAE-HDLWHIIKFHRASKA------KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGD 168 (438)
T ss_pred -CceEEEEehhhh-hhHHHHHHHhccchh------ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEecc
Confidence 588999999994 689999877654332 4789999999999999999999998 89999999999999877
Q ss_pred ----CcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 816 ----MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 816 ----~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
|.|||+|||+|+.+...-.. -.....++-|..|+|||.+.+. .||.+.||||.||++.||+|-++-|......-
T Consensus 169 gperG~VKIaDlGlaR~~~~plkp-l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~ 247 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKP-LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI 247 (438)
T ss_pred CCccCeeEeecccHHHHhhccccc-cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence 89999999999987654321 1123446789999999998885 68999999999999999999998886432210
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHH--------HHhhhhhc---------cccchhHHHHHHhhcccCc
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQ--------RLRQAKIN---------GKIECPISMVRIGVACSVE 953 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~--------~~~~~~~~---------~~~~~~~~l~~li~~cl~~ 953 (988)
.. ..+...+++..++.-...++..+|+..... .++..... ....-++...+|+.+++++
T Consensus 248 ~~----~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y 323 (438)
T KOG0666|consen 248 KT----KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY 323 (438)
T ss_pred cc----CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence 00 001122223333333333344444332221 01100000 0011233478999999999
Q ss_pred CCCCCCCHHHHHHH
Q 001974 954 SPQDRMSITNVVHE 967 (988)
Q Consensus 954 dP~~RPs~~evl~~ 967 (988)
||.+|.|+++.++.
T Consensus 324 DP~kRIta~qAleh 337 (438)
T KOG0666|consen 324 DPIKRITAEQALEH 337 (438)
T ss_pred CchhhccHHHHhcc
Confidence 99999999998864
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.87 Aligned_cols=277 Identities=27% Similarity=0.342 Sum_probs=197.2
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++. +++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4888999999999999999998899999999986433 223357889999999999999999999854 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~ 142 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL---------SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA 142 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999995 689888865432 3688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||++......... .....++..|+|||++.+.. ++.++|||||||++|||+||+.||......+ .........
T Consensus 143 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~ 217 (284)
T cd07860 143 DFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTL 217 (284)
T ss_pred eccchhhcccCccc----cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHh
Confidence 99998754332111 11234678999999877644 5889999999999999999999986321100 000000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .+...+.... ...+...................+.++.+++.+||+.||++|||++|+++
T Consensus 218 -~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 218 -GTP-DEVVWPGVTS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred -CCC-ChhhhhhhhH-HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 0000000000 00000000000000000011235677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=309.01 Aligned_cols=278 Identities=23% Similarity=0.289 Sum_probs=201.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 5888999999999999999998899999999997543 334567899999999999999999999854 457889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++|+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~ 141 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEE----------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIA 141 (286)
T ss_pred EEeccc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEe
Confidence 999999 999999986543 2689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.+........ .......++..|+|||.+.+. .++.++||||+|+++|||++|.+||..... ..........
T Consensus 142 dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~ 216 (286)
T cd07832 142 DFGLARLFSEEEP---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRT 216 (286)
T ss_pred eeeecccccCCCC---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHH
Confidence 9999986544321 111224588999999998654 468999999999999999999887753211 0111111110
Q ss_pred HhhhhhhhhccccccCcchhhhhhH-HHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNK-QRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
........ .+.. .+..+|..... ............+.+.++.+++.+|++.+|++|||++++++.
T Consensus 217 ~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 217 LGTPNEET-WPGL-TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCChHH-Hhhc-cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 0000 00000100000 000000001112456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=306.69 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=195.6
Q ss_pred ceeccccceeEEEEEECCCC------eEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 669 HLIGMGSFGSVYKGAFDQDG------TIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+.||+|+||.||+|++.... +.||+|.+.... ......+.+|+.+++.++||||+++++++.. .+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 46899999999999985433 679999885432 2345678899999999999999999998643 46789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-----
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM----- 816 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----- 816 (988)
+||||+++++|.+++........ ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERF----GPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhccc----CCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCc
Confidence 99999999999999965322110 112478899999999999999999998 999999999999999877
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.++++|||++.......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~ 224 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYR--KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQ 224 (269)
T ss_pred ceEECCcccccccccccccc--cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHH
Confidence 89999999997553322111 1112345788999999999999999999999999999998 99998632110 0000
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
. + +. ......+..++..+.+++.+||+.+|++||+++++++.|+
T Consensus 225 ~--------~----~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 H--------V----TA------------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred H--------H----hc------------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0 00 0001112346778999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.31 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=204.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||.|+||+||+|....++..||+|++.... ....+.+.+|+++++.++|+|++++++.+. .++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence 47899999999999999999998889999999986433 234578899999999999999999998854 457889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+
T Consensus 76 iv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~ 144 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP--------RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIA 144 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence 99999999999999865321 02578999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||++..................|+..|+|||++... .++.++|||||||++|||++|+.||....... .+.. .
T Consensus 145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~----~ 219 (267)
T cd06610 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLML----T 219 (267)
T ss_pred ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHH----H
Confidence 9999976654332211122334588999999998876 78999999999999999999999986431110 0000 0
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ..+..... ......+.++.+++.+||+.||++||+++|+++
T Consensus 220 ~~~-----~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 220 LQN-----DPPSLETG-----------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hcC-----CCCCcCCc-----------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000000 001245678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=304.32 Aligned_cols=239 Identities=23% Similarity=0.393 Sum_probs=188.0
Q ss_pred ceeccccceeEEEEEECCCC----------eEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 669 HLIGMGSFGSVYKGAFDQDG----------TIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46899999999999997665 35888887644333 6788999999999999999999998643 4
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC--
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-- 816 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 816 (988)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK----------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLN 140 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccc
Confidence 5689999999999999987643 2578889999999999999999998 999999999999999888
Q ss_pred -----cEEEeeecccccccccccccceeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHh-CCCCCCcccc
Q 001974 817 -----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVT-GKKPTDVMFE 888 (988)
Q Consensus 817 -----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 888 (988)
.+||+|||++...... ....++..|+|||++.+. .++.++|||||||++|||++ |..||.....
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred cCCceeEEeCCCCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 7999999999864331 113467789999998876 78999999999999999999 5777653211
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
. ....... ... ..+......+.+++.+||..+|++|||+.|+++.|
T Consensus 213 ~-----~~~~~~~--------~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 213 S-----EKERFYQ--------DQH---------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred h-----hHHHHHh--------cCC---------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0000000 000 00011125688999999999999999999999886
Q ss_pred H
Q 001974 969 Q 969 (988)
Q Consensus 969 ~ 969 (988)
+
T Consensus 259 ~ 259 (259)
T cd05037 259 N 259 (259)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.39 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=186.2
Q ss_pred ceeccccceeEEEEEECCC--CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQD--GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
+.||+|+||.||+|+.... ...+++|.++... ....+.+.+|+.+++.++||||++++++|.. ....++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 3689999999999986422 2356677765433 2345689999999999999999999998653 467899999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecc
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 825 (988)
|+++|+|.+++....... ...++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 76 YCELGDLKSYLSQEQWHR-------RNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred cCCCCcHHHHHHhhhccc-------ccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccc
Confidence 999999999997543211 2456777889999999999999998 999999999999999999999999999
Q ss_pred cccccccccccceeccccccccccccCcccCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-------SEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
+........ ........++..|+|||++.. ..++.++|||||||++|||++ |..||..... ....
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~ 218 (268)
T cd05086 146 GPSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVL 218 (268)
T ss_pred ccccCcchh--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence 864322111 011123457889999998753 245789999999999999997 5677753211 1111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.....+......++. ......+.+.+++..|| .+|++||+++||++.|.
T Consensus 219 ~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 219 NHVIKDQQVKLFKPQ----------------------LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHhhcccccCCCc----------------------cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111111111111 11234566889999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.67 Aligned_cols=252 Identities=24% Similarity=0.302 Sum_probs=202.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||+++++++. .++..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 367999999999999999999988889999999987555555677899999999999999999999854 347889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+
T Consensus 93 lv~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~ 157 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (293)
T ss_pred EEEecCCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEc
Confidence 999999999999998643 467888999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++........ ......+++.|+|||.+.+..++.++|||||||++|++++|+.||......+.
T Consensus 158 dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---------- 223 (293)
T cd06647 158 DFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------- 223 (293)
T ss_pred cCcceeccccccc----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----------
Confidence 9998875443221 11223588899999999888899999999999999999999999864211100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.... .... .........+..+.+++.+||..+|++||++.+++..
T Consensus 224 ---~~~~~----~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 224 ---LYLIA----TNGT-------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---eeehh----cCCC-------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000 0001112356678999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.50 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=198.4
Q ss_pred CCCCCceeccccceeEEEEEECC-CCeEEEEEEeeccc----------cchhHHHHHHHHHHHh-cCCCCceEEEeeccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQR----------HGASKSFLAECKALKN-IRHRNLVKVITSCSS 731 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 731 (988)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47888999999999999999976 67899999885321 2233557788888875 69999999999854
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. .+++||||+|+||+
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil 146 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKE-------KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIM 146 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEE
Confidence 44789999999999999988743211 013688899999999999999999963 28999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
++.++.+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 147 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~----- 216 (269)
T cd08528 147 LGEDDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----- 216 (269)
T ss_pred ECCCCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----
Confidence 9999999999999998654332 122345889999999999888999999999999999999999998532
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
........ ..+.... ......++.++.+++.+||+.||++||++.|+..+++
T Consensus 217 ~~~~~~~~--------~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 217 NMLSLATK--------IVEAVYE------------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHH--------HhhccCC------------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111100 0000000 0001135677999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=308.94 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=192.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHH-HHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKA-LKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++.. ++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 468899999999999999999998999999999875422 223455566665 555699999999999643 4778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ |+|.+++....... ..+++..++.++.||+.|++|||++ .+++||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKG-------LTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence 99999995 78887775432111 3689999999999999999999985 28999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC----CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
+|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +...
T Consensus 146 ~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~ 217 (283)
T cd06617 146 CDFGISGYLVDSVA-----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQL 217 (283)
T ss_pred eecccccccccccc-----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHH
Confidence 99999976533211 112357889999998765 45688999999999999999999998632111 1100
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. .. .....+.. ....++.++.+++.+||..+|++||+++++++
T Consensus 218 ~-~~-----~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 K-QV-----VEEPSPQL---------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred H-HH-----HhcCCCCC---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 00000000 01135678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.47 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=197.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc----------chhHHHHHHHHHHHhcCCCCceEEEeeccccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH----------GASKSFLAECKALKNIRHRNLVKVITSCSSID 733 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 733 (988)
+|...+.||+|+||.||+|....+++.||+|.++.... ...+.+..|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 47788999999999999999988899999998853211 11246788999999999999999999864
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
..+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+. +++||||+|+||+++
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~ 142 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLRTYG-----------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVD 142 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEc
Confidence 3478899999999999999987642 578889999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCC--CCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE--VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
.++.++++|||+++....... ........++..|+|||.+.... ++.++||||||+++||+++|..||.....
T Consensus 143 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--- 217 (272)
T cd06629 143 ADGICKISDFGISKKSDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--- 217 (272)
T ss_pred CCCeEEEeecccccccccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---
Confidence 999999999999975432211 11122345789999999987654 78999999999999999999999852211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... +........... ......++.++.+++.+||..||++|||++|+++.
T Consensus 218 -~~~~~---------~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 218 -IAAMF---------KLGNKRSAPPIP--------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -HHHHH---------HhhccccCCcCC--------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 000000000000 01112467789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.51 Aligned_cols=266 Identities=20% Similarity=0.227 Sum_probs=188.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeeccccchh-----------HHHHHHHHHHHhcCCCCceEEEe
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRHGAS-----------KSFLAECKALKNIRHRNLVKVIT 727 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 727 (988)
.++|.+.+.||+|+||.||+|++..+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999999766 66778886543322111 11223334455678999999998
Q ss_pred ecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 728 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
++... .......++++|++ ..++.+.+.... ..++..+..|+.|++.||+|||+. +|+||||||
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp 154 (294)
T PHA02882 91 CGSFK-RCRMYYRFILLEKL-VENTKEIFKRIK-----------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKP 154 (294)
T ss_pred eeeEe-cCCceEEEEEEehh-ccCHHHHHHhhc-----------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 75432 11122446788877 446665554321 356778899999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
+|||++.++.++|+|||+|+......... ........||+.|+|||+..+..++.++|||||||++|||++|+.||.
T Consensus 155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998654321111 111122459999999999999999999999999999999999999997
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
...... .............+ .... .....++..+.+++..||+.+|++||+++++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~-----------------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l 289 (294)
T PHA02882 235 GFGHNG-NLIHAAKCDFIKRL-----------------------HEGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDAL 289 (294)
T ss_pred ccccch-HHHHHhHHHHHHHh-----------------------hhhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence 532211 11111110000000 0000 0123567889999999999999999999999
Q ss_pred HHHH
Q 001974 965 VHEL 968 (988)
Q Consensus 965 l~~L 968 (988)
++.+
T Consensus 290 ~~~~ 293 (294)
T PHA02882 290 IKIF 293 (294)
T ss_pred HHhh
Confidence 9876
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.62 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=199.3
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++||||+++++++. .++..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3555689999999999999998899999999987555455567889999999999999999999854 34788999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
+||+++++|.+++... ++++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+||
T Consensus 95 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~ 159 (285)
T cd06648 95 MEFLEGGALTDIVTHT------------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159 (285)
T ss_pred EeccCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccc
Confidence 9999999999998652 478889999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
|.+........ ......|+..|+|||...+..++.++|||||||++|||++|+.||.... .......
T Consensus 160 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~---- 226 (285)
T cd06648 160 GFCAQVSKEVP----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKR---- 226 (285)
T ss_pred ccchhhccCCc----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHH----
Confidence 98875433211 1122458899999999988889999999999999999999999975311 0011100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.....+ .......++..+.+++.+||+.+|++||++.++++
T Consensus 227 -~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 227 -IRDNLPP--------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -HHhcCCC--------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0000000 00112236678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=305.39 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=200.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++ .++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4888999999999999999998889999999997432 23457889999999999999999999884 455789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+||+++++|.+++.... ++++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV-----------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC-----------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEE
Confidence 99999999999999986542 578899999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+........ .....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 142 ~d~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~ 213 (258)
T cd05578 142 TDFNIATKVTPDTL-----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAK 213 (258)
T ss_pred eecccccccCCCcc-----ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHH
Confidence 99999886543221 12345788999999999888999999999999999999999998743211 00000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH--HHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI--TNVV 965 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 965 (988)
.. ......+...+..+.+++.+||+.||.+||++ +|++
T Consensus 214 ~~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QE---------------------------TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hc---------------------------cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00 01111223466789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.21 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=205.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.+-++....+||.|.||.||-|....+|+..|+|.++... ....+...+|..++..++|||+|++||+- ...+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vHRe 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VHRE 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ecHH
Confidence 3456777889999999999999999999999999987443 33446788999999999999999999983 3457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..+|.||||++|+|.+.+...+ -.++.....+..|++.|++|||++ |||||||||+||+++.+|.+
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr-----------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR-----------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc-----------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcE
Confidence 8899999999999999997654 355666777999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCC---CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS---EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
|++|||.|..................||+.|||||++.+. ....++||||+|||+.||+||+.||...-. +
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e--- 1447 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---E--- 1447 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---h---
Confidence 9999999997766532222333456799999999998874 356789999999999999999999874311 1
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
|..... .-..++++.+.....+-.+++..|+..||++|.++.|+++.
T Consensus 1448 ------------------------~aIMy~-V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 ------------------------WAIMYH-VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------------------------hHHHhH-HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111111 11122334445577778999999999999999988877653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.84 Aligned_cols=275 Identities=22% Similarity=0.306 Sum_probs=201.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++.. ++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 36889999999999999999998889999999986432 2334678999999999999999999999643 4789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++++.+..+.... ..+++.++..++.||+.|++|||+. +++||||+|+||++++++.+||
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-----------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 9999999887776665432 2578999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +.......
T Consensus 142 ~d~g~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~ 216 (288)
T cd07833 142 CDFGFARALRARPA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQK 216 (288)
T ss_pred EeeecccccCCCcc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 99999986554332 111224578899999999887 8899999999999999999999998632111 00000000
Q ss_pred HHhhhhhh---hh--cccccc-CcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVID---IV--DPILIN-DVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~---~~--d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........ .. ++.... ...+.. .... .....+..++.++.+++.+||..+|++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 217 CLGPLPPSHQELFSSNPRFAGVAFPEPS--QPES---LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhCCCCHHHhhhcccCccccccccCCCC--CcHH---HHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00 000000 000000 0000 000112235788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.65 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=198.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
-++|+..++||+|.||.|.+++-+.+|+.+|+|+++.+- ......-..|-++++..+||.+..+-.. |+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 367889999999999999999999999999999997542 2333455678899999999999887655 66779
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
+.|+||||+.||.|.-++...+ .+++...+.+...|+.||.|||++ +||.||+|-+|.|+|.+|++
T Consensus 242 rlCFVMeyanGGeLf~HLsrer-----------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER-----------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh-----------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCce
Confidence 9999999999999998887654 688888999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++..-.. ......+.||+.|.|||++....|+.++|.|.+|||+|||++|+.||.....+ ...
T Consensus 308 KitDFGLCKE~I~~----g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLF- 377 (516)
T KOG0690|consen 308 KITDFGLCKEEIKY----GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLF- 377 (516)
T ss_pred Eeeecccchhcccc----cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHH-
Confidence 99999999743221 12234567999999999999999999999999999999999999998631000 000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
+-+-...+..+....++...|+...+.+||.+|.
T Consensus 378 ---------------------------eLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 378 ---------------------------ELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---------------------------HHHHhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0111112233456777889999999999999994
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.79 Aligned_cols=287 Identities=25% Similarity=0.325 Sum_probs=208.4
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 742 (988)
+...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|++++++++|+|||++++.-.+.. .-......+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455688999999999999999999999999997543 234467789999999999999999998744321 111355789
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC--CCC--cE
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDM--IA 818 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~ 818 (988)
|||||.+|||+..+...... ..+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..
T Consensus 95 vmEyC~gGsL~~~L~~PEN~--------~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA--------YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred EEeecCCCcHHHHhcCcccc--------cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence 99999999999999865432 4699999999999999999999998 999999999999983 334 58
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.|+..++.... ...+||..|.+||.... +.|+..+|.|||||++||..||..||..............
T Consensus 164 KLtDfG~Arel~d~s~~-----~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLF-----TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred eeecccccccCCCCCee-----eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 99999999988765533 34679999999999984 8889999999999999999999999976544322221111
Q ss_pred HHHHhhh--hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC--CHHHHHHHHHHHHH
Q 001974 898 RTALLDH--VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM--SITNVVHELQSVKN 973 (988)
Q Consensus 898 ~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~ 973 (988)
....... +.-..++.. ..+-+|...... +. .........+...+..++..+|++|- ...+....+..|..
T Consensus 239 ~~~tkkp~~v~i~~~~~e-Ngpv~~s~~lP~----p~-~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEE-NGPVEWSSTLPQ----PN-HLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhccCCCceeEeeeccc-CCceeeeccCCC----cc-cccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111111 111111111 111222211111 00 00112223456777788889999998 77788777777754
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=307.85 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=194.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.+.|+..+.||+|+||+||+|....+++.||+|++..... ...+++.+|+++++.++||||++++++|.. ++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CC
Confidence 3568899999999999999999988899999999864322 233568899999999999999999999654 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~ 154 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK----------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTV 154 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCE
Confidence 7899999995 67777665332 3588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+|+|||++....... ...++..|+|||++. ...++.++||||||+++|||+||+.||...... .
T Consensus 155 kL~dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~ 221 (307)
T cd06607 155 KLADFGSASLVSPAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----S 221 (307)
T ss_pred EEeecCcceecCCCC--------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----H
Confidence 999999987543221 234788999999874 456889999999999999999999997532100 0
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .... .... .....++.++.+++.+||+.+|++||++.+++..
T Consensus 222 ~~~~-~~~~-----------~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 222 ALYH-IAQN-----------DSPT--------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHH-HhcC-----------CCCC--------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000 0000 0011356678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.47 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=199.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
-|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4778899999999999999998889999999986432 233467889999999999999999999854 4478999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 80 v~e~~~~~~l~~~i~~~------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~d 144 (277)
T cd06641 80 IMEYLGGGSALDLLEPG------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLAD 144 (277)
T ss_pred EEEeCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEee
Confidence 99999999999998642 478899999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||++........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....
T Consensus 145 fg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~--- 212 (277)
T cd06641 145 FGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL--- 212 (277)
T ss_pred cccceecccchh----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH---
Confidence 999875543211 112235788999999998888999999999999999999999998632110 00000
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.. . ........++.++.+++.+||+.+|++||++.++++.
T Consensus 213 --~~~----~------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 --IPK----N------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --Hhc----C------------------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 0 0001122466789999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=314.33 Aligned_cols=204 Identities=25% Similarity=0.296 Sum_probs=171.2
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQG 736 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 736 (988)
...++|+..+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.++++++||||+++++++.... +.+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3467899999999999999999999989999999998532 2333456778999999999999999999865331 223
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||+ .++|.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~-------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQM-------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 155 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhh-------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCC
Confidence 35679999999 5688877642 367888999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
.+||+|||.++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 156 TLKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CEEEccCccceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999986543221 1223578899999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.86 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=196.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++.+.+..||.|+.|.||+++.+.+|...|||.+.... .+..+++...++++.+- ..|.||+.+|+|. .+...
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchH
Confidence 34456678999999999999999999999999997443 34456778888887766 4899999999954 34677
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++.||.| ......+++.-. +++++.-+-++...+++||.||.++ .+|+|||+||+|||+|+.|++|+
T Consensus 167 ~IcMelM-s~C~ekLlkrik----------~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKl 233 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRIK----------GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKL 233 (391)
T ss_pred HHHHHHH-HHHHHHHHHHhc----------CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEe
Confidence 8899998 556666665443 4678888888999999999999987 49999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||||++...-+....+ ...|-+.|||||.+.- ..|+.++||||||++++|+.||+.||.....+ +...
T Consensus 234 CDFGIsGrlvdSkAht-----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~l- 304 (391)
T KOG0983|consen 234 CDFGISGRLVDSKAHT-----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVL- 304 (391)
T ss_pred ecccccceeecccccc-----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHH-
Confidence 9999998765544333 3458999999998764 46889999999999999999999998743221 1100
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..+..-..|.+ .......+.+.+++..||++|+.+||...++++.
T Consensus 305 -----tkvln~ePP~L--------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 305 -----TKVLNEEPPLL--------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----HHHHhcCCCCC--------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 00111001111 1223466789999999999999999999998753
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.99 Aligned_cols=272 Identities=22% Similarity=0.286 Sum_probs=198.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-----hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-----ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|+..+.||+|++|.||+|.+..+++.||+|.++..... ....+..|++++++++|+||+++++++. +++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 478889999999999999999888999999999754322 3356778999999999999999999954 357
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+ +++|.+++.... ..+++..+..++.||++||+|||++ +|+||||+|+||+++.++.+
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~ 141 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKS----------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVL 141 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCE
Confidence 889999999 999999997543 1588999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+|+|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||.... ......
T Consensus 142 ~l~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~----~~~~~~ 213 (298)
T cd07841 142 KLADFGLARSFGSPNRK----MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS----DIDQLG 213 (298)
T ss_pred EEccceeeeeccCCCcc----ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc----cHHHHH
Confidence 99999999865443211 112346788999998865 467899999999999999999987765321 111111
Q ss_pred HH--HHhhhhhh-hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RT--ALLDHVID-IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~--~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ........ +.+.........+.... ...........+.++.+++.+||+.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 214 KIFEALGTPTEENWPGVTSLPDYVEFKPFP----PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHHHHcCCCchhhhhhcccccccccccccC----CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00 00000000 00000000000000000 00000111245677899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.21 Aligned_cols=286 Identities=22% Similarity=0.293 Sum_probs=199.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccc---c
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDF---Q 735 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 735 (988)
..++|++.+.||+|+||.||+|....+++.||+|.+..... .....+.+|++++++++||||++++++|..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999999998999999999864322 223456789999999999999999998765321 1
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.....++||||+. +++.+++.... ..+++.+++.++.||+.||+|||+. +++||||||+||+++.+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN----------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKD 155 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCC
Confidence 2345699999994 68888775433 2589999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||.+..................++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~ 233 (310)
T cd07865 156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQL 233 (310)
T ss_pred CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence 9999999999986543222111112234578899999987664 4788999999999999999999998632110 011
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhh-----hhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWD-----ATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
............++..... ....+. .......... -........+.+++.+||..||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 234 TLISQLCGSITPEVWPGVD--KLELFKKMELPQGQKRKVKER--LKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHhCCCChhhccccc--chhhhhhccCCCccchhhHHh--cccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1111100000000000000 000000 0000000000 001113456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.47 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=198.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-----ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-----RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|++++++++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 5789999999999999999999889999999987532 123345788999999999999999999986432 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-----------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGN 144 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 56789999999999999986542 478888999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
++|+|||.++........ ........++..|+|||++.+..++.++|||||||++||+++|+.||..... ... .
T Consensus 145 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~-~ 218 (264)
T cd06653 145 VKLGDFGASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAA-I 218 (264)
T ss_pred EEECcccccccccccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHH-H
Confidence 999999999865332111 1111234588999999999988899999999999999999999999863210 000 0
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ......+...++++.+++.+||. +|..||++.+++.
T Consensus 219 ~~~~~~--------------------------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 FKIATQ--------------------------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHcC--------------------------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000000 00011223466779999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=308.68 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=207.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch--hHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
....|.+.+.||+|.|+.|.+|++..++..||+|.++...... ...+.+|+++|+.++|||||+++.+. ....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence 4567899999999999999999999999999999997543322 24588999999999999999999994 4458
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..|+||||+.+|.+.+|+...+ ++.+..+..++.|+.+|++|+|++ .|||||||++||+++.+.++
T Consensus 129 ~lylV~eya~~ge~~~yl~~~g-----------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHG-----------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcc-----------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 8999999999999999998775 566688999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||++..+.......+ ..|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+...
T Consensus 195 kIaDfgfS~~~~~~~~lqt-----~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------- 259 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGLMLQT-----FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------- 259 (596)
T ss_pred eeeccccceeecccccccc-----cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----------
Confidence 9999999998876544443 459999999999999776 589999999999999999999997321
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+.+.-++.+.+.. ..+.-...++.+++++++..+|.+|++++++.+.
T Consensus 260 -------lk~Lr~rvl~gk~----------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 260 -------LKELRPRVLRGKY----------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------cccccchheeeee----------------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111111111 1122344567899999999999999999999865
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.57 Aligned_cols=278 Identities=24% Similarity=0.268 Sum_probs=198.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++... +....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 578999999999999999999988899999999974432 2234677899999999999999999986432 23789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l 147 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMK----------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKI 147 (293)
T ss_pred EEEehhcC-cCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEE
Confidence 99999995 69988886543 2589999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+......... .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...... ....... .
T Consensus 148 ~d~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~-~ 221 (293)
T cd07843 148 CDFGLAREYGSPLKP----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIF-K 221 (293)
T ss_pred eecCceeeccCCccc----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-H
Confidence 999999865443211 1123478899999998764 4689999999999999999999998632110 0000000 0
Q ss_pred HHhhh---hhhhhccccccCcchhhhhhHHHHhhhhhccccc-hhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDH---VIDIVDPILINDVEDWDATNKQRLRQAKINGKIE-CPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... ...............+.......+. ...+.. .++.+.+++.+||+.||++|||++|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLR---KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhh---ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 0000000000000000000000000 001111 4677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.90 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=199.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||+|....+|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+. .+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 4788899999999999999999899999999986432 233457889999999999999999999854 447899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 820 (988)
+|+||+++++|.+++..... ..+++..+..++.|+++|++|||+. +++||||||+||++++++ .+||
T Consensus 76 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l 143 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG---------VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKL 143 (257)
T ss_pred EEEecCCCCcHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEe
Confidence 99999999999999865432 2578999999999999999999998 999999999999999886 5699
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+......... .....|+..|+|||+..+..++.++||||||+++|||++|..||... .........
T Consensus 144 ~d~~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~ 214 (257)
T cd08225 144 GDFGIARQLNDSMEL----AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKI 214 (257)
T ss_pred cccccchhccCCccc----ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHH
Confidence 999999765432211 11235888999999998888999999999999999999999998632 111111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. .... ......+.++.+++.+||..+|++|||+.|+++.
T Consensus 215 ~~----~~~~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 CQ----GYFA-----------------------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred hc----ccCC-----------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 0000 0112456679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.97 Aligned_cols=277 Identities=21% Similarity=0.301 Sum_probs=215.6
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCC-----eEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeec
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDG-----TIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSC 729 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 729 (988)
.++....++++....+-+|.||.||.|.|...+ +.|-+|.++... .-....+..|.-.+....|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344455567888888999999999999886433 346677765332 23345688898889999999999999998
Q ss_pred ccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCC
Q 001974 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGN 809 (988)
Q Consensus 730 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 809 (988)
.+ +.+..++++.++.-|+|..|+...+.... ...+.++..+...++.|++.|++|||++ +|||.||.++|
T Consensus 357 ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~---~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRN 426 (563)
T KOG1024|consen 357 IE----DYATPFVLYPATGVGNLKSFLQICRGDDP---SYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARN 426 (563)
T ss_pred ee----ccCcceEEEeccCcchHHHHHHHhccCCC---ccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhc
Confidence 54 45778999999988999999985443211 1225788889999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcccc
Q 001974 810 VLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFE 888 (988)
Q Consensus 810 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~ 888 (988)
++||+..++||+|=.+++..-+.+..-- ......+..||+||.+....|+.++|||||||++|||+| |+.||....+
T Consensus 427 CvIdd~LqVkltDsaLSRDLFP~DYhcL--GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 427 CVIDDQLQVKLTDSALSRDLFPGDYHCL--GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred ceehhheeEEeccchhccccCccccccc--CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 9999999999999999987655432211 112335789999999999999999999999999999999 9999864311
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
.+ +..++ ..+-.+..+.+||+++..+|.-||+.+|++||++++++..|
T Consensus 505 fE--------------m~~yl------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 505 FE--------------MEHYL------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred HH--------------HHHHH------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 10 00000 01112234568999999999999999999999999999999
Q ss_pred HHHHHHhh
Q 001974 969 QSVKNALL 976 (988)
Q Consensus 969 ~~i~~~~~ 976 (988)
.+...++.
T Consensus 553 seF~~qlt 560 (563)
T KOG1024|consen 553 SEFHTQLT 560 (563)
T ss_pred HHHHHHHh
Confidence 99877653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=285.70 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=208.7
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
++++.+-++ +.||+|+|+.|--+....+|..||||++.+.......++.+|++++... .|+||++++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----- 144 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----- 144 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence 455554443 6899999999999999899999999999887667778899999999999 79999999999
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
|+++..+|+|||-|.||+|..++.+.. .+++.++.++.++|+.||+|||.+ ||.|||+||+|||-.
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~-----------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRK-----------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCE 210 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhh-----------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeec
Confidence 567799999999999999999997654 689999999999999999999999 999999999999997
Q ss_pred CCC---cEEEeeeccccccccc---ccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 814 NDM---IAHVGDFGLARVRQEV---SNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 814 ~~~---~~kL~DfG~a~~~~~~---~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
+.. -+|||||.++.-.... ....+..-...+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 655 4899999887532211 112222234567999999999753 23578899999999999999999999
Q ss_pred CCccccCCcchH-----HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC
Q 001974 883 TDVMFEGDLNLH-----NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957 (988)
Q Consensus 883 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 957 (988)
|...-..+-.|. ...+..+.+.+.+ ..+.-...+|. .++.+..+++...+..||.+
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE---GkYeFPdkdWa----------------hIS~eakdlisnLlvrda~~ 351 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQE---GKYEFPDKDWA----------------HISSEAKDLISNLLVRDAKQ 351 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhc---cCCcCChhhhH----------------HhhHHHHHHHHHHHhccHHh
Confidence 976544432221 2222333332222 11111222332 35667789999999999999
Q ss_pred CCCHHHHHH
Q 001974 958 RMSITNVVH 966 (988)
Q Consensus 958 RPs~~evl~ 966 (988)
|-++.++++
T Consensus 352 rlsa~~vln 360 (463)
T KOG0607|consen 352 RLSAAQVLN 360 (463)
T ss_pred hhhhhhccC
Confidence 999999886
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.46 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=185.7
Q ss_pred eeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHh---cCCCCceEEEeecccccccCCCceEEE
Q 001974 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKN---IRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.||+|+||.||+|.+..+++.||+|.+..... .....+.+|..+++. .+||+|+.+++++. .++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 48999999999999988899999999864321 112334445444333 47999999998854 34788999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+||
T Consensus 76 ~e~~~~~~L~~~i~~~~-----------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred EecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccC
Confidence 99999999999886543 689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
|++....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|..||......... .......
T Consensus 142 g~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~ 212 (279)
T cd05633 142 GLACDFSKKK------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL 212 (279)
T ss_pred CcceeccccC------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh
Confidence 9987543221 112358999999999864 56889999999999999999999998643221100 0000000
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
. .....+...+.++.+++.+||..||++|| |++|+++.
T Consensus 213 -----~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 -----T----------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----c----------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0 00011224667899999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.35 Aligned_cols=286 Identities=21% Similarity=0.194 Sum_probs=198.1
Q ss_pred CCCCCceeccccceeEEEEEECCC--CeEEEEEEeecc--ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQD--GTIVAIKVFNLQ--RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|++.+.||+|+||.||+|++..+ +..||+|++... .....+.+.+|+++++++ .||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 478889999999999999999877 889999998632 222346788899999999 599999999875432 12335
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++++||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~ 144 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQ-----------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCEL 144 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCE
Confidence 678899998 578998886542 688999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.++.................|+..|+|||++.+ ..++.++||||+||++|++++|+.||...... ......
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~ 222 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQI 222 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHH
Confidence 999999998654332211111223468999999998765 56899999999999999999999998642110 000000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.........+............+.......-...........+..+.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000000000000000000000112346779999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.35 Aligned_cols=288 Identities=21% Similarity=0.285 Sum_probs=200.7
Q ss_pred CCCCCceeccccceeEEEEEECC--CCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQ--DGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... .++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 47888999999999999999987 78999999997532 34456788999999999999999999996532 236
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC----
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---- 814 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---- 814 (988)
..++||||++ +++.+++........ ..+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~ 147 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAKR------VSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPE 147 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCCC------cCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCc
Confidence 7899999995 567766643322111 2688999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
++.+||+|||++......... ........++..|+|||++.+ ..++.++|||||||++|||++|++||..........
T Consensus 148 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 148 RGVVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred cceEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 999999999999865433221 111223457889999998766 457899999999999999999999997543322110
Q ss_pred HHHHHHHHhhhhhhhhcccccc------CcchhhhhhHHHHh--------hhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 894 HNYARTALLDHVIDIVDPILIN------DVEDWDATNKQRLR--------QAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~------~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
..+..... ..+.+.+...... ...++......... ............++.+++.+|++.||++||
T Consensus 227 ~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 305 (316)
T cd07842 227 NPFQRDQL-ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI 305 (316)
T ss_pred chhHHHHH-HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence 00100000 0111111100000 00000000000000 000000124556789999999999999999
Q ss_pred CHHHHHH
Q 001974 960 SITNVVH 966 (988)
Q Consensus 960 s~~evl~ 966 (988)
|+.|+++
T Consensus 306 s~~eil~ 312 (316)
T cd07842 306 TAEEALE 312 (316)
T ss_pred CHHHHhc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=302.56 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=197.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcC---CCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIR---HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 739 (988)
.|+..+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++ |||++++++++. .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 4778899999999999999998899999999986442 334467889999999996 999999999854 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+. +++||||+|+||++++++.++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~ 141 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG------------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVK 141 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEE
Confidence 89999999999999998542 578899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||.+........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 142 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~ 212 (277)
T cd06917 142 LCDFGVAALLNQNSS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM 212 (277)
T ss_pred EccCCceeecCCCcc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh
Confidence 999999986544321 1122458889999998875 45688999999999999999999998632110 0000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......+.+ .....+.++.+++.+||+.||++||++.|+++.
T Consensus 213 -----~~~~~~~~~~---------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 -----LIPKSKPPRL---------------------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -----ccccCCCCCC---------------------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000000000 001256779999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=296.38 Aligned_cols=250 Identities=28% Similarity=0.397 Sum_probs=202.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
+|+..+.||+|++|.||+|.+..+++.|++|++........+.+.+|++++++++|++++++++++. .+...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4788899999999999999998889999999997655446678999999999999999999999854 34788999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~ 142 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN----------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDF 142 (253)
T ss_pred EecCCCCcHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeec
Confidence 99999999999987653 2689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
|.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..........
T Consensus 143 ~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~ 212 (253)
T cd05122 143 GLSAQLSDTKA-----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATN 212 (253)
T ss_pred ccccccccccc-----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhc
Confidence 99986554321 1234578899999999888899999999999999999999999863210 0000000000
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ........++..+.+++.+||+.||++|||+.|+++
T Consensus 213 ------~~-------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 ------GP-------------------PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ------CC-------------------CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000111224677999999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.49 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=191.9
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||+||+|.+..+|+.||+|.+.... ......+..|+++++.++||||+++++++. ..+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 689999999999998899999999986432 223446678999999999999999998853 457899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||.+.
T Consensus 76 ~~~~L~~~l~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 76 NGGDLKYHIYNVGE---------PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred CCCcHHHHHHHcCc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchh
Confidence 99999999865432 2588999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
....... .....++..|+|||++.+..++.++||||+||++|+|++|+.||....... ... .+.....
T Consensus 144 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~-----~~~~~~~- 211 (277)
T cd05577 144 ELKGGKK-----IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKE-----ELKRRTL- 211 (277)
T ss_pred hhccCCc-----cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHH-----HHHhccc-
Confidence 6543111 122357889999999988889999999999999999999999986422110 000 0000000
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
......+...++.+.+++.+||+.||++|| ++.++++
T Consensus 212 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 212 ----------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000111224567899999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.35 Aligned_cols=272 Identities=20% Similarity=0.227 Sum_probs=194.4
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++.+.||+|+||.||+|....+++.||+|+++... ........+|+.+++++ .|+|++++++++... ..+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 677899999999999999998899999999986432 22223455788899988 499999999986532 2367899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||++ +++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|
T Consensus 78 v~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~d 142 (282)
T cd07831 78 VFELMD-MNLYELIKGRK----------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLAD 142 (282)
T ss_pred EEecCC-ccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEe
Confidence 999995 68888876533 2589999999999999999999998 9999999999999999 9999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.++......... ...++..|+|||++.. ..++.++||||+||++|||++|+.||..... .+.........
T Consensus 143 fg~~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~ 215 (282)
T cd07831 143 FGSCRGIYSKPPYT-----EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVL 215 (282)
T ss_pred cccccccccCCCcC-----CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHc
Confidence 99998654332211 2347889999997654 5578899999999999999999999864211 11111111111
Q ss_pred hhh---hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDH---VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... +........... ..+.......+ .......+.++.+++.+||+.+|++||+++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 216 GTPDAEVLKKFRKSRHMN-YNFPSKKGTGL----RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCCHHHHHhhccccccc-ccCcccccccH----HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 000000000000 00000000000 0111245788999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.27 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=204.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...+.|+..+.||+|++|.||+|.+..+++.||+|+++.... ..+.+.+|+++++.++|+|++++++++.. ++.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence 356678899999999999999999988899999999975544 45678899999999999999999998643 478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF----------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEE
Confidence 999999999999999997643 2689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||.+........ ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... .....
T Consensus 157 l~d~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~ 227 (286)
T cd06614 157 LADFGFAAQLTKEKS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFL 227 (286)
T ss_pred ECccchhhhhccchh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 999999875443221 112234788999999998888999999999999999999999997632110 00000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... . ........++..+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~~--------~-----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 228 ITTKG--------I-----------------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHhcC--------C-----------------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00000 0 0001112356789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.74 Aligned_cols=281 Identities=25% Similarity=0.288 Sum_probs=201.4
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
+...+++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 80 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---- 80 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----
Confidence 445678999999999999999999999989999999987532 22334678899999999999999999998643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.....++|+||+ +++|.+++... ++++..+..++.|+++||+|||+. +|+||||+|+||+++++
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTSR------------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 235789999999 67898887542 467778889999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.++|+|||.+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ....
T Consensus 145 ~~~~l~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~ 215 (328)
T cd07856 145 CDLKICDFGLARIQDPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQF 215 (328)
T ss_pred CCEEeCccccccccCCC-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence 99999999998754321 112347889999998766 5689999999999999999999999863211 0000
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
............++..........+...........+.......++.++.+++.+||+.+|++||++++++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111110111111000000000000000000000001112456789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.96 Aligned_cols=282 Identities=24% Similarity=0.267 Sum_probs=199.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+.++++++|+||+++++++... ..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 34679999999999999999999998999999999874432 2234567899999999999999999986432 235
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++.... ..+++.++..++.||+.|++|||+. +++||||||+||++++++.+
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 147 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMP----------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCL 147 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 6899999995 68888876543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.+......... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... .......
T Consensus 148 kL~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~ 221 (309)
T cd07845 148 KIADFGLARTYGLPAKP----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLI 221 (309)
T ss_pred EECccceeeecCCccCC----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 99999999865432211 112235788999999865 4578999999999999999999999863211 1111111
Q ss_pred HHHHhhhhhhhhcccc-ccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPIL-INDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
................ ......... ....... ........++++.+++.+|++.||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 222 IQLLGTPNESIWPGFSDLPLVGKFTL-PKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHhcCCCChhhchhhhcccccccccc-cCCCCCc-hHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1100000000000000 000000000 0000000 000011246678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=297.32 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=191.2
Q ss_pred HHhhCCCCCCcee--ccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 659 FKATDGFSSTHLI--GMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 659 ~~~~~~y~~~~~l--g~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
....++|++.+.+ |+|+||.||+++.+.+++.+|+|++....... .|+.....+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~---- 80 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT---- 80 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec----
Confidence 3344677777776 99999999999999899999999986432221 122222223 79999999998543
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
++..++||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.+
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG-----------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 478999999999999999996543 689999999999999999999998 99999999999999999
Q ss_pred C-cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 M-IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+ .++|+|||.+....... ...++..|+|||++.+..++.++||||+|+++|||++|+.||......+....
T Consensus 146 ~~~~~l~dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS--------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred CCeEEEecCccceecCCCc--------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 8 99999999987543321 23478999999999998999999999999999999999999874322221111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-HHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-ITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 966 (988)
.+.... ..........++.+.+++.+||+.+|.+||+ ++|+++
T Consensus 218 ~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQ-----------------------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhh-----------------------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111100 0000111246677999999999999999996 588774
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.32 Aligned_cols=283 Identities=22% Similarity=0.287 Sum_probs=198.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++++ +||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999998999999999864322 2346788899999999 5699999999876542222334
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIA 818 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 818 (988)
.++||||++ ++|.+++....... ...+++..++.++.||+.||+|||+. +|+||||+|+||+++. ++.+
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~ 150 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGP------GRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLL 150 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeE
Confidence 799999996 58888876433210 13579999999999999999999998 9999999999999998 8899
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.+......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.... ......
T Consensus 151 kl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~----~~~~~~ 222 (295)
T cd07837 151 KIADLGLGRAFSIPVKS----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS----ELQQLL 222 (295)
T ss_pred EEeecccceecCCCccc----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 99999998754332111 112246788999998765 457899999999999999999999986321 111111
Q ss_pred HH--HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RT--ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~--~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. .......... +... ....+..... .............+.++.+++.+||+.||++||+++|++.
T Consensus 223 ~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 223 HIFKLLGTPTEQVW-PGVS-KLRDWHEFPQ-WKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHhCCCChhhC-cchh-hccchhhcCc-ccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000000000 0000 0000000000 0000000111346778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.88 Aligned_cols=278 Identities=24% Similarity=0.319 Sum_probs=198.2
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+|++.+.||+|++|.||+|++..+|+.||+|+++.... ...+.+.+|++++++++|+||+++++++.. .+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 58889999999999999999988999999999875432 334667889999999999999999999643 478899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||++ ++|.+++...... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|
T Consensus 76 v~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d 143 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVR--------GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLAD 143 (284)
T ss_pred EEecCC-ccHHHHHHhcCCC--------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEee
Confidence 999996 5888887654311 2589999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ......... .
T Consensus 144 ~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~-~ 217 (284)
T cd07836 144 FGLARAFGIPVN----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRI-M 217 (284)
T ss_pred cchhhhhcCCcc----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH-h
Confidence 999975433211 11123468899999987664 5688999999999999999999998642111 001110000 0
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.....+.... +. ....+...................+..+.+++.+|++.||++||+++|+++
T Consensus 218 ~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 218 GTPTESTWPG-IS-QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCCChhhHHH-Hh-cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 00 000000000000000000111235677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=326.24 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=193.2
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-----
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSID----- 733 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 733 (988)
+-..+|+..+.||+||||.||+++.+-+|+.||||++... .......+.+|+..+++++|||||+++..+.+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456788899999999999999999999999999999754 2334467889999999999999999984431110
Q ss_pred --------------------------------------------------cc----------------------------
Q 001974 734 --------------------------------------------------FQ---------------------------- 735 (988)
Q Consensus 734 --------------------------------------------------~~---------------------------- 735 (988)
+.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 00
Q ss_pred -------------------------------CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHH
Q 001974 736 -------------------------------GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784 (988)
Q Consensus 736 -------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 784 (988)
.....||-||||+...++++++.+... -.....++++++
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----------~~~d~~wrLFre 705 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----------SQRDEAWRLFRE 705 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----------hhhHHHHHHHHH
Confidence 002357889999888888888766521 035678999999
Q ss_pred HHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccc----cc----------ccccceeccccccccccc
Q 001974 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ----EV----------SNLTQSCSVGVRGTIGYA 850 (988)
Q Consensus 785 i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~----~~----------~~~~~~~~~~~~gt~~y~ 850 (988)
|++||+|+|++ |||||||||.||++|++..|||+|||+|+... .. ........++.+||.-|+
T Consensus 706 IlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 706 ILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 99999999999 99999999999999999999999999998722 10 011111234578999999
Q ss_pred cCcccCCC---CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHH
Q 001974 851 APEYGLGS---EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQR 927 (988)
Q Consensus 851 aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 927 (988)
|||++.+. .|+.|+|+||+|||++||+. ||....+. ......++ +..+..+ +++
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER---------a~iL~~LR---~g~iP~~-~~f------- 839 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER---------ASILTNLR---KGSIPEP-ADF------- 839 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH---------HHHHHhcc---cCCCCCC-ccc-------
Confidence 99998875 49999999999999999986 56543221 11111111 1111111 000
Q ss_pred HhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 928 LRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 928 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+..+.-..+|.+|++.||.+||||.|+++
T Consensus 840 --------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 --------FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0111223468999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=310.28 Aligned_cols=292 Identities=21% Similarity=0.219 Sum_probs=207.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998889999999986533 34456889999999999999999999987654222234789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 9999996 68988886543 688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||.+......... ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||...... .........
T Consensus 146 dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~ 222 (330)
T cd07834 146 DFGLARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEV 222 (330)
T ss_pred ccCceEeecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHh
Confidence 99999866543211 0112234578899999999887 7899999999999999999999998643211 000000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSVKN 973 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 973 (988)
......+...........++...................+..+.+++.+||+.+|++||+++++++. ++.++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000000000000000000000000111123467789999999999999999999999974 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.29 Aligned_cols=255 Identities=25% Similarity=0.308 Sum_probs=192.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. |+||+++++++. .++..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence 4666789999999999999999899999999986433 234467889999999995 999999999854 347788
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
++|||+. +++.++...... .....+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYE------VLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred EEEeccc-CCHHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEe
Confidence 9999984 455443321000 0013688999999999999999999973 289999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC---CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS---EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||+++........ ....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ..
T Consensus 151 dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~----- 216 (288)
T cd06616 151 DFGISGQLVDSIAK-----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SV----- 216 (288)
T ss_pred ecchhHHhccCCcc-----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hH-----
Confidence 99999755432211 123478899999998876 68899999999999999999999986321 00
Q ss_pred HHHhhhhhhhh---ccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIV---DPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+.+.... .+.+.. .....++.++.+++.+||+.||++|||++||++.
T Consensus 217 ---~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 217 ---FDQLTQVVKGDPPILSN------------------SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---HHHHhhhcCCCCCcCCC------------------cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111100 000000 1112467789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=301.96 Aligned_cols=276 Identities=28% Similarity=0.345 Sum_probs=197.7
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++.+.||+|++|.||+|.+..+|+.||+|++.... ....+.+.+|+++++.++|||++++++++. +++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 677899999999999999998899999999987443 223467889999999999999999999854 4488999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+ +++|.+++..... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 76 v~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~d 142 (283)
T cd07835 76 VFEFL-DLDLKKYMDSSPL---------TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLAD 142 (283)
T ss_pred EEecc-CcCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEee
Confidence 99999 5789999865432 2589999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+......... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .......+. .
T Consensus 143 f~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~-~ 216 (283)
T cd07835 143 FGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRT-L 216 (283)
T ss_pred cccccccCCCccc----cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-h
Confidence 9999754322111 1123468899999987664 5788999999999999999999998632110 001111000 0
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........+. .. ...++...................+.++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 217 GTPDEDVWPG-VT-SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCChHHhhh-hh-hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 00 000000000000000001112346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=303.50 Aligned_cols=286 Identities=22% Similarity=0.300 Sum_probs=201.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccc----
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSID---- 733 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 733 (988)
...++|++.+.||+|+||.||+|.++.+++.||+|+++... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999999889999999997432 233356788999999999999999999875432
Q ss_pred -ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 734 -FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 734 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
..+....++|+||+++ ++.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili 149 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL----------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILL 149 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 1223478999999965 7777665432 2689999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
++++.+||+|||.+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++||.... ..
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~ 224 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEESR---PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--EL 224 (302)
T ss_pred CCCCcEEeCcccccccccCCccc---ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hH
Confidence 99999999999999865443211 1112346788999998765 457889999999999999999999986321 11
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhh-HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATN-KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.................... .. ....+.... ...............+..+.+++.+||+.||++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPD-VI-KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHhCCCChhhccc-cc-ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111111110000000 00 000000000 000000000112245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=328.14 Aligned_cols=276 Identities=22% Similarity=0.394 Sum_probs=213.1
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEEC---C----CCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEee
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFD---Q----DGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITS 728 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~---~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 728 (988)
++...++..+.+.+|+|.||.||+|... . ....||||..+.... ...+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444555667779999999999999863 1 145799999874433 4557899999999999 79999999999
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCC-CC--CchhhhHh--hcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDA-VP--QKDVEIEI--QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHC 803 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~--~~~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 803 (988)
|.. ++..++|+||++.|+|.+|++..+ .. ........ ..++..+.+.++.|||.|++||++. ++|||
T Consensus 371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHR 442 (609)
T KOG0200|consen 371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHR 442 (609)
T ss_pred ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccch
Confidence 875 488999999999999999999877 10 00000011 2389999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCC
Q 001974 804 DLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882 (988)
Q Consensus 804 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p 882 (988)
|+.++|||++++..+||+|||+|+..............+. -+..|||||.+....|+.++|||||||++||++| |..|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 9999999999999999999999996555443322211111 3556999999999999999999999999999999 9999
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|...... .++..+ +. .......+..|+.+++++|+.||+.+|++||+++
T Consensus 522 Yp~~~~~-~~l~~~------------l~------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~ 570 (609)
T KOG0200|consen 522 YPGIPPT-EELLEF------------LK------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS 570 (609)
T ss_pred CCCCCcH-HHHHHH------------Hh------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 8642100 000000 00 1112234557889999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 001974 963 NVVHELQSVKN 973 (988)
Q Consensus 963 evl~~L~~i~~ 973 (988)
++++.++....
T Consensus 571 ~~~~~~~~~l~ 581 (609)
T KOG0200|consen 571 ECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHHHHHH
Confidence 99999998543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=280.36 Aligned_cols=288 Identities=23% Similarity=0.319 Sum_probs=207.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEee--ccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc---cC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF---QG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 736 (988)
...|+...+||+|.||.||+|+.+.+|+.||+|.+- .+..+......+|++++..++|+|++.+++.|....- .+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345777789999999999999999999999998764 3344556788999999999999999999999875422 23
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||.+| .-+|...+.... .+++..++.++++++..||.|+|.. .|+|||+||+|++|+.+|
T Consensus 96 r~t~ylVf~~c-ehDLaGlLsn~~----------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 96 RATFYLVFDFC-EHDLAGLLSNRK----------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDG 161 (376)
T ss_pred cceeeeeHHHh-hhhHHHHhcCcc----------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCc
Confidence 34589999999 468888887664 4799999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+|+.+..............+.|..|++||.+.+ ..|+++.|||+.||++.||+||.+-++.-.+ .....
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~ 239 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLH 239 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHH
Confidence 99999999998766554443333445667999999998877 5799999999999999999999988653211 11111
Q ss_pred HHHHHHhhhhhhh---hccc-cccCc--chhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDI---VDPI-LINDV--EDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~---~d~~-l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+.........+. .|.. +.... +.........++.. -.+..-.++..+|+.+++..||.+|++++++++.
T Consensus 240 ~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~--~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 240 LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNR--LKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhh--cccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111111111 1100 00000 00000000001000 0112223467899999999999999999998754
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.00 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=203.4
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++|+|++++.+.+. .++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 47888999999999999999988899999999975433 45567889999999999999999999853 347889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||+++++|.+++...... ...+++.++..++.+++.|++|||+. +++|+||+|+||++++++.++|+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~ 145 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE-------GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLG 145 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc-------CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEEC
Confidence 999999999999998764311 13689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+........ ......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... .........
T Consensus 146 d~~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~ 216 (258)
T cd08215 146 DFGISKVLSSTVD----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKIL 216 (258)
T ss_pred CccceeecccCcc----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHh
Confidence 9999986544321 1122357889999999988889999999999999999999999986321 111111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. . ....+..++.++.+++.+||..+|++|||+.|+++
T Consensus 217 ~~--------~-------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 217 KG--------Q-------------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred cC--------C-------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0 00112246678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=257.83 Aligned_cols=198 Identities=28% Similarity=0.453 Sum_probs=171.0
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.|...++||+|.||+||+|+...+++.||+|+++.. +++......+|+-+++.++|.|||+++++. ..+...-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 466678999999999999999999999999999744 344557889999999999999999999984 4458889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||| ..+|..|..... +.++.+.+..++.|+++|+.++|++ ++.|||+||.|.+|+.+|+.|++
T Consensus 78 lvfe~c-dqdlkkyfdsln----------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLN----------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred EeHHHh-hHHHHHHHHhcC----------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEec
Confidence 999999 678998887654 3688899999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHh-CCCCCC
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVT-GKKPTD 884 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~ellt-g~~p~~ 884 (988)
|||+|+.+.- ...+....+.|..|++|.++.+.+ |++..|+||.||++.|+.. |++.|.
T Consensus 144 dfglarafgi----pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 144 DFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ccchhhhcCC----ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 9999986543 233445566899999999998864 7889999999999999988 665554
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.19 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=193.8
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
|+..+.||+|+||.||+|++..++..||+|++.... ......+.+|++++++++|||++++++++.. ++..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence 667889999999999999998899999999986432 2233578899999999999999999999643 46789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++ |++.+++.... .++++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+
T Consensus 102 lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEeCCC-CCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence 9999995 57777765432 3688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||++...... ....++..|+|||++. ...++.++|||||||++|||++|+.||...... ....
T Consensus 168 dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~ 234 (317)
T cd06635 168 DFGSASIASPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALY 234 (317)
T ss_pred cCCCccccCCc--------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHH
Confidence 99998754321 1234788999999974 456889999999999999999999997532100 0000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
. +..... ........+..+.+++.+||+.+|++||++.++++...
T Consensus 235 ~--------~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 235 H--------IAQNES------------------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred H--------HHhccC------------------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0 000000 00011245667899999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=309.29 Aligned_cols=286 Identities=22% Similarity=0.264 Sum_probs=199.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||+++++++... ++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 356789999999999999999999888999999988532 223345677899999999 999999999986432 33
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~ 145 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN------------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCR 145 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCc
Confidence 56899999995 6998888543 467888899999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccc-cceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 818 AHVGDFGLARVRQEVSNL-TQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+||+|||.+......... .........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+ ...
T Consensus 146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~ 223 (337)
T cd07852 146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLE 223 (337)
T ss_pred EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHH
Confidence 999999999865433211 0112223468899999998765 457889999999999999999999986321110 000
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...........+..+........+...................++.++.+++.+||+.||++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000000000000000000000000001112367889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=301.60 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=196.5
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEee
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
...+||+|+||.||+|....+++.||+|.+..........+.+|+.+++.++|+|++++++++. .++..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEec
Confidence 3468999999999999998899999999986554445567889999999999999999999854 45789999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccc
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 826 (988)
+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 99 ~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~ 163 (292)
T cd06657 99 LEGGALTDIVTHT------------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC 163 (292)
T ss_pred CCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999987532 478889999999999999999998 9999999999999999999999999988
Q ss_pred ccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhh
Q 001974 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVI 906 (988)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 906 (988)
........ ......++..|+|||.+.+..++.++||||+|+++|+|++|..||..... ..... . +.
T Consensus 164 ~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~-~----~~ 229 (292)
T cd06657 164 AQVSKEVP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMK-M----IR 229 (292)
T ss_pred eecccccc----cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH-H----HH
Confidence 75433211 11224578899999999888889999999999999999999999863100 00000 0 00
Q ss_pred hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 907 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
....+. ......++..+.+++.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~~--------------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 230 DNLPPK--------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred hhCCcc--------------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 000000 01112456778999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.90 Aligned_cols=288 Identities=21% Similarity=0.259 Sum_probs=203.9
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
..++...+++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4556778899999999999999999999998899999999986432 22345678899999999999999999986533
Q ss_pred c-ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 733 D-FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 733 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
. +......+++++++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 152 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA 152 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence 1 12334578888887 88998887532 578899999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
+++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~- 224 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI- 224 (345)
T ss_pred EcCCCCEEEeccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999999999999998754321 122357889999998766 56788999999999999999999998532110
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......... .....+............+...................++++.+++.+|++.||.+||++.++++.
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 225 DQLKLILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHHh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0111110000 000001000000000000000000000000000011346678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.85 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=193.9
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. ++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999998889999999986432 234467899999999999999999999854 457899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 ~~~~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 76 LGGELWTILRDRG-----------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred CCCcHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 9999999997643 478889999999999999999998 99999999999999999999999999998
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ......
T Consensus 142 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-------- 205 (262)
T cd05572 142 KLKSGQ-----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND-------- 205 (262)
T ss_pred ccCccc-----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH--------
Confidence 654432 1122357889999999988889999999999999999999999986432110 001000
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
+.+. ......+...+.++.+++.+||+.+|++||+ ++|+++
T Consensus 206 ~~~~------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 206 ILKG------------------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred Hhcc------------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000 0011122234678999999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.27 Aligned_cols=277 Identities=25% Similarity=0.310 Sum_probs=198.8
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+|++++++++|+|++++++++... ..+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999998889999999997553 33446788999999999999999999996532 1378999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||++ ++|.+++.... ..+++.+++.++.||+.|++|||+. +++|+||+|+||++++++.+||+|
T Consensus 78 v~e~~~-~~l~~~~~~~~----------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d 143 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE----------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLAD 143 (287)
T ss_pred Eecccc-ccHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcc
Confidence 999996 58988886543 2688999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 144 ~g~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~ 218 (287)
T cd07840 144 FGLARPYTKRNSA---DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELC 218 (287)
T ss_pred ccceeeccCCCcc---cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHh
Confidence 9999866543211 1122346788999998765 45789999999999999999999998632110 0000000000
Q ss_pred hhh-hhhhhccccccCcch--hhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDH-VIDIVDPILINDVED--WDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~-~~~~~d~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ...+.+......... ........+.. .....++.++.+++.+||+.+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLRE---FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHH---HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 000000000000000 00000000000 001114778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=296.85 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=186.8
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHH-hcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALK-NIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|.+..+++.||+|+++.... .....+..|..++. ..+|+|++++++++. .++..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 578999999999999988999999999864322 11233445555444 448999999999854 447899999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||
T Consensus 77 e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 77 EYLNGGDCASLIKTLG-----------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred eccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence 9999999999986542 578899999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 904 (988)
++..... .....++..|+|||.+.+..++.++||||||+++|||++|..||..... ...........
T Consensus 143 ~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 209 (260)
T cd05611 143 LSRNGLE--------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRR 209 (260)
T ss_pred cceeccc--------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcc
Confidence 9875432 1123478899999999888889999999999999999999999863211 11100000000
Q ss_pred hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 905 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .| .......++..+.+++.+||+.+|++||++.++.+.
T Consensus 210 ~-------------~~-----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 210 I-------------NW-----------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred c-------------CC-----------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 0 00 000112467789999999999999999987655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=301.72 Aligned_cols=279 Identities=24% Similarity=0.278 Sum_probs=196.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|++|.||+|.+..+++.||+|.++.... ...+.+.+|++++++++||||+++++++. .+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 578999999999999999999988999999999864322 23467889999999999999999999954 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 819 (988)
++||||++ +++.+++..... ..+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+|
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~k 143 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD---------FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALK 143 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC---------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEE
Confidence 99999994 688887754331 2357788899999999999999998 9999999999999985 56799
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||++........ ......++..|+|||++.+ ..++.++||||+||++|+|+||+.||......+ .+....
T Consensus 144 l~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~- 217 (294)
T PLN00009 144 LADFGLARAFGIPVR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIF- 217 (294)
T ss_pred EcccccccccCCCcc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-
Confidence 999999975433211 1112347889999998866 457899999999999999999999986321110 000000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...........+.. .+..++...................++++.+++.+|++.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 218 RILGTPNEETWPGV--TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHhCCCChhhcccc--ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000000 00000000000000000001123456778999999999999999999999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=300.65 Aligned_cols=278 Identities=24% Similarity=0.281 Sum_probs=197.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhc---CCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNI---RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 739 (988)
|++.+.||+|+||.||+|+++.+++.||+|+++.... .....+.+|+.+++++ .|+|++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999988899999999974322 2234566788777666 5999999999977653333345
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+|
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---------~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---------PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEE
Confidence 899999995 589888865431 2588999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||.+......... ....++..|+|||++.+..++.++|||||||++|||++|++||...... ..+......
T Consensus 148 l~dfg~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~ 221 (287)
T cd07838 148 IADFGLARIYSFEMAL-----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDV 221 (287)
T ss_pred EeccCcceeccCCccc-----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHH
Confidence 9999999765433211 1234788999999999989999999999999999999999998632111 011111100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........+.... ......+. ..............+..+.+++.+||+.||++||+++|++.
T Consensus 222 ~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 222 IGLPSEEEWPRNV-SLPRSSFP----SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCChHhcCCCc-ccchhhcc----cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000000 00000000 00000001111244577889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=308.51 Aligned_cols=283 Identities=22% Similarity=0.251 Sum_probs=199.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+|+.||+|+++.. .......+.+|++++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999889999999998643 22233568899999999999999999998754311 1224
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++|+||+. .++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 5689999994 57766542 2578889999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 157 kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-----~~~~~ 224 (342)
T cd07879 157 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQL 224 (342)
T ss_pred EEeeCCCCcCCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHH
Confidence 99999998754321 112357889999999876 468899999999999999999999986321 11111
Q ss_pred HHHHhh---hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHHH
Q 001974 898 RTALLD---HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSVK 972 (988)
Q Consensus 898 ~~~~~~---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 972 (988)
...... ...++.+.........+........+..........+.++.+++.+||+.||++||+++|++.. ++.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 110000 0000000000000000000000000000000012355678999999999999999999999954 66665
Q ss_pred H
Q 001974 973 N 973 (988)
Q Consensus 973 ~ 973 (988)
.
T Consensus 305 ~ 305 (342)
T cd07879 305 D 305 (342)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.05 Aligned_cols=248 Identities=30% Similarity=0.398 Sum_probs=201.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|++|.||+|+...+++.||+|.+..... ...+.+.+|++++++++|+|++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 47889999999999999999988899999999975543 34567899999999999999999999854 347889
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~ 141 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG-----------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLA 141 (254)
T ss_pred EEEecCCCCcHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 9999999999999986542 689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ....... .
T Consensus 142 d~~~~~~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~-~- 211 (254)
T cd06627 142 DFGVATKLNDVSKD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFR-I- 211 (254)
T ss_pred ccccceecCCCccc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH-H-
Confidence 99999866543221 122457889999999888888999999999999999999999986321 0000000 0
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ......+...+..+.+++.+||..+|++|||+.|++.
T Consensus 212 ---~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 ---VQ-----------------------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---hc-----------------------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 0000112245678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=324.88 Aligned_cols=281 Identities=19% Similarity=0.195 Sum_probs=188.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC-eEEEEE------------------EeeccccchhHHHHHHHHHHHhcCCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG-TIVAIK------------------VFNLQRHGASKSFLAECKALKNIRHRNL 722 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~-~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni 722 (988)
.++|++++.||+|+||+||++..+... ..++.| .++ ........+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 468999999999999999998764322 122222 111 111234568899999999999999
Q ss_pred eEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 001974 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLH 802 (988)
Q Consensus 723 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 802 (988)
+++++++. .++..++|+|++ ++++.+++........ ......++..|+.||+.||+|||++ +|||
T Consensus 226 v~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~~~------~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH 290 (501)
T PHA03210 226 LKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFDWK------DRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290 (501)
T ss_pred CcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhcccccc------ccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999954 347789999999 5778877754432111 1234567888999999999999998 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 803 CDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 803 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
|||||+|||++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCccccc---ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999865432211 12235689999999999999999999999999999999998754
Q ss_pred -CCccccCCcchHHHHHHHHhhh--hhhhhccccccCcchhhhhhHHHH-----hhhhhccccchhHHHHHHhhcccCcC
Q 001974 883 -TDVMFEGDLNLHNYARTALLDH--VIDIVDPILINDVEDWDATNKQRL-----RQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 883 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
+...... ...........-. ..++.+.. ..-|.......+ ...........+..+.+++.+|++.|
T Consensus 368 p~~~~~~~--~~~~~~~~~~~~~~~~~~~p~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 368 PIGDGGGK--PGKQLLKIIDSLSVCDEEFPDPP----CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred CccCCCCC--HHHHHHHHHHhcccChhhcCCcH----HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 3321111 1111110000000 00000000 000000000000 00000011235567888999999999
Q ss_pred CCCCCCHHHHHHH
Q 001974 955 PQDRMSITNVVHE 967 (988)
Q Consensus 955 P~~RPs~~evl~~ 967 (988)
|++|||+.|+++.
T Consensus 442 P~~Rpsa~elL~h 454 (501)
T PHA03210 442 WHLRPGAAELLAL 454 (501)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.95 Aligned_cols=254 Identities=25% Similarity=0.355 Sum_probs=203.6
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|+..+.||+|++|.||+|....+++.|++|++..... ...+.+.+|++++++++||||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 47788999999999999999988899999999875442 4457889999999999999999999986432 126789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+|+||+++++|.+++.... .+++.+++.++.|++.|++|||+. +++||||+|+||+++.++.++|+
T Consensus 78 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~ 143 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG-----------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLA 143 (260)
T ss_pred EEEEecCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence 9999999999999986543 688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||.+......... .......++..|+|||...+...+.++||||||+++|+|++|..||.... ......
T Consensus 144 d~~~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~---- 213 (260)
T cd06606 144 DFGCAKRLGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAAL---- 213 (260)
T ss_pred ccccEEeccccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHH----
Confidence 99999866543321 01123458889999999988889999999999999999999999987432 000000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ......+...+..+.+++.+|++.+|++||++.|+++
T Consensus 214 ----~~~~~~------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 214 ----YKIGSS------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ----Hhcccc------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000000 0001112245678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=297.93 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=193.3
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||.||+|++..+|+.||+|++..... ...+.+.+|++++++++||||+++++.+ ..+...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988899999999864433 3456788999999999999999998874 3457899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++.
T Consensus 76 ~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 76 PGGDLASLLENVG-----------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred CCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9999999986532 578999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccc----ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 828 VRQEVSNLT----QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 828 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
......... ........++..|+|||......++.++||||||+++||+++|+.||..... ......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~---- 212 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQN---- 212 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----
Confidence 543321100 1112234578899999999888899999999999999999999999863211 011100
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
+.. .. ..| ......+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 213 -~~~-------~~-~~~-------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 213 -ILN-------GK-IEW-------------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -Hhc-------CC-cCC-------------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000 00 000 00112367899999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.82 Aligned_cols=243 Identities=21% Similarity=0.268 Sum_probs=185.9
Q ss_pred eeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHH---HHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECK---ALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.||+|+||.||+|.+..+++.||+|.+..... .....+..|.. .++...||+|+++++++. .++..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 47999999999999988899999999864322 11122344443 344457999999998844 45789999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
|||+++++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 76 ~e~~~g~~L~~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~df 141 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL 141 (278)
T ss_pred EecCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccC
Confidence 99999999999886432 689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
|++....... .....|+..|+|||++.++ .++.++||||+||++|||++|+.||......... .....
T Consensus 142 g~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~--- 210 (278)
T cd05606 142 GLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM--- 210 (278)
T ss_pred cCccccCccC------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHH---
Confidence 9987543221 1123589999999998754 6899999999999999999999998643211100 00000
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
........+...+.++.+++.+|+..+|++|| ++.|+++.
T Consensus 211 -------------------------~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 211 -------------------------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -------------------------hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00000111224567899999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=295.51 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=200.7
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+|++.+.||+|+||.||++++..+++.+|+|.+.... ......+.+|++++++++|+||+++.+++. .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4888999999999999999998899999999987432 233457788999999999999999998854 348899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~ 145 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK-------RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIG 145 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEe
Confidence 999999999999998653211 13688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++....... .....++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... .......
T Consensus 146 d~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~- 213 (256)
T cd08530 146 DLGISKVLKKNM------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKV- 213 (256)
T ss_pred eccchhhhccCC------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-
Confidence 999998665431 1123478899999999998999999999999999999999999863211 0100000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. . .....+...+.++.+++.+|++.+|++||++.|+++
T Consensus 214 ~~-------~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 QR-------G-------------------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hc-------C-------------------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0 000111245677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.44 Aligned_cols=277 Identities=21% Similarity=0.276 Sum_probs=205.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-C-C----CceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-H-R----NLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~ 735 (988)
+++|.++..+|+|.||.|-++.+..++..||||+++.. ....+..+-|+++++++. + | -++.+.+| |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 67899999999999999999999888999999999743 234567788999999993 2 2 26667676 56
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN- 814 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 814 (988)
..++.|||+|.+ |.++.+++..+.. .+++..+++.|+.|++++++|||+. +++|-||||+||++.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y---------~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNY---------IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCc---------cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 679999999999 8899999988764 4789999999999999999999999 9999999999999932
Q ss_pred -------------------CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHH
Q 001974 815 -------------------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE 875 (988)
Q Consensus 815 -------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 875 (988)
+..++++|||.|+...+.. ...+.|..|+|||++.+-.++.++||||+||+|+|
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 2358999999998755433 23568999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccc-----cccCcchhhhhhHHH-----Hhhhh-----hccccchh
Q 001974 876 MVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPI-----LINDVEDWDATNKQR-----LRQAK-----INGKIECP 940 (988)
Q Consensus 876 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-----l~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~ 940 (988)
+.||...|+.-.. .+-...+...+.+-...++... .....-+|+.....+ .+..+ ........
T Consensus 302 lytG~~LFqtHen--~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 302 LYTGETLFQTHEN--LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred eeccceecccCCc--HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 9999999874321 1111122221111111111111 111122333222222 00000 00112334
Q ss_pred HHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 941 ISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 941 ~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.++.+|+++|+..||.+|+|+.|++.
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhc
Confidence 56999999999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.25 Aligned_cols=276 Identities=24% Similarity=0.272 Sum_probs=199.0
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++.+.||+|++|.||+|....+++.+|+|+++.... .....+.+|++++++++|+||+++++++. .++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 6778999999999999999988999999999864432 24567889999999999999999999854 4488999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
|+||++ +++.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.++|+|
T Consensus 76 v~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 141 (283)
T cd05118 76 VFEFMD-TDLYKLIKDRQ----------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLAD 141 (283)
T ss_pred EEeccC-CCHHHHHHhhc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEee
Confidence 999995 58888876543 2689999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+........ ......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...... +.........
T Consensus 142 f~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~ 215 (283)
T cd05118 142 FGLARSFGSPVR----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI--DQLFKIFRTL 215 (283)
T ss_pred eeeeEecCCCcc----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHc
Confidence 999976544321 11123578899999998876 7899999999999999999999998632110 0000000000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......... ...........................++.++.+++.+||+.||.+||++.+++.
T Consensus 216 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 216 GTPDPEVWP-KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCCchHhcc-cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000 0000000000000000000000111246778999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.41 Aligned_cols=279 Identities=22% Similarity=0.258 Sum_probs=199.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QG 736 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 736 (988)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999998899999999985322 2234568899999999999999999998653211 11
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~------------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE------------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 13468999999 78998887532 578899999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||++....... ....++..|+|||.+.+ ..++.++||||+||++|++++|+.||..... ...
T Consensus 156 ~~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~ 224 (343)
T cd07880 156 ELKILDFGLARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQ 224 (343)
T ss_pred CEEEeecccccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence 99999999997543311 12347889999998876 4588999999999999999999999863211 111
Q ss_pred HHHHHHhh--h-hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLD--H-VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~--~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... . ..++...........+........+.........++.++.+++.+|++.||++|||+.++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 225 -LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred -HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0 00000000000000000000000000000112356677899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.54 Aligned_cols=286 Identities=21% Similarity=0.258 Sum_probs=198.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccc--------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSID-------- 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 733 (988)
..+|++.+.||+|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999999899999999997666556678889999999999999999998755321
Q ss_pred -ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 734 -FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 734 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+......++||||++ ++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili 147 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG------------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFI 147 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 111245789999995 6898887532 578899999999999999999998 99999999999999
Q ss_pred C-CCCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 813 D-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 813 ~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
+ +++.+|++|||.++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred cCCCceEEECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7 45678999999997653321111 11112347889999998654 567889999999999999999999986432110
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
............ ..+........ .......................+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 -~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 -QMQLILESVPVV-REEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred -HHHHHHHhcCCC-ChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000 00000000000 000000000000000001112456778999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.80 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=197.3
Q ss_pred CCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc----cchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR----HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
+|++.+.||+|++|.||+|+.. .+++.||+|+++... ....+.+.+|++++.++ +||+|+++++.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4778899999999999999863 367889999986432 22345688999999999 699999999874 4
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.+...++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~ 141 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE-----------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSE 141 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC-----------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC
Confidence 4578899999999999999986432 578889999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCC--CCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE--VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
+.++|+|||+++........ ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... ...
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~ 217 (288)
T cd05583 142 GHVVLTDFGLSKEFLAEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQ 217 (288)
T ss_pred CCEEEEECcccccccccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chH
Confidence 99999999998765432211 112245789999999987655 788999999999999999999998531110 001
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..... .+.. .....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 218 ~~~~~-----~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 218 SEISR-----RILK-----------------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHH-----HHHc-----------------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01100 0000 00111224567789999999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=296.65 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=191.5
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
|...+.||+|+||+||+|++..+++.||+|++..... .....+.+|+++++.++|||++++++++.. +...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 5667889999999999999988999999999864322 233567889999999999999999999644 47789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+ .+++.+++.... .++++.++..++.||+.|++|||+. +++||||+|+||+++.++.+||+
T Consensus 98 lv~e~~-~~~l~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~ 163 (313)
T cd06633 98 LVMEYC-LGSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 163 (313)
T ss_pred EEEecC-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEe
Confidence 999999 467777775433 3588999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|||.+...... ....|+..|+|||++. ...++.++|||||||++|||++|..||..... .....
T Consensus 164 dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~ 230 (313)
T cd06633 164 DFGSASKSSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALY 230 (313)
T ss_pred ecCCCcccCCC--------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence 99998643211 1245888999999974 45688899999999999999999999753211 00000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
....... +. ......+..+.+++.+||+.+|.+||++.++++.
T Consensus 231 ~~~~~~~-----~~---------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 HIAQNDS-----PT---------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHhcCC-----CC---------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00 0011345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.59 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=201.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 738 (988)
++|.+.+.||+|+||.||+|+...+++.||+|++... .....+.+..|++++++++ ||||+++++++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4788999999999999999999989999999998642 2233467889999999998 99999999884 4457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG-----------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI 141 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence 8999999999999999997543 689999999999999999999998 99999999999999999999
Q ss_pred EEeeeccccccccccccc----------------ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 819 HVGDFGLARVRQEVSNLT----------------QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
+++|||++.......... ........++..|+|||...+..++.++||||||+++|++++|+.|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 999999998654432110 0112234578899999999888899999999999999999999999
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH-
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI- 961 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~- 961 (988)
|..... . ... +.+. ......+...++.+.+++.+||+.+|++||++
T Consensus 222 ~~~~~~----~-~~~-----~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 222 FRGSNE----Y-LTF-----QKIL-----------------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred CCCccH----H-HHH-----HHHH-----------------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 874310 0 000 0000 00111223457789999999999999999999
Q ss_pred ---HHHHH
Q 001974 962 ---TNVVH 966 (988)
Q Consensus 962 ---~evl~ 966 (988)
+|+++
T Consensus 269 ~~~~~ll~ 276 (280)
T cd05581 269 EGYDELKA 276 (280)
T ss_pred cCHHHHhc
Confidence 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.62 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=193.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ......+..|+.++.+. .||||+++++++.. +.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 3467899999999999999999998789999999997433 23345567788777777 59999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+ ++++.+++.... ..+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~ 154 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ----------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNV 154 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCE
Confidence 899999998 557776664422 2588899999999999999999973 289999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCC----CCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE----VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
||+|||++......... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... .
T Consensus 155 kL~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~- 225 (296)
T cd06618 155 KLCDFGISGRLVDSKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---F- 225 (296)
T ss_pred EECccccchhccCCCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---H-
Confidence 99999998765432211 1234788999999987653 788999999999999999999998632111 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... ....... .. ......++.++.+++.+||+.||++||++.++++.
T Consensus 226 ~~~~--------~~~~~~~----~~-------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 EVLT--------KILQEEP----PS-------------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHH--------HHhcCCC----CC-------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000000 00 00111356789999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.11 Aligned_cols=200 Identities=21% Similarity=0.303 Sum_probs=161.6
Q ss_pred ceeccc--cceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMG--SFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G--~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
..||+| +||+||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .++..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456666 89999999998899999999987433 233467889999999999999999999954 457889999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+.++++.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+
T Consensus 79 e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~ 146 (328)
T cd08226 79 PFMAYGSANSLLKTYFP---------EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS 146 (328)
T ss_pred ecccCCCHHHHHHhhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence 99999999999876432 2578899999999999999999998 99999999999999999999999998
Q ss_pred ccccccccccccc---eeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 825 LARVRQEVSNLTQ---SCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 825 ~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
.+........... .......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 6543322111000 000112356779999998763 478999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.06 Aligned_cols=269 Identities=19% Similarity=0.205 Sum_probs=188.4
Q ss_pred cceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccccch
Q 001974 675 SFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSL 752 (988)
Q Consensus 675 ~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL 752 (988)
++|.||.++...+++.||+|+++.. .....+.+.+|+++++.++|+||+++++++. ..+..+++|||+++++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence 4455666666668999999998754 3344568999999999999999999999853 45788999999999999
Q ss_pred hhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccccc
Q 001974 753 ENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832 (988)
Q Consensus 753 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 832 (988)
.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 87 ~~~l~~~~~---------~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~ 154 (314)
T cd08216 87 EDLLKTHFP---------EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH 154 (314)
T ss_pred HHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence 999875432 2578888999999999999999998 9999999999999999999999999988754322
Q ss_pred ccc---cceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 833 SNL---TQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 833 ~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
... .........++..|+|||++.. ..++.++|||||||++|||++|+.||....... ... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~-~~~~~~~~~ 229 (314)
T cd08216 155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLL-EKVRGTVPC 229 (314)
T ss_pred cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHHhccCcc
Confidence 111 0111123457788999999876 357899999999999999999999987431111 111 011101111
Q ss_pred hhccccccC----cc----hhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 908 IVDPILIND----VE----DWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 908 ~~d~~l~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.++...... .. .+.... ...............++.+++.+||+.||++|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 230 LLDKSTYPLYEDSMSQSRSSNEHPN--NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccCchhhhcCCcCcccccccccc--hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 111000000 00 000000 00000111122345678899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=309.58 Aligned_cols=283 Identities=21% Similarity=0.249 Sum_probs=199.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QG 736 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 736 (988)
...++|++.+.||+|++|.||+|++..+++.||+|++... .....+.+.+|+.++++++|||++++++++..... ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999999889999999998642 22334567789999999999999999887543211 22
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++|+||+ +++|.+++.. .++++.++..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 23489999999 7899998864 2588999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||...... ....
T Consensus 156 ~~kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~ 226 (343)
T cd07851 156 ELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLK 226 (343)
T ss_pred CEEEcccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHH
Confidence 9999999999865332 122357889999998765 46788999999999999999999998632110 0000
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
............+...........+........+..........+.++.+++.+||+.||++|||+.|+++.
T Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 227 RIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000000000000000000000000000112346789999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=299.38 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=193.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+.|+..+.||+|+||.||+|++..+++.||+|.+... .....+++.+|+++++.++|+|++++++++.. +..
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 3477788999999999999999888999999998632 22334567889999999999999999998643 477
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~----------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEE
Confidence 899999995 68877765332 2578899999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|+|||++...... ....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ..
T Consensus 156 l~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~ 222 (308)
T cd06634 156 LGDFGSASIMAPA--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA 222 (308)
T ss_pred ECCcccceeecCc--------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HH
Confidence 9999998754321 1234788999999874 356788999999999999999999997532100 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
... .... ..+. ......+..+.+++.+||+.+|++||+++++++.-.
T Consensus 223 ~~~-~~~~----~~~~---------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 223 LYH-IAQN----ESPA---------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHH-Hhhc----CCCC---------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 000 0000 0000 001245667899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=295.67 Aligned_cols=275 Identities=22% Similarity=0.250 Sum_probs=195.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|++.+.||+|++|+||+|+...+++.||+|.+..... .......+|+..+++++ |+|++++++++.. ++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 6778999999999999999988899999999864332 12234567999999998 9999999998543 588999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+ +|+|.+++..... ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|
T Consensus 76 v~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d 142 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG---------KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIAD 142 (283)
T ss_pred EEecC-CCCHHHHHHhccc---------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEee
Confidence 99999 8899988865431 3689999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.+......... ....++..|+|||++.. ..++.++||||||+++|||++|+.||......+ .........
T Consensus 143 ~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~ 215 (283)
T cd07830 143 FGLAREIRSRPPY-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVL 215 (283)
T ss_pred cccceeccCCCCc-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhc
Confidence 9999765432221 12347889999998754 567899999999999999999999986431110 000000000
Q ss_pred hhhhhh-hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVID-IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.....+ +.+.........+.. ...............+..+.+++.+||+.||++|||++|++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 216 GTPTKQDWPEGYKLASKLGFRF--PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CCCChhhhhhHhhhhccccccc--cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 000000000000000 000000000001123577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=301.34 Aligned_cols=285 Identities=23% Similarity=0.250 Sum_probs=198.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccc---cC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDF---QG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 736 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999998999999999864322 223467889999999999999999987654311 22
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++|+||+. +++.+.+.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~----------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS----------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQG 152 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 346799999995 56777665432 2689999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccc-------eeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQ-------SCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
.++|+|||+++.......... .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||.....
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999986543221111 11123457888999998765 4578999999999999999999999863211
Q ss_pred CCcchHHHHHHHHhhh-hhhhhccccccCcchhh--hhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 889 GDLNLHNYARTALLDH-VIDIVDPILINDVEDWD--ATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
. ............. ...+.+........++. ........ .........+.+++.+|++.||++|||+.|++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 233 I--DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE----ERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred H--HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHH----HHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 1 0000000000000 00000000000000000 00000000 01123446789999999999999999999987
Q ss_pred H
Q 001974 966 H 966 (988)
Q Consensus 966 ~ 966 (988)
.
T Consensus 307 ~ 307 (311)
T cd07866 307 E 307 (311)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=295.17 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=194.0
Q ss_pred CCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc----cchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR----HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
+|++.+.||+|+||.||.|... .+|+.||+|+++... ....+.+.+|+++++++ +|++|+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4788899999999999999874 478899999986432 22335678899999999 699999999884 3
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.+...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~ 141 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE-----------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSN 141 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCC
Confidence 4578899999999999999986542 578889999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
+.+||+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ...
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~ 217 (290)
T cd05613 142 GHVVLTDFGLSKEFHEDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQ 217 (290)
T ss_pred CCEEEeeCccceeccccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccH
Confidence 99999999999765332211 11224588999999998753 4678999999999999999999998632111 011
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
..... .+.. .....+..+++.+.+++.+||+.||++|| +++++++.
T Consensus 218 ~~~~~-----~~~~-----------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 218 AEISR-----RILK-----------------------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHH-----Hhhc-----------------------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11110 0000 00011234567789999999999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-33 Score=319.94 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=205.7
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
.++....++|+++++||+|+||.|..++.+.+++.||+|++... ......-|..|-.+|..-..+=|+.+..+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---- 143 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---- 143 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence 34455668899999999999999999999999999999999752 34455679999999988888888887765
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
|+++.+.|+|||||+||+|-.++.... ++++..++.++..|+.||+-+|+. |+|||||||+|||+
T Consensus 144 -FQD~~~LYlVMdY~pGGDlltLlSk~~-----------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 144 -FQDERYLYLVMDYMPGGDLLTLLSKFD-----------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLL 208 (1317)
T ss_pred -hcCccceEEEEecccCchHHHHHhhcC-----------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEe
Confidence 788899999999999999999998764 589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
|..|++||+|||.+.......... ....+|||.|.+||+++. +.|+..+|.||+||++|||+.|..||...
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~---s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad- 284 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVR---SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD- 284 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEE---eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-
Confidence 999999999999998776544322 233579999999999763 56899999999999999999999998521
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC---HHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS---ITNV 964 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev 964 (988)
.++.-... +...-+. +.. +...+++.+..+||.+.+. +|+.|.. ++|+
T Consensus 285 ----slveTY~K-----Im~hk~~----------------l~F---P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 285 ----SLVETYGK-----IMNHKES----------------LSF---PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred ----HHHHHHHH-----Hhchhhh----------------cCC---CcccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 11111111 1110000 000 0113577888999998764 8888887 8777
Q ss_pred HH
Q 001974 965 VH 966 (988)
Q Consensus 965 l~ 966 (988)
..
T Consensus 336 k~ 337 (1317)
T KOG0612|consen 336 KN 337 (1317)
T ss_pred Hh
Confidence 64
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=300.58 Aligned_cols=279 Identities=22% Similarity=0.269 Sum_probs=196.1
Q ss_pred hCCCCC-CceeccccceeEEEEEECCCCeEEEEEEeeccccch--------------hHHHHHHHHHHHhcCCCCceEEE
Q 001974 662 TDGFSS-THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--------------SKSFLAECKALKNIRHRNLVKVI 726 (988)
Q Consensus 662 ~~~y~~-~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 726 (988)
.++|.. .+.||+|+||+||+|.+..+++.||+|+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 467999999999999998899999999986432211 12577899999999999999999
Q ss_pred eecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 727 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
+++. .++..++||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||+
T Consensus 87 ~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~ 146 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMA-SDLKKVVDRKI-----------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLS 146 (335)
T ss_pred EEEe-----cCCcEEEEEeccc-cCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 9854 4478999999995 79998886432 588999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccc----------cceeccccccccccccCcccCCC-CCCCccchHHHHHHHHH
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNL----------TQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLE 875 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~e 875 (988)
|+||+++.++.+||+|||.+......... .........++..|+|||.+.+. .++.++||||+||++||
T Consensus 147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999999765411100 00111123467889999998764 46899999999999999
Q ss_pred HHhCCCCCCccccCCcchHHHHHHHHhhhhhh-hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC
Q 001974 876 MVTGKKPTDVMFEGDLNLHNYARTALLDHVID-IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 876 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
|++|+.||...... ................ +.+.........+........ .......+.++.+++.+||+.+
T Consensus 227 l~tg~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 227 LLTGKPLFPGENEI--DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL----KTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHhCCCCCCCCCHH--HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH----HHhCcCCChHHHHHHHHHcCCC
Confidence 99999998632111 1001110000000000 000000000000000000000 0112245677899999999999
Q ss_pred CCCCCCHHHHHH
Q 001974 955 PQDRMSITNVVH 966 (988)
Q Consensus 955 P~~RPs~~evl~ 966 (988)
|++|||++|++.
T Consensus 301 P~~R~s~~~~l~ 312 (335)
T PTZ00024 301 PLERISAKEALK 312 (335)
T ss_pred chhccCHHHHhc
Confidence 999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-34 Score=277.36 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=195.0
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEEEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
-...||.|+||+|++-.++.+|+..|||+++.... ...+++..|.+...+- +.||||++||.+.. ++..||.|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCM 142 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICM 142 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeH
Confidence 34679999999999999999999999999985544 4557788888866555 78999999999653 36789999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
|.| ..+++.+...-. ......+++.-+-+|+...+.||.||-+. ..|||||+||+|||++..|.+||||||
T Consensus 143 ELM-d~SlDklYk~vy------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVY------SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred HHH-hhhHHHHHHHHH------HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeeccc
Confidence 999 677776653211 12235788888888999999999999876 489999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
++..+..+-..+ ..+|-..|||||.+.. ..|+.+|||||+|+++||+.||+.||... .. ..
T Consensus 214 IcGqLv~SiAkT-----~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w----------~s--vf 276 (361)
T KOG1006|consen 214 ICGQLVDSIAKT-----VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW----------DS--VF 276 (361)
T ss_pred chHhHHHHHHhh-----hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH----------HH--HH
Confidence 998765543222 2358899999998865 35899999999999999999999998632 11 22
Q ss_pred hhhhhhh--c-cccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 903 DHVIDIV--D-PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 903 ~~~~~~~--d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+++..++ | |.+..+.+ ..+....+..++..|+.+|-.+||+..++.+.
T Consensus 277 eql~~Vv~gdpp~l~~~~~-----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 277 EQLCQVVIGDPPILLFDKE-----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHcCCCCeecCccc-----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3322211 1 11211111 13466779999999999999999999998764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=293.63 Aligned_cols=270 Identities=26% Similarity=0.314 Sum_probs=198.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|+..+.||+|++|.||+|+...+++.||+|++.... ....+.+..|+.++++++|+|++++++++. ..+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 567789999999999999999889999999997543 334467889999999999999999999854 3478999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|
T Consensus 76 v~e~~~-~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d 141 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP----------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLAD 141 (282)
T ss_pred EecCcC-cCHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEec
Confidence 999996 69999997643 2588999999999999999999998 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
||.++....... ......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ..........
T Consensus 142 ~g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~ 215 (282)
T cd07829 142 FGLARAFGIPLR----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQIL 215 (282)
T ss_pred CCcccccCCCcc----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHh
Confidence 999976543221 11123457789999998776 7899999999999999999999998632110 0000000000
Q ss_pred hhh---hhhhhccc--cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDH---VIDIVDPI--LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~---~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ........ .......+.. ..........+..+.+++.+||+.||++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 216 GTPTEESWPGVTKLPDYKPTFPKFPP-------KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CCCcHHHHHhhcccccccccccccCc-------cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 00000000 0000000000 0000111233677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=289.44 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=193.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-----ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-----RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
+|.+.+.||+|+||.||+|.+...+..+++|+.+.. .......+..|+.++++++||||+++++++. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 588899999999999999999777776777776521 1223345778999999999999999999854 346
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++...... ...+++.+++.++.|++.|++|||+. +++|+||+|+||++++ +.+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT-------GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc-------ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCE
Confidence 789999999999999888642211 13689999999999999999999998 9999999999999985 569
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
+|+|||.+........ ......|+..|+|||...+..++.++||||||+++|+|++|..||... .......
T Consensus 145 ~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~ 215 (260)
T cd08222 145 KIGDFGVSRLLMGSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVL 215 (260)
T ss_pred eecccCceeecCCCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHH
Confidence 9999999876533221 112245788999999998888899999999999999999999997521 1111110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. .... .....+..++.++.+++.+||+.+|++||++.|+++
T Consensus 216 ~-----~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 216 R-----IVEG----------------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred H-----HHcC----------------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 0000 000112245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=303.85 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=218.5
Q ss_pred cCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 653 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++.+...++.|++.+.||.|.+|.||+++...+++.+|+|+.....+ ..++...|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 4455566677889999999999999999999999999999999875543 446788899999988 79999999999988
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.+...++.+|+|||||.+|+..++++.... .++.|..+..|++.++.|+.+||.. .++|||||-.||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---------~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiL 155 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG---------NRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVL 155 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcc---------cchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEE
Confidence 777888999999999999999999987652 5799999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
++.++.+|++|||.+..++..... ....+||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+..+
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~gr----RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTVGR----RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred EeccCcEEEeeeeeeeeeeccccc----ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 999999999999999877654332 334679999999999764 35778899999999999999999997644
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.. .. .. +. +-+.+++..+.....++.++|..|+.+|.++||++.++++
T Consensus 232 HPmr--------aL-F~-Ip--------------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 HPMR--------AL-FL-IP--------------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhh--------hh-cc-CC--------------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 2210 00 00 00 0011122223345667899999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=284.47 Aligned_cols=237 Identities=27% Similarity=0.344 Sum_probs=191.5
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
||+|+||.||++.+..+++.||+|+++.... .....+..|+.++++++||||+++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999988899999999864432 2345788999999999999999999884 4558899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 ~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 76 PGGELFSHLSKEG-----------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred CCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcce
Confidence 9999999986543 578999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 828 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
....... ......++..|+|||...+...+.++|+||||+++|++++|+.||..... ...... +.
T Consensus 142 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~-----~~- 206 (250)
T cd05123 142 ELSSEGS----RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEK-----IL- 206 (250)
T ss_pred ecccCCC----cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH-----Hh-
Confidence 6543211 12234578899999999888889999999999999999999999863211 010000 00
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
......+...+.++.+++.+||..||++||++++
T Consensus 207 ----------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 ----------------------KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----------------------cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0011122244678899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=280.54 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=193.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
..+|..+.+||+|+||.|.+|..+.+.+.+|||+++..- ....+--+.|-++++-- +-|.++++..+ |+.-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence 456889999999999999999999999999999997431 22233445677777665 56788888777 4555
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..|+||||+.||+|--+++.-+ ++.+..+..+|.+||-||-+||++ |||.||||-+|||+|.+|+
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~G-----------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGH 488 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVG-----------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGH 488 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhc-----------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCc
Confidence 89999999999999998886553 688889999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++.---. ...+....||+.|+|||++...+|+.++|.|||||+||||+.|++||+.. ++..+
T Consensus 489 iKi~DFGmcKEni~~----~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~el---- 558 (683)
T KOG0696|consen 489 IKIADFGMCKENIFD----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDEL---- 558 (683)
T ss_pred eEeeecccccccccC----CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHH----
Confidence 999999999743221 22234567999999999999999999999999999999999999998732 11110
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
-+.+.......+...+.+...+.+..+.+.|.+|.
T Consensus 559 ---------------------------F~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 ---------------------------FQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---------------------------HHHHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 01112222334445667788999999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=258.30 Aligned_cols=286 Identities=19% Similarity=0.269 Sum_probs=211.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
..++|++++++|+|.|++||.|....+.+.++||++++.. .+.+.+|+.+++.++ ||||+++++...++ ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 3578999999999999999999988889999999997543 477889999999995 99999999997654 3466
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-CcE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIA 818 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 818 (988)
..+|+||+.+.+..... +.++..++..++.++++||.|+|++ ||.|||+||.|+|+|.. -.+
T Consensus 110 paLiFE~v~n~Dfk~ly--------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred chhHhhhhccccHHHHh--------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence 78999999888887665 4678889999999999999999999 99999999999999965 479
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+|+|+|+|.++.+...... .+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-........++..+
T Consensus 173 rlIDWGLAEFYHp~~eYnV-----RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 173 RLIDWGLAEFYHPGKEYNV-----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred eeeecchHhhcCCCceeee-----eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 9999999998776554433 346778899999876 4578889999999999999999999854333323333333
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhh-----ccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKI-----NGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQS 970 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~ 970 (988)
...-.++....+++.-..-.+.+........+..+. ...--..++..+++.+.+.+|-++|+||+|.+.. +..
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 333333343333332221111111111111111111 1111235778999999999999999999998864 344
Q ss_pred HHHH
Q 001974 971 VKNA 974 (988)
Q Consensus 971 i~~~ 974 (988)
+.++
T Consensus 328 ~~~~ 331 (338)
T KOG0668|consen 328 VREA 331 (338)
T ss_pred HHHH
Confidence 4433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=318.23 Aligned_cols=147 Identities=29% Similarity=0.446 Sum_probs=130.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|.+.++||+|+||.||+|.+..+++.||+|+++... ......+..|+.+++.++||||+++++++. ..+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 367999999999999999999998899999999986432 223367889999999999999999998853 447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... .+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~v 143 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG-----------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHI 143 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCE
Confidence 8999999999999999986542 578888999999999999999998 99999999999999999999
Q ss_pred EEeeecccc
Q 001974 819 HVGDFGLAR 827 (988)
Q Consensus 819 kL~DfG~a~ 827 (988)
||+|||+++
T Consensus 144 kL~DFGls~ 152 (669)
T cd05610 144 KLTDFGLSK 152 (669)
T ss_pred EEEeCCCCc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=276.66 Aligned_cols=136 Identities=26% Similarity=0.429 Sum_probs=121.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-----C---CCceEEEeecccccc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-----H---RNLVKVITSCSSIDF 734 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~ 734 (988)
.+|.+.++||.|.|++||+|.+....+.||+|+.+. .....+....||+++++++ | .+||++++.|... .
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence 689999999999999999999999999999999874 3456688899999999983 2 3799999998765 5
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.++.++|+|+|+. |.+|..+|..... +.++...+++|++||+.||.|||..| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y---------rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY---------RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC---------CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 7789999999999 8899999876653 57899999999999999999999997 99999999999998
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.47 Aligned_cols=222 Identities=20% Similarity=0.163 Sum_probs=176.7
Q ss_pred ccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccccchh
Q 001974 674 GSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLE 753 (988)
Q Consensus 674 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 753 (988)
|.+|.||+|++..+++.||+|+++... .+..|...+....||||+++++++. ..+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence 899999999999999999999986432 2334555555667999999999853 457899999999999999
Q ss_pred hhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccc
Q 001974 754 NWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833 (988)
Q Consensus 754 ~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 833 (988)
+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~ 139 (237)
T cd05576 74 SHISKFL-----------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC 139 (237)
T ss_pred HHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc
Confidence 9986432 588999999999999999999998 99999999999999999999999999886543321
Q ss_pred cccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhcccc
Q 001974 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPIL 913 (988)
Q Consensus 834 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 913 (988)
.+..++..|+|||...+..++.++||||+|+++|||++|+.|+...... ... .
T Consensus 140 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~----~- 192 (237)
T cd05576 140 -------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INT----H- 192 (237)
T ss_pred -------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccc----c-
Confidence 1233577899999998888999999999999999999999886421000 000 0
Q ss_pred ccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 914 INDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
.....+..++..+.+++.+|++.||++||++.+
T Consensus 193 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 193 -----------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred -----------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 000112235667899999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.15 Aligned_cols=242 Identities=23% Similarity=0.248 Sum_probs=194.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++.|+....+|.|+|+.|-.+.+..+++..+||++... ..+..+|+.++... .||||+++.+.+ .++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee-----cCCce
Confidence 356788888899999999999999999999999998644 23445677777666 899999999995 45689
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee-CCCCcE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL-DNDMIA 818 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~ 818 (988)
.++|||++.|+-+.+.+.... ....++..|+.+|+.|+.|||++ |+||||+||+|||+ ++.+++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~------------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP------------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred eeeeehhccccHHHHHHHhcc------------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcE
Confidence 999999999988877776543 22267788999999999999998 99999999999999 699999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
+|+|||.++..... ..+..-|..|.|||+.....|++++|+||||++||+|++|+.||...-.+
T Consensus 456 rltyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------- 519 (612)
T KOG0603|consen 456 RLTYFGFWSELERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------- 519 (612)
T ss_pred EEEEechhhhCchh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------
Confidence 99999999876554 11223688999999999999999999999999999999999998743221
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..+...+ ..+ .....++.+..+|+.+||+.||.+||+|.++...
T Consensus 520 ~ei~~~i-----------------------~~~--~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 IEIHTRI-----------------------QMP--KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHhh-----------------------cCC--ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 0000000 000 0113567788999999999999999999998754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=284.91 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=195.2
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEe
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 745 (988)
.++||+|.||+||-|.++++|+.||||++.+.+ ......+++|+.+++++.||.||.+...| +..+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence 478999999999999999999999999997433 23447899999999999999999998885 45589999999
Q ss_pred eccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---CcEEEee
Q 001974 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND---MIAHVGD 822 (988)
Q Consensus 746 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~D 822 (988)
-+ +|+..+.+-... ..++++.....+..||+.||.|||.+ +|||+|+||+|||+.+. -.+||||
T Consensus 644 Kl-~GDMLEMILSsE---------kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSE---------KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred hh-cchHHHHHHHhh---------cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecc
Confidence 99 666666654332 15788888899999999999999999 99999999999999644 3799999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||+|++..+... ...++||+.|.|||++....|...-|+||.||++|--++|..||... .++.+.++.
T Consensus 711 FGfARiIgEksF-----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQN--- 778 (888)
T KOG4236|consen 711 FGFARIIGEKSF-----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQN--- 778 (888)
T ss_pred ccceeecchhhh-----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhc---
Confidence 999998876433 23468999999999999999999999999999999999999998632 121111110
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
..+...+..| .++..+..++|...++..-++|-|.+.-+
T Consensus 779 --------AaFMyPp~PW----------------~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 779 --------AAFMYPPNPW----------------SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --------cccccCCCch----------------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1111112223 25666788999999999999999887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=277.22 Aligned_cols=262 Identities=23% Similarity=0.363 Sum_probs=202.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-------ccchhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-------RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
.++|-....||+|||+.||+|.+....+.||||+-... .....+...+|.++-+.+.||.||++|+++.-
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl--- 538 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL--- 538 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee---
Confidence 35688889999999999999999888999999987422 12233567889999999999999999999753
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC-
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD- 813 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 813 (988)
+.+.+|-|+|||+|-+|+-|++..+ -+++.+++.|+.||+.||.||.+. +++|||-||||.|||+-
T Consensus 539 -DtdsFCTVLEYceGNDLDFYLKQhk-----------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 539 -DTDSFCTVLEYCEGNDLDFYLKQHK-----------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN 605 (775)
T ss_pred -ccccceeeeeecCCCchhHHHHhhh-----------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence 4578999999999999999998765 689999999999999999999997 67999999999999995
Q ss_pred --CCCcEEEeeeccccccccccccc---ceeccccccccccccCcccCCC----CCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 814 --NDMIAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGS----EVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 814 --~~~~~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
.-|.+||+|||++++.+...... ...+.-..||.+|.+||.+.-+ +.+.|+||||.||++|..+.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 45789999999999877654321 1123345799999999986543 56889999999999999999999987
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
...... ++.++. .+.. . ........+.+..+..++|++|+++--++|....++
T Consensus 686 hnqsQQ-dILqeN------TIlk---A-----------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 686 HNQSQQ-DILQEN------TILK---A-----------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred CchhHH-HHHhhh------chhc---c-----------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 421110 000000 0000 0 000111223566778999999999999999888776
Q ss_pred HH
Q 001974 965 VH 966 (988)
Q Consensus 965 l~ 966 (988)
..
T Consensus 739 A~ 740 (775)
T KOG1151|consen 739 AC 740 (775)
T ss_pred cc
Confidence 53
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=260.95 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=200.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|...++||+|+|+.|.+++.+++.+.+|+|+++++ +.+...-.+.|-.+..+. +||.+|-+..+ |+.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence 457899999999999999999999999999999999743 334445567777777777 79999998887 566
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+...++|.||++||+|--++.+.+ +++++.++.+...|..||.|||++ |||.||+|.+||++|.+|
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr-----------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR-----------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEG 388 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh-----------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCC
Confidence 789999999999999988776653 799999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCcccc--CCcchH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFE--GDLNLH 894 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~--~~~~~~ 894 (988)
++||+|||+++.--.... .+..+.||+.|.|||++.+..|...+|.|++||+++||+.|+.||+.... .+.+..
T Consensus 389 hikltdygmcke~l~~gd----~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte 464 (593)
T KOG0695|consen 389 HIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE 464 (593)
T ss_pred ceeecccchhhcCCCCCc----ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence 999999999985333222 23346799999999999999999999999999999999999999986432 233333
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
++.-..+.+. ++..+...+.....+++.-+.+||.+|.
T Consensus 465 dylfqvilek---------------------------qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 465 DYLFQVILEK---------------------------QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHHHHHhhh---------------------------cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 3332222221 1112223444566888899999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=301.86 Aligned_cols=281 Identities=19% Similarity=0.187 Sum_probs=173.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCC----CeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccc-cccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQD----GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSS-IDFQ 735 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 735 (988)
..++|++.+.||+|+||.||+|++..+ +..||+|++..... .+....| .+....+.++..++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999878 89999998753221 1111111 1111122222222211111 1013
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhh---------hHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVE---------IEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.+...++||||+++++|.+++........... ..........+..++.||+.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45788999999999999999875432110000 0001122345678999999999999998 99999999
Q ss_pred CCCeeeCC-CCcEEEeeecccccccccccccceeccccccccccccCcccCCC----------------------CCCCc
Q 001974 807 PGNVLLDN-DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS----------------------EVSTN 863 (988)
Q Consensus 807 p~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 863 (988)
|+|||+++ ++.+||+|||+|+........ ......+++.|+|||.+... .++.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~---~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc---CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999986 579999999999865432211 12235689999999965322 23446
Q ss_pred cchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhh---hhccccchh
Q 001974 864 GDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQA---KINGKIECP 940 (988)
Q Consensus 864 sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 940 (988)
+|||||||++|||+++..|++. ....+........ .+...|........... .........
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 423 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRND----------YDLVAWRKLVEPRASPDLRRGFEVLDLDG 423 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcC----------CcHHHHHHhhccccchhhhhhhhhccccc
Confidence 7999999999999997766432 1111111110000 00111111000000000 000001122
Q ss_pred HHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 941 ISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 941 ~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
....+|+.+|++.||++|||++|+++.
T Consensus 424 ~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 424 GAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred hHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 345689999999999999999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=245.52 Aligned_cols=211 Identities=24% Similarity=0.279 Sum_probs=171.4
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
+....+....+..||+|++|.|-+-++..+|...|+|.++..- ....++...|+.+..+. .+|.+|++||.. .
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----F 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----h
Confidence 4445566677789999999999999999999999999997432 23446777888876665 799999999974 3
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.....+|.||.| ..+|+.+-++-- ...+.+++.-+-+||..+.+||.|||++ ..++|||+||+|||++.+
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~-------~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~ 185 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVL-------KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYD 185 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHH-------hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccC
Confidence 447889999999 678877754321 1224788889999999999999999997 589999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC----CCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
|++|+||||.+..+.++-..+ ...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+..+.
T Consensus 186 GqVKiCDFGIsG~L~dSiAkt-----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 186 GQVKICDFGISGYLVDSIAKT-----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred CcEEEcccccceeehhhhHHH-----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 999999999998766543222 1348889999998754 4789999999999999999999999986543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.20 Aligned_cols=243 Identities=22% Similarity=0.325 Sum_probs=198.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++..+..||-||||.|-++........+|+|++++. +....+.+..|-.+|...+.|.||++|-. |.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence 4456678899999999999998755556899988643 34445678889999999999999999987 556699
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|+.||-|-||.++..++..+ .++......++..+.+|++|||++ +||.|||||+|.++|.+|-+|
T Consensus 495 vYmLmEaClGGElWTiLrdRg-----------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG-----------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC-----------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceE
Confidence 999999999999999998765 688888999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|.|||+|+......... ++.||+.|.|||++.+...+.++|.||+|+++||+++|.+||...-+ +.-|
T Consensus 561 LVDFGFAKki~~g~KTw-----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----mktY--- 628 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKTW-----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----MKTY--- 628 (732)
T ss_pred EeehhhHHHhccCCcee-----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----HHHH---
Confidence 99999999887655433 35699999999999999999999999999999999999999874311 1111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
..+...+|. ...+..++....++|++....+|.+|..
T Consensus 629 ---n~ILkGid~---------------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 629 ---NLILKGIDK---------------------IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---HHHHhhhhh---------------------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111111111 1123345666789999999999999965
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=285.87 Aligned_cols=280 Identities=19% Similarity=0.236 Sum_probs=185.4
Q ss_pred hhCCCCCCceeccccceeEEEEEEC----------------CCCeEEEEEEeeccccchhHH--------------HHHH
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD----------------QDGTIVAIKVFNLQRHGASKS--------------FLAE 710 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 710 (988)
..++|++.++||+|+||+||+|.+. ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 245689999986543332233 3446
Q ss_pred HHHHHhcCCCCc-----eEEEeeccccc---ccCCCceEEEEeeccccchhhhcCCCCCCCc-------------hhhhH
Q 001974 711 CKALKNIRHRNL-----VKVITSCSSID---FQGNDFKALVYEFMTNGSLENWLHPDAVPQK-------------DVEIE 769 (988)
Q Consensus 711 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~ 769 (988)
+.++.+++|.++ ++++++|.... ....+..++||||+++++|.++++....... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 66777765421 1123568999999999999999975422110 00011
Q ss_pred hhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceecccccccccc
Q 001974 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGY 849 (988)
Q Consensus 770 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y 849 (988)
...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........... ....+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~---~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP---LYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc---cccCCCcce
Confidence 23467888999999999999999998 999999999999999999999999999975433221111 112357899
Q ss_pred ccCcccCCCCC----------------------CCccchHHHHHHHHHHHhCCC-CCCccccCCcchHHHHHHHHhhhhh
Q 001974 850 AAPEYGLGSEV----------------------STNGDIYSYGILLLEMVTGKK-PTDVMFEGDLNLHNYARTALLDHVI 906 (988)
Q Consensus 850 ~aPE~~~~~~~----------------------~~~sDvwslG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~ 906 (988)
+|||.+..... ..+.||||+||++|+|++|.. ||.....-...+..+ ....
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-----~~~~- 450 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-----DNDL- 450 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-----cchH-
Confidence 99998754321 124699999999999999875 654211100000000 0000
Q ss_pred hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCC---CCCCCHHHHHH
Q 001974 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP---QDRMSITNVVH 966 (988)
Q Consensus 907 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 966 (988)
..|........ .............+++.+|+..+| .+|+|++|+++
T Consensus 451 -----------~~~r~~~~~~~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 451 -----------NRWRMYKGQKY---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -----------HHHHhhcccCC---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00100000000 001112355678899999999866 68999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=293.60 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=188.5
Q ss_pred CCCCceecccccee-EEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGS-VYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~-Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
|...+.+|.|+.|+ ||+|.. .|+.||||++-. +......+|+..++.- +||||+++++. -.+....||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence 33446789999885 899999 789999998743 2335678999999988 79999999987 345688999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---C--Cc
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---D--MI 817 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~ 817 (988)
..|.| ..+|.+++..... +. ........+.+..|+++||++||+. +||||||||.||||+. + .+
T Consensus 581 alELC-~~sL~dlie~~~~---d~----~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 581 ALELC-ACSLQDLIESSGL---DV----EMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred EehHh-hhhHHHHHhcccc---ch----hhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCccee
Confidence 99999 7899999987411 11 1111145678899999999999998 9999999999999975 2 47
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
++|+|||+++........-.. ..+..||-+|+|||++....-+.++||||+||++|+.++ |..||......+.++
T Consensus 650 a~iSDfglsKkl~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--- 725 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--- 725 (903)
T ss_pred EEecccccccccCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---
Confidence 999999999987765443333 456779999999999999888889999999999999999 599997543322111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
........ ......++ +..+||.+|+++||..||+|.+|+
T Consensus 726 -----l~~~~~L~----------------------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 726 -----LTGNYTLV----------------------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----hcCcccee----------------------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 10000000 00001122 678999999999999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=265.34 Aligned_cols=239 Identities=29% Similarity=0.392 Sum_probs=191.0
Q ss_pred cceeEEEEEECCCCeEEEEEEeeccccch-hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccccchh
Q 001974 675 SFGSVYKGAFDQDGTIVAIKVFNLQRHGA-SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLE 753 (988)
Q Consensus 675 ~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 753 (988)
+||.||+|.+..+++.||+|++....... .+.+.+|++.+++++|+|++++++++.. +...++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997554443 6789999999999999999999998643 37889999999999999
Q ss_pred hhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccc
Q 001974 754 NWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833 (988)
Q Consensus 754 ~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 833 (988)
+++.... .+++..++.++.+++.+++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 76 ~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~ 141 (244)
T smart00220 76 DLLKKRG-----------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG 141 (244)
T ss_pred HHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc
Confidence 9986543 378889999999999999999998 99999999999999999999999999998765432
Q ss_pred cccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhcccc
Q 001974 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPIL 913 (988)
Q Consensus 834 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 913 (988)
......++..|+|||...+..++.++||||+|+++|++++|..||...... ...... ... ...
T Consensus 142 -----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~-~~~-------~~~ 204 (244)
T smart00220 142 -----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKK-IGK-------PKP 204 (244)
T ss_pred -----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHH-Hhc-------cCC
Confidence 112345788999999998888999999999999999999999998642110 000000 000 000
Q ss_pred ccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 914 INDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ......++.++.+++.+|+..+|++||++.++++
T Consensus 205 ~~-----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 205 PF-----------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CC-----------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 0000016678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=256.47 Aligned_cols=203 Identities=27% Similarity=0.377 Sum_probs=166.6
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeec--cccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
.+..+.||-|+||.||.+++..+|+.||+|.+.. .+-...+.+-+|++++..++|.|++..++.........=.+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4556899999999999999999999999998852 23344578889999999999999999887643221111145678
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
|+|.| ..+|...+-.. +.++...+.-+..||++||.|||+. +|.||||||.|.+++.+..+||||
T Consensus 135 ~TELm-QSDLHKIIVSP-----------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP-----------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHH-HhhhhheeccC-----------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecc
Confidence 99998 77888877544 4788899999999999999999999 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+|+..+...... ....+-|..|+|||++++. .|+.+.||||.||++.|++..+..|+.
T Consensus 200 FGLARvee~d~~~h---MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 200 FGLARTWDQRDRLN---MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cccccccchhhhhh---hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 99999654432211 1223568899999999984 689999999999999999999888763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=268.81 Aligned_cols=216 Identities=25% Similarity=0.319 Sum_probs=177.9
Q ss_pred HHHHHHh---hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEee
Q 001974 655 YESLFKA---TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITS 728 (988)
Q Consensus 655 ~~~l~~~---~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~ 728 (988)
|..+.++ ..-|..++.||-|+||+|.+++...+...||.|.+++.+. .....+..|-+||.....+=||++|..
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 4444443 3568888999999999999999988888999999875432 333567789999999999999999987
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
|++.+.+|+||+|++||++-.++-+.+ -+.+.-++.++.++..|+++.|.. |+|||||||+
T Consensus 698 -----FQDkdnLYFVMdYIPGGDmMSLLIrmg-----------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPD 758 (1034)
T KOG0608|consen 698 -----FQDKDNLYFVMDYIPGGDMMSLLIRMG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPD 758 (1034)
T ss_pred -----eccCCceEEEEeccCCccHHHHHHHhc-----------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCcc
Confidence 677899999999999999999886554 577888899999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeeeccccccc---------ccccc-----------------------------cceeccccccccccc
Q 001974 809 NVLLDNDMIAHVGDFGLARVRQ---------EVSNL-----------------------------TQSCSVGVRGTIGYA 850 (988)
Q Consensus 809 NIll~~~~~~kL~DfG~a~~~~---------~~~~~-----------------------------~~~~~~~~~gt~~y~ 850 (988)
|||||.+|++||+|||+++-+. ..... ........+||+.|+
T Consensus 759 NILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 759 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred ceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 9999999999999999986321 11000 000112346999999
Q ss_pred cCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccC
Q 001974 851 APEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889 (988)
Q Consensus 851 aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~ 889 (988)
|||++....++..+|.||.||+||||+.|++||.....+
T Consensus 839 apevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 839 APEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred ChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 999999999999999999999999999999999754433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=242.91 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=195.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+.|.+.+.+|+|.||.+-+++++.+.+.+|+|.+... ....++|.+|...--.+ .|.||+.-|++. |+..+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence 5688999999999999999999999999999998643 23457899998776666 689999988774 66678899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC--CCCcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDMIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 819 (988)
+++||++.|+|.+-+... .+.+....+++.|++.|+.|||++ ++||||||.+||||- +..++|
T Consensus 99 F~qE~aP~gdL~snv~~~------------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA------------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred EeeccCccchhhhhcCcc------------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence 999999999999888764 366778889999999999999999 999999999999993 334899
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCC-----CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-----EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||||..+..+..-. ....+..|.|||..... ...+.+|||.||+++|..+||+.||+...-.+..+.
T Consensus 164 lcDFG~t~k~g~tV~-------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~ 236 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVK-------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW 236 (378)
T ss_pred eeecccccccCceeh-------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence 999999986543221 12246789999975432 356789999999999999999999986555555555
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.|..-.-... +.+...+ ....+.+.++.++-+..+|++|-...++.++....
T Consensus 237 ~~~~w~~rk~------~~~P~~F-------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 237 EWEQWLKRKN------PALPKKF-------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHHHHhcccC------ccCchhh-------------------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 5543211111 0111111 12445678899999999999996655655554443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-30 Score=266.20 Aligned_cols=390 Identities=18% Similarity=0.169 Sum_probs=233.9
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCC-CCCCCcCCcccccCCCCceee
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSD-NDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~ 110 (988)
...+.++|..|+|+.+.+.+|+.++.||.||||+|+|+.+-|++|.++.+|.+|-+.+ |+|+...-++|++|..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4666677777777766666777777777777777777777777777777766666555 777755556677777777777
Q ss_pred cCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeecccccc------------CCCCCccccCcccc
Q 001974 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAF------------GGNIPNSLGQLKEL 178 (988)
Q Consensus 111 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l------------~~~~~~~~~~l~~L 178 (988)
+.-|++.-+..++|..|++|..|.+.+|.+..+--.+|.++.+++.++++.|.+ ....|-.++++.-.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 777777766677777777777777777777633333677777777777776662 12233344444444
Q ss_pred cccccccccccCccchhhccc-cCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEec
Q 001974 179 KSLGLGANNLSGIIPPSIYNL-SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEAL 257 (988)
Q Consensus 179 ~~L~L~~N~l~~~~~~~l~~l-~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 257 (988)
.-.-|.++++..+.+..|..- ..+..=..+.+...+..|...|.++++|++|+|++|+|+.+-+.+|..+..++.|.|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 444444444443333333221 1111111122223335666666777777777777777777777777777777777777
Q ss_pred cccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCC---------------CCCch
Q 001974 258 DNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG---------------ALPHS 322 (988)
Q Consensus 258 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~---------------~~p~~ 322 (988)
+|++..+....|.++..|+.|+|++|+|+.+.+. +|..+..|.+|.|-.|.+.- .....
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~------aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~ 380 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG------AFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP 380 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecc------cccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC
Confidence 7777777777777777777777777777665544 45666667777776665531 00000
Q ss_pred hhhccccccEEEccCCcccc---CCCcccc---------CCCcce-EEEeeCccCCCccCcccCCCCccCeEecccccCC
Q 001974 323 IANLSDQLQNLIMTSNQLHG---SIPSGIG---------NLVGLY-RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLS 389 (988)
Q Consensus 323 ~~~~~~~L~~L~L~~N~l~~---~~~~~~~---------~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 389 (988)
-+.-+..++.+.++.+.+.. ..|+..+ ..+-+. ...-|++.++ .+|..+. ..-.+|++.+|.++
T Consensus 381 ~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~ 457 (498)
T KOG4237|consen 381 RCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT 457 (498)
T ss_pred CCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc
Confidence 11122244555555443321 1111111 111121 1223333333 4443332 23457788888887
Q ss_pred CCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCC
Q 001974 390 GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434 (988)
Q Consensus 390 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 434 (988)
.+|.. .+.+| .+++++|+|...-.-.|.++++|.+|-|+.|
T Consensus 458 -~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 458 -SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 66665 56677 7888888887666777888888888887765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=265.58 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=170.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhcC---CCCceEEEeecc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNIR---HRNLVKVITSCS 730 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 730 (988)
..+|+..+.+|+|+||.|+.|.++.....|+||.+.+++- ...-..-.|+.+|..++ |+||++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-- 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-- 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence 4569999999999999999999998889999999864421 11123567999999996 9999999999
Q ss_pred cccccCCCceEEEEeec-cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCC
Q 001974 731 SIDFQGNDFKALVYEFM-TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGN 809 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 809 (988)
|++++++|++||-. ++-+|.+++..+. .+++.++..|++|++.|+++||+. +|||||||-+|
T Consensus 638 ---FEddd~yyl~te~hg~gIDLFd~IE~kp-----------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikden 700 (772)
T KOG1152|consen 638 ---FEDDDYYYLETEVHGEGIDLFDFIEFKP-----------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDEN 700 (772)
T ss_pred ---eecCCeeEEEecCCCCCcchhhhhhccC-----------ccchHHHHHHHHHHHhcccccccc---Cceeccccccc
Confidence 66779999999987 4569999998764 699999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 001974 810 VLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 810 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~ 884 (988)
|.++.+|-+||+|||.|......+ ...++||..|.|||++.+.+| +..-|||++|+++|.++....||.
T Consensus 701 vivd~~g~~klidfgsaa~~ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 701 VIVDSNGFVKLIDFGSAAYTKSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEecCCeEEEeeccchhhhcCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999997655433 223579999999999999887 456899999999999999988874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=273.47 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=207.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|+..+++|.|.||.||+|+++.+++..|+|+++.......+-.++|+-+++..+||||+.++|.+ ...+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCc
Confidence 356799999999999999999999999999999999988877788899999999999999999999984 445889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++.||||.+|+|.+.-+... ++++.++...++...+|++|||+. +-+|||||-.||++++.|.+|+
T Consensus 88 wicMEycgggslQdiy~~Tg-----------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvkl 153 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKL 153 (829)
T ss_pred EEEEEecCCCcccceeeecc-----------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceee
Confidence 99999999999998876553 789999999999999999999999 9899999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+|||.+..+...- .....+.||+.|||||+.. .+.|..++|||+.|++..|+-.-++|-....+
T Consensus 154 aDfgvsaqitati----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------- 220 (829)
T KOG0576|consen 154 ADFGVSAQITATI----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------- 220 (829)
T ss_pred cccCchhhhhhhh----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------
Confidence 9999987654322 1223467999999999853 46788999999999999999887777321100
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.....-.....+++.-..|...| .+.+-++++.|+.++|++||+++.++.
T Consensus 221 mr~l~LmTkS~~qpp~lkDk~kw-------------------s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTLKDKTKW-------------------SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHhhccCCCCCcccCCccc-------------------hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 00111111233344334444444 345789999999999999999998764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-30 Score=261.00 Aligned_cols=149 Identities=22% Similarity=0.263 Sum_probs=75.8
Q ss_pred EEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc-c
Q 001974 60 EINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR-N 138 (988)
Q Consensus 60 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N 138 (988)
..|-++-.++ .+|..+ -..-+.++|..|+|+.+.|.+|+.+.+|+.||||+|+|+.+.|++|.+|.+|.+|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3445555555 455443 23455666666666655556666666666666666666655566666666555554444 5
Q ss_pred cccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCC
Q 001974 139 NLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211 (988)
Q Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 211 (988)
+|+....+.|++|.+|+.|.+.-|++.-+..++|..|++|..|.|-+|.+..+--.+|..+..++.+.+..|.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 5554333444555555555544444444444444444444444444444442222244444444444444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=241.33 Aligned_cols=280 Identities=21% Similarity=0.241 Sum_probs=200.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 737 (988)
...+|.-.+.+|.|.- .|..|-+.-.++.||+|..... .....++..+|...+..+.|+||++++.++..... ..-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567878888999998 7888888888999999987422 23445778899999999999999999998764321 122
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...|+||||| ..+|.+.+.. .++-..+..|..|++.|++|||+. +|+||||||+||++..+..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~-------------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM-------------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH-------------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhh
Confidence 4578999999 7899888762 356667889999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||.|||+|+...... ..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|. +.....+|.
T Consensus 157 lKi~dfg~ar~e~~~~-----~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ 227 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWN 227 (369)
T ss_pred eeeccchhhcccCccc-----ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHH
Confidence 9999999998654431 2233568999999999999889999999999999999999998865 333444443
Q ss_pred HHHHhhh-h-hhhhccc---cc---cCcchhhh-----hhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 898 RTALLDH-V-IDIVDPI---LI---NDVEDWDA-----TNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 898 ~~~~~~~-~-~~~~d~~---l~---~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
...-.-. . ..+.+.. .. ...+.+.. ..+...-....+...-......+++.+||..||++|.|++++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 2211100 0 0000000 00 00000000 000000011111111233457899999999999999999999
Q ss_pred HHH
Q 001974 965 VHE 967 (988)
Q Consensus 965 l~~ 967 (988)
++.
T Consensus 308 L~H 310 (369)
T KOG0665|consen 308 LRH 310 (369)
T ss_pred hcC
Confidence 863
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.91 Aligned_cols=284 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred HhhCCCCCCceeccccceeEEEEEECC---CCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
...+.|..+++||+|+|++||+|.+.. .++.||+|.+... ........|+++|..+ .+.||+++.++ +.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~-----~r 105 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGC-----FR 105 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhh-----hc
Confidence 344678999999999999999999876 6789999998643 3457789999999999 68999999998 56
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN- 814 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 814 (988)
.++..++|+||++..+..++.. .++..++..+++.+..||+++|.. |||||||||+|++.+.
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~--------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR--------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRR 168 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh--------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccc
Confidence 6799999999999999888874 577889999999999999999999 9999999999999974
Q ss_pred CCcEEEeeecccccccccc------c----------------------------------ccceeccccccccccccCcc
Q 001974 815 DMIAHVGDFGLARVRQEVS------N----------------------------------LTQSCSVGVRGTIGYAAPEY 854 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~------~----------------------------------~~~~~~~~~~gt~~y~aPE~ 854 (988)
.+.-.|.|||+|...+... . ..........||++|+|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 5678899999998321110 0 00001123569999999999
Q ss_pred cCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh---hhhhhccccccC------cc----hh
Q 001974 855 GLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH---VIDIVDPILIND------VE----DW 920 (988)
Q Consensus 855 ~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~l~~~------~~----~~ 920 (988)
+.. ...++++||||.||++.-+++++.||-....+-..+...+...-... .....+..+... .. .|
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence 876 45689999999999999999999998655444444443332222221 111222200000 00 00
Q ss_pred hhhhHHHHhh-----hhhccccc-hhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 921 DATNKQRLRQ-----AKINGKIE-CPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 921 ~~~~~~~~~~-----~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.....+.... -......+ .+..+.+++.+|+..||.+|.||+|.++.
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000000000 01111122 34578999999999999999999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=253.85 Aligned_cols=200 Identities=26% Similarity=0.297 Sum_probs=168.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC------CCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR------HRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 735 (988)
-.+|.+....|+|-|++|..|.+...|..||||+++... ...+.=+.|+++|+++. --|+++++-. |.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----FK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----hh
Confidence 467999999999999999999999899999999997443 23355678999999994 3478888776 45
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
...++|+|+|-+ ..+|.+.++..+.. ..+....+..++.|+.-||..|-.. +|+|.||||+||||.+.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~n--------vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRN--------VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcc--------cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 569999999998 78999999876542 2577888999999999999999998 99999999999999875
Q ss_pred -CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 816 -MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 816 -~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
..+||||||.|.......... +..+..|.|||++.+-+|+...|+||.||+|||+.||+..|..
T Consensus 573 k~iLKLCDfGSA~~~~eneitP------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cceeeeccCccccccccccccH------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 478999999998765433211 2346689999999999999999999999999999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=235.46 Aligned_cols=211 Identities=30% Similarity=0.495 Sum_probs=180.5
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccc
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTN 749 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 749 (988)
||+|++|.||++....+++.+++|++...... ..+.+.+|++.++.++|++++++++++.. ....++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 68999999999999777999999999754432 34679999999999999999999998543 3788999999998
Q ss_pred cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcEEEeeeccccc
Q 001974 750 GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIAHVGDFGLARV 828 (988)
Q Consensus 750 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 828 (988)
++|.+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+..
T Consensus 76 ~~l~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 76 GSLKDLLKENE----------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred CcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 99999987542 2578899999999999999999998 9999999999999999 89999999999986
Q ss_pred ccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh
Q 001974 829 RQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907 (988)
Q Consensus 829 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (988)
...... ......+...|++||..... ..+.++|+|++|++++++
T Consensus 143 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 143 LTSDKS----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred ccCCcc----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 544321 11223478899999998887 788999999999999999
Q ss_pred hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 908 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.++.+++.+|++.+|++||+++++++.
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 126789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=232.36 Aligned_cols=199 Identities=32% Similarity=0.480 Sum_probs=170.3
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
|+..+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 56778999999999999999877899999999765444 56789999999999999999999998543 3778999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+||
T Consensus 76 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG----------KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EeccCCCCHHHHHHhccc----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence 999999999999875431 178889999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCccc-CCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG-LGSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
|.+........ .......++..|++||.. ....++.++|||+||+++|||++|+.||.
T Consensus 143 g~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 143 GLARFIHRDLA---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ceeeEecCccc---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99986654320 011223577889999998 66778889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=265.17 Aligned_cols=344 Identities=19% Similarity=0.245 Sum_probs=162.1
Q ss_pred ccccCCCCCCEEEcCCCc------ccccCCcccCCCC-CCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcc
Q 001974 50 PYIGNLSFLREINLMNNS------IQGEIPREFGRLF-RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPF 122 (988)
Q Consensus 50 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~ 122 (988)
.+|..+++|+.|.+..+. +...+|+.|..++ +|+.|++.++.++ .+|..| ...+|+.|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 445566666666665442 2223444444443 3555555555555 445544 2455555555555554 3444
Q ss_pred cccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCc
Q 001974 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL 202 (988)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 202 (988)
.+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..+.++++|+.|++++|.
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~--------------- 692 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCE--------------- 692 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCC---------------
Confidence 455555555555554432223332 4445555555555544333444445555555555554432
Q ss_pred cEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEeccc
Q 001974 203 ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAY 282 (988)
Q Consensus 203 ~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~ 282 (988)
..+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|++++|.+... |..+ .+++|++|.+.+
T Consensus 693 ---------~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~ 756 (1153)
T PLN03210 693 ---------NLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL-RLENLDELILCE 756 (1153)
T ss_pred ---------CcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc-cccccccccccc
Confidence 222444332 3444444444444322222221 12344444444444322 2211 344455554443
Q ss_pred ccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCc
Q 001974 283 NNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362 (988)
Q Consensus 283 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 362 (988)
+....... .+. .++......++.|+.|+|++|...+.+|..++.+++|+.|++++|
T Consensus 757 ~~~~~l~~-----------------------~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C 812 (1153)
T PLN03210 757 MKSEKLWE-----------------------RVQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENC 812 (1153)
T ss_pred cchhhccc-----------------------ccc-ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCC
Confidence 32211100 000 011111112234555666655555555666666666666666655
Q ss_pred cCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCC-CCCCccCc
Q 001974 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE-NGLNGTIP 441 (988)
Q Consensus 363 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p 441 (988)
...+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |++. .+|
T Consensus 813 ~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~ 886 (1153)
T PLN03210 813 INLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVS 886 (1153)
T ss_pred CCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccC
Confidence 4333455443 4556666666665433334432 245556666666665 4555566666666666655 3333 455
Q ss_pred hhhhhhcccccceecccc
Q 001974 442 EEIFNLTYLSNSLNLARN 459 (988)
Q Consensus 442 ~~~~~l~~l~~~L~ls~N 459 (988)
..+..++.| +.+++++|
T Consensus 887 ~~~~~L~~L-~~L~l~~C 903 (1153)
T PLN03210 887 LNISKLKHL-ETVDFSDC 903 (1153)
T ss_pred cccccccCC-CeeecCCC
Confidence 555555555 55555555
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-23 Score=261.53 Aligned_cols=339 Identities=22% Similarity=0.278 Sum_probs=214.9
Q ss_pred chhhccccCccEEEeccCCC------CCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCccc
Q 001974 193 PPSIYNLSLLANFSVPRNQF------HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLS 266 (988)
Q Consensus 193 ~~~l~~l~~L~~L~L~~N~i------~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~ 266 (988)
+.+|.++++|+.|.+..+.. ...+|..+..-..+|+.|++.+|.+. .+|..+ ...+|+.|++.+|++.. .+
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cc
Confidence 44556666666666644422 12344443322234666666666665 334444 34566666666666653 34
Q ss_pred ccccCCccccEEeccccc-CCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCC
Q 001974 267 VNFGGMKNLSYFNVAYNN-LGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIP 345 (988)
Q Consensus 267 ~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~ 345 (988)
..+..+++|+.|+|+++. +..++ .++.+++|++|+|++|.....+|..+..+. +|+.|++++|...+.+|
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip--------~ls~l~~Le~L~L~~c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp 698 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP--------DLSMATNLETLKLSDCSSLVELPSSIQYLN-KLEDLDMSRCENLEILP 698 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC--------ccccCCcccEEEecCCCCccccchhhhccC-CCCEEeCCCCCCcCccC
Confidence 445667777777776653 32222 245567777777777665556777766654 57777777765444666
Q ss_pred ccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccc-------ccccc
Q 001974 346 SGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS-------GVIPS 418 (988)
Q Consensus 346 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~p~ 418 (988)
..+ .+++|+.|++++|...+.+|.. ..+|+.|+|++|.+. .+|..+ .+++|+.|++.++... ...+.
T Consensus 699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~ 772 (1153)
T PLN03210 699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPL 772 (1153)
T ss_pred CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchh
Confidence 554 6777777777777655455543 356777777777776 566544 4677777777664321 11222
Q ss_pred ccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCC
Q 001974 419 CLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSY 498 (988)
Q Consensus 419 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 498 (988)
.+...++|+.|+|++|...+.+|..+.+++.| +.|++++|...+.+|..+ ++++|+.|+|++|..-..+|.. ..+
T Consensus 773 ~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L-~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 773 MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL-EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred hhhccccchheeCCCCCCccccChhhhCCCCC-CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccc
Confidence 23334677888888877666778877777777 778887765444677665 6777888888876554455543 356
Q ss_pred CcEEEecCccccccCCccccCccccCeeecCC-CcccCcCcccccCCCCcEEeCCCCc
Q 001974 499 LEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR-NNLSGLIPKFLEDLSLEYLNLSFND 555 (988)
Q Consensus 499 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~~~L~~l~l~~N~ 555 (988)
|+.|+|++|.++ .+|.++..+++|+.|+|++ |++...++....+..|+.++++++.
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 778888888887 6777888888888888877 6666665555667778888887764
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=268.07 Aligned_cols=204 Identities=14% Similarity=0.196 Sum_probs=139.2
Q ss_pred hcCC-CCceEEEeeccccc--ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHH
Q 001974 716 NIRH-RNLVKVITSCSSID--FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYL 792 (988)
Q Consensus 716 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L 792 (988)
.++| +||++++++|.... ....+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----------RSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----------ccccHHHHHHHHHHHHHHHHHH
Confidence 3455 57888888763221 12234567889988 779999997532 3689999999999999999999
Q ss_pred HcCCCCCeEeccCCCCCeeeCCC-------------------CcEEEeeecccccccccccc------c------ceecc
Q 001974 793 HHHCQEPVLHCDLKPGNVLLDND-------------------MIAHVGDFGLARVRQEVSNL------T------QSCSV 841 (988)
Q Consensus 793 H~~~~~~ivH~Dlkp~NIll~~~-------------------~~~kL~DfG~a~~~~~~~~~------~------~~~~~ 841 (988)
|++ +||||||||+|||++.. +.+|++|||+++........ . .....
T Consensus 97 H~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 HSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 998 99999999999999654 44556666666532110000 0 00011
Q ss_pred ccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhh
Q 001974 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWD 921 (988)
Q Consensus 842 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 921 (988)
...||+.|||||++.+..++.++|||||||++|||++|.+|+.... .... .+. .....+.
T Consensus 174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~-~~~---~~~~~~~--------- 233 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMS-SLR---HRVLPPQ--------- 233 (793)
T ss_pred ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHH-HHH---HhhcChh---------
Confidence 2357889999999999999999999999999999999988854210 0000 000 0000000
Q ss_pred hhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 922 ATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 922 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.....+...+++.+||+.+|.+||++.|+++.
T Consensus 234 --------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 234 --------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred --------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 00112335688899999999999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=213.68 Aligned_cols=170 Identities=22% Similarity=0.234 Sum_probs=126.2
Q ss_pred cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 750 GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 750 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
|+|.++++... ..+++.+++.|+.||+.||+|||+. + ||+||+++.++.+|+ ||.+...
T Consensus 1 GsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRG----------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEee
Confidence 67888886533 3689999999999999999999998 5 999999999999999 9999765
Q ss_pred cccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhh
Q 001974 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIV 909 (988)
Q Consensus 830 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (988)
.... ..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+.... .....
T Consensus 60 ~~~~---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-----~~~~~-- 123 (176)
T smart00750 60 TPEQ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-----NGMPA-- 123 (176)
T ss_pred cccc---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-----HHhcc--
Confidence 4321 2478999999999999999999999999999999999999863221111111110 00000
Q ss_pred ccccccCcchhhhhhHHHHhhhhhccccchh--HHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 910 DPILINDVEDWDATNKQRLRQAKINGKIECP--ISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 910 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
...... ....... .++.+++.+||+.+|++||++.|+++.+..+..+
T Consensus 124 -----~~~~~~-------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 124 -----DDPRDR-------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred -----CCcccc-------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000000 0001122 2589999999999999999999999998887544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=246.65 Aligned_cols=161 Identities=29% Similarity=0.392 Sum_probs=79.5
Q ss_pred cceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 353 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
+|+.|+|++|+|++ +|..+ .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... .+|+.|+++
T Consensus 303 ~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls 370 (788)
T PRK15387 303 GLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAY 370 (788)
T ss_pred ccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCCC---cccceehhh
Confidence 44444444444442 23211 23444445555554 23321 1245555555555552 33221 234445555
Q ss_pred CCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcccccc
Q 001974 433 ENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGS 512 (988)
Q Consensus 433 ~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 512 (988)
+|+|+ .+|... ..| +.|++++|+|+ .+|... ++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .
T Consensus 371 ~N~L~-~LP~l~---~~L-~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~ 436 (788)
T PRK15387 371 NNRLT-SLPALP---SGL-KELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-R 436 (788)
T ss_pred ccccc-cCcccc---ccc-ceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-c
Confidence 55554 344322 223 45555555555 334322 34566666666666 355432 34556666666666 5
Q ss_pred CCccccCccccCeeecCCCcccCcCcc
Q 001974 513 IPSSLSSLRAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 513 ~p~~~~~l~~L~~L~ls~N~l~~~~p~ 539 (988)
+|..+..+++|+.|+|++|+|++.+|.
T Consensus 437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 437 LPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cChHHhhccCCCeEECCCCCCCchHHH
Confidence 666666666666666666666665554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=245.24 Aligned_cols=262 Identities=29% Similarity=0.347 Sum_probs=200.8
Q ss_pred ccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccc
Q 001974 251 LEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQL 330 (988)
Q Consensus 251 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L 330 (988)
-..|++++|.++. +|..+. ++|+.|++++|+++.++. ..++|++|++++|+|+ .+|. .+++|
T Consensus 203 ~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~LP~----------lp~~Lk~LdLs~N~Lt-sLP~----lp~sL 264 (788)
T PRK15387 203 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLPA----------LPPELRTLEVSGNQLT-SLPV----LPPGL 264 (788)
T ss_pred CcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCCCCC----------CCCCCcEEEecCCccC-cccC----ccccc
Confidence 3456666666663 333343 367777888887776543 1367888888888888 5564 23578
Q ss_pred cEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccc
Q 001974 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410 (988)
Q Consensus 331 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 410 (988)
+.|++++|+++ .+|.. +.+|+.|++++|+|+ .+|.. +++|+.|+|++|+|++ +|... .+|+.|++++|
T Consensus 265 ~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N 332 (788)
T PRK15387 265 LELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNN 332 (788)
T ss_pred ceeeccCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccC
Confidence 99999999988 45543 357889999999998 56653 4789999999999995 55532 46888999999
Q ss_pred ccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccC
Q 001974 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIP 490 (988)
Q Consensus 411 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 490 (988)
+|++ +|... .+|+.|+|++|+|+ .+|... ..+ +.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|
T Consensus 333 ~L~~-LP~lp---~~Lq~LdLS~N~Ls-~LP~lp---~~L-~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP 398 (788)
T PRK15387 333 QLTS-LPTLP---SGLQELSVSDNQLA-SLPTLP---SEL-YKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLP 398 (788)
T ss_pred cccc-ccccc---cccceEecCCCccC-CCCCCC---ccc-ceehhhccccc-cCcccc---cccceEEecCCccc-CCC
Confidence 9984 56422 58999999999999 677643 234 77899999998 577643 57899999999999 577
Q ss_pred cccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCCC
Q 001974 491 SQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 491 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~ 563 (988)
.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+.++..+..+.+|+.|+|++|+|+|.+|..
T Consensus 399 ~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~ 464 (788)
T PRK15387 399 VL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQA 464 (788)
T ss_pred Cc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHHH
Confidence 54 367999999999999 578643 4678999999999976656688889999999999999987763
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=210.66 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=190.2
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
....+|.+...|+.|+|+| .|..+++|++.... ....++|..|.-.++.+.||||+.++|.|..+ ....++
T Consensus 193 nl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII 265 (448)
T ss_pred hhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence 3456788999999999999 55667788876432 33457899999999999999999999998654 678899
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe-ccCCCCCeeeCCCCcEEEe-
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLH-CDLKPGNVLLDNDMIAHVG- 821 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH-~Dlkp~NIll~~~~~~kL~- 821 (988)
..||+.|+|+..+++... -..+..++.+++.+||+|++|||+.. +++- --+.+..|++|++.+++|+
T Consensus 266 sq~mp~gslynvlhe~t~---------vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTS---------VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred eeeccchHHHHHHhcCcc---------EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheec
Confidence 999999999999987653 24677789999999999999999973 4443 4689999999999998874
Q ss_pred -eecccccccccccccceeccccccccccccCcccCCCCCC---CccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 822 -DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS---TNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 822 -DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|--++.. ..+..-.+.||+||.++..+.+ .++|+|||++++||+.|...||....+.+.
T Consensus 335 ad~kfsfq-----------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------ 397 (448)
T KOG0195|consen 335 ADTKFSFQ-----------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------ 397 (448)
T ss_pred ccceeeee-----------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------
Confidence 3222211 1123357899999999887654 578999999999999999999975432211
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
..+..+.......++.....+.++|.-|+..||.+||.+..|+-.|+++.
T Consensus 398 -------------------------gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 398 -------------------------GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------------------------hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11111222223345567778899999999999999999999999998763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=223.53 Aligned_cols=170 Identities=24% Similarity=0.202 Sum_probs=131.6
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECC-CCeEEEEEEeecc-----ccchhHHHHHHHHHHHhcCCCCceE-EEeeccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQ-----RHGASKSFLAECKALKNIRHRNLVK-VITSCSS 731 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~ 731 (988)
....++|++.+.||+|+||+||+|++.. +++.||||++... .....+.+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999875 6788899986532 1223456899999999999999985 4432
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC-CCCCe
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL-KPGNV 810 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NI 810 (988)
+..++||||++|++|... ... . ...++.|+++||+|||+. ||+|||| ||+||
T Consensus 91 ------~~~~LVmE~~~G~~L~~~-~~~--------------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NI 143 (365)
T PRK09188 91 ------GKDGLVRGWTEGVPLHLA-RPH--------------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNW 143 (365)
T ss_pred ------CCcEEEEEccCCCCHHHh-Ccc--------------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceE
Confidence 457999999999999632 110 0 135788999999999998 9999999 99999
Q ss_pred eeCCCCcEEEeeecccccccccccccc----eeccccccccccccCcccCCC
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQ----SCSVGVRGTIGYAAPEYGLGS 858 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 858 (988)
|++.++.+||+|||+|+.......... .......+++.|+|||++...
T Consensus 144 Lv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 144 LMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999999999999987654331111 111345688899999997654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=215.70 Aligned_cols=267 Identities=22% Similarity=0.261 Sum_probs=200.5
Q ss_pred CCCCCceeccccceeEEEEEECCCC-eEEEEEEeeccccchhHHHHHHHHHHHhcCC----CCceEEEeecccccccCCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDG-TIVAIKVFNLQRHGASKSFLAECKALKNIRH----RNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 738 (988)
+|.+.+.||+|+||.||.|.+..++ +.+|+|+...........+..|+.++..+.. +++..+++... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999997654 6789998765433333378889999988862 68888888732 3457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND--- 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 815 (988)
..++||+.+ |.+|.++...... +.++..++..|+.|++.+|++||+. |++||||||.|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~---------~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~ 161 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPP---------GRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRS 161 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCC---------CCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCc
Confidence 789999999 9999998765541 4799999999999999999999999 99999999999999865
Q ss_pred --CcEEEeeecccc--cccccccc---ccee-ccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 816 --MIAHVGDFGLAR--VRQEVSNL---TQSC-SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 816 --~~~kL~DfG~a~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
..+.+.|||+|+ ........ .... .....||..|+++....+...+.+.|+||++.++.|+..|..||....
T Consensus 162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 469999999998 32222211 1111 234569999999999999999999999999999999999999986432
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... ....... ... ..... .....|.++.++...+-..+..++|....+...
T Consensus 242 ~~~~-~~~~~~~-~~~---~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 242 MTDL-KSKFEKD-PRK---LLTDR-----------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccch-HHHHHHH-hhh---hcccc-----------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2111 0000000 000 00000 112345667777777777999999999999999
Q ss_pred HHHHHHHh
Q 001974 968 LQSVKNAL 975 (988)
Q Consensus 968 L~~i~~~~ 975 (988)
++....+.
T Consensus 294 l~~~~~~~ 301 (322)
T KOG1164|consen 294 LKDVFDSE 301 (322)
T ss_pred HHHHHHhc
Confidence 88876664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=189.79 Aligned_cols=269 Identities=21% Similarity=0.264 Sum_probs=198.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCC-CCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH-RNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 739 (988)
....|.++++||.|+||.+|.|....+|+.||+|+-+... ....+..|.++.+.+++ ..|..+..+ ..+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhh-----cccccc
Confidence 3467999999999999999999999999999999864332 23567889999999965 566666655 334577
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
-.+||+.. |.+|.+.+.-+. +.++..+++-+|-|++.-++|+|.+ ++|||||||+|+|+.- -.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~----------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~ 151 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCS----------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCN 151 (341)
T ss_pred ceeeeecc-CccHHHHHHHHh----------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccc
Confidence 78999999 999999887654 4789999999999999999999999 9999999999999963 34
Q ss_pred cEEEeeecccccccccccc---cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 817 IAHVGDFGLARVRQEVSNL---TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
.+.++|||+|+.+.+.... .........||.+|.+--...+...+.+.|+=|+|.++.++--|..||+......
T Consensus 152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--- 228 (341)
T KOG1163|consen 152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--- 228 (341)
T ss_pred eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh---
Confidence 7899999999876554322 2222344579999999888878788899999999999999999999998543221
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
.....+.+.+. ... -+...-....|.++.-.+.-|-..--++-|...-+-+...-+..
T Consensus 229 ----k~QKyEkI~Ek---K~s---------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 229 ----KKQKYEKISEK---KMS---------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred ----HHHHHHHHHHh---hcC---------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11111111110 000 00001122456677777778888888888887766666555554
Q ss_pred Hh
Q 001974 974 AL 975 (988)
Q Consensus 974 ~~ 975 (988)
.+
T Consensus 287 ~l 288 (341)
T KOG1163|consen 287 TL 288 (341)
T ss_pred hc
Confidence 43
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=196.29 Aligned_cols=266 Identities=19% Similarity=0.243 Sum_probs=200.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
-.|.+.++||+|+||+++.|..--+++.||||.-... ....++..|.+..+.+ ..+.|..+|.+ .+.+.+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 4689999999999999999999889999999986433 2346788899999988 56899988876 45567778
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-----
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM----- 816 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----- 816 (988)
+|+|.. |.+|.|++.-++ ++++..++..+|.|++.-++|+|++ .+|.|||||+|+||...+
T Consensus 101 LVidLL-GPSLEDLFD~Cg----------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCG----------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred hhhhhh-CcCHHHHHHHhc----------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCc
Confidence 999999 899998887665 5899999999999999999999999 999999999999997544
Q ss_pred cEEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 817 IAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
.+.++|||+|+.+.+..... ........||.+||+--...+.+.+.+.|+=|+|-++++.+-|..||+..... ..-
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-tnK 245 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-TNK 245 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-chH
Confidence 58899999999776544321 22233456999999999999999999999999999999999999999853221 111
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
..+ +.+.+ ....... +. -....|.++..-+.-.-..+-.+-|..+-+...+.++.+
T Consensus 246 ~kY------eKIGe---~Kr~T~i--------~~-------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 246 EKY------EKIGE---TKRSTPI--------EV-------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHH------HHhcc---ccccCCH--------HH-------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111 11111 0000000 00 012356666666666667788888887766666666655
Q ss_pred H
Q 001974 974 A 974 (988)
Q Consensus 974 ~ 974 (988)
.
T Consensus 302 r 302 (449)
T KOG1165|consen 302 R 302 (449)
T ss_pred h
Confidence 4
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=236.60 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=193.2
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccch----hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGA----SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...+.+|.|++|.|+.+......+.++.|.++.. .... ...+..|+.+-..++|+|++..+..+... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence 3467899999998888888766666666655311 1111 12256677778888999998877765443 23
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
..-+||||++ +|..++.... .++..++..+++|+..|++|+|+. ||.|||+|++|++++.+|.+|
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~-----------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lk 460 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG-----------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILK 460 (601)
T ss_pred chhhhhcccH-HHHHHHhccc-----------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceE
Confidence 3334999998 9999987652 578888999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCC-ccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVST-NGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||.+....-..........+.+|+.+|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+..+.....
T Consensus 461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~ 540 (601)
T KOG0590|consen 461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY 540 (601)
T ss_pred EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc
Confidence 9999999876655544445667788999999999999999976 479999999999999999999866555433200000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..|. .............|.+.+.+|.+|++.||.+|.|+++|++.
T Consensus 541 -------------------~~~~-----~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 -------------------SDQR-----NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -------------------cccc-----ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000 00000001112566778999999999999999999999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=229.04 Aligned_cols=279 Identities=23% Similarity=0.401 Sum_probs=150.5
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
..+.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4566777777766 4555443 35677777777777 4554442 46777777777776 5555443 357777777
Q ss_pred cccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCcc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 192 (988)
+|++. .+|..+. ++|+.|+|++|+|+ .+|+.+. .+|+.|++++|+++ .+|..+. ++|+.|+|++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-C
Confidence 77776 4555443 35677777777766 4555443 36677777777666 3444332 356666666666663 3
Q ss_pred chhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCC
Q 001974 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272 (988)
Q Consensus 193 ~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l 272 (988)
|..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|+|+ .+|..+ .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~l--------------------------p 366 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETL--------------------------P 366 (754)
T ss_pred Ccccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhh--------------------------c
Confidence 33322 45666666666665 4554432 45555555555554 233222 1
Q ss_pred ccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhc---cccccEEEccCCccccCCCcccc
Q 001974 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANL---SDQLQNLIMTSNQLHGSIPSGIG 349 (988)
Q Consensus 273 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~L~~N~l~~~~~~~~~ 349 (988)
++|+.|++++|+|+.++.. +. ..|+.|++++|+++ .+|..+..+ .+.+..|++.+|.+.. .
T Consensus 367 ~~L~~LdLs~N~Lt~LP~~-------l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~ 430 (754)
T PRK15370 367 PTITTLDVSRNALTNLPEN-------LP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------R 430 (754)
T ss_pred CCcCEEECCCCcCCCCCHh-------HH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------H
Confidence 3455555555555543321 00 23555556666655 455444332 1345667777776651 2
Q ss_pred CCCcceEEEeeCccCCC-ccCcccCCCCccCe
Q 001974 350 NLVGLYRLGMGGNQFTG-TIPKEMGKLQNLEG 380 (988)
Q Consensus 350 ~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 380 (988)
.+.+|+.| ++.+.+.| .++...+.+.+++.
T Consensus 431 tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~ 461 (754)
T PRK15370 431 TIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRV 461 (754)
T ss_pred HHHHHHHh-hhcccccCCcccccccccccccc
Confidence 34444444 33344432 23333444444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=229.30 Aligned_cols=201 Identities=23% Similarity=0.431 Sum_probs=107.8
Q ss_pred CcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecc
Q 001974 305 LRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLY 384 (988)
Q Consensus 305 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 384 (988)
|+.|+|++|++. .+|..+. ..|+.|++++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+++
T Consensus 243 L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 243 IQEMELSINRIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred ccEEECcCCccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence 444444444444 3343332 24555555555555 3444332 35556666666555 3343332 345666666
Q ss_pred cccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCC
Q 001974 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGS 464 (988)
Q Consensus 385 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 464 (988)
+|+++ .+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. +.| +.|++++|+|+ .
T Consensus 313 ~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L-~~LdLs~N~Lt-~ 381 (754)
T PRK15370 313 SNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTI-TTLDVSRNALT-N 381 (754)
T ss_pred CCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCc-CEEECCCCcCC-C
Confidence 66665 3443332 456666666666663 444443 46666666666665 5555442 344 66666666666 4
Q ss_pred CccccccccccceeecCCcccccccCccc----ccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCc
Q 001974 465 IPTKIGNLKYLRVFNVSSNNLSGEIPSQL----GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536 (988)
Q Consensus 465 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 536 (988)
+|..+. ..|+.|++++|+|+ .+|..+ +.++.+..|+|.+|.|+. ..+.+|+.| ++.+.+.|.
T Consensus 382 LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp 447 (754)
T PRK15370 382 LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGP 447 (754)
T ss_pred CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCC
Confidence 454443 25677777777776 455433 345677788888887762 344555555 444555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-20 Score=188.55 Aligned_cols=175 Identities=13% Similarity=0.145 Sum_probs=133.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHH---------HHHHHHHHHhcCCCCceEEEeecccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS---------FLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
..+|...+.+|.|+||.||++.. ++..+|+|+++......... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999766 56789999997543322222 68999999999999999998875432
Q ss_pred c---ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCC
Q 001974 733 D---FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGN 809 (988)
Q Consensus 733 ~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 809 (988)
. +......++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||++|+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 1 112356899999999999987731 222 2456999999999999 99999999999
Q ss_pred eeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHH
Q 001974 810 VLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMV 877 (988)
Q Consensus 810 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell 877 (988)
|+++.++ ++|+|||........... ..+.....+..++|+||||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999988754322111 11334445667999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-19 Score=198.94 Aligned_cols=264 Identities=27% Similarity=0.384 Sum_probs=193.6
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc---hhHHHHHHHHHHHhcCCC-CceEEEeecccccccCCCce
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG---ASKSFLAECKALKNIRHR-NLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 740 (988)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 677889999999999999996 78899998644332 357899999999999888 7999999852 33557
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 819 (988)
+++++|+.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~ 142 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK--------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVK 142 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEE
Confidence 9999999999999777654311 2578889999999999999999999 999999999999999988 799
Q ss_pred Eeeecccccccccccccc--eeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 820 VGDFGLARVRQEVSNLTQ--SCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++|||.+........... .......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ...
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~ 220 (384)
T COG0515 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SAT 220 (384)
T ss_pred EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccH
Confidence 999999985544322111 12344679999999999987 57889999999999999999999996533211 000
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
......+....... ......... .......+.+++..|+..+|..|.++.+....
T Consensus 221 ~~~~~~~~~~~~~~---~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQTLKIILELPTPS---LASPLSPSN---------------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhcCCcc---cccccCccc---------------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00101000000000 000000000 01123467899999999999999999887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=215.60 Aligned_cols=249 Identities=20% Similarity=0.230 Sum_probs=176.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-hhHHHHHHHHH--HHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKA--LKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
+|...+.+|.+.|=+|.+|++. .|. |+||++-..++. ..+.+.++++- ...++|||++++.-+ ...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence 6778899999999999999995 454 999999655432 22344443333 444599999998766 3345777
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
|+|-+|. .-+|+|.+.... -+...+.+.|+.|++.|+..+|.. ||+|||||.+||||+.-.-+.|
T Consensus 97 ylvRqyv-khnLyDRlSTRP-----------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP-----------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch-----------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence 8999998 679999997654 367778889999999999999999 9999999999999999999999
Q ss_pred eeeccccc--ccc--cccccceeccccccccccccCcccCCC----------C-CCCccchHHHHHHHHHHHh-CCCCCC
Q 001974 821 GDFGLARV--RQE--VSNLTQSCSVGVRGTIGYAAPEYGLGS----------E-VSTNGDIYSYGILLLEMVT-GKKPTD 884 (988)
Q Consensus 821 ~DfG~a~~--~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~vl~ellt-g~~p~~ 884 (988)
+||..-+. ..+ ...+..... +...-..|.|||.+... . .+++.||||+||++.|+++ |++||.
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFD-TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFD-TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEe-cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 99976542 111 222222221 22234579999976431 2 5788999999999999999 899986
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.. +.....-... +. ..+.+ +...+ ..+++++..|++.||++|.+|++.
T Consensus 241 LS--------QL~aYr~~~~--------------~~---~e~~L-----e~Ied--~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 241 LS--------QLLAYRSGNA--------------DD---PEQLL-----EKIED--VSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred HH--------HHHhHhccCc--------------cC---HHHHH-----HhCcC--ccHHHHHHHHHccCchhccCHHHH
Confidence 32 1110000000 00 00000 00111 247899999999999999999999
Q ss_pred HHH
Q 001974 965 VHE 967 (988)
Q Consensus 965 l~~ 967 (988)
++.
T Consensus 289 L~~ 291 (1431)
T KOG1240|consen 289 LQK 291 (1431)
T ss_pred HHh
Confidence 977
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.6e-20 Score=182.60 Aligned_cols=140 Identities=19% Similarity=0.169 Sum_probs=107.0
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccch---------h-----------------HHHHHHHHHHHhcCCCC
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA---------S-----------------KSFLAECKALKNIRHRN 721 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---------~-----------------~~~~~E~~~l~~l~h~n 721 (988)
...||+|++|.||+|... +|+.||||+++...... . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 89999999997542210 0 12235999999998776
Q ss_pred ceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHH-HcCCCCCe
Q 001974 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYL-HHHCQEPV 800 (988)
Q Consensus 722 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~i 800 (988)
+.....+. . ...++||||++++++....... .+++..++..++.|++.+|+|+ |+. +|
T Consensus 81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~l~H~~---gi 139 (190)
T cd05147 81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKD-----------APLSESKARELYLQVIQIMRILYQDC---RL 139 (190)
T ss_pred CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 63322221 0 2238999999887665443221 2578889999999999999999 687 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 801 LHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 801 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
+||||||+||+++ ++.++|+|||+|....
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 9999999999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=187.19 Aligned_cols=205 Identities=22% Similarity=0.223 Sum_probs=145.1
Q ss_pred CCCCceEEEeecccc----------------------cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCH
Q 001974 718 RHRNLVKVITSCSSI----------------------DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775 (988)
Q Consensus 718 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~ 775 (988)
+|||||++.++|.+. ....+...|+||..+ ..+|++|+.... .+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~------------~s~ 340 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH------------RSY 340 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC------------Cch
Confidence 699999999876433 123345678999988 679999987653 456
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee--CCCC--cEEEeeeccccccccccc--ccceecccccccccc
Q 001974 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL--DNDM--IAHVGDFGLARVRQEVSN--LTQSCSVGVRGTIGY 849 (988)
Q Consensus 776 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~DfG~a~~~~~~~~--~~~~~~~~~~gt~~y 849 (988)
....-|..|+++|+.|||.+ ||.|||+|++||++ |+|+ .+.++|||++--.+...- ...+.....-|...-
T Consensus 341 r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l 417 (598)
T KOG4158|consen 341 RTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL 417 (598)
T ss_pred HHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence 66778999999999999999 99999999999999 4444 578999998854332111 111112233477889
Q ss_pred ccCcccCCCC------CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhh
Q 001974 850 AAPEYGLGSE------VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDAT 923 (988)
Q Consensus 850 ~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 923 (988)
||||+....+ -..|+|.|+.|.+.||+++...||..-.+..-+...|-
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-------------------------- 471 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-------------------------- 471 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh--------------------------
Confidence 9999976532 13589999999999999999999863111100000000
Q ss_pred hHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 924 NKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 924 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
+...+.-+..+|+.+++++...++.||.+|+++.-....|.
T Consensus 472 -----e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 -----ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -----hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 00111234568889999999999999999999876666553
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-21 Score=177.46 Aligned_cols=164 Identities=32% Similarity=0.592 Sum_probs=118.2
Q ss_pred cccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccccc
Q 001974 347 GIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQL 426 (988)
Q Consensus 347 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 426 (988)
.+..+...+.|.||+|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3556778888999999998 77888999999999999999998 78888999999999999999998 889999999999
Q ss_pred ceeecCCCCCC-ccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEec
Q 001974 427 AILHLFENGLN-GTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR 505 (988)
Q Consensus 427 ~~L~l~~N~l~-~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 505 (988)
+.|||+.|++. ..+|..|+.++.+ ..|.|+.|.+. .+|..++.|++|+.|.+..|.+- .+|.+++.+..|++|.++
T Consensus 105 evldltynnl~e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhccccccccccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 99999998887 3456666666655 55555555554 55555555555555555555554 455555555555555555
Q ss_pred CccccccCCccc
Q 001974 506 GNFFHGSIPSSL 517 (988)
Q Consensus 506 ~N~l~~~~p~~~ 517 (988)
+|+++ .+|..+
T Consensus 182 gnrl~-vlppel 192 (264)
T KOG0617|consen 182 GNRLT-VLPPEL 192 (264)
T ss_pred cceee-ecChhh
Confidence 55544 444433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.9e-20 Score=190.19 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=150.5
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCC----------CCceEEEeeccc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRH----------RNLVKVITSCSS 731 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~ 731 (988)
+...+.||.|+++.||.+++..+++.+|||++..... ...+++.+|.-....+.+ -.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456789999999999999999999999999864332 233556666654444322 122221211110
Q ss_pred ---ccc----cCCC-----ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 001974 732 ---IDF----QGND-----FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP 799 (988)
Q Consensus 732 ---~~~----~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 799 (988)
..+ .+.. ..+++|+-+ .+||.+++..-...... ...+....+..+..|+++.+++||+. |
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~----~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT----HSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT----SHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc----cchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 000 0001 236788888 78888776421100000 12344556778889999999999999 9
Q ss_pred eEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC--------CCCCCccchHHHHH
Q 001974 800 VLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--------SEVSTNGDIYSYGI 871 (988)
Q Consensus 800 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~ 871 (988)
+||+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999988754432111 224578999997533 25788999999999
Q ss_pred HHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhccc
Q 001974 872 LLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACS 951 (988)
Q Consensus 872 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 951 (988)
++|.|++|..||+.......... +| ....+.|+.+..||..+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~------------------------~f-------------~~C~~~Pe~v~~LI~~lL 281 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW------------------------DF-------------SRCRDMPEPVQFLIRGLL 281 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG------------------------GG-------------TTSS---HHHHHHHHHHT
T ss_pred HHHHHHHccCCCCCCCccccccc------------------------cc-------------hhcCCcCHHHHHHHHHHc
Confidence 99999999999985432211000 01 112278889999999999
Q ss_pred CcCCCCC
Q 001974 952 VESPQDR 958 (988)
Q Consensus 952 ~~dP~~R 958 (988)
+.+|++|
T Consensus 282 ~~~~~~R 288 (288)
T PF14531_consen 282 QRNPEDR 288 (288)
T ss_dssp -SSGGGS
T ss_pred cCCcccC
Confidence 9999988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-21 Score=174.62 Aligned_cols=163 Identities=32% Similarity=0.503 Sum_probs=93.7
Q ss_pred ccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccc
Q 001974 52 IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLK 131 (988)
Q Consensus 52 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 131 (988)
+.++.+++.|-||+|+++ .+|..+.++.+|+.|++++|+|+ .+|..++.++.|+.|+++-|++. +.|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 444455555555555555 44455555555556666666555 55555555555666665555555 5555555556666
Q ss_pred cccccccccc-CCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccC
Q 001974 132 QLAMQRNNLT-GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRN 210 (988)
Q Consensus 132 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 210 (988)
.|+|..|++. ..+|..|..++.|+-|+|++|.+. .+|..++++++|+.|.+++|.+- .+|..++.+..|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 6666555554 245555555555666666666555 45555566666666666665555 45556666666666666666
Q ss_pred CCCCCCCCcc
Q 001974 211 QFHGSLPPSL 220 (988)
Q Consensus 211 ~i~~~lp~~~ 220 (988)
+++ .+|+.+
T Consensus 184 rl~-vlppel 192 (264)
T KOG0617|consen 184 RLT-VLPPEL 192 (264)
T ss_pred eee-ecChhh
Confidence 665 555433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.8e-19 Score=176.75 Aligned_cols=140 Identities=19% Similarity=0.153 Sum_probs=109.3
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccch--------------------------hHHHHHHHHHHHhcCCCC
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--------------------------SKSFLAECKALKNIRHRN 721 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 721 (988)
...||+|++|.||+|++. +|+.||||+++...... ...+..|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 478999999999999987 89999999997542110 112457899999999988
Q ss_pred ceEEEeecccccccCCCceEEEEeeccccchhhh-cCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCC
Q 001974 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENW-LHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEP 799 (988)
Q Consensus 722 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ 799 (988)
+.....+.. ...++||||++++++... +.. .+++..++..++.|++.++.++|+ . |
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~---g 138 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKD------------VPLEEEEAEELYEQVVEQMRRLYQEA---G 138 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhhh------------ccCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence 744333211 224899999988754332 221 256778899999999999999999 8 9
Q ss_pred eEeccCCCCCeeeCCCCcEEEeeecccccccc
Q 001974 800 VLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831 (988)
Q Consensus 800 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 831 (988)
|+||||||+||+++ ++.++|+|||+|.....
T Consensus 139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999999 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=171.80 Aligned_cols=187 Identities=15% Similarity=0.051 Sum_probs=136.8
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeecccc----chhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCce
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH----GASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.+...|++|+||+||.+.. .+..++.+.+..... .....+.+|+++|+++. |+++++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4578999999999998766 778888777653322 11225889999999994 5889999887 446
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC-CCCCeeeCCCCcEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL-KPGNVLLDNDMIAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~k 819 (988)
+++|||++|.+|...... ....++.|++.+++++|+. ||+|||| ||+||+++.++.++
T Consensus 74 ~lvmeyI~G~~L~~~~~~------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~ 132 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPA 132 (218)
T ss_pred EEEEeeecCccHHhhhhh------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEE
Confidence 899999999888644311 1134778999999999999 9999999 79999999999999
Q ss_pred Eeeecccccccccccccce-e--------ccccccccccccCcccCC-CCCC-CccchHHHHHHHHHHHhCCCCCC
Q 001974 820 VGDFGLARVRQEVSNLTQS-C--------SVGVRGTIGYAAPEYGLG-SEVS-TNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~-~--------~~~~~gt~~y~aPE~~~~-~~~~-~~sDvwslG~vl~elltg~~p~~ 884 (988)
|+|||+|............ . ..-...++.|++|+...- ...+ ...+.++-|+-+|.++|+..|+-
T Consensus 133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 9999999855432211000 0 001125667777764322 1223 56789999999999999988854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=194.66 Aligned_cols=218 Identities=25% Similarity=0.398 Sum_probs=162.0
Q ss_pred HHhcCCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH
Q 001974 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH 793 (988)
Q Consensus 714 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 793 (988)
|+.+.|.|+.+++|.+... ...++|.+||..|+|.+.+.... .++++.....+.++|+.||+|+|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~----------~~~d~~F~~s~~rdi~~Gl~ylh 65 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED----------IKLDYFFILSFIRDISKGLAYLH 65 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc----------cCccHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999997653 78899999999999999998744 47899999999999999999999
Q ss_pred cCCCCCe-EeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-------CCCCccc
Q 001974 794 HHCQEPV-LHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-------EVSTNGD 865 (988)
Q Consensus 794 ~~~~~~i-vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sD 865 (988)
+. +| +|+.++++|+++|..+.+||+|||+........ .........-..-|.|||.+... ..+.++|
T Consensus 66 ~s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gd 140 (484)
T KOG1023|consen 66 NS---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGD 140 (484)
T ss_pred cC---cceeeeeeccccceeeeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCC
Confidence 98 55 999999999999999999999999998764311 11111112245679999998764 1467799
Q ss_pred hHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHH
Q 001974 866 IYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVR 945 (988)
Q Consensus 866 vwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 945 (988)
|||||++++|+++.+.||+........ ...+.. +.....+.+.++.. ...+.++++..
T Consensus 141 iYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~-----~~~~~~~~~rP~i~----------------~~~e~~~~l~~ 198 (484)
T KOG1023|consen 141 IYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILR-----VKKGGSNPFRPSIE----------------LLNELPPELLL 198 (484)
T ss_pred eehHHHHHHHHHhccCccccccccCCh-HHHHHH-----HHhcCCCCcCcchh----------------hhhhcchHHHH
Confidence 999999999999999999864333221 111111 11100111111110 01145557899
Q ss_pred HhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 946 IGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 946 li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
++.+||..+|++||++++|-..++.+..
T Consensus 199 l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 199 LVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999999999999999999888877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=205.10 Aligned_cols=199 Identities=20% Similarity=0.250 Sum_probs=156.4
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC---CCCceEEEeeccccccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR---HRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 735 (988)
....+.|.+.+.+|+|+||+||+|.... |+.||+|+-+.. ...+|.--.+++.+++ -+-|..+..+ +.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~---~~WEfYI~~q~~~RLk~~~~~~~~~~~~a-----~~ 764 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP---NPWEFYICLQVMERLKPQMLPSIMHISSA-----HV 764 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC---CceeeeehHHHHHhhchhhhcchHHHHHH-----Hc
Confidence 3455678899999999999999999975 999999986533 2344444455555665 1233333333 22
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN- 814 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 814 (988)
..+.-++|+||.+.|+|.+++...+ .+++.-+..++.|++..+++||.. +||||||||+|+|+..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~-----------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNK-----------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRRE 830 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCC-----------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecc
Confidence 3366789999999999999998443 688999999999999999999999 9999999999999942
Q ss_pred ------CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 815 ------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 815 ------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
..-++|+|||.+....-.... ....+.++|-.+-.+|...+.+++.++|-|.++.+++-|+.|+.-
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 346899999999755433322 223456789999999999999999999999999999999999754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-19 Score=199.11 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=128.7
Q ss_pred ccCCcccEEEeccccccCc----ccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCc
Q 001974 246 SNASKLEFIEALDNSFSGK----LSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH 321 (988)
Q Consensus 246 ~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 321 (988)
..+..|+.|+++++.++.. ++..+...+++++++++++.+..........+..+..+++|+.|++++|.+.+..+.
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 3333444444444444221 222334445566666665555432222222233445566666666666666544444
Q ss_pred hhhhccc--cccEEEccCCcccc----CCCccccCC-CcceEEEeeCccCCCc----cCcccCCCCccCeEecccccCCC
Q 001974 322 SIANLSD--QLQNLIMTSNQLHG----SIPSGIGNL-VGLYRLGMGGNQFTGT----IPKEMGKLQNLEGMGLYDNQLSG 390 (988)
Q Consensus 322 ~~~~~~~--~L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~ 390 (988)
.+..+.. .|++|++++|++.+ .+...+..+ ++|+.|++++|.+++. ++..+..+.+|+.|+|++|.+++
T Consensus 100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 4433321 25555555555542 122233344 5556666666665522 22234444555555555555552
Q ss_pred C----CCCCCCCCCCCCEEEccccccccc----cccccccccccceeecCCCCCCccCchhhhhhcccccceeccccccc
Q 001974 391 E----IPSSLGNLSILSELLLNNNSLSGV----IPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 391 ~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 462 (988)
. ++..+..+++|+.|+|++|.+.+. ++..+..+++|+.|++++|.+++.....+...
T Consensus 180 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~--------------- 244 (319)
T cd00116 180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA--------------- 244 (319)
T ss_pred HHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH---------------
Confidence 1 122233334555555555555422 12233344455555555555542111111110
Q ss_pred CCCccccccccccceeecCCcccc----cccCcccccCCCCcEEEecCcccccc----CCccccCc-cccCeeecCCCcc
Q 001974 463 GSIPTKIGNLKYLRVFNVSSNNLS----GEIPSQLGLCSYLEEIYMRGNFFHGS----IPSSLSSL-RAVLAIDLSRNNL 533 (988)
Q Consensus 463 ~~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l 533 (988)
+ ....+.|+.|++++|.++ ..+...+..+++|+.+++++|.++.. +...+... +.|+.||+.+|.+
T Consensus 245 --~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 245 --L---LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred --H---hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 0 001256777777777765 22334455566777777777777743 33344444 6777777777753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-19 Score=193.76 Aligned_cols=226 Identities=25% Similarity=0.299 Sum_probs=175.7
Q ss_pred eeccccceeEEEEEE---CCCCeEEEEEEeeccccc--hhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceEEE
Q 001974 670 LIGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHG--ASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.+|+|+||.|++++. ...|..+|+|+.+..... .......|..++...+ ||.++++... ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 368999999987644 235677899887643221 1124556777888885 9999998877 5556888999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
++|..+|++...+.... .++......+...++-|++++|+. +|+|||+|++||+++.+|.+++.||
T Consensus 76 ld~~rgg~lft~l~~~~-----------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdf 141 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV-----------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDF 141 (612)
T ss_pred hhhcccchhhhccccCC-----------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCc
Confidence 99999999998887654 567777888999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
|+++..-..... .||..|||||++. ....++|.||||++++||+||..||..
T Consensus 142 glske~v~~~~~--------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------------ 193 (612)
T KOG0603|consen 142 GLSKEAVKEKIA--------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------------ 193 (612)
T ss_pred hhhhHhHhhhhc--------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------------
Confidence 999865433221 4899999999988 567889999999999999999999873
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
....++.......+.+......+++..++..+|..|--.
T Consensus 194 -------------------~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 -------------------DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -------------------HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 011122222333444566677888888999999988644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=166.69 Aligned_cols=140 Identities=17% Similarity=0.265 Sum_probs=107.3
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-----CCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-----RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+...+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++|++.+. .+.+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~--~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD--CGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC--CCCeE
Confidence 34567999999999995 6556555 69998765555567899999999999 579999999997553 11133
Q ss_pred -eEEEEee--ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEeccCCCCCeeeCC-
Q 001974 740 -KALVYEF--MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI-DYLHHHCQEPVLHCDLKPGNVLLDN- 814 (988)
Q Consensus 740 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~- 814 (988)
..+|+|| +++++|.+++... .+++. ..++.|++.++ +|||+. +||||||||+||+++.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~------------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~ 141 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC------------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRI 141 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc------------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEecc
Confidence 3478999 5579999999653 23333 35677888777 999999 9999999999999974
Q ss_pred ---CCcEEEeeeccc
Q 001974 815 ---DMIAHVGDFGLA 826 (988)
Q Consensus 815 ---~~~~kL~DfG~a 826 (988)
++.++|+||+-+
T Consensus 142 ~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 142 SESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCCcEEEEECCCC
Confidence 348999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=170.92 Aligned_cols=143 Identities=20% Similarity=0.158 Sum_probs=111.9
Q ss_pred CCCCCCceeccccceeEEEEE-ECCCCeEEEEEEeeccccc------------------------hhHHHHHHHHHHHhc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGA-FDQDGTIVAIKVFNLQRHG------------------------ASKSFLAECKALKNI 717 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 717 (988)
..|.+.+.||+|++|.||+|. +..+|+.||+|+++..... ....+..|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999998 5568999999998743210 012356899999999
Q ss_pred CC--CCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC
Q 001974 718 RH--RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH 795 (988)
Q Consensus 718 ~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 795 (988)
.+ ..+.+++++ ...++||||++++++..+..... .....++..++.||+.++++||+.
T Consensus 108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV-----------EPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred HhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC-----------CcchHHHHHHHHHHHHHHHHHHhc
Confidence 65 345555543 23479999998888876542221 344556788999999999999999
Q ss_pred CCCC-eEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 796 CQEP-VLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 796 ~~~~-ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
+ |+||||||+||+++ ++.++|+|||.|...
T Consensus 168 ---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 ---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999998743
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.4e-20 Score=202.59 Aligned_cols=154 Identities=23% Similarity=0.262 Sum_probs=86.1
Q ss_pred EEEcCCCCCc-ccccccccCCCCCCEEEcCCCcccc----cCCcccCCCCCCcEEECCCCCCCC------cCCcccccCC
Q 001974 36 VLNLRSKGLS-GSLSPYIGNLSFLREINLMNNSIQG----EIPREFGRLFRLEALFLSDNDLVG------EIPANLSYCS 104 (988)
Q Consensus 36 ~l~l~~~~~~-~~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~~~~l~ 104 (988)
.|+|..+.++ ......+..++.|++|+|+++.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3667777776 3444555666777888888887743 244456666777777777777662 2334455566
Q ss_pred CCceeecCcccccCCCcccccCccc---ccccccccccccC----CCCCcccCC-CccceeeccccccCCC----CCccc
Q 001974 105 RLTILFLGRNKLMGSIPFEFFSLYK---LKQLAMQRNNLTG----GIPPFIGNL-TSLESISLAANAFGGN----IPNSL 172 (988)
Q Consensus 105 ~L~~L~L~~N~i~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~ 172 (988)
+|+.|+|++|.+.+..+..|..+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 6777777766665545555554444 6666666666552 112223334 4555555555555421 12233
Q ss_pred cCccccccccccccccc
Q 001974 173 GQLKELKSLGLGANNLS 189 (988)
Q Consensus 173 ~~l~~L~~L~L~~N~l~ 189 (988)
..+++|++|+|++|.++
T Consensus 162 ~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 162 RANRDLKELNLANNGIG 178 (319)
T ss_pred HhCCCcCEEECcCCCCc
Confidence 34444555555555444
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-18 Score=181.54 Aligned_cols=127 Identities=27% Similarity=0.506 Sum_probs=107.2
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
.+.+|.|++|+..+|.+|+...... ...++.....++.|++.|++| + +.+|||+||.||++..+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~--------e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTG--------EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcc--------cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence 4678999999999999999755432 356778899999999999999 5 9999999999999999999
Q ss_pred EEEeeecccccccccccc--cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh
Q 001974 818 AHVGDFGLARVRQEVSNL--TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 878 (988)
+||+|||+.......... ........+||..||+||.+.+..|+.++||||+|++++|+++
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 999999999865544311 1112234579999999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.2e-16 Score=161.89 Aligned_cols=134 Identities=20% Similarity=0.314 Sum_probs=109.0
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccc--------hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--------ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
+.||+|++|.||+|.+ .|..|++|+....... ....+.+|++++..+.|+++.....++. ..+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 6799999999999988 6778999986533211 1235778999999999988766555532 23567
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++|++|.+++... .+ ++..++.+++.+|.++|+. +++|||++|+||+++ ++.+++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~--------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~l 135 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN--------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYL 135 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc--------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEE
Confidence 8999999999999887532 12 7788999999999999998 999999999999999 789999
Q ss_pred eeeccccc
Q 001974 821 GDFGLARV 828 (988)
Q Consensus 821 ~DfG~a~~ 828 (988)
+|||.+..
T Consensus 136 iDf~~a~~ 143 (211)
T PRK14879 136 IDFGLAEF 143 (211)
T ss_pred EECCcccC
Confidence 99998863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.7e-16 Score=157.29 Aligned_cols=140 Identities=24% Similarity=0.200 Sum_probs=109.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc----------------------hhHHHHHHHHHHHhcC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG----------------------ASKSFLAECKALKNIR 718 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~ 718 (988)
....|.+.+.||+|+||.||+|... +|+.||||+++..... ....+..|+.++.++.
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3334888899999999999999885 8999999987643210 1123677889999997
Q ss_pred CC--CceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC
Q 001974 719 HR--NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC 796 (988)
Q Consensus 719 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 796 (988)
|+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+.
T Consensus 92 ~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-----------------~~~~~~~~~i~~~l~~lh~~- 144 (198)
T cd05144 92 EEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-----------------EDPEEVLDEILEEIVKAYKH- 144 (198)
T ss_pred HcCCCCCceeec---------CCceEEEEEeCCcchhhcccc-----------------ccHHHHHHHHHHHHHHHHHC-
Confidence 77 45555443 345899999999998765321 23456889999999999998
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 797 QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 797 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
+|+||||||+||++++++.++|+|||.+....
T Consensus 145 --gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 145 --GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.3e-17 Score=185.40 Aligned_cols=212 Identities=25% Similarity=0.331 Sum_probs=147.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|+.++.|..|+||.||.++++.+.+.+|+|+=+ +.. ++ +||..+.+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----------il-----Rnilt~a~-----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----------IL-----RNILTFAG-----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----------hh-----hccccccC-----------Ccc
Confidence 468999999999999999999998888899996522 110 11 12333222 122
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
.| ||=.+.++..+ +++. +++.+++|+|+. +|||||+||+|.+|+.-|++|++
T Consensus 134 vv------gDc~tllk~~g-----------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlT 185 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIG-----------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLT 185 (1205)
T ss_pred ee------chhhhhcccCC-----------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeeccccccc
Confidence 33 34344443322 2222 238899999999 99999999999999999999999
Q ss_pred eecccccccccc-----------cccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 822 DFGLARVRQEVS-----------NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 822 DfG~a~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
|||+++..-... .........+.||+.|+|||++....|+..+|.|++|+++||.+.|+.||...-++
T Consensus 186 DfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe- 264 (1205)
T KOG0606|consen 186 DFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE- 264 (1205)
T ss_pred chhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-
Confidence 999987532211 01111223467999999999999999999999999999999999999998632111
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
......+.+. -.| .+.....+++.++++.+.++.+|.+|-
T Consensus 265 ----elfg~visd~-------------i~w------------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 265 ----ELFGQVISDD-------------IEW------------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----HHHhhhhhhh-------------ccc------------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111111111 111 122346788899999999999999994
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=179.13 Aligned_cols=144 Identities=23% Similarity=0.294 Sum_probs=111.2
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--cc------chhHHHHHHHHHHHhcCCCCceEEE
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RH------GASKSFLAECKALKNIRHRNLVKVI 726 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~ 726 (988)
+.........|...+.||+|+||+||+|.+. ++.+++|+.... .. ...+.+.+|+++++.++|++++...
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3333334455677899999999999999884 334444443211 11 1235688999999999999988776
Q ss_pred eecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 727 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.++.. +...++||||+++++|.+++. ....++.++++++.|||+. +++|||+|
T Consensus 403 ~~~~~-----~~~~~lv~E~~~g~~L~~~l~-------------------~~~~~~~~i~~~L~~lH~~---giiHrDlk 455 (535)
T PRK09605 403 IYDVD-----PEEKTIVMEYIGGKDLKDVLE-------------------GNPELVRKVGEIVAKLHKA---GIVHGDLT 455 (535)
T ss_pred EEEEe-----CCCCEEEEEecCCCcHHHHHH-------------------HHHHHHHHHHHHHHHHHhC---CCccCCCC
Confidence 65432 355689999999999998773 2456899999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeeeccccc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~ 828 (988)
|+||++ +++.++|+|||+++.
T Consensus 456 p~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 456 TSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred hHHEEE-ECCcEEEEeCccccc
Confidence 999999 678999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=154.93 Aligned_cols=130 Identities=22% Similarity=0.315 Sum_probs=102.1
Q ss_pred eeccccceeEEEEEECCCCeEEEEEEeeccccc--------hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--------ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.||+|+||.||+|.+ +++.|++|+....... ....+.+|++++..++|+++.....++. ..+..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 479999999999996 6788999986432111 1255778999999998876443333321 224568
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++|++|.+++.... . .++.+++.+|+++|+. +++|||++|+||+++ ++.++++
T Consensus 74 lv~e~~~g~~l~~~~~~~~-----------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~li 131 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN-----------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLI 131 (199)
T ss_pred EEEEEECCccHHHHHhhcH-----------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEE
Confidence 9999999999998874321 1 7899999999999998 999999999999999 8899999
Q ss_pred eeccccc
Q 001974 822 DFGLARV 828 (988)
Q Consensus 822 DfG~a~~ 828 (988)
|||.+..
T Consensus 132 Dfg~a~~ 138 (199)
T TIGR03724 132 DFGLGKY 138 (199)
T ss_pred ECCCCcC
Confidence 9999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-16 Score=170.90 Aligned_cols=174 Identities=30% Similarity=0.461 Sum_probs=88.2
Q ss_pred EEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccc
Q 001974 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412 (988)
Q Consensus 333 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 412 (988)
.+|+.|++. ++|..+..+..|..|.|.+|.|. .+|..++++..|++|||+.|+++ ..|..++.|+ |+.|-+++|++
T Consensus 80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence 344444444 44444444445555555555554 45555555555555555555555 4444444444 55555555555
Q ss_pred ccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcc
Q 001974 413 SGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492 (988)
Q Consensus 413 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 492 (988)
+ .+|..++.+..|..||.+.|.+. ++|..++++..+ +.|.+..|++. .+|.+++.|+ |..||+|.|+++ .+|-.
T Consensus 156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchh
Confidence 4 44444555555555555555554 555555555555 45555555554 4444444333 455555555555 45555
Q ss_pred cccCCCCcEEEecCccccccCCccc
Q 001974 493 LGLCSYLEEIYMRGNFFHGSIPSSL 517 (988)
Q Consensus 493 ~~~l~~L~~L~L~~N~l~~~~p~~~ 517 (988)
|..|..|++|-|.+|.|+ ..|..+
T Consensus 230 fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred hhhhhhheeeeeccCCCC-CChHHH
Confidence 555555555555555555 344443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=145.69 Aligned_cols=136 Identities=24% Similarity=0.239 Sum_probs=98.2
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchh--HH----------------------HHHHHHHHHhcCCC--C
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KS----------------------FLAECKALKNIRHR--N 721 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~E~~~l~~l~h~--n 721 (988)
.+.||+|+||+||+|.+. +++.||||+++....... .. ...|...+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999986 899999999874322111 11 13455666666433 3
Q ss_pred ceEEEeecccccccCCCceEEEEeeccccchhhh-cCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCC
Q 001974 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENW-LHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEP 799 (988)
Q Consensus 722 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ 799 (988)
+.+.+++ ...++||||++++++... +... ... .++..++.+++.++.++|+ . +
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~------------~~~-~~~~~~~~~~~~~l~~lh~~~---~ 135 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV------------RLL-EDPEELYDQILELMRKLYREA---G 135 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh------------hhc-ccHHHHHHHHHHHHHHHhhcc---C
Confidence 4445443 345899999988554211 1100 001 5678899999999999999 7 9
Q ss_pred eEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 800 VLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 800 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
|+||||||+||+++ ++.++++|||.+....
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-14 Score=138.66 Aligned_cols=136 Identities=22% Similarity=0.262 Sum_probs=111.4
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCC--CCceEEEeecccccccCCCceEEEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH--RNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+++.+|+|.++.||++... ++.+++|....... ...+.+|+.+++.++| .++.+++++.. ..+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEE
Confidence 4678999999999999984 47899999864433 4678899999999976 58889888743 336789999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||++++.+..+ +......++.+++++++++|.....+++|||++|+||+++..+.++++|||
T Consensus 73 e~~~g~~~~~~------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~ 134 (155)
T cd05120 73 EWIEGETLDEV------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134 (155)
T ss_pred EecCCeecccC------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence 99988777643 334566789999999999998644579999999999999998999999999
Q ss_pred ccccc
Q 001974 825 LARVR 829 (988)
Q Consensus 825 ~a~~~ 829 (988)
.++..
T Consensus 135 ~~~~~ 139 (155)
T cd05120 135 YAGYG 139 (155)
T ss_pred cccCC
Confidence 98743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-15 Score=177.01 Aligned_cols=258 Identities=24% Similarity=0.276 Sum_probs=189.8
Q ss_pred hCCCCCCceeccccceeEEEEEECC-CCeEEEEEEeeccc--cchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQR--HGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 737 (988)
...|...+.||+|+|+.|-.+.... ....+|+|.+.... ....+....|..+-+.+. |+|++++++. ..+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence 4568888899999999998877642 33457777665332 223344556777777775 9999999998 4455
Q ss_pred CceEEEEeeccccchhhhc-CCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEeccCCCCCeeeCCC
Q 001974 738 DFKALVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+..+++++|..++++.+.+ .... ...+...+..+..|+..++.|+| .. ++.|||+||+|.+++..
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~----------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s 160 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDS----------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDES 160 (601)
T ss_pred cccccccCcccccccccccccCCc----------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccC
Confidence 8889999999999999888 3332 13455667789999999999999 77 99999999999999999
Q ss_pred C-cEEEeeecccccccccccccceecccccc-ccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 816 M-IAHVGDFGLARVRQEVSNLTQSCSVGVRG-TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 816 ~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+ ..+++|||+|..+....... .......| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+..
T Consensus 161 ~~~l~~~df~~At~~~~~~g~~-~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~ 239 (601)
T KOG0590|consen 161 GSALKIADFGLATAYRNKNGAE-RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR 239 (601)
T ss_pred CCcccCCCchhhccccccCCcc-eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence 9 99999999998765522211 12233457 9999999998884 4567899999999999999999999876555433
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+..|...... .... ..........++..+++..+|..|.+.+++..
T Consensus 240 ~~~~~~~~~~------------~~~~----------------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 YSSWKSNKGR------------FTQL----------------PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ceeecccccc------------cccC----------------ccccCChhhhhcccccccCCchhccccccccc
Confidence 3333222100 0000 01133445678999999999999999888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=143.79 Aligned_cols=139 Identities=18% Similarity=0.160 Sum_probs=104.7
Q ss_pred Cceec-cccceeEEEEEECCCCeEEEEEEeeccc-------------cchhHHHHHHHHHHHhcCCCCc--eEEEeeccc
Q 001974 668 THLIG-MGSFGSVYKGAFDQDGTIVAIKVFNLQR-------------HGASKSFLAECKALKNIRHRNL--VKVITSCSS 731 (988)
Q Consensus 668 ~~~lg-~G~~g~Vy~a~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 731 (988)
...|| .||.|+||.+.. .+..+|||.+.... ......+.+|++++.+++|+++ ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35687 899999999988 47789999885311 1223567889999999988774 667766432
Q ss_pred ccccCCCceEEEEeeccc-cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 732 IDFQGNDFKALVYEFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
. .......++||||+++ .+|.+++... +++.. .+.+|+.++.+||+. ||+||||||+||
T Consensus 114 ~-~~~~~~~~lV~e~l~G~~~L~~~l~~~------------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NI 173 (239)
T PRK01723 114 R-HGLFYRADILIERIEGARDLVALLQEA------------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNI 173 (239)
T ss_pred e-cCcceeeeEEEEecCCCCCHHHHHhcC------------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhE
Confidence 1 1111233599999987 6999887542 23332 356899999999999 999999999999
Q ss_pred eeCCCCcEEEeeeccccc
Q 001974 811 LLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~ 828 (988)
|++.++.++|+|||.+..
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999999999999998875
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.6e-16 Score=166.26 Aligned_cols=197 Identities=29% Similarity=0.432 Sum_probs=174.8
Q ss_pred cCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccce
Q 001974 349 GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAI 428 (988)
Q Consensus 349 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 428 (988)
..+..-...||+.|++. ++|..++.+..|+.+.|+.|.+. .+|..++++..|+.|||+.|+++ ..|..++.|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 34555678899999999 89999999999999999999999 89999999999999999999999 7899999988 999
Q ss_pred eecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcc
Q 001974 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNF 508 (988)
Q Consensus 429 L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 508 (988)
|-+++|+++ .+|+.++.+..+ ..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|++++ .-.|..||+|.|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCc
Confidence 999999998 999999977777 88999999998 88999999999999999999999 7898888 4569999999999
Q ss_pred ccccCCccccCccccCeeecCCCcccCcCcccccCC---CCcEEeCCCCc
Q 001974 509 FHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL---SLEYLNLSFND 555 (988)
Q Consensus 509 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~---~L~~l~l~~N~ 555 (988)
++ .+|-.|.+|++|++|-|.+|.|...+..++..= =.++|+...+.
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhcc
Confidence 99 899999999999999999999987555442221 26777777664
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-14 Score=168.41 Aligned_cols=117 Identities=31% Similarity=0.481 Sum_probs=85.1
Q ss_pred ccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCC
Q 001974 474 YLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLS 552 (988)
Q Consensus 474 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~ 552 (988)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.|.|.+|..++.+++|+.|||++|+++|.+|.. ..+.+|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3667777777777777777777777777777777777777777777777777788887777777765 666677888888
Q ss_pred CCcCcccCCCC--cccCcccccccccccccCCCCCCCCCCccc
Q 001974 553 FNDLEGEVPTK--GVFANISRISVAGFNRLCGGIPELQLPKCT 593 (988)
Q Consensus 553 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~lcg~~~~~~~~~~~ 593 (988)
+|+++|.+|.. .....+..+.+.+|+.+||.+.. +.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l---~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL---RACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCC---CCCc
Confidence 88887777764 11223445678889999986542 4564
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.4e-14 Score=142.51 Aligned_cols=164 Identities=22% Similarity=0.369 Sum_probs=123.5
Q ss_pred HHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHH
Q 001974 711 CKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790 (988)
Q Consensus 711 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~ 790 (988)
..-+-.+.|.|++++..|+.+..+.+.....+++|||..|++..++++....+ ..+......+|+-||..||.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-------~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-------KALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-------hhhhHHHHHHHHHHHHhhhh
Confidence 33445567999999999987776666777889999999999999998765433 35777888999999999999
Q ss_pred HHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHH
Q 001974 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYG 870 (988)
Q Consensus 791 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 870 (988)
|||+. .++|+|+++.-+-|++..+|-+|++--.-...................+-++|.|||+-.....+.++|||+||
T Consensus 191 yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 191 YLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 99994 78999999999999999999988853211111000000011111122467899999987777778899999999
Q ss_pred HHHHHHHhCCCC
Q 001974 871 ILLLEMVTGKKP 882 (988)
Q Consensus 871 ~vl~elltg~~p 882 (988)
+...||..+..-
T Consensus 270 mcAlemailEiq 281 (458)
T KOG1266|consen 270 MCALEMAILEIQ 281 (458)
T ss_pred HHHHHHHHheec
Confidence 999999887654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=163.70 Aligned_cols=130 Identities=32% Similarity=0.492 Sum_probs=108.3
Q ss_pred CCCCCCCCC----ceeeeeEEeCCC----CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCC
Q 001974 11 NSWNDSGHF----CEWKGITCGLRH----RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRL 82 (988)
Q Consensus 11 ~~w~~~~~~----c~~~~v~c~~~~----~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 82 (988)
.+|.++ .| |.|.||.|.... ..|+.|+|++|++++.+|+.++.+++|+.|+|++|+|++.+|..++.+++|
T Consensus 390 ~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L 468 (623)
T PLN03150 390 FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468 (623)
T ss_pred CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence 489643 23 279999996422 258899999999999999999999999999999999999999999999999
Q ss_pred cEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCc-cccccccccccccc
Q 001974 83 EALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSL-YKLKQLAMQRNNLT 141 (988)
Q Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~N~l~ 141 (988)
+.|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+ .++..+++.+|...
T Consensus 469 ~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999999999999999999999999999998888887753 45666777777543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8e-14 Score=158.77 Aligned_cols=202 Identities=35% Similarity=0.483 Sum_probs=149.7
Q ss_pred EEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCC-ccCeEecccccCCCCCCCCCCCCCCCCEEEcccc
Q 001974 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQ-NLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410 (988)
Q Consensus 332 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 410 (988)
.+.++.|.+. .....+..++.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 23334555577888888888887 6666666664 8888888888887 66667788888888888888
Q ss_pred ccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccC
Q 001974 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIP 490 (988)
Q Consensus 411 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 490 (988)
+++ .+|...+..++|+.|++++|++. .+|........+ ++|.+++|.+. ..+..+..+.++..|.+++|++. .++
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~ 248 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP 248 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence 888 55655657788888888888887 788776555556 77888888644 56777788888888888888887 557
Q ss_pred cccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccC
Q 001974 491 SQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLED 543 (988)
Q Consensus 491 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 543 (988)
..++.+.++++|++++|.++ .++. ++.+..|+.||+++|.++..+|.....
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~ 299 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIALL 299 (394)
T ss_pred chhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhhhcc
Confidence 77788888888888888888 4444 788888888888888888877765433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=156.20 Aligned_cols=200 Identities=30% Similarity=0.425 Sum_probs=177.2
Q ss_pred eEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCC-CCCEEEccccccccccccccccccccceeecCC
Q 001974 355 YRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLS-ILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE 433 (988)
Q Consensus 355 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 433 (988)
..|+++.|.+. .....+..++.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus 96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 36899999986 34555677789999999999999 7788778775 9999999999999 6777899999999999999
Q ss_pred CCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccC
Q 001974 434 NGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSI 513 (988)
Q Consensus 434 N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 513 (988)
|+++ .+|.....++.+ +.|++++|+++ .+|..+..+..|+.|++++|.+. ..+..+..+.++..|.+++|++. .+
T Consensus 173 N~l~-~l~~~~~~~~~L-~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~ 247 (394)
T COG4886 173 NDLS-DLPKLLSNLSNL-NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DL 247 (394)
T ss_pred chhh-hhhhhhhhhhhh-hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ec
Confidence 9998 899888788888 89999999998 88887777788999999999766 68888999999999999999998 56
Q ss_pred CccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCCC
Q 001974 514 PSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 514 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~ 563 (988)
+..++.+..++.|++++|+++...+ .....+|++|++++|.+...+|..
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred cchhccccccceecccccccccccc-ccccCccCEEeccCccccccchhh
Confidence 8899999999999999999998877 777789999999999999888864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-11 Score=136.66 Aligned_cols=172 Identities=20% Similarity=0.247 Sum_probs=131.2
Q ss_pred EEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCC
Q 001974 681 KGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDA 760 (988)
Q Consensus 681 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 760 (988)
.|..+.++.+|.|.+++....+......+-++.++.++||+|+++++. ++..+..|+|+|.+. .|..++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk--- 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK--- 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH---
Confidence 456667899999999876655455667888999999999999999998 445578999999983 5666663
Q ss_pred CCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceec
Q 001974 761 VPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840 (988)
Q Consensus 761 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~ 840 (988)
.++...+...+.||+.||.|||+.| +++|++|.-+.|+|++.|..||++|.++........ ..
T Consensus 100 -----------~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~ 162 (690)
T KOG1243|consen 100 -----------ELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PA 162 (690)
T ss_pred -----------HhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----cc
Confidence 3445677788999999999999764 999999999999999999999999998865433221 00
Q ss_pred cccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCC
Q 001974 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKK 881 (988)
Q Consensus 841 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~ 881 (988)
....--..|..|+.+.... -..|.|.||+++||++.|..
T Consensus 163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 1111233466676544333 34699999999999999943
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-12 Score=145.26 Aligned_cols=251 Identities=24% Similarity=0.260 Sum_probs=181.2
Q ss_pred CCCCCceecc--ccceeEEEEEE--CCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 664 GFSSTHLIGM--GSFGSVYKGAF--DQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 664 ~y~~~~~lg~--G~~g~Vy~a~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .......-.+|+...+++ .|++.++.+.. +.+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4667788999 99999999998 778899999985422 223334455677777777 68999986555 566
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEeccCCCCCeee
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS----AIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.+..++-+|++ +.++.++.+.... -++...++.+..+..+ |+.++|+. +++|-|+||.||+.
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~----------~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN----------FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFT 255 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc----------cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheec
Confidence 78899999999 7899888876542 3666777888888888 99999998 99999999999999
Q ss_pred CCC-CcEEEeeeccccccccccccc-ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 813 DND-MIAHVGDFGLARVRQEVSNLT-QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 813 ~~~-~~~kL~DfG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
..+ ..++++|||+........... ........|...|++||...+ .++.++|+|++|.+..+..++..+........
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 999 889999999998776654222 222223357889999998654 67889999999999999999877644221110
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
|.. ++..+.. .+.......++...+..|++.+|..|++++.+.+
T Consensus 335 -----W~~----------~r~~~ip-----------------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -----WSQ----------LRQGYIP-----------------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccc----------cccccCc-----------------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 100 0000000 0011122344556888999999999999877654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.9e-12 Score=142.75 Aligned_cols=143 Identities=21% Similarity=0.250 Sum_probs=99.7
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchh----------------------------------------HHH
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS----------------------------------------KSF 707 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 707 (988)
.+.||.|++|.||+|+.. +|+.||||+.++...... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999986 899999999864321100 024
Q ss_pred HHHHHHHHhc----CCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHH
Q 001974 708 LAECKALKNI----RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783 (988)
Q Consensus 708 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~ 783 (988)
.+|++.+.++ +|.+-+.+-.++.+ .....++||||++|++|.++...... .. ....++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~----------~~---~~~~ia~ 263 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA----------GL---DRKALAE 263 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc----------CC---CHHHHHH
Confidence 4555555555 23333333333221 12456899999999999887642210 11 2345666
Q ss_pred HHHH-HHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccc
Q 001974 784 DVAS-AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831 (988)
Q Consensus 784 ~i~~-~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 831 (988)
+++. .+..+|.. |++|+|++|.||+++++++++++|||++...+.
T Consensus 264 ~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 264 NLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6666 46788988 999999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-12 Score=130.43 Aligned_cols=209 Identities=21% Similarity=0.209 Sum_probs=145.9
Q ss_pred CCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc-cccccccccccccc
Q 001974 344 IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN-NNSLSGVIPSCLGS 422 (988)
Q Consensus 344 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~ 422 (988)
+|-.+..+.+|+.+.+|++.-. .+-+....-+.|+.+...+.-++ ..|. +-....+..+.-+ .--..|..-..+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEecch
Confidence 3444455566777777776544 22222223356777777666655 2222 2122222222111 11233444455666
Q ss_pred ccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEE
Q 001974 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEI 502 (988)
Q Consensus 423 l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 502 (988)
++.|++||||+|.|+ .+.+++.-++.+ +.|++|+|.+. .+.. +..|++|+.||||+|.++ .+..+-..+-+.+.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccce-eEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 788999999999998 888888888888 89999999997 4333 888999999999999999 777777788899999
Q ss_pred EecCccccccCCccccCccccCeeecCCCcccCcCc--ccccCCCCcEEeCCCCcCcccCCC
Q 001974 503 YMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIP--KFLEDLSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 503 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~~~~L~~l~l~~N~l~~~~p~ 562 (988)
.|++|.+.. -..++.|-+|..||+++|+|..... .++.++-|+.+.|.+|.+.+.+.-
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 999998873 2457778889999999999986543 357888899999999999876653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.9e-11 Score=116.14 Aligned_cols=137 Identities=23% Similarity=0.164 Sum_probs=99.6
Q ss_pred ceeccccceeEEEEEECC------CCeEEEEEEeeccc----------------------cchhHHH----HHHHHHHHh
Q 001974 669 HLIGMGSFGSVYKGAFDQ------DGTIVAIKVFNLQR----------------------HGASKSF----LAECKALKN 716 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~------~~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~ 716 (988)
..||.|.-+.||.|.... .+..+|||+++... ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998643 35799999985211 0111223 379999999
Q ss_pred cC--CCCceEEEeecccccccCCCceEEEEeeccccchhh-hcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHH-
Q 001974 717 IR--HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLEN-WLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYL- 792 (988)
Q Consensus 717 l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L- 792 (988)
+. .-++.+++++ ..-++||||+.+..+.. .++. ..++..+...+..+++.+|.+|
T Consensus 83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd------------~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD------------AKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc------------cccCHHHHHHHHHHHHHHHHHHH
Confidence 84 3577777765 45689999996543321 1111 1244456677889999999999
Q ss_pred HcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 793 HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 793 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
|+. ++||||+++.||+++ ++.+.|+|||.|...+
T Consensus 142 H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 787 999999999999997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.5e-11 Score=135.95 Aligned_cols=147 Identities=18% Similarity=0.212 Sum_probs=96.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc----------------------------------hhH---
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG----------------------------------ASK--- 705 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~----------------------------------~~~--- 705 (988)
..|+. +.||+|++|.||+|+.+.+|+.||||+.++.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44666 7999999999999999866999999999743210 001
Q ss_pred ---HHHHHHHHHHhcC----CCCceEEEeecccccccCCCceEEEEeeccccchhhhc--CCCCCCCchhhhHhhcCCHH
Q 001974 706 ---SFLAECKALKNIR----HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLL 776 (988)
Q Consensus 706 ---~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~l~~~ 776 (988)
++.+|+.-+.+++ +...+.+-.++. +.....++||||++|+++.++- ...+. ....+...
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~~g~-------d~~~la~~ 267 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRAAGT-------DMKLLAER 267 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHhcCC-------CHHHHHHH
Confidence 2344554444442 333333322221 1125578999999999998752 21110 01133344
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC----cEEEeeecccccccc
Q 001974 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM----IAHVGDFGLARVRQE 831 (988)
Q Consensus 777 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~ 831 (988)
.+..++.|+. .. |++|+|+||.||+++.++ ++++.|||++...+.
T Consensus 268 ~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 268 GVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4444555544 35 999999999999999888 999999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.7e-11 Score=117.96 Aligned_cols=131 Identities=18% Similarity=0.088 Sum_probs=96.4
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC-ceEEEeecccccccCCCceEEEEee
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN-LVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
++.++.|.++.||+++. .++.|++|+...... ....+..|+.+++.+.+.. +.+++++. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 46789999999999987 478899999754322 2245678999999885544 34555542 1235799999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC--QEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
++|.++.+.- . ....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||
T Consensus 73 i~G~~l~~~~--~-----------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~ 132 (170)
T cd05151 73 IEGSELLTED--F-----------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE 132 (170)
T ss_pred cCCCcccccc--c-----------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence 9998876430 0 01235678999999999982 12359999999999999 6789999999
Q ss_pred cccc
Q 001974 825 LARV 828 (988)
Q Consensus 825 ~a~~ 828 (988)
.+..
T Consensus 133 ~a~~ 136 (170)
T cd05151 133 YAGM 136 (170)
T ss_pred cccC
Confidence 8863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.4e-12 Score=143.68 Aligned_cols=269 Identities=26% Similarity=0.256 Sum_probs=175.3
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
....++..++.+....-. ...+..+..+.++.|.|+ .+-..+..+.+|+.|++.+|+|+ .+...+..+.+|++|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecc
Confidence 334444444443322222 245677778888899888 34455788899999999999998 555557888999999999
Q ss_pred cccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCC-ccccCcccccccccccccccCc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 191 (988)
+|+|+.+. .+..++.|+.|++++|.|+. ...+..++.|+.+++++|++....+ . ...+.+|+.+++.+|.+..+
T Consensus 127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 127 FNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI 201 (414)
T ss_pred cccccccc--chhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc
Confidence 99987443 35566669999999999883 2456678899999999999884433 2 57788899999999998733
Q ss_pred cchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccC
Q 001974 192 IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271 (988)
Q Consensus 192 ~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~ 271 (988)
..+..+..+..+++..|.+. .+.........+|+.+++++|.+.. .+..+..+..+..|++.+|++..... +..
T Consensus 202 --~~~~~~~~l~~~~l~~n~i~-~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~ 275 (414)
T KOG0531|consen 202 --EGLDLLKKLVLLSLLDNKIS-KLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLEG--LER 275 (414)
T ss_pred --cchHHHHHHHHhhcccccce-eccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccccc--ccc
Confidence 34455556666688888887 3222111111137888888888873 33566677788888888888765332 344
Q ss_pred CccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCC
Q 001974 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317 (988)
Q Consensus 272 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 317 (988)
...+..+....|.+........ ..-......++...+..|.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 276 LPKLSELWLNDNKLALSEAISQ--EYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred cchHHHhccCcchhcchhhhhc--cccccccccccccccccCcccc
Confidence 5556666666666653221100 0012344555555555555553
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6e-12 Score=132.35 Aligned_cols=209 Identities=20% Similarity=0.179 Sum_probs=146.4
Q ss_pred CCCCCCcEEECCCCCCCCcCC--cccccCCCCceeecCcccccCCCc--ccccCcccccccccccccccCCCCC-cccCC
Q 001974 77 GRLFRLEALFLSDNDLVGEIP--ANLSYCSRLTILFLGRNKLMGSIP--FEFFSLYKLKQLAMQRNNLTGGIPP-FIGNL 151 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l 151 (988)
.++.+|+...|.+..+. ..+ .....|++++.||||+|-+....+ .-...|++|+.|+|+.|++..-... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45788999999999887 444 366789999999999998863222 2334789999999999998732222 22367
Q ss_pred CccceeeccccccCCC-CCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCC-CcccccCCCCcc
Q 001974 152 TSLESISLAANAFGGN-IPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLP-PSLGLTLPHLRL 229 (988)
Q Consensus 152 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp-~~~~~~l~~L~~ 229 (988)
+.|+.|.|+.|.++.. +......+|+|+.|+|..|....+......-++.|++|||++|++. ..+ ...-..++.|..
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhh
Confidence 8999999999999743 2233557899999999999654466677778899999999999998 444 333457888999
Q ss_pred eecccccccccc-Ccc-----cccCCcccEEEeccccccCccc-ccccCCccccEEecccccCCC
Q 001974 230 FQVHHNFFSGSI-PIS-----LSNASKLEFIEALDNSFSGKLS-VNFGGMKNLSYFNVAYNNLGS 287 (988)
Q Consensus 230 L~L~~N~l~~~~-p~~-----l~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~ 287 (988)
|+++.+.+..+- |+. ...+++|++|++..|+|..... ..+..+++|+.|.+..|.++.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 999998887542 332 3455667777777776643211 123334555555555555543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5e-12 Score=125.90 Aligned_cols=129 Identities=26% Similarity=0.287 Sum_probs=79.4
Q ss_pred CCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 55 LSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 55 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
...|++||||+|.|+ .+.++..-++.++.|++|+|.|. .+.. ++.|++|+.||||+|.++ .+.++-..|.+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 345666777777776 56666666667777777777766 3332 666667777777777666 5555555666666666
Q ss_pred cccccccCCCCCcccCCCccceeeccccccCCC-CCccccCccccccccccccccc
Q 001974 135 MQRNNLTGGIPPFIGNLTSLESISLAANAFGGN-IPNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 189 (988)
|+.|.|.. -..+..|.+|..||+++|+|... .-..+++|+-|++|.|.+|.|.
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 66666652 13355666666666666666522 1234566666666666666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.6e-11 Score=119.01 Aligned_cols=125 Identities=30% Similarity=0.366 Sum_probs=40.3
Q ss_pred ccCCCCCCEEEcCCCcccccCCcccC-CCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccc-cCccc
Q 001974 52 IGNLSFLREINLMNNSIQGEIPREFG-RLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEF-FSLYK 129 (988)
Q Consensus 52 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~ 129 (988)
+-+...+++|+|++|+|+. + +.++ .+.+|+.|+|++|.|+ .++ .+..+++|++|+|++|+|+. +...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 3444567888888888874 3 2354 5778888888888888 443 47777888888888888874 33334 35777
Q ss_pred ccccccccccccCCC-CCcccCCCccceeeccccccCCCCCc----cccCcccccccc
Q 001974 130 LKQLAMQRNNLTGGI-PPFIGNLTSLESISLAANAFGGNIPN----SLGQLKELKSLG 182 (988)
Q Consensus 130 L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ 182 (988)
|++|+|++|+|.... -..+..+++|++|+|.+|.+... +. .+..+|+|+.||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 888888888876321 13455666777777777766522 21 233455555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-11 Score=134.22 Aligned_cols=248 Identities=20% Similarity=0.170 Sum_probs=173.9
Q ss_pred hCCCCCCceeccccceeEEEEEEC-CCCeEEEEEEeeccccchhH--HHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD-QDGTIVAIKVFNLQRHGASK--SFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
..+|..+..||.|.|+.|+..... .++..|++|........... .-..|+.+...+ .|.+++.++..+. ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----cc
Confidence 457889999999999999998765 67788999987543332222 234566666666 6888888776633 33
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-C
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-M 816 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 816 (988)
...++--||+++++......-. +.+++..++++..|++.++.++|+. .++|+|+||+||++..+ +
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~-----------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTS-----------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGF 404 (524)
T ss_pred ccccCchhhhcCcchhhhhHHH-----------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchh
Confidence 5667889999999887666211 4678888999999999999999998 99999999999999886 7
Q ss_pred cEEEeeecccccccccccccceeccccccccccc--cCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA--APEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
..+++|||.+......... ..+.-+++ +|+......+..++|+||||..+.|..+|..--....
T Consensus 405 ~~~~~~~~~~t~~~~~~~~-------~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------- 470 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFSSGV-------FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------- 470 (524)
T ss_pred hhhccccccccccceeccc-------ccccccccccchhhccccccccccccccccccccccccCcccCcccc-------
Confidence 8899999998642221111 11233344 5556666788899999999999999999876421100
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.| .. ++.............+..+.+.+...++..||.+.++.....-+
T Consensus 471 ~~---------~~--------------------i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 QS---------LT--------------------IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cc---------ee--------------------eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00 00 00011111122335577888889999999999998887665444
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-09 Score=112.79 Aligned_cols=280 Identities=14% Similarity=0.107 Sum_probs=174.0
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccc--ccCCCceEE
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSID--FQGNDFKAL 742 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~--~~~~~~~~l 742 (988)
...+.||+|+.+.+|-.-. -+..+.|++......... +.+..|.+. .||-+-.-+.+-.... ........+
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 4567899999999996432 223456888644332222 233444444 5665443122211000 112233667
Q ss_pred EEeecccc-chhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 743 VYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 743 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
.|+.+++. ....+.......+ ......|...++.++.+|.+.+.||+. |.+-||+.++|+|+++++.+.|.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRq-----s~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQ-----SYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred ecccCCCccchhhhcCchhhcc-----cCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEE
Confidence 88887653 3444443322111 113578999999999999999999999 99999999999999999999998
Q ss_pred eecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhC-CCCCCccccCCc---c
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTG-KKPTDVMFEGDL---N 892 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~---~ 892 (988)
|=..-..... .......+|...|.+||.-. +...+...|-|.+||++++++.| +.||........ .
T Consensus 160 dsDsfqi~~n-----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 160 DSDSFQINAN-----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred cccceeeccC-----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 8544333211 11222357899999999744 34557789999999999999885 999976533211 1
Q ss_pred hHHHHHHHHhhhhhhhhc--cccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC--CCCCCCHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVD--PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES--PQDRMSITNVVHEL 968 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L 968 (988)
+...+.. ..+...-+ +-+...+..| .-.-.|+.+..+..+|+... |.-|||++.++..|
T Consensus 235 ~E~~Ia~---g~f~ya~~~~~g~~p~P~~~--------------P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 235 LETDIAH---GRFAYASDQRRGLKPPPRSI--------------PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred chhhhhc---ceeeechhccCCCCCCCCCC--------------ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 1100000 00000000 0000001110 11235778899999999754 67899999999999
Q ss_pred HHHHHHhhhhccc
Q 001974 969 QSVKNALLEAWNC 981 (988)
Q Consensus 969 ~~i~~~~~~~~~~ 981 (988)
.++.+++.+|...
T Consensus 298 ~al~~~L~~C~v~ 310 (637)
T COG4248 298 DALRQQLKKCTVS 310 (637)
T ss_pred HHHHHhhhhhhhc
Confidence 9999998887543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2e-12 Score=132.39 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=137.0
Q ss_pred ccccCCCCCCEEEcCCCcccc----cCCcccCCCCCCcEEECCCC---CCCCcCCccc-------ccCCCCceeecCccc
Q 001974 50 PYIGNLSFLREINLMNNSIQG----EIPREFGRLFRLEALFLSDN---DLVGEIPANL-------SYCSRLTILFLGRNK 115 (988)
Q Consensus 50 ~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~~-------~~l~~L~~L~L~~N~ 115 (988)
+.+.....+++|+||+|.+.. .+...+...++|+..++|+- ++...+|.++ ...++|++||||.|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 344556677778888887753 23344566677777777763 3333444433 345577777777777
Q ss_pred ccCCCcccc----cCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC-
Q 001974 116 LMGSIPFEF----FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG- 190 (988)
Q Consensus 116 i~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~- 190 (988)
+....+..| .++..|++|+|.+|.+.-.--..++ ..|.+|. .|+. .+.-++|++++.++|++..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeeccccccc
Confidence 654444333 3566788888887776511111111 1233333 2221 1223568888888888763
Q ss_pred ---ccchhhccccCccEEEeccCCCCCCCC---CcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCc
Q 001974 191 ---IIPPSIYNLSLLANFSVPRNQFHGSLP---PSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGK 264 (988)
Q Consensus 191 ---~~~~~l~~l~~L~~L~L~~N~i~~~lp---~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~ 264 (988)
.+...|...+.|+.+.++.|.|....- ...+..+++|++|||.+|.++..... .
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~--------------------~ 232 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV--------------------A 232 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH--------------------H
Confidence 234566677788888888888762111 11123455555555555555421110 1
Q ss_pred ccccccCCccccEEecccccCCCCCCCchhhhcccc-cCCCCcEEEeecccCCCC----CCchhhhccccccEEEccCCc
Q 001974 265 LSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLA-NCSNLRTLIFAANKLRGA----LPHSIANLSDQLQNLIMTSNQ 339 (988)
Q Consensus 265 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~----~p~~~~~~~~~L~~L~L~~N~ 339 (988)
+...+..+++|+.|+++++.+...+.. .+..++. ..++|+.|.+.+|.++.. +...+.. .+.|..|+|++|.
T Consensus 233 LakaL~s~~~L~El~l~dcll~~~Ga~--a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~e-k~dL~kLnLngN~ 309 (382)
T KOG1909|consen 233 LAKALSSWPHLRELNLGDCLLENEGAI--AFVDALKESAPSLEVLELAGNEITRDAALALAACMAE-KPDLEKLNLNGNR 309 (382)
T ss_pred HHHHhcccchheeecccccccccccHH--HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhc-chhhHHhcCCccc
Confidence 223344555666666666666544433 2222222 245666666666665521 1122222 2356667777776
Q ss_pred c
Q 001974 340 L 340 (988)
Q Consensus 340 l 340 (988)
+
T Consensus 310 l 310 (382)
T KOG1909|consen 310 L 310 (382)
T ss_pred c
Confidence 6
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.7e-11 Score=117.34 Aligned_cols=108 Identities=26% Similarity=0.369 Sum_probs=28.5
Q ss_pred CCCCCCcEEECCCCCCCCcCCcccc-cCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcc-cCCCcc
Q 001974 77 GRLFRLEALFLSDNDLVGEIPANLS-YCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSL 154 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L 154 (988)
.+..++++|+|++|+|+ .+. .++ .+.+|+.|||++|+|+. ++ .+..+++|++|++++|+|+. +.+.+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred ccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence 34445677777777776 332 344 45666777777777663 22 35556666666666666663 33233 345666
Q ss_pred ceeeccccccCCCC-CccccCccccccccccccccc
Q 001974 155 ESISLAANAFGGNI-PNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 155 ~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 189 (988)
++|+|++|+|.... -..+..+++|++|+|.+|.++
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 66666666665321 123445555555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-11 Score=138.21 Aligned_cols=152 Identities=28% Similarity=0.277 Sum_probs=66.7
Q ss_pred ccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccc-ccccccccc
Q 001974 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQL 426 (988)
Q Consensus 348 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L 426 (988)
+..+++|+.|++++|.|+... .+..++.|+.|++++|.|+ .+ ..+..++.|+.+++++|++..+.+ . ...+.+|
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISL 188 (414)
T ss_pred hhhhhcchheecccccccccc--chhhccchhhheeccCcch-hc-cCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence 444455555555555555221 1334444555555555554 12 223335555555555555553322 1 3444555
Q ss_pred ceeecCCCCCCccCchhhhhhcccccceecccccccCCCcccccccc--ccceeecCCcccccccCcccccCCCCcEEEe
Q 001974 427 AILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLK--YLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504 (988)
Q Consensus 427 ~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 504 (988)
+.+++.+|.+. .+ ..+..+..+ ..+++..|.++..-+ +..+. .|+.+++++|++. .++..+..+.++..|++
T Consensus 189 ~~l~l~~n~i~-~i-~~~~~~~~l-~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~ 262 (414)
T KOG0531|consen 189 EELDLGGNSIR-EI-EGLDLLKKL-VLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDL 262 (414)
T ss_pred HHHhccCCchh-cc-cchHHHHHH-HHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccch
Confidence 55555555554 11 122222222 233445555442211 11111 2455555555555 33344444444555555
Q ss_pred cCcccc
Q 001974 505 RGNFFH 510 (988)
Q Consensus 505 ~~N~l~ 510 (988)
.+|++.
T Consensus 263 ~~n~~~ 268 (414)
T KOG0531|consen 263 SSNRIS 268 (414)
T ss_pred hhcccc
Confidence 555444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.3e-11 Score=137.67 Aligned_cols=253 Identities=25% Similarity=0.283 Sum_probs=172.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
..+++.+.+-+-+|.++.++.+.-...|...+.|+...... ...+....+-.+.-..++|-+++.... +...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence 45677888888999999999888776775555555432111 111222222222222345555554433 3455
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++|++|..+++|...++... ..+..........+..+.+|||+. .++|||++|.|.+...++.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~-----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG-----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC-----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence 77899999999999999887664 234444556677788999999997 7999999999999999999
Q ss_pred EEEeeecccccccccc---------------------------cccceeccccccccccccCcccCCCCCCCccchHHHH
Q 001974 818 AHVGDFGLARVRQEVS---------------------------NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYG 870 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 870 (988)
.+++|||......-.. ...........||+.|.|||...+......+|.|+.|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 9999998443221100 0000113346799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcc
Q 001974 871 ILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVAC 950 (988)
Q Consensus 871 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 950 (988)
++++|.++|.+||......+ +++..+..+ ..+...+.+.+.+..+++...
T Consensus 1023 ~~l~e~l~g~pp~na~tpq~-----------------~f~ni~~~~-------------~~~p~g~~~~s~~aq~~~~~l 1072 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAETPQQ-----------------IFENILNRD-------------IPWPEGPEEGSYEAQDLINRL 1072 (1205)
T ss_pred hhhhhhhcCCCCCCCcchhh-----------------hhhccccCC-------------CCCCCCccccChhhhhhhhhh
Confidence 99999999999987432221 111111111 112233456677788999999
Q ss_pred cCcCCCCCCCHH
Q 001974 951 SVESPQDRMSIT 962 (988)
Q Consensus 951 l~~dP~~RPs~~ 962 (988)
+..+|.+|-.|.
T Consensus 1073 l~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1073 LTEEPTQRLGAK 1084 (1205)
T ss_pred hccCchhccCcc
Confidence 999999997665
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-11 Score=126.98 Aligned_cols=237 Identities=22% Similarity=0.254 Sum_probs=149.2
Q ss_pred CCCcEEEEEcCCCCCcc----cccccccCCCCCCEEEcCCCc---ccccCCc-------ccCCCCCCcEEECCCCCCCCc
Q 001974 30 RHRRVTVLNLRSKGLSG----SLSPYIGNLSFLREINLMNNS---IQGEIPR-------EFGRLFRLEALFLSDNDLVGE 95 (988)
Q Consensus 30 ~~~~v~~l~l~~~~~~~----~~~~~l~~l~~L~~L~L~~n~---l~~~~p~-------~~~~l~~L~~L~Ls~n~l~~~ 95 (988)
....++.++|++|-+.. .+.+.+.+.+.|+..++|+-- +...+|+ ++.+.++|++|+||+|-+.-.
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 34678999999999864 344567778999999998742 2234443 456678999999999998865
Q ss_pred CCccc----ccCCCCceeecCcccccCCCccc-------------ccCcccccccccccccccCC----CCCcccCCCcc
Q 001974 96 IPANL----SYCSRLTILFLGRNKLMGSIPFE-------------FFSLYKLKQLAMQRNNLTGG----IPPFIGNLTSL 154 (988)
Q Consensus 96 ~p~~~----~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L 154 (988)
-+..| ..+.+|+.|.|.+|.+.-..-.. ...-++|+++...+|++... +...|...+.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 55444 56789999999999886222222 22345677777777777522 22345666777
Q ss_pred ceeeccccccCCC----CCccccCcccccccccccccccC----ccchhhccccCccEEEeccCCCCCCCCCcccccCCC
Q 001974 155 ESISLAANAFGGN----IPNSLGQLKELKSLGLGANNLSG----IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPH 226 (988)
Q Consensus 155 ~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~ 226 (988)
+.+.++.|.|... ...+|.++++|++|||.+|-++. .+..++..++.|++|++++|.+.......++..
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~a--- 264 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDA--- 264 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHH---
Confidence 7777777777521 22356677777777777777762 234556666677777777776653322222110
Q ss_pred CcceeccccccccccCcccccCCcccEEEeccccccC----cccccccCCccccEEecccccCC
Q 001974 227 LRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG----KLSVNFGGMKNLSYFNVAYNNLG 286 (988)
Q Consensus 227 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~ 286 (988)
.-...++|+.|.+.+|.|+. .+.......+.|..|+|++|.+.
T Consensus 265 -----------------l~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 265 -----------------LKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred -----------------HhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 00123445555555555532 12223444677777777777774
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.3e-09 Score=100.55 Aligned_cols=129 Identities=24% Similarity=0.314 Sum_probs=96.7
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccc--cc------hhHHHHHHHHHHHhcCC--CCceEEEeecccccccCCC
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HG------ASKSFLAECKALKNIRH--RNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~------~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~ 738 (988)
..+++|+-+.||.+.+ -|..+++|.=.+.. .. ......+|++++.+++- -++..++++ +++
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 4678999999999977 55567777532211 11 12456789999998853 344555554 346
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
...|+|||++|..|.+++... ...++..+-.-+.-||.. +|||+|+.++||++..+. +
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i 130 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-I 130 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-E
Confidence 678999999999999888643 134667777888899999 999999999999998765 8
Q ss_pred EEeeeccccc
Q 001974 819 HVGDFGLARV 828 (988)
Q Consensus 819 kL~DfG~a~~ 828 (988)
.++|||++..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999974
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4e-11 Score=126.20 Aligned_cols=208 Identities=20% Similarity=0.201 Sum_probs=100.1
Q ss_pred cCCcccEEEeccccccCccc-ccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhh
Q 001974 247 NASKLEFIEALDNSFSGKLS-VNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIAN 325 (988)
Q Consensus 247 ~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (988)
++.+|+.+.|.+..+..... .....+++++.||||.|-+....+ ...-...+++|+.|+|+.|++.-........
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~----v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~ 194 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFP----VLKIAEQLPSLENLNLSSNRLSNFISSNTTL 194 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHH----HHHHHHhcccchhcccccccccCCccccchh
Confidence 44445555555544443221 233445666666666665543211 1112344555666666665554211111111
Q ss_pred ccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCc-cCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCE
Q 001974 326 LSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT-IPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSE 404 (988)
Q Consensus 326 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 404 (988)
.++.|+.|.|+.|.++-. +......+++|+.|+|..|...........-+..|++
T Consensus 195 ------------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 195 ------------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred ------------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 334455555555555411 1122334455555555555322233333444555555
Q ss_pred EEccccccccccc--cccccccccceeecCCCCCCccC--chh-----hhhhcccccceecccccccCCCc--ccccccc
Q 001974 405 LLLNNNSLSGVIP--SCLGSLKQLAILHLFENGLNGTI--PEE-----IFNLTYLSNSLNLARNHLVGSIP--TKIGNLK 473 (988)
Q Consensus 405 L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~--p~~-----~~~l~~l~~~L~ls~N~l~~~~p--~~~~~l~ 473 (988)
|+|++|++.. .+ ...+.++.|+.|+++.+.+. ++ |+. ....+++ ++|+++.|++. ..+ ..+..++
T Consensus 251 LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~-si~~~d~~s~~kt~~f~kL-~~L~i~~N~I~-~w~sl~~l~~l~ 326 (505)
T KOG3207|consen 251 LDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIA-SIAEPDVESLDKTHTFPKL-EYLNISENNIR-DWRSLNHLRTLE 326 (505)
T ss_pred ccccCCcccc-cccccccccccchhhhhccccCcc-hhcCCCccchhhhcccccc-eeeecccCccc-cccccchhhccc
Confidence 5665555542 22 23445555555666555555 22 221 2334455 66666666664 222 2344566
Q ss_pred ccceeecCCcccc
Q 001974 474 YLRVFNVSSNNLS 486 (988)
Q Consensus 474 ~L~~L~ls~N~l~ 486 (988)
+|+.|....|.|+
T Consensus 327 nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 327 NLKHLRITLNYLN 339 (505)
T ss_pred hhhhhhccccccc
Confidence 7777777788877
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=110.04 Aligned_cols=183 Identities=19% Similarity=0.206 Sum_probs=139.0
Q ss_pred cceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeeccc-cchh
Q 001974 675 SFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTN-GSLE 753 (988)
Q Consensus 675 ~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 753 (988)
-..+.|++....+|..|++|++...+.........-+++++++.|+|||++.+++....| .+...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence 345789999999999999999965444444445567889999999999999998875444 34678999999987 5887
Q ss_pred hhcCCCCCCC----chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 754 NWLHPDAVPQ----KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 754 ~~l~~~~~~~----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
++........ ..........++..+|.++.|++.||.++|+. |+.-+-+.+.+|+++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 7654433211 12223334678899999999999999999999 9999999999999999999999988877654
Q ss_pred cccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 830 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
...+. |-+. --.+-|.=.||.++..|.||..-
T Consensus 444 ~~d~~------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT------------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC------------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 43220 1111 12357999999999999999654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.1e-09 Score=108.04 Aligned_cols=146 Identities=19% Similarity=0.206 Sum_probs=108.3
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCC--CCceEEEeecccccccCCCceEEEE
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRH--RNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
.+.++.|..+.||+++.. +|+.+++|+...... ....++..|+++++.+.+ ..+.+++.+..... ..+..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 367899999999999885 468899999754322 134678899999999965 34577777643321 113568999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC----------------------------
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC---------------------------- 796 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------- 796 (988)
||++|.++.+.+... .++..+...++.++++++++||+..
T Consensus 80 e~i~G~~l~~~~~~~------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 80 ERVDGRVLRDRLLRP------------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred EEeCCEecCCCCCCC------------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 999999888765321 3566677777888888888887531
Q ss_pred -------------------------CCCeEeccCCCCCeeeCC--CCcEEEeeeccccc
Q 001974 797 -------------------------QEPVLHCDLKPGNVLLDN--DMIAHVGDFGLARV 828 (988)
Q Consensus 797 -------------------------~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~ 828 (988)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=5e-10 Score=135.71 Aligned_cols=129 Identities=26% Similarity=0.330 Sum_probs=78.0
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCC--CCCcCCcccccCCCCceeecCcccccCCCcccccCccccccc
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND--LVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQL 133 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 133 (988)
...+...+-+|++. .++.... .++|++|-+..|. +....+..|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 55666666666665 3444332 2356666666664 442333345666666666666665445666666666666666
Q ss_pred ccccccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccccccc
Q 001974 134 AMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANN 187 (988)
Q Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 187 (988)
+|++..++ .+|..+++|..|.+|++..+.-...+|..+..|.+|++|.+-.-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 66666666 566666666666666666665444455555666666666665443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.3e-09 Score=102.83 Aligned_cols=126 Identities=23% Similarity=0.281 Sum_probs=84.0
Q ss_pred eEEEEEECCCCeEEEEEEeecccc-------------c-------------hhHHHHHHHHHHHhcCCC--CceEEEeec
Q 001974 678 SVYKGAFDQDGTIVAIKVFNLQRH-------------G-------------ASKSFLAECKALKNIRHR--NLVKVITSC 729 (988)
Q Consensus 678 ~Vy~a~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~ 729 (988)
.||.|... +|..+|||+.+.... . ......+|++.|.++... ++.+++++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 38999885 888999999853210 0 013467899999999654 67788776
Q ss_pred ccccccCCCceEEEEeecc--ccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEeccCC
Q 001974 730 SSIDFQGNDFKALVYEFMT--NGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDY-LHHHCQEPVLHCDLK 806 (988)
Q Consensus 730 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk 806 (988)
..-++||||++ |..+..+... .++......++.+++..+.. +|.. ||||||+.
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~~-------------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs 134 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKDV-------------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLS 134 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHHC-------------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-S
T ss_pred --------eCCEEEEEecCCCccchhhHHhc-------------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCC
Confidence 34579999997 5555443321 11233456678888886666 4677 99999999
Q ss_pred CCCeeeCCCCcEEEeeeccccccc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
+.||+++++ .+.++|||.+....
T Consensus 135 ~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 135 EYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TTSEEEETT-CEEE--GTTEEETT
T ss_pred hhhEEeecc-eEEEEecCcceecC
Confidence 999999987 99999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-09 Score=96.96 Aligned_cols=141 Identities=25% Similarity=0.309 Sum_probs=100.3
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeecc--cc------chhHHHHHHHHHHHhcCCCC--ceEEEeecccccccC
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RH------GASKSFLAECKALKNIRHRN--LVKVITSCSSIDFQG 736 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~ 736 (988)
....+.+|+-+.|+++.+ .|+.++||.-... +. -..++..+|++.+.+++--. +.+++.+ +
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-------D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-------D 81 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-------e
Confidence 567899999999999998 7888788753211 11 11246788999999885322 2233321 2
Q ss_pred CCceEEEEeeccc-cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 737 NDFKALVYEFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 737 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
...-.|+|||++| .++.+++...... .........++..|-+.+.-||.. +||||||..+||++..+
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~---------~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~ 149 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMED---------ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSD 149 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccC---------cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecC
Confidence 2445799999966 4888888654421 122222367889999999999999 99999999999999655
Q ss_pred C---cEEEeeeccccc
Q 001974 816 M---IAHVGDFGLARV 828 (988)
Q Consensus 816 ~---~~kL~DfG~a~~ 828 (988)
+ .+.++|||++..
T Consensus 150 ~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 150 GNQITPILIDFGLSSV 165 (229)
T ss_pred CCcCceEEEeecchhc
Confidence 4 468999999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=102.66 Aligned_cols=135 Identities=23% Similarity=0.196 Sum_probs=100.4
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc----------------------chhHHHHHHHHHHHhcCCC--
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH----------------------GASKSFLAECKALKNIRHR-- 720 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 720 (988)
+.+...||-|.-+.||.|... .|.++|||.-+.... .......+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345689999999999999996 899999997542111 0113567899999999544
Q ss_pred CceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 001974 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPV 800 (988)
Q Consensus 721 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 800 (988)
.|.+.+++ +..++||||++|-.|...- ++....-.++..|++-+.-+-.. ||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r----------------~~~en~~~il~~il~~~~~~~~~---Gi 223 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR----------------LDVENPDEILDKILEEVRKAYRR---GI 223 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc----------------CcccCHHHHHHHHHHHHHHHHHc---Cc
Confidence 78888877 6678999999886665432 12333444555566555555565 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 801 LHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 801 vH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
||||+++-||+++++|.+.++||--+..
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCccccc
Confidence 9999999999999999999999976653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.4e-09 Score=85.23 Aligned_cols=61 Identities=34% Similarity=0.415 Sum_probs=38.4
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
++|++|+|++|+|+.+.+..|.++++|++|++++|.++...|.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3456666666666655555666666666666666666655556666666666666666654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-08 Score=101.88 Aligned_cols=146 Identities=14% Similarity=0.046 Sum_probs=100.0
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccc-hh----------HHHHHHHHHHHhcCC--CCceEEEeeccccccc
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-AS----------KSFLAECKALKNIRH--RNLVKVITSCSSIDFQ 735 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 735 (988)
+.+-+.....|++++. .|+.|.||........ .. ..+.+|...+.++.. -.+.+.+++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 4444444455777766 7889999987432211 01 147789888888832 2233444443221111
Q ss_pred CCCceEEEEeecccc-chhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 736 GNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 736 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.....++|||++++. +|.+++..... .+.+...+..++.+++..+.-||+. ||+|||++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---------~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---------NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHL 173 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---------cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEec
Confidence 124568999999875 89988753211 1345667788999999999999999 9999999999999975
Q ss_pred -------CCcEEEeeeccccc
Q 001974 815 -------DMIAHVGDFGLARV 828 (988)
Q Consensus 815 -------~~~~kL~DfG~a~~ 828 (988)
++.+.++||+.+..
T Consensus 174 ~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 174 PFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cccCCCCCceEEEEECCcccc
Confidence 46899999998853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.3e-09 Score=127.72 Aligned_cols=130 Identities=27% Similarity=0.375 Sum_probs=91.1
Q ss_pred CCCCcEEECCCCCCCCcCCcccccCCCCceeecCccc--ccCCCcccccCcccccccccccccccCCCCCcccCCCccce
Q 001974 79 LFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK--LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLES 156 (988)
Q Consensus 79 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 156 (988)
....++..+-+|.+. .++.... .++|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|+.++.|-+|++
T Consensus 522 ~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 356777777777777 5555443 3367777777775 44344445666788888888877655577777777888888
Q ss_pred eeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCC
Q 001974 157 ISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211 (988)
Q Consensus 157 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 211 (988)
|+|++..++ .+|..+.+|..|.+|++..+.-...+|.....+++|++|.+....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 888877777 677777777788888877776555556666667777777776544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.5e-09 Score=83.65 Aligned_cols=61 Identities=28% Similarity=0.377 Sum_probs=42.3
Q ss_pred cccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcc
Q 001974 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNL 533 (988)
Q Consensus 473 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 533 (988)
++|++|++++|+|+...+..|..+++|++|++++|++++..|..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3567777777777744445667777777777777777766666777777777777777764
|
... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.8e-09 Score=116.34 Aligned_cols=152 Identities=17% Similarity=0.287 Sum_probs=104.7
Q ss_pred HHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccc-----cceeccccccccccccCcccCC
Q 001974 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL-----TQSCSVGVRGTIGYAAPEYGLG 857 (988)
Q Consensus 783 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~ 857 (988)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+........+ +.....-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999987 69999999999999999999999999988755442211 1111111234568999999999
Q ss_pred CCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccc
Q 001974 858 SEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGK 936 (988)
Q Consensus 858 ~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~ 936 (988)
...+.++|+||+||++|.+.. |+.-+... .. .......+. .. ........
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~-~~~~~~~~~--~~-------------------------~~~~~~~s 234 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GG-LLSYSFSRN--LL-------------------------NAGAFGYS 234 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc-CC-cchhhhhhc--cc-------------------------cccccccc
Confidence 888999999999999999995 55443311 11 000000000 00 00011122
Q ss_pred cchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 937 IECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 937 ~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.++|.++.+=+.+++..++.-||++.++.
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 47888999999999999999999777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.6e-07 Score=89.16 Aligned_cols=143 Identities=17% Similarity=0.141 Sum_probs=104.7
Q ss_pred eccccceeEEEEEECCCCeEEEEEEeecc-----c-cchhHHHHHHHHHHHhcC--CCCceEEEeecccccccCCCceEE
Q 001974 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-----R-HGASKSFLAECKALKNIR--HRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 671 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
-|+||-+.|+.... .|+.+-+|.-... . +-....|.+|+..+.++. .-.+.+++ ++........-..+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36789999999887 4557888876411 1 234578999999999984 33355555 322111222344689
Q ss_pred EEeeccc-cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc--EE
Q 001974 743 VYEFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI--AH 819 (988)
Q Consensus 743 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~k 819 (988)
|+|-+++ .+|.+++..... .+.+......+..++++.++-||+. |+.|+|+.+.||+++.++. ++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~---------~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAV---------SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred EEEeCCCCccHHHHHhcCCc---------CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEE
Confidence 9998854 589888865432 2457777889999999999999999 9999999999999986666 99
Q ss_pred Eeeeccccc
Q 001974 820 VGDFGLARV 828 (988)
Q Consensus 820 L~DfG~a~~ 828 (988)
++||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999987763
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.8e-09 Score=93.74 Aligned_cols=134 Identities=19% Similarity=0.265 Sum_probs=75.3
Q ss_pred cceeecCCCCCCccCchhhhhhcccc--cceecccccccCCCcccccc-ccccceeecCCcccccccCcccccCCCCcEE
Q 001974 426 LAILHLFENGLNGTIPEEIFNLTYLS--NSLNLARNHLVGSIPTKIGN-LKYLRVFNVSSNNLSGEIPSQLGLCSYLEEI 502 (988)
Q Consensus 426 L~~L~l~~N~l~~~~p~~~~~l~~l~--~~L~ls~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 502 (988)
+-.++|+.+++. .+++....+.... ...+|++|.+. .+|..|.. .+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445555555553 4555444433321 33466666665 44444443 335666777777777 566667777777777
Q ss_pred EecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCCC
Q 001974 503 YMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 503 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~ 563 (988)
+++.|.|. ..|..+..|.+|-.||.-+|.+..++-+.......-..++.++.+.+..|..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCccc
Confidence 77777776 6666666677777777777776655444221112222344555555555543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-09 Score=120.98 Aligned_cols=123 Identities=28% Similarity=0.322 Sum_probs=52.1
Q ss_pred cceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcc-cccCCCCcEEEe
Q 001974 426 LAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEIYM 504 (988)
Q Consensus 426 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L 504 (988)
|...+.+.|++. .+..++.-++.+ +.|||++|+++ ... .+..|+.|++|||+.|.+. .+|.. ...|. |..|.|
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~al-e~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPAL-ESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHh-hhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 444444444444 344444444444 44444444444 211 3444444455555555444 33321 11222 444555
Q ss_pred cCccccccCCccccCccccCeeecCCCcccCcCcc--cccCCCCcEEeCCCCcC
Q 001974 505 RGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK--FLEDLSLEYLNLSFNDL 556 (988)
Q Consensus 505 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~L~~l~l~~N~l 556 (988)
++|-++.. ..+.+|++|+.||||+|-|.+--.- .+.+..|..|+|.+|.+
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 55544421 2344444555555555544432211 13333444455555544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.4e-07 Score=89.19 Aligned_cols=160 Identities=23% Similarity=0.241 Sum_probs=108.8
Q ss_pred HHhhccccCHHHHHHhhCCCCCCceec---cccceeEEEEEECCCCeEEEEEEeeccccch-------------------
Q 001974 646 LRKALQKVSYESLFKATDGFSSTHLIG---MGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA------------------- 703 (988)
Q Consensus 646 ~~~~~~~~~~~~l~~~~~~y~~~~~lg---~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------------------- 703 (988)
....+...+.+.+....++..+....| +|.-+.||+|... ++..||||+++......
T Consensus 28 ~~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~ 106 (268)
T COG1718 28 VDEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN 106 (268)
T ss_pred hhhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence 334556667777777777777666555 5666789999874 78999999996321100
Q ss_pred h-----HHHHHHHHHHHhc--CCCCceEEEeecccccccCCCceEEEEeeccccc-hhhhcCCCCCCCchhhhHhhcCCH
Q 001974 704 S-----KSFLAECKALKNI--RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGS-LENWLHPDAVPQKDVEIEIQKLTL 775 (988)
Q Consensus 704 ~-----~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~~l~~ 775 (988)
. .-..+|+.-|.++ .+-.+.+.+++ ..-.+||||+.... -.-.+. + -++..
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~---------~~nVLvMEfIg~~g~pAP~Lk-------D-----v~~e~ 165 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAF---------RNNVLVMEFIGDDGLPAPRLK-------D-----VPLEL 165 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceee---------cCCeEEEEeccCCCCCCCCcc-------c-----CCcCc
Confidence 0 1135577777777 34556666665 34479999994321 001111 1 12333
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 776 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
.+...+..++++.+.-|-.. .++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 166 ~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 166 EEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 36777888999999988873 2999999999999999 8899999999987554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6e-09 Score=92.48 Aligned_cols=9 Identities=22% Similarity=0.276 Sum_probs=3.6
Q ss_pred EEEeeCccC
Q 001974 356 RLGMGGNQF 364 (988)
Q Consensus 356 ~L~L~~N~l 364 (988)
.++|++|++
T Consensus 31 ~ldLssc~l 39 (177)
T KOG4579|consen 31 FLDLSSCQL 39 (177)
T ss_pred hcccccchh
Confidence 334444433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-06 Score=86.75 Aligned_cols=142 Identities=17% Similarity=0.183 Sum_probs=94.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHH---------HHHHHHHHHhc---CCCCceEEEee
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS---------FLAECKALKNI---RHRNLVKVITS 728 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l---~h~niv~~~~~ 728 (988)
...+|...+++-......|.+... +|+.+++|..+.......+. ..+++..+.++ .-.....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 346788888888877777777666 78999999986443322221 22333333333 22333333333
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
+....+......++||||++|..|.+... +++ .++..+++++.-+|+. |++|||..|.
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpg 164 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPG 164 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcC
Confidence 33222333355679999999988876642 222 2556788889999999 9999999999
Q ss_pred CeeeCCCCcEEEeeecccc
Q 001974 809 NVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 809 NIll~~~~~~kL~DfG~a~ 827 (988)
|+++++++ ++++||+..+
T Consensus 165 NFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 165 NFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred cEEEECCc-EEEEECcccc
Confidence 99999654 8999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=89.29 Aligned_cols=109 Identities=23% Similarity=0.238 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcC--CCCceEEEeecccccccCCCceEEEEeecccc-chhhhcCCCCCCCchhhhHhhcCCHHHHHHH
Q 001974 705 KSFLAECKALKNIR--HRNLVKVITSCSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781 (988)
Q Consensus 705 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i 781 (988)
....+|...+..+. .-.+.+.+++..... ......++|+|++++. +|.+++.... ..+......+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~-----------~~~~~~~~~l 123 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWE-----------QLDPSQRREL 123 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhc-----------ccchhhHHHH
Confidence 46778888877773 333555555544321 1124568999999874 8999886532 2455667889
Q ss_pred HHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC---cEEEeeeccccc
Q 001974 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM---IAHVGDFGLARV 828 (988)
Q Consensus 782 ~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~~ 828 (988)
+.+++..++-||+. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 124 l~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 124 LRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 988 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-42 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-23 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-23 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 8e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 9e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 8e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 9e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-04 | ||
| 3ul7_A | 278 | Crystal Structure Of The Tv3 Mutant F63w Length = 2 | 5e-04 | ||
| 3ula_A | 279 | Crystal Structure Of The Tv3 Mutant F63w-Md-2-Erito | 5e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 2z62_A | 276 | Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 A | 6e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 3ul9_A | 278 | Structure Of The Tv3 Mutant M41e Length = 278 | 7e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-04 | ||
| 3ul8_A | 279 | Crystal Structure Of The Tv3 Mutant V134l Length = | 7e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 8e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UL7|A Chain A, Crystal Structure Of The Tv3 Mutant F63w Length = 278 | Back alignment and structure |
|
| >pdb|3ULA|A Chain A, Crystal Structure Of The Tv3 Mutant F63w-Md-2-Eritoran Complex Length = 279 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2Z62|A Chain A, Crystal Structure Of The Tv3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UL9|A Chain A, Structure Of The Tv3 Mutant M41e Length = 278 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UL8|A Chain A, Crystal Structure Of The Tv3 Mutant V134l Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 501 bits (1293), Expect = e-165
Identities = 172/578 (29%), Positives = 264/578 (45%), Gaps = 26/578 (4%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
L++ S S + P++G+ S L+ +++ N + G+ R L+ L +S N VG
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
IP L L L NK G IP + L L + N+ G +PPF G+ +
Sbjct: 262 PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 154 LESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLSGIIPPSIYNLSL-LANFSVPRNQ 211
LES++L++N F G +P ++L +++ LK L L N SG +P S+ NLS L + N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 212 FHGSLPPSLG-LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFG 270
F G + P+L L+ + +N F+G IP +LSN S+L + N SG + + G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQL 330
+ L + N L GE L L TLI N L G +P ++N + L
Sbjct: 440 SLSKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCT-NL 492
Query: 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG 390
+ +++N+L G IP IG L L L + N F+G IP E+G ++L + L N +G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 391 EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN--GTIPEEIFNLT 448
IP+++ S + N ++G + + H N L G E++ L+
Sbjct: 553 TIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608
Query: 449 YLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNF 508
N N+ G N + ++S N LSG IP ++G YL + + N
Sbjct: 609 TR-NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 509 FHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFA 567
GSIP + LR + +DLS N L G IP+ + L L ++LS N+L G +P G F
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 568 NISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQR 605
LCG LP+C N+ QR
Sbjct: 728 TFPPAKFLNNPGLCG----YPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-152
Identities = 163/633 (25%), Positives = 286/633 (45%), Gaps = 38/633 (6%)
Query: 5 DPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLS---GSLSPYIGNLSFLREI 61
+ +L W+ + + C + G+TC R +VT ++L SK L+ ++S + +L+ L +
Sbjct: 25 PDKNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPA--NLSYCSRLTILFLGRNKLMGS 119
L N+ I G + F L +L LS N L G + +L CS L L + N L
Sbjct: 83 FLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 120 IPFE-FFSLYKLKQLAMQRNNLTGGIPPFI---GNLTSLESISLAANAFGGNIPNSLGQL 175
L L+ L + N+++G L+ ++++ N G++ + +
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRC 199
Query: 176 KELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
L+ L + +NN S I P + + S L + + N+ G ++ T L+L + N
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSN 257
Query: 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG-MKNLSYFNVAYNNLGSGESDEMS 294
F G IP L+++ +N F+G++ G L+ +++ N+ G +
Sbjct: 258 QFVGPIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF-YG-----A 309
Query: 295 FMNSLANCSNLRTLIFAANKLRGALP-HSIANLSDQLQNLIMTSNQLHGSIPSGIGNL-V 352
+CS L +L ++N G LP ++ + L+ L ++ N+ G +P + NL
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVLDLSFNEFSGELPESLTNLSA 368
Query: 353 GLYRLGMGGNQFTGTIPKEMGK--LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
L L + N F+G I + + L+ + L +N +G+IP +L N S L L L+ N
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428
Query: 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIG 470
LSG IPS LGSL +L L L+ N L G IP+E+ + L +L L N L G IP+ +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE-TLILDFNDLTGEIPSGLS 487
Query: 471 NLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR 530
N L ++S+N L+GEIP +G L + + N F G+IP+ L R+++ +DL+
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 531 NNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFN--RLCGGIPE-- 586
N +G IP + S ++ N + G+ + + N G E
Sbjct: 548 NLFNGTIPAAMFKQS---GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
Query: 587 LQLPKCTEKNSRNQKISQRLKAIISTLSAVLGI 619
+L N ++ +++ +
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 450 bits (1160), Expect = e-145
Identities = 178/574 (31%), Positives = 270/574 (47%), Gaps = 31/574 (5%)
Query: 25 ITCGLRHRRVTVLNLRSKGLSGSLSPYI---GNLSFLREINLMNNSIQGEIPREFGRLFR 81
++ GL+ + VL+L + +SG+ L+ + + N I G++ R
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
LE L +S N+ IP L CS L L + NKL G + +LK L + N
Sbjct: 202 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260
Query: 142 GGIPPFIGNLTSLESISLAANAFGGNIPNSL-GQLKELKSLGLGANNLSGIIPPSIYNLS 200
G IPP L SL+ +SLA N F G IP+ L G L L L N+ G +PP + S
Sbjct: 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS-KLEFIEALDN 259
LL + ++ N F G LP L + L++ + N FSG +P SL+N S L ++ N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 260 SFSGKLSVNFGG--MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317
+FSG + N L + N +G+ +L+NCS L +L + N L G
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGF-TGK-----IPPTLSNCSELVSLHLSFNYLSG 432
Query: 318 ALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQN 377
+P S+ +LS +L++L + N L G IP + + L L + N TG IP + N
Sbjct: 433 TIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491
Query: 378 LEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN 437
L + L +N+L+GEIP +G L L+ L L+NNS SG IP+ LG + L L L N N
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 438 GTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSN--NLSGEIPSQLGL 495
GTIP +F S +A N + G I N + + + N G QL
Sbjct: 552 GTIPAAMFKQ-----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 496 CSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFN 554
S + + G + + +++ +D+S N LSG IPK + + L LNL N
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 555 DLEGEVPTKGVFANISRISV--AGFNRLCGGIPE 586
D+ G +P + ++ +++ N+L G IP+
Sbjct: 667 DISGSIPDE--VGDLRGLNILDLSSNKLDGRIPQ 698
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-64
Identities = 103/383 (26%), Positives = 150/383 (39%), Gaps = 62/383 (16%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
+ L+L LSG++ +G+LS LR++ L N ++GEIP+E + LE L L ND
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 92 LVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNL 151
L GEIP+ LS C+ L + L N+L G IP L L L + N+ +G IP +G+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
SL + L N F G IP ++ + S + AN ++G I N + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGN- 592
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271
F G L+ S + G
Sbjct: 593 ----------------------LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT------ 624
Query: 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQ 331
+ N ++ L + N L G +P I ++ L
Sbjct: 625 ------------------------SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP-YLF 659
Query: 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGE 391
L + N + GSIP +G+L GL L + N+ G IP+ M L L + L +N LSG
Sbjct: 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719
Query: 392 IPSS--LGNLSILSELLLNNNSL 412
IP LNN L
Sbjct: 720 IPEMGQFETFPPAK--FLNNPGL 740
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = 2e-97
Identities = 97/597 (16%), Positives = 184/597 (30%), Gaps = 88/597 (14%)
Query: 12 SWNDSGHFCEW---KGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSI 68
+WN + W G++ + RVT L+L G SG + IG L+ L + L ++
Sbjct: 59 NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 69 QG----EIPREFGRLFRLEALFLSDNDLVGEIPANLSY--CSRLTILFLGRNKLMGSIPF 122
+ P+ E S L + + SI
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGG---------------- 166
K Q+ NN+T + + LT L + + F
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236
Query: 167 ---NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLT 223
LK+L + + +P + L + +V N+
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD--- 293
Query: 224 LPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF-SGKLSVNFGGMKNLSYFNVAY 282
K++ I N+ + + + MK L Y
Sbjct: 294 --------------DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 283 NNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG 342
N L + + + L +L A N++ +P + ++Q++NL N+L
Sbjct: 340 NQL-------EGKLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK- 390
Query: 343 SIPS--GIGNLVGLYRLGMGGNQFTG-------TIPKEMGKLQNLEGMGLYDNQLSGEIP 393
IP+ ++ + + N+ + K N+ + L +NQ+S
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 394 SSLGNLSILSELLLNNNSLSGV-------IPSCLGSLKQLAILHLFENGLNGTIPEEIF- 445
S LS + L N L+ + + L + L N L + ++
Sbjct: 451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRA 509
Query: 446 -NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVF------NVSSNNLSGEIPSQLGLCSY 498
L YL ++L+ N PT+ N L+ F + N E P + LC
Sbjct: 510 TTLPYLV-GIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 499 LEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL-EDLSLEYLNLSFN 554
L ++ + N ++ +D+ N + ++ + L ++
Sbjct: 568 LTQLQIGSNDIRKVNEKITPNIS---VLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 5e-72
Identities = 69/485 (14%), Positives = 156/485 (32%), Gaps = 43/485 (8%)
Query: 29 LRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88
+ + S S+ +I ++N+I + + RL +L ++
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMG 214
Query: 89 DNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI 148
++ V E C + + ++ +L L + + +P F+
Sbjct: 215 NSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 149 GNLTSLESISLAANAF--------GGNIPNSLGQLKELKSLGLGANNL-SGIIPPSIYNL 199
L ++ I++A N ++++ + +G NNL + + S+ +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 200 SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
L NQ G P+ G + L + +N + ++E + N
Sbjct: 330 KKLGMLECLYNQLEG-KLPAFG-SEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387
Query: 260 SFSG-KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFM-NSLANCSNLRTLIFAANKLRG 317
+ + +S + +YN +GS + + + N+ ++ + N++
Sbjct: 388 KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK 447
Query: 318 ALPHSIANLSDQLQNLIMTSNQLHG-------SIPSGIGNLVGLYRLGMGGNQFTGTIPK 370
+ S L ++ + N L N L + + N+ T +
Sbjct: 448 FPKELFSTGS-PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505
Query: 371 E--MGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL------LLNNNSLSGVIPSCLGS 422
+ L L G+ L N S P+ N S L N P +
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
Query: 423 LKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
L L + N + + E+I N++ L ++ N + + + ++ +
Sbjct: 565 CPSLTQLQIGSNDIR-KVNEKITPNISVL----DIKDNPNISIDLSYVCPYIEAGMYMLF 619
Query: 482 SNNLS 486
+
Sbjct: 620 YDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-61
Identities = 70/413 (16%), Positives = 134/413 (32%), Gaps = 41/413 (9%)
Query: 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV--- 93
N + NL L ++ + N ++P L ++ + ++ N +
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 94 -----GEIPANLSYCSRLTILFLGRNKLM-GSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147
+ A+ ++ I+++G N L + + KL L N L G P
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPA 348
Query: 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPP-SIYNLSLLANFS 206
G+ L S++LA N N G +++++L N L I ++S+++
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAID 408
Query: 207 VPRNQFHG-------SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
N+ L P+ ++ + +N S S S L I + N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPF-KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 260 SFSG-------KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAA 312
+ + NF L+ ++ +N L + SD+ L + +
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRA----TTLPYLVGIDLSY 522
Query: 313 NKLRGALPHSIANLS-----DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT 367
N P N S N+ P GI L +L +G N
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-K 580
Query: 368 IPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
+ +++ N+ + + DN S + +L + I C
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD-IRGCD 630
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-56
Identities = 63/438 (14%), Positives = 130/438 (29%), Gaps = 88/438 (20%)
Query: 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG----IIPPSIYNLSLLA 203
+ + + +SL G +P+++GQL EL+ L LG++ P I
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 204 NFSVPRNQFHGSLPPSLG-LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFS 262
R + + L ++ + SI S
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI--------------- 181
Query: 263 GKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHS 322
+ NN+ + +
Sbjct: 182 ---------TLKDTQIGQLSNNITF-------------------------------VSKA 201
Query: 323 IANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMG 382
+ L+ +L+ M ++ Q T + L++L +
Sbjct: 202 VMRLT-KLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVE 255
Query: 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSL--------SGVIPSCLGSLKQLAILHLFEN 434
+Y+ ++P+ L L + + + N + +++ I+++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 435 GL-NGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL 493
L + + + L L N L G +P G+ L N++ N ++ +
Sbjct: 316 NLKTFPVETSLQKMKKLG-MLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 494 GLCSYLEEIYMRGNFFHGSIPSSLS--SLRAVLAIDLSRNNLSGLIPKFLEDL------- 544
G +E + N IP+ S+ + AID S N + + K + L
Sbjct: 374 GFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 545 -SLEYLNLSFNDLEGEVP 561
++ +NLS N +
Sbjct: 433 INVSSINLSNNQISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-49
Identities = 42/331 (12%), Positives = 100/331 (30%), Gaps = 27/331 (8%)
Query: 230 FQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGE 289
F + + +SL++ ++ + SG++ G + L + + E
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 290 SDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS-DQLQNLIMTSNQLHGSIPSGI 348
+ ++ + + L + S+ SI
Sbjct: 122 R--LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 349 GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408
+ ++G N T + K + +L L + ++ E
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSE 233
Query: 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK 468
+LK L + ++ +P + L + +N+A N +
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM-QLINVACNRGIS----- 287
Query: 469 IGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN-FFHGSIPSSLSSLRAVLAID 527
+ + + ++ IY+ N + +SL ++ + ++
Sbjct: 288 -----------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLE 336
Query: 528 LSRNNLSGLIPKFLEDLSLEYLNLSFNDLEG 558
N L G +P F ++ L LNL++N +
Sbjct: 337 CLYNQLEGKLPAFGSEIKLASLNLAYNQITE 367
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 34/262 (12%), Positives = 79/262 (30%), Gaps = 22/262 (8%)
Query: 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG----EIPSSLGNLSILS 403
+ + + L + G +G +P +G+L LE + L + P +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 404 ELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN--GTIPEEIFNLTYLSNSLNLARNHL 461
+ ++ N +I + + N++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD-TQIGQLSNNI 195
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
+ + L LR F + ++ E + E + + +L+
Sbjct: 196 -TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLK 249
Query: 522 AVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISVA----- 575
+ +++ +P FL+ L ++ +N++ N K + ++ V
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 576 ---GFNRLCGGIPELQLPKCTE 594
G+N L E L K +
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 14/131 (10%), Positives = 38/131 (29%), Gaps = 8/131 (6%)
Query: 478 FNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI 537
FN + + L + + + G G +P ++ L + + L +
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 538 PKFL-----EDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC 592
F ++S E + + S + + + + + K
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI---KDCINSDPQQKSIKKS 178
Query: 593 TEKNSRNQKIS 603
+ ++ +I
Sbjct: 179 SRITLKDTQIG 189
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 2e-93
Identities = 88/309 (28%), Positives = 134/309 (43%), Gaps = 15/309 (4%)
Query: 293 MSFMNSLANCSNLR----TLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS--IPS 346
+ L N + L T G L + ++ NL ++ L IPS
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY-RVNNLDLSGLNLPKPYPIPS 70
Query: 347 GIGNLVGLYRLGMGG-NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL 405
+ NL L L +GG N G IP + KL L + + +SG IP L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 406 LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSI 465
+ N+LSG +P + SL L + N ++G IP+ + + L S+ ++RN L G I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 466 PTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLA 525
P NL L ++S N L G+ G ++I++ N + + + +
Sbjct: 191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 526 IDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGI 584
+DL N + G +P+ L L L LN+SFN+L GE+P G + A LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 585 PELQLPKCT 593
LP CT
Sbjct: 309 ----LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (624), Expect = 2e-73
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 20/305 (6%)
Query: 7 QGILNSWNDSGHFCE--WKGITCGLRHR--RVTVLNLRSKGLSGS--LSPYIGNLSFLRE 60
L+SW + C W G+ C + RV L+L L + + NL +L
Sbjct: 21 PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80
Query: 61 INLMN-NSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGS 119
+ + N++ G IP +L +L L+++ ++ G IP LS L L N L G+
Sbjct: 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140
Query: 120 IPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL-ESISLAANAFGGNIPNSLGQLKEL 178
+P SL L + N ++G IP G+ + L S++++ N G IP + L L
Sbjct: 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-L 199
Query: 179 KSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS 238
+ L N L G + + +N L +GL +L + +N
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGL-SKNLNGLDLRNNRIY 257
Query: 239 GSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNS 298
G++P L+ L + N+ G++ G ++ A N G +
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG--------SP 308
Query: 299 LANCS 303
L C+
Sbjct: 309 LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-61
Identities = 81/338 (23%), Positives = 124/338 (36%), Gaps = 63/338 (18%)
Query: 87 LSDNDLVGEIPANLSYCSRLTILFLGRNKLMGS--IPFEFFSLYKLKQLAMQ-RNNLTGG 143
+ +G + + R+ L L L IP +L L L + NNL G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
IPP I LT L + + G IP+ L Q+K L +L N LSG +PPSI +L L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263
+ N+ G++P S G + N +G IP + +N
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--------------- 197
Query: 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI 323
NL++ +++ N L G
Sbjct: 198 ----------NLAFVDLSR------------------------------NMLEGDASVLF 217
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
+ Q + + N L + +G L L + N+ GT+P+ + +L+ L + +
Sbjct: 218 GSDK-NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 384 YDNQLSGEIPSSLGNLSILSEL-LLNNNSLSGV-IPSC 419
N L GEIP GNL NN L G +P+C
Sbjct: 276 SFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 1e-88
Identities = 111/575 (19%), Positives = 197/575 (34%), Gaps = 39/575 (6%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
L+L L S + L+ ++L IQ + L L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGG-IPPFIGNLT 152
S S L L L F L LK+L + N + +P + NLT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 153 SLESISLAANAFGGNIPNSLGQLKELK----SLGLGANNLSGIIPPSIYNLSLLANFSVP 208
+LE + L++N L L ++ SL L N ++ I P + + L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH-KLTLR 208
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALD---------N 259
N ++ + L L + ++ F + + S LE + L +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 260 SFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGAL 319
+ + F + N+S F++ + + + + L K
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFGQFP 320
Query: 320 PHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ--FTGTIPKEMGKLQN 377
+ +L + L TSN+ + +L L L + N F G + +
Sbjct: 321 TLKLKSL----KRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 378 LEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGL 436
L+ + L N + + S+ L L L +++L + S SL+ L L +
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 437 NGTIPEEIFNLTYLSNSLNLARNHLVGSI-PTKIGNLKYLRVFNVSSNNLSGEIPSQLGL 495
L+ L L +A N + P L+ L ++S L P+
Sbjct: 434 RVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 496 CSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL--SLEYLNLSF 553
S L+ + M N F L ++ +D S N++ + L+ SL +LNL+
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 554 NDLEGEVPTKGVFANI--SRISVAGFNRLCGGIPE 586
ND + I R + R+ P
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 2e-74
Identities = 99/536 (18%), Positives = 174/536 (32%), Gaps = 43/536 (8%)
Query: 60 EINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGS 119
M + +IP F + L LS N L + L +L L R ++
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 120 IPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELK 179
+ SL L L + N + L+SL+ + +G LK LK
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 180 SLGLGANNLSGI-IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH----H 234
L + N + +P NL+ L + + N+ L L + L +
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSL 186
Query: 235 NFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN-FGGMKNLSYFNVAYNNLGSGESDEM 293
N + P + +L + +N S + G+ L + + + E
Sbjct: 187 NPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 294 SFMNSLANCSNLRTLIFAANKL---RGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350
++L NL F L + L+ + + + S +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIERVKD--FSY 302
Query: 351 LVGLYRLGMGGNQFT-------------------GTIPKEMGKLQNLEGMGLYDNQLS-- 389
G L + +F G L +LE + L N LS
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 390 GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLT 448
G S + L L L+ N + + + LG L+QL L + L +F +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 449 YLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEI-PSQLGLCSYLEEIYMRGN 507
L L+++ H + L L V ++ N+ P L + +
Sbjct: 422 NLI-YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 508 FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPT 562
P++ +SL ++ +++S NN L + L SL+ L+ S N +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 7e-74
Identities = 93/552 (16%), Positives = 178/552 (32%), Gaps = 40/552 (7%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
VL+L + +LS L + L N IQ F L L+ L + +L
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 95 EIPANLSYCSRLTILFLGRNKLMG-SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
+ + L L + N + +P F +L L+ L + N + + L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 154 LE----SISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPP-SIYNLSLLANFSVP 208
+ S+ L+ N P + +++ L L L N S + I L+ L +
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 209 RNQF--HGSLPPSLGLTLPHLRLFQVHHN------FFSGSIPISLSNASKLEFIEALDNS 260
+F G+L L L + ++ I + + + + +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL-------------ANCSNLRT 307
+F + + G + ++ + L + +L
Sbjct: 294 IER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351
Query: 308 LIFAANKL--RGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFT 365
L + N L +G S + L+ L ++ N + + S L L L +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409
Query: 366 GTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSC-LGSL 423
+ L+NL + + LS L L + NS L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 424 KQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSN 483
+ L L L + L P +L+ L LN++ N+ L L+V + S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 484 NLSGEIPSQLG-LCSYLEEIYMRGNFFHGSIPSS--LSSLRAVLAIDLSRNNLSGLIPKF 540
++ +L S L + + N F + L ++ + + + P
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 541 LEDLSLEYLNLS 552
+ + + LN++
Sbjct: 589 KQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 7e-67
Identities = 98/538 (18%), Positives = 168/538 (31%), Gaps = 53/538 (9%)
Query: 87 LSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP 146
+ + +IP NL L L N L + FFS +L+ L + R +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 147 FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFS 206
+L+ L ++ L N + L L+ L NL+ + I +L L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 207 VPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEAL--------- 257
V N P L +L + N L ++ +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 258 ------------------DNSFSGKLSVN-FGGMKNLSYFNVAYNNLGSGESDEMSFMNS 298
+N S + G+ L + + + E ++
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 299 LANCSNLRTLIFAANKL---RGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLY 355
L NL F L + L+ + + + S + G
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIERVKD--FSYNFGWQ 307
Query: 356 RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS-- 413
L + +F ++ L+ L G S +L L L L+ N LS
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 414 GVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI-GNL 472
G L L L NG+ T+ L L L+ ++L + +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSL 420
Query: 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSI-PSSLSSLRAVLAIDLSRN 531
+ L ++S + S LE + M GN F + P + LR + +DLS+
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 532 NLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISV--AGFNRLCGGIPE 586
L L P L SL+ LN+S N+ + ++ + V N + +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 3e-85
Identities = 112/571 (19%), Positives = 198/571 (34%), Gaps = 35/571 (6%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
+TVLNL L + S L +++ N+I P +L L+ L L N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 92 LVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNL 151
L ++C+ LT L L N + F L L + N L+ L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 152 TSLESISLAANAFGGNIPNSLG--QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPR 209
+L+ + L+ N L LK L L +N + P + + L +
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 210 NQFHGSLPPSL--GLTLPHLRLFQVHHNFFSGSIPISLSN--ASKLEFIEALDNSFSGKL 265
Q SL L L +R + ++ S + + + L ++ N+ +
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 266 SVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN---CSNLRTLIFAANKLRGALPHS 322
+ +F + L YF + YNN+ S + + ++ + + L S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 323 IANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE-------MGKL 375
L L++L M N + G + L+ L L + + + L
Sbjct: 325 FQWLK-CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
Query: 376 QNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFEN 434
L L N++S + L L L L N + + L+ + ++L N
Sbjct: 384 HILN---LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYN 440
Query: 435 GLNGTIPEEIFNLTYLSNSLNLARNHL--VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492
+ L L L R L V S P+ L+ L + ++S+NN++
Sbjct: 441 KYLQLTRNSFALVPSLQ-RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 493 LGLCSYLEEIYMRGN--------FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL 544
L LE + ++ N G L L + ++L N + + +DL
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 545 -SLEYLNLSFNDLEGEVPTKGVFANISRISV 574
L+ ++L N+L VF N +
Sbjct: 560 FELKIIDLGLNNLNTLPA--SVFNNQVSLKS 588
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 1e-81
Identities = 115/580 (19%), Positives = 208/580 (35%), Gaps = 47/580 (8%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
T L+L S + + L ++L +N + +L L+ L LS+N +
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 95 EIPANLSYC--SRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIG--- 149
L S L L L N++ P F ++ +L L + L + +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 150 NLTSLESISLAANAFGGNIPNSLGQLK--ELKSLGLGANNLSGIIPPSIYNLSLLANFSV 207
TS+ ++SL+ + + LK L L L NNL+ + S L L F +
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 208 PRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI---------PISLSNASKLEFIEALD 258
N SL L ++R + +F SI S LE + D
Sbjct: 280 EYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 259 NSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGA 318
N G S F G+ NL Y +++ + +F++ S L L NK+
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL--AHSPLHILNLTKNKISKI 396
Query: 319 LPHSIANLSDQLQNLIMTSNQLHGSIPSG-IGNLVGLYRLGMGGNQFTGTIPKEMGKLQN 377
+ + L L+ L + N++ + L ++ + + N++ + +
Sbjct: 397 ESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 378 LEGMGLYDNQLSG--EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENG 435
L+ + L L PS L L+ L L+NN+++ + L L++L IL L N
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN- 514
Query: 436 LNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGL 495
NL L ++ G + L +L + N+ SN
Sbjct: 515 ----------NLARLW------KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558
Query: 496 CSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL--SLEYLNLSF 553
L+ I + N + S ++ ++ +++L +N ++ + K +L L++ F
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 554 NDLEGEVPTKGVFANISRISVAGFNRL-----CGGIPELQ 588
N + + F N + L C P
Sbjct: 619 NPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 2e-81
Identities = 112/587 (19%), Positives = 193/587 (32%), Gaps = 48/587 (8%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
V + L+ + + + + +NL +N ++ F R +L +L + N +
Sbjct: 7 EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
P L +L L N+L F L +L + N++ +L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL--LANFSVPRNQF 212
++ L+ N + QL+ L+ L L N + + + + L + NQ
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALD---NSFSGKLSVNF 269
P + L +++ S+ L I L + S + F
Sbjct: 184 KEFSPGCFH-AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 270 GGMK--NLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIAN-- 325
G+K NL+ +++YNNL +D S A L N ++ HS+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGND------SFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 326 ------LSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLE 379
L ++ L L L L M N G L NL+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 380 GMGLYDNQLS-----GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
+ L ++ S E SL + L L L N +S + L L +L L N
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSP-LHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 435 GLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSG--EIPS 491
+ + + + L + + L+ N + + L+ + L PS
Sbjct: 416 EIGQELTGQEWRGLENIF-EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474
Query: 492 QLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS--------GLIPKFLED 543
L + + N L L + +DL NNL+ G FL+
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
Query: 544 LS-LEYLNLSFNDLEGEVPTKGVFANISRISV--AGFNRLCGGIPEL 587
LS L LNL N + VF ++ + + G N L +
Sbjct: 535 LSHLHILNLESNGFDEIPV--EVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-52
Identities = 81/449 (18%), Positives = 140/449 (31%), Gaps = 61/449 (13%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL 87
GL+ +T+L+L L+ + L L L N+IQ LF + L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 88 SDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147
+ T + L F F L L+ L M+ N++ G
Sbjct: 304 KRS---------------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 148 IGNLTSLESISLAANAFGGNIPNSLG----QLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
L +L+ +SL+ + + L L L N +S I + L L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263
+ N+ L L ++ + +N + S
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS------------------- 449
Query: 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI 323
F + +L + L + S + NL L + N + +
Sbjct: 450 -----FALVPSLQRLMLRRVAL----KNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 324 ANLSDQLQNLIMTSNQLH--------GSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKL 375
L +L+ L + N L G + L L+ L + N F + L
Sbjct: 501 EGLE-KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559
Query: 376 QNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG-SLKQLAILHLFEN 434
L+ + L N L+ S N L L L N ++ V G + + L L + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 435 GLNGTIPEEIFNLTYLSNSLNLARNHLVG 463
+ T ++ + N +N ++
Sbjct: 620 PFDCTCE----SIAWFVNWINETHTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-23
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 5/158 (3%)
Query: 402 LSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
++ L+ V ++ +L+L N L + L+ SL++ N +
Sbjct: 6 HEVADCSHLKLTQVPDDLPTNIT---VLNLTHNQLRRLPAANFTRYSQLT-SLDVGFNTI 61
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
P L L+V N+ N LS C+ L E+++ N + +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 522 AVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEG 558
++ +DLS N LS L +L+ L LS N ++
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 6e-77
Identities = 105/345 (30%), Positives = 168/345 (48%), Gaps = 50/345 (14%)
Query: 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECK 712
S L A+D FS+ +++G G FG VYKG DGT+VA+K +R G F E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+ HRNL+++ C + + LVY +M NGS+ + L Q
Sbjct: 80 MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLRERPESQP-------P 127
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE- 831
L +R IA+ A + YLH HC ++H D+K N+LLD + A VGDFGLA++
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 832 ---VSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMF- 887
V+ T VRGTIG+ APEY + S D++ YG++LLE++TG++ D+
Sbjct: 188 DTHVT--TA-----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 888 --EGDLNLHNYARTALLD-HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMV 944
+ D+ L ++ + L + + +VD L + + + Q ++
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY------KDEEVEQ------------LI 282
Query: 945 RIGVACSVESPQDRMSITNVVHELQSVKNALLEAWN-CTGEEVIR 988
++ + C+ SP +R ++ VV L+ + L E W EE+ R
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLEG--DGLAERWEEWQKEEMFR 325
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-74
Identities = 104/539 (19%), Positives = 188/539 (34%), Gaps = 26/539 (4%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
L L + L L ++L I F RL+ L L+ N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
LS L LF + + + L+ L + N+++ P
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 154 LESISLAANAFGGNIPNSLGQLKELK--SLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
L+ + NA + L++ SL L N+++G I P ++ ++ + + Q
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQ 213
Query: 212 FHGSLPPSL-GLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALD---NSFSGKLSV 267
+ L T+ L L P ++ +E+++ + F S
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSN 272
Query: 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS 327
F L ++ +L + L S L+ L+ +ANK S +N
Sbjct: 273 TFHCFSGLQELDLTATHLS-------ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 328 DQLQNLIMTSNQLHGSIPSG-IGNLVGLYRLGMGGNQFT--GTIPKEMGKLQNLEGMGLY 384
L +L + N + +G + NL L L + + ++ L +L+ + L
Sbjct: 326 -SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTIPEE 443
N+ + L L L L S +L L +L+L + L+ + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 444 IFNLTYLSNSLNLARNHLVGSIPTKIG---NLKYLRVFNVSSNNLSGEIPSQLGLCSYLE 500
L L LNL NH K L L + +S +LS +
Sbjct: 445 FDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503
Query: 501 EIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEG 558
+ + N S +LS L+ + ++L+ N++S ++P L L +NL N L+
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKG-IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-73
Identities = 110/550 (20%), Positives = 183/550 (33%), Gaps = 25/550 (4%)
Query: 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95
N + GL+ + + + + N + F RL L L L+ +
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 96 IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLE 155
RL L L N L+ LK L + ++ + N +LE
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 156 SISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGS 215
S+ L +N ++LK L N + + + +L N S+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 216 LPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS--KLEFIEALDNSFSGKLSVNFGGMK 273
+ I L N++ L D F G+
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 274 NLS--YFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQ 331
+S N+ + + S N+ S L+ L A L LP + LS L+
Sbjct: 253 EMSVESINLQKHYFFNISS------NTFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLK 304
Query: 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQL-- 388
L++++N+ N L L + GN + L+NL + L + +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 389 SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NL 447
S L NLS L L L+ N + QL +L L L + F NL
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 448 TYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGL---CSYLEEIYM 504
L LNL+ + L S L L+ N+ N+ + LE + +
Sbjct: 425 HLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 505 RGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKG 564
+ +SL+ + +DLS N L+ + L L YLNL+ N + +P
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILP--S 541
Query: 565 VFANISRISV 574
+ +S+
Sbjct: 542 LLPILSQQRT 551
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-51
Identities = 102/514 (19%), Positives = 183/514 (35%), Gaps = 49/514 (9%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL--SD 89
+ + L L S +S P L+ ++ NN+I + L + L L +
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 90 NDLVGEIPANLSYCSRLTILFLGRNKLMGSIP--FEFFSLYKLKQLAMQRNNLTGGIPPF 147
ND+ I + L G + + I + ++ L + + P
Sbjct: 189 NDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 148 IGNL--TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANF 205
L S+ESI+L + F N+ L+ L L A +LS +P +
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVG------- 299
Query: 206 SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265
L L+ + N F IS SN L + N+ +L
Sbjct: 300 ------------------LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 266 SVN-FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA 324
++NL +++++++ + + + N S+L++L + N+ +
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 325 NLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
QL+ L + +L NL L L + + + + L L+ + L
Sbjct: 398 ECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 384 YDNQLSGEI---PSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTI 440
N +SL L L L+L+ LS + SLK + + L N L +
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 441 PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE 500
E + +L + LNLA NH+ +P+ + L R N+ N L S + + +
Sbjct: 517 IEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC-TCSNIYFLEWYK 573
Query: 501 EIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS 534
E + ++ + LR V LS LS
Sbjct: 574 ENMQKLEDTEDTLCENPPLLRGV---RLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 65/392 (16%), Positives = 131/392 (33%), Gaps = 43/392 (10%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL 87
GL V +NL+ S S L+E++L + E+P L L+ L L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 88 SDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLT--GGI 144
S N + S LT L + N + L L++L + +++
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 145 PPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLAN 204
+ NL+ L+S++L+ N + + +L+ L L L S
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP-------- 420
Query: 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG- 263
F L L++ + H+ S L+ + N F
Sbjct: 421 -------FQN---------LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 264 --KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH 321
+ + + + L +++ +L S + + + + + + N+L +
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQH------AFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 322 SIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGM 381
++++L L + SN + +PS + L + + N T
Sbjct: 519 ALSHLK--GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYFLEW--Y 572
Query: 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLS 413
+L + N +L + L++ +LS
Sbjct: 573 KENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 36/206 (17%), Positives = 72/206 (34%), Gaps = 3/206 (1%)
Query: 377 NLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL 436
+ E + N L ++ L L+ L L + + S +L L L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 437 NGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLC 496
+ L L + + + N K L + SN++S +
Sbjct: 94 IFMAETALSGPKALK-HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 497 SYLEEIYMRGNFFHGSIPSSLSSLRA--VLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFN 554
L+ + + N H +SSL+ L+++L+ N+++G+ P + + LN
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 555 DLEGEVPTKGVFANISRISVAGFNRL 580
+ + I + + F +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDM 238
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 42/209 (20%), Positives = 69/209 (33%), Gaps = 7/209 (3%)
Query: 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442
+ L+ EIP +L N L + N L + + L L L L + +
Sbjct: 19 CENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 443 EIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEI 502
+ L ++L L N L+ T + K L+ +S L LE +
Sbjct: 76 TFQSQHRL-DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 503 YMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIP---KFLEDLSLEYLNLSFNDLEGE 559
Y+ N + +D N + L L+ + LNL+ ND+ G
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194
Query: 560 VPTKGVFANISRISVAGFNRLCGGIPELQ 588
P A ++ G L L+
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-72
Identities = 86/591 (14%), Positives = 186/591 (31%), Gaps = 84/591 (14%)
Query: 5 DPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLM 64
+ +WN + W + N + ++L
Sbjct: 294 NNTIHSLNWNFNKELDMWGDQPGVD----------------------LDNNGRVTGLSLA 331
Query: 65 NNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEF 124
+G +P G+L L+ L + + ++++ F
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391
Query: 125 FS-LYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGN------IPNSLGQLKE 177
+L + ++ + P + + ISL G I ++ +L +
Sbjct: 392 LDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTK 449
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
L+ + + + + + + + + S L L ++++
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELSWS-NLKDLTDVELYNCPN 503
Query: 238 SGSIPISLSNASKLEFIEALDNSFSG---------KLSVNFGGMKNLSYFNVAYNNLGSG 288
+P L + +L+ + N +L+ + + F + YNNL
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL--- 560
Query: 289 ESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI 348
+E SL L L NK+R + +L +L + NQ+ IP
Sbjct: 561 --EEFPASASLQKMVKLGLLDCVHNKVRH--LEAFGTNV-KLTDLKLDYNQIE-EIPEDF 614
Query: 349 GNLVG-LYRLGMGGNQFTGTIPK--EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSI---- 401
+ LG N+ IP + + + N++ E + ++
Sbjct: 615 CAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673
Query: 402 -LSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL-------NGTIPEEIFNLTYLSNS 453
S + L+ N + + ++ + L N + N L+ +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT-T 732
Query: 454 LNLARNHLVGSIPTKI--GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR------ 505
++L N L S+ L YL +VS N S P+Q S L+ +R
Sbjct: 733 IDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
Query: 506 GNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDL 556
GN P+ +++ +++ + + N++ + K L L+++ N
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTP--QLYILDIADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-53
Identities = 59/463 (12%), Positives = 129/463 (27%), Gaps = 33/463 (7%)
Query: 114 NKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLG 173
+ I ++ +L + + +N + + + + +G L
Sbjct: 262 KETAEYIK-DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
+ L L G +P +I L+ L S + S L +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 234 HNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEM 293
H + L +L + L ++ + +K S ++ +G+ +
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 294 SFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVG 353
++ + L+ + FA + ++ + + + NL
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAV------DWEDANSDYAKQYENEELSWSNLKD 492
Query: 354 LYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG---------EIPSSLGNLSILSE 404
L + + +P + L L+ + + N+ + +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552
Query: 405 LLLNNNSLSGVIPS-CLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463
+ N+L S L + +L +L N + E L L L N +
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKL-TDLKLDYNQIE- 608
Query: 464 SIPTKIG-NLKYLRVFNVSSNNLSGEIPSQLGL--CSYLEEIYMRGNFFHGSIPSSLSSL 520
IP + S N L IP+ + + N + S+
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 521 RAVLA-----IDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
+ LS N + + + + LS N +
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-24
Identities = 34/234 (14%), Positives = 72/234 (30%), Gaps = 37/234 (15%)
Query: 365 TGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP------- 417
G G++ L L G +P ++G L+ L L +S +
Sbjct: 315 PGVDLDNNGRVTGLS---LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 418 ---------------------SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNL 456
L +L N P + + L ++
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIG 431
Query: 457 ARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516
+ + I I L L++ +++ + + + + + + + S
Sbjct: 432 NLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELS 486
Query: 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANI 569
S+L+ + ++L +P FL DL L+ LN++ N K + +
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-16
Identities = 21/206 (10%), Positives = 51/206 (24%), Gaps = 36/206 (17%)
Query: 386 NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF 445
+ + L N ++ L L G +P +G L +L +L +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFG 367
Query: 446 NLTYLSNSLNLARNHLVGSIPTK-IGNLKYLRVFNVSSN--------------------- 483
+ + ++ + + + L + ++ +
Sbjct: 368 DEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD 427
Query: 484 -------NLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536
N I + + L+ IY + F + +
Sbjct: 428 TQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDW-----EDANSDYAKQYEN 482
Query: 537 IPKFLEDL-SLEYLNLSFNDLEGEVP 561
+L L + L ++P
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLP 508
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 9e-72
Identities = 91/341 (26%), Positives = 154/341 (45%), Gaps = 38/341 (11%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTI 690
K + S ++ +V L +AT+ F LIG G FG VYKG DG
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAK 65
Query: 691 VAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG 750
VA+K + + F E + L RH +LV +I C + L+Y++M NG
Sbjct: 66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENG 120
Query: 751 SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
+L+ L+ +P ++ QR+ I I A + YLH ++H D+K N+
Sbjct: 121 NLKRHLYGSDLPT-------MSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINI 170
Query: 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYG 870
LLD + + + DFG+++ E+ S V+GT+GY PEY + ++ D+YS+G
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228
Query: 871 ILLLEMVTGKKPTDVMF-EGDLNLHNYARTALLDHVID-IVDPILINDVEDWDATNKQRL 928
++L E++ + +NL +A + + ++ IVDP L + + + L
Sbjct: 229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI------RPESL 282
Query: 929 RQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969
R+ V C S +DR S+ +V+ +L+
Sbjct: 283 RK------------FGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 3e-68
Identities = 102/541 (18%), Positives = 190/541 (35%), Gaps = 35/541 (6%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
++L L S N S L+ ++L I+ + + L L L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLT 152
P + S + L L KL F L LK+L + N + +P + NLT
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 153 SLESISLAANAFGGNIPNSLGQLKELK----SLGLGANNLSGIIPPSIYNLSLLANFSVP 208
+L + L+ N N L L+E SL + N + I + + L ++
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLH-ELTLR 212
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALD--------NS 260
N ++ + L L + ++ F + + S +E + + +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
V F + N+S ++A ++ ++ + ++L +L+
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQ--- 321
Query: 321 HSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPK--EMGKLQNL 378
+L L++L +T N+ SI L L L + N + + +L
Sbjct: 322 FPTLDLP-FLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 379 EGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLN 437
+ L N + ++ L L L +++L V S SL++L L +
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 438 GTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLC 496
LT L N+L +A N + + + N L ++S L
Sbjct: 438 IDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 497 SYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFND 555
L+ + M N S + L ++ +D S N + SL + NL+ N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 556 L 556
+
Sbjct: 557 V 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-57
Identities = 93/562 (16%), Positives = 174/562 (30%), Gaps = 47/562 (8%)
Query: 46 GSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFR-LEALFLSDNDLVGEIPANLSYCS 104
GSL+P I + + M+ + ++P + + + + LS N L + S S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDD---IPSSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 105 RLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAF 164
L L L R ++ + L+ L L + N + P LTSLE++
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 165 GGNIPNSLGQLKELKSLGLGANNLSGI-IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLT 223
+GQL LK L + N + +P NL+ L + + N ++ +
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQF 175
Query: 224 LPHLRLFQV----HHNFFSGSIPISLSNASKLEFIEALDNSFSGKL-SVNFGGMKNLSYF 278
L + N I KL + N S + + L
Sbjct: 176 LRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 279 NVAYNNLGSGESDEMSFMNSLANCSNLRTLIF--AANKLRGALPHSIANLSDQLQNLIMT 336
+ + E+ + + ++ F L+ + + +
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA-NVSAMSLA 293
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFT-------------------GTIPKEMGKLQN 377
+ + L + Q G+I + L +
Sbjct: 294 GVSIK-YLEDVP-KHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPS 351
Query: 378 LEGMGLYDNQLSGEIPSSLGNLSILS--ELLLNNNSLSGVIPSCLGSLKQLAILHLFENG 435
L + L N LS S +L S L L+ N ++ + L++L L +
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHST 410
Query: 436 LNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ-L 493
L F +L L L+++ + L L ++ N+ S
Sbjct: 411 LKRVTEFSAFLSLEKLL-YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 494 GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552
+ L + + +L + +++S NNL L L SL L+ S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 553 FNDLEGEVPTKGVFANISRISV 574
FN +E + ++
Sbjct: 530 FNRIETSKG--ILQHFPKSLAF 549
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 7e-56
Identities = 73/493 (14%), Positives = 137/493 (27%), Gaps = 34/493 (6%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
+ L L + L+ L + + + G+L L+ L ++ N +
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 95 -EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSL----YKLKQLAMQRNNLTGGIPPFIG 149
++PA S + L + L N + + L L M N + I
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAF 201
Query: 150 NLTSLESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLAN---- 204
L ++L N NI L L L L I+ S++
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 205 ----FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
F + L ++ + + + K + + +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFH-CLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQ 318
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
+ L + N S +L L + N L +
Sbjct: 319 LK---QFPTLDLPFLKSLTLTMNKG--------SISFKKVALPSLSYLDLSRNALSFSGC 367
Query: 321 HSIANLS-DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNL 378
S ++L + L++L ++ N + + L L L + L+ L
Sbjct: 368 CSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 379 EGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSC-LGSLKQLAILHLFENGLN 437
+ + + L+ L+ L + NS S + L L L + L
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 438 GTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCS 497
L L LN++ N+L+ + L L + S N +
Sbjct: 487 QISWGVFDTLHRL-QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 498 YLEEIYMRGNFFH 510
L + N
Sbjct: 546 SLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 60/318 (18%), Positives = 110/318 (34%), Gaps = 20/318 (6%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL 87
GL + L L+ + ++L SI + + + F+ ++L +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSI 314
Query: 88 SDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT--GGIP 145
L +L L L L NK SI F+ +L L L + RN L+ G
Sbjct: 315 IRCQLKQFPTLDL---PFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCS 369
Query: 146 PFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPS-IYNLSLLAN 204
SL + L+ N + + L+EL+ L + L + S +L L
Sbjct: 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPIS-LSNASKLEFIEALDNSFSG 263
+ + L L L ++ N F + + +N + L F++
Sbjct: 429 LDISYTNTK-IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI 323
F + L N+++NNL +S +L TL + N++ +
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSS------HYNQLYSLSTLDCSFNRIET-SKGIL 540
Query: 324 ANLSDQLQNLIMTSNQLH 341
+ L +T+N +
Sbjct: 541 QHFPKSLAFFNLTNNSVA 558
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 4e-65
Identities = 90/334 (26%), Positives = 136/334 (40%), Gaps = 53/334 (15%)
Query: 650 LQKVSYESLFKATDGFSS------THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA 703
S+ L T+ F + +G G FG VYKG + T VA+K
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDIT 69
Query: 704 S----KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPD 759
+ + F E K + +H NLV+++ S D LVY +M NGSL + L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSC- 123
Query: 760 AVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819
L+ R IA A+ I++LH + +H D+K N+LLD A
Sbjct: 124 -------LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAK 173
Query: 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG 879
+ DFGLAR ++ + + + GT Y APE G E++ DIYS+G++LLE++TG
Sbjct: 174 ISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230
Query: 880 KKPTDVMFEGDLNLHNYARTALLD--HVIDIVDPILINDVEDWDATNKQRLRQAKINGKI 937
D E L + + + D +D + D D+T+ +
Sbjct: 231 LPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM----NDADSTSVEA---------- 275
Query: 938 ECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971
M + C E R I V LQ +
Sbjct: 276 -----MYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-58
Identities = 69/331 (20%), Positives = 122/331 (36%), Gaps = 42/331 (12%)
Query: 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA 713
E+L+ + + G FG V+K VA+K+F +Q S E +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL 773
L ++H N+++ I + D L+ F GSL ++L +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA------------NVV 118
Query: 774 TLLQRINIAIDVASAIDYLHHHCQE-------PVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
+ + +IA +A + YLH + H D+K NVLL N++ A + DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGK 880
+ + + + G GT Y APE L ++ D+Y+ G++L E+ +
Sbjct: 179 LKFE--AGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECP 940
D + + + P L D+++ K+R K
Sbjct: 236 TAADGPVDEY-------MLPFEEEIGQ--HPSL-EDMQEVVVHKKKRPVLRDYWQKHAGM 285
Query: 941 ISMVRIGVACSVESPQDRMSITNVVHELQSV 971
+ C + R+S V + +
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 53/310 (17%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
IG GSFG+V++ + G+ VA+K+ Q A FL E +K +RH N+V +
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + Q + ++V E+++ GSL LH ++ L +R+++A DVA
Sbjct: 101 GAVT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQ--------LDERRRLSMAYDVA 147
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
++YLH+ P++H +LK N+L+D V DFGL+R++ T S GT
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGT 202
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVI 906
+ APE + D+YS+G++L E+ T ++P + L+ V+
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP----WGN---LNPAQ-------VV 248
Query: 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966
V +RL + + I C P R S ++
Sbjct: 249 AAV------------GFKCKRLEIPR-----NLNPQVAAIIEGCWTNEPWKRPSFATIMD 291
Query: 967 ELQSVKNALL 976
L+ + + +
Sbjct: 292 LLRPLIKSAV 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 72/337 (21%), Positives = 119/337 (35%), Gaps = 45/337 (13%)
Query: 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK- 712
+ D LIG G +G+VYKG+ D VA+KVF+ ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA---NRQNFINEKNI 58
Query: 713 -ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ 771
+ + H N+ + I + G LV E+ NGSL +L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------------H 106
Query: 772 KLTLLQRINIAIDVASAIDYLH------HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGL 825
+ +A V + YLH H + + H DL NVL+ ND + DFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 826 ARV----RQEVSNLTQSCSVGVRGTIGYAAPEY-------GLGSEVSTNGDIYSYGILLL 874
+ R + ++ GTI Y APE D+Y+ G++
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 875 EMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLR-QAKI 933
E+ TD+ + + + A V + P D++ + KQR +
Sbjct: 227 EIFMRC--TDLFPGESVPEY---QMAFQTEVGN--HPT-FEDMQVLVSREKQRPKFPEAW 278
Query: 934 NGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970
S+ C + + R++ +
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-51
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 57/308 (18%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
++G G+FG V K + VAIK + K+F+ E + L + H N+VK+ +
Sbjct: 14 EVVGRGAFGVVCKAKWR--AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C N LV E+ GSL N LH T ++ + +
Sbjct: 70 CL------NPV-CLVMEYAEGGSLYNVLHGAEPLPY--------YTAAHAMSWCLQCSQG 114
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+ YLH + ++H DLKP N+LL + + DFG A Q +G+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-------MTNNKGSA 167
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907
+ APE GS S D++S+GI+L E++T +KP F+ +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDE-----------IGGPAFR 212
Query: 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967
I+ W N R K P + + C + P R S+ +V
Sbjct: 213 IM----------WAVHNGTRPPLIK-----NLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
Query: 968 LQSVKNAL 975
+ +
Sbjct: 258 MTHLMRYF 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 66/313 (21%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA--SKSFLAECKALKNIRHRNLVKVI 726
+ G ++KG + G + +KV ++ S+ F EC L+ H N++ V+
Sbjct: 16 TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+C S L+ +M GSL N LH E + Q + A+D+A
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLH---------EGTNFVVDQSQAVKFALDMA 121
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ +LH + + L +V++D DM A + + Q S G
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYA 171
Query: 847 IGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
+ APE + D++S+ +LL E+VT + P F L N
Sbjct: 172 PAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP----FAD---LSNME--- 218
Query: 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960
+ V A R + ++ C E P R
Sbjct: 219 ----IGMKV------------ALEGLRPTIPP-----GISPHVSKLMKICMNEDPAKRPK 257
Query: 961 ITNVVHELQSVKN 973
+V L+ +++
Sbjct: 258 FDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 76/315 (24%), Positives = 122/315 (38%), Gaps = 68/315 (21%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ----RHGASKSFLAECKALKNIRHRNLVK 724
+IG+G FG VY+ + G VA+K ++ E K ++H N++
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ C + + LV EF G L L +++ +N A+
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSG------------KRIPPDILVNWAVQ 113
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH--------VGDFGLARVRQEVSNLT 836
+A ++YLH P++H DLK N+L+ + + DFGLAR + ++
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
G + APE S S D++SYG+LL E++TG+ P F G +
Sbjct: 174 A------AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG---IDGL 220
Query: 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956
A V V A NK L CP ++ C P
Sbjct: 221 A-------VAYGV------------AMNKLALPIPS-----TCPEPFAKLMEDCWNPDPH 256
Query: 957 DRMSITNVVHELQSV 971
R S TN++ +L ++
Sbjct: 257 SRPSFTNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 78/307 (25%), Positives = 130/307 (42%), Gaps = 56/307 (18%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
IG GSFG+VYKG + D VA+K+ N+ ++F E L+ RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
++ A+V ++ SL + LH K + + I+IA A
Sbjct: 87 GYSTAPQL------AIVTQWCEGSSLYHHLHASE----------TKFEMKKLIDIARQTA 130
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+DYLH ++H DLK N+ L D +GDFGLA + S + G+
Sbjct: 131 RGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--SHQFEQLSGS 185
Query: 847 IGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903
I + APE + S D+Y++GI+L E++TG+ P + ++N D
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSN---INN------RD 232
Query: 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963
+I++V + L + CP M R+ C + +R S
Sbjct: 233 QIIEMV--------------GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
Query: 964 VVHELQS 970
++ E++
Sbjct: 279 ILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-49
Identities = 70/318 (22%), Positives = 118/318 (37%), Gaps = 72/318 (22%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-------KSFLAECKALKNIRHRN 721
IG G FG V+KG +D ++VAIK L + F E + N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+VK+ + +V EF+ G L + L A P + ++ +
Sbjct: 85 IVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHP----------IKWSVKLRL 127
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-----DMIAHVGDFGLARVRQEVSNLT 836
+D+A I+Y+ + P++H DL+ N+ L + + A V DFGL++ +
Sbjct: 128 MLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-- 184
Query: 837 QSCSVGVRGTIGYAAPE--YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
G+ G + APE + D YS+ ++L ++TG+ P F+
Sbjct: 185 -----GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDE----- 230
Query: 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKI--ECPISMVRIGVACSV 952
IN + R I +CP + + C
Sbjct: 231 -----------YSYGKIKFINMI----REEGLRP-------TIPEDCPPRLRNVIELCWS 268
Query: 953 ESPQDRMSITNVVHELQS 970
P+ R + +V EL
Sbjct: 269 GDPKKRPHFSYIVKELSE 286
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-48
Identities = 90/513 (17%), Positives = 177/513 (34%), Gaps = 26/513 (5%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117
+ ++L N ++ F L+ L LS ++ S L+ L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFG-GNIPNSLGQLK 176
F L L++L NL IG+L +L+ +++A N +P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 177 ELKSLGLGANNLSGIIPPSIYNLSLLANFSVP----RNQFHGSLPPSLGLTLPHLRLFQV 232
L+ L L +N + I + L + ++ N + + P L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA-FKEIRLHKLTL 207
Query: 233 HHNFFSGSIP----ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG 288
+NF S ++ L+ + + + ++ L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 289 ESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI 348
+ ++ +N+ + + + S + Q+L + + + P+
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFG-QFPT-- 321
Query: 349 GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLS--GEIPSSLGNLSILSELL 406
L L RL N+ + L +LE + L N LS G S + L L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 407 LNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSI 465
L+ N + + S L+QL L + L +F +L L L+++ H +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAF 437
Query: 466 PTKIGNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVL 524
L L V ++ N+ L + + P++ +SL ++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 525 AIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDL 556
++++ N L + + L SL+ + L N
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-41
Identities = 89/487 (18%), Positives = 160/487 (32%), Gaps = 39/487 (8%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL-V 93
+ L L + LS L+++ + ++ G L L+ L ++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLK----QLAMQRNNLTGGIPPFIG 149
++P S + L L L NK+ + L+++ L + N + I P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 150 NLTSLESISLAANAFGGNIP-NSLGQLKELKSLGL------GANNLSGIIPPSIYNLSLL 202
L ++L N N+ + L L+ L NL ++ L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 203 --ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
F + ++ L L ++ F + + S + +E ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCK 315
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLR--GA 318
F +K+L N G+ S + +L L + N L G
Sbjct: 316 FG---QFPTLKLKSLKRLTFTSNKGGN--------AFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 319 LPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQN 377
S + L+ L ++ N + ++ S L L L + + L+N
Sbjct: 365 CSQSDFGTT-SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 378 LEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPS-CLGSLKQLAILHLFENGL 436
L + + LS L L + NS L+ L L L + L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 437 NGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLG 494
+ F +L+ L LN+A N L S+P I L L+ + +N P
Sbjct: 483 E-QLSPTAFNSLSSL-QVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY 539
Query: 495 LCSYLEE 501
L +L +
Sbjct: 540 LSRWLNK 546
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-38
Identities = 100/506 (19%), Positives = 164/506 (32%), Gaps = 49/506 (9%)
Query: 87 LSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP 146
+ + +IP NL L L N L + FFS +L+ L + R +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 147 FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFS 206
+L+ L ++ L N + L L+ L NL+ + I +L L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 207 VPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEAL--------- 257
V N P L +L + N L ++ +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 258 ---DNSFSGK------LSVN----------FGGMKNLSYFNVAYNNLGSGESDEMSFMNS 298
+F L N G+ L + + + E ++
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 299 LANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLI---MTSNQLHGSIPSGIGNLVGLY 355
L NL F L I +L + L N+ + S + + N G
Sbjct: 251 LEGLCNLTIEEFRLAYLD-YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQ 307
Query: 356 RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS-- 413
L + +F ++ L+ L N+ S +L L L L+ N LS
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFK 362
Query: 414 GVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI-GNL 472
G L L L NG+ T+ L L L+ ++L + +L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSL 420
Query: 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPS-SLSSLRAVLAIDLSRN 531
+ L ++S + S LE + M GN F + + LR + +DLS+
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 532 NLSGLIPKFLEDL-SLEYLNLSFNDL 556
L L P L SL+ LN++ N L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-37
Identities = 97/466 (20%), Positives = 158/466 (33%), Gaps = 48/466 (10%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLV 93
L L+ + IG+L L+E+N+ +N IQ ++P F L LE L LS N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 94 GEIPANLSYCSRLTILF----LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP-FI 148
+L ++ +L L N + I F +L +L ++ N + + I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 149 GNLTSLESISLAANAFGGN---IPNSLGQLKELKSLGLGANNLSGI------IPPSIYNL 199
L LE L F L+ L +L + L+ + I L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 200 SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
+ +++FS+ S HL L F + L + +L F N
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP---TLKLKSLKRLTF---TSN 335
Query: 260 SFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN-------------------SLA 300
S + +L + +++ N L S +
Sbjct: 336 KGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL 393
Query: 301 NCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360
L L F + L+ S+ L L ++ + L L L M
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 361 GNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSC 419
GN F ++ +L+NL + L QL P++ +LS L L + +N L V
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 420 LGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSI 465
L L + L N + + P + YLS LN GS
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCP----RIDYLSRWLNKNSQKEQGSA 555
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 56/264 (21%), Positives = 100/264 (37%), Gaps = 16/264 (6%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
NL +NL ++ N L + L L + + L +L + L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEE 443
N + + LS L +L+ +L+ + +G LK L L++ N + E
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 444 IF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS---SNNLSGEIPSQLGLCSYL 499
F NLT L L+L+ N + T + L + + N+S S N I L
Sbjct: 144 YFSNLTNLE-HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 500 EEIYMRGNFFHGSIP-------SSLSSLRAVLAIDLSRNNLSGL---IPKFLEDLSLEYL 549
++ +R NF ++ + L R VL + NL + L +L++E
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 550 NLSFNDLEGEVPTKGVFANISRIS 573
L++ D + +F ++ +S
Sbjct: 263 RLAYLDYYLDDII-DLFNCLTNVS 285
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-48
Identities = 59/316 (18%), Positives = 120/316 (37%), Gaps = 44/316 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK--ALKNIRHRNLVKVI 726
+G G +G V++G++ G VA+K+F+ + KS+ E + +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFI 68
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S + L+ + GSL ++L L + + I + +A
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL------------TTLDTVSCLRIVLSIA 115
Query: 787 SAIDYLH-----HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
S + +LH + + H DLK N+L+ + + D GLA + + +N +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 842 GVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
GT Y APE + DI+++G++L E+ ++ + ++
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 896 YART-ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
+ + +V ++QR S+ ++ C ++
Sbjct: 236 VVPNDPSFEDMRKVV------------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 955 PQDRMSITNVVHELQS 970
P R++ + L
Sbjct: 284 PSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-47
Identities = 67/321 (20%), Positives = 112/321 (34%), Gaps = 44/321 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK--ALKNIRHRNLVKVI 726
IG G +G V+ G + G VA+KVF S+ E + +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ L+ ++ NGSL ++L L + +A
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYLKS------------TTLDAKSMLKLAYSSV 144
Query: 787 SAIDYLH-----HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
S + +LH + + H DLK N+L+ + + D GLA +N
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 842 GVRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
GT Y PE S + D+YS+G++L E+ ++ E L H+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 896 YA-RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
+ + +IV K R EC M ++ C +
Sbjct: 265 LVPSDPSYEDMREIV------------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 955 PQDRMSITNVVHELQSVKNAL 975
P R++ V L + +
Sbjct: 313 PASRLTALRVKKTLAKMSESQ 333
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-47
Identities = 102/510 (20%), Positives = 181/510 (35%), Gaps = 68/510 (13%)
Query: 52 IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111
L+ + L ++ + L ++ L + + + Y + LT +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNS 171
N+L P + +L KL + M N + I P + NLT+L ++L N P
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNNNQIAD-ITP-LANLTNLTGLTLFNNQITDIDP-- 129
Query: 172 LGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQ 231
L L L L L +N +S I S L L+
Sbjct: 130 LKNLTNLNRLELSSNTISDISALS---------------------------GLTSLQQLS 162
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
+ + L+N + LE ++ N S +S + NL N +
Sbjct: 163 FGNQV---TDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESLIATNNQISD---- 213
Query: 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNL 351
+ L +NL L N+L+ ++A+L+ L +L + +NQ+ P + L
Sbjct: 214 ----ITPLGILTNLDELSLNGNQLKD--IGTLASLT-NLTDLDLANNQISNLAP--LSGL 264
Query: 352 VGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNS 411
L L +G NQ + P + L L + L +NQL S + NL L+ L L N+
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNN 320
Query: 412 LSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGN 471
+S + P + SL +L L + N + + + NLT + N L+ N + P + N
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNI-NWLSAGHNQISDLTP--LAN 373
Query: 472 LKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRN 531
L + ++ + + S + P+++S + D++ N
Sbjct: 374 LTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWN 431
Query: 532 NLSGLIPKFLEDLSLEYLNLSFNDLEGEVP 561
S + G V
Sbjct: 432 LPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 8e-47
Identities = 93/477 (19%), Positives = 186/477 (38%), Gaps = 44/477 (9%)
Query: 81 RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNL 140
L + ++ + + +I + + LG+ + ++ L ++ L R +
Sbjct: 2 PLGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 141 TGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLS 200
+ L +L I+ + N P L L +L + + N ++ I P + NL+
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
L ++ NQ + P LT +L ++ N S +LS + L+ + N
Sbjct: 113 NLTGLTLFNNQIT-DIDPLKNLT--NLNRLELSSNTISD--ISALSGLTSLQQLS-FGNQ 166
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
+ + L +++ N + S ++ LA +NL +LI N++ P
Sbjct: 167 VTD--LKPLANLTTLERLDISSNKV--------SDISVLAKLTNLESLIATNNQISDITP 216
Query: 321 HSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380
+ L+ L L + NQL + +L L L + NQ + P + L L
Sbjct: 217 --LGILT-NLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTI 440
+ L NQ+S P L L+ L+ L LN N L + P + +LK L L L+ N ++
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 441 PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE 500
P + +LT L L N + S + + NL + + N +S P L + +
Sbjct: 326 P--VSSLTKLQ-RLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRIT 378
Query: 501 EIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
++ + + + + +++ ++ + + S ++++N
Sbjct: 379 QLGLNDQAWTNAPVNYKANV-SIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-44
Identities = 96/453 (21%), Positives = 179/453 (39%), Gaps = 59/453 (13%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
VT L G+ S+ + L+ L +IN NN + P L +L + +++N +
Sbjct: 48 VTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF------ 147
P L+ + LT L L N++ P + +L L +L + N ++ I
Sbjct: 104 DITP--LANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD-ISALSGLTSL 158
Query: 148 --------------IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIP 193
+ NLT+LE + +++N + + L +L L+SL N +S I P
Sbjct: 159 QQLSFGNQVTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP 216
Query: 194 PSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEF 253
+ L+ L S+ NQ +L +L +L + +N S P LS +KL
Sbjct: 217 --LGILTNLDELSLNGNQL--KDIGTLA-SLTNLTDLDLANNQISNLAP--LSGLTKLTE 269
Query: 254 IEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAAN 313
++ N S G+ L+ + N L ++ ++N NL L N
Sbjct: 270 LKLGANQISN--ISPLAGLTALTNLELNENQL--------EDISPISNLKNLTYLTLYFN 319
Query: 314 KLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMG 373
+ P +++L+ +LQ L +N++ S S + NL + L G NQ + P +
Sbjct: 320 NISDISP--VSSLT-KLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LA 372
Query: 374 KLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE 433
L + +GL D + + N+SI + + +L + P+ + +
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITW 430
Query: 434 NGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP 466
N + E + + ++ G++
Sbjct: 431 NLPSY-TNEVSYTFSQP-VTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-38
Identities = 95/410 (23%), Positives = 161/410 (39%), Gaps = 59/410 (14%)
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230
+ L E LG N++ + + +L + R + L +L
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVE-YLNNLTQI 73
Query: 231 QVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGES 290
+N + P L N +KL I +N + + NL+ + N +
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI----- 124
Query: 291 DEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS--------------------DQL 330
+ ++ L N +NL L ++N + +++ L+ L
Sbjct: 125 ---TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTL 179
Query: 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG 390
+ L ++SN++ S S + L L L NQ + P +G L NL+ + L NQL
Sbjct: 180 ERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
Query: 391 EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYL 450
+L +L+ L++L L NN +S + P L L +L L L N ++ P + LT L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 289
Query: 451 SNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510
+L L N L P I NLK L + NN+S P + + L+ ++ N
Sbjct: 290 -TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV- 343
Query: 511 GSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGE 559
S SSL++L + + N +S L P L +L + L L+
Sbjct: 344 -SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 62/316 (19%), Positives = 116/316 (36%), Gaps = 65/316 (20%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
LIG G FG VY G + + VAI++ +++R K+F E A + RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+C S A++ +L + + L + + IA ++
Sbjct: 96 GACMS-----PPHLAIITSLCKGRTLYSVVR----------DAKIVLDVNKTRQIAQEIV 140
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV-GVRG 845
+ YLH + +LH DLK NV DN + + DFGL + + + + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 846 TIGYAAPE---------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
+ + APE S + D+++ G + E+ + P F+
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT---QPAE 249
Query: 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956
A +I + ++ +I + I + C +
Sbjct: 250 A-------IIWQMG---------------TGMKPNLS--QIGMGKEISDILLFCWAFEQE 285
Query: 957 DRMSITNVVHELQSVK 972
+R + T ++ L+ +
Sbjct: 286 ERPTFTKLMDMLEKLP 301
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-46
Identities = 104/561 (18%), Positives = 202/561 (36%), Gaps = 41/561 (7%)
Query: 54 NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLG 112
L+ + L N I+ F L +L+ L L I L IL LG
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGG-NIP 169
+K+ P F L+ L +L + L+ + + NL +L + L+ N +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 170 NSLGQLKELKSLGLGANNLSGIIPPSIYNLSL--LANFSVPRNQFHGSLPPSLGLTLPHL 227
S G+L LKS+ +N + + + L L+ FS+ N + + G +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287
R + SG N ++ N+ S + + ++ ++N+
Sbjct: 202 RNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 288 GESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSG 347
D+ +F S++R L + + L L+ L + N+++ I
Sbjct: 255 --PDQNTFAGL--ARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKIN-KIADE 308
Query: 348 I-GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELL 406
L L L + N L + + L N ++ + L L L
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368
Query: 407 LNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG-SI 465
L +N+L + + + + + L N L T+P+ N ++L+ N L I
Sbjct: 369 LRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTA----NLIHLSENRLENLDI 418
Query: 466 PTKIGNLKYLRVFNVSSNNLSGEIPSQL-GLCSYLEEIYMRGNFFHGSIPSSL-----SS 519
+ + +L++ ++ N S Q LE++++ N + + L
Sbjct: 419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478
Query: 520 LRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISVAGFN 578
L + + L+ N L+ L P L +L L+L+ N L + + AN+ + ++ N
Sbjct: 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISR-N 536
Query: 579 RLCGGIPELQLPKCTEKNSRN 599
+L + + +
Sbjct: 537 QL-LAPNPDVFVSLSVLDITH 556
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-24
Identities = 71/456 (15%), Positives = 142/456 (31%), Gaps = 49/456 (10%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSF--LREINLMNNSIQGEIPREFGRLF------RLE 83
+ ++ S + + L L +L NS+ + ++G+ LE
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 84 ALFLSDNDLVGEIPAN------------LSYCSRLTILFLGRNKLMGSIPFEFFS---LY 128
L +S N +I N L + G + + F+
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI-KDPDQNTFAGLARS 266
Query: 129 KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNL 188
++ L + + L L+ ++LA N + L L+ L L N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 189 SGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNA 248
+ + Y L +A + +N + L L+ + N + ++
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFI 380
Query: 249 SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTL 308
+ I N +N + +++ N L + + + L +L+ L
Sbjct: 381 PSIPDIFLSGNKLVTLPKINL----TANLIHLSENRL-----ENLDILYFLLRVPHLQIL 431
Query: 309 IFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-----GNLVGLYRLGMGGNQ 363
I N+ + + L+ L + N L + + + L L L + N
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSL 423
P L L G+ L N+L+ + + + L L ++ N L P
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPD---VF 546
Query: 424 KQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARN 459
L++L + N F ++ +A
Sbjct: 547 VSLSVLDITHNKFICECELSTFINWLNHTNVTIAGP 582
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-24
Identities = 64/362 (17%), Positives = 114/362 (31%), Gaps = 44/362 (12%)
Query: 240 SIPISLSNASKLEF----IEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295
+P L+ +L I + S +F ++ L +
Sbjct: 18 QVPQVLNTTERLLLSFNYIRTVTAS-------SFPFLEQLQLLELGSQYTPLTIDK---- 66
Query: 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSI--PSGIGNLVG 353
+ N NLR L ++K+ P + L L L + L ++ NL
Sbjct: 67 -EAFRNLPNLRILDLGSSKIYFLHPDAFQGLF-HLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 354 LYRLGMGGNQFTG-TIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSI--LSELLLNNN 410
L RL + NQ + GKL +L+ + NQ+ L L LS L N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 411 SLSGVIPSCLGSLKQ------LAILHLFENGLNGTIPE---------EIFNLTYLSN--S 453
SL + G L IL + NG I + F+L +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
Query: 454 LNLARNHLVGSIPTKIGNLK--YLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHG 511
+++ L +R ++S + L+ + + N +
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK 304
Query: 512 SIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANIS 570
+ L + ++LS N L L L + Y++L N + + F +
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI--AIIQDQTFKFLE 362
Query: 571 RI 572
++
Sbjct: 363 KL 364
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-19
Identities = 79/424 (18%), Positives = 138/424 (32%), Gaps = 65/424 (15%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFL 87
GL V L+L + S L L+ +NL N I F L L+ L L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 88 SDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147
S N L +N ++ + L +N + F L KL+ L ++ N LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSV 207
I + S+ I L+ N +L L + L AN + +LS
Sbjct: 377 IHFIPSIPDIFLSGN-----------KLVTLPKINLTANLI---------HLS------- 409
Query: 208 PRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSV 267
N+ L +PHL++ ++ N FS
Sbjct: 410 -ENRLENLDILYFLLRVPHLQILILNQNRFSSCSG-----------------------DQ 445
Query: 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS 327
+L + N L E+ + S+L+ L N L P ++L+
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELC-WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504
Query: 328 DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQ 387
L+ L + SN+L + L L + NQ ++ +L + + N+
Sbjct: 505 -ALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDV--FVSLSVLDITHNK 558
Query: 388 LSGEIP-SSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFN 446
E S+ N + + + + + S +++ L G + +
Sbjct: 559 FICECELSTFINWLNHTNVTIAGPP-ADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
Query: 447 LTYL 450
+
Sbjct: 618 FSLF 621
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-46
Identities = 63/318 (19%), Positives = 118/318 (37%), Gaps = 44/318 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECK--ALKNIRHRNLVKVI 726
IG G FG V++G + G VA+K+F+ + +S+ E + +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + + LV ++ +GSL ++L+ +T+ I +A+ A
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTA 149
Query: 787 SAIDYLH-----HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
S + +LH + + H DLK N+L+ + + D GLA ++
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 842 GVRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
GT Y APE S + DIY+ G++ E+ + + L ++
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 896 YA-RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
++ + +V K R E M +I C +
Sbjct: 270 LVPSDPSVEEMRKVV------------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317
Query: 955 PQDRMSITNVVHELQSVK 972
R++ + L +
Sbjct: 318 GAARLTALRIKKTLSQLS 335
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-45
Identities = 101/521 (19%), Positives = 172/521 (33%), Gaps = 87/521 (16%)
Query: 48 LSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLS------ 101
++P + +FL+E ++++ E+P E + + + ++ P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 102 -------YCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
+ L L L S+P L+ L N+LT +P +L SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214
+ A P L+ LG+ N L + P + N S L V N
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK- 166
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
LP P L +N +P L N L I A +N L +
Sbjct: 167 KLPDL----PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNN----SLKKLPDLPLS 216
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLI 334
L N L + L N L T+ N L+ LP + L+ L
Sbjct: 217 LESIVAGNNIL--------EELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LEALN 263
Query: 335 MTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS 394
+ N L +P +L L + + P NL + N++ +
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCD 314
Query: 395 SLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSL 454
+L L+ ++NN L +P+ L+ L N L +PE NL L
Sbjct: 315 LPPSLEELN---VSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLK----QL 362
Query: 455 NLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIP 514
++ N L P +++ LR+ N+ E+P L L+++++ N P
Sbjct: 363 HVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPE---LPQNLKQLHVETNPLR-EFP 412
Query: 515 SSLSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFN 554
S+ + ++ + E LE +
Sbjct: 413 DIPESVE---DLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 91/473 (19%), Positives = 167/473 (35%), Gaps = 80/473 (16%)
Query: 97 PANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLES 156
P N+S L + L +P E ++ + + PP G +
Sbjct: 5 PRNVSNTF-LQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 157 ISLAANAFGG------------NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLAN 204
L ++P L+ L N+L+ +P +L L
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLV 118
Query: 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGK 264
+ LPP L +L + +N +P L N+S L+ I+ +N
Sbjct: 119 DNNNLKALS-DLPPLLE----YLGV---SNNQLE-KLP-ELQNSSFLKIIDVDNN----S 164
Query: 265 LSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA 324
L +L + N L + L N L + N L+ LP
Sbjct: 165 LKKLPDLPPSLEFIAAGNNQL--------EELPELQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 325 NLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLY 384
+ L++++ +N L + NL L + N T+P L+ L +
Sbjct: 216 S----LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VR 265
Query: 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444
DN L+ ++P +L+ L + LS + P+ L L+ N + ++ +
Sbjct: 266 DNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLP 316
Query: 445 FNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504
+L LN++ N L+ +P L+ L S N+L+ E+P L+++++
Sbjct: 317 PSLE----ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHV 364
Query: 505 RGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
N P S+ DL N+ +P+ + +L+ L++ N L
Sbjct: 365 EYNPLR-EFPDIPESVE-----DLRMNSHLAEVPELPQ--NLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 85/426 (19%), Positives = 146/426 (34%), Gaps = 70/426 (16%)
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
I P + T L+ ++ +P +K + PP +A
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 204 NFSVPRNQFHG------------SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKL 251
+ SLP HL N + +P + L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPP----HLESLVASCNSLT-ELPELPQSLKSL 116
Query: 252 EFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA 311
+ S L Y V+ N L + L N S L+ +
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLEK--------LPELQNSSFLKIIDVD 161
Query: 312 ANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE 371
N L+ LP + L+ + +NQL +P + NL L + N +P
Sbjct: 162 NNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDL 213
Query: 372 MGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHL 431
L+++ +N L L NL L+ + +NN L +P SL+ L++
Sbjct: 214 PLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA---LNV 264
Query: 432 FENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPS 491
+N L +PE +LT L+++ N + NL YL N SSN + +
Sbjct: 265 RDNYLT-DLPELPQSLT----FLDVSENIF-SGLSELPPNLYYL---NASSNEIR-SLCD 314
Query: 492 QLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNL 551
LEE+ + N +P+ L + S N+L+ + P+ + +L+ L++
Sbjct: 315 LP---PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEV-PELPQ--NLKQLHV 364
Query: 552 SFNDLE 557
+N L
Sbjct: 365 EYNPLR 370
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 28/224 (12%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
++G G FG K + G ++ +K ++FL E K ++ + H N++K I
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ + E++ G+L + D + QR++ A D+AS
Sbjct: 76 LY----KDKRL-NFITEYIKGGTLRGIIK-----SMDS-----QYPWSQRVSFAKDIASG 120
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG------ 842
+ YLH ++H DL N L+ + V DFGLAR+ + +
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 843 ----VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
V G + APE G D++S+GI+L E++
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-42
Identities = 97/535 (18%), Positives = 192/535 (35%), Gaps = 46/535 (8%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
V + RS+ + S G + ++ ++L N I + L+ L L + +
Sbjct: 8 GVCDGRSRSFTSIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-N 63
Query: 95 EIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTG-GIPPFIGNL 151
I + L L L N L S+ +F L LK L + N G+ NL
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 152 TSLESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRN 210
T+L+++ + I L L L + A +L S+ ++ + + ++ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 211 QFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFG 270
+ L L +R ++ + L ++ L S +F
Sbjct: 183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQL 330
+ L + + + + +C+ F ++ + + +
Sbjct: 242 ELLKLLRYILELSEV------------EFDDCTLNGLGDFNPSES-DVVSELGKVETVTI 288
Query: 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK-LQNLEGMGLYDNQLS 389
+ L + L + + L + R+ + ++ +P + L++LE + L +N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMV 347
Query: 390 GEI---PSSLGNLSILSELLLNNNSLS--GVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444
E + G L L+L+ N L L +LK L L + N + +P+
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406
Query: 445 FNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504
+ LNL+ + + T + L V +VS+NNL L L+E+Y+
Sbjct: 407 QWPEKMR-FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYI 458
Query: 505 RGNFFHGSIPSS--LSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDL 556
N ++P + L + +SRN L + + L SL+ + L N
Sbjct: 459 SRNKLK-TLPDASLFPVLL---VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 78/450 (17%), Positives = 149/450 (33%), Gaps = 38/450 (8%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQG-EIPREFGRLFRLEALFLSDNDLV 93
L+L LS S + G LS L+ +NLM N Q + F L L+ L + + +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 94 GEIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
EI + + L L + L S+ + L + + + F L+
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
S+ + L + L + + A S + S L L + + ++
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
Query: 213 H-----------------GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIE 255
+ + +R + + + S K++ I
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316
Query: 256 ALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKL 315
++ +K+L + +++ N + + +L+TL+ + N L
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC---KGAWPSLQTLVLSQNHL 373
Query: 316 R--GALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMG 373
R + L L +L ++ N H +P + L + +
Sbjct: 374 RSMQKTGEILLTLK-NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--C 428
Query: 374 KLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE 433
Q LE + + +N L L L EL ++ N L +P L ++ +
Sbjct: 429 IPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISR 482
Query: 434 NGLNGTIPEEIF-NLTYLSNSLNLARNHLV 462
N L ++P+ IF LT L + L N
Sbjct: 483 NQLK-SVPDGIFDRLTSLQ-KIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 76/476 (15%), Positives = 155/476 (32%), Gaps = 48/476 (10%)
Query: 87 LSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP 146
IP+ L+ + + L L NK+ + + L+ L ++ + + I
Sbjct: 12 GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEG 67
Query: 147 FI-GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPS-IYNLSLLAN 204
+L SLE + L+ N + G L LK L L N + S NL+ L
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGK 264
+ + + L L ++ SL + + + + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 265 LSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA 324
L + + ++ Y + NL + S + S ++ L F + L + +
Sbjct: 188 LEIFADILSSVRYLELRDTNL---ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244
Query: 325 NLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLY 384
L + L + + +G+G+ + T+ + + +
Sbjct: 245 KLLRYILEL--SEVEFDDCTLNGLGDFNPSESDVVSELGKVETV--------TIRRLHIP 294
Query: 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444
L ++ + L + + + N+ + V S LK L L L EN +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV------- 347
Query: 445 FNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSY---LEE 501
G L+ +S N+L + + L
Sbjct: 348 ---------------EEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS 391
Query: 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
+ + N FH +P S + ++LS + + + +LE L++S N+L+
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQ--TLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 60/434 (13%), Positives = 129/434 (29%), Gaps = 71/434 (16%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
R + L L + L + LS +R + L + ++ +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 92 LVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNL 151
+ + +L L +++ F+ +L L +++ +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEV----EFDDCTLNGLGDFNPSESDVVSELGKV--ET 285
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
++ + + ++ L+++K + + + + VP +
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF----------------LVPCSF 329
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271
L L + N + S G
Sbjct: 330 SQH---------LKSLEFLDLSENLMVEEYLKN---------------------SACKGA 359
Query: 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQ 331
+L ++ N+L S + NL +L + N +P S +++
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEIL----LTLKNLTSLDISRNTFH-PMPDSCQWPE-KMR 413
Query: 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGE 391
L ++S + + + I L L + N + + +LQ L + N+L
Sbjct: 414 FLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY---ISRNKLK-T 465
Query: 392 IPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLS 451
+P + +L + ++ N L V L L + L N + + P + YLS
Sbjct: 466 LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP----RIDYLS 520
Query: 452 NSLNLARNHLVGSI 465
LN GS
Sbjct: 521 RWLNKNSQKEQGSA 534
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 46/238 (19%), Positives = 84/238 (35%), Gaps = 7/238 (2%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
S SIPSG+ + L + N+ T ++ NL+ + L ++++ +
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLN 455
+L L L L++N LS + S G L L L+L N +F NLT L +L
Sbjct: 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ-TLR 129
Query: 456 LARNHLVGSIPTK-IGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIP 514
+ I L L + + +L L + + + + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 515 SSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRI 572
L +V ++L NL+ + + G V T F + ++
Sbjct: 190 IFADILSSVRYLELRDTNLAR-FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 47/238 (19%), Positives = 82/238 (34%), Gaps = 16/238 (6%)
Query: 29 LRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88
+ + L++ L LS L ++ I + N+ + L LE L LS
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342
Query: 89 DNDLVGEIPAN---LSYCSRLTILFLGRNKL--MGSIPFEFFSLYKLKQLAMQRNNLTGG 143
+N +V E N L L L +N L M +L L L + RN
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
+P + ++L++ + + + L+ L + NNL + L L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLDS-FSLFLPRLQEL- 456
Query: 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF 261
+ RN+ +LP P L + ++ N + L+ I N +
Sbjct: 457 --YISRNKLK-TLPD--ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 85/377 (22%), Positives = 143/377 (37%), Gaps = 35/377 (9%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117
+ + I P L L + + +T L + K+
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKE 177
SI L L+ L + N +T I P NL L ++ + N ++L L
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQITD-ISPL-SNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
L+ L L +N+S I P + NL+ + + ++ N S L + L V +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLS-NMTGLNYLTVTESKV 167
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
PI+ N + L + N + +L YF N + +
Sbjct: 168 KDVTPIA--NLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--------IT 215
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
+AN + L +L NK+ P +ANLS QL L + +NQ+ S + + +L L L
Sbjct: 216 PVANMTRLNSLKIGNNKITDLSP--LANLS-QLTWLEIGTNQI--SDINAVKDLTKLKML 270
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP 417
+G NQ + + L L + L +NQL E +G L+ L+ L L+ N ++ + P
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 418 SCLGSLKQLAILHLFEN 434
L SL ++
Sbjct: 329 --LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 72/381 (18%), Positives = 152/381 (39%), Gaps = 37/381 (9%)
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
+L ++ I P +L+ + + + L + V
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
+ SI + + LE++ N + + L+ + N + + ++
Sbjct: 57 A-SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--------TDIS 104
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
+L N +NLR L + + P +ANL+ ++ +L + +N S S + N+ GL L
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP 417
+ ++ P + L +L + L NQ+ P L +L+ L N ++ + P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 418 SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRV 477
+ ++ +L L + N + P + NL+ L+ L + N + S + +L L++
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLT-WLEIGTNQI--SDINAVKDLTKLKM 269
Query: 478 FNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI 537
NV SN +S S L S L +++ N + L + + LS+N+++ +
Sbjct: 270 LNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327
Query: 538 PKFLEDL-SLEYLNLSFNDLE 557
P L L ++ + + ++
Sbjct: 328 P--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 79/364 (21%), Positives = 147/364 (40%), Gaps = 34/364 (9%)
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230
L E L +++ ++ L + V + + L +L
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS--IQGIEY-LTNLEYL 71
Query: 231 QVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGES 290
++ N + P LSN KL + N + +S + NL + +N+
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNI----- 122
Query: 291 DEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350
S ++ LAN + + +L AN ++N++ L L +T +++ P I N
Sbjct: 123 ---SDISPLANLTKMYSLNLGANHNLS-DLSPLSNMT-GLNYLTVTESKVKDVTP--IAN 175
Query: 351 LVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
L LY L + NQ P + L +L Y NQ++ P + N++ L+ L + NN
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIG 470
++ + P L +L QL L + N + + + +LT L LN+ N + S + +
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKL-KMLNVGSNQI--SDISVLN 284
Query: 471 NLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR 530
NL L +++N L E +G + L +++ N P L+SL + + D +
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
Query: 531 NNLS 534
+
Sbjct: 343 QVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 62/320 (19%), Positives = 125/320 (39%), Gaps = 32/320 (10%)
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
++ ++ S + V +++++ VA + S + +
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS--------IQGIEYL 65
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
+NL L N++ P ++NL +L NL + +N++ + S + NL L L + +
Sbjct: 66 TNLEYLNLNGNQITDISP--LSNLV-KLTNLYIGTNKI--TDISALQNLTNLRELYLNED 120
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
+ P + L + + L N S L N++ L+ L + + + V P + +
Sbjct: 121 NISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IAN 175
Query: 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
L L L L N + + +LT L + N + P + N+ L + +
Sbjct: 176 LTDLYSLSLNYNQIED--ISPLASLTSL-HYFTAYVNQITDITP--VANMTRLNSLKIGN 230
Query: 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLE 542
N ++ P L S L + + N S +++ L + +++ N +S + L
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDISV--LN 284
Query: 543 DL-SLEYLNLSFNDLEGEVP 561
+L L L L+ N L E
Sbjct: 285 NLSQLNSLFLNNNQLGNEDM 304
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 33/161 (20%), Positives = 65/161 (40%), Gaps = 14/161 (8%)
Query: 402 LSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
+ L ++ + P L + L + + + +E L ++ L +A +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESIT-KLVVAGEKV 56
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
SI I L L N++ N ++ P L L +Y+ N + S+L +L
Sbjct: 57 -ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 522 AVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVP 561
+ + L+ +N+S + P L +L + LNL N ++
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS 149
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 52/316 (16%), Positives = 101/316 (31%), Gaps = 29/316 (9%)
Query: 240 SIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299
LS + D + N L + + L
Sbjct: 27 PYHDVLSQ---WQRHYNADRNRWHSAW-RQANSNNPQIETRTGRAL-------KATADLL 75
Query: 300 ANCS--NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
+ + L + L P LS LQ++ + + L +P + GL L
Sbjct: 76 EDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETL 132
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSI---------LSELLLN 408
+ N +P + L L + + E+P L + L L L
Sbjct: 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK 468
+ +P+ + +L+ L L + + L+ + I +L L L+L + + P
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE-ELDLRGCTALRNYPPI 248
Query: 469 IGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDL 528
G L+ + + +P + + LE++ +RG +PS ++ L A I +
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 529 SRNNLSGLIPKFLEDL 544
+ + L
Sbjct: 309 PPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 56/330 (16%), Positives = 108/330 (32%), Gaps = 28/330 (8%)
Query: 239 GSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNS 298
GS ++S E + ++ + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAW----------R 51
Query: 299 LANCSNLRTLIFAANKLRGALPHSIANL-SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
AN +N + L+ A + + L + S L P L L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP 417
+ +P M + LE + L N L +P+S+ +L+ L EL + +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 418 SCLGS---------LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK 468
L S L L L L G+ ++P I NL L SL + + L ++
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-ALGPA 224
Query: 469 IGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDL 528
I +L L ++ P G + L+ + ++ ++P + L + +DL
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 529 SRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
+P + L + + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 59/383 (15%), Positives = 112/383 (29%), Gaps = 58/383 (15%)
Query: 142 GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201
G + + E++ + + L Q + + + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 202 LANFSVPRNQFHGSLPPSLG-LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
+ + L T P ++ P
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFR------------- 102
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
+ +L + + L M +++ + L TL A N LR ALP
Sbjct: 103 -----------LSHLQHMTIDAAGL-------MELPDTMQQFAGLETLTLARNPLR-ALP 143
Query: 321 HSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380
SIA+L+ +L+ L + + +P + + E L NL+
Sbjct: 144 ASIASLN-RLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQS 187
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTI 440
+ L + +P+S+ NL L L + N+ LS + + L +L L L
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY 245
Query: 441 PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE 500
P L L L + ++P I L L ++ +PS +
Sbjct: 246 PPIFGGRAPLK-RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304
Query: 501 EIYMRGNFFHGSIPSSLSSLRAV 523
I + + + A
Sbjct: 305 IILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 60/370 (16%), Positives = 113/370 (30%), Gaps = 61/370 (16%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
E L+ + + LS R R + + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK 69
Query: 142 GGIPPFIGNLTS--LESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNL 199
+ + T ++ L + P+ +L L+ + + A L +P ++
Sbjct: 70 A-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 200 SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
+ L ++ RN +LP S+ +L LR + +P L++
Sbjct: 127 AGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLASTDASGEH----- 179
Query: 260 SFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGAL 319
G+ NL + + + S L
Sbjct: 180 ----------QGLVNLQSLRLEWTGIRS-------------------------------L 198
Query: 320 PHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLE 379
P SIANL L++L + ++ L ++ I +L L L + G P G L+
Sbjct: 199 PASIANLQ-NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 380 GMGLYD-NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438
+ L D + L +P + L+ L +L L +PS + L I+ + +
Sbjct: 257 RLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 439 TIPEEIFNLT 448
Sbjct: 316 LDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 8e-34
Identities = 61/378 (16%), Positives = 108/378 (28%), Gaps = 59/378 (15%)
Query: 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLK 176
MGS + L Q + + + N +S +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-------NRWHSAWRQA 53
Query: 177 ELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG-LTLPHLRLFQVHHN 235
+ + + + L T P ++
Sbjct: 54 NSNNPQIETRTGRALK----------------------ATADLLEDATQPGRVALELRSV 91
Query: 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295
P S L+ + +L L +A N L +
Sbjct: 92 PLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-------RAL 142
Query: 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLY 355
S+A+ + LR L A LP +A+ LV L
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLAST----------------DASGEHQGLVNLQ 186
Query: 356 RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV 415
L + ++P + LQNL+ + + ++ LS + ++ +L L EL L +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244
Query: 416 IPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYL 475
P G L L L + T+P +I LT L L+L + +P+ I L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPAN 303
Query: 476 RVFNVSSNNLSGEIPSQL 493
+ V +L ++
Sbjct: 304 CIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 46/250 (18%), Positives = 88/250 (35%), Gaps = 18/250 (7%)
Query: 29 LRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88
L LRS L LS L+ + + + E+P + LE L L+
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 89 DNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP---------FEFFSLYKLKQLAMQRNN 139
N L +PA+++ +RL L + + +P E L L+ L ++
Sbjct: 136 RNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194
Query: 140 LTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNL 199
+ +P I NL +L+S+ + + + ++ L +L+ L L PP
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 200 SLLANFSVP-RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALD 258
+ L + + +LP + L L + +P ++ I +
Sbjct: 253 APLKRLILKDCSNLL-TLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIIL-VP 309
Query: 259 NSFSGKLSVN 268
+L +
Sbjct: 310 PHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 41/200 (20%), Positives = 74/200 (37%), Gaps = 13/200 (6%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGR---------LFRLEAL 85
L L L +L I +L+ LRE+++ E+P L L++L
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 86 FLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP 145
L + +PA+++ L L + + L ++ L KL++L ++ P
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
Query: 146 PFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANF 205
P G L+ + L + +P + +L +L+ L L +P I L
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306
Query: 206 SVPRNQFHGSLPPSLGLTLP 225
VP + L + P
Sbjct: 307 LVPPHLQ-AQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 26/188 (13%), Positives = 51/188 (27%), Gaps = 32/188 (17%)
Query: 375 LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
E + + L N + I
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 435 GLNGTIPEEIFNLTYLS-NSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL 493
L + + + T +L L L P + L +L+ + + L E+P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 494 GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSF 553
+ LE + + N ++P+S++SL L L++
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLN-----------------------RLRELSIRA 159
Query: 554 NDLEGEVP 561
E+P
Sbjct: 160 CPELTELP 167
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
IG GSF +VYK D + VA ++ S + F E + LK ++H N+V+
Sbjct: 33 EIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
S S LV E MT+G+L+ +L + + + + +
Sbjct: 92 DSWESTVKGKKCI-VLVTELMTSGTLKTYLK-----------RFKVMKIKVLRSWCRQIL 139
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ +LH P++H DLK N+ + +GD GLA +++ V G
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIG 192
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T + APE + + D+Y++G+ +LEM T + P
Sbjct: 193 TPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-33
Identities = 77/404 (19%), Positives = 134/404 (33%), Gaps = 85/404 (21%)
Query: 102 YCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA 161
+ +L +G + L ++P + + L + NNLT +P L +LE ++
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSG 90
Query: 162 NAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG 221
N ++P L EL +L +P + L + NQ SLP
Sbjct: 91 NQL-TSLPVLPPGLLELSIFSNPLTHLPA-LPSGLCKLWIF------GNQLT-SLPVLPP 141
Query: 222 LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVA 281
L+ V N + S+P S L
Sbjct: 142 ----GLQELSVSDNQLA-SLPALPS---------------------------ELCKLWAY 169
Query: 282 YNNLGSGESDEMSFMNSL-ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQL 340
N L SL S L+ L + N+L +LP + L L +N+L
Sbjct: 170 NNQL-----------TSLPMLPSGLQELSVSDNQLA-SLPTLPSE----LYKLWAYNNRL 213
Query: 341 HGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLS 400
S+P+ L L + GN+ T ++P +L+ L + N+L+ +P L
Sbjct: 214 T-SLPALPSGLKELI---VSGNRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLL 264
Query: 401 ILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLN--LAR 458
LS + N L+ +P L L ++L N L+ + + +T +
Sbjct: 265 SLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRF 320
Query: 459 NHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEI 502
+ S P + L +++ L +
Sbjct: 321 DMAGASAPRETRALH-----LAAADWLVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 83/390 (21%), Positives = 136/390 (34%), Gaps = 65/390 (16%)
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
L +G + L+ +P + + + +P N SLP LR +V N
Sbjct: 42 NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP----ELRTLEVSGNQL 93
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
+ S+P+ +L S L + N L
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-----------T 134
Query: 298 SL-ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYR 356
SL L+ L + N+L +LP + L L +NQL S+P L
Sbjct: 135 SLPVLPPGLQELSVSDNQLA-SLPALPSEL----CKLWAYNNQLT-SLPMLPSGLQ---E 185
Query: 357 LGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVI 416
L + NQ ++P +L L Y+N+L+ +P+ L EL+++ N L+ +
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLW---AYNNRLT-SLPALPSGLK---ELIVSGNRLTS-L 236
Query: 417 PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLR 476
P LK+L + N L ++P L SL++ RN L +P + +L
Sbjct: 237 PVLPSELKEL---MVSGNRLT-SLPMLPSGLL----SLSVYRNQLT-RLPESLIHLSSET 287
Query: 477 VFNVSSNNLSGEIPSQLGLCSYLEEIYM----RGNFFHGSIPSSLSSLRAVLAIDLSRNN 532
N+ N LS E Q Y R + S P +L A L
Sbjct: 288 TVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
Query: 533 LSGLIP-----KFLEDLSLEYLNLSFNDLE 557
P F ++ + + +L + L
Sbjct: 347 EGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 64/327 (19%), Positives = 109/327 (33%), Gaps = 51/327 (15%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
+T L + L+ SL L R + + N + +P L L L
Sbjct: 63 ITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 94 GEIPANLSY--------------CSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNN 139
+P+ L L L + N+L S+P L KL N
Sbjct: 118 -ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL-ASLPALPSELCKLW---AYNNQ 172
Query: 140 LTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNL 199
LT +P L L S++ N ++P +L +L + N L+ + P L
Sbjct: 173 LTS-LPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYN---NRLTSL-PALPSGL 223
Query: 200 SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
L V N+ SLP L+ V N + S+P+ S L + N
Sbjct: 224 KEL---IVSGNRL-TSLPVLPS----ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRN 271
Query: 260 SFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRT----LIFAANKL 315
+ +L + + + + N+ N L + + S S +A +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 316 RGALPHSIAN-LSDQLQNLIMTSNQLH 341
AL + A+ L + +++ H
Sbjct: 331 TRALHLAAADWLVPAREGEPAPADRWH 357
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 9e-20
Identities = 65/328 (19%), Positives = 121/328 (36%), Gaps = 35/328 (10%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
L + L+ SL L +E+++ +N + +P L++L +N L
Sbjct: 164 CKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLW---AYNNRLT- 214
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
+PA S L L + N+L S+P +LK+L + N LT +P L SL
Sbjct: 215 SLPALPS---GLKELIVSGNRL-TSLPVL---PSELKELMVSGNRLTS-LPMLPSGLLSL 266
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214
S+ N +P SL L ++ L N LS ++ ++ +S P +F
Sbjct: 267 ---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
+ + L ++ + + A + DN + S+ +
Sbjct: 323 AGASAPRE---TRALHLAAADWLVPAREGEPAPADRWHMFGQEDN--ADAFSLFLDRLSE 377
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA-ANKLRGALPHSIANLSDQLQNL 333
+ ++ S++ LA LR FA A + + + Q++N+
Sbjct: 378 T----ENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQMKNV 433
Query: 334 IMTSNQLHGSIPSGIGNLV----GLYRL 357
+ N G + + LV ++RL
Sbjct: 434 QLVHNAEKGQYDNDLAALVATGREMFRL 461
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 58/457 (12%), Positives = 134/457 (29%), Gaps = 25/457 (5%)
Query: 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
R + + L +L+ + ++E++L N + + +LE L LS N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
E L S L L L N + E ++ L NN++ +
Sbjct: 71 Y-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQ 120
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY-NLSLLANFSVPRNQ 211
++I LA N G ++ L L N + + + + L + ++ N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271
+ + + L+ + N + + +A+ + +I +N +
Sbjct: 181 IY-DVKG--QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQ 331
+NL +F++ N + + + ++T+ K +
Sbjct: 236 SQNLEHFDLRGNGF-----HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 332 NLIMTSNQLHGSIPSGIGNL--VGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLS 389
L + L L G++ + E + Q
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYR 349
Query: 390 GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTY 449
I L +L + + + +L G + +
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSP 408
Query: 450 LSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLS 486
L + + + + + +R +++ + +
Sbjct: 409 LQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 69/493 (13%), Positives = 148/493 (30%), Gaps = 27/493 (5%)
Query: 47 SLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRL 106
++ N + + + ++S++ + + ++ L LS N L A+L+ ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 107 TILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGG 166
+L L N L + SL L+ L + N + + S+E++ A N
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI-S 112
Query: 167 NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPH 226
+ S GQ K++ L N ++ + S + + N+ L +
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 227 LRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLG 286
L + +NF + +KL+ ++ N + + F +++ ++ N L
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226
Query: 287 SGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPS 346
+ +L NL N + + ++Q + +
Sbjct: 227 ------VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQ 278
Query: 347 GIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG----EIPSSLGNLSIL 402
G +L L+ G + N +
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL- 461
E+ VI + L + L+ + L +L A +
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE 398
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
+ + L+ LR + E S ++Y + L L
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLN 458
Query: 522 AVLAIDLSRNNLS 534
+ L+ N +
Sbjct: 459 GEADLALASANAT 471
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 19/71 (26%), Positives = 27/71 (38%), Gaps = 1/71 (1%)
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLE 547
I + + + + ++ S S V +DLS N LS + L LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 548 YLNLSFNDLEG 558
LNLS N L
Sbjct: 62 LLNLSSNVLYE 72
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 32/224 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS- 728
LIG G FG V+K DG IK + E KAL + H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 729 -------CSSIDFQGNDFKALVY---EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
+S ++ EF G+LE W+ +K ++ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALE------ 126
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ + +DY+H +++ DLKP N+ L + +GDFGL + T+S
Sbjct: 127 --LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT+ Y +PE + D+Y+ G++L E++
Sbjct: 182 K-----GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITS 728
+G G +G VY+G + + VA+K + + FL E +K I+H NLV+++
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
C+ + F ++ EFMT G+L ++L E Q+++ + + +A ++SA
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYLR---------ECNRQEVSAVVLLYMATQISSA 330
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL +H +L N L+ + + V DFGL+R+ ++ T + G + I
Sbjct: 331 MEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIK 384
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE ++ S D++++G+LL E+ T G P
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLA----ECKALKNIRHRNLVK 724
+G G +VY A D VAIK + + L E + H+N+V
Sbjct: 18 KLGGGGMSTVYL-AEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 725 VITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+I D + LV E++ +L + L++ IN
Sbjct: 76 MI------D-VDEEDDCYYLVMEYIEGPTL-----------SEYIESHGPLSVDTAINFT 117
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ I + H ++H D+KP N+L+D++ + DFG+A+ E S LTQ+ V
Sbjct: 118 NQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHV- 172
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT+ Y +PE G DIYS GI+L EM+ G+ P F G+
Sbjct: 173 -LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-32
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 34/228 (14%)
Query: 670 LIGMGSFGSVYKGAFDQ--DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVI 726
I G G +Y A D+ +G V +K A +AE + L + H ++V++
Sbjct: 87 CIAHGGLGWIYL-ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
D G+ +V E++ SL+ + QKL + + I +++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK-------------RSKGQKLPVAEAIAYLLEIL 192
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
A+ YLH +++ DLKP N++L + + + D G + + GT
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVS------RINSFGYLY--GT 240
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
G+ APE + DIY+ G L + G
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT----RNGRYVDG 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 33/249 (13%)
Query: 647 RKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-- 704
+ + F++ + + IG GSFG +DG IK N+ R +
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 705 KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQK 764
+ E L N++H N+V+ S F+ N +V ++ G L
Sbjct: 68 EESRREVAVLANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKR--------- 113
Query: 765 DVEIEIQKLTLL---QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821
I QK L Q ++ + + A+ ++H +LH D+K N+ L D +G
Sbjct: 114 ---INAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG 167
Query: 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKK 881
DFG+ARV L ++C GT Y +PE + DI++ G +L E+ T K
Sbjct: 168 DFGIARVLNSTVELARACI----GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 882 PTDVMFEGD 890
FE
Sbjct: 224 A----FEAG 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 57/326 (17%), Positives = 114/326 (34%), Gaps = 40/326 (12%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRN 721
+ + ++G G+ +V++G + G + AIKVFN + E + LK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+VK+ + + K L+ EF GSL L + E E +
Sbjct: 69 IVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR------ 119
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVGDFGLARVRQEVSNLTQ 837
DV +++L + ++H ++KPGN++ D + + DFG AR ++
Sbjct: 120 --DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNG--------DIYSYGILLLEMVTGKKPTDVMFEG 889
GT Y P+ + + + D++S G+ TG P F
Sbjct: 175 LY-----GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRP 225
Query: 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPIS--MVRIG 947
++ +I I+ V+ + ++ + + + +
Sbjct: 226 FEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 948 VACSVESPQDRMSITNVVHELQSVKN 973
+ E + +
Sbjct: 284 ANILEADQEKCWGFDQFFAETSDILH 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 65/260 (25%), Positives = 100/260 (38%), Gaps = 27/260 (10%)
Query: 634 RGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAI 693
+ Q P P + + F IG G F VY+ A DG VA+
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMG-YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVAL 62
Query: 694 KVFNLQRHGASK---SFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG 750
K + +K + E LK + H N++K S F ++ +V E G
Sbjct: 63 KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAG 117
Query: 751 SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
L + K + I + T+ + + SA++++H V+H D+KP NV
Sbjct: 118 DLSRMIKH----FKKQKRLIPERTVW---KYFVQLCSALEHMHSRR---VMHRDIKPANV 167
Query: 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYG 870
+ + +GD GL R + S GT Y +PE + + DI+S G
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 871 ILLLEMVTGKKPTDVMFEGD 890
LL EM + P F GD
Sbjct: 224 CLLYEMAALQSP----FYGD 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-31
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVK-- 724
IG G+FG V+ G D T+VA+K R FL E + LK H N+V+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 725 -VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
V T I +V E + G +L + +L + + +
Sbjct: 179 GVCTQKQPI--------YIVMELVQGGDFLTFLRTEG----------ARLRVKTLLQMVG 220
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG- 842
D A+ ++YL + +H DL N L+ + + DFG++R + S +
Sbjct: 221 DAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-GVYAASGGLRQ 276
Query: 843 --VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
V+ T APE S+ D++S+GILL E + G P
Sbjct: 277 VPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V G + G VA+K ++ +++FLAE + +RH NLV+++
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ +V E+M GSL ++L L + ++DV A
Sbjct: 255 IV----EEKGGLYIVTEYMAKGSLVDYLRSR---------GRSVLGGDCLLKFSLDVCEA 301
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL + +H DL NVL+ D +A V DFGL + S + +
Sbjct: 302 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE-------ASSTQDTGKLPVK 351
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE + ST D++S+GILL E+ + G+ P
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 40/260 (15%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTI 690
+ RR + + S + ES F+ F +G GS+G V+K +DG +
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPESFFQ--QSFQRLSRLGHGSYGEVFKVRSKEDGRL 84
Query: 691 VAIKVFNLQRHGAS--KSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVYEFM 747
A+K G LAE + + + +H V++ + ++ L E
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELC 139
Query: 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807
SL Q+ E L Q D A+ +LH ++H D+KP
Sbjct: 140 -GPSL----------QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKP 185
Query: 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE-----YGLGSEVST 862
N+ L +GDFGL G Y APE YG +
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPELLQGSYGTAA---- 236
Query: 863 NGDIYSYGILLLEMVTGKKP 882
D++S G+ +LE+ +
Sbjct: 237 --DVFSLGLTILEVACNMEL 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 57/326 (17%), Positives = 114/326 (34%), Gaps = 40/326 (12%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRN 721
+ + ++G G+ +V++G + G + AIKVFN + E + LK + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+VK+ + + K L+ EF GSL L + E E +
Sbjct: 69 IVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL------- 118
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVGDFGLARVRQEVSNLTQ 837
DV +++L + ++H ++KPGN++ D + + DFG AR ++
Sbjct: 119 -RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNG--------DIYSYGILLLEMVTGKKPTDVMFEG 889
GT Y P+ + + + D++S G+ TG P F
Sbjct: 175 LY-----GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRP 225
Query: 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPIS--MVRIG 947
++ +I I+ V+ + ++ + + + +
Sbjct: 226 FEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 948 VACSVESPQDRMSITNVVHELQSVKN 973
+ E + +
Sbjct: 284 ANILEADQEKCWGFDQFFAETSDILH 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLA----ECKALKNIRHRNLVK 724
L+G G G VY+ A D IVA+K+ + + F E + ++ ++V
Sbjct: 41 LVGRGGMGDVYE-AEDTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 725 VITSCSSIDF---QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+ DF G + + + L L L + + I
Sbjct: 99 IH------DFGEIDGQLY--VDMRLINGVDLAAMLRRQG-----------PLAPPRAVAI 139
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ SA+D H H D+KP N+L+ D A++ DFG+A + LTQ +
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNT 195
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT+ Y APE S + DIY+ +L E +TG P ++GD
Sbjct: 196 --VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 53/323 (16%), Positives = 108/323 (33%), Gaps = 67/323 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G G F V DG A+K + E + H N+++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
++ L+ F G+L N + + ++ + LT Q + + + + +
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEI-------ERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS-----VGVR 844
+ +H H DLKP N+LL ++ + D G ++ R
Sbjct: 148 EAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 845 GTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
TI Y APE + + E + D++S G +L M+ G+ P ++
Sbjct: 205 CTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP----YDMV-------- 249
Query: 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPIS------MVRIGVACSV 952
K + ++ P S + ++ +
Sbjct: 250 ------------------------FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMT 285
Query: 953 ESPQDRMSITNVVHELQSVKNAL 975
P R I ++ +L++++
Sbjct: 286 VDPHQRPHIPLLLSQLEALQPPA 308
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 26/217 (11%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
H +G G +G VY+G + + VA+K + + FL E +K I+H NLV+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C+ + F ++ EFMT G+L ++L E Q+++ + + +A ++
Sbjct: 76 GVCT----REPPF-YIITEFMTYGNLLDYLR---------ECNRQEVSAVVLLYMATQIS 121
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
SA++YL +H DL N L+ + + V DFGL+R+ ++ T + G +
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFP 175
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
I + APE ++ S D++++G+LL E+ T G P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
++G G++G VY G + +AIK + S+ E K+++H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
F N F + E + GSL L P KD E I T + +
Sbjct: 88 ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK--------QILEGL 135
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
YLH + ++H D+K NVL++ + + DFG ++ ++ T++ GT+
Sbjct: 136 KYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET----FTGTLQ 188
Query: 849 YAAPE--YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE DI+S G ++EM TGK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 75/406 (18%), Positives = 147/406 (36%), Gaps = 37/406 (9%)
Query: 96 IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSL 154
I +NL Y + + FE +L K + + + + +P + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214
E ++L + ++ L +G N + + P N+ LL + RN
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
SLP + P L + +N + + L+ ++ N + V+ + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPS 187
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLI 334
L + NV+YN L ++LA + L + N + + ++ +L L
Sbjct: 188 LFHANVSYNLL-----------STLAIPIAVEELDASHNSIN-VVR---GPVNVELTILK 232
Query: 335 MTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIP 393
+ N L + N GL + + N+ I K+Q LE + + +N+L +
Sbjct: 233 LQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 288
Query: 394 SSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSN 452
+ L L L++N L + +L L+L N + T+ L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK---- 342
Query: 453 SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL--GLC 496
+L L+ N + + + + V + +I QL GLC
Sbjct: 343 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 74/415 (17%), Positives = 158/415 (38%), Gaps = 62/415 (14%)
Query: 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGE 95
+++ + L+ + + N++++ ++P ++E L L+D + E
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 96 IPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLT 152
I +Y + L++G N + +P F + L L ++RN+L+ +P I N
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
L ++S++ N ++ L++L L +N L+
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------------- 178
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
+ SL +P L V +N S +L+ +E ++A NS + V
Sbjct: 179 --HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVN 225
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQN 332
L+ + +NNL L N L + + N+L + H + +L+
Sbjct: 226 VELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLER 276
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
L +++N+L ++ + L L + N + + + LE + L N + +
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 333
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSL-KQLAILHLFENGLNGTIPEEIFN 446
L L L L++N + L +L + +A + + + I ++ +
Sbjct: 334 K--LSTHHTLKNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 69/403 (17%), Positives = 138/403 (34%), Gaps = 31/403 (7%)
Query: 192 IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKL 251
I ++ + + + +TL + ++ ++ L + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFE-DITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 252 EFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA 311
E + D + F + + +N + N L L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH------VFQNVPLLTVLVLE 125
Query: 312 ANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPK 370
N L N +L L M++N L I L L + N+ T +
Sbjct: 126 RNDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD- 181
Query: 371 EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILH 430
+ + +L + N LS +L + EL ++NS++ V+ +L IL
Sbjct: 182 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILK 232
Query: 431 LFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEI 489
L N L T + N L ++L+ N L I ++ L +S+N L +
Sbjct: 233 LQHNNL--TDTAWLLNYPGL-VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 490 PSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYL 549
L+ + + N + + + + L N++ L +L+ L
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH--TLKNL 344
Query: 550 NLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC 592
LS ND + + +F N++R +V ++ C +L+ C
Sbjct: 345 TLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-29
Identities = 72/379 (18%), Positives = 132/379 (34%), Gaps = 38/379 (10%)
Query: 208 PRNQFHGSLPPSLG--LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265
PR + + +L + + + + G I+L+N + NS KL
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVT----FKNSTMRKL 60
Query: 266 SVN-FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIA 324
+ + N+ + ++ + A ++ L N +R PH
Sbjct: 61 PAALLDSFRQVELLNLNDLQIEEIDT------YAFAYAHTIQKLYMGFNAIRYLPPHVFQ 114
Query: 325 NLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMG 382
N+ L L++ N L S+P GI N L L M N I + +L+ +
Sbjct: 115 NVP-LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQ 171
Query: 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442
L N+L+ + L + L ++ N LS L + L N +N +
Sbjct: 172 LSSNRLT-HVD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRG 222
Query: 443 EIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE 501
+ LT L L N+L + N L ++S N L + LE
Sbjct: 223 PVNVELT----ILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 276
Query: 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVP 561
+Y+ N ++ + + +DLS N+L + + LE L L N + +
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK 334
Query: 562 TKGVFANISRISVAGFNRL 580
+ ++++ N
Sbjct: 335 L-STHHTLKNLTLSH-NDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 61/398 (15%), Positives = 128/398 (32%), Gaps = 51/398 (12%)
Query: 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL 172
R I + + L + + ++ + L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV 232
++++ L L + I + + + N LPP + +P L + +
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124
Query: 233 HHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292
N S S+P + F L+ +++ NNL E D
Sbjct: 125 ERNDLS-SLPRGI-----------------------FHNTPKLTTLSMSNNNLERIEDD- 159
Query: 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLV 352
+ ++L+ L ++N+L I + L + ++ N L S + +
Sbjct: 160 -----TFQATTSLQNLQLSSNRLTHVDLSLIPS----LFHANVSYNLL-----STLAIPI 205
Query: 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412
+ L N + + L + L N L+ + L N L E+ L+ N L
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 260
Query: 413 SGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNL 472
++ +++L L++ N L + + L L+L+ NHL+ +
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQF 317
Query: 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510
L + N++ + L L+ + + N +
Sbjct: 318 DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 70/318 (22%), Positives = 116/318 (36%), Gaps = 64/318 (20%)
Query: 671 IGMGSFGSVYKGAF---DQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK 724
+G GSFG V +G + VA+K L + A F+ E A+ ++ HRNL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + + +V E GSL + L L A+
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQ 129
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
VA + YL +H DL N+LL + +GDFGL R + + +
Sbjct: 130 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-QEHRK 185
Query: 845 GTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900
+ APE S S D + +G+ L EM T G++P + G L+
Sbjct: 186 VPFAWCAPESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP----WIG---LNGS---- 231
Query: 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960
++ +D +RL + + CP + + V C P+DR +
Sbjct: 232 ---QILHKID------------KEGERLPRPED-----CPQDIYNVMVQCWAHKPEDRPT 271
Query: 961 ITNVVHELQSVKNALLEA 978
+ L + + A
Sbjct: 272 FVALRDFLLEAQPTDMRA 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 36/232 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVIT 727
IG GS+G K DG I+ K + + + ++E L+ ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY- 71
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRINIAIDVA 786
I + N +V E+ G L + + ++ + E + + + +
Sbjct: 72 --DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--------LRVMTQLT 121
Query: 787 SAIDYLH--HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
A+ H VLH DLKP NV LD +GDFGLAR+ ++ ++
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---- 177
Query: 845 GTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y +PE Y S DI+S G LL E+ P F
Sbjct: 178 GTPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP----FTAF 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLA----ECKALKNIRHRNLVK 724
++G G V+ A D VA+KV SF E + + H +V
Sbjct: 19 ILGFGGMSEVHL-ARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 725 VITSCSSIDFQGNDFKA------LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
V D G +V E++ +L +D+ +T +
Sbjct: 77 VY------D-TGEAETPAGPLPYIVMEYVDGVTL-----------RDIVHTEGPMTPKRA 118
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-VRQEVSNLTQ 837
I + D A+++ H + ++H D+KP N+++ V DFG+AR + +++TQ
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ +V GT Y +PE G V D+YS G +L E++TG+ P F GD
Sbjct: 176 TAAV--IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V G + G VA+K ++ +++FLAE + +RH NLV+++
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ +V E+M GSL ++L L + ++DV A
Sbjct: 83 IV----EEKGGLYIVTEYMAKGSLVDYLRSR---------GRSVLGGDCLLKFSLDVCEA 129
Query: 789 IDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
++YL ++ +H DL NVL+ D +A V DFGL + S + +
Sbjct: 130 MEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKE-------ASSTQDTGKLPV 178
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE + ST D++S+GILL E+ + G+ P
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V+ + T VA+K + ++FLAE +K ++H LVK+ +
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ ++ EFM GSL ++L D E K L + I+ + +A +
Sbjct: 254 ------KEPIYIITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEGMA 298
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
++ +H DL+ N+L+ ++ + DFGLARV + + + G + I +
Sbjct: 299 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWT 352
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE + D++S+GILL+E+VT G+ P
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-30
Identities = 97/592 (16%), Positives = 211/592 (35%), Gaps = 85/592 (14%)
Query: 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGE 95
++++++ + L+ + + N++++ ++P ++E L L+D + E
Sbjct: 34 IDMQTQDVYFGFED--ITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 96 IPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLT 152
I +Y + L++G N + +P F + L L ++RN+L+ +P I N
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
L ++S++ N ++ L++L L +N L+
Sbjct: 148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT----------------------- 184
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
+ SL +P L V +N S +L+ +E ++A NS + V
Sbjct: 185 --HVDLSL---IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN---VVRGPVN 231
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQN 332
L+ + +NNL L N L + + N+L + H + +L+
Sbjct: 232 VELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLER 282
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
L +++N+L ++ + L L + N + + + LE + L N + +
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSL-KQLAILHLFENGLNGTIPEEIFNLTYLS 451
L L L L++N + L +L + +A + + + I ++ +
Sbjct: 340 K--LSTHHTLKNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCK 394
Query: 452 NSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHG 511
S + L L+Y+ ++ ++ G CS + I + H
Sbjct: 395 ESDKPYLDRL----------LQYIA-----LTSVVEKVQRAQGRCSATDTINSVQSLSHY 439
Query: 512 SIPSSLSSLRAVLAIDLS----RNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFA 567
L+ ++ R + L + ++ L L +
Sbjct: 440 ITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLL-QGLHAEIDTNLRRYRLPKD 498
Query: 568 NISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAIISTLSAVLGI 619
++R S N++ + E Q K E +R + + K + +
Sbjct: 499 GLARSSDN-LNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIAL 549
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 81/479 (16%), Positives = 165/479 (34%), Gaps = 42/479 (8%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTS 153
I +NL Y + + FE +L K + + + + +P + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 154 LESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
+E ++L + ++ L +G N + + P N+ LL + RN
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMK 273
SLP + P L + +N + + L+ ++ N + V+ +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 192
Query: 274 NLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNL 333
+L + NV+YN L ++LA + L + N + + ++ +L L
Sbjct: 193 SLFHANVSYNLL-----------STLAIPIAVEELDASHNSIN-VVR---GPVNVELTIL 237
Query: 334 IMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEI 392
+ N L + + + N GL + + N+ I K+Q LE + + +N+L +
Sbjct: 238 KLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLS 451
+ L L L++N L + +L L+L N + T+ L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK--- 348
Query: 452 NSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE-------IY 503
+L L+ N + + N+ V + + C ++ Y
Sbjct: 349 -NLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407
Query: 504 MRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFNDLEGEVP 561
+ + + A I+ ++ + + L E L N+L EV
Sbjct: 408 IALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 68/378 (17%), Positives = 133/378 (35%), Gaps = 36/378 (9%)
Query: 208 PRNQFHGSLPPSL--GLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265
PR + + +L + + + + G I+L+N + + +++
Sbjct: 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLP 67
Query: 266 SVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIAN 325
+ + + N+ + ++ + A ++ L N +R PH N
Sbjct: 68 AALLDSFRQVELLNLNDLQIEEIDT------YAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121
Query: 326 LSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGL 383
+ L L++ N L S+P GI N L L M N I + +L+ + L
Sbjct: 122 VP-LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 178
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEE 443
N+L+ + L + L ++ N LS L + L N +N +
Sbjct: 179 SSNRLT-HVD--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGP 229
Query: 444 IF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEI 502
+ LT L L N+L + N L ++S N L + LE +
Sbjct: 230 VNVELT----ILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL 283
Query: 503 YMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPT 562
Y+ N ++ + + +DLS N+L + + LE L L N + +
Sbjct: 284 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLKL 341
Query: 563 KGVFANISRISVAGFNRL 580
+ ++++ N
Sbjct: 342 -STHHTLKNLTLSH-NDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-17
Identities = 50/258 (19%), Positives = 96/258 (37%), Gaps = 17/258 (6%)
Query: 326 LSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYD 385
+ Q + + + I S + Y + + E L N + + +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 386 NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF 445
+ + + L + + L LN+ + + + L++ N + +P +F
Sbjct: 61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119
Query: 446 -NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEI 502
N+ L+ L L RN L S+P I N L ++S+NNL I + L+ +
Sbjct: 120 QNVPLLT-VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176
Query: 503 YMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPT 562
+ N S + SL ++S N LS L +++E L+ S N + V
Sbjct: 177 QLSSNRLTHVDLSLIPSLF---HANVSYNLLSTLAI----PIAVEELDASHNSIN-VVR- 227
Query: 563 KGVFANISRISVAGFNRL 580
V ++ + + N L
Sbjct: 228 GPVNVELTILKLQH-NNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 5e-13
Identities = 52/369 (14%), Positives = 115/369 (31%), Gaps = 44/369 (11%)
Query: 50 PYIGNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTI 108
++ N L E++L N ++ +I F ++ RLE L++S+N LV + L +
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 109 LFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNI 168
L L N L+ + +L+ L + N++ + +L++++L+ N + N
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCN- 360
Query: 169 PNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLR 228
+ + + + + I + + S P L L ++
Sbjct: 361 -SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKE----------SDKPYLDRLLQYIA 409
Query: 229 LFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG 288
L V S + +++L + + + V G + L
Sbjct: 410 LTSVVEKV--QRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQL------------- 454
Query: 289 ESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI 348
E A L +L L A + L+ + + L +
Sbjct: 455 ---EAEVNELRAEVQQLTNEQIQQEQLLQGLH---AEIDTNLRRYRLPKDGL-ARSSDNL 507
Query: 349 GNLVGLYRLGMGGNQFTGTI--PKEMGKLQNLEGMGLYDNQLSGEIPSSLG-NLSILSEL 405
+ + + K + E + + L ++ + + E
Sbjct: 508 NKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQET 567
Query: 406 LLNNNSLSG 414
L +
Sbjct: 568 SLKRQKVKQ 576
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 52/311 (16%)
Query: 671 IGMGSFGSVYKG----AFDQDGTIVAIKVFNLQRHG--ASKSFLAECKALKNIRHRNLVK 724
+G G+FGSV D G +VA+K LQ G + F E + LK + +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
G LV E++ +G L ++L +L + + +
Sbjct: 89 YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHR----------ARLDASRLLLYSSQ 135
Query: 785 VASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG- 842
+ ++YL C +H DL N+L++++ + DFGLA++ + G
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 843 --VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899
+ APE + S D++S+G++L E+ T K E +
Sbjct: 192 SPIFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959
L ++++++ QRL CP + + C SPQDR
Sbjct: 248 PALSRLLELLE-------------EGQRLPAPP-----ACPAEVHELMKLCWAPSPQDRP 289
Query: 960 SITNVVHELQS 970
S + + +L
Sbjct: 290 SFSALGPQLDM 300
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 669 HLIGMGSFGSVYKG-AFDQDG--TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
++G G FGSV +G +DG VA+K ++ +S+ FL+E +K+ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+++++ C + QG ++ FM G L +L + + + L +
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-----KHIPLQTLLKF 152
Query: 782 AIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+D+A ++YL + + LH DL N +L +DM V DFGL++ + +
Sbjct: 153 MVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYS-GDYYRQGR 207
Query: 841 VG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ V+ A E + ++ D++++G+ + E+ T G P
Sbjct: 208 IAKMPVKWI----AIESLADRV---YTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 90/485 (18%), Positives = 164/485 (33%), Gaps = 41/485 (8%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
L +S N + +++ S+L IL + N++ F +L+ L + N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 142 GGIPPFIGNLTSLESISLAANAFGG-NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLS 200
I +L+ + L+ NAF I G + +LK LGL +L I +L+
Sbjct: 83 K-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
+ V + P L +H F + +
Sbjct: 140 ISKVLLVLGETYGEKEDPE---GLQDFNTESLHIVFPT-------------------NKE 177
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
F L V+ + NL N+ + S +S + L L L +
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 321 HSIANLSD--QLQNLIMTSNQLHGSIPSGIGNLVG-----LYRLGMGGNQFTGTIPKEMG 373
I L + +++ +L G + + G L + + F
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 374 KLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE 433
N+ + +S L +NN L+ + G L +L L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 434 NGLNGTIPEEIFNLTYLSN--SLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIP 490
N L + + T + + L++++N + K L N+SSN L+ I
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 491 SQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYL 549
L ++ + + N SIP + L A+ ++++ N L + + L SL+ +
Sbjct: 417 RCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473
Query: 550 NLSFN 554
L N
Sbjct: 474 WLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 94/477 (19%), Positives = 173/477 (36%), Gaps = 44/477 (9%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
T+LN+ +S + I +LS LR + + +N IQ F LE L LS N LV
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPF--EFFSLYKLKQLAMQRNNLTGGIPPFIGNL 151
L L L N ++P EF ++ +LK L + +L I +L
Sbjct: 83 KISCHPT---VNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYN----------LSL 201
+ + + +G L++ + L + I + LS
Sbjct: 139 NISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 202 LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSN---ASKLEFIEALD 258
+ + + T P L +++ + + I + + + + +
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 259 NSFSG-----KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAAN 313
G + +K LS V + G +S SN+ F +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF------SNMNIKNFTVS 310
Query: 314 KLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMG 373
R + +S +L ++N L ++ G+L L L + NQ + K
Sbjct: 311 GTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAE 368
Query: 374 ---KLQNLEGMGLYDNQL-SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAIL 429
++++L+ + + N + E L L +++N L+ I CL ++ +L
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426
Query: 430 HLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNL 485
L N + +IP+++ L L LN+A N L S+P I L L+ + +N
Sbjct: 427 DLHSNKIK-SIPKQVVKLEALQE-LNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 3e-14
Identities = 43/248 (17%), Positives = 81/248 (32%), Gaps = 16/248 (6%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
+LS + L ++ N + S I +L L L + N+ Q LE + L
Sbjct: 17 KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGV-IPSCLGSLKQLAILHLFENGLNGTIPE 442
N+L NL L L+ N+ + I G++ QL L L L +
Sbjct: 77 SHNKLVKISCHPTVNLKHLD---LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 443 EIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYL-----RVFNVSSNNLSGEIPSQLGLCS 497
I +L L L + P + + N + + +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 498 YLE---EIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL----IPKFLEDLSLEYLN 550
+ + SI + L + + + L+ + I + + ++ Y +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 551 LSFNDLEG 558
+S L+G
Sbjct: 254 ISNVKLQG 261
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 42/209 (20%), Positives = 80/209 (38%), Gaps = 7/209 (3%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
+ +++ + S S S + N + + ++ L S+N
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 92 LVGEIPANLSYCSRLTILFLGRNKL--MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI- 148
L + N + + L L L N+L + I + L+QL + +N+++
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
SL S+++++N I L +K L L +N + IP + L L +V
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVA 452
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
NQ S+P + L L+ +H N +
Sbjct: 453 SNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 37/186 (19%), Positives = 65/186 (34%), Gaps = 12/186 (6%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL- 92
+ + N G +S ++ NN + + G L LE L L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 93 ----VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPF 147
+ E+ + L L + +N + S L L M N LT F
Sbjct: 362 ELSKIAEMTTQMK---SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT--IF 416
Query: 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSV 207
++ + L +N +IP + +L+ L+ L + +N L + L+ L +
Sbjct: 417 RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWL 475
Query: 208 PRNQFH 213
N +
Sbjct: 476 HTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 29/171 (16%)
Query: 404 ELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLV 462
L ++ N +S + S + SL +L IL + N + + +F L L+L+ N LV
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL-EYLDLSHNKLV 82
Query: 463 GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRA 522
NLK+L ++S N +P F ++S L+
Sbjct: 83 KISCHPTVNLKHL---DLSFNAFD-ALP--------------ICKEF-----GNMSQLKF 119
Query: 523 VLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRIS 573
+ LS +L + L++ + L + GE + + S
Sbjct: 120 ---LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 37/222 (16%), Positives = 77/222 (34%), Gaps = 9/222 (4%)
Query: 440 IPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYL 499
+P+++ T LN+++N++ + I +L LR+ +S N + S L
Sbjct: 15 VPKDLSQKT---TILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 500 EEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL-IPKFLEDL-SLEYLNLSFNDLE 557
E + + N +L+ +DLS N L I K ++ L++L LS LE
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKH---LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 558 GEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC-TEKNSRNQKISQRLKAIISTLSAV 616
NIS++ + L TE ++ I+
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 617 LGIVMVFFLCFCWFKRRRGPSKQQPSRPILRKALQKVSYESL 658
+ + + + + ++ L ++ ++
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
+G G FG V+ G + T VA+K + G+ +FLAE +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + ++ E+M NGSL ++L KLT+ + +++A +A
Sbjct: 75 AVVT------QEPIYIITEYMENGSLVDFLK---------TPSGIKLTINKLLDMAAQIA 119
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ ++ +H DL+ N+L+ + + + DFGLAR+ + + + G +
Sbjct: 120 EGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFP 173
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
I + APE + D++S+GILL E+VT G+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 45/235 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK----- 724
++G G+FG V K D AIK + L+E L ++ H+ +V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 725 VITSCSSIDFQGNDFKALVY---EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+ K+ ++ E+ NG+L + + + + + L ++I
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYWRLFRQI-- 125
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
A+ Y+H ++H DLKP N+ +D +GDFGLA+ ++ + S
Sbjct: 126 ----LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 842 GVR----------GTIGYAAPE-------YGLGSEVSTNGDIYSYGILLLEMVTG 879
+ GT Y A E Y ++ D+YS GI+ EM+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIYP 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 66/313 (21%), Positives = 121/313 (38%), Gaps = 53/313 (16%)
Query: 671 IGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKS---FLAECKALKNIRHRNLV 723
+G G FG V + D G VA+K L+ E + L+N+ H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K C+ G + L+ EF+ +GSL+ +L + K+ L Q++ A+
Sbjct: 87 KYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNK----------NKINLKQQLKYAV 133
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ +DYL +H DL NVL++++ +GDFGL + +
Sbjct: 134 QICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 843 ---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898
V APE + S+ D++S+G+ L E++T + M +
Sbjct: 190 DSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
Query: 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958
+ +++ + +RL CP + ++ C P +R
Sbjct: 246 QMTVTRLVNTLK-------------EGKRLPCPP-----NCPDEVYQLMRKCWEFQPSNR 287
Query: 959 MSITNVVHELQSV 971
S N++ +++
Sbjct: 288 TSFQNLIEGFEAL 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V+ G + T VAIK + ++FL E + +K +RH LV++
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
S +V E+M+ GSL ++L + L L Q +++A +AS
Sbjct: 248 VSEEPIY------IVTEYMSKGSLLDFLK---------GETGKYLRLPQLVDMAAQIASG 292
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ Y+ +H DL+ N+L+ +++ V DFGLAR+ ++ + G + I
Sbjct: 293 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPIK 346
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE L + D++S+GILL E+ T G+ P
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 29/257 (11%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRNLVK---VI 726
+G G FG V + G VAIK + ++ E + +K + H N+V V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ ND L E+ G L +L+ E I+ LL D++
Sbjct: 82 DGLQKL--APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT--LLS------DIS 131
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLD---NDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
SA+ YLH + ++H DLKP N++L +I + D G A+ + T+
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---- 184
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903
GT+ Y APE + + D +S+G L E +TG +P F + +
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQPVQWHGKVREK 239
Query: 904 HVIDIVDPILINDVEDW 920
IV + +
Sbjct: 240 SNEHIVVYDDLTGAVKF 256
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 27/225 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK-SFLAECKALKNIRHRNLVKVITS 728
+G G FG V++ D AIK L ++ + E KAL + H +V+ +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 729 C----SSIDFQGNDFKALVY---EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
++ Q + K +Y + +L++W++ + +E + + L +I
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG----RCTIEERERSVCL----HI 123
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ +A A+++LH ++H DLKP N+ D + VGDFGL + +
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 842 GVR--------GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878
GT Y +PE G+ S DI+S G++L E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 45/231 (19%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNL--VKV 725
IG G V++ ++ I AIK NL+ S+ E L ++ + +++
Sbjct: 35 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ + +V E N L +WL + + + +R + ++
Sbjct: 94 YDY-----EITDQYIYMVMEC-GNIDLNSWLK-----------KKKSIDPWERKSYWKNM 136
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSCSVG 842
A+ +H H ++H DLKP N L+ + M+ + DFG+A Q +
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--- 189
Query: 843 VRGTIGYAAPE-----------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT+ Y PE S++S D++S G +L M GK P
Sbjct: 190 --GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V+ G + T VAIK + ++FL E + +K +RH LV++
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
S +V E+M+ GSL ++L + + L L Q +++A +AS
Sbjct: 331 VSEEPIY------IVTEYMSKGSLLDFLKGE---------TGKYLRLPQLVDMAAQIASG 375
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ Y+ +H DL+ N+L+ +++ V DFGLAR+ + + + G + I
Sbjct: 376 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIK 429
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ APE L + D++S+GILL E+ T G+ P
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 48/229 (20%)
Query: 671 IGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNLV 723
IG G G V G G VAIK + G + + FL+E + H N++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 724 K---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+ V+T +V E+M NGSL+ +L + T++Q +
Sbjct: 114 RLEGVVTRGRLA--------MIVTEYMENGSLDTFLRTHD----------GQFTIMQLVG 155
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ V + + YL +H DL NVL+D++++ V DFGL+RV ++ + + +
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 841 VG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G +R T APE + S S D++S+G+++ E++ G++P
Sbjct: 213 GGKIPIRWT----APEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERP 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 39/228 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNL--VKV 725
IG G V++ ++ I AIK NL+ S+ E L ++ + +++
Sbjct: 63 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ + +V E N L +WL + + + +R + ++
Sbjct: 122 YDY-----EITDQYIYMVMEC-GNIDLNSWLK-----------KKKSIDPWERKSYWKNM 164
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A+ +H H ++H DLKP N L+ + M+ + DFG+A Q + S G
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS--QVG 218
Query: 846 TIGYAAPE-----------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ Y PE S++S D++S G +L M GK P
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNL--VKV 725
IG G V++ ++ I AIK NL+ S+ E L ++ + +++
Sbjct: 16 QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ + +V E N L +WL + + + +R + ++
Sbjct: 75 YDY-----EITDQYIYMVMEC-GNIDLNSWLK-----------KKKSIDPWERKSYWKNM 117
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A+ +H H ++H DLKP N L+ + M+ + DFG+A Q + S G
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS--QVG 171
Query: 846 TIGYAAPE-----------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T+ Y PE S++S D++S G +L M GK P
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
IG G FG V+ G + + VAIK R GA + F+ E + + + H LV++
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C LV EFM +G L ++L + + +DV
Sbjct: 70 GVCLE-----QAPICLVTEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVC 114
Query: 787 SAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ YL +H DL N L+ + + V DFG+ R V + + S G +
Sbjct: 115 EGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKF 167
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ +A+PE S S+ D++S+G+L+ E+ + GK P
Sbjct: 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
+G G FG V G + + VA+K+ + G+ F E + + + H LVK
Sbjct: 14 KELGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
CS + +V E+++NG L N+L + L Q + + DV
Sbjct: 70 GVCS----KEYPI-YIVTEYISNGCLLNYLRSHG----------KGLEPSQLLEMCYDVC 114
Query: 787 SAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ +L H +H DL N L+D D+ V DFG+ R V + SVG +
Sbjct: 115 EGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKF 167
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ ++APE + S+ D++++GIL+ E+ + GK P
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 60/274 (21%), Positives = 99/274 (36%), Gaps = 51/274 (18%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDG--FSSTHLIGMGSFGSVYKGAFDQDG 688
+ P P P +++ E L + +G G F ++ +
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIP-EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTK 66
Query: 689 TIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKAL 742
+ A K+ L + + E +++ H+++V + +
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV--------FV 118
Query: 743 VYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL 801
V E SL +K + E E + L Q + YLH + V+
Sbjct: 119 VLELCRRRSLLELH----KRRKALTEPEARYY-LRQ-------IVLGCQYLHRNR---VI 163
Query: 802 HCDLKPGNVLLDNDMIAHVGDFGLA-RVRQEVSNLTQSCSVGVRGTIGYAAPEY----GL 856
H DLK GN+ L+ D+ +GDFGLA +V + C GT Y APE G
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-----GTPNYIAPEVLSKKGH 218
Query: 857 GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
EV D++S G ++ ++ GK P FE
Sbjct: 219 SFEV----DVWSIGCIMYTLLVGKPP----FETS 244
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 48/290 (16%), Positives = 104/290 (35%), Gaps = 23/290 (7%)
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328
V ++L + + + N++ L + N L +A +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALA------SLRQSAWNVKELDLSGNPLSQISAADLAPFT- 58
Query: 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL 388
+L+ L ++SN L+ + +L L L + N E+ ++E + +N +
Sbjct: 59 KLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 389 SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG-TIPEEIFNL 447
S + S G + L NN ++ + G ++ L L N ++ E +
Sbjct: 112 S-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 448 TYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507
L LNL N + + ++ L+ ++SSN L+ + + + + I +R N
Sbjct: 169 DTLE-HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224
Query: 508 FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
I +L + + DL N + + ++ ++
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 46/360 (12%), Positives = 103/360 (28%), Gaps = 46/360 (12%)
Query: 72 IPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLK 131
I R + ++D+ L + + + L L N L + KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 132 QLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGI 191
L + N L +L++L ++ L N L +++L NN+S +
Sbjct: 62 LLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 192 IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKL 251
+ + N+ L ++ + N ++
Sbjct: 115 SCSRGQGKKNI-YLA--NNKIT-MLRDLDEGCRSRVQYLDLKLN--------------EI 156
Query: 252 EFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA 311
+ + + L + N+ YN + + + L+TL +
Sbjct: 157 DTVNFAEL---------AASSDTLEHLNLQYNFI--------YDVKGQVVFAKLKTLDLS 199
Query: 312 ANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE 371
+NKL + + + + + + +N+L I + L + GN F
Sbjct: 200 SNKLA-FMGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLR 255
Query: 372 MGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHL 431
+N + + + ++ + + L L H
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 46/244 (18%), Positives = 90/244 (36%), Gaps = 21/244 (8%)
Query: 318 ALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQN 377
A+ N + + + +T + L ++ S + + L + GN + ++
Sbjct: 1 AIHEIKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 378 LEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN 437
LE + L N L L +LS L L LNNN + L + LH N ++
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 438 GTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSG-EIPSQLGL 495
+ ++ LA N + G ++ ++ N +
Sbjct: 113 -RVSCSRGQGKK----NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 496 CSYLEEIYMRGNFFHGSIPSS--LSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSF 553
LE + ++ NF + + + L+ +DLS N L+ + P+F + +++L
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVVFAKLK---TLDLSSNKLAFMGPEFQSAAGVTWISLRN 223
Query: 554 NDLE 557
N L
Sbjct: 224 NKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 49/311 (15%), Positives = 103/311 (33%), Gaps = 31/311 (9%)
Query: 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
R + + L +L+ + ++E++L N + + +LE L LS N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 92 LVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNL 151
L E L S L L L N + E ++ L NN++ +
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRG 119
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY-NLSLLANFSVPRN 210
++I LA N G ++ L L N + + + + L + ++ N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 211 QFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFG 270
+ + + L+ + N + + +A+ + +I +N +
Sbjct: 180 FIY-DVKGQVVFA--KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQL 330
+NL +F++ N +C LR +++ ++ L+ Q
Sbjct: 235 FSQNLEHFDLRGNGF---------------HCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 331 QNLIMTSNQLH 341
+ H
Sbjct: 280 EEECTVPTLGH 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 48/240 (20%), Positives = 84/240 (35%), Gaps = 29/240 (12%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVIT 727
++ G F VY+ G A+K +++ + E +K + H N+V+ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 728 SCSSIDFQGNDFKALVYEFM--TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ S + + +A G L +L + K I
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--------IFYQT 145
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS----- 840
A+ ++H + P++H DLK N+LL N + DFG A + + S
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 841 ---VGVRGTIGYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
+ T Y PE Y + DI++ G +L + + P FE L
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 59/228 (25%), Positives = 111/228 (48%), Gaps = 45/228 (19%)
Query: 671 IGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNL 722
IG G FG VYKG + VAIK + G + FL E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 723 VK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
++ VI+ + ++ E+M NG+L+ +L + ++LQ +
Sbjct: 109 IRLEGVISKYKPM--------MIITEYMENGALDKFLREKD----------GEFSVLQLV 150
Query: 780 NIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ +A+ + YL + + +H DL N+L++++++ V DFGL+RV ++ T +
Sbjct: 151 GMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 839 CSVGVRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ G + I + APE Y + ++ D++S+GI++ E++T G++P
Sbjct: 207 -TSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 36/224 (16%)
Query: 671 IGMGSFGSVYKG-AFDQDG--TIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNLV 723
IG G FG VY G DQ AIK + ++FL E ++ + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+I ++ +M +G L ++ + T+ I+ +
Sbjct: 86 ALIGIML----PPEGLPHVLLPYMCHGDLLQFIRSPQ----------RNPTVKDLISFGL 131
Query: 784 DVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
VA ++YL +H DL N +LD V DFGLAR + +
Sbjct: 132 QVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 843 VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
R + + A E +T D++S+G+LL E++T G P
Sbjct: 188 ARLPVKWTALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
+G G FG V G + + VAIK+ + G+ F+ E K + N+ H LV++
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C+ ++ E+M NG L N+L + Q + + DV
Sbjct: 86 GVCTK-----QRPIFIITEYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVC 130
Query: 787 SAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A++YL LH DL N L+++ + V DFGL+R V + + SVG +
Sbjct: 131 EAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKF 183
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ ++ PE + S+ S+ DI+++G+L+ E+ + GK P
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 671 IGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNL 722
+G G+FG+VYKG + +G VAIK R S L E + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPHV 79
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+++ C + Q L+ + M G L +++ + +N
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYVREHK----------DNIGSQYLLNWC 123
Query: 783 IDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ +A ++YL +H DL NVL+ + DFGLA++ +
Sbjct: 124 VQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-- 177
Query: 842 GVRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + I + A E + + + S D++SYG+ + E++T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMTFGSKP 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 48/234 (20%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK- 724
+G G F ++ + + A K+ L + + E +++ H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 725 --VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRINI 781
+ +V E SL +K + E E + L Q
Sbjct: 81 HGFFEDNDFV--------FVVLELCRRRSLLELH----KRRKALTEPEARYY-LRQ---- 123
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA-RVRQEVSNLTQSCS 840
+ YLH + V+H DLK GN+ L+ D+ +GDFGLA +V + C
Sbjct: 124 ---IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC- 176
Query: 841 VGVRGTIGYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE G EV D++S G ++ ++ GK P FE
Sbjct: 177 ----GTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP----FETS 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 671 IGMGSFGSVYKGAFDQDG--TIVAIKVF--NLQRHGASKSFLAECKALKNIRHRNLVKVI 726
+G G+FG+V KG + VA+K+ LAE ++ + + +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C + + LV E G L +L + + + I + V+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYLQ-----------QNRHVKDKNIIELVHQVS 127
Query: 787 SAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ YL + +H DL NVLL A + DFGL++ + N ++ +
Sbjct: 128 MGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKW 182
Query: 846 TIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + APE Y + S+ D++S+G+L+ E + G+KP
Sbjct: 183 PVKWYAPECINYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 671 IGMGSFGSVYKG-AFDQDG--TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLV 723
+G G FGSV + +DG VA+K+ L+ + S FL E +K H ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 724 KVITSCSSIDFQGNDFKAL-VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
K++ +G + + FM +G L +L + + L L +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-----FNLPLQTLVRFM 143
Query: 783 IDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+D+A ++YL + +H DL N +L DM V DFGL+R + +
Sbjct: 144 VDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYS-GDYYRQGCA 198
Query: 842 G---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
V+ A E L + + D++++G+ + E++T G+ P
Sbjct: 199 SKLPVKWL----ALESLADNL---YTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 58/254 (22%), Positives = 97/254 (38%), Gaps = 29/254 (11%)
Query: 632 RRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIV 691
+R GP + +L + L+ V YE + + +G GSFG V++ Q G
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 692 AIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGS 751
A+K L+ E A + +V + + + + + E + GS
Sbjct: 87 AVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGS 136
Query: 752 LENWL-HPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
L + +P E ++YLH +LH D+K NV
Sbjct: 137 LGQLIKQMGCLP----EDRALYYLG--------QALEGLEYLH---TRRILHGDVKADNV 181
Query: 811 LLDND-MIAHVGDFGLA-RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYS 868
LL +D A + DFG A ++ + + + GT + APE +G DI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 869 YGILLLEMVTGKKP 882
++L M+ G P
Sbjct: 242 SCCMMLHMLNGCHP 255
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 671 IGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNLV 723
+G G FG V G + VAIK + G + + FL E + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 724 K---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
+ V+T + +V E+M NGSL+++L + T++Q +
Sbjct: 110 RLEGVVTKSKPV--------MIVTEYMENGSLDSFLRKHD----------AQFTVIQLVG 151
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ +AS + YL +H DL N+L++++++ V DFGL RV ++ + +
Sbjct: 152 MLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-T 207
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + I + +PE + ++ D++SYGI+L E+++ G++P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 671 IGMGSFGSVYKGAFDQDG--TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVK 724
+G G+FGSV +G + VAIKV + G K+ + E + + + + +V+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+I C + LV E G L +L +++ + +
Sbjct: 75 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQ 118
Query: 785 VASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
V+ + YL + +H DL NVLL N A + DFGL++ + +
Sbjct: 119 VSMGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-RSAG 173
Query: 844 RGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + + APE + S S D++SYG+ + E ++ G+KP
Sbjct: 174 KWPLKWYAPECINFRKFSSRS---DVWSYGVTMWEALSYGQKP 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 57/267 (21%), Positives = 90/267 (33%), Gaps = 56/267 (20%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNL-QRHGASKSFLAECKALKNIRHRNLVKVIT 727
+G G FG V++ D AIK L R A + + E KAL + H +V+
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIE------------------ 769
+ + + + P + V+I
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 770 ------IQ-----KLTLLQRI---------------NIAIDVASAIDYLHHHCQEPVLHC 803
IQ K L + +I I +A A+++LH ++H
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 804 DLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR--------GTIGYAAPEYG 855
DLKP N+ D + VGDFGL + + GT Y +PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 856 LGSEVSTNGDIYSYGILLLEMVTGKKP 882
G+ S DI+S G++L E++
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 671 IGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRHGAS----KSFLAECKALKNIRHRNLV 723
IG G FG V++G + VAIK ++ S + FL E ++ H ++V
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K+I + ++ E T G L ++L L L I A
Sbjct: 80 KLIGVITENPVW------IIMELCTLGELRSFLQVRK----------YSLDLASLILYAY 123
Query: 784 DVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+++A+ YL +H D+ NVL+ ++ +GDFGL+R ++ + S
Sbjct: 124 QLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS---K 176
Query: 843 VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ I + APE + + S D++ +G+ + E++ G KP
Sbjct: 177 GKLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILMHGVKP 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 51/314 (16%)
Query: 671 IGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKS---FLAECKALKNIRHRNLV 723
+G G FG V + D G +VA+K L+ + + E L+ + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K C LV E++ GSL ++L + + L Q + A
Sbjct: 97 KYKGCCEDAGAASL---QLVMEYVPLGSLRDYL------PR------HSIGLAQLLLFAQ 141
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ + YLH H +H DL NVLLDND + +GDFGLA+ E +
Sbjct: 142 QICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-RED 196
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFE-GDLNLHNYARTA 900
+ + APE + D++S+G+ L E++T + +L +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960
+L + ++++ +RL + +CP + + C R +
Sbjct: 257 VLR-LTELLE-------------RGERLPRPD-----KCPAEVYHLMKNCWETEASFRPT 297
Query: 961 ITNVVHELQSVKNA 974
N++ L++V
Sbjct: 298 FENLIPILKTVHEK 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 49/224 (21%), Positives = 97/224 (43%), Gaps = 41/224 (18%)
Query: 671 IGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLV 723
+G G FG VY+G + + VA+K + + F++E +KN+ H ++V
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K+I ++ E G L ++L + L +L + ++
Sbjct: 77 KLIGIIEEEPTW------IIMELYPYGELGHYLERNK----------NSLKVLTLVLYSL 120
Query: 784 DVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ A+ YL +C +H D+ N+L+ + +GDFGL+R ++ S
Sbjct: 121 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---V 173
Query: 843 VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
R I + +PE + +T D++ + + + E+++ GK+P
Sbjct: 174 TRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/314 (20%), Positives = 124/314 (39%), Gaps = 47/314 (14%)
Query: 671 IGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVI 726
+G G+FGSV + D G +VA+K + F E + LK+++H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C S G L+ E++ GSL ++L +++ ++ + +
Sbjct: 78 GVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTSQIC 124
Query: 787 SAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
++YL +H DL N+L++N+ +GDFGL +V + +
Sbjct: 125 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV-KEPGES 179
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905
I + APE S+ S D++S+G++L E+ T + + +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR------------- 226
Query: 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIE----CPISMVRIGVACSVESPQDRMSI 961
+I + + + K NG++ CP + I C + R S
Sbjct: 227 -------MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 962 TNVVHELQSVKNAL 975
++ + +++ +
Sbjct: 280 RDLALRVDQIRDNM 293
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 671 IGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRHGASKS---FLAECKALKNIRHRNLV 723
+G G FG+V+KG + +G V IKV ++ +S A+ ++ H ++V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+++ C Q LV +++ GSL + + L +N +
Sbjct: 79 RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHR----------GALGPQLLLNWGV 122
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+A + YL H +H +L NVLL + V DFG+A +
Sbjct: 123 QIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--E 176
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ I + A E + + D++SYG+ + E++T G +P
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK- 724
+L+G GSF VY+ G VAIK+ + + + G + E K ++H ++++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 725 --VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+ + LV E NG + +L + E E + + Q
Sbjct: 77 YNYFEDSNYV--------YLVLEMCHNGEMNRYLK--NRVKPFSENEARHF-MHQ----- 120
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA-RVRQEVSNLTQSCSV 841
+ + + YLH H +LH DL N+LL +M + DFGLA +++ C
Sbjct: 121 --IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y +PE S D++S G + ++ G+ P F+ D
Sbjct: 174 ---GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTD 215
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 29/307 (9%), Positives = 70/307 (22%), Gaps = 47/307 (15%)
Query: 632 RRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTI 690
+ + + + + + L + + +G V+ D +
Sbjct: 31 KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFL-VRDVERLED 89
Query: 691 VAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVITSCS----------------- 730
A+KVF + A + + +
Sbjct: 90 FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 731 SIDFQGNDFKA----LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ +D+ L+ + LE V + +L + +
Sbjct: 150 QLSPGQDDYAVANYLLLMPAAS-VDLELLFST----LDFVYVFRGDEGILALHILTAQLI 204
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
L ++H P N+ + D +GD +
Sbjct: 205 RLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-------VP 254
Query: 847 IGYAAPEY--GLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
+ YA E+ + + + + G+ + + P F +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLR 310
Query: 905 VIDIVDP 911
V
Sbjct: 311 VPGTDSL 317
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 72/324 (22%), Positives = 131/324 (40%), Gaps = 23/324 (7%)
Query: 240 SIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299
++P + ++ ++ N F +L + N + + E +
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AF 76
Query: 300 ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLG 358
N NLRTL +N+L+ LS L L ++ N++ + + +L L L
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLS-NLTKLDISENKIV-ILLDYMFQDLYNLKSLE 134
Query: 359 MGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNNNSLSGVI 416
+G N I L +LE + L L+ IP+ +L +L L L L + +++ +
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 417 PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK-IGNLKYL 475
L +L +L + T+ L+ SL++ +L ++P + +L YL
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYL 250
Query: 476 RVFNVSSNNLSGEIPSQL--GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNL 533
R N+S N +S I + L L+EI + G P + L + +++S N L
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLR-LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308
Query: 534 SGLIPKFLEDL-SLEYLNLSFNDL 556
+ L + +LE L L N L
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 58/313 (18%), Positives = 124/313 (39%), Gaps = 16/313 (5%)
Query: 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRN 114
+ R ++L N I+ EF LE L L++N + + + L L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 115 KLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPNSL 172
+L IP F+ L L +L + N + + ++ +L +L+S+ + N +
Sbjct: 91 RL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148
Query: 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV 232
L L+ L L NL+ I ++ +L L + + ++ L L++ ++
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEI 207
Query: 233 HHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292
H + ++ + L + + + + + L + N++YN + + E
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG-- 265
Query: 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNL 351
+ L L+ + +L P++ L+ L+ L ++ NQL ++ + ++
Sbjct: 266 ----SMLHELLRLQEIQLVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSV 319
Query: 352 VGLYRLGMGGNQF 364
L L + N
Sbjct: 320 GNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 13/277 (4%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
+ R L N+++ A+ L+ L + N + ++ G NL L LG+
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFP-HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRS 89
Query: 362 NQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
N+ IP + L NL + + +N++ + +L L L + +N L +
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148
Query: 421 GSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFN 479
L L L L + L +IP E +L L L L ++ L L+V
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLI-VLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 480 VSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPS-SLSSLRAVLAIDLSRNNLSGLIP 538
+S + L + + ++P ++ L + ++LS N +S +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 539 KFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISV 574
L +L L+ + L L V F ++ + V
Sbjct: 266 SMLHELLRLQEIQLVGGQLA-VVE-PYAFRGLNYLRV 300
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 67/343 (19%), Positives = 123/343 (35%), Gaps = 30/343 (8%)
Query: 177 ELKSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQ 231
+ +++ + IP L L N ++ +++F PHL +
Sbjct: 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFAS---------FPHLEELE 62
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN-FGGMKNLSYFNVAYNNLGSGES 290
++ N S P + +N L + N + + F G+ NL+ +++ N +
Sbjct: 63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLD 121
Query: 291 DEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-G 349
+ NL++L N L + + L+ L+ L + L SIP+
Sbjct: 122 Y------MFQDLYNLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKCNLT-SIPTEALS 173
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
+L GL L + +L L+ + + + + L+ L + +
Sbjct: 174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITH 233
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTK 468
+L+ V + L L L+L N ++ TI + L L + L L +
Sbjct: 234 CNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRL-QEIQLVGGQL-AVVEPY 290
Query: 469 I-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510
L YLRV NVS N L+ S LE + + N
Sbjct: 291 AFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 14/234 (5%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
++P GI L +G N+ E +LE + L +N +S P + NL L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHL 461
L L +N L + L L L + EN + + + +F +L L SL + N L
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL-KSLEVGDNDL 140
Query: 462 VGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQL--GLCSYLEEIYMRGNFFHGSIPSSLS 518
V I + L L + NL+ IP++ L L + +R + S
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHG-LIVLRLRHLNINAIRDYSFK 197
Query: 519 SLRAVLAIDLSRNNLSGLI-PKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISR 571
L + +++S + P L L+L L+++ +L VP ++
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY-LAVRHLVY 249
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 64/313 (20%), Positives = 107/313 (34%), Gaps = 62/313 (19%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDN 90
+ L LRS L + + LS L ++++ N I + F L+ L++L + DN
Sbjct: 80 FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 91 DLVGEIPAN-LSYCSRLTILFLGRNKLMGSIPFE-FFSLYKLKQLAMQRNNLTGGIPPFI 148
DLV I S + L L L + L SIP E L+ L L ++ N+
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
L L+ + ++ + + + L SL + NL+ +VP
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT----------------AVP 240
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN 268
L +LR + +N + IE +
Sbjct: 241 YLAVRH---------LVYLRFLNLSYN--------------PISTIEG--SMLH------ 269
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328
+ L + L E + + LR L + N+L L S+ +
Sbjct: 270 --ELLRLQEIQLVGGQLAVVEPY------AFRGLNYLRVLNVSGNQLT-TLEESVFHSVG 320
Query: 329 QLQNLIMTSNQLH 341
L+ LI+ SN L
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 6/92 (6%)
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540
+P G+ + + + N +S + ++L+ N +S + P
Sbjct: 19 HRKRFV-AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 541 LEDL-SLEYLNLSFNDLEGEVPTKGVFANISR 571
+L +L L L N L+ +P GVF +S
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIP-LGVFTGLSN 105
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 36/226 (15%)
Query: 669 HLIGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+IG G FG VY G D A+K N FL E +K+ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
++ ++ C +G+ +V +M +G L N++ + T+ I
Sbjct: 88 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNET----------HNPTVKDLIGF 133
Query: 782 AIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ VA + YL +H DL N +LD V DFGLAR + +
Sbjct: 134 GLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 841 VGVRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + + + A E + S D++S+G+LL E++T G P
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKS---DVWSFGVLLWELMTRGAPP 232
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 79/503 (15%), Positives = 166/503 (33%), Gaps = 59/503 (11%)
Query: 24 GITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLE 83
G + ++++ ++ L+ + ++L NSI + L L
Sbjct: 23 GSMTPFSNELESMVDYSNRNLT---HVPKDLPPRTKALSLSQNSISELRMPDISFLSELR 79
Query: 84 ALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG 142
L LS N + + ++ + L L + N+L +I + L+ L + N+
Sbjct: 80 VLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDV 135
Query: 143 -GIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKS-LGLGANNLSGIIPPSIYNLS 200
+ GNLT L + L+A F + L L L + ++ G S+ +
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195
Query: 201 L------LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNA------ 248
S+ Q + S+ L L +++L + +
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 249 --------------------SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG 288
+E++ + + + ++ + ++ ++
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV--- 312
Query: 289 ESDEMSFMNSLA--NCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPS 346
++ F + + + + + + L T N S+
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 347 GIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL----SGEIPSSLGNLSIL 402
G L L L + N K +N+ + D L S + +
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462
L L++N L+G + CL ++ +L L N + +IP+++ +L L LN+A N L
Sbjct: 431 LVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQAL-QELNVASNQLK 486
Query: 463 GSIPTKI-GNLKYLRVFNVSSNN 484
S+P + L L+ + N
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 92/487 (18%), Positives = 166/487 (34%), Gaps = 47/487 (9%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNL 140
+AL LS N + ++S+ S L +L L N++ S+ F F L+ L + N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 141 TGGIPPFIGNLTSLESISLAANAFGGNIPNS--LGQLKELKSLGLGANNLSGIIPPSIYN 198
I + SL + L+ N F +P G L +L LGL A + + +
Sbjct: 113 QN-ISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 199 LSLLANFSVPRNQF--HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEF--I 254
L L + G L L ++ FS + +S++ L+ I
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 255 EALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANK 314
+ D + ++ + + NV ++ + + + L
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYL------ 281
Query: 315 LRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK 374
+ NL +T L L + F +
Sbjct: 282 --------------NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327
Query: 375 LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
+ L + + S + L N + + +LK+L L L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 435 GLNGTIPEEIF------NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488
GL + +L L SLN +H ++ L N+SSN L+G
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL---NLSSNMLTGS 443
Query: 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLE 547
+ L ++ + + N SIP ++ L+A+ ++++ N L + + L SL+
Sbjct: 444 VFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500
Query: 548 YLNLSFN 554
Y+ L N
Sbjct: 501 YIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 36/215 (16%), Positives = 70/215 (32%), Gaps = 9/215 (4%)
Query: 27 CGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALF 86
+ + + +++++ S + + L + L
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 87 LSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT----G 142
+ N + S RL L L RN L + + L +L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 143 GIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL 202
S+ ++L++N G++ L ++K L L N + IP + +L L
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQAL 475
Query: 203 ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
+V NQ S+P + L L+ +H N +
Sbjct: 476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 47/337 (13%), Positives = 101/337 (29%), Gaps = 66/337 (19%)
Query: 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLF---RLEALFLSDNDLV 93
LN + + + L + L + + + + F +E L + + +
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 94 GEIP-ANLSYCSR----LTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI 148
I +Y L I + + S + ++ + ++
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
+ +S ++ N F ++ LK L++L L N L + +
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK----------NFFKVALMT 399
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN 268
+N + L V N + S
Sbjct: 400 KN-------------MSSLETLDVSLNSLN-----------------------SHAYDRT 423
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328
+++ N++ N L + ++ L N++ ++P + +L
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCLP--------PKVKVLDLHNNRIM-SIPKDVTHLQ- 473
Query: 329 QLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQF 364
LQ L + SNQL S+P G+ L L + + N +
Sbjct: 474 ALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 80/444 (18%), Positives = 152/444 (34%), Gaps = 55/444 (12%)
Query: 52 IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111
L+ L ++ N+SI ++ +L L L + N++ + LS + LT L
Sbjct: 38 EEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPN- 170
NKL ++ L KL L N LT + + L ++ A N +
Sbjct: 93 DSNKL-TNLDVT--PLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARN----TLTEI 142
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230
+ +L L N I + + L N+ L S L
Sbjct: 143 DVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELDVS---QNKLLNRL 196
Query: 231 QVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGES 290
N + + L+ +L F++ N + ++ + L+YF+ + N L
Sbjct: 197 NCDTNNITK---LDLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTE--- 247
Query: 291 DEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350
++ S L TL L I +L+ Q + + + +
Sbjct: 248 ------LDVSTLSKLTTLHCIQTDL-----LEI-DLTHNTQLIYFQAEGCRKIKELDVTH 295
Query: 351 LVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
LY L T + + + L + L + +L+ E+ + + + L L N
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNA 349
Query: 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLN---LARNHLVGSIPT 467
+ S +G + L E T+P+E L+ +++ L + +I
Sbjct: 350 HIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEP 406
Query: 468 KIGNLKYLRVFNVSSNNLSGEIPS 491
G + ++ NLS + P+
Sbjct: 407 GDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 71/485 (14%), Positives = 146/485 (30%), Gaps = 78/485 (16%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
+ + ++ + + LT L + + E + L +L NN+T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLT--GLTKLICTSNNIT 77
Query: 142 GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201
+ + T+L ++ +N N+ + L +L L N L+
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT------------ 119
Query: 202 LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF 261
L S P L N + I +S+ ++L ++ N
Sbjct: 120 -------------KLDVS---QNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK 160
Query: 262 SGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH 321
KL + L+ + ++N + ++ L L N + L
Sbjct: 161 ITKL--DVTPQTQLTTLDCSFNKITE---------LDVSQNKLLNRLNCDTNNIT-KLD- 207
Query: 322 SIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGM 381
+ QL L +SN+L I + L L N T + + L L +
Sbjct: 208 -LNQNI-QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTL 259
Query: 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIP 441
L EI L + + L + + QL +L G+ +
Sbjct: 260 HCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD 313
Query: 442 EEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE 501
+ L L L L + + + L+ + + ++ + S +G L
Sbjct: 314 --LSQNPKLVY-LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNN 365
Query: 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSG----LIPKFLEDLSLEYLNLSFNDLE 557
+ +L++ +A+ + G + P +++ +L
Sbjct: 366 NFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS 425
Query: 558 GEVPT 562
+ P
Sbjct: 426 TDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 66/429 (15%), Positives = 130/429 (30%), Gaps = 52/429 (12%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117
+Q +L L +L ++ + ++ + + LT L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKE 177
+ L LA N LT + + LT L ++ N + Q
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
L L N L+ I + + + L N+ L + L N
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLDVT---PQTQLTTLDCSFNKI 182
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
+ + +S L + N+ + ++ L++ + + N L
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTE---------I 227
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
+ + L + N L L ++ LS +L L L I + + L
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELD--VSTLS-KLTTLHCIQTDLL-EID--LTHNTQLIYF 280
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP 417
G + + ++ L + ++ E+ L L L LNN L+ +
Sbjct: 281 QAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334
Query: 418 SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRV 477
+ +L L + + + L+N A + ++P + L
Sbjct: 335 --VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNN-NFEAEGQTI-TMPKETLTNNSL-T 387
Query: 478 FNVSSNNLS 486
VS + L
Sbjct: 388 IAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 64/439 (14%), Positives = 140/439 (31%), Gaps = 54/439 (12%)
Query: 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
+T L+ + ++ ++ I L+ L ++ +N+I + + L L N L
Sbjct: 43 TLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
+ ++ ++LT L NKL + L L RN LT I + + T
Sbjct: 98 T-NLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLTE-ID--VSHNT 148
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
L + N + + +L +L N ++ + + LL + N
Sbjct: 149 QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI 203
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
L + L N + I ++ ++L + + N + ++ +
Sbjct: 204 T-KLDLN---QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT---ELDVSTL 253
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSL-------------ANCSNLRTLIFAANKLRGAL 319
L+ + +L + + + + + L L A + L
Sbjct: 254 SKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL 312
Query: 320 PHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLE 379
++ +L L + + +L + + + L L +GK+ L
Sbjct: 313 D--LSQNP-KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALN 364
Query: 380 GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSG---VIPSCLGSLKQLAILHLFENGL 436
+ Q +L N S+ + + G I G + A + L
Sbjct: 365 NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424
Query: 437 NGTIPEEIFNLTYLSNSLN 455
+ P + T + ++
Sbjct: 425 STDNPAVTYTFTSENGAIV 443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 65/317 (20%), Positives = 126/317 (39%), Gaps = 53/317 (16%)
Query: 671 IGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNIRHRNLV 723
+G G+FGSV + D G +VA+K +H + F E + LK+++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K C S G L+ E++ GSL ++L +++ ++ +
Sbjct: 106 KYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTS 152
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ ++YL +H DL N+L++N+ +GDFGL +V + +
Sbjct: 153 QICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV-KEP 207
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902
I + APE S+ S D++S+G++L E+ T + + +
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---------- 257
Query: 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE----CPISMVRIGVACSVESPQDR 958
+I + + + K NG++ CP + I C + R
Sbjct: 258 ----------MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307
Query: 959 MSITNVVHELQSVKNAL 975
S ++ + +++ +
Sbjct: 308 PSFRDLALRVDQIRDQM 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 36/270 (13%), Positives = 78/270 (28%), Gaps = 49/270 (18%)
Query: 670 LIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQRHGAS---KSFLAECKALKNIRH------ 719
++G + + A DQ G + V S K E L+ +R
Sbjct: 85 VLGQEDPYAYLE-ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 720 -RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL----- 773
+ ++ I + V + + + Q +++ + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 774 -----TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828
R+ + + V + LHH+ ++H L+P +++LD + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 829 RQEVSNLTQSCSVGVRGTIGYAAPEY----------GLGSEVSTNGDIYSYGILLLEMVT 878
+ G+A PE + ++ D ++ G+ + +
Sbjct: 261 DGASAV--------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 879 GKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
P D L + +I
Sbjct: 313 ADLP----NTDDAALGGSE--WIFRSCKNI 336
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 66/329 (20%), Positives = 119/329 (36%), Gaps = 82/329 (24%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G FG VYKG A + VAIK + A F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLL 776
+V ++ + + ++++ + ++G L +L H D D L
Sbjct: 74 VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 777 QRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
+++ +A+ ++YL HH +H DL NVL+ + + + D GL R ++
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADY 183
Query: 836 TQSCSVG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFE 888
+ +R APE YG S + DI+SYG++L E+ + G +P
Sbjct: 184 YKLLGNSLLPIRWM----APEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP------ 230
Query: 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE----CPISMV 944
Y +N+ + + + CP +
Sbjct: 231 -------Y-----------------------CGYSNQDVVEMIRNRQVLPCPDDCPAWVY 260
Query: 945 RIGVACSVESPQDRMSITNVVHELQSVKN 973
+ + C E P R ++ L++ N
Sbjct: 261 ALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 48/248 (19%), Positives = 93/248 (37%), Gaps = 49/248 (19%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLA--------------ECKA 713
+ G F + ++D A+K + L++ E +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 714 LKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI 770
+ +I++ + +IT+ + + ++YE+M N S+ + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEV------Y--IIYEYMENDSILKFDEYF---FVLDKNYT 145
Query: 771 QKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
+ + I V ++ Y+H+ + H D+KP N+L+D + + DFG +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG---DIYSYGILLLEMVTGKKPTDVMF 887
+ + S GT + PE+ +E S NG DI+S GI L M P F
Sbjct: 204 D-KKIKGSR-----GTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFYNVVP----F 252
Query: 888 EGDLNLHN 895
++L
Sbjct: 253 SLKISLVE 260
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 36/226 (15%)
Query: 669 HLIGMGSFGSVYKGAF---DQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+IG G FG VY G D A+K N FL E +K+ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
++ ++ C +G+ +V +M +G L N++ + T+ I
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNET----------HNPTVKDLIGF 197
Query: 782 AIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ VA + +L +H DL N +LD V DFGLAR + +
Sbjct: 198 GLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 841 VGVRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + + + A E +T D++S+G+LL E++T G P
Sbjct: 254 TGAKLPVKWMALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G GSFG VY+G D+ T VAIK N AS FL E +K +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V+++ S QG ++ E MT G L+++L P + +L + I +
Sbjct: 90 VVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPSLSKMIQM 143
Query: 782 AIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A ++A + YL+ + +H DL N ++ D +GDFG+ R E ++ +
Sbjct: 144 AGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGG 198
Query: 841 VG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G VR +PE G+ +T D++S+G++L E+ T ++P
Sbjct: 199 KGLLPVRWM----SPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 671 IGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNL 722
+G G+FG+VYKG + +G VAIK R S L E + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPHV 79
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+++ C + Q L+ + M G L +++ + +N
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYVREHK----------DNIGSQYLLNWC 123
Query: 783 IDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ +A ++YL +H DL NVL+ + DFGLA++ +
Sbjct: 124 VQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-- 177
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
G + I + A E L + D++SYG+ + E++T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 75/410 (18%), Positives = 130/410 (31%), Gaps = 44/410 (10%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKL 116
+ ++L NSI F RL L+ L + I N S L IL L N+
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 117 MGSIPFEFF-SLYKLKQLAMQRNNLTGG-IPPFI-GNLTSLESISLAANAFGGNIPNSL- 172
+ F L L+ L + + NL G + LTSLE + L N P S
Sbjct: 92 -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV 232
++ L L N + I + N L L + L +
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF---------------TLLRLSSITLQDM 195
Query: 233 HHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292
+ + + + + ++ N F ++ F + +
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNL 351
+ + N A+ + + ++ +++ ++ + +
Sbjct: 256 FGH-TNFKDPDNFTFKGLEASGV---------------KTCDLSKSKIF-ALLKSVFSHF 298
Query: 352 VGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
L +L + N+ I L +L + L N L NL L L L+ N
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357
Query: 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARN 459
+ + L L L L N L ++P+ IF LT L + L N
Sbjct: 358 HIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK-IWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 67/412 (16%), Positives = 137/412 (33%), Gaps = 61/412 (14%)
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
+ + L N+++ + S L L V + + + L L + ++ +N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
+ F G+ NL + NL F
Sbjct: 92 L-QLETGA-----------------------FNGLANLEVLTLTQCNLDGAVLSGNFF-- 125
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI--------- 348
++L L+ N ++ P S + L +T N++ SI
Sbjct: 126 --KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHF 182
Query: 349 --GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELL 406
L + M K ++ + L N + + +++
Sbjct: 183 TLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 407 LNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP 466
S S + S G + GL + + +L+++ + ++
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS------GVKTC----DLSKSKI-FALL 291
Query: 467 TKI-GNLKYLRVFNVSSNNLSGEIPSQL--GLCSYLEEIYMRGNFFHGSIPS-SLSSLRA 522
+ + L ++ N ++ +I GL ++L ++ + NF GSI S +L
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL-THLLKLNLSQNFL-GSIDSRMFENLDK 348
Query: 523 VLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRIS 573
+ +DLS N++ L + L +L+ L L N L+ VP G+F ++ +
Sbjct: 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVP-DGIFDRLTSLQ 398
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 10/142 (7%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEAL 85
GL V +L + +L + + + L ++ L N I +I F L L L
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 86 FLSDNDLVGEIPANL-SYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGG 143
LS N L G I + + +L +L L N + ++ + F L LK+LA+ N L
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKS- 385
Query: 144 IPPFI-GNLTSLESISLAANAF 164
+P I LTSL+ I L N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/325 (22%), Positives = 129/325 (39%), Gaps = 73/325 (22%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG V+ + +D +VA+K A K F E + L N++H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTLLQRIN 780
C G+ +V+E+M +G L +L + +L L Q ++
Sbjct: 83 YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 781 IAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
IA +AS + YL H +H DL N L+ +++ +GDFG++R T
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYY 189
Query: 840 SVGVRGT--IGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNL 893
VG I + PE Y +T D++S+G++L E+ T GK+P
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQP----------- 235
Query: 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIE----CPISMVRIGVA 949
+ + +N + + +E CP + + +
Sbjct: 236 --W-----------------------FQLSNTEVIECITQGRVLERPRVCPKEVYDVMLG 270
Query: 950 CSVESPQDRMSITNVVHELQSVKNA 974
C PQ R++I + L ++ A
Sbjct: 271 CWQREPQQRLNIKEIYKILHALGKA 295
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 671 IGMGSFGSVYKGAFDQDG--TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLVK 724
+G G+FGSV +G + VAIKV + G K+ + E + + + + +V+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+I C + LV E G L +L +++ + +
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQ 444
Query: 785 VASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
V+ + YL + +H +L NVLL N A + DFGL++ + +
Sbjct: 445 VSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA-RSAG 499
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + + APE + S+ D++SYG+ + E ++ G+KP
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G FG+VY Q I+A+KV L++ G E + ++RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
F L+ E+ G++ L ++ K + ++
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTVYREL-----------QKLSKFDEQRTATYITEL 118
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A+A+ Y H V+H D+KP N+LL + + DFG + V S T C G
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC-----G 169
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y PE G D++S G+L E + GK P FE +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEAN 210
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 35/270 (12%), Positives = 74/270 (27%), Gaps = 48/270 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVI 726
++G + + + G + V A K E L+ +R K
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 727 TSCSSIDFQGNDFKAL-------VYEFMTNGSLENWLHPDAVPQKDVEIEIQKL------ 773
F + K V + + + Q +++ + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 774 ----TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829
R+ + + V + LHH+ ++H L+P +++LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-----------DIYSYGILLLEMVT 878
S + G+ PE + D ++ G+++ +
Sbjct: 255 -RDGARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 879 GKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
P D L + +I
Sbjct: 309 ADLP----ITKDAALGGSEW--IFRSCKNI 332
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 671 IGMGSFGSVYKG-AFDQDG----TIVAIKVFNLQRHGASKS----FLAECKALKNI-RHR 720
+G G+FG V + AF VA+K+ + A ++E K + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQHE 110
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---PDAVPQKDVEIEIQKLTLLQ 777
N+V ++ +C+ G ++ E+ G L N+L I +
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 778 RINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN-- 834
++ + VA + +L +C +H D+ NVLL N +A +GDFGLAR SN
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + + V+ APE + D++SYGILL E+ + G P
Sbjct: 222 VKGNARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS-FLAECKALKNI-RHRNLV 723
+G G+FG V + VA+K+ H + ++E K L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-------HPDAVPQKDVEIEIQKLTLL 776
++ +C+ G ++ E+ G L N+L +E + L L
Sbjct: 91 NLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 777 QRINIAIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN- 834
++ + VA + +L +C +H DL N+LL + I + DFGLAR + SN
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 835 -LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ + + V+ APE + D++SYGI L E+ + G P
Sbjct: 202 VVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVK---V 725
IG G++G+V+K + IVA+K L G S L E LK ++H+N+V+ V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT--LLQRINIAI 783
+ S + LV+EF L+ + D+ ++ LL+
Sbjct: 70 LHSDKKL--------TLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLK------ 112
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVG 842
+ + H VLH DLKP N+L++ + + +FGLAR V +
Sbjct: 113 ----GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-- 163
Query: 843 VRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y P+ G+++ ST+ D++S G + E+ +P +F G+
Sbjct: 164 ---TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV 725
+G G+FG V+ +QD +VA+K A + F E + L ++H+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWL----HPDAVPQKDVEIEIQKLTLLQRINI 781
C+ +G +V+E+M +G L +L + ++ L L Q + +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 782 AIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
A VA+ + YL H +H DL N L+ ++ +GDFG++R ++ +
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGG 218
Query: 841 VG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+R PE Y +T D++S+G++L E+ T GK+P
Sbjct: 219 RTMLPIRWM----PPESILYRK---FTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 36/232 (15%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNI-RHR 720
+G G+FG V + VA+K+ GA+ S ++E K L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKLTL 775
N+V ++ +C+ + ++ EF G+L +L ++ LTL
Sbjct: 92 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 776 LQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
I + VA +++L C +H DL N+LL + + DFGLAR + +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 835 LTQSCSVG---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ ++ APE + D++S+G+LL E+ + G P
Sbjct: 204 YVRK-GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-25
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 671 IGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRHGASKS----FLAECKALKNIRHRNLV 723
IG G FG V++G + VAIK ++ S S FL E ++ H ++V
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K+I + ++ E T G L ++L L L I A
Sbjct: 455 KLIGVITENPVW------IIMELCTLGELRSFLQVRK----------FSLDLASLILYAY 498
Query: 784 DVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
+++A+ YL +H D+ NVL+ ++ +GDFGL+R ++ + S
Sbjct: 499 QLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS---K 551
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ I + APE ++ D++ +G+ + E++ G KP
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 48/230 (20%), Positives = 88/230 (38%), Gaps = 45/230 (19%)
Query: 671 IGMGSFGSVYKGAFDQDG-------TIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLV 723
+G G+F ++KG + G T V +KV + S+SF + + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
C D LV EF+ GSL+ +L + + +L ++ +A
Sbjct: 76 LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNK----------NCINILWKLEVAK 120
Query: 784 DVASAIDYL-HHHCQEPVLHCDLKPGNVLLD--------NDMIAHVGDFGLARVRQEVSN 834
+A+A+ +L + +H ++ N+LL N + D G++
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--- 173
Query: 835 LTQSCSVGVRGTIGYAAPE-YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ PE ++ D +S+G L E+ + G KP
Sbjct: 174 -KDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 55/224 (24%), Positives = 87/224 (38%), Gaps = 32/224 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVI 726
+G G FG+VY Q+ I+A+KV L++ G E + ++RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
F L+ EF G L L QK + + ++A
Sbjct: 81 NY-----FHDRKRIYLMLEFAPRGELYKEL------QKH-----GRFDEQRSATFMEELA 124
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
A+ Y H V+H D+KP N+L+ + DFG + V C GT
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMC-----GT 175
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ Y PE G D++ G+L E + G P F+
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSP 215
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G G FG V K T VA+K+ + AS S L+E LK + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-------------HPDAVPQKDVEI 768
++K+ +CS Q L+ E+ GSL +L
Sbjct: 88 VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 769 EIQKLTLLQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827
+ + LT+ I+ A ++ + YL +H DL N+L+ + DFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 828 VRQEVSNLTQSCSVG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GK 880
E + + S G V+ A E + +T D++S+G+LL E+VT G
Sbjct: 199 DVYEEDSYVKR-SQGRIPVKWM----AIESLFDHI---YTTQSDVWSFGVLLWEIVTLGG 250
Query: 881 KP 882
P
Sbjct: 251 NP 252
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 669 HLIGMGSFGSVYKGAFDQDG--TIVAIKVFNLQRHGASKS----FLAECKALKNI-RHRN 721
+IG G+FG V K +DG AIK + ASK F E + L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKLTLL 776
++ ++ +C + L E+ +G+L ++L V + D I L+
Sbjct: 88 IINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 777 QRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
Q ++ A DVA +DYL +H DL N+L+ + +A + DFGL+R ++
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
T + VR A E S +TN D++SYG+LL E+V+ G P
Sbjct: 199 TMG-RLPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 45/248 (18%), Positives = 88/248 (35%), Gaps = 60/248 (24%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNI-RHRN 721
F IG G FGSV+K DG I AIK G+ ++ L E A + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRIN 780
+V+ ++ + +D + E+ GSL + + + E E++ +
Sbjct: 73 VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--------D 119
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-------------------MIAHVG 821
+ + V + Y+H ++H D+KP N+ + ++ +G
Sbjct: 120 LLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE-------YGLGSEVSTNGDIYSYGILLL 874
D G + Q G + A E + + DI++ + ++
Sbjct: 177 DLGHVTRI----SSPQVE----EGDSRFLANEVLQENYTHLPKA------DIFALALTVV 222
Query: 875 EMVTGKKP 882
+
Sbjct: 223 CAAGAEPL 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 44/232 (18%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G G+FG VY+G D VA+K S+ FL E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQN 94
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V+ I Q ++ E M G L+++L + P+ + L +L +++
Sbjct: 95 IVRCIGVSL----QSLPR-FILMELMAGGDLKSFLR-ETRPRPS---QPSSLAMLDLLHV 145
Query: 782 AIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDN---DMIAHVGDFGLARVRQEVSNLTQ 837
A D+A YL +H +H D+ N LL +A +GDFG+AR ++ +
Sbjct: 146 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-ASYYR 200
Query: 838 SCSVG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
V+ PE G+ ++ D +S+G+LL E+ + G P
Sbjct: 201 KGGCAMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 51/314 (16%), Positives = 100/314 (31%), Gaps = 41/314 (13%)
Query: 636 PSKQQPSRPILRKALQKVSYESLFK-ATDGFSSTHLIGMGSFGSVYKGAFD-----QDGT 689
P P+ + L + ++ F+ + HL+G G+F VY+ ++
Sbjct: 37 PVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQ 96
Query: 690 IVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTN 749
+KV + LK +K ++ + LV E +
Sbjct: 97 KFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSY 151
Query: 750 GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGN 809
G+L N + + + I+ A+ + I+ +H ++H D+KP N
Sbjct: 152 GTLLNAI------NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202
Query: 810 VLLDNDMIAHVG-----------DFGLA---RVRQEVSNLTQSCSVGVRGTIGYAAPEYG 855
+L N + D G + ++ + + T C T G+ E
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-----ETSGFQCVEML 257
Query: 856 LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH-NYARTALLDHVIDIVDPIL- 913
+ D + + M+ G G+ + R LD + +L
Sbjct: 258 SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN 317
Query: 914 INDVEDWDATNKQR 927
I D + + R
Sbjct: 318 IPDCHHLPSLDLLR 331
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 669 HLIGMGSFGSVYKG-------AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNI 717
+G G+FG V T VA+K+ A++ ++E + +K I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131
Query: 718 -RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQ 771
+H+N++ ++ +C+ Q ++ E+ + G+L +L +
Sbjct: 132 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 772 KLTLLQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830
+L+ ++ A VA ++YL C +H DL NVL+ D + + DFGLAR
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 831 EVSNLTQSCSVG---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
+ ++ + G V+ APE + D++S+G+LL E+ T G P
Sbjct: 243 HIDYYKKT-TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 35/233 (15%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRN 721
+ + +G G++ +VYKG +VA+K L+ GA + + E LK+++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 722 LVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
+V +I + S+ LV+E++ L+ +L + KL L Q
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHNV---KLFLFQL 109
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ + Y H VLH DLKP N+L++ + DFGLAR + + T
Sbjct: 110 L-------RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYD 158
Query: 839 CSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
V V T+ Y P+ LGS ST D++ G + EM TG +P +F G
Sbjct: 159 NEV-V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/234 (21%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 671 IGMGSFGSVYKG-------AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNI-R 718
+G G+FG V ++ VA+K+ + A++ ++E + +K I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 99
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKL 773
H+N++ ++ +C+ Q ++ E+ + G+L +L + +++
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 774 TLLQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
T ++ +A ++YL C +H DL NVL+ + + + DFGLAR +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 833 SNLTQSCSVG---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
++ + G V+ APE + D++S+G+L+ E+ T G P
Sbjct: 211 DYYKKT-TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 75/227 (33%), Positives = 108/227 (47%), Gaps = 39/227 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVK---V 725
+G G++G VYK A D G IVA+K L G + + E LK + H N+V V
Sbjct: 29 VGEGTYGVVYK-AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
I S + LV+EFM L+ L D + +I+ L Q +
Sbjct: 88 IHSERCL--------TLVFEFMEK-DLKKVL--DENKTGLQDSQIKIY-LYQ-------L 128
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVGVR 844
+ + H H +LH DLKP N+L+++D + DFGLAR V + T V
Sbjct: 129 LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV-V--- 181
Query: 845 GTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y AP+ +GS+ ST+ DI+S G + EM+TG KP +F G
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 36/228 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNL-QRHGASKSFLAECKALKNIRHRNLVK---VI 726
+G G++ +VYKG G VA+K L G + + E +K ++H N+V+ VI
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWL--HPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + + LV+EFM N L+ ++ + +E+ + K Q
Sbjct: 73 HTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ------- 116
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVGV 843
+ + + H + +LH DLKP N+L++ +GDFGLAR V+ + V
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV-V-- 170
Query: 844 RGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y AP+ +GS ST+ DI+S G +L EM+TG KP +F G
Sbjct: 171 --TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---LFPGT 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 50/238 (21%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLA-ECKALKNIRHRNLVK- 724
L+G GS+G V + + A+K+ L+R ++ + E + L+ +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 725 --VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V+ + +V E+ G E + D+VP+K Q ++
Sbjct: 72 VDVLYNEEKQKM------YMVMEYCVCGMQE--ML-DSVPEKRFP-VCQAHGYFCQL--- 118
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSC 839
++YLH ++H D+KPGN+LL + G+A + S
Sbjct: 119 ---IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 840 SVGVRGTIGYAAPE-------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
G+ + PE + G +V DI+S G+ L + TG P FEGD
Sbjct: 173 -----GSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYP----FEGD 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 42/238 (17%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGAS----KSFLAECKALKNI-RHR 720
+G G+FG V + VA+K+ + A ++ ++E K + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHE 109
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL------------HPDAVPQKDVEI 768
N+V ++ +C+ L++E+ G L N+L + + + E
Sbjct: 110 NIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 769 EIQKLTLLQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827
++ LT + A VA +++L C +H DL NVL+ + + + DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 828 VRQEVSN--LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
SN + + + V+ APE + D++SYGILL E+ + G P
Sbjct: 221 DIMSDSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 38/227 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITS 728
IG GS+G V+K G IVAIK F K L E + LK ++H NLV ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 729 CSSID-FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT--LLQRINIAIDV 785
+ F+ LV+E+ + ++ + L D + E ++ +T LQ
Sbjct: 69 ----EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQ-------- 113
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVGVR 844
A+++ H H +H D+KP N+L+ + + DFG AR+ +
Sbjct: 114 --AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---- 164
Query: 845 GTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T Y +PE +G D+++ G + E+++G P ++ G
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VP---LWPGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 70/229 (30%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVK---V 725
IG G++G VYK A + G A+K L+ G + + E LK ++H N+VK V
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT--LLQRINIAI 783
I + + LV+E + L+ L D + + LL
Sbjct: 69 IHTKKRL--------VLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLN------ 111
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ-EVSNLTQSCSVG 842
I Y H VLH DLKP N+L++ + + DFGLAR V T V
Sbjct: 112 ----GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-V- 162
Query: 843 VRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y AP+ +GS+ ST DI+S G + EMV G P +F G
Sbjct: 163 ---TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 50/234 (21%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 671 IGMGSFGSVYKG-------AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNI-R 718
+G G FG V ++ VA+K+ + A++ ++E + +K I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-----HPDAVPQKDVEIEIQKL 773
H+N++ ++ +C+ Q ++ E+ + G+L +L + +++
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 774 TLLQRINIAIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
T ++ +A ++YL C +H DL NVL+ + + + DFGLAR +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 833 SNLTQSCSVG---VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
++ + G V+ APE + D++S+G+L+ E+ T G P
Sbjct: 257 DYYKKT-TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 44/232 (18%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
+G G+FG VY+G D VA+K S+ FL E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V+ I Q ++ E M G L+++L + P+ L +L +++
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGDLKSFLR-ETRPRPSQP---SSLAMLDLLHV 186
Query: 782 AIDVASAIDYL-HHHCQEPVLHCDLKPGNVLLDN---DMIAHVGDFGLARVRQEVSNLTQ 837
A D+A YL +H +H D+ N LL +A +GDFG+AR + +
Sbjct: 187 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-AGYYR 241
Query: 838 SCSVG---VRGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
V+ PE G+ ++ D +S+G+LL E+ + G P
Sbjct: 242 KGGCAMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
++ IG G+ G+VY G VAI+ NLQ+ + + E ++ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ S + D +V E++ GSL + + + E +I + +
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAA--------VCRE 124
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS--VG 842
A+++LH V+H D+K N+LL D + DFG + +T S
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRST 175
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT + APE DI+S GI+ +EM+ G+ P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 65/267 (24%), Positives = 106/267 (39%), Gaps = 50/267 (18%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTI 690
+ + ++++K YE+L +G GS+G V K G I
Sbjct: 5 HHHHSSGVDLGTENLYFQSMEK--YENLGL----------VGEGSYGMVMKCRNKDTGRI 52
Query: 691 VAIKVFNL--QRHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGNDFKALVYEFM 747
VAIK F K + E K LK +RH NLV ++ + + LV+EF+
Sbjct: 53 VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL------EVCKKKKRWYLVFEFV 106
Query: 748 TNGSLENWLHPDAVPQKDVEIEIQKLT--LLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805
+ ++ + L + P +QK ++ I + H H ++H D+
Sbjct: 107 DH-TILDDL--ELFPNGLDYQVVQKYLFQIIN----------GIGFCHSHN---IIHRDI 150
Query: 806 KPGNVLLDNDMIAHVGDFGLARV-RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STN 863
KP N+L+ + + DFG AR + T Y APE +G
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-----TRWYRAPELLVGDVKYGKA 205
Query: 864 GDIYSYGILLLEMVTGKKPTDVMFEGD 890
D+++ G L+ EM G +P +F GD
Sbjct: 206 VDVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRN 721
D + +IG G+ V VAIK NL++ S L E +A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLEN---WLHPDAVPQKDVEIEIQKLTLLQR 778
+V TS F D LV + ++ GS+ + + + V E
Sbjct: 75 IVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST------- 122
Query: 779 INIAI---DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
IA +V ++YLH + Q +H D+K GN+LL D + DFG V ++
Sbjct: 123 --IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFG---VSAFLATG 174
Query: 836 TQSCSVGVRGT-IG---YAAPE-----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
VR T +G + APE G + DI+S+GI +E+ TG P
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 54/244 (22%)
Query: 671 IGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGASKS----FLAECKALKNIRHRN 721
IG G+FG V++ + T+VA+K+ + AS F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL-------------HPDAVPQKDVEI 768
+VK++ C+ G L++E+M G L +L + +
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 769 EIQKLTLLQRINIAIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827
L+ +++ IA VA+ + YL +H DL N L+ +M+ + DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 828 VRQEVSNLTQSCSVGVRGTIGY-----AAPE---YGLGSEVSTNGDIYSYGILLLEMVT- 878
S PE Y +T D+++YG++L E+ +
Sbjct: 223 N-------IYSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSY 272
Query: 879 GKKP 882
G +P
Sbjct: 273 GLQP 276
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 671 IGMGSFGSVYKGAFD--QDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIR---HRNLV 723
IG G++G V+K A D G VA+K +Q G S + E L+++ H N+V
Sbjct: 19 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
++ C+ LV+E + L +L D VP+ V E K + Q
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQ------ 128
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ +D+LH H V+H DLKP N+L+ + + DFGLAR+ LT V
Sbjct: 129 -LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-V-- 181
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T+ Y APE L S +T D++S G + EM +KP +F G
Sbjct: 182 --TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 43/250 (17%)
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIK----VFNLQRHGASKSFLA 709
+S F + + IG G+ G V A+D VAIK F Q H +K
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCA-AYDAILERNVAIKKLSRPFQNQTH--AKRAYR 73
Query: 710 ECKALKNIRHRNLVK---VITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQK 764
E +K + H+N++ V T S++ +F+ +V E M + L V Q
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-----DANLC--QVIQM 122
Query: 765 DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824
+++ E L Q + I +LH ++H DLKP N+++ +D + DFG
Sbjct: 123 ELDHERMSYLLYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
LAR +T T Y APE LG N DI+S G ++ EM+ G
Sbjct: 173 LARTAGTSFMMTPY-----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG---- 223
Query: 885 VMFEGDLNLH 894
V+F G ++
Sbjct: 224 VLFPGTDHID 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 48/233 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK-- 724
+G+G+FG V G G VA+K+ N ++ E + LK RH +++K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 725 -VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
VI++ + +V E+++ G L +++ + ++ ++ +
Sbjct: 78 QVISTPTDF--------FMVMEYVSGGELFDYI-----------CKHGRVEEMEARRLFQ 118
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ SA+DY H H V+H DLKP NVLLD M A + DFGL+ + + L SC
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---- 171
Query: 844 RGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
G+ YAAPE Y G EV DI+S G++L ++ G P F+ +
Sbjct: 172 -GSPNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLP----FDDE 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 36/231 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASK---------SFLAECKALKNIRH 719
IG+G++G+VYK G VA+K + G + L + L+ H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL---RRLEAFEH 73
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
N+V+++ C++ LV+E + L +L D P + E K + Q
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ-- 128
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
+D+LH +C ++H DLKP N+L+ + + DFGLAR+ LT
Sbjct: 129 -----FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
V T+ Y APE L S +T D++S G + EM +KP +F G+
Sbjct: 181 -V----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP---LFCGN 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 49/228 (21%), Positives = 79/228 (34%), Gaps = 44/228 (19%)
Query: 672 GMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITSC 729
G +V + G V ++ NL+ E K H N+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT- 94
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI---DVA 786
F ++ +V FM GS KD+ I + + + IA V
Sbjct: 95 ----FIADNELWVVTSFMAYGSA-----------KDL-ICTHFMDGMNELAIAYILQGVL 138
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA------RVRQEVSNLTQSCS 840
A+DY+HH +H +K ++L+ D ++ RQ V + S
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 841 VGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
V + + +PE G ++ DIYS GI E+ G P
Sbjct: 196 V---KVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
S IG GS G V G VA+K+ +L++ + E +++ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ S + + ++ EF+ G+L + + + E +I +
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGALTDIVSQVRLN----EEQIAT--------VCEA 149
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
V A+ YLH + V+H D+K ++LL D + DFG + +++ V R
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC------AQISK--DVPKR 198
Query: 845 GT-IG---YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ +G + APE S +T DI+S GI+++EMV G+ P
Sbjct: 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 49/227 (21%), Positives = 99/227 (43%), Gaps = 35/227 (15%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
+ +G G+FG VYK + G + A KV + + ++ E + L H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
++ + + + ++ EF G+++ + + +I++ +
Sbjct: 81 LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV----------VCRQ 125
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ A+++LH + ++H DLK GNVL+ + + DFG++ + + ++ R
Sbjct: 126 MLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS------AKNLK--TLQKR 174
Query: 845 GT-IG---YAAPEYGLGSEVSTNG-----DIYSYGILLLEMVTGKKP 882
+ IG + APE + + DI+S GI L+EM + P
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS-FLAECKALKNIRHRNLV 723
F+ IG GSFG V+KG ++ +VAIK+ +L+ E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
K S + + ++ E++ GS + L P + E +I I
Sbjct: 84 KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGPLD----ETQIA--------TILR 126
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
++ +DYLH E +H D+K NVLL + DFG+A LT +
Sbjct: 127 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA------GQLTD--TQIK 175
Query: 844 RGT-IG---YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
R T +G + APE S + DI+S GI +E+ G+ P
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 665 FSSTHLIGMGSFGS-VYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNL 722
F ++G G+ G+ VY+G FD VA+K + + E + L+ H N+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRINI 781
++ + + F+ + E +L+ + V QKD + ++ +TLLQ
Sbjct: 81 IRYFCT-----EKDRQFQYIAIELCA-ATLQ-----EYVEQKDFAHLGLEPITLLQ---- 125
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-----DMIAHVGDFGLARVRQEVSNLT 836
S + +LH ++H DLKP N+L+ + A + DFGL + +
Sbjct: 126 --QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHS 179
Query: 837 QSCSVGVRGTIGYAAPEY---GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S GV GT G+ APE + DI+S G + +++
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHRNLVK---V 725
IG G+FG V+K + G VA+K + ++ G + L E K L+ ++H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 726 ITSCSSIDFQGNDFKALVYEFMTN---GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+ +S + LV++F + G L N + K +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQM----- 132
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR-----VRQEVSNLTQ 837
+ + + Y+H + +LH D+K NVL+ D + + DFGLAR + + T
Sbjct: 133 --LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT- 186
Query: 838 SCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGK 880
+ V T+ Y PE LG D++ G ++ EM T
Sbjct: 187 NRVV----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 16/243 (6%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFT--GTIPKEMGKLQNLEG 380
+ L + SN+L S+P G+ L L +L + N + G + +L+
Sbjct: 24 TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGT 439
+ L N + + S+ L L L +++L + S SL+ L L +
Sbjct: 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-V 140
Query: 440 IPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQL--GL 495
IF L+ L L +A N + I L+ L ++S L ++ L
Sbjct: 141 AFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 198
Query: 496 CSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL--SLEYLNLSF 553
S L+ + M N F L ++ +D S N++ + L+ SL +LNL+
Sbjct: 199 SS-LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
Query: 554 NDL 556
ND
Sbjct: 258 NDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 58/291 (19%), Positives = 100/291 (34%), Gaps = 52/291 (17%)
Query: 179 KSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
+ + L+ + IP S L L +N S+P F L L +
Sbjct: 10 TEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDK---------LTQLTKLSLS 60
Query: 234 HNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEM 293
N L F S G +L Y ++++N + + S+
Sbjct: 61 SN--------------GLSFKGCCSQSDFG--------TTSLKYLDLSFNGVITMSSN-- 96
Query: 294 SFMNSLANCSNLRTLIFAANKLRGALPHSI-ANLSDQLQNLIMTSNQLHGSIPSGI-GNL 351
L L F + L+ S+ +L L L ++ +GI L
Sbjct: 97 -----FLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-NLIYLDISHTHTR-VAFNGIFNGL 149
Query: 352 VGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNN 409
L L M GN F ++ +L+NL + L QL ++ + +LS L L +++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARN 459
N+ + L L +L N + T ++ + LNL +N
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 47/286 (16%), Positives = 85/286 (29%), Gaps = 37/286 (12%)
Query: 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL-- 116
EI + + +P L L N L ++LT L L N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL-GQL 175
G F LK L + N + + L LE + + S+ L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 176 KELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
+ L L + + LS L + N F + P + L +L +
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295
+ + F + +L N+++NN S ++
Sbjct: 186 QLE-QLSPTA-----------------------FNSLSSLQVLNMSHNNFFSLDT----- 216
Query: 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLH 341
++L+ L ++ N + + + + L L +T N
Sbjct: 217 -FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 26/121 (21%), Positives = 47/121 (38%), Gaps = 8/121 (6%)
Query: 451 SNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNF- 508
+ L S+PT I + L + SN L + L ++ + N
Sbjct: 9 GTEIRCNSKGLT-SVPTGIPSSATRL---ELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 509 -FHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFA 567
F G S ++ +DLS N + + FL LE+L+ ++L+ ++ VF
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 123
Query: 568 N 568
+
Sbjct: 124 S 124
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 69/250 (27%), Positives = 105/250 (42%), Gaps = 43/250 (17%)
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIK----VFNLQRHGASKSFLA 709
+S F + + IG G+ G V A+D VAIK F Q H +K
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTH--AKRAYR 110
Query: 710 ECKALKNIRHRNLVK---VITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQK 764
E +K + H+N++ V T +++ +F+ LV E M + L V Q
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLC--QVIQM 159
Query: 765 DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824
+++ E L Q + I +LH ++H DLKP N+++ +D + DFG
Sbjct: 160 ELDHERMSYLLYQMLC-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
LAR +T T Y APE LG N DI+S G ++ EMV K
Sbjct: 210 LARTAGTSFMMTPY-----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK---- 260
Query: 885 VMFEGDLNLH 894
++F G +
Sbjct: 261 ILFPGRDYID 270
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 47/231 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVK---V 725
IG G+F V G VAIK+ + + + + E + +K + H N+VK V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
I + ++ L+ E+ + G + ++L + ++ + + +
Sbjct: 83 IETEKTL--------YLIMEYASGGEVFDYL-----------VAHGRMKEKEARSKFRQI 123
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
SA+ Y H ++H DLK N+LLD DM + DFG + L C G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----G 175
Query: 846 TIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
YAAPE Y G EV D++S G++L +V+G P F+G
Sbjct: 176 APPYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP----FDGQ 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 69/250 (27%), Positives = 107/250 (42%), Gaps = 38/250 (15%)
Query: 647 RKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS 706
++L ++ +L F L+G G++G VYKG + G + AIKV ++ +
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEE 66
Query: 707 FLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA-LVYEFMTNGSLENWLHPDAVPQK 764
E LK HRN+ + + G D + LV EF GS+
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-----------T 115
Query: 765 DVEIEIQKLTLLQRINIAI---DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821
D+ I+ K L+ IA ++ + +LH H V+H D+K NVLL + +
Sbjct: 116 DL-IKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171
Query: 822 DFGLARVRQEVSNLTQSCSVGVRGT-IG---YAAPEYGLGSEVSTNG-----DIYSYGIL 872
DFG++ + L + +VG R T IG + APE E D++S GI
Sbjct: 172 DFGVS------AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 873 LLEMVTGKKP 882
+EM G P
Sbjct: 224 AIEMAEGAPP 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 52/273 (19%)
Query: 635 GPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK 694
G + + + Q + D F ++G GSF +V AIK
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 695 VFN---LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGS 751
+ + + E + + H VK+ + FQ ++ + NG
Sbjct: 62 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGE 116
Query: 752 LENWLHPDAVPQKDVEIEIQKLTLLQRINI---------AIDVASAIDYLHHHCQEPVLH 802
L L +++I ++ SA++YLH ++H
Sbjct: 117 L--------------------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIH 153
Query: 803 CDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV 860
DLKP N+LL+ DM H+ DFG A+V S ++ S GT Y +PE
Sbjct: 154 RDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFV--GTAQYVSPELLTEKSA 209
Query: 861 STNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
+ D+++ G ++ ++V G P ++F+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 242
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 44/232 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVK---V 725
+G G++G VYK VAIK L+ G + + E LK ++HRN+++ V
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
I + L++E+ N L+ ++ DV + + K L Q +
Sbjct: 102 IHHNHRL--------HLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQ-------L 141
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG-----DFGLARVRQ-EVSNLTQSC 839
+ +++ H LH DLKP N+LL + DFGLAR + T
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 840 SVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ T+ Y PE LGS ST+ DI+S + EM+ P +F GD
Sbjct: 199 -I----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 47/225 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNL-----QRHGASKSFLAECKALKNIRHRNLVK- 724
+G G F +VYK IVAIK L + G +++ L E K L+ + H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 725 --VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
S+I +LV++FM LE + +++ I K +L
Sbjct: 78 LDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVLTPSHI---KAYMLM----- 120
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
++YLH H +LH DLKP N+LLD + + + DFGLA+ S
Sbjct: 121 --TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK----------SFGSP 165
Query: 843 VRG------TIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGK 880
R T Y APE G+ + D+++ G +L E++
Sbjct: 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRNLVK---V 725
+G G++G V VA+K+ +++R + E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ L E+ + G L + + PD E + Q+ Q +
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPD---IGMPEPDAQRF-FHQLM------ 115
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSCSVG 842
+ + YLH + H D+KP N+LLD + DFGLA V + + L + C
Sbjct: 116 -AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--- 168
Query: 843 VRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
GT+ Y APE + V D++S GI+L M+ G+ P ++ +
Sbjct: 169 --GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 74/233 (31%), Positives = 112/233 (48%), Gaps = 48/233 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK-- 724
+G+G+FG V G + G VA+K+ N ++ E + LK RH +++K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 725 -VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
VI++ S I +V E+++ G L +++ + E E ++ L Q+I
Sbjct: 83 QVISTPSDI--------FMVMEYVSGGELFDYI---CKNGRLDEKESRR--LFQQI---- 125
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
S +DY H H V+H DLKP NVLLD M A + DFGL+ + + L SC
Sbjct: 126 --LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---- 176
Query: 844 RGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
G+ YAAPE Y G EV DI+S G++L ++ G P F+ D
Sbjct: 177 -GSPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLP----FDDD 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 48/231 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLA-----ECKALKNIRHRNL 722
+G G+FG V+ + V +K + + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 723 VK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
+K + + LV E +G L+ + + + E + +++
Sbjct: 92 IKVLDIFENQGFF--------QLVMEKHGSG-LDLF---AFIDRHPRLDEPLASYIFRQL 139
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
SA+ YL ++H D+K N+++ D + DFG A + C
Sbjct: 140 ------VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 840 SVGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
GTI Y APE Y G E+ +++S G+ L +V + P
Sbjct: 191 -----GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVFEENPFC 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 47/255 (18%)
Query: 651 QKVSYESL---FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF 707
+ YES + D + +G G + V++ + V +K+ + K
Sbjct: 21 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKI 77
Query: 708 LAECKALKNIR-HRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ 763
E K L+N+R N++ ++ S ALV+E + N + Q
Sbjct: 78 KREIKILENLRGGPNIITLADIVKDPVS----RTP--ALVFEHVNNTDFKQLY------Q 125
Query: 764 KDVEIEIQKLT--LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHV 820
+ +I+ +L+ A+DY H ++H D+KP NV++D++ +
Sbjct: 126 TLTDYDIRFYMYEILK----------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRL 172
Query: 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTG 879
D+GLA V V + + PE + ++ + D++S G +L M+
Sbjct: 173 IDWGLAEFYHPGQEYN----VRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
Query: 880 KKPTDVMFEGDLNLH 894
K+P F G N
Sbjct: 228 KEP---FFHGHDNYD 239
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 49/239 (20%), Positives = 91/239 (38%), Gaps = 38/239 (15%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKAL-KNIRHRNLV 723
S ++G GS G+V G VA+K + L E K L ++ H N++
Sbjct: 17 VVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNVI 72
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ S + F + E N +L++ + + + ++ I++
Sbjct: 73 RYYCS-----ETTDRFLYIALELC-NLNLQDLV----ESKNVSDENLKLQKEYNPISLLR 122
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-------------DMIAHVGDFGLARVRQ 830
+AS + +LH ++H DLKP N+L+ ++ + DFGL +
Sbjct: 123 QIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-------DIYSYGILLLEMVTGKKP 882
+ ++ GT G+ APE S DI+S G + +++ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 32/250 (12%)
Query: 637 SKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF 696
Q P R+ + + + F +G GS+GSVYK + G IVAIK
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 697 NLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWL 756
++ + + E ++ ++VK S + N +V E+ GS+ + +
Sbjct: 63 PVE--SDLQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSVSDII 115
Query: 757 HPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816
+ EI I ++YLH +H D+K GN+LL+ +
Sbjct: 116 RLRNKTLTEDEIAT----------ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEG 162
Query: 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGT-IG---YAAPEYGLGSEVSTNGDIYSYGIL 872
A + DFG+A LT ++ R T IG + APE + DI+S GI
Sbjct: 163 HAKLADFGVA------GQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 873 LLEMVTGKKP 882
+EM GK P
Sbjct: 215 AIEMAEGKPP 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 49/240 (20%)
Query: 671 IGMGSFGSVYKG--AFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK---V 725
+G G++G VYK +D A+K G S S E L+ ++H N++ V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 726 ITSCSSIDFQGNDFKALVYEFM---------TNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
S + L++++ + + + P +P+ V K L
Sbjct: 87 FLSHADRKV------WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV-----KSLLY 135
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH----VGDFGLARV-RQE 831
Q ++ I YLH + VLH DLKP N+L+ + + D G AR+
Sbjct: 136 QILD-------GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 832 VSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ L V V T Y APE LG+ + DI++ G + E++T +P +F
Sbjct: 186 LKPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEP---IFHCR 239
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 64/387 (16%), Positives = 122/387 (31%), Gaps = 99/387 (25%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
L + SD L ++P +L +L L NK+ +F +L L L + N ++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 142 GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201
++ AF L +L+ L L N L
Sbjct: 90 ----------------KISPGAFAP--------LVKLERLYLSKNQLK------------ 113
Query: 202 LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF 261
+P L LR+ H N + + + F
Sbjct: 114 ----ELPEKMPKT---------LQELRV---HENEIT-KVR---------------KSVF 141
Query: 262 SGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH 321
+ G+ + + N L S + +F L + A + +P
Sbjct: 142 N--------GLNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIRIADTNIT-TIP- 187
Query: 322 SIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380
L L L + N++ + + L L +LG+ N + + +L
Sbjct: 188 --QGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV------IPSCLGSLKQLAILHLFEN 434
+ L +N+L ++P L + + + L+NN++S + P + + LF N
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 435 GLNGT-IPEEIF-NLTYLSNSLNLARN 459
+ I F + + ++ L
Sbjct: 304 PVQYWEIQPSTFRCVYVRA-AVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 59/284 (20%), Positives = 116/284 (40%), Gaps = 24/284 (8%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
+ L NK+ NL L LI+ +N++ I G LV L RL +
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL--SGVIPSC 419
NQ +P++M + L+ + +++N+++ S L+ + + L N L SG+
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 420 LGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRV 477
+K+L+ + + + + TIP+ + +LT L+L N + + L L
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGLPPSLT----ELHLDGNKI-TKVDAASLKGLNNLAK 220
Query: 478 FNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL- 536
+S N++S L +L E+++ N +P L+ + + + L NN+S +
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIG 279
Query: 537 -----IPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFANISRISV 574
P + S ++L N ++ F + +
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 50/238 (21%), Positives = 99/238 (41%), Gaps = 13/238 (5%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
+L L + +N++ NL L+ L + N+ + P L LE + L
Sbjct: 48 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL-NGTIPE 442
NQL E+P + L EL ++ N ++ V S L Q+ ++ L N L + I
Sbjct: 108 SKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 443 EIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL--GLCSYL 499
F + LS + +A ++ +IP G L ++ N ++ ++ + GL + L
Sbjct: 165 GAFQGMKKLS-YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGL-NNL 218
Query: 500 EEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
++ + N SL++ + + L+ N L + + ++ + L N++
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 17/234 (7%)
Query: 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL 388
L+ + + L +P + L + N+ T + L+NL + L +N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 389 SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NL 447
S P + L L L L+ N L +P K L L + EN + + + +F L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 448 TYLSNSLNLARNHL-VGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR 505
+ + L N L I +K L ++ N++ IP GL L E+++
Sbjct: 145 NQM-IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200
Query: 506 GNFFHGSIPS-SLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
GN + + SL L + + LS N++S + L + L L+L+ N L
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 61/292 (20%), Positives = 110/292 (37%), Gaps = 26/292 (8%)
Query: 34 VTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
+L+L++ ++ + NL L + L+NN I P F L +LE L+LS N L
Sbjct: 54 TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLT-GGIPP--FI 148
E+P + L L + N++ + F+ L ++ + + N L GI F
Sbjct: 113 K-ELPEKMP--KTLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
G + L I +A IP L L L L N ++ + S+ L+ LA +
Sbjct: 169 G-MKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG----- 263
N ++ PHLR +++N +P L++ ++ + +N+ S
Sbjct: 225 FNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 264 -KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANK 314
+ S ++ N + E +F + K
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF----RCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 52/292 (17%), Positives = 106/292 (36%), Gaps = 27/292 (9%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRNKL 116
++L NN I +F L L L L +N + +I + +L L+L +N+L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNI--PNSLG 173
+P + L++L + N +T + + L + + L N + +
Sbjct: 113 -KELPEKMPK--TLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 174 QLKELKSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLR 228
+K+L + + N++ I +PPS+ L L N V G L +L
Sbjct: 169 GMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKG---------LNNLA 219
Query: 229 LFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG 288
+ N S SL+N L + +N K+ K + + NN+ +
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
Query: 289 ESDEMSFMNSLANCSNLRTLIFAANKLRGAL--PHSIANLSDQLQNLIMTSN 338
S++ ++ + +N ++ P + + + + +
Sbjct: 279 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY-VRAAVQLGNY 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 60/255 (23%), Positives = 94/255 (36%), Gaps = 42/255 (16%)
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGAS--------- 704
L ++ I GS+G+V D +G VAIK VFN G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 705 -KSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDA 760
K L E + L + H N++ + + LV E M L +H
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRT-DLAQVIHDQR 128
Query: 761 VPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820
+ I + + + + LH + V+H DL PGN+LL ++ +
Sbjct: 129 IVISPQHI---QYFMYH-------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITI 175
Query: 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTG 879
DF LAR +N T + Y APE + + T D++S G ++ EM
Sbjct: 176 CDFNLAREDTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 880 KKPTDVMFEGDLNLH 894
K +F G +
Sbjct: 231 K----ALFRGSTFYN 241
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 49/237 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRNLVK---V 725
+G G++G V VA+K+ +++R + E K + H N+VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ L E+ + G L + + PD E + Q+ Q +
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPD---IGMPEPDAQRF-FHQLM------ 115
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN---LTQSCSVG 842
+ + YLH + H D+KP N+LLD + DFGLA V + + L + C
Sbjct: 116 -AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--- 168
Query: 843 VRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
GT+ Y APE + V D++S GI+L M+ G+ P ++ +
Sbjct: 169 --GTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDS 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 7e-21
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 35/226 (15%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-KSFLAECKALKNIRHRN 721
D F +G G+ G V+K + G ++A K+ +L+ A + E + L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 722 LVKVITSCSSIDFQGNDFKA----LVYEFMTNGSLENWL-HPDAVPQKDVEIEIQKLTLL 776
+V F G + + E M GSL+ L +P E + K
Sbjct: 93 IVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGK---- 135
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
++I V + YL + ++H D+KP N+L+++ + DFG++ L
Sbjct: 136 ----VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG------QLI 183
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S + GT Y +PE G+ S DI+S G+ L+EM G+ P
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 49/233 (21%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK-- 724
+G GSFG V + VA+K + L++ E LK +RH +++K
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 725 -VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
VIT+ + I +V E+ G L +++ +E +++T +
Sbjct: 76 DVITTPTDI--------VMVIEY-AGGELFDYI-----------VEKKRMTEDEGRRFFQ 115
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGV 843
+ AI+Y H H ++H DLKP N+LLD+++ + DFGL+ + + + L SC
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---- 168
Query: 844 RGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
G+ YAAPE Y G EV D++S GI+L M+ G+ P F+ +
Sbjct: 169 -GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLP----FDDE 211
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 67/254 (26%), Positives = 98/254 (38%), Gaps = 39/254 (15%)
Query: 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGASKSF---- 707
+ E K D F + G G+FG+V G G VAIK V F
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRE 66
Query: 708 LAECKALKNIRHRNLVK---VITSCSSIDFQGND-FKALVYEFMTNGSLENWLHPDAVPQ 763
L + L + H N+V+ + D D + +V E++ +L Q
Sbjct: 67 LQIMQDLAVLHHPNIVQLQSYFYTLGERDR--RDIYLNVVMEYV-PDTLHRCCRNYYRRQ 123
Query: 764 KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGD 822
+ K+ L Q + +I LH V H D+KP NVL++ D + D
Sbjct: 124 VAPPPILIKVFLFQ-------LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCD 175
Query: 823 FGLARVRQEVSNLTQ-SCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGK 880
FG A+ CS R Y APE G+ +T DI+S G + EM+ G
Sbjct: 176 FGSAKKLSPSEPNVAYICS---R---YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG- 228
Query: 881 KPTDVMFEGDLNLH 894
+P +F GD +
Sbjct: 229 EP---IFRGDNSAG 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 59/251 (23%), Positives = 96/251 (38%), Gaps = 57/251 (22%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLA----------------- 709
IG GS+G V + D T A+KV + L R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 710 ------ECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ 763
E LK + H N+VK++ +D D +V+E + G + VP
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVME------VPT 130
Query: 764 KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823
E Q Q D+ I+YLH+ ++H D+KP N+L+ D + DF
Sbjct: 131 LKPLSEDQARFYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 824 GLARV-RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG---DIYSYGILLLEMVTG 879
G++ + + L+ + GT + APE + +G D+++ G+ L V G
Sbjct: 182 GVSNEFKGSDALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 880 KKPTDVMFEGD 890
+ P F +
Sbjct: 237 QCP----FMDE 243
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFN--------LQRHGASKSFLAECKALKNIRHR 720
+G G+ G V + VAI++ + + + + E + LK + H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
++K+ + D+ +V E M G L + + + ++L
Sbjct: 201 CIIKIKNFFDAEDYY------IVLELMEGGELFDKV-----------VGNKRLKEATCKL 243
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQ 837
+ A+ YLH + ++H DLKP NVLL + D + + DFG +++ E S +
Sbjct: 244 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 838 SCSVGVRGTIGYAAPE-------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
C GT Y APE G V D +S G++L ++G P
Sbjct: 301 LC-----GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 343
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-20
Identities = 57/314 (18%), Positives = 105/314 (33%), Gaps = 41/314 (13%)
Query: 148 IGNLTSLESISL--AANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANF 205
I N SL S + + ++ + ++ G N ++ + ++ +
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64
Query: 206 SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265
+ R SLP +L P + + ++ N S+P ++ LE+++A DN S L
Sbjct: 65 QLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TL 115
Query: 266 SVNFGGMKNLSYFNVAYNNL-------GSGESDEMSFMNSL----ANCSNLRTLIFAANK 314
+K+L +V N L E N L ++L L N+
Sbjct: 116 PELPASLKHL---DVDNNQLTMLPELPALLEYINADN-NQLTMLPELPTSLEVLSVRNNQ 171
Query: 315 LRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGL----YRLGMGGNQFTGTIPK 370
L LP +L + L +++N L S+P+ N+ T IP+
Sbjct: 172 LT-FLPELPESL----EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPE 224
Query: 371 EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILH 430
+ L + L DN LS I SL + + S + +
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLAD 282
Query: 431 LFENGLNGTIPEEI 444
++
Sbjct: 283 AVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-18
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 41/212 (19%)
Query: 367 TIPKEMGKLQNLEGMGLYDNQLSG---EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSL 423
+I + +L Y N +SG + S+ + N N ++ CL +
Sbjct: 2 SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 424 KQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFN--- 479
Q + L L L+ ++P+ + +T L + +N L+ S+P +L+YL +
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLPPQIT----VLEITQNALI-SLPELPASLEYLDACDNRL 112
Query: 480 --------------VSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLA 525
V +N L+ +P L LE I N +P +SL
Sbjct: 113 STLPELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTSLE---V 164
Query: 526 IDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
+ + N L+ L P+ E SLE L++S N LE
Sbjct: 165 LSVRNNQLTFL-PELPE--SLEALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 50/330 (15%), Positives = 96/330 (29%), Gaps = 70/330 (21%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
+N + L+ L +L +++ NN + +P LEAL +S N L
Sbjct: 143 EYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE- 193
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
+PA + N +T
Sbjct: 194 SLPAVPVRNHHSEET--------------------EIFFRCRENRIT------------- 220
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214
+IP ++ L ++ L N LS I S+ + ++ PR F
Sbjct: 221 ------------HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS- 267
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
H L +F + +S E ++ + S + +
Sbjct: 268 --MSDGQQNTLHRPLADAVTAWFPENKQSDVSQ--IWHAFEHEEH--ANTFSAFLDRLSD 321
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA-ANKLRGALPHSIANLSDQLQNL 333
N +++ L+ + LR FA A + +A + L+
Sbjct: 322 TVSA----RNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKT 377
Query: 334 IMTSNQLHGSIPSGIGNLV----GLYRLGM 359
++ G + G L+ ++RL +
Sbjct: 378 LLVHQASEGLFDNDTGALLSLGREMFRLEI 407
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 4e-20
Identities = 65/310 (20%), Positives = 106/310 (34%), Gaps = 64/310 (20%)
Query: 81 RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNL 140
+ + + L E+P + S L L N + F L+ L+ L + RN++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 141 TGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLS 200
+ AF G L L +L L N L+ I + LS
Sbjct: 112 R----------------QIEVGAFNG--------LASLNTLELFDNWLTVIPSGAFEYLS 147
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
L + N S+P +P L + L KLE+I + +
Sbjct: 148 KLRELWLRNNPIE-SIPSYAFNRVPSLMR-------------LDLGELKKLEYIS--EGA 191
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
F G+ NL Y N+ N+ M +L L L + N P
Sbjct: 192 FE--------GLFNLKYLNLGMCNI--------KDMPNLTPLVGLEELEMSGNHFPEIRP 235
Query: 321 HSIANLSDQLQNLIMTSNQLHGSIPSG-IGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNL 378
S LS L+ L + ++Q+ I L L L + N + ++P ++ L+ L
Sbjct: 236 GSFHGLS-SLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYL 292
Query: 379 EGMGLYDNQL 388
+ L+ N
Sbjct: 293 VELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 10/234 (4%)
Query: 327 SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386
S+Q ++ T L +P GI L + N L +LE + L N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF- 445
+ + L+ L+ L L +N L+ + L +L L L N + +IP F
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 446 NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504
+ L L+L + I L L+ N+ N+ ++P+ L LEE+ M
Sbjct: 169 RVPSL-MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPL-VGLEELEM 225
Query: 505 RGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
GN F P S L ++ + + + +S + + L SL LNL+ N+L
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 16/237 (6%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSD 89
LNL + + +L L + L NSI+ +I F L L L L D
Sbjct: 75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132
Query: 90 NDLVGEIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPP- 146
N L IP+ Y S+L L+L N + SIP F+ + L +L + I
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 147 -FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANF 205
F G L +L+ ++L ++P +L L L+ L + N+ I P S + LS L
Sbjct: 191 AFEG-LFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 206 SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPIS-LSNASKLEFIEALDNSF 261
V +Q + + L L + HN S S+P + L + N +
Sbjct: 248 WVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 62/291 (21%), Positives = 104/291 (35%), Gaps = 53/291 (18%)
Query: 177 ELKSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQ 231
+ + LS + IP + L+L+ N + + F L HL + Q
Sbjct: 55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRH---------LHHLEVLQ 105
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
+ N + IE +F+G + +L+ + N L S
Sbjct: 106 LGRN--------------SIRQIEV--GAFNG--------LASLNTLELFDNWLTVIPSG 141
Query: 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTS-NQLHGSIPSGI-G 349
+ S LR L N + ++ + L L + +L I G
Sbjct: 142 ------AFEYLSKLRELWLRNNPIESIPSYAFNRVP-SLMRLDLGELKKLE-YISEGAFE 193
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L L L +G +P + L LE + + N P S LS L +L + N
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARN 459
+ +S + + L L L+L N L+ ++P ++F L YL L+L N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV-ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-15
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 12/233 (5%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRNKL 116
R +NLM N+IQ F L LE L L N + +I + + L L L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL 135
Query: 117 MGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIP-NSLG 173
IP F L KL++L ++ N + IP + + SL + L I +
Sbjct: 136 -TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
L LK L LG N+ + P++ L L + N F + P L L+ V
Sbjct: 194 GLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVM 250
Query: 234 HNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN-FGGMKNLSYFNVAYNNL 285
++ S + + L + N+ S L + F ++ L ++ +N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 19/114 (16%)
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540
+ LS E+P G+ S + + N + L + + L RN++ +
Sbjct: 62 TRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA 118
Query: 541 LEDL-SLEYLNLSFNDLEGEVPTKGVFAN-------------ISRISVAGFNRL 580
L SL L L N L +P+ G F I I FNR+
Sbjct: 119 FNGLASLNTLELFDNWLT-VIPS-GAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 7e-20
Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 46/218 (21%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
++G G+F V+ G + A+K S E LK I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
++ LV + ++ G L + + +E T + V SA+
Sbjct: 75 ----YESTTHYYLVMQLVSGGELFDRI-----------LERGVYTEKDASLVIQQVLSAV 119
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDND------MIAHVGDFGLARVRQEVSNLTQSCSVGV 843
YLH + ++H DLKP N+L MI DFGL+++ Q ++ +C
Sbjct: 120 KYLHENG---IVHRDLKPENLLYLTPEENSKIMIT---DFGLSKMEQN-GIMSTAC---- 168
Query: 844 RGTIGYAAPE----YGLGSEVSTNGDIYSYG----ILL 873
GT GY APE V D +S G ILL
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 47/221 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFN--------LQRHGASKSFLAECKALKNIRHRNL 722
+G G+ G V + VAIK+ + + + + E + LK + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+K+ F D+ +V E M G L + + + ++L
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELFDKV-----------VGNKRLKEATCKLYF 120
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSC 839
+ A+ YLH + ++H DLKP NVLL + D + + DFG +++ E S + C
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 840 SVGVRGTIGYAAPE-------YGLGSEVSTNGDIYSYGILL 873
GT Y APE G V D +S G++L
Sbjct: 178 -----GTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 7e-20
Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 12/251 (4%)
Query: 327 SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386
S+Q +I L +P GI L + NQ L++LE + L N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF- 445
+ + L+ L+ L L +N L+ + L +L L L N + +IP F
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
Query: 446 NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504
+ L L+L + I L LR N++ NL EIP+ L L+E+ +
Sbjct: 158 RIPSL-RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPL-IKLDELDL 214
Query: 505 RGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTK 563
GN P S L + + + ++ + + ++L SL +NL+ N+L +P
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLP-H 272
Query: 564 GVFANISRISV 574
+F + +
Sbjct: 273 DLFTPLHHLER 283
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 9e-19
Identities = 69/332 (20%), Positives = 108/332 (32%), Gaps = 84/332 (25%)
Query: 81 RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNL 140
+ + +L E+P +S + +L L N++ F L L+ L + RN++
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 141 TGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLS 200
++ AF G L L +L L N L+ I + LS
Sbjct: 101 R----------------TIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYLS 136
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS 260
L + N S+P +P LR + L +L +I + +
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRR-------------LDLGELKRLSYIS--EGA 180
Query: 261 FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALP 320
F G + NL Y N+A NL + +L L L + N L P
Sbjct: 181 FEG--------LSNLRYLNLAMCNL--------REIPNLTPLIKLDELDLSGNHLSAIRP 224
Query: 321 HSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380
S L LQ L M +Q+ I F LQ+L
Sbjct: 225 GSFQGLM-HLQKLWMIQSQIQ-VIERNA---------------FDN--------LQSLVE 259
Query: 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412
+ L N L+ L L + L++N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 61/236 (25%), Positives = 92/236 (38%), Gaps = 14/236 (5%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSD 89
+LNL + + +L L + L N I+ I F L L L L D
Sbjct: 64 TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121
Query: 90 NDLVGEIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPF 147
N L IP Y S+L L+L N + SIP F+ + L++L + I
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 148 I-GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFS 206
L++L ++LA IP +L L +L L L N+LS I P S L L
Sbjct: 180 AFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 207 VPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPIS-LSNASKLEFIEALDNSF 261
+ ++Q + + L L + HN + +P + LE I N +
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 26/265 (9%)
Query: 177 ELKSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQ 231
+ + NL + I + L+L N + N F L HL + Q
Sbjct: 44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKH---------LRHLEILQ 94
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
+ N + + + L +E DN + + F + L + N + S S
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSY 154
Query: 292 EMSFMNSLANCSNLRTL-IFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGN 350
+ +LR L + +L + LS L+ L + L IP+ +
Sbjct: 155 ------AFNRIPSLRRLDLGELKRLSYISEGAFEGLS-NLRYLNLAMCNLR-EIPN-LTP 205
Query: 351 LVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L+ L L + GN + I L +L+ + + +Q+ ++ NL L E+ L +
Sbjct: 206 LIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH 264
Query: 410 NSLSGVIPSCLGSLKQLAILHLFEN 434
N+L+ + L L +HL N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 43/163 (26%), Positives = 65/163 (39%), Gaps = 7/163 (4%)
Query: 54 NLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFL 111
LS L+E+ L NN I+ IP F R+ L L L + + I S L L L
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPN 170
L IP L KL +L + N+L+ I P L L+ + + + N
Sbjct: 193 AMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
+ L+ L + L NNL+ + L L + N ++
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 29/222 (13%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G+FG V++ G + K N + E + + H L+ + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F+ L+ EF++ G L D + +D K++ + IN +
Sbjct: 117 ---FEDKYEMVLILEFLSGGELF-----DRIAAEDY-----KMSEAEVINYMRQACEGLK 163
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++H H ++H D+KP N++ + + V DFGLA + + T
Sbjct: 164 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAE 215
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+AAPE V D+++ G+L +++G P F G+
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGE 253
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 61/269 (22%), Positives = 111/269 (41%), Gaps = 44/269 (16%)
Query: 637 SKQQPSRPILRKALQKVS-YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK- 694
+ R + +++++ + + + +G G++GSV + G VA+K
Sbjct: 2 AHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 61
Query: 695 ---VFNLQRHGASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKA--LVYEF 746
F H +K E + LK+++H N++ V T S++ +F LV
Sbjct: 62 LSRPFQSIIH--AKRTYRELRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHL 115
Query: 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806
M L+ + ++ QKLT + + + Y+H ++H DLK
Sbjct: 116 M-----GADLN--NI------VKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLK 159
Query: 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-D 865
P N+ ++ D + DFGLA R +T + T Y APE L D
Sbjct: 160 PSNLAVNEDCELKILDFGLA--RHTADEMTGYVA-----TRWYRAPEIMLNWMHYNQTVD 212
Query: 866 IYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
I+S G ++ E++TG+ +F G ++
Sbjct: 213 IWSVGCIMAELLTGR----TLFPGTDHID 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 32/259 (12%)
Query: 637 SKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFD-QDGTIVAIK- 694
+ V +F +++ IG G++G V A+D + VAIK
Sbjct: 2 HHHHHMAAAAAAGPEMV-RGQVFDVGPRYTNLSYIGEGAYGMVCS-AYDNLNKVRVAIKK 59
Query: 695 VFNLQRHGASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGS 751
+ + + L E K L RH N++ +I + + D +V + M
Sbjct: 60 ISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM--KDV-YIVQDLM---- 112
Query: 752 LENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811
E L+ + ++ Q L+ + + Y+H VLH DLKP N+L
Sbjct: 113 -ETDLY--KL------LKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLL 160
Query: 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYG 870
L+ + DFGLARV + T + V T Y APE L S+ T DI+S G
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 871 ILLLEMVTGKKPTDVMFEG 889
+L EM++ + +F G
Sbjct: 220 CILAEMLSNR----PIFPG 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 65/258 (25%), Positives = 102/258 (39%), Gaps = 37/258 (14%)
Query: 635 GPSKQQPSRPILRK-ALQKVSYESLFKATD---GFSSTHLIGMGSFGSVYKGAFDQDGTI 690
P R +L+ LF D FS IG GSFG+VY ++ +
Sbjct: 22 FQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV 81
Query: 691 VAIKVFNLQRHGAS---KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747
VAIK + ++ + + E + L+ +RH N ++ + LV E+
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC-----YLREHTAWLVMEYC 136
Query: 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807
GS + L P ++VEI + + YLH ++H D+K
Sbjct: 137 -LGSASDLLEVHKKPLQEVEIAA----------VTHGALQGLAYLH---SHNMIHRDVKA 182
Query: 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG--- 864
GN+LL + +GDFG A S + + S GT + APE L +
Sbjct: 183 GNILLSEPGLVKLGDFGSA------SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 865 DIYSYGILLLEMVTGKKP 882
D++S GI +E+ K P
Sbjct: 235 DVWSLGITCIELAERKPP 252
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 50/284 (17%), Positives = 99/284 (34%), Gaps = 25/284 (8%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
+ L N + L L L++ +N++ I L L +L +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL--SGVIPSC 419
N IP + +L + ++DN++ L ++ + + N L SG P
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 420 LGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRV 477
LK L L + E L IP+++ L L+L N + +I + L
Sbjct: 169 FDGLK-LNYLRISEAKLT-GIPKDLPETLN----ELHLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 478 FNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL- 536
+ N + L L E+++ N +P+ L L+ + + L NN++ +
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG 280
Query: 537 ------IPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISV 574
+ ++ ++L N + F ++
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/348 (18%), Positives = 114/348 (32%), Gaps = 68/348 (19%)
Query: 177 ELKSLGLGANNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQ 231
L+ + L + I P L L N + ++ F G L HL
Sbjct: 34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKG---------LQHLYALV 84
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
+ +N K+ I + +FS ++ L ++ N+L +
Sbjct: 85 LVNN--------------KISKIH--EKAFSP--------LRKLQKLYISKNHLVEIPPN 120
Query: 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQL-HGSIPSGIGN 350
S+L L N++R + L + + M N L + G +
Sbjct: 121 --LP-------SSLVELRIHDNRIRKVPKGVFSGLR-NMNCIEMGGNPLENSGFEPGAFD 170
Query: 351 LVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNN 409
+ L L + + T IPK++ + L + L N++ I L S L L L +
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP--- 466
N + + L L L LHL N L+ +P + +L L + L N++ +
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLL-QVVYLHTNNIT-KVGVND 283
Query: 467 ----TKIGNLKYLRVFNVSSNNLS-GEIPSQL--GLCSYLEEIYMRGN 507
Y ++ +N + E+ + I
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD-RLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 29/271 (10%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSG-IGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGM 381
+S L + +N + + L LY L + N+ + I ++ L+ L+ +
Sbjct: 50 KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKL 107
Query: 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL-NGTI 440
+ N L EIP +L S L EL +++N + V L+ + + + N L N
Sbjct: 108 YISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 441 PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYL 499
F+ L+ L ++ L IP + L ++ N + I + L S L
Sbjct: 165 EPGAFDGLKLN-YLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 500 EEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEG 558
+ + N SLS L + + L N LS +P L DL L+ + L N
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN---- 274
Query: 559 EVPTKGVFANISRISVAGFNRLCGGIPELQL 589
NI+++ V F + G+
Sbjct: 275 ---------NITKVGVNDFCPVGFGVKRAYY 296
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 55/294 (18%), Positives = 104/294 (35%), Gaps = 30/294 (10%)
Query: 58 LREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRNK 115
++L NN I E+ ++ F L L AL L +N + +I S +L L++ +N
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113
Query: 116 LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNI--PNSL 172
L IP S L +L + N + +P + L ++ I + N + P +
Sbjct: 114 L-VEIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 173 GQLKELKSLGLGANNLSGI---IPPSIYNLSLLAN--FSVPRNQFHGSLPPSLGLTLPHL 227
LK L L + L+GI +P ++ L L N ++ L
Sbjct: 170 DGLK-LNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLR---------YSKL 219
Query: 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287
+ HN SLS L + +N S ++ +K L + NN+
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278
Query: 288 GESDEMSFMNSLANCSNLRTLIFAANKLRGAL--PHSIANLSDQLQNLIMTSNQ 339
++ + + + N + P + ++ + + +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT-DRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 47/219 (21%), Positives = 78/219 (35%), Gaps = 32/219 (14%)
Query: 367 TIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQL 426
+PKE+ + + L +N +S L L L+L NN +S + L++L
Sbjct: 47 AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104
Query: 427 AILHLFENGLNGTIPEEIF-NLTYLS--------------------NSLNLARNHL-VGS 464
L++ +N L IP + +L L N + + N L
Sbjct: 105 QKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163
Query: 465 IPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPS-SLSSLRAV 523
+ L +S L+ IP L L E+++ N +I L +
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKL 219
Query: 524 LAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVP 561
+ L N + + L L +L L+L N L VP
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 13/119 (10%)
Query: 54 NLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112
S L + L +N I+ I L L L L +N L +PA L L +++L
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 113 RNKLMGSIPFEFFS-------LYKLKQLAMQRNNLT-GGIPPFI-GNLTSLESISLAAN 162
N + + F +++ N + + P +T +I
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 38/255 (14%)
Query: 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK---VFNLQRHGASKSFLA 709
+ ++ + F L+G G++G V G IVAIK F+ + L
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF--ALRTLR 58
Query: 710 ECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV 766
E K LK+ +H N++ + S +F N+ ++ E M + LH V
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLH--RV----- 103
Query: 767 EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
I Q L+ A+ LH V+H DLKP N+L++++ V DFGLA
Sbjct: 104 -ISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 827 RVRQEVSNLTQSCSVGVRG------TIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTG 879
R+ E + + G T Y APE L S + D++S G +L E+
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 880 KKPTDVMFEGDLNLH 894
+ +F G H
Sbjct: 220 R----PIFPGRDYRH 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 48/238 (20%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK---VI 726
IG G+FG +VA+K E +++RH N+V+ VI
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVI 85
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ + + A++ E+ + G L + + E E + Q++
Sbjct: 86 LTPTHL--------AIIMEYASGGELYERI---CNAGRFSEDEARF--FFQQL------L 126
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH--VGDFGLARVRQEVSNLTQSCSVGVR 844
S + Y H + H DLK N LLD + DFG ++ S +
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178
Query: 845 GTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896
GT Y APE Y G D++S G+ L M+ G P FE +Y
Sbjct: 179 GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP----FEDPEEPRDY 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 56/262 (21%), Positives = 89/262 (33%), Gaps = 58/262 (22%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRNLVKV 725
IG GS+G V +Q I AIK+ N + + E + +K + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSL-----------------------------ENWL 756
++ + LV E G L N
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 757 HPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816
+ E NI + SA+ YLH+ + H D+KP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 817 IAHV--GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE------YGLGSEVSTNGDIYS 868
+ DFGL++ +++N GT + APE G + D +S
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWS 261
Query: 869 YGILLLEMVTGKKPTDVMFEGD 890
G+LL ++ G P F G
Sbjct: 262 AGVLLHLLLMGAVP----FPGV 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 62/274 (22%), Positives = 93/274 (33%), Gaps = 58/274 (21%)
Query: 636 PSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV 695
S P + L + + + L+G G FGSVY G D VAIK
Sbjct: 18 GSHMAPCNDLHATKLAPGKEKEPLE--SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 75
Query: 696 FN---LQRHGASKSFLA---ECKALKNIRHR--NLVK---VITSCSSIDFQGNDFKALVY 744
+ G + E LK + +++ S L+
Sbjct: 76 VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF--------VLIL 127
Query: 745 EFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHC 803
E L +++ E L + V A+ + H+ VLH
Sbjct: 128 ERPEPVQDLFDFI-----------TERGALQEELARSFFWQVLEAVRHCHNCG---VLHR 173
Query: 804 DLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE------YGL 856
D+K N+L+D N + DFG + ++ + T GT Y+ PE Y
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFD-----GTRVYSPPEWIRYHRY-H 226
Query: 857 GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
G ++S GILL +MV G P FE D
Sbjct: 227 GRSA----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-19
Identities = 70/252 (27%), Positives = 107/252 (42%), Gaps = 48/252 (19%)
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK----VFNLQRHGASKSFLAE 710
++ ++ + S +G G++GSV + G VAIK F + +K E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF--AKRAYRE 73
Query: 711 CKALKNIRHRNLVK---VITSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKD 765
LK+++H N++ V T SS+ +F LV FM + L + K
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQ-KIMGLKF 123
Query: 766 VEIEIQKLT--LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823
E +IQ L +L+ + Y+H V+H DLKPGN+ ++ D + DF
Sbjct: 124 SEEKIQYLVYQMLK----------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 170
Query: 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKP 882
GLAR +T T Y APE L DI+S G ++ EM+TGK
Sbjct: 171 GLARHADA--EMTGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-- 221
Query: 883 TDVMFEGDLNLH 894
+F+G L
Sbjct: 222 --TLFKGKDYLD 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 31/229 (13%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
S T ++G G FG V+K G +A K+ + + E + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + F+ + LV E++ G L D + + LT L I
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELF-----DRIIDESY-----NLTELDTILFMKQ 195
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ I ++H +LH DLKP N+L D I + DFGLAR + L +
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNF-- 249
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE VS D++S G++ +++G P F GD
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP----FLGD 291
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 48/223 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---------HGASKSFLAECKALKNI-RHR 720
+G G V + A+K+ ++ ++ L E L+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N++++ + ++ N F LV++ M G L ++L E L+ +
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL-----------TEKVTLSEKETRK 128
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
I + I LH ++H DLKP N+LLD+DM + DFG + L + C
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC- 184
Query: 841 VGVRGTIGYAAPE----------YGLGSEVSTNGDIYSYGILL 873
GT Y APE G G EV D++S G+++
Sbjct: 185 ----GTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 54/263 (20%), Positives = 102/263 (38%), Gaps = 21/263 (7%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGM 381
+ L++ +++L +++N++ I + V L L + N TI ++ L +LE +
Sbjct: 48 SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHL 105
Query: 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTI 440
L N LS S LS L+ L L N + S L +L IL + I
Sbjct: 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 441 PEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQL-GLCS 497
+ F LT+L L + + L S K +++ + + + + S
Sbjct: 166 QRKDFAGLTFL-EELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTS 222
Query: 498 YLEEIYMRGNFFHGSIPSSLSS--------LRAVLAIDLSRNNLSGLIPKFLEDLSLEYL 549
+E + +R S LS+ + ++ +L ++ + L L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLEL 282
Query: 550 NLSFNDLEGEVPTKGVFANISRI 572
S N L+ VP G+F ++ +
Sbjct: 283 EFSRNQLKS-VP-DGIFDRLTSL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 44/249 (17%), Positives = 85/249 (34%), Gaps = 19/249 (7%)
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI-ANLS 327
NL + N + + E +S ++ +L L + N L L S LS
Sbjct: 72 LQRCVNLQALVLTSNGINTIEE------DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124
Query: 328 DQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYD 385
L L + N + + +L L L +G I ++ L LE + +
Sbjct: 125 -SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 386 NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF 445
+ L P SL ++ +S L+L+ ++ + + L L + L+ E+
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 446 NLTYLS-------NSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSY 498
S ++ + L + + + L S N L +
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302
Query: 499 LEEIYMRGN 507
L++I++ N
Sbjct: 303 LQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 53/257 (20%), Positives = 82/257 (31%), Gaps = 26/257 (10%)
Query: 34 VTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDND 91
V L+L + ++ +S L+ + L +N I I + F L LE L LS N
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 92 LVGEIPANL-SYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI- 148
L + ++ S LT L L N FS L KL+ L + + I
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 149 GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208
LT LE + + A+ P SL ++ + L L +
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI----------------LLL 214
Query: 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN 268
L L L H + S SL ++ D S ++
Sbjct: 215 EIFVDV-TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKL 272
Query: 269 FGGMKNLSYFNVAYNNL 285
+ L + N L
Sbjct: 273 LNQISGLLELEFSRNQL 289
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 65/264 (24%), Positives = 107/264 (40%), Gaps = 35/264 (13%)
Query: 636 PSKQQPSRPILRKALQKVSYESLFKAT-DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK 694
PS + ++ + + T + F L+G G+FG V G A+K
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 179
Query: 695 VF---NLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGS 751
+ + L E + L+N RH L + S FQ +D V E+ G
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVMEYANGGE 234
Query: 752 LENWLHPDAV-PQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
L L + V + R A ++ SA+DYLH ++ V++ DLK N+
Sbjct: 235 LFFHLSRERVFSEDRA-----------RFYGA-EIVSALDYLHS--EKNVVYRDLKLENL 280
Query: 811 LLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSY 869
+LD D + DFGL + + ++ C GT Y APE ++ D +
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFC-----GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 870 GILLLEMVTGKKP-----TDVMFE 888
G+++ EM+ G+ P + +FE
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 65/248 (26%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKSFLAECKALKNI 717
F + +G G G V+ A D D VAIK L + K L E K ++ +
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFS-AVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL 65
Query: 718 RHRNLVKVI-------TSCSSIDFQGNDFKA--LVYEFMTNGSLENWLHPDAVPQKDVEI 768
H N+VKV + + + + +V E+M E L V +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLA--NV------L 112
Query: 769 EIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLAR 827
E L + + Y+H VLH DLKP N+ ++ D++ +GDFGLAR
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 828 VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVM 886
+ + S G+ T Y +P L T D+++ G + EM+TGK +
Sbjct: 170 IMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TL 224
Query: 887 FEGDLNLH 894
F G L
Sbjct: 225 FAGAHELE 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-19
Identities = 77/352 (21%), Positives = 126/352 (35%), Gaps = 79/352 (22%)
Query: 632 RRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFD-QDGTI 690
++ G ++Q + S ++ D + HLIG GS+G V + A+D + +
Sbjct: 24 QQEGQQRKQHHSS--KPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCE-AYDKLEKRV 80
Query: 691 VAIK-VFNLQRH-GASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYE 745
VAIK + + K L E L + H ++VK ++ F ++ +V E
Sbjct: 81 VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF--DEL-YVVLE 137
Query: 746 FMTNGSLENWLHPDAV---PQKDVEIEIQKLT--LLQRINIAIDVASAIDYLHHHCQEPV 800
++ + P E+ I+ L LL + Y+H +
Sbjct: 138 IA-----DSDFK--KLFRTPVYLTELHIKTLLYNLLV----------GVKYVHSA---GI 177
Query: 801 LHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG------------ 848
LH DLKP N L++ D V DFGLAR N + R
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 849 -----------YAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDV-------MFEG 889
Y APE L E T D++S G + E++ K +F G
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
Query: 890 D----LNLHNYARTALLDHVIDIVDPI-LINDV------EDWDATNKQRLRQ 930
L+ A H D + +I ++ ED +A K+ ++
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 70/269 (26%), Positives = 113/269 (42%), Gaps = 48/269 (17%)
Query: 637 SKQQPSRPILRKALQKVSYE---SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAI 693
S P+R E + ++ + +G G++G+V + G VAI
Sbjct: 2 SSPPPARS------GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAI 55
Query: 694 K-VFN-LQRHGASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKA--LVYEF 746
K ++ Q +K E + LK++RH N++ V T ++D DF LV F
Sbjct: 56 KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD----DFTDFYLVMPF 111
Query: 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806
M L + ++ +KL + + + + Y+H ++H DLK
Sbjct: 112 M-----GTDLG--KL------MKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLK 155
Query: 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG-D 865
PGN+ ++ D + DFGLAR S +T T Y APE L T D
Sbjct: 156 PGNLAVNEDCELKILDFGLARQAD--SEMTGYVV-----TRWYRAPEVILNWMRYTQTVD 208
Query: 866 IYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
I+S G ++ EM+TGK +F+G +L
Sbjct: 209 IWSVGCIMAEMITGK----TLFKGSDHLD 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 56/246 (22%), Positives = 81/246 (32%), Gaps = 66/246 (26%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN-------LQRHGASKSFLAECKALKNIR---- 718
L+G G FG+V+ G D VAIKV + L E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 719 HRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGS-LENWLHPDAVPQKDVEIEIQKLT 774
H +++ + LV E L +++ E L
Sbjct: 97 HPGVIRLLDWFETQEGF--------MLVLERPLPAQDLFDYI-----------TEKGPLG 137
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM----IAHVGDFGLARVRQ 830
V +AI + H V+H D+K N+L+D + DFG +
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI---DFGSGALLH 191
Query: 831 EVSNLTQSCSVGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884
+ T GT Y+ PE Y ++S GILL +MV G P
Sbjct: 192 D-EPYTDFD-----GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVCGDIP-- 238
Query: 885 VMFEGD 890
FE D
Sbjct: 239 --FERD 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 30/247 (12%)
Query: 645 ILRKALQKVSYESLFKAT-DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA 703
I K+S E + T + IG G++GSV K G I+A+K
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 704 S-KSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAV 761
K L + +++ +V+ + F+ D + E M + S + +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIVQFYGAL----FREGDCW-ICMELM-STSFDKFYKYVYS 116
Query: 762 PQKDV--EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819
DV E + K I + A+++L + + ++H D+KP N+LLD
Sbjct: 117 VLDDVIPEEILGK--------ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIK 166
Query: 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE----YGLGSEVSTNGDIYSYGILLLE 875
+ DFG++ Q V ++ ++ G Y APE D++S GI L E
Sbjct: 167 LCDFGIS--GQLVDSIAKTRDA---GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
Query: 876 MVTGKKP 882
+ TG+ P
Sbjct: 222 LATGRFP 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 53/262 (20%), Positives = 105/262 (40%), Gaps = 46/262 (17%)
Query: 670 LIGMGSFGSVYKGAFD-QDGTIVAIKVF-NLQRHGASKSFLAECKALKNIR--------H 719
+G G F +V+ A D + T VA+K+ + + ++ E K L+ +
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDS 82
Query: 720 RNLVKVITSCSSIDFQGNDFK--ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
++ + +G + +V+E + +L + + E + + L+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK---------KYEHRGIPLIY 132
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH------VGDFGLAR-VRQ 830
I+ + +DY+H C ++H D+KP NVL++ + D G A +
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+N Q+ Y +PE LG+ DI+S L+ E++TG D +FE D
Sbjct: 191 HYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPD 238
Query: 891 LNLHNYARTALLDHVIDIVDPI 912
+ +I+++ +
Sbjct: 239 EGHSYTKDDDHIAQIIELLGEL 260
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 55/270 (20%)
Query: 631 KRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSST----HLIGMGSFGSVYKGAFDQ 686
++ ++ + + + +++ + A F +IG G V +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 687 DGTIVAIKVFNLQR--------HGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGN 737
G A+K+ + ++ E L+ + H +++ +I S ++ +
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESS 172
Query: 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQ 797
F LV++ M G L ++L E L+ + +I + A+ +LH +
Sbjct: 173 SFMFLVFDLMRKGELFDYL-----------TEKVALSEKETRSIMRSLLEAVSFLHANN- 220
Query: 798 EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE---- 853
++H DLKP N+LLD++M + DFG + + L + C GT GY APE
Sbjct: 221 --IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-----GTPGYLAPEILKC 273
Query: 854 ------YGLGSEVSTNGDIYSYG----ILL 873
G G EV D+++ G LL
Sbjct: 274 SMDETHPGYGKEV----DLWACGVILFTLL 299
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-19
Identities = 61/263 (23%), Positives = 90/263 (34%), Gaps = 40/263 (15%)
Query: 632 RRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSST----HLIGMGSFGSVYKGAFDQD 687
+ LQ + S +G G++G V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 688 GTIVAIKVFNLQRHGASK--SFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745
AIK+ S L E LK + H N++K+ F+ LV E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVME 116
Query: 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805
G L D I K + I V S + YLH H ++H DL
Sbjct: 117 CYKGGEL-----------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDL 162
Query: 806 KPGNVLLDND------MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE 859
KP N+LL++ I DFGL+ V + + + GT Y APE L +
Sbjct: 163 KPENLLLESKEKDALIKIV---DFGLSAVFENQKKMKERL-----GTAYYIAPEV-LRKK 213
Query: 860 VSTNGDIYSYGILLLEMVTGKKP 882
D++S G++L ++ G P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-19
Identities = 61/235 (25%), Positives = 95/235 (40%), Gaps = 34/235 (14%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIR 718
D F ++G G FG V+ G + A K N +R G + + E K L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVH 243
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
R +V + F+ LV M G + H V + + + +
Sbjct: 244 SRFIVS-LAYA----FETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRA----I 292
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLT 836
A + S +++LH +++ DLKP NVLLD+D +V D GLA + T
Sbjct: 293 FYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKT 346
Query: 837 QS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ GT G+ APE LG E + D ++ G+ L EM+ + P F
Sbjct: 347 KGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP----FRAR 392
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 9e-19
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 35/225 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G+FG V++ G A K ++ E + + +RH LV + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F+ ++ ++YEFM+ G L + V + K++ + + V +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELF-----EKVADEH-----NKMSEDEAVEYMRQVCKGLC 269
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDND-----MIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
++H + +H DLKP N++ + DFGL ++ + G
Sbjct: 270 HMHEN---NYVHLDLKPENIMFTTKRSNELKLI---DFGLTAHLDPKQSVKVTT-----G 318
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
T +AAPE G V D++S G+L +++G P F G+
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGE 359
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-KSFLAECK-ALKNIRHRNLVKVITS 728
+G G++G V K G I+A+K + K L + +++ + V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-EIEIQKLTLLQRINIAIDVAS 787
F+ D + E M + SL+ + + + E + K IA+ +
Sbjct: 75 L----FREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--------IAVSIVK 120
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
A+++LH V+H D+KP NVL++ + DFG++ V ++ + G
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDIDA---GCK 173
Query: 848 GYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE S DI+S GI ++E+ + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 64/265 (24%), Positives = 105/265 (39%), Gaps = 44/265 (16%)
Query: 635 GPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK 694
GP + S +D + ++G GSFG V G A+K
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 695 VFN---LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGS 751
V + +++ +S L E + LK + H N++K+ F+ + LV E T G
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGE 112
Query: 752 LENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811
L + + I ++ + + I V S I Y+H + ++H DLKP N+L
Sbjct: 113 LFDEI-----------ISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLL 158
Query: 812 LDND------MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGD 865
L++ I DFGL+ + + GT Y APE L D
Sbjct: 159 LESKSKDANIRII---DFGLSTHFEASKKMKDKI-----GTAYYIAPEV-LHGTYDEKCD 209
Query: 866 IYSYGILLLEMVTGKKPTDVMFEGD 890
++S G++L +++G P F G
Sbjct: 210 VWSTGVILYILLSGCPP----FNGA 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 57/248 (22%), Positives = 88/248 (35%), Gaps = 64/248 (25%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVI 726
+IG G+F V Q G + A+K+ N + + G F E L N R + ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID-- 784
+ FQ ++ LV E+ G L LTLL + I
Sbjct: 128 FA-----FQDENYLYLVMEYYVGGDL--------------------LTLLSKFGERIPAE 162
Query: 785 --------VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLA-RVRQEVS 833
+ AID +H +H D+KP N+LLD H+ DFG ++R + +
Sbjct: 163 MARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGT 217
Query: 834 NLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIY-------SYGILLLEMVTGKKP--- 882
+ GT Y +PE Y + G+ EM G+ P
Sbjct: 218 VRSLVAV-----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272
Query: 883 --TDVMFE 888
T +
Sbjct: 273 DSTAETYG 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 52/251 (20%), Positives = 91/251 (36%), Gaps = 62/251 (24%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRN 721
F +IG G+FG V + A+K+ N + + + F E L N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+ + + FQ ++ LV ++ G L LTLL +
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDL--------------------LTLLSKFED 170
Query: 782 AID----------VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLA-RV 828
+ + AID +H +H D+KP N+L+D + H+ DFG ++
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCLKL 225
Query: 829 RQEVSNLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNG-----DIYSYGILLLEMVTGKKP 882
++ + + GT Y +PE E D +S G+ + EM+ G+ P
Sbjct: 226 MEDGTVQSSVAV-----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
Query: 883 -----TDVMFE 888
+
Sbjct: 281 FYAESLVETYG 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 45/218 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITS 728
+G G+F V + G A K+ N ++ A + E + + ++H N+V++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
Q F LV++ +T G L + + + + + + +
Sbjct: 74 -----IQEESFHYLVFDLVTGGELFEDI-----------VAREFYSEADASHCIQQILES 117
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
I Y H + ++H +LKP N+LL + DFGLA + G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----G 169
Query: 846 TIGYAAPE------YGLGSEVSTNGDIYSYG----ILL 873
T GY +PE Y V DI++ G ILL
Sbjct: 170 TPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 54/215 (25%), Positives = 76/215 (35%), Gaps = 42/215 (19%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG GS+G V A K F E + +K++ H N++++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F+ N LV E T G L + + + I DV SA+
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERV-----------VHKRVFRESDAARIMKDVLSAVA 120
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDN---DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
Y H V H DLKP N L D + DFGLA + + GT
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTP 172
Query: 848 GYAAPE-----YGLGSEVSTNGDIYSYG----ILL 873
Y +P+ YG E D +S G +LL
Sbjct: 173 YYVSPQVLEGLYGP--EC----DEWSAGVMMYVLL 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRN 721
F IG GSFG V + + A+K N ++ E + ++ + H
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
LV + S FQ + +V + + G L L Q++V + + + ++ I
Sbjct: 77 LVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHL------QQNVHFKEETV----KLFI 121
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
++ A+DYL + ++H D+KP N+LLD H+ DF +A + + +T
Sbjct: 122 C-ELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-- 175
Query: 842 GVRGTIGYAAPE-------YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE G V D +S G+ E++ G++P
Sbjct: 176 ---GTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 61/243 (25%), Positives = 112/243 (46%), Gaps = 35/243 (14%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGASKSFLAECKALKNI 717
++ T +IG GSFG VY+ G +VAIK V +R E + ++ +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKL 104
Query: 718 RHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
H N+V+ SS + + + LV +++ ++ + ++ + + KL
Sbjct: 105 DHCNIVRLRYFFY--SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHVGDFGLARV-RQEV 832
+ Q + ++ Y+H + H D+KP N+LLD D + + DFG A+ +
Sbjct: 162 MYQ-------LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
N++ CS R Y APE G+ +++ D++S G +L E++ G +P +F GD
Sbjct: 212 PNVSYICS---R---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGDS 261
Query: 892 NLH 894
+
Sbjct: 262 GVD 264
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 17/205 (8%)
Query: 377 NLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL 436
+ + L+ N++S +S L+ L L++N L+ + + L L L L +N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 437 NGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQ-L 493
++ F L L ++L+L R L + + L L+ + N L +P
Sbjct: 93 LRSVDPATFHGLGRL-HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 494 GLCSYLEEIYMRGNFFHGSIP----SSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEY 548
L +++ GN S+P L SL + L +N ++ + P DL L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR---LLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 549 LNLSFNDLEGEVPTKGVFANISRIS 573
L L N+L +P A + +
Sbjct: 206 LYLFANNLS-ALP-TEALAPLRALQ 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 13/218 (5%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
++P GI R+ + GN+ + +NL + L+ N L+ ++ L++L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 403 SELLLNNNS-LSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNH 460
+L L++N+ L V P+ L +L LHL GL + +F L L L L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL-QYLYLQDNA 140
Query: 461 LVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQL--GLCSYLEEIYMRGNFFHGSIPSSL 517
L ++P +L L + N +S +P + GL S L+ + + N P +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS-LDRLLLHQNRVAHVHPHAF 197
Query: 518 SSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFN 554
L ++ + L NNLS L + L L +L+YL L+ N
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 46/204 (22%), Positives = 73/204 (35%), Gaps = 6/204 (2%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
+ L +S + L + L +N + F L LE L LSDN +
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 95 EIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNL 151
+ RL L L R L + F L L+ L +Q N L +P +L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
+L + L N + L L L L N ++ + P + +L L + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHN 235
+LP L L+ +++ N
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 17/224 (7%)
Query: 240 SIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299
++P+ + + + I N S + +F +NL+ + N L ++ +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA------AAF 76
Query: 300 ANCSNLRTLIFAAN-KLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRL 357
+ L L + N +LR P + L +L L + L + G+ L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134
Query: 358 GMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVI 416
+ N +P + L NL + L+ N++S + L L LLL+ N ++ V
Sbjct: 135 YLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 417 PSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARN 459
P L +L L+LF N L+ +P E L L L L N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY-LRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 10/209 (4%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRNKL 116
+ I L N I F L L+L N L I A + + L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 117 MGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIP-NSLG 173
+ S+ F L +L L + R L + P + L +L+ + L NA +P ++
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL-QALPDDTFR 150
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
L L L L N +S + + L L + +N+ + P L L +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209
Query: 234 HNFFSGSIPIS-LSNASKLEFIEALDNSF 261
N S ++P L+ L+++ DN +
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 47/235 (20%), Positives = 81/235 (34%), Gaps = 26/235 (11%)
Query: 186 NNLSGI---IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS 240
L + IP + + L N VP F +L + +H N +
Sbjct: 21 QGLQAVPVGIPAASQRIFLHGNRISHVPAASFRA---------CRNLTILWLHSNVLARI 71
Query: 241 IPISLSNASKLEFIEALDNSFSGKLSVN-FGGMKNLSYFNVAYNNLGSGESDEMSFMNSL 299
+ + + LE ++ DN+ + F G+ L ++ L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG------LF 125
Query: 300 ANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLG 358
+ L+ L N L+ + +L L +L + N++ S+P L L RL
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLG-NLTHLFLHGNRIS-SVPERAFRGLHSLDRLL 183
Query: 359 MGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412
+ N+ + L L + L+ N LS +L L L L LN+N
Sbjct: 184 LHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 7/161 (4%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSD 89
+ L+L S+ P L L ++L +Q E+ F L L+ L+L D
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138
Query: 90 NDLVGEIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI 148
N L +P + LT LFL N++ F L+ L +L + +N + + P
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHA 196
Query: 149 -GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNL 188
+L L ++ L AN +L L+ L+ L L N
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 48/255 (18%), Positives = 83/255 (32%), Gaps = 38/255 (14%)
Query: 136 QRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPS 195
+ L +P I + + I L N S + L L L +N L+ I +
Sbjct: 19 PQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 196 IYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIE 255
L+LL + N S+ P+ L L + + L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL---------- 124
Query: 256 ALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKL 315
F G+ L Y + N L + D + + NL L N++
Sbjct: 125 -------------FRGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGNRI 165
Query: 316 RGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKE-MG 373
+ L L L++ N++ + +L L L + N + +P E +
Sbjct: 166 SSVPERAFRGLH-SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALA 222
Query: 374 KLQNLEGMGLYDNQL 388
L+ L+ + L DN
Sbjct: 223 PLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 41/184 (22%), Positives = 65/184 (35%), Gaps = 33/184 (17%)
Query: 391 EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTY 449
+P + + + L+ N +S V + + + L IL L N L I F L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 450 LSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNF 508
L L+L+ N + S+ L L ++ L E+ L
Sbjct: 82 L-EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL--------------- 124
Query: 509 FHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTKGVFA 567
F G L++L+ + L N L L DL +L +L L N + VP F
Sbjct: 125 FRG-----LAALQY---LYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPE-RAFR 174
Query: 568 NISR 571
+
Sbjct: 175 GLHS 178
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 52/252 (20%), Positives = 89/252 (35%), Gaps = 67/252 (26%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRN 721
+ +IG G+FG V + A+K+ + + + S F E +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+V++ + FQ + + +V E+M G L + L+ ++
Sbjct: 131 VVQLFYA-----FQDDRYLYMVMEYMPGGDL--------------------VNLMSNYDV 165
Query: 782 AIDVA--------SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLA-RVRQ 830
A A+D +H +H D+KP N+LLD H+ DFG ++ +
Sbjct: 166 PEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK 220
Query: 831 EVSNLTQS-CSVGVRGTIGYAAPE--------YGLGSEVSTNGDIYSYGILLLEMVTGKK 881
E + GT Y +PE G E D +S G+ L EM+ G
Sbjct: 221 EGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDT 271
Query: 882 P-----TDVMFE 888
P +
Sbjct: 272 PFYADSLVGTYS 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-18
Identities = 58/269 (21%), Positives = 97/269 (36%), Gaps = 36/269 (13%)
Query: 628 CWFKRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD 687
+ + S R K F ++G G FG V
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRAT 208
Query: 688 GTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743
G + A K +R G L E + L+ + R +V + + ++ D LV
Sbjct: 209 GKMYACKKLEKKRIKKRKGE-AMALNEKQILEKVNSRFVVSLAYA-----YETKDALCLV 262
Query: 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHC 803
M G L+ ++ + + + A ++ ++ LH +++
Sbjct: 263 LTLMNGGDLKFHIY---------HMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYR 310
Query: 804 DLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS 861
DLKP N+LLD+ H+ D GLA E + GT+GY APE +
Sbjct: 311 DLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVVKNERYT 363
Query: 862 TNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ D ++ G LL EM+ G+ P F+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP----FQQR 388
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 44/217 (20%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITS 728
+G GSFG V K A+KV N + L E + LK + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ + +V E T G L + + I+ ++ + I V S
Sbjct: 90 -----LEDSSSFYIVGELYTGGELFDEI-----------IKRKRFSEHDAARIIKQVFSG 133
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
I Y+H H ++H DLKP N+LL + D + DFGL+ Q+ + + G
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-----G 185
Query: 846 TIGYAAPE-----YGLGSEVSTNGDIYSYG----ILL 873
T Y APE Y + D++S G ILL
Sbjct: 186 TAYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-18
Identities = 61/261 (23%), Positives = 115/261 (44%), Gaps = 37/261 (14%)
Query: 640 QPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNL 698
P++ I A ++ + +++ +IG GSFG V++ A + VAIK V
Sbjct: 20 DPNKVIKVLA---SDGKTGEQREIAYTNCKVIGNGSFGVVFQ-AKLVESDEVAIKKVLQD 75
Query: 699 QRHGASKSFLAECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENW 755
+R E + ++ ++H N+V S + D + F LV E++ ++
Sbjct: 76 KRFK-----NRELQIMRIVKHPNVVDLKAFFYS--NGDKKDEVFLNLVLEYV-PETVYRA 127
Query: 756 LHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-N 814
A ++ + + + KL + Q + ++ Y+H + H D+KP N+LLD
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQ-------LLRSLAYIHSIG---ICHRDIKPQNLLLDPP 177
Query: 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILL 873
+ + DFG A++ + Y APE G+ +TN DI+S G ++
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYIC-----SRYYRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 874 LEMVTGKKPTDVMFEGDLNLH 894
E++ G +P +F G+ +
Sbjct: 233 AELMQG-QP---LFPGESGID 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 36/225 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V++ K + + E L RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
F+ + +++EF++ + + + +L + ++ V A+
Sbjct: 70 ---FESMEELVMIFEFISGLDIF-----ERINTSAF-----ELNEREIVSYVHQVCEALQ 116
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDND-----MIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+LH H + H D++P N++ I +FG AR + N
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKII---EFGQARQLKPGDNFRLLF-----T 165
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
Y APE VST D++S G L+ +++G P F +
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAE 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 670 LIGMGSFGSVY---KGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRNL 722
++G G +G V+ K G I A+KV ++ + AE L+ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAV-PQKDVEIEIQKLTLLQRINI 781
V +I + FQ L+ E+++ G L L + + + +
Sbjct: 84 VDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-----------CFYL 127
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS- 838
A +++ A+ +LH +++ DLKP N++L++ HV DFGL + +T +
Sbjct: 128 A-EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTF 181
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
C GTI Y APE + S + D +S G L+ +M+TG P +
Sbjct: 182 C-----GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 31/226 (13%), Positives = 51/226 (22%), Gaps = 63/226 (27%)
Query: 670 LIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQRHGASKS---FLAECKALKNIRHRNLVKV 725
G ++ A D VA+ + Q L+ L I + +V
Sbjct: 38 FHGGVPPLQFWQ-ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 726 ITSCSSIDF-QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ D +V E++ GSL+ P I
Sbjct: 97 L------DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-------------GAIRAMQS 137
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+A+A D H V P V + D +
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ DI G L ++ + P
Sbjct: 175 ----TMPD-------ANPQDDIRGIGASLYALLVNRWP----LPEA 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 44/233 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK------SFLAECKALKNIRHRNLVK 724
+G G F V K G A K ++ AS+ E L+ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ ++ L+ E ++ G L ++L + + L+ + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL-----------AQKESLSEEEATSFIKQ 123
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDND-------MIAHVGDFGLARVRQEVSNLTQ 837
+ ++YLH + H DLKP N++L + + DFGLA ++
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI---DFGLAHEIEDGVEFKN 177
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE + D++S G++ +++G P F GD
Sbjct: 178 IF-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 221
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 41/252 (16%)
Query: 635 GPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK 694
GP + + + K +D + +G G+F V + G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 695 VFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSL 752
+ N ++ A + E + + ++H N+V++ S Q F LV++ +T G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL 115
Query: 753 ENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812
+ + + + + + +I Y H + ++H +LKP N+LL
Sbjct: 116 FEDI-----------VAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 161
Query: 813 ---DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE----YGLGSEVSTNGD 865
+ DFGLA + GT GY +PE V D
Sbjct: 162 ASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GTPGYLSPEVLKKDPYSKPV----D 212
Query: 866 IYSYG----ILL 873
I++ G ILL
Sbjct: 213 IWACGVILYILL 224
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 38/230 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS------FLAECKALKNIRHRNLVK 724
+G G F V K G A K ++ AS+ E L+ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ ++ L+ E ++ G L ++L + + L+ + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL-----------AQKESLSEEEATSFIKQ 123
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ ++YLH + H DLKP N++L + DFGLA ++
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE + D++S G++ +++G P F GD
Sbjct: 180 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS-KSFLAECKAL-KNIRHRNLVKVITS 728
+G G+ G V+K F + G ++A+K + K L + + K+ +V+ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLH-PDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
D + E M + + +P E + K + + +
Sbjct: 93 F----ITNTDVF-IAMELMGTCAEKLKKRMQGPIP----ERILGK--------MTVAIVK 135
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
A+ YL + V+H D+KP N+LLD + DFG++ + V + + S G
Sbjct: 136 ALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSA---GCA 188
Query: 848 GYAAPE-----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE + D++S GI L+E+ TG+ P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-17
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 50/233 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVITS 728
+G GSFG V K A+KV N + L E + LK + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ + +V E T G L D I+ ++ + I V S
Sbjct: 90 -----LEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDND------MIAHVGDFGLARVRQEVSNLTQSCSVG 842
I Y+H H ++H DLKP N+LL++ I DFGL+ Q+ + +
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKII---DFGLSTCFQQNTKMKDRI--- 184
Query: 843 VRGTIGYAAPE-----YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE Y + D++S G++L +++G P F G
Sbjct: 185 --GTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGK 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 59/262 (22%), Positives = 95/262 (36%), Gaps = 48/262 (18%)
Query: 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIK----VFNLQRHGASKSFLA 709
D + HLIG GS+G VY A+D++ VAIK +F K L
Sbjct: 18 GIKNVHVPDNYIIKHLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRMFEDLID--CKRILR 74
Query: 710 ECKALKNIRHRNLVK---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV 766
E L ++ +++ +I + F ++ +V E ++ L + +
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKF--DEL-YIVLEIA-----DSDLK--KLFKTP- 123
Query: 767 EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLA 826
LT I ++ +++H + ++H DLKP N LL+ D V DFGLA
Sbjct: 124 ----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 827 RVRQEVSNLTQSCSVGVRGTIG------------------YAAPEYGLGSEVSTNG-DIY 867
R + + G Y APE L E T DI+
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236
Query: 868 SYGILLLEMVTGKKPTDVMFEG 889
S G + E++ +
Sbjct: 237 STGCIFAELLNMLQSHINDPTN 258
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 41/230 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSC 729
+G G+FG V+ G IK N R + AE + LK++ H N++K+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
F+ +V E G L + + + L+ + + +A+
Sbjct: 89 ----FEDYHNMYIVMETCEGGELL-----ERIVSAQARGK--ALSEGYVAELMKQMMNAL 137
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDND------MIAHVGDFGLARVRQEVSNLTQSCSVGV 843
Y H V+H DLKP N+L + I DFGLA + + + T +
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKII---DFGLAELFKSDEHSTNAA---- 187
Query: 844 RGTIGYAAPE---YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE + + DI+S G+++ ++TG P F G
Sbjct: 188 -GTALYMAPEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP----FTGT 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 59/250 (23%), Positives = 93/250 (37%), Gaps = 49/250 (19%)
Query: 635 GPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIK 694
G + P I + +D F +G G+ VY+ A+K
Sbjct: 33 GTASLVPDYWIDGSNRDAL--------SDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 695 VFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLEN 754
V + K E L + H N++K+ F+ +LV E +T G L +
Sbjct: 85 VLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFD 137
Query: 755 WLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL-- 812
+ +E + + + A+ YLH + ++H DLKP N+L
Sbjct: 138 RI-----------VEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYAT 183
Query: 813 -DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE----YGLGSEVSTNGDIY 867
D + DFGL+++ + + C GT GY APE G EV D++
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPGYCAPEILRGCAYGPEV----DMW 234
Query: 868 SYG----ILL 873
S G ILL
Sbjct: 235 SVGIITYILL 244
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 53/308 (17%), Positives = 115/308 (37%), Gaps = 37/308 (12%)
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
+ I A ++ + +V + ++ + + + + +
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--------IEGVQYL 62
Query: 303 SNLRTLIFAANKLRGALPHSIANLSD--QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360
+NL L N++ +A L + ++ L ++ N L S I L + L +
Sbjct: 63 NNLIGLELKDNQIT-----DLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLT 115
Query: 361 GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
Q T P + L NL+ + L NQ++ I S L L+ L L + N +S + P L
Sbjct: 116 STQITDVTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTP--L 169
Query: 421 GSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNV 480
+L +L L +N + + + +L L ++L N + P + N L + +
Sbjct: 170 ANLSKLTTLKADDNKI--SDISPLASLPNLIE-VHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540
++ ++ + + G P+++S + NL+ + F
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVK--GPSGAPIAPATISDN-----GTYASPNLTWNLTSF 277
Query: 541 LEDLSLEY 548
+ ++S +
Sbjct: 278 INNVSYTF 285
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/253 (20%), Positives = 96/253 (37%), Gaps = 24/253 (9%)
Query: 299 LANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLG 358
+N + + + + A+L D + L + +I G+ L L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADL-DGITTLSAFGTGVT-TI-EGVQYLNNLIGLE 69
Query: 359 MGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPS 418
+ NQ T P + L + + L N L S++ L + L L + ++ V P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 419 CLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN--SLNLARNHLVGSIPTKIGNLKYLR 476
L L L +L+L N + I L L+N L++ + P + NL L
Sbjct: 125 -LAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT 176
Query: 477 VFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536
N +S +I L L E++++ N S S L++ + + L+ ++
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQ 232
Query: 537 IPKFLEDLSLEYL 549
+ +L + +
Sbjct: 233 PVFYNNNLVVPNV 245
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 24/231 (10%)
Query: 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL 388
+ + + +L G+ L G T TI + L NL G+ L DNQ+
Sbjct: 20 NAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 389 SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLT 448
+ + L NL+ ++EL L+ N L V + L+ + L L + ++ L
Sbjct: 76 TD--LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT-----DVTPLA 126
Query: 449 YLSN--SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRG 506
LSN L L N + P + L L+ ++ + +S P L S L +
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182
Query: 507 NFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFNDL 556
N I S L+SL ++ + L N +S + P L + S L + L+ +
Sbjct: 183 NKIS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 42/289 (14%), Positives = 99/289 (34%), Gaps = 54/289 (18%)
Query: 126 SLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGA 185
+L ++A ++N+T +L + ++S I + L L L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 186 NNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISL 245
N ++ + P + NL+ + + N + L ++ +
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTST---------- 117
Query: 246 SNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNL 305
++ + L + NL + N + + ++ LA +NL
Sbjct: 118 ----QITDVTPLAG------------LSNLQVLYLDLNQI--------TNISPLAGLTNL 153
Query: 306 RTLIFAANKLRGALPHSIANLSD--QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ 363
+ L ++ + L++ +L L N++ I S + +L L + + NQ
Sbjct: 154 QYLSIGNAQVS-----DLTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQ 206
Query: 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412
+ P + NL + L + ++ + NL + + + + +
Sbjct: 207 ISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 48/251 (19%), Positives = 97/251 (38%), Gaps = 19/251 (7%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
L L+ ++ L+P + NL+ + E+ L N ++ + L ++ L L+ +
Sbjct: 66 IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQI-T 120
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
++ L+ S L +L+L N++ P L L+ L++ ++ + P + NL+ L
Sbjct: 121 DVT-PLAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTP-LANLSKL 175
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214
++ N +I L L L + L N +S + P + N S L ++
Sbjct: 176 TTLKADDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT- 230
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEF--IEALDNSFSGKLSVNFGGM 272
+ P L + V + P ++S+ + SF +S F
Sbjct: 231 NQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQS 288
Query: 273 KNLSYFNVAYN 283
V ++
Sbjct: 289 VTFKNTTVPFS 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 36/181 (19%), Positives = 64/181 (35%), Gaps = 13/181 (7%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
VL L ++ ++SP + L+ L+ +++ N + P L +L L DN +
Sbjct: 132 QVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS- 186
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
+I L+ L + L N++ P + L + + +T + NL
Sbjct: 187 DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
Query: 155 ESISLAANAFGGNI-PNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
+ G I P ++ S L NL+ I Y + F F
Sbjct: 244 NVVK---GPSGAPIAPATISDNGTYASPNL-TWNLTSFINNVSYTFNQSVTFKNTTVPFS 299
Query: 214 G 214
G
Sbjct: 300 G 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-17
Identities = 61/281 (21%), Positives = 99/281 (35%), Gaps = 60/281 (21%)
Query: 636 PSKQQPSRPILRKALQKVSYESLFKA-----TDGFSSTHLIGMGSFGSVYKGAFDQDGTI 690
R L ++ + + + +G G++G V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 691 VAIKV-------------FNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737
AIKV N + E LK++ H N++K+ F+
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDK 118
Query: 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQ 797
+ LV EF G L + I K NI + S I YLH H
Sbjct: 119 KYFYLVTEFYEGGELFEQI-----------INRHKFDECDAANIMKQILSGICYLHKHN- 166
Query: 798 EPVLHCDLKPGNVLLDN-DMIAH--VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPE- 853
++H D+KP N+LL+N + + + + DFGL+ + L GT Y APE
Sbjct: 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-----GTAYYIAPEV 219
Query: 854 ----YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
Y + D++S G+++ ++ G P F G
Sbjct: 220 LKKKY--NEKC----DVWSCGVIMYILLCGYPP----FGGQ 250
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 55/328 (16%), Positives = 89/328 (27%), Gaps = 67/328 (20%)
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
+ S ++ +D + +L V + S +
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGAL---RVLGI 94
Query: 303 SNLRTLIFAANKLRGALPHSIANLSD-QLQNLIMTSNQLHG--SIPSGIGNLV--GLYRL 357
S L+ L ++ G P + + L L + + + + + + GL L
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSS----LGNLSILSELLLNNN--- 410
+ +++ L + L DN GE L L L N
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIG 470
+ SGV + + QL L L N L +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP---------------------S 253
Query: 471 NLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR 530
L L N+S L ++P L P+ LS L DLS
Sbjct: 254 QLNSL---NLSFTGLK-QVPKGL--------------------PAKLSVL------DLSY 283
Query: 531 NNLSGLIPKFLEDLSLEYLNLSFNDLEG 558
N L P E + L+L N
Sbjct: 284 NRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 20/238 (8%)
Query: 371 EMGKLQNLEGMGLYDNQLSGEIPSS---LGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427
++ K +L+ + + ++ I + +S L EL L N ++G P L
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 428 ILHLFENGLN-GTIPEEIFNLTYLSN----SLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
+ L ++ T + L L++A+ H + ++ L ++S
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 483 NNLSGEIPSQLGLC----SYLEEIYMRGNFFH---GSIPSSLSSLRAVLAIDLSRNNLSG 535
N GE LC L+ + +R G + ++ + +DLS N+L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 536 LIP--KFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPK 591
L LNLSF L+ +VP KG+ A +S + + +NRL +LP+
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVP-KGLPAKLSVLDL-SYNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 21/244 (8%)
Query: 58 LREINLMNNSIQGEIPREFGRLF---RLEALFLSDNDLVGEIPANLS--YCSRLTILFLG 112
L+ + + I I R+ L+ L L + ++ G P L L IL L
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 113 RNKLMGSIPF----EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNI 168
+ + + LK L++ + + + +L ++ L+ N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 169 -------PNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG 221
P L+ L G SG+ L + N +
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249
Query: 222 LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVA 281
L + +P L +KL ++ N S + + ++
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS--PDELPQVGNLSLK 304
Query: 282 YNNL 285
N
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 53/317 (16%), Positives = 90/317 (28%), Gaps = 59/317 (18%)
Query: 106 LTILFLGRNKLMGSIPF-EFFSLYKLKQLAMQRNNLTGGIPP---FIGNLTSLESISLAA 161
L L + F + LK+L ++ + I + ++ L+ ++L
Sbjct: 45 LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104
Query: 162 NAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG 221
G P L + P + L+L R+ + L L
Sbjct: 105 LEVTGTAPPPLLEAT----------------GPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 222 LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL----SVNFGGMKNLSY 277
L L + Q H FS L ++ DN G+ ++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPA---LSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 278 FNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTS 337
+ + E+ A L+ L + N LR A + QL +L ++
Sbjct: 206 LALRNAGM---ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
Query: 338 NQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLG 397
L +P G+ L + L N+L PS
Sbjct: 263 TGLK-QVPKGL--------------------------PAKLSVLDLSYNRLD-RNPSPDE 294
Query: 398 NLSILSELLLNNNSLSG 414
L + L L N
Sbjct: 295 -LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 52/324 (16%), Positives = 92/324 (28%), Gaps = 64/324 (19%)
Query: 53 GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSY---CSRLTIL 109
G S + ++ + + L+ L + + I S L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 110 FLGRNKLMGSIPFEFFSLY--KLKQLAMQRNNLTGGIPPFIGNL-----TSLESISLAAN 162
L ++ G+ P L L + RN ++ L L+ +S+A
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNL-RNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 163 AFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGL 222
+ L +L L N G +L P
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERG------------------LISALCPL--- 198
Query: 223 TLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAY 282
P L++ + + + SG S L ++++
Sbjct: 199 KFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQGLDLSH 237
Query: 283 NNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG 342
N+L S S L +L + L+ +P L +L L ++ N+L
Sbjct: 238 NSLRDAAGAP-----SCDWPSQLNSLNLSFTGLK-QVP---KGLPAKLSVLDLSYNRLD- 287
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTG 366
PS L + L + GN F
Sbjct: 288 RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 45/251 (17%), Positives = 76/251 (30%), Gaps = 22/251 (8%)
Query: 227 LRLFQVHHNFFSGSIPISLS---NASKLEFIEALDNSFSGKLSVNFG--GMKNLSYFNVA 281
L+ V I S L+ + + +G +L+ N+
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 282 YNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLH 341
+ + ++ L L+ L A + L L ++ N
Sbjct: 130 NVSWATRDAWLAELQQWLK--PGLKVLSIAQAHSLNFSCEQVRVFP-ALSTLDLSDNPEL 186
Query: 342 GSI-------PSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS 394
G P L L G +G L+G+ L N L +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
Query: 395 SL-GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNS 453
S L+ L L+ L V P L + +L++L L N L+ P L + +
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQV-PKGLPA--KLSVLDLSYNRLD-RNPSPDE-LPQVG-N 300
Query: 454 LNLARNHLVGS 464
L+L N + S
Sbjct: 301 LSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 30/171 (17%), Positives = 53/171 (30%), Gaps = 13/171 (7%)
Query: 28 GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPRE----FGRLFRLE 83
+ VL++ + L ++L +N GE + L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 84 ALFLSDN---DLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNN 139
L L + G A + +L L L N L + +L L +
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 140 LTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190
L +P + L + L+ N P S +L ++ +L L N
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 61/278 (21%)
Query: 629 WFKRRRGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDG 688
K +K+ + + + F +G GSFG V + G
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVKHKESG 66
Query: 689 TIVAIKVFNLQRHGASKSF---LAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745
A+K+ + Q+ K L E + L+ + LVK+ S F+ N +V E
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSNLYMVME 121
Query: 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI---------AIDVASAIDYLHHHC 796
++ G + + L+RI A + +YLH
Sbjct: 122 YVAGGEM--------------------FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 797 QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS-CSVGVRGTIGYAAPEYG 855
+++ DLKP N+L+D V DFG A+ V T + C GT APE
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLC-----GTPEALAPEII 210
Query: 856 LGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
L + D ++ G+L+ EM G P ++E
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-16
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 60/245 (24%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRN 721
F +G GSFG V+ +G A+KV + R + E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
++++ + FQ ++ +++ G L +LL++
Sbjct: 68 IIRMWGT-----FQDAQQIFMIMDYIEGGEL--------------------FSLLRKSQR 102
Query: 782 ---------AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND---MIAHVGDFGLARVR 829
A +V A++YLH +++ DLKP N+LLD + I DFG A+
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT---DFGFAK-- 154
Query: 830 QEVSNLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----T 883
V ++T + C GT Y APE + + D +S+GIL+ EM+ G P T
Sbjct: 155 -YVPDVTYTLC-----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 884 DVMFE 888
+E
Sbjct: 209 MKTYE 213
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 31/186 (16%), Positives = 71/186 (38%), Gaps = 9/186 (4%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
S + + + A + + L + + + + + +GI + L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQM-NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
T P + L NLE + + ++ + +L L+ L+ L +++++ I + + +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
L ++ + L NG I + L L SLN+ + + I + L S
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPEL-KSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 483 NNLSGE 488
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 30/160 (18%), Positives = 65/160 (40%), Gaps = 11/160 (6%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
+T + L + ++ L+ I ++++ + N P L LE L + D+
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
+ NLS + LT+L + + SI + +L K+ + + N I P + L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPE 160
Query: 154 LESISLAANAFGGNIPN--SLGQLKELKSLGLGANNLSGI 191
L+S+++ + + + + +L L + + G
Sbjct: 161 LKSLNIQFD----GVHDYRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 27/166 (16%), Positives = 62/166 (37%), Gaps = 13/166 (7%)
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSD--QLQNLIMTSNQLHGSIPSGIGNLVGLY 355
+ A ++L + A + + + +++L + + + + I L L
Sbjct: 39 TEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIHA--TNYNPISGLSNLE 91
Query: 356 RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV 415
RL + G T + L +L + + + I + + L ++ + L+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 416 IPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
I L +L +L L++ +G++ I + L N L +
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL-NQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 27/158 (17%), Positives = 59/158 (37%), Gaps = 8/158 (5%)
Query: 54 NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGR 113
L +S ++ L + L++ + V ++ + Y + L +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDLT-GIEYAHNIKDLTINN 75
Query: 114 NKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLG 173
P L L++L + ++T P + LTSL + ++ +A +I +
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
L ++ S+ L N I P + L L + ++ +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 31/160 (19%), Positives = 60/160 (37%), Gaps = 14/160 (8%)
Query: 398 NLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN--SLN 455
LL +S + + + + L + L + ++ + Y N L
Sbjct: 21 TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINV-----TDLTGIEYAHNIKDLT 72
Query: 456 LARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPS 515
+ H P I L L + +++ + L + L + + + SI +
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 516 SLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFN 554
+++L V +IDLS N I L+ L L+ LN+ F+
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 24/218 (11%), Positives = 63/218 (28%), Gaps = 43/218 (19%)
Query: 125 FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPN--SLGQLKELKSLG 182
K + + SL I+LA N+ + + +K L
Sbjct: 17 IPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLT 72
Query: 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIP 242
+ + + P ++ L +L ++ +
Sbjct: 73 INNIHATNYNP--------ISG-------------------LSNLERLRIMGKDVTSDKI 105
Query: 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANC 302
+LS + L ++ ++ + + ++ +++YN ++ + L
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA-------ITDIMPLKTL 158
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQL 340
L++L + + I + +L L S +
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFP-KLNQLYAFSQTI 193
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 48/251 (19%), Positives = 94/251 (37%), Gaps = 43/251 (17%)
Query: 636 PSKQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV 695
P IL A V +E +++ + +IG G F V + + G A+K+
Sbjct: 3 PGISGGGGGILDMADDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKI 56
Query: 696 -----FNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG 750
F +++ E ++H ++V+++ + + + +V+EFM
Sbjct: 57 VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGA 111
Query: 751 SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
L + ++ + + + A+ Y H + ++H D+KP V
Sbjct: 112 DLC-----FEIVKR--ADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCV 161
Query: 811 LL---DNDMIAHVGDFGLAR-VRQEVSNLTQSCSVGVRGTIGYAAPE----YGLGSEVST 862
LL +N +G FG+A + + GT + APE G V
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-----GTPHFMAPEVVKREPYGKPV-- 214
Query: 863 NGDIYSYGILL 873
D++ G++L
Sbjct: 215 --DVWGCGVIL 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 38/229 (16%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHR-NLVKVIT 727
+G G F V + G A K +R G L E L+ + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
++ L+ E+ G + + + + ++ I + +
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLC---------LPELAEMVSENDVIRLIKQILE 142
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDND------MIAHVGDFGLARVRQEVSNLTQSCSV 841
+ YLH + ++H DLKP N+LL + I DFG++R L +
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIM-- 194
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT Y APE ++T D+++ GI+ ++T P F G+
Sbjct: 195 ---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGE 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 55/247 (22%)
Query: 663 DGFSSTHLIGMGSFGSVY---KGAFDQDGTIVAIKVFNLQRHGASKSFL-----AECKA- 713
F ++G GSFG V+ K + + A+KV K+ L K
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76
Query: 714 ---LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI 770
L + H +VK+ + FQ L+ +F+ G L L K+V
Sbjct: 77 RDILVEVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL------SKEV---- 121
Query: 771 QKLTLLQ-RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLAR 827
T + +A ++A A+D+LH +++ DLKP N+LLD + H+ DFGL++
Sbjct: 122 -MFTEEDVKFYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK 174
Query: 828 VRQEVSNLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP---- 882
+ S C GT+ Y APE + + D +S+G+L+ EM+TG P
Sbjct: 175 ESIDHEKKAYSFC-----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 883 -TDVMFE 888
Sbjct: 230 DRKETMT 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 44/233 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASK------SFLAECKALKNIRHRNLVK 724
+G G F V K G A K +R +S+ E L+ IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ F+ L+ E ++ G L ++L E + LT +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL-----------AEKESLTEDEATQFLKQ 116
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDND-------MIAHVGDFGLARVRQEVSNLTQ 837
+ + YLH + H DLKP N++L + + DFG+A + +
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI---DFGIAHKIEAGNEFKN 170
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE + D++S G++ +++G P F G+
Sbjct: 171 IF-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGE 214
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 47/219 (21%), Positives = 81/219 (36%), Gaps = 46/219 (21%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
+G G+F V + G A + N ++ + E + + ++H N+V++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
L+++ +T G L + + + + + + A
Sbjct: 79 -----ISEEGHHYLIFDLVTGGELFEDI-----------VAREYYSEADASHCIQQILEA 122
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLAR-VRQEVSNLTQSCSVGVR 844
+ + H V+H +LKP N+LL + DFGLA V E
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA----- 174
Query: 845 GTIGYAAPE------YGLGSEVSTNGDIYSYG----ILL 873
GT GY +PE YG V D+++ G ILL
Sbjct: 175 GTPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 40/231 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKS------FLAECKALKNIRHRNLVK 724
+G G F V K G A K +R +S+ E LK I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ ++ L+ E + G L ++L E + LT +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFL-----------AEKESLTEEEATEFLKQ 122
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLL-----DNDMIAHVGDFGLARVRQEVSNLTQSC 839
+ + + YLH + H DLKP N++L I + DFGLA +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIK-IIDFGLAHKIDFGNEFKNIF 178
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
GT + APE + D++S G++ +++G P F GD
Sbjct: 179 -----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 46/253 (18%)
Query: 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIK-VFN-LQRHGASKSFLAECKALK 715
+ +G G++G V+K + D+ G +VA+K +F+ Q ++ E L
Sbjct: 5 RHVLRKYELVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 716 NIR-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLT 774
+ H N+V ++ + + D LV+++M E LH AV I L
Sbjct: 64 ELSGHENIVNLLNVLRADND--RDV-YLVFDYM-----ETDLH--AV------IRANILE 107
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
+ + + + I YLH +LH D+KP N+LL+ + V DFGL+R +
Sbjct: 108 PVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 835 LTQSCSVGVRGTIG-----------------YAAPEYGLGSEVSTNG-DIYSYGILLLEM 876
+T + + + Y APE LGS T G D++S G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 877 VTGKKPTDVMFEG 889
+ GK +F G
Sbjct: 225 LCGK----PIFPG 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKALKNIRHRNLVKVI 726
L+G G+FG V G A+K+ + + E + L+N RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ-RINIAIDV 785
+ FQ +D V E+ G L L ++ + T + R A ++
Sbjct: 72 YA-----FQTHDRLCFVMEYANGGELFFHL------SRE-----RVFTEERARFYGA-EI 114
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS-CSVG 842
SA++YLH V++ D+K N++LD D H+ DFGL + ++ C
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFC--- 166
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
GT Y APE ++ D + G+++ EM+ G+ P + +FE
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 47/259 (18%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIK-VFNLQRHGASKSFLAECKALKNIRHRNLV 723
+S +G GSFG V + + G A+K V R+ E +K + H N++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVNII 63
Query: 724 K---VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI------EIQKLT 774
K + + + + + N H + E T
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 775 LLQRINIAIDVAS----------------AIDYLHHHCQEPVLHCDLKPGNVLLD-NDMI 817
L + + I A+ ++H + H D+KP N+L++ D
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNT 180
Query: 818 AHVGDFGLARVRQEVSNLTQ-SCSVGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLE 875
+ DFG A+ CS R Y APE LG+ T D++S G + E
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICS---R---FYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 876 MVTGKKPTDVMFEGDLNLH 894
++ G KP +F G+ ++
Sbjct: 235 LILG-KP---LFSGETSID 249
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-15
Identities = 58/270 (21%), Positives = 92/270 (34%), Gaps = 49/270 (18%)
Query: 629 WFKRRRGPSKQQPSRPILRKALQKVSYESLFKAT-DGFSSTHLIGMGSFGSVYKGAFDQD 687
R ++ + Q + E T + FS +IG G FG VY
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT 213
Query: 688 GTIVAIKVFN----LQRHGASKSFLAECKAL---KNIRHRNLVKVITSCSSIDFQGNDFK 740
G + A+K + + G L E L +V + + F D
Sbjct: 214 GKMYAMKCLDKKRIKMKQGE-TLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKL 267
Query: 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPV 800
+ + + M G L L + + A ++ ++++H+ V
Sbjct: 268 SFILDLMNGGDLHYHLS-----------QHGVFSEADMRFYAAEIILGLEHMHNRF---V 313
Query: 801 LHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS-CSVGVRGTIGYAAPE---- 853
++ DLKP N+LLD HV D GLA + GT GY APE
Sbjct: 314 VYRDLKPANILLDEH--GHVRISDLGLA--CDFSKKKPHASV-----GTHGYMAPEVLQK 364
Query: 854 -YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S D +S G +L +++ G P
Sbjct: 365 GVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 44/239 (18%), Positives = 89/239 (37%), Gaps = 28/239 (11%)
Query: 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS 327
N+ ++ + +++ +I + ++ S+ +
Sbjct: 16 PDDAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDIK-----SVQGIQ 62
Query: 328 D--QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYD 385
+ L + N+L I + NL L L + N+ + L+ L+ + L
Sbjct: 63 YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEH 118
Query: 386 NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF 445
N +S +I + L +L L L L NN ++ + + L L +L L L +N + + +
Sbjct: 119 NGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLA 172
Query: 446 NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYM 504
LT L +L L++NH+ S + LK L V + S + + +
Sbjct: 173 GLTKL-QNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 9e-14
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 21/257 (8%)
Query: 54 NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGR 113
+ + NL S+ + L ++ + +++D+ + + Y +T LFL
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74
Query: 114 NKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLG 173
NKL P +L L L + N + + + +L L+S+SL N +I L
Sbjct: 75 NKLTDIKPLT--NLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGI-SDING-LV 128
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
L +L+SL LG N ++ I + L+ L S+ NQ + P GLT L+ +
Sbjct: 129 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVPLAGLT--KLQNLYLS 183
Query: 234 HNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS-GESDE 292
N S L + L+ ++ L+ L+ NL N N GS +
Sbjct: 184 KNHIS-----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 293 MSFMNSLANCSNLRTLI 309
+S + L
Sbjct: 239 ISDDGDYEKPNVKWHLP 255
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 4e-13
Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 46/231 (19%)
Query: 330 LQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLS 389
+ I S + I + + T + + +L +++ + ++ +
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 390 GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTY 449
+ + L +++L LN N L+ + P L +LK L L L EN + +++ +L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI-----KDLSSLKD 107
Query: 450 LSN--SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507
L SL+L N + S + +L L + +N ++
Sbjct: 108 LKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--------------------- 144
Query: 508 FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
+ LS L + + L N +S ++P L L L+ L LS N +
Sbjct: 145 -----DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 4e-12
Identities = 54/260 (20%), Positives = 95/260 (36%), Gaps = 20/260 (7%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
T L L L+ + P + NL L + L N I+ ++ L +L++L L N +
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS- 122
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
+I L + +L L+LG NK+ L KL L+++ N ++ I P LT L
Sbjct: 123 DIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVPL-AGLTKL 177
Query: 155 ESISLAANAFGGNIPN--SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
+++ L+ N +I + +L LK L L L + NL +
Sbjct: 178 QNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
S V + + +S + +A F G+++ +
Sbjct: 234 VTPEIIS---DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA-KARFHGRVTQPLKEV 289
Query: 273 KNLSYFNVAYNNLGSGESDE 292
+SY E+
Sbjct: 290 YTVSYDVDGTVIKTKVEAGT 309
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 53/278 (19%), Positives = 96/278 (34%), Gaps = 74/278 (26%)
Query: 669 HLIGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRHGAS----KSFLAECKALKNI-R 718
+G G+FG V + VA+K+ + GA+ ++ ++E K L +I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGH 84
Query: 719 HRNLVKVITSCSSIDF------------------------------------QGNDFKAL 742
H N+V ++ +C+ QG D+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 743 VYEFMTNGS---------------LENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
+ + E L + ++ LTL I + VA
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG--VRG 845
+++L +H DL N+LL + + DFGLAR + + + ++
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882
APE + D++S+G+LL E+ + G P
Sbjct: 262 M----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 48/238 (20%), Positives = 88/238 (36%), Gaps = 38/238 (15%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
IP + L + N L+ + L ++ + +LS L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHL 461
S L+L N + + L L L E L ++ +L L LN+A N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL-KELNVAHNLI 136
Query: 462 VGSIP-----TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516
S + + NL++L ++SSN + I +
Sbjct: 137 Q-SFKLPEYFSNLTNLEHL---DLSSNKIQ-SIYC--------------TDL------RV 171
Query: 517 LSSLRAV-LAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRIS 573
L + + L++DLS N ++ + P +++ L+ L L N L+ VP G+F ++ +
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVP-DGIFDRLTSLQ 227
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 17/211 (8%)
Query: 35 TVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
L+L L L Y + L+ ++L IQ + L L L L+ N +
Sbjct: 31 KNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI- 88
Query: 94 GEIPANL-SYCSRLTILFLGRNKLMGSIP-FEFFSLYKLKQLAMQRNNLTGGIPP--FIG 149
+ S S L L L S+ F L LK+L + N + P F
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS- 146
Query: 150 NLTSLESISLAANAFGGNIPN----SLGQLKELK-SLGLGANNLSGIIPPSIYNLSLLAN 204
NLT+LE + L++N +I L Q+ L SL L N ++ I P + L
Sbjct: 147 NLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
++ NQ S+P + L L+ +H N
Sbjct: 205 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 45/252 (17%), Positives = 78/252 (30%), Gaps = 52/252 (20%)
Query: 192 IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS 249
+P S NL L N + F P L++ +
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFS---------FPELQVLDLSRC-------------- 62
Query: 250 KLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLI 309
+++ IE ++ + +LS + N + S + + S+L+ L+
Sbjct: 63 EIQTIED--GAYQS--------LSHLSTLILTGNPIQSLAL------GAFSGLSSLQKLV 106
Query: 310 FAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPS-GI-GNLVGLYRLGMGGNQFTGT 367
L +L + L+ L + N + S NL L L + N+ +
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-S 163
Query: 368 IPKEM-GKLQNLEGMG----LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
I L + + L N ++ I L EL L+ N L V
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222
Query: 423 LKQLAILHLFEN 434
L L + L N
Sbjct: 223 LTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 19/213 (8%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKL 116
+ ++L N ++ F L+ L LS ++ I S L+ L L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPI 88
Query: 117 MGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGG-NIPNSLG 173
S+ FS L L++L NL + F G+L +L+ +++A N +P
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP----RNQFHGSLPPSL--GLTLPHL 227
L L+ L L +N + I + L + ++ N + + P + L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 228 RLFQVHHNFFSGSIPI-SLSNASKLEFIEALDN 259
L N S+P + L+ I N
Sbjct: 206 AL---DTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 58/240 (24%), Positives = 107/240 (44%), Gaps = 54/240 (22%)
Query: 670 LIGMGSFGSVY---KGAFDQDGTIVAIKVFN----LQRHGASKSFLAECKALKNIRHRN- 721
++G G++G V+ K + G + A+KV +Q+ ++ E + L++IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ-RIN 780
LV + + FQ L+ +++ G L L + ++ T + +I
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGELFTHL------SQR-----ERFTEHEVQIY 164
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVR-QEVSNLTQ 837
+ ++ A+++LH +++ D+K N+LLD++ HV DFGL++ + +
Sbjct: 165 VG-EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAY 218
Query: 838 S-CSVGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
C GTI Y AP+ G V D +S G+L+ E++TG P F D
Sbjct: 219 DFC-----GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP----FTVD 265
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 59/242 (24%), Positives = 85/242 (35%), Gaps = 82/242 (33%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA----ECKALKNIR-HRNLVKV 725
+G GSF K + A+K+ + K A E ALK H N+VK+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI------ 779
F LV E + G L +RI
Sbjct: 72 HEV-----FHDQLHTFLVMELLNGGEL-----------------------FERIKKKKHF 103
Query: 780 ------NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND------MIAHVGDFGLAR 827
I + SA+ ++H V+H DLKP N+L ++ I DFG AR
Sbjct: 104 SETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKII---DFGFAR 157
Query: 828 -VRQEVSNLTQSCSVGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILLLEMVTGK 880
+ L C T+ YAAPE Y D++S G++L M++G+
Sbjct: 158 LKPPDNQPLKTPC-----FTLHYAAPELLNQNGYDE--SC----DLWSLGVILYTMLSGQ 206
Query: 881 KP 882
P
Sbjct: 207 VP 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 50/215 (23%), Positives = 80/215 (37%), Gaps = 22/215 (10%)
Query: 300 ANCS-NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRL 357
+ + + L ALP +L L ++ N L + L +L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLL-YTFSLATLMPYTRLTQL 60
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP 417
+ + T + G L L + L NQL +P L L+ L ++ N L+ +
Sbjct: 61 NLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 418 SCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIP----TKIGNL 472
L L +L L+L N L T+P + L L+LA N+L +P + NL
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEK-LSLANNNLT-ELPAGLLNGLENL 174
Query: 473 KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507
L + N+L IP L ++ GN
Sbjct: 175 DTL---LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 46/233 (19%), Positives = 82/233 (35%), Gaps = 41/233 (17%)
Query: 327 SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386
+ L ++P + L + N + L + L
Sbjct: 9 VASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF- 445
+L+ ++ G L +L L L++N L +P +L L +L + N L ++P
Sbjct: 66 ELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 446 NLTYLSNSLNLARNHLVGSIP----TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE 501
L L L L N L ++P T L+ L ++++NNL+ E+P+
Sbjct: 122 GLGELQE-LYLKGNELK-TLPPGLLTPTPKLEKL---SLANNNLT-ELPA---------- 165
Query: 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFN 554
+G L +L + L N+L + F L + L N
Sbjct: 166 -----GLLNG-----LENLDT---LLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 51/226 (22%), Positives = 74/226 (32%), Gaps = 34/226 (15%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
+N + L+ +L P + ++L N + RL L L +L
Sbjct: 13 LEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-T 68
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
++ L L L N+L S+P +L L L + N LT
Sbjct: 69 KLQV-DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT------------- 113
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY-NLSLLANFSVPRNQFH 213
SL A G L EL+ L L N L +PP + L S+ N
Sbjct: 114 ---SLPLGALRG--------LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
Query: 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDN 259
LP L L +L + N +IP + L F N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 37/155 (23%), Positives = 57/155 (36%), Gaps = 9/155 (5%)
Query: 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
+ +L +P +L TIL L N L +L QL + R LT
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 142 GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY-NLS 200
+ G L L ++ L+ N ++P L L L + N L+ +P L
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLG 124
Query: 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
L + N+ +LPP L P L + +N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANN 158
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 38/236 (16%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKAL-KNIRHR 720
F ++G GSFG V+ F + AIK + + + E + L H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
L + + FQ + V E++ G L + K L +
Sbjct: 79 FLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHIQSC-----------HKFDLSRATF 122
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS 838
A ++ + +LH +++ DLK N+LLD D H+ DFG+ + T +
Sbjct: 123 YAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNT 177
Query: 839 -CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
C GT Y APE LG + + + D +S+G+LL EM+ G+ P + +F
Sbjct: 178 FC-----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 51/257 (19%), Positives = 86/257 (33%), Gaps = 37/257 (14%)
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMG 360
C ++ I +L Q L + L +IPS NL + R+ +
Sbjct: 10 CHQEEDFRVTCKDIQ-----RIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63
Query: 361 GNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSS-LGNLSILSELLLNNNSLSGVIP- 417
+ + L + + + + + I L L +L L + N L + P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 418 -SCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYL 475
+ + S IL + +N +IP F L + +L L N S+ N L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKL 181
Query: 476 RVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSG 535
++ N I + F G + S S L D+S+ +++
Sbjct: 182 DAVYLNKNKYLTVIDK---------------DAFGG-VYSGPSLL------DVSQTSVTA 219
Query: 536 LIPKFLEDL-SLEYLNL 551
L K LE L L N
Sbjct: 220 LPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 34/205 (16%), Positives = 77/205 (37%), Gaps = 16/205 (7%)
Query: 377 NLEGMGLYDNQLSGEIPS-SLGNLSILSELLLN-NNSLSGVIPSCLGSLKQLAILHLFEN 434
+ + + L + L IPS + NL +S + ++ + +L + +L ++ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 435 GLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIP--TKIGNLKYLRVFNVSSNNLSGEIPS 491
I + L L L + L P TK+ + + ++ N IP
Sbjct: 91 RNLTYIDPDALKELPLL-KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 492 QL--GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNN-LSGLIPKFLEDL--SL 546
GLC+ + + N F S+ + + A+ L++N L+ + +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 547 EYLNLSFNDLEGEVPTKGVFANISR 571
L++S + +P+ ++
Sbjct: 208 SLLDVSQTSVT-ALPS-KGLEHLKE 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 26/168 (15%), Positives = 66/168 (39%), Gaps = 10/168 (5%)
Query: 58 LREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNK 115
+ + L+ ++ IP F L + +++S + + ++ ++ S++T + + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 116 LMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGGNIPNSL 172
+ I + L LK L + L P + + + + N + +IP +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 173 --GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPP 218
G E +L L N + + +N + L + +N++ +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 43/265 (16%), Positives = 86/265 (32%), Gaps = 48/265 (18%)
Query: 177 ELKSLGLGANNLSGI--IPPSIYNLSLLANF--SVPRNQFHGSLPPSLGLTLPHLRLFQV 232
+ + + ++ I +PPS L L+ ++P + F LP++ V
Sbjct: 12 QEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSN---------LPNISRIYV 62
Query: 233 HHNFFSGSIPI-SLSNASKLEFIEALDNSFSGKLSVN-FGGMKNLSYFNVAYNNLGSGES 290
+ + S N SK+ IE + + + + L + + L
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM--- 119
Query: 291 DEMSFMNSLANCSNLRTLIFAANKLRGALP-HSIANLSDQLQNLIMTSNQLHGSIPSGIG 349
+ + + L N ++P ++ L ++ L + +N S+
Sbjct: 120 --FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA- 175
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL--GNLSILSELLL 407
F GT KL + L N+ I G S S L +
Sbjct: 176 --------------FNGT------KLDAVY---LNKNKYLTVIDKDAFGGVYSGPSLLDV 212
Query: 408 NNNSLSGVIPSCLGSLKQLAILHLF 432
+ S++ + L LK+L + +
Sbjct: 213 SQTSVTALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 8/134 (5%)
Query: 54 NLSFLREINLMNNSIQGEIP--REFGRLFRLEALFLSDNDLVGEIPANL--SYCSRLTIL 109
L L+ + + N ++ P + L ++DN + IP N C+ L
Sbjct: 103 ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 110 FLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGGN 167
L N S+ F+ KL + + +N I F G + + ++ +
Sbjct: 162 KLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220
Query: 168 IPNSLGQLKELKSL 181
L LKEL +
Sbjct: 221 PSKGLEHLKELIAR 234
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKAL-KNIRHRNLVKV 725
+IG GSFG V + A+KV + + K ++E L KN++H LV +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ-RINIAID 784
S FQ D V +++ G L L Q++ + + R A +
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGELFYHL------QRE-----RCFLEPRARFYAA-E 147
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS-CSV 841
+ASA+ YLH +++ DLKP N+LLD+ H+ DFGL + E ++ T + C
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC-- 200
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
GT Y APE D + G +L EM+ G P T M++
Sbjct: 201 ---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 55/228 (24%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITS 728
++G G+ V A+K+ Q E + L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI--------- 779
F+ D LV+E M GS+ L I
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSI-----------------------LSHIHKRRHFNEL 111
Query: 780 ---NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVS 833
+ DVASA+D+LH+ + H DLKP N+L + + DF L +
Sbjct: 112 EASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 834 NLTQSCSVGVR---GTIGYAAPEYGLGSEVSTNG-----DIYSYGILL 873
+ + + + G+ Y APE + D++S G++L
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 48/227 (21%), Positives = 79/227 (34%), Gaps = 70/227 (30%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKAL-KNIRHRNLVKVITSC 729
IG+GS+ + A+K+ + + ++ E + L + +H N++ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV- 84
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI---------- 779
+ + +V E M G L L +I
Sbjct: 85 ----YDDGKYVYVVTELMKGGEL-----------------------LDKILRQKFFSERE 117
Query: 780 --NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDMIAHVGDFGLAR-VRQEV 832
+ + ++YLH V+H DLKP N+L N + DFG A+ +R E
Sbjct: 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 833 SNLTQSCSVGVRGTIGYAAPE------YGLGSEVSTNGDIYSYGILL 873
L C T + APE Y DI+S G+LL
Sbjct: 175 GLLMTPC-----YTANFVAPEVLERQGYDA--AC----DIWSLGVLL 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 1e-14
Identities = 56/275 (20%), Positives = 108/275 (39%), Gaps = 41/275 (14%)
Query: 628 CWFKRRRGPSKQQPSRPILRKALQKVSYESLFKAT-DGFSSTHLIGMGSFGSVYKGAFDQ 686
+ + + G + P + + + + F+ ++G GSFG V
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG 364
Query: 687 DGTIVAIKVFN----LQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 741
+ A+K+ +Q + + E + L + L + + SC FQ D
Sbjct: 365 TDELYAVKILKKDVVIQDDDV-ECTMVEKRVLALPGKPPFLTQ-LHSC----FQTMDRLY 418
Query: 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL 801
V E++ G L + ++ + + A ++A + +L ++
Sbjct: 419 FVMEYVNGGDLMYHIQ-----------QVGRFKEPHAVFYAAEIAIGLFFLQSK---GII 464
Query: 802 HCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS-CSVGVRGTIGYAAPEYGLGS 858
+ DLK NV+LD++ H+ DFG+ + T++ C GT Y APE
Sbjct: 465 YRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTFC-----GTPDYIAPEIIAYQ 517
Query: 859 EVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
+ D +++G+LL EM+ G+ P D +F+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 57/265 (21%), Positives = 103/265 (38%), Gaps = 30/265 (11%)
Query: 224 LPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYN 283
+ + ++ + + ++ I A ++ + + N++ + N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGN 78
Query: 284 NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD--QLQNLIMTSNQLH 341
L + LAN NL L NK++ +++L D +L++L + N +
Sbjct: 79 KLTD--------IKPLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI- 124
Query: 342 GSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSI 401
S +G+ +L L L +G N+ T + +L L+ + L DNQ+S +I L L+
Sbjct: 125 -SDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 179
Query: 402 LSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
L L L+ N +S + L LK L +L LF NL N++ L
Sbjct: 180 LQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVP-NTVKNTDGSL 236
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLS 486
V P I + NV +
Sbjct: 237 VT--PEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 44/238 (18%), Positives = 90/238 (37%), Gaps = 28/238 (11%)
Query: 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS 327
+ N+ ++ + +++ +I + ++ S+ +
Sbjct: 19 SDDAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDIK-----SVQGIQ 65
Query: 328 D--QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYD 385
+ L + N+L I + NL L L + N+ + L+ L+ + L
Sbjct: 66 YLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEH 121
Query: 386 NQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF 445
N +S +I + L +L L L L NN ++ + + L L +L L L +N + + +
Sbjct: 122 NGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLA 175
Query: 446 NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIY 503
LT L +L L++NH+ S + LK L V + S + + +
Sbjct: 176 GLTKL-QNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 59/264 (22%), Positives = 102/264 (38%), Gaps = 23/264 (8%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
NL+ K ++ L+ + +I N+ I+ + L + LFL+ N L
Sbjct: 26 TIKDNLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT 81
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
+I L+ L LFL NK+ + L KLK L+++ N ++ I + +L
Sbjct: 82 -DIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-LVHLPQ 135
Query: 154 LESISLAANAFGGNIPN--SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
LES+ L N I + L +L +L +L L N +S I + L+ L N + +N
Sbjct: 136 LESLYLGNN----KITDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNH 189
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGG 271
L GL +L + ++ SN ++ D S ++ G
Sbjct: 190 IS-DLRALAGLK--NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDG 246
Query: 272 MKNLSYFNVAYNNLGSGESDEMSF 295
+ NV ++ F
Sbjct: 247 --DYEKPNVKWHLPEFTNEVSFIF 268
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 20/187 (10%)
Query: 374 KLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE 433
L ++ + L+ + +++ NN+ + V + L + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 434 NGLNGTIPEEIFNLTYLSN--SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPS 491
N L +I L L N L L N + + + + +LK L+ ++ N +S +I
Sbjct: 78 NKL-----TDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING 129
Query: 492 QLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLN 550
L LE +Y+ N + + LS L + + L N +S ++P L L L+ L
Sbjct: 130 -LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 551 LSFNDLE 557
LS N +
Sbjct: 185 LSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 45/270 (16%), Positives = 96/270 (35%), Gaps = 30/270 (11%)
Query: 172 LGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQ 231
E L +++ + + L+ + + S+ L ++
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLP--NVTKLF 74
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
++ N + I L+N L ++ +N LS + +K L ++ +N +
Sbjct: 75 LNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD---- 126
Query: 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD--QLQNLIMTSNQLHGSIPSGIG 349
+N L + L +L NK+ I LS +L L + NQ+ I +
Sbjct: 127 ----INGLVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQIS-DI-VPLA 175
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L L L + N + + + L+NL+ + L+ + + + NL + + + +
Sbjct: 176 GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGT 439
SL V P + ++ + T
Sbjct: 234 GSL--VTPEIISDDGDYEKPNVKWHLPEFT 261
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 37/223 (16%), Positives = 72/223 (32%), Gaps = 11/223 (4%)
Query: 336 TSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSS 395
+++ IPS + L + +LE + + N + I +
Sbjct: 17 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 396 -LGNLSILSEL-LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNS 453
NL L E+ + N+L + P +L L L + G+ +P+ +
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 454 LNLARNHLVGSIPTKI--GNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEIYMRGNFFH 510
L++ N + +I G + ++ N + EI + E N
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
Query: 511 GSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552
+ +D+SR + L LE+L L +
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 37/188 (19%), Positives = 61/188 (32%), Gaps = 9/188 (4%)
Query: 54 NLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFL 111
L +I + N + I + F L +L + + + + I L L +
Sbjct: 52 GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111
Query: 112 GRNKLMGSIP-FEFFSLYKLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGGNI 168
+ +P + L +Q N I F+G + L N I
Sbjct: 112 SNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEI 169
Query: 169 PNSLGQLKELKSLGLGANNLSGIIPPSI-YNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227
NS +L L L NN +P + + S + R + H SLP L L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 228 RLFQVHHN 235
R ++
Sbjct: 229 RARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 39/220 (17%), Positives = 77/220 (35%), Gaps = 18/220 (8%)
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTL-IFAANKLRGALPHSIANLS 327
F G +L ++ N++ + +N L + I AN L P + NL
Sbjct: 50 FSGFGDLEKIEISQNDVLEVIEA-----DVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 328 DQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM--GKLQNLEGMGLY 384
LQ L++++ + +P + + L + N TI + G + L
Sbjct: 105 -NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444
N + S+ + L +NN+L + IL + ++ ++P
Sbjct: 163 KNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
Query: 445 F-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSN 483
NL L + + +PT + L L +++
Sbjct: 222 LENLKKLR-ARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 32/190 (16%), Positives = 60/190 (31%), Gaps = 8/190 (4%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPAN-LSYCSRLTILFLGRNKL 116
E+ + ++ F LE + +S ND++ I A+ S +L + + +
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 117 MGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPNSL-- 172
+ I E F L L+ L + + +P + + + N I +
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV 232
G E L L N + I + L N LP + + +
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDI 209
Query: 233 HHNFFSGSIP 242
S+P
Sbjct: 210 SRTRIH-SLP 218
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 52/240 (21%)
Query: 670 LIGMGSFGSVYKGAFD-QDGTIVAIKVF-NLQR-HGASKSFLAECKALKNIRHR---NLV 723
+IG GSFG V K A+D + VA+K+ N +R H + E + L+++R + N +
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTM 159
Query: 724 KVITSCSSIDFQGN---DFKAL---VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
VI + F+ + F+ L +YE + Q +L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF------------------QGFSLPL 201
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH--VGDFGLA-RVRQEVSN 834
A + +D LH + ++HCDLKP N+LL + V DFG + Q V
Sbjct: 202 VRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
QS Y APE LG+ D++S G +L E++TG + G+
Sbjct: 259 YIQSRF--------YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGD 306
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 46/235 (19%), Positives = 81/235 (34%), Gaps = 64/235 (27%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKAL-KNIRHRNLVKVITS 728
++G+G G V + + G A+K+ S E + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI--------- 779
++ ++ E M G L RI
Sbjct: 91 YENMHHGKRCL-LIIMECMEGGEL-----------------------FSRIQERGDQAFT 126
Query: 780 -----NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQE 831
I D+ +AI +LH H + H D+KP N+L + D + + DFG A+ +
Sbjct: 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 832 VSNLTQSCSVGVRGTIGYAAPE----YGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ L C T Y APE D++S G+++ ++ G P
Sbjct: 184 -NALQTPC-----YTPYYVAPEVLGPEKYDKSC----DMWSLGVIMYILLCGFPP 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 49/269 (18%), Positives = 85/269 (31%), Gaps = 74/269 (27%)
Query: 634 RGPSKQQPSRPILRKALQKVSYESLFKATDGFSSTH-----LIGMGSFGSVYKGAFDQDG 688
P++ P P S L + + ++G+G G V + +
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKS--GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ 87
Query: 689 TIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKALVYEFM 747
A+K+ E + + ++V+++ + + G +V E +
Sbjct: 88 EKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECL 141
Query: 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI--------------NIAIDVASAIDYLH 793
G L RI I + AI YLH
Sbjct: 142 DGGEL-----------------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 794 HHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
+ H D+KP N+L + I + DFG A+ ++LT C T Y
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-----YTPYYV 230
Query: 851 APE------YGLGSEVSTNGDIYSYGILL 873
APE Y D++S G+++
Sbjct: 231 APEVLGPEKYDK--SC----DMWSLGVIM 253
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 54/240 (22%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKAL-KNIRHR 720
F+ ++G GSFG V + A+K+ + + + + E + L +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ--- 777
L ++ + FQ D V E++ G L H IQ++ +
Sbjct: 82 FLTQLHSC-----FQTMDRLYFVMEYVNGGDL--MYH------------IQQVGRFKEPH 122
Query: 778 -RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSN 834
A ++A + +L +++ DLK NV+LD++ H+ DFG+ +
Sbjct: 123 AVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV 176
Query: 835 LTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVMFE 888
T++ C GT Y APE + D +++G+LL EM+ G+ P D +F+
Sbjct: 177 TTKTFC-----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 65/242 (26%), Positives = 95/242 (39%), Gaps = 46/242 (19%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKALKNI-R 718
D F ++G GSFG V + G + A+KV + + + + E + L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ- 777
H L ++ FQ D V EF+ G L H IQK
Sbjct: 83 HPFLTQLFCC-----FQTPDRLFFVMEFVNGGDL--MFH------------IQKSRRFDE 123
Query: 778 ---RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEV 832
R A ++ SA+ +LH +++ DLK NVLLD++ H DFG+ +
Sbjct: 124 ARARFYAA-EIISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICN 177
Query: 833 SNLTQS-CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP-----TDVM 886
T + C GT Y APE D ++ G+LL EM+ G P D +
Sbjct: 178 GVTTATFC-----GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 887 FE 888
FE
Sbjct: 233 FE 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKAL-KNIRHRNLVKV 725
+IG GS+ V + I A+KV + E + H LV +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ----RINI 781
+ FQ V E++ G L H +Q+ L R
Sbjct: 76 HSC-----FQTESRLFFVIEYVNGGDL--MFH------------MQRQRKLPEEHARFYS 116
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS- 838
A +++ A++YLH +++ DLK NVLLD++ H+ D+G+ + + T +
Sbjct: 117 A-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF 170
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
C GT Y APE G + + D ++ G+L+ EM+ G+ P
Sbjct: 171 C-----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVF---NLQRHGASKSFLAECKAL-KNIRHRNLVKV 725
+IG GS+ V + I A++V + E + H LV +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ----RINI 781
+ FQ V E++ G L H +Q+ L R
Sbjct: 119 HSC-----FQTESRLFFVIEYVNGGDL--MFH------------MQRQRKLPEEHARFYS 159
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQS- 838
A +++ A++YLH +++ DLK NVLLD++ H+ D+G+ + + T +
Sbjct: 160 A-EISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF 213
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
C GT Y APE G + + D ++ G+L+ EM+ G+ P
Sbjct: 214 C-----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 9/182 (4%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKL 116
++++L +N + + F RL +L L+L+DN L +PA + L L++ NKL
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 117 MGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPNSL-G 173
++P F L L +L + RN L +PP + +LT L +SL N ++P +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFD 154
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
+L LK L L N L + + L+ L + NQ +P +L L++ Q+
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQ 213
Query: 234 HN 235
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 57/237 (24%), Positives = 90/237 (37%), Gaps = 45/237 (18%)
Query: 327 SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386
++ ++ +S +L +IPS I T + L+ L N
Sbjct: 15 NNNKNSVDCSSKKLT-AIPSNI---------------PADT--------KKLD---LQSN 47
Query: 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF- 445
+LS + L+ L L LN+N L + LK L L + +N L +P +F
Sbjct: 48 KLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFD 106
Query: 446 NLTYLSNSLNLARNHLVGSIP----TKIGNLKYLRVFNVSSNNLSGEIPSQL--GLCSYL 499
L L L L RN L S+P + L YL ++ N L +P + L S L
Sbjct: 107 QLVNL-AELRLDRNQLK-SLPPRVFDSLTKLTYL---SLGYNELQ-SLPKGVFDKLTS-L 159
Query: 500 EEIYMRGNFFHGSIPSSL-SSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFN 554
+E+ + N +P L + + L N L + + L L+ L L N
Sbjct: 160 KELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 56/279 (20%), Positives = 88/279 (31%), Gaps = 91/279 (32%)
Query: 136 QRNNLT---GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192
LT IP + + L +N + +L +L+ L L N L
Sbjct: 24 SSKKLTAIPSNIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ--- 74
Query: 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLE 252
++P F L +L V N ++PI +
Sbjct: 75 -------------TLPAGIFKE---------LKNLETLWVTDNKLQ-ALPIGV------- 104
Query: 253 FIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAA 312
F + NL+ + N L S F +SL + L L
Sbjct: 105 ----------------FDQLVNLAELRLDRNQLKSLPPR--VF-DSL---TKLTYLSLGY 142
Query: 313 NKLRGALPHSI-ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE 371
N+L+ +LP + L+ L+ L + +NQL +P G F
Sbjct: 143 NELQ-SLPKGVFDKLT-SLKELRLYNNQLK-RVPEGA---------------FD------ 178
Query: 372 MGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
KL L+ + L +NQL + +L L L L N
Sbjct: 179 --KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 7e-12
Identities = 59/302 (19%), Positives = 100/302 (33%), Gaps = 84/302 (27%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-----HRNLV 723
+G G F +V+ Q VA+KV H + L E + LK++R N
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNRE 101
Query: 724 KVITSCSSIDFQGNDFK--ALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
V+ G + +V+E + G L W+ + + + K + Q
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWII--KSNYQGLPLPCVKKIIQQ--- 154
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---------------------------- 812
V +DYLH C+ ++H D+KP N+LL
Sbjct: 155 ----VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 813 ---------------------DNDMIAHVGDFGLAR-VRQEVSNLTQSCSVGVRGTIGYA 850
+ + D G A V + + Q T Y
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--------TRQYR 260
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVD 910
+ E +GS +T DI+S + E+ TG D +FE + +I+++
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATG----DYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 911 PI 912
+
Sbjct: 317 KV 318
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 37/175 (21%), Positives = 69/175 (39%), Gaps = 17/175 (9%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEM--GKLQNLEGMGLYDNQLSGEIPS-SLGNL 399
++P + L + N + + E +L NL + L N L+ I S + +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 400 SILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLAR 458
L L L++N L + L+ L +L L+ N + + F ++ L L L++
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK-LYLSQ 145
Query: 459 NHLVGSIPTKI----GNLKYLRVFNVSSNNLSGEIPSQLGLCSYL--EEIYMRGN 507
N + P ++ L L + ++SSN L + L +Y+ N
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 34/181 (18%), Positives = 59/181 (32%), Gaps = 30/181 (16%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI--GNLSFLREINLMNNSIQGEIPRE-FGRLFRLEALFLS 88
+L+L LS L L+ L + L +N + I E F + L L LS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 89 DNDLVGEIPAN-LSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPP 146
N L + S L +L L N + + F + +L++L + +N ++
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS----- 149
Query: 147 FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFS 206
+L +L L L +N L + + L
Sbjct: 150 -----------RFPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 207 V 207
+
Sbjct: 194 L 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 36/193 (18%)
Query: 368 IPKEMGKLQNLEGMGLYDNQLSGEIPS--SLGNLSILSELLLNNNSLSGVIPSCLGSLKQ 425
+P L L N LS + + + L+ L LLL++N L+ + +
Sbjct: 37 LPSYTALLD------LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89
Query: 426 LAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSN 483
L L L N L+ T+ E +F +L L L L NH+V + ++ L+ +S N
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEV-LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 484 NLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLED 543
+S P +L + L L +DLS N L L L+
Sbjct: 147 QIS-RFPVEL---------------IKD--GNKLPKLML---LDLSSNKLKKLPLTDLQK 185
Query: 544 L-SLEYLNLSFND 555
L + L ++
Sbjct: 186 LPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 33/196 (16%), Positives = 63/196 (32%), Gaps = 35/196 (17%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFE--FFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
+P +L S +L L N L + E L L L + N+L
Sbjct: 32 NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN----------- 77
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
+++ AF + L+ L L +N+L + +L L + N
Sbjct: 78 -----FISSEAFVP--------VPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPI-SLSNASKLEFIEALD---NSFSGKLSVN 268
+ + + L+ + N S P+ + + +KL + LD N +
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 269 FGGMKNLSYFNVAYNN 284
+ + +N
Sbjct: 183 LQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 29/146 (19%), Positives = 54/146 (36%), Gaps = 30/146 (20%)
Query: 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328
F + NL Y +++ N+L + + ++ L L+ N + ++ +++
Sbjct: 84 FVPVPNLRYLDLSSNHLHTLDEF------LFSDLQALEVLLLYNNHIVVVDRNAFEDMA- 136
Query: 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL 388
QLQ L ++ NQ+ P + KL L + L N+L
Sbjct: 137 QLQKLYLSQNQIS-RFPVEL---------------IKD-----GNKLPKLMLLDLSSNKL 175
Query: 389 SGEIPSSLGNLSILSE--LLLNNNSL 412
+ L L + L L+NN L
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 29/141 (20%), Positives = 61/141 (43%), Gaps = 15/141 (10%)
Query: 439 TIPEEIFNLTYLSNSLNLARNHLVGSIPTKI--GNLKYLRVFNVSSNNLSGEIPSQL--G 494
+P+ + + T L+L+ N+L + + L L +S N+L+ I S+
Sbjct: 32 NVPQSLPSYT---ALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 495 LCSYLEEIYMRGNFFHGSIPS-SLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552
+ L + + N H ++ S L+A+ + L N++ + ED+ L+ L LS
Sbjct: 87 V-PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 553 FNDLEGEVPTKGVFANISRIS 573
N + P + + +++
Sbjct: 145 QNQIS-RFP-VELIKDGNKLP 163
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 1e-11
Identities = 33/146 (22%), Positives = 57/146 (39%), Gaps = 7/146 (4%)
Query: 10 LNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQ 69
+D + + + V VL+L K L+ L ++ L + ++L +N ++
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLR 476
Query: 70 GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMG-SIPFEFFSLY 128
+P L LE L SDN L + ++ RL L L N+L + S
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 129 KLKQLAMQRNNLTGGIPPFIGNLTSL 154
+L L +Q N+L L +
Sbjct: 534 RLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 38/221 (17%), Positives = 66/221 (29%), Gaps = 22/221 (9%)
Query: 257 LDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN----SLANCSNLRTLIFAA 312
L + + L ++ +S+ S N L T+I
Sbjct: 333 LLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLM 392
Query: 313 NKLR--GALPHSIANLSD-------QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ 363
L ++ S + L ++ + L +
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSL 423
T + + +L + + L N+L +P +L L L L ++N+L V + +L
Sbjct: 453 LT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANL 507
Query: 424 KQLAILHLFENGLNGTIPEEIFNLTYLSN--SLNLARNHLV 462
+L L L N L I L LNL N L
Sbjct: 508 PRLQELLLCNNRL--QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 32/197 (16%), Positives = 68/197 (34%), Gaps = 11/197 (5%)
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
++ + L L + + + S L + L EL N I +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+L L + + YL + R+ + +RV +++
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL----RSKFLLENSVLKMEYADVRVLHLA 449
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
+L+ + L + + + N ++P +L++LR + + S N L + +
Sbjct: 450 HKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--V 504
Query: 542 EDL-SLEYLNLSFNDLE 557
+L L+ L L N L+
Sbjct: 505 ANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 34/211 (16%), Positives = 60/211 (28%), Gaps = 29/211 (13%)
Query: 47 SLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDN-------------DLV 93
L L + E L+ L + D +
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398
Query: 94 GEIPANLSYCSRLTIL--------FLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP 145
L Y S L + R+K + ++ L + +LT +
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VL 456
Query: 146 PFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANF 205
+ L + + L+ N +P +L L+ L+ L N L + + NL L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQEL 513
Query: 206 SVPRNQFHGSLPPSLGL-TLPHLRLFQVHHN 235
+ N+ L + P L L + N
Sbjct: 514 LLCNNRL-QQSAAIQPLVSCPRLVLLNLQGN 543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 43/233 (18%), Positives = 83/233 (35%), Gaps = 37/233 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS- 728
IG G FG +Y A V ++ F E K + + ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102
Query: 729 -------------CSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLT 774
+F+G ++ +V E + G L+ + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-----------KISGQNGTFK 149
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDMIAHVGDFGLA---RVR 829
+ + I + ++Y+H + +H D+K N+LL N ++ D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
++ G GTI + + + G +S D+ G +L + GK P
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 5/134 (3%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
+ L L N+L+ L + + +L L + +NQL S+P G+ +L L +L +GG
Sbjct: 59 TKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG 116
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL-GNLSILSELLLNNNSLSGVIPSCL 420
NQ +L L+ + L NQL IP+ L+ L L L+ N L V
Sbjct: 117 NQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF 175
Query: 421 GSLKQLAILHLFEN 434
L +L + LF N
Sbjct: 176 DRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 46/158 (29%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 258 DNSFSGKLSVNFGGMKNLSYFNVAYNNLGS---GESDEMSFMNSLANCSNLRTLIFAANK 314
+ F G+ L++ N+ YN L + G D+++ L TL A N+
Sbjct: 44 STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT---------ELGTLGLANNQ 94
Query: 315 LRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM- 372
L +LP + + QL L + NQL S+PSG+ L L L + NQ +IP
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF 151
Query: 373 GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
KL NL+ + L NQL + L L + L N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 48/170 (28%), Positives = 65/170 (38%), Gaps = 13/170 (7%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
S+PSGI +L + L L + L NQL +L+ L
Sbjct: 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85
Query: 403 SELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHL 461
L L NN L+ + L QL L+L N L ++P +F LT L L L N L
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE-LRLNTNQL 143
Query: 462 VGSIPT----KIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507
SIP K+ NL+ L + N L L+ I + GN
Sbjct: 144 -QSIPAGAFDKLTNLQTLSLST---NQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 43/159 (27%), Positives = 60/159 (37%), Gaps = 13/159 (8%)
Query: 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQL-- 388
+ L + S L + L L L + NQ L L +GL +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 389 --SGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFN 446
G + L L L L N L + L +L L L N L +IP F+
Sbjct: 98 LPLG-VFDHLTQLDKLY---LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 447 -LTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSN 483
LT L +L+L+ N L S+P L L+ + N
Sbjct: 153 KLTNL-QTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 40/134 (29%), Positives = 60/134 (44%), Gaps = 12/134 (8%)
Query: 35 TVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
T LNL L +LS + +L+ L + L NN + F L +L+ L+L N L
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK 120
Query: 94 GEIPA----NLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFI 148
+P+ L ++L L L N+L SIP F L L+ L++ N L
Sbjct: 121 -SLPSGVFDRL---TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF 175
Query: 149 GNLTSLESISLAAN 162
L L++I+L N
Sbjct: 176 DRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 28/170 (16%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
L+L+S GL+ L+ L +NL N +Q F L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 95 EIPANL-SYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFIGNLT 152
+P + + ++L L+LG N+L S+P F L KLK+L + N L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ----------- 144
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL 202
S+ A AF + L L+ L L N L + + L L
Sbjct: 145 -----SIPAGAF-----DKLTNLQT---LSLSTNQLQSVPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 9/157 (5%)
Query: 83 EALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLT 141
E L L L A ++LT L L N+L ++ F L +L L + N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 142 GGIPPFI-GNLTSLESISLAANAFGGNIPNSL-GQLKELKSLGLGANNLSGIIPPSIYN- 198
+P + +LT L+ + L N +P+ + +L +LK L L N L IP ++
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDK 153
Query: 199 LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
L+ L S+ NQ S+P L L+ + N
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 16/201 (7%)
Query: 346 SGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL 405
L + +G T + ++ +L ++ ++ + + + + + L EL
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 406 LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSI 465
L++N +S + P L L +L L + N L L+ L L N L
Sbjct: 69 HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSR----LFLDNNEL--RD 120
Query: 466 PTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLA 525
+ +LK L + ++ +N L I LG S LE + + GN + L+ L+ V
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGN--EITNTGGLTRLKKVNW 176
Query: 526 IDLSRNNLSGLIPKFLEDLSL 546
IDL+ K+ +L +
Sbjct: 177 IDLTGQKCVNEPVKYQPELYI 197
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 37/180 (20%), Positives = 70/180 (38%), Gaps = 19/180 (10%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
NL + ++ L LS ++ N N++IQ + L+ L LS N +
Sbjct: 21 AVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS 76
Query: 94 GEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTS 153
++ L ++L L + RN+L L +L + N L + +L +
Sbjct: 77 -DLS-PLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHLKN 129
Query: 154 LESISLAANAFGGNIPN--SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211
LE +S+ N + + LG L +L+ L L N ++ + L + + +
Sbjct: 130 LEILSIRNN----KLKSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 43/261 (16%), Positives = 85/261 (32%), Gaps = 24/261 (9%)
Query: 52 IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111
L+ + NL S+ + L ++ ++++ + + + + L L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHL 70
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPN- 170
N++ P + L KL++L++ RN L + L + L N + +
Sbjct: 71 SHNQISDLSPLK--DLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNN----ELRDT 121
Query: 171 -SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRL 229
SL LK L+ L + N L I + LS L + N+ + L +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTGGLTR--LKKVNW 176
Query: 230 FQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGE 289
+ ++ D + ++ SY +
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS----NGGSYVDGCVLWELPVY 232
Query: 290 SDEMSFMNSLANCSNLRTLIF 310
+DE+S+ S IF
Sbjct: 233 TDEVSYKFSEYINVGETEAIF 253
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 29/157 (18%), Positives = 58/157 (36%), Gaps = 19/157 (12%)
Query: 404 ELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN--SLNLARNHL 461
E + ++ V P L +L + + ++ + LS + N +++
Sbjct: 1 ESIQRPTPINQVFP--DPGLANAVKQNLGKQSV-----TDLVSQKELSGVQNFNGDNSNI 53
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
+ L+ ++S N +S ++ S L + LEE+ + N + L
Sbjct: 54 --QSLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLS 109
Query: 522 AVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLSFNDLE 557
+ L N L L L +LE L++ N L+
Sbjct: 110 ---RLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 44/268 (16%), Positives = 86/268 (32%), Gaps = 49/268 (18%)
Query: 172 LGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQ 231
L LG +++ ++ L ++ F
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--------QKE-------------------LSGVQNFN 47
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESD 291
++ S+ + + L+ + N S LS + L +V N L
Sbjct: 48 GDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRL------ 97
Query: 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNL 351
+N + + L L N+LR S+ +L L+ L + +N+L SI +G L
Sbjct: 98 --KNLNGIPSA-CLSRLFLDNNELRD--TDSLIHLK-NLEILSIRNNKLK-SI-VMLGFL 149
Query: 352 VGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNS 411
L L + GN+ T T + +L+ + + L + E L I + + +
Sbjct: 150 SKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGR 207
Query: 412 LSGVIPSCLGSLKQLAILHLFENGLNGT 439
+ P + + + T
Sbjct: 208 W--ISPYYISNGGSYVDGCVLWELPVYT 233
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 670 LIGMGSFGSVYKGAFD-QDGTIVAIKVF-NLQR-HGASKSFLAECKALKNIRHR---NLV 723
LIG GSFG V K A+D + VAIK+ N + ++ E + L+ +
Sbjct: 61 LIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKY 116
Query: 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK--------LTL 775
++ F+ + LV+E ++ +L ++ + L L
Sbjct: 117 YIVHLKRHFMFRNHLC--LVFEMLSY-NLY---------------DLLRNTNFRGVSLNL 158
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH--VGDFGLA-RVRQEV 832
++ A + +A+ +L + ++HCDLKP N+LL N + + DFG + ++ Q +
Sbjct: 159 TRKF--AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
QS Y +PE LG D++S G +L+EM TG+ +F G
Sbjct: 216 YQYIQSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE----PLFSGANE 263
Query: 893 LH 894
+
Sbjct: 264 VD 265
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 9/136 (6%)
Query: 34 VTVLNLRSKGLSGSLSP--YIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND 91
L L + + L L LR+IN NN I F + + L+ N
Sbjct: 34 TAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 92 LVGEIPANL-SYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFI- 148
L + + L L L N++ + + F L ++ L++ N +T + P
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 149 GNLTSLESISLAANAF 164
L SL +++L AN F
Sbjct: 150 DTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 28/134 (20%), Positives = 55/134 (41%), Gaps = 4/134 (2%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
L N+ I QL+ + ++N++ I G G+ + +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 362 NQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
N+ + +M L++L+ + L N+++ S LS + L L +N ++ V P
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149
Query: 421 GSLKQLAILHLFEN 434
+L L+ L+L N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 30/132 (22%), Positives = 54/132 (40%), Gaps = 12/132 (9%)
Query: 282 YNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSI-ANLSDQLQNLIMTSNQL 340
N E+ + LR + F+ NK+ + S + +++TSN+L
Sbjct: 41 NNEFTVLEATGI-----FKKLPQLRKINFSNNKIT-DIEEGAFEGAS-GVNEILLTSNRL 93
Query: 341 HGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSSLGN 398
++ + L L L + N+ T + + L ++ + LYDNQ++ P +
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 399 LSILSELLLNNN 410
L LS L L N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 11/149 (7%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPSS 395
SNQ IP I L + N+FT + KL L + +N+++ +
Sbjct: 19 SNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA 76
Query: 396 LGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSL 454
S ++E+LL +N L V L+ L L L N + + + F L+ + L
Sbjct: 77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV-RLL 134
Query: 455 NLARNHLVGSIP----TKIGNLKYLRVFN 479
+L N + ++ + +L L +
Sbjct: 135 SLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 27/171 (15%), Positives = 55/171 (32%), Gaps = 34/171 (19%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFE--FFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
+IP ++ L L N+ + F L +L+++ N +T
Sbjct: 25 KIPEHIP--QYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT----------- 70
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSI-YNLSLLANFSVPRNQ 211
+ AF G + + L +N L + + L L + N+
Sbjct: 71 -----DIEEGAFEG--------ASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNR 116
Query: 212 FHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPI-SLSNASKLEFIEALDNSF 261
+ + L +RL ++ N + ++ + L + L N F
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRH-RNLVKVITS 728
IG GSFG +Y G G VAIK+ + L E K K ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 729 CSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
D+ +V E + G SLE+ +K +L + +A + S
Sbjct: 74 G-----AEGDYNVMVMELL--GPSLEDLF----------NFCSRKFSLKTVLLLADQMIS 116
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLARVRQEVSNLTQSC---SV 841
I+Y+H +H D+KP N L+ + ++ DFGLA+ ++ +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT YA+ LG E S D+ S G +L+ G P
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 6e-10
Identities = 37/201 (18%), Positives = 61/201 (30%), Gaps = 34/201 (16%)
Query: 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV--------FNLQRHGASKSFL 708
S T+ IG G FG V++ D T VAIK+ N + L
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 709 AE---CKALKNIRHRNLVKVITSCSSIDF---QGNDFKALVYEFM----TNGSLENWLHP 758
E K L + + QG+ L+ + T GS +
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 759 DAVPQKDVEIE------------IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806
Q + +E + +L +I + +++ + H DL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 807 PGNVLLDNDMIAHVGDFGLAR 827
GNVLL + + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 36/133 (27%), Positives = 63/133 (47%), Gaps = 4/133 (3%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
+N + L N++ L + + L+ L + SNQL ++P G+ +L L L +G
Sbjct: 40 TNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGT 97
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
NQ T +L +L+ + + N+L+ E+P + L+ L+ L L+ N L +
Sbjct: 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 422 SLKQLAILHLFEN 434
L L +LF N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 37/154 (24%), Positives = 56/154 (36%), Gaps = 34/154 (22%)
Query: 258 DNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317
DN + F + NL + N LG+
Sbjct: 49 DNQITKLEPGVFDSLINLKELYLGSNQLGA------------------------------ 78
Query: 318 ALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMGKLQ 376
LP + + QL L + +NQL +PS + LV L L M N+ T +P+ + +L
Sbjct: 79 -LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLT 135
Query: 377 NLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
+L + L NQL + LS L+ L N
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 10/119 (8%)
Query: 368 IPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427
IP L L+DNQ++ P +L L EL L +N L + SL QL
Sbjct: 38 IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 428 ILHLFENGLNGTIPEEIFN-LTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNL 485
+L L N L +P +F+ L +L L + N L +P I L +L + N L
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKE-LFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 11/133 (8%)
Query: 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDL----VGEIPANLSYCSRLTILFLGRN 114
+ + L +N I P F L L+ L+L N L VG + +L ++LT+L LG N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSL---TQLTVLDLGTN 98
Query: 115 KLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLG 173
+L +P F L LK+L M N LT +P I LT L ++L N +
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 174 QLKELKSLGLGAN 186
+L L L N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 70/258 (27%)
Query: 670 LIGMGSFGSVYKGAFD--QDGTIVAIKVF-NLQR-HGASKSFLAECKALKNIRHR---NL 722
+G G+FG V + D + + VA+K+ N+ + A++ E LK I+ + N
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENK 81
Query: 723 VKVITSCSSIDFQGN---DFKAL---VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+ +F G+ F+ L +EF+ + Q L
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF------------------QPYPLP 123
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG--------------- 821
++A + A+ +LH + + H DLKP N+L N +
Sbjct: 124 HVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 822 ----DFGLA-RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
DFG A + + + + R Y PE L + D++S G +L E
Sbjct: 181 IRVADFGSATFDHEHHTTIVAT-----R---HYRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 877 VTGKKPTDVMFEGDLNLH 894
G +F+ N
Sbjct: 233 YRGF----TLFQTHENRE 246
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 31/131 (23%), Positives = 55/131 (41%), Gaps = 6/131 (4%)
Query: 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKLM 117
EI L N+I+ P F +L + LS+N + E+ + L L L NK+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI- 92
Query: 118 GSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPNSLGQL 175
+P F L+ L+ L + N + + +L +L +SL N + L
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 176 KELKSLGLGAN 186
+ ++++ L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 31/143 (21%), Positives = 60/143 (41%), Gaps = 12/143 (8%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS-SLGNLSI 401
IP+ + + + + N P + L + L +NQ+S E+ + L
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 402 LSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNH 460
L+ L+L N ++ + S L L +L L N +N + + F +L L N L+L N
Sbjct: 82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL-NLLSLYDNK 139
Query: 461 LVGSIP----TKIGNLKYLRVFN 479
L +I + + ++ + +
Sbjct: 140 L-QTIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 26/127 (20%), Positives = 49/127 (38%), Gaps = 5/127 (3%)
Query: 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442
L N + P + L + L+NN +S + P L+ L L L+ N + +P+
Sbjct: 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPK 97
Query: 443 EIF-NLTYLSNSLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE 500
+F L L L L N + + +L L + ++ N L ++
Sbjct: 98 SLFEGLFSL-QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ 155
Query: 501 EIYMRGN 507
+++ N
Sbjct: 156 TMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 29/168 (17%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
EIP NL +T + L +N + P F KL+++ + N ++
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS------------- 69
Query: 155 ESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSI-YNLSLLANFSVPRNQFH 213
LA +AF G L+ L SL L N ++ +P S+ L L + N+ +
Sbjct: 70 ---ELAPDAFQG--------LRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN 117
Query: 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF 261
L L +L L ++ N + S ++ + N F
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 32 RRVTVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDN 90
+++ ++L + +S L+P L L + L N I F LF L+ L L+ N
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114
Query: 91 DLVGEIPANL-SYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRN 138
+ + + L +L L NKL +I F L ++ + + +N
Sbjct: 115 KIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 34/223 (15%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRNLVKVITSC 729
IG GSFG +++G + VAIK + + L E + K L
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYK-----LLAGCTGIP 69
Query: 730 SSIDF-QGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
+ F Q LV + + G SLE+ L ++ +K ++ A + +
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLL----------DLCGRKFSVKTVAMAAKQMLA 117
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLL-----DNDMIAHVGDFGLA---RVRQEVSNLTQSC 839
+ +H +++ D+KP N L+ N + +V DFG+ R ++
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT Y + LG E S D+ + G + + + G P
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 87/652 (13%), Positives = 163/652 (25%), Gaps = 238/652 (36%)
Query: 320 PHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLE 379
L L L N V + G+ G GK +
Sbjct: 134 LQPYLKLRQALLELRPAKN-------------VLID--GVLG----------SGK-TWVA 167
Query: 380 GMGLYDNQLSGEIPS-----SLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
++ ++ +L N + +L L I S
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR----------- 216
Query: 435 GLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK--------IGNLKYLRVFNVSSNNLS 486
+ N+ +S+ L+ S P + + N K FN+S
Sbjct: 217 ------SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS----- 265
Query: 487 GEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSL-RAVLAIDLSRNNLSGLIPKFLEDLS 545
C L + R + LS+ +++D ++ L P ++ L
Sbjct: 266 ---------CKIL--LTTR----FKQVTDFLSAATTTHISLD---HHSMTLTPDEVKSLL 307
Query: 546 LEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPE-LQLPKCTEKNSRNQKISQ 604
L+YL+ DL EV + R I E ++ T N ++ +
Sbjct: 308 LKYLDCRPQDLPREV-------------LTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 605 RLKAIISTLSAV-----------LGI------VMVFFLCFCWFKRRRGPSKQQPSRPILR 647
I S+L+ + L + + L WF + ++
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD-----VIKSDVMVVVN 409
Query: 648 KALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSF 707
K + SL + ST I
Sbjct: 410 KLHKY----SLVEK-QPKESTISI-----------------------------PSIYLEL 435
Query: 708 LAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVE 767
+ + + HR++ +D Y + + D +P
Sbjct: 436 KVKLENEYAL-HRSI---------VDH---------YNI-----PKTFDSDDLIPPYL-- 469
Query: 768 IEIQKLTLLQRINIAIDVASAID-----YLHHHCQ--EPVLHCDLKPGNVLLDNDMIAHV 820
D ++ HH + E L V LD +
Sbjct: 470 ----------------------DQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLE-- 504
Query: 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
++R + + S GS ++T + Y +
Sbjct: 505 -----QKIRHDSTAWNAS------------------GSILNTLQQLKFYK----PYICDN 537
Query: 881 KPTDVMFEGDL--NLHNYARTALLDHVIDIVDPILINDVED-WDATNKQRLR 929
P + L + D++ L+ + E ++ +KQ R
Sbjct: 538 DPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-08
Identities = 90/617 (14%), Positives = 176/617 (28%), Gaps = 199/617 (32%)
Query: 90 NDLVGEIPANLSYCSRLTILFLGRNK-----------------LMGSIPFEFFSLYKLKQ 132
+ ++ +S RL L + + LM I E +
Sbjct: 52 DHIIMS-KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE----QRQPS 106
Query: 133 LAM-----QRNNLTGGIPPFI-GNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGAN 186
+ QR+ L F N++ L+ + +L +L+ K++ +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--------KLRQALLELRPAKNVLI--- 155
Query: 187 NLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG-----LTLPHLRLFQVHHNFFSGSI 241
G LG + L ++V
Sbjct: 156 --------------------------DG----VLGSGKTWVALDVCLSYKVQCKMDFKIF 185
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSY-FNVAYNNLGSGESDEMSFMNSLA 300
++L N + E + L+ ++ L Y + + + S+ ++S+
Sbjct: 186 WLNLKNCNSPETV--LEM------------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 301 NCSNLRTLIFAANKLRGALPHSIANLSD------------QLQNLIMTSNQLHGSIPSGI 348
LR L+ + + + L + + L+ T + + +
Sbjct: 232 A--ELRRLLKSKP-----YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFK---QVTDFL 281
Query: 349 GNLVGLY-RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSS--LGN---LSIL 402
+ L T P E+ + Y + ++P N LSI+
Sbjct: 282 SAATTTHISLDHHSMTLT---PDEV-----KSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 403 SELL------------LNNNSLSGVIPSCLGSL---------KQLAILHLFENGLNGTIP 441
+E + +N + L+ +I S L L +L++ F + IP
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPSAH--IP 388
Query: 442 EEIFNLTYLSNSLNLARNHLVGSIPTKIGN-LKYLRVFNVSSNNLSGEIPS-QLGLCSYL 499
+ L+L ++ S + N L + + IPS L L L
Sbjct: 389 TIL---------LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKL 439
Query: 500 EEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFL-------------EDLSL 546
E Y H SI + + + DL L + +
Sbjct: 440 ENEYA----LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495
Query: 547 EYLNLSFNDLEGEVPTKGVFANISRISVAGFNRL-------CGGIPELQ---------LP 590
+L+ F LE ++ N S + +L C P+ + LP
Sbjct: 496 VFLDFRF--LEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 591 KCTEK--NSRNQKISQR 605
K E S+ + +
Sbjct: 554 KIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 80/541 (14%), Positives = 162/541 (29%), Gaps = 130/541 (24%)
Query: 13 WNDSGHFCEWKGITCGLRH--RRVTVLNLRSKGLSGSLSP--YI---GNL----SFLREI 61
+ND+ F + + R L LR + L L P + G L +++
Sbjct: 120 YNDNQVFAK--------YNVSRLQPYLKLR-QALL-ELRPAKNVLIDGVLGSGKTWVALD 169
Query: 62 NLMNNSIQGEIPRE-----FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116
++ +Q ++ + E + L ++ + R+
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL----------LYQIDPNWTSRSDH 219
Query: 117 MGSIPFEFFSLY-KLKQLAMQRNNLTGGIPPFIGNLTSLESI--SLAANAFGG------- 166
+I S+ +L++L + P+ L L ++ + A NAF
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSK--------PYENCLLVLLNVQNAKAWNAFNLSCKILLT 271
Query: 167 ----NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGL 222
+ + L + L ++ + P SLL + + LP +
Sbjct: 272 TRFKQVTDFLSAATT-THISLD-HHSMTLTPD--EVKSLLLKYL---DCRPQDLPREVLT 324
Query: 223 TLP-HLRLF-QVHHNFFSGSIPISLSNASKLE-----FIEALDNSFSGKLSVNFGGMKNL 275
T P L + + + + N KL + L+ + F L
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAEYRKMF---DRL 378
Query: 276 SYF----NVAYNNLG-----SGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANL 326
S F ++ L +SD M +N L +L+ K SI ++
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK----YSLV---EKQPKESTISIPSI 431
Query: 327 SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386
+L+ + LH SI V Y + + P + G L +
Sbjct: 432 YLELKVKLENEYALHRSI-------VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484
Query: 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFN 446
+ + ++ + L+ L+Q I H + I N
Sbjct: 485 EHPERM-------TLFRMVFLD-----------FRFLEQ-KIRH---DSTAWNASGSILN 522
Query: 447 LTYLSNSLNLARNHLVGSIPTKIGNLKYLRVF--NVSSNNLSGEIPS--QLGLCSYLEEI 502
L + ++ + P + + F + N + + ++ L + E I
Sbjct: 523 TL---QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAI 579
Query: 503 Y 503
+
Sbjct: 580 F 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 5e-07
Identities = 79/511 (15%), Positives = 157/511 (30%), Gaps = 162/511 (31%)
Query: 530 RNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANI--SRISVAGFNRLCGGIPEL 587
++ LS F+++ + + D+ + +K +I S+ +V+G RL +
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQ----DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74
Query: 588 Q-------LPKCTEKN---------SRNQKISQRLKAIISTLSAVLGIVMVFFLCFCWFK 631
Q + + N + ++ S + I + VF
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF-------- 126
Query: 632 RRRGPSKQQPSRP----ILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD 687
+K SR LR+AL ++ G+ G K
Sbjct: 127 -----AKYNVSRLQPYLKLRQALLELRPAK-------NVLID--GVLGSG---K------ 163
Query: 688 GTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV----ITSCSSIDFQGNDFKALV 743
T VA+ V C + K ++ + K+ + +C+S + + L+
Sbjct: 164 -TWVALDV---------------CLSYK-VQCKMDFKIFWLNLKNCNSPETVLEMLQKLL 206
Query: 744 YEFMTNGSLENWLHPDAVPQK--DVEIEIQKLTLLQRINIAI----DVASA--IDYLHHH 795
Y+ N + H + + ++ E+++L + + +V +A + +
Sbjct: 207 YQIDPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 796 CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG 855
C+ +L L V DF A +S T+ P+
Sbjct: 266 CK--IL---------LTTRF--KQVTDFLSAATTTHIS------LDHHSMTLT---PDEV 303
Query: 856 LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH--VIDIVDPIL 913
LL +P D+ R L + + I+ +
Sbjct: 304 KS---------------LLLKYLDCRPQDL-----------PREVLTTNPRRLSIIAESI 337
Query: 914 INDVEDWDATNKQRLRQAKINGKIEC------PISMVRIGVACSV--ES---PQDRMSI- 961
+ + WD N + + K+ IE P ++ SV S P +S+
Sbjct: 338 RDGLATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 962 ---------TNVVHELQSVKNALLEAWNCTG 983
VV++L K +L+E
Sbjct: 396 WFDVIKSDVMVVVNKL--HKYSLVEKQPKES 424
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 68/471 (14%), Positives = 140/471 (29%), Gaps = 150/471 (31%)
Query: 495 LCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFN 554
L S EE+ + F + + L + + + P + + +E + +N
Sbjct: 71 LLSKQEEMVQK--FVEEVLRINYKFLMSPIK---TEQR----QPSMMTRMYIEQRDRLYN 121
Query: 555 DLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCTEKNSRNQKISQRLKAII---- 610
D +V K N+SR+ P L+L + + + + +I
Sbjct: 122 D--NQVFAKY---NVSRLQ-----------PYLKLRQALLELRPAKNV------LIDGVL 159
Query: 611 ----STLSA-VL---GIVMVF-FLCFCW--FKRRRGPSKQQPSRPILRKALQKVSYE--- 656
+ ++ V + F F W K P +L + LQK+ Y+
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSP------ETVL-EMLQKLLYQIDP 211
Query: 657 SLFKATDGFSST------------HLIGMGSFGSVYKGAF---D--QDGTIVAIKVFNLQ 699
+ +D S+ L+ Y+ Q+ FNL
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLL----KSKPYENCLLVLLNVQNAKA--WNAFNLS 265
Query: 700 RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH-- 757
CK L R + + +++ ++ + + L +L
Sbjct: 266 -----------CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 758 PDAVPQKDVEIEIQKLTLLQRINIA---IDVASAIDYLHHHCQEPVLHC------DLKPG 808
P +P++ + ++L++ IA D + D H + + L+P
Sbjct: 315 PQDLPREVLTTNPRRLSI-----IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 809 N---------VLLDNDMI-AHVGDFGLARV-----RQEVSNLTQSCSVGVRGTIGYAAPE 853
V + I + L+ + + +V + +
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMVVVNKLH------------K 413
Query: 854 YGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
Y L V + I + + K E + LH +++DH
Sbjct: 414 YSL---VEKQPKESTISIPSIYLELKVKL-----ENEYALHR----SIVDH 452
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 2e-04
Identities = 41/249 (16%), Positives = 94/249 (37%), Gaps = 58/249 (23%)
Query: 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL--TL 775
++++++ V +F D + + ++ ++ + KD +L TL
Sbjct: 17 QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID-----HIIMSKDAVSGTLRLFWTL 71
Query: 776 LQR----INIAIDVASAIDY------LHHHCQEPVLHCDL--KPGNVLL-DNDMIA--HV 820
L + + ++ I+Y + ++P + + + + L DN + A +V
Sbjct: 72 LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 821 GDFGLAR------VRQEVSNLTQSCSVGVRGTIGYAAPEYG---LGSEVSTNGDI---YS 868
+R +RQ + L + +V + G +G G + +V + +
Sbjct: 132 -----SRLQPYLKLRQALLELRPAKNVLIDGVLG-----SGKTWVALDVCLSYKVQCKMD 181
Query: 869 YGILLLEMVTGKKPTDVMFEGDLNLH-----NYARTALLDHVIDIVDPILINDVEDWDAT 923
+ I L + P V+ E L N+ T+ DH +I + I+ ++
Sbjct: 182 FKIFWLNLKNCNSPETVL-EMLQKLLYQIDPNW--TSRSDHSSNI--KLRIHSIQAE--- 233
Query: 924 NKQRLRQAK 932
+RL ++K
Sbjct: 234 -LRRLLKSK 241
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 32/225 (14%)
Query: 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH-RNLVKVI 726
IG G+FG + G VAIK+ + E + K + + +V
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71
Query: 727 TSCSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ A+V E + G SLE+ ++ + +L + IAI +
Sbjct: 72 YFG-----PCGKYNAMVLELL--GPSLEDLF----------DLCDRTFSLKTVLMIAIQL 114
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLL-----DNDMIAHVGDFGLARVRQEVSNLTQ--- 837
S ++Y+H +++ D+KP N L+ + H+ DF LA+ +
Sbjct: 115 ISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPY 171
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT Y + LG E S D+ + G + + + G P
Sbjct: 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 38/117 (32%), Positives = 62/117 (52%), Gaps = 5/117 (4%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
SN+ +P GI + L + GNQFT +PKE+ ++L + L +N++S S
Sbjct: 18 SNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSF 74
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSN 452
N++ L L+L+ N L + P LK L +L L N ++ +PE F +L+ LS+
Sbjct: 75 SNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSH 130
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 27/107 (25%), Positives = 50/107 (46%), Gaps = 7/107 (6%)
Query: 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKLM 117
E+ L N +P+E L + LS+N + + S ++L L L N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 118 GSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAAN 162
IP F L L+ L++ N+++ +P +L++L +++ AN
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 31/107 (28%), Positives = 42/107 (39%), Gaps = 5/107 (4%)
Query: 34 VTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
VT L L + + + N L I+L NN I + F + +L L LS N L
Sbjct: 33 VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL- 90
Query: 94 GEIPANL-SYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRN 138
IP L +L L N + +P F L L LA+ N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 53/257 (20%), Positives = 97/257 (37%), Gaps = 64/257 (24%)
Query: 670 LIGMGSFGSVYKGAFD-QDGTIVAIKVF-NLQR-HGASKSFLAECKALKNIRHR-----N 721
+G G+FG V + A+KV N+++ ++K E LK I++ N
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNN 97
Query: 722 LVKVITSCSSIDFQGN---DFKAL---VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
+VK + + F+ L +YE +T N + +
Sbjct: 98 IVKYH---GKFMYYDHMCLIFEPLGPSLYEIITR----NNYNG--FH----------IED 138
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
++ I++ A++YL + H DLKP N+LLD+ + +
Sbjct: 139 IKLY--CIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 836 TQSCSVGVR----G--------------TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMV 877
++ S G++ G T Y APE L + D++S+G +L E+
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253
Query: 878 TGKKPTDVMFEGDLNLH 894
TG ++F ++
Sbjct: 254 TG----SLLFRTHEHME 266
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 40/236 (16%), Positives = 83/236 (35%), Gaps = 38/236 (16%)
Query: 669 HLIGMGSFGSVYKGAFD-----QDGTIVAIKV-----------FNLQRHGASKSFLAECK 712
IG G FG +Y + +KV + A + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQ 771
+ +++ + K D G ++ ++ + G L+ E +
Sbjct: 101 RTRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQKIY----------EANAK 147
Query: 772 KLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDMIAHVGDFGLA--- 826
+ + + +++ + ++Y+H H +H D+K N+LL+ N ++ D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 827 RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GTI + + + G S GD+ G +++ +TG P
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 38/237 (16%), Positives = 85/237 (35%), Gaps = 44/237 (18%)
Query: 671 IGMGSFGSVYKGAFDQDGTI--------VAIKV----------FNLQRHGASKSFLAECK 712
+ G +Y+ A T ++K+ N + A + + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQ 771
L + + + + ++ LV + G SL++ L D P+ +
Sbjct: 110 KLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQSAL--DVSPKHVLSE--- 158
Query: 772 KLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL--DNDMIAHVGDFGLARV- 828
+ L +A + A+++LH + +H ++ N+ + ++ + +G A
Sbjct: 159 RSVLQ----VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 829 ---RQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ V+ + S S G + + + + G S D+ S G +L+ + G P
Sbjct: 212 CPSGKHVAYVEGSRS-PHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 39/195 (20%), Positives = 65/195 (33%), Gaps = 56/195 (28%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSC 729
+G+G G V + + A+K+ E + + ++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI---------- 779
+ + G +V E + G E L RI
Sbjct: 81 EN-LYAGRKCLLIVMECLDGG------------------E-----LFSRIQDRGDQAFTE 116
Query: 780 ----NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLAR-VRQE 831
I + AI YLH + H D+KP N+L + I + DFG A+ E
Sbjct: 117 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
Query: 832 VSNLTQSC---SVGV 843
+SC S+GV
Sbjct: 174 --KYDKSCDMWSLGV 186
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLA-ECKALKNIRHRNLVKVITSC 729
IG GSFG +Y G Q VAIK+ + L E K + ++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGI-----P 66
Query: 730 SSIDF-QGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVAS 787
+ F D+ LV + + G SLE+ +KL+L + +A + +
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLF----------NFCSRKLSLKTVLMLADQMIN 114
Query: 788 AIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIAHVGDFGLA---RVRQEVSNLTQSCSV 841
++++H LH D+KP N L+ ++ DFGLA R ++ +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT YA+ LG E S D+ S G +L+ + G P
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 70/258 (27%)
Query: 670 LIGMGSFGSVYKGAFDQ--DGTIVAIKVF-NLQR-HGASKSFLAECKALKNIRHR---NL 722
+G G+FG V + D G VA+K+ N+ R A++S E + L+++ +
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNST 76
Query: 723 VKVITSCSSIDFQGN---DFKAL---VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+ + + G+ F+ L Y+F+ N P L +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE----NGFLP--FR----------LDHI 120
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG--------------- 821
+++ A + ++++LH + + H DLKP N+L
Sbjct: 121 RKM--AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 822 ----DFGLA-RVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEM 876
DFG A + S L + R Y APE L S D++S G +L+E
Sbjct: 176 IKVVDFGSATYDDEHHSTLVST-----RH---YRAPEVILALGWSQPCDVWSIGCILIEY 227
Query: 877 VTGKKPTDVMFEGDLNLH 894
G +F +
Sbjct: 228 YLGF----TVFPTHDSKE 241
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 24/162 (14%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFT--GTIPKEMGKLQNLEGM 381
+ + + + + L + ++ + I L N+ +
Sbjct: 15 DDAFAETIKANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LPNVRYL 68
Query: 382 GLYDNQLSGEIPSSLG---NLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438
L N+L + L+ L+ L+L N L + L L L L EN L
Sbjct: 69 ALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 439 TIPEEIFN-LTYLSNSLNLARNHLVGSIPT----KIGNLKYL 475
++P+ +F+ LT L+ LNLA N L S+P K+ NL L
Sbjct: 123 SLPDGVFDKLTNLTY-LNLAHNQLQ-SLPKGVFDKLTNLTEL 162
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 19/199 (9%)
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
L + I L N L L + +S + N
Sbjct: 33 DAVTQNELNSIDQIIANNSDIKSVQGIQ-YLPNVRYLA----LGGNKLHDISA-LKELTN 86
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLI 334
L+Y + N L S + +NL+ L+ N+L+ +LP + + L L
Sbjct: 87 LTYLILTGNQLQSLPN------GVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139
Query: 335 MTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEI 392
+ NQL S+P G+ L L L + NQ ++P+ + KL L+ + LY NQL +
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-V 196
Query: 393 PS-SLGNLSILSELLLNNN 410
P L+ L + L++N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 16/136 (11%)
Query: 35 TVLNLRSKGLSGSLSPYI-GNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLV 93
T L L L SL + L+ L+E+ L+ N +Q F +L L L L+ N L
Sbjct: 88 TYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 94 GEIPA----NLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIP--P 146
+P L+ LT L L N+L S+P F L +LK L + +N L +P
Sbjct: 147 -SLPKGVFDKLT---NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGV 200
Query: 147 FIGNLTSLESISLAAN 162
F LTSL+ I L N
Sbjct: 201 F-DRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 54/204 (26%), Positives = 77/204 (37%), Gaps = 42/204 (20%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
NL+ K ++ L+ + +I N+ I+ L + L L N L
Sbjct: 22 IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH- 76
Query: 95 EIPA--NLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPPFIGNL 151
+I A L+ LT L L N+L S+P F L LK+L + N L
Sbjct: 77 DISALKELT---NLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ---------- 122
Query: 152 TSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY-NLSLLANFSVPRN 210
SL F +L L L L N L +P ++ L+ L + N
Sbjct: 123 ------SLPDGVFD--------KLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYN 167
Query: 211 QFHGSLPPSL--GLT-LPHLRLFQ 231
Q SLP + LT L LRL+Q
Sbjct: 168 QLQ-SLPEGVFDKLTQLKDLRLYQ 190
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 38/148 (25%), Positives = 64/148 (43%), Gaps = 10/148 (6%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
+Q S+P+GI L + N +L +L + L N+L
Sbjct: 15 YSQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFN-LTYLSNSLN 455
L+ L+ L L+ N L + L QL L L N L ++P+ +F+ LT L L
Sbjct: 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQL-KDLR 130
Query: 456 LARNHLVGSIPT----KIGNLKYLRVFN 479
L +N L S+P ++ +L+Y+ + +
Sbjct: 131 LYQNQL-KSVPDGVFDRLTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 7/111 (6%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGG 361
++L L NKL+ +LP+ + N L L +++NQL S+P+G+ L L L +
Sbjct: 52 TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNT 109
Query: 362 NQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNNN 410
NQ ++P + KL L+ + LY NQL +P L+ L + L++N
Sbjct: 110 NQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 37/134 (27%), Positives = 55/134 (41%), Gaps = 10/134 (7%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
+ Q L + +N L L L +L +GGN+ KL +L + L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83
Query: 384 YDNQLSGEIPS----SLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGT 439
NQL +P+ L L L+ LN N L + L QL L L++N L +
Sbjct: 84 STNQLQ-SLPNGVFDKLTQLKELA---LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-S 138
Query: 440 IPEEIF-NLTYLSN 452
+P+ +F LT L
Sbjct: 139 VPDGVFDRLTSLQY 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 34/145 (23%), Positives = 69/145 (47%), Gaps = 18/145 (12%)
Query: 370 KEMGKLQNLEGMGLYDNQLSG--EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427
++ E + L+ + ++ ++L L L L+ N++ + S L ++ L
Sbjct: 17 RKSVVATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLR 73
Query: 428 ILHLFENGLNGTIPEEIFNLTYLSNS---LNLARNHLVGSIPTKIGNLKYLRVFNVSSNN 484
IL L N + ++I NL ++++ L ++ N + + + I L LRV +S+N
Sbjct: 74 ILSLGRNLI-----KKIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNK 126
Query: 485 LS--GEIPSQLGLCSYLEEIYMRGN 507
++ GEI +L LE++ + GN
Sbjct: 127 ITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 10/121 (8%)
Query: 85 LFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGG 143
L + ++ A LS L L N + I S + L+ L++ RN +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKI--SSLSGMENLRILSLGRNLIK-K 84
Query: 144 IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203
I +LE + ++ N ++ + +L L+ L + N ++ I L+ L
Sbjct: 85 IENLDAVADTLEELWISYNQI-ASLSG-IEKLVNLRVLYMSNNKITNW--GEIDKLAALD 140
Query: 204 N 204
Sbjct: 141 K 141
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 20/97 (20%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 367 TIPKEMGKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNNNSLSGVIPSCLGSLKQ 425
+ +NL + + + Q + L L L L + + L V P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 426 LAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462
L+ L+L N L ++ + L L L+ N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 26/102 (25%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 386 NQLSGEIPSSLGNLSILSELLL-NNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444
+ + L L+EL + N L + L L +L L + ++GL + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 445 F-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNL 485
F LS LNL+ N L S+ K L+ +S N L
Sbjct: 76 FHFTPRLS-RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 8/105 (7%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE----MGKLQNLEGMGLYDNQLSGEI 392
+ + L L + Q + +G+L+NL + + L
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT---IVKSGLRFVA 72
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN 437
P + LS L L+ N+L + + L L L L N L+
Sbjct: 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 9/98 (9%)
Query: 464 SIPTKIGNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEIYMRGNFFHGSIP----SSLS 518
+ + L + + + + L L + + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 519 SLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDL 556
L ++LS N L L K ++ LSL+ L LS N L
Sbjct: 81 RLSR---LNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 19/108 (17%), Positives = 36/108 (33%), Gaps = 25/108 (23%)
Query: 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFIGNLTS 153
+ +L LT L++ + + + L +L+ L + ++ L
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69
Query: 154 LESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201
+A +AF L L L N L + ++ LSL
Sbjct: 70 ----FVAPDAFHF--------TPRLSRLNLSFNALESLSWKTVQGLSL 105
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 8/103 (7%)
Query: 20 CEWKGITCGLRH----RRVTVLNLRSKGLSGSLSPY-IGNLSFLREINLMNNSIQGEIPR 74
C G L H +T L + ++ L + L LR + ++ + ++ +
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP 73
Query: 75 E-FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116
+ F RL L LS N L + L L L N L
Sbjct: 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 331 QNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLS 389
L + SN+L S+P G+ L L +L + NQ KL L + L++N+L
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 390 GEIPSSL-GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
+P+ + L+ L EL L+ N L V L L + L N
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 34/115 (29%), Positives = 47/115 (40%), Gaps = 12/115 (10%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS----SLGN 398
S+P+GI RL + N+ KL L + L NQ+ +P L
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 399 LSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSN 452
L+IL L+ N L + L QL L L N L ++P+ IF LT L
Sbjct: 78 LTILY---LHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQK 128
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-06
Identities = 60/340 (17%), Positives = 105/340 (30%), Gaps = 60/340 (17%)
Query: 271 GMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKL--RGA--LPHSIANL 326
++ + L ++S L L L +N+L G + +
Sbjct: 26 LLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 327 SDQLQNLIMTSNQLH----GSIPSGIGNLVGLYRLGMGGNQFTGT--------IPKEMGK 374
S ++Q L + + L G + S + L L L + N + +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 375 LQNLEGMGLYDNQLSGE----IPSSLGNLSILSELLLNNNSLS--GVIPSCLG---SLKQ 425
L+ L+ L LS + S L EL ++NN ++ GV C G S Q
Sbjct: 144 LEKLQ---LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 426 LAILHLFENGLN----GTIPEEIFNLTYLSNSLNLARNHLVGS-----IPTKIGNLKYLR 476
L L L G+ + + + L L L N L P + LR
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRE-LALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 477 VFNVSSNNLSGE----IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSL-----RAVLAID 527
+ ++ + + L L+E+ + GN L + ++
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319
Query: 528 LSRNNLSGLIPKFLEDLS--------LEYLNLSFNDLEGE 559
+ + + S L L +S N LE
Sbjct: 320 VKSCSFT---AACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 75/457 (16%), Positives = 152/457 (33%), Gaps = 95/457 (20%)
Query: 32 RRVTVLNLRSKGLS----GSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFR-----L 82
++ V+ L GL+ +S + L E+NL +N + + + +
Sbjct: 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 83 EALFLSDNDL----VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS------LYKLKQ 132
+ L L + L G + + L L L L N L G + +L++
Sbjct: 88 QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL-GDAGLQLLCEGLLDPQCRLEK 146
Query: 133 LAMQRNNLT----GGIPPFIGNLTSLESISLAANAFGGNIPNSLGQ-LKE----LKSLGL 183
L ++ +L+ + + + ++++ N L Q LK+ L++L L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206
Query: 184 GANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPI 243
+ ++ + +L + V +L L L N
Sbjct: 207 ESCGVT---SDNCRDLCGI----VASKA-----------SLRELAL---GSN-------- 237
Query: 244 SLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCS 303
L + E L + L + + + ++ + L
Sbjct: 238 KLGDVGMAELCPGLLHP-----------SSRLRTLWIWECGITAKGCGDLCRV--LRAKE 284
Query: 304 NLRTLIFAANKLRG----ALPHSIANLSDQLQNLIMTSNQLHG----SIPSGIGNLVGLY 355
+L+ L A N+L L ++ QL++L + S S + L
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 356 RLGMGGNQFTGTIPKEMGKL-----QNLEGMGLYDNQLSGE----IPSSLGNLSILSELL 406
L + N+ +E+ + L + L D +S + ++L L EL
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404
Query: 407 LNNNSL--SGVIPSCLGSLKQ----LAILHLFENGLN 437
L+NN L +G++ ++Q L L L++ +
Sbjct: 405 LSNNCLGDAGILQLVES-VRQPGCLLEQLVLYDIYWS 440
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 54 NLSFLREINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112
S ++E+ L N+ G++ LE L + L I ANL ++L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSLESISLAAN 162
N++ G + L L + N + + L +L+S+ L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 82 LEALFLSDNDL-VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNL 140
++ L L ++ G++ L L L SI L KLK+L + N +
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELSDNRV 76
Query: 141 TGGIPPFIGNLTSLESISLAANAFGG-NIPNSLGQLKELKSLGLGAN 186
+GG+ +L ++L+ N + L +L+ LKSL L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 6/96 (6%)
Query: 366 GTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQ 425
G + + + LE + + L+ I ++L L+ L +L L++N +SG +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 426 LAILHLFENGLNGTIPEEIFNLTYLSN--SLNLARN 459
L L+L N + I L L N SL+L
Sbjct: 90 LTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 27/115 (23%), Positives = 38/115 (33%), Gaps = 11/115 (9%)
Query: 398 NLSILSEL-LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN--SL 454
+ + EL L N S G I L L L GL + NL L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKL 76
Query: 455 NLARNHLVGSIPTKIGNLKYLRVFNVSSNNLS--GEIPSQLGLCSYLEEIYMRGN 507
L+ N + G + L L N+S N L + L L+ + +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 27/111 (24%), Positives = 44/111 (39%), Gaps = 12/111 (10%)
Query: 82 LEALFLSDNDL-VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNL 140
+ L L + G+I + L L L L+ L KLK+L + N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELSENRI 83
Query: 141 TGGIPPFIGNLTSLESISLAANAFGGNIPN-----SLGQLKELKSLGLGAN 186
GG+ L +L ++L+ N + + L +L+ LKSL L
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGN----KLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 6/111 (5%)
Query: 34 VTVLNLRSKGLS-GSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
V L L + + G + L ++L+N + + +L +L+ L LS+N +
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRI 83
Query: 93 VGEIPANLSYCSRLTILFLGRNKL--MGSIPFEFFSLYKLKQLAMQRNNLT 141
G + LT L L NKL + ++ L LK L + +T
Sbjct: 84 FGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 54 NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGR 113
N RE++L I I L + +A+ SDN++ ++ RL L +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 114 NKLMGSIPFEFFSLYKLKQLAMQRNNLT--GGIPPFIGNLTSLESISLAAN 162
N++ +L L +L + N+L G + P + +L SL + + N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 30/111 (27%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 37 LNLRSKGLSGSLSPYIGNL----SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
+ R L G P I NL I+ +N I+ ++ F L RL+ L +++N +
Sbjct: 19 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRI 76
Query: 93 VGEIPANLSYCSRLTILFLGRNKL--MGSIPFEFFSLYKLKQLAMQRNNLT 141
LT L L N L +G + SL L L + RN +T
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLVELGDLD-PLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 21/114 (18%), Positives = 35/114 (30%), Gaps = 14/114 (12%)
Query: 79 LFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQR 137
R L L + I + + + N++ + F L +LK L +
Sbjct: 18 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKTLLVNN 73
Query: 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPN-----SLGQLKELKSLGLGAN 186
N + L L + L N ++ L LK L L + N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNN----SLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 19/103 (18%), Positives = 34/103 (33%), Gaps = 8/103 (7%)
Query: 89 DNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT--GGIPP 146
+L+ + + R L L K+ I +L + + N + G P
Sbjct: 5 TAELIEQAA-QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP- 61
Query: 147 FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLS 189
L L+++ + N L +L L L N+L
Sbjct: 62 ---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 49/292 (16%), Positives = 99/292 (33%), Gaps = 58/292 (19%)
Query: 323 IANLSDQLQNLIMTSNQLHG----SIPSGIGNLVGLYRLGMGGNQFT-------GTIPKE 371
+A S ++ + + + S+ + + + + + GN
Sbjct: 1 MARFS--IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 372 MGKLQNLEGMGLYDNQLSGEIP-------SSLGNLSILSELLLNNNSLS--GVIP--SCL 420
L+ E ++ ++ EIP +L L + L++N+ P L
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 421 GSLKQLAILHLFENGL-------------NGTIPEEIFNLTYLSNSLNLARNHL----VG 463
L L+L NGL + ++ N L S+ RN L +
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR-SIICGRNRLENGSMK 177
Query: 464 SIPTKIGNLKYLRVFNVSSNNLSGE-----IPSQLGLCSYLEEIYMRGNFFHG----SIP 514
+ + L + N + E + L C L+ + ++ N F ++
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 515 SSLSSLRAVLAIDLSRNNLS--GLIP-----KFLEDLSLEYLNLSFNDLEGE 559
+L S + + L+ LS G LE++ L+ L L +N++E +
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 57/362 (15%), Positives = 111/362 (30%), Gaps = 66/362 (18%)
Query: 130 LKQLAMQRNNLTG----GIPPFIGNLTSLESISLAANAFGGN----IPNSLGQLKELKSL 181
++ +++ + +T + + S++ I L+ N G + ++ K+L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS--G 239
+ L LL +L L P L ++ N F
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQ--------------AL-LKCPKLHTVRLSDNAFGPTA 110
Query: 240 SIPIS--LSNASKLEFIEALDNSFS-------------GKLSVNFGGMKNLSYFNVAYNN 284
P+ LS + LE + +N ++ L N
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 285 LGSGESDEMSFMNSLANCSNLRTLIFAANKLR-----GALPHSIANLSDQLQNLIMTSNQ 339
L +G E + + L T+ N +R L +A +L+ L + N
Sbjct: 171 LENGSMKEWAKT--FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNT 227
Query: 340 LHG----SIPSGIGNLVGLYRLGMGGNQFTGT----IPKEMGKLQN--LEGMGLYDNQLS 389
++ + + L LG+ + + KL+N L+ + L N++
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 390 GEIPSSLG-----NLSILSELLLNNNSLS---GVIPSCLGSLKQLAILHLFENGLNGTIP 441
+ +L + L L LN N S V+ L E +
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELT 347
Query: 442 EE 443
+E
Sbjct: 348 DE 349
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 31/178 (17%), Positives = 55/178 (30%), Gaps = 28/178 (15%)
Query: 29 LRHRRVTVLNLRSKGLSG----SLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEA 84
L+ ++ + L L ++ + L + L NN + +
Sbjct: 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ-----------AG 139
Query: 85 LFLSDNDLVGEIPANLSYCSRLTILFLGRNKL----MGSIPFEFFSLYKLKQLAMQRNNL 140
++ + L + GRN+L M F S L + M +N +
Sbjct: 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 199
Query: 141 TG-GIPPFIGNL----TSLESISLAANAFGGN----IPNSLGQLKELKSLGLGANNLS 189
GI + L+ + L N F + +L L+ LGL LS
Sbjct: 200 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 36/135 (26%), Positives = 53/135 (39%), Gaps = 33/135 (24%)
Query: 35 TVLNLRSKGLSGSLSP--YIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
T L L L +S G L L ++ L N + G P F
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA------------- 77
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFF-SLYKLKQLAMQRNNLTGGIPP--FIG 149
S + L LG NK+ I + F L++LK L + N ++ + P F
Sbjct: 78 -----------SHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSF-E 123
Query: 150 NLTSLESISLAANAF 164
+L SL S++LA+N F
Sbjct: 124 HLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 25/107 (23%)
Query: 304 NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ 363
+L L N+L + + + +Q L + N++ I + +
Sbjct: 55 HLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKM--------------- 97
Query: 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410
F L L+ + LYDNQ+S +P S +L+ L+ L L +N
Sbjct: 98 FL--------GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMG---KLQNLE 379
+ Q L + NQ+ + G+ L L RL + NQ T +P G KL L
Sbjct: 26 TGIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLTQLT 81
Query: 380 GMGLYDNQLSGEIPS-SLGNLSILSELLLNNN 410
+ L DNQL IP + NL L+ + L NN
Sbjct: 82 QLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 988 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.3 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.0 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.58 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.9 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.82 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.82 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.56 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.55 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.77 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.52 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 91.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 88.52 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-79 Score=750.90 Aligned_cols=581 Identities=31% Similarity=0.461 Sum_probs=464.0
Q ss_pred cCCccccCCCCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCccc---cc-----------------------ccccCCCC
Q 001974 4 HDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGS---LS-----------------------PYIGNLSF 57 (988)
Q Consensus 4 ~~~~~~~~~w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~---~~-----------------------~~l~~l~~ 57 (988)
.||+ .++||+.++|||+|.||+|+ +++|+.|||+++++.|. +| +.++.+++
T Consensus 25 ~~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~ 101 (768)
T 3rgz_A 25 PDKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101 (768)
T ss_dssp SCTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTT
T ss_pred CCcc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCC
Confidence 3898 99999988999999999998 78999999999999887 55 46677778
Q ss_pred CCEEEcCCCcccccCCc--ccCCCCCCcEEECCCCCCCCcCCccc-ccCCCCceeecCcccccCCCccc---ccCccccc
Q 001974 58 LREINLMNNSIQGEIPR--EFGRLFRLEALFLSDNDLVGEIPANL-SYCSRLTILFLGRNKLMGSIPFE---FFSLYKLK 131 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L~~N~i~~~~~~~---~~~l~~L~ 131 (988)
|++|+|++|++++.+|. .|+.+++|++|+|++|.+.+.+|..+ ..+++|++|+|++|++++..|.. +.++++|+
T Consensus 102 L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~ 181 (768)
T 3rgz_A 102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181 (768)
T ss_dssp CCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCC
T ss_pred CCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCC
Confidence 88888888888877777 78888888888888888877777665 67777777777777777666655 55666666
Q ss_pred ccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCC
Q 001974 132 QLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ 211 (988)
Q Consensus 132 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 211 (988)
+|++++|.+++..+. ..+++|++|+|++|++.+.+|. |+++++|++|+|++|++++.+|..+..+++|++|++++|+
T Consensus 182 ~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 258 (768)
T 3rgz_A 182 HLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258 (768)
T ss_dssp EEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred EEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCc
Confidence 666666666544332 5566666666666666655554 6666666666666666666666666666666666666555
Q ss_pred CC----------------------CCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCccccc-
Q 001974 212 FH----------------------GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN- 268 (988)
Q Consensus 212 i~----------------------~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~- 268 (988)
+. +.+|..++..+++|++|+|++|++++.+|..+.++++|++|++++|++.+.+|..
T Consensus 259 l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~ 338 (768)
T 3rgz_A 259 FVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338 (768)
T ss_dssp CEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHH
T ss_pred ccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHH
Confidence 54 4555555544577777777777777777777777778888888888777666654
Q ss_pred ccCCccccEEecccccCCCCCCCchhhhc-------------------cccc--CCCCcEEEeecccCCCCCCchhhhcc
Q 001974 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMN-------------------SLAN--CSNLRTLIFAANKLRGALPHSIANLS 327 (988)
Q Consensus 269 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-------------------~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~~~ 327 (988)
|..+++|++|++++|.+++..+..+.... .+.. +++|++|++++|++++.+|..+..+.
T Consensus 339 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~ 418 (768)
T 3rgz_A 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418 (768)
T ss_dssp HTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT
T ss_pred HhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC
Confidence 77777888888888877644333222111 1112 56677777778877777787777765
Q ss_pred ccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEc
Q 001974 328 DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLL 407 (988)
Q Consensus 328 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 407 (988)
+|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|
T Consensus 419 -~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 497 (768)
T 3rgz_A 419 -ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497 (768)
T ss_dssp -TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred -CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEc
Confidence 6888888888888888888888888999999999988888888888899999999999998888888999999999999
Q ss_pred cccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCcccc------------------
Q 001974 408 NNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI------------------ 469 (988)
Q Consensus 408 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~------------------ 469 (988)
++|++++.+|.+|+.+++|+.|+|++|+++|.+|..+..++.| +.|++++|+++|.+|..+
T Consensus 498 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~ 576 (768)
T 3rgz_A 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred cCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence 9999998899999999999999999999998999999999888 889999998887777544
Q ss_pred ----------------------------------------------------ccccccceeecCCcccccccCcccccCC
Q 001974 470 ----------------------------------------------------GNLKYLRVFNVSSNNLSGEIPSQLGLCS 497 (988)
Q Consensus 470 ----------------------------------------------------~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 497 (988)
+.+++|+.|||++|+++|.+|..|+.++
T Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~ 656 (768)
T 3rgz_A 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656 (768)
T ss_dssp EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence 3357799999999999999999999999
Q ss_pred CCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCcccCccccccccc
Q 001974 498 YLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAG 576 (988)
Q Consensus 498 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 576 (988)
+|+.|+|++|+++|.+|.+|+++++|+.||||+|+++|.+|.. ..+.+|++|||++|+|+|.+|..+++.++...++.|
T Consensus 657 ~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~g 736 (768)
T 3rgz_A 657 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLN 736 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCS
T ss_pred cCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcC
Confidence 9999999999999999999999999999999999999999987 778899999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCcccccC
Q 001974 577 FNRLCGGIPELQLPKCTEKN 596 (988)
Q Consensus 577 n~~lcg~~~~~~~~~~~~~~ 596 (988)
|+++||.|.. .|....
T Consensus 737 N~~Lcg~~l~----~C~~~~ 752 (768)
T 3rgz_A 737 NPGLCGYPLP----RCDPSN 752 (768)
T ss_dssp CTEEESTTSC----CCCSCC
T ss_pred CchhcCCCCc----CCCCCc
Confidence 9999998753 575443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-66 Score=636.75 Aligned_cols=513 Identities=35% Similarity=0.514 Sum_probs=449.3
Q ss_pred EEEEEcCCCCCccccccc---ccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceee
Q 001974 34 VTVLNLRSKGLSGSLSPY---IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 34 v~~l~l~~~~~~~~~~~~---l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (988)
++.|||++|.+++..+.. +..+++|++|+|++|++++..| +..+++|++|+|++|.+++.+|. |+.+++|++|+
T Consensus 153 L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~ 229 (768)
T 3rgz_A 153 LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229 (768)
T ss_dssp CSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred CCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence 444444444444444433 4455555555555555554333 26778888888888888877776 88888899999
Q ss_pred cCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCc-cccccccccccccc
Q 001974 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQL-KELKSLGLGANNLS 189 (988)
Q Consensus 111 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~ 189 (988)
|++|++++..|..|.++++|++|+|++|.+++.+|.. .+++|++|++++|++++.+|..+.++ ++|++|+|++|+++
T Consensus 230 Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp CCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred CcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 9988888888888888889999999999888777765 78889999999999988888888775 99999999999999
Q ss_pred CccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCC-cccEEEeccccccCccccc
Q 001974 190 GIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS-KLEFIEALDNSFSGKLSVN 268 (988)
Q Consensus 190 ~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~N~i~~~~~~~ 268 (988)
+.+|..|.++++|++|++++|++.+.+|...+..+++|++|++++|++++.+|..+.+++ +|+.|++++|++++..+..
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 999999999999999999999998889988777899999999999999999999999887 8999999999999888888
Q ss_pred ccC--CccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCc
Q 001974 269 FGG--MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPS 346 (988)
Q Consensus 269 ~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~ 346 (988)
+.. +++|++|++++|.+++..+. .+..+++|++|++++|++++.+|..+..+. +|+.|++++|++.+.+|.
T Consensus 388 ~~~~~~~~L~~L~L~~n~l~~~~p~------~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~ 460 (768)
T 3rgz_A 388 LCQNPKNTLQELYLQNNGFTGKIPP------TLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQ 460 (768)
T ss_dssp TTCSTTCCCCEEECCSSEEEEECCG------GGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCG
T ss_pred hhhcccCCccEEECCCCccccccCH------HHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCH
Confidence 777 88999999999999865443 578899999999999999999999998886 799999999999999999
Q ss_pred cccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccccc
Q 001974 347 GIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQL 426 (988)
Q Consensus 347 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 426 (988)
.+..+++|++|++++|++++.+|..+.++++|++|+|++|++++.+|.+++.+++|++|+|++|++++.+|..++.+++|
T Consensus 461 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 540 (768)
T 3rgz_A 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC
T ss_pred HHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecCCCCCCccCchhhhh------------------------------------------------------------
Q 001974 427 AILHLFENGLNGTIPEEIFN------------------------------------------------------------ 446 (988)
Q Consensus 427 ~~L~l~~N~l~~~~p~~~~~------------------------------------------------------------ 446 (988)
+.|++++|+++|.+|..++.
T Consensus 541 ~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 620 (768)
T 3rgz_A 541 IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620 (768)
T ss_dssp CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEE
T ss_pred CEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccccccccccee
Confidence 99999999999999987654
Q ss_pred ----------hcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCcc
Q 001974 447 ----------LTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516 (988)
Q Consensus 447 ----------l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 516 (988)
++.+ +.|||++|+++|.+|..++.+++|+.|||++|+++|.+|..|+.+++|+.|||++|+++|.+|..
T Consensus 621 ~g~~~~~~~~l~~L-~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~ 699 (768)
T 3rgz_A 621 GGHTSPTFDNNGSM-MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699 (768)
T ss_dssp EEECCCSCSSSBCC-CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred cccCchhhhccccc-cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence 2345 78999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCc-Cccc
Q 001974 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFND-LEGE 559 (988)
Q Consensus 517 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~-l~~~ 559 (988)
++.++.|++||||+|+|+|.+|.......+....+.+|. |.|.
T Consensus 700 l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp GGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred HhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 999999999999999999999988766677777788885 5553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-61 Score=589.16 Aligned_cols=564 Identities=21% Similarity=0.195 Sum_probs=482.1
Q ss_pred CCceeeeeEEeC---------CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECC
Q 001974 18 HFCEWKGITCGL---------RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88 (988)
Q Consensus 18 ~~c~~~~v~c~~---------~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 88 (988)
|.|.+..|.|.. .+.+++.|+|++|++++..+..|+.+++|++|+|++|++++..|.+|+++++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 346666777774 23689999999999998888889999999999999999999999999999999999999
Q ss_pred CCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCC
Q 001974 89 DNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNI 168 (988)
Q Consensus 89 ~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 168 (988)
+|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|++++|.+++..
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 161 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence 99999666668999999999999999999888899999999999999999999888999999999999999999999777
Q ss_pred Ccccc--CcccccccccccccccCccchhhccc---------------------------cCccEEEeccCCCCCCCCCc
Q 001974 169 PNSLG--QLKELKSLGLGANNLSGIIPPSIYNL---------------------------SLLANFSVPRNQFHGSLPPS 219 (988)
Q Consensus 169 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l---------------------------~~L~~L~L~~N~i~~~lp~~ 219 (988)
+..|. .+++|++|+|++|++++..|..+..+ ++|+.|++++|++.+..|..
T Consensus 162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~ 241 (680)
T 1ziw_A 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241 (680)
T ss_dssp HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence 77665 56899999999999998888877765 45677778888887444443
Q ss_pred ccccCC--CCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhh-
Q 001974 220 LGLTLP--HLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFM- 296 (988)
Q Consensus 220 ~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~- 296 (988)
+..++ +|+.|++++|++++..|..|..+++|++|++++|.+.+..+..|.++++|+.|++++|........ ...+
T Consensus 242 -~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~-~~lp~ 319 (680)
T 1ziw_A 242 -FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL-ASLPK 319 (680)
T ss_dssp -TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------CCE
T ss_pred -hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc-ccccc
Confidence 44554 499999999999988888899999999999999999999888999999999999988754421100 0000
Q ss_pred ---cccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCcccc--CCCccccCC--CcceEEEeeCccCCCccC
Q 001974 297 ---NSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG--SIPSGIGNL--VGLYRLGMGGNQFTGTIP 369 (988)
Q Consensus 297 ---~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~p 369 (988)
..|..+++|++|++++|++++..|..+..+. +|++|++++|.+.. .....+..+ ++|+.|++++|++++..|
T Consensus 320 i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~ 398 (680)
T 1ziw_A 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT
T ss_pred cChhhcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh
Confidence 1567889999999999999987777777765 79999999998542 222334333 589999999999998889
Q ss_pred cccCCCCccCeEecccccCCCCCC-CCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCC--ccCchhhhh
Q 001974 370 KEMGKLQNLEGMGLYDNQLSGEIP-SSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN--GTIPEEIFN 446 (988)
Q Consensus 370 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~ 446 (988)
..|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+. +.+|..+.+
T Consensus 399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~ 478 (680)
T 1ziw_A 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTT
T ss_pred hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccccc
Confidence 999999999999999999987666 67999999999999999999999999999999999999999987 578999999
Q ss_pred hcccccceecccccccCCCccccccccccceeecCCcccccccC--------cccccCCCCcEEEecCccccccCCcccc
Q 001974 447 LTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIP--------SQLGLCSYLEEIYMRGNFFHGSIPSSLS 518 (988)
Q Consensus 447 l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 518 (988)
++.| +.|++++|++++..|..|..+++|+.|+|++|++++..+ ..|+.+++|+.|+|++|+++...+..|.
T Consensus 479 l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 557 (680)
T 1ziw_A 479 LRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557 (680)
T ss_dssp CTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence 9999 999999999998888889999999999999999996422 2378999999999999999954445799
Q ss_pred CccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCc--ccCcccccccccccccCCCCC
Q 001974 519 SLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKG--VFANISRISVAGFNRLCGGIP 585 (988)
Q Consensus 519 ~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~lcg~~~ 585 (988)
.+++|+.|||++|+|++.++.. ..+++|++|+|++|++++.+|... .+..+..+.+.+||+.|+|..
T Consensus 558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 9999999999999999988876 677899999999999999887532 467788889999999999863
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=560.12 Aligned_cols=535 Identities=19% Similarity=0.182 Sum_probs=344.6
Q ss_pred CCCCCCCce--eeeeEEeCC---------CCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCC
Q 001974 13 WNDSGHFCE--WKGITCGLR---------HRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFR 81 (988)
Q Consensus 13 w~~~~~~c~--~~~v~c~~~---------~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 81 (988)
|-+..|.|. +..|.|... +..++.|||++|.|++..|.+|+.+++|++|+|++|+|+++.|.+|.++++
T Consensus 3 ~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 82 (606)
T 3t6q_A 3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82 (606)
T ss_dssp ---CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTT
T ss_pred cccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccc
Confidence 334555554 455666531 234555555555555444555555555555555555555555555555555
Q ss_pred CcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccc
Q 001974 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA 161 (988)
Q Consensus 82 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (988)
|++|+|++|++++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|++++.....+.++++|++|++++
T Consensus 83 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 162 (606)
T 3t6q_A 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162 (606)
T ss_dssp CCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCS
T ss_pred cCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEccc
Confidence 55555555555544555555555555555555555544445555555555555555555543323333355555555555
Q ss_pred cccCCCCCccccCccccc--ccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccc-
Q 001974 162 NAFGGNIPNSLGQLKELK--SLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS- 238 (988)
Q Consensus 162 N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~- 238 (988)
|++++..+..|+.+++|+ .|++++|++++..|..+.. .+|+.|++++|... + ..+..+.++....+..+.+.
T Consensus 163 n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~---~-~~~~~l~~~~l~~l~~~~~~~ 237 (606)
T 3t6q_A 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNL---L-VIFKGLKNSTIQSLWLGTFED 237 (606)
T ss_dssp SCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCH---H-HHHHHTTTCEEEEEECCCCTT
T ss_pred CcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhH---H-HHhhhccccchhheechhhcc
Confidence 555544445555555555 4555555555444433332 34555555554311 1 11112222221111111111
Q ss_pred ----cccCcccccCC--cccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeec
Q 001974 239 ----GSIPISLSNAS--KLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAA 312 (988)
Q Consensus 239 ----~~~p~~l~~l~--~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 312 (988)
...+..+..+. +|+.|++++|.+.+..+..|..+++|++|++++|.++.++. .+..+++|++|++++
T Consensus 238 ~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~-------~l~~l~~L~~L~l~~ 310 (606)
T 3t6q_A 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS-------GLVGLSTLKKLVLSA 310 (606)
T ss_dssp SCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS-------SCCSCTTCCEEECTT
T ss_pred ccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh-------hhcccccCCEEECcc
Confidence 11122233332 67888888888888887778888888888888888875543 356778888888888
Q ss_pred ccCCCCCCchhhhccccccEEEccCCccccCCCc-cccCCCcceEEEeeCccCCCcc--CcccCCCCccCeEecccccCC
Q 001974 313 NKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPS-GIGNLVGLYRLGMGGNQFTGTI--PKEMGKLQNLEGMGLYDNQLS 389 (988)
Q Consensus 313 N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~ 389 (988)
|++++..|..+..++ +|+.|++++|.+.+.+|. .+..+++|++|++++|++++.. +..+..+++|++|++++|+++
T Consensus 311 n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 389 (606)
T 3t6q_A 311 NKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389 (606)
T ss_dssp CCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCE
T ss_pred CCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCC
Confidence 888866666666664 688888888888765554 4778888888888888887655 667888888888888888888
Q ss_pred CCCCCCCCCCCCCCEEEccccccccccccc-cccccccceeecCCCCCCccCchhhhhhcccccceecccccccCC---C
Q 001974 390 GEIPSSLGNLSILSELLLNNNSLSGVIPSC-LGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGS---I 465 (988)
Q Consensus 390 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~---~ 465 (988)
+..|..|..+++|+.|++++|++.+..|.. |..+++|+.|++++|.+++..|..+..++.| ++|++++|++++. .
T Consensus 390 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~ 468 (606)
T 3t6q_A 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQK 468 (606)
T ss_dssp EECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECS
T ss_pred cCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC-CEEECCCCCCCcccccc
Confidence 777788888888888888888887665543 7788888888888888887777777778887 7888888888752 2
Q ss_pred ccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCC
Q 001974 466 PTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDL 544 (988)
Q Consensus 466 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~ 544 (988)
+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..|.+++.| .|||++|++++.+|.. ..++
T Consensus 469 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~ 547 (606)
T 3t6q_A 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS 547 (606)
T ss_dssp SCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHH
T ss_pred chhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCC
Confidence 3567788888888888888887777888888888888888888888888888888888 8888888888887775 5666
Q ss_pred CCcEEeCCCCcCcccCCC
Q 001974 545 SLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 545 ~L~~l~l~~N~l~~~~p~ 562 (988)
+|++|++++|++++.++.
T Consensus 548 ~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 548 QQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp TSSEEECTTCCEECSGGG
T ss_pred CCCEEeCCCCCccccCCc
Confidence 788888888888876663
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=556.80 Aligned_cols=523 Identities=19% Similarity=0.201 Sum_probs=461.6
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeec
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (988)
.+++.|||++|.+++..|..++.+++|++|+|++|+|++..+.+|+++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 57899999999999999999999999999999999999766678999999999999999999887889999999999999
Q ss_pred CcccccCCCcccccCcccccccccccccccCCCCCccc--CCCccceeeccccccCCCCCccccCc--------------
Q 001974 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIG--NLTSLESISLAANAFGGNIPNSLGQL-------------- 175 (988)
Q Consensus 112 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l-------------- 175 (988)
++|++++..|..|.++++|++|++++|.+++..+..+. .+++|++|++++|++++..|..|..+
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 99999999999999999999999999999977766654 56899999999999998888877755
Q ss_pred -------------ccccccccccccccCccchhhccccC--ccEEEeccCCCCCCCCCcccccCCCCcceeccccccccc
Q 001974 176 -------------KELKSLGLGANNLSGIIPPSIYNLSL--LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS 240 (988)
Q Consensus 176 -------------~~L~~L~L~~N~l~~~~~~~l~~l~~--L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 240 (988)
++|+.|+|++|++++..|..+.+++. |+.|++++|++. .++...+..+++|+.|++++|++++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN-VVGNDSFAWLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC-ccCcccccCcccccEeeCCCCccCcc
Confidence 45678888899999888999998866 999999999999 55555667899999999999999999
Q ss_pred cCcccccCCcccEEEeccccccC---------cccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEee
Q 001974 241 IPISLSNASKLEFIEALDNSFSG---------KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA 311 (988)
Q Consensus 241 ~p~~l~~l~~L~~L~l~~N~i~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 311 (988)
.|..+..+++|+.|++++|...+ +....|..+++|++|++++|.++.+.+. .|..+++|++|+++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN------MFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT------TTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh------HhccccCCcEEECC
Confidence 99999999999999999876553 2223788999999999999999987665 57789999999999
Q ss_pred cccCCC-CCCc-hhhhcc-ccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccC-cccCCCCccCeEeccccc
Q 001974 312 ANKLRG-ALPH-SIANLS-DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIP-KEMGKLQNLEGMGLYDNQ 387 (988)
Q Consensus 312 ~N~l~~-~~p~-~~~~~~-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 387 (988)
+|.+.. .++. .+.... +.|+.|++++|++++..|..+..+++|+.|++++|++++.+| ..|.++++|++|+|++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 998643 2222 222221 479999999999999999999999999999999999987666 689999999999999999
Q ss_pred CCCCCCCCCCCCCCCCEEEccccccc--cccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCC
Q 001974 388 LSGEIPSSLGNLSILSELLLNNNSLS--GVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSI 465 (988)
Q Consensus 388 l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~ 465 (988)
+++..+..|..+++|+.|++++|.+. +..|..|..+++|+.|++++|++++..|..+.+++.| ++|++++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccc
Confidence 99888999999999999999999987 5789999999999999999999996556678889999 99999999998542
Q ss_pred c--------cccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcC
Q 001974 466 P--------TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI 537 (988)
Q Consensus 466 p--------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 537 (988)
+ ..+..+++|+.|+|++|+++...+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|++.+
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 2 24789999999999999999444457999999999999999999777777899999999999999999999
Q ss_pred cccc--cCCCCcEEeCCCCcCcccCCC
Q 001974 538 PKFL--EDLSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 538 p~~~--~~~~L~~l~l~~N~l~~~~p~ 562 (988)
|... .+++|+.|+|++|++.+..+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 8763 578999999999999998874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=561.25 Aligned_cols=510 Identities=20% Similarity=0.171 Sum_probs=283.8
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCccccc-CCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCcee
Q 001974 31 HRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGE-IPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTIL 109 (988)
Q Consensus 31 ~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 109 (988)
+..++.|||++|.|++..|.+|..+++|++|+|++|.+.+. .|.+|.++++|++|+|++|.+++..|..|+++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 34566666666666655566666666666666666643322 35556666666666666666665556666666666666
Q ss_pred ecCcccccCCCccc--ccCcccccccccccccccCCCC-CcccCCCccceeeccccccCCCCCccccCc--ccccccccc
Q 001974 110 FLGRNKLMGSIPFE--FFSLYKLKQLAMQRNNLTGGIP-PFIGNLTSLESISLAANAFGGNIPNSLGQL--KELKSLGLG 184 (988)
Q Consensus 110 ~L~~N~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~ 184 (988)
+|++|++++..|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+ ++|+.|+|+
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 66666665544433 5666666666666666654433 345666666666666666665555556555 556666666
Q ss_pred cccccCccchhhccccC------ccEEEeccCCCCCCCCCcccccC--CCCcceeccc---------cccccccCccccc
Q 001974 185 ANNLSGIIPPSIYNLSL------LANFSVPRNQFHGSLPPSLGLTL--PHLRLFQVHH---------NFFSGSIPISLSN 247 (988)
Q Consensus 185 ~N~l~~~~~~~l~~l~~------L~~L~L~~N~i~~~lp~~~~~~l--~~L~~L~L~~---------N~l~~~~p~~l~~ 247 (988)
+|.+.+..|..+..+.+ |+.|++++|.+.+.++..+...+ ..+..|.++. |.+.+..+..|..
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence 66666555555444443 66666666666555555444322 3344444442 2222222333333
Q ss_pred C--CcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhh
Q 001974 248 A--SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIAN 325 (988)
Q Consensus 248 l--~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 325 (988)
+ ++|+.|++++|.+.+..+..|..+++|+.|+|++|.++.+.+. .|..+++|++|+|++|++++..|..+..
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 336 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNLSYNLLGELYSSNFYG 336 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTT------TTTTCSSCCEEEEESCCCSCCCSCSCSS
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChH------HhcCCCCCCEEECCCCCCCccCHHHhcC
Confidence 3 4566666666666666566666666666666666666554433 3455566666666666665555555555
Q ss_pred ccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEE
Q 001974 326 LSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL 405 (988)
Q Consensus 326 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 405 (988)
++ +|+.|++++|++.+..+..|..+++|+.|+|++|.+++ ++ .+++|+.|++++|+++ .+|.. ..+++.|
T Consensus 337 l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L 406 (844)
T 3j0a_A 337 LP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLPKI---NLTANLI 406 (844)
T ss_dssp CT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCC-CCCCC---CTTCCEE
T ss_pred CC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcc-ccccc---cccccee
Confidence 43 46666666666665555556666666666666666652 22 2455666666666665 33432 3445566
Q ss_pred Ecccccccccc-ccccccccccceeecCCCCCCccCch-hhhhhcccccceeccccccc-----CCCcccccccccccee
Q 001974 406 LLNNNSLSGVI-PSCLGSLKQLAILHLFENGLNGTIPE-EIFNLTYLSNSLNLARNHLV-----GSIPTKIGNLKYLRVF 478 (988)
Q Consensus 406 ~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~-----~~~p~~~~~l~~L~~L 478 (988)
++++|++++.. +..+..+++|+.|+|++|++++..+. .+..++.| +.|+|++|.++ +..|..|..+++|+.|
T Consensus 407 ~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L-~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L 485 (844)
T 3j0a_A 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL-EQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485 (844)
T ss_dssp ECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC-CBCEEESCCCSSSCCSCCCSSCSSCBCCEECC
T ss_pred ecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc-ccccCCCCccccccccccchhhhcCcccccEE
Confidence 66666665431 12234556666666666666532222 12334444 56666666654 2333445556666666
Q ss_pred ecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcc
Q 001974 479 NVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEG 558 (988)
Q Consensus 479 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~ 558 (988)
+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|... .+|+.|++++|++.+
T Consensus 486 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~--~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 486 YLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF--VSLSVLDITHNKFIC 561 (844)
T ss_dssp CCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC--SSCCEEEEEEECCCC
T ss_pred ECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh--CCcCEEEecCCCccc
Confidence 6666666655555566666666666666666654444444 556666666666666655442 255666666666655
Q ss_pred cCC
Q 001974 559 EVP 561 (988)
Q Consensus 559 ~~p 561 (988)
.++
T Consensus 562 ~c~ 564 (844)
T 3j0a_A 562 ECE 564 (844)
T ss_dssp SSS
T ss_pred ccc
Confidence 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=549.43 Aligned_cols=504 Identities=20% Similarity=0.173 Sum_probs=363.1
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|++
T Consensus 16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l 92 (606)
T 3vq2_A 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92 (606)
T ss_dssp EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence 444455554 3444333 4555555555555555555555555555555555555544455555555555555555555
Q ss_pred cCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCC-CCCccccCcccccccccccccccCccchh
Q 001974 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGG-NIPNSLGQLKELKSLGLGANNLSGIIPPS 195 (988)
Q Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 195 (988)
++..|.+|.++++|++|+|++|.+++..+..|+++++|++|++++|++++ .+|..|+++++|++|+|++|++++..+..
T Consensus 93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~ 172 (606)
T 3vq2_A 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172 (606)
T ss_dssp CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence 55555555555555555555555554444555555555555555555543 23555555555555555555555555555
Q ss_pred hccccCcc----EEEeccCCCCCCCCCcccccCCCCcceeccccccc-cccCcccccCCcccE-----------------
Q 001974 196 IYNLSLLA----NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS-GSIPISLSNASKLEF----------------- 253 (988)
Q Consensus 196 l~~l~~L~----~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~----------------- 253 (988)
+..+++|+ .|++++|++. .++...+... +|+.|++++|.++ +..|..+.+++.|+.
T Consensus 173 ~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~ 250 (606)
T 3vq2_A 173 LQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250 (606)
T ss_dssp THHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred hhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence 55544443 4555555555 4444444332 5555555555554 233334444444444
Q ss_pred ---------------EEe-ccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCC
Q 001974 254 ---------------IEA-LDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317 (988)
Q Consensus 254 ---------------L~l-~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 317 (988)
+++ ..|.+.+..+. |..+++|+.|++++|.++.++ .+..+++|++|++++|++ +
T Consensus 251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~ 320 (606)
T 3vq2_A 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-K 320 (606)
T ss_dssp CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-S
T ss_pred ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-c
Confidence 444 66777777777 888999999999999987654 367788999999999999 5
Q ss_pred CCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCc--cCcccCCCCccCeEecccccCCCCCCCC
Q 001974 318 ALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT--IPKEMGKLQNLEGMGLYDNQLSGEIPSS 395 (988)
Q Consensus 318 ~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 395 (988)
.+|. + .+ ++|+.|++++|+..+.. .+..+++|+.|++++|++++. .|..+..+++|+.|+|++|.++ .+|..
T Consensus 321 ~lp~-~-~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~ 394 (606)
T 3vq2_A 321 QFPT-L-DL-PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSAN 394 (606)
T ss_dssp SCCC-C-CC-SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCC
T ss_pred cccc-C-CC-CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhh
Confidence 8884 4 44 57999999999665444 677899999999999999865 3788899999999999999998 46788
Q ss_pred CCCCCCCCEEEccccccccccc-cccccccccceeecCCCCCCccCchhhhhhcccccceecccccccC-CCcccccccc
Q 001974 396 LGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG-SIPTKIGNLK 473 (988)
Q Consensus 396 ~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~-~~p~~~~~l~ 473 (988)
+..+++|+.|++++|++.+..| ..|..+++|+.|++++|++++.+|..+.+++.| ++|++++|++++ .+|..++.++
T Consensus 395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~ 473 (606)
T 3vq2_A 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTT 473 (606)
T ss_dssp CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCT
T ss_pred ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC-CEEECCCCcCCCcchHHhhccCC
Confidence 9999999999999999998877 688999999999999999998888888999998 899999999987 4788899999
Q ss_pred ccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCC-CCcEEeCC
Q 001974 474 YLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552 (988)
Q Consensus 474 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~-~L~~l~l~ 552 (988)
+|+.|+|++|++++..|..|+.+++|+.|+|++|++++.+|..|..+++|+.|||++|+|+..++.+..++ +|++|+++
T Consensus 474 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~ 553 (606)
T 3vq2_A 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553 (606)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECC
T ss_pred CCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEcc
Confidence 99999999999998888999999999999999999998889999999999999999999997666666776 59999999
Q ss_pred CCcCcccCCC
Q 001974 553 FNDLEGEVPT 562 (988)
Q Consensus 553 ~N~l~~~~p~ 562 (988)
+|++.+..+.
T Consensus 554 ~N~~~c~c~~ 563 (606)
T 3vq2_A 554 NNSVACICEH 563 (606)
T ss_dssp SCCCCCSSTT
T ss_pred CCCcccCCcc
Confidence 9999987775
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=548.25 Aligned_cols=495 Identities=19% Similarity=0.158 Sum_probs=440.8
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeec
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (988)
..++.|+|++|++++..|.+|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|+|
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 58999999999999988999999999999999999999999999999999999999999999877889999999999999
Q ss_pred CcccccCCCcccccCcccccccccccccccCCCCCcccCCCccc--eeeccccccCCCCCccccCccccccccccccccc
Q 001974 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLE--SISLAANAFGGNIPNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 112 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 189 (988)
++|++++.....+..+++|++|++++|.+++..+..|+.+++|+ +|++++|.+++..|..|.. .+|+.|++++|.
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~-- 213 (606)
T 3t6q_A 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ-- 213 (606)
T ss_dssp CSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS--
T ss_pred CCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch--
Confidence 99999976656667799999999999999988888899999999 8999999999877777665 689999999997
Q ss_pred CccchhhccccCccEEEeccCCCCC----CCCCcccccCC--CCcceeccccccccccCcccccCCcccEEEeccccccC
Q 001974 190 GIIPPSIYNLSLLANFSVPRNQFHG----SLPPSLGLTLP--HLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263 (988)
Q Consensus 190 ~~~~~~l~~l~~L~~L~L~~N~i~~----~lp~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~ 263 (988)
..+..+.++.+++...+..+.+.+ .++...+.++. +|+.|++++|.+++..+..|..+++|+.|++++|+++
T Consensus 214 -~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~- 291 (606)
T 3t6q_A 214 -NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS- 291 (606)
T ss_dssp -CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-
T ss_pred -hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-
Confidence 456677777766665555444331 44555555554 7999999999999988888999999999999999998
Q ss_pred cccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccC
Q 001974 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS 343 (988)
Q Consensus 264 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~ 343 (988)
.+|..+..+++|++|++++|.++...+. .+..+++|++|++++|.+.+.+|.......++|++|++++|++.+.
T Consensus 292 ~lp~~l~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 365 (606)
T 3t6q_A 292 ELPSGLVGLSTLKKLVLSANKFENLCQI------SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365 (606)
T ss_dssp CCCSSCCSCTTCCEEECTTCCCSBGGGG------CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEE
T ss_pred CCChhhcccccCCEEECccCCcCcCchh------hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccc
Confidence 5677799999999999999999865443 5778999999999999999888776444445899999999999976
Q ss_pred C--CccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCC-CCCCCCCCCEEEcccccccccccccc
Q 001974 344 I--PSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS-SLGNLSILSELLLNNNSLSGVIPSCL 420 (988)
Q Consensus 344 ~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~ 420 (988)
. +..+..+++|+.|++++|++.+..|..|..+++|+.|++++|++++..|. .+.++++|+.|++++|.+.+..|..|
T Consensus 366 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 445 (606)
T 3t6q_A 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLF 445 (606)
T ss_dssp EESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTT
T ss_pred cCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHH
Confidence 6 78899999999999999999988899999999999999999999977665 48999999999999999999999999
Q ss_pred ccccccceeecCCCCCCcc---CchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCC
Q 001974 421 GSLKQLAILHLFENGLNGT---IPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCS 497 (988)
Q Consensus 421 ~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 497 (988)
..+++|+.|++++|++++. .+..+..++.| +.|++++|++++..|..|..+++|+.|+|++|++++..|..|..++
T Consensus 446 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 524 (606)
T 3t6q_A 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL-EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524 (606)
T ss_dssp TTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCC
T ss_pred hCCCCCCEEECCCCCCCccccccchhhccCCCc-cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccc
Confidence 9999999999999999863 23568889999 9999999999988899999999999999999999999999999999
Q ss_pred CCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc
Q 001974 498 YLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 498 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 539 (988)
+| .|+|++|++++..|..+..+++|+.|++++|.+....+.
T Consensus 525 ~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 525 GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 99 999999999999999999999999999999999986653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=558.33 Aligned_cols=525 Identities=22% Similarity=0.232 Sum_probs=456.7
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcC-CcccccCCCCceeecCc
Q 001974 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEI-PANLSYCSRLTILFLGR 113 (988)
Q Consensus 35 ~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~ 113 (988)
...|.++++++ .+|. ..++|++|||++|+|++..|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 35577788888 5565 4578999999999999999999999999999999999665555 88999999999999999
Q ss_pred ccccCCCcccccCcccccccccccccccCCCCCc--ccCCCccceeeccccccCCCCC-ccccCcccccccccccccccC
Q 001974 114 NKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF--IGNLTSLESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 114 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 190 (988)
|+|++..|.+|.++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9999888999999999999999999999766654 9999999999999999987655 579999999999999999999
Q ss_pred ccchhhccc--cCccEEEeccCCCCCCCCCcccccCC------CCcceeccccccccccCcccccC---CcccEEEec--
Q 001974 191 IIPPSIYNL--SLLANFSVPRNQFHGSLPPSLGLTLP------HLRLFQVHHNFFSGSIPISLSNA---SKLEFIEAL-- 257 (988)
Q Consensus 191 ~~~~~l~~l--~~L~~L~L~~N~i~~~lp~~~~~~l~------~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~l~-- 257 (988)
..+..+..+ ++|+.|+++.|.+.+..|..+. .++ +|+.|++++|.+++..+..+... .+++.+.++
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~ 241 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred eCHHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence 999999988 8999999999999977776543 333 49999999999998888777654 567888876
Q ss_pred -------cccccCcccccccCC--ccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccc
Q 001974 258 -------DNSFSGKLSVNFGGM--KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328 (988)
Q Consensus 258 -------~N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 328 (988)
.|.+.+.....|.++ ++|+.|++++|.++...+. .|..+++|++|+|++|++++..|..+..+.
T Consensus 242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~- 314 (844)
T 3j0a_A 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR------VFETLKDLKVLNLAYNKINKIADEAFYGLD- 314 (844)
T ss_dssp CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC------CSSSCCCCCEEEEESCCCCEECTTTTTTCS-
T ss_pred cccccccccccCCCChhhhhccccCCccEEECCCCcccccChh------hhhcCCCCCEEECCCCcCCCCChHHhcCCC-
Confidence 344555556667665 7899999999999876554 578899999999999999988888887775
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
+|++|+|++|++++..|..+..+++|+.|++++|++.+..+..|.++++|+.|+|++|.+++ ++ .+++|+.|+++
T Consensus 315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~ 389 (844)
T 3j0a_A 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLS 389 (844)
T ss_dssp SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEE
T ss_pred CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccC
Confidence 79999999999998889999999999999999999998888889999999999999999984 33 38899999999
Q ss_pred ccccccccccccccccccceeecCCCCCCccCch--hhhhhcccccceecccccccCCCcc-ccccccccceeecCCccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE--EIFNLTYLSNSLNLARNHLVGSIPT-KIGNLKYLRVFNVSSNNL 485 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~l~~~L~ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l 485 (988)
+|+++ .+|.. ..+++.|++++|++++ ++. .+.+++.| +.|+|++|++++..+. .+..+++|+.|+|++|.+
T Consensus 390 ~N~l~-~l~~~---~~~l~~L~ls~N~l~~-l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l 463 (844)
T 3j0a_A 390 GNKLV-TLPKI---NLTANLIHLSENRLEN-LDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463 (844)
T ss_dssp SCCCC-CCCCC---CTTCCEEECCSCCCCS-STTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCC
T ss_pred CCCcc-ccccc---ccccceeecccCcccc-CchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCcc
Confidence 99999 45554 4679999999999984 433 45588888 9999999999865443 456689999999999999
Q ss_pred c-----cccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccC
Q 001974 486 S-----GEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEV 560 (988)
Q Consensus 486 ~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~ 560 (988)
+ +..|..|..+++|+.|+|++|.|++..|..|..+++|+.|||++|+|++.+|.... ++|+.|+|++|+|++.+
T Consensus 464 ~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~ 542 (844)
T 3j0a_A 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN 542 (844)
T ss_dssp SSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred ccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence 7 45567789999999999999999999999999999999999999999998887755 78999999999999999
Q ss_pred CCCcccCcccccccccccccCCCCC
Q 001974 561 PTKGVFANISRISVAGFNRLCGGIP 585 (988)
Q Consensus 561 p~~~~~~~~~~~~~~~n~~lcg~~~ 585 (988)
|.. +..+..+.+.+||+.|.|..
T Consensus 543 ~~~--~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 543 PDV--FVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCC--CSSCCEEEEEEECCCCSSSC
T ss_pred hhH--hCCcCEEEecCCCccccccc
Confidence 965 67888889999999998763
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=537.61 Aligned_cols=503 Identities=19% Similarity=0.149 Sum_probs=444.2
Q ss_pred CCcee----eeeEEeC---------CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcE
Q 001974 18 HFCEW----KGITCGL---------RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEA 84 (988)
Q Consensus 18 ~~c~~----~~v~c~~---------~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 84 (988)
+.|.| ..|.|.. ...+++.|+|++|++++..+.+|..+++|++|+|++|+|+++.|.+|.++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 44655 3677864 2368999999999999888889999999999999999999989999999999999
Q ss_pred EECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccC-CCCCcccCCCccceeeccccc
Q 001974 85 LFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSLESISLAANA 163 (988)
Q Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~ 163 (988)
|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|+
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 9999999998889999999999999999999998888999999999999999999986 569999999999999999999
Q ss_pred cCCCCCccccCccccc----ccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceec-------
Q 001974 164 FGGNIPNSLGQLKELK----SLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV------- 232 (988)
Q Consensus 164 l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L------- 232 (988)
+++..+..|+.+++|+ +|++++|.++++.+..+... +|+.|++++|.+.+......+..+++|+.+++
T Consensus 165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~ 243 (606)
T 3vq2_A 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243 (606)
T ss_dssp CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence 9988888899888876 79999999997766666655 89999999998863333333344555554444
Q ss_pred --------------------------cccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCC
Q 001974 233 --------------------------HHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLG 286 (988)
Q Consensus 233 --------------------------~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 286 (988)
..|.+.+.+|. +..+++|+.|++++|.+.... .+..+++|+.|++++|.++
T Consensus 244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l~ 320 (606)
T 3vq2_A 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQLK 320 (606)
T ss_dssp SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCCS
T ss_pred CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccCc
Confidence 67777777777 899999999999999997654 7899999999999999996
Q ss_pred CCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccC--CCccccCCCcceEEEeeCccC
Q 001974 287 SGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS--IPSGIGNLVGLYRLGMGGNQF 364 (988)
Q Consensus 287 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l 364 (988)
.++ .+ .+++|++|++++|+..+.. .+..+ ++|++|++++|++++. .|..+..+++|+.|++++|.+
T Consensus 321 ~lp--------~~-~l~~L~~L~l~~n~~~~~~--~~~~l-~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 388 (606)
T 3vq2_A 321 QFP--------TL-DLPFLKSLTLTMNKGSISF--KKVAL-PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388 (606)
T ss_dssp SCC--------CC-CCSSCCEEEEESCSSCEEC--CCCCC-TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSE
T ss_pred ccc--------cC-CCCccceeeccCCcCccch--hhccC-CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcc
Confidence 554 23 7899999999999665444 33344 4799999999999976 488899999999999999999
Q ss_pred CCccCcccCCCCccCeEecccccCCCCCC-CCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCcc-Cch
Q 001974 365 TGTIPKEMGKLQNLEGMGLYDNQLSGEIP-SSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGT-IPE 442 (988)
Q Consensus 365 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~ 442 (988)
+ .+|..+..+++|+.|++++|++.+..| ..+.++++|+.|++++|.+.+..|..|..+++|+.|++++|++++. +|.
T Consensus 389 ~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 467 (606)
T 3vq2_A 389 I-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467 (606)
T ss_dssp E-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECS
T ss_pred c-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHH
Confidence 9 577899999999999999999998877 6899999999999999999999999999999999999999999974 788
Q ss_pred hhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCcc-
Q 001974 443 EIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR- 521 (988)
Q Consensus 443 ~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~- 521 (988)
.+..++.| +.|++++|++++..|..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|+|+ .+|..+..++
T Consensus 468 ~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~ 545 (606)
T 3vq2_A 468 VFANTTNL-TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPK 545 (606)
T ss_dssp CCTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCT
T ss_pred hhccCCCC-CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcc
Confidence 89999999 99999999999999999999999999999999999988999999999999999999999 7888899997
Q ss_pred ccCeeecCCCcccCcCcc
Q 001974 522 AVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 522 ~L~~L~ls~N~l~~~~p~ 539 (988)
+|+.|++++|.+....+.
T Consensus 546 ~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 546 SLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TCCEEECCSCCCCCSSTT
T ss_pred cCcEEEccCCCcccCCcc
Confidence 699999999999976654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=540.51 Aligned_cols=485 Identities=21% Similarity=0.279 Sum_probs=259.8
Q ss_pred CccccCCCCCCCCCcee---eeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCccc------c------
Q 001974 6 PQGILNSWNDSGHFCEW---KGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQ------G------ 70 (988)
Q Consensus 6 ~~~~~~~w~~~~~~c~~---~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~------~------ 70 (988)
+.....+|..++|||.| .||+|+.. ++|+.|+|++++++|.+|++++.|++|++|+|++|++. +
T Consensus 53 ~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~ 131 (636)
T 4eco_A 53 GTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131 (636)
T ss_dssp -----CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCT
T ss_pred CCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCcccccccccc
Confidence 33455699999999999 99999855 89999999999999999999999999999999999873 1
Q ss_pred cCCcccCCCCCCcEEECCCCCCCCcCCccccc-CCCCceeecCcccccCCCcccccCcccccccccc--cccccCCCCCc
Q 001974 71 EIPREFGRLFRLEALFLSDNDLVGEIPANLSY-CSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQ--RNNLTGGIPPF 147 (988)
Q Consensus 71 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~--~N~l~~~~~~~ 147 (988)
.+|... +.+|+ +++++|.+.+.+|..++. +.++..+++....+.. .....++.+.+. .|++++ +|..
T Consensus 132 ~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~ 201 (636)
T 4eco_A 132 NMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKA 201 (636)
T ss_dssp TCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGG
T ss_pred CchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHH
Confidence 233332 44566 777777777777666653 2233334443222210 111222333332 456665 5666
Q ss_pred ccCCCccceeeccccccCCC-----------------CCcccc--CcccccccccccccccCccchhhccccCccEEEec
Q 001974 148 IGNLTSLESISLAANAFGGN-----------------IPNSLG--QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208 (988)
Q Consensus 148 ~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 208 (988)
|+++++|++|+|++|++++. +|..++ ++++|++|+|++|++.+.+|..+.++++|++|+++
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 66666666666666666653 566666 66666666666666666666666666666666666
Q ss_pred cCC-CCC-CCCCcccc-----cCCCCcceeccccccccccCc--ccccCCcccEEEeccccccCcccccccCCccccEEe
Q 001974 209 RNQ-FHG-SLPPSLGL-----TLPHLRLFQVHHNFFSGSIPI--SLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFN 279 (988)
Q Consensus 209 ~N~-i~~-~lp~~~~~-----~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 279 (988)
+|+ +++ .+|..++. .+++|+.|++++|+++ .+|. .+.++++|+.|++++|++.+.+| .|..+++|+.|+
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 665 554 45554431 2356666666666666 5555 56666666666666666665555 566666666666
Q ss_pred cccccCCCCCCCchhhhcccccCCC-CcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEE
Q 001974 280 VAYNNLGSGESDEMSFMNSLANCSN-LRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLG 358 (988)
Q Consensus 280 L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 358 (988)
+++|.++.++. .+..+++ |++|++++|+++ .+|..+.... +++|+.|+
T Consensus 360 L~~N~l~~lp~-------~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~-----------------------l~~L~~L~ 408 (636)
T 4eco_A 360 LAYNQITEIPA-------NFCGFTEQVENLSFAHNKLK-YIPNIFDAKS-----------------------VSVMSAID 408 (636)
T ss_dssp CCSSEEEECCT-------TSEEECTTCCEEECCSSCCS-SCCSCCCTTC-----------------------SSCEEEEE
T ss_pred CCCCccccccH-------hhhhhcccCcEEEccCCcCc-ccchhhhhcc-----------------------cCccCEEE
Confidence 66666552221 2334444 444444444444 3333322211 11344444
Q ss_pred eeCccCCCccCcccC-------CCCccCeEecccccCCCCCCCC-CCCCCCCCEEEccccccccccccccc-------cc
Q 001974 359 MGGNQFTGTIPKEMG-------KLQNLEGMGLYDNQLSGEIPSS-LGNLSILSELLLNNNSLSGVIPSCLG-------SL 423 (988)
Q Consensus 359 L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~-------~l 423 (988)
+++|++++.+|..+. .+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++...+..+. ++
T Consensus 409 Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l 487 (636)
T 4eco_A 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT 487 (636)
T ss_dssp CCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTG
T ss_pred CcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccccccccc
Confidence 444444333333333 3333333333333333 12221 22233333333333333311111111 11
Q ss_pred cccceeecCCCCCCccCchhhh--hhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcE
Q 001974 424 KQLAILHLFENGLNGTIPEEIF--NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEE 501 (988)
Q Consensus 424 ~~L~~L~l~~N~l~~~~p~~~~--~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 501 (988)
++|+.|+|++|+++ .+|..++ .++.| +.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L-~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~----------------- 547 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYL-VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR----------------- 547 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-----------------
T ss_pred CCccEEECcCCcCC-ccChhhhhccCCCc-CEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-----------------
Confidence 24444444444444 4444443 44444 444444444443 44444444444444443322
Q ss_pred EEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcc
Q 001974 502 IYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEG 558 (988)
Q Consensus 502 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~ 558 (988)
++++|++.+.+|..+..+++|+.|||++|+| +.+|.... ++|++|+|++|++..
T Consensus 548 -~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 548 -DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNIS 601 (636)
T ss_dssp -CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTCE
T ss_pred -ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCcc
Confidence 1244555555555555555666666666665 33333211 456666666665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=506.64 Aligned_cols=498 Identities=19% Similarity=0.206 Sum_probs=359.2
Q ss_pred CCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCC
Q 001974 18 HFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIP 97 (988)
Q Consensus 18 ~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 97 (988)
..|.|.|+ |+ +++++++ .+|+.+. ++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|
T Consensus 2 ~~C~~~~~-c~----------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 2 LSCDASGV-CD----------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp CEECTTSE-EE----------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred ccCCCCce-EE----------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 35899888 84 5567777 6776664 789999999999998889999999999999999999998888
Q ss_pred cccccCCCCceeecCcccccCCCcccccCcccccccccccccccC-CCCCcccCCCccceeeccccc-cCCCCCccccCc
Q 001974 98 ANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSLESISLAANA-FGGNIPNSLGQL 175 (988)
Q Consensus 98 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l 175 (988)
.+|+.+++|++|+|++|++++..|..|.++++|++|+|++|.+++ ..|..|+++++|++|++++|. +....+..|.++
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l 147 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence 999999999999999999998888889999999999999999986 357789999999999999998 454445789999
Q ss_pred ccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccccccccc--C-cccccCCccc
Q 001974 176 KELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI--P-ISLSNASKLE 252 (988)
Q Consensus 176 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~--p-~~l~~l~~L~ 252 (988)
++|++|+|++|++++..|..+..+++|++|+++.|.+. .+|..++..+++|++|++++|++++.. | .....+++|+
T Consensus 148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~ 226 (549)
T 2z81_A 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226 (549)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred cccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence 99999999999999999999999999999999999987 778777777899999999999998753 2 2234577889
Q ss_pred EEEeccccccCcccc----cccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccc
Q 001974 253 FIEALDNSFSGKLSV----NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSD 328 (988)
Q Consensus 253 ~L~l~~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 328 (988)
.|++++|.+.+..+. .+..+++|+.+++++|.+.+...-.......+..+.+|+.|++.++.+..... +
T Consensus 227 ~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~--~----- 299 (549)
T 2z81_A 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL--F----- 299 (549)
T ss_dssp EEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG--S-----
T ss_pred ceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh--c-----
Confidence 999999988765443 34567788888888888766543222222345566777777777776552100 0
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCccc-CCCCccCeEecccccCCCCCC---CCCCCCCCCCE
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQLSGEIP---SSLGNLSILSE 404 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~ 404 (988)
..++..+..+.+|+.|++++|++. .+|..+ .++++|++|+|++|++++.+| ..++.+++|+.
T Consensus 300 -------------~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~ 365 (549)
T 2z81_A 300 -------------YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365 (549)
T ss_dssp -------------CCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCE
T ss_pred -------------ccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcE
Confidence 001111222344555555555555 444443 345555555555555554432 23455566666
Q ss_pred EEccccccccccc--cccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCC
Q 001974 405 LLLNNNSLSGVIP--SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482 (988)
Q Consensus 405 L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~ 482 (988)
|+|++|++++..+ ..+..+++|+.|++++|+++ .+|..+..++.| ++|++++|+++ .+|..+. ++|++|||++
T Consensus 366 L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~ 440 (549)
T 2z81_A 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCIP--QTLEVLDVSN 440 (549)
T ss_dssp EECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTSC--TTCSEEECCS
T ss_pred EEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchhc--CCceEEECCC
Confidence 6666666654322 34556666666666666665 556555555555 66666666665 3333332 4677777777
Q ss_pred cccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCC
Q 001974 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 483 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p 561 (988)
|+|++.+ +.+++|++|+|++|+|+ .+|. ...+++|+.|||++|++++.+|.. ..+.+|++|+|++|++++.+|
T Consensus 441 N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 441 NNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 7777532 46677777777777777 5665 456777778888888887777764 566678888888888777766
Q ss_pred C
Q 001974 562 T 562 (988)
Q Consensus 562 ~ 562 (988)
.
T Consensus 515 ~ 515 (549)
T 2z81_A 515 R 515 (549)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=517.09 Aligned_cols=484 Identities=18% Similarity=0.193 Sum_probs=380.0
Q ss_pred CCCCCC-----CC--cee------------eeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEc-CCCccccc
Q 001974 12 SWNDSG-----HF--CEW------------KGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINL-MNNSIQGE 71 (988)
Q Consensus 12 ~w~~~~-----~~--c~~------------~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L-~~n~l~~~ 71 (988)
+|+.++ ++ |.| .||+|+. .++|+.|+|+++++.|.+|++|+.|++|++|+| ++|.++|.
T Consensus 285 ~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~ 363 (876)
T 4ecn_A 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363 (876)
T ss_dssp GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHT
T ss_pred CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHHhccccceEeeeccccccccc
Confidence 897554 55 999 9999986 689999999999999999999999999999999 99999876
Q ss_pred CCcccCCC-CCCcE-----E---------E-CCCCCCC-----------CcCCcccccCCCCceeecCc--ccccCCCcc
Q 001974 72 IPREFGRL-FRLEA-----L---------F-LSDNDLV-----------GEIPANLSYCSRLTILFLGR--NKLMGSIPF 122 (988)
Q Consensus 72 ~p~~~~~l-~~L~~-----L---------~-Ls~n~l~-----------~~~p~~~~~l~~L~~L~L~~--N~i~~~~~~ 122 (988)
.|...... ..+.. + + .....+. ...+.......+++.+.++. |++++ +|.
T Consensus 364 ~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~ 442 (876)
T 4ecn_A 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISK 442 (876)
T ss_dssp TCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECG
T ss_pred ccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhH
Confidence 44321111 00000 0 0 0000000 01111112233444455544 77775 677
Q ss_pred cccCcccccccccccccccC-----------------CCCCccc--CCCccceeeccccccCCCCCccccCccccccccc
Q 001974 123 EFFSLYKLKQLAMQRNNLTG-----------------GIPPFIG--NLTSLESISLAANAFGGNIPNSLGQLKELKSLGL 183 (988)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 183 (988)
.|+++++|++|+|++|++++ .+|+.++ ++++|++|+|++|.+.+.+|..|+++++|++|+|
T Consensus 443 ~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~L 522 (876)
T 4ecn_A 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522 (876)
T ss_dssp GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEEC
T ss_pred HHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEEC
Confidence 77777777777777777776 3888877 9999999999999988888999999999999999
Q ss_pred cccc-ccC-ccchhhcccc-------CccEEEeccCCCCCCCCC-cccccCCCCcceeccccccccccCcccccCCcccE
Q 001974 184 GANN-LSG-IIPPSIYNLS-------LLANFSVPRNQFHGSLPP-SLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEF 253 (988)
Q Consensus 184 ~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~i~~~lp~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 253 (988)
++|+ +++ .+|..+..++ +|+.|+|++|++. .+|. ..+..+++|+.|+|++|+++ .+| .+..+++|+.
T Consensus 523 s~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~ 599 (876)
T 4ecn_A 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD 599 (876)
T ss_dssp TTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESE
T ss_pred cCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceE
Confidence 9998 887 7888777776 9999999999998 8887 34458899999999999998 677 8899999999
Q ss_pred EEeccccccCcccccccCCcc-ccEEecccccCCCCCCCchhhhcccccC--CCCcEEEeecccCCCCCCchh---hhc-
Q 001974 254 IEALDNSFSGKLSVNFGGMKN-LSYFNVAYNNLGSGESDEMSFMNSLANC--SNLRTLIFAANKLRGALPHSI---ANL- 326 (988)
Q Consensus 254 L~l~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~p~~~---~~~- 326 (988)
|++++|++. .+|..+..+++ |+.|++++|.++.++. .+..+ ++|+.|++++|++++.+|... ..+
T Consensus 600 L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~-------~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~ 671 (876)
T 4ecn_A 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN-------IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671 (876)
T ss_dssp EECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS-------CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCC
T ss_pred EECcCCccc-cchHHHhhccccCCEEECcCCCCCcCch-------hhhccccCCCCEEECcCCcCCCccccchhhhcccc
Confidence 999999998 67777888988 9999999999885542 23344 459999999999987665432 111
Q ss_pred cccccEEEccCCccccCCCccc-cCCCcceEEEeeCccCCCccCcccCCC--------CccCeEecccccCCCCCCCCCC
Q 001974 327 SDQLQNLIMTSNQLHGSIPSGI-GNLVGLYRLGMGGNQFTGTIPKEMGKL--------QNLEGMGLYDNQLSGEIPSSLG 397 (988)
Q Consensus 327 ~~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~ 397 (988)
..+|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+ .+|..+... ++|+.|+|++|+|+ .+|..+.
T Consensus 672 ~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~ 748 (876)
T 4ecn_A 672 GINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFR 748 (876)
T ss_dssp CCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGS
T ss_pred CCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhh
Confidence 137999999999999 566555 48899999999999999 666654332 39999999999999 7888887
Q ss_pred --CCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCcccccccccc
Q 001974 398 --NLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYL 475 (988)
Q Consensus 398 --~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L 475 (988)
.+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+ ++++|++.+.+|..+..+++|
T Consensus 749 ~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~-------------------~ls~N~l~~~ip~~l~~L~~L 808 (876)
T 4ecn_A 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR-------------------DAEGNRILRQWPTGITTCPSL 808 (876)
T ss_dssp TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-------------------CTTCCBCCCCCCTTGGGCSSC
T ss_pred hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-------------------CcccccccccChHHHhcCCCC
Confidence 99999999999999997 78889999999999999987 567888888889999999999
Q ss_pred ceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCccc
Q 001974 476 RVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS 534 (988)
Q Consensus 476 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 534 (988)
+.|+|++|+| +.+|..+. ++|+.|+|++|++....+..+.....+..+.|++|++.
T Consensus 809 ~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 809 IQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred CEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 9999999999 58888766 68999999999988777777777777778888887765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=499.59 Aligned_cols=506 Identities=19% Similarity=0.188 Sum_probs=416.2
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
++.++.+++ .+|..+. +++++|+|++|+|++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 455566666 4555443 4688899999998887788888899999999999988877778888888999999999988
Q ss_pred cCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCC-CCccccCcccccccccccccccCccchh
Q 001974 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGN-IPNSLGQLKELKSLGLGANNLSGIIPPS 195 (988)
Q Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 195 (988)
++..|.+|.++++|++|++++|++++..+..|+++++|++|++++|.+++. +|..|+++++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~ 168 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGG
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHH
Confidence 877778888899999999999988866555788888999999999988863 5888888899999999999888777888
Q ss_pred hccccCc----cEEEeccCCCCCCCCCcccccCCCCcceecccccccc-ccCcccccCCcccEEEeccccc------cCc
Q 001974 196 IYNLSLL----ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSG-SIPISLSNASKLEFIEALDNSF------SGK 264 (988)
Q Consensus 196 l~~l~~L----~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~l~~N~i------~~~ 264 (988)
+..+++| +.|++++|.+. .++...+... +|+.|++++|.... ..+..+..+..++.+.+..+.+ ...
T Consensus 169 ~~~l~~L~~~~~~L~l~~n~l~-~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~ 246 (570)
T 2z63_A 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246 (570)
T ss_dssp GHHHHTCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred ccchhccchhhhhcccCCCCce-ecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence 8888888 88889999888 5555555444 78888888886542 3455566777777666554322 223
Q ss_pred ccccccCCcc--ccEEecccc-cCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccc
Q 001974 265 LSVNFGGMKN--LSYFNVAYN-NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLH 341 (988)
Q Consensus 265 ~~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~ 341 (988)
....|.++.+ ++.++++++ .+....+. .+..+++|++|++++|.++ .+|..+... .|+.|++++|.+.
T Consensus 247 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~------~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n~~~ 317 (570)
T 2z63_A 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIID------LFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNCKFG 317 (570)
T ss_dssp CTTTTGGGGGSEEEEEEEEETTEEESCSTT------TTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESCBCS
T ss_pred chhhhccccccchhhhhhhcchhhhhhchh------hhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccCccc
Confidence 3334444443 456777766 44443332 5678899999999999998 688887776 7999999999998
Q ss_pred cCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCC--CCCCCCCCCCCEEEccccccccccccc
Q 001974 342 GSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI--PSSLGNLSILSELLLNNNSLSGVIPSC 419 (988)
Q Consensus 342 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~ 419 (988)
.+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++|++++.. |..+.++++|+.|++++|.+.+..+.
T Consensus 318 -~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~- 391 (570)
T 2z63_A 318 -QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN- 391 (570)
T ss_dssp -SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-
T ss_pred -ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-
Confidence 5665 5788999999999999866655 78899999999999998554 67788999999999999999965555
Q ss_pred cccccccceeecCCCCCCccCc-hhhhhhcccccceecccccccCCCccccccccccceeecCCcccc-cccCcccccCC
Q 001974 420 LGSLKQLAILHLFENGLNGTIP-EEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLS-GEIPSQLGLCS 497 (988)
Q Consensus 420 ~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~ 497 (988)
+..+++|+.|++++|.+.+..| ..+.+++.| ++|++++|.+++..|..+..+++|+.|+|++|+++ +.+|..|+.++
T Consensus 392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~ 470 (570)
T 2z63_A 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470 (570)
T ss_dssp EETCTTCCEEECTTSEEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred ccccCCCCEEEccCCccccccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhccc
Confidence 9999999999999999986655 467788888 99999999999999999999999999999999998 68999999999
Q ss_pred CCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCC
Q 001974 498 YLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 498 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~ 563 (988)
+|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|.. ..+++|++|++++|+++|.+|..
T Consensus 471 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 9999999999999998999999999999999999999998875 77889999999999999999875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=492.58 Aligned_cols=493 Identities=19% Similarity=0.165 Sum_probs=427.7
Q ss_pred CCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceee
Q 001974 31 HRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILF 110 (988)
Q Consensus 31 ~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (988)
+..++.|||++|++++..+.+|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 35799999999999988888999999999999999999988889999999999999999999988889999999999999
Q ss_pred cCcccccCCCcccccCcccccccccccccccC-CCCCcccCCCccceeeccccccCCCCCccccCcccc----ccccccc
Q 001974 111 LGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKEL----KSLGLGA 185 (988)
Q Consensus 111 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~ 185 (988)
|++|++++..+..|.++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..|+.+++| +.|++++
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 99999997777789999999999999999986 468999999999999999999998888899999999 8999999
Q ss_pred ccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccccc------ccccCcccccCC--cccEEEec
Q 001974 186 NNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF------SGSIPISLSNAS--KLEFIEAL 257 (988)
Q Consensus 186 N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l------~~~~p~~l~~l~--~L~~L~l~ 257 (988)
|.++++.|..+... +|+.|++++|......-......+++++.+.+..+.+ .......+..+. .++.++++
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 99998888888776 8999999998654222222334566666655543322 222223333333 36777888
Q ss_pred cc-cccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEcc
Q 001974 258 DN-SFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMT 336 (988)
Q Consensus 258 ~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~ 336 (988)
++ .+.+..+..|..+++|+.|++++|.++.++. .+..+ +|++|++++|++. .+|.. ..++|+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~-------~~~~~-~L~~L~l~~n~~~-~l~~~---~l~~L~~L~l~ 333 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD-------FSYNF-GWQHLELVNCKFG-QFPTL---KLKSLKRLTFT 333 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB-------CCSCC-CCSEEEEESCBCS-SCCBC---BCSSCCEEEEE
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchhhhh-------hhccC-CccEEeeccCccc-ccCcc---cccccCEEeCc
Confidence 88 7888888999999999999999999986543 35566 9999999999998 77763 23479999999
Q ss_pred CCccccCCCccccCCCcceEEEeeCccCCCcc--CcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccc
Q 001974 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTI--PKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSG 414 (988)
Q Consensus 337 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 414 (988)
+|.+.+..+. ..+++|+.|++++|++++.. |..+..+++|++|++++|.+++..+. +..+++|+.|++++|.+.+
T Consensus 334 ~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~ 410 (570)
T 2z63_A 334 SNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQ 410 (570)
T ss_dssp SCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEES
T ss_pred CCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCcccc
Confidence 9999876665 78899999999999998554 67889999999999999999955444 9999999999999999998
Q ss_pred ccc-cccccccccceeecCCCCCCccCchhhhhhcccccceeccccccc-CCCccccccccccceeecCCcccccccCcc
Q 001974 415 VIP-SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV-GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492 (988)
Q Consensus 415 ~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 492 (988)
..| ..+..+++|+.|++++|++.+..|..+.+++.| +.|++++|.++ +.+|..+..+++|+.|+|++|++++..|..
T Consensus 411 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 489 (570)
T 2z63_A 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489 (570)
T ss_dssp CTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC-cEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence 766 578999999999999999998888899999999 99999999998 678999999999999999999999888999
Q ss_pred cccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc
Q 001974 493 LGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540 (988)
Q Consensus 493 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 540 (988)
|+.+++|++|+|++|++++..|..|..+++|+.|++++|.+++.+|..
T Consensus 490 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999999999999988889999999999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=445.34 Aligned_cols=271 Identities=25% Similarity=0.408 Sum_probs=214.6
Q ss_pred CCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+ +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 46788899999999999999874 3578999999987666667889999999999999999999999754 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCc--hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQK--DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+..++|||||++|+|.++++....... ........+++.+++.|+.|||.||+|||++ +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 789999999999999999975421000 0000113699999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~ 237 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N 237 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H
T ss_pred CcEEECCcccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 99999999999865443221 12233468999999999999999999999999999999999 9999874211 1
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+... .+.. ......+..+|+++.+|+.+||+.||++|||++||++.|+++.++
T Consensus 238 ~~~~-----~i~~----------------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 EVIE-----CITQ----------------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHH-----HHHH----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH-----HHHc----------------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 0100 011123446888999999999999999999999999999998765
Q ss_pred h
Q 001974 975 L 975 (988)
Q Consensus 975 ~ 975 (988)
-
T Consensus 291 ~ 291 (299)
T 4asz_A 291 S 291 (299)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=447.89 Aligned_cols=270 Identities=26% Similarity=0.420 Sum_probs=209.3
Q ss_pred CCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|.+.++||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+ +
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 45677889999999999999974 3578999999987666667889999999999999999999999754 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
+..++|||||++|+|.++++........ ......+++|.+++.|+.|||.||+|||++ +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 7899999999999999999765432110 111124699999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLN 892 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~ 892 (988)
+++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---- 266 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---- 266 (329)
T ss_dssp TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----
T ss_pred CCCcEEEcccccceeccCCCcc--eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----
Confidence 9999999999999865443221 11223569999999999999999999999999999999999 9999874211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.+... .+.. ......+..+++++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 267 -~~~~~-----~i~~----------------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 267 -TEAID-----CITQ----------------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp -HHHHH-----HHHH----------------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHH-----HHHc----------------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11110 0100 0111234468889999999999999999999999999999987
Q ss_pred HH
Q 001974 973 NA 974 (988)
Q Consensus 973 ~~ 974 (988)
+.
T Consensus 319 ~~ 320 (329)
T 4aoj_A 319 QA 320 (329)
T ss_dssp HS
T ss_pred hC
Confidence 64
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=438.85 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=207.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
...++|++.++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||+++|+|..
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------ 103 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------ 103 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------
Confidence 34567889999999999999999874 259999987433 2345789999999999999999999998642
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..+||||||++|+|.+++.... .++++.++..|+.|||.||+|||++ +||||||||+|||++++++
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~----------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~ 170 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQE----------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLT 170 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEE
T ss_pred CeEEEEEEcCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCc
Confidence 46799999999999999997554 3689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||+|||+|+........ .......||+.|||||++.+ .+|+.++|||||||++|||+||+.||......
T Consensus 171 ~Ki~DFGla~~~~~~~~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~----- 243 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR----- 243 (307)
T ss_dssp EEECCCSSCBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred EEEeeccCceecccCCcc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----
Confidence 999999999865443221 12234579999999999864 46899999999999999999999998642111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
......+... ...+.+ ...+..+|+++.+|+.+||+.||++||||+||++.|+.++..
T Consensus 244 ~~~~~~~~~~---~~~p~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 244 DQIIFMVGRG---YASPDL-------------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHHHHHHTT---CCCCCS-------------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHhcC---CCCCCc-------------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1111111110 001100 012346788999999999999999999999999999988765
Q ss_pred hh
Q 001974 975 LL 976 (988)
Q Consensus 975 ~~ 976 (988)
++
T Consensus 302 lp 303 (307)
T 3omv_A 302 LP 303 (307)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=437.48 Aligned_cols=266 Identities=21% Similarity=0.332 Sum_probs=209.2
Q ss_pred CCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++++.++||+|+||+||+|++. .+++.||||+++.... ...++|.+|+.++++++|||||+++|+|.. +
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence 4567789999999999999973 3578999999975433 345789999999999999999999999754 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+..++|||||++|+|.+++......... .......+++.++..|+.|||+||+|||++ +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 7789999999999999999654321100 001123689999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
++++++||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--- 253 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 253 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred CCCCCEEECCcccceeccCCCce--eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999999999866443221 11234569999999999999999999999999999999999 8999874311
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
.+... .+.. ......+..+|.++.+||.+||+.||++||||+||++.|+++
T Consensus 254 --~~~~~-----~i~~----------------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 --QDVVE-----MIRN----------------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHH-----HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHH-----HHHc----------------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 0100 001123446889999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=442.72 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=202.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
-++|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++|||||++++++. +++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 368999999999999999999999999999999997543 234567999999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|||||||+||+|.+++..... ..+++.+++.|+.||+.||+|||++ +||||||||+|||+++++.+|
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~---------~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vK 165 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKG---------VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQ 165 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTT---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEE
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEE
Confidence 9999999999999999964432 2578999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||... ........
T Consensus 166 l~DFGla~~~~~~~~----~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~ 236 (350)
T 4b9d_A 166 LGDFGIARVLNSTVE----LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKNLVLK 236 (350)
T ss_dssp ECSTTEESCCCHHHH----HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHH
T ss_pred EcccccceeecCCcc----cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHHHH
Confidence 999999987654221 122356999999999999999999999999999999999999998632 11111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... ....+..+++++.+|+.+||+.||++|||++|+++
T Consensus 237 i~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 237 IISGS---------------------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHTC---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCC---------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100 00112356788999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=438.48 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=209.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+.|+..++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++. +++..||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 56899999999999999999999999999999998766666678999999999999999999999954 4588999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
|||||++|+|.+++.. .++++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|
T Consensus 149 vmEy~~gg~L~~~l~~------------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 213 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD 213 (346)
T ss_dssp EECCCTTEEHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred EEeCCCCCcHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEec
Confidence 9999999999999853 2589999999999999999999999 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHh
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 902 (988)
||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ......
T Consensus 214 FGla~~~~~~~~~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~----- 279 (346)
T 4fih_A 214 FGFCAQVSKEVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAM----- 279 (346)
T ss_dssp CTTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH-----
T ss_pred CcCceecCCCCCc----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHH-----
Confidence 9999876543221 22457999999999999999999999999999999999999998632 111111
Q ss_pred hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 903 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+.....+ . ......+++++.+|+.+||+.||++|||++|+++
T Consensus 280 ~~i~~~~~~----~----------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 280 KMIRDNLPP----R----------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHSSCC----C----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCCC----C----------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111110000 0 1112356788999999999999999999999876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=473.63 Aligned_cols=485 Identities=17% Similarity=0.116 Sum_probs=356.1
Q ss_pred CCceeeeeEEeC--CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCc
Q 001974 18 HFCEWKGITCGL--RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95 (988)
Q Consensus 18 ~~c~~~~v~c~~--~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 95 (988)
+-|++.+++... ....++.|||++|++++..|.+|+.+++|++|+|++|+|++..|.+|..+++|++|+|++|++++.
T Consensus 10 c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 89 (549)
T 2z81_A 10 CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL 89 (549)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSC
T ss_pred EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCcc
Confidence 345666665543 236899999999999988899999999999999999999999999999999999999999999988
Q ss_pred CCcccccCCCCceeecCcccccCC-CcccccCcccccccccccccccCCC-CCcccCCCccceeeccccccCCCCCcccc
Q 001974 96 IPANLSYCSRLTILFLGRNKLMGS-IPFEFFSLYKLKQLAMQRNNLTGGI-PPFIGNLTSLESISLAANAFGGNIPNSLG 173 (988)
Q Consensus 96 ~p~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 173 (988)
.|..|+.+++|++|+|++|++++. .|..|.++++|++|++++|.+.+.+ +..|.++++|++|++++|++++..|..|+
T Consensus 90 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 169 (549)
T 2z81_A 90 SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169 (549)
T ss_dssp CHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTT
T ss_pred CHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhh
Confidence 777899999999999999999863 5678999999999999999844344 46899999999999999999988999999
Q ss_pred CcccccccccccccccCccchhhccccCccEEEeccCCCCCCC--CCcccccCCCCcceeccccccccccC----ccccc
Q 001974 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSL--PPSLGLTLPHLRLFQVHHNFFSGSIP----ISLSN 247 (988)
Q Consensus 174 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~l--p~~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~ 247 (988)
.+++|++|+++.|.+....+..+..+++|++|++++|++.+.. |..+...+++|+.|++++|.+++..+ ..+..
T Consensus 170 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~ 249 (549)
T 2z81_A 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249 (549)
T ss_dssp TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGG
T ss_pred ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhh
Confidence 9999999999999998544444567999999999999998431 44455678899999999999987544 34567
Q ss_pred CCcccEEEeccccccCccc------ccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCc
Q 001974 248 ASKLEFIEALDNSFSGKLS------VNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH 321 (988)
Q Consensus 248 l~~L~~L~l~~N~i~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 321 (988)
+.+|+.+++++|.+.+... ..+..+.+|+.|++.++.+...... ......+....+|++|++++|+++ .+|.
T Consensus 250 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~-~~l~~~~~~~~~L~~L~l~~n~l~-~ip~ 327 (549)
T 2z81_A 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVF-LVPC 327 (549)
T ss_dssp CTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGS-CCCCHHHHHSTTCCEEEEESSCCC-CCCH
T ss_pred hccccccccccccccccccccccchhhhhhhcccccccccccccchhhhc-ccchhhhhhcccceEEEeccCccc-cCCH
Confidence 8899999999999877432 3456788999999999887542110 000001223456666666666665 5555
Q ss_pred hhhhccccccEEEccCCccccCCC---ccccCCCcceEEEeeCccCCCccC--cccCCCCccCeEecccccCCCCCCCCC
Q 001974 322 SIANLSDQLQNLIMTSNQLHGSIP---SGIGNLVGLYRLGMGGNQFTGTIP--KEMGKLQNLEGMGLYDNQLSGEIPSSL 396 (988)
Q Consensus 322 ~~~~~~~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~ 396 (988)
.++...++|++|++++|++.+.+| ..+..+++|+.|+|++|++++..+ ..+..+++|++|+|++|+++ .+|..+
T Consensus 328 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 406 (549)
T 2z81_A 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406 (549)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCC
T ss_pred HHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhh
Confidence 554323355555555555554432 224445555555555555553221 23444555555555555554 344444
Q ss_pred CCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccc
Q 001974 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLR 476 (988)
Q Consensus 397 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~ 476 (988)
..+++|++|+|++| +++ .+|..+. +.+ ++|++++|++++.+ ..+++|+
T Consensus 407 ~~~~~L~~L~Ls~N------------------------~l~-~l~~~~~--~~L-~~L~Ls~N~l~~~~----~~l~~L~ 454 (549)
T 2z81_A 407 QWPEKMRFLNLSST------------------------GIR-VVKTCIP--QTL-EVLDVSNNNLDSFS----LFLPRLQ 454 (549)
T ss_dssp CCCTTCCEEECTTS------------------------CCS-CCCTTSC--TTC-SEEECCSSCCSCCC----CCCTTCC
T ss_pred cccccccEEECCCC------------------------Ccc-cccchhc--CCc-eEEECCCCChhhhc----ccCChhc
Confidence 44444555555554 444 3333321 233 56666666665432 4577888
Q ss_pred eeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc
Q 001974 477 VFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 477 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 539 (988)
.|+|++|+|+ .+|. .+.+++|+.|+|++|++++.+|..|..+++|+.|+|++|.+.+..|.
T Consensus 455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 8888888888 6776 46788899999999999988888888899999999999998887773
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=437.69 Aligned_cols=270 Identities=22% Similarity=0.242 Sum_probs=214.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.+.|+..++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++++++|||||++++++. +++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 3567888899999999999999999999999999975432 247999999999999999999954 458899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 820 (988)
||||||+||+|.++++.. ..+++.++..|+.||+.||+|||++ +||||||||+|||++.+| .+||
T Consensus 127 ivmEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl 192 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM-----------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL 192 (336)
T ss_dssp EEECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEE
T ss_pred EEEeccCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEE
Confidence 999999999999999643 3699999999999999999999998 999999999999999988 6999
Q ss_pred eeecccccccccccccc-eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQ-SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+|+.......... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ ....+.
T Consensus 193 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~- 269 (336)
T 4g3f_A 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIA- 269 (336)
T ss_dssp CCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHH-
T ss_pred eeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH-
Confidence 99999987654332211 11233569999999999999999999999999999999999999997432221 110000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh---h
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL---L 976 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~---~ 976 (988)
... . .....+..+++++.+++.+||+.||++|||++|+++.|.....+. .
T Consensus 270 --~~~------------~-------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~ 322 (336)
T 4g3f_A 270 --SEP------------P-------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322 (336)
T ss_dssp --HSC------------C-------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred --cCC------------C-------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence 000 0 001123467888999999999999999999999999998887653 4
Q ss_pred hhcccCCcc
Q 001974 977 EAWNCTGEE 985 (988)
Q Consensus 977 ~~~~~~~~~ 985 (988)
.+|....++
T Consensus 323 hPw~~~~~~ 331 (336)
T 4g3f_A 323 SPWKGEYKE 331 (336)
T ss_dssp SCSSSSCCC
T ss_pred CCCcCCCCC
Confidence 466554433
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=476.59 Aligned_cols=557 Identities=18% Similarity=0.149 Sum_probs=303.7
Q ss_pred cCCccccCCCCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCc
Q 001974 4 HDPQGILNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLE 83 (988)
Q Consensus 4 ~~~~~~~~~w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 83 (988)
.|+-..+++|.... +..|..|.|...... .|.++.+++ .+|+.+. +++++|||++|+|+++.|.+|.++++|+
T Consensus 7 ~~~~~~~~~~~~~~-p~~~~~c~~~~~~~~---~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~ 79 (635)
T 4g8a_A 7 KDDDDKLAAANSSI-PESWEPCVEVVPNIT---YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQ 79 (635)
T ss_dssp -------------------CCSEEEETTTE---EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCcchhhcccCCC-CCCCCCccccCCCCE---EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCC
Confidence 35556677886443 456777777644333 367777777 5666553 4688999999999877778899999999
Q ss_pred EEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccc
Q 001974 84 ALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA 163 (988)
Q Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 163 (988)
+|+|++|+|++..|.+|+++++|++|+|++|+|++..+++|.++++|++|+|++|++++..+..|+++++|++|+|++|+
T Consensus 80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 99999999987777888999999999999999987777888899999999999999987777778899999999999998
Q ss_pred cCCC-CCccccCcccccccccccccccCccchhhccccCcc----EEEeccCCCCCCCCCcccccCCCCcceeccccccc
Q 001974 164 FGGN-IPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA----NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS 238 (988)
Q Consensus 164 l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~ 238 (988)
++.. .|..++.+++|++|+|++|+|++..+..+..+.+++ .++++.|.+. .++...+ ....+..+++++|...
T Consensus 160 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n~~~ 237 (635)
T 4g8a_A 160 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNNFDS 237 (635)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSS
T ss_pred cccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCcccc-cchhhhhhhhhccccc
Confidence 8753 577788889999999999999888888887776654 5788888887 5666555 3345667777777655
Q ss_pred c-ccCcccccCCcccEEEecccc------ccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEee
Q 001974 239 G-SIPISLSNASKLEFIEALDNS------FSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFA 311 (988)
Q Consensus 239 ~-~~p~~l~~l~~L~~L~l~~N~------i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 311 (988)
. ..+..+..+..++...+..+. +.......+..+..+....+..+........ ....+....+++.+++.
T Consensus 238 ~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~---~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 238 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDG---IIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp HHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEE---CTTTTGGGTTCSEEEEE
T ss_pred ccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccc---hhhhhhhhccccccccc
Confidence 3 223345556666555554332 2222233344444444444444332211111 01123334444555555
Q ss_pred cccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCC-
Q 001974 312 ANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG- 390 (988)
Q Consensus 312 ~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~- 390 (988)
+|.+....+ +.. ...++.|++.+|.+....+ ..+..|+.+++++|.+.. +.....+++|+.|++++|.+..
T Consensus 315 ~~~~~~~~~--~~~-~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~--~~~~~~l~~L~~L~ls~n~l~~~ 386 (635)
T 4g8a_A 315 SVTIERVKD--FSY-NFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFK 386 (635)
T ss_dssp SCEEEECGG--GGS-CCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCC--BCCCCBCTTCCEEECCSSCCBEE
T ss_pred ccccccccc--ccc-chhhhhhhcccccccCcCc---ccchhhhhcccccccCCC--Ccccccccccccchhhccccccc
Confidence 544432111 111 1234555555554443222 123344444444444431 1122344445555555544431
Q ss_pred -CCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCch-hhhhhcccccceecccccccCCCccc
Q 001974 391 -EIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE-EIFNLTYLSNSLNLARNHLVGSIPTK 468 (988)
Q Consensus 391 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~~~~p~~ 468 (988)
..+..+..+.+|+.|++..|.+.. .+..+..+++|+.+++++|...+..+. .+.++..+ +.++++.|.+.+..|..
T Consensus 387 ~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l-~~l~ls~n~l~~~~~~~ 464 (635)
T 4g8a_A 387 GCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGI 464 (635)
T ss_dssp EECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTC-CEEECTTSCCEECCTTT
T ss_pred cccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccc-ccccccccccccccccc
Confidence 122333344444444444444442 233344444444444444444432222 22333333 44444444444444444
Q ss_pred cccccccceeecCCccc-ccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCC
Q 001974 469 IGNLKYLRVFNVSSNNL-SGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSL 546 (988)
Q Consensus 469 ~~~l~~L~~L~ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L 546 (988)
+..++.|+.|+|++|.+ .+.+|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|.. ..+++|
T Consensus 465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 544 (635)
T 4g8a_A 465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 544 (635)
T ss_dssp TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence 44444444444444442 2234444444444444555444444444444444444444555544444444432 333444
Q ss_pred cEEeCCCCcCcccCCCC-ccc-CcccccccccccccCC
Q 001974 547 EYLNLSFNDLEGEVPTK-GVF-ANISRISVAGFNRLCG 582 (988)
Q Consensus 547 ~~l~l~~N~l~~~~p~~-~~~-~~~~~~~~~~n~~lcg 582 (988)
++|+|++|+|++.+|.. ..+ .++..+.+.+||+.|.
T Consensus 545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 44455544444444432 111 2333444444444444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=470.94 Aligned_cols=465 Identities=19% Similarity=0.194 Sum_probs=322.0
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 35 ~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
+.+|+++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45788888887 5666665 77888888888888766677888888888888888888777777888888888888888
Q ss_pred cccCCCcccccCcccccccccccccccC-CCCCcccCCCccceeeccccccCCCCCccccCcccc--cccccccccc--c
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKEL--KSLGLGANNL--S 189 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 189 (988)
+|+ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|++++ ..|..+++| ++|+|++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 877 45544 67777788888777775 356777777777777777777764 356666666 7777777777 5
Q ss_pred Cccchhhcccc-CccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCccccc
Q 001974 190 GIIPPSIYNLS-LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVN 268 (988)
Q Consensus 190 ~~~~~~l~~l~-~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~ 268 (988)
+..|..+..+. +...+++++|++.+.++...+..+++|+.|++++|...... ..+.+.++ .
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~-----------------~~~~~~~~-~ 215 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC-----------------SYFLSILA-K 215 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTT-----------------HHHHHHHH-G
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccc-----------------ceeecchh-h
Confidence 66666666654 23345566666655555555545555555555554400000 00222222 3
Q ss_pred ccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccc
Q 001974 269 FGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGI 348 (988)
Q Consensus 269 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~ 348 (988)
|..+++|+.|++++|.++...... ... ....+ +|++|++++|++++.+|..+
T Consensus 216 l~~l~~L~~L~l~~~~l~~~~~~~--~~~-~~~~~-------------------------~L~~L~l~~n~l~~~~p~~~ 267 (520)
T 2z7x_B 216 LQTNPKLSNLTLNNIETTWNSFIR--ILQ-LVWHT-------------------------TVWYFSISNVKLQGQLDFRD 267 (520)
T ss_dssp GGGCTTCCEEEEEEEEEEHHHHHH--HHH-HHHTS-------------------------SCSEEEEEEEEEESCCCCCC
T ss_pred hccccchhhccccccccCHHHHHH--HHH-HhhhC-------------------------cccEEEeecccccCccccch
Confidence 444444445554444443210000 000 00112 45555555555555555555
Q ss_pred -----cCCCcceEEEeeCccCCCccC-cccCCC---CccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccc
Q 001974 349 -----GNLVGLYRLGMGGNQFTGTIP-KEMGKL---QNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSC 419 (988)
Q Consensus 349 -----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 419 (988)
..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..
T Consensus 268 ~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~ 343 (520)
T 2z7x_B 268 FDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFEN 343 (520)
T ss_dssp CCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTT
T ss_pred hhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhh
Confidence 7777888888888887 344 444444 56888888888876322 1257788888888888888778888
Q ss_pred cccccccceeecCCCCCCc--cCchhhhhhcccccceecccccccCCCccc-cccccccceeecCCcccccccCcccccC
Q 001974 420 LGSLKQLAILHLFENGLNG--TIPEEIFNLTYLSNSLNLARNHLVGSIPTK-IGNLKYLRVFNVSSNNLSGEIPSQLGLC 496 (988)
Q Consensus 420 ~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l 496 (988)
++.+++|+.|++++|++++ .+|..+..++.| ++|++++|++++.+|.. +..+++|+.|++++|++++.+|..+.
T Consensus 344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-- 420 (520)
T 2z7x_B 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-- 420 (520)
T ss_dssp CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred hccCCCCCEEEccCCccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence 8888888888888888875 556677788888 88888888888756654 77888999999999999888887765
Q ss_pred CCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc-cccCCCCcEEeCCCCcCcccCCC
Q 001974 497 SYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK-FLEDLSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 497 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~L~~l~l~~N~l~~~~p~ 562 (988)
++|+.|+|++|+++ .+|..+..+++|+.|||++|+|++.++. +..+++|++|+|++|++++.++.
T Consensus 421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 78999999999998 8888888999999999999999977666 46778899999999999887663
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=431.37 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=208.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|++++++++|||||++++++ ++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 5699999999999999999999999999999999743 234457899999999999999999999994 45688
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.|+||||++||+|.+++... ..+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 107 ~yivmEy~~gG~L~~~i~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI-----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEE
Confidence 99999999999999999643 3699999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +.......
T Consensus 173 l~DFGla~~~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~~~ 245 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEGLIFAK 245 (311)
T ss_dssp ECCCTTCEECCTTTTC--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred EEEcCCceecCCCCCc--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHH
Confidence 9999999876543221 1223457999999999999999999999999999999999999998632 11111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+. ......+..+++++.+|+.+||+.||++|||++|++.
T Consensus 246 -----i~-----------------------~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 246 -----II-----------------------KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -----HH-----------------------HTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -----HH-----------------------cCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 10 0111223356778999999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=419.62 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=192.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|++..+|+.||+|+++... ....+.+.+|++++++++||||+++++++ .+++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 68999999999999999999999999999999996432 23346799999999999999999999995 45588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+ +|+|.+++.... ++++.++..++.||+.||+|||++ +|+||||||+|||+++++.+|
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~-----------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD-----------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC-----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred EEEEEeCC-CCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence 99999999 789999986543 699999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+|+....... .....||+.|||||++.+..+ +.++||||+||++|||+||+.||... .......
T Consensus 153 l~DFGla~~~~~~~~-----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~~~ 222 (275)
T 3hyh_A 153 IADFGLSNIMTDGNF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVLFK 222 (275)
T ss_dssp ECCSSCC--------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH
T ss_pred EeecCCCeecCCCCc-----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHHHH
Confidence 999999986544322 123569999999999998876 57999999999999999999998631 1111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. +. ......+..+++++.+++.+||+.||++|||++|+++
T Consensus 223 ~-----i~-----------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 N-----IS-----------------------NGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp H-----HH-----------------------HTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-----HH-----------------------cCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 10 0111122356778999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=429.98 Aligned_cols=280 Identities=23% Similarity=0.285 Sum_probs=204.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++++|... .......++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~-~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEec-CCCceEEEE
Confidence 4577889999999999999998 689999999964322 222344566667788999999999998754 112236799
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEeccCCCCCeeeCCCCc
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC-----QEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~ 817 (988)
|||||++|+|.++++.. ++++.++.+|+.|++.||+|||+++ .++||||||||+|||++++++
T Consensus 79 V~Ey~~~gsL~~~l~~~------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEECCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred EecCCCCCcHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 99999999999999643 5899999999999999999999752 458999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+||+|||+|+.................||+.|||||++.+. .++.++|||||||++|||+||++||........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 99999999987655443322233345799999999998764 467899999999999999999988754322211
Q ss_pred chHHHH-----HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYA-----RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~-----~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.... ...+.. .+.+..+.+..++ .....+++..+.+|+.+||+.||++||||+||++
T Consensus 227 p~~~~~~~~~~~~~~~~---~~~~~~~rp~~p~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRK---VVCEQKLRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHH---HHTTSCCCCCCCG-------------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchhcccccchHHHHHH---HHhcccCCCCCCc-------------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 110000 000000 0011111111100 0112246678999999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 967 ELQSVKNA 974 (988)
Q Consensus 967 ~L~~i~~~ 974 (988)
.|+++.++
T Consensus 291 ~L~~l~~~ 298 (303)
T 3hmm_A 291 TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHH
Confidence 99998764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=471.40 Aligned_cols=541 Identities=20% Similarity=0.167 Sum_probs=439.6
Q ss_pred CCccccCCCCCCCCCceeeeeEEeCC---------CCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcc
Q 001974 5 DPQGILNSWNDSGHFCEWKGITCGLR---------HRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPRE 75 (988)
Q Consensus 5 ~~~~~~~~w~~~~~~c~~~~v~c~~~---------~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~ 75 (988)
..+.+-.+|.+-.+.+....|.|... +..++.|||++|+|+.+.+.+|..+++|++|||++|+|+++.|++
T Consensus 16 ~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~ 95 (635)
T 4g8a_A 16 ANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 95 (635)
T ss_dssp ---------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred ccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhH
Confidence 33445567742111112245788742 357999999999999888889999999999999999999888999
Q ss_pred cCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccC-CCCCcccCCCcc
Q 001974 76 FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTG-GIPPFIGNLTSL 154 (988)
Q Consensus 76 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L 154 (988)
|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|.+++ ..|..++.+++|
T Consensus 96 f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 175 (635)
T 4g8a_A 96 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 175 (635)
T ss_dssp TTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC
T ss_pred hcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhh
Confidence 9999999999999999997777889999999999999999998888899999999999999999985 357888999999
Q ss_pred ceeeccccccCCCCCccccCccccc----ccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcce
Q 001974 155 ESISLAANAFGGNIPNSLGQLKELK----SLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230 (988)
Q Consensus 155 ~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L 230 (988)
++|+|++|++++..+..|..+.+++ .++++.|.++.+.+..+ ....++.+++.+|.....++...+.++..++..
T Consensus 176 ~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~ 254 (635)
T 4g8a_A 176 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 254 (635)
T ss_dssp CEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEE
T ss_pred hhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccc
Confidence 9999999999988888888877665 57899999996555544 445678899999877655555666677777777
Q ss_pred ecccccc------ccccCcccccCCcccEEEeccccccC---cccccccCCccccEEecccccCCCCCCCchhhhccccc
Q 001974 231 QVHHNFF------SGSIPISLSNASKLEFIEALDNSFSG---KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301 (988)
Q Consensus 231 ~L~~N~l------~~~~p~~l~~l~~L~~L~l~~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 301 (988)
.+..+.. .......+.....+...++..+.... .....+..+.+++.+.+..|.+..+. .+..
T Consensus 255 ~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~ 326 (635)
T 4g8a_A 255 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSY 326 (635)
T ss_dssp EEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGS
T ss_pred cccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--------cccc
Confidence 6654433 33344556666777777776655433 23345677888999999998876543 3456
Q ss_pred CCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCC--CccCcccCCCCccC
Q 001974 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFT--GTIPKEMGKLQNLE 379 (988)
Q Consensus 302 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~ 379 (988)
...|+.|++++|.+.+..+..+ ..|+.++++.|.+... .....+++|+.|++++|.+. +..+..+..+.+|+
T Consensus 327 ~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~ 400 (635)
T 4g8a_A 327 NFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLK 400 (635)
T ss_dssp CCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCC
T ss_pred chhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhh
Confidence 6789999999999985444322 3689999999998743 33567899999999999996 34566777889999
Q ss_pred eEecccccCCCCCCCCCCCCCCCCEEEccccccccccc-cccccccccceeecCCCCCCccCchhhhhhcccccceeccc
Q 001974 380 GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLAR 458 (988)
Q Consensus 380 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~ 458 (988)
.|+++.|.+. ..+..+..+++|+.+++++|.+....+ ..|..+++++.++++.|.+.+..|..+..++.+ +.|++++
T Consensus 401 ~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~ 478 (635)
T 4g8a_A 401 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAG 478 (635)
T ss_dssp EEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTT
T ss_pred hhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhh-hhhhhhh
Confidence 9999999988 466778999999999999888765544 568899999999999999998778888888888 9999999
Q ss_pred cccc-CCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcC
Q 001974 459 NHLV-GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI 537 (988)
Q Consensus 459 N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 537 (988)
|.+. +..|..|..+++|++|||++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|||++|+|++.+
T Consensus 479 N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~ 558 (635)
T 4g8a_A 479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 558 (635)
T ss_dssp CEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCC
T ss_pred cccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCC
Confidence 9854 457889999999999999999999989999999999999999999999999999999999999999999999999
Q ss_pred ccc-ccC-CCCcEEeCCCCcCcccCCC
Q 001974 538 PKF-LED-LSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 538 p~~-~~~-~~L~~l~l~~N~l~~~~p~ 562 (988)
|.. ..+ .+|++|+|++|++++....
T Consensus 559 ~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 559 KQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp SSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred HHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 987 455 4799999999999987653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=439.68 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=209.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.+.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++. +++..|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEE
Confidence 356999999999999999999999999999999998766666778999999999999999999999954 458899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
||||||+||+|.+++.. .++++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+
T Consensus 225 iVmEy~~gG~L~~~i~~------------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~ 289 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 289 (423)
T ss_dssp EEEECCTTEEHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEEC
T ss_pred EEEeCCCCCcHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEe
Confidence 99999999999999853 2589999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ......
T Consensus 290 DFGla~~~~~~~~~----~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~~~~---- 356 (423)
T 4fie_A 290 DFGFCAQVSKEVPR----RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPLKAM---- 356 (423)
T ss_dssp CCTTCEECCSSCCC----BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHH----
T ss_pred cCccceECCCCCcc----ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHHHH----
Confidence 99999876543221 23457999999999999999999999999999999999999998632 111111
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+.....+. ......+++++.+|+.+||+.||++|||++|+++
T Consensus 357 -~~i~~~~~~~--------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 357 -KMIRDNLPPR--------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -HHHHHSCCCC--------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHcCCCCC--------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111100000 1112356788999999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=436.24 Aligned_cols=279 Identities=22% Similarity=0.317 Sum_probs=218.6
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeecccc-chhHHHHHHHHHHHhcCC-CCceEEEee
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQRH-GASKSFLAECKALKNIRH-RNLVKVITS 728 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~ 728 (988)
+.++...++|++.+.||+|+||+||+|++... ++.||||+++.... ...+.+.+|+++|++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 44556678899999999999999999998543 36899999975433 334679999999999965 899999999
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCCCCC-----chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ-----KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHC 803 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 803 (988)
|.. .++..++|||||++|+|.++++...... .........+++.++..|+.|||+||+|||++ +||||
T Consensus 137 ~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 137 CTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp ECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 753 2467899999999999999997542110 00001124689999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCC
Q 001974 804 DLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKP 882 (988)
Q Consensus 804 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p 882 (988)
||||+|||+++++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999866543322 12234568999999999999999999999999999999998 9999
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|......+ .....+.+ ......+..+++++.++|.+||+.||++||||+
T Consensus 288 f~~~~~~~-----~~~~~i~~--------------------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ 336 (353)
T 4ase_A 288 YPGVKIDE-----EFCRRLKE--------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 336 (353)
T ss_dssp STTCCCSH-----HHHHHHHH--------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCHHH-----HHHHHHHc--------------------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence 87432110 11110000 011122346788999999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 001974 963 NVVHELQSVKNA 974 (988)
Q Consensus 963 evl~~L~~i~~~ 974 (988)
||++.|+++.++
T Consensus 337 eil~~L~~llq~ 348 (353)
T 4ase_A 337 ELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=419.20 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=198.9
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
+..++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||||++++++... ...++..++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 56678999999999999999999999999996442 23346799999999999999999999987543 2334668999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeCC-CCcEEE
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLDN-DMIAHV 820 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kL 820 (988)
||||++|+|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||+|||++. ++.+||
T Consensus 108 mEy~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred EeCCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEE
Confidence 9999999999999643 3689999999999999999999998 6 999999999999984 799999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... .......
T Consensus 174 ~DFGla~~~~~~~------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~----~~~~~~~-- 240 (290)
T 3fpq_A 174 GDLGLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYR-- 240 (290)
T ss_dssp CCTTGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHH--
T ss_pred EeCcCCEeCCCCc------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC----cHHHHHH--
Confidence 9999998543321 223579999999999865 69999999999999999999999986321 1111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.....+ ...+..+++++.+|+.+||+.||++|||++|+++
T Consensus 241 ---~i~~~~~~---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 241 ---RVTSGVKP---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---HHTTTCCC---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHcCCCC---------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110000 0011245677999999999999999999999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=472.24 Aligned_cols=463 Identities=19% Similarity=0.254 Sum_probs=339.5
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEEC-CCCCCCCcCCcccccC----CCC--ceeec----------Cccccc-
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFL-SDNDLVGEIPANLSYC----SRL--TILFL----------GRNKLM- 117 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~l----~~L--~~L~L----------~~N~i~- 117 (988)
..++.|+|++|+|+|.+|.+|+.|++|++|+| ++|.+.|..|-..... ..+ +.+.. ....+.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46789999999999999999999999999999 9998887644321111 000 00000 000000
Q ss_pred ----------CCCcccccCccccccccccc--ccccCCCCCcccCCCccceeeccccccCC-----------------CC
Q 001974 118 ----------GSIPFEFFSLYKLKQLAMQR--NNLTGGIPPFIGNLTSLESISLAANAFGG-----------------NI 168 (988)
Q Consensus 118 ----------~~~~~~~~~l~~L~~L~L~~--N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~~ 168 (988)
...+........++.+.+.. |++++ +|..|+++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 01111123344566666665 99997 89999999999999999999997 38
Q ss_pred Ccccc--CcccccccccccccccCccchhhccccCccEEEeccCC-CCC-CCCCccc------ccCCCCcceeccccccc
Q 001974 169 PNSLG--QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQ-FHG-SLPPSLG------LTLPHLRLFQVHHNFFS 238 (988)
Q Consensus 169 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-i~~-~lp~~~~------~~l~~L~~L~L~~N~l~ 238 (988)
|..++ ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+. ..+++|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 88887 99999999999999999999999999999999999998 887 6887553 34569999999999999
Q ss_pred cccCc--ccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCC-CcEEEeecccC
Q 001974 239 GSIPI--SLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSN-LRTLIFAANKL 315 (988)
Q Consensus 239 ~~~p~--~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l 315 (988)
.+|. .+.++++|+.|++++|+++ .+| .|..+++|+.|+|++|.++.++. .+..+++ |++|+|++|++
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~-------~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE-------DFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT-------TSCEECTTCCEEECCSSCC
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH-------HHhhccccCCEEECcCCCC
Confidence 7888 8999999999999999999 666 89999999999999999985443 4778888 99999999999
Q ss_pred CCCCCchhhhcc-ccccEEEccCCccccCCCccc---c--CCCcceEEEeeCccCCCccCccc-CCCCccCeEecccccC
Q 001974 316 RGALPHSIANLS-DQLQNLIMTSNQLHGSIPSGI---G--NLVGLYRLGMGGNQFTGTIPKEM-GKLQNLEGMGLYDNQL 388 (988)
Q Consensus 316 ~~~~p~~~~~~~-~~L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l 388 (988)
+ .+|..+.... .+|+.|+|++|++.+.+|... . .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|
T Consensus 632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L 709 (876)
T 4ecn_A 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLM 709 (876)
T ss_dssp C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCC
T ss_pred C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcC
Confidence 9 7887766553 248888888888887665322 2 3347888888888888 555543 4778888888888888
Q ss_pred CCCCCCCCCCC--------CCCCEEEccccccccccccccc--cccccceeecCCCCCCccCchhhhhhcccccceeccc
Q 001974 389 SGEIPSSLGNL--------SILSELLLNNNSLSGVIPSCLG--SLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLAR 458 (988)
Q Consensus 389 ~~~~p~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~ 458 (988)
+ .+|..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+++++.| +.|+|++
T Consensus 710 ~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L-~~L~Ls~ 785 (876)
T 4ecn_A 710 T-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL-KAFGIRH 785 (876)
T ss_dssp S-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTC-CEEECCC
T ss_pred C-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCC-CEEECCC
Confidence 7 555543322 26666666666666 4555554 66666666666666663 56666666655 5666666
Q ss_pred ccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCc
Q 001974 459 NHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIP 538 (988)
Q Consensus 459 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 538 (988)
|+ ++++|++.+.+|..|+.+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+
T Consensus 786 N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 786 QR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred CC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 54 5566777778888888888888888888888 57777765 577777888777765554
Q ss_pred cc-ccCCCCcEEeCCCCcC
Q 001974 539 KF-LEDLSLEYLNLSFNDL 556 (988)
Q Consensus 539 ~~-~~~~~L~~l~l~~N~l 556 (988)
.. .....+..+.|++|++
T Consensus 845 ~~~~~~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 845 TSVCPYIEAGMYVLLYDKT 863 (876)
T ss_dssp GGGHHHHHTTCCEEECCTT
T ss_pred HHccccccchheeecCCCc
Confidence 33 2222344444555543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=465.48 Aligned_cols=469 Identities=20% Similarity=0.264 Sum_probs=294.4
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccc
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAM 135 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 135 (988)
.+++.|+|++|+++|.+|.+|+.|++|++|+|++|.+. ..+..++... +...+|... +..|+ +++
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l 145 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKG-----------ISANMSDEQ--KQKMR-MHY 145 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTS-----------BCTTCCHHH--HHHHH-THH
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccc-----------cccCchHHH--HHHHH-hhH
Confidence 35788999999999999999999999999999999763 2222221100 001223222 44555 666
Q ss_pred ccccccCCCCCcccC-CCccceeeccccccCCCCCccccCcccccccccc--cccccCccchhhccccCccEEEeccCCC
Q 001974 136 QRNNLTGGIPPFIGN-LTSLESISLAANAFGGNIPNSLGQLKELKSLGLG--ANNLSGIIPPSIYNLSLLANFSVPRNQF 212 (988)
Q Consensus 136 ~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~--~N~l~~~~~~~l~~l~~L~~L~L~~N~i 212 (988)
++|.+.+.+|..+.. +..+..+++....+.. .....++.+.+. .|++++ +|.++.++++|++|+|++|++
T Consensus 146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l 218 (636)
T 4eco_A 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218 (636)
T ss_dssp HHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC
T ss_pred HHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc
Confidence 666665555544442 2233333433332221 112233333333 467776 677777777777777777777
Q ss_pred CCC-----------------CCCccc-ccCCCCcceeccccccccccCcccccCCcccEEEecccc-ccC-cccccccCC
Q 001974 213 HGS-----------------LPPSLG-LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS-FSG-KLSVNFGGM 272 (988)
Q Consensus 213 ~~~-----------------lp~~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~-i~~-~~~~~~~~l 272 (988)
++. +|..+. ..+++|++|+|++|++.+.+|..+.++++|++|++++|+ +++ .+|..+..+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp CGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred ccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 642 443332 134444444444444444444444444444444444444 444 344333332
Q ss_pred ccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCc--hhhhccccccEEEccCCccccCCCccccC
Q 001974 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPH--SIANLSDQLQNLIMTSNQLHGSIPSGIGN 350 (988)
Q Consensus 273 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 350 (988)
..+..+++|++|++++|+++ .+|. .+..+. +|+.|++++|+++|.+| .+..
T Consensus 299 ------------------------~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~ 351 (636)
T 4eco_A 299 ------------------------ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGS 351 (636)
T ss_dssp ------------------------HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEE
T ss_pred ------------------------hccccCCCCCEEECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCC
Confidence 01122355555555555555 5555 555543 56666666666666666 6666
Q ss_pred CCcceEEEeeCccCCCccCcccCCCCc-cCeEecccccCCCCCCCCCCCCC--CCCEEEccccccccccccccc------
Q 001974 351 LVGLYRLGMGGNQFTGTIPKEMGKLQN-LEGMGLYDNQLSGEIPSSLGNLS--ILSELLLNNNSLSGVIPSCLG------ 421 (988)
Q Consensus 351 l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~------ 421 (988)
+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++ +|+.|++++|++++..|..|.
T Consensus 352 l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~ 429 (636)
T 4eco_A 352 EIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429 (636)
T ss_dssp EEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSC
T ss_pred CCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccccc
Confidence 666777777777666 66666666666 777777777766 5666665544 677777777777766666666
Q ss_pred -cccccceeecCCCCCCccCchhhhh-hcccccceecccccccCCCcccccc--------ccccceeecCCcccccccCc
Q 001974 422 -SLKQLAILHLFENGLNGTIPEEIFN-LTYLSNSLNLARNHLVGSIPTKIGN--------LKYLRVFNVSSNNLSGEIPS 491 (988)
Q Consensus 422 -~l~~L~~L~l~~N~l~~~~p~~~~~-l~~l~~~L~ls~N~l~~~~p~~~~~--------l~~L~~L~ls~N~l~~~~p~ 491 (988)
.+++|+.|+|++|+++ .+|..++. ++.| +.|+|++|+++ .+|..+.. +++|+.|+|++|+++ .+|.
T Consensus 430 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 505 (636)
T 4eco_A 430 FKGINVSSINLSNNQIS-KFPKELFSTGSPL-SSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSD 505 (636)
T ss_dssp CCCCCEEEEECCSSCCC-SCCTHHHHTTCCC-SEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCG
T ss_pred ccCCCCCEEECcCCccC-cCCHHHHccCCCC-CEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccCh
Confidence 6667777777777776 56665543 5666 67777777776 44443322 237888888888888 6887
Q ss_pred ccc--cCCCCcEEEecCccccccCCccccCccccCeeec------CCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCC
Q 001974 492 QLG--LCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDL------SRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 492 ~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l------s~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~ 562 (988)
.+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|.. ..+++|++|+|++|++ +.+|.
T Consensus 506 ~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~ 583 (636)
T 4eco_A 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNE 583 (636)
T ss_dssp GGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCS
T ss_pred hhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCH
Confidence 776 88888888888888886 8888888888888888 678899988875 7888999999999999 77776
Q ss_pred CcccCcccccccccccccCC
Q 001974 563 KGVFANISRISVAGFNRLCG 582 (988)
Q Consensus 563 ~~~~~~~~~~~~~~n~~lcg 582 (988)
. ....+..+.+.+|+..|-
T Consensus 584 ~-~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 584 K-ITPNISVLDIKDNPNISI 602 (636)
T ss_dssp C-CCTTCCEEECCSCTTCEE
T ss_pred h-HhCcCCEEECcCCCCccc
Confidence 5 336788888888887764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=421.12 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=193.1
Q ss_pred hCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|++.+.||+|+||+||+|++. .+++.||+|+++... ......+.+|++++++++|||||++++++. +
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~ 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----T 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----E
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----E
Confidence 357999999999999999999873 467899999996432 223357889999999999999999999954 4
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..|+|||||+||+|.+++... ..+++.++..++.||+.||+|||++ +||||||||+|||+++++
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEG 163 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCC
Confidence 58899999999999999999653 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+|+....... ......||+.|||||++.+..|+.++||||+||++|||+||+.||... +....
T Consensus 164 ~vKl~DFGla~~~~~~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~ 234 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKET 234 (304)
T ss_dssp CEEEESSEEEEC-----C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH
T ss_pred CEEecccccceeccCCCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHHH
Confidence 999999999986543221 122356999999999999999999999999999999999999998632 11111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
... + .......+..+++++.+++.+||+.||++|||+
T Consensus 235 ~~~-----i-----------------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 235 MTM-----I-----------------------LKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHH-----H-----------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHH-----H-----------------------HcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 0 001112233567889999999999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=449.45 Aligned_cols=462 Identities=19% Similarity=0.172 Sum_probs=328.6
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 35 ~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
+.+|+++++++. +|..+. ++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..|.+|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 788999999994 776664 78999999999999888889999999999999999999888899999999999999999
Q ss_pred cccCCCcccccCcccccccccccccccCC-CCCcccCCCccceeeccccccCCCCCccccCcccc--cccccccccc--c
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTGG-IPPFIGNLTSLESISLAANAFGGNIPNSLGQLKEL--KSLGLGANNL--S 189 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 189 (988)
+|+ .+|.. .+++|++|+|++|++++. +|..|+++++|++|++++|+++.. .|..+++| ++|+|++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 998 55555 789999999999999863 457889999999999999988753 45555555 8899999888 7
Q ss_pred Cccchhhcccc--CccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccc
Q 001974 190 GIIPPSIYNLS--LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSV 267 (988)
Q Consensus 190 ~~~~~~l~~l~--~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~ 267 (988)
+..|..+..++ .+ .++++.|.+.+.++...+..+++|+.|++++|+.... .+.+. ..
T Consensus 185 ~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-------------------~l~~~-~~ 243 (562)
T 3a79_B 185 GGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-------------------RLMTF-LS 243 (562)
T ss_dssp SSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-------------------HHHHH-HH
T ss_pred ccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc-------------------hHHHH-HH
Confidence 77777777654 23 4566777776555555554555555555555431100 01101 11
Q ss_pred cccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCcc
Q 001974 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSG 347 (988)
Q Consensus 268 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~ 347 (988)
.|.++++|+.|+++++.+...... ..+ .....+ +|++|++++|++++.+|..
T Consensus 244 ~l~~l~~L~~L~L~~~~l~~~~~~--~~~-~~~~~~-------------------------~L~~L~l~~n~l~~~ip~~ 295 (562)
T 3a79_B 244 ELTRGPTLLNVTLQHIETTWKCSV--KLF-QFFWPR-------------------------PVEYLNIYNLTITERIDRE 295 (562)
T ss_dssp HHHSCSSCEEEEEEEEEECHHHHH--HHH-HHHTTS-------------------------SEEEEEEEEEEECSCCCCC
T ss_pred HHhccCcceEEEecCCcCcHHHHH--HHH-Hhhhcc-------------------------cccEEEEeccEeeccccch
Confidence 233444444444444433211000 000 001112 4555555555555555555
Q ss_pred c-----cCCCcceEEEeeCccCCCccC-cccCCC---CccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccc
Q 001974 348 I-----GNLVGLYRLGMGGNQFTGTIP-KEMGKL---QNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPS 418 (988)
Q Consensus 348 ~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 418 (988)
+ ..++.|+.++++.|.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|++++|++++..|.
T Consensus 296 ~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~ 371 (562)
T 3a79_B 296 EFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQ 371 (562)
T ss_dssp CCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred hhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhh
Confidence 5 5666677777777766 334 222222 56788888888775321 125677888888888888877788
Q ss_pred ccccccccceeecCCCCCCc--cCchhhhhhcccccceecccccccCCCcc-ccccccccceeecCCcccccccCccccc
Q 001974 419 CLGSLKQLAILHLFENGLNG--TIPEEIFNLTYLSNSLNLARNHLVGSIPT-KIGNLKYLRVFNVSSNNLSGEIPSQLGL 495 (988)
Q Consensus 419 ~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~L~ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 495 (988)
.+..+++|+.|++++|++++ .+|..+.+++.| ++|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+.
T Consensus 372 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~- 449 (562)
T 3a79_B 372 GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449 (562)
T ss_dssp TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-
T ss_pred hhcccCCCCEEECCCCCcCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-
Confidence 88888888888888888874 334566777777 7888888888874554 477788899999999999887777655
Q ss_pred CCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc-cccCCCCcEEeCCCCcCcccCCC
Q 001974 496 CSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK-FLEDLSLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 496 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~L~~l~l~~N~l~~~~p~ 562 (988)
++|+.|+|++|+|+ .+|..+..+++|+.|||++|+|++.++. +..+++|++|+|++|++++.+|.
T Consensus 450 -~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 450 -PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp -TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred -CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 68999999999988 7888777899999999999999977776 56777899999999999887764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=450.26 Aligned_cols=465 Identities=18% Similarity=0.201 Sum_probs=360.2
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRN 138 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 138 (988)
++||+++|+|+ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|+|++..|.+|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 57899999998 5776665 88999999999998777788888999999999999988777888888888888888888
Q ss_pred cccCCCCCcccCCCccceeeccccccCC-CCCccccCcccccccccccccccCccchhhccccCc--cEEEeccCCCCCC
Q 001974 139 NLTGGIPPFIGNLTSLESISLAANAFGG-NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL--ANFSVPRNQFHGS 215 (988)
Q Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~N~i~~~ 215 (988)
+++ .+|.. .+++|++|+|++|++++ ..|..|+++++|++|+|++|++++ ..+..+++| ++|++++|++.+
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~- 152 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG- 152 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT-
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc-
Confidence 888 45655 78888888888888876 357788888888888888888774 345556655 666666666610
Q ss_pred CCCcccccCCCCcceeccccccccccCcccccCC-cccEEEeccccccCccc-ccccCCccccEEecccccCCCCCCCch
Q 001974 216 LPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS-KLEFIEALDNSFSGKLS-VNFGGMKNLSYFNVAYNNLGSGESDEM 293 (988)
Q Consensus 216 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~ 293 (988)
.+..|..+..+. +...+++++|.+.+..+ ..+..+++|+.|++++|..........
T Consensus 153 ----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 210 (520)
T 2z7x_B 153 ----------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210 (520)
T ss_dssp ----------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred ----------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence 233344444443 34456788888766444 457778888888888886211111111
Q ss_pred hhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCccc-
Q 001974 294 SFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEM- 372 (988)
Q Consensus 294 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~- 372 (988)
.....+..+++|++|++++|.+++..+..+ . ..+ ..++|+.|++++|++++.+|..+
T Consensus 211 ~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~--------------------~-~~~-~~~~L~~L~l~~n~l~~~~p~~~~ 268 (520)
T 2z7x_B 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRI--------------------L-QLV-WHTTVWYFSISNVKLQGQLDFRDF 268 (520)
T ss_dssp HHHHGGGGCTTCCEEEEEEEEEEHHHHHHH--------------------H-HHH-HTSSCSEEEEEEEEEESCCCCCCC
T ss_pred cchhhhccccchhhccccccccCHHHHHHH--------------------H-HHh-hhCcccEEEeecccccCccccchh
Confidence 222356667777777777766652111111 1 111 23589999999999999999998
Q ss_pred ----CCCCccCeEecccccCCCCCC-CCCCCC---CCCCEEEccccccccccccccccccccceeecCCCCCCccCchhh
Q 001974 373 ----GKLQNLEGMGLYDNQLSGEIP-SSLGNL---SILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEI 444 (988)
Q Consensus 373 ----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 444 (988)
.++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|++.... .+..+++|+.|++++|++++.+|..+
T Consensus 269 ~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~ 344 (520)
T 2z7x_B 269 DYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENC 344 (520)
T ss_dssp CCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred hcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhh
Confidence 9999999999999999 455 445444 67999999999987432 23788999999999999998899999
Q ss_pred hhhcccccceecccccccC--CCccccccccccceeecCCcccccccCcc-cccCCCCcEEEecCccccccCCccccCcc
Q 001974 445 FNLTYLSNSLNLARNHLVG--SIPTKIGNLKYLRVFNVSSNNLSGEIPSQ-LGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521 (988)
Q Consensus 445 ~~l~~l~~~L~ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 521 (988)
..++.| ++|++++|++++ .+|..++.+++|++|||++|++++.+|.. +..+++|+.|+|++|++++.+|..+. +
T Consensus 345 ~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~ 421 (520)
T 2z7x_B 345 GHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P 421 (520)
T ss_dssp CCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred ccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence 999999 999999999996 56788999999999999999999867764 88999999999999999988888775 7
Q ss_pred ccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCC-CcccCcccccccccccccCCCC
Q 001974 522 AVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPT-KGVFANISRISVAGFNRLCGGI 584 (988)
Q Consensus 522 ~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~~ 584 (988)
+|+.|||++|+|+..++....+++|++|+|++|++++.++. ...+..+..+.+.+|++.|.|.
T Consensus 422 ~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 422 RIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 99999999999997666668888999999999999965544 3456677788899999988754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=410.88 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=190.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccc-------
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDF------- 734 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 734 (988)
++|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 358999999999999999999999999999999975443 344678999999999999999999998754321
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
......|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||++ +||||||||+|||++.
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~--------~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI--------EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM 153 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG--------GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC--------ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC
Confidence 1223579999999999999999765421 2456777899999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccc--------eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQ--------SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
++.+||+|||+|+.......... ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99999999999987654322111 11234579999999999999999999999999999999996 76421
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. +... ....+.. ... +.. .....+...+++.+||+.||++|||++|+++
T Consensus 231 ~----~~~~-----~~~~~~~---~~~---p~~----------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 M----ERVR-----TLTDVRN---LKF---PPL----------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----HHHH-----HHHHHHT---TCC---CHH----------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----HHHH-----HHHHHhc---CCC---CCC----------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0000 0000100 000 000 1123445678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=422.07 Aligned_cols=277 Identities=22% Similarity=0.242 Sum_probs=206.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccc-cccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSI-DFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~ 738 (988)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|+.++|||||++++++... .+.+.+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999999999999999996432 23346788999999999999999999987643 244567
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..|+||||| +|+|.+++.... ++++.++..|+.||+.||+|||++ +||||||||+|||++.++.+
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~~~-----------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHSSQ-----------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTSSS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCE
T ss_pred EEEEEEeCC-CCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCE
Confidence 899999999 578999997653 699999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+|+................+||+.|||||++.+. .++.++||||+||++|||++|++||..... ......+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I 275 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLI 275 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHH
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence 9999999987654333333334456799999999998875 568999999999999999999999863211 1111111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhh-----------hhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQA-----------KINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... ....|........... ........++++.+|+.+||+.||++|||++|+++
T Consensus 276 ~~~~g~p-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 276 MMVLGTP-----------SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHCCC-----------CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCC-----------ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1110000 0000000000000000 00011245678899999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=400.50 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=169.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
...++|++.+.||+|+||+||+|+++ .+++.||+|++.... ....+.+|+++++.+ +||||+++++++ .
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 45678999999999999999999874 357899999986443 346788999999998 799999999985 4
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
++++.++||||+++|+|.+++. .+++.+++.++.||+.||+|||++ +||||||||+|||++.+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~--------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN--------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRR 153 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT--------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred ECCEEEEEEeCCCcccHHHHHc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCC
Confidence 4588999999999999999983 478899999999999999999999 99999999999999876
Q ss_pred -CcEEEeeeccccccccccccc------------------------ceeccccccccccccCcccCCC-CCCCccchHHH
Q 001974 816 -MIAHVGDFGLARVRQEVSNLT------------------------QSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSY 869 (988)
Q Consensus 816 -~~~kL~DfG~a~~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwsl 869 (988)
+.+||+|||+|+......... .......+||+.|||||++.+. .++.++||||+
T Consensus 154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 799999999998654322110 0112235699999999998875 48999999999
Q ss_pred HHHHHHHHhCCCCCCc
Q 001974 870 GILLLEMVTGKKPTDV 885 (988)
Q Consensus 870 G~vl~elltg~~p~~~ 885 (988)
||++|||+||+.||..
T Consensus 234 G~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 234 GVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHTCSSSSC
T ss_pred HHHHHHHHHCCCCCCC
Confidence 9999999999999853
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=422.54 Aligned_cols=465 Identities=18% Similarity=0.205 Sum_probs=348.5
Q ss_pred CCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccc
Q 001974 57 FLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQ 136 (988)
Q Consensus 57 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 136 (988)
..+++|+++|+++ .+|..+. ++|++|+|++|.|++..|..|+.+++|++|+|++|+|++..|.+|.++++|++|+|+
T Consensus 32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 4478899999888 4666553 788888888888887777788888888888888888887778888888888888888
Q ss_pred cccccCCCCCcccCCCccceeeccccccCCC-CCccccCcccccccccccccccCccchhhccccCc--cEEEeccCCCC
Q 001974 137 RNNLTGGIPPFIGNLTSLESISLAANAFGGN-IPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL--ANFSVPRNQFH 213 (988)
Q Consensus 137 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~N~i~ 213 (988)
+|+++ .+|.. .+++|++|+|++|++++. .|..|+++++|++|+|++|++++. .+..+++| ++|++++|++.
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~ 182 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH 182 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence 88887 45554 778888888888888753 356777777777777777777642 33334433 55555555551
Q ss_pred CCCCCcccccCCCCcceeccccccccccCcccccCC-cccEEEeccccccCccc-ccccCCccccEEecccccCCCCCCC
Q 001974 214 GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNAS-KLEFIEALDNSFSGKLS-VNFGGMKNLSYFNVAYNNLGSGESD 291 (988)
Q Consensus 214 ~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~ 291 (988)
. ++..|..+..+. +.-.+++++|.+.+..+ ..+..+++|+.+++++|..... .
T Consensus 183 ~-----------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~--~ 237 (562)
T 3a79_B 183 I-----------------------KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ--R 237 (562)
T ss_dssp C-----------------------CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH--H
T ss_pred c-----------------------cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc--h
Confidence 0 334444444443 12255888888876544 3566788888888888852100 0
Q ss_pred chhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcc
Q 001974 292 EMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKE 371 (988)
Q Consensus 292 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 371 (988)
.......+..+++|+.|+++++.+. +|.+.+ ++..+ ..++|++|++++|++++.+|..
T Consensus 238 l~~~~~~l~~l~~L~~L~L~~~~l~--------------------~~~~~~-~~~~~-~~~~L~~L~l~~n~l~~~ip~~ 295 (562)
T 3a79_B 238 LMTFLSELTRGPTLLNVTLQHIETT--------------------WKCSVK-LFQFF-WPRPVEYLNIYNLTITERIDRE 295 (562)
T ss_dssp HHHHHHHHHSCSSCEEEEEEEEEEC--------------------HHHHHH-HHHHH-TTSSEEEEEEEEEEECSCCCCC
T ss_pred HHHHHHHHhccCcceEEEecCCcCc--------------------HHHHHH-HHHhh-hcccccEEEEeccEeeccccch
Confidence 1122234566777777777666554 222221 11222 2358999999999999999988
Q ss_pred c-----CCCCccCeEecccccCCCCCC-CCCCC---CCCCCEEEccccccccccccccccccccceeecCCCCCCccCch
Q 001974 372 M-----GKLQNLEGMGLYDNQLSGEIP-SSLGN---LSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442 (988)
Q Consensus 372 ~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 442 (988)
+ ..++.|+.++++.|.+ .+| ..+.. ..+|+.|++++|.+.... .+..+++|+.|++++|++++.+|.
T Consensus 296 ~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~ 371 (562)
T 3a79_B 296 EFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQ 371 (562)
T ss_dssp CCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred hhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhh
Confidence 7 7888888888888887 344 22222 267999999999987432 237889999999999999988999
Q ss_pred hhhhhcccccceecccccccCC--CccccccccccceeecCCcccccccCc-ccccCCCCcEEEecCccccccCCccccC
Q 001974 443 EIFNLTYLSNSLNLARNHLVGS--IPTKIGNLKYLRVFNVSSNNLSGEIPS-QLGLCSYLEEIYMRGNFFHGSIPSSLSS 519 (988)
Q Consensus 443 ~~~~l~~l~~~L~ls~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 519 (988)
.+.+++.+ ++|++++|++++. +|..+..+++|+.|++++|++++.+|. .+..+++|++|+|++|++++.+|..+.
T Consensus 372 ~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~- 449 (562)
T 3a79_B 372 GCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449 (562)
T ss_dssp TCCSCSSC-CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-
T ss_pred hhcccCCC-CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-
Confidence 99999999 9999999999963 457799999999999999999985665 588999999999999999988887765
Q ss_pred ccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCC-CcccCcccccccccccccCCCC
Q 001974 520 LRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPT-KGVFANISRISVAGFNRLCGGI 584 (988)
Q Consensus 520 l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~lcg~~ 584 (988)
++|+.|||++|+|+.+++....+++|++|+|++|++++.++. ...+..+..+.+.+|++.|.|+
T Consensus 450 -~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 450 -PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp -TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred -CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 799999999999997777778888999999999999965554 4556677888899999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=413.40 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=200.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHH---HHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFL---AECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.++||+|+||+||+|+++.+|+.||+|+++... ........ .++.+++.++|||||++++++ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 367999999999999999999999999999999996432 12222333 346667778999999999994 5
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++ +||||||||+|||++.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~-----------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~ 328 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQH-----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH 328 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTT
T ss_pred ECCEEEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCC
Confidence 568999999999999999999654 3699999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
|.+||+|||+|+...... ....+||+.|||||++.. ..|+.++||||+||++|||++|++||......+ ..
T Consensus 329 G~vKL~DFGlA~~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~ 400 (689)
T 3v5w_A 329 GHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH 400 (689)
T ss_dssp SCEEECCCTTCEECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HH
T ss_pred CCEEecccceeeecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HH
Confidence 999999999998764432 223579999999999975 579999999999999999999999996422111 11
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
...... .......+..+++++.+|+.+||+.||++|++ ++||++
T Consensus 401 ~i~~~i----------------------------~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 401 EIDRMT----------------------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHH----------------------------HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHHhh----------------------------cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111100 01111223356788999999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=416.68 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=209.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++||||+++++++ .+++..+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 36899999999999999999999999999999999866655667899999999999999999999994 4568999
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC--CcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND--MIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~k 819 (988)
+|||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+|
T Consensus 231 iv~E~~~gg~L~~~i~~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vK 297 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELK 297 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT----------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEeecCCCcHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEE
Confidence 9999999999999997543 3689999999999999999999999 99999999999999854 8999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+......... ..+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......
T Consensus 298 l~DFG~a~~~~~~~~~~-----~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----~~~~~~ 367 (573)
T 3uto_A 298 LIDFGLTAHLDPKQSVK-----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRN 367 (573)
T ss_dssp ECCCSSCEECCTTSEEE-----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH
T ss_pred EeeccceeEccCCCcee-----eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH
Confidence 99999999765533222 24699999999999999999999999999999999999999863211 111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+. ........ .....+++++.+|+.+||+.||++|||++|+++
T Consensus 368 -----i~---~~~~~~~~----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 368 -----VK---SCDWNMDD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -----HH---TTCCCCCS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HH---hCCCCCCc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 00000000 011246678899999999999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=399.59 Aligned_cols=402 Identities=22% Similarity=0.290 Sum_probs=229.7
Q ss_pred CCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceee
Q 001974 79 LFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESIS 158 (988)
Q Consensus 79 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 158 (988)
.++|++|++++|.+ +.+|.+|+++++|++|+|++|++.+.+|.+++++.+|+.+++.+|.. .++++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 35556666666665 35566666666666666666666656666666666665555554432 2455566
Q ss_pred ccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccc
Q 001974 159 LAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS 238 (988)
Q Consensus 159 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~ 238 (988)
+++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++. .+|.. .++|++|++++|+++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLE 144 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCC
Confidence 66666553 2321 2456666666666664 3432 255666666666665 33321 146666666666666
Q ss_pred cccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCC
Q 001974 239 GSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGA 318 (988)
Q Consensus 239 ~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 318 (988)
+ +| .+.++++|++|++++|++++. |.. ..+|++|++++|.++.++ .+..+++|++|++++|++++
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~- 209 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK- 209 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-
Confidence 4 44 466666777777777766653 222 247777777777776542 25667777777777777773
Q ss_pred CCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCC
Q 001974 319 LPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGN 398 (988)
Q Consensus 319 ~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 398 (988)
+|.. +++|++|++++|+++ .+|. +..+++|+.|++++|++++ +|.. +++|+.|++++|++++ +|..
T Consensus 210 l~~~----~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~--- 275 (454)
T 1jl5_A 210 LPDL----PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL--- 275 (454)
T ss_dssp CCCC----CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---
T ss_pred CCCC----cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---
Confidence 4432 236888888888888 5663 7888888888888888884 5543 3688888888888885 5553
Q ss_pred CCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhh-cccccceecccccccCCCccccccccccce
Q 001974 399 LSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNL-TYLSNSLNLARNHLVGSIPTKIGNLKYLRV 477 (988)
Q Consensus 399 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~ 477 (988)
+++|+.|++++|++++. |.. .++|+.|++++|++++ ++. + +.+ ++|++++|++++ +|.. +++|+.
T Consensus 276 ~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~----~~~~L-~~L~Ls~N~l~~-lp~~---~~~L~~ 341 (454)
T 1jl5_A 276 PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCD----LPPSL-EELNVSNNKLIE-LPAL---PPRLER 341 (454)
T ss_dssp CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECC----CCTTC-CEEECCSSCCSC-CCCC---CTTCCE
T ss_pred cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccC----CcCcC-CEEECCCCcccc-cccc---CCcCCE
Confidence 37788888888888862 221 2578888888888873 432 2 245 788888888885 5654 477888
Q ss_pred eecCCcccccccCcccccCCCCcEEEecCccccc--cCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCc
Q 001974 478 FNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHG--SIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFND 555 (988)
Q Consensus 478 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~ 555 (988)
|++++|+++ .+|. .+++|+.|+|++|++++ .+|.++..+ +.|++.|.+|.. ..+|++|++++|+
T Consensus 342 L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~--~~~L~~L~ls~N~ 407 (454)
T 1jl5_A 342 LIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL--PQNLKQLHVETNP 407 (454)
T ss_dssp EECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-----------------------
T ss_pred EECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc--cCcCCEEECCCCc
Confidence 888888888 5776 47888888898888887 677766543 346666666653 3467777777777
Q ss_pred Ccc--cCCC
Q 001974 556 LEG--EVPT 562 (988)
Q Consensus 556 l~~--~~p~ 562 (988)
++| .+|.
T Consensus 408 l~~~~~iP~ 416 (454)
T 1jl5_A 408 LREFPDIPE 416 (454)
T ss_dssp ---------
T ss_pred CCccccchh
Confidence 776 5553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=401.45 Aligned_cols=378 Identities=20% Similarity=0.234 Sum_probs=255.7
Q ss_pred CCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcC-CcccccCCCCceeecCcccccC
Q 001974 40 RSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEI-PANLSYCSRLTILFLGRNKLMG 118 (988)
Q Consensus 40 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~~N~i~~ 118 (988)
.+++++ .+|. + .++|++|+|++|+|++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++
T Consensus 18 ~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~ 93 (455)
T 3v47_A 18 INRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93 (455)
T ss_dssp CSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCE
T ss_pred CCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCc
Confidence 345555 4554 2 278899999999999888889999999999999999887544 6678999999999999999988
Q ss_pred CCcccccCcccccccccccccccCCCCC--cccCCCccceeeccccccCCCCCcc-ccCcccccccccccccccCccchh
Q 001974 119 SIPFEFFSLYKLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGGNIPNS-LGQLKELKSLGLGANNLSGIIPPS 195 (988)
Q Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~ 195 (988)
..|..|.++++|++|+|++|++++..+. .|..+++|++|+|++|++++..|.. |.++++|++|+|++|++++..+..
T Consensus 94 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 173 (455)
T 3v47_A 94 LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED 173 (455)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT
T ss_pred cChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh
Confidence 8888999999999999999998864443 4888999999999999998777776 788999999999999998888888
Q ss_pred hccc--cCccEEEeccCCCCCCCCCccc--------ccCCCCcceeccccccccccCcccccC---CcccEEEecccccc
Q 001974 196 IYNL--SLLANFSVPRNQFHGSLPPSLG--------LTLPHLRLFQVHHNFFSGSIPISLSNA---SKLEFIEALDNSFS 262 (988)
Q Consensus 196 l~~l--~~L~~L~L~~N~i~~~lp~~~~--------~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~l~~N~i~ 262 (988)
+..+ .+|+.|++++|.+. .++.... ..+++|+.|++++|++++..|..+... .+|+.|++++|.+.
T Consensus 174 l~~l~~~~L~~L~l~~n~l~-~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 252 (455)
T 3v47_A 174 LLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252 (455)
T ss_dssp SGGGTTCEEEEEECTTCBCT-TCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTT
T ss_pred hhccccccccccccccCccc-ccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccc
Confidence 8776 67888888888887 3333221 133455555555555555444444332 44444444444433
Q ss_pred CcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCcccc
Q 001974 263 GKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG 342 (988)
Q Consensus 263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~ 342 (988)
+... ..+.+.......+. -...++|++|++++|++++..|..+..+. +|++|++++|++++
T Consensus 253 ~~~~--------------~~~~~~~~~~~~~~----~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~ 313 (455)
T 3v47_A 253 GSSF--------------GHTNFKDPDNFTFK----GLEASGVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEINK 313 (455)
T ss_dssp SCCT--------------TCCSSCCCCTTTTG----GGTTSCCCEEECCSSCCCEECTTTTTTCT-TCCEEECTTSCCCE
T ss_pred cccc--------------chhhhccCcccccc----cccccCceEEEecCccccccchhhcccCC-CCCEEECCCCcccc
Confidence 2110 11111111111000 01235666666666666655555555543 56666666666666
Q ss_pred CCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccc
Q 001974 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422 (988)
Q Consensus 343 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 422 (988)
..|..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..
T Consensus 314 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhcc
Confidence 66666666666666666666666555666666666666666666666666666666666666666666666555555666
Q ss_pred ccccceeecCCCCCCccCc
Q 001974 423 LKQLAILHLFENGLNGTIP 441 (988)
Q Consensus 423 l~~L~~L~l~~N~l~~~~p 441 (988)
+++|+.|++++|++++..|
T Consensus 394 l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 394 LTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTCCEEECCSSCBCCCTT
T ss_pred CCcccEEEccCCCcccCCC
Confidence 6666666666666665555
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=378.81 Aligned_cols=268 Identities=24% Similarity=0.387 Sum_probs=218.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.. ++..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 4678999999999999999999998999999999876666667889999999999999999999999653 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 150 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD----------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVA 150 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEEC
T ss_pred EEEEecCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEe
Confidence 9999999999999997543 3689999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccc----------eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 822 DFGLARVRQEVSNLTQ----------SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
|||+++.......... .......||+.|+|||++.+..++.++||||||+++|||++|..||........
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~ 230 (310)
T 3s95_A 151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230 (310)
T ss_dssp CCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT
T ss_pred ecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH
Confidence 9999986544322111 011135699999999999999999999999999999999999999864332211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
....... . ......+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus 231 ~~~~~~~--------~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 231 DFGLNVR--------G----------------------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp TSSBCHH--------H----------------------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhhhh--------c----------------------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1000000 0 000112345777899999999999999999999999999999
Q ss_pred HHHhhh
Q 001974 972 KNALLE 977 (988)
Q Consensus 972 ~~~~~~ 977 (988)
+..+..
T Consensus 281 ~~~~~~ 286 (310)
T 3s95_A 281 RMHLAG 286 (310)
T ss_dssp HHHHHH
T ss_pred HHhccC
Confidence 987665
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=377.70 Aligned_cols=286 Identities=31% Similarity=0.534 Sum_probs=226.9
Q ss_pred ccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 652 KVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 652 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
.+++.++...+++|+..+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 105 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD- 105 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence 3445555667899999999999999999999975 78999999987766666788999999999999999999999964
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.++..++||||+++|+|.+++....... ..+++.+++.++.|++.||+|||+. +|+||||||+||+
T Consensus 106 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil 171 (321)
T 2qkw_B 106 ----ERNEMILIYKYMENGNLKRHLYGSDLPT-------MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINIL 171 (321)
T ss_dssp ----CTTCCEEEEECCTTCBTGGGSSSSCCCS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEE
T ss_pred ----CCCeEEEEEEcCCCCcHHHHHhccCCCc-------cccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEE
Confidence 4478899999999999999997654321 2589999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC-
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD- 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~- 890 (988)
++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 172 ~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 172 LDENFVPKITDFGISKKGTELDQT--HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp ECTTCCEEECCCTTCEECSSSSCC--CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred ECCCCCEEEeeccccccccccccc--ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 999999999999999864432211 11223458999999999988899999999999999999999999997544332
Q ss_pred cchHHHHHHHHhh-hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 891 LNLHNYARTALLD-HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 891 ~~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
.....+....... .+...+++.... ....+++.++.+++.+||+.||++|||++|+++.|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 250 VNLAEWAVESHNNGQLEQIVDPNLAD------------------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCHHHHTHHHHTTTCCCSSSSSSCTT------------------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhhhccccccHHHhcChhhcc------------------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2233332222111 122222222211 112356788999999999999999999999999999
Q ss_pred HHHH
Q 001974 970 SVKN 973 (988)
Q Consensus 970 ~i~~ 973 (988)
.+.+
T Consensus 312 ~~l~ 315 (321)
T 2qkw_B 312 YALR 315 (321)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 9865
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=393.34 Aligned_cols=420 Identities=24% Similarity=0.235 Sum_probs=169.7
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
+++.|++++|++ +.+|++++.+++|++|+|++|++++.+|.+++.+.+|+.+++++|.. .+|++|+++
T Consensus 12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l~ 79 (454)
T 1jl5_A 12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELELN 79 (454)
T ss_dssp -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEECT
T ss_pred cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEec
Confidence 444555555555 35555555555555555555555555555555554431000000000 012444444
Q ss_pred cccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCcc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 192 (988)
+|++++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|+|++|++++ +
T Consensus 80 ~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-l 146 (454)
T 1jl5_A 80 NLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-L 146 (454)
T ss_dssp TSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-C
T ss_pred CCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-C
Confidence 444442 2221 1344455555555443 3322 2445555555555442 1111 1345555555555553 3
Q ss_pred chhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCC
Q 001974 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272 (988)
Q Consensus 193 ~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l 272 (988)
| ++.++++|++|++++|+++ .+|.. .++|++|++++|++++ +| .+.++++|+.|++++|++++... . .
T Consensus 147 p-~~~~l~~L~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~-~---~ 214 (454)
T 1jl5_A 147 P-ELQNSSFLKIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD-L---P 214 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC-C---C
T ss_pred c-ccCCCCCCCEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC-C---c
Confidence 3 3555555555555555554 34432 1355555555555554 23 35555555555555555554221 1 1
Q ss_pred ccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCC
Q 001974 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLV 352 (988)
Q Consensus 273 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 352 (988)
++|++|++++|.++.++ .+..+++|++|++++|++++ +|.. .++|+.|++++|++++ +|.. ++
T Consensus 215 ~~L~~L~l~~n~l~~lp--------~~~~l~~L~~L~l~~N~l~~-l~~~----~~~L~~L~l~~N~l~~-l~~~---~~ 277 (454)
T 1jl5_A 215 LSLESIVAGNNILEELP--------ELQNLPFLTTIYADNNLLKT-LPDL----PPSLEALNVRDNYLTD-LPEL---PQ 277 (454)
T ss_dssp TTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-CCSC----CTTCCEEECCSSCCSC-CCCC---CT
T ss_pred CcccEEECcCCcCCccc--------ccCCCCCCCEEECCCCcCCc-cccc----ccccCEEECCCCcccc-cCcc---cC
Confidence 35555566655555332 13455556666666665552 3331 2356666666666663 3332 25
Q ss_pred cceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 353 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
+|+.|++++|++++ +|.. .++|+.|++++|++++ ++.. .++|+.|++++|++++ +|.. +++|+.|+++
T Consensus 278 ~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~ 345 (454)
T 1jl5_A 278 SLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIAS 345 (454)
T ss_dssp TCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred cCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECC
Confidence 56666666666663 2211 1456666666666663 2211 1356666666666664 3433 3566666666
Q ss_pred CCCCCccCchhhhhhcccccceecccccccC--CCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcccc
Q 001974 433 ENGLNGTIPEEIFNLTYLSNSLNLARNHLVG--SIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510 (988)
Q Consensus 433 ~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 510 (988)
+|+++ .+|. .++.+ ++|++++|++++ .+|..+..+ +.|.+.|.+|.. +++|+.|++++|+++
T Consensus 346 ~N~l~-~lp~---~l~~L-~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 346 FNHLA-EVPE---LPQNL-KQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLR 409 (454)
T ss_dssp SSCCS-CCCC---CCTTC-CEEECCSSCCSSCCCCCTTCCEE--------ECCC--------------------------
T ss_pred CCccc-cccc---hhhhc-cEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCC
Confidence 66666 4555 24455 666666776665 455544432 335556666653 467788888888887
Q ss_pred c--cCCccccCccccCeeecCCCcccCcCccc
Q 001974 511 G--SIPSSLSSLRAVLAIDLSRNNLSGLIPKF 540 (988)
Q Consensus 511 ~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 540 (988)
+ .+|.+ |+.|.+++|.+.+.+|-.
T Consensus 410 ~~~~iP~s------l~~L~~~~~~~~~~~~~~ 435 (454)
T 1jl5_A 410 EFPDIPES------VEDLRMNSERVVDPYEFA 435 (454)
T ss_dssp --------------------------------
T ss_pred ccccchhh------HhheeCcCcccCCccccC
Confidence 6 56644 445567777777766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=392.65 Aligned_cols=391 Identities=18% Similarity=0.200 Sum_probs=244.3
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCC-CcccccCccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGS-IPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~ 137 (988)
+.++.++++++ .+|. + .++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+. .+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 56777888887 5565 3 36788888888888877777788888888888888877533 355677777777777777
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCcc--ccCcccccccccccccccCccchh-hccccCccEEEeccCCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNS--LGQLKELKSLGLGANNLSGIIPPS-IYNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~i~~ 214 (988)
|++++..|..|.++++|++|+|++|++++..+.. |.++++|++|+|++|++++..|.. +.++++|++|++++|++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~- 167 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK- 167 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS-
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc-
Confidence 7777666666777777777777777666433322 566666666666666666554444 455555555555555555
Q ss_pred CCCCcccccCCCCcceeccccccccccCcccccC--CcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCc
Q 001974 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNA--SKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292 (988)
Q Consensus 215 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 292 (988)
+..+..+..+ .+|+.|++++|.+.+..+..+.
T Consensus 168 ------------------------~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~---------------------- 201 (455)
T 3v47_A 168 ------------------------SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG---------------------- 201 (455)
T ss_dssp ------------------------CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT----------------------
T ss_pred ------------------------ccChhhhhccccccccccccccCcccccchhhcc----------------------
Confidence 3333333322 2333333433333332222111
Q ss_pred hhhhcccccCCCCcEEEeecccCCCCCCchhhhcc--ccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCc
Q 001974 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLS--DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPK 370 (988)
Q Consensus 293 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 370 (988)
......+..+++|++|++++|++++..|..+.... .+|+.|++++|.+.+.. +..+.+.+..+.
T Consensus 202 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~ 267 (455)
T 3v47_A 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNF 267 (455)
T ss_dssp HHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTT
T ss_pred ccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCccc
Confidence 00001122334455555555555444444443321 24555555555544221 111222222222
Q ss_pred ccCC--CCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhc
Q 001974 371 EMGK--LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLT 448 (988)
Q Consensus 371 ~~~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 448 (988)
.+.. .++|+.|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+.+++
T Consensus 268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 347 (455)
T 3v47_A 268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347 (455)
T ss_dssp TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence 2322 25677777777777766777777777777777777777777777777777777777777777755566667777
Q ss_pred ccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCc
Q 001974 449 YLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPS 515 (988)
Q Consensus 449 ~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 515 (988)
.| ++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|.
T Consensus 348 ~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 348 KL-EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp TC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cC-CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 77 7778888877777788888888999999999999976666778899999999999999988773
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=369.30 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=208.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 4689999999999999999999988999999999987666667789999999999999999999998643 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 94 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~ 158 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (297)
T ss_dssp EEEECCTTCBHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEECCCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEe
Confidence 999999999999998542 478999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .......
T Consensus 159 Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~-~~~~~~~ 229 (297)
T 3fxz_A 159 DFGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----L-RALYLIA 229 (297)
T ss_dssp CCTTCEECCSTTCC----BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----H-HHHHHHH
T ss_pred eCCCceecCCcccc----cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHHH
Confidence 99999865443221 2235699999999999999999999999999999999999999863211 0 0000000
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ......+..++..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~-------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 230 TNG-------------------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHC-------------------------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hCC-------------------------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 0001122356778999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=379.83 Aligned_cols=289 Identities=35% Similarity=0.592 Sum_probs=227.9
Q ss_pred hhccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEE
Q 001974 648 KALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVI 726 (988)
Q Consensus 648 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 726 (988)
.....+++.++....++|++.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 44677899999999999999999999999999999865 789999999875432 2334789999999999999999999
Q ss_pred eecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 727 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
+++. .++..++||||+++|+|.+++....... ..+++..++.++.|++.||+|||+.+.++|+|||||
T Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 94 GFCM-----TPTERLLVYPYMANGSVASCLRERPESQ-------PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp EEEC-----CSSCCEEEEECCTTCBHHHHHHCCSTTC-------CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred EEEe-----cCCceEEEEEeccCCCHHHHHHhccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 9964 3477899999999999999997654321 258999999999999999999999866799999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSSSC---EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred hhhEEECCCCCEEeccCccccccCccccc---ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999866433221 122345899999999998888999999999999999999999999632
Q ss_pred c---cCCcchHHHHHHHHhhh-hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 887 F---EGDLNLHNYARTALLDH-VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 887 ~---~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
. ..+.....+........ .....+..... ....+.+..+.+++.+||+.||++|||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 300 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG------------------NYKDEEVEQLIQVALLCTQSSPMERPKMS 300 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT------------------SCCHHHHHHHHHHHHHHTCSCGGGSCCHH
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhcc------------------ccCHHHHHHHHHHHHHHhCcCCccCCCHH
Confidence 2 11222333322222211 11222221111 12235667899999999999999999999
Q ss_pred HHHHHHHH
Q 001974 963 NVVHELQS 970 (988)
Q Consensus 963 evl~~L~~ 970 (988)
|+++.|++
T Consensus 301 ell~~L~~ 308 (326)
T 3uim_A 301 EVVRMLEG 308 (326)
T ss_dssp HHHHHHHT
T ss_pred HHHHHhcC
Confidence 99999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.87 Aligned_cols=268 Identities=23% Similarity=0.380 Sum_probs=208.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHh--cCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKN--IRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46899999999999999999998 7899999998643 33556667777766 7999999999987653 334567
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeccCCCCCee
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH--------HHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIl 811 (988)
.++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nil 145 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT------------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNIL 145 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEE
T ss_pred eEEehhhccCCCHHHHHhhc------------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEE
Confidence 89999999999999999543 5899999999999999999999 76 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhC------
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTG------ 879 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg------ 879 (988)
++.++.+||+|||+|+.................||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 99999999999999986655433222223334699999999998876 456799999999999999999
Q ss_pred ----CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCC
Q 001974 880 ----KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955 (988)
Q Consensus 880 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 955 (988)
+.||......+............... .+.. ... .....++.++.+++.+||+.||
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~---~~~--------------~~~~~~~~~l~~li~~cl~~dP 284 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ----RPNI---PNR--------------WFSDPTLTSLAKLMKECWYQNP 284 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCC---CGG--------------GGGSHHHHHHHHHHHHHCCSSG
T ss_pred cccccccccccCCCCcchhhhhHHHhccCC----CCCC---Chh--------------hccCccHHHHHHHHHHHhhcCh
Confidence 77776544443333322222111110 0000 000 0122467789999999999999
Q ss_pred CCCCCHHHHHHHHHHH
Q 001974 956 QDRMSITNVVHELQSV 971 (988)
Q Consensus 956 ~~RPs~~evl~~L~~i 971 (988)
++|||++|+++.|+++
T Consensus 285 ~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 285 SARLTALRIKKTLTKI 300 (301)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHhcc
Confidence 9999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.80 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=204.7
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
....++|++.+.||+|+||+||+|++ .|+.||||++..... ...+.+.+|++++++++||||+++++++. .
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 105 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----Q 105 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence 34456799999999999999999988 688999999865432 33467899999999999999999999954 4
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLDN 814 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~ 814 (988)
++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. + |+||||||+||+++.
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGA--------REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTH--------HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECT
T ss_pred CCceEEEEecCCCCcHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeC
Confidence 4778999999999999999976431 13589999999999999999999998 8 999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----- 245 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----- 245 (309)
T ss_dssp TCCEEECCCC---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----
T ss_pred CCcEEECCCCCCcccccccc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999975433211 122346899999999999999999999999999999999999998642111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
...... . ........+..+++++.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 246 ~~~~~~-----~---------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 246 QVVAAV-----G---------------------FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHH-----H---------------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHH-----H---------------------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 110000 0 00011122345778899999999999999999999999999999776
Q ss_pred hhhh
Q 001974 975 LLEA 978 (988)
Q Consensus 975 ~~~~ 978 (988)
...+
T Consensus 300 ~~p~ 303 (309)
T 3p86_A 300 AVPP 303 (309)
T ss_dssp ----
T ss_pred CCCC
Confidence 5543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=372.94 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=206.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+++++.++||||+++++++. .++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 3568999999999999999999998899999999997542 234467889999999999999999999954 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++... .++++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH-----------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred EEEEEEECCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCE
Confidence 899999999999999998543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCC-CccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS-TNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||++........ .....||+.|+|||++.+..++ .++||||+||++|||++|+.||... ......
T Consensus 154 kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~ 223 (328)
T 3fe3_A 154 KIADFGFSNEFTVGGK-----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLKELR 223 (328)
T ss_dssp EECSTTCCGGGSSSCG-----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHH
T ss_pred EEeeccCceecCCCCc-----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHHHHH
Confidence 9999999986544322 2234699999999999888765 7899999999999999999998632 111111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... .......+..+++++.+++.+||+.||++|||++|+++.
T Consensus 224 ~~i----------------------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 224 ERV----------------------------LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHH----------------------------HHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHH----------------------------HhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100 011112233467789999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=369.53 Aligned_cols=282 Identities=22% Similarity=0.350 Sum_probs=213.4
Q ss_pred hCCCCCCceeccccceeEEEEE----ECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGA----FDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||+||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++... +.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 4679999999999999999999 4568899999999866666667899999999999999999999987542 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 152 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred CceEEEEEeCCCCCHHHHHHhcc----------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCe
Confidence 56899999999999999996543 3589999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++......... .......++..|+|||++.+..++.++||||||+++|||+||..||..... .+.
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~ 225 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFM 225 (295)
T ss_dssp EEECCCCSCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHH
T ss_pred EEEccCcccccccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHH
Confidence 9999999998765432211 112233477889999999999999999999999999999999999763211 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALL 976 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 976 (988)
........... .................+..+++++.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus 226 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 226 RMIGNDKQGQM----------IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHCTTCCTHH----------HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hhhcCccccch----------hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 00000000000 0000000011111223345688899999999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=370.45 Aligned_cols=263 Identities=24% Similarity=0.443 Sum_probs=210.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC---eEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++..++ ..||||+++.. .....+.+.+|+.++++++||||+++++++.. +
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----G 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----G
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 357888999999999999999997544 45999999754 23345679999999999999999999999643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD----------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred CccEEEeeCCCCCcHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCC
Confidence 77899999999999999996543 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++......... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 190 ~kl~Dfg~a~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~ 263 (325)
T 3kul_A 190 CKVSDFGLSRVLEDDPDAA-YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DV 263 (325)
T ss_dssp EEECCCSSCEECC----CC-EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HH
T ss_pred EEECCCCcccccccCccce-eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HH
Confidence 9999999998765432221 12223446789999999998899999999999999999999 99998632111 11
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.. .+.. ......+..++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 264 ~~-----~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 264 IS-----SVEE----------------------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HH-----HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HH-----HHHc----------------------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 00 0000 0011223467788999999999999999999999999999997653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=364.43 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=212.8
Q ss_pred cccCHHHHHHhhCC----------CCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCC
Q 001974 651 QKVSYESLFKATDG----------FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR 720 (988)
Q Consensus 651 ~~~~~~~l~~~~~~----------y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 720 (988)
..++++++..+++. |+..+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666766666543 66778999999999999999889999999999876666667899999999999999
Q ss_pred CceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 001974 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPV 800 (988)
Q Consensus 721 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 800 (988)
||+++++++.. ++..++||||+++++|.+++... .+++.++..++.|++.||+|||+. +|
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~------------~l~~~~~~~i~~qi~~~L~~LH~~---~i 162 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV------------RLNEEQIATVCEAVLQALAYLHAQ---GV 162 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 99999999654 47899999999999999998643 588999999999999999999998 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCC
Q 001974 801 LHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880 (988)
Q Consensus 801 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~ 880 (988)
+||||||+||+++.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 238 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865443211 22346999999999999999999999999999999999999
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||..... .... ..+.....+. ......+++++.+++.+||+.||++|||
T Consensus 239 ~pf~~~~~-----~~~~-----~~~~~~~~~~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 288 (321)
T 2c30_A 239 PPYFSDSP-----VQAM-----KRLRDSPPPK--------------------LKNSHKVSPVLRDFLERMLVRDPQERAT 288 (321)
T ss_dssp CTTTTSCH-----HHHH-----HHHHHSSCCC--------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCH-----HHHH-----HHHhcCCCCC--------------------cCccccCCHHHHHHHHHHccCChhhCcC
Confidence 99863211 1111 0111100000 0112246778999999999999999999
Q ss_pred HHHHHHH
Q 001974 961 ITNVVHE 967 (988)
Q Consensus 961 ~~evl~~ 967 (988)
++|+++.
T Consensus 289 ~~ell~h 295 (321)
T 2c30_A 289 AQELLDH 295 (321)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=373.07 Aligned_cols=272 Identities=20% Similarity=0.403 Sum_probs=213.1
Q ss_pred hCCCCCCceeccccceeEEEEEEC-------CCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD-------QDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+.+++++ +||||++++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467899999999999999999874 3456899999975432 3346789999999999 8999999999964
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchh-----hhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDV-----EIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
.++..++||||+++|+|.+++.......... ......+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 3478999999999999999997654211100 01113589999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTC--TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hhEEECCCCCEEEccccCCcccCccccee--cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999998654432211 1223457889999999999999999999999999999999 99998642
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .. ... +.. ......+..++.++.+++.+||+.||++|||++|+++
T Consensus 310 ~~~--~~---~~~-----~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 310 PVE--EL---FKL-----LKE----------------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp CGG--GH---HHH-----HHT----------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH--HH---HHH-----Hhc----------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 00 000 000 0011223457788999999999999999999999999
Q ss_pred HHHHHHHHh
Q 001974 967 ELQSVKNAL 975 (988)
Q Consensus 967 ~L~~i~~~~ 975 (988)
.|+++.+..
T Consensus 358 ~L~~il~~~ 366 (370)
T 2psq_A 358 DLDRILTLT 366 (370)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=379.68 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=212.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
...++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++. .++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCC
Confidence 345678999999999999999999988999999999874422 23356889999999999999999999964 347
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~ 252 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG----------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVL 252 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred CcEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcE
Confidence 7899999999999999986432 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+| |..||...... . .
T Consensus 253 kl~DfG~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~-~ 324 (377)
T 3cbl_A 253 KISDFGMSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----Q-T 324 (377)
T ss_dssp EECCGGGCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----H-H
T ss_pred EECcCCCceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----H-H
Confidence 9999999986433211 111111235778999999998899999999999999999999 99998643111 0 0
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.+.+.. ......+..++.++.+++.+||+.||++|||++++++.|++++++
T Consensus 325 --------~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 325 --------REFVEK------------------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --------HHHHHT------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHc------------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 000000 001122335788899999999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=366.31 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=205.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++.. .......+.+|+++++.++||||+++++++. ..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 46799999999999999999999999999999999743 2334567889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE-----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred EEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCE
Confidence 899999999999999988643 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||... .......
T Consensus 145 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~ 215 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFE 215 (337)
T ss_dssp EECCCTTCBCSCCTTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH
T ss_pred EEeeccchhhcccCCC----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHHHHHH
Confidence 9999999985332211 122356999999999999999999999999999999999999998632 1111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 967 (988)
... ......+..+++++.+++.+||+.||++|| +++|+++.
T Consensus 216 ~i~----------------------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 216 LIL----------------------------MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHH----------------------------HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHH----------------------------cCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 100 001112335677899999999999999999 89998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.10 Aligned_cols=284 Identities=23% Similarity=0.282 Sum_probs=210.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.||+|+||+||+|++ .++.||||+++... ........|+.++++++||||+++++++.... .....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCce
Confidence 3457899999999999999999998 48999999996443 23355667999999999999999999976541 12345
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC-------CCCCeEeccCCCCCeee
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH-------CQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlkp~NIll 812 (988)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +.++|+||||||+||++
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred EEEEEecCCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence 79999999999999999542 589999999999999999999985 13389999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-----CCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-----EVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
+.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CCCCeEEEccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999866543321 112335689999999998873 56678999999999999999999987533
Q ss_pred cCCc-chHHHHHHH-Hhhhhhh-hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 888 EGDL-NLHNYARTA-LLDHVID-IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 888 ~~~~-~~~~~~~~~-~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.... .+....... ....+.+ ............ ......++.++.+++.+||+.||++|||++|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD-------------YWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG-------------GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chhccchhhhhccCCchhhhhhhhhcccCCCCccc-------------cccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 2211 111000000 0000000 000000000000 00112456779999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 965 VHELQSVKNA 974 (988)
Q Consensus 965 l~~L~~i~~~ 974 (988)
++.|+++.+.
T Consensus 310 l~~L~~l~~~ 319 (322)
T 3soc_A 310 GERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=368.84 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc------hhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG------ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.+.|++.+.||+|+||.||+|+++.+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 46799999999999999999999999999999999754322 2467899999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~ 151 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE-----------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCC
Confidence 4588999999999999999997543 689999999999999999999999 99999999999999887
Q ss_pred C----cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 816 M----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 816 ~----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+ .+||+|||++........ .....||+.|+|||++.+..++.++||||+||++|+|++|..||....
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---- 222 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---- 222 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----
T ss_pred CCCccCEEEEecCCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----
Confidence 7 799999999987654322 123469999999999999999999999999999999999999986321
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... +. ......... ....++.++.+++.+||..||++|||++|+++
T Consensus 223 -~~~~~~~-----i~---~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 223 -KQETLAN-----IT---AVSYDFDEE----------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HHHHHHH-----HH---TTCCCCCHH----------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHH-----HH---hcCCCCCch----------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110 00 000000000 01246678999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=372.52 Aligned_cols=281 Identities=16% Similarity=0.232 Sum_probs=214.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCC-----CeEEEEEEeeccccch-----------hHHHHHHHHHHHhcCCCCceE
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQD-----GTIVAIKVFNLQRHGA-----------SKSFLAECKALKNIRHRNLVK 724 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 724 (988)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356899999999999999999999654 5789999986543211 123445566677788999999
Q ss_pred EEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecc
Q 001974 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCD 804 (988)
Q Consensus 725 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 804 (988)
+++++... .......++||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||+. +|+|||
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrD 177 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA----------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGD 177 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEec
Confidence 99997653 22335689999999 999999996543 3689999999999999999999999 999999
Q ss_pred CCCCCeeeC--CCCcEEEeeecccccccccccccc---eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhC
Q 001974 805 LKPGNVLLD--NDMIAHVGDFGLARVRQEVSNLTQ---SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG 879 (988)
Q Consensus 805 lkp~NIll~--~~~~~kL~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg 879 (988)
|||+|||++ .++.+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 257 (364)
T 3op5_A 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257 (364)
T ss_dssp CCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999 889999999999987654322111 111334599999999999999999999999999999999999
Q ss_pred CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 880 KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 880 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
+.||...... ..+...........+.+++++.+. ...+|.++.+++..||+.||++||
T Consensus 258 ~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 258 HLPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFP---------------------AANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp CCTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSC---------------------TTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCccccccC-HHHHHHHHHHhhhhHHHHHHHhcc---------------------cccCHHHHHHHHHHHhcCCCCCCC
Confidence 9999743222 222222222222223333322221 125678899999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhhh
Q 001974 960 SITNVVHELQSVKNALLEA 978 (988)
Q Consensus 960 s~~evl~~L~~i~~~~~~~ 978 (988)
+++++++.|+++.++....
T Consensus 316 ~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 316 LYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CHHHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHHHHcCCC
Confidence 9999999999998875443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=364.50 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=206.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.++||||+++++++. +.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 468999999999999999999999999999999987443 34567889999999999999999999964 347899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC--CCcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN--DMIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~k 819 (988)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 78 lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~k 144 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEEeCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEE
Confidence 9999999999999997653 2689999999999999999999999 9999999999999987 78999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|..||..... ......
T Consensus 145 l~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~ 214 (321)
T 1tki_A 145 IIEFGQARQLKPGDNF-----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIEN 214 (321)
T ss_dssp ECCCTTCEECCTTCEE-----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred EEECCCCeECCCCCcc-----ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHH
Confidence 9999999876543221 224589999999999998899999999999999999999999863211 111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ......... ....++.++.+++.+||+.||++|||++|+++.
T Consensus 215 i~--------~~~~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 215 IM--------NAEYTFDEE----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH--------HTCCCCCHH----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HH--------cCCCCCChh----------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 000000000 012467789999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.89 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=211.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ...+++.+|++++++++||||+++++++. +++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPI 80 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCce
Confidence 3467999999999999999999997 68889999997543 33477999999999999999999999954 44778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl 147 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV 147 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEE
T ss_pred EEEEEeCCCCcHHHHHHhcC----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEe
Confidence 99999999999999996544 3689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||..... .....
T Consensus 148 ~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----~~~~~- 218 (269)
T 4hcu_A 148 SDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVE- 218 (269)
T ss_dssp CCTTGGGGBCCHHH---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-
T ss_pred cccccccccccccc---ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH-
Confidence 99999986543221 11223457888999999998899999999999999999999 9999863211 11110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.+... .....+...+.++.+++.+||+.||++|||++|+++.|+++.++
T Consensus 219 ----~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 219 ----DISTG----------------------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ----HHHTT----------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHhcC----------------------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 00000 01111234567899999999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.77 Aligned_cols=263 Identities=24% Similarity=0.462 Sum_probs=200.6
Q ss_pred hCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++. .++..||||+++... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence 457999999999999999999986 457789999997543 334467999999999999999999999964 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 185 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD----------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV 185 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred CceEEEEeCCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCC
Confidence 78899999999999999997653 3689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++.......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 186 ~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~ 259 (373)
T 2qol_A 186 CKVSDFGLGRVLEDDPEAAY-TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDV 259 (373)
T ss_dssp EEECCC-----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHH
T ss_pred EEECcCccccccccCCccce-eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence 99999999987654322111 1122346788999999998999999999999999999998 9999863211 010
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. ..+... .....+..++.++.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 260 ~---------~~i~~~------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 260 I---------KAVDEG------------------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp H---------HHHHTT------------------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred H---------HHHHcC------------------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0 000000 011123367788999999999999999999999999999997653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=356.37 Aligned_cols=284 Identities=31% Similarity=0.458 Sum_probs=222.9
Q ss_pred hccccCHHHHHHhhCCCCCC------ceeccccceeEEEEEECCCCeEEEEEEeecc----ccchhHHHHHHHHHHHhcC
Q 001974 649 ALQKVSYESLFKATDGFSST------HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ----RHGASKSFLAECKALKNIR 718 (988)
Q Consensus 649 ~~~~~~~~~l~~~~~~y~~~------~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~ 718 (988)
....+++.++..++++|... +.||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999988877 8999999999999987 6889999998643 2234567899999999999
Q ss_pred CCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 001974 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQE 798 (988)
Q Consensus 719 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 798 (988)
||||+++++++. .++..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.
T Consensus 89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~--- 152 (307)
T 2nru_A 89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDG--------TPPLSWHMRCKIAQGAANGINFLHEN--- 152 (307)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGG--------CCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhcC---
Confidence 999999999954 34788999999999999999864321 13589999999999999999999998
Q ss_pred CeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh
Q 001974 799 PVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878 (988)
Q Consensus 799 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 878 (988)
+|+||||||+||++++++.+||+|||+++....... ........||+.|+|||.+.+ .++.++||||||+++|+|++
T Consensus 153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~ 229 (307)
T 2nru_A 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT 229 (307)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence 999999999999999999999999999986544322 112233468999999998765 58899999999999999999
Q ss_pred CCCCCCccccCCcchHHHHHHHHhh--hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCC
Q 001974 879 GKKPTDVMFEGDLNLHNYARTALLD--HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956 (988)
Q Consensus 879 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 956 (988)
|+.||....... ....+....... .+.+.+++.+. .....++..+.+++.+||+.||+
T Consensus 230 g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 230 GLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMN-------------------DADSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp CCCSBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCS-------------------CCCHHHHHHHHHHHHHHTCSSTT
T ss_pred CCCCcccCcchH-HHHHHHHHhhhhhhhhhhhcccccc-------------------ccchHHHHHHHHHHHHHcCCCcc
Confidence 999987543322 122221111111 12222222221 11234667899999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 001974 957 DRMSITNVVHELQSVKN 973 (988)
Q Consensus 957 ~RPs~~evl~~L~~i~~ 973 (988)
+|||++|+++.|+++.+
T Consensus 290 ~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 290 KRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TSCCHHHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHHHHhc
Confidence 99999999999998854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.26 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. .++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 4689999999999999999999999999999999864432 23466889999999999999999999954 45788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl 146 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI 146 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT-----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEcCCCCcHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEE
Confidence 99999999999999997553 689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........+..+..
T Consensus 147 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~- 223 (323)
T 3tki_A 147 SDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE- 223 (323)
T ss_dssp CCCTTCEECEETTE--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-
T ss_pred EEeeccceeccCCc--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-
Confidence 99999986543221 111223569999999999988775 77899999999999999999999743222111111100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... .......++.++.+++.+||+.||++|||++|+++.
T Consensus 224 -----------~~~------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 -----------KKT------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----------TCT------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----------ccc------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 000112466778999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=381.00 Aligned_cols=264 Identities=19% Similarity=0.212 Sum_probs=209.3
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
+.++....++|++.++||+|+||+||+|+++.+++.||+|+++... ......+.+|+.++..++||||+++++++.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~- 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ- 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence 4455566789999999999999999999999899999999996422 222345889999999999999999999854
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
+++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +||||||||+|||
T Consensus 145 ----~~~~~~lV~Ey~~gg~L~~~l~~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NIL 207 (437)
T 4aw2_A 145 ----DDNNLYLVMDYYVGGDLLTLLSKFE----------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNIL 207 (437)
T ss_dssp ----CSSEEEEEECCCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred ----eCCEEEEEEecCCCCcHHHHHHHcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHee
Confidence 4588999999999999999997643 3689999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
++.++.+||+|||+|+........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCE---ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EcCCCCEEEcchhhhhhcccCCCc---ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999765443221 122356999999999986 567899999999999999999999998632
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNV 964 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ev 964 (988)
. ............ .. ...+.....+++++.+++.+|+..+|++ ||+++|+
T Consensus 285 ~-----~~~~~~~i~~~~-~~----------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei 336 (437)
T 4aw2_A 285 S-----LVETYGKIMNHK-ER----------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF 336 (437)
T ss_dssp S-----HHHHHHHHHTHH-HH----------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred C-----hhHHHHhhhhcc-cc----------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence 1 111111110000 00 0000111246788999999999999988 9999998
Q ss_pred HHH
Q 001974 965 VHE 967 (988)
Q Consensus 965 l~~ 967 (988)
++.
T Consensus 337 l~H 339 (437)
T 4aw2_A 337 KKH 339 (437)
T ss_dssp HTS
T ss_pred hCC
Confidence 763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=371.89 Aligned_cols=283 Identities=22% Similarity=0.316 Sum_probs=219.2
Q ss_pred cCHHHHHHhhCCCCCCceeccccceeEEEEE-----ECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEE
Q 001974 653 VSYESLFKATDGFSSTHLIGMGSFGSVYKGA-----FDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKV 725 (988)
Q Consensus 653 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 725 (988)
+...++....++|++.+.||+|+||.||+|+ ...+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3455566677899999999999999999999 455678999999975432 3346799999999999 89999999
Q ss_pred EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCch----------------------------------------
Q 001974 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD---------------------------------------- 765 (988)
Q Consensus 726 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------- 765 (988)
++++.. .+...++||||+++|+|.+++.........
T Consensus 92 ~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 999754 235689999999999999999765421000
Q ss_pred ---------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeeccccccc
Q 001974 766 ---------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQ 830 (988)
Q Consensus 766 ---------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 830 (988)
.......+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 000012389999999999999999999999 99999999999999999999999999998654
Q ss_pred ccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhhhhhhhh
Q 001974 831 EVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLDHVIDIV 909 (988)
Q Consensus 831 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (988)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ........
T Consensus 245 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~------ 311 (359)
T 3vhe_A 245 KDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKE------ 311 (359)
T ss_dssp SCTTC--EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHH------
T ss_pred ccccc--hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHc------
Confidence 43221 12233568899999999999999999999999999999998 999986432110 00000000
Q ss_pred ccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 910 DPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 910 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
......+..+++++.+++.+||+.||++|||++|+++.|+++.++.
T Consensus 312 --------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 312 --------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0011122346778999999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=360.56 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=206.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence 467999999999999999999999899999999986432 233467899999999999999999999954 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... .++++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH-----------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred eEEEEEeCCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 899999999999999998643 2689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .....
T Consensus 151 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~ 222 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLT---QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAI 222 (294)
T ss_dssp EECCCSSSTTC----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHH
T ss_pred EEEeCCCcccccccccc---ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence 99999999865443211 12234689999999999999999999999999999999999999864211 11111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-CHHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-SITNVVHELQSVKN 973 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 973 (988)
........ .........+|+.+.+++.+||+.||++|| +++++.+.|+++..
T Consensus 223 ~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 223 KHIQDSVP-----------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSSCCC-----------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred HHhhccCC-----------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 11111000 000112235778899999999999999998 89999998887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=366.55 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++. ..+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 357999999999999999999999999999999986432 334567889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV-----------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEecCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCE
Confidence 8999999999999999997643 689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 155 kL~DFG~a~~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~ 227 (384)
T 4fr4_A 155 HITDFNIAAMLPRETQ-----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKE 227 (384)
T ss_dssp EECCCTTCEECCTTCC-----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHH
T ss_pred EEeccceeeeccCCCc-----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHH
Confidence 9999999986544322 223569999999999874 45899999999999999999999998632211 1111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-HHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-ITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 966 (988)
.... +.......+..++.++.+++.+||+.||++||+ ++++.+
T Consensus 228 ~~~~----------------------------~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 228 IVHT----------------------------FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHH----------------------------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHH----------------------------HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1100 011111223456778999999999999999998 666654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=362.29 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=204.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc------hhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG------ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
++|++.+.||+|+||.||+|++..+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 4689999999999999999999989999999999754321 3467999999999999999999999954 4
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+...++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKE-----------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSS-----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC-----------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 578999999999999999997543 689999999999999999999998 999999999999999887
Q ss_pred ----cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 817 ----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 817 ----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---- 222 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---- 222 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSCC-----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----
T ss_pred CCCCCEEEEECCCCeECCCCCcc-----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----
Confidence 8999999999876443221 234599999999999999999999999999999999999999863211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... +.. ....... .....++..+.+++.+||+.||++|||++|+++
T Consensus 223 -~~~~~~-----~~~---~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 -QETLAN-----VSA---VNYEFED----------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HHHHHH-----HHH---TCCCCCH----------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHHHHH-----HHh---cCCCcCc----------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011000 000 0000000 011245677899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=357.30 Aligned_cols=271 Identities=17% Similarity=0.180 Sum_probs=215.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++ +|+|++++++++. .+...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence 467999999999999999999998899999999986432 335688999999999 8999999999854 45788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc---
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI--- 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 817 (988)
++||||+ +++|.+++.... .++++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEEec-CCCHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCC
Confidence 9999999 999999997543 3689999999999999999999998 9999999999999987776
Q ss_pred --EEEeeecccccccccccccc---eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 818 --AHVGDFGLARVRQEVSNLTQ---SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 818 --~kL~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 225 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-- 225 (298)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--
T ss_pred CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--
Confidence 99999999987654322111 11234569999999999999999999999999999999999999997532221
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
....... +.... ...........+++++.+++.+||+.||++|||+++|++.|+++.
T Consensus 226 ~~~~~~~-~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 226 NKQKYER-IGEKK----------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHHH-HHHHH----------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHHH-HHhhc----------------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1111100 00000 000000112256788999999999999999999999999999998
Q ss_pred HHhhhh
Q 001974 973 NALLEA 978 (988)
Q Consensus 973 ~~~~~~ 978 (988)
++....
T Consensus 283 ~~~~~~ 288 (298)
T 1csn_A 283 ERLNTT 288 (298)
T ss_dssp HHTTCC
T ss_pred HhcCCC
Confidence 876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.22 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=203.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++. .++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 46799999999999999999999999999999998643 2233467899999999999999999999964 447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+ +|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK-----------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCE
T ss_pred EEEEEEECC-CCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCE
Confidence 899999999 78999888543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||++......... ....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+......
T Consensus 148 kl~DFG~s~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------- 215 (336)
T 3h4j_B 148 KIADFGLSNIMTDGNFL-----KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------- 215 (336)
T ss_dssp EECCSSCTBTTTTSBTT-----CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------
T ss_pred EEEEeccceeccCCccc-----ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------
Confidence 99999999865543222 23459999999999988776 689999999999999999999987421110
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... ......+..+++++.+++.+||+.||++|||++|+++.
T Consensus 216 ----------~~~~i~----------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 216 ----------LFKKVN----------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----------CBCCCC----------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----------HHHHHH----------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000000 00011223467789999999999999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=371.62 Aligned_cols=368 Identities=18% Similarity=0.194 Sum_probs=289.1
Q ss_pred CCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCc
Q 001974 42 KGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121 (988)
Q Consensus 42 ~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~ 121 (988)
.+..+..+.+++.+++|++|+|++|+|++. | .|..+++|++|+|++|++++ +| ++.+++|++|+|++|+|++. +
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~ 101 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D 101 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e
Confidence 344556667888899999999999999964 5 68899999999999999995 44 88899999999999999864 3
Q ss_pred ccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccC
Q 001974 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201 (988)
Q Consensus 122 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 201 (988)
|.++++|++|++++|++++ ++ ++.+++|++|++++|++++. .++++++|++|++++|+..+.+ .+..+++
T Consensus 102 --~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~ 171 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQ 171 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTT
T ss_pred --cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCc
Confidence 8889999999999999986 44 88999999999999999864 3888999999999999554444 4788899
Q ss_pred ccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecc
Q 001974 202 LANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVA 281 (988)
Q Consensus 202 L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~ 281 (988)
|++|++++|+++ .+| +..+++|+.|++++|++++. .+..+++|+.|++++|+++++ | +..+++|+.|+++
T Consensus 172 L~~L~ls~n~l~-~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~ 241 (457)
T 3bz5_A 172 LTTLDCSFNKIT-ELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCS 241 (457)
T ss_dssp CCEEECCSSCCC-CCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECC
T ss_pred CCEEECCCCccc-eec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEee
Confidence 999999999998 566 45788899999999998865 478888899999999988874 3 7788888999999
Q ss_pred cccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeC
Q 001974 282 YNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGG 361 (988)
Q Consensus 282 ~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 361 (988)
+|++++.+. ..+++|+.|++++|+ |+.|++++|.+.+.+| +..+++|+.|++++
T Consensus 242 ~N~l~~~~~---------~~l~~L~~L~l~~n~---------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~ 295 (457)
T 3bz5_A 242 VNPLTELDV---------STLSKLTTLHCIQTD---------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTH 295 (457)
T ss_dssp SSCCSCCCC---------TTCTTCCEEECTTCC---------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTT
T ss_pred CCcCCCcCH---------HHCCCCCEEeccCCC---------------CCEEECCCCccCCccc--ccccccCCEEECCC
Confidence 888887542 356778888877764 4567788888776666 46778888888888
Q ss_pred ccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCc
Q 001974 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIP 441 (988)
Q Consensus 362 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 441 (988)
|.+.+.+|. ...+|+.|++++| ++|++|+|++|++++. + ++.+++|+.|++++|++++ +
T Consensus 296 n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l- 354 (457)
T 3bz5_A 296 NTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-F- 354 (457)
T ss_dssp CTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-C-
T ss_pred Ccccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-c-
Confidence 887766664 3355666655554 6788888888888874 3 8888888888888888874 3
Q ss_pred hhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccc
Q 001974 442 EEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLG 494 (988)
Q Consensus 442 ~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 494 (988)
+.+ ..|++++|.++|. +.+..|..+++++|+++|.+|..+.
T Consensus 355 ------~~L-~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 355 ------SSV-GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp ------TTG-GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred ------ccc-ccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 334 5677888888765 3556677788888888888876654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.16 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=209.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++. +++.||+|+++.... ..+.+.+|++++++++||||+++++++. .++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPI 78 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCce
Confidence 3567999999999999999999886 678899999975433 3467999999999999999999999954 45788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l 145 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG----------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV 145 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEE
T ss_pred EEEEEccCCCcHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEE
Confidence 99999999999999986432 3689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ ....+..+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....
T Consensus 146 ~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~ 217 (268)
T 3sxs_A 146 SDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLK 217 (268)
T ss_dssp CCTTCEEECCTTCE---EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred ccCccceecchhhh---hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHH
Confidence 99999986544322 12233456788999999998899999999999999999999 99998632111 11000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+.. ......+..+++++.+++.+||+.||++|||++|+++.|++++++
T Consensus 218 -----~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 218 -----VSQ----------------------GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----HHT----------------------TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----HHc----------------------CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 000 000111224567899999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=368.83 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=201.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.++||+|+||+||+|+++.+++.||+|+++... ....+.+..|..++.++ +||||+++++++ ..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 3467999999999999999999999999999999997542 23345688999999887 899999999985 44
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +||||||||+|||++.++
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g 190 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEG 190 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CCEEEEEEEcCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCC
Confidence 58899999999999999988643 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc---ch
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL---NL 893 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~---~~ 893 (988)
.+||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ..
T Consensus 191 ~ikL~DFGla~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 191 HIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp CEEECCCTTCBCCCCTTC----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred CEEEeecceeeecccCCC----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence 999999999985322211 12335699999999999999999999999999999999999999964321110 00
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
.... .+.+.......+..++.++.+++.+||+.||++||++
T Consensus 267 ~~~~---------------------------~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 267 EDYL---------------------------FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHH---------------------------HHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHH---------------------------HHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000 0111111222334567889999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.66 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=200.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+..|..+++.+ +||||+++++++ ..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 457899999999999999999999999999999999743 223446788999999988 799999999995 44
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g 161 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKS-----------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG 161 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCC
Confidence 57899999999999999998643 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...
T Consensus 162 ~ikL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~ 232 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGV----TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDL 232 (353)
T ss_dssp CEEECCCTTCBCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred CEEEccccceeecccCCc----cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHH
Confidence 999999999975332211 12235699999999999988899999999999999999999999863211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH------HHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI------TNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 966 (988)
.... .......+...+.++.+++.+||+.||++||++ +|+++
T Consensus 233 ~~~i----------------------------~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 233 FEAI----------------------------LNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHH----------------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHH----------------------------HcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1110 011112233466789999999999999999998 66664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=365.32 Aligned_cols=261 Identities=23% Similarity=0.413 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeE----EEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTI----VAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|++.+.||+|+||+||+|++..+++. ||+|.++.. .....+.+.+|+.++++++||||++++++|..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence 35689999999999999999999777765 577777533 23445789999999999999999999999753
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+..++|+||+++|+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+||+++.++
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~ 154 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHST----------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred -CCeEEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCC
Confidence 34789999999999999997543 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+|+........ .......+|..|+|||++.+..++.++|||||||++|||+| |+.||...... ....
T Consensus 155 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~ 230 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS 230 (327)
T ss_dssp EEEECCTTHHHHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH
T ss_pred CEEEccCcceeEccCCccc--ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHH
Confidence 9999999999876543321 11223457889999999999999999999999999999999 99998743211 1100
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.+.. ......+..++.++.+++.+||+.||++|||++|+++.|+++....
T Consensus 231 ------------~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 231 ------------ILEK------------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ------------HHHT------------------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ------------HHHc------------------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 0000 0011223356778999999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=367.82 Aligned_cols=253 Identities=19% Similarity=0.252 Sum_probs=206.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+|++++++++||||+++++++. +++..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 467999999999999999999999999999999997655555568899999999999999999999954 458899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC--CCcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN--DMIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~k 819 (988)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 125 lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vk 191 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVK 191 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEE
T ss_pred EEEEcCCCCcHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceE
Confidence 9999999999999997653 2689999999999999999999998 9999999999999974 57899
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 192 L~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~ 261 (387)
T 1kob_A 192 IIDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQN 261 (387)
T ss_dssp ECCCTTCEECCTTSCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH
T ss_pred EEecccceecCCCcce-----eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9999999876543221 123589999999999999999999999999999999999999863211 111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.. ....... .....+++++.+++.+||+.||++|||++|+++
T Consensus 262 -----i~~---~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 262 -----VKR---CDWEFDE----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -----HHH---CCCCCCS----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----HHh---CCCCCCc----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 0000000 111246778999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=357.04 Aligned_cols=262 Identities=25% Similarity=0.422 Sum_probs=210.1
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+....++|++.+.||+|+||.||+|.+. +++.||+|+++.... ..+++.+|++++++++||||+++++++. .+
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 91 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQ 91 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cC
Confidence 3445678999999999999999999986 788899999975433 3477999999999999999999999954 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~ 158 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGV 158 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG----------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSC
T ss_pred CCeEEEEeccCCCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCC
Confidence 78999999999999999997533 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||...... ..
T Consensus 159 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~ 230 (283)
T 3gen_A 159 VKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ET 230 (283)
T ss_dssp EEECSTTGGGGBCCHHH---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH
T ss_pred EEEcccccccccccccc---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HH
Confidence 99999999986543221 11223457788999999998899999999999999999998 99998642111 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
. ..+.... ....+..+++.+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 231 ~-----~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 231 A-----EHIAQGL----------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp H-----HHHHTTC----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-----HHHhccc----------------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0 0011000 0111234567899999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=354.72 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=203.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch-------hHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-------SKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||+||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 467999999999999999999999899999999986433221 1678999999999999999999999643
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeee
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLL 812 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll 812 (988)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. + |+||||||+||++
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~ 157 (287)
T 4f0f_A 95 ----PPRMVMEFVPCGDLYHRLLDKA----------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFL 157 (287)
T ss_dssp ----TTEEEEECCTTCBHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEE
T ss_pred ----CCeEEEEecCCCCHHHHHhccc----------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEE
Confidence 2369999999999998886544 3689999999999999999999998 8 9999999999999
Q ss_pred CCCCc-----EEEeeecccccccccccccceeccccccccccccCcccC--CCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 813 DNDMI-----AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL--GSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 813 ~~~~~-----~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+.++. +||+|||+++..... .....||+.|+|||++. ...++.++||||+||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 158 QSLDENAPVCAKVADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp SCCCTTCSCCEEECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eccCCCCceeEEeCCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 88776 999999999754321 12346899999999984 45678999999999999999999999874
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
....+.. ........ ......+..+++++.+++.+||+.||++|||++|++
T Consensus 231 ~~~~~~~---~~~~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 281 (287)
T 4f0f_A 231 YSYGKIK---FINMIREE--------------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281 (287)
T ss_dssp CCCCHHH---HHHHHHHS--------------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccHHH---HHHHHhcc--------------------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 3222110 01000000 001112335778899999999999999999999999
Q ss_pred HHHHHH
Q 001974 966 HELQSV 971 (988)
Q Consensus 966 ~~L~~i 971 (988)
+.|+++
T Consensus 282 ~~L~~l 287 (287)
T 4f0f_A 282 KELSEL 287 (287)
T ss_dssp HHHHTC
T ss_pred HHHHhC
Confidence 999763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=358.17 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=203.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|+...+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++. +.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 467999999999999999999999999999999997432 234467889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ-----------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS-----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred EEEEEEeCCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCE
Confidence 8999999999999999996542 689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ......
T Consensus 146 kL~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~ 213 (318)
T 1fot_A 146 KITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----TMKTYE 213 (318)
T ss_dssp EECCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHH
T ss_pred EEeecCcceecCCc-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 99999999865432 123469999999999999999999999999999999999999986321 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
... ......+...+.++.+++.+||+.||++|| +++|+++
T Consensus 214 ~i~----------------------------~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 214 KIL----------------------------NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHH----------------------------HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHH----------------------------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 000 001112234667899999999999999999 8888874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=377.23 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=208.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|.+ .++.||||+++... ..+.+.+|++++++++||||+++++++.. .+...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCce
Confidence 456788999999999999999998 57899999997543 45789999999999999999999999653 23578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl 330 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGR---------SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 330 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCT---------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCCcHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEE
Confidence 999999999999999975431 2478999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++...... ....++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ....
T Consensus 331 ~DfG~a~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~--- 398 (450)
T 1k9a_A 331 SDFGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR--- 398 (450)
T ss_dssp CCCTTCEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHH---
T ss_pred eeCCCcccccccc-------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---
Confidence 9999998543211 11247889999999999999999999999999999999 999987432211 1000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+.. ......+..+++++.++|.+||+.||++|||++|+++.|+++.+.
T Consensus 399 -----i~~----------------------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 399 -----VEK----------------------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----HHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHc----------------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 000 001122346788999999999999999999999999999999765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.60 Aligned_cols=268 Identities=19% Similarity=0.210 Sum_probs=212.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++++ +||||+++++++. .++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence 467999999999999999999998899999999986543 235688999999999 9999999999854 34788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc---
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI--- 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--- 817 (988)
++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~ 146 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD----------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQ 146 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCT
T ss_pred EEEEEeC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCC
Confidence 9999999 999999987542 3689999999999999999999999 9999999999999998887
Q ss_pred --EEEeeecccccccccccccc---eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 818 --AHVGDFGLARVRQEVSNLTQ---SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 818 --~kL~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~ 224 (330)
T 2izr_A 147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--T 224 (330)
T ss_dssp TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--S
T ss_pred ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--c
Confidence 99999999986544322111 1123457999999999999999999999999999999999999999753222 1
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.............. .........+| ++.+++.+||+.||.+||++++|.+.|+++.
T Consensus 225 ~~~~~~~i~~~~~~-----------------------~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 225 LKERYQKIGDTKRA-----------------------TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHHHHHHHHHHH-----------------------SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhhcc-----------------------CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 11111110000000 00000011345 8999999999999999999999999999988
Q ss_pred HHhh
Q 001974 973 NALL 976 (988)
Q Consensus 973 ~~~~ 976 (988)
++..
T Consensus 281 ~~~~ 284 (330)
T 2izr_A 281 DRKG 284 (330)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 7653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.20 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=198.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------------------------chhHHHHHHHHHHH
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------------------------GASKSFLAECKALK 715 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 715 (988)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999998999999999864321 12356889999999
Q ss_pred hcCCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC
Q 001974 716 NIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH 795 (988)
Q Consensus 716 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 795 (988)
+++||||+++++++... .++..++||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL------------KPLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS------------SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999997532 34778999999999999887543 2589999999999999999999999
Q ss_pred CCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCC---CCCccchHHHHHH
Q 001974 796 CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE---VSTNGDIYSYGIL 872 (988)
Q Consensus 796 ~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~v 872 (988)
+|+||||||+||+++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||+
T Consensus 157 ---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~ 229 (298)
T 2zv2_A 157 ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229 (298)
T ss_dssp ---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred ---CeeccCCCHHHEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence 9999999999999999999999999999865443211 22346999999999988765 4778999999999
Q ss_pred HHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccC
Q 001974 873 LLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952 (988)
Q Consensus 873 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 952 (988)
+|||++|+.||... ........ +... .. .......+++++.+++.+||+
T Consensus 230 l~~l~~g~~pf~~~-----~~~~~~~~-~~~~-------~~------------------~~~~~~~~~~~l~~li~~~l~ 278 (298)
T 2zv2_A 230 LYCFVFGQCPFMDE-----RIMCLHSK-IKSQ-------AL------------------EFPDQPDIAEDLKDLITRMLD 278 (298)
T ss_dssp HHHHHHSSCSSCCS-----SHHHHHHH-HHHC-------CC------------------CCCSSSCCCHHHHHHHHHHTC
T ss_pred HHHHHHCCCCCCCc-----cHHHHHHH-Hhcc-------cC------------------CCCCccccCHHHHHHHHHHhh
Confidence 99999999998632 11111100 0000 00 001123567889999999999
Q ss_pred cCCCCCCCHHHHHH
Q 001974 953 ESPQDRMSITNVVH 966 (988)
Q Consensus 953 ~dP~~RPs~~evl~ 966 (988)
.||++|||++|+++
T Consensus 279 ~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 279 KNPESRIVVPEIKL 292 (298)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=365.66 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=204.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++. +++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 4579999999999999999999999999999999975432 33467889999999999999999999954 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC---
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM--- 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 816 (988)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE-----------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred EEEEEecCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 899999999999999987543 589999999999999999999999 999999999999998654
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 169 ~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~~~ 238 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRL 238 (362)
T ss_dssp CEEECCCTTCBCCTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred CEEEeecCcceEecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HHHH
Confidence 599999999986654322 123469999999999999999999999999999999999999986321 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... +.. ......... ...+++++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~-----i~~---~~~~~~~~~----------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 239 YAQ-----IKA---GAYDYPSPE----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHH-----HHH---TCCCCCTTG----------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHH-----HHh---CCCCCCccc----------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 000 000000011 12467789999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=369.60 Aligned_cols=268 Identities=23% Similarity=0.382 Sum_probs=209.0
Q ss_pred hCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.. .......+.+|+.++++++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 35688999999999999999994 446789999998643 2334457889999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.+...++||||+++|+|.+++........ ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPS----QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 217 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSS----SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccC----ccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecC
Confidence 34778999999999999999975432110 013589999999999999999999999 99999999999999955
Q ss_pred C---cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 816 M---IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 816 ~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--- 292 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--- 292 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred CCCceEEECCCccccccccccccc--cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 5 59999999998654322211 1122457899999999998999999999999999999998 9999863211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
...... +.. ......+..++.++.+++.+||+.||++|||++|+++.|+.+
T Consensus 293 --~~~~~~-----i~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 293 --QEVLEF-----VTS----------------------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --HHHHHH-----HHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHH-----HHc----------------------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111100 000 001112335778899999999999999999999999999998
Q ss_pred HHHh
Q 001974 972 KNAL 975 (988)
Q Consensus 972 ~~~~ 975 (988)
.+..
T Consensus 344 ~~~~ 347 (367)
T 3l9p_A 344 TQDP 347 (367)
T ss_dssp HHCH
T ss_pred hhCh
Confidence 7653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.38 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=203.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeeccccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 735 (988)
...++|++.+.||+|+||.||+|+++.+|+.||+|+++... ....+.+..|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----- 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----- 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----
Confidence 45678999999999999999999999999999999997432 23446788899999887 9999999999854
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..++||||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSC-----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD 154 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCC
Confidence 457899999999999999998643 3689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...
T Consensus 155 g~vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~ 225 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEE 225 (345)
T ss_dssp SCEEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH
T ss_pred CCEEEeEChhhhhcccCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-----HHH
Confidence 9999999999975432211 1223569999999999999999999999999999999999999986321 111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH-HHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT-NVV 965 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 965 (988)
.... +. ......+..++.++.+++.+||+.||++||++. |++
T Consensus 226 ~~~~-----i~-----------------------~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 226 LFHS-----IR-----------------------MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHH-----HH-----------------------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHH-----HH-----------------------hCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1100 00 001112234667899999999999999999997 664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=353.55 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=200.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||.||+|.+..+ +..||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence 356789999999999999999998543 4579999986433 234467899999999999999999999853
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 153 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 153 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred cCccEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCC
Confidence 256799999999999999996543 2589999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~ 228 (281)
T 1mp8_A 154 CVKLGDFGLSRYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG 228 (281)
T ss_dssp EEEECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH
T ss_pred CEEECccccccccCcccccc---cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHH
Confidence 99999999998764432211 122346789999999988899999999999999999997 999987432211 000
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. +. . ......+..+++++.+++.+||+.||++|||++|+++.|+++.++.
T Consensus 229 ~--------i~---~-------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 R--------IE---N-------------------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp H--------HH---T-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H--------HH---c-------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 00 0 0001123357788999999999999999999999999999997754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=363.70 Aligned_cols=282 Identities=22% Similarity=0.312 Sum_probs=215.5
Q ss_pred hCCCCCCceeccccceeEEEEEE----CCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence 36799999999999999999994 56889999999987666666789999999999999999999998653 245
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~ 165 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR----------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 165 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ceEEEEEeecCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCC
Confidence 67899999999999999986432 3689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++........ ........||..|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 166 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~ 238 (327)
T 3lxl_A 166 VKIADFGLAKLLPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FL 238 (327)
T ss_dssp EEECCGGGCEECCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HH
T ss_pred EEEcccccceecccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hh
Confidence 999999999876543321 11222345888899999999888999999999999999999999997632110 00
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
..... ..+...................+..+++++.+++.+||+.||++|||++|+++.|+.+......
T Consensus 239 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 239 RMMGC-----------ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHCC---------------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hhccc-----------ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 00000 0000000000011111112233456788999999999999999999999999999998765544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=368.44 Aligned_cols=365 Identities=19% Similarity=0.167 Sum_probs=235.2
Q ss_pred cccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCC
Q 001974 67 SIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPP 146 (988)
Q Consensus 67 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (988)
.+.+..+..++.+++|++|+|++|.+++ +| .|+.+++|++|+|++|+|++. | +..+++|++|++++|++++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred CcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-
Confidence 3343445566777777777777777774 34 577777777777777777753 3 66777777777777777643 2
Q ss_pred cccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCC
Q 001974 147 FIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPH 226 (988)
Q Consensus 147 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~ 226 (988)
|+++++|++|++++|++++. + ++.+++|++|++++|+++++ .+..+++|++|++++|+..+.+
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~---------- 164 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL---------- 164 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC----------
T ss_pred -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc----------
Confidence 66677777777777776642 2 66666666666666666643 2455555555555555332222
Q ss_pred CcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCc
Q 001974 227 LRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLR 306 (988)
Q Consensus 227 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 306 (988)
.+..+++|+.|++++|++++. + +..+++|+.|++++|.++.+. +..++
T Consensus 165 -----------------~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~---------l~~l~--- 212 (457)
T 3bz5_A 165 -----------------DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD---------LNQNI--- 212 (457)
T ss_dssp -----------------CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC---------CTTCT---
T ss_pred -----------------ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec---------cccCC---
Confidence 123334444444444444432 1 344444555555555444321 22233
Q ss_pred EEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccc
Q 001974 307 TLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDN 386 (988)
Q Consensus 307 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 386 (988)
+|+.|++++|++++ +| +..+++|+.|++++|++++.. +..+++|+.|++++|
T Consensus 213 ----------------------~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 213 ----------------------QLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp ----------------------TCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC
T ss_pred ----------------------CCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC
Confidence 35555555555553 33 566667777777777777532 445667777777665
Q ss_pred cCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCc
Q 001974 387 QLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP 466 (988)
Q Consensus 387 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p 466 (988)
+ |+.|++++|.+.+.+| ++.+++|+.|++++|.+.|.+|.. ...+ +.|++++|
T Consensus 265 ~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L-~~L~l~~~------- 317 (457)
T 3bz5_A 265 D--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGI-TELDLSQN------- 317 (457)
T ss_dssp C--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCC-SCCCCTTC-------
T ss_pred C--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcc-eEechhhc-------
Confidence 3 4567777887777666 567788888888888887777753 3444 55666555
Q ss_pred cccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCC
Q 001974 467 TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSL 546 (988)
Q Consensus 467 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L 546 (988)
++|+.|++++|+|++ ++ ++.+++|+.|++++|+|++ ++.|..|++++|+++|. + .+..|
T Consensus 318 ------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~---~~~~l 376 (457)
T 3bz5_A 318 ------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G---QTITM 376 (457)
T ss_dssp ------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E---EEEEC
T ss_pred ------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c---eeeec
Confidence 578999999999997 43 8889999999999999886 25677788999999887 2 34467
Q ss_pred cEEeCCCCcCcccCCCC
Q 001974 547 EYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 547 ~~l~l~~N~l~~~~p~~ 563 (988)
..++|++|+++|.+|..
T Consensus 377 ~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 377 PKETLTNNSLTIAVSPD 393 (457)
T ss_dssp CCBCCBTTBEEEECCTT
T ss_pred CccccccCcEEEEcChh
Confidence 88899999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.16 Aligned_cols=273 Identities=22% Similarity=0.292 Sum_probs=212.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+++++.++|++++..++++.. .++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 4578999999999999999999998899999999875433 23468899999999998888877776533 45788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~ 817 (988)
++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTC
T ss_pred EEEEEcc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCe
Confidence 9999999 999999986433 3689999999999999999999999 99999999999999 78899
Q ss_pred EEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc--c
Q 001974 818 AHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL--N 892 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~--~ 892 (988)
+||+|||+++......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 9999999998765433211 1122345689999999999999999999999999999999999999975432211 1
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
+........ ..........+++++.+++.+||+.||++|||++++++.|+++.
T Consensus 227 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 227 YERISEKKM---------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHH---------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhcccc---------------------------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 111111000 00000111246778999999999999999999999999999998
Q ss_pred HHhhhhcc
Q 001974 973 NALLEAWN 980 (988)
Q Consensus 973 ~~~~~~~~ 980 (988)
++....+.
T Consensus 280 ~~~~~~~~ 287 (296)
T 4hgt_A 280 HRQGFSYD 287 (296)
T ss_dssp HHHTCCTT
T ss_pred HHhCCCcc
Confidence 88765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.15 Aligned_cols=285 Identities=20% Similarity=0.300 Sum_probs=213.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 457999999999999999999999899999999997433 23356788999999999999999999986532 33578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee----CCCC
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDM 816 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 816 (988)
++||||+++++|.+++...... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA--------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCE
T ss_pred EEEEeCCCCCCHHHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCc
Confidence 9999999999999999764311 2389999999999999999999999 99999999999999 7888
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccC--------CCCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL--------GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
.+||+|||+++........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 154 ~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp EEEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred eEEEccCCCceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999876543322 2245899999999875 57889999999999999999999999874332
Q ss_pred CCcchHHHHHHHHhhhhhhhhccc--cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPI--LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ................... ......+|..... .........+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 229 PRRN-KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp GGGC-HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cchh-HHHHHHHhcCCCcccchhhhcccCCccccCccCC-----cccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 2211 1222222211111100000 0001111111000 000122356778999999999999999999999999
Q ss_pred HHHHH
Q 001974 967 ELQSV 971 (988)
Q Consensus 967 ~L~~i 971 (988)
...+.
T Consensus 303 h~~d~ 307 (319)
T 4euu_A 303 ETSDI 307 (319)
T ss_dssp HHHHH
T ss_pred ccHHH
Confidence 88764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=368.51 Aligned_cols=265 Identities=24% Similarity=0.413 Sum_probs=200.5
Q ss_pred CCCCCceeccccceeEEEEEECCC---CeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.|++.+.||+|+||+||+|++..+ +..||+|.++.. .....+.+.+|+.++++++||||++++++|.. .++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCC
Confidence 466778999999999999997533 246899998643 33445789999999999999999999998643 3467
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k 232 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVK 232 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred eEEEEECCCCCCHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEE
Confidence 899999999999999997654 2578899999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++.................+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ .....
T Consensus 233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~- 309 (373)
T 3c1x_A 233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL- 309 (373)
T ss_dssp ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH-
T ss_pred EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH-
Confidence 99999998654432222222233457889999999999999999999999999999999 777776432111 11100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
.. ......+..++.++.+++.+||+.||++|||++|+++.|+++...+..
T Consensus 310 ---~~--------------------------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 310 ---LQ--------------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ---HT--------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---Hc--------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00 000112235778899999999999999999999999999999887654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.19 Aligned_cols=277 Identities=23% Similarity=0.343 Sum_probs=205.5
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc--CCCCceEEEeecccccccCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI--RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~ 737 (988)
...++|++.+.||+|+||.||+|++ .++.||||++.... ...+..|.+++... +||||+++++++... ....
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-TGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCCC
Confidence 3457899999999999999999998 58999999986432 24455566666554 999999999997543 2222
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC-----QEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll 812 (988)
...++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+.+ .++|+||||||+||++
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CceEEEEeccCCCcHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 678999999999999999853 25899999999999999999999751 3489999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCc------cchHHHHHHHHHHHhC-------
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTN------GDIYSYGILLLEMVTG------- 879 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~vl~elltg------- 879 (988)
+.++.+||+|||+++.................||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997654433222222234569999999999988766665 9999999999999999
Q ss_pred ---CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCC
Q 001974 880 ---KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956 (988)
Q Consensus 880 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 956 (988)
+.||......+..+............ .+ .... ......++.++.+++.+||+.||+
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~-------------~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKL----RP----SFPN-------------RWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CC----CCCG-------------GGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhcc----Cc----cccc-------------cchhhHHHHHHHHHHHHhhhhChh
Confidence 55555433333332222211111100 00 0000 011235778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHh
Q 001974 957 DRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 957 ~RPs~~evl~~L~~i~~~~ 975 (988)
+|||++|+++.|+++.+..
T Consensus 315 ~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHhhc
Confidence 9999999999999998753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=371.86 Aligned_cols=254 Identities=19% Similarity=0.232 Sum_probs=203.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+++++.++||||+++++++. +++.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCE
Confidence 4679999999999999999999999999999999975432 23467889999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC---CCC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD---NDM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 816 (988)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~-----------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE-----------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred EEEEEEeCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence 999999999999999886543 689999999999999999999999 999999999999998 467
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ....
T Consensus 151 ~vkL~DFG~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~~~ 221 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQA----WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QHRL 221 (444)
T ss_dssp CEEECCCSSCBCCCTTCCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH
T ss_pred cEEEccCceeEEecCCCce----eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HHHH
Confidence 8999999999865543221 223569999999999999999999999999999999999999986321 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .. ......... ...+++++.+++.+||+.||++|||++|+++.
T Consensus 222 ~~~i-~~-------~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 222 YQQI-KA-------GAYDFPSPE----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHH-HH-------TCCCCCTTT----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH-Hh-------CCCCCCccc----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 00 000000001 12467789999999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.30 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=200.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+.+|..+++++ +||||+++++++. .+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence 357899999999999999999999999999999997542 23345688999999988 8999999999954 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence 8899999999999999998643 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+... ...
T Consensus 149 ~kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~ 223 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-QNT 223 (345)
T ss_dssp EEECCGGGCBCSCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------C
T ss_pred EEEEeccccccccCCCC----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-ccc
Confidence 99999999985332211 1223569999999999999999999999999999999999999996432211000 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI 961 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 961 (988)
..... ..+.......+..++.++.+++.+||+.||++||++
T Consensus 224 ~~~~~-----------------------~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 224 EDYLF-----------------------QVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHH-----------------------HHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHH-----------------------HHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 00000 011111112234567789999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.76 Aligned_cols=282 Identities=24% Similarity=0.275 Sum_probs=204.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-----cchhHHHHHHHHHHHhcC---CCCceEEEeecccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIR---HRNLVKVITSCSSI 732 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 732 (988)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999998899999999986432 122356778888887774 99999999998654
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
........++||||+. ++|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---------PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILV 153 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence 2222336799999995 699999976542 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+.++.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~ 226 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--D 226 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTCCCS-----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--H
T ss_pred cCCCCEEEeeCccccccCCCccc-----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence 99999999999999865433221 2346899999999999999999999999999999999999998642111 0
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...........................+. ............+++.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFP----PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHCCCCTTTSCSSCSSCGGGSC----CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCChhhccchhhccccccC----CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 10001000000000000000000000000 00000001112356788999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.40 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=204.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|+++... ....+.+.+|+++++.++||||+++++++. +++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence 357999999999999999999999899999999996432 234467889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI-----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred EEEEEEcCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCE
Confidence 899999999999999998643 2689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......
T Consensus 181 kL~DFg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~ 248 (350)
T 1rdq_E 181 QVTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYE 248 (350)
T ss_dssp EECCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred EEcccccceeccCC-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----HHHHHH
Confidence 99999999865432 123468999999999999999999999999999999999999986321 111110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
. + .......+..++.++.+++.+||+.||++||+ ++|+++
T Consensus 249 ~-----i-----------------------~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 K-----I-----------------------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp H-----H-----------------------HHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred H-----H-----------------------HcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 0 00111223356778999999999999999998 788765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=356.38 Aligned_cols=265 Identities=25% Similarity=0.447 Sum_probs=216.9
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+....++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++. .+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cC
Confidence 334567899999999999999999999988999999999743 334578999999999999999999999954 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNR---------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHL 149 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCT---------TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEcCCCCcHHHHHHhccc---------CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCC
Confidence 788999999999999999965432 3589999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||.+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 150 ~~l~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~-- 222 (288)
T 3kfa_A 150 VKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY-- 222 (288)
T ss_dssp EEECCCCGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--
T ss_pred EEEccCccceeccCCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH--
Confidence 99999999986654321 12233457889999999998899999999999999999999 99998642111 000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
+.+.. ......+..+++++.+++.+||+.||++|||++|+++.|+++..+.
T Consensus 223 ----------~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 223 ----------ELLEK------------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----------HHHHT------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------HHHhc------------------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000 0011223457788999999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.42 Aligned_cols=267 Identities=24% Similarity=0.419 Sum_probs=209.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
..+|++.+.||+|+||+||+|++..+ ...||+|.+.... ....+.+.+|+.++++++||||++++++|.. .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence 35688899999999999999997533 3368999986433 3345678999999999999999999998643 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCC
T ss_pred CceEEEEeCCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCC
Confidence 67899999999999999997543 3578999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++.................+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||......+ ....
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~ 244 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY 244 (298)
T ss_dssp EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHH
T ss_pred EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHH
Confidence 9999999998765443333333344568889999999998899999999999999999999 555654321111 1000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhh
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALL 976 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 976 (988)
. . .......+..++.++.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus 245 ~----~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 245 L----L--------------------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp H----H--------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred H----h--------------------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 0 000111123467789999999999999999999999999999988654
Q ss_pred h
Q 001974 977 E 977 (988)
Q Consensus 977 ~ 977 (988)
.
T Consensus 295 ~ 295 (298)
T 3f66_A 295 G 295 (298)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=369.87 Aligned_cols=260 Identities=19% Similarity=0.249 Sum_probs=207.2
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
.++....++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 139 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-- 139 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence 44555678999999999999999999999999999999999642 1223356889999999999999999999954
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+++..++||||+++|+|.+++... .+++..++.++.||+.||+|||++ +||||||||+|||+
T Consensus 140 ---~~~~~~lV~E~~~gg~L~~~l~~~------------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl 201 (410)
T 3v8s_A 140 ---DDRYLYMVMEYMPGGDLVNLMSNY------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLL 201 (410)
T ss_dssp ---CSSEEEEEECCCTTEEHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ---ECCEEEEEEeCCCCCcHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeE
Confidence 458899999999999999998532 578999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCC----CCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE----VSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+.++.+||+|||+|+....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-- 276 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-- 276 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSE---EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred CCCCCEEEeccceeEeeccCCc---ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--
Confidence 9999999999999986544321 1122456999999999987655 789999999999999999999998632
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC--CCCHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD--RMSITNVVH 966 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 966 (988)
............. . .........++.++.+++.+||+.+|++ ||+++||++
T Consensus 277 ---~~~~~~~~i~~~~-~-----------------------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 277 ---SLVGTYSKIMNHK-N-----------------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ---SHHHHHHHHHTHH-H-----------------------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ---ChhhHHHHHHhcc-c-----------------------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111111100000 0 0000111256788999999999999999 999999986
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 330 H 330 (410)
T 3v8s_A 330 H 330 (410)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.50 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=194.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc----chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH----GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... ...+.+.+|+++++.++||||+++++++. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 46799999999999999999998 589999999864322 23467899999999999999999999964 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN--- 814 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 814 (988)
+..++||||+++++|.+++... .+++..++.++.|++.||+|||+....+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK------------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS------------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred CceEEEEEcCCCCCHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 7789999999999999998642 5889999999999999999999981112999999999999986
Q ss_pred -----CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccC
Q 001974 815 -----DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889 (988)
Q Consensus 815 -----~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~ 889 (988)
++.+||+|||.++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTK------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp SSCCSSCCEEECCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred cccccCcceEEccCCcccccccccc------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 77899999999986543221 1245899999999999889999999999999999999999998642110
Q ss_pred CcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHH
Q 001974 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969 (988)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 969 (988)
........ .. .....+..+++++.+++.+||+.||++|||++|+++.|+
T Consensus 221 -----~~~~~~~~--------~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 221 -----AVAYGVAM--------NK------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp -----HHHHHHHT--------SC------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHhhhc--------CC------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 00000000 00 001122356788999999999999999999999999998
Q ss_pred HH
Q 001974 970 SV 971 (988)
Q Consensus 970 ~i 971 (988)
++
T Consensus 270 ~l 271 (271)
T 3dtc_A 270 TI 271 (271)
T ss_dssp C-
T ss_pred cC
Confidence 64
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.37 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=203.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++. +..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcE
Confidence 35688999999999999999998 5789999998633 34578999999999999999999999854 3478
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc-EEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI-AHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL 820 (988)
+||||+++|+|.+++...... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPL--------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSE--------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred EEEEcCCCCCHHHHHhccCCC--------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 999999999999999764320 24788899999999999999999932239999999999999998886 799
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......
T Consensus 148 ~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~- 216 (307)
T 2eva_A 148 CDFGTACDIQTHM-------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWA- 216 (307)
T ss_dssp CCCCC-------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHHHHH-
T ss_pred ccccccccccccc-------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHHHHH-
Confidence 9999997543321 12358999999999999999999999999999999999999987432111 000000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
... .........++..+.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 217 ----~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 217 ----VHN----------------------GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----HHT----------------------TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----Hhc----------------------CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 000 000112235678899999999999999999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=371.78 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=204.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+++.++||||+++++++. .++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 467999999999999999999999899999999996432 233467899999999999999999999954 347
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG-----------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS-----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCe
Confidence 8999999999999999997543 689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||++........ .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... .....
T Consensus 156 kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~~~~ 225 (476)
T 2y94_A 156 KIADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VPTLF 225 (476)
T ss_dssp EECCCSSCEECCTTCC-----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SHHHH
T ss_pred EEEeccchhhcccccc-----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HHHHH
Confidence 9999999987644322 123459999999999988766 689999999999999999999986321 11111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. +. + .....+..+++++.+++.+||+.||++|||++|+++
T Consensus 226 ~~-----i~---~--------------------~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 KK-----IC---D--------------------GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HH-----HH---T--------------------TCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH-----Hh---c--------------------CCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 10 00 0 001112346678999999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.11 Aligned_cols=277 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|++++++++||||+++++++. .++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence 478999999999999999999996 69999999986432 233467889999999999999999999954 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENK----------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEcCCC-CCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEE
Confidence 999999996 58888876543 3589999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ......
T Consensus 160 l~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~ 233 (311)
T 3niz_A 160 LADFGLARAFGIPVRS----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIF 233 (311)
T ss_dssp ECCCTTCEETTSCCC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHH
T ss_pred EccCcCceecCCCccc----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH
Confidence 9999999865432211 123458999999999876 568999999999999999999999997533221 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHH-HhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQR-LRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
............. ......|....... ...........+++++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 234 SILGTPNPREWPQ--VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHCCCCTTTSGG--GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHCCCChHHhhh--hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111100000000 00000000000000 000000112345678899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=350.81 Aligned_cols=270 Identities=22% Similarity=0.289 Sum_probs=214.1
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++.++|++++..+.++.. .++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCce
Confidence 3578999999999999999999998899999999986543 23578999999999999887777766533 35778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~ 817 (988)
++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~ 146 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTC
T ss_pred EEEEEec-CCCHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCe
Confidence 9999999 999999986433 3689999999999999999999999 99999999999999 48889
Q ss_pred EEEeeecccccccccccccc---eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc-c-
Q 001974 818 AHVGDFGLARVRQEVSNLTQ---SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL-N- 892 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~- 892 (988)
+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 99999999987654332111 112345699999999999999999999999999999999999999975332211 1
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
+........ ..........+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 227 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 227 YERISEKKM---------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHH---------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhccccc---------------------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 111111000 00000112356788999999999999999999999999999998
Q ss_pred HHhhh
Q 001974 973 NALLE 977 (988)
Q Consensus 973 ~~~~~ 977 (988)
++...
T Consensus 280 ~~~~~ 284 (296)
T 3uzp_A 280 HRQGF 284 (296)
T ss_dssp HHTTC
T ss_pred HhcCC
Confidence 77544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.43 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=200.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 579999999999999999999999999999999974432 33467889999999999999999999964 44789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++ ++.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl 142 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN----------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEecCCC-CHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 999999965 6655554322 3689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|||++|..||...... ......
T Consensus 143 ~Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~----~~~~~~ 214 (292)
T 3o0g_A 143 ANFGLARAFGIPVR----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKR 214 (292)
T ss_dssp CCCTTCEECCSCCS----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHH
T ss_pred eecccceecCCccc----cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH----HHHHHH
Confidence 99999986543221 122346899999999988765 799999999999999999988885322111 111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhH---------HHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNK---------QRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .... .....|..... .............++.++.+++.+||+.||++|||++|+++
T Consensus 215 i~~-----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 215 IFR-----LLGT---PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHH-----HHCC---CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHH-----HhCC---CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 100 0000 00000100000 00000011122356788999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=379.56 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=212.1
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
....++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence 345567899999999999999999996 67889999997543 34678999999999999999999999864 35
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~ 323 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE---------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVC 323 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCE
T ss_pred ccEEEEeecCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcE
Confidence 6899999999999999996432 13688999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++....... .......++..|+|||++....++.++|||||||++|||+| |+.||..... ....
T Consensus 324 kl~DFG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~~~~ 395 (454)
T 1qcf_A 324 KIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVI 395 (454)
T ss_dssp EECSTTGGGGBCCHHH---HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHH
T ss_pred EEeeCCCceEcCCCce---eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence 9999999986543211 11123346789999999998899999999999999999999 9999863211 0111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. .+.. ......+..+++++.++|.+||+.||++|||+++|++.|+++.++.
T Consensus 396 ~-----~i~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 396 R-----ALER----------------------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp H-----HHHH----------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred H-----HHHc----------------------CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 0000 0011223467889999999999999999999999999999875543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.01 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=202.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+..|..++..+ +||+|+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 457899999999999999999999988999999999743 223456788999999988 899999999985 44
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQV-----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCC
Confidence 58899999999999999998643 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 159 ~vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~ 229 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDEL 229 (353)
T ss_dssp CEEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred cEEEEeCCcccccccCCc----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----HHHH
Confidence 999999999985332211 1223569999999999999999999999999999999999999986321 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
... +. ......+..++.++.+++.+||+.||++||+ ++|+++
T Consensus 230 ~~~-----i~-----------------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 230 FQS-----IM-----------------------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHH-----HH-----------------------HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHH-----HH-----------------------hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 110 00 0111223356778999999999999999995 466654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=365.13 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=202.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++. .+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 46999999999999999999999999999999986322 123577999999999999999999999864 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRAD-------AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence 789999999999999888753211 012489999999999999999999999 9999999999999986654
Q ss_pred ---EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 ---AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ---~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~ 238 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------E 238 (351)
T ss_dssp TCCEEECCCTTCEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------H
T ss_pred CCcEEEecCcceeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------H
Confidence 99999999987654321 1223469999999999999999999999999999999999999986421 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ..+ ........... ...++.++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~-----~~i---~~~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 RLF-----EGI---IKGKYKMNPRQ----------------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHH-----HHH---HHTCCCCCHHH----------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-----HHH---HcCCCCCCccc----------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 100 00000001111 1246778999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=361.35 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=206.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeE----EEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTI----VAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|++.+.||+|+||+||+|++..+++. ||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------ 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------
Confidence 35789999999999999999999877765 7777775332 233456789999999999999999999864
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~ 152 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR----------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPS 152 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG----------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSS
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc----------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCC
Confidence 256899999999999999997643 3688999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... ......+|..|+|||++.+..++.++|||||||++|||+| |+.||...... ....
T Consensus 153 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~ 228 (325)
T 3kex_A 153 QVQVADFGVADLLPPDDKQL--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPD 228 (325)
T ss_dssp CEEECSCSGGGGSCCCTTCC--C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHH
T ss_pred eEEECCCCcccccCcccccc--cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHH
Confidence 99999999998765433211 1223457889999999998899999999999999999999 99998743211 0000
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. +.. ......+..++.++.+++.+||+.||++|||++|+++.|+++...-
T Consensus 229 ~------------~~~------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 229 L------------LEK------------------GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp H------------HHT------------------TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred H------------HHc------------------CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 000 0011122345667889999999999999999999999999986543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=365.45 Aligned_cols=276 Identities=23% Similarity=0.357 Sum_probs=212.8
Q ss_pred HHhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
....++|++.+.||+|+||.||+|++. .+++.||+|+++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--
Confidence 345678999999999999999999996 3458999999975432 33567899999999999999999999964
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCc-------------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-------------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP 799 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 799 (988)
.++..++||||+++|+|.+++........ ........+++.+++.++.||+.||+|||++ +
T Consensus 121 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 121 ---VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ---cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 34788999999999999999975431100 0000114689999999999999999999999 9
Q ss_pred eEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-
Q 001974 800 VLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT- 878 (988)
Q Consensus 800 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt- 878 (988)
|+||||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 999999999999999999999999999865433211 11223457899999999988899999999999999999999
Q ss_pred CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC
Q 001974 879 GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958 (988)
Q Consensus 879 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 958 (988)
|+.||..... ...... +. +. .....+..++.++.+++.+||+.||++|
T Consensus 273 g~~p~~~~~~-----~~~~~~-----~~---~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 273 GLQPYYGMAH-----EEVIYY-----VR---DG-------------------NILACPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp TCCTTTTSCH-----HHHHHH-----HH---TT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCcCCCCCh-----HHHHHH-----Hh---CC-------------------CcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999863211 111100 00 00 0011223577889999999999999999
Q ss_pred CCHHHHHHHHHHHHHHhh
Q 001974 959 MSITNVVHELQSVKNALL 976 (988)
Q Consensus 959 Ps~~evl~~L~~i~~~~~ 976 (988)
||++|+++.|+++.+.+.
T Consensus 321 ps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 321 PSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CCHHHHHHHHHHTTC---
T ss_pred CCHHHHHHHHHHHHhhhh
Confidence 999999999999876544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=376.84 Aligned_cols=203 Identities=29% Similarity=0.374 Sum_probs=161.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++....+.....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999998643 2234467899999999999999999999986655556678
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV-----------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred EEEEEecc-ccchhhhcccCC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEe
Confidence 99999998 689999986543 689999999999999999999999 999999999999999999999
Q ss_pred Eeeeccccccccccccc-----------------------ceeccccccccccccCccc-CCCCCCCccchHHHHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLT-----------------------QSCSVGVRGTIGYAAPEYG-LGSEVSTNGDIYSYGILLLE 875 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~e 875 (988)
|+|||+|+......... .....+.+||+.|+|||++ .+..++.++|||||||++||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 99999998764322110 0122345789999999976 56679999999999999999
Q ss_pred HHhC
Q 001974 876 MVTG 879 (988)
Q Consensus 876 lltg 879 (988)
|++|
T Consensus 277 lltg 280 (458)
T 3rp9_A 277 LLNM 280 (458)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9994
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=359.63 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=189.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++. .++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 3567999999999999999999999899999999997543 3467889999999999999999999964 34789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~ 817 (988)
++||||+++++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~ 189 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG-----------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAP 189 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCC
T ss_pred EEEEEeCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCC
Confidence 99999999999999997653 589999999999999999999999 9999999999999975 889
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...
T Consensus 190 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~ 259 (349)
T 2w4o_A 190 LKIADFGLSKIVEHQVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFM 259 (349)
T ss_dssp EEECCCC---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHH
T ss_pred EEEccCccccccCcccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHH
Confidence 99999999986543221 12345899999999999999999999999999999999999998632111 000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...+.. ....... .....++.++.+++.+||+.||++|||++|+++
T Consensus 260 ~~~i~~-------~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 260 FRRILN-------CEYYFIS----------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHT-------TCCCCCT----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHh-------CCCccCC----------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0000000 011246778999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.65 Aligned_cols=272 Identities=24% Similarity=0.365 Sum_probs=212.9
Q ss_pred hhCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
..++|.+.+.||+|+||.||+|++ ..+++.||+|+++... ....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 457799999999999999999998 3456899999997543 334467899999999999999999999954
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCc-------------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQK-------------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL 801 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 801 (988)
.++..++||||+++++|.+++........ ........+++.+++.++.||+.||+|||++ +|+
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 44788999999999999999975432100 0001123589999999999999999999999 999
Q ss_pred eccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CC
Q 001974 802 HCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GK 880 (988)
Q Consensus 802 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~ 880 (988)
||||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE--ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccc--eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865443221 11223457889999999998889999999999999999999 99
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||...... ..... +.. ......+..+++++.+++.+||+.||++|||
T Consensus 251 ~p~~~~~~~--~~~~~--------~~~----------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 251 NPYPGIPPE--RLFNL--------LKT----------------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp CSSTTCCGG--GHHHH--------HHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHH--HHHHH--------hhc----------------------CCcCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 998642211 00000 000 0011123357788999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 001974 961 ITNVVHELQSVKNA 974 (988)
Q Consensus 961 ~~evl~~L~~i~~~ 974 (988)
++|+++.|+++.++
T Consensus 299 ~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 299 FADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=355.89 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=204.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC-------eEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG-------TIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||+||+|++..++ +.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 467899999999999999999997666 579999997666666788999999999999999999999964
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 148 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNK----------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIR 148 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEE
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEec
Confidence 3477899999999999999996543 3589999999999999999999999 9999999999999998
Q ss_pred CCc--------EEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCC-CC
Q 001974 815 DMI--------AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKP-TD 884 (988)
Q Consensus 815 ~~~--------~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p-~~ 884 (988)
++. +||+|||.+....... ...||+.|+|||++.+ ..++.++|||||||++|||++|..| |.
T Consensus 149 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 149 EEDRKTGNPPFIKLSDPGISITVLPKD--------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp CCBGGGTBCCEEEECCCCSCTTTSCHH--------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcccccccceeeeccCcccccccCcc--------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 887 9999999997543321 1347889999999887 6789999999999999999995544 43
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.. .. ...... .......+...+.++.+++.+||+.||++|||++|+
T Consensus 221 ~~-~~----~~~~~~-----------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 221 AL-DS----QRKLQF-----------------------------YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp TS-CH----HHHHHH-----------------------------HHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred cc-ch----HHHHHH-----------------------------hhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 21 10 000000 000111122445678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 965 VHELQSVKNA 974 (988)
Q Consensus 965 l~~L~~i~~~ 974 (988)
++.|+++...
T Consensus 267 l~~l~~l~~p 276 (289)
T 4fvq_A 267 IRDLNSLFTP 276 (289)
T ss_dssp HHHHHTCC--
T ss_pred HHHHHHhcCC
Confidence 9999988653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=358.83 Aligned_cols=276 Identities=24% Similarity=0.404 Sum_probs=257.9
Q ss_pred cCCccccCCCCCCCCCce--eeeeEEeCCC--CcEEEEEcCCCCCcc--cccccccCCCCCCEEEcCC-CcccccCCccc
Q 001974 4 HDPQGILNSWNDSGHFCE--WKGITCGLRH--RRVTVLNLRSKGLSG--SLSPYIGNLSFLREINLMN-NSIQGEIPREF 76 (988)
Q Consensus 4 ~~~~~~~~~w~~~~~~c~--~~~v~c~~~~--~~v~~l~l~~~~~~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~ 76 (988)
.||. .+++|..+++||. |.||+|+..+ ++|+.|+|+++++++ .+|+.++.+++|++|+|++ |++++.+|..|
T Consensus 19 ~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l 97 (313)
T 1ogq_A 19 GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97 (313)
T ss_dssp TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred CCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhH
Confidence 4776 8999998899998 9999998665 899999999999999 8999999999999999995 99999999999
Q ss_pred CCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCC-ccc
Q 001974 77 GRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT-SLE 155 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~ 155 (988)
+.+++|++|+|++|++++.+|..|+.+++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..|..++ +|+
T Consensus 98 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~ 177 (313)
T 1ogq_A 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177 (313)
T ss_dssp GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred hcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999989999999998 999
Q ss_pred eeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccc
Q 001974 156 SISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235 (988)
Q Consensus 156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N 235 (988)
+|++++|++++..|..|..++ |++|+|++|++++..|..+..+++|+.|+|++|++.+.+|. +..+++|++|+|++|
T Consensus 178 ~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~Ls~N 254 (313)
T 1ogq_A 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNN 254 (313)
T ss_dssp EEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--CCCCTTCCEEECCSS
T ss_pred EEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc--ccccCCCCEEECcCC
Confidence 999999999989999999998 99999999999999999999999999999999999865555 457899999999999
Q ss_pred ccccccCcccccCCcccEEEeccccccCcccccccCCccccEEeccccc
Q 001974 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNN 284 (988)
Q Consensus 236 ~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 284 (988)
++++.+|..+..+++|+.|++++|++++.+|.. ..+++|+.+++++|.
T Consensus 255 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 999999999999999999999999999888875 788889999998887
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=362.33 Aligned_cols=274 Identities=21% Similarity=0.374 Sum_probs=198.3
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCe---EEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID 733 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 733 (988)
....++|++.+.||+|+||.||+|++..+++ .||||+++.. .....+.+.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456789999999999999999999876665 8999999754 3344578999999999999999999999975431
Q ss_pred cc-CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 734 FQ-GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 734 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.. .....++||||+++|+|.+++........ ...+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-----PFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC--------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhcccc-----ccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 11 11123899999999999999854321100 02589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
++++.+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~- 247 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYR--QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE- 247 (323)
T ss_dssp CTTSCEEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred cCCCCEEEeecccccccccccccc--ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-
Confidence 999999999999998654433211 1223347889999999999999999999999999999999 999987432110
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
. .... ........+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 248 -~---~~~~---------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 248 -I---YNYL---------------------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -H---HHHH---------------------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H---HHHH---------------------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0000 00011122346778899999999999999999999999999998
Q ss_pred HHH
Q 001974 972 KNA 974 (988)
Q Consensus 972 ~~~ 974 (988)
.+.
T Consensus 297 l~~ 299 (323)
T 3qup_A 297 LGH 299 (323)
T ss_dssp HHC
T ss_pred HHH
Confidence 764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=363.20 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=198.9
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEEeec
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFM 747 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 747 (988)
.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence 568999999999999999899999999998765556678999999999999999999999964 347899999999
Q ss_pred cccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee--CCCCcEEEeeecc
Q 001974 748 TNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL--DNDMIAHVGDFGL 825 (988)
Q Consensus 748 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~ 825 (988)
++++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 169 ~~~~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 169 DGGELFDRIIDES----------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp TTCEEHHHHHHTG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 9999998885432 3689999999999999999999999 99999999999999 6778999999999
Q ss_pred cccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhh
Q 001974 826 ARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905 (988)
Q Consensus 826 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 905 (988)
++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 236 a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~------ 299 (373)
T 2x4f_A 236 ARRYKPREKL-----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----AETLNN------ 299 (373)
T ss_dssp CEECCTTCBC-----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH------
T ss_pred ceecCCcccc-----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH------
Confidence 9876543221 224589999999999999999999999999999999999999863211 111111
Q ss_pred hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH--HHHHH
Q 001974 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH--ELQSV 971 (988)
Q Consensus 906 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 971 (988)
+......... .....+++++.+++.+||+.||++|||++|+++ .+...
T Consensus 300 --i~~~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 300 --ILACRWDLED----------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --HHHTCCCSCS----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --HHhccCCCCh----------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 0000000000 011246778999999999999999999999987 44443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=360.58 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=200.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++... ...+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE-ETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc-CCCCc
Confidence 4689999999999999999999988999999999975432 2345788999999999999999999987643 11223
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCE
T ss_pred ccEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCE
Confidence 459999999999999998643 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 156 kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~ 229 (311)
T 3ork_A 156 KVMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAY 229 (311)
T ss_dssp EECCCSCC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred EEeeccCcccccccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence 99999999865443221 1112234689999999999999999999999999999999999999863211 11111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH-HHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV-HELQSVKN 973 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i~~ 973 (988)
....... . ........++.++.+++.+||+.||++||++.+++ ..+.++..
T Consensus 230 ~~~~~~~--------~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 QHVREDP--------I----------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHCCC--------C----------------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHhcCCC--------C----------------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1000000 0 00011224678899999999999999999666654 45655543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=364.51 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=196.1
Q ss_pred hCCCCCC-ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSST-HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|.+. +.||+|+||+||+|.+..+++.||||+++. ...+.+|+.++.+. +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 3457666 689999999999999999999999999863 24677888887554 899999999987542 334567
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
.++||||+++|+|.+++..... ..+++.+++.|+.||+.||+|||+. +|+||||||+||+++. ++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD---------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCc
Confidence 8999999999999999976432 3589999999999999999999998 9999999999999997 78
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc--hH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN--LH 894 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~ 894 (988)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 202 ~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp CEEECCCTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred cEEEEecccccccCCCCc-----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 999999999986543222 12345899999999999999999999999999999999999999643221110 10
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .. ...... .....++.++.+++.+||+.||++|||++|+++.
T Consensus 277 ~~i~----~~-------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 277 TRIR----MG-------QYEFPN----------------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHH----HT-------CCCCCT----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHH----cC-------cccCCC----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00 000000 0112467789999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.64 Aligned_cols=279 Identities=22% Similarity=0.388 Sum_probs=205.2
Q ss_pred HHHHhhCCCCCCceeccccceeEEEEEECC---CCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 657 ~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
++....++|.+.+.||+|+||.||+|.+.. +++.||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 334456789999999999999999998864 45689999987443 2334678999999999999999999999765
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.........++||||+++++|.+++........ ...+++.+++.++.||+.||+|||+. +|+||||||+||+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIl 179 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG-----PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCM 179 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTS-----CCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcC-----CccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEE
Confidence 432223456999999999999999843221100 13689999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
++.++.+||+|||+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 256 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH- 256 (313)
T ss_dssp ECTTSCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EcCCCcEEEeecCcceecccccccC--cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-
Confidence 9999999999999998654432111 1122347889999999999999999999999999999999 88998642111
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
.... . +. .......+..++.++.+++.+||+.||++|||++++++.|++
T Consensus 257 -~~~~---~-----~~----------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 257 -EMYD---Y-----LL----------------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp -GHHH---H-----HH----------------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH---H-----HH----------------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0000 0 00 000112233577889999999999999999999999999999
Q ss_pred HHHHhhh
Q 001974 971 VKNALLE 977 (988)
Q Consensus 971 i~~~~~~ 977 (988)
+.+++++
T Consensus 306 l~~~lp~ 312 (313)
T 3brb_A 306 LLESLPD 312 (313)
T ss_dssp HHHHC--
T ss_pred HHHhcCC
Confidence 9887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.33 Aligned_cols=277 Identities=22% Similarity=0.360 Sum_probs=210.4
Q ss_pred hCCCCCCceeccccceeEEEEE----ECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGA----FDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.+.|++.+.||+|+||.||+|+ ...+++.||+|+++... ....+.+.+|++++++++||||+++++++... .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3458889999999999999999 45688999999997443 33447889999999999999999999997542 3
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~ 163 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 163 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCC
Confidence 366899999999999999985432 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||++......... ........||..|+|||++.+..++.++||||+|+++|||++|..|+..... ..
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~ 236 (302)
T 4e5w_A 164 QVKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LF 236 (302)
T ss_dssp EEEECCCTTCEECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HH
T ss_pred CEEECcccccccccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HH
Confidence 9999999999876543321 1222334588899999999998999999999999999999999998642210 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
. .. ..+.... ..................+..+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 237 ~-~~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 237 L-KM--------IGPTHGQ--MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H-HH--------HCSCCGG--GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h-hc--------cCCcccc--cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 00 0000000 0000000111111122234467889999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=363.10 Aligned_cols=275 Identities=21% Similarity=0.380 Sum_probs=214.8
Q ss_pred hhCCCCCCceeccccceeEEEEEECC-------CCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++|.+.+.||+|+||+||+|++.. .++.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 34678999999999999999999743 346899999975432 3346789999999999 9999999999964
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.++..++||||+++|+|.+++......... .......+++.+++.|+.||+.||+|||+. +|+|||||
T Consensus 146 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 218 (382)
T 3tt0_A 146 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218 (382)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred ----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 347789999999999999999754321100 000113589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEEcCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999866543221 11223457889999999999999999999999999999999 9999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.. ...... .+.. ......+..++.++.+++.+||+.||++|||++|++
T Consensus 297 ~~-----~~~~~~-----~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 344 (382)
T 3tt0_A 297 VP-----VEELFK-----LLKE----------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 344 (382)
T ss_dssp CC-----HHHHHH-----HHHT----------------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CC-----HHHHHH-----HHHc----------------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 21 111110 0000 001122346778899999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 001974 966 HELQSVKNALLE 977 (988)
Q Consensus 966 ~~L~~i~~~~~~ 977 (988)
+.|+++......
T Consensus 345 ~~L~~~~~~~~~ 356 (382)
T 3tt0_A 345 EDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHHHSCS
T ss_pred HHHHHHHHHHhc
Confidence 999999876433
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.82 Aligned_cols=266 Identities=25% Similarity=0.435 Sum_probs=212.2
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
....++|++.+.||+|+||.||+|.+. +++.||+|+++... ...+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 80 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QE 80 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CC
Confidence 344578999999999999999999986 67889999987543 34578999999999999999999999854 25
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 148 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPS---------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSC 148 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred CcEEEEecCCCCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCE
Confidence 5899999999999999996432 13689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 149 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~~ 220 (279)
T 1qpc_A 149 KIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVI 220 (279)
T ss_dssp EECCCTTCEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHH
T ss_pred EECCCcccccccCccc---ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----HHHH
Confidence 9999999986644321 11223457889999999988889999999999999999999 9999863211 0111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
. .+... .....+..++.++.+++.+||+.||++|||++++++.|+++..+...
T Consensus 221 ~-----~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 221 Q-----NLERG----------------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp H-----HHHTT----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred H-----HHhcc----------------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 0 00000 00112235678899999999999999999999999999999877554
Q ss_pred hc
Q 001974 978 AW 979 (988)
Q Consensus 978 ~~ 979 (988)
.+
T Consensus 274 ~~ 275 (279)
T 1qpc_A 274 QY 275 (279)
T ss_dssp --
T ss_pred CC
Confidence 33
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=379.64 Aligned_cols=259 Identities=25% Similarity=0.466 Sum_probs=212.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..++..||||+++... ...+.+.+|+.++++++||||++++++|.. ++..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence 3466888999999999999999998889999999997543 345789999999999999999999999653 4778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNR---------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCT---------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred EEEEEccCCCCHHHHHHhcCc---------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEE
Confidence 999999999999999975432 3588999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++...... ........++..|+|||++.+..++.++|||||||++|||+| |+.||...... ..
T Consensus 360 ~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~------ 428 (495)
T 1opk_A 360 ADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV------ 428 (495)
T ss_dssp CCTTCEECCTTCC---EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH------
T ss_pred eecccceeccCCc---eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HH------
Confidence 9999998654322 111223456789999999998899999999999999999999 99998643111 00
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.+.+.. ......+..++.++.++|.+||+.||++|||++|+++.|+.+.
T Consensus 429 ------~~~~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 429 ------YELLEK------------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ------HHHHHT------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------HHHHHc------------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 000000 0011223467888999999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=359.47 Aligned_cols=277 Identities=23% Similarity=0.340 Sum_probs=210.7
Q ss_pred HhhCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
...++|++.+.||+|+||.||+|++ ..+++.||+|+++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 4567899999999999999999997 345678999999743 233457899999999999 9999999999964
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCch------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPV 800 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 800 (988)
.++..++||||+++|+|.+++......... .......+++.+++.++.||+.||+|||+. +|
T Consensus 120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 347889999999999999999765421100 001123589999999999999999999998 99
Q ss_pred EeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-C
Q 001974 801 LHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-G 879 (988)
Q Consensus 801 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g 879 (988)
+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999866543221 12233457889999999988899999999999999999998 9
Q ss_pred CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC
Q 001974 880 KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959 (988)
Q Consensus 880 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 959 (988)
..||....... ......... .....+..+++++.+++.+||+.||++||
T Consensus 272 ~~p~~~~~~~~-----~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 320 (344)
T 1rjb_A 272 VNPYPGIPVDA-----NFYKLIQNG--------------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRP 320 (344)
T ss_dssp CCSSTTCCCSH-----HHHHHHHTT--------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCcccCCcHH-----HHHHHHhcC--------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 99986432110 000000000 00112235678899999999999999999
Q ss_pred CHHHHHHHHHHHHHHhhh
Q 001974 960 SITNVVHELQSVKNALLE 977 (988)
Q Consensus 960 s~~evl~~L~~i~~~~~~ 977 (988)
|++|+++.|+.+.+...+
T Consensus 321 s~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 321 SFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CHHHHHHHHHHHC-----
T ss_pred CHHHHHHHHHHHHHHHHH
Confidence 999999999998765443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=357.55 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=200.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccc------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF------ 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 734 (988)
.++|++.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356899999999999999999999899999999997543 3345789999999999999999999998754310
Q ss_pred ----------------------------------------------cCCCceEEEEeeccccchhhhcCCCCCCCchhhh
Q 001974 735 ----------------------------------------------QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEI 768 (988)
Q Consensus 735 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 768 (988)
......++||||+++++|.+++......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------ 158 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL------ 158 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc------
Confidence 1123479999999999999999765421
Q ss_pred HhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccc--------eec
Q 001974 769 EIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ--------SCS 840 (988)
Q Consensus 769 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~--------~~~ 840 (988)
...++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......... ...
T Consensus 159 --~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 159 --EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp --GGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred --cchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 3467778999999999999999998 999999999999999999999999999987654321111 112
Q ss_pred cccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchh
Q 001974 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDW 920 (988)
Q Consensus 841 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 920 (988)
....||+.|+|||++.+..++.++|||||||++|||++|..|+... ......... ... .
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------~~~~~~~~~---~~~----~-- 292 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------VRIITDVRN---LKF----P-- 292 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------HHHHHHHHT---TCC----C--
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------HHHHHHhhc---cCC----C--
Confidence 3356999999999999999999999999999999999998773210 000000000 000 0
Q ss_pred hhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 921 DATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 921 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......++++.+++.+||+.||++|||++|+++
T Consensus 293 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 -------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 001134566789999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.76 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=205.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|++ .++.||||+++... ....+.+.+|+.++++++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 46799999999999999999999 58999999997543 23346799999999999999999999997532 2367
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeCCCCc
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 817 (988)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~ 151 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTN---------FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMT 151 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSS---------CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSC
T ss_pred eEeeecccCCCcHHHHHhhccc---------CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcc
Confidence 8999999999999999976542 2589999999999999999999998 7 999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCC---ccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVST---NGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||......
T Consensus 152 ~~l~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----- 217 (271)
T 3kmu_A 152 ARISMADVKFSFQS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----- 217 (271)
T ss_dssp EEEEGGGSCCTTSC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----
T ss_pred eeEEeccceeeecc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----
Confidence 99999988764222 1235899999999988766554 799999999999999999998632111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
......... ......+..+++++.+++.+||+.||++|||++|+++.|+++.+
T Consensus 218 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EIGMKVALE--------------------------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHS--------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhc--------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 110000000 00111223577889999999999999999999999999998854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.58 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=210.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|.+. +++.||+|+++.... ..+.+.+|++++++++||||+++++++. .++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPI 78 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCe
Confidence 3467899999999999999999996 788999999975433 3478999999999999999999999964 34778
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl 145 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV 145 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEE
T ss_pred EEEEeCCCCCcHHHHHhhCc----------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEE
Confidence 99999999999999996543 3588999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ .......++..|+|||++.+..++.++||||+|+++|||++ |+.||..... .....
T Consensus 146 ~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~- 216 (267)
T 3t9t_A 146 SDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVE- 216 (267)
T ss_dssp CCTTGGGGBCCHHH---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH-
T ss_pred cccccccccccccc---cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHH-
Confidence 99999986543211 11223457889999999988889999999999999999999 8999863211 11110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.+.... ....+..++..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 217 ----~i~~~~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 217 ----DISTGF----------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----HHHTTC----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHhcCC----------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 010000 0011224567899999999999999999999999999999763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=370.04 Aligned_cols=203 Identities=26% Similarity=0.278 Sum_probs=169.1
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 737 (988)
..++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999743 3344567889999999999999999999975432 1334
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++ +++.+.+.. .+++.++..++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~~-------------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQM-------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHTS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred CeEEEEEeCCC-CCHHHHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCC
Confidence 56899999995 456666632 478899999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+||+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 203 ~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 203 LKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp EEECCCCCC-----CCC-----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEEEEeeeecCCCcc-----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999986554322 2235699999999999999999999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.15 Aligned_cols=267 Identities=22% Similarity=0.366 Sum_probs=211.0
Q ss_pred HHHhhCCCCCCc-eeccccceeEEEEEE--CCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 658 LFKATDGFSSTH-LIGMGSFGSVYKGAF--DQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 658 l~~~~~~y~~~~-~lg~G~~g~Vy~a~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
+....++|.+.+ .||+|+||.||+|.+ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-- 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-- 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--
Confidence 334456788888 999999999999954 5567899999997443 233567999999999999999999999862
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.+..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 89 ----~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~ 150 (291)
T 1xbb_A 89 ----AESWMLVMEMAELGPLNKYLQQNR-----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLL 150 (291)
T ss_dssp ----SSSEEEEEECCTTEEHHHHHHHCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ----CCCcEEEEEeCCCCCHHHHHHhCc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEE
Confidence 367899999999999999996542 589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+.++.+||+|||++........... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-- 227 (291)
T 1xbb_A 151 VTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-- 227 (291)
T ss_dssp EETTEEEECCCTTCEECCTTCSEEE-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--
T ss_pred eCCCcEEEccCCcceeeccCCCccc-ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 9999999999999986654332111 1122346789999999988889999999999999999999 99998642110
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
... ..+.. ......+..++.++.+++.+||+.||++|||++|+++.|+++
T Consensus 228 ---~~~-----~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 228 ---EVT-----AMLEK----------------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---HHH-----HHHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---HHH-----HHHHc----------------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 00000 000112335778899999999999999999999999999999
Q ss_pred HHHhhh
Q 001974 972 KNALLE 977 (988)
Q Consensus 972 ~~~~~~ 977 (988)
......
T Consensus 278 ~~~~~~ 283 (291)
T 1xbb_A 278 YYDVVN 283 (291)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 877654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.78 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=207.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++++++||||+++++++. ++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 3567999999999999999999999999999999986432 223467889999999999999999999964 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~ 147 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL-----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGE 147 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSC
T ss_pred CEEEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCC
Confidence 7899999999999999998543 3689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||++....... .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .....
T Consensus 148 ~~l~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~ 216 (279)
T 3fdn_A 148 LKIADFGWSVHAPSSR------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQETY 216 (279)
T ss_dssp EEECSCCEESCC--------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHH
T ss_pred EEEEeccccccCCccc------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HHHHH
Confidence 9999999986543322 123458999999999999999999999999999999999999986321 11100
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
. .+.......+..++..+.+++.+||+.||++|||++|+++.-. +......
T Consensus 217 ~----------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~-~~~~~~~ 267 (279)
T 3fdn_A 217 K----------------------------RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW-ITANSSK 267 (279)
T ss_dssp H----------------------------HHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH-HHHHCSS
T ss_pred H----------------------------HHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc-ccCCccC
Confidence 0 0011111223346778999999999999999999999998522 2233333
Q ss_pred hcccCCcc
Q 001974 978 AWNCTGEE 985 (988)
Q Consensus 978 ~~~~~~~~ 985 (988)
...|+.++
T Consensus 268 ~~~~~~~~ 275 (279)
T 3fdn_A 268 PSNCQNKE 275 (279)
T ss_dssp CCCC----
T ss_pred cccccccc
Confidence 44444443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=366.64 Aligned_cols=209 Identities=26% Similarity=0.319 Sum_probs=172.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++....+....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 357899999999999999999999999999999999643 223446789999999999999999999997655444447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTPI-----------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSSC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred eEEEEEecC-CcCHHHHHhccC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCE
Confidence 799999999 579999997543 589999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccccccccc------------------ceeccccccccccccCccc-CCCCCCCccchHHHHHHHHHHHhC
Q 001974 819 HVGDFGLARVRQEVSNLT------------------QSCSVGVRGTIGYAAPEYG-LGSEVSTNGDIYSYGILLLEMVTG 879 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg 879 (988)
||+|||+|+......... .......+||+.|+|||++ ....++.++||||+||++|||++|
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 999999998765432110 0112345799999999985 556799999999999999999997
Q ss_pred CCCCC
Q 001974 880 KKPTD 884 (988)
Q Consensus 880 ~~p~~ 884 (988)
..||.
T Consensus 249 ~~p~~ 253 (432)
T 3n9x_A 249 LQSHI 253 (432)
T ss_dssp CTTTC
T ss_pred ccccc
Confidence 66654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=350.40 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=209.5
Q ss_pred CCCCCceeccccceeEEEEEECCCCe---EEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.|...+.||+|+||+||+|++..+++ .||+|++..... ...+.+.+|+.++++++||||+++++++.. .+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence 45667899999999999999754443 799999864333 345678999999999999999999999643 2344
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ----------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred cEEEEecccCCCHHHHHhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 589999999999999997643 3678999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++.................+++.|+|||.+.+..++.++||||||+++|||++|..|+...... .......
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~-- 241 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFL-- 241 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHH--
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHh--
Confidence 9999999865443322222333456889999999999999999999999999999999965554321111 0000000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
. .......+..++.++.+++.+||+.||++|||++|+++.|+++.+++..
T Consensus 242 --~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 242 --A--------------------------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp --H--------------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred --h--------------------------cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0 0001112335677899999999999999999999999999999888654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.32 Aligned_cols=262 Identities=23% Similarity=0.403 Sum_probs=204.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEE----EEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIV----AIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|++.+.||+|+||.||+|++..+++.| |+|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 467999999999999999999998777654 66666432 33455789999999999999999999999653
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~ 154 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred -CCceEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCC
Confidence 34789999999999999987543 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ...
T Consensus 155 ~~kL~DfG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~ 230 (327)
T 3lzb_A 155 HVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230 (327)
T ss_dssp EEEECCTTC------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH
T ss_pred CEEEccCcceeEccCcccc--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH
Confidence 9999999999876443221 11223457889999999999999999999999999999999 999987432111 100
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. +. .......+..++.++.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 231 ~------------~~------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 231 I------------LE------------------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp H------------HH------------------TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred H------------HH------------------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 0 00 00011223356778999999999999999999999999999997543
Q ss_pred h
Q 001974 976 L 976 (988)
Q Consensus 976 ~ 976 (988)
.
T Consensus 281 ~ 281 (327)
T 3lzb_A 281 Q 281 (327)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.04 Aligned_cols=243 Identities=22% Similarity=0.341 Sum_probs=203.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhcCCCCceEEEeeccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNIRHRNLVKVITSCSSID 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 733 (988)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--- 99 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--- 99 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 4679999999999999999999999999999999975431 12346778999999999999999999954
Q ss_pred ccCCCceEEEEeecccc-chhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 734 FQGNDFKALVYEFMTNG-SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.++..++||||+.+| +|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+||++
T Consensus 100 --~~~~~~lv~e~~~~g~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 163 (335)
T 3dls_A 100 --NQGFFQLVMEKHGSGLDLFAFIDRHP-----------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVI 163 (335)
T ss_dssp --CSSEEEEEEECCTTSCBHHHHHHTCC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred --eCCEEEEEEEeCCCCccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEE
Confidence 457899999999776 9999997653 589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+.++.+||+|||+++........ ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-- 236 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKLF-----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-- 236 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCCB-----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--
T ss_pred cCCCcEEEeecccceECCCCCce-----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--
Confidence 99999999999999876543322 22458999999999988877 78999999999999999999998632110
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... ....+..++.++.+++.+||+.||++|||++|+++.
T Consensus 237 -----------------~~~--------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----------------VEA--------------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------------TTT--------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------------Hhh--------------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011123467789999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=359.59 Aligned_cols=272 Identities=21% Similarity=0.222 Sum_probs=204.0
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-----ccchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-----RHGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
+....++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-- 98 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-- 98 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence 344567899999999999999999999999999999998643 2344578999999999999999999999964
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCc-----------------------------hhhhHhhcCCHHHHHHHHH
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-----------------------------DVEIEIQKLTLLQRINIAI 783 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------------------------~~~~~~~~l~~~~~~~i~~ 783 (988)
+++..++||||+++|+|.+++........ ........+++..++.++.
T Consensus 99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 45789999999999999999852110000 0000012356778899999
Q ss_pred HHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC--cEEEeeecccccccccccccceeccccccccccccCcccCC--CC
Q 001974 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM--IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SE 859 (988)
Q Consensus 784 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 859 (988)
||+.||+|||+. +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||++.+ ..
T Consensus 176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 999999999999 999999999999998776 89999999998664433222222334569999999999875 67
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccch
Q 001974 860 VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIEC 939 (988)
Q Consensus 860 ~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 939 (988)
++.++|||||||++|||++|+.||...... ..... +......... .....+
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~--------~~~~~~~~~~----------------~~~~~~ 303 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQ--------VLNKKLCFEN----------------PNYNVL 303 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH--------HHHCCCCTTS----------------GGGGGS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHHH--------HHhcccccCC----------------cccccC
Confidence 899999999999999999999998642111 11111 1111110000 011245
Q ss_pred hHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 940 PISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 940 ~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
++++.+++.+||+.||++|||+.|+++
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 778999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=360.37 Aligned_cols=273 Identities=19% Similarity=0.241 Sum_probs=205.1
Q ss_pred hCCCCCCceeccccceeEEEEEECC---CCeEEEEEEeeccccc-----------hhHHHHHHHHHHHhcCCCCceEEEe
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQRHG-----------ASKSFLAECKALKNIRHRNLVKVIT 727 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 727 (988)
.++|++.+.||+|+||.||+|++.. +++.||+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999986 7789999998754321 1234677888999999999999999
Q ss_pred ecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 728 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
++... +.++...++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 179 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQN-----------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKA 179 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGG-----------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCH
Confidence 97653 34467899999999 99999998754 2689999999999999999999999 999999999
Q ss_pred CCeeeCCCC--cEEEeeecccccccccccc---cceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 808 GNVLLDNDM--IAHVGDFGLARVRQEVSNL---TQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 808 ~NIll~~~~--~~kL~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
+||+++.++ .+||+|||+++........ .........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 259 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999887 9999999999866443211 11112345699999999999999999999999999999999999999
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|.......... ..........+...+. .......++.++.+++.+||+.||++|||++
T Consensus 260 f~~~~~~~~~~-~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 317 (345)
T 2v62_A 260 WEQNLKDPVAV-QTAKTNLLDELPQSVL---------------------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ 317 (345)
T ss_dssp TGGGTTCHHHH-HHHHHHHHHTTTHHHH---------------------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred ccccccccHHH-HHHHHhhcccccHHHH---------------------hhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence 86322211111 1111111111100000 0001125778899999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 963 NVVHELQSVK 972 (988)
Q Consensus 963 evl~~L~~i~ 972 (988)
++++.|+++.
T Consensus 318 ~l~~~L~~~~ 327 (345)
T 2v62_A 318 ALKKILNPHG 327 (345)
T ss_dssp HHHHHHCTTC
T ss_pred HHHHHHhccC
Confidence 9999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=365.56 Aligned_cols=286 Identities=18% Similarity=0.209 Sum_probs=206.2
Q ss_pred HhhCCCCCCceeccc--cceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 660 KATDGFSSTHLIGMG--SFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G--~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
...++|++.+.||+| +||+||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----- 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI----- 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence 345789999999999 99999999999999999999997543 233467888999999999999999999965
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.++..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~ 164 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFM---------DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD 164 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCT---------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 34789999999999999999865432 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccc---cceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 816 MIAHVGDFGLARVRQEVSNL---TQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
+.+||+|||.+......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999998754332111 1111223468999999999987 678999999999999999999999997532221
Q ss_pred cchHHHHHHHHhhhhhhhhccccccC---------------cchh-hh--hhHHHHhhhhhccccchhHHHHHHhhcccC
Q 001974 891 LNLHNYARTALLDHVIDIVDPILIND---------------VEDW-DA--TNKQRLRQAKINGKIECPISMVRIGVACSV 952 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~---------------~~~~-~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 952 (988)
. ...... .......+...... ..+. .. ................+++++.+++.+||+
T Consensus 245 ~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 245 M-LLEKLN----GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp H-HHHC------------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred H-HHHHhc----CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 1 100000 00000000000000 0000 00 000000001111234567889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 001974 953 ESPQDRMSITNVVHE 967 (988)
Q Consensus 953 ~dP~~RPs~~evl~~ 967 (988)
.||++|||++|+++.
T Consensus 320 ~dP~~Rpta~ell~h 334 (389)
T 3gni_B 320 RNPDARPSASTLLNH 334 (389)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.60 Aligned_cols=286 Identities=24% Similarity=0.328 Sum_probs=191.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|++++++++||||+++++++. .++.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 77 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENK 77 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCe
Confidence 3568999999999999999999999899999999997543 234477889999999999999999999954 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++ |+|.+++........ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 148 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNT-----PRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLK 148 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSC-----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEEecC-CCHHHHHHhcccccc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEE
Confidence 999999996 699988854321100 02588999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 149 l~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~ 222 (317)
T 2pmi_A 149 LGDFGLARAFGIPVNT----FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIF 222 (317)
T ss_dssp ECCCSSCEETTSCCCC----CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred ECcCccceecCCCccc----CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence 9999999865432211 123458999999999876 46899999999999999999999998642211 1111111
Q ss_pred HHHhhhhhhhhccc--cccCcchhhhhhHHHH-hhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPI--LINDVEDWDATNKQRL-RQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~--l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.............. ...............+ ..........++.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 11000000000000 0000000000000000 00011122356778999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=354.55 Aligned_cols=265 Identities=25% Similarity=0.453 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC----eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.++|+..+.||+|+||.||+|.+..++ ..||+|+++.... .....+.+|++++++++||||+++++++. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence 356778899999999999999986443 4699999975432 33457899999999999999999999954 4
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.+..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~ 184 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNL 184 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCC
Confidence 578999999999999999986543 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~ 258 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HE 258 (333)
T ss_dssp CEEECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH
T ss_pred cEEECCCCcchhhccccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HH
Confidence 99999999998765432211 11122346789999999998899999999999999999999 9999863211 01
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.. ..+.. . .....+..++.++.+++.+||+.||++||+++|+++.|+++.+..
T Consensus 259 ~~-----~~~~~---~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 259 VM-----KAIND---G-------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HH-----HHHHT---T-------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HH-----HHHHC---C-------------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 00000 0 001123357788999999999999999999999999999998765
Q ss_pred hh
Q 001974 976 LE 977 (988)
Q Consensus 976 ~~ 977 (988)
..
T Consensus 312 ~~ 313 (333)
T 1mqb_A 312 DS 313 (333)
T ss_dssp GG
T ss_pred hh
Confidence 44
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=345.52 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=204.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||+++++++. .++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 456999999999999999999999899999999998666666788999999999999999999999964 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCcE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIA 818 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 818 (988)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 83 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK-----------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEeccCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence 999999999999988543 3689999999999999999999999 99999999999999 788999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++......... ....||+.|+|||++.+. ++.++||||||+++|||++|+.||...... ....
T Consensus 149 ~l~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~ 217 (277)
T 3f3z_A 149 KLIDFGLAARFKPGKMM-----RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVML 217 (277)
T ss_dssp EECCCTTCEECCTTSCB-----CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred EEEecccceeccCccch-----hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHH
Confidence 99999999865543221 224589999999998664 899999999999999999999998642111 1110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. +.. ........ ....+++++.+++.+||+.||++|||+.|+++.
T Consensus 218 ~-~~~-------~~~~~~~~----------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 218 K-IRE-------GTFTFPEK----------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp H-HHH-------CCCCCCHH----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred H-HHh-------CCCCCCch----------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 00000000 012467789999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.47 Aligned_cols=275 Identities=23% Similarity=0.332 Sum_probs=211.2
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHh--cCCCCceEEEeecccccccC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKN--IRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~ 736 (988)
....++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|++++.. ++||||+++++++... ...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~-~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD-NGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC-CSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc-CCc
Confidence 34457899999999999999999998 6899999998643 34677889998887 6999999999997543 111
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeccCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH--------HHCQEPVLHCDLKPG 808 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~ 808 (988)
....++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred cceeEEEEeecCCCcHHHHHhcc------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 23789999999999999998532 5899999999999999999999 76 9999999999
Q ss_pred CeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhC---
Q 001974 809 NVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTG--- 879 (988)
Q Consensus 809 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg--- 879 (988)
||+++.++.+||+|||++..................||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 99999999999999999987654432222222345699999999998775 334789999999999999999
Q ss_pred -------CCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccC
Q 001974 880 -------KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952 (988)
Q Consensus 880 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 952 (988)
..||......+.....+....... ........ .....+++..+.+++.+||+
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-------------~~~~~~~~~~l~~li~~cl~ 315 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--------KLRPNIPN-------------RWQSCEALRVMAKIMRECWY 315 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS--------CCCCCCCG-------------GGGTSHHHHHHHHHHHHHCC
T ss_pred CCcccccccCccccCcCcccHHHHHHHHHHH--------HhCCCCcc-------------cccchhHHHHHHHHHHHHhc
Confidence 677765433333332222211111 01111000 00122566789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHh
Q 001974 953 ESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 953 ~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.||++|||++|+++.|+++.++.
T Consensus 316 ~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 316 ANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999997753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=353.96 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=204.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc------hhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG------ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 35689999999999999999999989999999999754321 3467999999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.++..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKE-----------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS-----------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence 4578999999999999999997543 588999999999999999999999 99999999999999988
Q ss_pred C----cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 816 M----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 816 ~----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+ .+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 223 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGVEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--- 223 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTCCC-----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---
T ss_pred CCCcCCEEEccCccceecCccccc-----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---
Confidence 8 7999999999866543221 234589999999999999999999999999999999999999863211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... +.. ...... . .....++..+.+++.+||+.||++|||++|+++
T Consensus 224 --~~~~~~-----i~~---~~~~~~-~---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 --QETLAN-----ITS---VSYDFD-E---------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --HHHHHH-----HHT---TCCCCC-H---------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --HHHHHH-----HHh---cccccC-h---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111100 000 000000 0 001246677999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.25 Aligned_cols=262 Identities=28% Similarity=0.457 Sum_probs=197.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
...++|++.+.||+|+||+||+|++. ..||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence 34578999999999999999999874 2599999874432 33467899999999999999999999743 3
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE----------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC-------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred CccEEEEEecCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCC
Confidence 56899999999999999997554 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||+|||+++........ .......||+.|+|||++. +..++.++||||||+++|||++|+.||...... .
T Consensus 159 ~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~ 232 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGS--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----D 232 (289)
T ss_dssp EEECCCC--------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH----H
T ss_pred EEEccceecccccccccc--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH----H
Confidence 999999999765432211 1122346899999999986 567888999999999999999999998643211 1
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
... ...... ...... ......+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 233 ~~~-~~~~~~-------~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 233 QII-EMVGRG-------SLSPDL---------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHH-HHHHHT-------SCCCCT---------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH-HHhccc-------ccCcch---------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 100000 000000 0112357788999999999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=374.25 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=207.1
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
..++|++.+.||+|+||.||+|++..+|+.||+|++... .......+.+|++++++++||||+++++++. ++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence 346799999999999999999999999999999999643 2233467889999999999999999999854 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +||||||||+||+++.++.
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~---------~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~ 324 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQ---------AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGH 324 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSS---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCC
Confidence 789999999999999999875432 2589999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 325 vKL~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~ 398 (576)
T 2acx_A 325 IRISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVE 398 (576)
T ss_dssp EEECCCTTCEECCTTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHH
T ss_pred eEEEecccceecccCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHH
Confidence 99999999987644322 123469999999999999999999999999999999999999997432211 100000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
.. + .......+..+++++.+++.+||+.||++|| +++|+++
T Consensus 399 -~~----i-----------------------~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 399 -RL----V-----------------------KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -HH----H-----------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -HH----h-----------------------hcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 0 0011112235677899999999999999999 7888875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=354.26 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=193.0
Q ss_pred hCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc----cchhHHHHHHHHHHHhcCCCCceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+.++++++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 467999999999999999999984 588999999997432 223456788999999999999999999954
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.++..++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 92 -~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~ 156 (327)
T 3a62_A 92 -TGGKLYLILEYLSGGELFMQLERE-----------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNH 156 (327)
T ss_dssp -CSSCEEEEEECCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECT
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECC
Confidence 457899999999999999998643 3588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~ 227 (327)
T 3a62_A 157 QGHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----K 227 (327)
T ss_dssp TSCEEECCCSCC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H
T ss_pred CCcEEEEeCCcccccccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----H
Confidence 99999999999975432211 12234689999999999999999999999999999999999999863211 1
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
..... +. ......+..++.++.+++.+||+.||++|| +++|+++
T Consensus 228 ~~~~~-----i~-----------------------~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 228 KTIDK-----IL-----------------------KCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHH-----HH-----------------------HTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHH-----HH-----------------------hCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11100 00 011112235677899999999999999999 6777765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.01 Aligned_cols=262 Identities=22% Similarity=0.379 Sum_probs=206.9
Q ss_pred hhCCCCCCceeccccceeEEEEEECC---CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||.||+|++.. ++..||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 45679999999999999999999753 34569999987542 3345778999999999999999999998542
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 150 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK----------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPE 150 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETT
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCC
Confidence 45689999999999999986432 3589999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||.+.......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 151 ~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~ 225 (281)
T 3cc6_A 151 CVKLGDFGLSRYIEDEDYYK---ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIG 225 (281)
T ss_dssp EEEECCCCGGGCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHH
T ss_pred cEEeCccCCCcccccccccc---cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHH
Confidence 99999999998654432111 122347889999999988899999999999999999998 99998632211 1100
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
... . ......+..+++.+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 226 ~~~--------~----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 226 VLE--------K----------------------GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp HHH--------H----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHh--------c----------------------CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 000 0 0001122356778999999999999999999999999999987654
Q ss_pred h
Q 001974 976 L 976 (988)
Q Consensus 976 ~ 976 (988)
.
T Consensus 276 ~ 276 (281)
T 3cc6_A 276 K 276 (281)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=360.10 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=196.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++. .++..
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence 3578999999999999999999999999999999997443 33467889999999999999999999964 45789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc--E
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI--A 818 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~ 818 (988)
++||||+++|+|.+++... .++++..++.++.|++.||+|||++ +|+||||||+||+++.++. +
T Consensus 92 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~ 157 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA-----------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRL 157 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCE
T ss_pred EEEEEeCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceE
Confidence 9999999999999998543 3689999999999999999999998 9999999999999987765 9
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCc-cchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTN-GDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++....... .....||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .+....
T Consensus 158 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~ 231 (361)
T 3uc3_A 158 KICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTI 231 (361)
T ss_dssp EECCCCCC--------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHH
T ss_pred EEeecCccccccccCC-----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHH
Confidence 9999999974332221 123459999999999988877655 899999999999999999987432211 111111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... ... .......+++++.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~--------~~~------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 QRILS--------VKY------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHT--------TCC------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhc--------CCC------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11100 000 001112467789999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=348.88 Aligned_cols=271 Identities=24% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||+||+|++ .+++.||+|+++.... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 5789999999999999999999 5899999999864432 23467889999999999999999999954 44789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||++ ++|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 141 (288)
T 1ob3_A 76 VLVFEHLD-QDLKKLLDVCE----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI 141 (288)
T ss_dssp EEEEECCS-EEHHHHHHTST----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEEecC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence 99999996 59999886543 3688999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...... .
T Consensus 142 ~Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~-~ 215 (288)
T 1ob3_A 142 ADFGLARAFGIPVR----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIF-R 215 (288)
T ss_dssp CCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-H
T ss_pred eECccccccCcccc----ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-H
Confidence 99999986543211 1122458999999999876 458999999999999999999999987432110 000000 0
Q ss_pred HHhhhh-hhhhc----cccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHV-IDIVD----PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~-~~~~d----~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ..+.. +........+ ...........++.++.+++.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 216 ILGTPNSKNWPNVTELPKYDPNFTVY-------EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCC-------CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHCCCChhhchhhhcccccccccccc-------cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000 0000000000 000001122356788999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.35 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=212.2
Q ss_pred hCCCCCCc-eeccccceeEEEEEEC--CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTH-LIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~-~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|+++... ....+.+.+|++++++++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence 35566666 9999999999999863 467889999997543 234567899999999999999999999962 2
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~ 148 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 148 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC----------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCC
Confidence 56899999999999999997543 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||++.......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 149 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~ 222 (287)
T 1u59_A 149 AKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EV 222 (287)
T ss_dssp EEECCCTTCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----HH
T ss_pred EEECcccceeeeccCccee-eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----HH
Confidence 9999999998764432211 11222346889999999988889999999999999999999 99998642111 00
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhh
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALL 976 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 976 (988)
.. .+.. ......+..+++++.+++.+||+.||++||++.|+++.|+++..+..
T Consensus 223 ~~-----~i~~----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 223 MA-----FIEQ----------------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HH-----HHHT----------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HH-----HHhc----------------------CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 0000 00012234678889999999999999999999999999999988766
Q ss_pred hh
Q 001974 977 EA 978 (988)
Q Consensus 977 ~~ 978 (988)
..
T Consensus 276 ~~ 277 (287)
T 1u59_A 276 SK 277 (287)
T ss_dssp TT
T ss_pred Cc
Confidence 53
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=355.37 Aligned_cols=280 Identities=23% Similarity=0.374 Sum_probs=215.8
Q ss_pred hCCCCCCceeccccceeEEEEEE----CCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++ ..+++.||+|++........+.+.+|++++++++||||+++++++... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence 45688999999999999999994 568899999999876666667899999999999999999999986532 23
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 183 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 183 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST----------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred CceEEEEECCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCc
Confidence 57899999999999999997543 3589999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||++.......... .......++..|+|||.+.+..++.++||||||+++|||+||..||..... .+.
T Consensus 184 ~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~ 256 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFM 256 (326)
T ss_dssp EEECCCTTCEECCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHH
T ss_pred EEEecCcchhhcccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHH
Confidence 9999999998765433211 112223477889999999888899999999999999999999999753210 000
Q ss_pred HHHHhhhhhhhhccccccCcchhh-hhhHHHH-hhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWD-ATNKQRL-RQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
....... ...+. ....+.+ .......+..++.++.+++.+||+.||++|||++|+++.|+++++++
T Consensus 257 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 257 RMIGNDK------------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHCTTC------------CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hhhcccc------------chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000000 00000 0000000 01112234467889999999999999999999999999999998876
Q ss_pred h
Q 001974 976 L 976 (988)
Q Consensus 976 ~ 976 (988)
.
T Consensus 325 ~ 325 (326)
T 2w1i_A 325 A 325 (326)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=353.11 Aligned_cols=274 Identities=23% Similarity=0.354 Sum_probs=214.1
Q ss_pred hhCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
..++|++.+.||+|+||.||+|++ ..+++.||+|+++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 456799999999999999999985 34678999999975433 3456789999999999 9999999999964
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCc-------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQK-------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.++..++||||+++|+|.+++........ ........+++.+++.++.||+.||+|||+. +|+|||||
T Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 34778999999999999999975432100 0001113589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cceEEEcCCCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999876543321 11223457889999999988899999999999999999999 9999864
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
..... ....... ... ....+..++.++.+++.+||+.||++|||++|++
T Consensus 251 ~~~~~-----~~~~~~~----~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 299 (313)
T 1t46_A 251 MPVDS-----KFYKMIK----EGF----------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (313)
T ss_dssp CCSSH-----HHHHHHH----HTC----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccchh-----HHHHHhc----cCC----------------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 32110 0000000 000 0011235677899999999999999999999999
Q ss_pred HHHHHHHHHh
Q 001974 966 HELQSVKNAL 975 (988)
Q Consensus 966 ~~L~~i~~~~ 975 (988)
+.|+++..+.
T Consensus 300 ~~L~~~~~~~ 309 (313)
T 1t46_A 300 QLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999987754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.99 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=201.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++ .|+.||+|+++.. ...+.+.+|++++++++||||+++++++.. .++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence 346799999999999999999998 5899999998643 345789999999999999999999998643 33578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 158 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 158 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH---------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred EEEEecCCCCCHHHHHHhcc---------cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEE
Confidence 99999999999999985321 12489999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||++........ ...+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... . ....
T Consensus 159 ~Dfg~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~---~~~~ 226 (278)
T 1byg_A 159 SDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D---VVPR 226 (278)
T ss_dssp CCCCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--G---HHHH
T ss_pred eecccccccccccc-------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--H---HHHH
Confidence 99999975443211 1247889999999988899999999999999999998 99998642111 0 0000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
+.. ......+..+++++.+++.+||+.||++|||++|+++.|++++...
T Consensus 227 -----~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 227 -----VEK----------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----HTT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----Hhc----------------------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 000 0011123357788999999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=361.64 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=193.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHH-HHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKA-LKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.... .....+..|..+ ++.++||||+++++++. ..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eC
Confidence 4679999999999999999999999999999999975432 233456677776 56789999999999854 45
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 177 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE-----------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGH 177 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence 8899999999999999998643 3688999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....
T Consensus 178 ikL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~~~~~ 248 (373)
T 2r5t_A 178 IVLTDFGLCKENIEHNS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMY 248 (373)
T ss_dssp EEECCCCBCGGGBCCCC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----HHHHH
T ss_pred EEEeeCccccccccCCC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHH
Confidence 99999999985332211 1223569999999999999999999999999999999999999986321 11111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. +. ......+..++.++.+++.+||+.||++||++.+.++
T Consensus 249 ~~-----i~-----------------------~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 249 DN-----IL-----------------------NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp HH-----HH-----------------------HSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred HH-----HH-----------------------hcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 10 00 0011223356778999999999999999999864433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=346.79 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=204.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++. .++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 5789999999999999999999998999999999975432 33467889999999999999999999954 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc--
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI-- 817 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 817 (988)
.++||||+++++|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~ 145 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 145 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTC
T ss_pred EEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCC
Confidence 89999999999998887543 3689999999999999999999999 9999999999999986655
Q ss_pred -EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 818 -AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 -~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||.+......... ....||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ...
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~ 215 (284)
T 3kk8_A 146 AVKLADFGLAIEVNDSEAW-----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRL 215 (284)
T ss_dssp CEEECCCTTCEECCSSCBC-----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred cEEEeeceeeEEcccCccc-----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHH
Confidence 999999999765543221 234589999999999999999999999999999999999999863211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .... .... ......+++++.+++.+||+.||++|||++|+++.
T Consensus 216 ~~~~-~~~~-------~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 216 YAQI-KAGA-------YDYP----------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHH-HHTC-------CCCC----------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHH-Hhcc-------ccCC----------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1100 0000 0000 00112467789999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.64 Aligned_cols=263 Identities=21% Similarity=0.235 Sum_probs=205.8
Q ss_pred CHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecc
Q 001974 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCS 730 (988)
Q Consensus 654 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 730 (988)
.+.+.....++|++.+.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|..++..++||||+++++++
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 130 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF- 130 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-
Confidence 34445556789999999999999999999999899999999996432 22335688999999999999999999985
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
.+++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +||||||||+||
T Consensus 131 ----~~~~~~~lVmE~~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NI 193 (412)
T 2vd5_A 131 ----QDENYLYLVMEYYVGGDLLTLLSKFG----------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNI 193 (412)
T ss_dssp ----ECSSEEEEEECCCCSCBHHHHHHHHS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred ----eeCCEEEEEEcCCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHe
Confidence 44588999999999999999996432 2689999999999999999999998 999999999999
Q ss_pred eeCCCCcEEEeeecccccccccccccceeccccccccccccCcccC-------CCCCCCccchHHHHHHHHHHHhCCCCC
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-------GSEVSTNGDIYSYGILLLEMVTGKKPT 883 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~elltg~~p~ 883 (988)
|++.++.+||+|||+++....... .......||+.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 194 Lld~~g~vkL~DFGla~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 194 LLDRCGHIRLADFGSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp EECTTSCEEECCCTTCEECCTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eecCCCCEEEeechhheeccCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 999999999999999986544322 1122356999999999987 457899999999999999999999998
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC---CC
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR---MS 960 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps 960 (988)
..... ........... ... ........++.++.+++.+||. +|++| |+
T Consensus 271 ~~~~~-----~~~~~~i~~~~-~~~----------------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~ 321 (412)
T 2vd5_A 271 YADST-----AETYGKIVHYK-EHL----------------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGG 321 (412)
T ss_dssp CCSSH-----HHHHHHHHTHH-HHC----------------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTT
T ss_pred CCCCH-----HHHHHHHHhcc-cCc----------------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence 63211 11111100000 000 0000112567889999999999 99998 58
Q ss_pred HHHHHH
Q 001974 961 ITNVVH 966 (988)
Q Consensus 961 ~~evl~ 966 (988)
++|+++
T Consensus 322 ~~ei~~ 327 (412)
T 2vd5_A 322 AGDFRT 327 (412)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 888865
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=363.99 Aligned_cols=344 Identities=26% Similarity=0.379 Sum_probs=186.4
Q ss_pred CCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 55 LSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 55 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
+++++.|+++++.++. +| .+..+++|++|+|++|.+++..| |+.+++|++|+|++|++++..+ |.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 4566667777666663 44 25666667777777776664333 6666667777777776664433 66666667777
Q ss_pred cccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCC
Q 001974 135 MQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 214 (988)
+++|.+++..+ +.++++|++|++++|.+.+ ++ .++++++|++|+++ |.+.+.. .+.++++|++|++++|++.
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~- 190 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS- 190 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC-
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC-
Confidence 76666664322 6666666666666666663 22 36666666666665 3444322 2666666666666666665
Q ss_pred CCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchh
Q 001974 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMS 294 (988)
Q Consensus 215 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 294 (988)
.++. +..+++|+.|++++|.+++..| +..+++|+.|++++|++.+. ..+..+++|+.|++++|.++...+
T Consensus 191 ~~~~--l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~---- 260 (466)
T 1o6v_A 191 DISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP---- 260 (466)
T ss_dssp CCGG--GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG----
T ss_pred CChh--hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh----
Confidence 3322 3355556666666665554433 44455555555555555543 234455555555555555543221
Q ss_pred hhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCC
Q 001974 295 FMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK 374 (988)
Q Consensus 295 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 374 (988)
+..+++|++|++++|++++..+ +..+ ++|+.|++++|++.+..+ +..+++|+.|++++|++++..| +..
T Consensus 261 ----~~~l~~L~~L~l~~n~l~~~~~--~~~l-~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~ 329 (466)
T 1o6v_A 261 ----LSGLTKLTELKLGANQISNISP--LAGL-TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329 (466)
T ss_dssp ----GTTCTTCSEEECCSSCCCCCGG--GTTC-TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred ----hhcCCCCCEEECCCCccCcccc--ccCC-CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence 3444555555555555542221 2222 245555555555543322 4455555555555555554333 445
Q ss_pred CCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCC
Q 001974 375 LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN 437 (988)
Q Consensus 375 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 437 (988)
+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|.++
T Consensus 330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 55555555555555532 234555555555555555554444 455555555555555554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.76 Aligned_cols=272 Identities=19% Similarity=0.221 Sum_probs=211.0
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++... .......
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCcee
Confidence 356799999999999999999999889999999999766666667899999999999999999999997532 1234578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++...... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-------GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEE
Confidence 9999999999999998642110 13689999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccc-----ceeccccccccccccCcccCCCC---CCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 821 GDFGLARVRQEVSNLT-----QSCSVGVRGTIGYAAPEYGLGSE---VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+|||.+.......... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.........
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999987543211110 00011234799999999987654 688999999999999999999998632221111
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
..... .. .........++.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 256 ~~~~~------------~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 256 VALAV------------QN------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHH------------HC------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhHHh------------hc------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11000 00 0001112356778999999999999999999999999999875
Q ss_pred H
Q 001974 973 N 973 (988)
Q Consensus 973 ~ 973 (988)
.
T Consensus 306 ~ 306 (317)
T 2buj_A 306 P 306 (317)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.47 Aligned_cols=276 Identities=24% Similarity=0.376 Sum_probs=211.6
Q ss_pred CCCCceeccccceeEEEEEE----CCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 665 FSSTHLIGMGSFGSVYKGAF----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
|++++.||+|+||+||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++... ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 48899999999999988765 34788999999975432 3356789999999999999999999997542 3467
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~k 174 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH------------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVK 174 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEecccCCcHHHHHhhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEE
Confidence 89999999999999999643 478999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++......... ........+|..|+|||++.+..++.++||||||+++|||++|+.||............+...
T Consensus 175 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 175 IGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp ECCGGGCEECCTTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred ECCccccccccccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 9999999876543221 112223457889999999999899999999999999999999999976321110000000000
Q ss_pred -HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 900 -ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 900 -~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
.....+.+.+ ........+..++.++.+++.+||+.||++|||++|+++.|+++.+++..
T Consensus 254 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 254 QMTVLRLTELL------------------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHHHH------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred chhHHHHHHHH------------------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 0000000000 01111223446788999999999999999999999999999999988764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=356.34 Aligned_cols=289 Identities=22% Similarity=0.292 Sum_probs=205.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHH--HHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA--LKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|++ +++.||||+++... ...+..|.++ +..++||||+++++++.........
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 357899999999999999999987 78999999986433 2344444444 4558999999999876554455556
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEeccCCCCCeee
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC------QEPVLHCDLKPGNVLL 812 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll 812 (988)
..++||||+++|+|.+++... ..++..++.++.||+.||+|||+.+ .++|+||||||+||++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred eEEEEEecCCCCcHHHHHhhc------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 789999999999999999543 4588899999999999999999862 2389999999999999
Q ss_pred CCCCcEEEeeeccccccccccccc----ceeccccccccccccCcccCC-------CCCCCccchHHHHHHHHHHHhCCC
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLT----QSCSVGVRGTIGYAAPEYGLG-------SEVSTNGDIYSYGILLLEMVTGKK 881 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltg~~ 881 (988)
+.++.+||+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 999999999999998665432111 111223469999999999887 456778999999999999999977
Q ss_pred CCCccccCCcchHHHHHHHHhh----hhhhhh-ccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCC
Q 001974 882 PTDVMFEGDLNLHNYARTALLD----HVIDIV-DPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQ 956 (988)
Q Consensus 882 p~~~~~~~~~~~~~~~~~~~~~----~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 956 (988)
||............+....... ...... ......... ........+++++.+++.+||+.||+
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP------------EAWKENSLAVRSLKETIEDCWDQDAE 301 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC------------TTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC------------cccccccchHHHHHHHHHHHhcCChh
Confidence 7643221111000000000000 000000 000000000 00011223667899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHhhhh
Q 001974 957 DRMSITNVVHELQSVKNALLEA 978 (988)
Q Consensus 957 ~RPs~~evl~~L~~i~~~~~~~ 978 (988)
+|||++|+++.|+++...+...
T Consensus 302 ~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 302 ARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp GSCCHHHHHHHHHHHHHCCCC-
T ss_pred hCcchHHHHHHHHHHHHHHHhc
Confidence 9999999999999998776553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.11 Aligned_cols=275 Identities=20% Similarity=0.399 Sum_probs=213.0
Q ss_pred hhCCCCCCceeccccceeEEEEEEC-------CCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFD-------QDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++|++.+.||+|+||.||+|++. .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 4578999999999999999999985 3567899999975432 3346789999999999 9999999999964
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
.++..++||||+++|+|.+++......... .......+++.+++.++.||+.||+|||+. +|+|||||
T Consensus 112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 184 (334)
T 2pvf_A 112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 184 (334)
T ss_dssp ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence 347889999999999999999765421110 011123589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEEcCCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999999999865543221 11223457889999999988889999999999999999999 9999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.. ....... +.. ......+..++.++.+++.+||+.||++|||++|++
T Consensus 263 ~~-----~~~~~~~-----~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 310 (334)
T 2pvf_A 263 IP-----VEELFKL-----LKE----------------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310 (334)
T ss_dssp CC-----HHHHHHH-----HHH----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CC-----HHHHHHH-----Hhc----------------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 21 1111100 000 000112235678899999999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 001974 966 HELQSVKNALLE 977 (988)
Q Consensus 966 ~~L~~i~~~~~~ 977 (988)
+.|+++.+....
T Consensus 311 ~~L~~l~~~~~~ 322 (334)
T 2pvf_A 311 EDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHhcccc
Confidence 999999876544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=361.76 Aligned_cols=212 Identities=25% Similarity=0.343 Sum_probs=182.9
Q ss_pred hhccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-----CCCc
Q 001974 648 KALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-----HRNL 722 (988)
Q Consensus 648 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 722 (988)
.....+++.+.....++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+..|+.+++.++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 4456677777667788999999999999999999999989999999998632 234467788999999986 9999
Q ss_pred eEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 001974 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLH 802 (988)
Q Consensus 723 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 802 (988)
+++++++.. .+..++||||+ +++|.+++..... ..+++.+++.++.||+.||+|||+. +|||
T Consensus 99 v~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH 160 (360)
T 3llt_A 99 VKYHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNY---------NGFHIEDIKLYCIEILKALNYLRKM---SLTH 160 (360)
T ss_dssp CCEEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ecccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence 999998653 47899999999 9999999975432 2588999999999999999999998 9999
Q ss_pred ccCCCCCeeeCC-------------------------CCcEEEeeecccccccccccccceeccccccccccccCcccCC
Q 001974 803 CDLKPGNVLLDN-------------------------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG 857 (988)
Q Consensus 803 ~Dlkp~NIll~~-------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 857 (988)
|||||+|||++. ++.+||+|||+|+...... ....||+.|+|||++.+
T Consensus 161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILN 233 (360)
T ss_dssp SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTT
T ss_pred CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcC
Confidence 999999999975 7899999999998644321 23458999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 858 SEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 858 ~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
..++.++|||||||++|||++|+.||..
T Consensus 234 ~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 234 LGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.45 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++. .++..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 357899999999999999999999899999999997443 334578899999999999999999999864 34788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT-----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCcHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence 99999999999999997542 689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+........ ........|++.|+|||++.+..+ +.++||||||+++|||++|+.||.........+..+..
T Consensus 147 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 223 (276)
T 2yex_A 147 SDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE- 223 (276)
T ss_dssp CCCTTCEECEETTE--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT-
T ss_pred eeCCCccccCCCcc--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh-
Confidence 99999986543221 111223568999999999988765 77899999999999999999999753322111111100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .......++..+.+++.+||+.||++|||++|+++
T Consensus 224 -----------~~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 224 -----------KKT------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----------TCT------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------ccc------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000 00011246678999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=353.16 Aligned_cols=282 Identities=22% Similarity=0.335 Sum_probs=217.6
Q ss_pred CHHHHHHhhCCCCCCceeccccceeEEEEEE-----CCCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEE
Q 001974 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVI 726 (988)
Q Consensus 654 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 726 (988)
....+....++|++.+.||+|+||+||+|++ ..+++.||||+++.... ...+.+.+|+.+++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678899999999999999999985 34678999999975433 3346789999999999 799999999
Q ss_pred eecccccccCCCceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 001974 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL 801 (988)
Q Consensus 727 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 801 (988)
+++.. .+...++||||+++++|.+++......... .......+++.+++.++.|++.||+|||+. +|+
T Consensus 98 ~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~ 170 (316)
T 2xir_A 98 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 170 (316)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 99643 235689999999999999999765421100 000012388999999999999999999999 999
Q ss_pred eccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CC
Q 001974 802 HCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GK 880 (988)
Q Consensus 802 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~ 880 (988)
||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865443221 11223457889999999998899999999999999999998 99
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||......+ ... ..... ......+..+++++.+++.+||+.||++|||
T Consensus 249 ~p~~~~~~~~----~~~-~~~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 249 SPYPGVKIDE----EFC-RRLKE--------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp CSSTTCCCSH----HHH-HHHHH--------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcccchhH----HHH-HHhcc--------------------------CccCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 9986432110 000 00000 0001122346778999999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 001974 961 ITNVVHELQSVKNAL 975 (988)
Q Consensus 961 ~~evl~~L~~i~~~~ 975 (988)
++|+++.|+++.++.
T Consensus 298 ~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 298 FSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999999997654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.01 Aligned_cols=277 Identities=19% Similarity=0.236 Sum_probs=205.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|++++++++ ||||+++++++... .....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCce
Confidence 46799999999999999999999989999999998643 3477899999999996 99999999997542 24678
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 819 (988)
++||||+++++|.+++. .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+|
T Consensus 109 ~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~k 171 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ--------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLR 171 (330)
T ss_dssp EEEEECCCCCCHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEEEeccCchhHHHHHH--------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEE
Confidence 99999999999999873 578889999999999999999999 999999999999999776 899
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++........ ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.....
T Consensus 172 l~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 172 LIDWGLAEFYHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp ECCCTTCEECCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred EEeCCCceEcCCCCcc-----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 9999999865543322 22458999999999877 67899999999999999999999998543222111211111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHH----H-HhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQ----R-LRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........+.++.........+...... . ...........+++++.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111111111110000000000000 0 000001112236788999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=374.13 Aligned_cols=263 Identities=28% Similarity=0.472 Sum_probs=206.9
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.+|++++++++||||+++++++.. +.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 34567889999999999999999996 56779999997543 335789999999999999999999998642 56
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+||++++++.+|
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k 320 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGET---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 320 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHH---------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred eEEEehhhcCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEE
Confidence 899999999999999996421 13589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 321 l~DfG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~- 391 (452)
T 1fmk_A 321 VADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVL- 391 (452)
T ss_dssp ECCCCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHH-
T ss_pred ECCCccceecCCCce---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHH-
Confidence 999999986543221 11223447889999999998899999999999999999999 99998632110 100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
..+.. ......+..++..+.++|.+||+.||++|||++++++.|+++.+....
T Consensus 392 ----~~i~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 392 ----DQVER----------------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp ----HHHHT----------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ----HHHHc----------------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 00000 001122346788899999999999999999999999999988655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=351.43 Aligned_cols=245 Identities=22% Similarity=0.254 Sum_probs=192.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.++||+|+||+||+|++..+|+.||||++..... .....+..|+..+.++ +||||++++++|. .++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 569999999999999999999998999999999864322 2234555666666665 9999999999965 3488
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG----------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEE
T ss_pred EEEEEecc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence 99999999 789998886543 3689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|..|+... . .+
T Consensus 198 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~---~~--- 261 (311)
T 3p1a_A 198 LGDFGLLVELGTAGA-----GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----E---GW--- 261 (311)
T ss_dssp ECCCTTCEECC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----H---HH---
T ss_pred EccceeeeecccCCC-----CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----c---HH---
Confidence 999999986544322 123458999999999876 7899999999999999999997765421 0 00
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+ ..... .. .....+++++.+++.+||+.||++|||++|+++
T Consensus 262 ---~~~---~~~~~---~~---------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 ---QQL---RQGYL---PP---------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHH---TTTCC---CH---------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHH---hccCC---Cc---------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 00000 00 011246778999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.42 Aligned_cols=280 Identities=23% Similarity=0.322 Sum_probs=196.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++++. ||||+++++++... +.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence 457899999999999999999999999999999998533 2334567889999999996 99999999997532 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA------------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred CEEEEEecccC-cCHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCC
Confidence 57899999995 799988854 2588999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccc-----------------cceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhC
Q 001974 818 AHVGDFGLARVRQEVSNL-----------------TQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTG 879 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg 879 (988)
+||+|||+|+........ .........||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 999999999865331110 0111233579999999999886 6789999999999999999999
Q ss_pred CCCCCccccCCcchHHHHHHHHhhhhhhhhccc----------------------cccCcchhhhhhHHHHhhhhhcccc
Q 001974 880 KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPI----------------------LINDVEDWDATNKQRLRQAKINGKI 937 (988)
Q Consensus 880 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~----------------------l~~~~~~~~~~~~~~~~~~~~~~~~ 937 (988)
++||...... ...............+.+... .......|.. .........
T Consensus 228 ~~pf~~~~~~--~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~ 299 (388)
T 3oz6_A 228 KPIFPGSSTM--NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN------LLLKINPKA 299 (388)
T ss_dssp SCSCCCSSHH--HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHH------HHHHHCTTC
T ss_pred CCCCCCCCHH--HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhh------hcccccccc
Confidence 9998642111 000000000000000000000 0000001100 001111223
Q ss_pred chhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 938 ECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 938 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+++++.+++.+||+.||++|||++|+++.
T Consensus 300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 300 DCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 567889999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=345.97 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=184.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence 467999999999999999999998899999999996432 223467899999999999999999999954 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV----------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCE
T ss_pred eEEEEEecCCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence 8999999999999999997653 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||.+......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 152 kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------- 219 (278)
T 3cok_A 152 KIADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------- 219 (278)
T ss_dssp EECCCTTCEECC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------
T ss_pred EEEeecceeeccCCCCc----ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------
Confidence 99999999865432211 122458999999999999899999999999999999999999986421110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
........+ ...+..++.++.+++.+||+.||++|||++|+++
T Consensus 220 ---------~~~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 220 ---------TLNKVVLAD----------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -------------CCSSC----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---------HHHHHhhcc----------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000000000 0112346678999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=352.41 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=199.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 679999999999999999999998999999999864432 23466889999999999999999999964 34788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR-----------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEeCCCchHHHHHhhhc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEE
Confidence 99999999999998876543 589999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.+......... .....||..|+|||++.+ ..++.++||||+|+++|||++|+.||...... ........
T Consensus 144 ~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~ 217 (311)
T 4agu_A 144 CDFGFARLLTGPSDY----YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRK 217 (311)
T ss_dssp CCCTTCEECC----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH
T ss_pred eeCCCchhccCcccc----cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence 999999865533221 123458999999999876 67899999999999999999999998643211 11111111
Q ss_pred HHhhhhh---h------hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVI---D------IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~---~------~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... . ........+..... ........++.++.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDME---------PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHCSCCHHHHHHHHTCGGGTTCCCCCCSSCC---------CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HhcccccccccccccccccccCcCCCccccc---------hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1110000 0 00000000000000 000011356778999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=348.13 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=207.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF------- 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 734 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++...++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356899999999999999999998899999999997543 456789999999999999999998754211
Q ss_pred ----cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 735 ----QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 735 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni 153 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---------EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG---------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence 123557999999999999999964321 3689999999999999999999998 999999999999
Q ss_pred eeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
++++++.+||+|||++......... ....|++.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 224 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---- 224 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSCC-----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----
T ss_pred EEcCCCCEEECcchhheeccccccc-----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----
Confidence 9999999999999999866543221 2245899999999999999999999999999999999999885310
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
......+ .+. ..+..++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 225 --------~~~~~~~---~~~----------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 225 --------SKFFTDL---RDG----------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp --------HHHHHHH---HTT----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------HHHHHHh---hcc----------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0000000 000 0112456778999999999999999999999999999
Q ss_pred HHHHh
Q 001974 971 VKNAL 975 (988)
Q Consensus 971 i~~~~ 975 (988)
+++..
T Consensus 272 ~~~~~ 276 (284)
T 2a19_B 272 WKKSP 276 (284)
T ss_dssp HTC--
T ss_pred HhhCC
Confidence 86553
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=353.88 Aligned_cols=275 Identities=25% Similarity=0.403 Sum_probs=211.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEE--EEEEeecc-ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIV--AIKVFNLQ-RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|++..+++.+ |+|+++.. .....+.+.+|+++++++ +||||+++++++.. +
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence 367999999999999999999998888765 99988643 233456789999999999 99999999999643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhh-----hHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVE-----IEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+..++||||+++++|.+++........... .....+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence 789999999999999999976531000000 0013689999999999999999999998 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--- 247 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 247 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred cCCCeEEEcccCcCcccccccc-----ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---
Confidence 9999999999999974332211 112347889999999988889999999999999999998 9999863211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
... .+.+... .....+..+++++.+++.+||+.||++|||++|+++.|+++
T Consensus 248 --~~~-----~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 248 --AEL-----YEKLPQG----------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --HHH-----HHHGGGT----------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH-----HHHhhcC----------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 010 0011000 01122335678899999999999999999999999999999
Q ss_pred HHHhhhhccc
Q 001974 972 KNALLEAWNC 981 (988)
Q Consensus 972 ~~~~~~~~~~ 981 (988)
.++.....+.
T Consensus 299 ~~~~~~~~~~ 308 (327)
T 1fvr_A 299 LEERKTYVNT 308 (327)
T ss_dssp HHSSSCSBCC
T ss_pred HHhhcCcccc
Confidence 8876554433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.00 Aligned_cols=261 Identities=20% Similarity=0.243 Sum_probs=200.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.. ++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 4789999999999999999999988999999999964422 224678899999999999999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ-----------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred eEEEEEEecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence 899999999999999998643 2689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++......... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 174 kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~ 244 (309)
T 2h34_A 174 YLVDFGIASATTDEKLT---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMG 244 (309)
T ss_dssp EECSCCC-------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHH
T ss_pred EEecCccCccccccccc---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHH
Confidence 99999999765443211 11234589999999999999999999999999999999999999863211 0111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-CHHHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-SITNVVHELQSVKNA 974 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~ 974 (988)
....... . . .......++.++.+++.+||+.||++|| +++++++.|+++.+.
T Consensus 245 ~~~~~~~----~-----~---------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 245 AHINQAI----P-----R---------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHHSCC----C-----C---------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HHhccCC----C-----C---------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1110000 0 0 0011235778899999999999999999 999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=379.12 Aligned_cols=262 Identities=22% Similarity=0.383 Sum_probs=206.0
Q ss_pred CCCCCc-eeccccceeEEEEEEC--CCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 664 GFSSTH-LIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 664 ~y~~~~-~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++||||++++++|.. +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 333444 7999999999999875 356679999997543 3355789999999999999999999999642 45
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred eEEEEEeCCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEE
Confidence 899999999999999997653 3689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++.......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .. .
T Consensus 477 L~DFGla~~~~~~~~~~~-~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~---~- 549 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EV---M- 549 (613)
T ss_dssp ECCCSTTTTCC---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HH---H-
T ss_pred EeeccCcccccCCCceee-eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HH---H-
Confidence 999999987643322111 1122346789999999998999999999999999999998 99998743211 00 0
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
+.+.. ......+..+++++.++|.+||+.||++||+++++++.|+.+..+...
T Consensus 550 ----~~i~~----------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 ----AFIEQ----------------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp ----HHHHT----------------------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred ----HHHHc----------------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 00000 001122346888999999999999999999999999999999877654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.08 Aligned_cols=269 Identities=23% Similarity=0.294 Sum_probs=202.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.++++++||||+++++++.. ++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 457999999999999999999998899999999997432 3345678899999999999999999999654 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKK-------QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred cEEEEEecCCCCCHHHHHHHhcc-------cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence 88999999999999999853210 113589999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .......
T Consensus 176 kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~ 248 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCK 248 (310)
T ss_dssp EECCC----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHH
T ss_pred EEEeccceeeecCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHH
Confidence 9999999986543221 11234589999999999999999999999999999999999999863211 1111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhhh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLEA 978 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 978 (988)
. +... ... ......++.++.+++.+||+.||++|||++++++.|+++.......
T Consensus 249 ~-----~~~~---~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 249 K-----IEQC---DYP------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp H-----HHTT---CSC------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred H-----hhcc---cCC------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0 0000 000 0011246778999999999999999999999999999998876553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.90 Aligned_cols=274 Identities=21% Similarity=0.233 Sum_probs=199.7
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeeccccc---ccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSID---FQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~ 736 (988)
...+|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++.... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999999899999999987666666678999999999995 999999999874221 134
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLDN 814 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~ 814 (988)
....++||||+ +|+|.+++..... ...+++.+++.++.||+.||+|||+. + |+||||||+||+++.
T Consensus 106 ~~~~~lv~e~~-~g~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 106 QAEFLLLTELC-KGQLVEFLKKMES--------RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp SEEEEEEEECC-SEEHHHHHHHHHT--------TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECT
T ss_pred CceEEEEEEec-CCCHHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECC
Confidence 45689999999 5899988854211 13589999999999999999999998 7 999999999999999
Q ss_pred CCcEEEeeecccccccccccccc--------eeccccccccccccCccc---CCCCCCCccchHHHHHHHHHHHhCCCCC
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQ--------SCSVGVRGTIGYAAPEYG---LGSEVSTNGDIYSYGILLLEMVTGKKPT 883 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~ 883 (988)
++.+||+|||+++.......... .......||+.|+|||++ .+..++.++|||||||++|||++|+.||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 253 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999987654322110 011134589999999998 5667899999999999999999999998
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
...... ........ .......+..+.+++.+||+.||++|||++|
T Consensus 254 ~~~~~~-----------------~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 298 (337)
T 3ll6_A 254 EDGAKL-----------------RIVNGKYS------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298 (337)
T ss_dssp -----------------------------CC------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHH
T ss_pred cchhHH-----------------HhhcCccc------------------CCcccccchHHHHHHHHHccCChhhCcCHHH
Confidence 632110 00000000 0111234556889999999999999999999
Q ss_pred HHHHHHHHHHHhhhhccc
Q 001974 964 VVHELQSVKNALLEAWNC 981 (988)
Q Consensus 964 vl~~L~~i~~~~~~~~~~ 981 (988)
+++.|+++.+........
T Consensus 299 ~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 299 VVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp HHHHHHHHHHHTTCCTTS
T ss_pred HHHHHHHHHhccCCCCCc
Confidence 999999998765544433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=372.22 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=195.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+|+.||||+++.. .......+.+|+.+++.++||||+++++++.. ++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 46799999999999999999999999999999999743 23334567889999999999999999999653 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCc
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ . +||||||||+|||++.++.
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE-----------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSC
T ss_pred EEEEEEeeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCC
Confidence 899999999999999988543 368999999999999999999998 7 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....
T Consensus 288 ~kl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~ 358 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLF 358 (446)
T ss_dssp EEECCCCCCCTTCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred EEEccCCCceeccCCCc----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHH
Confidence 99999999975332211 1223569999999999999999999999999999999999999986321 11111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
... .......+..+++++.+++.+||+.||++|| +++|+++
T Consensus 359 ~~i----------------------------~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 359 ELI----------------------------LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHH----------------------------HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHH----------------------------HhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 110 0011112335677899999999999999999 9999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=362.44 Aligned_cols=288 Identities=20% Similarity=0.295 Sum_probs=215.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++... .....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 457999999999999999999999899999999997433 23346788999999999999999999986532 33578
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee----CCCC
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDM 816 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 816 (988)
++||||+++|+|.+++...... ..+++.+++.++.||+.||+|||+. +|+||||||+||++ +.++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA--------YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCE
T ss_pred EEEEecCCCCCHHHHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCce
Confidence 9999999999999999764311 2389999999999999999999999 99999999999999 7888
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC--------CCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--------SEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 154 ~~kL~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 154 VYKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp EEEECCGGGCEECCCGGGS-----SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred eEEEecCCCceEccCCCcc-----ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 8999999999876543221 23458999999998764 4678899999999999999999999875433
Q ss_pred CCcchHHHHHHHHhhhhhhhhccc--cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPI--LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~--l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ...............+... ......+|..... .........+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 229 PRRN-KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TTTC-HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred ccch-HHHHHHHhcCCCcccchhheeccCCCcccCccCC-----cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222 1222222221111100000 0000111111000 000112356778999999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 967 ELQSVKNA 974 (988)
Q Consensus 967 ~L~~i~~~ 974 (988)
.++++.+.
T Consensus 303 ~l~~il~~ 310 (396)
T 4eut_A 303 ETSDILHR 310 (396)
T ss_dssp HHHHHHTC
T ss_pred HHHHHhhc
Confidence 99988654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=358.10 Aligned_cols=280 Identities=21% Similarity=0.247 Sum_probs=198.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 738 (988)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+++++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 57899999999999999999999999999999998543 2233467889999999999999999999975431 12224
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred eEEEEEecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence 569999999 8999999854 2588999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......
T Consensus 168 kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i 238 (367)
T 1cm8_A 168 KILDFGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEI 238 (367)
T ss_dssp EECCCTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred EEEeeecccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999999865432 123468999999999877 67999999999999999999999998632110 000001
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.........+............+...................++.+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000000000000000000000000000001112356788999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.01 Aligned_cols=290 Identities=21% Similarity=0.220 Sum_probs=209.4
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 3344578999999999999999999999999999999997433 233467889999999999999999999987654455
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
....++||||++ |+|.+++.. ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~ 165 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTC 165 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred cceEEEEEcccC-cCHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCC
Confidence 567899999995 699988853 2589999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~ 242 (364)
T 3qyz_A 166 DLKICDFGLARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLN 242 (364)
T ss_dssp CEEECCCTTCEECCGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG--GHHH
T ss_pred CEEEEeCcceEecCCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH--HHHH
Confidence 99999999998665432211 11223469999999998654 55899999999999999999999998643211 1111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...........+............+..................++.++.+++.+||+.||++|||++|+++
T Consensus 243 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111100000000000000000000000000000112346778999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=352.03 Aligned_cols=267 Identities=22% Similarity=0.272 Sum_probs=200.0
Q ss_pred hCCCCCC-ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSST-HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.+.|++. +.||+|+||.||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++. .++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence 3568774 7899999999999999889999999999866555667899999999995 7999999999964 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc--
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI-- 817 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 817 (988)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 151 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR-----------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVS 151 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSC
T ss_pred EEEEEEcCCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcC
Confidence 99999999999999998643 3689999999999999999999999 9999999999999998776
Q ss_pred -EEEeeecccccccccccc---cceeccccccccccccCcccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 818 -AHVGDFGLARVRQEVSNL---TQSCSVGVRGTIGYAAPEYGLG-----SEVSTNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 818 -~kL~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+||+|||++......... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp SEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 999999999765432111 1111223458999999999875 4688999999999999999999999975433
Q ss_pred CCcchHHHH-----HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 889 GDLNLHNYA-----RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 889 ~~~~~~~~~-----~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
.+..+.... .....+.+.. ....... .....++.++.+++.+||+.||++|||++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~i~~---~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 232 SDCGWDRGEACPACQNMLFESIQE---GKYEFPD----------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp SCSCC----CCHHHHHHHHHHHHH---CCCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccccccccccchhHHHHHHHHHhc---cCcccCc----------------hhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 321111000 0000010000 0000000 001246778999999999999999999999
Q ss_pred HHH
Q 001974 964 VVH 966 (988)
Q Consensus 964 vl~ 966 (988)
+++
T Consensus 293 ~l~ 295 (316)
T 2ac3_A 293 VLQ 295 (316)
T ss_dssp HHH
T ss_pred Hhc
Confidence 987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.37 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=205.8
Q ss_pred cCHHHHHHhhCCCCCC-ceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhc-CCCCceEEEee
Q 001974 653 VSYESLFKATDGFSST-HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNI-RHRNLVKVITS 728 (988)
Q Consensus 653 ~~~~~l~~~~~~y~~~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 728 (988)
+.+.......++|.+. +.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++++ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444444556678777 89999999999999999899999999997433 23357889999999999 56999999999
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
+. .++..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+
T Consensus 98 ~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~ 160 (327)
T 3lm5_A 98 YE-----NTSEIILILEYAAGGEIFSLCLPELA---------EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQ 160 (327)
T ss_dssp EE-----CSSEEEEEEECCTTEEGGGGGSSCC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred EE-----eCCeEEEEEEecCCCcHHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChH
Confidence 54 45789999999999999999865432 3689999999999999999999999 9999999999
Q ss_pred CeeeCC---CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 809 NVLLDN---DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 809 NIll~~---~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+++. ++.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 161 NILLSSIYPLGDIKIVDFGMSRKIGHACEL-----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp GEEESCBTTBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HEEEecCCCCCcEEEeeCccccccCCcccc-----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998 789999999999866443221 224589999999999999999999999999999999999999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.... ..... +... .... .......++..+.+++.+||+.||++|||++|++
T Consensus 236 ~~~~-----~~~~~-----i~~~---~~~~----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 236 EDNQ-----ETYLN-----ISQV---NVDY----------------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp SSHH-----HHHHH-----HHHT---CCCC----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCch-----HHHHH-----HHhc---cccc----------------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 2110 00000 0000 0000 0011225677899999999999999999999997
Q ss_pred HH
Q 001974 966 HE 967 (988)
Q Consensus 966 ~~ 967 (988)
+.
T Consensus 287 ~h 288 (327)
T 3lm5_A 287 SH 288 (327)
T ss_dssp TC
T ss_pred CC
Confidence 53
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=363.06 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=194.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
..++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-- 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 35789999999999999999999999999999999864321 12235789999999999999999999853
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
.+..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 211 ----~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 211 ----AEDYYIVLELMEGGELFDKVVGNK-----------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp ----SSEEEEEEECCTTCBGGGGTSSSC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred ----cCceEEEEEcCCCCcHHHHHhccC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 245799999999999999987653 689999999999999999999998 99999999999999
Q ss_pred CCC---CcEEEeeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 813 DND---MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 813 ~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
+.+ +.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ecCCCcceEEEeecccceecCCCcc-----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 754 4599999999987654322 123468999999999864 57888999999999999999999998743
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ....... .. ...... .....+++++.+++.+||+.||++|||++|+++
T Consensus 348 ~~~~-~~~~~i~----~~-------~~~~~~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 348 RTQV-SLKDQIT----SG-------KYNFIP----------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSSC-CHHHHHH----TT-------CCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchH-HHHHHHh----cC-------CCCCCc----------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2211 1111110 00 000000 011246778999999999999999999999986
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=358.09 Aligned_cols=345 Identities=28% Similarity=0.392 Sum_probs=227.7
Q ss_pred CCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCcccee
Q 001974 78 RLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESI 157 (988)
Q Consensus 78 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 157 (988)
.+++|+.|++++|.+. .+|. +..+++|++|+|++|++++..+ |.++++|++|++++|.+++..+ +.++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 4678999999999998 5664 8899999999999999986554 9999999999999999996554 8999999999
Q ss_pred eccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccccc
Q 001974 158 SLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237 (988)
Q Consensus 158 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l 237 (988)
++++|.+++..+ +.++++|++|+|++|.+++. + .+..+++|++|+++ |.+. .++. +..+++|+.|++++|.+
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~-~~~~--~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVT-DLKP--LANLTTLERLDISSNKV 189 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCC-CCGG--GTTCTTCCEEECCSSCC
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Cccc-Cchh--hccCCCCCEEECcCCcC
Confidence 999999986533 89999999999999999853 3 58899999999996 5555 3332 55778888888888888
Q ss_pred ccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCC
Q 001974 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317 (988)
Q Consensus 238 ~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 317 (988)
++. ..+..+++|+.|++++|.+.+..+ +..+++|+.|++++|.++.++ .+..+++|++|++++|++++
T Consensus 190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~n~l~~ 257 (466)
T 1o6v_A 190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG--------TLASLTNLTDLDLANNQISN 257 (466)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--------GGGGCTTCSEEECCSSCCCC
T ss_pred CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch--------hhhcCCCCCEEECCCCcccc
Confidence 754 246777777777777777776655 566777777777777766531 34556666666666666653
Q ss_pred CCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCC
Q 001974 318 ALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLG 397 (988)
Q Consensus 318 ~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 397 (988)
..| +..+ ++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +.
T Consensus 258 ~~~--~~~l-~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~ 328 (466)
T 1o6v_A 258 LAP--LSGL-TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VS 328 (466)
T ss_dssp CGG--GTTC-TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GG
T ss_pred chh--hhcC-CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hc
Confidence 322 2222 245555555555553322 4445555555555555543222 4445555555555555544333 44
Q ss_pred CCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceeccccccc
Q 001974 398 NLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 398 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 462 (988)
.+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..++.+ +.|++++|.++
T Consensus 329 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L-~~L~l~~n~~~ 388 (466)
T 1o6v_A 329 SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRI-TQLGLNDQAWT 388 (466)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTC-CEEECCCEEEE
T ss_pred cCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCC-CEEeccCCccc
Confidence 445555555555555432 234445555555555555543333 4444444 44444444444
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.97 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=204.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. .++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 367999999999999999999999899999999986432 223467899999999999999999999954 447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKH-----------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCE
T ss_pred EEEEEEEeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCE
Confidence 889999999999999998643 2589999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++....... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 154 kl~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~ 222 (284)
T 2vgo_A 154 KIADFGWSVHAPSLR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHR 222 (284)
T ss_dssp EECCCTTCEECSSSC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH
T ss_pred EEecccccccCcccc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHH
Confidence 999999987544321 12345899999999999999999999999999999999999998632110 0000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+. ......+..++.++.+++.+||+.||++|||++|+++.
T Consensus 223 -----~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 223 -----RIV-----------------------NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----HHH-----------------------TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----HHh-----------------------ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 000 00111223467789999999999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=354.15 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=179.7
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceEEEEee
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++. ++...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence 47899999999999999999999999998643 3467889999999996 999999999954 45789999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC---cEEEeee
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM---IAHVGDF 823 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~Df 823 (988)
+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 88 ~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 88 LNGGELFERIKKKK-----------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp CCSCBHHHHHHHCS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred cCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecc
Confidence 99999999996543 689999999999999999999998 999999999999997765 8999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCC--cchHHHHHHHH
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD--LNLHNYARTAL 901 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~ 901 (988)
|+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........
T Consensus 154 g~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 227 (325)
T 3kn6_A 154 GFARLKPPDNQP----LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-- 227 (325)
T ss_dssp TTCEECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH--
T ss_pred ccceecCCCCCc----ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH--
Confidence 999865432211 123458999999999999999999999999999999999999987432210 011111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+........... ...+++++.+++.+||+.||++|||++|+++
T Consensus 228 ------i~~~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 228 ------IKKGDFSFEGEA----------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ------HTTTCCCCCSHH----------------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ------HHcCCCCCCccc----------------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000000000111 1246778999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.53 Aligned_cols=279 Identities=23% Similarity=0.351 Sum_probs=214.8
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECCCCe-----EEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeecc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGT-----IVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCS 730 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 730 (988)
+....++|++.+.||+|+||.||+|.+..+++ .||+|+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999876554 799999975432 3456789999999999 8999999999964
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCC---CchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVP---QKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
.++..++||||+++|+|.+++...... ..........+++..++.++.||+.||+|||+. +|+||||||
T Consensus 121 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 121 -----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred -----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 347889999999999999998643100 000000123579999999999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ceEEECCCCeEEECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999865443221 12223457889999999988899999999999999999999 99998643
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ......... .....+..++..+.+++.+||+.||++|||++|+++
T Consensus 271 ~~~~-----~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 271 LVNS-----KFYKLVKDG--------------------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CSSH-----HHHHHHHHT--------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhH-----HHHHHHhcC--------------------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2110 000000000 001112346778999999999999999999999999
Q ss_pred HHHHHHHHhhh
Q 001974 967 ELQSVKNALLE 977 (988)
Q Consensus 967 ~L~~i~~~~~~ 977 (988)
.|+++.++...
T Consensus 320 ~L~~~~~~~~~ 330 (333)
T 2i1m_A 320 FLQEQAQEDRR 330 (333)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHhhhc
Confidence 99998776543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=367.69 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=206.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCC
Confidence 467999999999999999999999899999999996432 233467889999999999999999999854 457
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++....... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~v 328 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDN-------PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNV 328 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred EEEEEEEeccCCCHHHHHHHhhccc-------ccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCE
Confidence 8999999999999999986543211 2689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 329 kL~DFGla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~ 403 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTK----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ 403 (543)
T ss_dssp EECCCTTCEECCTTCCC----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHH
T ss_pred EEeecceeeeccCCCcc----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHH
Confidence 99999999865443221 223469999999999999999999999999999999999999997432111 1111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH-----HHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI-----TNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 966 (988)
. +.......+..++.++.+++.+||+.||++||++ +|+++
T Consensus 404 ~----------------------------i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 404 R----------------------------VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp H----------------------------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred H----------------------------HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 0011112233567889999999999999999975 55653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.80 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=198.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
+.|+..+.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.. ++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 458889999999999999999988999999999974432 233578899999999999999999999653 478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++ |++.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred EEEEEecCC-CCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence 999999996 78887774322 3689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|+|||++...... ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 195 L~DfG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~ 261 (348)
T 1u5q_A 195 LGDFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA 261 (348)
T ss_dssp ECCCTTCBSSSSB--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH
T ss_pred EeeccCceecCCC--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHH
Confidence 9999999765432 1245899999999974 56789999999999999999999999863211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... +.....+. .....++..+.+++.+||+.||++|||++|+++.
T Consensus 262 ~~~-----~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 262 LYH-----IAQNESPA---------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHH-----HHHSCCCC---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHH-----HHhcCCCC---------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 100 00000000 0112456779999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=352.45 Aligned_cols=283 Identities=23% Similarity=0.306 Sum_probs=203.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc---cC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF---QG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 736 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 467999999999999999999999899999999986433 2334678899999999999999999999765321 11
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||++ +++.+.+.... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL----------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG 161 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred CceEEEEEeccC-CCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCC
Confidence 457899999996 57777775543 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~ 239 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLA 239 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHH
Confidence 99999999998765433322233344568999999999876 56899999999999999999999998742111 1111
Q ss_pred HHHHHHhhhhhhhhccc----cccCcc---hhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPI----LINDVE---DWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~----l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...........+..... ...... .........+. ....++.+.+++.+||+.||++|||++|+++
T Consensus 240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHH------HHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhh------hccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111000000000000 000000 00000000000 0012566899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.69 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=205.1
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 568999999999999999999998999999999874422 13578999999999999999999999964 3
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
+...++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK-----------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKN 145 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS
T ss_pred CCeEEEEEeecCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCC
Confidence 47889999999999999998542 3689999999999999999999998 999999999999998877
Q ss_pred ----cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 817 ----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 817 ----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
.+||+|||.+......... ....|++.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 216 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---- 216 (283)
T ss_dssp SSSCCEEECCCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----
T ss_pred CCCCceEEEecccceeccCCCcc-----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----
Confidence 8999999999865443221 224589999999999999999999999999999999999999864211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH--HHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH--ELQS 970 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 970 (988)
...... +.. ...... ......++..+.+++.+||+.||++|||++|+++ .+++
T Consensus 217 -~~~~~~-----~~~---~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 217 -QETLTN-----ISA---VNYDFD----------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp -HHHHHH-----HHT---TCCCCC----------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred -HHHHHH-----hHh---cccCCc----------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 011000 000 000000 0011246678999999999999999999999997 4566
Q ss_pred HHHH
Q 001974 971 VKNA 974 (988)
Q Consensus 971 i~~~ 974 (988)
+..+
T Consensus 272 ~~~~ 275 (283)
T 3bhy_A 272 IRRR 275 (283)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 5443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.76 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 467999999999999999999999899999999986442 234567889999999999999999999964 347
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 154 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR-----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 154 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred EEEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCE
Confidence 889999999999999987543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||.+......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 155 kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~ 225 (294)
T 2rku_A 155 KIGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL 225 (294)
T ss_dssp EECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH
T ss_pred EEEeccCceecccCccc----cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 99999999865432211 1224589999999999998999999999999999999999999864211 00000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. + .......+..++..+.+++.+||+.||++|||++|+++.
T Consensus 226 ~-----~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 R-----I-----------------------KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp H-----H-----------------------HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred H-----H-----------------------hhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 000111223566789999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.05 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=200.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++... ...+...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceE
Confidence 34778889999999999999999999999999987443 33456789999999999999999999987643 3345678
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeC-CCCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLD-NDMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~ 817 (988)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+. + |+||||||+||+++ +++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~ 170 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSC
T ss_pred EEEEEecCCCCHHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCC
Confidence 9999999999999998643 3689999999999999999999998 7 99999999999998 7899
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ....
T Consensus 171 ~kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~ 239 (290)
T 1t4h_A 171 VKIGDLGLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIY 239 (290)
T ss_dssp EEECCTTGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHH
T ss_pred EEEeeCCCcccccccc------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHH
Confidence 9999999997544322 122458999999998764 5899999999999999999999998642111 1111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. +.....+ .......++++.+++.+||+.||++|||++|+++
T Consensus 240 ~~-----~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 RR-----VTSGVKP---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HH-----HTTTCCC---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HH-----HhccCCc---------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 10 0000000 0111245567999999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.69 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=199.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.... ...+|++++.++ +||||+++++++. +++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEE
Confidence 4679999999999999999999999999999999975432 245788888888 7999999999954 45889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC----C
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND----M 816 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~ 816 (988)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||++.++ +
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK-----------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcC
Confidence 99999999999999987543 589999999999999999999999 99999999999998543 3
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~ 231 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEI 231 (342)
T ss_dssp GEEECCCTTCEECBCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHH
T ss_pred eEEEEECCCcccCcCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHH
Confidence 5999999999865443221 22346899999999998888999999999999999999999998742111 11111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... .. ....... .....++.++.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~i-~~-------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 232 LARI-GS-------GKFSLSG----------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHH-HH-------CCCCCCS----------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHH-cc-------CCcccCc----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110 00 0000000 0112467789999999999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.72 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=201.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|.+.+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|+.++++++||||+++++++. .++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 457899999999999999999999899999999998655445567899999999999999999999854 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCcE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIA 818 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 818 (988)
+||||+++++|.+++... ..+++.+++.++.|++.||+|||+. +|+||||||+||++ ++++.+
T Consensus 83 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER-----------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp EEECCCCSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCE
T ss_pred EEEEcCCCccHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCE
Confidence 999999999999988543 3689999999999999999999999 99999999999999 788999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ....
T Consensus 149 kl~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~- 216 (304)
T 2jam_A 149 MITDFGLSKMEQNGI------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLF- 216 (304)
T ss_dssp EBCSCSTTCCCCCBT------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHH-
T ss_pred EEccCCcceecCCCc------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHH-
Confidence 999999997543321 1223589999999999999999999999999999999999999863211 1111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.+.. ...... ......++.++.+++.+||+.||++|||++|+++
T Consensus 217 ----~~i~~---~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 217 ----EKIKE---GYYEFE----------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ----HHHHH---CCCCCC----------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ----HHHHc---CCCCCC----------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00100 000000 0111256778999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.64 Aligned_cols=277 Identities=22% Similarity=0.352 Sum_probs=213.5
Q ss_pred CHHHHHHhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEe
Q 001974 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVIT 727 (988)
Q Consensus 654 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 727 (988)
..+++....++|++.+.||+|+||.||+|++. .+++.||+|++..... .....+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455566788999999999999999999875 3578899999874432 33457889999999999999999999
Q ss_pred ecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 728 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
++. .++..++||||+++|+|.+++........ .......+++..++.++.||+.||+|||++ +|+||||||
T Consensus 96 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp 166 (322)
T 1p4o_A 96 VVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMA-NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166 (322)
T ss_dssp EEC-----SSSSCEEEEECCTTCBHHHHHHHHHHHHH-HCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred EEc-----cCCccEEEEEeCCCCcHHHHHHHhchhhc-cCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence 954 44788999999999999999864210000 000002568999999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCcc
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVM 886 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~ 886 (988)
+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceEEEcCCCeEEECcCcccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999999999999865443221 11223357889999999998899999999999999999999 89998632
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ........ .. .....+..++..+.+++.+||+.||++|||++|+++
T Consensus 245 ~~-----~~~~~~~~--------~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~ 292 (322)
T 1p4o_A 245 SN-----EQVLRFVM--------EG-------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292 (322)
T ss_dssp CH-----HHHHHHHH--------TT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CH-----HHHHHHHH--------cC-------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11 11111000 00 001123357788999999999999999999999999
Q ss_pred HHHHHHH
Q 001974 967 ELQSVKN 973 (988)
Q Consensus 967 ~L~~i~~ 973 (988)
.|+++.+
T Consensus 293 ~L~~~~~ 299 (322)
T 1p4o_A 293 SIKEEME 299 (322)
T ss_dssp HHGGGSC
T ss_pred HHHHhhc
Confidence 9988644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=340.72 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=196.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 467999999999999999999998899999999996432 233467899999999999999999999954 347
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH-----------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCE
T ss_pred eEEEEEeccCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCE
Confidence 899999999999999998643 2588999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||.+........ .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .....
T Consensus 151 ~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~ 220 (276)
T 2h6d_A 151 KIADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VPTLF 220 (276)
T ss_dssp EECCCCGGGCCCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHH
T ss_pred EEeecccccccCCCcc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HHHHH
Confidence 9999999986544321 122458999999999988765 689999999999999999999986321 11110
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. .+. ......+..++.++.+++.+||+.||++|||++|+++.
T Consensus 221 ~-----~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 221 K-----KIR-----------------------GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp H-----HHH-----------------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H-----Hhh-----------------------cCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 000 00011123456789999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.18 Aligned_cols=253 Identities=25% Similarity=0.305 Sum_probs=197.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 56899999999999999999999899999999997543 234578899999999999999999999964 447899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCcE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMIA 818 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~ 818 (988)
+||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 97 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQ-------ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp EEECCCSCCBHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred EEEEeCCCCcHHHHHHhhh-------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence 9999999999999885321 1113689999999999999999999998 99999999999999 456789
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++........ .....||+.|+|||++. ..++.++||||||+++|||++|+.||.... ......
T Consensus 167 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~~~~ 235 (285)
T 3is5_A 167 KIIDFGLAELFKSDEH-----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEEVQQ 235 (285)
T ss_dssp EECCCCCCCC---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred EEEeeecceecCCccc-----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHHHHh
Confidence 9999999986544322 12345899999999876 468899999999999999999999986421 111110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..... .+.. .......++++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~------~~~~-------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 KATYK------EPNY-------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHC------CCCC-------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhccC------Cccc-------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000 0011235678899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=357.44 Aligned_cols=282 Identities=21% Similarity=0.262 Sum_probs=188.8
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccc-cccCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSI-DFQGN 737 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 737 (988)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+++++.++||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999999999999999998643 223456788999999999999999999987543 12234
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++|+||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp CCCEEEEECC-CEECC-----C------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred CeEEEEeccc-CCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCC
Confidence 6689999999 89999988642 589999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......
T Consensus 171 ~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~ 241 (367)
T 2fst_X 171 LKILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKL 241 (367)
T ss_dssp EEECC----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred EEEeecccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 999999999864432 123468999999999887 6789999999999999999999999864211 011111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..........+.+..........+.......-...........++.+.+|+.+||+.||++|||++|+++.
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111110011110000000000000000000000000112456789999999999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=378.49 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=201.4
Q ss_pred ceeccccceeEEEEEE--CCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAF--DQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
+.||+|+||.||+|.+ +..++.||||+++.... ...+++.+|++++++++||||++++++|.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999965 45678999999975432 335789999999999999999999998642 4578999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++... ..+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 449 E~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 449 EMAELGPLNKYLQQN-----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp ECCTTEEHHHHHHHC-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EccCCCCHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 999999999999643 2689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
+|+......... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ... +
T Consensus 515 la~~~~~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~-----~ 583 (635)
T 4fl3_A 515 LSKALRADENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----EVT-----A 583 (635)
T ss_dssp HHHHTTC--------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHH-----H
T ss_pred CccccccCcccc-ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-----H
Confidence 998765433211 11222346789999999999999999999999999999998 99998642111 000 0
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.+.. ......+..++.++.++|.+||+.||++|||+++|++.|+++...+
T Consensus 584 ~i~~----------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 584 MLEK----------------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHc----------------------CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0000 0011223467889999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=354.27 Aligned_cols=277 Identities=22% Similarity=0.314 Sum_probs=196.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-hhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-ASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|++.+.||+|+||+||+|++..+++.||+|+++..... ....+.+|++++++++||||+++++++. .++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 5799999999999999999999989999999998643322 2234567999999999999999999954 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++ |+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~ 142 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCG----------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLA 142 (324)
T ss_dssp EEEECCS-EEHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEEC
T ss_pred EEecccc-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEc
Confidence 9999995 69998886543 3589999999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus 143 Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~ 216 (324)
T 3mtl_A 143 DFGLARAKSIPTK----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRI 216 (324)
T ss_dssp SSSEEECC----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHH
T ss_pred cCcccccccCCcc----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHH
Confidence 9999975443221 1123458999999999876 56899999999999999999999998642111 111111111
Q ss_pred HhhhhhhhhccccccCcchhhhhh-HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATN-KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
............... ..+.... ..............+++++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 217 LGTPTEETWPGILSN--EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HCCCCTTTSTTGGGC--HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChHhchhhhcc--hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111000000000000 0000000 000000001112356778999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=357.25 Aligned_cols=272 Identities=13% Similarity=0.175 Sum_probs=208.5
Q ss_pred hCCCCCCceeccccceeEEEEEECC--------CCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEE--------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ--------DGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKV-------- 725 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-------- 725 (988)
.++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|++++++++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999976 4789999998643 467899999999999999884
Q ss_pred -------EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 001974 726 -------ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQE 798 (988)
Q Consensus 726 -------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 798 (988)
++++. ..+...++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||++
T Consensus 116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~--- 178 (352)
T 2jii_A 116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP---------KHVLSERSVLQVACRLLDALEFLHEN--- 178 (352)
T ss_dssp TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 44432 2357889999999 999999997542 14689999999999999999999999
Q ss_pred CeEeccCCCCCeeeCCCC--cEEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHH
Q 001974 799 PVLHCDLKPGNVLLDNDM--IAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILL 873 (988)
Q Consensus 799 ~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl 873 (988)
+|+||||||+||+++.++ .+||+|||+++......... ........||+.|+|||++.+..++.++|||||||++
T Consensus 179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 999999999999999998 99999999998665432211 1112234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCc
Q 001974 874 LEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953 (988)
Q Consensus 874 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 953 (988)
|||++|+.||................ .........+. . .....++.++.+++.+||+.
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~----------------~~~~~~~~~l~~li~~~l~~ 316 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQK-FVDKPGPFVGP-----C----------------GHWIRPSETLQKYLKVVMAL 316 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHH-HHHSCCCEECT-----T----------------SCEECCCHHHHHHHHHHHTC
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHh-ccCChhhhhhh-----c----------------cccCCCcHHHHHHHHHHHhC
Confidence 99999999987532221111111100 00000000000 0 00124578899999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 954 SPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 954 dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
||++|||++|+++.|+++.++...
T Consensus 317 dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 317 TYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHHHhcCC
Confidence 999999999999999999877543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.96 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. +++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 467999999999999999999999899999999986442 234567889999999999999999999964 447
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR-----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred eEEEEEecCCCCCHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence 899999999999999987543 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||++......... .....||..|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 181 kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~ 251 (335)
T 2owb_A 181 KIGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYL 251 (335)
T ss_dssp EECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH
T ss_pred EEeeccCceecccCccc----ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH
Confidence 99999999865432211 1234589999999999998999999999999999999999999863211 01000
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
. +.......+..++..+.+++.+||+.||++|||++|+++.
T Consensus 252 ~----------------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 252 R----------------------------IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp H----------------------------HHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred H----------------------------HhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001111223466778999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=362.35 Aligned_cols=269 Identities=23% Similarity=0.280 Sum_probs=209.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCC-CceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR-NLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.++||+|+||.||+|++..+++.||||++..... ...+..|+++++.++|+ ++..+..++ ...+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~-----~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG-----VEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE-----EETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE-----eeCCEE
Confidence 4689999999999999999999988999999999864432 34688999999999774 444444442 235788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCCCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DNDMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~ 817 (988)
++||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||++ +||||||||+|||+ +.++.
T Consensus 79 ~lvme~~-g~sL~~ll~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTC
T ss_pred EEEEECC-CCCHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCe
Confidence 9999999 999999996433 3689999999999999999999999 99999999999999 68899
Q ss_pred EEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 AHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||+|||+++......... ........||..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~ 222 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KK 222 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HH
Confidence 9999999998765433211 111224569999999999999999999999999999999999999997543221 11
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
............. ........++.++.+++.+||+.||++||++++|++.|+++...
T Consensus 223 ~~~~~i~~~~~~~-----------------------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 223 QKYEKISEKKVAT-----------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHHHHS-----------------------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccc-----------------------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 1111100000000 00011125678899999999999999999999999999999775
Q ss_pred hh
Q 001974 975 LL 976 (988)
Q Consensus 975 ~~ 976 (988)
..
T Consensus 280 ~~ 281 (483)
T 3sv0_A 280 EG 281 (483)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=341.72 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=206.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.+.|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 467999999999999999999998899999999997543 3345789999999999999999999998653 4788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 96 ~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEeCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEE
Confidence 9999999999999998642 588999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 161 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~-- 229 (303)
T 3a7i_A 161 ADFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLF-- 229 (303)
T ss_dssp CCCTTCEECBTTBC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHH--
T ss_pred eecccceecCcccc----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHH--
Confidence 99999986544321 112346899999999999999999999999999999999999998632110 0000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
.+... ........++..+.+++.+||+.||++|||++|+++..
T Consensus 230 ---~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 230 ---LIPKN----------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---HHHHS----------------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---HhhcC----------------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 00000 00111235677899999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.07 Aligned_cols=268 Identities=23% Similarity=0.386 Sum_probs=204.7
Q ss_pred hCCCCCCceeccccceeEEEEE-----ECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGA-----FDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||.||+|+ ...+++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 4679999999999999999999 4457789999999643 2334567899999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN- 814 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~- 814 (988)
.++..++||||+++++|.+++........ ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPS----QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 176 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSS----STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhccccc----ccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence 34778999999999999999976532111 113589999999999999999999999 9999999999999984
Q ss_pred --CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCc
Q 001974 815 --DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDL 891 (988)
Q Consensus 815 --~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 891 (988)
+..+||+|||++.......... ......|++.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 251 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--- 251 (327)
T ss_dssp STTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred CCcceEEECccccccccccccccc--cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---
Confidence 4469999999998554322111 1223457899999999988899999999999999999998 9999863211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
..... .+.. ......+..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 252 --~~~~~-----~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 252 --QEVLE-----FVTS----------------------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp --HHHHH-----HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHH-----HHhc----------------------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11110 0000 000112235678899999999999999999999999999998
Q ss_pred HHHh
Q 001974 972 KNAL 975 (988)
Q Consensus 972 ~~~~ 975 (988)
...-
T Consensus 303 ~~~~ 306 (327)
T 2yfx_A 303 TQDP 306 (327)
T ss_dssp HHCH
T ss_pred hcCH
Confidence 7643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=360.35 Aligned_cols=329 Identities=21% Similarity=0.194 Sum_probs=226.8
Q ss_pred eeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccC
Q 001974 24 GITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYC 103 (988)
Q Consensus 24 ~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l 103 (988)
+|.|..... .++.++++++ .+|..+. +++++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|+++
T Consensus 6 ~C~C~~~~~---~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 79 (477)
T 2id5_A 6 RCECSAQDR---AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNL 79 (477)
T ss_dssp TCEEETTTT---EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred CCeECCCCC---EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCC
Confidence 345543322 3455667777 5666553 588999999999998888899999999999999999998889999999
Q ss_pred CCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccc
Q 001974 104 SRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGL 183 (988)
Q Consensus 104 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 183 (988)
++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 80 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 159 (477)
T 2id5_A 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159 (477)
T ss_dssp TTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEE
T ss_pred ccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEEC
Confidence 99999999999998777778889999999999999998877888888888888888888888777888888888888888
Q ss_pred ccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccC
Q 001974 184 GANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263 (988)
Q Consensus 184 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~ 263 (988)
++|++++..+..+.++++|+.|++++|.+. .++.. .|..+++|+.|++++|.+.+
T Consensus 160 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~-~~~~~------------------------~~~~l~~L~~L~l~~~~~~~ 214 (477)
T 2id5_A 160 EKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDY------------------------SFKRLYRLKVLEISHWPYLD 214 (477)
T ss_dssp ESCCCSSCCHHHHTTCTTCCEEEEESCCCC-EECTT------------------------CSCSCTTCCEEEEECCTTCC
T ss_pred CCCcCcccChhHhcccCCCcEEeCCCCcCc-EeChh------------------------hcccCcccceeeCCCCcccc
Confidence 888888766677777777777777777776 33433 34444555555555554444
Q ss_pred cccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccC
Q 001974 264 KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS 343 (988)
Q Consensus 264 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~ 343 (988)
..+.......+|+.|++++|.++.++.
T Consensus 215 ~~~~~~~~~~~L~~L~l~~n~l~~~~~----------------------------------------------------- 241 (477)
T 2id5_A 215 TMTPNCLYGLNLTSLSITHCNLTAVPY----------------------------------------------------- 241 (477)
T ss_dssp EECTTTTTTCCCSEEEEESSCCCSCCH-----------------------------------------------------
T ss_pred ccCcccccCccccEEECcCCcccccCH-----------------------------------------------------
Confidence 444433333355555555554432211
Q ss_pred CCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccc
Q 001974 344 IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSL 423 (988)
Q Consensus 344 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 423 (988)
..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus 242 --~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 319 (477)
T 2id5_A 242 --LAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSV 319 (477)
T ss_dssp --HHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCG
T ss_pred --HHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCC
Confidence 123334444555555555544444445555555555555555555555556666666666666666665555556666
Q ss_pred cccceeecCCCCCCc
Q 001974 424 KQLAILHLFENGLNG 438 (988)
Q Consensus 424 ~~L~~L~l~~N~l~~ 438 (988)
++|+.|+|++|.+..
T Consensus 320 ~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 320 GNLETLILDSNPLAC 334 (477)
T ss_dssp GGCCEEECCSSCEEC
T ss_pred cccCEEEccCCCccC
Confidence 666666666666653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.90 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=204.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... .+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 467999999999999999999999899999999997543 23446789999999999999999999986432 3467
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEeccCCCCCeeeCC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP-----VLHCDLKPGNVLLDN 814 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~ 814 (988)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~ 151 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK-------ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDG 151 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECS
T ss_pred EEEEEeCCCCCCHHHHHHhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcC
Confidence 8999999999999999864221 112489999999999999999999998 7 999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++.+||+|||.++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~ 222 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTSF----AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----K 222 (279)
T ss_dssp SSCEEECCCCHHHHC---CHH----HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H
T ss_pred CCCEEEecCchheeecccccc----ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----H
Confidence 999999999999865432211 1224589999999999998999999999999999999999999874311 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 968 (988)
... ..+... .....+..++.++.+++.+||+.||++|||++|+++.+
T Consensus 223 ~~~-----~~i~~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 223 ELA-----GKIREG----------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHH-----HHHHHT----------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHH-----HHHhhc----------------------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 111 001000 00011235677899999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=364.05 Aligned_cols=262 Identities=14% Similarity=0.134 Sum_probs=197.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHH---HHHhcCCCCceEEEeecccc--c
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECK---ALKNIRHRNLVKVITSCSSI--D 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~--~ 733 (988)
.++|++.+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+. ++++++||||+++++.+... .
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999999889999999999732 3344578899994 55555899999998443211 0
Q ss_pred ccCCC-----------------ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC
Q 001974 734 FQGND-----------------FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC 796 (988)
Q Consensus 734 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 796 (988)
+..++ ..++||||+ +|+|.+++..... .......+++..++.|+.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 225 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS----HSSTHKSLVHHARLQLTLQVIRLLASLHHY- 225 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH----TTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc----cccccccccHHHHHHHHHHHHHHHHHHHhC-
Confidence 11111 378999999 7899999964320 000013455688999999999999999999
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-----------CCCCccc
Q 001974 797 QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-----------EVSTNGD 865 (988)
Q Consensus 797 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sD 865 (988)
+|+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|
T Consensus 226 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 226 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred --CeecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 999999999999999999999999999985332 1123457 999999999887 8999999
Q ss_pred hHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHH
Q 001974 866 IYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVR 945 (988)
Q Consensus 866 vwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 945 (988)
||||||++|||++|+.||......+ .... .......+++++.+
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~-------------~~~~------------------------~~~~~~~~~~~~~~ 338 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALG-------------GSEW------------------------IFRSCKNIPQPVRA 338 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------C-------------CSGG------------------------GGSSCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCccccccc-------------chhh------------------------hhhhccCCCHHHHH
Confidence 9999999999999999986321110 0000 00112356788999
Q ss_pred HhhcccCcCCCCCCCHHHHHH--HHHHHHHHhh
Q 001974 946 IGVACSVESPQDRMSITNVVH--ELQSVKNALL 976 (988)
Q Consensus 946 li~~cl~~dP~~RPs~~evl~--~L~~i~~~~~ 976 (988)
++.+||+.||++|||+.|+++ .++.+.+...
T Consensus 339 li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 339 LLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371 (377)
T ss_dssp HHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred HHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence 999999999999999999996 5666665543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=362.50 Aligned_cols=347 Identities=22% Similarity=0.197 Sum_probs=210.9
Q ss_pred cEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEeccc
Q 001974 203 ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAY 282 (988)
Q Consensus 203 ~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~ 282 (988)
+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|++++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 45677777777 7776654 5678888888888877777888888888888888888877777788888888888888
Q ss_pred ccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCc
Q 001974 283 NNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362 (988)
Q Consensus 283 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 362 (988)
|.++.++.. .|..+++|++|+|++|++++ ..+..|..+++|+.|+|++|
T Consensus 90 n~l~~~~~~------~~~~l~~L~~L~Ls~n~i~~-------------------------~~~~~~~~l~~L~~L~l~~n 138 (477)
T 2id5_A 90 NRLKLIPLG------VFTGLSNLTKLDISENKIVI-------------------------LLDYMFQDLYNLKSLEVGDN 138 (477)
T ss_dssp SCCCSCCTT------SSTTCTTCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEEECCT
T ss_pred CcCCccCcc------cccCCCCCCEEECCCCcccc-------------------------CChhHccccccCCEEECCCC
Confidence 877765543 34455566666666655553 34444555555555555555
Q ss_pred cCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCch
Q 001974 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442 (988)
Q Consensus 363 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 442 (988)
.+++..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.
T Consensus 139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~ 218 (477)
T 2id5_A 139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218 (477)
T ss_dssp TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence 55544455555555555555555555544444455555555555555555555555555555555555555555555555
Q ss_pred hhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccc
Q 001974 443 EIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRA 522 (988)
Q Consensus 443 ~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 522 (988)
..+....| ++|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++
T Consensus 219 ~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 297 (477)
T 2id5_A 219 NCLYGLNL-TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY 297 (477)
T ss_dssp TTTTTCCC-SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred ccccCccc-cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence 55554455 55666666665333345566666666666666666555556666666666666666666666666666666
Q ss_pred cCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCcccCcccccccccccccCCCCC
Q 001974 523 VLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIP 585 (988)
Q Consensus 523 L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~ 585 (988)
|+.|||++|+|++.++.. ..+++|++|+|++|++++..+....+.......+.++...|+.|.
T Consensus 298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 666666666666666554 445566666666666665544321111222233445555555443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=345.54 Aligned_cols=254 Identities=21% Similarity=0.303 Sum_probs=200.1
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++. .++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeE
Confidence 3567999999999999999999999899999999997666666788999999999999999999999964 34789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+. +++||||||+||+++.++.+||
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 158 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD----------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRL 158 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred EEEEEeCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999885432 3689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCccc-----CCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG-----LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+|||++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..... ..
T Consensus 159 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~ 229 (302)
T 2j7t_A 159 ADFGVSAKNLKTLQ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MR 229 (302)
T ss_dssp CCCHHHHHHHHHHH----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HH
T ss_pred EECCCCcccccccc----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH
Confidence 99999864322111 11224589999999987 467789999999999999999999999864211 11
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......... .+ ....+..++.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~-----~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 230 VLLKIAKSD-----PP--------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHSC-----CC--------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHhccC-----Cc--------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110000000 00 00112346778999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=340.22 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=199.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|.....||+|+||.||+|++..+++.||+|++........+.+.+|+.+++.++||||+++++++.. .+..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 345666799999999999999998999999999987666666889999999999999999999999643 478899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-CCcEEEe
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-DMIAHVG 821 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~ 821 (988)
||||+++++|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 97 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~ 165 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGP--------LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKIS 165 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCC--------CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEEC
T ss_pred EEEeCCCCCHHHHHHhhccC--------CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEe
Confidence 99999999999998654321 2467888999999999999999998 9999999999999987 8999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCC--CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE--VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|||.+........ ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ......
T Consensus 166 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~ 238 (295)
T 2clq_A 166 DFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKV 238 (295)
T ss_dssp CTTTCEESCC---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHH
T ss_pred ecccccccCCCCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhh
Confidence 9999986543221 122346899999999987643 7889999999999999999999986321110 000000
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. ........+..++.++.+++.+||+.||++|||++|+++
T Consensus 239 ----~-----------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 239 ----G-----------------------MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----H-----------------------HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----c-----------------------cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000011122356788999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=351.64 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=202.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhc-CCCCceEEEeecc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNI-RHRNLVKVITSCS 730 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 730 (988)
...++|++.+.||+|+||.||+|++..+|+.||||+++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 345679999999999999999999988999999999975432 1235678999999999 8999999999854
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
.....++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 171 -----~~~~~~lv~e~~~g~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI 231 (365)
T 2y7j_A 171 -----SSSFMFLVFDLMRKGELFDYLTEK-----------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231 (365)
T ss_dssp -----BSSEEEEEECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred -----eCCEEEEEEEeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 347899999999999999998532 3689999999999999999999998 999999999999
Q ss_pred eeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC------CCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG------SEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
+++.++.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGEKL-----RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EECCCCCEEEEecCcccccCCCccc-----ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999866543221 23468999999998753 368899999999999999999999986
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.... ...... +.. ......... ...++..+.+++.+||+.||++|||++|+
T Consensus 307 ~~~~-----~~~~~~-i~~-------~~~~~~~~~----------------~~~~~~~~~~li~~~L~~dP~~Rps~~el 357 (365)
T 2y7j_A 307 HRRQ-----ILMLRM-IME-------GQYQFSSPE----------------WDDRSSTVKDLISRLLQVDPEARLTAEQA 357 (365)
T ss_dssp CSSH-----HHHHHH-HHH-------TCCCCCHHH----------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCH-----HHHHHH-HHh-------CCCCCCCcc----------------cccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 3210 011100 000 000000000 12456779999999999999999999999
Q ss_pred HH
Q 001974 965 VH 966 (988)
Q Consensus 965 l~ 966 (988)
++
T Consensus 358 l~ 359 (365)
T 2y7j_A 358 LQ 359 (365)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=351.07 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=194.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCC--CCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRH--RNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++| |||+++++++. .+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 467999999999999999999985 789999999975432 334678999999999976 99999999954 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++|||+ .+++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++ ++.
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~ 145 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKK-----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGM 145 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTE
T ss_pred CEEEEEEeC-CCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCc
Confidence 789999995 4899999997543 689999999999999999999999 999999999999997 678
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----------SEVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 146 ~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 146 LKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp EEECCCSSSCCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEEeecccccccCccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 999999999866443211 11223569999999999754 67889999999999999999999998642
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ... ....+++... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~----~~~--------~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 224 INQ----ISK--------LHAIIDPNHE------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CSH----HHH--------HHHHHCTTSC------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhH----HHH--------HHHHhcCCcc------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111 000 1111111111 1122245567899999999999999999999986
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 274 h 274 (343)
T 3dbq_A 274 H 274 (343)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.34 Aligned_cols=202 Identities=25% Similarity=0.276 Sum_probs=165.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 738 (988)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999999899999999997432 234467889999999999999999999975431 12334
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 166 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 166 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred ceEEEEEcCC-CCHHHHHh-------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCE
Confidence 7899999995 67888774 2478899999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 167 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 167 KILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp EECCCCC---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEeecccccccccc-----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999986543221 1234689999999999999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.49 Aligned_cols=275 Identities=24% Similarity=0.349 Sum_probs=200.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence 4679999999999999999999998999999999864433 224567899999999999999999999653 478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN-----------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEecCCcchHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEE
Confidence 899999999999988865432 589999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ......
T Consensus 165 l~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~- 238 (331)
T 4aaa_A 165 LCDFGFARTLAAPGEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIM- 238 (331)
T ss_dssp ECCCTTC----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-
T ss_pred EEeCCCceeecCCccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH-
Confidence 9999999765432211 1234589999999998875 78999999999999999999999986432110 000000
Q ss_pred HHHhhh---hhhhhc--cccccC-cchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDH---VIDIVD--PILIND-VEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~---~~~~~d--~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... ....+. +..... ..... ...........+++++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIK------EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCCCCCCS------SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHhCCCChhhhhHhhhccccccccCcccc------ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000000 000000 00000 0000001123567889999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=376.22 Aligned_cols=262 Identities=28% Similarity=0.475 Sum_probs=210.4
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.||+|+||.||+|.+. .+..||||+++... ...+++.+|+++|++++||||+++++++.. +.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred cchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 34567889999999999999999996 56789999997543 335789999999999999999999998642 56
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ...+++.+++.|+.||+.||+|||++ +||||||||+|||+++++.+|
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k 403 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGET---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 403 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHH---------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred ceEeeehhcCCcHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEE
Confidence 899999999999999996421 13589999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 404 l~DFG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~- 474 (535)
T 2h8h_A 404 VADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVL- 474 (535)
T ss_dssp ECCTTSTTTCCCHHH---HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHH-
T ss_pred EcccccceecCCCce---ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-
Confidence 999999986543211 11123446789999999998899999999999999999999 99998642110 110
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALL 976 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 976 (988)
+.+.. ......+..++.++.++|.+||+.||++|||+++|++.|+++.....
T Consensus 475 ----~~i~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 475 ----DQVER----------------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ----HHHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ----HHHHc----------------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 00000 00111234678889999999999999999999999999998765433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.03 Aligned_cols=279 Identities=24% Similarity=0.297 Sum_probs=194.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
...++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 345789999999999999999999999999999999964432 22456789999999999999999999964 44
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee-----
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----- 812 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----- 812 (988)
+..++||||++ |+|.+++.... .+++.+++.|+.||+.||+|||+. +|+||||||+||++
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~~~-----------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDKNP-----------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHHCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred CEEEEEEecCC-CCHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence 78999999996 69999986543 589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 245 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID- 245 (329)
T ss_dssp --CCEEEECCTTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred CccceEEECcCCCccccCCccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-
Confidence 4556699999999986543221 11234589999999998874 48999999999999999999999986421110
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHH-HhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQR-LRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... ............ ......|....... ...........++.++.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFE-VLGLPDDTTWPG--VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHH-HHCCCCTTTSTT--GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHH-HhCCCchhhhhh--hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000000000 00000000000000 000000011235678999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.95 Aligned_cols=276 Identities=23% Similarity=0.305 Sum_probs=197.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-----chhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-----GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
..++|++.+.||+|+||.||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG----- 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence 45789999999999999999999988999999999864322 12357889999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
..+..++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 83 ~~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 148 (346)
T 1ua2_A 83 HKSNISLVFDFME-TDLEVIIKDNS----------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 148 (346)
T ss_dssp CTTCCEEEEECCS-EEHHHHHTTCC----------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred eCCceEEEEEcCC-CCHHHHHHhcC----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCC
Confidence 4578899999996 58998887654 2578889999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.... ...
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~----~~~ 220 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLD 220 (346)
T ss_dssp CCEEECCCGGGSTTTSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred CCEEEEecccceeccCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC----HHH
Confidence 9999999999986543221 12234689999999998764 58899999999999999999999986321 111
Q ss_pred HHHHH--HHhhh-hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYART--ALLDH-VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~--~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... ..... ...+.+..-..+...+.... ..........++.++.+++.+||+.||++|||++|+++.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP----GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC----CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChhhhhhhccCcccccccccC----CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11110 00000 00000000000000000000 000000113466789999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.65 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=198.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|+..+.++ +||||+++++++.. ++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 45799999999999999999999989999999999753 233456788999999999 99999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND--- 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--- 815 (988)
..++||||+++++|.+++.... .....+++.+++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENY-------RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred eEEEEEEecCCCcHHHHHHhhc-------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence 8999999999999999986431 0113589999999999999999999999 99999999999999844
Q ss_pred ----------------CcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHh
Q 001974 816 ----------------MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVT 878 (988)
Q Consensus 816 ----------------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~ellt 878 (988)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence 479999999998654322 13489999999998875 66789999999999999999
Q ss_pred CCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC
Q 001974 879 GKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958 (988)
Q Consensus 879 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 958 (988)
|.+|+... .. + ..+. .. .....+..++.++.+++.+||+.||++|
T Consensus 227 ~~~~~~~~----~~---~------~~~~---~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 227 AEPLPRNG----DQ---W------HEIR---QG-------------------RLPRIPQVLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp CCCCCSSS----HH---H------HHHH---TT-------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCcch----hH---H------HHHH---cC-------------------CCCCCCcccCHHHHHHHHHHhCCCcccC
Confidence 99875421 00 0 0000 00 0011223567889999999999999999
Q ss_pred CCHHHHHH
Q 001974 959 MSITNVVH 966 (988)
Q Consensus 959 Ps~~evl~ 966 (988)
||++|+++
T Consensus 272 ps~~~ll~ 279 (289)
T 1x8b_A 272 PSAMALVK 279 (289)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.59 Aligned_cols=175 Identities=15% Similarity=0.164 Sum_probs=116.4
Q ss_pred cCCCCCCCCCce-eeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECC
Q 001974 10 LNSWNDSGHFCE-WKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLS 88 (988)
Q Consensus 10 ~~~w~~~~~~c~-~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 88 (988)
+++|..+.+||. |.++.|.....++ ............-..++++++|++++|.++...+..|..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 688998877774 6666676443333 1211111122223346788999999999986665667888999999999
Q ss_pred CCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCC
Q 001974 89 DNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNI 168 (988)
Q Consensus 89 ~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 168 (988)
+|.+++..+..|+.+++|++|+|++|++++..|..|.++++|++|+|++|.++...+..|.++++|++|++++|++++..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 99988777778888888888888888888777777778888888888888777444444667777777777777776666
Q ss_pred CccccCccccccccccccccc
Q 001974 169 PNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 169 ~~~~~~l~~L~~L~L~~N~l~ 189 (988)
+..|.++++|++|+|++|+++
T Consensus 158 ~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 158 DDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp TTTTSSCTTCCEEECCSSCCS
T ss_pred hhhccCCCCCCEEECCCCcCC
Confidence 666666666666666666665
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=375.74 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=204.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 457899999999999999999999999999999999743 234456788999999988 799999999984 45
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
.+..++||||+++|+|.+++... ..+++..++.|+.||+.||+|||+. +||||||||+|||++.++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQV-----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSS
T ss_pred CCEEEEEEeCcCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCC
Confidence 58899999999999999998643 3689999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 480 ~ikL~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~~~~ 550 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----EDEL 550 (674)
T ss_dssp CEEECCCTTCEECCCTTC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH
T ss_pred cEEEeecceeeccccCCc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----HHHH
Confidence 999999999985332221 1233569999999999999999999999999999999999999986321 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCH-----HHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSI-----TNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 966 (988)
... + . ......+..++.++.+|+.+||+.||++||++ +||++
T Consensus 551 ~~~-----i---~--------------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 551 FQS-----I---M--------------------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHH-----H---H--------------------SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHH-----H---H--------------------hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 0 0 01112233567889999999999999999997 56653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.75 Aligned_cols=280 Identities=19% Similarity=0.282 Sum_probs=204.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 457999999999999999999999899999999997543 3345678999999999999999999998653 4789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-----------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEECCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEE
Confidence 9999999999999998643 2689999999999999999999983 18999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........
T Consensus 174 ~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~ 245 (360)
T 3eqc_A 174 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQ 245 (360)
T ss_dssp CCCCCCHHHHHHC----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC--
T ss_pred EECCCCccccccc------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhccc
Confidence 9999997553321 123468999999999999999999999999999999999999987432111 00000000
Q ss_pred Hhhhh----------hhhhccccccCc--chhhhhhHHHHhhhhhc-cccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 901 LLDHV----------IDIVDPILINDV--EDWDATNKQRLRQAKIN-GKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 901 ~~~~~----------~~~~d~~l~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... ............ ................. ....++.++.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 000000000000 00000000001111111 112367789999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=365.71 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=201.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|++..+++.||||++... .......+.+|++++++++||||+++++++. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence 35699999999999999999999989999999998633 2234578899999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC---CCC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD---NDM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~ 816 (988)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKR-----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 99999999999999888543 3689999999999999999999999 999999999999995 456
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ...
T Consensus 162 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~ 230 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDI 230 (486)
T ss_dssp CEEECSCSCTTTBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred CEEEEECCcCeECCCCCc-----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 899999999986544322 123469999999999876 589999999999999999999999863211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... ........... ...+++++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~i--------~~~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 231 LKRV--------ETGKYAFDLPQ----------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHH--------HHTCCCSCSGG----------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHH--------HhCCCCCCCcc----------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 00001111111 12467789999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=366.09 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=200.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++. .+..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 346999999999999999999999999999999997443 334578899999999999999999999964 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---C
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND---M 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 816 (988)
.++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.. +
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR-----------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred EEEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCC
Confidence 99999999999999888543 3689999999999999999999999 99999999999999764 4
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ...
T Consensus 177 ~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~ 245 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEI 245 (494)
T ss_dssp CEEECCCTTCEECBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred cEEEEECCCCeECCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 599999999987654322 12346999999999976 4689999999999999999999999864211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSV 971 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 971 (988)
..... ..........| ..+++++.+++.+||+.||++|||++|+++. +.+.
T Consensus 246 ~~~i~--------~~~~~~~~~~~----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 246 LRKVE--------KGKYTFDSPEW----------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHH--------HTCCCCCSGGG----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHH--------hCCCCCCchhc----------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11100 00011111111 2467789999999999999999999999864 4444
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=352.41 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=200.8
Q ss_pred hCCCCCCceeccccceeEEEEEEC---CCCeEEEEEEeeccc----cchhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFD---QDGTIVAIKVFNLQR----HGASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 357999999999999999999984 478999999986432 23345677899999999 6999999999854
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.++..++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQR-----------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLD 193 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred --eCceEEEEeecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC
Confidence 347889999999999999998643 3689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~- 269 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN- 269 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-
T ss_pred CCCcEEEeeCCCCeecccCCCC---cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-
Confidence 9999999999999865432211 1223469999999999886 357899999999999999999999987432211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
......... .......+..++..+.+++.+||+.||++|| +++|+++
T Consensus 270 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 270 SQAEISRRI----------------------------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp CHHHHHHHH----------------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred hHHHHHHHH----------------------------hccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 111111110 0011122335677899999999999999999 9999987
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 322 h 322 (355)
T 1vzo_A 322 H 322 (355)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=354.10 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=193.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcC--CCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIR--HRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++.. ++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 45999999999999999999986 58999999997543 234467899999999996 5999999998643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++|||+ .+++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+|||++ ++.+
T Consensus 130 ~~~lv~E~-~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~ 193 (390)
T 2zmd_A 130 YIYMVMEC-GNIDLNSWLKKKK-----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML 193 (390)
T ss_dssp EEEEEEEC-CSEEHHHHHHHCS-----------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCE
T ss_pred EEEEEEec-CCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeE
Confidence 79999995 5899999987543 578889999999999999999998 999999999999996 5899
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----------SEVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 194 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 194 KLIDFGIANQMQPDTTS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp EECCCSSSCCC-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEEecCccccccCCCcc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 99999999865432211 11223569999999999865 368899999999999999999999986421
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.. ... +..++++.... ..+...+.++.+++.+||+.||++|||++|+++.
T Consensus 272 ~~----~~~--------~~~~~~~~~~~------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 272 NQ----ISK--------LHAIIDPNHEI------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CH----HHH--------HHHHHCTTSCC------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH----HHH--------HHHHhCccccC------------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 000 11111111111 1122345678999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.13 Aligned_cols=252 Identities=26% Similarity=0.338 Sum_probs=199.6
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.++++++||||+++++++.. ++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 4578999999999999999999999899999999997543 35788999999999999999999999643 4788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 166 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN----------KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL 166 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred EEEeecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEE
Confidence 99999999999999985322 3689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||.+........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 167 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~- 236 (314)
T 3com_A 167 ADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFM- 236 (314)
T ss_dssp CCCTTCEECBTTBS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH-
T ss_pred eecccchhhhhhcc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH-
Confidence 99999976543221 112345899999999999999999999999999999999999998632110 00000
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.....+ ....+..++..+.+++.+||+.||++|||+.|+++
T Consensus 237 ----~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 237 ----IPTNPPP--------------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----HHHSCCC--------------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----HhcCCCc--------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 00112245678999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=347.01 Aligned_cols=268 Identities=23% Similarity=0.302 Sum_probs=203.3
Q ss_pred cccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeec
Q 001974 651 QKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSC 729 (988)
Q Consensus 651 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 729 (988)
..+.++++....++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34445555567789999999999999999999998899999999997543 3457889999999999 899999999997
Q ss_pred ccccc-cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 730 SSIDF-QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 730 ~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
..... ...+..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~ 158 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---------NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 158 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGG
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHH
Confidence 64311 114678999999999999999865321 3689999999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCC
Q 001974 809 NVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPT 883 (988)
Q Consensus 809 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~ 883 (988)
||+++.++.+||+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|+.||
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp GEEECTTCCEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999986543221 112345899999999987 567899999999999999999999998
Q ss_pred CccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH
Q 001974 884 DVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963 (988)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 963 (988)
...... ..... +.....+ ......++..+.+++.+||+.||++|||++|
T Consensus 235 ~~~~~~-----~~~~~-----~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 235 CDMHPM-----RALFL-----IPRNPAP---------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp TTSCHH-----HHHHH-----HHHSCCC---------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCcHH-----HHHHH-----hhcCccc---------------------cCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 632110 00000 0000000 0012346778999999999999999999999
Q ss_pred HHH
Q 001974 964 VVH 966 (988)
Q Consensus 964 vl~ 966 (988)
+++
T Consensus 284 ll~ 286 (326)
T 2x7f_A 284 LMK 286 (326)
T ss_dssp HHT
T ss_pred Hhh
Confidence 986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=367.69 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=204.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++||||+++++++. ..+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 356999999999999999999999999999999996432 334578999999999999999999999954 458
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee---CCC
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL---DND 815 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~ 815 (988)
..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.+
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK-----------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS-----------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred EEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC
Confidence 8999999999999999986543 689999999999999999999999 99999999999999 567
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+.+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~ 234 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKKM-----KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----YD 234 (484)
T ss_dssp CCEEECCTTHHHHBCCCCSH-----HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred CcEEEEeeeeeEEccccccc-----ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----HH
Confidence 89999999999876543322 22459999999999876 689999999999999999999999864211 11
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... .........+. ...+++++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~i--------~~~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 235 ILKKV--------EKGKYTFELPQ----------------WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHH--------HHCCCCCCSGG----------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHH--------HcCCCCCCCcc----------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11110 00000001111 12467789999999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.66 Aligned_cols=280 Identities=22% Similarity=0.206 Sum_probs=202.6
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-----------hhHHHHHHHHHHHhcCCCCce
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-----------ASKSFLAECKALKNIRHRNLV 723 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv 723 (988)
..++....++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++++++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567778899999999999999999999986 5999999998533221 126789999999999999999
Q ss_pred EEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 001974 724 KVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHC 803 (988)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 803 (988)
++++++...........++||||++ |+|.+++.... ..+++..++.++.||+.||+|||+. +|+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~ 158 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----------IVISPQHIQYFMYHILLGLHVLHEA---GVVHR 158 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEec
Confidence 9999976543344567899999996 78888886543 3689999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCC
Q 001974 804 DLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 804 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p 882 (988)
||||+||+++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.|
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHHEEEcCCCCEEEEecCcccccccccc-----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999975443222 122458999999999877 6789999999999999999999999
Q ss_pred CCccccCCcchHHHHHHHHhhh------------hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcc
Q 001974 883 TDVMFEGDLNLHNYARTALLDH------------VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVAC 950 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 950 (988)
|...... ............. ..+.+......... ..........++.+.+++.+|
T Consensus 234 f~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~ 300 (362)
T 3pg1_A 234 FRGSTFY--NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA-----------RAWTAVVPTADPVALDLIAKM 300 (362)
T ss_dssp CCCSSHH--HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC-----------CCHHHHSTTSCHHHHHHHHHH
T ss_pred CCCCCHH--HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh-----------hhHHhhCCCCCHHHHHHHHHH
Confidence 8742111 0001000000000 00000000000000 000111234567899999999
Q ss_pred cCcCCCCCCCHHHHHHH
Q 001974 951 SVESPQDRMSITNVVHE 967 (988)
Q Consensus 951 l~~dP~~RPs~~evl~~ 967 (988)
|+.||++|||++|+++.
T Consensus 301 L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 301 LEFNPQRRISTEQALRH 317 (362)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred hcCChhhCCCHHHHHcC
Confidence 99999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.10 Aligned_cols=282 Identities=20% Similarity=0.240 Sum_probs=201.5
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc----
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF---- 734 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 734 (988)
....++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999999999999999864322 23479999999999999999998754311
Q ss_pred -----------------------------cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHH
Q 001974 735 -----------------------------QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785 (988)
Q Consensus 735 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 785 (988)
......++||||++ |+|.+.+.... .....+++..++.++.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-------RSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHH-------HTTCCCCHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-------hcCCCCCHHHHHHHHHHH
Confidence 23455889999996 68777664211 011368999999999999
Q ss_pred HHHHHHHHcCCCCCeEeccCCCCCeeeC-CCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCc
Q 001974 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTN 863 (988)
Q Consensus 786 ~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 863 (988)
+.||+|||+. +|+||||||+||+++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.+
T Consensus 151 ~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~ 222 (383)
T 3eb0_A 151 FRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----VAYICSRFYRAPELMLGATEYTPS 222 (383)
T ss_dssp HHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-----CCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred HHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-----cCcccCCCccCHHHhcCCCCCCcc
Confidence 9999999998 999999999999997 6889999999999865443322 234589999999998775 48999
Q ss_pred cchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhh-h--hcccccc------CcchhhhhhHHHHhhhhhc
Q 001974 864 GDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID-I--VDPILIN------DVEDWDATNKQRLRQAKIN 934 (988)
Q Consensus 864 sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~--~d~~l~~------~~~~~~~~~~~~~~~~~~~ 934 (988)
+||||+||++|||++|+.||......+ .+..... .......+ + .++.... ....|. ..
T Consensus 223 ~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 289 (383)
T 3eb0_A 223 IDLWSIGCVFGELILGKPLFSGETSID-QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-----------KI 289 (383)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHH-----------HH
T ss_pred hhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHH-----------hh
Confidence 999999999999999999987421110 0111110 00000000 0 0000000 001110 11
Q ss_pred cccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHHHH
Q 001974 935 GKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSVKN 973 (988)
Q Consensus 935 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 973 (988)
.+..++.++.+++.+||+.||++|||+.|+++. +++++.
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 233467889999999999999999999999853 555544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=337.86 Aligned_cols=255 Identities=19% Similarity=0.326 Sum_probs=200.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc----cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR----HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 468999999999999999999999899999999996432 2345779999999999999999999998642 234
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
...++||||++++ +.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPE---------KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTT---------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred CeEEEEehhccCC-HHHHHHhCcc---------cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCc
Confidence 6789999999765 6666654321 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCC--CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE--VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+||+|||.+.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||... ....
T Consensus 148 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~ 220 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYK 220 (305)
T ss_dssp EEECCCTTCEECCTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH
T ss_pred EEeeccccccccCcccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHH
Confidence 9999999998654322111 122345899999999987644 477999999999999999999998632 1111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.... + .......+..++..+.+++.+||+.||++|||++|+++.
T Consensus 221 ~~~~-----i-----------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 LFEN-----I-----------------------GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHH-----H-----------------------HHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHH-----H-----------------------hcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1100 0 011112233577889999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=344.58 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=197.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhcCCCCceEEEeeccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNIRHRNLVKVITSCSSID 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 733 (988)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 4579999999999999999999998999999999864321 122458899999999999999999998642
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
+..++||||+++++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNK-----------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 148 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred ----CceEEEEecCCCCcHHHHHhccC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence 34899999999999999987543 689999999999999999999998 999999999999998
Q ss_pred CCCc---EEEeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHhCCCCCCccc
Q 001974 814 NDMI---AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVTGKKPTDVMF 887 (988)
Q Consensus 814 ~~~~---~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 887 (988)
.++. +||+|||+++....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCCHH-----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cCCCCCeEEEccCccceecccccc-----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 7664 99999999986543221 11245899999999863 5678999999999999999999999987432
Q ss_pred cCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 888 EGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ........ . ...... .....++.++.+++.+||+.||++|||++|+++
T Consensus 224 ~~~-~~~~~~~~----~-------~~~~~~----------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 224 TQV-SLKDQITS----G-------KYNFIP----------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CSS-CHHHHHHH----T-------CCCCCH----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHH-HHHHHHHh----C-------ccccCc----------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 221 11111100 0 000000 001246778999999999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.75 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=202.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---------chhHHHHHHHHHHHhcC-CCCceEEEeecc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---------GASKSFLAECKALKNIR-HRNLVKVITSCS 730 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 730 (988)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999999999999999975431 22356889999999995 999999999954
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
.++..++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||
T Consensus 95 -----~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni 155 (298)
T 1phk_A 95 -----TNTFFFLVFDLMKKGELFDYLTEK-----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI 155 (298)
T ss_dssp -----CSSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred -----cCCeEEEEEeccCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence 457899999999999999998643 3689999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeeecccccccccccccceeccccccccccccCcccC------CCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL------GSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 811 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
+++.++.+||+|||.+......... ....|++.|+|||++. ...++.++||||||+++|||++|+.||.
T Consensus 156 l~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 230 (298)
T 1phk_A 156 LLDDDMNIKLTDFGFSCQLDPGEKL-----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230 (298)
T ss_dssp EECTTCCEEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEcCCCcEEEecccchhhcCCCccc-----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence 9999999999999999865443221 2245899999999874 4568899999999999999999999986
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
.... ....... .. ....... .....++.++.+++.+||+.||++|||++|+
T Consensus 231 ~~~~-----~~~~~~~-~~-------~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 231 HRKQ-----MLMLRMI-MS-------GNYQFGS----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp CSSH-----HHHHHHH-HH-------TCCCCCT----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CccH-----HHHHHHH-hc-------CCcccCc----------------ccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 3211 1111100 00 0000000 0112467789999999999999999999999
Q ss_pred HH
Q 001974 965 VH 966 (988)
Q Consensus 965 l~ 966 (988)
++
T Consensus 282 l~ 283 (298)
T 1phk_A 282 LA 283 (298)
T ss_dssp TT
T ss_pred Hh
Confidence 75
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=350.95 Aligned_cols=282 Identities=23% Similarity=0.239 Sum_probs=205.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..++|++.+.||+|+||.||+|++..+|+.||||+++.... .....+.+|++++++++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35789999999999999999999998999999999964332 33467889999999999999999999987655566688
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++ ++|.+++.. +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 89 ~~lv~e~~~-~~L~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST------------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred EEEEEeccC-ccHHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEE
Confidence 999999995 799988853 2589999999999999999999999 999999999999999999999
Q ss_pred Eeeecccccccccccccc------eeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 820 VGDFGLARVRQEVSNLTQ------SCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
|+|||+++.......... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 230 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--H 230 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence 999999986653321111 11223468999999998654 77899999999999999999999998742110 0
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhh-------hhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQ-------AKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.............. +.... .... ....+.... ........+++++.+++.+||+.||++|||++|++
T Consensus 231 ~~~~~~~~~~~~~~---~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 231 QLLLIFGIIGTPHS---DNDLR-CIES--PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp HHHHHHHHHCCCCS---TTTTT-TCCC--HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhCCCch---hcccc-cccc--chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00000000000000 00000 0000 000000000 00011235778899999999999999999999998
Q ss_pred H
Q 001974 966 H 966 (988)
Q Consensus 966 ~ 966 (988)
+
T Consensus 305 ~ 305 (353)
T 2b9h_A 305 E 305 (353)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=365.20 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=200.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-------------chhHHHHHHHHHHHhcCCCCceEEEee
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-------------GASKSFLAECKALKNIRHRNLVKVITS 728 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 728 (988)
.++|++.++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 5689999999999999999999999999999999864321 234678999999999999999999999
Q ss_pred cccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 729 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
+. ++...++||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 115 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~ 175 (504)
T 3q5i_A 115 FE-----DKKYFYLVTEFYEGGELFEQIINR-----------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPE 175 (504)
T ss_dssp EE-----CSSEEEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EE-----cCCEEEEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHH
Confidence 54 458899999999999999988543 3689999999999999999999999 9999999999
Q ss_pred CeeeCCCC---cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 809 NVLLDNDM---IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 809 NIll~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
||+++.++ .+||+|||++......... ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDYKL-----RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTSCB-----CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCCcc-----ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99998776 6999999999876543221 23459999999999874 689999999999999999999999863
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
... ....... ...........| ..+++++.+++.+||+.||++|||++|++
T Consensus 250 ~~~-----~~~~~~i--------~~~~~~~~~~~~----------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 250 QND-----QDIIKKV--------EKGKYYFDFNDW----------------KNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp SSH-----HHHHHHH--------HHCCCCCCHHHH----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCH-----HHHHHHH--------HcCCCCCCcccc----------------CCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 211 1111110 000010011111 24677899999999999999999999998
Q ss_pred HH
Q 001974 966 HE 967 (988)
Q Consensus 966 ~~ 967 (988)
+.
T Consensus 301 ~h 302 (504)
T 3q5i_A 301 NS 302 (504)
T ss_dssp TS
T ss_pred cC
Confidence 53
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.25 Aligned_cols=283 Identities=22% Similarity=0.255 Sum_probs=198.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccc--------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSID-------- 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 733 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999999889999999998666666678999999999999999999999864321
Q ss_pred -ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 734 -FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 734 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
+......++||||++ |+|.+++... ++++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG------------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFI 153 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC------------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence 234577899999996 7999998642 578899999999999999999999 99999999999999
Q ss_pred C-CCCcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCC
Q 001974 813 D-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890 (988)
Q Consensus 813 ~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 890 (988)
+ +++.+||+|||+++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 231 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL- 231 (320)
T ss_dssp ETTTTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred cCCCCeEEEccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-
Confidence 7 56799999999998654322111 11223457899999998765 67899999999999999999999998743211
Q ss_pred cchHHHHHHHHhhh-h-hhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 891 LNLHNYARTALLDH-V-IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 891 ~~~~~~~~~~~~~~-~-~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.......... . ..............+..................++.++.+++.+||+.||++|||++|+++
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 ----EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp ----HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111100000 0 0000000000000000000000000000112356788999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.93 Aligned_cols=277 Identities=22% Similarity=0.232 Sum_probs=198.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568999999999999999999999999999999997432 2334678899999999999999999999754311 1112
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++. ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEEcccc-ccHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence 3499999995 78988874 2488999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....
T Consensus 184 kL~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~ 251 (371)
T 4exu_A 184 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQL 251 (371)
T ss_dssp EECSTTCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred EEEecCcccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHH
Confidence 99999999865432 123468999999999887 688999999999999999999999986421 11111
Q ss_pred HHHHh---hhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALL---DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
..... ....+............+..................+++++.+++.+||+.||++|||++|+++.
T Consensus 252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11100 00001000000000000000000000000001123467889999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.53 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=197.9
Q ss_pred hCCCCCCceeccccceeEEEEEECC-CC--eEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ-DG--TIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||+||+|++.. ++ ..||+|+++.. .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 4579999999999999999998743 33 36899998643 23445788999999999999999999999643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
...++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR 157 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG----------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET
T ss_pred --CCceeeEecccCCCHHHHHHhcc----------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCC
Confidence 34789999999999999986432 3689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||++......... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~ 231 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----S 231 (291)
T ss_dssp TEEEECCCTTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H
T ss_pred CCEEEccccccccccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----H
Confidence 99999999999876543221 111223457889999999988889999999999999999999 9999863211 1
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
......... . .....+..++.++.+++.+||+.||++|||++++++.|+++...
T Consensus 232 ~~~~~~~~~--------~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 232 QILHKIDKE--------G------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHHTS--------C------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHcc--------C------------------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111100000 0 00112235778899999999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=348.01 Aligned_cols=260 Identities=15% Similarity=0.136 Sum_probs=204.5
Q ss_pred HhhCCCCCCceeccccceeEEEEE-----ECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC---CCCceEEEeeccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGA-----FDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR---HRNLVKVITSCSS 731 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 731 (988)
...++|.+.+.||+|+||+||+|. ...+++.||+|+++.. ...++..|+++++.++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 5668899999998643 3467788888888885 9999999999643
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
++..++||||+++|+|.+++...... ....+++.+++.|+.||+.||+|||+. +||||||||+|||
T Consensus 139 -----~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIl 204 (365)
T 3e7e_A 139 -----QNGSVLVGELYSYGTLLNAINLYKNT------PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFI 204 (365)
T ss_dssp -----SSCEEEEECCCCSCBHHHHHHHHHTS------TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEE
T ss_pred -----CCCcEEEEeccCCCcHHHHHHHhhcc------cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 47889999999999999999642110 013689999999999999999999998 9999999999999
Q ss_pred eCC-----------CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCC
Q 001974 812 LDN-----------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880 (988)
Q Consensus 812 l~~-----------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~ 880 (988)
++. ++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 998 89999999999976543221 12223456999999999999999999999999999999999999
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCC-C
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR-M 959 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-P 959 (988)
.||.....+... ....+ .....++.+.+++..|++.+|.+| |
T Consensus 283 ~pf~~~~~~~~~----------------~~~~~---------------------~~~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 283 YMKVKNEGGECK----------------PEGLF---------------------RRLPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp CCCEEEETTEEE----------------ECSCC---------------------TTCSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred CccccCCCCcee----------------echhc---------------------cccCcHHHHHHHHHHHcCCCCCCcch
Confidence 998532221100 00000 001234568899999999999999 6
Q ss_pred CHHHHHHHHHHHHHHh
Q 001974 960 SITNVVHELQSVKNAL 975 (988)
Q Consensus 960 s~~evl~~L~~i~~~~ 975 (988)
+++++.+.|+++.++.
T Consensus 326 ~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 326 SLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHh
Confidence 8888888888876653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=354.01 Aligned_cols=198 Identities=24% Similarity=0.357 Sum_probs=170.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc------CCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI------RHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 735 (988)
..+|++.+.||+|+||+||+|.+..+++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 46799999999999999999999989999999999643 23346677888888887 56799999998643
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
....++||||+ +++|.+++..... ..+++..++.|+.||+.||+|||+. +||||||||+|||++.+
T Consensus 171 -~~~~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 171 -RNHICMTFELL-SMNLYELIKKNKF---------QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ 236 (429)
T ss_dssp -TTEEEEEECCC-CCBHHHHHHHTTT---------CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST
T ss_pred -CCeEEEEEecc-CCCHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC
Confidence 47899999999 5799998865432 3589999999999999999999999 99999999999999998
Q ss_pred Cc--EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 816 MI--AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 816 ~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
+. +||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 237 ~~~~vkL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TSCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcceEEeecccceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 87 999999999754332 1224689999999999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=341.34 Aligned_cols=276 Identities=25% Similarity=0.343 Sum_probs=205.3
Q ss_pred HhhCCCCCCceeccccceeEEEEEEC-CCCeEEEEEEeecccc--chhHHHHHHHHHHHhc---CCCCceEEEeeccccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFD-QDGTIVAIKVFNLQRH--GASKSFLAECKALKNI---RHRNLVKVITSCSSID 733 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 733 (988)
...++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999994 6789999999864332 2234667788777766 8999999999976432
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.......++||||++ |+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~ 154 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE---------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT 154 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT---------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEc
Confidence 334577899999996 799999865432 2589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
.++.+||+|||.++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 225 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---- 225 (326)
T ss_dssp TTCCEEECSCCSCCCCCGGGG-----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred CCCCEEEecCcccccccCCCC-----ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH----
Confidence 999999999999986543221 12345899999999999999999999999999999999999998743111
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhH-------HHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNK-------QRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... .. .. .....+|..... .............++..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~i~-~~----~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 -DQLGKIL-DV----IG---LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp -HHHHHHH-HH----HC---CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHH-HH----cC---CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111100 00 00 000001100000 00000111223457788999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=343.49 Aligned_cols=274 Identities=23% Similarity=0.296 Sum_probs=186.1
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 85 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----K 85 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----S
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----c
Confidence 345678999999999999999999998899999999986433 2345678899999999999999999999643 4
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++++|.+++........ .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 159 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGE---HKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGS 159 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTT---TTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccc---cccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCC
Confidence 778999999999999999863110000 0013589999999999999999999998 9999999999999999999
Q ss_pred EEEeeeccccccccccccc-ceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 818 AHVGDFGLARVRQEVSNLT-QSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+||+|||.+.......... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .
T Consensus 160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~ 235 (303)
T 2vwi_A 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----V 235 (303)
T ss_dssp EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----H
T ss_pred EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----H
Confidence 9999999998654332111 111223468999999999865 568999999999999999999999987432211 0
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......... +..... .........++.++.+++.+||+.||++|||++|+++
T Consensus 236 -~~~~~~~~~-----~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 -LMLTLQNDP-----PSLETG-------------VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HHHHHTSSC-----CCTTC------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHhccCC-----Cccccc-------------cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000 000000 0001122356778999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.68 Aligned_cols=269 Identities=10% Similarity=0.022 Sum_probs=187.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhc--CCCCceEEEeecc------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNI--RHRNLVKVITSCS------ 730 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~~~------ 730 (988)
...|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+++.+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458899999999999999999998999999999986432 3345677886555555 6999988653321
Q ss_pred -cccc------c------CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHH------HHHHHHHHHHHHH
Q 001974 731 -SIDF------Q------GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR------INIAIDVASAIDY 791 (988)
Q Consensus 731 -~~~~------~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~ 791 (988)
.... . .....++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------~~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----------FVYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----------HSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----------cccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 1100 0 0134799999997 89999996532 23344445 6788999999999
Q ss_pred HHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC--CCCCCccchHHH
Q 001974 792 LHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSY 869 (988)
Q Consensus 792 LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwsl 869 (988)
||++ +||||||||+|||++.++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||||
T Consensus 210 LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 210 LQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-------cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 9999 99999999999999999999999999998654321 12347799999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhc
Q 001974 870 GILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVA 949 (988)
Q Consensus 870 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 949 (988)
||++|||++|+.||......... ............ ..........+++.+.+++.+
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~---------------~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKG---------------SWKRPSLRVPGT---------DSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTT---------------CCCBCCTTSCCC---------CSCCCTTSSCCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcCccccc---------------chhhhhhhhccc---------cccchhhccCCCHHHHHHHHH
Confidence 99999999999999754222100 000000000000 000011123678889999999
Q ss_pred ccCcCCCCCCCHHHHHH--HHHHHHHHh
Q 001974 950 CSVESPQDRMSITNVVH--ELQSVKNAL 975 (988)
Q Consensus 950 cl~~dP~~RPs~~evl~--~L~~i~~~~ 975 (988)
||+.||++|||++|+++ .++++....
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence 99999999999999985 355555443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=350.57 Aligned_cols=281 Identities=20% Similarity=0.272 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC--------CCCceEEEeeccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR--------HRNLVKVITSCSSID 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 733 (988)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~- 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS- 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-
Confidence 46799999999999999999999989999999999643 334567889999999985 78899999986532
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
...+...++||||+ ++++.+++..... +.+++..++.|+.||+.||+|||+++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~ 181 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY---------QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS 181 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEEC
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEe
Confidence 12446789999999 6666666543321 36899999999999999999999852 899999999999999
Q ss_pred CCC-------------------------------------------------cEEEeeecccccccccccccceeccccc
Q 001974 814 NDM-------------------------------------------------IAHVGDFGLARVRQEVSNLTQSCSVGVR 844 (988)
Q Consensus 814 ~~~-------------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 844 (988)
.++ .+||+|||.++...... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------~~~~ 254 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------TEDI 254 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------CSCC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------ccCC
Confidence 775 79999999998654321 2245
Q ss_pred cccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhh----hhhh----------hc
Q 001974 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH----VIDI----------VD 910 (988)
Q Consensus 845 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~----------~d 910 (988)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+..........+.+. .... +.
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 899999999999999999999999999999999999999754332211111110111000 0000 00
Q ss_pred cc----cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 911 PI----LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 911 ~~----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. .......|. ...............+.++.+|+.+||+.||++|||++|+++
T Consensus 335 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 335 KKGDLKHITKLKPWG---LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TTSSBSSCCCCCCCC---HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CccccccccccCCcc---hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 000000000 001111112233456778999999999999999999999985
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=364.38 Aligned_cols=183 Identities=15% Similarity=0.175 Sum_probs=118.5
Q ss_pred ccCCccccCCCCCCCCCce-eeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCC
Q 001974 3 AHDPQGILNSWNDSGHFCE-WKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFR 81 (988)
Q Consensus 3 ~~~~~~~~~~w~~~~~~c~-~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 81 (988)
.-+.+..+++|.++.+||. |.++.|...+.++ +....... .+..-..+++++.|++++|.++...+..|..+++
T Consensus 2 ~g~~~~~l~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~ 76 (597)
T 3oja_B 2 GGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHI---DMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76 (597)
T ss_dssp ---------CCCSEECCCCC--CCSEEECSCEE---CSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCC
T ss_pred CCcccccccCCCCCCcCcccCcCceeEecCcee---cccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCC
Confidence 3466778899998888874 3333343222222 11111111 1111224578888999999888766667788888
Q ss_pred CcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccc
Q 001974 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA 161 (988)
Q Consensus 82 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (988)
|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|.++++|++|+|++|.+++..+..|+++++|++|+|++
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~ 156 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN 156 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence 88888888888877777888888888888888888877777777787888888877777755555567777777777777
Q ss_pred cccCCCCCccccCcccccccccccccccC
Q 001974 162 NAFGGNIPNSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 162 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 190 (988)
|.+++..|..|+++++|++|+|++|.+++
T Consensus 157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 157 NNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 77766666666666666666666666653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=346.04 Aligned_cols=291 Identities=22% Similarity=0.228 Sum_probs=193.7
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF- 734 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 734 (988)
+......++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999999899999999986432 334567788888999999999999999765321
Q ss_pred -cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEeccCCCCCee
Q 001974 735 -QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLH--HHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 735 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIl 811 (988)
......++||||+++ ++.+.+..... ....+++..+..++.|++.||+||| +. +|+||||||+||+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR-------RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVL 163 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT-------TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh-------cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEE
Confidence 112337899999965 44433321000 0136788999999999999999999 77 9999999999999
Q ss_pred eCC-CCcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccC
Q 001974 812 LDN-DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889 (988)
Q Consensus 812 l~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~ 889 (988)
++. ++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEPN-----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSCC-----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCCc-----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 996 899999999999866543221 234589999999998765 4899999999999999999999998742111
Q ss_pred CcchHHHHHHHHhhh---hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 890 DLNLHNYARTALLDH---VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 890 ~~~~~~~~~~~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..+..... ..... .....++..... ++...................+.++.+++.+||+.||++|||++|+++
T Consensus 239 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 239 -GQLHEIVR-VLGCPSREVLRKLNPSHTDV--DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp -HHHHHHHH-HHCCCCHHHHHHHCTTCCCG--GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHH-HcCCCCHHHHHhcccchhhc--cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01111111 10000 001111100000 000000000111111223346788999999999999999999999986
Q ss_pred H
Q 001974 967 E 967 (988)
Q Consensus 967 ~ 967 (988)
.
T Consensus 315 h 315 (360)
T 3e3p_A 315 H 315 (360)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=339.65 Aligned_cols=256 Identities=20% Similarity=0.221 Sum_probs=186.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||+||+|++..+|+.||+|+++.... ...+.+..+...++.++||||+++++++. .++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 35789999999999999999999998999999999974422 22233445555677889999999999964 347
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ |+|.+++..... ....+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVID-------KGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCE
T ss_pred CEEEEEehhc-cchHHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCE
Confidence 8999999996 688777643110 113689999999999999999999984 289999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCccc----CCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG----LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
||+|||+++........ ....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .
T Consensus 150 kl~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~- 220 (290)
T 3fme_A 150 KMCDFGISGYLVDDVAK-----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---F- 220 (290)
T ss_dssp EBCCC--------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---H-
T ss_pred EEeecCCcccccccccc-----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---H-
Confidence 99999999865443221 123589999999996 5667899999999999999999999998632111 0
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ....... .....++.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~--------~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 221 QQLKQV--------VEEPSPQ------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHH--------HHSCCCC------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHH--------hccCCCC------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 0000000 011246778999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=343.94 Aligned_cols=267 Identities=17% Similarity=0.243 Sum_probs=202.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccch-----------------hHHHHHHHHHHHhcCCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA-----------------SKSFLAECKALKNIRHRNLVK 724 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 724 (988)
.++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 89999999996432211 178999999999999999999
Q ss_pred EEeecccccccCCCceEEEEeeccccchhhh------cCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCC
Q 001974 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENW------LHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQ 797 (988)
Q Consensus 725 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~ 797 (988)
+++++. .++..++||||+++++|.++ +..... ..+++..++.++.|++.||+|||+ .
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~-- 171 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---------CFIPIQVIKCIIKSVLNSFSYIHNEK-- 171 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSC---------CCCCHHHHHHHHHHHHHHHHHHHHTS--
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccc---------cCCCHHHHHHHHHHHHHHHHHHhccC--
Confidence 999964 34789999999999999999 544211 368999999999999999999999 8
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCC-ccchHHHHHHHHH
Q 001974 798 EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVST-NGDIYSYGILLLE 875 (988)
Q Consensus 798 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~vl~e 875 (988)
+|+||||||+||+++.++.+||+|||.+...... ......|+..|+|||++.+. .++. ++|||||||++||
T Consensus 172 -~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 172 -NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp -CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred -CEeecCCChHhEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999999999999865432 12234589999999999887 6666 9999999999999
Q ss_pred HHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCC
Q 001974 876 MVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955 (988)
Q Consensus 876 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 955 (988)
|++|+.||...... ............ . .......+... ............++.++.+++.+||+.||
T Consensus 245 l~~g~~pf~~~~~~----~~~~~~i~~~~~-~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP 311 (348)
T 2pml_X 245 MFYNVVPFSLKISL----VELFNNIRTKNI-E-----YPLDRNHFLYP---LTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311 (348)
T ss_dssp HHHSSCSSCCSSCS----HHHHHHHTSCCC-C-----CCCSSSSSTTT---TCC--------CCCHHHHHHHHHHCCSSG
T ss_pred HHhCCCCCCCCCcH----HHHHHHHhccCc-C-----Cccchhhhhcc---ccccccccchhhcCHHHHHHHHHHccCCh
Confidence 99999998743221 111111111000 0 00000000000 00000011123577889999999999999
Q ss_pred CCCCCHHHHHH
Q 001974 956 QDRMSITNVVH 966 (988)
Q Consensus 956 ~~RPs~~evl~ 966 (988)
++|||++|+++
T Consensus 312 ~~Rps~~e~l~ 322 (348)
T 2pml_X 312 AERITSEDALK 322 (348)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=369.85 Aligned_cols=260 Identities=22% Similarity=0.375 Sum_probs=206.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECC---CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQ---DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
..++|++.+.||+|+||.||+|.+.. .+..||+|+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------ 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence 34678889999999999999999854 34679999986433 233467899999999999999999999863
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~ 528 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK----------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 528 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCC
Confidence 256899999999999999996443 2589999999999999999999999 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 529 ~vkL~DFG~a~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~ 600 (656)
T 2j0j_A 529 CVKLGDFGLSRYMEDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----D 600 (656)
T ss_dssp EEEECCCCCCCSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred CEEEEecCCCeecCCCccee---ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----H
Confidence 99999999998664432211 122346789999999988899999999999999999997 99998642111 1
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
... .+.. ......+..+++.+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 601 ~~~-----~i~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 VIG-----RIEN----------------------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHH-----HHHH----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-----HHHc----------------------CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 100 0000 001112346778899999999999999999999999999999765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=344.22 Aligned_cols=280 Identities=21% Similarity=0.210 Sum_probs=198.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 738 (988)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999899999999986432 2334678899999999999999999998654311 1113
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~ 165 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL 165 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCE
T ss_pred eEEEEecccc-CCHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcE
Confidence 4599999995 799888742 478999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus 166 kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i 236 (353)
T 3coi_A 166 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQI 236 (353)
T ss_dssp EECSTTCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHH
T ss_pred EEeecccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 99999999864332 123458999999999887 67899999999999999999999998642110 000000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.........++...........+........+.........+++++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000000000000000000000000000011123567889999999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=354.62 Aligned_cols=270 Identities=21% Similarity=0.299 Sum_probs=195.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 741 (988)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|++++++++||||+++++++..... .+....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999999899999999986432 223479999999999999999998754311 1223467
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC-CcEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 820 (988)
+||||++ +++.+.+.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 130 lv~e~~~-~~l~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 130 LVLDYVP-ETVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp EEEECCC-EEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred eehhccc-ccHHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence 9999996 46665553210 0113689999999999999999999998 99999999999999955 67899
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.....
T Consensus 199 ~DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~- 271 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIK- 271 (420)
T ss_dssp CCCTTCEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-
T ss_pred ccchhhhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-
Confidence 99999986543322 1234689999999998765 7899999999999999999999998642111 01111111
Q ss_pred HHhh----hhhhhhcccccc------CcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLD----HVIDIVDPILIN------DVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~----~~~~~~d~~l~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... .+... ++.... ....|.. ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 272 ~lg~p~~~~~~~~-~~~~~~~~~p~~~~~~~~~-----------~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 272 VLGTPTREQIREM-NPNYTEFKFPQIKAHPWTK-----------VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCHHHHHHH-CSCCCCCCCCCCCCCCHHH-----------HSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHhh-ChhhhhhccCccCCCCHHH-----------hcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 01110 110000 0001100 012346788999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.43 Aligned_cols=252 Identities=25% Similarity=0.316 Sum_probs=200.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 467999999999999999999998899999999986432 234578899999999999999999999954 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC---C
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND---M 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 816 (988)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++.+ +
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR-----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred EEEEEEccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcc
Confidence 89999999999999887543 3689999999999999999999999 99999999999999754 4
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||++......... ....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...
T Consensus 162 ~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~ 230 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTKM-----KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDI 230 (287)
T ss_dssp CEEECSTTGGGTBCCCSSC-----SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred cEEEeccCcceeecCCCcc-----ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence 7999999999865443221 12348899999999876 489999999999999999999999864211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... +.. ....... .....++.++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~-----~~~---~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 231 LKR-----VET---GKYAFDL----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHH-----HHH---CCCCCCS----------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHH-----HHc---CCCCCCc----------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 110 000 0000000 0112467789999999999999999999999873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.73 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=195.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccc--------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSID-------- 733 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 733 (988)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45789999999999999999999889999999999643 334577899999999999999999999875421
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.......++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN----------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID 150 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC----------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc----------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence 123467899999999999999997543 3678889999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecccccccccccc----------cceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCC
Q 001974 814 NDMIAHVGDFGLARVRQEVSNL----------TQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p 882 (988)
.++.+||+|||.+......... .........||+.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 9999999999999865432110 01112234689999999998864 68999999999999999998 5
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|..... .......+... ..... .......+..+.+++.+||+.||++|||++
T Consensus 228 ~~~~~~---------~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 279 (303)
T 1zy4_A 228 FSTGME---------RVNILKKLRSV-SIEFP------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279 (303)
T ss_dssp CSSHHH---------HHHHHHHHHST-TCCCC------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCchh---------HHHHHHhcccc-ccccC------------------ccccccchHHHHHHHHHHHhcCcccCcCHH
Confidence 432100 00001111100 00000 011235667789999999999999999999
Q ss_pred HHHH
Q 001974 963 NVVH 966 (988)
Q Consensus 963 evl~ 966 (988)
|+++
T Consensus 280 ~ll~ 283 (303)
T 1zy4_A 280 TLLN 283 (303)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 9986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=338.71 Aligned_cols=259 Identities=20% Similarity=0.260 Sum_probs=177.5
Q ss_pred hhCCCCCCc-eeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTH-LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~-~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..++|.+.+ .||+|+||+||+|++..+++.||||++.... .........++.+.||||+++++++... ...+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCce
Confidence 356788855 6999999999999999899999999986421 2222233345667999999999997643 223456
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
.++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD---------QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C---------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred EEEEEeccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCc
Confidence 8999999999999999976532 3689999999999999999999999 9999999999999976 45
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .
T Consensus 169 ~~kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~- 239 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--P- 239 (336)
T ss_dssp CEEECCCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eEEEeccccceeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--h-
Confidence 69999999998654321 12245899999999998889999999999999999999999998643211100 0
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.....+. ...... .......++.++.+++.+||+.||++|||++|+++.
T Consensus 240 ---~~~~~~~---~~~~~~----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 240 ---GMKRRIR---LGQYGF----------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------------CC----------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---hHHHhhh---cccccc----------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 000000 001113567889999999999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.34 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=199.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc------hhHHHHHHHHHHHhcC--CCCceEEEeeccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG------ASKSFLAECKALKNIR--HRNLVKVITSCSS 731 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~ 731 (988)
...++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 3457899999999999999999999989999999999754321 2245778999999995 599999999954
Q ss_pred ccccCCCceEEEEeeccc-cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 732 IDFQGNDFKALVYEFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
.++..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 180 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITER-----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI 180 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence 44789999999976 8999998643 3689999999999999999999998 999999999999
Q ss_pred eeC-CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCcccc
Q 001974 811 LLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFE 888 (988)
Q Consensus 811 ll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~ 888 (988)
+++ +++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred EEeCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 999 78999999999998664322 122458999999999877665 678999999999999999999986310
Q ss_pred CCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 889 GDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. . .. ........++.++.+++.+||+.||++|||++|+++
T Consensus 254 ------~---------~---~~--------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ------E---------I---IR--------------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------H---------H---HH--------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------h---------h---hc--------------------ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00 000112356778999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=342.78 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=201.6
Q ss_pred HHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccc
Q 001974 655 YESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSI 732 (988)
Q Consensus 655 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 732 (988)
..++....++|++.+.||+|+||.||+|++.. .||+|+++... ....+.+.+|+.++++++||||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS- 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-
Confidence 34444556889999999999999999999853 49999986432 2334567889999999999999999999653
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL 812 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 812 (988)
++..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 101 ----~~~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 101 ----PPHLAIITSLCKGRTLYSVVRDAK----------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFY 163 (319)
T ss_dssp ----SSCEEEECBCCCSEEHHHHTTSSC----------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEE
T ss_pred ----CCceEEEeecccCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEE
Confidence 477999999999999999997654 2588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccc-cceeccccccccccccCcccCC---------CCCCCccchHHHHHHHHHHHhCCCC
Q 001974 813 DNDMIAHVGDFGLARVRQEVSNL-TQSCSVGVRGTIGYAAPEYGLG---------SEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 813 ~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~vl~elltg~~p 882 (988)
+ ++.+||+|||+++........ .........|++.|+|||++.+ ..++.++||||||+++|||++|+.|
T Consensus 164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 8 679999999998754322111 1111223458999999999874 3578899999999999999999999
Q ss_pred CCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH
Q 001974 883 TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962 (988)
Q Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 962 (988)
|..... ..... .+.....+. .....++.++.+++.+||+.||++|||++
T Consensus 243 ~~~~~~-----~~~~~-----~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 291 (319)
T 2y4i_B 243 FKTQPA-----EAIIW-----QMGTGMKPN---------------------LSQIGMGKEISDILLFCWAFEQEERPTFT 291 (319)
T ss_dssp SSSCCH-----HHHHH-----HHHTTCCCC---------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred CCCCCH-----HHHHH-----HhccCCCCC---------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 863211 11110 010000000 01124567799999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 001974 963 NVVHELQSVKNAL 975 (988)
Q Consensus 963 evl~~L~~i~~~~ 975 (988)
|+++.|+++.++.
T Consensus 292 ~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 292 KLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHTTC----
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987664
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=347.15 Aligned_cols=277 Identities=21% Similarity=0.239 Sum_probs=192.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 740 (988)
..+|++.+.||+|+||+||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++..... .+....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3469999999999999999999975555 88887753322 22379999999999999999999765421 233447
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC-CCCcEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAH 819 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 819 (988)
++||||++++.+........ ..+.+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.+|
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAK--------LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHH--------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred EEEeeccCccHHHHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEE
Confidence 89999997654433221100 013689999999999999999999999 999999999999999 799999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|+|||+|+........ ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.....
T Consensus 183 L~DFG~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~ 256 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPN-----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIK 256 (394)
T ss_dssp ECCCTTCEECCTTCCC-----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred EeeCCCcccccCCCCC-----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 9999999865443221 234589999999998765 5899999999999999999999998642111 00111111
Q ss_pred HHHhhhhh---hhhcccccc-CcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDHVI---DIVDPILIN-DVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~~~---~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
....... ...++.... ...... .. .........+++++.+++.+||+.||++|||+.|+++.
T Consensus 257 -~~g~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 257 -VLGTPSREQIKTMNPNYMEHKFPQIR---PH---PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp -HHCCCCHHHHHHHCGGGSSSCCCCCC---CC---CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HhCCCCHHHHHhhChhhhhhcccccc---CC---cHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000 000000000 000000 00 00001123467889999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=337.56 Aligned_cols=277 Identities=19% Similarity=0.259 Sum_probs=202.9
Q ss_pred hCCCCCCceeccccceeEEEEEE-CCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC------ceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAF-DQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN------LVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46899999999999999999998 557899999998643 234567889999999987654 999999854
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
.++..++||||+ +++|.+++..... .++++.+++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 88 -~~~~~~lv~e~~-~~~l~~~l~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 88 -HHGHICIVFELL-GLSTYDFIKENGF---------LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ 153 (339)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred -cCCcEEEEEcCC-CCCHHHHHHhcCC---------CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEec
Confidence 347899999999 8999999865432 2588999999999999999999999 9999999999999987
Q ss_pred -------------------CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHH
Q 001974 815 -------------------DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE 875 (988)
Q Consensus 815 -------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 875 (988)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence 6689999999998643321 22458999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhc-----cccccCcchhhhhhHHH--Hh------hhhhccccchhHH
Q 001974 876 MVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVD-----PILINDVEDWDATNKQR--LR------QAKINGKIECPIS 942 (988)
Q Consensus 876 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----~~l~~~~~~~~~~~~~~--~~------~~~~~~~~~~~~~ 942 (988)
|++|+.||...... ................+.. ........+|....... .. ..........+++
T Consensus 227 l~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 227 YYLGFTVFPTHDSK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp HHHSSCSCCCSCHH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 99999998743111 1111111111100000000 00000111121111000 00 0001122346788
Q ss_pred HHHHhhcccCcCCCCCCCHHHHHH
Q 001974 943 MVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 943 l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.+++.+||+.||++|||++|+++
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhCcCcccccCHHHHhc
Confidence 999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=336.78 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=193.0
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc------hhHHHHHHHHHHHhc----CCCCceEEEeec
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG------ASKSFLAECKALKNI----RHRNLVKVITSC 729 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~~ 729 (988)
...++|++.+.||+|+||.||+|++..+++.||+|+++..... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999999889999999999644321 223456799999998 899999999995
Q ss_pred ccccccCCCceEEEEee-ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 001974 730 SSIDFQGNDFKALVYEF-MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPG 808 (988)
Q Consensus 730 ~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 808 (988)
. ..+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 108 ~-----~~~~~~~v~e~~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 168 (312)
T 2iwi_A 108 E-----TQEGFMLVLERPLPAQDLFDYITEK-----------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE 168 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred e-----cCCeEEEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence 4 34778999999 7899999998643 2589999999999999999999999 9999999999
Q ss_pred CeeeC-CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCC-CccchHHHHHHHHHHHhCCCCCCcc
Q 001974 809 NVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVS-TNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 809 NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
||+++ .++.+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||...
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 99999 88999999999998665432 1234589999999998776664 5899999999999999999998631
Q ss_pred ccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 887 FEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. . +. . .....+..++.++.+++.+||+.||++|||++|+++
T Consensus 243 ~-------~---------~~---~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 Q-------E---------IL---E--------------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-------H---------HH---H--------------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-------H---------Hh---h--------------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00 0 001112346778999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.38 Aligned_cols=281 Identities=19% Similarity=0.270 Sum_probs=202.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-----------CCCceEEEeecc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-----------HRNLVKVITSCS 730 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 730 (988)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46799999999999999999999989999999998643 234467889999999886 899999999876
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCe
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 810 (988)
.. .......++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ +|+||||||+||
T Consensus 97 ~~-~~~~~~~~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NI 163 (373)
T 1q8y_A 97 HK-GPNGVHVVMVFEVL-GENLLALIKKYEH---------RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENV 163 (373)
T ss_dssp EE-ETTEEEEEEEECCC-CEEHHHHHHHTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGE
T ss_pred cc-CCCCceEEEEEecC-CCCHHHHHHHhhc---------cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHe
Confidence 43 12234789999999 9999999865432 35899999999999999999999942 899999999999
Q ss_pred eeC------CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 811 LLD------NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 811 ll~------~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
+++ ..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEeccCCCcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 994 44589999999998654321 12358999999999999999999999999999999999999997
Q ss_pred ccccCCcchHHHHHHHHhhhhhh--------------hhccc-ccc---CcchhhhhhHHHHhhhhhccccchhHHHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVID--------------IVDPI-LIN---DVEDWDATNKQRLRQAKINGKIECPISMVRI 946 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~d~~-l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 946 (988)
................+.+.... +++.. ... ....|. ...........+..++.++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP---LEDVLTEKYKFSKDEAKEISDF 313 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC---HHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccc---hhhhhhhcccCCcchHHHHHHH
Confidence 43221110000000000000000 00000 000 000000 0111122223345677889999
Q ss_pred hhcccCcCCCCCCCHHHHHH
Q 001974 947 GVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 947 i~~cl~~dP~~RPs~~evl~ 966 (988)
+.+||+.||++|||++|+++
T Consensus 314 i~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHhccCccccCCHHHHhh
Confidence 99999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=344.37 Aligned_cols=211 Identities=24% Similarity=0.310 Sum_probs=156.0
Q ss_pred CCCC-CceeccccceeEEEEEEC--CCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSS-THLIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~-~~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|++ .++||+|+||+||+|++. .+++.||+|++... .....+.+|+.++++++||||+++++++.. ..+...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence 3555 468999999999999975 46889999998643 234678899999999999999999999643 235788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee----CCCC
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL----DNDM 816 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 816 (988)
++||||++ ++|.+++........ ......+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKA--NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred EEEEeCCC-CCHHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 99999994 688887753210000 00012589999999999999999999999 99999999999999 7788
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCcc
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVM 886 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 886 (988)
.+||+|||+|+........ ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CEEECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cEEEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999876432211 1112335689999999998874 5899999999999999999999999643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=335.96 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=197.6
Q ss_pred ccccCHHHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcC--CCCceEE
Q 001974 650 LQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIR--HRNLVKV 725 (988)
Q Consensus 650 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~ 725 (988)
...+.+.++....++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++ ||||+++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 334444445556678999999999999999999986 68999999997443 234467899999999996 5999999
Q ss_pred EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 726 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
++++.. ++..++|||+ .+++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||
T Consensus 94 ~~~~~~-----~~~~~lv~e~-~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dl 153 (313)
T 3cek_A 94 YDYEIT-----DQYIYMVMEC-GNIDLNSWLKKKK-----------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDL 153 (313)
T ss_dssp EEEEEC-----SSEEEEEECC-CSEEHHHHHHHCS-----------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred EEEeec-----CCEEEEEEec-CCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCC
Confidence 998643 4779999995 5899999986543 688999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC-----------CCCCCccchHHHHHHHH
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-----------SEVSTNGDIYSYGILLL 874 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~ 874 (988)
||+||++++ +.+||+|||+++........ .......|++.|+|||++.+ ..++.++||||||+++|
T Consensus 154 kp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 154 KPANFLIVD-GMLKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CGGGEEEET-TEEEECCCSSSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CcccEEEEC-CeEEEeeccccccccCcccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 999999974 89999999999865433211 11123458999999999875 46888999999999999
Q ss_pred HHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcC
Q 001974 875 EMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954 (988)
Q Consensus 875 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 954 (988)
||++|+.||...... ... .....++... ...+...+.++.+++.+||+.|
T Consensus 231 el~~g~~pf~~~~~~----~~~--------~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~d 280 (313)
T 3cek_A 231 YMTYGKTPFQQIINQ----ISK--------LHAIIDPNHE------------------IEFPDIPEKDLQDVLKCCLKRD 280 (313)
T ss_dssp HHHHSSCTTTTCCSH----HHH--------HHHHHCTTSC------------------CCCCCCSCHHHHHHHHHHTCSS
T ss_pred HHHhCCCchhhHHHH----HHH--------HHHHHhcccc------------------cCCcccchHHHHHHHHHHccCC
Confidence 999999998643211 000 0111111110 0112245677999999999999
Q ss_pred CCCCCCHHHHHHH
Q 001974 955 PQDRMSITNVVHE 967 (988)
Q Consensus 955 P~~RPs~~evl~~ 967 (988)
|++|||++|+++.
T Consensus 281 p~~Rps~~ell~h 293 (313)
T 3cek_A 281 PKQRISIPELLAH 293 (313)
T ss_dssp TTTSCCHHHHHTS
T ss_pred cccCcCHHHHhcC
Confidence 9999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.82 Aligned_cols=201 Identities=26% Similarity=0.334 Sum_probs=169.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CC-----CceEEEeecccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HR-----NLVKVITSCSSIDF 734 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~ 734 (988)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+++++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE---
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc---
Confidence 457899999999999999999999989999999999643 233467788999988884 55 49999998543
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC-
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD- 813 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~- 813 (988)
.+..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||++ ..+||||||||+||+++
T Consensus 128 --~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 128 --RNHLCLVFEMLS-YNLYDLLRNTNF---------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN 194 (382)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHTTT---------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred --CCceEEEEecCC-CCHHHHHhhcCc---------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence 478999999994 699999875432 2589999999999999999999952 23999999999999995
Q ss_pred -CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 814 -NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 814 -~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
.++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQRI-------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTSCCEEECCCTTCEETTCCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCcEEEEeccCceeccccc-------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 57889999999998654321 224589999999999999999999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.76 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=179.4
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHH-HHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECK-ALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
..++|++.+.||+|+||.||+|.+..+|+.||||+++.... .....+..|+. +++.++||||+++++++.. ++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence 34789999999999999999999988999999999975432 23345566666 6677799999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||++ ++|.+++..... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 95 DCWICMELMS-TSFDKFYKYVYS------VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp EEEEEECCCS-EEHHHHHHHHHH------TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEE
T ss_pred ceEEEEeecC-CChHHHHHHHHh------hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCE
Confidence 8899999996 588777642100 0013688999999999999999999984 289999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCccc----CCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG----LGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
||+|||+++........ ....||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 166 kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 236 (327)
T 3aln_A 166 KLCDFGISGQLVDSIAK-----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---- 236 (327)
T ss_dssp EECCCSSSCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------
T ss_pred EEccCCCceeccccccc-----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----
Confidence 99999999865432211 123589999999998 45678999999999999999999999986421110
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
+..... .......+ .......++.++.+++.+||+.||++|||++|+++.
T Consensus 237 --------~~~~~~----~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 237 --------DQLTQV----VKGDPPQL-----------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -----------CCC----CCSCCCCC-----------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------HHHHHH----hcCCCCCC-----------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000 00000000 001123567889999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=354.69 Aligned_cols=286 Identities=21% Similarity=0.255 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. .....+.+.+|++++++++||||+++++++.... +..++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999889999999998654 2334567899999999999999999999875421 233677
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc--
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI-- 817 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 817 (988)
.++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~--------~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC--------CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT--------TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSC
T ss_pred EEEEEEeCCCCCHHHHHHhcccC--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCce
Confidence 89999999999999999764321 2578889999999999999999998 9999999999999997664
Q ss_pred -EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 818 -AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 -~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||.+......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...|
T Consensus 162 ~vKL~DFG~a~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~ 232 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGELC-----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQW 232 (676)
T ss_dssp EEEECSCCCCCBTTSCCCC-----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHS
T ss_pred eEEEccccccccccccccc-----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhh
Confidence 999999999876543321 234689999999999999999999999999999999999999864211 0010
Q ss_pred HHHHHhhhhh-hhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHH-----HHHHHHH
Q 001974 897 ARTALLDHVI-DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN-----VVHELQS 970 (988)
Q Consensus 897 ~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~ 970 (988)
.......... ........+.. .|.. .. .........++..+.+++.+||+.||++|||++| +.+.++.
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~-~~~~----~l-p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAV-KFSS----VL-PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp STTCC------CCSCCCCSSSC-CCCS----SS-CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhcccchhhhhhhhhcccc-cccc----cc-CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0000000000 00000000000 0000 00 0000122347788999999999999999999998 4555555
Q ss_pred HHH
Q 001974 971 VKN 973 (988)
Q Consensus 971 i~~ 973 (988)
+.+
T Consensus 307 iL~ 309 (676)
T 3qa8_A 307 ILS 309 (676)
T ss_dssp HHC
T ss_pred HHh
Confidence 543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=334.64 Aligned_cols=277 Identities=18% Similarity=0.255 Sum_probs=199.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC-eEEEEEEeeccccchhHHHHHHHHHHHhcCCCC------ceEEEeecccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG-TIVAIKVFNLQRHGASKSFLAECKALKNIRHRN------LVKVITSCSSIDF 734 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 734 (988)
.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 468999999999999999999997776 79999999643 234567889999999997665 888888754
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeee--
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLL-- 812 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-- 812 (988)
..+..++||||+ ++++.+++..... ..+++.+++.++.||+.||+|||+. +|+||||||+||++
T Consensus 93 -~~~~~~lv~e~~-~~~l~~~l~~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 93 -FHGHMCIAFELL-GKNTFEFLKENNF---------QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN 158 (355)
T ss_dssp -ETTEEEEEEECC-CCBHHHHHHHTTT---------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESC
T ss_pred -eCCeEEEEEecc-CCChHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec
Confidence 347899999999 6677766654321 3689999999999999999999998 99999999999999
Q ss_pred -----------------CCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHH
Q 001974 813 -----------------DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLE 875 (988)
Q Consensus 813 -----------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 875 (988)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence 567899999999998643321 22458999999999999999999999999999999
Q ss_pred HHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccc-----cccCcchhhhhhHH--HHhh------hhhccccchhHH
Q 001974 876 MVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPI-----LINDVEDWDATNKQ--RLRQ------AKINGKIECPIS 942 (988)
Q Consensus 876 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-----l~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~ 942 (988)
|++|+.||...... ................+.... .......|...... .... .........+.+
T Consensus 232 l~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 232 YYRGFTLFQTHENR--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHhCCCCCCCCCHH--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 99999998743211 111111111111000000000 00000011110000 0000 001112234668
Q ss_pred HHHHhhcccCcCCCCCCCHHHHHH
Q 001974 943 MVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 943 l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.+++.+||+.||++|||++|+++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.14 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=180.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc-h-hHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG-A-SKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|++..+|+.||||++...... . .+.+..+..+++.++||||+++++++. .++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence 46788999999999999999999989999999999754332 2 233445555678889999999999964 3478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
.++||||+ ++.+..+..... ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQ----------GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEecc-CCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCE
Confidence 99999999 666665543221 368999999999999999999998 5 89999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcch
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 893 (988)
||+|||++........ .....|++.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 165 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 235 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---- 235 (318)
T ss_dssp EECCCTTC-------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred EEEECCCchhccCCcc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----
Confidence 9999999976543222 12245899999999984 456889999999999999999999998642111
Q ss_pred HHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 894 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.......... ..+ .......++.++.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~-----~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 FEVLTKVLQE-----EPP--------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHHS-----CCC--------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHhcc-----CCC--------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111110000 000 001122467889999999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=343.87 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=183.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
+.|...+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +||||+++++++. .++..+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEE
Confidence 3455568899999999987654 48999999998643 235678999999987 8999999999853 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC------
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND------ 815 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------ 815 (988)
+||||+ +|+|.+++......... ....++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 86 lv~E~~-~gsL~~~l~~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 86 IALELC-NLNLQDLVESKNVSDEN----LKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp EEECCC-SEEHHHHHHTC----------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSC
T ss_pred EEEecC-CCCHHHHHhccCCCchh----hhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccc
Confidence 999999 57999999765421110 01123445678999999999999998 99999999999999754
Q ss_pred -------CcEEEeeecccccccccccccceeccccccccccccCcccCC-------CCCCCccchHHHHHHHHHHHh-CC
Q 001974 816 -------MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-------SEVSTNGDIYSYGILLLEMVT-GK 880 (988)
Q Consensus 816 -------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~ 880 (988)
+.+||+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||+| |+
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765433221112233569999999999875 578999999999999999999 99
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||....... ..+.... .+.. .. .......++.++.+++.+||+.||++|||
T Consensus 238 ~Pf~~~~~~~--------~~i~~~~---~~~~---~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (434)
T 2rio_A 238 HPFGDKYSRE--------SNIIRGI---FSLD---EM--------------KCLHDRSLIAEATDLISQMIDHDPLKRPT 289 (434)
T ss_dssp CTTCSTTTHH--------HHHHHTC---CCCC---CC--------------TTCCCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCchhhH--------HHHhcCC---CCcc---cc--------------cccccccchHHHHHHHHHHhhCChhhCCC
Confidence 9986321110 0000000 0000 00 00011245678999999999999999999
Q ss_pred HHHHHH
Q 001974 961 ITNVVH 966 (988)
Q Consensus 961 ~~evl~ 966 (988)
++|+++
T Consensus 290 ~~eil~ 295 (434)
T 2rio_A 290 AMKVLR 295 (434)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999985
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=330.56 Aligned_cols=337 Identities=18% Similarity=0.174 Sum_probs=239.7
Q ss_pred cccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccE
Q 001974 198 NLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSY 277 (988)
Q Consensus 198 ~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 277 (988)
.+++++.|++++|.++ .+|..++..+++|++|++++|.+++..+..|..+++|++|++++|.+.+..+..|.++++|++
T Consensus 43 ~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 3566777777777776 666666666667777777777666655556666666666666666666655555555555555
Q ss_pred EecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEE
Q 001974 278 FNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357 (988)
Q Consensus 278 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 357 (988)
|++++|.++.++.. .|..++ +|++|++++|++.+..+..+..+++|+.|
T Consensus 122 L~L~~n~l~~l~~~------~~~~l~-------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 122 LVLERNDLSSLPRG------IFHNTP-------------------------KLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp EECCSSCCCCCCTT------TTTTCT-------------------------TCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred EECCCCccCcCCHH------HhcCCC-------------------------CCcEEECCCCccCccChhhccCCCCCCEE
Confidence 55555555433322 122333 56666666666665666667777788888
Q ss_pred EeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCC
Q 001974 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLN 437 (988)
Q Consensus 358 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 437 (988)
++++|++++. .+..+++|+.|++++|.+++. ...++|+.|++++|.+... |..+ .++|+.|++++|+++
T Consensus 171 ~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~ 239 (390)
T 3o6n_A 171 QLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLT 239 (390)
T ss_dssp ECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCC
T ss_pred ECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCc
Confidence 8888887743 255667788888888877632 2345788888888888754 3322 467888888888887
Q ss_pred ccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccc
Q 001974 438 GTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSL 517 (988)
Q Consensus 438 ~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 517 (988)
+ + ..+..++.| ++|++++|.+++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+
T Consensus 240 ~-~-~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~ 314 (390)
T 3o6n_A 240 D-T-AWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314 (390)
T ss_dssp C-C-GGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGH
T ss_pred c-c-HHHcCCCCc-cEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccc
Confidence 4 3 467778888 88888888888777888888999999999999998 46777788899999999999998 678888
Q ss_pred cCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCCCcccCcccccccccccccCCCCC
Q 001974 518 SSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIP 585 (988)
Q Consensus 518 ~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~ 585 (988)
..+++|+.|+|++|+++... ...+++|++|++++|++++.... ..+..+....+.+++..|+++.
T Consensus 315 ~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 315 PQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp HHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTTC
T ss_pred cccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecccc
Confidence 88999999999999998764 45567899999999998875432 2344555556677777887644
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=350.11 Aligned_cols=343 Identities=19% Similarity=0.191 Sum_probs=248.0
Q ss_pred ccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEE
Q 001974 199 LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYF 278 (988)
Q Consensus 199 l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 278 (988)
+++++.|++++|.+. .+|..++..+++|+.|+|++|.+++..|..|..+++|++|++++|.+++..+..|.++++|++|
T Consensus 50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 456667777777766 6666666666666666666666666655566666666666666666666555555555555555
Q ss_pred ecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEE
Q 001974 279 NVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLG 358 (988)
Q Consensus 279 ~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 358 (988)
+|++|.++.+++. .|..++ +|+.|+|++|.+++..|..|..+++|+.|+
T Consensus 129 ~L~~n~l~~l~~~------~~~~l~-------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 129 VLERNDLSSLPRG------IFHNTP-------------------------KLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp ECCSSCCCCCCTT------TTTTCT-------------------------TCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred EeeCCCCCCCCHH------HhccCC-------------------------CCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 5555555443332 122333 566666666666666667777778888888
Q ss_pred eeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCc
Q 001974 359 MGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438 (988)
Q Consensus 359 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 438 (988)
|++|.+++. .+..+++|+.|++++|.+++ +...++|+.|++++|.+....+. + .++|+.|+|++|.+++
T Consensus 178 L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 178 LSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD 246 (597)
T ss_dssp CTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC
T ss_pred CcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC
Confidence 888887753 24556778888888887774 23345788888888888744332 2 2578888888888875
Q ss_pred cCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCcccc
Q 001974 439 TIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLS 518 (988)
Q Consensus 439 ~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 518 (988)
+..+..++.| +.|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..++.+++|+.|+|++|.++ .+|..+.
T Consensus 247 --~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~ 321 (597)
T 3oja_B 247 --TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321 (597)
T ss_dssp --CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred --ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccc
Confidence 4677888888 889999999988888899999999999999999995 7888888999999999999999 6888889
Q ss_pred CccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcccCCCCcccCcccccccccccccCCCCCCCCCCcc
Q 001974 519 SLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKC 592 (988)
Q Consensus 519 ~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~~~~~~~~~ 592 (988)
.+++|+.|+|++|+|++.+ ...+++|+.|+|++|++++..+. ..+..+....+.+++..|+.+.......|
T Consensus 322 ~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~c 392 (597)
T 3oja_B 322 QFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLEHGLC 392 (597)
T ss_dssp HHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEETTEE
T ss_pred cCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhccCCcc
Confidence 9999999999999998875 44567899999999999886542 33455666677888899997655443444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=323.45 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=206.8
Q ss_pred cccEEEccCCcccc--CCCccccCCCcceEEEeeC-ccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEE
Q 001974 329 QLQNLIMTSNQLHG--SIPSGIGNLVGLYRLGMGG-NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL 405 (988)
Q Consensus 329 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 405 (988)
+++.|+|++|.+.+ .+|..+..+++|++|+|++ |++.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 56677777777776 6777777888888888884 77877788888888888888888888877788888888888888
Q ss_pred EccccccccccccccccccccceeecCCCCCCccCchhhhhhc-ccccceecccccccCCCccccccccccceeecCCcc
Q 001974 406 LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLT-YLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNN 484 (988)
Q Consensus 406 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 484 (988)
+|++|.+++.+|..|..+++|++|++++|+++|.+|..++.++ .+ +.|++++|++++.+|..+..+. |+.|+|++|+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L-~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF-TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC-CEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcC-cEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 8888888877888888888888888888888878888888877 55 7888888888888888888876 8888888888
Q ss_pred cccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCC
Q 001974 485 LSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 485 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~ 563 (988)
+++.+|..|+.+++|+.|+|++|.+++.+|. +..+++|+.|||++|++++.+|.. ..+++|++|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 8888888888888888888888888866665 777888888888888888777765 66778888888888888888887
Q ss_pred cccCcccccccccccccCCCCCC
Q 001974 564 GVFANISRISVAGFNRLCGGIPE 586 (988)
Q Consensus 564 ~~~~~~~~~~~~~n~~lcg~~~~ 586 (988)
+.+..+..+.+.+|+++||.|+.
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSS
T ss_pred ccccccChHHhcCCCCccCCCCC
Confidence 77788888888999999997653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=339.68 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=183.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...+|.+.+.||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +||||+++++++. ++..
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~ 92 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DRQF 92 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTE
T ss_pred ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCE
Confidence 345688899999999999664433 4889999999864332 3456899999999 8999999999854 4478
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-----
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN----- 814 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----- 814 (988)
.++||||+ +|+|.+++..... ...+.+++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 93 ~~lv~E~~-~g~L~~~l~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 93 QYIAIELC-AATLQEYVEQKDF----------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp EEEEEECC-SEEHHHHHHSSSC----------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTT
T ss_pred EEEEEECC-CCCHHHHHHhcCC----------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCC
Confidence 89999999 5799999976542 234445678999999999999999 9999999999999953
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccC---CCCCCCccchHHHHHHHHHHHh-CCCCCCccccCC
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL---GSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGD 890 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 890 (988)
...+||+|||+|+........ ........||+.|+|||++. ...++.++|||||||++|||++ |..||......
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~- 236 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR- 236 (432)
T ss_dssp BCCEEECCTTEEECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-
T ss_pred ceeEEEecccceeeccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-
Confidence 336889999999876543211 11223456999999999987 4567889999999999999999 99998532111
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
............ ........+..+.+++.+||+.||++|||++|+++
T Consensus 237 -----~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 -----QANILLGACSLD------------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----HHHHHTTCCCCT------------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhccCCcc------------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000000000 00011134456789999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=334.42 Aligned_cols=260 Identities=15% Similarity=0.132 Sum_probs=188.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCC-CCceEE------------
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRH-RNLVKV------------ 725 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~------------ 725 (988)
...|...+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.+++.++| +|...+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457778899999999999999998999999999873322 235789999999999977 322111
Q ss_pred ---------EeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC
Q 001974 726 ---------ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC 796 (988)
Q Consensus 726 ---------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 796 (988)
..+............+++|+++ +++|.+++...... ......+++..++.++.||+.||+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~----~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH----SSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH----TTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc----cccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 1111100000123467778876 79999988411000 00014688889999999999999999998
Q ss_pred CCCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCccc----------CCCCCCCccch
Q 001974 797 QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYG----------LGSEVSTNGDI 866 (988)
Q Consensus 797 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv 866 (988)
+||||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 9999999999999999999999999999864432 223457 999999998 66678899999
Q ss_pred HHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHH
Q 001974 867 YSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRI 946 (988)
Q Consensus 867 wslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 946 (988)
|||||++|||++|+.||......+ ..... ......+++++.++
T Consensus 301 wSlGvil~elltg~~Pf~~~~~~~-----------------~~~~~--------------------~~~~~~~~~~~~~l 343 (413)
T 3dzo_A 301 WTLGLAIYWIWCADLPNTDDAALG-----------------GSEWI--------------------FRSCKNIPQPVRAL 343 (413)
T ss_dssp HHHHHHHHHHHHSSCCCCTTGGGS-----------------CSGGG--------------------GSSCCCCCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCcchhh-----------------hHHHH--------------------HhhcccCCHHHHHH
Confidence 999999999999999986421110 00000 11122567889999
Q ss_pred hhcccCcCCCCCCCHHHHHHH--HHHHHHH
Q 001974 947 GVACSVESPQDRMSITNVVHE--LQSVKNA 974 (988)
Q Consensus 947 i~~cl~~dP~~RPs~~evl~~--L~~i~~~ 974 (988)
+.+||+.||++|||+.|+++. ++++.+.
T Consensus 344 i~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 999999999999999998653 4444333
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=315.92 Aligned_cols=235 Identities=13% Similarity=0.075 Sum_probs=185.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++.. ++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence 3679999999999999999999998899999999975432 234678999999999999999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... ....++.+|+.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~-------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTS-------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTC-------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCE
T ss_pred cEEEEEEecCCCCHHHHHhcC-------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCE
Confidence 899999999999999999532 24556888999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+++| |++ .++.++|||||||++|||+||+.||......+..
T Consensus 169 kl~~~~------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~------ 211 (286)
T 3uqc_A 169 VLAYPA------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL------ 211 (286)
T ss_dssp EECSCC------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS------
T ss_pred EEEecc------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh------
Confidence 998443 333 3688999999999999999999998743221100
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
. ............ .......+++++.+++.+||+.||++| |++|+++.|+++....
T Consensus 212 -------~-~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 212 -------A-PAERDTAGQPIE------------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -------E-ECCBCTTSCBCC------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -------H-HHHHHhccCCCC------------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 000000000000 001123577889999999999999999 9999999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=352.64 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=196.6
Q ss_pred hCCCCCCceeccccceeEEEEEECC-CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQ-DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|++++++++||||+++++++..........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999975 78999999986433 234467889999999999999999999976542222222
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++++|.+++.. .+++.+++.|+.||+.||+|||++ +||||||||+||+++.+ .+|
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp EEEEEECCCCEECC----C-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred eEEEEEeCCCCcHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence 6999999999999887643 488999999999999999999999 99999999999999985 999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||........
T Consensus 222 l~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------- 284 (681)
T 2pzi_A 222 LIDLGAVSRINSF--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------- 284 (681)
T ss_dssp ECCCTTCEETTCC--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------
T ss_pred EEecccchhcccC--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------
Confidence 9999999865432 2245899999999987654 8899999999999999999988763211100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-CHHHHHHHHHHHHHHh
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-SITNVVHELQSVKNAL 975 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 975 (988)
.... .....++.+.+++.+||+.||++|| +++++...+..+..+.
T Consensus 285 --------------~~~~-----------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 285 --------------PEDD-----------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp --------------CTTC-----------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred --------------cccc-----------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 0000 0012345688999999999999999 5667777787775544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.57 Aligned_cols=237 Identities=20% Similarity=0.313 Sum_probs=182.4
Q ss_pred hCCCCCC-ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHH-HhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSST-HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKAL-KNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++ +..+||||+++++++... ...+..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 3567776 789999999999999998999999999853 25677888888 555999999999987542 233577
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD---------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTC
T ss_pred EEEEEeecCCCcHHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCC
Confidence 8999999999999999975432 2589999999999999999999999 9999999999999998 78
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||++.... +..++.++||||+||++|||++|+.||.......
T Consensus 158 ~~kl~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~------ 205 (299)
T 3m2w_A 158 ILKLTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------ 205 (299)
T ss_dssp CEEECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------
T ss_pred cEEEeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh------
Confidence 99999999986422 2346789999999999999999999986421110
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
....... ....... .+. ......++.++.+++.+||+.||++|||++|+++.
T Consensus 206 ----~~~~~~~---~~~~~~~-~~~-----------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 206 ----ISPGMKT---RIRMGQY-EFP-----------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ------CCSCC---SSCTTCC-SSC-----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----hhHHHHH---HHhhccc-cCC-----------chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0000000 000 00012467889999999999999999999999873
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=310.04 Aligned_cols=306 Identities=21% Similarity=0.307 Sum_probs=175.9
Q ss_pred ccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCcccc
Q 001974 197 YNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLS 276 (988)
Q Consensus 197 ~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~ 276 (988)
..+++|+.|++++|.+. .+|. +..+++|++|++++|++++..+ +..+++|++|++++|.++.. ..|..+++|+
T Consensus 41 ~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 41 EELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred hhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 34444455555555444 3332 2234444444444444443222 44444444444444444432 1344555555
Q ss_pred EEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceE
Q 001974 277 YFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYR 356 (988)
Q Consensus 277 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 356 (988)
+|++++|.++..+. +..+++|++|++++|. .... +..+..+++|+.
T Consensus 114 ~L~l~~n~i~~~~~--------~~~l~~L~~L~l~~n~-------------------------~~~~-~~~~~~l~~L~~ 159 (347)
T 4fmz_A 114 ELYLNEDNISDISP--------LANLTKMYSLNLGANH-------------------------NLSD-LSPLSNMTGLNY 159 (347)
T ss_dssp EEECTTSCCCCCGG--------GTTCTTCCEEECTTCT-------------------------TCCC-CGGGTTCTTCCE
T ss_pred EEECcCCcccCchh--------hccCCceeEEECCCCC-------------------------Cccc-ccchhhCCCCcE
Confidence 55555555443211 2334444444444443 3222 223555666666
Q ss_pred EEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCC
Q 001974 357 LGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGL 436 (988)
Q Consensus 357 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 436 (988)
|++++|.+.+..+ +..+++|+.|++++|++++. +. +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++
T Consensus 160 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l 233 (347)
T 4fmz_A 160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI 233 (347)
T ss_dssp EECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred EEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence 6666666653322 55666666666666666632 22 5666666666666666664433 66666666666666666
Q ss_pred CccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCcc
Q 001974 437 NGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516 (988)
Q Consensus 437 ~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 516 (988)
+ .++. +..++.+ ++|++++|.+++ + ..+..+++|+.|++++|++++ + +.+..+++|+.|+|++|.+++..|..
T Consensus 234 ~-~~~~-~~~l~~L-~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~ 306 (347)
T 4fmz_A 234 T-DLSP-LANLSQL-TWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEV 306 (347)
T ss_dssp C-CCGG-GTTCTTC-CEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred C-CCcc-hhcCCCC-CEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhH
Confidence 6 3443 5566666 666777776663 2 346677777778888877774 3 35777778888888888887777777
Q ss_pred ccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCc
Q 001974 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557 (988)
Q Consensus 517 ~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~ 557 (988)
+..+++|+.|+|++|++++.+| ...+++|++|++++|.++
T Consensus 307 l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 307 IGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC---
T ss_pred hhccccCCEEEccCCccccccC-hhhhhccceeehhhhccc
Confidence 7778888888888888877766 666777888888888764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=311.23 Aligned_cols=308 Identities=24% Similarity=0.353 Sum_probs=204.6
Q ss_pred cccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccc
Q 001974 51 YIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKL 130 (988)
Q Consensus 51 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 130 (988)
.+..+++|++|++++|.++. +| .+..+++|++|++++|++++ +|. |..+++|++|+|++|+++. + .+|.++++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 34567778888888888873 44 37778888888888888874 333 7788888888888888874 3 357788888
Q ss_pred cccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccC
Q 001974 131 KQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRN 210 (988)
Q Consensus 131 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 210 (988)
++|++++|.+++. +. +..+++|++|++++|..... +..+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCc-hh-hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 8888888887743 33 77788888888888865533 3347778888888888888774433 677777777777777
Q ss_pred CCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCC
Q 001974 211 QFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGES 290 (988)
Q Consensus 211 ~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 290 (988)
.+. .++. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.++.++
T Consensus 188 ~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~- 259 (347)
T 4fmz_A 188 QIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN- 259 (347)
T ss_dssp CCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-
T ss_pred ccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCCh-
Confidence 776 4443 4456666666666666664433 5556666666666666655443 555556666666665554321
Q ss_pred CchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCc
Q 001974 291 DEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPK 370 (988)
Q Consensus 291 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 370 (988)
.+..+++ |+.|++++|++++. ..+..+++|+.|++++|++++..|.
T Consensus 260 -------~~~~l~~-------------------------L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 260 -------AVKDLTK-------------------------LKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp -------GGTTCTT-------------------------CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred -------hHhcCCC-------------------------cCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 2334444 55555555555432 3466667777777777777766667
Q ss_pred ccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccc
Q 001974 371 EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS 413 (988)
Q Consensus 371 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 413 (988)
.+..+++|+.|+|++|++++..| +..+++|+.|++++|.|+
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777777777777777775544 677777777777777765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.67 Aligned_cols=293 Identities=18% Similarity=0.201 Sum_probs=158.9
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
++.++++++.++ .+|..+ .++|++|+|++|.+++..|..|+.+++|++|+|++|+|++..|.+|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444444 333333 13445555555555444444455555555555555555444444555555555555555
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccccccccc--CccchhhccccCccEEEeccCCCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLS--GIIPPSIYNLSLLANFSVPRNQFHGS 215 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~i~~~ 215 (988)
|+++ .+|..+. ++|++|++++|+++...+..|.++++|++|++++|.++ +..+..+..+ +|+.|++++|+++ .
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~ 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-G 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-S
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-c
Confidence 5554 3333322 45555555555555444445555555555555555554 2445555555 5666666666665 4
Q ss_pred CCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhh
Q 001974 216 LPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295 (988)
Q Consensus 216 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 295 (988)
+|..++ ++|+.|++++|++++..+..+..+++|+.|++++|++.+..+..|..+++|+.|++++|.++.++.
T Consensus 187 l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~----- 258 (332)
T 2ft3_A 187 IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPA----- 258 (332)
T ss_dssp CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCT-----
T ss_pred cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecCh-----
Confidence 555443 566677777777766666666666666777776666666666666666666666666666654332
Q ss_pred hcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCC--CccCcccC
Q 001974 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFT--GTIPKEMG 373 (988)
Q Consensus 296 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~ 373 (988)
.+..+++|++|++++|++++..+..+.... + ......|+.|++++|.+. +..|..|.
T Consensus 259 --~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~-----------------~--~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 259 --GLPDLKLLQVVYLHTNNITKVGVNDFCPVG-----------------F--GVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp --TGGGCTTCCEEECCSSCCCBCCTTSSSCSS-----------------C--CSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred --hhhcCccCCEEECCCCCCCccChhHccccc-----------------c--ccccccccceEeecCcccccccCccccc
Confidence 234455555555555555522222221110 0 011356778888888776 56677788
Q ss_pred CCCccCeEeccccc
Q 001974 374 KLQNLEGMGLYDNQ 387 (988)
Q Consensus 374 ~l~~L~~L~L~~N~ 387 (988)
.+++|+.|+|++|+
T Consensus 318 ~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 318 CVTDRLAIQFGNYK 331 (332)
T ss_dssp TBCCSTTEEC----
T ss_pred ccchhhhhhccccc
Confidence 88888888888774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=301.82 Aligned_cols=198 Identities=20% Similarity=0.274 Sum_probs=106.7
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
+++++++++.++ .+|..+. ++|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 344444444444 2333321 3444444444444443333444444555555555544444444555555555555555
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC--ccchhhccccCccEEEeccCCCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG--IIPPSIYNLSLLANFSVPRNQFHGS 215 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~N~i~~~ 215 (988)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|.++. ..+..+.++++|++|++++|+++ .
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~ 185 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-S
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-c
Confidence 5554 2333332 466666666666665555566667777777777777642 55667777777777777777777 5
Q ss_pred CCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcc
Q 001974 216 LPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265 (988)
Q Consensus 216 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~ 265 (988)
+|..++ ++|+.|++++|++++..|..+..+++|+.|++++|++++..
T Consensus 186 l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 232 (330)
T 1xku_A 186 IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232 (330)
T ss_dssp CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC
Confidence 665443 45566666666555544444444444444444444444333
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=302.10 Aligned_cols=288 Identities=21% Similarity=0.292 Sum_probs=189.3
Q ss_pred CccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEec
Q 001974 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNV 280 (988)
Q Consensus 201 ~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L 280 (988)
+++.+++++|.++ .+|..++ ++|+.|++++|.+++..|..|.++++|++|++++|++++..+..|.++++|++|++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 5677777777776 6666553 46666677666666655666666666666666666666655555555555555555
Q ss_pred ccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEee
Q 001974 281 AYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360 (988)
Q Consensus 281 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 360 (988)
++|.++. +|..+. ++|++|++++|++.+..+..+..+++|+.|+++
T Consensus 110 ~~n~l~~-------------------------------l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 110 SKNHLVE-------------------------------IPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CSSCCCS-------------------------------CCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred CCCcCCc-------------------------------cCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence 5555543 333322 356667777777665555567777778888888
Q ss_pred CccCC--CccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCc
Q 001974 361 GNQFT--GTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438 (988)
Q Consensus 361 ~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 438 (988)
+|.++ +..|..+..+ +|+.|++++|++++ +|..+. ++|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 88775 3556667766 77888888888774 555443 677777777777777666777777777777777777775
Q ss_pred cCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCccccc------CCCCcEEEecCcccc--
Q 001974 439 TIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGL------CSYLEEIYMRGNFFH-- 510 (988)
Q Consensus 439 ~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~-- 510 (988)
..+..+..++.| +.|++++|+++ .+|..+..+++|+.|++++|+|++..+..|.. ..+|+.|++++|.+.
T Consensus 232 ~~~~~~~~l~~L-~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 232 IENGSLSFLPTL-RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CCTTGGGGCTTC-CEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred CChhHhhCCCCC-CEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 555566666666 67777777776 66666777777777777777777555555543 245677777777766
Q ss_pred ccCCccccCccccCeeecCCCc
Q 001974 511 GSIPSSLSSLRAVLAIDLSRNN 532 (988)
Q Consensus 511 ~~~p~~~~~l~~L~~L~ls~N~ 532 (988)
+..|..|..+++|+.|+|++|+
T Consensus 310 ~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 310 EVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GSCGGGGTTBCCSTTEEC----
T ss_pred ccCcccccccchhhhhhccccc
Confidence 5566667777777777777664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=314.78 Aligned_cols=196 Identities=21% Similarity=0.204 Sum_probs=161.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--------cchhHHHHHHHHHHHhcC---------CCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--------HGASKSFLAECKALKNIR---------HRNLVK 724 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 724 (988)
.++|++.+.||+|+||+||+|++ +|+.||||+++... ....+.+.+|+.++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45688999999999999999998 78999999997542 223377899999999886 777777
Q ss_pred EEeecccc-------------------------cccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHH
Q 001974 725 VITSCSSI-------------------------DFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779 (988)
Q Consensus 725 ~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~ 779 (988)
+.+++... ++.+++..++||||+++|++.+.+.. ..+++.+++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------------~~~~~~~~~ 164 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------------KLSSLATAK 164 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------------TCCCHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------------cCCCHHHHH
Confidence 76653210 01236789999999999977766643 257899999
Q ss_pred HHHHHHHHHHHHHH-cCCCCCeEeccCCCCCeeeCCCC--------------------cEEEeeecccccccccccccce
Q 001974 780 NIAIDVASAIDYLH-HHCQEPVLHCDLKPGNVLLDNDM--------------------IAHVGDFGLARVRQEVSNLTQS 838 (988)
Q Consensus 780 ~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~ 838 (988)
.|+.||+.||+||| +. +||||||||+|||++.++ .+||+|||+|+.....
T Consensus 165 ~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------ 235 (336)
T 2vuw_A 165 SILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------ 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred HHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence 99999999999999 88 999999999999999887 9999999999865432
Q ss_pred eccccccccccccCcccCCCCCCCccchHHHHHH-HHHHHhCCCCCC
Q 001974 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGIL-LLEMVTGKKPTD 884 (988)
Q Consensus 839 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~v-l~elltg~~p~~ 884 (988)
...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 236 ---~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 236 ---IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp ---EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ---cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 235899999999998766 889999998777 778889999964
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-31 Score=297.24 Aligned_cols=289 Identities=21% Similarity=0.267 Sum_probs=190.6
Q ss_pred CccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEec
Q 001974 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNV 280 (988)
Q Consensus 201 ~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L 280 (988)
+++.++++++.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|++++|++++..|..|..+++|++|++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 4556666666665 5555443 45666666666666555556666666666666666666666666666666666666
Q ss_pred ccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEee
Q 001974 281 AYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360 (988)
Q Consensus 281 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 360 (988)
++|.++.+ |..+. ++|++|++++|++++..+..+..+++|+.|+++
T Consensus 108 s~n~l~~l-------------------------------~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 153 (330)
T 1xku_A 108 SKNQLKEL-------------------------------PEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153 (330)
T ss_dssp CSSCCSBC-------------------------------CSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred CCCcCCcc-------------------------------Chhhc---ccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence 66655533 32222 256666666666665556667777777778887
Q ss_pred CccCCC--ccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCc
Q 001974 361 GNQFTG--TIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438 (988)
Q Consensus 361 ~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 438 (988)
+|.++. ..+..+.++++|+.|++++|+++ .+|..+. ++|++|+|++|++++..|..|..+++|+.|++++|++++
T Consensus 154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 230 (330)
T 1xku_A 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 230 (330)
T ss_dssp SSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred CCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence 777753 55667777788888888888877 4555443 678888888888877777778888888888888888775
Q ss_pred cCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCccccc------CCCCcEEEecCccccc-
Q 001974 439 TIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGL------CSYLEEIYMRGNFFHG- 511 (988)
Q Consensus 439 ~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~- 511 (988)
..+..+..++.| +.|++++|+++ .+|..+..+++|++|++++|+|++..+..|.. ..+|+.|++++|.+..
T Consensus 231 ~~~~~~~~l~~L-~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 231 VDNGSLANTPHL-RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp ECTTTGGGSTTC-CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred eChhhccCCCCC-CEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence 555566666776 77777777776 66767777777777777777777555555543 2566777777777653
Q ss_pred -cCCccccCccccCeeecCCCc
Q 001974 512 -SIPSSLSSLRAVLAIDLSRNN 532 (988)
Q Consensus 512 -~~p~~~~~l~~L~~L~ls~N~ 532 (988)
..|..|..+..|+.++|++|+
T Consensus 309 ~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 309 EIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GSCGGGGTTCCCGGGEEC----
T ss_pred ccCccccccccceeEEEecccC
Confidence 455666667777777777764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-36 Score=347.52 Aligned_cols=384 Identities=16% Similarity=0.160 Sum_probs=193.9
Q ss_pred ccceeeccccccCCCCCc-cccCcccccccccccccccC----ccchhhccccCccEEEeccCCCCCCCCCcccccCC--
Q 001974 153 SLESISLAANAFGGNIPN-SLGQLKELKSLGLGANNLSG----IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLP-- 225 (988)
Q Consensus 153 ~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~-- 225 (988)
+|++|+|++|+++..... .+..+++|++|+|++|+++. .++..+..+++|++|+|++|++.+..+..++..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 344444444444322111 13444445555555554442 22344444455555555555554222223333333
Q ss_pred --CCcceecccccccc----ccCcccccCCcccEEEeccccccCccccccc-----CCccccEEecccccCCCCCCCchh
Q 001974 226 --HLRLFQVHHNFFSG----SIPISLSNASKLEFIEALDNSFSGKLSVNFG-----GMKNLSYFNVAYNNLGSGESDEMS 294 (988)
Q Consensus 226 --~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~ 294 (988)
+|++|+|++|+++. .++..+..+++|+.|++++|.+++..+..+. ..++|++|++++|.++..... .
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~ 161 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--P 161 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--H
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--H
Confidence 46666666666553 3456666666777777777766544333322 244677777777766543221 1
Q ss_pred hhcccccCCCCcEEEeecccCCCCCCchhhhc----cccccEEEccCCccccC----CCccccCCCcceEEEeeCccCCC
Q 001974 295 FMNSLANCSNLRTLIFAANKLRGALPHSIANL----SDQLQNLIMTSNQLHGS----IPSGIGNLVGLYRLGMGGNQFTG 366 (988)
Q Consensus 295 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 366 (988)
....+..+++|++|++++|++++..+..+... .++|++|++++|.+++. ++..+..+++|+.|++++|++++
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 22344556666777776666653333222221 12455555555555432 23334444455555555554442
Q ss_pred ccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccc----cccccccccccceeecCCCCCCccCch
Q 001974 367 TIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV----IPSCLGSLKQLAILHLFENGLNGTIPE 442 (988)
Q Consensus 367 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~ 442 (988)
.....+ .+..+..+++|++|+|++|+++.. ++..+..+++|+.|++++|.+++..+.
T Consensus 242 ~~~~~l-------------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 242 VGMAEL-------------------CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHHHH-------------------HHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHHHHH-------------------HHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 211000 011122344555555555555432 344444555555555555555433333
Q ss_pred hhhhh-----cccccceecccccccCC----CccccccccccceeecCCcccccccCccccc-----CCCCcEEEecCcc
Q 001974 443 EIFNL-----TYLSNSLNLARNHLVGS----IPTKIGNLKYLRVFNVSSNNLSGEIPSQLGL-----CSYLEEIYMRGNF 508 (988)
Q Consensus 443 ~~~~l-----~~l~~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~ 508 (988)
.+... +.+ ++|++++|.+++. ++..+..+++|+.|||++|++++..+..+.. .++|++|+|++|.
T Consensus 303 ~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 303 LLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 33322 244 5566666655543 3445555667777777777776554444432 5577777777777
Q ss_pred ccc----cCCccccCccccCeeecCCCcccCcCccc------ccCCCCcEEeCCCCcCcc
Q 001974 509 FHG----SIPSSLSSLRAVLAIDLSRNNLSGLIPKF------LEDLSLEYLNLSFNDLEG 558 (988)
Q Consensus 509 l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~------~~~~~L~~l~l~~N~l~~ 558 (988)
+++ .+|..+..+++|+.|||++|++++..... .....|+.|++.+|....
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 765 66666777777777777777776532111 112246777777766544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-33 Score=304.45 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=181.8
Q ss_pred ccCCccccCCC----CCCCCCceeeeeEEeC--------CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccc
Q 001974 3 AHDPQGILNSW----NDSGHFCEWKGITCGL--------RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQG 70 (988)
Q Consensus 3 ~~~~~~~~~~w----~~~~~~c~~~~v~c~~--------~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~ 70 (988)
..||.+.+++| ...+++|.|.|++|.. ...+|+.|+|++|+++ .+|+.++.+++|++|+|++|+|+
T Consensus 40 ~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~- 117 (328)
T 4fcg_A 40 NADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117 (328)
T ss_dssp HHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-
T ss_pred cCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-
Confidence 46888999999 5678999999999952 3467888888888888 77777888888888888888888
Q ss_pred cCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccC
Q 001974 71 EIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGN 150 (988)
Q Consensus 71 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 150 (988)
.+|..|+.+++|++|+|++|+++ .+|..|+.+++|++|+|++|++.+.+|..+... ..+..|.+
T Consensus 118 ~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~ 181 (328)
T 4fcg_A 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---------------DASGEHQG 181 (328)
T ss_dssp CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEE
T ss_pred chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc---------------cchhhhcc
Confidence 77888888888888888888888 778888888888888888887777777765540 11122344
Q ss_pred CCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcce
Q 001974 151 LTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230 (988)
Q Consensus 151 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L 230 (988)
+++|++|+|++|+++ .+|..|+++++|++|+|++|++++ +|..+..+++|++|+|++|.+.+.+|..+. .+++|+.|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~-~l~~L~~L 258 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRL 258 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTT-CCCCCCEE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhc-CCCCCCEE
Confidence 555555555555555 445555555555555555555553 344455555555555555555545544332 55666666
Q ss_pred eccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCC
Q 001974 231 QVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287 (988)
Q Consensus 231 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 287 (988)
+|++|.+.+.+|..+.++++|+.|++++|++.+.+|..+..+++|+.+++..|.+..
T Consensus 259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp ECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred ECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 666666666666666666667777777777666777777777777777777665543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=300.58 Aligned_cols=286 Identities=18% Similarity=0.173 Sum_probs=221.4
Q ss_pred CCCCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCC
Q 001974 11 NSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDN 90 (988)
Q Consensus 11 ~~w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n 90 (988)
..|....++|.|.++ | |+++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 21 ~~~~~~~~~C~~~~~-c----------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 86 (353)
T 2z80_A 21 ESSNQASLSCDRNGI-C----------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86 (353)
T ss_dssp ------CCEECTTSE-E----------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCccCCCCCCCeE-e----------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCC
Confidence 345667778888776 6 45677777 5676655 58999999999999877779999999999999999
Q ss_pred CCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCC-CcccCCCccceeecccc-ccCCCC
Q 001974 91 DLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP-PFIGNLTSLESISLAAN-AFGGNI 168 (988)
Q Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~ 168 (988)
++++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .++...
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 87 GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166 (353)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred ccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC
Confidence 9998888899999999999999999997777779999999999999999995444 48999999999999999 577667
Q ss_pred CccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccc--
Q 001974 169 PNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLS-- 246 (988)
Q Consensus 169 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-- 246 (988)
+..|.++++|++|++++|++++..|..+..+++|++|++++|++. .+|..++..+++|+.|++++|++++..+..+.
T Consensus 167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 245 (353)
T 2z80_A 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245 (353)
T ss_dssp TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccc
Confidence 888999999999999999999888999999999999999999997 78877777789999999999999876555433
Q ss_pred -cCCcccEEEeccccccC----cccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCC
Q 001974 247 -NASKLEFIEALDNSFSG----KLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG 317 (988)
Q Consensus 247 -~l~~L~~L~l~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 317 (988)
....++.++++++.+.+ .+|..+..+++|+.|++++|+++.++.. .|..+++|++|++++|++.+
T Consensus 246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~------~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG------IFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCBCC
T ss_pred cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH------HHhcCCCCCEEEeeCCCccC
Confidence 34456666666666554 2344455566666666666666544332 23445555555555555553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-35 Score=346.39 Aligned_cols=359 Identities=16% Similarity=0.118 Sum_probs=194.7
Q ss_pred CcEEEEEcCCCCCccccccc-ccCCCCCCEEEcCCCcccc----cCCcccCCCCCCcEEECCCCCCCCcCCcccc-cCC-
Q 001974 32 RRVTVLNLRSKGLSGSLSPY-IGNLSFLREINLMNNSIQG----EIPREFGRLFRLEALFLSDNDLVGEIPANLS-YCS- 104 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~-l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~- 104 (988)
.+++.|||++++++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46778888888876544433 6677888888888888774 3456677778888888888887754443332 344
Q ss_pred ---CCceeecCcccccC----CCcccccCcccccccccccccccCCCCCccc-----CCCccceeeccccccCCCC----
Q 001974 105 ---RLTILFLGRNKLMG----SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIG-----NLTSLESISLAANAFGGNI---- 168 (988)
Q Consensus 105 ---~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~---- 168 (988)
+|++|+|++|+|+. .++..|..+++|++|+|++|.+++..+..+. ..++|++|++++|+++...
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777777763 3466677777777777777776533222221 2345666666666665422
Q ss_pred CccccCcccccccccccccccCccchhhcc-----ccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCc
Q 001974 169 PNSLGQLKELKSLGLGANNLSGIIPPSIYN-----LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPI 243 (988)
Q Consensus 169 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~ 243 (988)
+..+..+++|++|+|++|.++...+..+.. .++|++|++++|.+++.... .++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~---------------------~l~~ 221 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR---------------------DLCG 221 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH---------------------HHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH---------------------HHHH
Confidence 334445556666666666655433333321 33455555555544411000 1234
Q ss_pred ccccCCcccEEEeccccccCcc-----cccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCC
Q 001974 244 SLSNASKLEFIEALDNSFSGKL-----SVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGA 318 (988)
Q Consensus 244 ~l~~l~~L~~L~l~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 318 (988)
.+..+++|+.|++++|.+.+.. +..+..+++|++|++++|.++..... ..+..+..+++|++|++++|++++.
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG--DLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--HHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--HHHHHHhhCCCcceEECCCCCCchH
Confidence 4445555555555555554332 22223456666666666666532111 1223445566666666666666533
Q ss_pred CCchhhhc----cccccEEEccCCccccC----CCccccCCCcceEEEeeCccCCCccCcccCC-----CCccCeEeccc
Q 001974 319 LPHSIANL----SDQLQNLIMTSNQLHGS----IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK-----LQNLEGMGLYD 385 (988)
Q Consensus 319 ~p~~~~~~----~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~ 385 (988)
.+..+... .++|++|++++|.+++. ++..+..+++|+.|++++|++++..+..+.. .++|+.|+|++
T Consensus 300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 33333322 12455555555555533 2344445556666666666555433332221 34555555555
Q ss_pred ccCCC----CCCCCCCCCCCCCEEEccccccc
Q 001974 386 NQLSG----EIPSSLGNLSILSELLLNNNSLS 413 (988)
Q Consensus 386 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 413 (988)
|++++ .+|..+..+++|++|+|++|+++
T Consensus 380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 55543 34444444555555555555554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=283.46 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=194.6
Q ss_pred CCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCc
Q 001974 16 SGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95 (988)
Q Consensus 16 ~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 95 (988)
..+.|.|.+++|. +++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|+|++|+++..
T Consensus 3 ~~C~C~~~~l~c~------------~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 3 SRCSCSGTEIRCN------------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp TTCEEETTEEECC------------SSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred CCCeeCCCEEEcC------------CCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc
Confidence 4567888888886 34455 4555443 6899999999999965556689999999999999999833
Q ss_pred --CCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCC-CcccCCCccceeeccccccCCCCCccc
Q 001974 96 --IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP-PFIGNLTSLESISLAANAFGGNIPNSL 172 (988)
Q Consensus 96 --~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~ 172 (988)
.|..+..+++|++|+|++|.++ .+|..|.++++|++|++++|++++..+ ..|..+++|++|++++|.+.+..+..|
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 146 (306)
T 2z66_A 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146 (306)
T ss_dssp EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence 3677778999999999999998 677778999999999999999986554 578899999999999999988888888
Q ss_pred cCcccccccccccccccC-ccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcc
Q 001974 173 GQLKELKSLGLGANNLSG-IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKL 251 (988)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 251 (988)
.++++|++|+|++|.+++ ..|..+..+++|++|++++|+++ .++...+..+++|+.|+|++|++++..+..+..+++|
T Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 225 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225 (306)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTC
T ss_pred ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcC-CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccC
Confidence 999999999999999886 57778888888888888888887 4443444466777777777777766655566666666
Q ss_pred cEEEeccccccCcccccccCCc-cccEEecccccCC
Q 001974 252 EFIEALDNSFSGKLSVNFGGMK-NLSYFNVAYNNLG 286 (988)
Q Consensus 252 ~~L~l~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~ 286 (988)
+.|++++|++.+..+..+..++ +|++|++++|.++
T Consensus 226 ~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~ 261 (306)
T 2z66_A 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261 (306)
T ss_dssp CEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred CEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence 6666666666666666665553 5666666666554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=298.67 Aligned_cols=298 Identities=25% Similarity=0.301 Sum_probs=160.1
Q ss_pred ccCCccccCCCCCCCCCceeeeeEEeC------CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCccc
Q 001974 3 AHDPQGILNSWNDSGHFCEWKGITCGL------RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREF 76 (988)
Q Consensus 3 ~~~~~~~~~~w~~~~~~c~~~~v~c~~------~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~ 76 (988)
..|....+++|..+++||.|.+..|.. ....++.|++++|+++ .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 5 ~~~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~-- 78 (622)
T 3g06_A 5 PAEYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA-- 78 (622)
T ss_dssp -----CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC--
T ss_pred HHHHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC--
Confidence 356778899999889999996642211 1234666777777776 5555554 56677777777666 3443
Q ss_pred CCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccce
Q 001974 77 GRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLES 156 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 156 (988)
.+++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|++++|+++. +|
T Consensus 79 -~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp----------- 137 (622)
T 3g06_A 79 -LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LP----------- 137 (622)
T ss_dssp -CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CC-----------
T ss_pred -cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CC-----------
Confidence 3566666666666666 3443 44556666666665553 222 33444455555554442 22
Q ss_pred eeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccc
Q 001974 157 ISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNF 236 (988)
Q Consensus 157 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~ 236 (988)
.. +++|++|+|++|++++ +|. .+++|+.|++++|+++ .+| ..+++|+.|++++|+
T Consensus 138 -------------~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l~----~~~~~L~~L~Ls~N~ 192 (622)
T 3g06_A 138 -------------VL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT-SLP----MLPSGLQELSVSDNQ 192 (622)
T ss_dssp -------------CC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSC
T ss_pred -------------CC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC-CCc----ccCCCCcEEECCCCC
Confidence 21 2455555555555553 222 2345556666666655 333 112233333333333
Q ss_pred cccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCC
Q 001974 237 FSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLR 316 (988)
Q Consensus 237 l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 316 (988)
++ .++.. .++
T Consensus 193 l~------------------------------------------------~l~~~----------~~~------------ 202 (622)
T 3g06_A 193 LA------------------------------------------------SLPTL----------PSE------------ 202 (622)
T ss_dssp CS------------------------------------------------CCCCC----------CTT------------
T ss_pred CC------------------------------------------------CCCCc----------cch------------
Confidence 22 11100 012
Q ss_pred CCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCC
Q 001974 317 GALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396 (988)
Q Consensus 317 ~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 396 (988)
|+.|++++|.++ .+|.. +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|.
T Consensus 203 -------------L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~-- 258 (622)
T 3g06_A 203 -------------LYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM-- 258 (622)
T ss_dssp -------------CCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC--
T ss_pred -------------hhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc--
Confidence 222233333322 12211 2455666666666653 34 33456777777777776 3444
Q ss_pred CCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhc
Q 001974 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLT 448 (988)
Q Consensus 397 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 448 (988)
.+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|.+++.+|..+..++
T Consensus 259 -~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 259 -LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp -CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred -ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 4567777777777777 5577777777888888888887776666665554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=276.53 Aligned_cols=250 Identities=20% Similarity=0.212 Sum_probs=193.2
Q ss_pred cEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCc--cCcccCCCCccCeEec
Q 001974 306 RTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT--IPKEMGKLQNLEGMGL 383 (988)
Q Consensus 306 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L 383 (988)
+.++++++.++ .+|..+. +.|++|++++|+++...+..|..+++|+.|+|++|+++.. .+..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 45666666666 5555443 3677788888877754445567888888888888887732 2566667788888888
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccc-cccccccccceeecCCCCCCccCchhhhhhcccccceeccccccc
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 462 (988)
++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.+..|..+..++.| ++|++++|.++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~ 163 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQ 163 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTC-CEEECTTCEEG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCC-CEEECCCCccc
Confidence 888887 466667788888888888888876554 567788888888888888876677777777777 78888888887
Q ss_pred C-CCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-
Q 001974 463 G-SIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF- 540 (988)
Q Consensus 463 ~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~- 540 (988)
+ .+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|||++|++++.+|..
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence 6 57788888888888888888888777888888888889999988888777778888888899999999888888765
Q ss_pred ccCC-CCcEEeCCCCcCcccCC
Q 001974 541 LEDL-SLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 541 ~~~~-~L~~l~l~~N~l~~~~p 561 (988)
..++ +|++|+|++|.+++..+
T Consensus 244 ~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 244 QHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CCCCTTCCEEECTTCCEECSGG
T ss_pred HhhhccCCEEEccCCCeecccC
Confidence 5554 78899999998887654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=287.72 Aligned_cols=247 Identities=21% Similarity=0.197 Sum_probs=169.8
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456666666666 4554442 4666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccccc-ccccCccchhhccccCccEEEeccCCCCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGA-NNLSGIIPPSIYNLSLLANFSVPRNQFHGSL 216 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~l 216 (988)
|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+++ .+
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cc
Confidence 666655555566666666666666666655555666667777777766 4454444456667777777777777776 45
Q ss_pred CCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhh
Q 001974 217 PPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFM 296 (988)
Q Consensus 217 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 296 (988)
|. +..+++|+.|+|++|++++..|..|.++++|+.|++++|++.+..+..|.++++|+.|+|++|+++.++..
T Consensus 212 ~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----- 284 (452)
T 3zyi_A 212 PN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD----- 284 (452)
T ss_dssp CC--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT-----
T ss_pred cc--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH-----
Confidence 53 34677777777777777777777788888888888888888877777788888888888888888766654
Q ss_pred cccccCCCCcEEEeecccCC
Q 001974 297 NSLANCSNLRTLIFAANKLR 316 (988)
Q Consensus 297 ~~l~~l~~L~~L~Ls~N~l~ 316 (988)
.+..+++|++|+|++|.+.
T Consensus 285 -~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 285 -LFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp -SSTTCTTCCEEECCSSCEE
T ss_pred -HhccccCCCEEEccCCCcC
Confidence 4566778888888888776
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-32 Score=323.80 Aligned_cols=450 Identities=14% Similarity=0.108 Sum_probs=250.2
Q ss_pred CceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcc---cccCCcccC------------CCCCCc
Q 001974 19 FCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSI---QGEIPREFG------------RLFRLE 83 (988)
Q Consensus 19 ~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L~ 83 (988)
|++|.++.+.. ..+ +.+.. .....++..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~-~~~---l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET-REH---VTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH-CCE---EEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc-ccE---EEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 45798885432 122 22322 23334455667889999999988643 134444444 678899
Q ss_pred EEECCCCCCCCcCCcccccC--CCCceeecCccc-ccC-CCcccccCcccccccccccccccCC----CCCcccCCCccc
Q 001974 84 ALFLSDNDLVGEIPANLSYC--SRLTILFLGRNK-LMG-SIPFEFFSLYKLKQLAMQRNNLTGG----IPPFIGNLTSLE 155 (988)
Q Consensus 84 ~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~N~-i~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~ 155 (988)
+|+|++|.+++..+..++.. .+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 99999998887777767664 459999998886 221 1122234678899999999988754 333456778899
Q ss_pred eeeccccccCCC----CCccccCcccccccccccccccCccchhhccccCccEEEeccCCCC---CCCCCcccccCCCCc
Q 001974 156 SISLAANAFGGN----IPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH---GSLPPSLGLTLPHLR 228 (988)
Q Consensus 156 ~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~---~~lp~~~~~~l~~L~ 228 (988)
+|++++|.+++. ++..+.++++|++|+|++|.+.+ ++..+..+++|++|+++.+... +..+.. ...+++|+
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~-l~~~~~L~ 273 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMN-LVFPRKLC 273 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSC-CCCCTTCC
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHH-hhcccccc
Confidence 999998888733 34445678889999999888884 6788888888888888753322 011111 12445566
Q ss_pred ceeccccccccccCcccccCCcccEEEeccccccCccc-ccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcE
Q 001974 229 LFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLS-VNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRT 307 (988)
Q Consensus 229 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 307 (988)
.|+++++.. ..+|..+..+++|+.|++++|.+++... ..+..+++|+.|+++ +.+... ........+++|++
T Consensus 274 ~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~-----~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 274 RLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR-----GLEVLAQYCKQLKR 346 (592)
T ss_dssp EEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH-----HHHHHHHHCTTCCE
T ss_pred ccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH-----HHHHHHHhCCCCCE
Confidence 666655422 2344555555566666666555443322 223455555555555 222211 11111233455555
Q ss_pred EEeec-----------ccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCC-C
Q 001974 308 LIFAA-----------NKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGK-L 375 (988)
Q Consensus 308 L~Ls~-----------N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l 375 (988)
|++++ |.+++.....+ ...+++|++|+++.|++++..+..+.. +
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l------------------------~~~~~~L~~L~l~~~~l~~~~~~~l~~~~ 402 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIAL------------------------AQGCQELEYMAVYVSDITNESLESIGTYL 402 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHH------------------------HHHCTTCSEEEEEESCCCHHHHHHHHHHC
T ss_pred EEeecCccccccccccCccCHHHHHHH------------------------HhhCccCeEEEeecCCccHHHHHHHHhhC
Confidence 55552 33331111111 223455555555555555444444433 5
Q ss_pred CccCeEecc----cccCCCC-----CCCCCCCCCCCCEEEcccc--ccccccccccc-cccccceeecCCCCCCc-cCch
Q 001974 376 QNLEGMGLY----DNQLSGE-----IPSSLGNLSILSELLLNNN--SLSGVIPSCLG-SLKQLAILHLFENGLNG-TIPE 442 (988)
Q Consensus 376 ~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~-~~p~ 442 (988)
++|+.|+|+ .|++++. ++..+.++++|+.|+|++| .+++..+..+. .+++|+.|++++|++++ .++.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 556666664 4445432 1122344566666666532 24433333333 25566666666666653 2333
Q ss_pred hhhhhcccccceecccccccCC-CccccccccccceeecCCcccccccCccc-ccCCCCcEEEecCc
Q 001974 443 EIFNLTYLSNSLNLARNHLVGS-IPTKIGNLKYLRVFNVSSNNLSGEIPSQL-GLCSYLEEIYMRGN 507 (988)
Q Consensus 443 ~~~~l~~l~~~L~ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~L~~N 507 (988)
.+.+++.| +.|++++|.+++. ++..+..+++|+.|+|++|++++.-...+ ..++.+....+..+
T Consensus 483 ~~~~~~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 483 FSRGCPNL-QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHTCCTTC-CEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHhcCccc-CeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 34455555 6666666665433 23333456666666776666664422222 24455555444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=284.21 Aligned_cols=280 Identities=18% Similarity=0.193 Sum_probs=134.8
Q ss_pred CCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccc
Q 001974 57 FLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQ 136 (988)
Q Consensus 57 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 136 (988)
.....++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|+
T Consensus 32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 3344555555555 3444332 355555555555554333355555555555555555554444445555555555555
Q ss_pred cccccCCCCCcccCCCccceeeccccccCCCCC-ccccCcccccccccccc-cccCccchhhccccCccEEEeccCCCCC
Q 001974 137 RNNLTGGIPPFIGNLTSLESISLAANAFGGNIP-NSLGQLKELKSLGLGAN-NLSGIIPPSIYNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 137 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 214 (988)
+|++++..+..|.++++|++|++++|+++...+ ..|.++++|++|++++| .++...+..+.++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l--------------- 173 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL--------------- 173 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC---------------
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC---------------
Confidence 554443222234444444444444444442222 23444444444444444 2332222233333
Q ss_pred CCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchh
Q 001974 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMS 294 (988)
Q Consensus 215 ~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 294 (988)
++|+.|++++|++++..|..+.++++|+.|++++|++.......+.
T Consensus 174 ----------~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~------------------------ 219 (353)
T 2z80_A 174 ----------TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD------------------------ 219 (353)
T ss_dssp ----------CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHH------------------------
T ss_pred ----------CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhh------------------------
Confidence 3333333333333333333444444444444444444332222222
Q ss_pred hhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCC----ccCc
Q 001974 295 FMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTG----TIPK 370 (988)
Q Consensus 295 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~p~ 370 (988)
.+++|++|++++|++++..+..+.. ......++.+++++|.+.+ .+|.
T Consensus 220 ------~~~~L~~L~L~~n~l~~~~~~~l~~----------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~ 271 (353)
T 2z80_A 220 ------VTSSVECLELRDTDLDTFHFSELST----------------------GETNSLIKKFTFRNVKITDESLFQVMK 271 (353)
T ss_dssp ------HTTTEEEEEEESCBCTTCCCC----------------------------CCCCCCEEEEESCBCCHHHHHHHHH
T ss_pred ------hcccccEEECCCCcccccccccccc----------------------ccccchhhccccccccccCcchhhhHH
Confidence 3445555555555554322221110 1122334555555555543 3566
Q ss_pred ccCCCCccCeEecccccCCCCCCCC-CCCCCCCCEEEccccccccccc
Q 001974 371 EMGKLQNLEGMGLYDNQLSGEIPSS-LGNLSILSELLLNNNSLSGVIP 417 (988)
Q Consensus 371 ~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p 417 (988)
.+..+++|+.|+|++|+++ .+|.. |.++++|++|+|++|.+.+..|
T Consensus 272 ~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 272 LLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred HHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 7777888888888888888 44544 5788888888888888875443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=271.00 Aligned_cols=226 Identities=20% Similarity=0.302 Sum_probs=154.2
Q ss_pred CCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeE
Q 001974 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGM 381 (988)
Q Consensus 302 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 381 (988)
.++++.|+|++|+++ .+|..+..+. +|++|+|++|.++ .+|..+..+++|++|+|++|+++ .+|..+.++++|++|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 466777777777777 6666666643 6777777777777 67777777777777777777777 667777777777777
Q ss_pred ecccccCCCCCCCCCCC---------CCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhccccc
Q 001974 382 GLYDNQLSGEIPSSLGN---------LSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN 452 (988)
Q Consensus 382 ~L~~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~ 452 (988)
+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..++.+++|+.|+|++|+++ .+|..+..++.| +
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L-~ 232 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-E 232 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTC-C
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCC-C
Confidence 77777777777776654 666666666666666 55666666666666666666666 455556666666 6
Q ss_pred ceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCc
Q 001974 453 SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNN 532 (988)
Q Consensus 453 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 532 (988)
+|++++|.+.+.+|..++.+++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..++++++|+.++++.|.
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~ 312 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312 (328)
T ss_dssp EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGG
T ss_pred EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHH
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666555
Q ss_pred cc
Q 001974 533 LS 534 (988)
Q Consensus 533 l~ 534 (988)
+.
T Consensus 313 ~~ 314 (328)
T 4fcg_A 313 QA 314 (328)
T ss_dssp SC
T ss_pred HH
Confidence 44
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=286.21 Aligned_cols=268 Identities=14% Similarity=0.141 Sum_probs=174.1
Q ss_pred cCCCCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCccc-ccCCcccC-------CCCC
Q 001974 10 LNSWNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQ-GEIPREFG-------RLFR 81 (988)
Q Consensus 10 ~~~w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~-------~l~~ 81 (988)
..+|.....|+.+..+........++.+++++|.+ .+|..+... |++|+|++|+++ ..+|..+. ++++
T Consensus 21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~ 96 (312)
T 1wwl_A 21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG 96 (312)
T ss_dssp SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence 34555444555555444333344566677777777 566655544 777777777773 34555554 6777
Q ss_pred CcEEECCCCCCCCcCCccc--ccCCCCceeecCcccccCCCcccccCc-----ccccccccccccccCCCCCcccCCCcc
Q 001974 82 LEALFLSDNDLVGEIPANL--SYCSRLTILFLGRNKLMGSIPFEFFSL-----YKLKQLAMQRNNLTGGIPPFIGNLTSL 154 (988)
Q Consensus 82 L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L 154 (988)
|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..|.++ ++|++|+|++|++++..+..|+++++|
T Consensus 97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 175 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence 7777777777777777765 7777777777777777755 6666666 777777777777776666777777777
Q ss_pred ceeeccccccCCC--CCccc--cCcccccccccccccccC---ccchhhccccCccEEEeccCCCCCCCCCcccccCCCC
Q 001974 155 ESISLAANAFGGN--IPNSL--GQLKELKSLGLGANNLSG---IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227 (988)
Q Consensus 155 ~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L 227 (988)
++|+|++|++.+. .+..+ .++++|++|+|++|+|++ .....+.++++|++|++++|++++..|...+..+++|
T Consensus 176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 255 (312)
T 1wwl_A 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255 (312)
T ss_dssp CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTC
T ss_pred CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCC
Confidence 7777777776543 22333 677777777777777762 1223345667777777777777755554555556677
Q ss_pred cceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCC
Q 001974 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287 (988)
Q Consensus 228 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 287 (988)
+.|+|++|+|+ .+|..+. ++|++|++++|++++. |. +..+++|++|++++|.+++
T Consensus 256 ~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 77777777776 4455444 5666666666666655 33 5666666666666666543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=281.98 Aligned_cols=203 Identities=19% Similarity=0.184 Sum_probs=120.5
Q ss_pred CCCcceEEEeeCccCCCccCccc--CCCCccCeEecccccCCCCCCCCCCCC-----CCCCEEEcccccccccccccccc
Q 001974 350 NLVGLYRLGMGGNQFTGTIPKEM--GKLQNLEGMGLYDNQLSGEIPSSLGNL-----SILSELLLNNNSLSGVIPSCLGS 422 (988)
Q Consensus 350 ~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 422 (988)
.+++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++.+..|..|+.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 45555555555555555555544 5555555555555555544 5444444 55555555555555555555555
Q ss_pred ccccceeecCCCCCCcc--Cchhh--hhhcccccceecccccccC--CCc-cccccccccceeecCCcccccccC-cccc
Q 001974 423 LKQLAILHLFENGLNGT--IPEEI--FNLTYLSNSLNLARNHLVG--SIP-TKIGNLKYLRVFNVSSNNLSGEIP-SQLG 494 (988)
Q Consensus 423 l~~L~~L~l~~N~l~~~--~p~~~--~~l~~l~~~L~ls~N~l~~--~~p-~~~~~l~~L~~L~ls~N~l~~~~p-~~~~ 494 (988)
+++|+.|+|++|++.|. +|..+ ..++.| ++|++++|++++ .++ ..+..+++|+.|||++|++++..| ..+.
T Consensus 172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGERGLISALCPLKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTC-CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred CCCCCEEECCCCCcCcchHHHHHHHhccCCCC-CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 55555555555555543 22333 445555 556666665552 111 223455677777777777776554 4455
Q ss_pred cCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCcc
Q 001974 495 LCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEG 558 (988)
Q Consensus 495 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~ 558 (988)
.+++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |.+..+++|++|+|++|++++
T Consensus 251 ~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred hcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence 5677777777777777 6666665 6777777777777776 446666677777777777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=281.23 Aligned_cols=254 Identities=22% Similarity=0.205 Sum_probs=164.9
Q ss_pred eeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccC
Q 001974 24 GITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYC 103 (988)
Q Consensus 24 ~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l 103 (988)
.+.|... ...++..+++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++
T Consensus 38 ~C~C~~~---~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l 111 (440)
T 3zyj_A 38 VCSCSNQ---FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGL 111 (440)
T ss_dssp SSEECTT---SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTC
T ss_pred CCEeCCC---CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCC
Confidence 3556432 234566777777 5666554 678888888888887777888888888888888888887777788888
Q ss_pred CCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccc-cccCCCCCccccCcccccccc
Q 001974 104 SRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA-NAFGGNIPNSLGQLKELKSLG 182 (988)
Q Consensus 104 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~ 182 (988)
++|++|+|++|+|+...+..|.++++|++|+|++|.++...+..|.++++|++|+|++ |.+....+..|.++++|++|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 112 ANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred ccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 8888888888888866666788888888888888887766666777777777777777 444434444666677777777
Q ss_pred cccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEecccccc
Q 001974 183 LGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFS 262 (988)
Q Consensus 183 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~ 262 (988)
|++|+++. +| .+..+++|++|+|++|+++ +..|..|.++++|+.|++++|+++
T Consensus 192 L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 192 LAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-------------------------AIRPGSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CTTSCCSS-CC-CCTTCSSCCEEECTTSCCC-------------------------EECTTTTTTCTTCCEEECTTCCCC
T ss_pred CCCCcCcc-cc-ccCCCcccCEEECCCCccC-------------------------ccChhhhccCccCCEEECCCCcee
Confidence 77776662 33 2455555555555555554 444444455555555555555555
Q ss_pred CcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCC
Q 001974 263 GKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLR 316 (988)
Q Consensus 263 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 316 (988)
+..+..|.++++|+.|+|++|+++.++.. .|..+++|+.|+|++|.+.
T Consensus 245 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 245 VIERNAFDNLQSLVEINLAHNNLTLLPHD------LFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp EECTTSSTTCTTCCEEECTTSCCCCCCTT------TTSSCTTCCEEECCSSCEE
T ss_pred EEChhhhcCCCCCCEEECCCCCCCccChh------HhccccCCCEEEcCCCCcc
Confidence 55555555555555555555555544433 2344555555555555554
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-28 Score=278.04 Aligned_cols=251 Identities=25% Similarity=0.281 Sum_probs=220.9
Q ss_pred CCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEec
Q 001974 304 NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383 (988)
Q Consensus 304 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 383 (988)
....++.+++.++ .+|..+. +.++.|+|++|++++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 3567788888887 7776554 47899999999999888899999999999999999999777889999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCch-hhhhhcccccceeccccccc
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE-EIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~ 462 (988)
++|++++..+..|..+++|++|+|++|+|+...+..|..+++|+.|++++|+..+.++. .+.+++.| ++|+|++|+++
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~ 198 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL-RYLNLAMCNLR 198 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC-CEEECTTSCCS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc-CeecCCCCcCc
Confidence 99999977777899999999999999999988888999999999999999555446665 57788888 99999999998
Q ss_pred CCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-c
Q 001974 463 GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-L 541 (988)
Q Consensus 463 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~ 541 (988)
.+| .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|||++|+|++.++.. .
T Consensus 199 -~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 276 (440)
T 3zyj_A 199 -EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276 (440)
T ss_dssp -SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred -ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence 566 4888999999999999999888999999999999999999999999999999999999999999999988876 6
Q ss_pred cCCCCcEEeCCCCcCcccCC
Q 001974 542 EDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 542 ~~~~L~~l~l~~N~l~~~~p 561 (988)
.+.+|+.|+|++|.+.....
T Consensus 277 ~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 277 PLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp SCTTCCEEECCSSCEECSST
T ss_pred cccCCCEEEcCCCCccCCCC
Confidence 67789999999999876554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-28 Score=278.81 Aligned_cols=251 Identities=22% Similarity=0.244 Sum_probs=218.8
Q ss_pred CCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEec
Q 001974 304 NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383 (988)
Q Consensus 304 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 383 (988)
....++.+++.++ .+|..+. +.++.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence 3567778888877 6776554 47999999999999888899999999999999999999888889999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCch-hhhhhcccccceeccccccc
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE-EIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~l~~~L~ls~N~l~ 462 (988)
++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|++++|...+.+|. .+.+++.| ++|+|++|+++
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~ 209 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL-KYLNLGMCNIK 209 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTC-CEEECTTSCCS
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCC-CEEECCCCccc
Confidence 99999977777799999999999999999988888899999999999999544446666 56778888 99999999998
Q ss_pred CCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-c
Q 001974 463 GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-L 541 (988)
Q Consensus 463 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~ 541 (988)
+ +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|||++|+|++.++.. .
T Consensus 210 ~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 287 (452)
T 3zyi_A 210 D-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287 (452)
T ss_dssp S-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred c-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence 4 44 5888999999999999999888999999999999999999999999999999999999999999999888876 5
Q ss_pred cCCCCcEEeCCCCcCcccCC
Q 001974 542 EDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 542 ~~~~L~~l~l~~N~l~~~~p 561 (988)
.+++|+.|+|++|.+.....
T Consensus 288 ~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 288 PLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TCTTCCEEECCSSCEECSTT
T ss_pred cccCCCEEEccCCCcCCCCC
Confidence 67789999999999877654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-31 Score=315.54 Aligned_cols=397 Identities=14% Similarity=0.087 Sum_probs=245.1
Q ss_pred CCCccceeeccccccCCCCCccccCc--cccccccccccc-ccC-ccchhhccccCccEEEeccCCCCCCCCC---cccc
Q 001974 150 NLTSLESISLAANAFGGNIPNSLGQL--KELKSLGLGANN-LSG-IIPPSIYNLSLLANFSVPRNQFHGSLPP---SLGL 222 (988)
Q Consensus 150 ~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~-l~~-~~~~~l~~l~~L~~L~L~~N~i~~~lp~---~~~~ 222 (988)
.+++|++|+|++|.++...+..+..+ .+|++|+|++|. ++. .++.....+++|++|+|++|.+.+.-.. .+..
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 45555666666555544334444432 236666666554 110 1122223556666666666655432111 1233
Q ss_pred cCCCCcceeccccccc----cccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcc
Q 001974 223 TLPHLRLFQVHHNFFS----GSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNS 298 (988)
Q Consensus 223 ~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 298 (988)
.+++|+.|++++|.++ ..++..+.++++|+.|++++|.+.+ .+..+..+++|+.|+++........ ......
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~ 265 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM---PEKYMN 265 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC---TTSSSC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch---HHHHHH
Confidence 4566666666666665 2233445566777777777777765 4456777777777777753222110 111234
Q ss_pred cccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCC-ccccCCCcceEEEeeCccCC-CccCcccCCCC
Q 001974 299 LANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIP-SGIGNLVGLYRLGMGGNQFT-GTIPKEMGKLQ 376 (988)
Q Consensus 299 l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~ 376 (988)
+..+++|+.|+++++... .+|..+... ++|++|++++|.+++... ..+..+++|+.|+++ |.+. +.++..+..++
T Consensus 266 l~~~~~L~~L~l~~~~~~-~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~ 342 (592)
T 3ogk_B 266 LVFPRKLCRLGLSYMGPN-EMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCK 342 (592)
T ss_dssp CCCCTTCCEEEETTCCTT-TGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCT
T ss_pred hhccccccccCccccchh-HHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCC
Confidence 566778888888775433 555555444 478888888888764433 335778888999888 4444 33444456678
Q ss_pred ccCeEeccc-----------ccCCCC-CCCCCCCCCCCCEEEcccccccccccccccc-ccccceeecC----CCCCCcc
Q 001974 377 NLEGMGLYD-----------NQLSGE-IPSSLGNLSILSELLLNNNSLSGVIPSCLGS-LKQLAILHLF----ENGLNGT 439 (988)
Q Consensus 377 ~L~~L~L~~-----------N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~----~N~l~~~ 439 (988)
+|++|+|++ |.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++.
T Consensus 343 ~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~ 422 (592)
T 3ogk_B 343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL 422 (592)
T ss_dssp TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence 889999983 566532 1222345788888998888888776666665 8888888885 7778743
Q ss_pred -----Cchhhhhhcccccceecccc--cccCCCcccccc-ccccceeecCCccccc-ccCcccccCCCCcEEEecCcccc
Q 001974 440 -----IPEEIFNLTYLSNSLNLARN--HLVGSIPTKIGN-LKYLRVFNVSSNNLSG-EIPSQLGLCSYLEEIYMRGNFFH 510 (988)
Q Consensus 440 -----~p~~~~~l~~l~~~L~ls~N--~l~~~~p~~~~~-l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~ 510 (988)
++..+.+++.| +.|++++| .+++..+..+.. +++|+.|+|++|++++ .++..+..+++|++|+|++|.++
T Consensus 423 p~~~~~~~~~~~~~~L-~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 423 PLDNGVRSLLIGCKKL-RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp CCHHHHHHHHHHCTTC-CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred hHHHHHHHHHHhCCCC-CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 44446667777 88888743 365555555543 7888999999988876 34555677888999999999887
Q ss_pred cc-CCccccCccccCeeecCCCcccCcCccc--ccCCCCcEEeCCCC
Q 001974 511 GS-IPSSLSSLRAVLAIDLSRNNLSGLIPKF--LEDLSLEYLNLSFN 554 (988)
Q Consensus 511 ~~-~p~~~~~l~~L~~L~ls~N~l~~~~p~~--~~~~~L~~l~l~~N 554 (988)
+. ++..+..+++|+.|+|++|++++..... ..++.+....+..+
T Consensus 502 ~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 502 ERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 55 3344467888899999999888653322 34455544444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=264.65 Aligned_cols=253 Identities=20% Similarity=0.188 Sum_probs=187.2
Q ss_pred cEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEeccc
Q 001974 306 RTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYD 385 (988)
Q Consensus 306 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 385 (988)
++++++++.++ .+|..+ +++|++|++++|++++..+..|..+++|++|++++|++++..|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56677777776 556543 34688888888888877777788888888888888888877788888888888888888
Q ss_pred cc-CCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCC
Q 001974 386 NQ-LSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGS 464 (988)
Q Consensus 386 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 464 (988)
|+ ++...|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..+..++.| ++|++++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL-THLFLHGNRISSV 168 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCEE
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCc-cEEECCCCccccc
Confidence 86 776667788888888888888888887778888888888888888888874444446667777 7777777777755
Q ss_pred CccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCC
Q 001974 465 IPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL 544 (988)
Q Consensus 465 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~ 544 (988)
.+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|.+++..+..+..+++|+.|+|++|.+....+......
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~ 248 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHH
Confidence 55567777777888888887777777777777777777777777776555667777777777777777776554332222
Q ss_pred CCcEEeCCCCcCcccCCCC
Q 001974 545 SLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 545 ~L~~l~l~~N~l~~~~p~~ 563 (988)
.++.+..+.|.+.+..|..
T Consensus 249 ~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHHCCSEECCCBEEESGG
T ss_pred HHHhcccccCccccCCchH
Confidence 3455556666666666653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=294.55 Aligned_cols=215 Identities=17% Similarity=0.121 Sum_probs=145.0
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
+|+.|+|++|.+++..|..|..+++|+.|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 56677777777766666667777777777777777765444 6677777777777777764322 2667777777
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccc-cccccceeecCCccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIG-NLKYLRVFNVSSNNLSG 487 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~ 487 (988)
+|.|++..+.. +++|+.|+|++|.+++..|..+..++.| +.|+|++|.+++..|..+. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 77777555432 4567777777777776556666667776 6777777777766666665 57777777777777775
Q ss_pred ccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCc
Q 001974 488 EIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557 (988)
Q Consensus 488 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~ 557 (988)
. |. +..+++|+.|+|++|.|++ +|..+..+++|+.|||++|+|++.++.+..+++|+.|++++|.++
T Consensus 184 ~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 184 V-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp E-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBC
T ss_pred c-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCc
Confidence 4 22 3347777777777777775 444477777777777777777776555566667777777777776
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=261.94 Aligned_cols=252 Identities=22% Similarity=0.233 Sum_probs=219.4
Q ss_pred ccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccc
Q 001974 330 LQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409 (988)
Q Consensus 330 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 409 (988)
-+.++.+++.++ .+|..+ .++|+.|++++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 468999999998 566654 46999999999999977778899999999999999999988899999999999999999
Q ss_pred cc-cccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 410 NS-LSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 410 N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
|. +....|..|..+++|+.|++++|++++..|..+.+++.| ++|++++|++++..+..++.+++|+.|+|++|++++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCC-CEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence 97 887779999999999999999999997667888899999 9999999999977777899999999999999999976
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCcccC
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKGVFA 567 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~~~~ 567 (988)
.+..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++.++.. ..+++|++|+|++|++++..+....+.
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~ 248 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHH
Confidence 6677999999999999999999999999999999999999999999988874 778899999999999998776543223
Q ss_pred cccccccccccccCCCCC
Q 001974 568 NISRISVAGFNRLCGGIP 585 (988)
Q Consensus 568 ~~~~~~~~~n~~lcg~~~ 585 (988)
.+.......+...|..|.
T Consensus 249 ~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHCCSEECCCBEEESG
T ss_pred HHHhcccccCccccCCch
Confidence 333333444555555443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=256.11 Aligned_cols=220 Identities=24% Similarity=0.322 Sum_probs=186.5
Q ss_pred CCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCc
Q 001974 16 SGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95 (988)
Q Consensus 16 ~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 95 (988)
+.++|.|.|+.|.-. ..++.+++++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+++..
T Consensus 1 ~~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i 76 (270)
T 2o6q_A 1 NEALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76 (270)
T ss_dssp CCCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC
T ss_pred CCccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee
Confidence 358999998877532 34567999999999 5776654 6899999999999987777899999999999999999966
Q ss_pred CCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCc
Q 001974 96 IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQL 175 (988)
Q Consensus 96 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 175 (988)
.+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+
T Consensus 77 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 77 PAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp CTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 66778899999999999999998777888999999999999999998777888999999999999999987777778899
Q ss_pred ccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccc
Q 001974 176 KELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS 240 (988)
Q Consensus 176 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~ 240 (988)
++|++|+|++|+++++.+..|..+++|++|+|++|+++ .+|...+..+++|+.|+|++|.+.+.
T Consensus 157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC-cCCHHHhccccCCCEEEecCCCeeCC
Confidence 99999999999998777777888888888888888888 67777666777788888887777643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=277.57 Aligned_cols=262 Identities=26% Similarity=0.303 Sum_probs=131.6
Q ss_pred CccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEec
Q 001974 201 LLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNV 280 (988)
Q Consensus 201 ~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L 280 (988)
+++.|++++|.++ .+|..++ ++|+.|+|++|.|+. +|. .+++|++|++++|+++.+.. .+++|++|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEEC
Confidence 4566666666666 5555543 455666666665553 222 23445555555555543222 3445555555
Q ss_pred ccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEee
Q 001974 281 AYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360 (988)
Q Consensus 281 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 360 (988)
++|.++.++. .+++|++|++++|+++ .+|. . +++|++|+|+
T Consensus 109 s~N~l~~l~~----------~l~~L~~L~L~~N~l~-~lp~-------------------------~---l~~L~~L~Ls 149 (622)
T 3g06_A 109 FSNPLTHLPA----------LPSGLCKLWIFGNQLT-SLPV-------------------------L---PPGLQELSVS 149 (622)
T ss_dssp CSCCCCCCCC----------CCTTCCEEECCSSCCS-CCCC-------------------------C---CTTCCEEECC
T ss_pred cCCcCCCCCC----------CCCCcCEEECCCCCCC-cCCC-------------------------C---CCCCCEEECc
Confidence 5555543322 1234444444444444 2222 1 2444444444
Q ss_pred CccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccC
Q 001974 361 GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTI 440 (988)
Q Consensus 361 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 440 (988)
+|++++ +|. .+.+|+.|++++|+|++ +| ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.++ .+
T Consensus 150 ~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l 216 (622)
T 3g06_A 150 DNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SL 216 (622)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SC
T ss_pred CCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-cc
Confidence 444442 222 12344455555555542 33 223445555555555543 2221 244555555555554 44
Q ss_pred chhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCc
Q 001974 441 PEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSL 520 (988)
Q Consensus 441 p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 520 (988)
|.. ++.| +.|++++|++++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++
T Consensus 217 ~~~---~~~L-~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l 283 (622)
T 3g06_A 217 PAL---PSGL-KELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL 283 (622)
T ss_dssp CCC---CTTC-CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred CCC---CCCC-CEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence 432 1333 555555555553 34 33455666666666666 4554 4556666666666666 566666666
Q ss_pred cccCeeecCCCcccCcCcc
Q 001974 521 RAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 521 ~~L~~L~ls~N~l~~~~p~ 539 (988)
++|+.|+|++|.+++.+|.
T Consensus 284 ~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 284 SSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CTTCEEECCSCCCCHHHHH
T ss_pred cccCEEEecCCCCCCcCHH
Confidence 6666666666666666554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=272.83 Aligned_cols=158 Identities=19% Similarity=0.196 Sum_probs=74.5
Q ss_pred CCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhh-hhcccccceecccccccCCCcccccccccccee
Q 001974 400 SILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVF 478 (988)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L 478 (988)
++|+.|++++|++++..+..+..+++|+.|++++|++++..|..+. .++.+ ++|+|++|++++. |. ...+++|+.|
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L-~~L~L~~N~l~~~-~~-~~~l~~L~~L 196 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL-EHLNLQYNFIYDV-KG-QVVFAKLKTL 196 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC-CEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcC-CEEECCCCcCccc-cc-ccccccCCEE
Confidence 3344444444444444444444444444444444444433333332 33344 4444444444422 21 1224555555
Q ss_pred ecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCccc-CcCccc-ccCCCCcEEeCC-CCc
Q 001974 479 NVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS-GLIPKF-LEDLSLEYLNLS-FND 555 (988)
Q Consensus 479 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~-~~~~~L~~l~l~-~N~ 555 (988)
+|++|+++ .+|..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.++ +.+|.. ..+++|+.|+++ .+.
T Consensus 197 ~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~ 274 (317)
T 3o53_A 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK 274 (317)
T ss_dssp ECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred ECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchh
Confidence 55555555 23444555555555555555555 34555555555555555555555 444443 444455555555 234
Q ss_pred CcccCCC
Q 001974 556 LEGEVPT 562 (988)
Q Consensus 556 l~~~~p~ 562 (988)
++|..|.
T Consensus 275 l~~~~~~ 281 (317)
T 3o53_A 275 LTGQNEE 281 (317)
T ss_dssp HHSSSSC
T ss_pred ccCCchh
Confidence 5554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=269.55 Aligned_cols=267 Identities=16% Similarity=0.138 Sum_probs=128.9
Q ss_pred ccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEec
Q 001974 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEAL 257 (988)
Q Consensus 178 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 257 (988)
++.++++.+.+.......+..+++|++|+|++|+++ .++...+..+++|+.|+|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~------------------ 72 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYE------------------ 72 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCC-CCCHHHHTTCTTCCEEECTTSCCEE------------------
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccC-cCCHHHhhCCCcCCEEECCCCcCCc------------------
Confidence 455566666666554555555556666666666665 3333333344444444444444443
Q ss_pred cccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccC
Q 001974 258 DNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTS 337 (988)
Q Consensus 258 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~ 337 (988)
..+ |..+++|++|++++|.++++ ...++|++|++++|+++
T Consensus 73 ------~~~--~~~l~~L~~L~Ls~n~l~~l-----------~~~~~L~~L~l~~n~l~--------------------- 112 (317)
T 3o53_A 73 ------TLD--LESLSTLRTLDLNNNYVQEL-----------LVGPSIETLHAANNNIS--------------------- 112 (317)
T ss_dssp ------EEE--ETTCTTCCEEECCSSEEEEE-----------EECTTCCEEECCSSCCS---------------------
T ss_pred ------chh--hhhcCCCCEEECcCCccccc-----------cCCCCcCEEECCCCccC---------------------
Confidence 222 44444455555554444321 11234444444444443
Q ss_pred CccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCC-CCCCCCCEEEcccccccccc
Q 001974 338 NQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL-GNLSILSELLLNNNSLSGVI 416 (988)
Q Consensus 338 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~ 416 (988)
+..+. .+++|+.|++++|++++..+..+..+++|++|+|++|++++..+..+ ..+++|++|+|++|++++.
T Consensus 113 ----~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~- 184 (317)
T 3o53_A 113 ----RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV- 184 (317)
T ss_dssp ----EEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-
T ss_pred ----CcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-
Confidence 22211 12334444444444444334444444444444444444444333333 2344555555555555433
Q ss_pred ccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccc-cccCccccc
Q 001974 417 PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLS-GEIPSQLGL 495 (988)
Q Consensus 417 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~ 495 (988)
+. ...+++|+.|+|++|+++ .+|..+..++.| +.|++++|+++ .+|..+..+++|+.|++++|+++ +.+|..++.
T Consensus 185 ~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L-~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~ 260 (317)
T 3o53_A 185 KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (317)
T ss_dssp EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTC-SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHT
T ss_pred cc-ccccccCCEEECCCCcCC-cchhhhcccCcc-cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhc
Confidence 21 222455555555555554 344445555555 55555555555 34555555556666666666665 555555566
Q ss_pred CCCCcEEEec-CccccccCCc
Q 001974 496 CSYLEEIYMR-GNFFHGSIPS 515 (988)
Q Consensus 496 l~~L~~L~L~-~N~l~~~~p~ 515 (988)
+++|+.|+++ .+.++|..|.
T Consensus 261 ~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 261 NQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CHHHHHHHHHHHHHHHSSSSC
T ss_pred cccceEEECCCchhccCCchh
Confidence 6666666665 3344444443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=284.21 Aligned_cols=186 Identities=16% Similarity=0.046 Sum_probs=130.0
Q ss_pred eeccccceeEEEEEECCCCeEEEEEEeeccc----------cchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR----------HGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 670 ~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
..+.|++|.+..++..-.|+.||+|++.... ....+++.+|+++|+++ .|+||++++++ +++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence 3566777777776666678899999996432 12235699999999999 79999999999 45668
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..||||||++|++|.+++.... +++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~-----------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~v 378 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE-----------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHA 378 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC-----------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCE
T ss_pred EEEEEEecCCCCcHHHHHHhCC-----------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCE
Confidence 9999999999999999997654 45543 5899999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
||+|||+|+....... .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 379 KL~DFGlAr~~~~~~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 379 RLIDFGSIVTTPQDCS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EECCCTTEESCC---C----CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EEeecccCeeCCCCCc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999986544322 1223579999999999876 467789999999998887766554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=274.83 Aligned_cols=235 Identities=20% Similarity=0.191 Sum_probs=196.3
Q ss_pred CCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeE
Q 001974 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGM 381 (988)
Q Consensus 302 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 381 (988)
.++|++|+|++|.+++..|..+..++ +|+.|+|++|.+++..| +..+++|+.|+|++|.|++..+ .++|+.|
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44788888888888866666776664 78899999998886655 8899999999999999984332 3899999
Q ss_pred ecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhh-hhcccccceeccccc
Q 001974 382 GLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNH 460 (988)
Q Consensus 382 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~l~~~L~ls~N~ 460 (988)
+|++|.+++..+.. +++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++.+|..+. .++.| +.|+|++|.
T Consensus 105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L-~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL-EHLNLQYNF 180 (487)
T ss_dssp ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC-CEEECTTSC
T ss_pred ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcc-cEEecCCCc
Confidence 99999999766553 57899999999999998899999999999999999999988888876 68888 999999999
Q ss_pred ccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCccc-CcCcc
Q 001974 461 LVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS-GLIPK 539 (988)
Q Consensus 461 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~ 539 (988)
+++. |. +..+++|+.|+|++|.|++ +|..|+.+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|.
T Consensus 181 l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 9865 33 4468999999999999995 56669999999999999999995 7888999999999999999998 66665
Q ss_pred c-ccCCCCcEEeCC
Q 001974 540 F-LEDLSLEYLNLS 552 (988)
Q Consensus 540 ~-~~~~~L~~l~l~ 552 (988)
. ..++.|+.++++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 5 555567666665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-29 Score=303.15 Aligned_cols=463 Identities=15% Similarity=0.114 Sum_probs=249.9
Q ss_pred CCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccc---cCCcc------------cCCCCCC
Q 001974 18 HFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQG---EIPRE------------FGRLFRL 82 (988)
Q Consensus 18 ~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~---~~p~~------------~~~l~~L 82 (988)
-|++|.++... ....++++..... ..+..+..+++|++|+|+++.... ..|.. +..+++|
T Consensus 33 vck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 33 VCKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp SCHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 35579888221 2234555544322 233456778999999999986321 22221 2357789
Q ss_pred cEEECCCCCCCCcCCcccc-cCCCCceeecCcc-cccCC-CcccccCcccccccccccccccCCCCCccc----CCCccc
Q 001974 83 EALFLSDNDLVGEIPANLS-YCSRLTILFLGRN-KLMGS-IPFEFFSLYKLKQLAMQRNNLTGGIPPFIG----NLTSLE 155 (988)
Q Consensus 83 ~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~ 155 (988)
++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999888877666665 6888999999888 55422 334444788888888888887754444333 566888
Q ss_pred eeeccccccCCCCCccc----cCcccccccccccc-cccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcce
Q 001974 156 SISLAANAFGGNIPNSL----GQLKELKSLGLGAN-NLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLF 230 (988)
Q Consensus 156 ~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L 230 (988)
+|++++|. .......+ .++++|++|+|++| .++ .++..+..+++|++|+++.+...
T Consensus 188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~----------------- 248 (594)
T 2p1m_B 188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAE----------------- 248 (594)
T ss_dssp EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCC-----------------
T ss_pred EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCc-----------------
Confidence 88888876 21212222 34578888888877 444 36777777788888876554321
Q ss_pred eccccccccccCcccccCCcccEE-EeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEE
Q 001974 231 QVHHNFFSGSIPISLSNASKLEFI-EALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLI 309 (988)
Q Consensus 231 ~L~~N~l~~~~p~~l~~l~~L~~L-~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 309 (988)
++.|.+.+ ++..+.++++|+.| .+.+... ...+..+..+++|++|++++|.++.. .....+..+++|++|+
T Consensus 249 -~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~-----~l~~~~~~~~~L~~L~ 320 (594)
T 2p1m_B 249 -VRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSY-----DLVKLLCQCPKLQRLW 320 (594)
T ss_dssp -CCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHH-----HHHHHHTTCTTCCEEE
T ss_pred -cchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHH-----HHHHHHhcCCCcCEEe
Confidence 22333332 22245555566655 2222211 22233333556667777766664321 1112234566666666
Q ss_pred eecccCCCCCCchhhhccccccEEEccC---------CccccCCCcccc-CCCcceEEEeeCccCCCccCcccC-CCCcc
Q 001974 310 FAANKLRGALPHSIANLSDQLQNLIMTS---------NQLHGSIPSGIG-NLVGLYRLGMGGNQFTGTIPKEMG-KLQNL 378 (988)
Q Consensus 310 Ls~N~l~~~~p~~~~~~~~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L 378 (988)
+++| ++......+....++|++|++++ +.+++.....+. .+++|+.|.++.|++++..+..+. .+++|
T Consensus 321 l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L 399 (594)
T 2p1m_B 321 VLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399 (594)
T ss_dssp EEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC
T ss_pred CcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc
Confidence 6666 32111111222223455555522 222221111111 244555555555555433333332 24455
Q ss_pred CeEecccccCCCCCCCCCCCCCCCCEEEcccccccc-----ccccccccccccceeecCCCCCCccCchhhhh-hccccc
Q 001974 379 EGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSG-----VIPSCLGSLKQLAILHLFENGLNGTIPEEIFN-LTYLSN 452 (988)
Q Consensus 379 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~l~~ 452 (988)
+.|+|+.|...+ -|.++. .++..+..+++|+.|++++ .+++..+..+.. ++.| +
T Consensus 400 ~~L~L~~~~~~~------------------~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L-~ 459 (594)
T 2p1m_B 400 TRFRLCIIEPKA------------------PDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKM-E 459 (594)
T ss_dssp CEEEEEESSTTC------------------CCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTC-C
T ss_pred ceeEeecccCCC------------------cccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhc-c
Confidence 555555111000 022321 1122244556666666655 454444444444 4555 6
Q ss_pred ceecccccccCCCcccc-ccccccceeecCCcccccccCc-ccccCCCCcEEEecCccccccCCccc-cCccccCeeecC
Q 001974 453 SLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGEIPS-QLGLCSYLEEIYMRGNFFHGSIPSSL-SSLRAVLAIDLS 529 (988)
Q Consensus 453 ~L~ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls 529 (988)
.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++......+ ..+++|+...+.
T Consensus 460 ~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~ 539 (594)
T 2p1m_B 460 MLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVID 539 (594)
T ss_dssp EEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEEC
T ss_pred EeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEec
Confidence 66666666654444333 4567777777777777544333 33446777777777777754333333 345666666666
Q ss_pred CCcc
Q 001974 530 RNNL 533 (988)
Q Consensus 530 ~N~l 533 (988)
.+.-
T Consensus 540 ~~~~ 543 (594)
T 2p1m_B 540 ERGA 543 (594)
T ss_dssp SSSC
T ss_pred CCCc
Confidence 5543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=240.28 Aligned_cols=228 Identities=19% Similarity=0.189 Sum_probs=126.6
Q ss_pred EEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEeccccc
Q 001974 308 LIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQ 387 (988)
Q Consensus 308 L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 387 (988)
.+..+..++ .+|..+. +.|++|++++|++++..+..+..+++|++|++++|++++..+..|.++++|++|+|++|+
T Consensus 12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 344444444 4444332 356666666666665555566666666666666666665555566666666666666666
Q ss_pred CCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCc-cCchhhhhhcccccceecccccccCCCc
Q 001974 388 LSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG-TIPEEIFNLTYLSNSLNLARNHLVGSIP 466 (988)
Q Consensus 388 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~l~~~L~ls~N~l~~~~p 466 (988)
+++..+..|.++++|++|++++|++.+..+..+..+++|+.|++++|++++ .+|..+.+++.| ++|++++|++++..+
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L-~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL-EHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTC-CEEECCSSCCCEECG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCC-CEEECCCCCCCcCCH
Confidence 665555666666666666666666665555556666666666666666653 234455555444 455555555544444
Q ss_pred cccccccccceeecCCcccccccCcccccCCCCc-EEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCC
Q 001974 467 TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLE-EIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDL 544 (988)
Q Consensus 467 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~ 544 (988)
..+..+.+|+ .|. .|++++|.+++..+..+.. .+|+.|+|++|++++.++.. ..++
T Consensus 167 ~~~~~l~~L~---------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~ 224 (276)
T 2z62_A 167 TDLRVLHQMP---------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLT 224 (276)
T ss_dssp GGGHHHHTCT---------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCC
T ss_pred HHhhhhhhcc---------------------ccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccc
Confidence 4444444444 010 4555555555333333322 24555555555555555443 3445
Q ss_pred CCcEEeCCCCcCcccCCC
Q 001974 545 SLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 545 ~L~~l~l~~N~l~~~~p~ 562 (988)
+|++|+|++|++++..|.
T Consensus 225 ~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 225 SLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp SCCEEECCSSCBCCCTTT
T ss_pred cccEEEccCCcccccCCc
Confidence 566666666666665553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=241.68 Aligned_cols=220 Identities=18% Similarity=0.171 Sum_probs=170.8
Q ss_pred EcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccccc
Q 001974 38 NLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 38 ~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~ 117 (988)
+..+.+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33444555 4555553 57999999999999888889999999999999999999777788999999999999999999
Q ss_pred CCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCC-CCccccCcccccccccccccccCccchhh
Q 001974 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGN-IPNSLGQLKELKSLGLGANNLSGIIPPSI 196 (988)
Q Consensus 118 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 196 (988)
+..+..|.++++|++|++++|.+++..+..|.++++|++|++++|++++. +|..|.++++|++|+|++|++++..+..+
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 88888999999999999999999977777899999999999999999864 58889999999999999999998777888
Q ss_pred ccccCcc----EEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEecccccc
Q 001974 197 YNLSLLA----NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFS 262 (988)
Q Consensus 197 ~~l~~L~----~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~ 262 (988)
..+++|+ .|++++|++. .++...+. ..+|+.|++++|++++..+..+..+++|+.|++++|++.
T Consensus 170 ~~l~~L~~l~l~L~ls~n~l~-~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 170 RVLHQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp HHHHTCTTCCEEEECCSSCCC-EECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred hhhhhccccceeeecCCCccc-ccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 8877777 7777777777 45444442 235555555555555444444444444444444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-29 Score=300.79 Aligned_cols=230 Identities=14% Similarity=0.088 Sum_probs=157.4
Q ss_pred cccEEEccCCccccCCC-ccccCCCcceEEEeeCccCCCc-cCcccCCCCccCeEeccc---------ccCCCCCCCCCC
Q 001974 329 QLQNLIMTSNQLHGSIP-SGIGNLVGLYRLGMGGNQFTGT-IPKEMGKLQNLEGMGLYD---------NQLSGEIPSSLG 397 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~p~~~~ 397 (988)
+|+.|++++|.+++... ..+..+++|+.|++++| +... ++.....+++|+.|+|++ |.+++.....+.
T Consensus 290 ~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~ 368 (594)
T 2p1m_B 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS 368 (594)
T ss_dssp TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHH
T ss_pred CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHH
Confidence 56666666666543222 22456778888888887 4322 222233577888888843 444432222222
Q ss_pred -CCCCCCEEEccccccccccccccc-cccccceeecC--C----CCCCc-----cCchhhhhhcccccceecccccccCC
Q 001974 398 -NLSILSELLLNNNSLSGVIPSCLG-SLKQLAILHLF--E----NGLNG-----TIPEEIFNLTYLSNSLNLARNHLVGS 464 (988)
Q Consensus 398 -~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~-----~~p~~~~~l~~l~~~L~ls~N~l~~~ 464 (988)
++++|+.|.++.|.+++..+..+. .+++|+.|+++ + |.+++ .++..+..++.| +.|++++ .+++.
T Consensus 369 ~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L-~~L~L~~-~l~~~ 446 (594)
T 2p1m_B 369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL-RRLSLSG-LLTDK 446 (594)
T ss_dssp HHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTC-CEEECCS-SCCHH
T ss_pred HhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCc-cEEeecC-cccHH
Confidence 378899999999999876666665 58999999999 4 66662 122235667788 9999987 67666
Q ss_pred Ccccccc-ccccceeecCCcccccccCccc-ccCCCCcEEEecCccccccCCc-cccCccccCeeecCCCcccCcCccc-
Q 001974 465 IPTKIGN-LKYLRVFNVSSNNLSGEIPSQL-GLCSYLEEIYMRGNFFHGSIPS-SLSSLRAVLAIDLSRNNLSGLIPKF- 540 (988)
Q Consensus 465 ~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~- 540 (988)
.+..+.. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+.|++++|+++......
T Consensus 447 ~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l 526 (594)
T 2p1m_B 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLL 526 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHH
T ss_pred HHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHH
Confidence 5666665 8999999999999987766666 6799999999999999765554 3456899999999999985432222
Q ss_pred -ccCCCCcEEeCCCCcCcccCC
Q 001974 541 -LEDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 541 -~~~~~L~~l~l~~N~l~~~~p 561 (988)
..++.|+...+..+.-....|
T Consensus 527 ~~~lp~l~i~~~~~~~~~~~~~ 548 (594)
T 2p1m_B 527 GQKMPKLNVEVIDERGAPDSRP 548 (594)
T ss_dssp HHHCTTEEEEEECSSSCGGGSC
T ss_pred HHhCCCCEEEEecCCCcccccc
Confidence 345677766676665444333
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-25 Score=232.69 Aligned_cols=192 Identities=22% Similarity=0.215 Sum_probs=166.6
Q ss_pred CCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcC
Q 001974 17 GHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEI 96 (988)
Q Consensus 17 ~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 96 (988)
.+||.|.||+|.. ..+.+++++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|++..
T Consensus 2 ~~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 75 (251)
T 3m19_A 2 KTCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS 75 (251)
T ss_dssp --CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred ccCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC
Confidence 4689999999963 3446899999998 6776665 68999999999999888889999999999999999999888
Q ss_pred CcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcc
Q 001974 97 PANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLK 176 (988)
Q Consensus 97 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 176 (988)
|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.+++
T Consensus 76 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 76 AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 88899999999999999999988888889999999999999999977777788899999999999999877777888899
Q ss_pred cccccccccccccCccchhhccccCccEEEeccCCCCC
Q 001974 177 ELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 177 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 214 (988)
+|++|+|++|+|++..+..+..+++|+.|+|++|.+.+
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 99999999999987777788888888888888888873
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-24 Score=229.36 Aligned_cols=201 Identities=20% Similarity=0.252 Sum_probs=141.5
Q ss_pred CCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccc
Q 001974 57 FLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQ 136 (988)
Q Consensus 57 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 136 (988)
..+.+++++++++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4678888888888 5666553 678888888888886666678888888888888888886666667778888888888
Q ss_pred cccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCC
Q 001974 137 RNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSL 216 (988)
Q Consensus 137 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~l 216 (988)
+|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+++ .+
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-Ee
Confidence 88887666667777888888888888887766777777777777777777777665556667777777777777766 45
Q ss_pred CCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccc
Q 001974 217 PPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSF 261 (988)
Q Consensus 217 p~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i 261 (988)
|...+..+++|+.|+|++|++++..+..+..+++|+.|++++|.+
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 555454555555555555555544444444444444444444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=232.25 Aligned_cols=205 Identities=20% Similarity=0.202 Sum_probs=125.8
Q ss_pred ccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccc
Q 001974 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427 (988)
Q Consensus 348 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 427 (988)
+..+++++.+++++|+++ .+|..+. ++++.|+|++|++++..|..|.++++|+.|+|++|.|++..+ ...+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 334455555555555555 3443332 455555555555555555555555666666666666554322 15556666
Q ss_pred eeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCc
Q 001974 428 ILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507 (988)
Q Consensus 428 ~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 507 (988)
.|++++|+++ .+|..+..++.+ ++|++++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 6666666665 556555556665 66666666666555566667777777777777777555556667777777777777
Q ss_pred cccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCCcCccc
Q 001974 508 FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEGE 559 (988)
Q Consensus 508 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~ 559 (988)
+|++..+..|..+++|+.|+|++|+|+..++......+|+.|+|++|.+...
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence 7775545556667777777777777776655556666677777777766543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=230.55 Aligned_cols=197 Identities=22% Similarity=0.188 Sum_probs=93.2
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
.++.+++++++++ .+|+.+. +++++|+|++|+|++..|..|..+++|++|+|++|.|++..+ . +.+++|++|+|+
T Consensus 11 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls 85 (290)
T 1p9a_G 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLS 85 (290)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECC
T ss_pred CccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECC
Confidence 3444555555554 3333332 345555555555554444555555555555555555553222 1 444555555555
Q ss_pred cccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCcc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 192 (988)
+|+|+ .+|..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|+.+.
T Consensus 86 ~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 164 (290)
T 1p9a_G 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (290)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred CCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccC
Confidence 55554 34444445555555555555555444444455555555555555554444444444445555555555544433
Q ss_pred chhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccccc
Q 001974 193 PPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237 (988)
Q Consensus 193 ~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l 237 (988)
+..|..+++|+.|+|++|+++ .+|..++ .+++|+.|+|++|.+
T Consensus 165 ~~~~~~l~~L~~L~L~~N~l~-~ip~~~~-~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 165 AGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPW 207 (290)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCB
T ss_pred HHHhcCcCCCCEEECCCCcCC-ccChhhc-ccccCCeEEeCCCCc
Confidence 334444444444444444444 4444333 223344444444433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=231.07 Aligned_cols=223 Identities=24% Similarity=0.285 Sum_probs=147.6
Q ss_pred EcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccccc
Q 001974 38 NLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 38 ~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~ 117 (988)
++..+.+... ..+..+++|++|++++|.++. + ..+..+++|++|+|++|.+++ + ..++.+++|++|+|++|+++
T Consensus 25 ~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~ 98 (272)
T 3rfs_A 25 NLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQ 98 (272)
T ss_dssp HHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCC
T ss_pred HhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccC
Confidence 3444444433 234556677777777777762 2 246667777777777777764 2 35667777777777777777
Q ss_pred CCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhc
Q 001974 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIY 197 (988)
Q Consensus 118 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~ 197 (988)
+..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..+..+.
T Consensus 99 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 178 (272)
T 3rfs_A 99 SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFD 178 (272)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhc
Confidence 66666677777777777777777766666667777777777777777766666667777777777777777766666667
Q ss_pred cccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCcc
Q 001974 198 NLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274 (988)
Q Consensus 198 ~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~ 274 (988)
.+++|++|++++|+++ .++...+..+++|+.|++++|.+.+. ++.|+.|+++.|.++|.+|..++.+..
T Consensus 179 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 179 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CCccCCEEECCCCcCC-ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence 7777777777777776 45555555677777777777766543 335666677777777777766655543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=227.51 Aligned_cols=207 Identities=22% Similarity=0.215 Sum_probs=190.1
Q ss_pred CcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeec
Q 001974 32 RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111 (988)
Q Consensus 32 ~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (988)
..++.|+++++.++. + +.+..+++|++|+|++|++++ + ..+..+++|++|+|++|.+++..+..|+.+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 578999999999884 3 358999999999999999995 3 47999999999999999999888888999999999999
Q ss_pred CcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCc
Q 001974 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 112 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 191 (988)
++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++..+..|+++++|++|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSV 196 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCcc
Confidence 99999988888899999999999999999988788899999999999999999988888899999999999999999998
Q ss_pred cchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCc
Q 001974 192 IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASK 250 (988)
Q Consensus 192 ~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 250 (988)
.+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+|..++.+..
T Consensus 197 ~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 197 PDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCC--------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred CHHHHhCCcCCCEEEccCCCccc--------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 88889999999999999999884 4668999999999999999999887754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=226.84 Aligned_cols=185 Identities=14% Similarity=0.139 Sum_probs=132.4
Q ss_pred cccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCC-CCCcCCcccccCCCCceeecCc-ccccCCCcccc
Q 001974 47 SLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDND-LVGEIPANLSYCSRLTILFLGR-NKLMGSIPFEF 124 (988)
Q Consensus 47 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-N~i~~~~~~~~ 124 (988)
.+|. +. ++|++|+|++|+|+++.+..|.++++|++|+|++|. ++...+..|..+++|++|+|++ |+|++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4554 33 378999999999997777789999999999999996 8866666888888888998888 88887677788
Q ss_pred cCcccccccccccccccCCCCCcccCCCccc---eeecccc-ccCCCCCccccCccccc-ccccccccccCccchhhccc
Q 001974 125 FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLE---SISLAAN-AFGGNIPNSLGQLKELK-SLGLGANNLSGIIPPSIYNL 199 (988)
Q Consensus 125 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~l~~l 199 (988)
.++++|++|++++|++++ +|. |..+++|+ +|++++| +++...+..|.++++|+ +|+|++|+++.+.+..+..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~- 178 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG- 178 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-
Confidence 888888888888888874 555 77777777 7777777 77766666677777777 7777777776333333333
Q ss_pred cCccEEEeccCC-CCCCCCCcccccC-CCCcceeccccccc
Q 001974 200 SLLANFSVPRNQ-FHGSLPPSLGLTL-PHLRLFQVHHNFFS 238 (988)
Q Consensus 200 ~~L~~L~L~~N~-i~~~lp~~~~~~l-~~L~~L~L~~N~l~ 238 (988)
++|+.|++++|+ ++ .+|...+.++ ++|+.|++++|+++
T Consensus 179 ~~L~~L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 179 TKLDAVYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CEEEEEECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCCEEEcCCCCCcc-cCCHHHhhccccCCcEEECCCCccc
Confidence 566666666663 55 4554444445 55555555555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-25 Score=256.72 Aligned_cols=187 Identities=17% Similarity=0.170 Sum_probs=142.1
Q ss_pred CCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--------chhHHHHHHHHHHHhcCCCCce--EEEeecccccc
Q 001974 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--------GASKSFLAECKALKNIRHRNLV--KVITSCSSIDF 734 (988)
Q Consensus 665 y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv--~~~~~~~~~~~ 734 (988)
+...+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+ .++++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~------ 409 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV------ 409 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE------
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE------
Confidence 34567999999999999955 678899998643221 1134589999999999999999 55544
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
..+..++||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 410 -~~~~~~lVmE~~~ggsL~~~l~~-------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 410 -DLDNKRIMMSYINGKLAKDVIED-------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK 466 (540)
T ss_dssp -ETTTTEEEEECCCSEEHHHHSTT-------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS
T ss_pred -eCCccEEEEECCCCCCHHHHHHH-------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC
Confidence 23566999999999999999864 347999999999999998 9999999999999998
Q ss_pred CCcEEEeeecccccccccccccce---eccccccccccccCcccCC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQS---CSVGVRGTIGYAAPEYGLG--SEVSTNGDIYSYGILLLEMVTGKKPTD 884 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~ 884 (988)
.+||+|||+|+........... ......||+.|||||++.. ..|+..+|+|+..+-..+-..++.+|.
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999999976543221100 1124569999999999887 567888999999999888888777763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-24 Score=237.05 Aligned_cols=225 Identities=17% Similarity=0.196 Sum_probs=126.7
Q ss_pred CCCcEEEeecccCCCCCCchhhh--ccccccEEEccCCccccCCCccc--cCCCcceEEEeeCccCCCccC----cccCC
Q 001974 303 SNLRTLIFAANKLRGALPHSIAN--LSDQLQNLIMTSNQLHGSIPSGI--GNLVGLYRLGMGGNQFTGTIP----KEMGK 374 (988)
Q Consensus 303 ~~L~~L~Ls~N~l~~~~p~~~~~--~~~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 374 (988)
..++.+.+.++.++...-..+.. ..++|++|++++|.+.+..|..+ ..+++|+.|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 45777888777665211111111 01247777777777777777766 677777777777777775444 23456
Q ss_pred CCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccc--c--ccccccccccceeecCCCCCCccCchh----hhh
Q 001974 375 LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV--I--PSCLGSLKQLAILHLFENGLNGTIPEE----IFN 446 (988)
Q Consensus 375 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~~----~~~ 446 (988)
+++|++|+|++|++++..|..|+++++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .+|.. +..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 67777777777777766667777777777777777776542 1 222356677777777777775 34432 233
Q ss_pred hcccccceecccccccCCCccccccc---cccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCcccc
Q 001974 447 LTYLSNSLNLARNHLVGSIPTKIGNL---KYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAV 523 (988)
Q Consensus 447 l~~l~~~L~ls~N~l~~~~p~~~~~l---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 523 (988)
++.| ++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|
T Consensus 223 l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L 296 (310)
T 4glp_A 223 GVQP-HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV 296 (310)
T ss_dssp TCCC-SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred CCCC-CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence 4444 555555555554445444443 35555555555555 3444332 4444444444444432 22 3344444
Q ss_pred CeeecCCCccc
Q 001974 524 LAIDLSRNNLS 534 (988)
Q Consensus 524 ~~L~ls~N~l~ 534 (988)
+.|+|++|+|+
T Consensus 297 ~~L~L~~N~l~ 307 (310)
T 4glp_A 297 DNLTLDGNPFL 307 (310)
T ss_dssp SCEECSSTTTS
T ss_pred cEEECcCCCCC
Confidence 44444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=231.39 Aligned_cols=224 Identities=17% Similarity=0.131 Sum_probs=183.8
Q ss_pred cccEEEccCCccccCCCc---cccCCCcceEEEeeCccCCCccCccc--CCCCccCeEecccccCCCCCC----CCCCCC
Q 001974 329 QLQNLIMTSNQLHGSIPS---GIGNLVGLYRLGMGGNQFTGTIPKEM--GKLQNLEGMGLYDNQLSGEIP----SSLGNL 399 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l 399 (988)
.++.|.+.++.+...... .+..+++|++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 478888888877532111 12234669999999999998899888 899999999999999997655 345678
Q ss_pred CCCCEEEccccccccccccccccccccceeecCCCCCCcc--Cch--hhhhhcccccceecccccccCCCcc----cccc
Q 001974 400 SILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGT--IPE--EIFNLTYLSNSLNLARNHLVGSIPT----KIGN 471 (988)
Q Consensus 400 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~--~~~~l~~l~~~L~ls~N~l~~~~p~----~~~~ 471 (988)
++|++|+|++|++.+..|..|+.+++|++|+|++|++.+. ++. .+..++.| ++|+|++|+++ .+|. .++.
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAI-QNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCC-CSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCC-CEEECCCCCCC-chHHHHHHHHhc
Confidence 9999999999999988889999999999999999998753 332 23577888 99999999997 4443 2577
Q ss_pred ccccceeecCCcccccccCcccccC---CCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcE
Q 001974 472 LKYLRVFNVSSNNLSGEIPSQLGLC---SYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEY 548 (988)
Q Consensus 472 l~~L~~L~ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~ 548 (988)
+++|++|||++|+|++..|..++.+ ++|++|+|++|+|+ .+|..+. ++|+.|||++|+|++. |....+++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~ 298 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDN 298 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccE
Confidence 8999999999999998888888877 69999999999999 7788775 7999999999999986 44667788999
Q ss_pred EeCCCCcCcc
Q 001974 549 LNLSFNDLEG 558 (988)
Q Consensus 549 l~l~~N~l~~ 558 (988)
|+|++|+++.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=223.83 Aligned_cols=214 Identities=19% Similarity=0.171 Sum_probs=185.5
Q ss_pred CCCCCcee-eee--EEeC------CCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCc-ccccCCcccCCCCCCcE
Q 001974 15 DSGHFCEW-KGI--TCGL------RHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNS-IQGEIPREFGRLFRLEA 84 (988)
Q Consensus 15 ~~~~~c~~-~~v--~c~~------~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~ 84 (988)
+..+.|.+ ..+ .|.. .+..++.|++++|++++..+..|..+++|++|+|++|+ ++++.+..|.++++|++
T Consensus 5 p~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~ 84 (239)
T 2xwt_C 5 SPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84 (239)
T ss_dssp SSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCE
T ss_pred CCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcE
Confidence 44566755 544 4864 34579999999999998777799999999999999997 99778889999999999
Q ss_pred EECCC-CCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccc---ccccccc-cccCCCCCcccCCCccc-eee
Q 001974 85 LFLSD-NDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLK---QLAMQRN-NLTGGIPPFIGNLTSLE-SIS 158 (988)
Q Consensus 85 L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~ 158 (988)
|+|++ |++++..+..|..+++|++|+|++|++++ +|. |..+++|+ +|++++| .+++..+..|.++++|+ +|+
T Consensus 85 L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~ 162 (239)
T 2xwt_C 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162 (239)
T ss_dssp EEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEE
T ss_pred EECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEE
Confidence 99999 99997777899999999999999999995 665 88888888 9999999 99977777899999999 999
Q ss_pred ccccccCCCCCccccCccccccccccccc-ccCccchhhccc-cCccEEEeccCCCCCCCCCcccccCCCCcceecccc
Q 001974 159 LAANAFGGNIPNSLGQLKELKSLGLGANN-LSGIIPPSIYNL-SLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235 (988)
Q Consensus 159 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l-~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N 235 (988)
+++|+++...+..|.. ++|+.|+|++|+ ++.+.+..|.++ ++|+.|++++|+++ .+|.. .+++|+.|+++++
T Consensus 163 l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 163 LYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT---TCTTCSEEECTTC
T ss_pred cCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh---HhccCceeeccCc
Confidence 9999999555555665 899999999995 997778899999 99999999999999 78776 4678888887765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=233.14 Aligned_cols=245 Identities=17% Similarity=0.135 Sum_probs=180.7
Q ss_pred CCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCC
Q 001974 18 HFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIP 97 (988)
Q Consensus 18 ~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 97 (988)
|.|+|..|.|. +++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~------------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQ------------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEE------------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEec------------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 44677666665 56666 567666 3679999999999997777789999999999999999866555
Q ss_pred -cccccCCCCce-eecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccc-cccCCCCCccccC
Q 001974 98 -ANLSYCSRLTI-LFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA-NAFGGNIPNSLGQ 174 (988)
Q Consensus 98 -~~~~~l~~L~~-L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~ 174 (988)
.+|.++++|+. +.+++|+|+.+.|++|.++++|++|++++|+++...+..+....++..|++.+ |++....+.+|..
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 56888888765 66778999888888999999999999999999876666777777888888865 6777666677877
Q ss_pred cc-cccccccccccccCccchhhccccCccEEEecc-CCCCCCCCCcccccCCCCcceeccccccccccCcccccCCccc
Q 001974 175 LK-ELKSLGLGANNLSGIIPPSIYNLSLLANFSVPR-NQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLE 252 (988)
Q Consensus 175 l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~-N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 252 (988)
+. .++.|+|++|+|+.+ |.......+|++|++++ |.++ .+|..+|.++++|+.|+|++|+|+...+..+.++.+|+
T Consensus 152 ~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~ 229 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 229 (350)
T ss_dssp SBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEE
T ss_pred cchhhhhhccccccccCC-ChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhh
Confidence 75 588899999999854 44444556788888875 5565 88888888888888888888888865555555444444
Q ss_pred EEEeccccccCcccccccCCccccEEecccc
Q 001974 253 FIEALDNSFSGKLSVNFGGMKNLSYFNVAYN 283 (988)
Q Consensus 253 ~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N 283 (988)
.++ +.--...| .+..+++|+.++++++
T Consensus 230 ~l~---~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 230 ARS---TYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CTT---CTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred hcc---CCCcCcCC-CchhCcChhhCcCCCC
Confidence 333 22222333 2555666666666543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-25 Score=246.14 Aligned_cols=269 Identities=16% Similarity=0.157 Sum_probs=176.8
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCC----cccCCCC-CCcEEECCCCCCCCcCCcccccC-----CC
Q 001974 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIP----REFGRLF-RLEALFLSDNDLVGEIPANLSYC-----SR 105 (988)
Q Consensus 36 ~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l-----~~ 105 (988)
.+++++|++++.+|..+...++|++|||++|+|++..+ ..|..++ +|++|+|++|.+++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788899998888877777779999999999987666 6788888 89999999999987777777775 88
Q ss_pred CceeecCcccccCCCcccccCc-----ccccccccccccccCCCCCccc----C-CCccceeeccccccCCCCC----cc
Q 001974 106 LTILFLGRNKLMGSIPFEFFSL-----YKLKQLAMQRNNLTGGIPPFIG----N-LTSLESISLAANAFGGNIP----NS 171 (988)
Q Consensus 106 L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~----~~ 171 (988)
|++|+|++|++++..+..+... ++|++|+|++|.+++..+..+. . .++|++|+|++|+++...+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999887777655543 7888888888888865554433 3 2588888888888875433 33
Q ss_pred ccCcc-cccccccccccccCccchhhccc-----cCccEEEeccCCCCCC----CCCcccccCCCCcceecccccccccc
Q 001974 172 LGQLK-ELKSLGLGANNLSGIIPPSIYNL-----SLLANFSVPRNQFHGS----LPPSLGLTLPHLRLFQVHHNFFSGSI 241 (988)
Q Consensus 172 ~~~l~-~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~N~i~~~----lp~~~~~~l~~L~~L~L~~N~l~~~~ 241 (988)
+..++ +|++|+|++|+|++..+..+... ++|++|+|++|+|++. ++..+....++|+.|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34454 78888888888876666544433 4777777777777632 22222211235555555555554332
Q ss_pred CcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCc-hhhhcccccCCCCcEEEeecccCCCCCC
Q 001974 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE-MSFMNSLANCSNLRTLIFAANKLRGALP 320 (988)
Q Consensus 242 p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 320 (988)
+..+ ...+..+++|+.|++++|.+..+.... ......+..+++|+.|++++|++.+..+
T Consensus 242 ~~~l--------------------~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 242 LENL--------------------KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHH--------------------HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHH--------------------HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 2111 122344556666666666654443321 1222345566667777777777765544
Q ss_pred chhh
Q 001974 321 HSIA 324 (988)
Q Consensus 321 ~~~~ 324 (988)
..+.
T Consensus 302 ~~~~ 305 (362)
T 3goz_A 302 IPIS 305 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.3e-25 Score=244.42 Aligned_cols=81 Identities=19% Similarity=0.084 Sum_probs=43.4
Q ss_pred EEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCC----cccccCC-CCceeecCcccccCCCcccccCc-----ccc
Q 001974 61 INLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIP----ANLSYCS-RLTILFLGRNKLMGSIPFEFFSL-----YKL 130 (988)
Q Consensus 61 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l-----~~L 130 (988)
+.|++|++++.+|..+....+|++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4556666665555555555556666666666654443 4455555 55555555555554445444443 444
Q ss_pred ccccccccccc
Q 001974 131 KQLAMQRNNLT 141 (988)
Q Consensus 131 ~~L~L~~N~l~ 141 (988)
++|+|++|.++
T Consensus 83 ~~L~Ls~n~l~ 93 (362)
T 3goz_A 83 TSLNLSGNFLS 93 (362)
T ss_dssp CEEECCSSCGG
T ss_pred cEEECcCCcCC
Confidence 44444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=216.35 Aligned_cols=180 Identities=21% Similarity=0.215 Sum_probs=95.9
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
..+.++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3455666666665 4444433 355555555555555445555555555555555555555445455555555555555
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
+|++++..+..|..+++|+.|+|++|+++ +..+..|..+++|+.|+|++|+|++.
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLK-------------------------SLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCC-------------------------CcChhHhccCCcccEEECcCCcCCcc
Confidence 55555444444555555555555555444 22233344455555555555555544
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCc
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 536 (988)
.+..|+.+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 444555555555555555555554445555555555555555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9.4e-25 Score=246.98 Aligned_cols=232 Identities=16% Similarity=0.230 Sum_probs=176.0
Q ss_pred cccEEEccCCccccC----CCccccCCCcceEEEeeCcc---CCCccCccc-------CCCCccCeEecccccCCC----
Q 001974 329 QLQNLIMTSNQLHGS----IPSGIGNLVGLYRLGMGGNQ---FTGTIPKEM-------GKLQNLEGMGLYDNQLSG---- 390 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~---l~~~~p~~~-------~~l~~L~~L~L~~N~l~~---- 390 (988)
.|+.|+|++|.+... ++..+..+++|+.|+|++|. +++.+|..+ ..+++|++|+|++|++++
T Consensus 33 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 112 (386)
T 2ca6_A 33 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 112 (386)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHH
Confidence 355555555555433 22345667788888888753 444455444 678889999999998886
Q ss_pred CCCCCCCCCCCCCEEEccccccccccccccc----cc---------cccceeecCCCCCC-ccCc---hhhhhhcccccc
Q 001974 391 EIPSSLGNLSILSELLLNNNSLSGVIPSCLG----SL---------KQLAILHLFENGLN-GTIP---EEIFNLTYLSNS 453 (988)
Q Consensus 391 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~l~~~ 453 (988)
.+|..+..+++|++|+|++|.+....+..+. .+ ++|+.|+|++|+++ +.+| ..+..++.| ++
T Consensus 113 ~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~ 191 (386)
T 2ca6_A 113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL-HT 191 (386)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-CE
T ss_pred HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc-CE
Confidence 3666778888999999999988755444444 33 88999999999997 4555 456677787 89
Q ss_pred eeccccccc--C---CCccccccccccceeecCCcccc----cccCcccccCCCCcEEEecCcccccc----CCccc--c
Q 001974 454 LNLARNHLV--G---SIPTKIGNLKYLRVFNVSSNNLS----GEIPSQLGLCSYLEEIYMRGNFFHGS----IPSSL--S 518 (988)
Q Consensus 454 L~ls~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~--~ 518 (988)
|++++|+++ | ..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. +|..+ +
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~ 271 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTC
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhc
Confidence 999999887 2 34557888999999999999996 67888999999999999999999876 56777 3
Q ss_pred CccccCeeecCCCcccC----cCccc--ccCCCCcEEeCCCCcCcccCC
Q 001974 519 SLRAVLAIDLSRNNLSG----LIPKF--LEDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 519 ~l~~L~~L~ls~N~l~~----~~p~~--~~~~~L~~l~l~~N~l~~~~p 561 (988)
.+++|+.|+|++|++++ .+|.. ..+++|++|+|++|++++..|
T Consensus 272 ~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp SSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred cCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 48999999999999998 35543 446899999999999987554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=206.22 Aligned_cols=160 Identities=24% Similarity=0.240 Sum_probs=110.6
Q ss_pred CCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCC
Q 001974 15 DSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94 (988)
Q Consensus 15 ~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 94 (988)
+..+.|.|.+|.|.. ++++ .+|..+ .++|++|+|++|+|++..+..|..+++|++|+|++|++++
T Consensus 2 p~~C~C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 66 (208)
T 2o6s_A 2 PSRCSCSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS 66 (208)
T ss_dssp CTTCEEETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred cCCCEECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc
Confidence 356779999999963 3344 344433 3578888888888887666778888888888888888886
Q ss_pred cCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccC
Q 001974 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQ 174 (988)
Q Consensus 95 ~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 174 (988)
..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..
T Consensus 67 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 146 (208)
T 2o6s_A 67 LPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR 146 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhcc
Confidence 66666777888888888888877666666677777777777777776555555666666666666666666544444555
Q ss_pred ccccccccccccccc
Q 001974 175 LKELKSLGLGANNLS 189 (988)
Q Consensus 175 l~~L~~L~L~~N~l~ 189 (988)
+++|++|+|++|.+.
T Consensus 147 l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 147 LTSLQYIWLHDNPWD 161 (208)
T ss_dssp CTTCCEEECCSCCBC
T ss_pred CCCccEEEecCCCee
Confidence 555555555555444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-25 Score=247.16 Aligned_cols=138 Identities=17% Similarity=0.249 Sum_probs=94.8
Q ss_pred CCCCEEEccccccc-cccc---cccccccccceeecCCCCCC--c---cCchhhhhhcccccceeccccccc----CCCc
Q 001974 400 SILSELLLNNNSLS-GVIP---SCLGSLKQLAILHLFENGLN--G---TIPEEIFNLTYLSNSLNLARNHLV----GSIP 466 (988)
Q Consensus 400 ~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~l~~~L~ls~N~l~----~~~p 466 (988)
++|++|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | .+|..+..++.| +.|+|++|.++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L-~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL-KVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC-CEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCc-cEEECcCCCCCcHHHHHHH
Confidence 56666666666665 2333 34556666777777777665 2 233355566666 66777777764 4566
Q ss_pred cccccccccceeecCCcccccc----cCccc--ccCCCCcEEEecCccccc----cCCccc-cCccccCeeecCCCcccC
Q 001974 467 TKIGNLKYLRVFNVSSNNLSGE----IPSQL--GLCSYLEEIYMRGNFFHG----SIPSSL-SSLRAVLAIDLSRNNLSG 535 (988)
Q Consensus 467 ~~~~~l~~L~~L~ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~ 535 (988)
..+..+++|+.|+|++|++++. +|..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 7777778888888888888765 55666 337888888888888887 477777 567888888888888887
Q ss_pred cCc
Q 001974 536 LIP 538 (988)
Q Consensus 536 ~~p 538 (988)
..+
T Consensus 318 ~~~ 320 (386)
T 2ca6_A 318 EDD 320 (386)
T ss_dssp TSH
T ss_pred chh
Confidence 775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=220.13 Aligned_cols=192 Identities=20% Similarity=0.317 Sum_probs=114.0
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
+|+.|++++|.+.. ++ .+..+++|+.|++++|++++. +. +..+++|++|+|++|++++ ++ .+..+++|+.|+|+
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECC
Confidence 56777777777663 33 466667777777777776633 33 6666777777777777663 23 46666667777777
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
+|++++. +. +..+++|+.|++++|+++ .++. +..++.| +.|++++|++++ ++. +..+++|+.|++++|++++.
T Consensus 116 ~n~l~~~-~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L-~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 116 STQITDV-TP-LAGLSNLQVLYLDLNQIT-NISP-LAGLTNL-QYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp TSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GGGCTTC-CEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCc-hh-hcCCCCCCEEECCCCccC-cCcc-ccCCCCc-cEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcC
Confidence 7766643 22 666666666666666666 3333 5555555 566666666653 222 55566666666666666532
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcC
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLI 537 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 537 (988)
+. +..+++|+.|+|++|++++.. .+..+++|+.|+|++|++++.+
T Consensus 189 -~~-l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 189 -SP-LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp -GG-GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEECCC
T ss_pred -hh-hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeecCC
Confidence 22 555566666666666665433 2555556666666666655533
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=216.22 Aligned_cols=152 Identities=17% Similarity=0.127 Sum_probs=120.8
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------------------chhHHHHHHHHHHHhc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------------------GASKSFLAECKALKNI 717 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 717 (988)
..+......|.+.+.||+|+||.||+|++ .+|+.||+|+++.... .....+.+|+.+++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556677889999999999999999 7899999999964321 1245688999999999
Q ss_pred CCCCceEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCC
Q 001974 718 RHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQ 797 (988)
Q Consensus 718 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 797 (988)
+|+++..+++. +..++||||+++++|.+ +... +...++.|++.||+|||+.
T Consensus 162 ~~~~v~~~~~~---------~~~~lvmE~~~g~~L~~-l~~~-----------------~~~~i~~qi~~~l~~lH~~-- 212 (282)
T 1zar_A 162 QGLAVPKVYAW---------EGNAVLMELIDAKELYR-VRVE-----------------NPDEVLDMILEEVAKFYHR-- 212 (282)
T ss_dssp TTSSSCCEEEE---------ETTEEEEECCCCEEGGG-CCCS-----------------CHHHHHHHHHHHHHHHHHT--
T ss_pred cCCCcCeEEec---------cceEEEEEecCCCcHHH-cchh-----------------hHHHHHHHHHHHHHHHHHC--
Confidence 85444444322 45699999999999998 4221 2346999999999999998
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccC
Q 001974 798 EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL 856 (988)
Q Consensus 798 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 856 (988)
+|+||||||+|||++ ++.+||+|||+|+. +..|+|||++.
T Consensus 213 -giiHrDlkp~NILl~-~~~vkl~DFG~a~~-----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 213 -GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-----------------VGEEGWREILE 252 (282)
T ss_dssp -TEECSCCSTTSEEEE-TTEEEECCCTTCEE-----------------TTSTTHHHHHH
T ss_pred -CCEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------------CCCCCHHHHHH
Confidence 999999999999999 99999999999962 44578898864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-23 Score=231.58 Aligned_cols=252 Identities=14% Similarity=0.157 Sum_probs=196.8
Q ss_pred CCcEEEeecccCCCCCCchhhhc-cccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCc-cCcccCCCCccCeE
Q 001974 304 NLRTLIFAANKLRGALPHSIANL-SDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT-IPKEMGKLQNLEGM 381 (988)
Q Consensus 304 ~L~~L~Ls~N~l~~~~p~~~~~~-~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 381 (988)
.++.+++++|.+. |..+..+ ...++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3566666666655 3333333 14688888888888866554 56789999999999998865 77888899999999
Q ss_pred ecccccCCCCCCCCCCCCCCCCEEEcccc-ccccc-cccccccccccceeecCCC-CCCcc-Cchhhhhhc-ccccceec
Q 001974 382 GLYDNQLSGEIPSSLGNLSILSELLLNNN-SLSGV-IPSCLGSLKQLAILHLFEN-GLNGT-IPEEIFNLT-YLSNSLNL 456 (988)
Q Consensus 382 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~-~l~~~L~l 456 (988)
+|++|++++..|..++.+++|++|+|++| .+++. ++..+..+++|+.|++++| .+++. ++..+..++ .| ++|++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L-~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC-CEEEe
Confidence 99999998778888888999999999999 67753 6777888999999999999 88854 677788888 88 89999
Q ss_pred ccc--ccc-CCCccccccccccceeecCCcc-cccccCcccccCCCCcEEEecCcc-ccccCCccccCccccCeeecCCC
Q 001974 457 ARN--HLV-GSIPTKIGNLKYLRVFNVSSNN-LSGEIPSQLGLCSYLEEIYMRGNF-FHGSIPSSLSSLRAVLAIDLSRN 531 (988)
Q Consensus 457 s~N--~l~-~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N 531 (988)
++| .++ +.+|..+..+++|+.|++++|. +++..+..++.+++|++|+|++|. +.......++.+++|+.|+|++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 999 454 4567788889999999999999 787888899999999999999996 32222236788999999999999
Q ss_pred cccCcCcccccCC-CCcEEeCCCCcCcccCCCC
Q 001974 532 NLSGLIPKFLEDL-SLEYLNLSFNDLEGEVPTK 563 (988)
Q Consensus 532 ~l~~~~p~~~~~~-~L~~l~l~~N~l~~~~p~~ 563 (988)
++... +..+. .|..|++++|++++..|..
T Consensus 283 -i~~~~--~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 283 -VPDGT--LQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp -SCTTC--HHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred -cCHHH--HHHHHhhCcceEEecccCccccCCc
Confidence 33211 12222 4777889999999988863
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=7.3e-22 Score=215.18 Aligned_cols=192 Identities=22% Similarity=0.348 Sum_probs=103.9
Q ss_pred cCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCe
Q 001974 301 NCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEG 380 (988)
Q Consensus 301 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 380 (988)
.+++|++|++++|.++ .+| .+..+ ++|+.|++++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|+.
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l-~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~ 111 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYL-NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKT 111 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGC-TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhcc-CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCE
Confidence 4455566666666555 333 23333 246666666666553322 5555666666666666553 22 4555566666
Q ss_pred EecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceeccccc
Q 001974 381 MGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNH 460 (988)
Q Consensus 381 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~ 460 (988)
|+|++|++++ ++. +..+++|++|+|++|++++..+ +..+++|+.|++++|+++ .++. +..++.| +.|++++|+
T Consensus 112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L-~~L~l~~n~ 184 (308)
T 1h6u_A 112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKL-TTLKADDNK 184 (308)
T ss_dssp EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCGG-GTTCTTC-CEEECCSSC
T ss_pred EECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC-CChh-hcCCCCC-CEEECCCCc
Confidence 6666666553 222 5555666666666666654332 555556666666666655 3333 5555555 556666666
Q ss_pred ccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcccc
Q 001974 461 LVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510 (988)
Q Consensus 461 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 510 (988)
+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 185 ISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred cCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 653322 555556666666666665332 2555566666666666655
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-23 Score=239.17 Aligned_cols=207 Identities=24% Similarity=0.277 Sum_probs=148.0
Q ss_pred cccCCCCCCCCCc-----eeeee-EEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCC
Q 001974 8 GILNSWNDSGHFC-----EWKGI-TCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFR 81 (988)
Q Consensus 8 ~~~~~w~~~~~~c-----~~~~v-~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 81 (988)
+.+.+|..+.+.| .|.++ .|. ..+++.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++
T Consensus 31 ~~l~~W~~~~~~~~~~~~~~~~l~~C~--~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~ 101 (571)
T 3cvr_A 31 SAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPAS 101 (571)
T ss_dssp HHHHHHHTTCCTTCCHHHHHHHHHHHH--HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTT
T ss_pred HHHHHHhccCCccccccchhhhccccc--cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCC
Confidence 3577898788888 79999 785 3578899999999986 777664 78999999999999 566 45788
Q ss_pred CcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccc
Q 001974 82 LEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA 161 (988)
Q Consensus 82 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (988)
|++|+|++|+|++ +|. |.. +|++|+|++|+|++ +|. .+++|++|+|++|.|++ +|. .+++|++|+|++
T Consensus 102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 9999999999985 776 665 88999999999885 554 57888888888888885 555 567888888888
Q ss_pred cccCCCCCccccCcccccccccccccccCccchhhccccCc-------cEEEeccCCCCCCCCCcccccCCCCcceeccc
Q 001974 162 NAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL-------ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHH 234 (988)
Q Consensus 162 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L-------~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~ 234 (988)
|+|++ +|. |. ++|+.|+|++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..++. +++|+.|+|++
T Consensus 170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~-l~~L~~L~L~~ 239 (571)
T 3cvr_A 170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS-LDPTCTIILED 239 (571)
T ss_dssp SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG-SCTTEEEECCS
T ss_pred CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc-CCCCCEEEeeC
Confidence 88875 555 55 77888888888877 4444 443 45 56666666665 45554442 55555555555
Q ss_pred cccccccCccc
Q 001974 235 NFFSGSIPISL 245 (988)
Q Consensus 235 N~l~~~~p~~l 245 (988)
|.+++.+|..+
T Consensus 240 N~l~~~~p~~l 250 (571)
T 3cvr_A 240 NPLSSRIRESL 250 (571)
T ss_dssp SSCCHHHHHHH
T ss_pred CcCCCcCHHHH
Confidence 55544444333
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=217.81 Aligned_cols=240 Identities=20% Similarity=0.206 Sum_probs=163.0
Q ss_pred cEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccC-cccCCCCccCe-Eec
Q 001974 306 RTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIP-KEMGKLQNLEG-MGL 383 (988)
Q Consensus 306 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 383 (988)
++++.++++++ .+|..+ ++.+++|+|++|+|+...+..|..+++|++|+|++|++.+.+| ..|.++++|.. +.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 56777777777 677655 3468888888888886555678888888888888888865555 46778877664 666
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCC-CCCCccCch-hhhhhcccccceecccccc
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFE-NGLNGTIPE-EIFNLTYLSNSLNLARNHL 461 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~~l~~l~~~L~ls~N~l 461 (988)
++|+++...|..|..+++|++|++++|++++..+..+....++..|++++ |++. .+|. .+..+...++.|+|++|+|
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhccccccc
Confidence 77888877778888888888888888888877776777777777888755 5565 5554 4445554446777888887
Q ss_pred cCCCccccccccccceeecCC-cccccccC-cccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc
Q 001974 462 VGSIPTKIGNLKYLRVFNVSS-NNLSGEIP-SQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 462 ~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 539 (988)
+ .+|.......+|+.|++++ |.++ .+| ..|..+++|+.|+|++|+|+...+..|.+|++|+.+++ +++ ..+|.
T Consensus 167 ~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l-~~lP~ 241 (350)
T 4ay9_X 167 Q-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLPT 241 (350)
T ss_dssp C-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTC-CCCCC
T ss_pred c-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCc-CcCCC
Confidence 7 4444444556677777764 5555 454 45677777888888888777443344454444444333 223 34455
Q ss_pred cccCCCCcEEeCCCCc
Q 001974 540 FLEDLSLEYLNLSFND 555 (988)
Q Consensus 540 ~~~~~~L~~l~l~~N~ 555 (988)
...+.+|+.++++++.
T Consensus 242 l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 242 LEKLVALMEASLTYPS 257 (350)
T ss_dssp TTTCCSCCEEECSCHH
T ss_pred chhCcChhhCcCCCCc
Confidence 5666677777776553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4.8e-23 Score=228.43 Aligned_cols=233 Identities=16% Similarity=0.180 Sum_probs=185.7
Q ss_pred CCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccC-CCccccCCCcceEEEeeCccCCCccCcccCCCCccCeE
Q 001974 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGS-IPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGM 381 (988)
Q Consensus 303 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 381 (988)
++++.|++++|.+.+..+. ++.+ ++|++|++++|.+++. ++..+..+++|++|+|++|++++..+..++.+++|++|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~-~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSP-FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCC-BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh-hccC-CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 5666777777776655444 3333 4688888888887755 67778888999999999999988888888999999999
Q ss_pred ecccc-cCCCC-CCCCCCCCCCCCEEEcccc-ccccc-ccccccccc-ccceeecCCC--CCC-ccCchhhhhhcccccc
Q 001974 382 GLYDN-QLSGE-IPSSLGNLSILSELLLNNN-SLSGV-IPSCLGSLK-QLAILHLFEN--GLN-GTIPEEIFNLTYLSNS 453 (988)
Q Consensus 382 ~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~~~~l~~l~~~ 453 (988)
+|++| .+++. ++..+.++++|++|+|++| .+++. ++..+..++ +|+.|++++| .++ +.+|..+..++.| +.
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L-~~ 226 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL-VH 226 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC-SE
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCC-CE
Confidence 99999 67752 5666788999999999999 88864 677788999 9999999999 555 4678888889998 99
Q ss_pred eeccccc-ccCCCccccccccccceeecCCcc-cccccCcccccCCCCcEEEecCccccccCCccccCc-cccCeeecCC
Q 001974 454 LNLARNH-LVGSIPTKIGNLKYLRVFNVSSNN-LSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSL-RAVLAIDLSR 530 (988)
Q Consensus 454 L~ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~ls~ 530 (988)
|++++|. +++..+..+..+++|+.|++++|. +.......++.+++|+.|++++| ++ ...+..+ .+|..|++++
T Consensus 227 L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~ 302 (336)
T 2ast_B 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINC 302 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESC
T ss_pred EeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEec
Confidence 9999999 777788899999999999999995 33333336889999999999999 32 2345555 3588999999
Q ss_pred CcccCcCccccc
Q 001974 531 NNLSGLIPKFLE 542 (988)
Q Consensus 531 N~l~~~~p~~~~ 542 (988)
|++++..|....
T Consensus 303 n~l~~~~~~~~~ 314 (336)
T 2ast_B 303 SHFTTIARPTIG 314 (336)
T ss_dssp CCSCCTTCSSCS
T ss_pred ccCccccCCccc
Confidence 999999887643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=227.34 Aligned_cols=189 Identities=25% Similarity=0.348 Sum_probs=116.2
Q ss_pred CCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEec
Q 001974 304 NLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383 (988)
Q Consensus 304 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 383 (988)
+|+.|+|++|++++ +|..++ ++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|+.|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence 56666666666663 554442 35666666666666 445 335667777777777764 555 444 6777777
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccC
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~ 463 (988)
++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +. +.| +.|+|++|+|+
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L-~~L~Ls~N~L~- 193 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESL-EALDVSTNLLE- 193 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTC-CEEECCSSCCS-
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCC-CEEECcCCCCC-
Confidence 7777764 444 45667777777777664 443 45666667777776663 555 33 444 66666666666
Q ss_pred CCcccccccccc-------ceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccc
Q 001974 464 SIPTKIGNLKYL-------RVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRA 522 (988)
Q Consensus 464 ~~p~~~~~l~~L-------~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 522 (988)
.+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus 194 ~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 194 SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 4554 443 45 67777777777 56666666777777777777777666666665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-21 Score=196.31 Aligned_cols=160 Identities=22% Similarity=0.182 Sum_probs=76.5
Q ss_pred cceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 353 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 45555555555554333344555555555555555554434444555555555555555554444444555555555555
Q ss_pred CCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCcccccc
Q 001974 433 ENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGS 512 (988)
Q Consensus 433 ~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 512 (988)
+|++++..+..+..++.| +.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.
T Consensus 109 ~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQL-KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp SSCCCCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTT
T ss_pred CCcCcccCHhHhccCCcC-CEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCce
Confidence 555542222223334444 444444444443333334445555555555554442 233455555555555555
Q ss_pred CCccccCc
Q 001974 513 IPSSLSSL 520 (988)
Q Consensus 513 ~p~~~~~l 520 (988)
+|.+++.+
T Consensus 181 ip~~~~~l 188 (208)
T 2o6s_A 181 VRNSAGSV 188 (208)
T ss_dssp BBCTTSSB
T ss_pred eeccCccc
Confidence 55555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-21 Score=198.83 Aligned_cols=163 Identities=28% Similarity=0.265 Sum_probs=138.0
Q ss_pred CCCCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCC
Q 001974 13 WNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92 (988)
Q Consensus 13 w~~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 92 (988)
|..+++.|+|.+|.|. +++++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus 12 ~~~~~~~Cs~~~v~c~------------~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCR------------SKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp CCCTTCEEETTEEECT------------TSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCCCEEeCCEeEcc------------CCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 4457889999999996 33444 5555444 8899999999999988899999999999999999999
Q ss_pred CCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccc
Q 001974 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL 172 (988)
Q Consensus 93 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 172 (988)
+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|
T Consensus 77 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~ 155 (229)
T 3e6j_A 77 GALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155 (229)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred CCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHH
Confidence 8666677899999999999999999777778889999999999999998 678888888899999999998887777778
Q ss_pred cCcccccccccccccccCc
Q 001974 173 GQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~~ 191 (988)
..+++|+.|+|++|.+.+.
T Consensus 156 ~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 156 DRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTCTTCCEEECTTSCBCTT
T ss_pred hCCCCCCEEEeeCCCccCC
Confidence 8888888888888888743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=193.96 Aligned_cols=151 Identities=23% Similarity=0.281 Sum_probs=129.1
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
+++++++++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 444567777 5666554 6899999999999988888999999999999999999988899999999999999999999
Q ss_pred cCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC
Q 001974 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 190 (988)
+...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 97777778889999999999999988778888888888888888888887777778888888888888888763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=208.82 Aligned_cols=175 Identities=20% Similarity=0.206 Sum_probs=140.7
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccC-CCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFG-RLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 36 ~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
.+++++++++ .+|..+. +.+++|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 5677888888 5666554 4589999999999988888887 8999999999999999777788999999999999999
Q ss_pred cccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccc---cCcccccccccccccccCc
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL---GQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~ 191 (988)
+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..| ..+++|+.|+|++|+|+.+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 9987777788899999999999999987778888888889999998888886555555 5677888888888888766
Q ss_pred cchhhccccCc--cEEEeccCCCC
Q 001974 192 IPPSIYNLSLL--ANFSVPRNQFH 213 (988)
Q Consensus 192 ~~~~l~~l~~L--~~L~L~~N~i~ 213 (988)
.+..+..++.+ +.|+|++|.+.
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CHHHhhhccHhhcceEEecCCCcc
Confidence 66666666653 56666666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=189.83 Aligned_cols=153 Identities=22% Similarity=0.227 Sum_probs=130.9
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCC-cccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIP-REFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 36 ~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
.+++++|+++ .+|..+. +.+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|+.+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5677788887 4676654 356899999999997755 45889999999999999999777788999999999999999
Q ss_pred cccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCc
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGI 191 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 191 (988)
+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99988888899999999999999999988888888999999999999999877788888888888888888888753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=185.69 Aligned_cols=152 Identities=22% Similarity=0.259 Sum_probs=128.7
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRN 138 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 138 (988)
+.+++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57899999998 6676654 68999999999999777778999999999999999998888888999999999999999
Q ss_pred cccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCC
Q 001974 139 NLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213 (988)
Q Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~ 213 (988)
+|+...+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 998666667888888888888888888877888888888888888888888777777877888888888877775
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=196.16 Aligned_cols=183 Identities=26% Similarity=0.369 Sum_probs=110.6
Q ss_pred cCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccC
Q 001974 39 LRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMG 118 (988)
Q Consensus 39 l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 118 (988)
+..+.+++.. .+..+++|++|++++|.++.. + .+..+++|++|+|++|++++..+ ++.+++|++|+|++|++++
T Consensus 31 l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 104 (291)
T 1h6t_A 31 LKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (291)
T ss_dssp TTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC
Confidence 4444444322 234566777777777777633 3 36667777777777777774433 6777777777777777763
Q ss_pred CCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhcc
Q 001974 119 SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYN 198 (988)
Q Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 198 (988)
++ .+..+++|++|+|++|++++. +.+..+++|++|++++|++++. ..++.+++|++|+|++|++++..+ +..
T Consensus 105 -~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~ 176 (291)
T 1h6t_A 105 -LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAG 176 (291)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcC
Confidence 22 366667777777777776642 3466666667777766666643 456666666666666666664433 666
Q ss_pred ccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccc
Q 001974 199 LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS 238 (988)
Q Consensus 199 l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~ 238 (988)
+++|+.|++++|+++ .+|. +..+++|+.|++++|+++
T Consensus 177 l~~L~~L~L~~N~i~-~l~~--l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 177 LTKLQNLYLSKNHIS-DLRA--LAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CTTCCEEECCSSCCC-BCGG--GTTCTTCSEEEEEEEEEE
T ss_pred CCccCEEECCCCcCC-CChh--hccCCCCCEEECcCCccc
Confidence 666666666666665 3332 334455555555555444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=203.15 Aligned_cols=177 Identities=21% Similarity=0.190 Sum_probs=145.4
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccc-cCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLS-YCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
+.+++++|+|+ .+|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 58999999999 5776653 4689999999999977777787 899999999999999988888899999999999999
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhh---ccccCccEEEeccCCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSI---YNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l---~~l~~L~~L~L~~N~i~~ 214 (988)
|+|+...+..|.++++|++|+|++|+|+...|..|.++++|+.|+|++|+|+.+.+..| ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~- 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK- 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC-
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC-
Confidence 99987777788999999999999999987778889999999999999999986555555 56788888888888887
Q ss_pred CCCCcccccCCC--Ccceecccccccc
Q 001974 215 SLPPSLGLTLPH--LRLFQVHHNFFSG 239 (988)
Q Consensus 215 ~lp~~~~~~l~~--L~~L~L~~N~l~~ 239 (988)
.+|...+..++. ++.|+|++|.+.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 677666656665 3667777777664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=194.09 Aligned_cols=190 Identities=22% Similarity=0.340 Sum_probs=125.1
Q ss_pred ccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccc
Q 001974 330 LQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409 (988)
Q Consensus 330 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 409 (988)
+..+.+..+.+.+.. .+..+++|+.|++++|.++. ++ .+..+++|+.|+|++|++++..+ +.++++|+.|+|++
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 444556666665432 24567778888888888873 34 37777888888888888875443 77788888888888
Q ss_pred cccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCccccccc
Q 001974 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEI 489 (988)
Q Consensus 410 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 489 (988)
|++++ +| .+..+++|+.|++++|+++ .+ +.+..++.| +.|++++|++++. ..+..+++|+.|+|++|++++..
T Consensus 100 n~l~~-~~-~l~~l~~L~~L~L~~n~i~-~~-~~l~~l~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 100 NKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQL-ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTC-CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CcCCC-Ch-hhccCCCCCEEECCCCcCC-CC-hhhcCCCCC-CEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 88775 33 3777778888888888776 33 345666666 6677777766643 45666666666666666666433
Q ss_pred CcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCc
Q 001974 490 PSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536 (988)
Q Consensus 490 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 536 (988)
| +..+++|+.|+|++|.+++ +| .+..+++|+.|++++|+++..
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred h--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 3 6666666666666666663 33 366666666666666666553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.5e-22 Score=231.57 Aligned_cols=207 Identities=18% Similarity=0.174 Sum_probs=124.8
Q ss_pred CCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccc-------------ccCCCcccccCcccccccc-cccccccC
Q 001974 77 GRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK-------------LMGSIPFEFFSLYKLKQLA-MQRNNLTG 142 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-------------i~~~~~~~~~~l~~L~~L~-L~~N~l~~ 142 (988)
..+++|+.|+|++|+|+ .+|..++.+++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 34566666666666665 566666666666666665553 3445666677777777777 5555442
Q ss_pred CCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccc
Q 001974 143 GIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGL 222 (988)
Q Consensus 143 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~ 222 (988)
.|+.+.+++|.++...+ ..|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|..+.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~- 483 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA- 483 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG-
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh-
Confidence 44455555555542211 135666666666664 343 666666666666666666 5655433
Q ss_pred cCCCCcceeccccccccccCcccccCCcccEEEeccccccCcc-cccccCCccccEEecccccCCCCCCCchhhhccccc
Q 001974 223 TLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL-SVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301 (988)
Q Consensus 223 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 301 (988)
.+++|+.|+|++|+|++ +| .+..+++|+.|++++|++++.. |..|..+++|+.|+|++|.+++.++.... .+..
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~---l~~~ 558 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER---LAEM 558 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH---HHHH
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH---HHHH
Confidence 56666666666666665 34 5666677777777777777665 66677777777777777777665543211 2334
Q ss_pred CCCCcEEEe
Q 001974 302 CSNLRTLIF 310 (988)
Q Consensus 302 l~~L~~L~L 310 (988)
+++|+.|++
T Consensus 559 lp~L~~L~l 567 (567)
T 1dce_A 559 LPSVSSILT 567 (567)
T ss_dssp CTTCSEEEC
T ss_pred CcccCccCC
Confidence 677777753
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.9e-19 Score=182.43 Aligned_cols=153 Identities=18% Similarity=0.201 Sum_probs=74.9
Q ss_pred eEecccccCCCCCCCCCCCCCCCCEEEccccccccccc-cccccccccceeecCCCCCCccCchhhhhhcccccceeccc
Q 001974 380 GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIP-SCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLAR 458 (988)
Q Consensus 380 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~ 458 (988)
.+++++|.++ .+|..+. ..++.|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..+.+++.| ++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L-~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV-NEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC-CEEECCC
Confidence 4444444444 2333332 223445555555544322 234445555555555555543222233444444 4444444
Q ss_pred ccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCc
Q 001974 459 NHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGL 536 (988)
Q Consensus 459 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 536 (988)
|++++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 444434444455555555555555555555555555555555555555555555555555555555555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.6e-20 Score=215.28 Aligned_cols=194 Identities=22% Similarity=0.324 Sum_probs=154.8
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
.+..+.+..+.+....+ +..+++|+.|++++|.|. .++ .+..+++|+.|+|++|+|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 45667777787775443 567888999999999988 444 58888999999999999986544 8889999999999
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
+|+|++ +| .+..+++|+.|+|++|++. .+ +.+..++.| +.|+|++|++++. ..+..+++|+.|+|++|+|++.
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~-~l-~~l~~l~~L-~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQL-ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCC-CC-GGGGGCTTC-SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCC-CC-ccccCCCcc-CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 999885 33 6888899999999999987 44 457788888 8888888888854 5688888888888888888866
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcc
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK 539 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 539 (988)
.| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+..
T Consensus 169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence 55 88888888888888888853 4588888888888888888876543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-20 Score=223.81 Aligned_cols=246 Identities=20% Similarity=0.183 Sum_probs=121.4
Q ss_pred cCCCC-CCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCC-----EEEcCCCcccccCCcccCCCCCCc
Q 001974 10 LNSWN-DSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLR-----EINLMNNSIQGEIPREFGRLFRLE 83 (988)
Q Consensus 10 ~~~w~-~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~-----~L~L~~n~l~~~~p~~~~~l~~L~ 83 (988)
-..|. ..+..+.|.++.++ ..+++.|+|.+|++.. ++..+.....|+ .++++.|.+. ..|+.|..+.+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~s--~~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~ 227 (727)
T 4b8c_D 152 KQQPTGDSTPSGTATNSAVS--TPLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWH 227 (727)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred cCCCcCCCCccccCCCceec--CCccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCc
Confidence 34553 34556789888886 4689999999999985 444443333222 2334445555 5688899999999
Q ss_pred EEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccc
Q 001974 84 ALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA 163 (988)
Q Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 163 (988)
.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|.+|++|++|+|++|+|+ .+|..|++|++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 9999999999 78888889999999999999998 88889999999999999999999 779999999999999999999
Q ss_pred cCCCCCccccCcccccccccccccccCccchhhccccCc-cEEEeccCCCCCCCCCcccccCCCCcceeccccccccccC
Q 001974 164 FGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL-ANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIP 242 (988)
Q Consensus 164 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L-~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p 242 (988)
|+ .+|..|++|++|++|+|++|.|++.+|..+..+... ..|+|++|.+.+.+|. .|+.|++++|... -
T Consensus 305 l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~-------~l~~l~l~~n~~~---~ 373 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH-------ERRFIEINTDGEP---Q 373 (727)
T ss_dssp CC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-------C----------------
T ss_pred CC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc-------ccceeEeeccccc---c
Confidence 98 678789999999999999999998888888765332 3467888888766664 3455666665110 0
Q ss_pred cccccCCcccEEEeccccccCcccccccCCccccEEecccccCC
Q 001974 243 ISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLG 286 (988)
Q Consensus 243 ~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 286 (988)
.. .+.+.+..+..+..+..+....+++|.+.
T Consensus 374 ~~-------------~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 374 RE-------------YDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp -----------------------------------------CCC
T ss_pred cc-------------cCCccccccchhhcccccceeeeeccccc
Confidence 01 11223333344555666667777777664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.4e-22 Score=231.59 Aligned_cols=119 Identities=22% Similarity=0.280 Sum_probs=69.3
Q ss_pred cceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEec
Q 001974 426 LAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR 505 (988)
Q Consensus 426 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 505 (988)
|+.|+|++|+|+ .+|. +..++.| +.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|+.+++|+.|+|+
T Consensus 443 L~~L~Ls~n~l~-~lp~-~~~l~~L-~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 443 VRVLHLAHKDLT-VLCH-LEQLLLV-THLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp CSEEECTTSCCS-SCCC-GGGGTTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred ceEEEecCCCCC-CCcC-ccccccC-cEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 555666666665 3554 5555555 56666666665 555566666666666666666663 44 55666666666666
Q ss_pred CccccccC-CccccCccccCeeecCCCcccCcCcccc----cCCCCcEEe
Q 001974 506 GNFFHGSI-PSSLSSLRAVLAIDLSRNNLSGLIPKFL----EDLSLEYLN 550 (988)
Q Consensus 506 ~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~----~~~~L~~l~ 550 (988)
+|+|++.. |..|+.+++|+.|+|++|+|++.+|... .+++|+.||
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 66666554 6666666666666666666666555431 144555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=212.41 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=159.0
Q ss_pred CCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEe
Q 001974 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMG 382 (988)
Q Consensus 303 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 382 (988)
..+..+.++.+.+.+..+ +..+ +.|+.|++++|.+.. ++ .+..+++|+.|+|++|+|++..| +..+++|+.|+
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L-~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHH-TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHhccCCCcccccc--hhcC-CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 345555666777764444 2333 478999999999884 44 58889999999999999986544 88899999999
Q ss_pred cccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceeccccccc
Q 001974 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 383 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~ 462 (988)
|++|+|++ +| .+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++ + ..+..++.| +.|+|++|+++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L-~~L~Ls~N~l~ 166 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKL-DTLSLEDNQIS 166 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTC-SEEECCSSCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCC-c-hhhcccCCC-CEEECcCCcCC
Confidence 99999984 44 688899999999999999863 358889999999999999984 4 677888888 89999999998
Q ss_pred CCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCcccc
Q 001974 463 GSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAV 523 (988)
Q Consensus 463 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 523 (988)
+..| +..+++|+.|+|++|+|++ + +.+..+++|+.|+|++|++.+.....+..+..+
T Consensus 167 ~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~ 223 (605)
T 1m9s_A 167 DIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223 (605)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEE
T ss_pred Cchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCcccccccEEec
Confidence 6656 8889999999999999985 4 468889999999999999986544444444333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=180.88 Aligned_cols=152 Identities=23% Similarity=0.276 Sum_probs=118.9
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
-+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|.++++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 357888888888 5666553 7888888888888877788888888888888888888766667778888888888888
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFH 213 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~ 213 (988)
|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 8888666667788888888888888887 56777777788888888888777666666777777777777777765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.5e-19 Score=185.78 Aligned_cols=138 Identities=20% Similarity=0.182 Sum_probs=107.1
Q ss_pred CCCCCceeccccceeEEEEEECCCCeE--EEEEEeeccccc------------------------hhHHHHHHHHHHHhc
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTI--VAIKVFNLQRHG------------------------ASKSFLAECKALKNI 717 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 717 (988)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367789999999999999999668999 999997543111 013678999999999
Q ss_pred CCCCc--eEEEeecccccccCCCceEEEEeeccc-c----chhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHH
Q 001974 718 RHRNL--VKVITSCSSIDFQGNDFKALVYEFMTN-G----SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790 (988)
Q Consensus 718 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~ 790 (988)
.|+++ ..++++ +..++||||+.+ | +|.++.. ..++.++..++.|++.||.
T Consensus 128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~--------------~~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR--------------ELKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG--------------GGGGSCHHHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh--------------ccChHHHHHHHHHHHHHHH
Confidence 88753 444443 356899999942 3 5665532 1224457789999999999
Q ss_pred HHH-cCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 791 YLH-HHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 791 ~LH-~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
||| +. +||||||||+|||+++ .++|+|||+|...
T Consensus 185 ~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 185 RLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999 88 9999999999999998 9999999999754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-19 Score=220.37 Aligned_cols=119 Identities=29% Similarity=0.295 Sum_probs=46.4
Q ss_pred CccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccc
Q 001974 345 PSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLK 424 (988)
Q Consensus 345 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 424 (988)
++.+..++.|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|+ .+|..|+.++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 333444444444444444444 33333334444444444444444 33433444444444444444444 3343444444
Q ss_pred ccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccc
Q 001974 425 QLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTK 468 (988)
Q Consensus 425 ~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~ 468 (988)
+|+.|+|++|.|+ .+|..+..++.| +.|+|++|.|++.+|..
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~p~~ 335 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNL-QFLGVEGNPLEKQFLKI 335 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTC-CCEECTTSCCCSHHHHH
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCc-cEEeCCCCccCCCChHH
Confidence 4444444444443 333333333333 33444444443333333
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-19 Score=188.41 Aligned_cols=170 Identities=24% Similarity=0.320 Sum_probs=88.5
Q ss_pred CcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeec
Q 001974 352 VGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHL 431 (988)
Q Consensus 352 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 431 (988)
.++..+++++|.+++ ++ .+..+++|+.|++++|+++ .+| .+..+++|+.|+|++|+|++..+ +..+++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 344444455555542 22 3444555555555555555 233 35555555555555555554333 555555555555
Q ss_pred CCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccc
Q 001974 432 FENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHG 511 (988)
Q Consensus 432 ~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 511 (988)
++|+++ .+|.... +.| +.|++++|++++ ++ .+..+++|+.|+|++|++++ +| .++.+++|+.|+|++|++++
T Consensus 93 ~~N~l~-~l~~~~~--~~L-~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 93 NRNRLK-NLNGIPS--ACL-SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CSSCCS-CCTTCCC--SSC-CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCccC-CcCcccc--Ccc-cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcc
Confidence 555555 2333221 333 455555555543 22 35555666666666666663 33 45566666666666666664
Q ss_pred cCCccccCccccCeeecCCCcccCcC
Q 001974 512 SIPSSLSSLRAVLAIDLSRNNLSGLI 537 (988)
Q Consensus 512 ~~p~~~~~l~~L~~L~ls~N~l~~~~ 537 (988)
. ..+..+++|+.|++++|.+++.+
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred h--HHhccCCCCCEEeCCCCcccCCc
Confidence 4 44555666666666666665543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-18 Score=172.87 Aligned_cols=153 Identities=16% Similarity=0.231 Sum_probs=91.4
Q ss_pred cCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccce
Q 001974 349 GNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAI 428 (988)
Q Consensus 349 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 428 (988)
..+++|+.|++++|+++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..|+.+++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45566777777777776 445 4666777777777777554 2235666777777777777777666666777777777
Q ss_pred eecCCCCCCccCchhhhhhcccccceeccccc-ccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCc
Q 001974 429 LHLFENGLNGTIPEEIFNLTYLSNSLNLARNH-LVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507 (988)
Q Consensus 429 L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N 507 (988)
|++++|++++..|..+..++.| ++|++++|. ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L-~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKV-NSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSC-CEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEecCCccCcHhHHHHhhCCCC-CEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 7777777765555555555555 555555555 32 333 35555555555555555553 33 4455555555555555
Q ss_pred ccc
Q 001974 508 FFH 510 (988)
Q Consensus 508 ~l~ 510 (988)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=184.48 Aligned_cols=164 Identities=23% Similarity=0.239 Sum_probs=101.8
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 35 ~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
+.++++.+.++... .+..+++|++|++++|+|+ .+| .+..+++|++|+|++|+|++..| |+.+++|++|+|++|
T Consensus 22 ~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 22 VKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 34556666666333 4666677777777777776 344 56667777777777777764333 666777777777777
Q ss_pred cccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccch
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPP 194 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 194 (988)
++++. |.. .. ++|++|+|++|++++. +.+..+++|++|+|++|++++. + .+..+++|++|+|++|+|++. .
T Consensus 96 ~l~~l-~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~ 166 (263)
T 1xeu_A 96 RLKNL-NGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G 166 (263)
T ss_dssp CCSCC-TTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred ccCCc-Ccc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence 77643 222 22 6666777777766642 2466666666666666666643 2 466666666666666666644 4
Q ss_pred hhccccCccEEEeccCCCC
Q 001974 195 SIYNLSLLANFSVPRNQFH 213 (988)
Q Consensus 195 ~l~~l~~L~~L~L~~N~i~ 213 (988)
.+..+++|+.|++++|.+.
T Consensus 167 ~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 167 GLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TSTTCCCCCEEEEEEEEEE
T ss_pred HhccCCCCCEEeCCCCccc
Confidence 5666666666666666665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.4e-18 Score=174.11 Aligned_cols=152 Identities=16% Similarity=0.221 Sum_probs=79.8
Q ss_pred CCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhccccc
Q 001974 373 GKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN 452 (988)
Q Consensus 373 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~ 452 (988)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|+.|++++|++++..|..+..++.| +
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L-~ 115 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL-T 115 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC-C
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC-C
Confidence 55566777777777776 445 46667777777777775542 2356666666666666666654444444444444 4
Q ss_pred ceecccccccCCCccccccccccceeecCCcc-cccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCC
Q 001974 453 SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNN-LSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRN 531 (988)
Q Consensus 453 ~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 531 (988)
+|++++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 45555555544444444444444444444444 33 333 34444444444444444442 22 3444444444444444
Q ss_pred cc
Q 001974 532 NL 533 (988)
Q Consensus 532 ~l 533 (988)
++
T Consensus 192 ~i 193 (197)
T 4ezg_A 192 TI 193 (197)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=168.58 Aligned_cols=87 Identities=17% Similarity=0.238 Sum_probs=49.2
Q ss_pred cceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCC
Q 001974 452 NSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRN 531 (988)
Q Consensus 452 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N 531 (988)
++|+|++|++++..|..|..+++|+.|+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 57 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 136 (192)
T 1w8a_A 57 VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp CEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred CEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCC
Confidence 34444444444444455555555566666666666555555556666666666666666655666666666666666666
Q ss_pred cccCcCc
Q 001974 532 NLSGLIP 538 (988)
Q Consensus 532 ~l~~~~p 538 (988)
.+++..+
T Consensus 137 ~l~c~c~ 143 (192)
T 1w8a_A 137 PFNCNCH 143 (192)
T ss_dssp CBCCSGG
T ss_pred CccCcCc
Confidence 6665444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-18 Score=169.81 Aligned_cols=157 Identities=22% Similarity=0.229 Sum_probs=127.6
Q ss_pred ceeecCCCCCCccCchhhhhhcccccceecccccccCCCcc-ccccccccceeecCCcccccccCcccccCCCCcEEEec
Q 001974 427 AILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPT-KIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR 505 (988)
Q Consensus 427 ~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 505 (988)
+.+++++|+++ .+|..+.. .+ +.|++++|++++..+. .|+.+++|++|+|++|+|++..|..|+.+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l-~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HT-TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TC-SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CC-CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 67788888885 77776544 45 7888888888866554 48999999999999999999889999999999999999
Q ss_pred CccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCcccCcccccccccccccCCCC
Q 001974 506 GNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGI 584 (988)
Q Consensus 506 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~lcg~~ 584 (988)
+|+|++..|..|..+++|+.|||++|+|++.+|.. ..+++|++|+|++|.+++..+.......+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999999999999999999999999999998876 67789999999999999987753211122223445566678766
Q ss_pred CCC
Q 001974 585 PEL 587 (988)
Q Consensus 585 ~~~ 587 (988)
...
T Consensus 167 ~~l 169 (192)
T 1w8a_A 167 SKV 169 (192)
T ss_dssp TTT
T ss_pred hHH
Confidence 543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=183.87 Aligned_cols=289 Identities=11% Similarity=0.047 Sum_probs=148.8
Q ss_pred cccccccccccccccCCCCCcccC-CCccceeeccccccCCCCCccccCcccccccccccccccCccchhhcc-------
Q 001974 127 LYKLKQLAMQRNNLTGGIPPFIGN-LTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYN------- 198 (988)
Q Consensus 127 l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~------- 198 (988)
+.+|++|.++++- ...-...+.. +++|++|+|++|++. .....-+.++.++.+.+..|. +.+.+|.+
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~---I~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANF---VPAYAFSNVVNGVTK 98 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTE---ECTTTTEEEETTEEE
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeE-EecCccccccccccccccccc---cCHHHhccccccccc
Confidence 6677788877642 1111112233 667888888888876 111111222334445555553 33455666
Q ss_pred -ccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEecccc----ccCcccccccCCc
Q 001974 199 -LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNS----FSGKLSVNFGGMK 273 (988)
Q Consensus 199 -l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~----i~~~~~~~~~~l~ 273 (988)
+++|+.|+|.+ .++ .++...|.++++|+.+++++|.+..+.+.+|.++.++..+.+..+. .......+|.+..
T Consensus 99 g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp ECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred ccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 77777777777 666 6777777777777777777777666666666666666555544421 1223333444444
Q ss_pred ccc-EEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCC
Q 001974 274 NLS-YFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLV 352 (988)
Q Consensus 274 ~L~-~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 352 (988)
.|+ .+.+.... .++ ......-....+++.+.+.++-.. .....+....++|+.|+|++|+++.+.+..|..+.
T Consensus 177 ~L~~~i~~~~~~--~l~---~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~ 250 (329)
T 3sb4_A 177 PLETTIQVGAMG--KLE---DEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKK 250 (329)
T ss_dssp CCEEEEEECTTC--CHH---HHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCT
T ss_pred ccceeEEecCCC--cHH---HHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCC
Confidence 444 23322110 000 000000112334445555443111 11111112223566666666666655555566666
Q ss_pred cceEEEeeCccCCCccCcccCCCCccC-eEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceee
Q 001974 353 GLYRLGMGGNQFTGTIPKEMGKLQNLE-GMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILH 430 (988)
Q Consensus 353 ~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (988)
+|+.|+|.+| ++.+.+..|.++.+|+ .+++.+ +++...+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++
T Consensus 251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6666666665 5544445566666666 666655 45544455566666666666666666655555666666666554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.2e-17 Score=178.80 Aligned_cols=89 Identities=17% Similarity=0.157 Sum_probs=42.8
Q ss_pred ccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCccc-EEEeccccccCcccccccCCccccE
Q 001974 199 LSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLE-FIEALDNSFSGKLSVNFGGMKNLSY 277 (988)
Q Consensus 199 l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~l~~N~i~~~~~~~~~~l~~L~~ 277 (988)
+++|+.|+|++|+++ .+|...|.++++|+.++|.+| ++.+.+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 444555555555544 455555545555555555444 4434444444444454 444444 444444444444444444
Q ss_pred EecccccCCCCCC
Q 001974 278 FNVAYNNLGSGES 290 (988)
Q Consensus 278 L~L~~N~l~~~~~ 290 (988)
++++.|+++.++.
T Consensus 302 l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 302 VLATGDKITTLGD 314 (329)
T ss_dssp EEECSSCCCEECT
T ss_pred EEeCCCccCccch
Confidence 4444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=158.12 Aligned_cols=136 Identities=32% Similarity=0.358 Sum_probs=102.4
Q ss_pred CCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCc
Q 001974 16 SGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95 (988)
Q Consensus 16 ~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~ 95 (988)
..+.|+|.++.|. +++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+|++.
T Consensus 3 ~~C~C~~~~l~~~------------~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (177)
T 2o6r_A 3 SRCSCSGTEIRCN------------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL 67 (177)
T ss_dssp TTCEEETTEEECC------------SSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEeCCCEEEec------------CCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe
Confidence 4566788777775 44555 3444333 6889999999999877777788888899999998888866
Q ss_pred CCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCC
Q 001974 96 IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGG 166 (988)
Q Consensus 96 ~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 166 (988)
.+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+.+
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 66677888888888888888887666677778888888888888776555556777777777777777664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-16 Score=158.93 Aligned_cols=126 Identities=25% Similarity=0.301 Sum_probs=80.1
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccc
Q 001974 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK 115 (988)
Q Consensus 36 ~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 115 (988)
.+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4556666666 4554443 46777777777776 556667777777777777777776666666666666666666666
Q ss_pred ccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccC
Q 001974 116 LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFG 165 (988)
Q Consensus 116 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 165 (988)
|++..+.+|.++++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66555556666666666666666666444445555566666666555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.66 E-value=6.1e-16 Score=173.72 Aligned_cols=242 Identities=16% Similarity=0.145 Sum_probs=146.4
Q ss_pred CCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 55 LSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 55 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
...++.+.+.+ .++.+...+|.+. +|+.+.|.+| ++.+...+|.+ .+|+.+.|.+ .++.+.+.+|.++.+|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35566666653 4554556667664 6777777666 55455666666 3577777765 55556667777777777777
Q ss_pred cccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCC
Q 001974 135 MQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHG 214 (988)
Q Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 214 (988)
|.+|.++.....+|. ..+|+.+.|.++ ++.+...+|.++++|+.++|..| ++.+...+|.+ .+|+.+.+ .+.++
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~- 260 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT- 260 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-
Confidence 777777755555555 467777777644 55556667777777777777764 45455666666 66777777 34455
Q ss_pred CCCCcccccCCCCcceeccccccc-----cccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCC
Q 001974 215 SLPPSLGLTLPHLRLFQVHHNFFS-----GSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGE 289 (988)
Q Consensus 215 ~lp~~~~~~l~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 289 (988)
.++...|.++++|+.+++.+|.+. .+.+.+|.++.+|+.+++. +.+..+...+|.++++|+.+.+..| ++.+.
T Consensus 261 ~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~ 338 (401)
T 4fdw_A 261 NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQIN 338 (401)
T ss_dssp EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEEC
T ss_pred EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEc
Confidence 566666666667777766666554 2334455555555555555 3355555555555555555555333 43333
Q ss_pred CCchhhhcccccCCCCcEEEeecccCC
Q 001974 290 SDEMSFMNSLANCSNLRTLIFAANKLR 316 (988)
Q Consensus 290 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 316 (988)
.. +|.++ +|+.+++++|.+.
T Consensus 339 ~~------aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 339 FS------AFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp TT------SSSSS-CCCEEEECCSSCC
T ss_pred HH------hCCCC-CCCEEEEcCCCCc
Confidence 32 34444 5555555555444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8.9e-17 Score=158.09 Aligned_cols=132 Identities=23% Similarity=0.205 Sum_probs=76.9
Q ss_pred CCCCEEEcCCCccc-ccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 56 SFLREINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 56 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
++|++|+|++|+|+ +.+|..|..+++|++|+|++|.+++. ..|+.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 45565566666666666666666633 5566666666666666666654555555566666666
Q ss_pred cccccccCCC-CCcccCCCccceeeccccccCCCCC---ccccCccccccccccccccc
Q 001974 135 MQRNNLTGGI-PPFIGNLTSLESISLAANAFGGNIP---NSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 135 L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~ 189 (988)
|++|.+++.. +..+..+++|++|++++|.+++..+ ..|..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666665321 1455555566666666665553333 24555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.2e-16 Score=157.51 Aligned_cols=128 Identities=24% Similarity=0.327 Sum_probs=108.2
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRN 138 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 138 (988)
+++++++|+|+ .+|..+ .++|++|+|++|+|+ .+|..|..+++|++|+|++|+|++..+.+|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57899999998 667655 368999999999998 77888999999999999999998888888888999999999999
Q ss_pred cccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccC
Q 001974 139 NLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190 (988)
Q Consensus 139 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 190 (988)
+|++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 8887777788888888888888888887666678888888888888888763
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-15 Score=169.19 Aligned_cols=256 Identities=13% Similarity=0.105 Sum_probs=213.8
Q ss_pred CCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcc
Q 001974 43 GLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPF 122 (988)
Q Consensus 43 ~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~ 122 (988)
.++.+-..+|.+ .+|+.+.|.++ ++.+...+|.+. +|+.+.+.+ .++...+.+|.++.+|+.++|++|+++.+...
T Consensus 123 ~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~ 198 (401)
T 4fdw_A 123 SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAS 198 (401)
T ss_dssp TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTT
T ss_pred ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechh
Confidence 455444556776 47999999877 887778889884 799999996 77767789999999999999999999977777
Q ss_pred cccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCc
Q 001974 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL 202 (988)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 202 (988)
+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.| .|.++.+...+|.++++|
T Consensus 199 aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L 273 (401)
T 4fdw_A 199 TFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPEL 273 (401)
T ss_dssp TTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTC
T ss_pred hEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCC
Confidence 777 589999999855 77677889999999999999976 56577888988 88999999 566777889999999999
Q ss_pred cEEEeccCCCC----CCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEE
Q 001974 203 ANFSVPRNQFH----GSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYF 278 (988)
Q Consensus 203 ~~L~L~~N~i~----~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 278 (988)
+.+++.+|.+. ..++...|.++++|+.++|. +.++.+...+|.++.+|+.+.+..| +..+...+|.++ +|+.+
T Consensus 274 ~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l 350 (401)
T 4fdw_A 274 AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEV 350 (401)
T ss_dssp CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEE
T ss_pred CEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEE
Confidence 99999998774 24888999999999999999 4588777889999999999999655 888888999999 99999
Q ss_pred ecccccCCCCCCCchhhhcccccC-CCCcEEEeecccCC
Q 001974 279 NVAYNNLGSGESDEMSFMNSLANC-SNLRTLIFAANKLR 316 (988)
Q Consensus 279 ~L~~N~l~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~ 316 (988)
++++|.+..+... .|..+ .+++.|++..+.+.
T Consensus 351 ~l~~n~~~~l~~~------~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 351 KVEGTTPPQVFEK------VWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp EECCSSCCBCCCS------SCCCSCTTCCEEEECGGGHH
T ss_pred EEcCCCCcccccc------cccCCCCCccEEEeCHHHHH
Confidence 9999998877655 34555 36777777766543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=153.91 Aligned_cols=84 Identities=26% Similarity=0.269 Sum_probs=47.0
Q ss_pred CcceEEEeeCccCC-CccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceee
Q 001974 352 VGLYRLGMGGNQFT-GTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILH 430 (988)
Q Consensus 352 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (988)
++|+.|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 45555555555555 44555555555566666666655533 4455555555555555555544555555555555555
Q ss_pred cCCCCCC
Q 001974 431 LFENGLN 437 (988)
Q Consensus 431 l~~N~l~ 437 (988)
+++|+++
T Consensus 102 Ls~N~l~ 108 (168)
T 2ell_A 102 LSGNKLK 108 (168)
T ss_dssp CBSSSCC
T ss_pred ccCCccC
Confidence 5555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-16 Score=152.53 Aligned_cols=127 Identities=22% Similarity=0.164 Sum_probs=83.9
Q ss_pred CCCCEEEcCCCccc-ccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 56 SFLREINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 56 ~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..|+.+++|++|+|++|+|++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56677777777776 56666677777777777777777744 5667777777777777777755666666667777777
Q ss_pred cccccccCC-CCCcccCCCccceeeccccccCCCCC---ccccCcccccccccc
Q 001974 135 MQRNNLTGG-IPPFIGNLTSLESISLAANAFGGNIP---NSLGQLKELKSLGLG 184 (988)
Q Consensus 135 L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~ 184 (988)
+++|.+++. .+..+..+++|++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 777776642 22556666666666666666664443 355666666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-15 Score=150.25 Aligned_cols=132 Identities=21% Similarity=0.178 Sum_probs=102.6
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
.+.+++++|+++ .+|..+ .++|++|++++|++++..+..|+.+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 367888888888 456544 36888888888888866666778888888888888888876667778888888888888
Q ss_pred ccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCcc
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 192 (988)
|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+.+..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 8888666667778888888888888887666666677778888888888777543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=9.6e-16 Score=147.30 Aligned_cols=107 Identities=19% Similarity=0.249 Sum_probs=46.3
Q ss_pred ccCeEecccccCC-CCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhccccccee
Q 001974 377 NLEGMGLYDNQLS-GEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLN 455 (988)
Q Consensus 377 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ 455 (988)
+|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++.+|..+..++.+ ++|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL-THLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC-CEEE
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC-CEEE
Confidence 4444444444444 34444444444444444444444433 334444455555555555543334333333333 3333
Q ss_pred cccccccCC-CccccccccccceeecCCcccc
Q 001974 456 LARNHLVGS-IPTKIGNLKYLRVFNVSSNNLS 486 (988)
Q Consensus 456 ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~ 486 (988)
+++|++++. .|..++.+++|+.|++++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 333333321 1233344444444444444444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=165.18 Aligned_cols=141 Identities=16% Similarity=0.204 Sum_probs=102.6
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc--------------hhH--------HHHHHHHHHHhc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG--------------ASK--------SFLAECKALKNI 717 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l 717 (988)
....-|++.+.||+|++|.||+|.+. +|+.||||+++..... ... ...+|...|.++
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33345899999999999999999985 7999999998532110 001 123466666666
Q ss_pred CCCCc--eEEEeecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC
Q 001974 718 RHRNL--VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH 795 (988)
Q Consensus 718 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 795 (988)
.+..+ ...+++ ...++||||++|++|.++.... ....++.|++.+|.|||+.
T Consensus 171 ~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~~-----------------~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSVP-----------------DPASLYADLIALILRLAKH 224 (397)
T ss_dssp HHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCCS-----------------CHHHHHHHHHHHHHHHHHT
T ss_pred HhcCCCCCeeeec---------cCceEEEEecCCccHhhhcccH-----------------HHHHHHHHHHHHHHHHHHC
Confidence 44332 223332 2347999999999987664321 2346889999999999998
Q ss_pred CCCCeEeccCCCCCeeeCCCC----------cEEEeeeccccccc
Q 001974 796 CQEPVLHCDLKPGNVLLDNDM----------IAHVGDFGLARVRQ 830 (988)
Q Consensus 796 ~~~~ivH~Dlkp~NIll~~~~----------~~kL~DfG~a~~~~ 830 (988)
|||||||||.|||+++++ .+.|+||+-+....
T Consensus 225 ---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 225 ---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred ---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999999999998776 38999999886543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.8e-14 Score=162.66 Aligned_cols=316 Identities=13% Similarity=0.066 Sum_probs=148.3
Q ss_pred ccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCc
Q 001974 68 IQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147 (988)
Q Consensus 68 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (988)
++.+-..+|.++.+|+.+.|..+ ++.+-..+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +......+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 34344455656666666666533 44344455666666666666543 44344555666666665555433 22233444
Q ss_pred ccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCC
Q 001974 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227 (988)
Q Consensus 148 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L 227 (988)
|.++..++....... ......+|.++++|+.+.+.++..+ +...+|.++.+|+.+.+..| ++ .++...|..+..|
T Consensus 136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L 210 (394)
T 4fs7_A 136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILL 210 (394)
T ss_dssp TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTC
T ss_pred eecccccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ce-EeCchhhcccccc
Confidence 554433332222221 1123345555555666555543322 44555555555555555544 33 4555555555555
Q ss_pred cceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcE
Q 001974 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRT 307 (988)
Q Consensus 228 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 307 (988)
+.+.+..+... +.........|+.+.+.+ .+..+....|.+...++.+.+..+... +... +|..+..++.
T Consensus 211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~------~F~~~~~l~~ 280 (394)
T 4fs7_A 211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGS------LFYNCSGLKK 280 (394)
T ss_dssp CBCCCCTTCCE--ECTTTTTTCCCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSC------TTTTCTTCCE
T ss_pred ceeecCCCceE--eehhhcccCCCceEEECC-CceecccccccccccceeEEcCCCcce-eecc------ccccccccce
Confidence 55555544332 122222334455555432 223334445555555555555544321 1111 2344444544
Q ss_pred EEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEeccccc
Q 001974 308 LIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQ 387 (988)
Q Consensus 308 L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 387 (988)
+....+.+ + ...|....+|+.+.+.++ ++.+...+|.++.+|+.++|.++
T Consensus 281 ~~~~~~~i----~------------------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 281 VIYGSVIV----P------------------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp EEECSSEE----C------------------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred eccCceee----c------------------------cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence 44433321 1 123444445555555433 33233344555555555555432
Q ss_pred CCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 388 LSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 388 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
++.....+|.++++|+.+.+..| ++.+...+|.++++|+.+++.
T Consensus 331 v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 44333445555555555555444 443444555555555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.57 E-value=5.4e-17 Score=164.30 Aligned_cols=148 Identities=23% Similarity=0.304 Sum_probs=82.8
Q ss_pred CCCccCeEecccccCCCCCCC------CCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhh
Q 001974 374 KLQNLEGMGLYDNQLSGEIPS------SLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNL 447 (988)
Q Consensus 374 ~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 447 (988)
....++.++++.|.+++..|. .+..+++|++|+|++|++++ +| .+..+++|+.|++++|+++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 334455555555555555444 55555666666666666654 34 5555666666666666665 555555555
Q ss_pred cccccceecccccccCCCccccccccccceeecCCcccccccC-cccccCCCCcEEEecCccccccCCcc----------
Q 001974 448 TYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIP-SQLGLCSYLEEIYMRGNFFHGSIPSS---------- 516 (988)
Q Consensus 448 ~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~---------- 516 (988)
+.+ ++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+++.+|..
T Consensus 93 ~~L-~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 93 DTL-EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHC-SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CcC-CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 555 566666666653 33 45556666666666666663221 35556666666666666665554432
Q ss_pred ccCccccCeee
Q 001974 517 LSSLRAVLAID 527 (988)
Q Consensus 517 ~~~l~~L~~L~ 527 (988)
+..+++|+.||
T Consensus 170 ~~~l~~L~~Ld 180 (198)
T 1ds9_A 170 VKRLPNLKKLD 180 (198)
T ss_dssp HHHCSSCSEEC
T ss_pred HHhCCCcEEEC
Confidence 44555555554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=149.40 Aligned_cols=134 Identities=20% Similarity=0.238 Sum_probs=89.7
Q ss_pred ccccCCCCCCEEEcCCCcccccCCcccCCCC-CCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcc
Q 001974 50 PYIGNLSFLREINLMNNSIQGEIPREFGRLF-RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLY 128 (988)
Q Consensus 50 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~ 128 (988)
+.+...++|++|+|++|+|+. +|. +..+. +|++|+|++|+|++. ..|+.+++|++|+|++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 345566777777777777773 443 44443 777777777777743 5677777777777777777755445556777
Q ss_pred cccccccccccccCCCCC--cccCCCccceeeccccccCCCCCc----cccCccccccccccccccc
Q 001974 129 KLKQLAMQRNNLTGGIPP--FIGNLTSLESISLAANAFGGNIPN----SLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 129 ~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~ 189 (988)
+|++|+|++|+++ .+|. .+..+++|++|++++|.+. ..|. .+..+++|+.||+++|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777777777775 3444 6667777777777777776 3444 3667777777777777665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.54 E-value=9.8e-14 Score=156.64 Aligned_cols=335 Identities=14% Similarity=0.034 Sum_probs=251.2
Q ss_pred CcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCccc
Q 001974 44 LSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFE 123 (988)
Q Consensus 44 ~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~ 123 (988)
++.+-..+|.++++|+.+.|.. .++.+...+|.++.+|+.++|.++ ++.....+|.++.+|+.+.+..+ +..+...+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a 135 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA 135 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence 4444556788999999999974 588777889999999999999866 66567788999999999988765 44467778
Q ss_pred ccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCcc
Q 001974 124 FFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203 (988)
Q Consensus 124 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 203 (988)
|.+...++....... ......+|.++++|+.+.+.++... +...+|.++.+|+.+++..| ++.+...+|.++..|+
T Consensus 136 F~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 136 FKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp TTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred eecccccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 888765554444333 2244578999999999999876543 67788999999999999877 6657788999999999
Q ss_pred EEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccc
Q 001974 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYN 283 (988)
Q Consensus 204 ~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N 283 (988)
.+.+..+... +....+ ...+|+.+.+..+ ++.+....+..+..|+.+.+..+.. .+....|.....++.+....+
T Consensus 212 ~i~~~~~~~~--i~~~~~-~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~ 286 (394)
T 4fs7_A 212 NMEFPNSLYY--LGDFAL-SKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSV 286 (394)
T ss_dssp BCCCCTTCCE--ECTTTT-TTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSS
T ss_pred eeecCCCceE--eehhhc-ccCCCceEEECCC-ceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCce
Confidence 9988776543 333333 4568888888654 3435566788999999999987754 467778999999999988776
Q ss_pred cCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCcc
Q 001974 284 NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ 363 (988)
Q Consensus 284 ~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 363 (988)
.+.. .+|..+.+|+.+.+..+ ++ .+...+|..+.+|+.+++.++
T Consensus 287 ~i~~---------~~F~~~~~L~~i~l~~~-i~-------------------------~I~~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 287 IVPE---------KTFYGCSSLTEVKLLDS-VK-------------------------FIGEEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp EECT---------TTTTTCTTCCEEEECTT-CC-------------------------EECTTTTTTCTTCCEECCCTT-
T ss_pred eecc---------ccccccccccccccccc-cc-------------------------eechhhhcCCCCCCEEEeCCc-
Confidence 5432 14567777777776543 22 233456777788888888654
Q ss_pred CCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccccccee
Q 001974 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAIL 429 (988)
Q Consensus 364 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 429 (988)
++.+...+|.++.+|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...|.++++|+.+
T Consensus 331 v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 66455678899999999999876 66566778999999999999765 44 345678888888764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-16 Score=161.84 Aligned_cols=153 Identities=19% Similarity=0.204 Sum_probs=116.4
Q ss_pred CCcceEEEeeCccCCCccCc------ccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccc
Q 001974 351 LVGLYRLGMGGNQFTGTIPK------EMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLK 424 (988)
Q Consensus 351 l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 424 (988)
...++.+++++|.+++..|. .+..+++|++|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 33445555555555555554 77888888888888888885 66 7788888888888888888 5677777788
Q ss_pred ccceeecCCCCCCccCchhhhhhcccccceecccccccCCCc-cccccccccceeecCCcccccccCcc----------c
Q 001974 425 QLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIP-TKIGNLKYLRVFNVSSNNLSGEIPSQ----------L 493 (988)
Q Consensus 425 ~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~----------~ 493 (988)
+|+.|++++|+++ .+| .+..++.+ +.|++++|++++..+ ..+..+++|+.|++++|.+++.+|.. +
T Consensus 94 ~L~~L~L~~N~l~-~l~-~~~~l~~L-~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 94 TLEELWISYNQIA-SLS-GIEKLVNL-RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp HCSEEEEEEEECC-CHH-HHHHHHHS-SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred cCCEEECcCCcCC-cCC-ccccCCCC-CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence 8888888888887 465 67788888 888888888874322 46888899999999999998776653 7
Q ss_pred ccCCCCcEEEecCccccc
Q 001974 494 GLCSYLEEIYMRGNFFHG 511 (988)
Q Consensus 494 ~~l~~L~~L~L~~N~l~~ 511 (988)
..+++|+.|| +|.++.
T Consensus 171 ~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp HHCSSCSEEC--CGGGTT
T ss_pred HhCCCcEEEC--CcccCH
Confidence 8899999886 777763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=8.2e-15 Score=145.09 Aligned_cols=109 Identities=24% Similarity=0.302 Sum_probs=61.7
Q ss_pred ccCCCcceEEEeeCccCCCccCcccCCCC-ccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccccccccc
Q 001974 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQ-NLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQL 426 (988)
Q Consensus 348 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 426 (988)
+..+.+|+.|++++|+++ .+|. +..+. +|+.|+|++|++++. ..|..+++|+.|+|++|+|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445566666777777666 3343 33333 666666666666643 456666666666666666665444445666666
Q ss_pred ceeecCCCCCCccCch--hhhhhcccccceeccccccc
Q 001974 427 AILHLFENGLNGTIPE--EIFNLTYLSNSLNLARNHLV 462 (988)
Q Consensus 427 ~~L~l~~N~l~~~~p~--~~~~l~~l~~~L~ls~N~l~ 462 (988)
+.|++++|+++ .+|. .+..++.+ +.|++++|.++
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L-~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSL-TYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTC-CEEECCSSGGG
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCC-CEEEecCCCCC
Confidence 66666666664 4444 33444444 44444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=6.7e-14 Score=137.36 Aligned_cols=103 Identities=25% Similarity=0.234 Sum_probs=66.0
Q ss_pred EEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccc
Q 001974 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK 115 (988)
Q Consensus 36 ~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 115 (988)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 4566666666 3555443 667777777777776666667777777777777777775555556666666666666666
Q ss_pred ccCCCcccccCccccccccccccccc
Q 001974 116 LMGSIPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 116 i~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
|++..+..|.++++|++|+|++|.+.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 66555555666666666666666555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=134.66 Aligned_cols=105 Identities=26% Similarity=0.260 Sum_probs=79.1
Q ss_pred CCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccccc
Q 001974 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQR 137 (988)
Q Consensus 58 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 137 (988)
.++|++++|+|+ .+|..+ .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 367888888888 466655 37788888888888877777788888888888888888766666777777777777777
Q ss_pred ccccCCCCCcccCCCccceeeccccccC
Q 001974 138 NNLTGGIPPFIGNLTSLESISLAANAFG 165 (988)
Q Consensus 138 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 165 (988)
|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 7777655556777777777777777766
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.4e-13 Score=135.46 Aligned_cols=104 Identities=25% Similarity=0.250 Sum_probs=62.6
Q ss_pred EEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcc
Q 001974 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRN 114 (988)
Q Consensus 35 ~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N 114 (988)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45667777765 4555443 56666777776666666666666666666666666666444444556666666666666
Q ss_pred cccCCCcccccCccccccccccccccc
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 665444444555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-13 Score=131.65 Aligned_cols=112 Identities=26% Similarity=0.341 Sum_probs=79.9
Q ss_pred cEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccc
Q 001974 331 QNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNN 410 (988)
Q Consensus 331 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 410 (988)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666665 4555443 67777777777777666777777888888888888887655556777888888888888
Q ss_pred ccccccccccccccccceeecCCCCCCccCchhhhh
Q 001974 411 SLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFN 446 (988)
Q Consensus 411 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 446 (988)
+|++..+..|..+++|+.|+|++|.+. ..+..+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~~~ 126 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRDIMY 126 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGGGHH
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc-cccccHHH
Confidence 888666666888888888888888887 44444433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.4e-12 Score=142.78 Aligned_cols=108 Identities=24% Similarity=0.234 Sum_probs=85.4
Q ss_pred CceeeeeEEeCCCCcEEEEEcCCC-CCcccccccccCCCCCCEEEcCC-CcccccCCcccCCCCCCcEEECCCCCCCCcC
Q 001974 19 FCEWKGITCGLRHRRVTVLNLRSK-GLSGSLSPYIGNLSFLREINLMN-NSIQGEIPREFGRLFRLEALFLSDNDLVGEI 96 (988)
Q Consensus 19 ~c~~~~v~c~~~~~~v~~l~l~~~-~~~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 96 (988)
.|.|..|.|. ++ +++ .+|. |..+++|++|+|++ |+|++..+..|.+|++|++|+|++|+|++..
T Consensus 7 ~C~~~~v~~~------------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 72 (347)
T 2ifg_A 7 PHGSSGLRCT------------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (347)
T ss_dssp CSSSSCEECC------------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred cccCCEEEcC------------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeC
Confidence 4777777765 34 676 4777 88889999999986 9999877788999999999999999998888
Q ss_pred CcccccCCCCceeecCcccccCCCcccccCccccccccccccccc
Q 001974 97 PANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 97 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
|..|++|++|++|+|++|+|++..+..|..++ |++|+|.+|.+.
T Consensus 73 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp TTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 88888888888888888888866666665555 777777777665
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=7.3e-11 Score=133.05 Aligned_cols=112 Identities=12% Similarity=0.076 Sum_probs=59.3
Q ss_pred cCCcccccCC-CCceeecCcccccCCCcccccCccccccccccccc---ccCCCCCcccCCCccceeeccccccCCCCCc
Q 001974 95 EIPANLSYCS-RLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNN---LTGGIPPFIGNLTSLESISLAANAFGGNIPN 170 (988)
Q Consensus 95 ~~p~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 170 (988)
+-..+|.+++ .|+.+.+..+ ++.+...+|.++++|+.+.+.+|. ++..-..+|.++.+|+.+.+.++ ++.+...
T Consensus 54 Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~ 131 (394)
T 4gt6_A 54 IGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSE 131 (394)
T ss_dssp ECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTT
T ss_pred cCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhh
Confidence 3345566553 4666666543 554556666666666666666553 33333445556666665555443 3324444
Q ss_pred cccCcccccccccccccccCccchhhccccCccEEEecc
Q 001974 171 SLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPR 209 (988)
Q Consensus 171 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 209 (988)
+|.++.+|+.+.+..+ +..+...+|..+.+|+.+.+..
T Consensus 132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~ 169 (394)
T 4gt6_A 132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPD 169 (394)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCT
T ss_pred hhhhhcccccccccce-eeeecccceecccccccccccc
Confidence 5555555555555433 2224444555555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.2e-12 Score=141.73 Aligned_cols=107 Identities=21% Similarity=0.161 Sum_probs=77.5
Q ss_pred ceecccc-cccCCCccccccccccceeecCC-cccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCC
Q 001974 453 SLNLARN-HLVGSIPTKIGNLKYLRVFNVSS-NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSR 530 (988)
Q Consensus 453 ~L~ls~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 530 (988)
.++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|+.+++|+.|+|++|+|++..|..|.+|++|+.|||++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 4666 77777777777775 777766667777777777777777777777777777777777777777
Q ss_pred CcccCcCcccccCCCCcEEeCCCCcCcccCC
Q 001974 531 NNLSGLIPKFLEDLSLEYLNLSFNDLEGEVP 561 (988)
Q Consensus 531 N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p 561 (988)
|+|+++++..+....|+.|+|++|++.....
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 7777777766555557777888777776543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.30 E-value=5.9e-11 Score=133.79 Aligned_cols=156 Identities=12% Similarity=0.100 Sum_probs=73.0
Q ss_pred CCcccCCCC-CCcEEECCCCCCCCcCCcccccCCCCceeecCccc---ccCCCcccccCcccccccccccccccCCCCCc
Q 001974 72 IPREFGRLF-RLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK---LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPF 147 (988)
Q Consensus 72 ~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~---i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (988)
-..+|.+.. .|+.+.+..+ ++.+-..+|.++.+|+.+.++.|. ++.+...+|.++.+|+.+.+.++ ++.....+
T Consensus 55 g~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~a 132 (394)
T 4gt6_A 55 GDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEA 132 (394)
T ss_dssp CTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred CHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhh
Confidence 334454442 3555555433 343444555555555555555442 33344455555555555555433 23233445
Q ss_pred ccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCC
Q 001974 148 IGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227 (988)
Q Consensus 148 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L 227 (988)
|.++.+|+.+.+..+. ..+...+|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. .+....|..+.++
T Consensus 133 F~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~--~i~~~af~~c~~l 207 (394)
T 4gt6_A 133 FHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT--RIGTNAFSECFAL 207 (394)
T ss_dssp TTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC--EECTTTTTTCTTC
T ss_pred hhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc--ccccchhhhcccc
Confidence 5555555555554332 2244445555555555555543 33244444433 3455555544322 2333344444444
Q ss_pred cceeccc
Q 001974 228 RLFQVHH 234 (988)
Q Consensus 228 ~~L~L~~ 234 (988)
.......
T Consensus 208 ~~~~~~~ 214 (394)
T 4gt6_A 208 STITSDS 214 (394)
T ss_dssp CEEEECC
T ss_pred ceecccc
Confidence 4444333
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=6e-14 Score=155.93 Aligned_cols=88 Identities=13% Similarity=0.045 Sum_probs=44.9
Q ss_pred ccccccceeecCCcccccc----cCcccccCCCCcEEEecCcccccc----CCccccCccccCeeecCCCcccCcCccc-
Q 001974 470 GNLKYLRVFNVSSNNLSGE----IPSQLGLCSYLEEIYMRGNFFHGS----IPSSLSSLRAVLAIDLSRNNLSGLIPKF- 540 (988)
Q Consensus 470 ~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~- 540 (988)
..+++|++|||++|.|++. ++..+..+++|+.|+|++|.|+.. ++..+...++|+.|||++|.|+......
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 4445566666666666532 234455556666666666666542 2333444566777777777766443322
Q ss_pred ccC---CC--CcEEe--CCCCcCc
Q 001974 541 LED---LS--LEYLN--LSFNDLE 557 (988)
Q Consensus 541 ~~~---~~--L~~l~--l~~N~l~ 557 (988)
... .. |+.+. +..|.++
T Consensus 260 ~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 260 RDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHCC------CEEECCCC----CH
T ss_pred HHHhcCCCccchhhHhhhcCCccC
Confidence 111 11 66666 6666654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1e-12 Score=145.90 Aligned_cols=135 Identities=18% Similarity=0.177 Sum_probs=90.5
Q ss_pred cccceeecCCCCCCccCchhhh-hhcccccceecccccccCCCcccc-----ccccccceeecCCccccc----ccCccc
Q 001974 424 KQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKI-----GNLKYLRVFNVSSNNLSG----EIPSQL 493 (988)
Q Consensus 424 ~~L~~L~l~~N~l~~~~p~~~~-~l~~l~~~L~ls~N~l~~~~p~~~-----~~l~~L~~L~ls~N~l~~----~~p~~~ 493 (988)
++|+.|+|++|.++......+. .+..+ +.|+|++|.++......+ ...++|+.|+|++|.|+. .++..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L-~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRA-RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTE-EEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhc-cHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 4555555555555422222222 23344 556666665543322222 234679999999999975 345556
Q ss_pred ccCCCCcEEEecCcccccc----CCccccCccccCeeecCCCcccCcCcc-----cccCCCCcEEeCCCCcCccc
Q 001974 494 GLCSYLEEIYMRGNFFHGS----IPSSLSSLRAVLAIDLSRNNLSGLIPK-----FLEDLSLEYLNLSFNDLEGE 559 (988)
Q Consensus 494 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~-----~~~~~~L~~l~l~~N~l~~~ 559 (988)
..+++|++|+|++|.|+.. ++..+...++|+.|||++|+|+..... ....++|++|||++|.++..
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 7899999999999999853 356677788999999999999864322 23557899999999998653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=127.69 Aligned_cols=147 Identities=14% Similarity=0.073 Sum_probs=112.5
Q ss_pred HHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCC
Q 001974 659 FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 659 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 737 (988)
.....+|++....+.|+.+.||++.. .++.+++|+...........+.+|+++++.+ .+..+.++++++. ..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~ 82 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD 82 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence 34456788888899999999999976 4688999998643223345688999999998 4677888888754 34
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC---------------------
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC--------------------- 796 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------- 796 (988)
+..++||||++|.++.+.+... .+...++.+++++++.||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~~----------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYEDE----------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCTT----------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CceEEEEEecCCeehhhccCCc----------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 6789999999999998764211 123468889999999999821
Q ss_pred -----------------------------------CCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 797 -----------------------------------QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 797 -----------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
...++|||++|.||+++++..+.|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=6e-10 Score=117.88 Aligned_cols=138 Identities=17% Similarity=0.084 Sum_probs=97.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC--ceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN--LVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~ 740 (988)
.+|.+....+.|..+.||++.. .+|+.+++|+.... ....+..|+++++.+.+.+ +.+++++.. .++..
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~ 90 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRD 90 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCC
Confidence 4455433334566699999976 36778999997543 2356789999999985444 556777643 33668
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC------------------------
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC------------------------ 796 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------ 796 (988)
++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 91 ~~v~e~i~G~~l~--~~~--------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SSH--------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEEECCSSEETT--TSC--------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCcccC--cCc--------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 9999999998884 211 11 1256777888888888742
Q ss_pred -------------------------------CCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 797 -------------------------------QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 797 -------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
...++|||++|.||++++++.+.|+|||.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.00 E-value=8.4e-09 Score=115.52 Aligned_cols=128 Identities=9% Similarity=0.054 Sum_probs=67.4
Q ss_pred ccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccc
Q 001974 50 PYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYK 129 (988)
Q Consensus 50 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~ 129 (988)
+++....+|+.+.+. ..++.+-..+|.++.+|+.+.|..+ ++..-..+|.++ +|+.+.+..+ ++.+...+|.. .+
T Consensus 40 ~~~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 40 PWYKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TTGGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred cccccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 345555667777775 3466566667777777887777654 554555666665 5666665533 44344445544 35
Q ss_pred ccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCccccccccccc
Q 001974 130 LKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGA 185 (988)
Q Consensus 130 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 185 (988)
|+.+.+.++... .....|.+. +|+.+.+..+ ++.....+|....+++.+.+..
T Consensus 115 L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~ 167 (379)
T 4h09_A 115 LDDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSS 167 (379)
T ss_dssp CSEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECT
T ss_pred cccccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhccccccccccccc
Confidence 666666544222 233334332 3444444332 2223344444445554444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.92 E-value=3.1e-08 Score=110.92 Aligned_cols=82 Identities=9% Similarity=0.052 Sum_probs=38.5
Q ss_pred cccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCc
Q 001974 123 EFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLL 202 (988)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L 202 (988)
++....+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|... +|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 344455566665543 234344455666666666666433 443444555554 3444444322 332333344332 45
Q ss_pred cEEEecc
Q 001974 203 ANFSVPR 209 (988)
Q Consensus 203 ~~L~L~~ 209 (988)
+.+.+..
T Consensus 116 ~~i~lp~ 122 (379)
T 4h09_A 116 DDFEFPG 122 (379)
T ss_dssp SEEECCT
T ss_pred ccccCCC
Confidence 5554443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=5.5e-09 Score=116.02 Aligned_cols=148 Identities=14% Similarity=0.156 Sum_probs=107.6
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEee--cccc-chhHHHHHHHHHHHhcC--CCCceEEEeecccccccCCCce
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRH-GASKSFLAECKALKNIR--HRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~ 740 (988)
..++.++.|.++.||++... +..+++|+.. .... .....+.+|+++++.+. +..+.++++++... ...+..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence 34678999999999998873 4678888875 3221 22356888999999996 45678888886542 112457
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC------------------------
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC------------------------ 796 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------ 796 (988)
++||||++|..+.+... ..++..++..++.+++++|+.||+..
T Consensus 117 ~~vme~v~G~~l~~~~~-------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp EEEEECCCCBCCCCTTC-------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred EEEEEecCCeecCCCcc-------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 89999999887754211 24677888899999999999999731
Q ss_pred -------------------------------CCCeEeccCCCCCeeeCCCCc--EEEeeeccccccc
Q 001974 797 -------------------------------QEPVLHCDLKPGNVLLDNDMI--AHVGDFGLARVRQ 830 (988)
Q Consensus 797 -------------------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~ 830 (988)
...++|||++|.||+++.++. +.|+||+.+....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 247999999999999997753 6899999987543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.5e-10 Score=121.66 Aligned_cols=164 Identities=12% Similarity=0.113 Sum_probs=83.9
Q ss_pred cccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccc--cccccceeecCC--CCCCccCchhhh
Q 001974 370 KEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG--SLKQLAILHLFE--NGLNGTIPEEIF 445 (988)
Q Consensus 370 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~~p~~~~ 445 (988)
..+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.+.......++ .+++|+.|+|+. |...|.. .+.
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~~ 240 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DMN 240 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CGG
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hHH
Confidence 33455567777777666311 1222 32 66777777776666543333333 566777776642 1111110 000
Q ss_pred hhcccccceecccccccCCCccccccccccceeecCCcccccccCcccc---cCCCCcEEEecCcccccc----CCcccc
Q 001974 446 NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLG---LCSYLEEIYMRGNFFHGS----IPSSLS 518 (988)
Q Consensus 446 ~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~----~p~~~~ 518 (988)
.+..+ +. ...+++|++|+|++|.+.+..+..+. .+++|+.|+|+.|.|+.. ++..+.
T Consensus 241 ~l~~~----------l~------~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~ 304 (362)
T 2ra8_A 241 VFRPL----------FS------KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD 304 (362)
T ss_dssp GTGGG----------SC------TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHH
T ss_pred HHHHH----------Hh------cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcc
Confidence 00000 00 02356677777777776644433332 356777777777777653 333344
Q ss_pred CccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCc
Q 001974 519 SLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFND 555 (988)
Q Consensus 519 ~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~ 555 (988)
.+++|+.|+|++|.|+...-.. .... ...++++.|.
T Consensus 305 ~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 305 KIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred cCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence 5677777777777766432211 1100 2456777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=7e-10 Score=121.93 Aligned_cols=187 Identities=13% Similarity=0.150 Sum_probs=99.3
Q ss_pred CCcEEEEEcCCCCCcc-c-------ccccccCCCCCCEEEcCCCccc---------ccCCcccCCCCCCcEEECCCCC-C
Q 001974 31 HRRVTVLNLRSKGLSG-S-------LSPYIGNLSFLREINLMNNSIQ---------GEIPREFGRLFRLEALFLSDND-L 92 (988)
Q Consensus 31 ~~~v~~l~l~~~~~~~-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~-l 92 (988)
..+|+.|.+...+..+ . +..++..+++|+.|.+.++... +.+...+..+++|++|+|++|. +
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3467788887766552 2 2344566789999988765432 1233445667788888887773 2
Q ss_pred CCcCCcccccCCCCceeecCcccccCCCccccc--Cccccccccccc--ccccCCCCCcccCCCccceeeccccccCCCC
Q 001974 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFF--SLYKLKQLAMQR--NNLTGGIPPFIGNLTSLESISLAANAFGGNI 168 (988)
Q Consensus 93 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~--N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 168 (988)
. ++. +. +++|++|+|..|.+.......+. .+++|++|+|+. |...+.. .+.. |
T Consensus 186 ~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~~~---l-------------- 242 (362)
T 2ra8_A 186 S--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DMNV---F-------------- 242 (362)
T ss_dssp B--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CGGG---T--------------
T ss_pred e--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hHHH---H--------------
Confidence 2 232 33 67777777777766533333333 566777776642 2211100 0000 0
Q ss_pred Cccc--cCcccccccccccccccCccchhhc---cccCccEEEeccCCCCCCCCCccc---ccCCCCcceeccccccccc
Q 001974 169 PNSL--GQLKELKSLGLGANNLSGIIPPSIY---NLSLLANFSVPRNQFHGSLPPSLG---LTLPHLRLFQVHHNFFSGS 240 (988)
Q Consensus 169 ~~~~--~~l~~L~~L~L~~N~l~~~~~~~l~---~l~~L~~L~L~~N~i~~~lp~~~~---~~l~~L~~L~L~~N~l~~~ 240 (988)
...+ ..+++|++|+|++|.+....+..+. .+++|++|+|+.|.+.+..+..+. ..+++|+.|+|++|.|+..
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 0011 1345566666666665533333332 355666666666666532211121 2456677777777766643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.8e-09 Score=116.80 Aligned_cols=193 Identities=16% Similarity=0.151 Sum_probs=123.0
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCC--ceEEEeecccccccCCCceEEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRN--LVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~~~~~~~~~lv 743 (988)
.++.++.|....||++. ..+++|+.... .....+.+|+++++.+ .+.. +.+++...... ......++|
T Consensus 24 ~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~v 94 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAG 94 (304)
T ss_dssp CCCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEE
T ss_pred eeEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEE
Confidence 35678999999999863 45888986422 3456788999999888 3332 44555543211 111245789
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC---------------------------
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC--------------------------- 796 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------- 796 (988)
||+++|.++.+... ..++..++..++.+++..++.||+..
T Consensus 95 m~~i~G~~l~~~~~-------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp EECCCCEECCHHHH-------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred EcccCCeECCcccc-------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 99999988864321 25677788888888998888888621
Q ss_pred ----------------------------CCCeEeccCCCCCeeeCC--CCcEEEeeecccccccccccccceecc-----
Q 001974 797 ----------------------------QEPVLHCDLKPGNVLLDN--DMIAHVGDFGLARVRQEVSNLTQSCSV----- 841 (988)
Q Consensus 797 ----------------------------~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~~~~~~~~~~~~~~----- 841 (988)
.+.++|+|++|.||++++ ...+.++||+.+...+...+.......
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~ 241 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYG 241 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCC
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccC
Confidence 135899999999999998 456789999998754332111100000
Q ss_pred -----cccccccccc-CcccCCCCCCCccchHHHHHHHHHHHhCCCCC
Q 001974 842 -----GVRGTIGYAA-PEYGLGSEVSTNGDIYSYGILLLEMVTGKKPT 883 (988)
Q Consensus 842 -----~~~gt~~y~a-PE~~~~~~~~~~sDvwslG~vl~elltg~~p~ 883 (988)
......+... |+.... .....+.|++|.++|.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000001111 111110 112268999999999999998874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.63 E-value=7.2e-10 Score=115.18 Aligned_cols=151 Identities=17% Similarity=0.142 Sum_probs=79.9
Q ss_pred CceeeeeEEeCCCCcEEEEEcCCC---CCccccc-ccccCCC---------CCCEEEcCCCcccccCCcccCCCCCCcE-
Q 001974 19 FCEWKGITCGLRHRRVTVLNLRSK---GLSGSLS-PYIGNLS---------FLREINLMNNSIQGEIPREFGRLFRLEA- 84 (988)
Q Consensus 19 ~c~~~~v~c~~~~~~v~~l~l~~~---~~~~~~~-~~l~~l~---------~L~~L~L~~n~l~~~~p~~~~~l~~L~~- 84 (988)
.|.|.|+.|.....+|+.+...+. .+.+.++ ..+..++ .-+.|||+. |...+.|..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~----------l~~dp~L~~~ 146 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKG----------LRSDPDLVAQ 146 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTT----------GGGCHHHHHT
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHH----------cCCCcchhhc
Confidence 589999999977777777666441 1222222 1222221 223344432 333333443
Q ss_pred -EECCCCCCCCcCCcc----cccCCCCceeecCcccccC--CCcccccCcccccccccccccccCCCCCcccCCC--ccc
Q 001974 85 -LFLSDNDLVGEIPAN----LSYCSRLTILFLGRNKLMG--SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT--SLE 155 (988)
Q Consensus 85 -L~Ls~n~l~~~~p~~----~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~ 155 (988)
++++.|+.. .++.. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+
T Consensus 147 ~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~ 223 (267)
T 3rw6_A 147 NIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLE 223 (267)
T ss_dssp TCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCS
T ss_pred CccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcc
Confidence 455555433 22221 1345566666666666664 2234555666666666666666643 2233333 677
Q ss_pred eeeccccccCCCCCc-------cccCcccccccc
Q 001974 156 SISLAANAFGGNIPN-------SLGQLKELKSLG 182 (988)
Q Consensus 156 ~L~L~~N~l~~~~~~-------~~~~l~~L~~L~ 182 (988)
+|+|++|.+.+..|+ .+..+++|+.||
T Consensus 224 ~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 224 ELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred eEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 777777777654442 355677777766
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=6.1e-09 Score=103.20 Aligned_cols=72 Identities=17% Similarity=0.084 Sum_probs=47.4
Q ss_pred ccccccccCCCCCCEEEcCCC-cccc----cCCcccCCCCCCcEEECCCCCCCCc----CCcccccCCCCceeecCcccc
Q 001974 46 GSLSPYIGNLSFLREINLMNN-SIQG----EIPREFGRLFRLEALFLSDNDLVGE----IPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 46 ~~~~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~N~i 116 (988)
..+...+...+.|++|+|++| .|.. .+...+...++|++|+|++|+|... +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344556667788888888888 7763 2344566677788888888877642 233344456677777777766
Q ss_pred c
Q 001974 117 M 117 (988)
Q Consensus 117 ~ 117 (988)
.
T Consensus 106 ~ 106 (185)
T 1io0_A 106 S 106 (185)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.40 E-value=5.6e-08 Score=100.95 Aligned_cols=65 Identities=20% Similarity=0.279 Sum_probs=30.3
Q ss_pred ccccceeecCCccccc--ccCcccccCCCCcEEEecCccccccCCccccCcc--ccCeeecCCCcccCcCc
Q 001974 472 LKYLRVFNVSSNNLSG--EIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR--AVLAIDLSRNNLSGLIP 538 (988)
Q Consensus 472 l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p 538 (988)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 4445555555555544 2334444455555555555555532 2222222 45555555555554433
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-06 Score=93.21 Aligned_cols=137 Identities=16% Similarity=0.087 Sum_probs=97.9
Q ss_pred ceeccccce-eEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceEEEEee
Q 001974 669 HLIGMGSFG-SVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 669 ~~lg~G~~g-~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
+.+..|..| .||+......+..+++|+-.. ....++.+|...++.+. +--+.++++++.. ++..++|||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~ 101 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTA 101 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEEC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEe
Confidence 345556665 699988876778899998653 23467888999998883 3346677777543 3678999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC------------------------------ 796 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------ 796 (988)
++|.++.+.... .......++.+++..|+.||+..
T Consensus 102 l~G~~~~~~~~~---------------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (272)
T 4gkh_A 102 IPGKTAFQVLEE---------------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD 166 (272)
T ss_dssp CCSEEHHHHHHH---------------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred eCCccccccccC---------------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence 999888765421 11223456667777777777531
Q ss_pred -------------------------CCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 797 -------------------------QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 797 -------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877777999998853
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=2e-07 Score=92.27 Aligned_cols=18 Identities=17% Similarity=0.241 Sum_probs=8.8
Q ss_pred cCCCCccCeEecccc-cCC
Q 001974 372 MGKLQNLEGMGLYDN-QLS 389 (988)
Q Consensus 372 ~~~l~~L~~L~L~~N-~l~ 389 (988)
+...++|++|+|++| .|.
T Consensus 32 l~~~~~L~~L~L~~n~~i~ 50 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIP 50 (185)
T ss_dssp HTTCTTCCEEECTTCTTCC
T ss_pred HhcCCCCCEEEecCCCCCC
Confidence 344445555555555 443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=4.1e-06 Score=90.22 Aligned_cols=138 Identities=15% Similarity=0.106 Sum_probs=93.2
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCC---CceEEEeecccccccCCCceEEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR---NLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.++.++.|....||+. |+.+++|+.. .......+.+|+++++.+.+. .+.+++.++. ...+..++|
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v 91 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVG 91 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEE
Confidence 3467888998999987 4568888853 223456789999999999642 3556666543 123567899
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC----------------------------
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH---------------------------- 795 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------- 795 (988)
|||++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 92 ~e~i~G~~l~~~~~-------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~ 158 (306)
T 3tdw_A 92 YRKVQGQILGEDGM-------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVED 158 (306)
T ss_dssp EECCCSEECHHHHH-------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHH
T ss_pred EeccCCeECchhhh-------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHH
Confidence 99999988875321 1233444444555555555555532
Q ss_pred -----------------------------CCCCeEeccCCCCCeeeCC---CCc-EEEeeeccccc
Q 001974 796 -----------------------------CQEPVLHCDLKPGNVLLDN---DMI-AHVGDFGLARV 828 (988)
Q Consensus 796 -----------------------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DfG~a~~ 828 (988)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 159 ~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 159 QVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999997 455 48999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.5e-05 Score=88.05 Aligned_cols=85 Identities=6% Similarity=-0.083 Sum_probs=56.5
Q ss_pred Ccee-ccccceeEEEEEEC--C----CCeEEEEEEeeccc---cchhHHHHHHHHHHHhcC-C--CCceEEEeecccccc
Q 001974 668 THLI-GMGSFGSVYKGAFD--Q----DGTIVAIKVFNLQR---HGASKSFLAECKALKNIR-H--RNLVKVITSCSSIDF 734 (988)
Q Consensus 668 ~~~l-g~G~~g~Vy~a~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 734 (988)
.+.| +.|....+|+.... . +++.+++|+..... ......+..|+.+++.+. + -.+.++++++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 3567 88889999998763 1 16788999865332 111256788999888883 2 35777887754321
Q ss_pred cCCCceEEEEeeccccchhh
Q 001974 735 QGNDFKALVYEFMTNGSLEN 754 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~ 754 (988)
..+..++||||++|..+.+
T Consensus 104 -~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 -VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp -TTSSCEEEEECCCCBCCCB
T ss_pred -ccCCceEEEEecCCCChhh
Confidence 1135689999999877764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.3e-05 Score=87.96 Aligned_cols=76 Identities=17% Similarity=0.063 Sum_probs=50.0
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeecccc-------chhHHHHHHHHHHHhcCC--C-CceEEEeecccccccCC
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-------GASKSFLAECKALKNIRH--R-NLVKVITSCSSIDFQGN 737 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 737 (988)
.+.+|.|..+.||++....+++.|+||....... .....+..|.++++.+.. + .+.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 5689999999999997655678899998653211 123466789999888732 3 344566542 2
Q ss_pred CceEEEEeecccc
Q 001974 738 DFKALVYEFMTNG 750 (988)
Q Consensus 738 ~~~~lv~e~~~~g 750 (988)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 3458999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=5.9e-05 Score=80.36 Aligned_cols=78 Identities=18% Similarity=0.183 Sum_probs=57.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCC---CCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH---RNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~ 740 (988)
....++.+|.|..+.||+.+.. +|+.|++|+...........+..|++.|+.+.. --+.+++++ +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---------~~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---------DDR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------ETT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------cCc
Confidence 3445678999999999999985 889999998765444444678899999998832 245666665 234
Q ss_pred EEEEeeccccc
Q 001974 741 ALVYEFMTNGS 751 (988)
Q Consensus 741 ~lv~e~~~~gs 751 (988)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999997654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=7.7e-06 Score=78.46 Aligned_cols=83 Identities=8% Similarity=0.045 Sum_probs=39.6
Q ss_pred CCCcEEECCCCCCCCcCCcccccCCCCceeecCccc-ccCCCcccccCc----cccccccccccc-ccCCCCCcccCCCc
Q 001974 80 FRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK-LMGSIPFEFFSL----YKLKQLAMQRNN-LTGGIPPFIGNLTS 153 (988)
Q Consensus 80 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~ 153 (988)
.+|++|||+++.|+..--..+..+++|++|+|++|. |+...-..+..+ ++|++|+|++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666554444445556666666666653 442222233332 245555555542 44222223334444
Q ss_pred cceeecccc
Q 001974 154 LESISLAAN 162 (988)
Q Consensus 154 L~~L~L~~N 162 (988)
|++|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 444444444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00029 Score=77.09 Aligned_cols=152 Identities=18% Similarity=0.119 Sum_probs=80.5
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC--CCCceEEEeeccccc-ccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR--HRNLVKVITSCSSID-FQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~-~~~~~~~~lv~e 745 (988)
+.++.|..+.||++... +..+++|+.... ...+..|+.+++.+. .-.+.+++....... ...++..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778999999873 345899998642 234445666666553 123444443211100 012456789999
Q ss_pred eccccchhh--------------hcC----CCCCCCchhhhHhhcCCHHH------------------------------
Q 001974 746 FMTNGSLEN--------------WLH----PDAVPQKDVEIEIQKLTLLQ------------------------------ 777 (988)
Q Consensus 746 ~~~~gsL~~--------------~l~----~~~~~~~~~~~~~~~l~~~~------------------------------ 777 (988)
|++|.++.. .++ ....+... ......-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGV-PIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTC-CCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccc-hhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 998865420 011 00000000 00000000100
Q ss_pred -HHHHHHHHHHHHHHHHc----------CCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 778 -RINIAIDVASAIDYLHH----------HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 778 -~~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
...+..++..++++|++ .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122334456677763 013589999999999999888899999999775
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.48 E-value=2.2e-05 Score=75.29 Aligned_cols=82 Identities=11% Similarity=0.065 Sum_probs=38.3
Q ss_pred ccccccccccccCCCCCcccCCCccceeeccccc-cCCCCCccccCc----cccccccccccc-ccCccchhhccccCcc
Q 001974 130 LKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA-FGGNIPNSLGQL----KELKSLGLGANN-LSGIIPPSIYNLSLLA 203 (988)
Q Consensus 130 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~l~~l~~L~ 203 (988)
|++|+++++.++..--..+.++++|++|+|++|. |+..--..++.+ ++|++|+|++|. |+..--..+..+++|+
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~ 142 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK 142 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence 4444444444433222334444555555555543 332222223332 246666666653 5543334455566666
Q ss_pred EEEeccCC
Q 001974 204 NFSVPRNQ 211 (988)
Q Consensus 204 ~L~L~~N~ 211 (988)
+|+|+++.
T Consensus 143 ~L~L~~c~ 150 (176)
T 3e4g_A 143 YLFLSDLP 150 (176)
T ss_dssp EEEEESCT
T ss_pred EEECCCCC
Confidence 66666553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00044 Score=73.91 Aligned_cols=76 Identities=16% Similarity=0.105 Sum_probs=58.0
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC---CCCceEEEeecccccccCCCceEEE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR---HRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
..+.++.|....+|+... +++.+++|+.... ....+..|++.|+.+. ...+.++++++.. ++..++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEE
Confidence 356789999999999876 5678889987532 3467889999998883 3567888877432 3678999
Q ss_pred Eeeccccch
Q 001974 744 YEFMTNGSL 752 (988)
Q Consensus 744 ~e~~~~gsL 752 (988)
|||+++..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999988764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00043 Score=78.02 Aligned_cols=79 Identities=13% Similarity=0.078 Sum_probs=49.8
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCC---CCCCccchHHHHHHHH
Q 001974 798 EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS---EVSTNGDIYSYGILLL 874 (988)
Q Consensus 798 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~ 874 (988)
..++|||++|.|||++.++ ++++||+.+.......+...... .-...|.+|+..... ......++.+....+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG---NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH---HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH---HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999999876443221111000 012346666654321 1122355667888888
Q ss_pred HHHhCC
Q 001974 875 EMVTGK 880 (988)
Q Consensus 875 elltg~ 880 (988)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.29 E-value=1.2e-05 Score=78.79 Aligned_cols=71 Identities=14% Similarity=0.137 Sum_probs=45.8
Q ss_pred cccccccCCCCCCEEEcCCC-cccc----cCCcccCCCCCCcEEECCCCCCCCcC----CcccccCCCCceeecCccccc
Q 001974 47 SLSPYIGNLSFLREINLMNN-SIQG----EIPREFGRLFRLEALFLSDNDLVGEI----PANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 47 ~~~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~~L~~L~L~~N~i~ 117 (988)
.+...+.+-+.|++|+|++| +|.. .+.+++..-+.|+.|+|++|+|...- ...+..-+.|++|+|++|.|.
T Consensus 32 ~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 32 CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33444555678888888885 7753 24455666777888888888887432 233334566777777777765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00095 Score=71.41 Aligned_cols=74 Identities=8% Similarity=0.011 Sum_probs=46.4
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceEEEE
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
.-++.|+.|....+|+. +.+++|+...... ...+..+|+.+++.+. +.-..++++++ ++.-++|+
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~ 86 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT 86 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence 33788999999999998 4588898754321 1123456888887773 22224566552 13346899
Q ss_pred eec-cccchh
Q 001974 745 EFM-TNGSLE 753 (988)
Q Consensus 745 e~~-~~gsL~ 753 (988)
||+ ++.++.
T Consensus 87 e~i~~g~~l~ 96 (301)
T 3dxq_A 87 RYIAGAQTMS 96 (301)
T ss_dssp ECCTTCEECC
T ss_pred eecCCCccCC
Confidence 999 665553
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0012 Score=64.67 Aligned_cols=103 Identities=17% Similarity=0.112 Sum_probs=66.5
Q ss_pred cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 750 GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 750 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
-+|.+.+.... +++++.++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~----------~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-- 97 (229)
T 2yle_A 33 LSLEEILRLYN----------QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-- 97 (229)
T ss_dssp EEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----
T ss_pred ccHHHHHHHcC----------CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--
Confidence 47888876554 589999999999999999888722100 1 1233456889999999987764 1110
Q ss_pred cccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001974 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882 (988)
Q Consensus 830 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 882 (988)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 --------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0233567888763 3456788999999999999884444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0014 Score=71.86 Aligned_cols=145 Identities=11% Similarity=0.132 Sum_probs=83.3
Q ss_pred CceeccccceeEEEEEECC-------CCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 668 THLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
++.+..|-...+|++.... +++.|++|+.... ......+.+|.++++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~--- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E--- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T---
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C---
Confidence 4577778889999988742 3578999986432 223456778999998883 333456676632 1
Q ss_pred eEEEEeeccccchhhh-cC----------------CCCCCCchhhhHhhcC--CHHHHHHHHHHHHH-------------
Q 001974 740 KALVYEFMTNGSLENW-LH----------------PDAVPQKDVEIEIQKL--TLLQRINIAIDVAS------------- 787 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~-l~----------------~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~------------- 787 (988)
.+||||++|.++..- +. ....... ... -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~------~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFT------KEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSC------CSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCC------CCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 289999998666421 11 1000000 011 12334444433321
Q ss_pred ------HHHHH----HcC-CCCCeEeccCCCCCeeeCCC----CcEEEeeeccccc
Q 001974 788 ------AIDYL----HHH-CQEPVLHCDLKPGNVLLDND----MIAHVGDFGLARV 828 (988)
Q Consensus 788 ------~L~~L----H~~-~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~ 828 (988)
.++.| ... ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22232 221 23468999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0029 Score=71.42 Aligned_cols=76 Identities=16% Similarity=0.103 Sum_probs=49.3
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCc-eEEEeecccccccCCCceEEEEee
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL-VKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
++.|+.|-...+|++.....++.+++|+...... ..-+...|..+++.+...++ .++++++. + ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~-------~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT-------N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET-------T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-------C--eEEEEe
Confidence 4678889899999998854358899998753321 11223688999988854444 56776631 1 259999
Q ss_pred ccccchh
Q 001974 747 MTNGSLE 753 (988)
Q Consensus 747 ~~~gsL~ 753 (988)
++|.++.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9886653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.007 Score=65.26 Aligned_cols=170 Identities=13% Similarity=0.071 Sum_probs=88.6
Q ss_pred ccCHHHHHHhhCCCCC-----CceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC--ceE
Q 001974 652 KVSYESLFKATDGFSS-----THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN--LVK 724 (988)
Q Consensus 652 ~~~~~~l~~~~~~y~~-----~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 724 (988)
.++.+++......|.. .+.++.|....+|+.... +| .+++|+.... .....+..|+.+++.+.... +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 3455555555555654 345667888899999874 34 6889988642 12345667888887773222 344
Q ss_pred EEeeccccc-ccCCCceEEEEeeccccchhh------------------hcCCCCCCCchhhhHhhcCCHHHHH------
Q 001974 725 VITSCSSID-FQGNDFKALVYEFMTNGSLEN------------------WLHPDAVPQKDVEIEIQKLTLLQRI------ 779 (988)
Q Consensus 725 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~------------------~l~~~~~~~~~~~~~~~~l~~~~~~------ 779 (988)
++....... ....+..++||+|++|..+.. ............. ....|....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~---~~~~w~~~~~~~~~~ 158 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNAL---SVDGWKVLWDKSEER 158 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTT---SHHHHHHHHHHHGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCcc---ChHHHHHHHHHHHHH
Confidence 443211000 011245689999998865421 0111010000000 000011100
Q ss_pred ------HHHHHHHHHHHHHHcC----CCCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 780 ------NIAIDVASAIDYLHHH----CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 780 ------~i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
.+...+...++++++. ...+++|+|+.+.||+++++..+.++||+.+..
T Consensus 159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0011234445555431 134799999999999999876668999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0072 Score=65.34 Aligned_cols=154 Identities=14% Similarity=0.148 Sum_probs=82.3
Q ss_pred ceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCC--CceEEEeeccccc-ccCCCceEEEEe
Q 001974 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHR--NLVKVITSCSSID-FQGNDFKALVYE 745 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~-~~~~~~~~lv~e 745 (988)
+.++ |....||++... +|+.+++|+...... ....+..|..+++.+... .+.+++.. .... ...++..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEE
Confidence 4566 888899987663 566799999863321 235677788888877322 24444443 1100 112356688999
Q ss_pred eccccchhh-----h---------c----CCCCCCC-chhhhH---------h---hcCCHH---HHHHHHHHHHHHHHH
Q 001974 746 FMTNGSLEN-----W---------L----HPDAVPQ-KDVEIE---------I---QKLTLL---QRINIAIDVASAIDY 791 (988)
Q Consensus 746 ~~~~gsL~~-----~---------l----~~~~~~~-~~~~~~---------~---~~l~~~---~~~~i~~~i~~~L~~ 791 (988)
|++|..+.. + + ....... ...... . ..++.. .....+.+++..+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998755421 0 0 0000000 000000 0 001110 111122222222322
Q ss_pred HHc-CCCCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 792 LHH-HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 792 LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
... .....++|||+++.||+++ + .+.++||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 211 1234689999999999999 4 899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0023 Score=71.93 Aligned_cols=75 Identities=15% Similarity=0.167 Sum_probs=50.7
Q ss_pred CceeccccceeEEEEEECC-------CCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 668 THLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
++.|+.|....||++.... .++.+++|+.... .....+..|..+++.+. +.-..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C---
Confidence 4678888899999998752 2578999998431 11145668999988884 333456666531 1
Q ss_pred eEEEEeeccccchh
Q 001974 740 KALVYEFMTNGSLE 753 (988)
Q Consensus 740 ~~lv~e~~~~gsL~ 753 (988)
.+|+||++|.++.
T Consensus 148 -g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 -GRLEEYIPSRPLS 160 (429)
T ss_dssp -EEEECCCCEEECC
T ss_pred -CEEEEEeCCcccC
Confidence 3899999875553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00019 Score=70.21 Aligned_cols=17 Identities=6% Similarity=0.053 Sum_probs=8.4
Q ss_pred ccccCCCCcEEEeeccc
Q 001974 298 SLANCSNLRTLIFAANK 314 (988)
Q Consensus 298 ~l~~l~~L~~L~Ls~N~ 314 (988)
.+...+.|+.|+++.|.
T Consensus 152 aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 152 AIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHCSSCCEEECCCCC
T ss_pred HHHhCCCcCeEeccCCC
Confidence 34444555555555443
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0037 Score=57.03 Aligned_cols=55 Identities=22% Similarity=0.250 Sum_probs=27.1
Q ss_pred EEEcCCCCCc-ccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCC
Q 001974 36 VLNLRSKGLS-GSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92 (988)
Q Consensus 36 ~l~l~~~~~~-~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 92 (988)
.+|.++++++ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555566554 23443221 2355555555555544444455555555555555544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0022 Score=58.51 Aligned_cols=57 Identities=21% Similarity=0.284 Sum_probs=35.6
Q ss_pred CEEEcCCCccc-ccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccccc
Q 001974 59 REINLMNNSIQ-GEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 59 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~ 117 (988)
..++.++++++ ..+|..+ -.+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777776 2344332 235677777777777555566666667777777766553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.004 Score=68.65 Aligned_cols=75 Identities=11% Similarity=0.166 Sum_probs=45.2
Q ss_pred CceeccccceeEEEEEECC--------CCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC-ceEEEeecccccccCCC
Q 001974 668 THLIGMGSFGSVYKGAFDQ--------DGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN-LVKVITSCSSIDFQGND 738 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~ 738 (988)
.+.++.|....+|+..... .++.+++|+...... ...+...|.++++.+.... +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--------- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--------- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE---------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec---------
Confidence 3567888889999998742 126889998754321 1123467888888874323 44666542
Q ss_pred ceEEEEeeccccch
Q 001974 739 FKALVYEFMTNGSL 752 (988)
Q Consensus 739 ~~~lv~e~~~~gsL 752 (988)
.-++||||++|.++
T Consensus 108 ~~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 NGGRIEEWLYGDPL 121 (369)
T ss_dssp TTEEEEECCCSEEC
T ss_pred CCcEEEEEecCCcC
Confidence 12689999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0098 Score=64.46 Aligned_cols=33 Identities=24% Similarity=0.236 Sum_probs=28.1
Q ss_pred CCCeEeccCCCCCeeeCCC----CcEEEeeecccccc
Q 001974 797 QEPVLHCDLKPGNVLLDND----MIAHVGDFGLARVR 829 (988)
Q Consensus 797 ~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~~ 829 (988)
...++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999875 68999999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0081 Score=65.22 Aligned_cols=32 Identities=25% Similarity=0.352 Sum_probs=28.2
Q ss_pred CCeEeccCCCCCeeeCCCCcEEEeeecccccc
Q 001974 798 EPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829 (988)
Q Consensus 798 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 829 (988)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.029 Score=62.35 Aligned_cols=75 Identities=11% Similarity=0.138 Sum_probs=49.7
Q ss_pred CceeccccceeEEEEEECCC-------CeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCc
Q 001974 668 THLIGMGSFGSVYKGAFDQD-------GTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 739 (988)
++.+..|-...+|+...... ++.|++|+..... ...-+..+|.++++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~---------~ 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF---------P 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE---------T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc---------C
Confidence 45677788889999987521 5789999875332 22234567888888883 33345566542 1
Q ss_pred eEEEEeeccccch
Q 001974 740 KALVYEFMTNGSL 752 (988)
Q Consensus 740 ~~lv~e~~~~gsL 752 (988)
-+.||||++|.++
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.77 E-value=0.15 Score=56.61 Aligned_cols=30 Identities=27% Similarity=0.369 Sum_probs=25.5
Q ss_pred eEeccCCCCCeee------CCCCcEEEeeecccccc
Q 001974 800 VLHCDLKPGNVLL------DNDMIAHVGDFGLARVR 829 (988)
Q Consensus 800 ivH~Dlkp~NIll------~~~~~~kL~DfG~a~~~ 829 (988)
++|+|+.+.||++ +++..++++||.+|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 45678999999988753
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.52 E-value=0.23 Score=34.60 Aligned_cols=28 Identities=18% Similarity=0.158 Sum_probs=13.7
Q ss_pred hhhhhHHHHHHHHHHHhhhhhccccCCC
Q 001974 609 IISTLSAVLGIVMVFFLCFCWFKRRRGP 636 (988)
Q Consensus 609 ii~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (988)
+.+++++++++++++++.+++++||+.+
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3344444555555555555555554443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.00 E-value=0.3 Score=33.90 Aligned_cols=30 Identities=10% Similarity=0.164 Sum_probs=14.2
Q ss_pred hhhhhhHHHHHHHHHHHhhhhhccccCCCC
Q 001974 608 AIISTLSAVLGIVMVFFLCFCWFKRRRGPS 637 (988)
Q Consensus 608 ~ii~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (988)
++.+++.++++++++.+..++|++||+.++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 333444445555555555455555444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=88.52 E-value=0.38 Score=33.33 Aligned_cols=28 Identities=29% Similarity=0.324 Sum_probs=13.6
Q ss_pred hhhhhHHHHHHHHHHHhhhhhccccCCC
Q 001974 609 IISTLSAVLGIVMVFFLCFCWFKRRRGP 636 (988)
Q Consensus 609 ii~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (988)
+++.+++++.++++.++.++|.|||+..
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 3344444444444445555555555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 988 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-56
Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 56/312 (17%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHRNLVKVI 726
IG GSFG+VYKG + D VA+K+ N+ ++F E L+ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ A+V ++ SL + LH I K +++ I+IA A
Sbjct: 71 ------GYSTAPQLAIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTA 114
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+DYLH ++H DLK N+ L D+ +GDFGLA V+ S Q + G+
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ--LSGS 169
Query: 847 IGYAAPEYGLGSE---VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903
I + APE + S D+Y++GI+L E++TG+ P + N R ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINN-----RDQIIF 220
Query: 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITN 963
V ++ V CP +M R+ C + +R
Sbjct: 221 MVGRGYLSPDLSKVRS------------------NCPKAMKRLMAECLKKKRDERPLFPQ 262
Query: 964 VVHELQSVKNAL 975
++ ++ + +L
Sbjct: 263 ILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (448), Expect = 5e-50
Identities = 66/332 (19%), Positives = 138/332 (41%), Gaps = 63/332 (18%)
Query: 654 SYESLFKATDGFSST---------HLIGMGSFGSVYKGAFDQDG---TIVAIKVFNLQRH 701
++E +A F+ +IG G FG V G G VAIK
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 702 -GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDA 760
+ FL+E + H N++ + + + ++ EFM NGSL+++L +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 761 VPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820
T++Q + + +A+ + YL +H DL N+L++++++ V
Sbjct: 123 GQF----------TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 169
Query: 821 GDFGLAR-VRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG 879
DFGL+R + + S+ T + ++G + I + APE + ++ D++SYGI++ E+++
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 880 KKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIEC 939
+ + N VI+ ++ + ++ ++C
Sbjct: 230 GER---PYWDMTN----------QDVINAIE------------------QDYRLPPPMDC 258
Query: 940 PISMVRIGVACSVESPQDRMSITNVVHELQSV 971
P ++ ++ + C + R +V+ L +
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-50
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 25/223 (11%)
Query: 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-RHGASKSFLAECKALKNIRH 719
D F +G G+ G V+K + G ++A K+ +L+ + + E + L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
+V + S + ++ E M GSL+ L + ++
Sbjct: 64 PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK-----------KAGRIPEQILG 107
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
++I V + YL ++H D+KP N+L+++ + DFG++ L S
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ------LIDSM 159
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT Y +PE G+ S DI+S G+ L+EM G+ P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-50
Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 38/314 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G FG V++G G VA+K+F+ R S AE +RH N++ I + +
Sbjct: 11 IGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
+ LV ++ +GSL ++L+ +T+ I +A+ AS +
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTASGLA 114
Query: 791 YLHHHC-----QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+LH + + H DLK N+L+ + + D GLA ++ G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 846 TIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899
T Y APE S E DIY+ G++ E+ + + L ++ +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959
+ ++ K R E M +I C + R+
Sbjct: 235 -----------DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 960 SITNVVHELQSVKN 973
+ + L +
Sbjct: 284 TALRIKKTLSQLSQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 3e-48
Identities = 64/301 (21%), Positives = 125/301 (41%), Gaps = 54/301 (17%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V+ G + T VA+K Q + +FLAE +K ++H+ LV++
Sbjct: 19 ERLGAGQFGEVWMG-YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ + ++ E+M NGSL ++L KLT+ + +++A +A
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK---------TPSGIKLTINKLLDMAAQIAEG 121
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ ++ +H DL+ N+L+ + + + DFGLAR+ + + + G + I
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIK 175
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
+ APE + D++S+GILL E+VT + ++ ++
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------PGMTNPEVIQNLERG 226
Query: 909 VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968
+ ++ CP + ++ C E P+DR + + L
Sbjct: 227 YRMVRPDN----------------------CPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 969 Q 969
+
Sbjct: 265 E 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 18/233 (7%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS--KSFLAECKALKNIRHR 720
+ + + IG GS+G K DG I+ K + + + ++E L+ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N+V+ + N +V E+ G L + + E Q L +
Sbjct: 64 NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVIT-------KGTKERQYLDEEFVLR 113
Query: 781 IAIDVASAIDYLHHH--CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ + A+ H VLH DLKP NV LD +GDFGLAR+ ++ ++
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
GT Y +PE + DI+S G LL E+ P + +L
Sbjct: 174 ----FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-47
Identities = 69/311 (22%), Positives = 118/311 (37%), Gaps = 52/311 (16%)
Query: 670 LIGMGSFGSVYKGAF---DQDGTIVAIKVFN-LQRHGASKSFLAECKALKNIRHRNLVKV 725
+IG G FG VY G D A+K N + G FL E +K+ H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
+ C + +V +M +G L N++ E T+ I + V
Sbjct: 94 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 139
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
A + + +H DL N +LD V DFGLAR + + G +
Sbjct: 140 AKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905
+ + A E + +T D++S+G+LL E++T P D+N
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTF----------- 241
Query: 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965
DI +L +RL Q + CP + + + C + R S + +V
Sbjct: 242 -DITVYLL----------QGRRLLQPE-----YCPDPLYEVMLKCWHPKAEMRPSFSELV 285
Query: 966 HELQSVKNALL 976
+ ++ + +
Sbjct: 286 SRISAIFSTFI 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 58/305 (19%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
IG G FG V G D G VA+K ++ +++FLAE + +RH NLV+++
Sbjct: 13 QTIGKGEFGDVMLG--DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ +V E+M GSL ++L L + ++DV A
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLR---------SRGRSVLGGDCLLKFSLDVCEA 115
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
++YL + +H DL NVL+ D +A V DFGL + + + +
Sbjct: 116 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVK 165
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
+ APE + ST D++S+GILL E+ + + + L + + +D
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPRVEKGYKMDA 221
Query: 909 VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968
D CP ++ + C R S + +L
Sbjct: 222 PD---------------------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
Query: 969 QSVKN 973
+ +K
Sbjct: 255 EHIKT 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-47
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
IG GSF +VYKG + VA ++ + F E + LK ++H N+V+ S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
S +G LV E MT+G+L+ +L + + + + +
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLK-----------RFKVMKIKVLRSWCRQILKG 124
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLL-DNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+ +LH P++H DLK N+ + +GD GLA +++ S + V GT
Sbjct: 125 LQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTP 177
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907
+ APE + + D+Y++G+ +LEM T + P + N + V
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAA-----QIYRRVTS 227
Query: 908 IVDPILINDVEDWDA 922
V P + V +
Sbjct: 228 GVKPASFDKVAIPEV 242
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-46
Identities = 70/302 (23%), Positives = 124/302 (41%), Gaps = 54/302 (17%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
+G G FG V+ G T VAIK ++FL E + +K +RH LV++
Sbjct: 23 VKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
S + +V E+M+ GSL ++L + + Q +++A +AS
Sbjct: 81 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP---------QLVDMAAQIASG 125
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ Y+ +H DL+ N+L+ +++ V DFGLAR+ ++ + G + I
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPIK 179
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
+ APE L + D++S+GILL E+ T + + G +N +LD V
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVN------REVLDQVERG 230
Query: 909 VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHEL 968
+ CP S+ + C + P++R + + L
Sbjct: 231 YRMPCPPE----------------------CPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
Query: 969 QS 970
+
Sbjct: 269 ED 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 7e-46
Identities = 61/324 (18%), Positives = 117/324 (36%), Gaps = 55/324 (16%)
Query: 658 LFKATDGFSSTHL-IGMGSFGSVYKGAF--DQDGTIVAIKVFNLQ-RHGASKSFLAECKA 713
LF D + +G G+FGSV +G + + VAIKV ++ + E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL 773
+ + + +V++I C + LV E G L +L +++
Sbjct: 63 MHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR----------EEI 106
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833
+ + V+ + YL +H DL NVLL N A + DFGL++
Sbjct: 107 PVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
+ + S G + + APE + S+ D++SYG+ + E ++ + ++
Sbjct: 164 SYYTARSAGK-WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP---YKK---- 215
Query: 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953
+++ I + ECP + + C +
Sbjct: 216 ---------MKGPEVMAFIEQGKRMECPP---------------ECPPELYALMSDCWIY 251
Query: 954 SPQDRMSITNVVHELQSVKNALLE 977
+DR V +++ +L
Sbjct: 252 KWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 63/304 (20%), Positives = 115/304 (37%), Gaps = 54/304 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
IG G FG V+ G + + VAIK + F+ E + + + H LV++ C
Sbjct: 13 IGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
LV+EFM +G L ++L + + + +DV
Sbjct: 71 E-----QAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVCEG-- 113
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
+ + + V+H DL N L+ + + V DFG+ R V + + S G + + +A
Sbjct: 114 -MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKWA 169
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVD 910
+PE S S+ D++S+G+L+ E+ + K N N + +
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVEDISTGFRLYK 223
Query: 911 PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970
P L + +I C E P+DR + + ++ +L
Sbjct: 224 PRL-------------------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
Query: 971 VKNA 974
+ +
Sbjct: 259 IAES 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 61/335 (18%), Positives = 118/335 (35%), Gaps = 60/335 (17%)
Query: 654 SYESLFKATDGFSSTHLIGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQRH-GASKSF 707
SL + IG G+FG V++ + T+VA+K+ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 708 LAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH---------- 757
E + + N+VK++ C+ L++E+M G L +L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 758 ---PDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814
+ + L+ +++ IA VA+ + YL +H DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLL 874
+M+ + DFGL+R + I + PE + +T D+++YG++L
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDA--IPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 875 EMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKIN 934
E+ + + G +++ + ++
Sbjct: 234 EIFSYGLQ---PYYG-------------MAHEEVIYYVRDGNILACPE------------ 265
Query: 935 GKIECPISMVRIGVACSVESPQDRMSITNVVHELQ 969
CP+ + + C + P DR S ++ LQ
Sbjct: 266 ---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 3e-45
Identities = 73/331 (22%), Positives = 137/331 (41%), Gaps = 61/331 (18%)
Query: 641 PSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR 700
PS P +Y+ + H +G G +G VY+G + + VA+K
Sbjct: 4 PSSP---------NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT 54
Query: 701 HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDA 760
+ FL E +K I+H NLV+++ C+ ++ EFMT G+L ++L
Sbjct: 55 -MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLR--- 105
Query: 761 VPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820
E Q+++ + + +A ++SA++YL +H DL N L+ + + V
Sbjct: 106 ------ECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV 156
Query: 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK 880
DFGL+R+ ++ T + G + I + APE ++ S D++++G+LL E+ T
Sbjct: 157 ADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213
Query: 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECP 940
+ G L V ++++ + + CP
Sbjct: 214 MS---PYPGI----------DLSQVYELLEKDYRMERPEG------------------CP 242
Query: 941 ISMVRIGVACSVESPQDRMSITNVVHELQSV 971
+ + AC +P DR S + +++
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-45
Identities = 62/321 (19%), Positives = 115/321 (35%), Gaps = 59/321 (18%)
Query: 669 HLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRN 721
++G G+FG V VA+K+ + ++ ++E K + + H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH------------PDAVPQKDVEIE 769
+V ++ +C+ + L++E+ G L N+L + + + E +
Sbjct: 103 IVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 770 IQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVR 829
+ LT + A VA +++L +H DL NVL+ + + + DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 830 QEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEG 889
SN R + + APE + D++SYGILL E+ + + G
Sbjct: 215 MSDSNYVVRG--NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPG 269
Query: 890 DLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVA 949
N+ + ++ D + + I +
Sbjct: 270 IPVDANFYK---------LIQNGFKMDQPFY------------------ATEEIYIIMQS 302
Query: 950 CSVESPQDRMSITNVVHELQS 970
C + R S N+ L
Sbjct: 303 CWAFDSRKRPSFPNLTSFLGC 323
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 54/301 (17%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCS 730
+G G FG V G + VAIK+ F+ E K + N+ H LV++ C+
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAID 790
++ E+M NG L N+L + Q + + DV A++
Sbjct: 70 K-----QRPIFIITEYMANGCLLNYLRE----------MRHRFQTQQLLEMCKDVCEAME 114
Query: 791 YLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYA 850
YL LH DL N L+++ + V DFGL+R V + + SVG + + ++
Sbjct: 115 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWS 168
Query: 851 APEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDIVD 910
PE + S+ S+ DI+++G+L+ E+ + K +E N +H+ +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP---YERFTNSE------TAEHIAQGLR 219
Query: 911 PILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970
+ + I +C E +R + ++ +
Sbjct: 220 LYRPHL----------------------ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
Query: 971 V 971
V
Sbjct: 258 V 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (402), Expect = 3e-44
Identities = 57/239 (23%), Positives = 96/239 (40%), Gaps = 32/239 (13%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRH 719
+ F +G G FG+VY Q I+A+KV L++ G E + ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
N++++ L+ E+ G++ L ++ K +
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQ-----------KLSKFDEQRTA 109
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
++A+A+ Y H V+H D+KP N+LL + + DFG + + S
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV------HAPSSR 160
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
+ GT+ Y PE G D++S G+L E + GK P FE + Y R
Sbjct: 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR 215
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 55/255 (21%), Positives = 99/255 (38%), Gaps = 23/255 (9%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRN 721
+ + +G G++G V VA+K+ +++R ++ E K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+VK + + + L E+ + G L + + PD +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRF 108
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSV 841
+ + + YLH + H D+KP N+LLD + DFGLA V + N +
Sbjct: 109 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLN 163
Query: 842 GVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
+ GT+ Y APE E D++S GI+L M+ G+ P D + ++
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223
Query: 901 LLDHVIDIVDPILIN 915
+ +D +
Sbjct: 224 TYLNPWKKIDSAPLA 238
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-44
Identities = 63/318 (19%), Positives = 127/318 (39%), Gaps = 53/318 (16%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNI-R 718
+ +IG G+FG V K +DG + + ++ + + + F E + L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKL 773
H N++ ++ +C + + L E+ +G+L ++L V + D I L
Sbjct: 70 HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833
+ Q ++ A DVA + + Q+ +H DL N+L+ + +A + DFGL+R ++
Sbjct: 125 SSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
T + + A E S +TN D++SYG+LL E+V+ + G
Sbjct: 182 KKTMGR-----LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCG---- 229
Query: 894 HNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVE 953
++ + + + ++ + C + + C E
Sbjct: 230 ---------MTCAELYEKL---------------PQGYRLEKPLNCDDEVYDLMRQCWRE 265
Query: 954 SPQDRMSITNVVHELQSV 971
P +R S ++ L +
Sbjct: 266 KPYERPSFAQILVSLNRM 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 57/304 (18%), Positives = 108/304 (35%), Gaps = 56/304 (18%)
Query: 671 IGMGSFGSVYKGAF--DQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVI 726
+G G+FG+V KG + + VA+K+ + + LAE ++ + + +V++I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
C + LV E G L +L + + + I + V+
Sbjct: 75 GICE------AESWMLVMEMAELGPLNKYLQQN-----------RHVKDKNIIELVHQVS 117
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
+ YL +H DL NVLL A + DFGL++ + N +
Sbjct: 118 MGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWP 173
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVI 906
+ + APE + S+ D++S+G+L+ E + + + G
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRG-------------MKGS 217
Query: 907 DIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966
++ + + A CP M + C ++R V
Sbjct: 218 EVTAMLEKGERMGCPA---------------GCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 967 ELQS 970
L++
Sbjct: 263 RLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 62/316 (19%), Positives = 110/316 (34%), Gaps = 54/316 (17%)
Query: 669 HLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRN 721
+G G+FG V + VA+K+ H ++ ++E K L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH-------PDAVPQKDVEIEIQKLT 774
+V ++ +C+ ++ E+ G L N+L +E + L
Sbjct: 89 IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
L ++ + VA + +L +H DL N+LL + I + DFGLAR + SN
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
+ R + + APE + D++SYGI L E+ + D +
Sbjct: 201 YVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
++ ++ P P M I C
Sbjct: 259 K-----MIKEGFRMLSP-------------------------EHAPAEMYDIMKTCWDAD 288
Query: 955 PQDRMSITNVVHELQS 970
P R + +V ++
Sbjct: 289 PLKRPTFKQIVQLIEK 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 4e-43
Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 64/310 (20%)
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL---QRHGASKSFLAECKALKNIR 718
FS IG GSFG+VY ++ +VAIK + Q + + + E + L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
H N ++ LV E+ + + + L ++
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHK-----------KPLQEVEI 117
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
+ + YLH H ++H D+K GN+LL + +GDFG A + ++
Sbjct: 118 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---- 170
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNG---DIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
GT + APE L + D++S GI +E+ K P L N
Sbjct: 171 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------LFN 216
Query: 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESP 955
+ L H+ P L + +C + P
Sbjct: 217 MNAMSALYHIAQNESPALQSG---------------------HWSEYFRNFVDSCLQKIP 255
Query: 956 QDRMSITNVV 965
QDR + ++
Sbjct: 256 QDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 645 ILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS 704
IL K VS ++ IG G+ G+VY G VAI+ NLQ+
Sbjct: 5 ILEKLRSIVSVGD---PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 705 KSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQK 764
+ + E ++ ++ N+V + S D +V E++ GSL + + + +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG 116
Query: 765 DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824
Q + + A+++LH + V+H D+K N+LL D + DFG
Sbjct: 117 ------------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
QS + GT + APE DI+S GI+ +EM+ G+ P
Sbjct: 162 FCA----QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 63/311 (20%), Positives = 125/311 (40%), Gaps = 55/311 (17%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRH-GASKSFLAECKALKNIRH 719
+ +IG G FG VYKG VAIK FL E + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
N++++ S ++ E+M NG+L+ +L + ++LQ +
Sbjct: 69 HNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKD----------GEFSVLQLV 113
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
+ +A+ + YL + +H DL N+L++++++ V DFGL+RV ++ T +
Sbjct: 114 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT- 169
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899
+ G + I + APE + ++ D++S+GI++ E++T + +L+ H
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNH----- 220
Query: 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM 959
V+ ++ +CP ++ ++ + C + R
Sbjct: 221 ----EVMKAINDGFRLPTPM------------------DCPSAIYQLMMQCWQQERARRP 258
Query: 960 SITNVVHELQS 970
++V L
Sbjct: 259 KFADIVSILDK 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-43
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 30/236 (12%)
Query: 655 YESL---FKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAEC 711
YE + D + +G G+FG VYK + + A KV + + + ++ E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 712 KALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQ 771
L + H N+VK++ + + ++ EF G+++ + P
Sbjct: 61 DILASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLELERP--------- 106
Query: 772 KLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQE 831
LT Q + A++YLH + ++H DLK GN+L D + DFG++
Sbjct: 107 -LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162
Query: 832 VSNLTQSCSVGVRGTIGYAAPEY-----GLGSEVSTNGDIYSYGILLLEMVTGKKP 882
S GT + APE D++S GI L+EM + P
Sbjct: 163 TIQRRDS----FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-42
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 24/226 (10%)
Query: 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKN 716
K + F ++G GSF +V AIK+ + + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+ H VK+ + FQ ++ + NG L ++ +I
Sbjct: 65 LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIR-----------KIGSFDET 108
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
++ SA++YLH ++H DLKP N+LL+ DM + DFG A+V S
Sbjct: 109 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 837 QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
++ S GT Y +PE + D+++ G ++ ++V G P
Sbjct: 166 RANSFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 5e-42
Identities = 65/336 (19%), Positives = 124/336 (36%), Gaps = 58/336 (17%)
Query: 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKV-----FNLQRHGASKSFLAECK 712
+ K T+ F ++G G+FG+VYKG + +G V I V A+K L E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 713 ALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+ ++ + ++ +++ C + Q L+ + M G L +++
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVRE----------HKDN 107
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
+ +N + +A ++YL ++H DL NVL+ + DFGLA++
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
+ G + I + A E L + D++SYG+ + E++T ++G
Sbjct: 165 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPA 219
Query: 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSV 952
+ I++ +RL Q C I + I V C +
Sbjct: 220 ----------SEISSILE-------------KGERLPQPP-----ICTIDVYMIMVKCWM 251
Query: 953 ESPQDRMSITNVVHELQSVKNALLEAWNCTGEEVIR 988
R ++ E + G+E +
Sbjct: 252 IDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (387), Expect = 3e-41
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 25/222 (11%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
D + +G G+FG V++ G A K ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V + + F+ ++ ++YEFM+ G L + E K++ + +
Sbjct: 86 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVAD----------EHNKMSEDEAVEYM 130
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCS 840
V + ++H + +H DLKP N++ + DFGL ++ +
Sbjct: 131 RQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 186
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT +AAPE G V D++S G+L +++G P
Sbjct: 187 ----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-41
Identities = 62/308 (20%), Positives = 119/308 (38%), Gaps = 48/308 (15%)
Query: 669 HLIGMGSFGSVYKG-----AFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNL 722
+G GSFG VY+G D+ T VAIK N FL E +K ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
V+++ ++ E MT G L+++L P + +L + I +A
Sbjct: 86 VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLR-PAMANNPVLAPPSLSKMIQMA 139
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVG 842
++A + YL+ + +H DL N ++ D +GDFG+ R E +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-- 194
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALL 902
+ + +PE +T D++S+G++L E+ T + ++G N
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGLSNEQVLRF---- 247
Query: 903 DHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT 962
+++ L++ ++ CP + + C +P+ R S
Sbjct: 248 -----VMEGGLLDKPDN-------------------CPDMLFELMRMCWQYNPKMRPSFL 283
Query: 963 NVVHELQS 970
++ ++
Sbjct: 284 EIISSIKE 291
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 67/308 (21%), Positives = 111/308 (36%), Gaps = 56/308 (18%)
Query: 671 IGMGSFGSVYKGAFDQD---GTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVK 724
+G GSFG V +G +D VA+K L + A F+ E A+ ++ HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ + + +V E GSL + L L A+
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQ 119
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
VA + YL +H DL N+LL + +GDFGL R + ++ +
Sbjct: 120 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRK 175
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
+ APE S D + +G+ L EM T + + G +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIG-------------LN 219
Query: 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964
I+ I +RL + + +CP + + V C P+DR + +
Sbjct: 220 GSQILHKID---------KEGERLPRPE-----DCPQDIYNVMVQCWAHKPEDRPTFVAL 265
Query: 965 VHELQSVK 972
L +
Sbjct: 266 RDFLLEAQ 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (377), Expect = 5e-40
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNL 722
D + +G G+FG V++ G + K N + E + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIA 782
+ + + F+ L+ EF++ G L + + E K++ + IN
Sbjct: 89 INLHDA-----FEDKYEMVLILEFLSGGELFDRIAA----------EDYKMSEAEVINYM 133
Query: 783 IDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCS 840
+ ++H H ++H D+KP N++ + + V DFGLA + +
Sbjct: 134 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 189
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T +AAPE V D+++ G+L +++G P
Sbjct: 190 ----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 7e-40
Identities = 61/316 (19%), Positives = 118/316 (37%), Gaps = 49/316 (15%)
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIR 718
+D + ++G G V+ + VA+KV + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
H +V V + + + +V E++ +L + +H +T +
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH-----------TEGPMTPKRA 113
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
I + D A+++ H + ++H D+KP N+++ V DFG+AR + N
Sbjct: 114 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
+ V GT Y +PE G V D+YS G +L E++TG+ P F G
Sbjct: 171 TA-AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG--------- 216
Query: 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDR 958
D + + + D A ++ + + + ++P++R
Sbjct: 217 ----DSPVSVAYQHVREDPIPPSARHE------------GLSADLDAVVLKALAKNPENR 260
Query: 959 M-SITNVVHELQSVKN 973
+ + +L V N
Sbjct: 261 YQTAAEMRADLVRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 62/306 (20%), Positives = 114/306 (37%), Gaps = 57/306 (18%)
Query: 670 LIGMGSFGSVYKGAF---DQDGTIVAIKVF-NLQRHGASKSFLAECKALKNIRHRNLVKV 725
IG G FG V++G + + VAIK N + FL E ++ H ++VK+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 726 ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
I + + ++ E T G L ++L + L L I A +
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQ----------VRKYSLDLASLILYAYQL 117
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
++A+ YL +H D+ NVL+ ++ +GDFGL+R ++ + S +
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK---GKL 171
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHV 905
I + APE ++ D++ +G+ + E++
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG----------------VKN 215
Query: 906 IDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965
D++ I N +RL CP ++ + C P R T +
Sbjct: 216 NDVIGRIE----------NGERLPMPP-----NCPPTLYSLMTKCWAYDPSRRPRFTELK 260
Query: 966 HELQSV 971
+L ++
Sbjct: 261 AQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 60/321 (18%), Positives = 109/321 (33%), Gaps = 53/321 (16%)
Query: 669 HLIGMGSFGSVYKGAF-----DQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNL 722
+G G+FG V + VA+K+ H ++ ++E K L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 723 VKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLH-----PDAVPQKDVEIEIQKLTLLQ 777
V + + ++ EF G+L +L ++ LTL
Sbjct: 79 VVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQ 837
I + VA +++L +H DL N+LL + + DFGLAR + + +
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 838 SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897
R + + APE + D++S+G+LL E+ + Y
Sbjct: 193 KGD--ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------------PYP 238
Query: 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957
+ + + D+ M + + C P
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDY------------------TTPEMYQTMLDCWHGEPSQ 280
Query: 958 RMSITNVVHELQSVKNALLEA 978
R + + +V L + LL+A
Sbjct: 281 RPTFSELVEHLGN----LLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 7e-38
Identities = 50/222 (22%), Positives = 81/222 (36%), Gaps = 22/222 (9%)
Query: 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHR 720
D + ++G G+F V + +VAIK + G S E L I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N+V + ++ L+ + ++ G L + + E T
Sbjct: 68 NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIV-----------EKGFYTERDASR 111
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ V A+ YLH LD D + DFGL+++ S L+ +C
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC- 170
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT GY APE S D +S G++ ++ G P
Sbjct: 171 ----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 56/317 (17%), Positives = 117/317 (36%), Gaps = 55/317 (17%)
Query: 669 HLIGMGSFGSVYKG-------AFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RH 719
+G G+FG V T VA+K+ ++E + +K I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEI-----QKLT 774
+N++ ++ +C+ + ++ E+ + G+L +L P + ++L+
Sbjct: 79 KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 775 LLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSN 834
++ A VA + + + +H DL NVL+ D + + DFGLAR +
Sbjct: 134 SKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 835 LTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
++ + R + + APE + D++S+G+LL E+ T + G
Sbjct: 191 YKKTTN--GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVPV-- 243
Query: 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
+ + ++ R+ + C + + C
Sbjct: 244 --------EELFKLLK-------------EGHRMDKPS-----NCTNELYMMMRDCWHAV 277
Query: 955 PQDRMSITNVVHELQSV 971
P R + +V +L +
Sbjct: 278 PSQRPTFKQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (347), Expect = 8e-37
Identities = 59/282 (20%), Positives = 108/282 (38%), Gaps = 49/282 (17%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---------KSFLAECKA 713
+ + ++G G V + A+K+ ++ G+ ++ L E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 714 LKNIR-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
L+ + H N++++ ++ N F LV++ M G L ++L E
Sbjct: 63 LRKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLT-----------EKVT 106
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L+ + I + I LH ++H DLKP N+LLD+DM + DFG +
Sbjct: 107 LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG------DIYSYGILLLEMVTGKKP---- 882
L + C GT Y APE S + D++S G+++ ++ G P
Sbjct: 164 EKLREVC-----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218
Query: 883 -----TDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVED 919
++ G+ + D V D+V L+ +
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 43/318 (13%)
Query: 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALK 715
+F +++ IG G++G V + + VAIK + H + L E K L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 716 NIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTL 775
RH N++ + + + LV M L L Q L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT------------QHLSN 108
Query: 776 LQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNL 835
+ + Y+H VLH DLKP N+LL+ + DFGLARV +
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 836 TQSCSVGVRGTIGYAAPEYGLGSEVSTN-GDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894
T + V T Y APE L S+ T DI+S G +L EM++ + F G L
Sbjct: 166 TGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI----FPGKHYLD 220
Query: 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVES 954
I+ + ED + + R ++ + + R+ ++
Sbjct: 221 QLNH---------ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
Query: 955 -----------PQDRMSI 961
P R+ +
Sbjct: 272 LDLLDKMLTFNPHKRIEV 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 66/303 (21%), Positives = 123/303 (40%), Gaps = 27/303 (8%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITS 728
IG G+FG V+K + G VA+K ++ G + L E K L+ ++H N+V +I
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 729 CSSIDFQGNDFKA---LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDV 785
C + N K LV++F + + + K TL + + +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----------VLVKFTLSEIKRVMQML 126
Query: 786 ASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
+ L++ + +LH D+K NVL+ D + + DFGLAR N +
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 846 TIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
T+ Y PE LG + D++ G ++ EM T +G+ H A + L
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALISQLCG 239
Query: 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPIS---MVRIGVACSVESPQDRMSI 961
I +++ E ++ + ++ K+ +++ + + + V P R+
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 962 TNV 964
+
Sbjct: 300 DDA 302
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 26/215 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
+G G FG V++ K ++ E L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES- 69
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
F+ + +++EF++ + ++ A L + ++ V A+
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSAFE----------LNEREIVSYVHQVCEAL 115
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV--GDFGLARVRQEVSNLTQSCSVGVRGTI 847
+LH H + H D++P N++ + + +FG AR + N
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-----TAP 167
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE VST D++S G L+ +++G P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-35
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 31/232 (13%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKAL-KNIR 718
+ F ++G GSFG V+ F + AIK + + + E + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 719 HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQR 778
H L + + Q + V E++ G L + K L +
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ-----------SCHKFDLSRA 105
Query: 779 INIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQS 838
A ++ + +LH +++ DLK N+LLD D + DFG+ + + L +
Sbjct: 106 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE----NMLGDA 158
Query: 839 CSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ GT Y APE LG + + + D +S+G+LL EM+ G+ P F G
Sbjct: 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ 206
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 67/300 (22%), Positives = 112/300 (37%), Gaps = 30/300 (10%)
Query: 671 IGMGSFGSVYKG-AFDQDGTIVAIKVFNLQ--RHGASKSFLAE---CKALKNIRHRNLVK 724
IG G++G V+K G VA+K +Q G S + E + L+ H N+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
+ C+ LV+E + + + ++
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----------VPEPGVPTETIKDMMFQ 124
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
+ +D+LH H V+H DLKP N+L+ + + DFGLAR+ LT
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV----- 176
Query: 845 GTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDH 904
T+ Y APE L S +T D++S G + EM K F G ++ + +LD
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGK--ILDV 230
Query: 905 VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964
+ + DV + Q + + + C +P R+S +
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 9e-35
Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 26/228 (11%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
IG GSFG +Y G G VAIK+ ++ E K K ++ + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
D+ +V E + + + +K +L + +A + S I
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRI 116
Query: 790 DYLHHHCQEPVLHCDLKPGNVL---LDNDMIAHVGDFGLARVRQEVSNLTQSCSV---GV 843
+Y+H +H D+KP N L + ++ DFGLA+ ++ +
Sbjct: 117 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 844 RGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
GT YA+ LG E S D+ S G +L+ G P +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (330), Expect = 5e-34
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 29/216 (13%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFN---LQRHGASKSFLAECKALKNIRHRNLVKVI 726
+G GSFG V+ +G A+KV + R + E L + H ++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 727 TSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVA 786
+ Q ++ +++ G L + L Q+ A +V
Sbjct: 71 GTF-----QDAQQIFMIMDYIEGGELFSLLRKS-----------QRFPNPVAKFYAAEVC 114
Query: 787 SAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGT 846
L + + +++ DLKP N+LLD + + DFG A+ +V+ + GT
Sbjct: 115 L---ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-------TLCGT 164
Query: 847 IGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
Y APE + + D +S+GIL+ EM+ G P
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-34
Identities = 50/236 (21%), Positives = 96/236 (40%), Gaps = 25/236 (10%)
Query: 665 FSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVK 724
++ T +IG GSFG VY+ G +VAIK + + E + ++ + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 725 VITSC-SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAI 783
+ SS + + + LV +++ H Q L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--------YSRAKQTLPVIYVKLYMY 129
Query: 784 DVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGDFGLARVRQEVSNLTQSCSVG 842
+ ++ Y+H + H D+KP N+LLD D + + DFG A+ +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR----GEPNVSY 182
Query: 843 VRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
+ A ++ +++ D++S G +L E++ G+ F GD +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVE 234
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 131 bits (331), Expect = 8e-34
Identities = 54/260 (20%), Positives = 95/260 (36%), Gaps = 32/260 (12%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL------QRHGASKSFLAECKALKN 716
+ FS +IG G FG VY G + A+K + Q + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
+V + + F D + + + M G L L V +
Sbjct: 64 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----------- 107
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLT 836
A ++ ++++H+ V++ DLKP N+LLD + D GLA + +
Sbjct: 108 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------DFS 158
Query: 837 QSCSVGVRGTIGYAAPEYGL-GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895
+ GT GY APE G ++ D +S G +L +++ G P D + +
Sbjct: 159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
Query: 896 YARTALLDHVIDIVDPILIN 915
+ + D P L +
Sbjct: 219 RMTLTMAVELPDSFSPELRS 238
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 67/304 (22%), Positives = 108/304 (35%), Gaps = 27/304 (8%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNL--QRHGASKSFLAECKALKNIRHR 720
+ F IG G++G VYK G +VA+K L + G + + E LK + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 721 NLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRIN 780
N+VK++ + LV+EF+ + + + L +
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA----------SALTGIPLPLIKS 106
Query: 781 IAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCS 840
+ + + H H VLH DLKP N+L++ + + DFGLAR ++ +
Sbjct: 107 YLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYT 160
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900
V A ST DI+S G + EMVT + F GD + R
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRIF 216
Query: 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960
D V + + D+ + + RQ + P R+S
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276
Query: 961 ITNV 964
Sbjct: 277 AKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 6e-33
Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ-----RHGASKSFLAECKALKNIRHRNLVK 724
+G G F +VYK IVAIK L + G +++ L E K L+ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 725 VITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAID 784
++ + +LV++FM LT +
Sbjct: 65 LLDAF-----GHKSNISLVFDFMETDLEVIIKDNS-----------LVLTPSHIKAYMLM 108
Query: 785 VASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVR 844
++YLH H +LH DLKP N+LLD + + + DFGLA+
Sbjct: 109 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS----PNRAYTHQV 161
Query: 845 GTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
T Y APE G+ + D+++ G +L E++ GD +L R
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTR 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-33
Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 34/230 (14%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS------KSFLAECKALKN 716
D + + +G G F V K G A K +R +S + E LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 717 IRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLL 776
I+H N++ + ++ L+ E + G L ++L E + LT
Sbjct: 70 IQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA-----------EKESLTEE 113
Query: 777 QRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA----HVGDFGLARVRQEV 832
+ + + +++ + H DLKP N++L + + + DFGLA
Sbjct: 114 EATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
+ GT + APE + D++S G++ +++G P
Sbjct: 171 NEFKNIF-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (313), Expect = 3e-32
Identities = 65/297 (21%), Positives = 110/297 (37%), Gaps = 31/297 (10%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
IG G++G VYK A + G A+K L++ G + + E LK ++H N+VK+
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
+ LV+E + + + L + + + + +
Sbjct: 69 IHT-----KKRLVLVFEHLDQDLKKLLDVCE-----------GGLESVTAKSFLLQLLNG 112
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
I Y H VLH DLKP N+L++ + + DFGLAR T+
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI----PVRKYTHEIVTLW 165
Query: 849 YAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907
Y AP+ +GS+ ST DI+S G + EMV G F G R + +
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRIFRILGTPN 221
Query: 908 IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964
+ + ++ +D + S + + P R++
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 4e-32
Identities = 39/230 (16%), Positives = 76/230 (33%), Gaps = 28/230 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSC 729
IG GSFG +++G + VAIK R + E + K + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 730 SSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAI 789
Q LV + + + +K ++ A + + +
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARV 114
Query: 790 DYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG-----DFGLARVRQEVSNLTQSCSV--- 841
+H +++ D+KP N L+ + DFG+ + ++
Sbjct: 115 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 842 GVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
+ GT Y + LG E S D+ + G + + + G P +
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-32
Identities = 45/217 (20%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITS 728
++G+G G V + + A+K+ E + + ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
++ + G +V E + G L + + + Q T + I + A
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQ---------DRGDQAFTEREASEIMKSIGEA 123
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLD---NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRG 845
I YLH + H D+KP N+L + I + DFG A+ ++LT C
Sbjct: 124 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----- 175
Query: 846 TIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
T Y APE + + D++S G+++ ++ G P
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 58/296 (19%), Positives = 105/296 (35%), Gaps = 27/296 (9%)
Query: 671 IGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITS 728
IG G++G+V+K + IVA+K L G S L E LK ++H+N+V++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
S + LV+EF + + + + + +
Sbjct: 70 LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----------IVKSFLFQLLKG 113
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIG 848
+ + H VLH DLKP N+L++ + + +FGLAR + S V
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWY 167
Query: 849 YAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVIDI 908
ST+ D++S G + E+ +P +F G+ R L
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTE 224
Query: 909 VDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964
+ + D+ + +N + + + +P R+S
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 7e-31
Identities = 65/265 (24%), Positives = 102/265 (38%), Gaps = 38/265 (14%)
Query: 634 RGPSKQQPSRPILRKA----LQKVSYESLFKAT-DGFSSTHLIGMGSFGSVYKGAFDQDG 688
+ S+Q+ + L KA L+K S A D F +G GSFG V + G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 689 TIVAIKVFNLQRHGASK---SFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYE 745
A+K+ + Q+ K L E + L+ + LVK+ S V E
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VME 121
Query: 746 FMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805
++ G + + L I + + A + +YLH +++ DL
Sbjct: 122 YVAGGEMFSHLR-----------RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDL 167
Query: 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGD 865
KP N+L+D V DFG A+ + + + GT APE L + D
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRV-------KGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 866 IYSYGILLLEMVTGKKPTDVMFEGD 890
++ G+L+ EM G P F D
Sbjct: 221 WWALGVLIYEMAAGYPP----FFAD 241
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-31
Identities = 59/263 (22%), Positives = 87/263 (33%), Gaps = 41/263 (15%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGA------SKSFLAECKALKNIR--HRN 721
L+G G FGSVY G D VAIK R E LK +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 722 LVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINI 781
+++++ D L+ E E L +
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFI----------TERGALQEELARSF 115
Query: 782 AIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCS 840
V A+ + H+ VLH D+K N+L+D N + DFG + L +
Sbjct: 116 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL------LKDTVY 166
Query: 841 VGVRGTIGYAAPEYGLGSEVSTNG-DIYSYGILLLEMVTGKKPTDVMFEGD---LNLHNY 896
GT Y+ PE+ ++S GILL +MV G P FE D + +
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVF 222
Query: 897 ARTALLDHVIDIVDPILINDVED 919
R + ++ L D
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSD 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 26/223 (11%)
Query: 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGAS---KSFLAECKALKNIRH 719
+ F L+G G+FG V G A+K+ + A + E + L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 720 RNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRI 779
L + + Q +D V E+ G L L + + T +
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE-----------RVFTEERAR 108
Query: 780 NIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSC 839
++ SA L + V++ D+K N++LD D + DFGL + ++
Sbjct: 109 FYGAEIVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 840 SVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKP 882
GT Y APE ++ D + G+++ EM+ G+ P
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-30
Identities = 68/330 (20%), Positives = 121/330 (36%), Gaps = 35/330 (10%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKA 713
++ ++ + +G G++G+V + G VAIK Q +K E +
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFK-ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
LK++RH N++ ++ + + + LV FM + H +K
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-------------EK 117
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
L + + + + Y+H H DLKPGN+ ++ D + DFGLAR
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891
G T Y APE L + DI+S G ++ EM+TGK F+G
Sbjct: 175 MT-------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSD 223
Query: 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGV--A 949
+L + + E + + K I S + + +
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283
Query: 950 CSVESPQDRMSITNVV-HE-LQSVKNALLE 977
V + R++ + H +S+ + E
Sbjct: 284 MLVLDAEQRVTAGEALAHPYFESLHDTEDE 313
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 1e-29
Identities = 57/282 (20%), Positives = 105/282 (37%), Gaps = 34/282 (12%)
Query: 654 SYESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKA 713
S+ + D + +G G + V++ + V +K+ + K E K
Sbjct: 26 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKI 82
Query: 714 LKNIR-HRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
L+N+R N++ + + ALV+E + N + Q
Sbjct: 83 LENLRGGPNIITLADIVKDPV---SRTPALVFEHVNNTDFKQL--------------YQT 125
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND-MIAHVGDFGLARVRQE 831
LT ++ A+DY H ++H D+KP NV++D++ + D+GLA
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 832 VSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGD 890
+ + PE + + + D++S G +L M+ K+P F G
Sbjct: 183 GQEYNVRV-----ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 234
Query: 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAK 932
N R A + D+ D I ++E N R ++
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-29
Identities = 56/246 (22%), Positives = 88/246 (35%), Gaps = 29/246 (11%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKA 713
+S F + + IG G+ G V VAIK + Q +K E
Sbjct: 10 DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 714 LKNIRHRNLVKVITSCSSID-FQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQK 772
+K + H+N++ ++ + + LV E M +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------- 116
Query: 773 LTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEV 832
+ + + I +LH H DLKP N+++ +D + DFGLAR
Sbjct: 117 -DHERMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 833 SNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892
+T T Y APE LG N DI+S G ++ EMV K F G
Sbjct: 173 FMMTPYV-----VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDY 223
Query: 893 LHNYAR 898
+ + +
Sbjct: 224 IDQWNK 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-29
Identities = 48/245 (19%), Positives = 94/245 (38%), Gaps = 27/245 (11%)
Query: 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFN--LQRHGASKSFLAECKA 713
+++++ + + + +G G++GSV + G VA+K + Q +K E +
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 714 LKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKL 773
LK+++H N++ ++ + + + L N + QKL
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------------QKL 118
Query: 774 TLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVS 833
T + + + Y+H H DLKP N+ ++ D + DFGLAR
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR------ 169
Query: 834 NLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNL 893
+ + V A + DI+S G ++ E++TG+ F G ++
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHI 225
Query: 894 HNYAR 898
Sbjct: 226 DQLKL 230
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 1e-28
Identities = 47/258 (18%), Positives = 101/258 (39%), Gaps = 10/258 (3%)
Query: 669 HLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITS 728
+G G F +V+ + T VA+K+ + +++ E K L+ + + K +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 729 CSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASA 788
++ + D + + + + + + E + + L+ I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 789 IDYLHHHCQEPVLHCDLKPGNVLLD-NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTI 847
+DY+H C ++H D+KP NVL++ D ++ +A + + T
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQTR 193
Query: 848 GYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLDHVID 907
Y +PE LG+ DI+S L+ E++TG FE D + +I+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL----FEPDEGHSYTKDDDHIAQIIE 249
Query: 908 IVDPILINDVEDWDATNK 925
++ + + + T
Sbjct: 250 LLGELPSYLLRNGKYTRT 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-28
Identities = 57/270 (21%), Positives = 106/270 (39%), Gaps = 41/270 (15%)
Query: 638 KQQPSRPILRKALQKVSYESLFKATDGFSSTHLIGMGSFGSVYKG---AFDQDGTIVAIK 694
K + L +KV + F ++G G++G V+ + G + A+K
Sbjct: 6 KHELRTANLTGHAEKVG-------IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 58
Query: 695 VFN----LQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVYEFMTNG 750
V +Q+ ++ E + L++IR + + FQ L+ +++ G
Sbjct: 59 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA----FQTETKLHLILDYINGG 114
Query: 751 SLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNV 810
L L + + I V + L H + +++ D+K N+
Sbjct: 115 ELFTHLS--------------QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160
Query: 811 LLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNG--DIYS 868
LLD++ + DFGL+ +E + GTI Y AP+ G + + D +S
Sbjct: 161 LLDSNGHVVLTDFGLS---KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 217
Query: 869 YGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898
G+L+ E++TG P F D ++ A
Sbjct: 218 LGVLMYELLTGASP----FTVDGEKNSQAE 243
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 2e-22
Identities = 81/386 (20%), Positives = 143/386 (37%), Gaps = 29/386 (7%)
Query: 175 LKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLT-LPHLRLFQVH 233
L E LG N++ + + +L + R S+ G+ L +L
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID---GVEYLNNLTQINFS 74
Query: 234 HNFFSGSIPIS----LSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGE 289
+N + P+ L + A + ++ + N ++ +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 290 SDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIG 349
+ N++++ S L L G + L++ + + S S +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L L L NQ + P + NL+ + L NQL +L +L+ L++L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 410 NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKI 469
N +S + P L L +L L L N ++ P L L+ NL N + I
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPI 303
Query: 470 GNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLS 529
NLK L + NN+S P + + L+ ++ N S SSL++L + +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG 359
Query: 530 RNNLSGLIPKFLEDL-SLEYLNLSFN 554
N +S L P L +L + L L+
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.6 bits (226), Expect = 4e-20
Identities = 76/392 (19%), Positives = 142/392 (36%), Gaps = 30/392 (7%)
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPN--SLGQLKELK 179
F +L + + + + N+T + +L + ++ I + + L L
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL----GIKSIDGVEYLNNLT 69
Query: 180 SLGLGANNLSGIIP----PSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
+ N L+ I P + ++ + N + +
Sbjct: 70 QINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295
+ + LS+ + + + +LS N+ S+++S
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLY 355
++ LA +NL +LI N++ P I L L + NQL + +L L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 356 RLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGV 415
L + NQ + P + L L + L NQ+S P L L+ L+ L LN N L +
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 300
Query: 416 IPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYL 475
P +LK L L L+ N ++ P + +LT L L A N + S + + NL +
Sbjct: 301 SPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKV--SDVSSLANLTNI 353
Query: 476 RVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGN 507
+ N +S P L + + ++ +
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 4e-18
Identities = 71/393 (18%), Positives = 134/393 (34%), Gaps = 41/393 (10%)
Query: 54 NLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGR 113
L+ + L ++ + + L ++ L + + + Y + LT +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 114 NKLMGSIPFEFFSLYKLKQLAM------------QRNNLTGGIPPFIGNLTSLESISLAA 161
N+L P + +L KL + M NLTG +L
Sbjct: 76 NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 162 NAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG 221
N++ + L L G + L+ L + S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 222 LTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVA 281
L +L +N S P+ + L+ + N + + NL+ ++A
Sbjct: 194 AKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLA 249
Query: 282 YNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLH 341
N + S + L+ + L L AN++ P L+ + N+
Sbjct: 250 NNQI--------SNLAPLSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQ 296
Query: 342 GSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSI 401
S I NL L L + N + P + L L+ + +N++S SSL NL+
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 402 LSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
++ L +N +S + P L +L ++ L L +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 79.7 bits (195), Expect = 3e-16
Identities = 70/378 (18%), Positives = 132/378 (34%), Gaps = 39/378 (10%)
Query: 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDL 92
+VT L G+ S+ + L+ L +IN NN + P L +L + +++N
Sbjct: 45 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ- 99
Query: 93 VGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152
I + + L + +L L +L + N + I L+
Sbjct: 100 ---IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTI-----SDISALS 151
Query: 153 SLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQF 212
L S+ + L L L+ L + +N + L+ L + NQ
Sbjct: 152 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKLTNLESLIATNNQI 209
Query: 213 HGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGM 272
P + L L L + N +L++ + L ++ +N S G+
Sbjct: 210 SDITPLGILTNLDELSL---NGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGL 262
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQN 332
L+ + N + ++++ + L L S + L
Sbjct: 263 TKLTELKLGANQI-----------SNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
L + N + P + +L L RL N+ + + L N+ + NQ+S
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 393 PSSLGNLSILSELLLNNN 410
P L NL+ +++L LN+
Sbjct: 368 P--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 1e-13
Identities = 42/194 (21%), Positives = 66/194 (34%), Gaps = 30/194 (15%)
Query: 13 WNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEI 72
+ + IT + L+L L + +L+ L +++L NN I
Sbjct: 200 ESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257
Query: 73 PREFGRLFRLEALFLSDNDLVGEIP--------------------ANLSYCSRLTILFLG 112
P L +L L L N + P + +S LT L L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315
Query: 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL 172
N + P SL KL++L N ++ + NLT++ +S N P L
Sbjct: 316 FNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 173 GQLKELKSLGLGAN 186
L + LGL
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 1e-09
Identities = 35/166 (21%), Positives = 58/166 (34%), Gaps = 28/166 (16%)
Query: 18 HFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIP---- 73
+ + K I +T L+L + +S + L+ L E+ L N I P
Sbjct: 227 NGNQLKDIGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPLAGL 284
Query: 74 ----------------REFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117
L L L L N++ P +S ++L LF NK+
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV- 341
Query: 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANA 163
S +L + L+ N ++ P + NLT + + L A
Sbjct: 342 -SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.1 bits (108), Expect = 1e-05
Identities = 53/304 (17%), Positives = 103/304 (33%), Gaps = 36/304 (11%)
Query: 272 MKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQ 331
+ ++ + S ++ + +NL + F+ N+L P + NL+ +L
Sbjct: 43 LDQVTTLQADRLGIKS--------IDGVEYLNNLTQINFSNNQLTDITP--LKNLT-KLV 91
Query: 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMG---------KLQNLEGMG 382
+++M +NQ+ P + L + + ++ +
Sbjct: 92 DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALS 151
Query: 383 LYDNQLSGEIPSSLGNLSILSEL----LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438
+ + + +L L+ L L+ +S S L L L L N ++
Sbjct: 152 GLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISD 211
Query: 439 TIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCS 497
P I NL L +L N L + +L L ++++N +S P L +
Sbjct: 212 ITPLGILTNLDEL----SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLT 263
Query: 498 YLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLE 557
L E+ + N P + + N I +L YL L FN++
Sbjct: 264 KLTELKLGANQISNISPLAGLTALT---NLELNENQLEDISPISNLKNLTYLTLYFNNIS 320
Query: 558 GEVP 561
P
Sbjct: 321 DISP 324
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 4e-20
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 16/263 (6%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
+ L NK+ NL L LI+ +N++ P LV L RL + N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
Q K LQ L ++ + + L + ++ EL N SG+
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148
Query: 423 LKQLAILHLFENGLNGTIPEEIF-NLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVS 481
+K+L+ + + + + TIP+ + +LT L +L N + + L L +S
Sbjct: 149 MKKLSYIRIADTNIT-TIPQGLPPSLTEL----HLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 482 SNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPK-- 539
N++S L +L E+++ N +P L+ + + + L NN+S +
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 540 -----FLEDLSLEYLNLSFNDLE 557
+ S ++L N ++
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 1e-18
Identities = 51/306 (16%), Positives = 92/306 (30%), Gaps = 39/306 (12%)
Query: 20 CEWKGITCGLRH---------RRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQG 70
C + + C +L+L++ ++ NL L + L+NN I
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 71 EIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKL 130
P F L +LE L+LS N L L + K+ S+ F + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIV 128
Query: 131 KQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSG 190
+L +G + L I +A IP L L L L N ++
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITK 185
Query: 191 IIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASK 250
+ S+ L+ LA + N G L ++H N
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISA---VDNGSLANTPHLRELHLNNNKLVKVP------- 235
Query: 251 LEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIF 310
K + + NN+ + S++ ++ +
Sbjct: 236 ----------------GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279
Query: 311 AANKLR 316
+N ++
Sbjct: 280 FSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.1 bits (196), Expect = 8e-17
Identities = 39/235 (16%), Positives = 81/235 (34%), Gaps = 5/235 (2%)
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383
+L L + +N++ NL L+ L + N+ + P L LE + L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEE 443
NQL L L + + + L + + L +G
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGA 145
Query: 444 IFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIY 503
+ LS +A ++ +IP G L ++ N ++ + L + L ++
Sbjct: 146 FQGMKKLSYI-RIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 504 MRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFNDLEG 558
+ N SL++ + + L+ N L + + ++ + L N++
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 1e-16
Identities = 62/327 (18%), Positives = 110/327 (33%), Gaps = 47/327 (14%)
Query: 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSL 172
+ + +P + L +Q N +T NL +L ++ L N P +
Sbjct: 18 SDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQV 232
L +L+ L L N L LP + TL LR+ +
Sbjct: 76 APLVKLERLYLSKNQLK-------------------------ELPEKMPKTLQELRVHEN 110
Query: 233 HHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDE 292
S+ L+ +E SG + F GMK LSY +A N+ +
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTN-PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG- 168
Query: 293 MSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLV 352
+L L NK+ S+ L + L L ++ N + + N
Sbjct: 169 --------LPPSLTELHLDGNKITKVDAASLKGL-NNLAKLGLSFNSISAVDNGSLANTP 219
Query: 353 GLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG------EIPSSLGNLSILSELL 406
L L + N+ +P + + ++ + L++N +S P + S +
Sbjct: 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 278
Query: 407 LNNNSLS--GVIPSCLGSLKQLAILHL 431
L +N + + PS + A + L
Sbjct: 279 LFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 48/285 (16%), Positives = 92/285 (32%), Gaps = 15/285 (5%)
Query: 58 LREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLM 117
LR + + ++ ++P++ L L +N + + L L L NK+
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 118 GSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKE 177
P F L KL++L + +N L L L ++ N L Q+
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 178 LKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFF 237
+ LG SGI + + L+ + ++P L P L + N
Sbjct: 129 V-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKI 183
Query: 238 SGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMN 297
+ SL + L + NS S + + +L ++ N L +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-------VKVPG 236
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG 342
LA+ ++ + N + + + + L
Sbjct: 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.4 bits (189), Expect = 6e-16
Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 9/245 (3%)
Query: 337 SNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
S+ +P + L + N+ T + L+NL + L +N++S P +
Sbjct: 18 SDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNL 456
L L L L+ N L + +L++L + + ++ + + + L
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--ELGT 133
Query: 457 ARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516
G +K L ++ N++ IP GL L E+++ GN +S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190
Query: 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDLS-LEYLNLSFNDLEGEVPTKGVFANISRISVA 575
L L + + LS N++S + L + L L+L+ N L I + +
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 576 GFNRL 580
N +
Sbjct: 251 N-NNI 254
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 88.3 bits (217), Expect = 2e-19
Identities = 67/319 (21%), Positives = 108/319 (33%), Gaps = 36/319 (11%)
Query: 7 QGILNSWNDSGHFCE--WKGITC--GLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREIN 62
L+SW + C W G+ C + RV L+L L
Sbjct: 21 PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY-------------- 66
Query: 63 LMNNSIQGEIPREFGRLFRLEALFLSDND-LVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
IP L L L++ + LVG IP ++ ++L L++ + G+IP
Sbjct: 67 --------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSL 181
+ L L N L+G +PP I +L +L I+ N G IP+S G +L +
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 182 GLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSI 241
+ N + + L V ++ S+
Sbjct: 179 MTISRN--RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
+ + L ++ +N G L +K L NV++NNL GE + N
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL-CGE------IPQGGN 289
Query: 302 CSNLRTLIFAANKLRGALP 320
+A NK P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 3e-16
Identities = 59/267 (22%), Positives = 97/267 (36%), Gaps = 11/267 (4%)
Query: 170 NSLGQLKELKSLGLGANNLSGI--IPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227
++ Q + +L L NL IP S+ NL L + P L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287
+ H SG+IP LS L ++ N+ SG L + + NL N +
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 288 GESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSG 347
D + L + N+L G +P + AN + S + S
Sbjct: 164 AIPDSYGSFSKLFTSMT-----ISRNRLTGKIPPTFAN---LNLAFVDLSRNMLEGDASV 215
Query: 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLL 407
+ + ++G +NL G+ L +N++ G +P L L L L +
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 408 NNNSLSGVIPSCLGSLKQLAILHLFEN 434
+ N+L G IP G+L++ + N
Sbjct: 276 SFNNLCGEIPQ-GGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.6 bits (192), Expect = 3e-16
Identities = 63/276 (22%), Positives = 104/276 (37%), Gaps = 15/276 (5%)
Query: 149 GNLTSLESISLAANAFGGN--IPNSLGQLKELKSLGLGAN-NLSGIIPPSIYNLSLLANF 205
+ ++ L+ IP+SL L L L +G NL G IPP+I L+ L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 206 SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKL 265
+ G+ P + L +N SG++P S+S+ L I N SG +
Sbjct: 107 YITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 266 SVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIAN 325
++G L N +G+ +LA R ++ + +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 326 LSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYD 385
+ +L ++ S +L N+ GT+P+ + +L+ L + +
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDL--------RNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 386 NQLSGEIPSSLGNLSILSEL-LLNNNSLSGV-IPSC 419
N L GEIP GNL NN L G +P+C
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 1e-13
Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 31/299 (10%)
Query: 297 NSLANCSNLRTLIFAANKLRGA--LPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGL 354
++ + L + L +P S+ANL I N L G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 355 YRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSG 414
+ L + +G IP + +++ L + N LSG +P S+ +L L + + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 415 VIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKY 474
IP GS +L N + L+ + +++ + +
Sbjct: 164 AIPDSYGSFSKLFTSMTISR--NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 475 LRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLS 534
+ N ++GL L + +R N +G++P L+ L+ + ++++S NNL
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 535 GLIPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRLCGGIPELQLPKCT 593
G IP+ + + N LCG LP CT
Sbjct: 282 GEIPQGGNLQRFDVSAYANN-----------------------KCLCGS----PLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 5e-09
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 3/92 (3%)
Query: 13 WNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEI 72
+ + + L+LR+ + G+L + L FL +N+ N++ GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 73 PREFGRLFRLEALFLSDNDLVGEIPANLSYCS 104
P + G L R + ++N + P L C+
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 41/132 (31%), Positives = 58/132 (43%), Gaps = 2/132 (1%)
Query: 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNG--TIPEEIFNLTYLSNSLNLARNHLVGSIP 466
N + GV+ ++ L L L IP + NL YL+ N+LVG IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 467 TKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAI 526
I L L ++ N+SG IP L L + N G++P S+SSL ++ I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 527 DLSRNNLSGLIP 538
N +SG IP
Sbjct: 155 TFDGNRISGAIP 166
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 3e-18
Identities = 47/257 (18%), Positives = 80/257 (31%), Gaps = 6/257 (2%)
Query: 303 SNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGN 362
+ + + N++ S + + ++ + G +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 363 QFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGS 422
Q P L L + L L P L+ L L L +N+L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 423 LKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSS 482
L L L L N ++ L L L +N + P +L L + +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 483 NNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVL-AIDLSRNNLSGLIPKFL 541
NNLS L L+ + + N + L A L S + + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQRL 268
Query: 542 EDLSLEYLNLSFNDLEG 558
L L+ NDL+G
Sbjct: 269 AGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (195), Expect = 8e-17
Identities = 53/263 (20%), Positives = 91/263 (34%), Gaps = 11/263 (4%)
Query: 273 KNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQN 332
+ N + + S C NL L +N L + L+ Q
Sbjct: 32 AASQRIFLHGNRISHVPA------ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
+ + QL P+ L L+ L + P L L+ + L DN L
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 393 PSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSN 452
+ +L L+ L L+ N +S V L L L L +N + P +L L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 453 SLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGS 512
L N+L + L+ L+ ++ N + + L ++L++ + S
Sbjct: 206 L-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCS 263
Query: 513 IPSSLSSLRAVLAIDLSRNNLSG 535
+P L+ L+ N+L G
Sbjct: 264 LPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (175), Expect = 3e-14
Identities = 42/271 (15%), Positives = 85/271 (31%), Gaps = 13/271 (4%)
Query: 168 IPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHL 227
+P + + + L N +S + S L + N +
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 228 RLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGS 287
+L + P + +L + F G+ L Y + N L +
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 288 GESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSG 347
D + + NL L N++ + L L L++ N++ P
Sbjct: 144 LPDD------TFRDLGNLTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRVAHVHPHA 196
Query: 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLL 407
+L L L + N + + + L+ L+ + L DN + + + L +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRG 255
Query: 408 NNNSLSGVIPSCLGSLKQLAILHLFENGLNG 438
+++ + +P L + L N L G
Sbjct: 256 SSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 4e-13
Identities = 52/272 (19%), Positives = 82/272 (30%), Gaps = 34/272 (12%)
Query: 20 CEWKGIT---CGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEI---- 72
C +G+ G+ + L +S + L + L +N +
Sbjct: 18 CPQQGLQAVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 73 ---------------------PREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111
P F L RL L L L P + L L+L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNS 171
N L F L L L + N ++ L SL+ + L N P++
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 172 LGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQ 231
L L +L L ANNLS + ++ L L + N + L+ F+
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD--CRARPLWAWLQKFR 254
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSFSG 263
+ S+P L+ + N G
Sbjct: 255 GSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 9e-13
Identities = 38/202 (18%), Positives = 66/202 (32%), Gaps = 4/202 (1%)
Query: 13 WNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEI 72
R+ L+L GL L+ L+ + L +N++Q
Sbjct: 86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 73 PREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQ 132
F L L LFL N + L L L +N++ P F L +L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 133 LAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGII 192
L + NNL+ + L +L+ + L N + + L+ ++ + +
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSL 264
Query: 193 PPSIYNLSLLANFSVPRNQFHG 214
P + L + N G
Sbjct: 265 PQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (151), Expect = 3e-11
Identities = 52/248 (20%), Positives = 93/248 (37%), Gaps = 5/248 (2%)
Query: 343 SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSIL 402
++P GI R+ + GN+ + +NL + L+ N L+ ++ L++L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 403 SELLLNNNSLSGVI-PSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
+L L++N+ + P+ L +L LHL GL P L L L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL-YLQDNAL 141
Query: 462 VGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLR 521
+L L + N +S L+ + + N P + L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 522 AVLAIDLSRNNLSGL-IPKFLEDLSLEYLNLSFNDLEGEVPTKGVFANISRISVAGFNRL 580
++ + L NNLS L +L+YL L+ N + + ++A + + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261
Query: 581 CGGIPELQ 588
C L
Sbjct: 262 CSLPQRLA 269
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 8e-18
Identities = 25/170 (14%), Positives = 50/170 (29%), Gaps = 38/170 (22%)
Query: 670 LIGMGSFGSVYKGAFDQDGTIVAIKVFNL----------QRHGASKSFLAECKALKNIRH 719
L+G G +V+ + + +K + +R F
Sbjct: 7 LMGEGKESAVFN-CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 720 RNLVKV--ITSCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQ 777
R L K+ + ++GN A++ E + L
Sbjct: 66 RALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRVRVE------------------N 104
Query: 778 RINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827
+ + + +H ++H DL NVL+ + I + DF +
Sbjct: 105 PDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 37/209 (17%), Positives = 69/209 (33%), Gaps = 7/209 (3%)
Query: 348 IGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLL 407
+ + + T +P ++ K + + L +N L ++L + L++L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 408 NNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPT 467
+ L+ + +L L L L N L ++ N L
Sbjct: 63 DRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS--FNRLTSLPLG 118
Query: 468 KIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAID 527
+ L L+ + N L P L LE++ + N L+ L + +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 528 LSRNNLSGLIPKFLEDLSLEYLNLSFNDL 556
L N+L + F L + L N
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 43/210 (20%), Positives = 72/210 (34%), Gaps = 8/210 (3%)
Query: 52 IGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFL 111
+ ++ E+N ++ +P + + L LS+N L A L +RLT L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 112 GRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNS 171
R +L + +N +P L +L + ++ N +
Sbjct: 63 DRAELTKLQVDGTL---PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 172 LGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQ 231
L L EL+ L L N L + P + L S+ N L L +L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDTLL 178
Query: 232 VHHNFFSGSIPISLSNASKLEFIEALDNSF 261
+ N +IP + L F N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 8e-07
Identities = 38/198 (19%), Positives = 65/198 (32%), Gaps = 14/198 (7%)
Query: 215 SLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKN 274
+LPP L L L N +L ++L + + G +
Sbjct: 24 ALPPDLPKDTTILHL---SENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPV 78
Query: 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLI 334
L ++++N L S + + L +LP +LQ L
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT--------SLPLGALRGLGELQELY 130
Query: 335 MTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPS 394
+ N+L P + L +L + N T + L+NL+ + L +N L IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 395 SLGNLSILSELLLNNNSL 412
+L L+ N
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 43/210 (20%), Positives = 76/210 (36%), Gaps = 9/210 (4%)
Query: 301 NCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG 360
++ + L ALP +L L ++ N L+ + + L +L +
Sbjct: 8 KVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 361 GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL 420
+ T + G L L + L NQL ++ + + N L+ + L
Sbjct: 64 RAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV-SFNRLTSLPLGAL 120
Query: 421 GSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNV 480
L +L L+L N T+P + T L+LA N+L + L+ L +
Sbjct: 121 RGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 481 SSNNLSGEIPSQLGLCSYLEEIYMRGNFFH 510
N+L IP L ++ GN +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 41/209 (19%), Positives = 68/209 (32%), Gaps = 26/209 (12%)
Query: 26 TCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEAL 85
+ V N + L+ +L P + ++L N + RL L
Sbjct: 5 EVSKVASHLEV-NCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 86 FLSDN---------------------DLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEF 124
L + + +P LT+L + N+L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 125 FSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLG 184
L +L++L ++ N L P + LE +SLA N L L+ L +L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 185 ANNLSGIIPPSIYNLSLLANFSVPRNQFH 213
N+L IP + LL + N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 25/118 (21%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 383 LYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPE 442
L L+ + L L +++ L L++N L + P+ L L L + + N
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALENV 58
Query: 443 EIFNLTYLSNSLNLARNHLVG-SIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYL 499
+ L L N L + + + L + N+ N+L E Q L L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 22/108 (20%), Positives = 40/108 (37%), Gaps = 7/108 (6%)
Query: 454 LNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSI 513
L+LA L ++ + L + ++S N L P+ L + ++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA---LAALRCLEVLQASDNALEN 57
Query: 514 PSSLSSLRAVLAIDLSRNNLSGL-IPKFLEDL-SLEYLNLSFNDLEGE 559
+++L + + L N L + L L LNL N L E
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 36 VLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGE 95
VL+L K L+ ++ L + ++L +N ++ P L LE L SDN E
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LE 56
Query: 96 IPANLSYCSRLTILFLGRNKLMGSIPFEFFS-LYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
++ RL L L N+L S + +L L +Q N+L L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 7/124 (5%)
Query: 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEI 392
L + L ++ + L+ + L + N+ P + L+ LE + DN E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LEN 57
Query: 393 PSSLGNLSILSELLLNNNSLSGV-IPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLS 451
+ NL L ELLL NN L L S +L +L+L N L L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
Query: 452 NSLN 455
S++
Sbjct: 117 PSVS 120
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 9/89 (10%)
Query: 362 NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLG 421
N + I +LE + + +N+L E+P+ L L+ + N L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPELPQ 324
Query: 422 SLKQLAILHLFENGLNGTIPEEIFNLTYL 450
+LKQ LH+ N L P+ ++ L
Sbjct: 325 NLKQ---LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 26/93 (27%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 62 NLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIP 121
N+ EI LE L +S+N L+ E+PA RL L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHL-AEVP 320
Query: 122 FEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL 154
LKQL ++ N L P ++ L
Sbjct: 321 ---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 20/94 (21%), Positives = 31/94 (32%), Gaps = 10/94 (10%)
Query: 110 FLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIP 169
N I L++L + N L +P L L + N +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVP 320
Query: 170 NSLGQLKELKSLGLGANNLSGI--IPPSIYNLSL 201
LK+L + N L IP S+ +L +
Sbjct: 321 ELPQNLKQLH---VEYNPLREFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 23/94 (24%), Positives = 39/94 (41%), Gaps = 11/94 (11%)
Query: 430 HLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEI 489
+ N + I L LN++ N L+ +P L+ L S N+L+ E+
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLE-ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EV 319
Query: 490 PSQLGLCSYLEEIYMRGNFFHG--SIPSSLSSLR 521
P L L+++++ N IP S+ LR
Sbjct: 320 PE---LPQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 86 FLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP 145
N EI + L L + NKL+ +P +L++L N+L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VP 320
Query: 146 PFIGNLTSLESISLAANAFGGNIPNSLGQLKELK 179
NL L + N P+ +++L+
Sbjct: 321 ELPQNLKQL---HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 27/197 (13%), Positives = 59/197 (29%), Gaps = 13/197 (6%)
Query: 242 PISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLAN 301
++ ++ + + A + + + NL + N + + +
Sbjct: 34 TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAPLKNLTKITELE 91
Query: 302 CSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMG- 360
S +A ++ + + + + + + L
Sbjct: 92 LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 361 ------GNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSG 414
+ + L L + DN++S P L +L L E+ L NN +S
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209
Query: 415 VIPSCLGSLKQLAILHL 431
V P L + L I+ L
Sbjct: 210 VSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 32/217 (14%), Positives = 72/217 (33%), Gaps = 22/217 (10%)
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L ++ G + T T+ + L + + + ++ + L+ L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 410 NSL------SGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463
N + + L + ++ +I T +++ LA +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 464 SIPTKIGNLKYLRVF-------NVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516
+ + + + +S N + L S L + N P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552
L+SL ++ + L N +S + P L + +L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 39/236 (16%), Positives = 78/236 (33%), Gaps = 26/236 (11%)
Query: 174 QLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVH 233
L + G +N++ + + +L + S ++ L +L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLN--NLIGLELK 71
Query: 234 HNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEM 293
N + P+ + ++ ++
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST------------QI 119
Query: 294 SFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVG 353
+ + LA SNL+ L N++ +I+ L+ ++ S + + NL
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTPLANLSK 174
Query: 354 LYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNN 409
L L N+ + P + L NL + L +NQ+S P L N S L + L N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 26/201 (12%), Positives = 61/201 (30%), Gaps = 20/201 (9%)
Query: 375 LQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFEN 434
L N + + ++ + + +L ++ L ++ + + L L L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 435 GLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLG 494
+ P + ++ + L ++ + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 495 LCSYLEEIYMRGNFFHG-------------SIPSSLSSLRAVLAIDLSRNNLSGLIPKFL 541
L L +I S + L++L + + N +S + P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 542 EDL-SLEYLNLSFNDLEGEVP 561
L +L ++L N + P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 16/61 (26%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 99 NLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESIS 158
L+ S+LT L NK+ P SL L ++ ++ N ++ P + N ++L ++
Sbjct: 168 PLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 159 L 159
L
Sbjct: 224 L 224
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 35/217 (16%), Positives = 74/217 (34%), Gaps = 24/217 (11%)
Query: 343 SIPSGIG------NLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSL 396
++P+ I + + T + + +L +++ + ++ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 397 GNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNL 456
L +++L LN N L+ L +LK L L L EN + + + +
Sbjct: 65 QYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 457 ARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSS 516
+ + G + NN +I L +
Sbjct: 123 GISDINGLVH------LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAG 176
Query: 517 LSSLRAVLAIDLSRNNLSGLIPKFLEDL-SLEYLNLS 552
L+ L+ + LS+N++S L + L L +L+ L L
Sbjct: 177 LTKLQN---LYLSKNHISDL--RALAGLKNLDVLELF 208
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 38/328 (11%), Positives = 92/328 (28%), Gaps = 29/328 (8%)
Query: 125 FSLY--KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGN----IPNSLGQLKEL 178
FS+ LK A+ + + + S++ I L+ N G + ++ K+L
Sbjct: 3 FSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 179 KSLGLGAN---NLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235
+ + IP ++ L A P+ + G T + + +
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQ-ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG------E 289
+ + + + ++ L N L +G +
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 290 SDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIG 349
+ + + L L ++ ++ +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 350 NLVGLYRLGMGGNQFTGTIPKEMG------KLQNLEGMGLYDNQLSGEIPSSL-----GN 398
+ L LG+ + + + L+ + L N++ + +L
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 399 LSILSELLLNNNSLSGVIPSCLGSLKQL 426
+ L L LN N S + ++++
Sbjct: 301 MPDLLFLELNGNRFSE-EDDVVDEIREV 327
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 13/81 (16%), Positives = 29/81 (35%), Gaps = 9/81 (11%)
Query: 354 LYRLGMGGNQFTGT----IPKEMGKLQNLEGMGLYDNQLSGEIPSSLG-----NLSILSE 404
L L + + + + + +L + L +N L L +L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 405 LLLNNNSLSGVIPSCLGSLKQ 425
L+L + S + L +L++
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 14/88 (15%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 453 SLNLARNHLVGSIPTKI-GNLKYLRVFNVSSNNLSGE----IPSQLGLCSYLEEIYMRGN 507
SL++ L + ++ L+ +V + L+ I S L + L E+ +R N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 508 FFHGSIPSSLSSLRAVLAIDLSRNNLSG 535
+ + + + +L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 11/97 (11%)
Query: 13 WNDSGHFCEWKGITCGLRHRRVTVLNLRSKGLSG----SLSPYIGNLSFLREINLMNNSI 68
D+G +G+ + VL L +S SL+ + LRE++L NN +
Sbjct: 352 LEDAGVRELCQGLGQP--GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409
Query: 69 QGEIPREFGRLFR-----LEALFLSDNDLVGEIPANL 100
+ R LE L L D E+ L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 9/91 (9%)
Query: 471 NLKYLRVFNVSSNNLSGE----IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSS-----LR 521
LRV ++ ++S + + L L E+ + N + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 522 AVLAIDLSRNNLSGLIPKFLEDLSLEYLNLS 552
+ + L S + L+ L + +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 13/89 (14%), Positives = 31/89 (34%), Gaps = 11/89 (12%)
Query: 475 LRVFNVSSNNLSGEIPSQL-GLCSYLEEIYMRGNFFHG----SIPSSLSSLRAVLAIDLS 529
++ ++ LS ++L L + + + I S+L A+ ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 530 RNNLSGLIPKFLED------LSLEYLNLS 552
N L + + ++ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 17/90 (18%), Positives = 32/90 (35%), Gaps = 6/90 (6%)
Query: 377 NLEGMGLYDNQLSGE-IPSSLGNLSILSELLLNNNSLSGV----IPSCLGSLKQLAILHL 431
+++ + + +LS L L + L++ L+ I S L LA L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 432 FENGLNGTIPEEIFNLTYLSNSLNLARNHL 461
N L + + S + + L
Sbjct: 63 RSNELGDVGVHCVLQGL-QTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 6/88 (6%)
Query: 268 NFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRG----ALPHSI 323
L +A ++ S S +L +LR L + N L L S+
Sbjct: 364 LGQPGSVLRVLWLADCDVSD--SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 324 ANLSDQLQNLIMTSNQLHGSIPSGIGNL 351
L+ L++ + + L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 15/82 (18%), Positives = 27/82 (32%), Gaps = 10/82 (12%)
Query: 490 PSQLGLCSYLEEIYMRGNFFHG----SIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL- 544
S L +++ S+ ++L + ++ +DLS N L L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 545 -----SLEYLNLSFNDLEGEVP 561
LE L L E+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 20/93 (21%), Positives = 35/93 (37%), Gaps = 3/93 (3%)
Query: 49 SPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTI 108
+ N RE++L I I L + +A+ SDN++ RL
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 109 LFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141
L + N++ +L L +L + N+L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 25/136 (18%), Positives = 45/136 (33%), Gaps = 8/136 (5%)
Query: 298 SLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRL 357
N R L K+ + + A L DQ + + N++ G L L L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATL-DQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68
Query: 358 GMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSG-EIPSSLGNLSILSELLLNN---NSLS 413
+ N+ L +L + L +N L L +L L+ L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 414 GVIPSCLGSLKQLAIL 429
+ + Q+ +L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 5e-04
Identities = 20/106 (18%), Positives = 41/106 (38%), Gaps = 3/106 (2%)
Query: 35 TVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94
L+L K L ++ + + + + + + F FR++ + LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 95 E-IPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNN 139
+ LS CS+L L L +L I L +L + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 36/256 (14%), Positives = 69/256 (26%), Gaps = 42/256 (16%)
Query: 257 LDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLR 316
SF + + + +++ + + + L+ CS L+ L +L
Sbjct: 30 CPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS-----TLHGILSQCSKLQNLSLEGLRLS 84
Query: 317 GALPHSIANLS-------DQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIP 369
+ +++A S + Q S S + L + +
Sbjct: 85 DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 144
Query: 370 KEMGKLQNLEGMGLYDN-------------------------QLSGEIPSSLGNLSILSE 404
+ L G N L + L+ L
Sbjct: 145 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204
Query: 405 LLLNN-NSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463
L L+ + LG + L L +F +GT+ L L + +H
Sbjct: 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP----HLQINCSHFTT 260
Query: 464 SIPTKIGNLKYLRVFN 479
IGN K ++
Sbjct: 261 IARPTIGNKKNQEIWG 276
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 17/146 (11%), Positives = 36/146 (24%), Gaps = 3/146 (2%)
Query: 103 CSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFI-GNLTSLESISLAA 161
+ L R+ + L +L ++ + L L ++++
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 162 NAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLG 221
+ P++ L L + N + L + N H S
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLN-LSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 222 LTLPHLRLFQVHHNFFSGSIPISLSN 247
L V L++
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 24/134 (17%), Positives = 41/134 (30%), Gaps = 6/134 (4%)
Query: 368 IPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLA 427
+ M K + L L L +I L ++ + + ++ +L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 428 ILHLFENGLNGT--IPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNL 485
L+L N L + + L LNL+ N L L + N+L
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLK-ILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 486 SGEIPSQLGLCSYL 499
S Q S +
Sbjct: 128 SDTFRDQSTYISAI 141
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 988 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.84 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.43 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.27 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=427.76 Aligned_cols=266 Identities=28% Similarity=0.450 Sum_probs=208.1
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
...++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++||||+++++++..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------ 75 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------ 75 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------
Confidence 34678999999999999999999864 35999998643 33445789999999999999999999998642
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|+|.+++.... .++++.++..|+.|||+||+|||++ +||||||||+|||++.++.
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~ 142 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIE----------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 142 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSS
T ss_pred cEEEEEEecCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCC
Confidence 56799999999999999996554 3689999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+||+|||+|+........ .......||+.|||||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 143 ~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~----- 215 (276)
T d1uwha_ 143 VKIGDFGLATVKSRWSGS--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR----- 215 (276)
T ss_dssp EEECCCCCSCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred EEEccccceeeccccCCc--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----
Confidence 999999999866543221 12234569999999999864 35789999999999999999999998743111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.......... ...+.. ......+|+++.+++.+||+.||++||||+||++.|+.+.++
T Consensus 216 ~~~~~~~~~~---~~~p~~-------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 216 DQIIFMVGRG---YLSPDL-------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHT---SCCCCG-------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcC---CCCCcc-------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1111111110 000100 112346788999999999999999999999999999999876
Q ss_pred hh
Q 001974 975 LL 976 (988)
Q Consensus 975 ~~ 976 (988)
++
T Consensus 274 ~P 275 (276)
T d1uwha_ 274 LP 275 (276)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=420.53 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=204.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++. +++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 3679999999999999999999999999999999975432 33467899999999999999999999954 45889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +||||||||+|||+++++.+||
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL 144 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI-----------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI 144 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT-----------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred EEEEeccCCCcHHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEE
Confidence 99999999999999997543 689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+|+....... .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.........+....
T Consensus 145 ~DFG~a~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-- 220 (271)
T d1nvra_ 145 SDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-- 220 (271)
T ss_dssp CCCTTCEECEETTE--ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--
T ss_pred ccchhheeeccCCc--cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--
Confidence 99999987654322 112234579999999999988776 5789999999999999999999974332211111100
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... .......+++++.+++.+||+.||++|||++|+++
T Consensus 221 ----------~~~~------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 ----------EKKT------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----------TTCT------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------cCCC------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 00111245678899999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=419.04 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=208.6
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++. .++..+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEE
Confidence 357999999999999999999999999999999998766666678999999999999999999999954 457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++.. ..+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+
T Consensus 94 ivmEy~~gg~L~~~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~ 158 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (293)
T ss_dssp EEEECCTTCBHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCcHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeec
Confidence 99999999999988753 2589999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTAL 901 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 901 (988)
|||+|+........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ........
T Consensus 159 DFG~a~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~ 229 (293)
T d1yhwa1 159 DFGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIA 229 (293)
T ss_dssp CCTTCEECCSTTCC----BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHH
T ss_pred cchhheeecccccc----ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHH
Confidence 99999876443221 2235699999999999999999999999999999999999999863211 11111100
Q ss_pred hhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 902 LDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 902 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... ......+..+++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~-------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 230 TNG-------------------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHC-------------------------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hCC-------------------------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0001122356788999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=415.75 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=201.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++||||++++|+|.. ++..+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~ 76 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC 76 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceE
Confidence 467899999999999999999986 67889999997543 345789999999999999999999999754 47789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++.... ..+++..+..|+.|||.||+|||+. +|+||||||+||++++++.+||+
T Consensus 77 lv~E~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~ 143 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS 143 (263)
T ss_dssp EEEECCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEEC
T ss_pred EEEEecCCCcHHHHhhccc----------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEec
Confidence 9999999999999987654 3689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhC-CCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG-KKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||... .......
T Consensus 144 DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~-- 213 (263)
T d1sm2a_ 144 DFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVE-- 213 (263)
T ss_dssp SCC---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHH--
T ss_pred ccchheeccCCCcee---ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHH--
Confidence 999998665432221 2235689999999999999999999999999999999995 5554321 1111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.+... .....+..+++++.+++.+||+.||++||||+||++.|++|.++
T Consensus 214 ---~i~~~----------------------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 214 ---DISTG----------------------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---HHHHT----------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHhc----------------------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11100 01112335678899999999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=415.31 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=206.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++. +++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence 5699999999999999999999999999999998633 2344567899999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++... ..+++.++..|+.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~-----------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKL-----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEeecCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEe
Confidence 99999999999999998643 3689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+...... .....||+.|||||++.+..++.++|||||||++|||++|+.||... ........
T Consensus 147 l~DFG~a~~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~ 215 (263)
T d2j4za1 147 IADFGWSVHAPSSR------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKR 215 (263)
T ss_dssp ECCCCSCSCCCCCC------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH
T ss_pred ecccceeeecCCCc------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHHHHH
Confidence 99999998654322 12346999999999999999999999999999999999999998632 11111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+ .......+..+++++.+++.+||+.||++|||++|+++
T Consensus 216 -----i-----------------------~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 -----I-----------------------SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----H-----------------------HTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H-----------------------HcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 01111223356788999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-49 Score=422.15 Aligned_cols=261 Identities=23% Similarity=0.465 Sum_probs=199.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe---EEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT---IVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.+.||+|+||+||+|+++.+++ .||||.+.... ....+.|.+|++++++++|||||+++|+|.. ++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence 457778999999999999999976654 68999886433 3345679999999999999999999999643 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... ..+++.++..|+.|||+||+|||++ +||||||||+|||++.++++
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~----------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred EEEEEEEecCCCcceeeecccc----------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcE
Confidence 8899999999999999887654 3689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccc-eeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQ-SCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
||+|||+|+.......... ....+..||+.|||||++.+..++.++|||||||++|||+| |+.||..... ...
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~ 242 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDV 242 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHH
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----HHH
Confidence 9999999987654332221 12233468999999999999999999999999999999998 8999864211 111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKN 973 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 973 (988)
.. .+.. ......+.+++.++.+++.+||+.||++||||+||++.|+++.+
T Consensus 243 ~~-----~i~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 243 IN-----AIEQ----------------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HH-----HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH-----HHHc----------------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 10 0100 01112234678899999999999999999999999999998865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=416.98 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=210.3
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.+.+|++++++++||||++++|++.. +.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 34567899999999999999999986 77899999997543 345789999999999999999999998642 45
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++.... ..++++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+|
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~---------~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~K 149 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS---------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeeccccee
Confidence 789999999999999876432 14689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||..|+..... .....
T Consensus 150 l~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----~~~~~-- 220 (272)
T d1qpca_ 150 IADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----NPEVI-- 220 (272)
T ss_dssp ECCCTTCEECSSSCE---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHH--
T ss_pred eccccceEEccCCcc---ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----HHHHH--
Confidence 999999987654322 122345689999999999989999999999999999999996555432111 11111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
..+... .....+..+++++.+++.+||+.||++||||+||++.|+++..+
T Consensus 221 ---~~i~~~----------------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 221 ---QNLERG----------------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---HHHHTT----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHhc----------------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 011110 01122335778899999999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-49 Score=422.20 Aligned_cols=265 Identities=25% Similarity=0.430 Sum_probs=215.1
Q ss_pred HHHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 656 ESLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 656 ~~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
++++...++|++.+.||+|+||+||+|++..+++.||||+++... ...+++.+|++++++++||||++++++|.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT----- 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----
Confidence 334445678999999999999999999999899999999987543 34578999999999999999999999964
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..++||||+++|+|.+++..... ..+++..+..|+.|||.||+|||++ +||||||||+|||++++
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~---------~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNR---------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT---------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred eCCeeEEEeecccCcchHHHhhhccc---------cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCC
Confidence 44788999999999999999865432 3689999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
+.+||+|||+|+....... ....+..|++.|+|||++.+..++.++|||||||++|||++|..||.... ....
T Consensus 152 ~~~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~ 224 (287)
T d1opja_ 152 HLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQ 224 (287)
T ss_dssp GCEEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHH
T ss_pred CcEEEccccceeecCCCCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----hHHH
Confidence 9999999999987654322 12233458999999999999999999999999999999999777653211 1111
Q ss_pred HHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 896 YARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
.. +.+... .....+..+++++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 225 ~~---------~~i~~~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 225 VY---------ELLEKD------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HH---------HHHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH---------HHHhcC------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 10 111000 011223467888999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=416.43 Aligned_cols=259 Identities=23% Similarity=0.304 Sum_probs=196.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|++++++++||||+++++++.+. .++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 367999999999999999999999999999999987543 23346789999999999999999999986532 3466
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeccCCCCCeeeCCCCc
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC--QEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~ 817 (988)
.++||||+++|+|.+++.... .....+++.+++.++.||+.||+|||++. ..+||||||||+|||++.++.
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~-------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~ 152 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGT-------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 152 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHHhcc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc
Confidence 899999999999999985321 11136899999999999999999999861 124999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+..
T Consensus 153 vkl~DFG~a~~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~~~~ 223 (269)
T d2java1 153 VKLGDFGLARILNHDTSF----AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKELA 223 (269)
T ss_dssp EEECCHHHHHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred EEEeeccceeecccCCCc----cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----HHHHH
Confidence 999999999876543221 223569999999999999999999999999999999999999986321 11111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. .+.. . .....+..+++++.+++.+||+.||++|||++|+++
T Consensus 224 ~-----~i~~---~-------------------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 G-----KIRE---G-------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp H-----HHHH---T-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----HHHc---C-------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 0100 0 001122356788999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=416.36 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=206.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
+.|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++. +++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 46899999999999999999999999999999998766667788999999999999999999999964 4588999
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEee
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGD 822 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 822 (988)
||||+++|+|.+++.... ..+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|
T Consensus 87 vmEy~~~g~L~~~~~~~~----------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~D 153 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE----------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLAD 153 (288)
T ss_dssp EEECCTTEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEe
Confidence 999999999999875432 3689999999999999999999999 999999999999999999999999
Q ss_pred ecccccccccccccceeccccccccccccCcccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 823 FGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGL-----GSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 823 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
||+|+....... ......||+.|+|||++. +..++.++|||||||++|||+||+.||......+ ..
T Consensus 154 FG~a~~~~~~~~----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~ 224 (288)
T d2jfla1 154 FGVSAKNTRTIQ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VL 224 (288)
T ss_dssp CTTCEECHHHHH----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HH
T ss_pred chhhhccCCCcc----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HH
Confidence 999976543211 122356999999999974 4568899999999999999999999986431111 00
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
....... . .....+..+++++.+++.+||+.||++|||++|+++
T Consensus 225 ~~i~~~~------------~-------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 LKIAKSE------------P-------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHSC------------C-------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCC------------C-------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0 011123356788999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=412.74 Aligned_cols=264 Identities=23% Similarity=0.400 Sum_probs=212.5
Q ss_pred CCCCCCce-eccccceeEEEEEECC--CCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHL-IGMGSFGSVYKGAFDQ--DGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~-lg~G~~g~Vy~a~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence 45666664 9999999999998753 45589999997543 3345789999999999999999999998642 4
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++.... ..+++.++..|+.|||.||+|||++ +||||||||+||+++.++.+
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred eEEEEEEeCCCCcHHHHhhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCce
Confidence 5899999999999999986554 3689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 897 (988)
||+|||+|+......... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .....
T Consensus 149 Kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~- 224 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAF- 224 (285)
T ss_dssp EECCCTTCEECTTCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHH-
T ss_pred eeccchhhhccccccccc-ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH-
Confidence 999999998765433221 12233458999999999999999999999999999999998 99998743111 11100
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhh
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLE 977 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 977 (988)
+.. ......+..+|+++.+|+.+||+.||++|||+.+|++.|+.+..++..
T Consensus 225 -------i~~----------------------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 225 -------IEQ----------------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp -------HHT----------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -------HHc----------------------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 100 011123346888999999999999999999999999999988776554
Q ss_pred h
Q 001974 978 A 978 (988)
Q Consensus 978 ~ 978 (988)
.
T Consensus 276 ~ 276 (285)
T d1u59a_ 276 K 276 (285)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=401.52 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=210.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.++||+|+||+||+|+++ +++.||||+++.... ..+++.+|+.++++++||||++++|+|.. ++..+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceE
Confidence 478999999999999999999995 888999999975443 45789999999999999999999999653 47899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|++.+++.... ..+++..+.+++.|||+||+|||+. +|+||||||+||++++++.+||+
T Consensus 76 iv~Ey~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~ 142 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS 142 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG----------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEccCCCcHHHhhhccc----------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEEC
Confidence 9999999999999976543 4688999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+..... +..
T Consensus 143 DfG~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----~~~--- 211 (258)
T d1k2pa_ 143 DFGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETA--- 211 (258)
T ss_dssp CCSSCCBCSSSSCC---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHH---
T ss_pred cchhheeccCCCce---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----HHH---
Confidence 99999866543222 2233568999999999999999999999999999999998 89998743111 111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
..+... .....+..+++++.+++.+||+.||++|||++|+++.|.+
T Consensus 212 --~~i~~~----------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 212 --EHIAQG----------------------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --HHHHTT----------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --HHHHhC----------------------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111110 0111233567889999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=412.14 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=204.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|++++++++||||+++++++ .+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 5799999999999999999999989999999999643 233456799999999999999999999995 44588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|.+++... +.+++.+++.++.|++.||+|||+. +||||||||+|||+++++.+|
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKI-----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred EEEEEEccCCCCHHHhhhcc-----------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEE
Confidence 99999999999999988643 3689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ .......||+.|+|||++.+..++.++||||+||++|||+||+.||... +......
T Consensus 149 l~DFG~a~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~- 220 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQ- 220 (288)
T ss_dssp ECCCTTCEECC------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHH-
T ss_pred ecccccceecccCCcc--cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHHHHHH-
Confidence 9999999876543221 1122356999999999999999999999999999999999999998632 1111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.+. ......+..+++++.+|+.+||+.||++|||++|+++.
T Consensus 221 ----~i~-----------------------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 221 ----KII-----------------------KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----HHH-----------------------TTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----HHH-----------------------cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 000 01111233567789999999999999999999997653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=406.62 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=199.1
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
+..++||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+...++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 56678999999999999999999999999987543 23446789999999999999999999997653 3345678999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeccCCCCCeeeC-CCCcEEE
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEP--VLHCDLKPGNVLLD-NDMIAHV 820 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL 820 (988)
|||+++|+|.+++... ..+++.+++.++.||++||+|||++ + ||||||||+|||++ +++.+||
T Consensus 91 mE~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp EECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred EeCCCCCcHHHHHhcc-----------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEE
Confidence 9999999999998643 3689999999999999999999998 6 99999999999996 5789999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
+|||+|+...... .....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ......
T Consensus 157 ~DFGla~~~~~~~------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~-- 223 (270)
T d1t4ha_ 157 GDLGLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYR-- 223 (270)
T ss_dssp CCTTGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHH--
T ss_pred eecCcceeccCCc------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHH--
Confidence 9999998643321 123569999999999875 599999999999999999999999863211 111111
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+.....+ ......+++++.+++.+||+.||++|||++|+++
T Consensus 224 ---~i~~~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 ---RVTSGVKP---------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---HHTTTCCC---------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHcCCCC---------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11100000 0111245677999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=406.52 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=202.7
Q ss_pred ceeccccceeEEEEEEC--CCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEEE
Q 001974 669 HLIGMGSFGSVYKGAFD--QDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALVY 744 (988)
Q Consensus 669 ~~lg~G~~g~Vy~a~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 744 (988)
++||+|+||+||+|.+. .+++.||||+++.. +....+++.+|++++++++||||++++|+|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 47999999999999874 34578999999643 23345679999999999999999999999742 4578999
Q ss_pred eeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeeec
Q 001974 745 EFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDFG 824 (988)
Q Consensus 745 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 824 (988)
||+++|+|.+++.... .+++.+++.|+.||+.||+|||++ +||||||||+||+++.++.+||+|||
T Consensus 87 E~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR-----------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp ECCTTEEHHHHHHHCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EcCCCCcHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchh
Confidence 9999999999986543 689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHHHhh
Q 001974 825 LARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 825 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
+|+........ ........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+.. .
T Consensus 153 la~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~-----~ 221 (277)
T d1xbba_ 153 LSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVT-----A 221 (277)
T ss_dssp TCEECCTTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHH-----H
T ss_pred hhhhccccccc-cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHH-----H
Confidence 99876543322 122233568999999999999999999999999999999998 8999874211 1110 0
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHh
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNAL 975 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 975 (988)
.+.. ......+..+|+++.+|+.+||+.||++|||++||++.|+.+....
T Consensus 222 ~i~~----------------------~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 222 MLEK----------------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHc----------------------CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 0000 0111233467889999999999999999999999999998875443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=406.85 Aligned_cols=263 Identities=24% Similarity=0.433 Sum_probs=202.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCC----eEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDG----TIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 736 (988)
++.|+..++||+|+||+||+|.++.++ ..||||+++.... ....+|.+|++++++++|||||+++|+|..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----- 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----- 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----
Confidence 456888999999999999999986544 4799999864433 334578999999999999999999999653
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||+.++++.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~ 147 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNL 147 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred CCceEEEEEecccCcchhhhhccc----------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCC
Confidence 478899999999999998876543 3689999999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+|+......... ....+..||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..+.
T Consensus 148 ~~Kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~~~~ 222 (283)
T d1mqba_ 148 VCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----NHEV 222 (283)
T ss_dssp CEEECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHH
T ss_pred eEEEcccchhhcccCCCccc-eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----HHHH
Confidence 99999999998765432211 122345689999999999999999999999999999999996666432111 1111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
. +.+.+. .....+..++.++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 223 ~-----~~i~~~----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 223 M-----KAINDG----------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp H-----HHHHTT----------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H-----HHHhcc----------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 111110 01122346788899999999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=412.02 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=191.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.+.|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|++++++++||||+++++++ .+++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 4679999999999999999999999999999999974432 2345688999999999999999999995 455889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC---CCCc
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD---NDMI 817 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 817 (988)
++||||++||+|.+++.... .+++.++..++.||+.||+|||++ +||||||||+||+++ +++.
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG-----------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEeccCCCcHHHhhhccc-----------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence 99999999999999997543 689999999999999999999998 999999999999994 5789
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+||+|||+|+....... .....||+.|||||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 149 vkl~DFG~a~~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~ 218 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLF 218 (307)
T ss_dssp EEECCC-----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred EEEeccceeEEccCCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHH
Confidence 99999999986544322 1234699999999999999999999999999999999999999863211 1111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... ..... ......+++++.+++.+||+.||++|||++|+++
T Consensus 219 ~~i~~~--------~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 219 EQILKA--------EYEFD----------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHTT--------CCCCC----------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcc--------CCCCC----------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 110000 00000 0112356788999999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=418.04 Aligned_cols=285 Identities=19% Similarity=0.272 Sum_probs=208.8
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
..++|++++.||+|+||+||+|++..+|+.||+|+++... ....+.+.+|+.++++++||||+++++++. +++.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 3578999999999999999999999999999999997543 334567899999999999999999999964 4578
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ + +|+||||||+|||+++++.+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~v 144 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA-----------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEI 144 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCE
T ss_pred EEEEEEcCCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCE
Confidence 99999999999999998643 368999999999999999999997 5 89999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+|+...... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... ......
T Consensus 145 kl~DFGla~~~~~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~--~~~~~~ 216 (322)
T d1s9ja_ 145 KLCDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFG 216 (322)
T ss_dssp EECCCCCCHHHHHHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH--HHHHC-
T ss_pred EEeeCCCccccCCCc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 999999998654322 123579999999999999999999999999999999999999996432111 000000
Q ss_pred HHHhhhhhhh----------hcc-ccccCcchhhhhhHHHHhh-hhhcc-ccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 899 TALLDHVIDI----------VDP-ILINDVEDWDATNKQRLRQ-AKING-KIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 899 ~~~~~~~~~~----------~d~-~l~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
.......... ... ................... ..... ....+.++.+++.+||+.||++||||+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L 296 (322)
T d1s9ja_ 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296 (322)
T ss_dssp -----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 0000000000 000 0000000000000000000 00001 113467899999999999999999999998
Q ss_pred H--HHHHHH
Q 001974 966 H--ELQSVK 972 (988)
Q Consensus 966 ~--~L~~i~ 972 (988)
+ .+++..
T Consensus 297 ~Hpf~~~~~ 305 (322)
T d1s9ja_ 297 VHAFIKRSD 305 (322)
T ss_dssp TSHHHHHHH
T ss_pred hCHhhCcCC
Confidence 7 355543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-47 Score=416.07 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=208.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.++++++||||+++++++. +++..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 357999999999999999999999999999999997666566678999999999999999999999954 458899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC--CCCcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDMIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 819 (988)
+||||+++|+|.+++.... .++++.++..|+.||+.||+|||++ +||||||||+|||++ .++.+|
T Consensus 100 ivmE~~~gg~L~~~l~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vk 166 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELK 166 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT----------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEE
T ss_pred EEEEcCCCCCHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEE
Confidence 9999999999999996543 3699999999999999999999999 999999999999996 467899
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ ....||+.|||||++.+..++.++||||+||++|||++|+.||... ........
T Consensus 167 L~DFG~a~~~~~~~~~-----~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~ 236 (350)
T d1koaa2 167 LIDFGLTAHLDPKQSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRN 236 (350)
T ss_dssp ECCCTTCEECCTTSCE-----EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred Eeecchheeccccccc-----ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHHHHHHH
Confidence 9999999876543322 2246999999999999999999999999999999999999998632 11111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ...... .....+++++.+++.+||+.||++|||++|+++
T Consensus 237 i~~~--------~~~~~~----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 237 VKSC--------DWNMDD----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHT--------CCCSCC----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhC--------CCCCCc----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000 111246778999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-47 Score=414.12 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=208.3
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++ .+++..+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999999866555567888999999999999999999995 4558899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC--CCCcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD--NDMIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~k 819 (988)
+||||+++|+|.+++.... .++++.+++.|+.||+.||+|||++ +||||||||+|||++ .++.+|
T Consensus 103 ivmE~~~gg~L~~~~~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vk 169 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVK 169 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEE
T ss_pred EEEEcCCCChHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEE
Confidence 9999999999999886654 3699999999999999999999998 999999999999998 678999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......
T Consensus 170 L~DFGla~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~ 239 (352)
T d1koba_ 170 IIDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQN 239 (352)
T ss_dssp ECCCTTCEECCTTSCE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHH
T ss_pred EeecccceecCCCCce-----eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9999999876553322 224589999999999999999999999999999999999999863211 111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
+.. ...... ......+++++.+|+.+||+.||++|||++|+++
T Consensus 240 -----i~~---~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 240 -----VKR---CDWEFD----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -----HHH---CCCCCC----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----HHh---CCCCCC----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000 0112356788999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=411.12 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=207.3
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCC-----eEEEEEEeecc-ccchhHHHHHHHHHHHhc-CCCCceEEEeeccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDG-----TIVAIKVFNLQ-RHGASKSFLAECKALKNI-RHRNLVKVITSCSSID 733 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 733 (988)
..++|++.+.||+|+||+||+|++...+ ..||+|++... .......+.+|+.++.++ +|||||++++++.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--- 111 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 111 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe---
Confidence 3467999999999999999999986544 36999998643 334456899999999998 8999999999964
Q ss_pred ccCCCceEEEEeeccccchhhhcCCCCCCCch------------hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 001974 734 FQGNDFKALVYEFMTNGSLENWLHPDAVPQKD------------VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVL 801 (988)
Q Consensus 734 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 801 (988)
..+..++||||+++|+|.++++........ .......+++.+++.|+.||++||+|||++ +||
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 112 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 447899999999999999999765421110 011124689999999999999999999998 999
Q ss_pred eccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CC
Q 001974 802 HCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GK 880 (988)
Q Consensus 802 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~ 880 (988)
||||||+||+++.++.+||+|||+|+........ ....+..||+.|||||++.+..++.++|||||||++|||+| |+
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 9999999999999999999999999866543322 12234568999999999999999999999999999999998 89
Q ss_pred CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC
Q 001974 881 KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS 960 (988)
Q Consensus 881 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 960 (988)
.||...... ..+... +.. . .....+..+++++.+||.+||+.||++|||
T Consensus 265 ~Pf~~~~~~-~~~~~~----~~~--------~------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt 313 (325)
T d1rjba_ 265 NPYPGIPVD-ANFYKL----IQN--------G------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313 (325)
T ss_dssp CSSTTCCCS-HHHHHH----HHT--------T------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHH-HHHHHH----Hhc--------C------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcC
Confidence 998642211 011100 000 0 011223467888999999999999999999
Q ss_pred HHHHHHHHH
Q 001974 961 ITNVVHELQ 969 (988)
Q Consensus 961 ~~evl~~L~ 969 (988)
++||++.|.
T Consensus 314 ~~ei~~~L~ 322 (325)
T d1rjba_ 314 FPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-47 Score=407.33 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=199.8
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc---chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH---GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.|+..+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++.. ++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence 48999999999999999999999999999999975432 234578899999999999999999999643 4789
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|||||++|++..++... .++++.+++.|+.||+.||+|||++ +||||||||+|||+++++.+||
T Consensus 91 ~iv~E~~~~g~l~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEecCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence 9999999999998766433 3689999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC---CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG---SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
+|||+|+..... ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ....
T Consensus 157 ~DFG~a~~~~~~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~ 223 (309)
T d1u5ra_ 157 GDFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSAL 223 (309)
T ss_dssp CCCTTCBSSSSB--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHH
T ss_pred eecccccccCCC--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence 999999865432 12469999999999864 4689999999999999999999999863211 1111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
... .....+. .....+++++.+++.+||+.||++|||++|+++
T Consensus 224 ~~i-----~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHI-----AQNESPA---------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHH-----HHSCCCC---------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHH-----HhCCCCC---------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 100 0000000 011246778999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=398.94 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=201.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||.||+|++ .|+.||||+++.. ...+.+.+|++++++++||||++++|+|.+ ..+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 45688899999999999999999 5789999999643 345789999999999999999999998743 335679
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||+++|+|.+++.... ...+++..+++|+.||+.||+|||+. +||||||||+||+++.++.+|++
T Consensus 78 lv~ey~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~ 145 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS 145 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH---------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred EEEeccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeec
Confidence 9999999999999986432 13689999999999999999999998 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++....... ...+|..|+|||++.+..++.++|||||||++|||+| |++||...... .....+
T Consensus 146 dfg~s~~~~~~~~-------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i--- 213 (262)
T d1byga_ 146 DFGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV--- 213 (262)
T ss_dssp CCCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH---
T ss_pred ccccceecCCCCc-------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHH---
Confidence 9999986543221 2347899999999999999999999999999999998 78887632111 111110
Q ss_pred HhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 901 LLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 901 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.. ......+..+++++.+++.+||+.||++||||+|+++.|+++++.
T Consensus 214 -----~~----------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 214 -----EK----------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----TT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----Hc----------------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 00 011123346778899999999999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=407.08 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=207.3
Q ss_pred HhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
...++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||+++|+|.. +.
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 34578999999999999999999996 55779999997443 345789999999999999999999998642 45
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+++|+|..++.... .+.+++.+++.|+.|||.||+|||+. +|+||||||+|||+++++++|
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~---------~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~k 153 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGET---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 153 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHH---------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred eEEEEEecCCCchhhhhhhcc---------cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEE
Confidence 789999999999999886432 13689999999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+||..|+..... .......
T Consensus 154 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~ 226 (285)
T d1fmka3 154 VADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQ 226 (285)
T ss_dssp ECCCCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHH
T ss_pred EcccchhhhccCCCce---eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----HHHHHHH
Confidence 9999999866443221 12234689999999999999999999999999999999997666432111 1111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhhhc
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLEAW 979 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 979 (988)
+.. ......+..+++++.+++.+||+.||++|||+++|++.|+++.....+.+
T Consensus 227 -----i~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 227 -----VER----------------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp -----HHT----------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred -----HHh----------------------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 000 00112234678889999999999999999999999999988766554433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=402.86 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=205.0
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------chhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 3679999999999999999999999999999999864321 23467999999999999999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+. +||||||||+||+++.+
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~-----------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK-----------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 149 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCS
T ss_pred ECCEEEEEEEcCCCccccchhccc-----------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecC
Confidence 458899999999999999998643 3699999999999999999999999 99999999999999877
Q ss_pred C----cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 816 M----IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 816 ~----~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+ .+|++|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~~~-----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--- 221 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--- 221 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSCBC-----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred CCcccceEecchhhhhhcCCCccc-----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---
Confidence 6 5999999999876543322 234689999999999999999999999999999999999999863211
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...... +.. ...... ......++.++.+++.+||+.||++|||++|+++
T Consensus 222 --~~~~~~-----i~~---~~~~~~----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 --QETLAN-----VSA---VNYEFE----------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HHHHHH-----HHT---TCCCCC----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHH-----HHh---cCCCCC----------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 000 000000 0011246778999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=406.91 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=205.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCe----EEEEEEeecc-ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGT----IVAIKVFNLQ-RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
++|+++++||+|+||+||+|++..+|+ .||+|.++.. .....+.+.+|++++++++|||||+++|+|.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987776 5888887643 33456789999999999999999999999753
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++++||+.+|+|.+++.... ..+++..++.|+.|||.||+|||++ +||||||||+||+++.++.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~ 149 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 149 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTS----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred CCeeEEEEeccCCcccccccccc----------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCC
Confidence 45688999999999998876554 3789999999999999999999998 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+|+......... ......||+.|+|||++.++.++.++|||||||++|||+| |++||+..... .+...
T Consensus 150 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~ 225 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSI 225 (317)
T ss_dssp EEECCCSHHHHTTTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHH
T ss_pred eEeeccccceecccccccc--cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHH
Confidence 9999999998765433221 1223468999999999999999999999999999999999 88888642111 11111
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+. .......+..+++++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 226 i~------------------------------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 226 LE------------------------------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HH------------------------------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HH------------------------------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 00 0011123346788899999999999999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=401.33 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=200.8
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeecccccccCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 737 (988)
.++|++.+.||+|+||+||+|++..+ +..||||+++.... ...+.+.+|++++++++||||+++++++. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 46799999999999999999998644 35689998864333 33467999999999999999999999863 2
Q ss_pred CceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCc
Q 001974 738 DFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
+..++||||+++|++.+++.... ..+++.+++.++.||++||+|||++ +||||||||+||++++++.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred CeEEEEEEeccCCcHHhhhhccC----------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCc
Confidence 56899999999999999876543 3689999999999999999999999 9999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchHHH
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 896 (988)
+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...... .....
T Consensus 147 ~Kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~ 221 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR 221 (273)
T ss_dssp EEECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH
T ss_pred EEEccchhheeccCCcce---eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH
Confidence 999999999875543222 1223458999999999999999999999999999999998 89998643221 11000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
+. .......+..+++++.+|+.+||+.||++|||++||++.|+++.++
T Consensus 222 --------i~----------------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 222 --------IE----------------------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --------HH----------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HH----------------------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00 0011122346788999999999999999999999999999998765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=404.54 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=207.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++ .+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 35799999999999999999999999999999999743 233457789999999999999999999995 4558
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +||||||||+|||++++|.+
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~-----------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~v 144 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE-----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred ccccceeccCCCchhhhhhcc-----------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCE
Confidence 899999999999999998654 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|++||.... ......
T Consensus 145 kl~DFG~a~~~~~~~~----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~ 215 (337)
T d1o6la_ 145 KITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFE 215 (337)
T ss_dssp EECCCTTCBCSCCTTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred EEeecccccccccCCc----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----HHHHHH
Confidence 9999999986543222 1223569999999999999999999999999999999999999986321 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
. +.......+..+++++.+|+.+||+.||++||+ ++|+++
T Consensus 216 ~----------------------------i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 L----------------------------ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp H----------------------------HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred H----------------------------HhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 111112233457788999999999999999995 788876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.1e-46 Score=396.56 Aligned_cols=266 Identities=22% Similarity=0.345 Sum_probs=206.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++++.++||||+++++++... .....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCc
Confidence 467999999999999999999999999999999997432 23345789999999999999999999997653 12234
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++++|.+++... .++++.+++.|+.||+.||+|||++ +||||||||+||+++.++..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE-----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCE
T ss_pred eEEEEEECCCCCEehhhhccc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccc
Confidence 578999999999999887543 3689999999999999999999998 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
+++|||.+......... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.... ......
T Consensus 151 ~l~d~~~~~~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~ 224 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAY 224 (277)
T ss_dssp EECCCTTCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH
T ss_pred eeehhhhhhhhcccccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----HHHHHH
Confidence 99999998755433221 112234569999999999999999999999999999999999999986321 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-CHHHHHHHHHHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-SITNVVHELQSVK 972 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 972 (988)
...... +. ........+++++.+++.+||+.||++|| |++++++.|.++.
T Consensus 225 ~~~~~~------~~------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 225 QHVRED------PI------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHCC------CC------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcC------CC------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111110 00 00011235778899999999999999999 8999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-45 Score=399.74 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=205.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++. +++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence 5699999999999999999999999999999999643 2334578899999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||++||++..++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+|
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ-----------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS-----------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred eeeEeeecCCccccccccccc-----------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEE
Confidence 999999999999999887554 678889999999999999999998 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+...... ....||+.|||||++.+..++.++||||+||++|||+||+.||... +.......
T Consensus 145 L~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~ 212 (316)
T d1fota_ 145 ITDFGFAKYVPDVT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEK 212 (316)
T ss_dssp ECCCSSCEECSSCB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH
T ss_pred EecCccceEecccc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CHHHHHHH
Confidence 99999998754322 2356999999999999999999999999999999999999998632 11111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
+.......+..+++++.+++.+||+.||++|| |++|+++
T Consensus 213 ----------------------------i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ----------------------------ILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------------------------HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------------------------HHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01111122345678899999999999999996 8999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=403.28 Aligned_cols=273 Identities=23% Similarity=0.361 Sum_probs=211.7
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
++...++|++.+.||+|+||+||+|+++ .+++.||||+++.... ...+++.+|++++++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3445678999999999999999999975 3567899999975433 334679999999999999999999999654
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCc-------------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-------------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQE 798 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~ 798 (988)
.+..++||||+++|+|.+++........ ........+++.+++.|+.|++.||+|||++
T Consensus 88 -----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 88 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred -----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 4788999999999999999864332110 0001123589999999999999999999998
Q ss_pred CeEeccCCCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh
Q 001974 799 PVLHCDLKPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT 878 (988)
Q Consensus 799 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt 878 (988)
+||||||||+|||++.++.+||+|||+|+......... ......|++.|+|||.+.+..++.++|||||||++|||++
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 99999999999999999999999999998654432221 1223568899999999999999999999999999999999
Q ss_pred CC-CCCCccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCC
Q 001974 879 GK-KPTDVMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQD 957 (988)
Q Consensus 879 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 957 (988)
|. +||..... .+.... +.+ . .....+..+++++.+|+.+||+.||++
T Consensus 238 ~~~~p~~~~~~-----~e~~~~-----v~~---~-------------------~~~~~p~~~~~~~~~li~~cl~~~P~~ 285 (301)
T d1lufa_ 238 YGLQPYYGMAH-----EEVIYY-----VRD---G-------------------NILACPENCPLELYNLMRLCWSKLPAD 285 (301)
T ss_dssp TTCCTTTTSCH-----HHHHHH-----HHT---T-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cCCCCCCCCCH-----HHHHHH-----HHc---C-------------------CCCCCCccchHHHHHHHHHHcCCChhH
Confidence 85 56653211 111111 100 0 011223467888999999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 001974 958 RMSITNVVHELQSVK 972 (988)
Q Consensus 958 RPs~~evl~~L~~i~ 972 (988)
||||.||+++|++|+
T Consensus 286 RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 286 RPSFCSIHRILQRMC 300 (301)
T ss_dssp SCCHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHHhc
Confidence 999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=398.60 Aligned_cols=263 Identities=23% Similarity=0.419 Sum_probs=210.4
Q ss_pred CceeccccceeEEEEEECCCC---eEEEEEEeec-cccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEEE
Q 001974 668 THLIGMGSFGSVYKGAFDQDG---TIVAIKVFNL-QRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKALV 743 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 743 (988)
.++||+|+||+||+|++..++ ..||||+++. ......++|.+|++++++++||||++++|+|.. .++..++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 468999999999999986443 3699999864 344455789999999999999999999999754 23678999
Q ss_pred EeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEeee
Q 001974 744 YEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVGDF 823 (988)
Q Consensus 744 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 823 (988)
|||+++|+|.+++.... ..+++.+++.++.|+|.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 108 ~E~~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF 174 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 174 (311)
T ss_dssp EECCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred EEEeecCchhhhhcccc----------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence 99999999999987654 3577888999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHHHhh
Q 001974 824 GLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTALLD 903 (988)
Q Consensus 824 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 903 (988)
|+++.................||+.|+|||.+.+..++.++||||||+++|||+||+.||....... .....
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~------- 246 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY------- 246 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH-------
T ss_pred cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH-------
Confidence 9998766544433333445679999999999999999999999999999999999888765322111 11110
Q ss_pred hhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHHhhhh
Q 001974 904 HVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNALLEA 978 (988)
Q Consensus 904 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 978 (988)
+.. ......+..+++++.+++.+||+.||++||||.||++.|+++.+.+..+
T Consensus 247 -i~~----------------------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 247 -LLQ----------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp -HHT----------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -HHc----------------------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 000 0011123356788999999999999999999999999999998876553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=399.43 Aligned_cols=277 Identities=22% Similarity=0.324 Sum_probs=203.8
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEECC-----CCeEEEEEEeeccc-cchhHHHHHHHHHHHhc-CCCCceEEEeecc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFDQ-----DGTIVAIKVFNLQR-HGASKSFLAECKALKNI-RHRNLVKVITSCS 730 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 730 (988)
+....++|++.+.||+|+||.||+|++.. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 33445789999999999999999999743 44789999987433 23446788888888887 7899999999864
Q ss_pred cccccCCCceEEEEeeccccchhhhcCCCCCCC-----chhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 731 SIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQ-----KDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 731 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
. .+...++||||+++|+|.++++...... .........+++.+++.++.||++||+|||++ +||||||
T Consensus 88 ~----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 88 K----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp S----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred c----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 3 3467899999999999999996543110 00011124689999999999999999999998 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhC-CCCCC
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTG-KKPTD 884 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~~ 884 (988)
||+|||+++++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSC--CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceeECCCCcEEEccCcchhhcccccccc--ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998654433221 22345699999999999999999999999999999999996 45665
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
..... ..+... +.+ ......+..+++++.+++.+||+.||++|||++|+
T Consensus 239 ~~~~~-~~~~~~----~~~--------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei 287 (299)
T d1ywna1 239 GVKID-EEFCRR----LKE--------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287 (299)
T ss_dssp TCCCS-HHHHHH----HHH--------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCHH-HHHHHH----Hhc--------------------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 32111 111110 000 01112233577889999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 965 VHELQSVKNA 974 (988)
Q Consensus 965 l~~L~~i~~~ 974 (988)
++.|+++.++
T Consensus 288 l~~L~~ilq~ 297 (299)
T d1ywna1 288 VEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhC
Confidence 9999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=394.42 Aligned_cols=280 Identities=23% Similarity=0.285 Sum_probs=204.3
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|...+.||+|+||.||+|++ +|+.||||+++.... .......|+..+..++||||++++++|... .......++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~-~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKD-NGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE-CSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeC-CCcceEEEE
Confidence 4677889999999999999997 789999999864322 122233455555678999999999998764 222346899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEeccCCCCCeeeCCCCc
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH-----CQEPVLHCDLKPGNVLLDNDMI 817 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~ 817 (988)
||||+++|+|.++++.. ++++.++++++.|+|.||+|+|+. ..++||||||||+|||+++++.
T Consensus 79 v~Ey~~~g~L~~~l~~~------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEECCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEecccCCCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 99999999999999643 589999999999999999999973 1249999999999999999999
Q ss_pred EEEeeecccccccccccccceeccccccccccccCcccCCC------CCCCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 818 AHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS------EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 818 ~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
+||+|||+++.................||+.|+|||++.+. .++.++|||||||++|||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 99999999987765443333333456799999999998764 267789999999999999999988754222211
Q ss_pred chHHH-----HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNY-----ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~-----~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+... ......+ ...+..+.++..+ .....+.+..+.+++.+||+.||++|||+.||++
T Consensus 227 ~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~-------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRK---VVCEQKLRPNIPN-------------RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTTSCSSCCHHHHHH---HHTTSCCCCCCCG-------------GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhhcccccchHHHHHH---HHhccccCCCCCc-------------ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11000 0000000 0011111111100 0112245567999999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 967 ELQSVKNA 974 (988)
Q Consensus 967 ~L~~i~~~ 974 (988)
.|+++.++
T Consensus 291 ~L~~i~~~ 298 (303)
T d1vjya_ 291 TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=392.44 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=198.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCC---CeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQD---GTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
.++|++.+.||+|+||.||+|++... ...||||+++.. .....++|.+|+.++++++||||++++|+|..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----
Confidence 35699999999999999999987433 247899998643 33445689999999999999999999999743
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
+..++||||+++|++.+++.... ..+++..++.++.|||.||+|||++ +|+||||||+||+++.+
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~ 147 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR 147 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG----------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET
T ss_pred --cchheeeeeecCcchhhhhhccc----------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccc
Confidence 45689999999999998875432 4699999999999999999999998 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+++......... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||... ...
T Consensus 148 ~~vkl~DfGl~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~ 221 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGS 221 (273)
T ss_dssp TEEEECCCTTCEECCC-CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH
T ss_pred cceeeccchhhhhcccCCCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHH
Confidence 999999999999765443221 12223457889999999999999999999999999999998 89998632 111
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSV 971 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 971 (988)
......... ......+..+|.++.+++.+||+.||++||||+||++.|++.
T Consensus 222 ~~~~~i~~~--------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKE--------------------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTS--------------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhC--------------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111000 001122346788899999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-45 Score=388.68 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=203.4
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccc---------hhHHHHHHHHHHHhcC-CCCceEEEeeccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHG---------ASKSFLAECKALKNIR-HRNLVKVITSCSS 731 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 731 (988)
.++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 36899999999999999999999999999999999754321 2246889999999996 99999999995
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
.+++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +||||||||+||+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~-----------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nil 142 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEK-----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL 142 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEE
Confidence 4568999999999999999999643 3699999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCC------CCCCCccchHHHHHHHHHHHhCCCCCCc
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG------SEVSTNGDIYSYGILLLEMVTGKKPTDV 885 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~~~ 885 (988)
++.++.+||+|||+|+........ ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 143 l~~~~~~kl~DFG~a~~~~~~~~~-----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 143 LDDDMNIKLTDFGFSCQLDPGEKL-----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp ECTTCCEEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EcCCCCeEEccchheeEccCCCce-----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 999999999999999876543222 23569999999998753 4578899999999999999999999873
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
... .. ....+... ... ........+++++.+++.+||+.||++|||++|++
T Consensus 218 ~~~-----~~-~~~~i~~~-------~~~----------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 218 RKQ-----ML-MLRMIMSG-------NYQ----------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp SSH-----HH-HHHHHHHT-------CCC----------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCH-----HH-HHHHHHhC-------CCC----------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 211 01 10101100 000 00011235778899999999999999999999986
Q ss_pred H
Q 001974 966 H 966 (988)
Q Consensus 966 ~ 966 (988)
+
T Consensus 269 ~ 269 (277)
T d1phka_ 269 A 269 (277)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-45 Score=401.54 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=205.0
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+++++.++||||+++++++. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence 5799999999999999999999999999999998643 2334567899999999999999999999954 4588
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEE
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAH 819 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 819 (988)
.++||||+.+|+|.+++... ..+++.+++.|+.||+.||.|||++ +||||||||+|||++.++.+|
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRI-----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred cccccccccccchhhhHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEE
Confidence 99999999999999998644 3689999999999999999999999 999999999999999999999
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+|+...... ....||+.|||||++.+..++.++||||+||++|||+||+.||... ........
T Consensus 182 L~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~ 249 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEK 249 (350)
T ss_dssp ECCCTTCEECSSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred eeeceeeeeccccc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHHHHHH
Confidence 99999998764321 2346999999999999999999999999999999999999998632 11111110
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCC-----CHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRM-----SITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 966 (988)
+.......+..+++++.+++.+||+.||++|+ |++|+++
T Consensus 250 ----------------------------i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 ----------------------------IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----------------------------HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------------------------HhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 01111122345778899999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=394.80 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++++.++||||+++++++ .+++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999999999999999997543 2345688999999999999999999995 4458899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC--CcEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND--MIAH 819 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~k 819 (988)
+|||||+||+|.+++.... .++++.+++.|+.||+.||+|||++ +|+||||||+|||++.+ ..+|
T Consensus 78 lvmE~~~gg~L~~~i~~~~----------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred EEEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEE
Confidence 9999999999999997654 2689999999999999999999998 99999999999999854 5899
Q ss_pred EeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 820 VGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
|+|||+++........ ....+|+.|+|||...+..++.++||||+||++|||++|+.||..... ......
T Consensus 145 l~DFG~~~~~~~~~~~-----~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----~~~~~~ 214 (321)
T d1tkia_ 145 IIEFGQARQLKPGDNF-----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQIIEN 214 (321)
T ss_dssp ECCCTTCEECCTTCEE-----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred EcccchhhccccCCcc-----cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 9999999876443222 224589999999999999999999999999999999999999863211 111111
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.. ........ .....+++++.+++.+||+.||++|||++|+++
T Consensus 215 i~--------~~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 215 IM--------NAEYTFDE----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HH--------HTCCCCCH----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH--------hCCCCCCh----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000 001246678899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=397.21 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=202.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc---ccchhHHHHHHHHHHH-hcCCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ---RHGASKSFLAECKALK-NIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+..|..++. .++||||+++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 5799999999999999999999999999999999643 2333456777777765 67999999999995 4458
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..++||||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~-----------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSC-----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred ceeEEEeecCCCcHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCce
Confidence 899999999999999999654 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ......
T Consensus 143 kl~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~ 213 (320)
T d1xjda_ 143 KIADFGMCKENMLGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFH 213 (320)
T ss_dssp EECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred eccccchhhhcccccc----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence 9999999986543222 1223569999999999999999999999999999999999999986321 111111
Q ss_pred HHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHH-HHHH
Q 001974 899 TALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSIT-NVVH 966 (988)
Q Consensus 899 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 966 (988)
. +.......+..+++++.+|+.+||+.||++|||+. |+++
T Consensus 214 ~----------------------------i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 S----------------------------IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp H----------------------------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred H----------------------------HHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 01111122335678899999999999999999995 6753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=395.24 Aligned_cols=269 Identities=25% Similarity=0.409 Sum_probs=208.2
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeE--EEEEEeecc-ccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCC
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTI--VAIKVFNLQ-RHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 738 (988)
++|++.++||+|+||+||+|+++.+|.. ||||+++.. .....+.+.+|+++++++ +||||++++++|.. ++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 5688899999999999999999877764 677777533 333456899999999999 79999999999754 47
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCch-----hhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKD-----VEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
..++||||+++|+|.++++........ .......+++.++..++.|||.||.|||+. +||||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 899999999999999999765310000 000124689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCC-CCCccccCCcc
Q 001974 814 NDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKK-PTDVMFEGDLN 892 (988)
Q Consensus 814 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~-p~~~~~~~~~~ 892 (988)
.++.+||+|||+|+........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||... .
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-----~ 231 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-----T 231 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----C
T ss_pred CCCceEEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-----C
Confidence 9999999999999865443221 22458999999999999999999999999999999999764 55421 1
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
..... +.+.. ...+..+..+++++.+|+.+||+.||++||||+||++.|+++.
T Consensus 232 ~~~~~-----~~i~~----------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 232 CAELY-----EKLPQ----------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHHH-----HHGGG----------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH-----HHHHh----------------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 11110 0111233467889999999999999999999999999999997
Q ss_pred HHhh
Q 001974 973 NALL 976 (988)
Q Consensus 973 ~~~~ 976 (988)
+...
T Consensus 285 ~~~~ 288 (309)
T d1fvra_ 285 EERK 288 (309)
T ss_dssp HSSS
T ss_pred hcCc
Confidence 6543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-45 Score=401.05 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=198.9
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc---cchhHHHHH---HHHHHHhcCCCCceEEEeeccccccc
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR---HGASKSFLA---ECKALKNIRHRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 735 (988)
-++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+ |+++++.++||||+++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 367999999999999999999999999999999986322 112233444 466777778999999999954
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCC
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDND 815 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 815 (988)
.++..++||||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +||||||||+|||++.+
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~-----------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~ 143 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQH-----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH 143 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS
T ss_pred ECCEEEEEEEecCCCcHHHHHHhc-----------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCC
Confidence 458899999999999999998654 3688999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 816 MIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
+.+||+|||+|+...... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||......+ ..
T Consensus 144 g~iKl~DFGla~~~~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~ 215 (364)
T d1omwa3 144 GHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH 215 (364)
T ss_dssp SCEEECCCTTCEECSSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HH
T ss_pred CcEEEeeeceeeecCCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence 999999999998665432 123469999999999875 568999999999999999999999997432211 11
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
..... . .......+..+++++.+++.+||+.||++||| |+|+++
T Consensus 216 ~~~~~------------~----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 EIDRM------------T----------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHH------------S----------------SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHh------------c----------------ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00000 0 00011123357788999999999999999999 688775
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=397.50 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=201.0
Q ss_pred hCCCCCCc-eeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 662 TDGFSSTH-LIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 662 ~~~y~~~~-~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
.++|++.. .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++ +||||+++++++... +..+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46788875 59999999999999998999999999853 35677899987665 899999999987543 234577
Q ss_pred eEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC---CC
Q 001974 740 KALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN---DM 816 (988)
Q Consensus 740 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 816 (988)
.|+|||||+||+|.+++..... ..+++.+++.|+.||+.||+|||+. +|+||||||+|||+++ .+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~---------~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD---------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC---------CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTC
T ss_pred EEEEEECCCCCcHHHHHHhcCC---------CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccc
Confidence 8999999999999999976432 3689999999999999999999999 9999999999999985 56
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
.+||+|||+|+........ ....||+.|+|||++.+..|+.++||||+||++|||+||+.||....... ....
T Consensus 152 ~~Kl~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~ 224 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHNSL-----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPG 224 (335)
T ss_dssp CEEECCCTTCEECCCCCCC-----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------
T ss_pred cccccccceeeeccCCCcc-----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHH
Confidence 7999999999866543322 23469999999999999999999999999999999999999986422111 0000
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
. ...+ ..... ++.. .....+++++.+|+.+||+.||++|||++|+++
T Consensus 225 ~----~~~i-------~~~~~-~~~~-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 225 M----KTRI-------RMGQY-EFPN-----------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -------CC-------CSCSS-SCCT-----------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HHHH-------hcCCC-CCCC-----------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0000 00000 0000 001246778999999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=387.62 Aligned_cols=271 Identities=22% Similarity=0.380 Sum_probs=208.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCC-------eEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeeccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDG-------TIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSS 731 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 731 (988)
..++|++.+.||+|+||.||+|+....+ ..||||+++.... ....++.+|+..+.++ +||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3567999999999999999999975443 4799999975443 3346788999999888 89999999999754
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCc-----hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-----DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLK 806 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 806 (988)
++..++||||+++|+|.+++........ ........+++.+++.++.||+.||+|||+. +|||||||
T Consensus 91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiK 162 (299)
T d1fgka_ 91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 162 (299)
T ss_dssp -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeec
Confidence 4789999999999999999976543211 0111224689999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCCc
Q 001974 807 PGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTDV 885 (988)
Q Consensus 807 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~ 885 (988)
|+|||++.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceeecCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 999999999999999999998765543222 2234568999999999999999999999999999999998 7888763
Q ss_pred cccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHH
Q 001974 886 MFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVV 965 (988)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 965 (988)
... .... +.+.. ......+..+++++.+|+.+||+.||++||||+||+
T Consensus 241 ~~~-----~~~~-----~~i~~----------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil 288 (299)
T d1fgka_ 241 VPV-----EELF-----KLLKE----------------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288 (299)
T ss_dssp CCH-----HHHH-----HHHHT----------------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCH-----HHHH-----HHHHc----------------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 211 1110 00100 011122345778899999999999999999999999
Q ss_pred HHHHHHHH
Q 001974 966 HELQSVKN 973 (988)
Q Consensus 966 ~~L~~i~~ 973 (988)
+.|++|.+
T Consensus 289 ~~L~~i~a 296 (299)
T d1fgka_ 289 EDLDRIVA 296 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 99999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=388.84 Aligned_cols=274 Identities=23% Similarity=0.366 Sum_probs=213.1
Q ss_pred HhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhc-CCCCceEEEeecccc
Q 001974 660 KATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNI-RHRNLVKVITSCSSI 732 (988)
Q Consensus 660 ~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 732 (988)
...++|++.++||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++++ +||||++++++|..
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~- 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-
Confidence 34578999999999999999999863 4667999999975433 3445789999999999 79999999999654
Q ss_pred cccCCCceEEEEeeccccchhhhcCCCCCCCc-------hhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 001974 733 DFQGNDFKALVYEFMTNGSLENWLHPDAVPQK-------DVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDL 805 (988)
Q Consensus 733 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 805 (988)
++..++||||+++|+|.++++....... ........+++.++..++.||++||+|||++ +||||||
T Consensus 99 ----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDL 171 (311)
T d1t46a_ 99 ----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL 171 (311)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccc
Confidence 4778999999999999999875442110 0111224689999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001974 806 KPGNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVT-GKKPTD 884 (988)
Q Consensus 806 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~ 884 (988)
||+||+++.++.+|++|||.++........ .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999876543322 22334679999999999999999999999999999999999 555543
Q ss_pred ccccCCcchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHH
Q 001974 885 VMFEGDLNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNV 964 (988)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 964 (988)
. ......+...+. . ......+..++.++.+|+.+||+.||++||||+||
T Consensus 250 ~-~~~~~~~~~~i~----~--------------------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 250 G-MPVDSKFYKMIK----E--------------------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp T-CCSSHHHHHHHH----H--------------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C-CCHHHHHHHHHh----c--------------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 2 222111111110 0 00111223567889999999999999999999999
Q ss_pred HHHHHHHHHH
Q 001974 965 VHELQSVKNA 974 (988)
Q Consensus 965 l~~L~~i~~~ 974 (988)
+++|+++..+
T Consensus 299 l~~L~~~i~~ 308 (311)
T d1t46a_ 299 VQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHhhcc
Confidence 9999887543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=388.63 Aligned_cols=282 Identities=22% Similarity=0.242 Sum_probs=204.5
Q ss_pred hhCCCCCCceeccccceeEEEEEECCC-CeEEEEEEeeccc--cchhHHHHHHHHHHHhc---CCCCceEEEeecccccc
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQD-GTIVAIKVFNLQR--HGASKSFLAECKALKNI---RHRNLVKVITSCSSIDF 734 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~ 734 (988)
..++|++++.||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999999655 6789999986432 22334567788877766 79999999999865544
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
......+++|||++++.+........ ..+++..++.++.|++.||+|||++ +||||||||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 151 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred ccCceEEEEEEeccCCchhhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcC
Confidence 55678899999998887765543332 3689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchH
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLH 894 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 894 (988)
++.+||+|||.++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~-----~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~ 224 (305)
T d1blxa_ 152 SGQIKLADFGLARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQL 224 (305)
T ss_dssp TCCEEECSCCSCCCCCGGGG-----GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred CCCeeecchhhhhhhccccc-----CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHH
Confidence 99999999999986543322 23356999999999999999999999999999999999999998632111 000
Q ss_pred HHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 895 NYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 895 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
..................... ....................++.+.+|+.+||+.||++||||+|+++
T Consensus 225 ~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 225 GKILDVIGLPGEEDWPRDVAL----PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHCCCCGGGSCTTCSS----CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhhCCCchhcccccccc----hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000000000 00000000001111223456778999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=384.17 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc------chhHHHHHHHHHHHhcC--CCCceEEEeecccccc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------GASKSFLAECKALKNIR--HRNLVKVITSCSSIDF 734 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 734 (988)
++|++.+.||+|+||+||+|++..+|+.||||+++.... .....+.+|+.++++++ ||||+++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 579999999999999999999999999999999864321 11234678999999996 89999999995
Q ss_pred cCCCceEEEEeeccc-cchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC
Q 001974 735 QGNDFKALVYEFMTN-GSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD 813 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 813 (988)
.+++..++||||+.+ +++.+++... ..+++.+++.++.||+.||+|||+. +||||||||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-----------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 144 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEe
Confidence 445889999999975 6787777543 3689999999999999999999998 999999999999998
Q ss_pred C-CCcEEEeeecccccccccccccceeccccccccccccCcccCCCCC-CCccchHHHHHHHHHHHhCCCCCCccccCCc
Q 001974 814 N-DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEV-STNGDIYSYGILLLEMVTGKKPTDVMFEGDL 891 (988)
Q Consensus 814 ~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 891 (988)
. ++.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---- 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred cCCCeEEECccccceeccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----
Confidence 5 5799999999998654322 223569999999999887665 567899999999999999999986310
Q ss_pred chHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 892 NLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.+ .......+..+++++.+++.+||+.||++|||++|+++
T Consensus 215 ------------~i-----------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 ------------EI-----------------------IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------------HH-----------------------HHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HH-----------------------hhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 00011123356788999999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=385.99 Aligned_cols=271 Identities=23% Similarity=0.266 Sum_probs=195.0
Q ss_pred CCceeccccceeEEEEEECCCCeEEEEEEeecccc-----chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceE
Q 001974 667 STHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH-----GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 667 ~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
.+++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 45789999999999999999999999999864322 1235788999999999999999999995 4457899
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEEe
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHVG 821 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 821 (988)
+||||++++++..+..... .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 77 ivmE~~~~~~~~~~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL-----------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS-----------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred ehhhhhcchHHhhhhhccc-----------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccc
Confidence 9999998888777765432 688889999999999999999999 99999999999999999999999
Q ss_pred eecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+|+........ ....+||+.|+|||++.+. .++.++||||+||++|||+||++||..... .+........
T Consensus 143 DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~ 216 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFET 216 (299)
T ss_dssp CCGGGSTTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH
T ss_pred cCccccccCCCccc----ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHh
Confidence 99999865443221 2234689999999998754 579999999999999999999999863211 1111111111
Q ss_pred Hhhhhhh-hhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 901 LLDHVID-IVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 901 ~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
......+ +.+..-......+..... ..........++++.+|+.+||+.||++||||+|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 217 LGTPTEEQWPDMCSLPDYVTFKSFPG----IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCC----CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCChhhccchhccchhhhhccCCC----CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 000000000000000000 0000011245678999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=384.76 Aligned_cols=272 Identities=25% Similarity=0.311 Sum_probs=198.8
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++. +++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 68999999999999999999999999999999996433 233578999999999999999999999954 45889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++||||+.++.+........ ..+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~----------~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl 143 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASAL----------TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL 143 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEeecCCchhhhhhhhcc----------cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCccee
Confidence 99999996544443322222 3689999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.|+....... ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||..... .......
T Consensus 144 ~DFG~a~~~~~~~~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i 215 (298)
T d1gz8a_ 144 ADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRI 215 (298)
T ss_dssp CSTTHHHHHCCCSB----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHH
T ss_pred ccCCcceeccCCcc----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHH
Confidence 99999986644322 122346999999999877765 57899999999999999999999864211 1111110
Q ss_pred HHh-hhhhhhhcc------ccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALL-DHVIDIVDP------ILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~-~~~~~~~d~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
... ....+...+ ........+.. ..........+.++.+++.+||+.||++|||++|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWAR-------QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTSCCCCC-------CCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCCchhhccccccccccccccccccc-------cchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000000000 00000000000 00000112455778999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=390.00 Aligned_cols=273 Identities=22% Similarity=0.350 Sum_probs=211.3
Q ss_pred HHHhhCCCCCCceeccccceeEEEEEEC-----CCCeEEEEEEeecccc-chhHHHHHHHHHHHhcCCCCceEEEeeccc
Q 001974 658 LFKATDGFSSTHLIGMGSFGSVYKGAFD-----QDGTIVAIKVFNLQRH-GASKSFLAECKALKNIRHRNLVKVITSCSS 731 (988)
Q Consensus 658 l~~~~~~y~~~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 731 (988)
+....++|++.+.||+|+||+||+|.+. .+++.||||+++.... .....+.+|+.++++++||||++++++|..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3345578899999999999999999884 2357899999974332 334568999999999999999999999643
Q ss_pred ccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCee
Q 001974 732 IDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVL 811 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 811 (988)
++..++||||+++|+|.+++....... ........+++..+.+++.|+|+||.|||++ +||||||||+|||
T Consensus 95 -----~~~~~lv~e~~~~g~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 95 -----GQPTLVIMELMTRGDLKSYLRSLRPAM-ANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 165 (308)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHHHHHH-HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred -----CCceeEEEeecCCCCHHHHHHhccccc-ccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCcee
Confidence 478899999999999999986432100 0000012478999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCC-CCCCccccCC
Q 001974 812 LDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGK-KPTDVMFEGD 890 (988)
Q Consensus 812 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~ 890 (988)
+++++++||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||+||. +||...
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---- 239 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---- 239 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----
T ss_pred ecCCceEEEeecccceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC----
Confidence 999999999999999876554322 2223346899999999999999999999999999999999985 666432
Q ss_pred cchHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHH
Q 001974 891 LNLHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQS 970 (988)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 970 (988)
......... .+. .....+..++..+.+++.+||+.||++|||++||++.|++
T Consensus 240 -~~~~~~~~i--------~~~-------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ 291 (308)
T d1p4oa_ 240 -SNEQVLRFV--------MEG-------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291 (308)
T ss_dssp -CHHHHHHHH--------HTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred -CHHHHHHHH--------HhC-------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111110 010 1112234577889999999999999999999999999877
Q ss_pred HHH
Q 001974 971 VKN 973 (988)
Q Consensus 971 i~~ 973 (988)
..+
T Consensus 292 ~~~ 294 (308)
T d1p4oa_ 292 EME 294 (308)
T ss_dssp GSC
T ss_pred hcC
Confidence 644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-43 Score=374.44 Aligned_cols=276 Identities=23% Similarity=0.279 Sum_probs=200.5
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|+++++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 68999999999999999999996 88999999996442 333578999999999999999999999954 45889
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
+++|||+.++.+..+.... +.+++.+++.++.||+.||+|||+. +||||||||+|||++.++.+|+
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl 141 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI 141 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeehhhhHHHHHhhc-----------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEe
Confidence 9999999877777776544 3699999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.|......... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.... .
T Consensus 142 ~DfG~a~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~-~ 215 (286)
T d1ob3a_ 142 ADFGLARAFGIPVRK----YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIF-R 215 (286)
T ss_dssp CCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH-H
T ss_pred cccccceecccCccc----cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHH-H
Confidence 999999875443221 223458999999999876 456899999999999999999999986432111 000000 0
Q ss_pred HHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.............. ....+...................++++.+++.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 216 ILGTPNSKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHCCCCTTTSTTGG--GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhCCCChhhccchh--hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 000000000000011111223456678999999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=373.66 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=204.4
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCceEE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFKAL 742 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 742 (988)
++|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+..|+++++.++|++++..++.+. ..++..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 57999999999999999999999899999999986543 2356889999999998877666555543 34578899
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeC---CCCcEE
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLD---NDMIAH 819 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~k 819 (988)
||||+ ++++.+.+.... ..+++..+..++.|++.||+|||++ +||||||||+|||++ .+..+|
T Consensus 81 vme~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vk 146 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146 (299)
T ss_dssp EEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEc-CCchhhhhhhcc----------CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceee
Confidence 99999 667766654333 3689999999999999999999999 999999999999986 455799
Q ss_pred Eeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHH
Q 001974 820 VGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNY 896 (988)
Q Consensus 820 L~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 896 (988)
|+|||+|+......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||........... .
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~ 225 (299)
T d1ckia_ 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-Y 225 (299)
T ss_dssp ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------H
T ss_pred eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-H
Confidence 99999999765543221 1122345799999999999999999999999999999999999999975332211110 0
Q ss_pred HHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHHHH
Q 001974 897 ARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVKNA 974 (988)
Q Consensus 897 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 974 (988)
.... ..............+|+++.+++.+||+.+|++||+++++.+.|+.+..+
T Consensus 226 ~~~~------------------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 226 ERIS------------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHH------------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhh------------------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0000 00000001111235788899999999999999999999999999887554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=382.49 Aligned_cols=285 Identities=21% Similarity=0.214 Sum_probs=201.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc-cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR-HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.+|++++||||+++++++....+......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999999999999999996443 3345678999999999999999999999876544444455
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++++ |+.+|+|.+++.. .++++..++.++.||+.||+|||++ +||||||||+|||++.++.+||
T Consensus 87 ~l~~-~~~~g~L~~~l~~------------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKT------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp EEEE-ECCCEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred EEEE-eecCCchhhhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEE
Confidence 5554 5569999999853 2589999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+|+........ ........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ .......
T Consensus 151 ~DfG~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~ 227 (345)
T d1pmea_ 151 CDFGLARVADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILG 227 (345)
T ss_dssp CCCTTCEECCGGGCB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH
T ss_pred cccCceeeccCCCcc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhh
Confidence 999999865443221 112234569999999999855 467889999999999999999999986432111 0000000
Q ss_pred HHhhhhhhhhccccccCcchhhhhh--HHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 900 ALLDHVIDIVDPILINDVEDWDATN--KQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 900 ~~~~~~~~~~d~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.............. ....+.... ...............+.++.+++.+||+.||++||||+|+++.
T Consensus 228 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 228 ILGSPSQEDLNCII--NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHCSCCHHHHHTCC--CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCChhhhhhhh--hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 000000000 0000000000112345678999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=375.03 Aligned_cols=283 Identities=22% Similarity=0.288 Sum_probs=199.5
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecc--ccchhHHHHHHHHHHHhcCCCCceEEEeeccccc---ccC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ--RHGASKSFLAECKALKNIRHRNLVKVITSCSSID---FQG 736 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~ 736 (988)
.++|+++++||+|+||+||+|++..+|+.||||++... .....+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999999999999998643 3344578899999999999999999999875432 123
Q ss_pred CCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC
Q 001974 737 NDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM 816 (988)
Q Consensus 737 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 816 (988)
++..++||||++++.+..+.... ..+++..++.++.||+.||.|||+. +||||||||+|||++.++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~-----------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG 154 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred CceEEEEEeccCCCccchhhhcc-----------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCC
Confidence 46789999999877776555433 2688899999999999999999998 999999999999999999
Q ss_pred cEEEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHH
Q 001974 817 IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHN 895 (988)
Q Consensus 817 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 895 (988)
.+||+|||+++.................||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .....
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~ 232 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLA 232 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHH
Confidence 999999999986654433333333345699999999998765 689999999999999999999999863211 11111
Q ss_pred HHHHHHhhhhhhhhccc----cccCc---chhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 896 YARTALLDHVIDIVDPI----LINDV---EDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 896 ~~~~~~~~~~~~~~d~~----l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
...........+..... ..... ..-.......+. .....+.+.+|+.+||+.||++||||+|+++
T Consensus 233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK------AYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHH------HHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhc------cccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111110000000000 00000 000000000000 0123456789999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.7e-42 Score=366.99 Aligned_cols=270 Identities=17% Similarity=0.185 Sum_probs=211.2
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCC-CCceEEEeecccccccCCCce
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRH-RNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 740 (988)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|++.++.++| +|++.+++++. .+...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence 367999999999999999999999999999999986432 23567889999999965 89999998853 45788
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC-----C
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN-----D 815 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~ 815 (988)
++||||+ +++|.+++.... ..+++.++..++.|++.||+|||+. +||||||||+||+++. +
T Consensus 77 ~~vme~~-~~~l~~~~~~~~----------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~ 142 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCG----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA 142 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEEec-CCCHHHHHHhhc----------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccC
Confidence 9999999 799999886544 3689999999999999999999999 9999999999999974 5
Q ss_pred CcEEEeeeccccccccccccc---ceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 816 MIAHVGDFGLARVRQEVSNLT---QSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 816 ~~~kL~DfG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
+.+||+|||+|+......... ........||+.|||||++.+..++.++|||||||++|||+||+.||........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~- 221 (293)
T d1csna_ 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN- 221 (293)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-
T ss_pred CceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-
Confidence 789999999998765432211 1123345799999999999999999999999999999999999999974322211
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHHHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHELQSVK 972 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 972 (988)
...... +.+.. . ..........+|+++.+++..|++.+|++||+++.+.+.++++.
T Consensus 222 -~~~~~~-i~~~~-~---------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 222 -KQKYER-IGEKK-Q---------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp -HHHHHH-HHHHH-H---------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHHH-HHhcc-C---------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 110000 00000 0 00000112357788999999999999999999999999998887
Q ss_pred HHhhh
Q 001974 973 NALLE 977 (988)
Q Consensus 973 ~~~~~ 977 (988)
++...
T Consensus 278 ~~~~~ 282 (293)
T d1csna_ 278 ERLNT 282 (293)
T ss_dssp HHTTC
T ss_pred HHcCC
Confidence 66543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=380.84 Aligned_cols=281 Identities=21% Similarity=0.243 Sum_probs=198.1
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeeccccc-ccCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSID-FQGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 738 (988)
.++|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++||||+++++++.... .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999999899999999997432 233467889999999999999999999976542 12334
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
+.++||||+ +.+|..+.+. .++++..++.++.||+.||+|||++ +||||||||+|||++.++.+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~ 160 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 160 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred eEEEEEecc-cccHHHHHHh------------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccc
Confidence 679999999 7788877643 3689999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|++|||.|+...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......
T Consensus 161 kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~ 231 (346)
T d1cm8a_ 161 KILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEI 231 (346)
T ss_dssp EECCCTTCEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred ccccccceeccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHH
Confidence 999999998654322 23469999999999876 45689999999999999999999998643111 000000
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
.........+............+...................++++.+|+.+||+.||++||||+|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000000000000000000000000000011123456788999999999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7e-42 Score=374.99 Aligned_cols=275 Identities=20% Similarity=0.234 Sum_probs=200.9
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeecccccccCCCceE
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQGNDFKA 741 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 741 (988)
++|+++++||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 6799999999999999999999999999999998643 3467889999999995 9999999998653 2446789
Q ss_pred EEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEEE
Q 001974 742 LVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHV 820 (988)
Q Consensus 742 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL 820 (988)
+||||+++++|..+. +.+++.+++.++.||+.||+|||++ +||||||||+|||++.++ .+||
T Consensus 109 ~v~e~~~~~~L~~~~--------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl 171 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY--------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL 171 (328)
T ss_dssp EEEECCCSCBGGGTT--------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEeecCCCcHHHHh--------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeee
Confidence 999999999998764 2689999999999999999999999 999999999999998655 6999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||+|+........ ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............. .
T Consensus 172 ~DFG~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~-~ 245 (328)
T d3bqca1 172 IDWGLAEFYHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA-K 245 (328)
T ss_dssp CCGGGCEECCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH-H
T ss_pred cccccceeccCCCcc-----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHH-H
Confidence 999999876543322 234589999999998765 479999999999999999999999864322111111111 1
Q ss_pred HHhh-hhhhhhccccccCcchhhhhhH-----HHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLD-HVIDIVDPILINDVEDWDATNK-----QRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~-~~~~~~d~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.... ...+.....-......+..... .............+++++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0100 0011100000000000000000 00000011112345678999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=373.06 Aligned_cols=280 Identities=21% Similarity=0.254 Sum_probs=196.9
Q ss_pred CCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCCceEE
Q 001974 664 GFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGNDFKAL 742 (988)
Q Consensus 664 ~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 742 (988)
+|+..++||+|+||+||+|++..+|+.||||+++.... ...+|++++++++||||+++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58888999999999999999999999999999975432 23479999999999999999999754321 33456789
Q ss_pred EEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCC-cEEEe
Q 001974 743 VYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDM-IAHVG 821 (988)
Q Consensus 743 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 821 (988)
||||++++.+..+.... .....+++.+++.|+.||+.||+|||++ +||||||||+|||++.++ .+||+
T Consensus 97 v~Ey~~~~~~~~l~~~~--------~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp EEECCSEEHHHHHHHHH--------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEEC
T ss_pred EEeccCCccHHHHHhhh--------hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEe
Confidence 99999765433332110 0113689999999999999999999998 999999999999999775 89999
Q ss_pred eecccccccccccccceeccccccccccccCcccCC-CCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHHH
Q 001974 822 DFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLG-SEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYARTA 900 (988)
Q Consensus 822 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 900 (988)
|||+++........ ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.... ..
T Consensus 166 DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~-~~ 238 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPN-----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEII-KV 238 (350)
T ss_dssp CCTTCEECCTTSCC-----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHH-HH
T ss_pred cccchhhccCCccc-----ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHH-HH
Confidence 99999866543322 23469999999998765 578999999999999999999999986422110 011100 00
Q ss_pred Hhhh----hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH--HHHH
Q 001974 901 LLDH----VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE--LQSV 971 (988)
Q Consensus 901 ~~~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 971 (988)
.... +................. ...........++++.+|+.+||+.||++||||+|+++. ++++
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKA------HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCC------CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hCCChHHhhhhhccchhhcccccccc------CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 000000000000000000 000001122467789999999999999999999999863 4444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=364.64 Aligned_cols=277 Identities=21% Similarity=0.266 Sum_probs=204.7
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccccCCCce
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGNDFK 740 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 740 (988)
++|+++++||+|+||+||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++. +.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 57999999999999999999999999999999996443 234578899999999999999999999954 45888
Q ss_pred EEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcEEE
Q 001974 741 ALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIAHV 820 (988)
Q Consensus 741 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 820 (988)
++|+|++.++++..++.... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl 142 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG-----------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred eEEeeecccccccccccccc-----------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceee
Confidence 99999999999988876543 688999999999999999999998 9999999999999999999999
Q ss_pred eeecccccccccccccceeccccccccccccCcccCCCC-CCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHHH
Q 001974 821 GDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSE-VSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYART 899 (988)
Q Consensus 821 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 899 (988)
+|||.|+........ .....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.........+ .....
T Consensus 143 ~DFG~a~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~ 217 (292)
T d1unla_ 143 ANFGLARAFGIPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFR 217 (292)
T ss_dssp CCCTTCEECCSCCSC----CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHH
T ss_pred eecchhhcccCCCcc----ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHh
Confidence 999999876543322 12235788999999987765 6899999999999999999999974321111111 11111
Q ss_pred HHhhhhhhhhcccc-ccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 900 ALLDHVIDIVDPIL-INDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 900 ~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.............. ........ ...............++++.+|+.+||+.||++||||+|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 218 LLGTPTEEQWPSMTKLPDYKPYP---MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCC---CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcCCCChhhhhhhhhcccccccc---cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110000000000 00000000 000000111122345677899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=374.51 Aligned_cols=282 Identities=22% Similarity=0.176 Sum_probs=194.7
Q ss_pred hCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccc--cchhHHHHHHHHHHHhcCCCCceEEEeecccccc-cCCC
Q 001974 662 TDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQR--HGASKSFLAECKALKNIRHRNLVKVITSCSSIDF-QGND 738 (988)
Q Consensus 662 ~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 738 (988)
.++|+++++||+|+||+||+|++..+|+.||||+++... ....+.+.+|+.++++++||||+++++++..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999999999999999997432 2334578899999999999999999999764422 3557
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..|+||||+.++.+. .+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eeEEEEeccchHHHH-hhh-------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccce
Confidence 889999999665554 442 2578999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYAR 898 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 898 (988)
|++|||.++........ ....+|+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 159 kl~df~~~~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~ 231 (355)
T d2b1pa1 159 KILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVI 231 (355)
T ss_dssp EECCCCC--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred eeechhhhhcccccccc-----ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--HHHHHHH
Confidence 99999998865543322 2345899999999999999999999999999999999999998632110 0000000
Q ss_pred HHHhhh-----------hhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHHH
Q 001974 899 TALLDH-----------VIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVHE 967 (988)
Q Consensus 899 ~~~~~~-----------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 967 (988)
...... .....+.........+...................++++.+|+.+||+.||++||||+|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 011111110000000000000000000001112346678999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=375.60 Aligned_cols=282 Identities=20% Similarity=0.244 Sum_probs=199.2
Q ss_pred hhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeecccc--chhHHHHHHHHHHHhcCCCCceEEEeecccccccCCC
Q 001974 661 ATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH--GASKSFLAECKALKNIRHRNLVKVITSCSSIDFQGND 738 (988)
Q Consensus 661 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 738 (988)
.+++|+++++||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++||||+++++++......+..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46789999999999999999999999999999999974432 3345788999999999999999999987544322334
Q ss_pred ceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCCCCcE
Q 001974 739 FKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDNDMIA 818 (988)
Q Consensus 739 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 818 (988)
..+++++|+.+|+|.+++... ++++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~------------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred ceEEEEEeecCCchhhhcccc------------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccc
Confidence 456667778899999998543 589999999999999999999999 99999999999999999999
Q ss_pred EEeeecccccccccccccceeccccccccccccCcccCCC-CCCCccchHHHHHHHHHHHhCCCCCCccccCCcchHHHH
Q 001974 819 HVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS-EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLNLHNYA 897 (988)
Q Consensus 819 kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 897 (988)
|++|||.|...... .....|++.|+|||...+. .++.++||||+||++|+|++|+.||..... .......
T Consensus 161 kl~dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i 231 (348)
T d2gfsa1 161 KILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLI 231 (348)
T ss_dssp EECCC----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred cccccchhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 99999999765332 2234589999999987765 468899999999999999999999863211 0111111
Q ss_pred HHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCCHHHHHH
Q 001974 898 RTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMSITNVVH 966 (988)
Q Consensus 898 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 966 (988)
.........+............+...................++++.+|+.+||+.||++||||+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 110000000000000000000000000000000000011245677899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=367.53 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=200.1
Q ss_pred CCCCCCceeccccceeEEEEEE---CCCCeEEEEEEeecc----ccchhHHHHHHHHHHHhcCC-CCceEEEeecccccc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAF---DQDGTIVAIKVFNLQ----RHGASKSFLAECKALKNIRH-RNLVKVITSCSSIDF 734 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 734 (988)
++|++++.||+|+||+||+|+. +.+|+.||||+++.. +....+.+.+|++++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 5699999999999999999987 346899999998633 22334678899999999966 89999999854
Q ss_pred cCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCCeeeCC
Q 001974 735 QGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKPGNVLLDN 814 (988)
Q Consensus 735 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 814 (988)
+....++||||+.+|+|.+++.... .+++..+..++.||+.||+|+|+. +||||||||+||+++.
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~-----------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRE-----------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 164 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred -cCCceeeeeecccccHHHHHHHhcc-----------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence 4578999999999999999986543 578889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecccccccccccccceeccccccccccccCcccCCC--CCCCccchHHHHHHHHHHHhCCCCCCccccCCcc
Q 001974 815 DMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGS--EVSTNGDIYSYGILLLEMVTGKKPTDVMFEGDLN 892 (988)
Q Consensus 815 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 892 (988)
++.+||+|||+|+........ ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~ 240 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-S 240 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-C
T ss_pred CCCEEEeeccchhhhcccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 999999999999865443221 12235689999999998764 46789999999999999999999997543221 1
Q ss_pred hHHHHHHHHhhhhhhhhccccccCcchhhhhhHHHHhhhhhccccchhHHHHHHhhcccCcCCCCCCC-----HHHHHH
Q 001974 893 LHNYARTALLDHVIDIVDPILINDVEDWDATNKQRLRQAKINGKIECPISMVRIGVACSVESPQDRMS-----ITNVVH 966 (988)
Q Consensus 893 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 966 (988)
........ .......+..+++++.+++.+||++||++||| ++|+++
T Consensus 241 ~~~i~~~~----------------------------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 241 QAEISRRI----------------------------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHH----------------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHhc----------------------------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111110 01111223467888999999999999999994 788875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.3e-37 Score=333.30 Aligned_cols=277 Identities=24% Similarity=0.390 Sum_probs=250.6
Q ss_pred cCCccccCCCCCCCCCc--eeeeeEEeCCC--CcEEEEEcCCCCCcc--cccccccCCCCCCEEEcCC-CcccccCCccc
Q 001974 4 HDPQGILNSWNDSGHFC--EWKGITCGLRH--RRVTVLNLRSKGLSG--SLSPYIGNLSFLREINLMN-NSIQGEIPREF 76 (988)
Q Consensus 4 ~~~~~~~~~w~~~~~~c--~~~~v~c~~~~--~~v~~l~l~~~~~~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~ 76 (988)
.||. .++||.+++||| .|.||+|+..+ .||+.|||+++++++ .+|+++++|++|++|+|++ |+++|.+|.+|
T Consensus 19 ~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i 97 (313)
T d1ogqa_ 19 GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97 (313)
T ss_dssp TCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred CCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccccc
Confidence 3554 699999999999 49999999744 489999999999987 5789999999999999997 89999999999
Q ss_pred CCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCcc-c
Q 001974 77 GRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSL-E 155 (988)
Q Consensus 77 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~ 155 (988)
+++++|++|+|++|++.+..|..+..+.+|+++++++|++.+.+|..|.++++|+++++++|.+++.+|+.+..+..+ +
T Consensus 98 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~ 177 (313)
T d1ogqa_ 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177 (313)
T ss_dssp GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred ccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999988876 8
Q ss_pred eeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccc
Q 001974 156 SISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHN 235 (988)
Q Consensus 156 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N 235 (988)
.+++++|++++..|..+..+..+ .+++++|...+.+|..+..+++++.+++++|.+.+.+| . +..+++|+.|+|++|
T Consensus 178 ~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~-~~~~~~L~~L~Ls~N 254 (313)
T d1ogqa_ 178 SMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-K-VGLSKNLNGLDLRNN 254 (313)
T ss_dssp EEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-G-CCCCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-c-cccccccccccCccC
Confidence 89999999999899888887655 69999999999999999999999999999999986554 3 346789999999999
Q ss_pred ccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccC
Q 001974 236 FFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNL 285 (988)
Q Consensus 236 ~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 285 (988)
++++.+|..+.++++|++|+|++|+++|.+|. +..+++|+.+++++|+.
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSE
T ss_pred eecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCcc
Confidence 99999999999999999999999999988874 67788888888888874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-36 Score=333.60 Aligned_cols=281 Identities=19% Similarity=0.219 Sum_probs=190.6
Q ss_pred CCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-----------CCCceEEEeeccc
Q 001974 663 DGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-----------HRNLVKVITSCSS 731 (988)
Q Consensus 663 ~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 731 (988)
.+|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999999999999999997432 33467788999888875 5789999888653
Q ss_pred ccccCCCceEEEEeeccccch-hhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCC
Q 001974 732 IDFQGNDFKALVYEFMTNGSL-ENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGN 809 (988)
Q Consensus 732 ~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~N 809 (988)
. .....+++++++..+.. ........ ...+++..++.++.||+.||+|||+ . +|+||||||+|
T Consensus 92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~N 156 (362)
T d1q8ya_ 92 K---GPNGVHVVMVFEVLGENLLALIKKYE---------HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPEN 156 (362)
T ss_dssp E---ETTEEEEEEEECCCCEEHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGG
T ss_pred c---cccceeeeeeeccccccccccccccc---------ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhH
Confidence 2 33555666666644432 22221111 1368889999999999999999998 5 99999999999
Q ss_pred eeeCCCC------cEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHHHHHHhCCCCC
Q 001974 810 VLLDNDM------IAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILLLEMVTGKKPT 883 (988)
Q Consensus 810 Ill~~~~------~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~ 883 (988)
||++.++ .++++|||.|....... ....||+.|+|||++.+..++.++||||+||+++||++|+.||
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred eeeeccCcccccceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 9998665 49999999997543322 2345999999999999999999999999999999999999998
Q ss_pred CccccCCc-c-hHHHHH--HHHhhh----------hhhhhccc-cccCcchhhhhhHHHHhhhhhccccchhHHHHHHhh
Q 001974 884 DVMFEGDL-N-LHNYAR--TALLDH----------VIDIVDPI-LINDVEDWDATNKQRLRQAKINGKIECPISMVRIGV 948 (988)
Q Consensus 884 ~~~~~~~~-~-~~~~~~--~~~~~~----------~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 948 (988)
........ . ...... ...... .....+.. ...........................++++.+|+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 74322110 0 000000 000000 00000000 000000000000111111122233456778999999
Q ss_pred cccCcCCCCCCCHHHHHH
Q 001974 949 ACSVESPQDRMSITNVVH 966 (988)
Q Consensus 949 ~cl~~dP~~RPs~~evl~ 966 (988)
+|++.||++||||+|+++
T Consensus 310 ~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp GGGCSSTTTCBCHHHHHT
T ss_pred HHCCCChhHCcCHHHHhc
Confidence 999999999999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=5e-33 Score=302.74 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=219.4
Q ss_pred cccEEEccCCcccc--CCCccccCCCcceEEEeeC-ccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEE
Q 001974 329 QLQNLIMTSNQLHG--SIPSGIGNLVGLYRLGMGG-NQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSEL 405 (988)
Q Consensus 329 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 405 (988)
+++.|+|++|.+.+ .+|..++.+++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 46667777776665 4678888888999999986 78888888889999999999999999988888888888999999
Q ss_pred EccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCccc
Q 001974 406 LLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNL 485 (988)
Q Consensus 406 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 485 (988)
++++|.+.+.+|..+..+++|+.+++++|.+.|.+|..+..+..+++.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9999998888888899999999999999999888998888888877888999999998888888877654 689999999
Q ss_pred ccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCcccCCCCc
Q 001974 486 SGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLEGEVPTKG 564 (988)
Q Consensus 486 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~~~~p~~~ 564 (988)
.|.+|..++.+++|+.+++++|.+.+.+| .++.++.|+.|||++|+|+|.+|.. ..+++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999987654 6888899999999999999888765 778889999999999999999877
Q ss_pred ccCcccccccccccccCCCCC
Q 001974 565 VFANISRISVAGFNRLCGGIP 585 (988)
Q Consensus 565 ~~~~~~~~~~~~n~~lcg~~~ 585 (988)
.+.++..+.+.+|+.+||.|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTS
T ss_pred cCCCCCHHHhCCCccccCCCC
Confidence 788888888999999999865
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=8e-29 Score=278.03 Aligned_cols=193 Identities=30% Similarity=0.411 Sum_probs=119.5
Q ss_pred ccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccc
Q 001974 346 SGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQ 425 (988)
Q Consensus 346 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 425 (988)
..+..+++++.|++++|.+++..| +...++|+.|++++|+++. + ..+..+++|+.|++++|.+++..+ +..+++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~ 264 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTK 264 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred cccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--cccccc
Confidence 344555566666666666664333 3444566666666666652 2 245566666666666666664332 556666
Q ss_pred cceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcccccCCCCcEEEec
Q 001974 426 LAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMR 505 (988)
Q Consensus 426 L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 505 (988)
|+.|++++|+++ .++ .+..++.+ +.+++++|++++ ...+..+++++.|++++|++++. + .+..+++|++|+|+
T Consensus 265 L~~L~l~~~~l~-~~~-~~~~~~~l-~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~ 337 (384)
T d2omza2 265 LTELKLGANQIS-NIS-PLAGLTAL-TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFA 337 (384)
T ss_dssp CSEEECCSSCCC-CCG-GGTTCTTC-SEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECC
T ss_pred CCEeeccCcccC-CCC-cccccccc-cccccccccccc--ccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECC
Confidence 666666666665 333 24455555 566666666653 22356667777777777777743 2 26677777777777
Q ss_pred CccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCCCC
Q 001974 506 GNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLSFN 554 (988)
Q Consensus 506 ~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~~N 554 (988)
+|+|++ +| .++++++|++|||++|+|++.+| +..+++|++|+|++|
T Consensus 338 ~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 338 NNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 777763 33 57777777777777777777655 556667777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=2.2e-28 Score=274.42 Aligned_cols=187 Identities=31% Similarity=0.435 Sum_probs=128.3
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
.++.+++++|.+++..| +...++|+.|++++|+++. + +.+..+++|+.|++++|++++..+ +..+++|+.|+++
T Consensus 198 ~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 198 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence 45555555555554332 3445566677777776663 2 346666777777777777764332 5667777777777
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
+|++++..+ +..++.++.+++++|.+++ + ..+..++.+ +.|++++|++++.. .+..+++|+.|++++|+|++
T Consensus 272 ~~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l-~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~- 343 (384)
T d2omza2 272 ANQISNISP--LAGLTALTNLELNENQLED-I-SPISNLKNL-TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD- 343 (384)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCSC-C-GGGGGCTTC-SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred CcccCCCCc--ccccccccccccccccccc-c-cccchhccc-CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-
Confidence 777764432 6667777777777777763 3 345666666 77788888777543 27778888888888888883
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCc
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNN 532 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 532 (988)
+| .|+.+++|++|+|++|+|++..| +.++++|+.|+|++|.
T Consensus 344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 44 58888888888888888886554 7888888999988883
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.4e-27 Score=256.47 Aligned_cols=279 Identities=18% Similarity=0.239 Sum_probs=204.2
Q ss_pred CCCCCceeeeeEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCC
Q 001974 15 DSGHFCEWKGITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVG 94 (988)
Q Consensus 15 ~~~~~c~~~~v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~ 94 (988)
++.|-|.|.+|+|. +++++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+..
T Consensus 5 p~~c~c~~~~~~C~------------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 5 PFRCQCHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CTTCEEETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEecCCEEEec------------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc
Confidence 45677888888886 34566 5666664 678999999999986666688999999999999999997
Q ss_pred cCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccC--CCCCccc
Q 001974 95 EIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFG--GNIPNSL 172 (988)
Q Consensus 95 ~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~ 172 (988)
..|.+|..+++|++|+|++|+|+ .+|..+. ..|+.|++.+|.+....+..+.....++.++...|... ...+..|
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~ 146 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred cchhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccc
Confidence 77888999999999999999988 4444332 46777888888888666666777777788888777544 2345567
Q ss_pred cCcccccccccccccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCccc
Q 001974 173 GQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLE 252 (988)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 252 (988)
..+++|+.+++++|.++. +|..+ .++|+.|++++|.+.+ .+...+.+++.++.|++++|.+++..+..+.++++|+
T Consensus 147 ~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~-~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~ 222 (305)
T d1xkua_ 147 QGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222 (305)
T ss_dssp GGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCC
T ss_pred ccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCC-CChhHhhccccccccccccccccccccccccccccce
Confidence 777888888888888773 34332 4677778888877773 3444455777777888888877777777777778888
Q ss_pred EEEeccccccCcccccccCCccccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCC
Q 001974 253 FIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLR 316 (988)
Q Consensus 253 ~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 316 (988)
+|+|++|+++.+ |..|..+++|++|+|++|+|+.++...+..+..+..+.+|+.|+|++|+++
T Consensus 223 ~L~L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 223 ELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp EEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred eeeccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 888888877754 556777888888888888887776665544444555666777777777664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.5e-25 Score=242.16 Aligned_cols=279 Identities=19% Similarity=0.284 Sum_probs=178.5
Q ss_pred cccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEec
Q 001974 129 KLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVP 208 (988)
Q Consensus 129 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 208 (988)
.+++++-+++.++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+..+.|.+|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3445555555565 4455443 456666666666664444566666666666666666666666666666666666666
Q ss_pred cCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCC
Q 001974 209 RNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSG 288 (988)
Q Consensus 209 ~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 288 (988)
+|+++ .+|...+ ..+..|++++|.+.+..+..+.....+..++...|. ....
T Consensus 88 ~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~------------------------~~~~ 139 (305)
T d1xkua_ 88 KNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP------------------------LKSS 139 (305)
T ss_dssp SSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSC------------------------CCGG
T ss_pred CCccC-cCccchh---hhhhhhhccccchhhhhhhhhhcccccccccccccc------------------------cccc
Confidence 66666 5554433 345555555555554444344444444444444433 2211
Q ss_pred CCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCcc
Q 001974 289 ESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTI 368 (988)
Q Consensus 289 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 368 (988)
... ...+..+++|+.+++++|+++ .+|..+ .++|+.|++++|.+.+..+..+..++.++.|++++|.+++..
T Consensus 140 ~~~----~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 140 GIE----NGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp GBC----TTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred CCC----ccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 110 113444555566666666555 344333 246778888888877777788888888888888888888777
Q ss_pred CcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccccccccccc------ccccccceeecCCCCCC-ccCc
Q 001974 369 PKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCL------GSLKQLAILHLFENGLN-GTIP 441 (988)
Q Consensus 369 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~L~l~~N~l~-~~~p 441 (988)
+..+.++++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+.+....| ..+.+|+.|+|++|.+. ..++
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~ 290 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence 778888888888888888888 567788888888888888888886544443 45677889999999885 4555
Q ss_pred hhhhhh
Q 001974 442 EEIFNL 447 (988)
Q Consensus 442 ~~~~~l 447 (988)
+..+.+
T Consensus 291 ~~~f~~ 296 (305)
T d1xkua_ 291 PSTFRC 296 (305)
T ss_dssp GGGGTT
T ss_pred HhHhcc
Confidence 555444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-25 Score=240.25 Aligned_cols=252 Identities=20% Similarity=0.180 Sum_probs=187.5
Q ss_pred cEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecc-
Q 001974 306 RTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLY- 384 (988)
Q Consensus 306 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~- 384 (988)
..++.++++++ .+|..+. +.+++|+|++|+|++..+..|..+++|++|++++|++.+..+..+..+..++.++..
T Consensus 14 ~~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~ 89 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 34566666776 6676543 467888888888886666778888888888888888887777778888888887654
Q ss_pred cccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCC
Q 001974 385 DNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGS 464 (988)
Q Consensus 385 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~ 464 (988)
.|.++...|..|.++++|++|++++|.+....+..+..+++|+.+++++|++++..+..+..++.+ +.|++++|++++.
T Consensus 90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L-~~L~l~~N~l~~l 168 (284)
T d1ozna_ 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL-THLFLHGNRISSV 168 (284)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCEE
T ss_pred ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccch-hhcccccCccccc
Confidence 566776667788888888888888888887777778888888888888888873333445566666 7788888888776
Q ss_pred CccccccccccceeecCCcccccccCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCC
Q 001974 465 IPTKIGNLKYLRVFNVSSNNLSGEIPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDL 544 (988)
Q Consensus 465 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~ 544 (988)
.+..|.++++|+.+++++|++++..|..|..+++|++|++++|++.+..|..|..+++|+.|+|++|.+....+...-..
T Consensus 169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~ 248 (284)
T d1ozna_ 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHH
Confidence 77777788888888888888887777888888888888888888887777777788888888888887776544322222
Q ss_pred CCcEEeCCCCcCcccCCC
Q 001974 545 SLEYLNLSFNDLEGEVPT 562 (988)
Q Consensus 545 ~L~~l~l~~N~l~~~~p~ 562 (988)
.++.+....+.+.+..|.
T Consensus 249 ~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 249 WLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp HHHHCCSEECCCBEEESG
T ss_pred HHHhCcCCCCceEeCCch
Confidence 355555566666655554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-24 Score=232.54 Aligned_cols=267 Identities=20% Similarity=0.251 Sum_probs=190.9
Q ss_pred EEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecc-cc
Q 001974 205 FSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVA-YN 283 (988)
Q Consensus 205 L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~-~N 283 (988)
++.++++++ ++|..++ +++++|+|++|+|+.+.+.+|.++++|++|++++|++..+.+..+..+..+..+... .|
T Consensus 16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 445555555 6665544 356677777777776666667777777777777777777777777777777776553 55
Q ss_pred cCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCcc
Q 001974 284 NLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQ 363 (988)
Q Consensus 284 ~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 363 (988)
.++.+++. +|.++++|++|++++|.+.. ++.........|+.+++++|+|++..+..|..+++|+.|++++|+
T Consensus 92 ~~~~l~~~------~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 92 QLRSVDPA------TFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp TCCCCCTT------TTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccccccch------hhcccccCCEEecCCccccc-ccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence 55555443 45677777777777777763 333333334578888888888887777788888889999999999
Q ss_pred CCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchh
Q 001974 364 FTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEE 443 (988)
Q Consensus 364 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 443 (988)
+++..+..|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|..+++|+.|++++|.+.+.-+..
T Consensus 165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 98777888889999999999999998888888999999999999999999888888999999999999999988654321
Q ss_pred hhhhcccccceecccccccCCCccccccccccceeecCCccccc
Q 001974 444 IFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSG 487 (988)
Q Consensus 444 ~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 487 (988)
+-...+ +.+....+++....|..+.+ ....+++.+.|+|
T Consensus 245 -~l~~~l-~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 245 -PLWAWL-QKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp -HHHHHH-HHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred -HHHHHH-HhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 111222 55666667776666665543 3445555555554
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.2e-24 Score=226.16 Aligned_cols=206 Identities=21% Similarity=0.181 Sum_probs=178.4
Q ss_pred eEEeCCCCcEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCC
Q 001974 25 ITCGLRHRRVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCS 104 (988)
Q Consensus 25 v~c~~~~~~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 104 (988)
|.|....+.++ +|.++++++ .+|+.+. +++++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.++
T Consensus 4 C~~~~~~~~~~-v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~ 77 (266)
T d1p9ag_ 4 CEVSKVASHLE-VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLP 77 (266)
T ss_dssp SEEECSTTCCE-EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCT
T ss_pred cEEcccCCCeE-EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccc
Confidence 45664444443 488999999 5787665 57999999999999777788999999999999999999 555 467899
Q ss_pred CCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccc
Q 001974 105 RLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLG 184 (988)
Q Consensus 105 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 184 (988)
+|++|+|++|+++ ..+..+.++++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 9999999999998 567789999999999999999998888888999999999999999998888888999999999999
Q ss_pred cccccCccchhhccccCccEEEeccCCCCCCCCCcccccCCCCcceecccccccc
Q 001974 185 ANNLSGIIPPSIYNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSG 239 (988)
Q Consensus 185 ~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~ 239 (988)
+|+|+++.+..|..+++|++|+|++|+|+ .+|..++ .+++|+.|+|++|.+.+
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~-~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF-GSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT-TTCCCSEEECCSCCBCC
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHC-CCCCCCEEEecCCCCCC
Confidence 99999888888999999999999999998 8888877 67888888888887764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.2e-23 Score=218.34 Aligned_cols=196 Identities=19% Similarity=0.190 Sum_probs=105.0
Q ss_pred cccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 329 QLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 329 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
.+.+++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccc
Confidence 3455677777777 4565543 35667777777776544556666777777777777666 3332 4556666666666
Q ss_pred ccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc
Q 001974 409 NNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE 488 (988)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 488 (988)
+|+++ ..+..+..+++|+.|++++|.+.+..+..+..+..+ +.|++++|.+++..+..+..+++|+.|++++|+|++.
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l-~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL-QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred ccccc-ccccccccccccccccccccccceeecccccccccc-ccccccccccceeccccccccccchhccccccccccc
Confidence 66666 345556666666666666666653233333333443 4444444444433334444444444444444444443
Q ss_pred cCcccccCCCCcEEEecCccccccCCccccCccccCeeecCCCc
Q 001974 489 IPSQLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNN 532 (988)
Q Consensus 489 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 532 (988)
.+..|..+++|++|+|++|+|+ .+|.++..+++|+.|+|++|.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 3344444444444444444444 344444444444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=2.3e-20 Score=205.57 Aligned_cols=95 Identities=26% Similarity=0.322 Sum_probs=48.3
Q ss_pred cEEEEEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecC
Q 001974 33 RVTVLNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLG 112 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 112 (988)
+++.|||++++++ .+|+. .++|++|+|++|+|+ .+|.. +.+|++|++++|+++ .++.. .+.|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 3455666666665 34432 345566666666665 44543 235556666666555 33321 1235555555
Q ss_pred cccccCCCcccccCccccccccccccccc
Q 001974 113 RNKLMGSIPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 113 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
+|.|. .+|. +..+++|++|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccc
Confidence 55554 3332 344555555555555554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.2e-22 Score=202.01 Aligned_cols=169 Identities=20% Similarity=0.161 Sum_probs=120.0
Q ss_pred CCCceeccccceeEEEEEECCCCeEEEEEEeecccc------------------chhHHHHHHHHHHHhcCCCCceEEEe
Q 001974 666 SSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRH------------------GASKSFLAECKALKNIRHRNLVKVIT 727 (988)
Q Consensus 666 ~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~ 727 (988)
.+.++||+|+||+||+|++. +|+.||||+++.... ........|+..+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999985 799999998753211 01123456888999999999999887
Q ss_pred ecccccccCCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 001974 728 SCSSIDFQGNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHCQEPVLHCDLKP 807 (988)
Q Consensus 728 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 807 (988)
+ ...++||||+++..+.++ +...+..++.|++.|++|||++ +|+||||||
T Consensus 82 ~---------~~~~lvme~~~~~~~~~l------------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP 131 (191)
T d1zara2 82 W---------EGNAVLMELIDAKELYRV------------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 131 (191)
T ss_dssp E---------ETTEEEEECCCCEEGGGC------------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred e---------cCCEEEEEeeccccccch------------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence 6 223799999987665432 3334567999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeeecccccccccccccceeccccccccccccCcccCCCCCCCccchHHHHHHH
Q 001974 808 GNVLLDNDMIAHVGDFGLARVRQEVSNLTQSCSVGVRGTIGYAAPEYGLGSEVSTNGDIYSYGILL 873 (988)
Q Consensus 808 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl 873 (988)
+|||++++ .++|+|||.|........... ......... |. ....|+.++|+||..--+
T Consensus 132 ~NILv~~~-~~~liDFG~a~~~~~~~~~~~-l~rd~~~~~-----~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 132 YNVLVSEE-GIWIIDFPQSVEVGEEGWREI-LERDVRNII-----TY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSEEEETT-EEEECCCTTCEETTSTTHHHH-HHHHHHHHH-----HH-HHHHHCCCCCHHHHHHHH
T ss_pred hheeeeCC-CEEEEECCCcccCCCCCcHHH-HHHHHHHHH-----HH-HcCCCCCcccHHHHHHHH
Confidence 99999965 589999999976543221100 000000000 11 135678899999975443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=9.6e-20 Score=200.55 Aligned_cols=315 Identities=24% Similarity=0.268 Sum_probs=232.1
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCccccccccc
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAM 135 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 135 (988)
.++++|||++|+|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36899999999999 57754 578999999999999 778764 58999999999998 34432 146999999
Q ss_pred ccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhccccCccEEEeccCCCCCC
Q 001974 136 QRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLANFSVPRNQFHGS 215 (988)
Q Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~ 215 (988)
++|.++ .+|. ++.+++|++|++++|.+.. .+..+ ..+..|.+..+... ....+..++.++.|++++|.+. .
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~-~ 176 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-K 176 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS-S
T ss_pred cccccc-cccc-hhhhccceeeccccccccc-ccccc---ccccchhhcccccc--ccccccccccceeccccccccc-c
Confidence 999998 5564 6889999999999999883 44433 45666666666654 3456788999999999999987 4
Q ss_pred CCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCcccccccCCccccEEecccccCCCCCCCchhh
Q 001974 216 LPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGKLSVNFGGMKNLSYFNVAYNNLGSGESDEMSF 295 (988)
Q Consensus 216 lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 295 (988)
++... ...+.+....+.+. .++ .+..++.|+.+++++|...... ....++..+.+.+|.+.....
T Consensus 177 ~~~~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~~~~~~~~~~~~~~----- 241 (353)
T d1jl5a_ 177 LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVRDNYLTDLPE----- 241 (353)
T ss_dssp CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCTTCCEEECCSSCCSCCCC-----
T ss_pred ccccc----cccccccccccccc-ccc-cccccccccccccccccccccc----ccccccccccccccccccccc-----
Confidence 44322 33456666666655 222 4567889999999999876532 335678889999988865432
Q ss_pred hcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCC
Q 001974 296 MNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKL 375 (988)
Q Consensus 296 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 375 (988)
....+...++..+.+.+ +..++......++..|.+.+. + ..+++|++|+|++|+|+ .+|.. +
T Consensus 242 -----~~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~-~---~~~~~L~~L~Ls~N~l~-~lp~~---~ 303 (353)
T d1jl5a_ 242 -----LPQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSL-C---DLPPSLEELNVSNNKLI-ELPAL---P 303 (353)
T ss_dssp -----CCTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE-C---CCCTTCCEEECCSSCCS-CCCCC---C
T ss_pred -----ccccccccccccccccc-----cccccchhcccccccCccccc-c---ccCCCCCEEECCCCccC-ccccc---c
Confidence 23567777777776652 223334566778888887733 2 34678999999999998 67754 5
Q ss_pred CccCeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 376 QNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 376 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.... +|+.|.+.
T Consensus 304 ~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~~ 352 (353)
T d1jl5a_ 304 PRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMN 352 (353)
T ss_dssp TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT---TCCEEECC
T ss_pred CCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc---ccCeeECc
Confidence 78999999999998 56753 468999999999998 5676443 46666553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=5.5e-20 Score=190.74 Aligned_cols=215 Identities=16% Similarity=0.101 Sum_probs=157.3
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcC-CcccccCCCCceeecC-cc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEI-PANLSYCSRLTILFLG-RN 114 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~L~-~N 114 (988)
++.++++++ .+|+.+. +++++|||++|+|+.+.+.+|.++++|++|+|++|.+...+ +.+|.++.++++|++. .|
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 444556777 6776553 57899999999999777778999999999999999987644 5578899999999876 46
Q ss_pred cccCCCcccccCcccccccccccccccCCCC-CcccCCCccceeeccccccCCCCCccccCcc-cccccccccccccCcc
Q 001974 115 KLMGSIPFEFFSLYKLKQLAMQRNNLTGGIP-PFIGNLTSLESISLAANAFGGNIPNSLGQLK-ELKSLGLGANNLSGII 192 (988)
Q Consensus 115 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~ 192 (988)
++....+..|.++++|++|++++|.+....+ ..+..+..+..+..+++.+....+..|.+++ .++.|++++|+++.+.
T Consensus 90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~ 169 (242)
T d1xwdc1 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 169 (242)
T ss_dssp TCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEEC
T ss_pred cccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccc
Confidence 7877788889999999999999999874332 2345566677777778888766677777765 7888888888888554
Q ss_pred chhhccccCccEE-EeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEe
Q 001974 193 PPSIYNLSLLANF-SVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEA 256 (988)
Q Consensus 193 ~~~l~~l~~L~~L-~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l 256 (988)
+..+. ..+++++ ++++|+++ .+|...|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 170 ~~~~~-~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 170 NCAFN-GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTTT-TCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccccc-chhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 44443 4444444 56777777 777777777777777777777776554445555555555444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=3.6e-20 Score=184.09 Aligned_cols=154 Identities=27% Similarity=0.304 Sum_probs=121.1
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccc-cCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQG-EIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNK 115 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~ 115 (988)
+|+++++++ .+|+.+. +++++|+|++|+|++ ..+..|.++++|++|+|++|.+....+..|..+++|++|+|++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 455577777 6777664 688999999999975 445678899999999999999998888899999999999999999
Q ss_pred ccCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccch
Q 001974 116 LMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPP 194 (988)
Q Consensus 116 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 194 (988)
|+.+.+.+|.++++|++|+|++|+|++..+++|.++++|++|+|++|.+... .....-...++.+.+..|.+....|.
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCCh
Confidence 9988888899999999999999999987788888899999999998888733 22222223466666666666654443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=2.2e-21 Score=222.26 Aligned_cols=387 Identities=17% Similarity=0.181 Sum_probs=167.6
Q ss_pred cccccccccccccCCC-CCcccCCCccceeeccccccCC----CCCccccCcccccccccccccccCccchhhccccCcc
Q 001974 129 KLKQLAMQRNNLTGGI-PPFIGNLTSLESISLAANAFGG----NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSLLA 203 (988)
Q Consensus 129 ~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 203 (988)
+|++|+++.|++++.. .+.+..+++|++|+|++|.++. .++.++..+++|++|||++|.|+......+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~------ 76 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL------ 76 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH------
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHH------
Confidence 4566666666665311 2223445555555565555541 1223344455555555555555321111111
Q ss_pred EEEeccCCCCCCCCCcccccCCCCcceeccccccccc----cCcccccCCcccEEEeccccccCccccccc-----CCcc
Q 001974 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGS----IPISLSNASKLEFIEALDNSFSGKLSVNFG-----GMKN 274 (988)
Q Consensus 204 ~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~i~~~~~~~~~-----~l~~ 274 (988)
..+.....+|++|+|++|+++.. ++..+..+++|++|++++|.+.......+. ....
T Consensus 77 --------------~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~ 142 (460)
T d1z7xw1 77 --------------QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 142 (460)
T ss_dssp --------------HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred --------------HHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccc
Confidence 11111123455555555555432 233455556666666666665433222111 1112
Q ss_pred ccEEecccccCCCCCCCchhhhcccccCCCCcEEEeecccCCCC----CCchhhhccccccEEEccCCccccCC----Cc
Q 001974 275 LSYFNVAYNNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGA----LPHSIANLSDQLQNLIMTSNQLHGSI----PS 346 (988)
Q Consensus 275 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~~~~~L~~L~L~~N~l~~~~----~~ 346 (988)
..........+... ........+.....++.++++++..... ....+.........+++..+.+.... ..
T Consensus 143 ~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~ 220 (460)
T d1z7xw1 143 LEKLQLEYCSLSAA--SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 220 (460)
T ss_dssp CCEEECTTSCCBGG--GHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred cccccccccccchh--hhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccc
Confidence 22333333322211 1111222344556677777766654311 00111122223445555555443211 11
Q ss_pred cccCCCcceEEEeeCccCCCc-----cCcccCCCCccCeEecccccCCCCC----CCCCCCCCCCCEEEccccccccccc
Q 001974 347 GIGNLVGLYRLGMGGNQFTGT-----IPKEMGKLQNLEGMGLYDNQLSGEI----PSSLGNLSILSELLLNNNSLSGVIP 417 (988)
Q Consensus 347 ~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p 417 (988)
.+...+.++.+++++|++... .+........|+.|++++|.+.... ...+...+.++.+++++|.+.....
T Consensus 221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~ 300 (460)
T d1z7xw1 221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 300 (460)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 223345556666666654311 1222333445555555555554211 1112234445555555555432111
Q ss_pred ccc-----ccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccc----
Q 001974 418 SCL-----GSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGE---- 488 (988)
Q Consensus 418 ~~~-----~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~---- 488 (988)
..+ .....|+.+++++|.++..-...+. ..+...++|+.|||++|+|++.
T Consensus 301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~---------------------~~~~~~~~L~~L~Ls~N~i~~~g~~~ 359 (460)
T d1z7xw1 301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFS---------------------SVLAQNRFLLELQISNNRLEDAGVRE 359 (460)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH---------------------HHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred chhhccccccccccccccccccchhhhhhhhcc---------------------cccccccchhhhheeeecccCcccch
Confidence 111 1123444555555544422111111 1122334566666666666532
Q ss_pred cCcccc-cCCCCcEEEecCcccccc----CCccccCccccCeeecCCCcccCcCcc-----cc-cCCCCcEEeCCCCcCc
Q 001974 489 IPSQLG-LCSYLEEIYMRGNFFHGS----IPSSLSSLRAVLAIDLSRNNLSGLIPK-----FL-EDLSLEYLNLSFNDLE 557 (988)
Q Consensus 489 ~p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~-----~~-~~~~L~~l~l~~N~l~ 557 (988)
++..+. ..+.|+.|+|++|.|+.. ++..+...++|++|||++|+|+..... .. ....|+.|++++|.+.
T Consensus 360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 222232 344566666666666532 334445556666667776666542211 11 1224777777777765
Q ss_pred c
Q 001974 558 G 558 (988)
Q Consensus 558 ~ 558 (988)
.
T Consensus 440 ~ 440 (460)
T d1z7xw1 440 E 440 (460)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.7e-18 Score=171.75 Aligned_cols=173 Identities=21% Similarity=0.291 Sum_probs=140.9
Q ss_pred CcEEEeecccCCCCCCchhhhccccccEEEccCCcccc-CCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEec
Q 001974 305 LRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHG-SIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGL 383 (988)
Q Consensus 305 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 383 (988)
.+++++++++++ .+|..+. ..+++|+|++|+|++ ..+..|..+++|+.|+|++|++.+..+..|..+++|++|+|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 356777888887 7776653 478999999999975 44567789999999999999999888899999999999999
Q ss_pred ccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccC
Q 001974 384 YDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVG 463 (988)
Q Consensus 384 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~ 463 (988)
++|+|+...|..|.++++|++|+|++|+|+++.|+.|..+++|++|+|++|.+....+..+ -...+ +.+.+..|.++.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l-~~~~l~~~~~~c 163 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWL-RKKSLNGGAARC 163 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHH-HHHCCSGGGCBB
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-Hhhhh-hhhcccCCCeEe
Confidence 9999998888899999999999999999999889999999999999999999984433222 22233 567778888877
Q ss_pred CCccccccccccceeecCCcccc
Q 001974 464 SIPTKIGNLKYLRVFNVSSNNLS 486 (988)
Q Consensus 464 ~~p~~~~~l~~L~~L~ls~N~l~ 486 (988)
..|..+ ..++.+||+.|.+.
T Consensus 164 ~~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 164 GAPSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp CSSTTT---TTSBGGGSCTTTCC
T ss_pred CCChhh---cCCEeeecCHhhCc
Confidence 667554 45667788888876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=5e-18 Score=175.68 Aligned_cols=218 Identities=15% Similarity=0.060 Sum_probs=110.4
Q ss_pred EEEeccCCCCCCCCCcccccCCCCcceeccccccccccCcccccCCcccEEEeccccccCc-ccccccCCccccEEeccc
Q 001974 204 NFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFSGSIPISLSNASKLEFIEALDNSFSGK-LSVNFGGMKNLSYFNVAY 282 (988)
Q Consensus 204 ~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~l~~L~~L~L~~ 282 (988)
.++.+++.++ .+|..++ +++++|++++|+|+.+.+.+|.++++|++|++++|.+... .+..|.++++++++.+..
T Consensus 12 ~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 3444444444 4444433 2445555555555544444455555555555555554432 233455555555555432
Q ss_pred -ccCCCCCCCchhhhcccccCCCCcEEEeecccCCCCCCchhhhccccccEEEccCCccccCCCccccCCC-cceEEEee
Q 001974 283 -NNLGSGESDEMSFMNSLANCSNLRTLIFAANKLRGALPHSIANLSDQLQNLIMTSNQLHGSIPSGIGNLV-GLYRLGMG 360 (988)
Q Consensus 283 -N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~ 360 (988)
|++...... .|..+++|+++++++|++....+.........+..+...++.+....+..+..++ .++.|+++
T Consensus 88 ~n~l~~~~~~------~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 88 ANNLLYINPE------AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp CTTCCEECTT------SEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred cccccccccc------cccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecc
Confidence 344333322 3445555555555555554222222222223344444555555544445555443 56667777
Q ss_pred CccCCCccCcccCCCCcc-CeEecccccCCCCCCCCCCCCCCCCEEEccccccccccccccccccccceeecC
Q 001974 361 GNQFTGTIPKEMGKLQNL-EGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLF 432 (988)
Q Consensus 361 ~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 432 (988)
+|+++...+..+ ...++ +.+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 162 ~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 162 KNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp SSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 777763333333 33333 333456666664444456667777777777777765555556666666666553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.2e-18 Score=176.24 Aligned_cols=185 Identities=22% Similarity=0.313 Sum_probs=102.9
Q ss_pred EEcCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccc
Q 001974 37 LNLRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKL 116 (988)
Q Consensus 37 l~l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i 116 (988)
++++.+++++.+ .+..+.+|++|++++|+|+. ++ .+..+++|++|++++|++++..| +..+++|++|++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 345555555433 34555666777777777763 32 46667777777777777664333 66666677777776666
Q ss_pred cCCCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhh
Q 001974 117 MGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSI 196 (988)
Q Consensus 117 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 196 (988)
+. + ..|.++++|+.++++++...+. ..+...+.++.+.++++.+... ..+.++++|++|++++|.++... .+
T Consensus 98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 98 KN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp SC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GG
T ss_pred cc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hh
Confidence 52 2 2455666666666666665522 2244555666666666655422 23555566666666666655322 25
Q ss_pred ccccCccEEEeccCCCCCCCCCcccccCCCCcceeccccccc
Q 001974 197 YNLSLLANFSVPRNQFHGSLPPSLGLTLPHLRLFQVHHNFFS 238 (988)
Q Consensus 197 ~~l~~L~~L~L~~N~i~~~lp~~~~~~l~~L~~L~L~~N~l~ 238 (988)
.++++|+.|+|++|+++ .++. +..+++|++|+|++|+++
T Consensus 170 ~~l~~L~~L~Ls~n~l~-~l~~--l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp TTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCC
T ss_pred cccccceecccCCCccC-CChh--hcCCCCCCEEECcCCcCC
Confidence 55555555555555555 3332 234444444444444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.3e-18 Score=176.15 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=113.9
Q ss_pred EEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcccccc
Q 001974 333 LIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSL 412 (988)
Q Consensus 333 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 412 (988)
++++.+++++.. .+..+.+|+.|++++|+|+ .++ .+..+++|++|++++|++++..| +..+++|+.+++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 344444444322 3344555666666666665 232 35566666666666666653322 55566666666666665
Q ss_pred ccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCcc
Q 001974 413 SGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492 (988)
Q Consensus 413 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 492 (988)
+. ++ .+..+++|+.+++++|...+ ++ .+...+.+ ..+.++++.+... ..+...++|+.|++++|.+++.. .
T Consensus 98 ~~-i~-~l~~l~~L~~l~l~~~~~~~-~~-~~~~~~~~-~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 98 KN-VS-AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNL-QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--P 168 (227)
T ss_dssp SC-CG-GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTC-CEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--G
T ss_pred cc-cc-cccccccccccccccccccc-cc-hhccccch-hhhhchhhhhchh--hhhccccccccccccccccccch--h
Confidence 52 22 35556666666666666552 21 23333344 5566666665432 22455666677777777666322 2
Q ss_pred cccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcEEeCC
Q 001974 493 LGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEYLNLS 552 (988)
Q Consensus 493 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~l~l~ 552 (988)
++.+++|++|+|++|++++ +| .++++++|+.|+|++|++++.+| +..+++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 5666777777777777663 33 26666777777777777765443 5556667777665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=7.5e-22 Score=226.14 Aligned_cols=109 Identities=19% Similarity=0.222 Sum_probs=72.6
Q ss_pred cEEEEEcCCCCCcccc-cccccCCCCCCEEEcCCCcccc----cCCcccCCCCCCcEEECCCCCCCCc----CCcccc-c
Q 001974 33 RVTVLNLRSKGLSGSL-SPYIGNLSFLREINLMNNSIQG----EIPREFGRLFRLEALFLSDNDLVGE----IPANLS-Y 102 (988)
Q Consensus 33 ~v~~l~l~~~~~~~~~-~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~-~ 102 (988)
.++.||++++++++.. ..-+..+++++.|+|++|+|+. .++..+..+++|++|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5778888888887532 3445667788888888888773 3345567778888888888887531 222222 2
Q ss_pred CCCCceeecCcccccCC----CcccccCccccccccccccccc
Q 001974 103 CSRLTILFLGRNKLMGS----IPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 103 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
..+|++|+|++|+|+.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 24678888888877633 2345666777777777777765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.4e-18 Score=170.12 Aligned_cols=161 Identities=27% Similarity=0.405 Sum_probs=80.2
Q ss_pred cCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccC
Q 001974 39 LRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMG 118 (988)
Q Consensus 39 l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 118 (988)
++.+.+++.++. ..+..|++|++++|+|++. + .+..+++|++|+|++|+|++. + .++.+++|++|++++|+|++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc
Confidence 344444433332 2344556666666666532 2 245556666666666666532 2 24555566666666665552
Q ss_pred CCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhcc
Q 001974 119 SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYN 198 (988)
Q Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 198 (988)
+| .+.++++|+.|++++|.+.. + ..+.+++.|+.+++++|.++. +..+..+++|+++++++|+++++. .+.+
T Consensus 105 -l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~ 176 (210)
T d1h6ta2 105 -LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAG 176 (210)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTT
T ss_pred -cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccC
Confidence 22 35555555555555555542 1 234555555555555555542 223444555555555555554321 1444
Q ss_pred ccCccEEEeccCCCC
Q 001974 199 LSLLANFSVPRNQFH 213 (988)
Q Consensus 199 l~~L~~L~L~~N~i~ 213 (988)
+++|++|+|++|+|+
T Consensus 177 l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 177 LTKLQNLYLSKNHIS 191 (210)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CCCCCEEECCCCCCC
Confidence 445555555544444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=9.3e-18 Score=168.90 Aligned_cols=179 Identities=23% Similarity=0.372 Sum_probs=101.5
Q ss_pred EccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccccc
Q 001974 334 IMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNSLS 413 (988)
Q Consensus 334 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 413 (988)
++..+.+++.++. ..+.+|+.|++++|+++. ++ .+..+++|++|+|++|+|++ ++ .++.+++|+.|++++|+|+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 4444555433332 234566666666666663 22 25566666666666666664 22 2456666666666666666
Q ss_pred cccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCccc
Q 001974 414 GVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPSQL 493 (988)
Q Consensus 414 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 493 (988)
+ +| .+..+++|+.|++++|.+. .++ .+..++.+ +.+++++|.+++ +..+..+++|+.+++++|++++ ++ .+
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l-~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l 174 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQL-ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PL 174 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTC-CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GG
T ss_pred c-cc-ccccccccccccccccccc-ccc-cccccccc-cccccccccccc--cccccccccccccccccccccc-cc-cc
Confidence 3 33 3666666666666666664 332 34455555 556666665542 2234556666666666666663 32 25
Q ss_pred ccCCCCcEEEecCccccccCCccccCccccCeeecC
Q 001974 494 GLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLS 529 (988)
Q Consensus 494 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 529 (988)
+++++|+.|+|++|+++ .+| .+.++++|++|+||
T Consensus 175 ~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence 56666666666666665 333 46666666666665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=2.6e-17 Score=164.09 Aligned_cols=177 Identities=26% Similarity=0.376 Sum_probs=91.3
Q ss_pred EEEccCCccccCCCccccCCCcceEEEeeCccCCCccCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEccccc
Q 001974 332 NLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGTIPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLNNNS 411 (988)
Q Consensus 332 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 411 (988)
.+.++.+.+++.++ ...+.+++.|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|+.|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34455666554332 2345566666666666662 22 35556666666666666664322 5666666666666666
Q ss_pred cccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccccceeecCCcccccccCc
Q 001974 412 LSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKYLRVFNVSSNNLSGEIPS 491 (988)
Q Consensus 412 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 491 (988)
+.. ++ .+..+++|+.|++++|.+.. ++ . +..+++|+.|++++|++. .+|
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~-~~-~-------------------------~~~l~~L~~L~l~~n~l~-~~~- 144 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITD-ID-P-------------------------LKNLTNLNRLELSSNTIS-DIS- 144 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCC-CG-G-------------------------GTTCTTCSEEECCSSCCC-CCG-
T ss_pred ccc-cc-cccccccccccccccccccc-cc-c-------------------------cchhhhhHHhhhhhhhhc-ccc-
Confidence 653 22 25556666666666665542 21 2 334444555555555554 222
Q ss_pred ccccCCCCcEEEecCccccccCCccccCccccCeeecCCCcccCcCcccccCCCCcE
Q 001974 492 QLGLCSYLEEIYMRGNFFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKFLEDLSLEY 548 (988)
Q Consensus 492 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~L~~ 548 (988)
.+..+++|+.|++++|++++. + .++++++|+.|++++|++++. +.+..+.+|++
T Consensus 145 ~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~~l~~L~~L~~ 198 (199)
T d2omxa2 145 ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI-SVLAKLTNLES 198 (199)
T ss_dssp GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSE
T ss_pred cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC-ccccCCCCCCc
Confidence 344555555555555555532 1 245555555555555555542 23344444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2.8e-17 Score=163.91 Aligned_cols=161 Identities=22% Similarity=0.359 Sum_probs=81.2
Q ss_pred cCCCCCcccccccccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccC
Q 001974 39 LRSKGLSGSLSPYIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMG 118 (988)
Q Consensus 39 l~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 118 (988)
++.+.+++.++ ...+.++++|++++|+|+. + +.+..+++|++|+|++|++++..| |+++++|++|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc
Confidence 44444443332 2344555666666666653 2 234555666666666666653322 5555666666666665542
Q ss_pred CCcccccCcccccccccccccccCCCCCcccCCCccceeeccccccCCCCCccccCcccccccccccccccCccchhhcc
Q 001974 119 SIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAANAFGGNIPNSLGQLKELKSLGLGANNLSGIIPPSIYN 198 (988)
Q Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 198 (988)
++ .+.++++|+.|++++|.+... +.+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.. .+.+
T Consensus 99 -~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~ 170 (199)
T d2omxa2 99 -IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLAN 170 (199)
T ss_dssp -CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTT
T ss_pred -cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccC
Confidence 22 255555555555555555421 234555555555555555542 2 23555555555555555555321 2444
Q ss_pred ccCccEEEeccCCCC
Q 001974 199 LSLLANFSVPRNQFH 213 (988)
Q Consensus 199 l~~L~~L~L~~N~i~ 213 (988)
+++|++|++++|+++
T Consensus 171 l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 171 LTTLERLDISSNKVS 185 (199)
T ss_dssp CTTCCEEECCSSCCC
T ss_pred CCCCCEEECCCCCCC
Confidence 555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.1e-15 Score=145.61 Aligned_cols=128 Identities=20% Similarity=0.183 Sum_probs=84.2
Q ss_pred cccCCCCCCEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccc
Q 001974 51 YIGNLSFLREINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKL 130 (988)
Q Consensus 51 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 130 (988)
.+.+...+++|||++|+|+ .++..+..+++|++|+|++|+|+ .++ .|+.+++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4556667778888888887 34555667777888888888777 443 46777777777777777775555555667777
Q ss_pred cccccccccccCCCC-CcccCCCccceeeccccccCCCCCc----cccCcccccccc
Q 001974 131 KQLAMQRNNLTGGIP-PFIGNLTSLESISLAANAFGGNIPN----SLGQLKELKSLG 182 (988)
Q Consensus 131 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ 182 (988)
++|++++|+++.... ..+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 777777777763211 345666677777777776652 232 355566666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.53 E-value=6.3e-15 Score=133.29 Aligned_cols=102 Identities=22% Similarity=0.268 Sum_probs=48.5
Q ss_pred CEEEcCCCcccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccc
Q 001974 59 REINLMNNSIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRN 138 (988)
Q Consensus 59 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 138 (988)
|+|||++|+|+ .++ .+..+++|++|++++|+|+ .+|..|+.+++|++|++++|+|++ +| .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 34555555555 222 2455555555555555555 444445555555555555555542 22 2444555555555555
Q ss_pred cccCCC-CCcccCCCccceeeccccccC
Q 001974 139 NLTGGI-PPFIGNLTSLESISLAANAFG 165 (988)
Q Consensus 139 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 165 (988)
+|+... ...+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 544221 123444444444444444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=4.2e-15 Score=141.63 Aligned_cols=111 Identities=19% Similarity=0.143 Sum_probs=65.6
Q ss_pred cCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccc
Q 001974 76 FGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLE 155 (988)
Q Consensus 76 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 155 (988)
|.+..+|++|+|++|+|+ .+|..+..+++|++|+|++|+|+. + ..|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 456666777777777776 445555666677777777777663 2 2356666666666666666644444445566666
Q ss_pred eeeccccccCCCCC-ccccCccccccccccccccc
Q 001974 156 SISLAANAFGGNIP-NSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 156 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 189 (988)
+|++++|+|+.... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666652211 23455555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=2.7e-15 Score=158.22 Aligned_cols=227 Identities=14% Similarity=0.132 Sum_probs=150.3
Q ss_pred ccEEEccCCccccCCCccccCCCcceEEEeeCccCCCc-cCcccCCCCccCeEecccccCCCCCCCCCCCCCCCCEEEcc
Q 001974 330 LQNLIMTSNQLHGSIPSGIGNLVGLYRLGMGGNQFTGT-IPKEMGKLQNLEGMGLYDNQLSGEIPSSLGNLSILSELLLN 408 (988)
Q Consensus 330 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 408 (988)
+..+.++...+... ........+|++|++++|.++.. ++..+..+++|++|+|+++.+++..+..++.+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 44555555555422 23344556888889988888743 34557788889999999988877677778888889999998
Q ss_pred cc-ccccc-cccccccccccceeecCCC-CCCc-cCchhhhhh-cccccceecccc--cccCC-Cccccccccccceeec
Q 001974 409 NN-SLSGV-IPSCLGSLKQLAILHLFEN-GLNG-TIPEEIFNL-TYLSNSLNLARN--HLVGS-IPTKIGNLKYLRVFNV 480 (988)
Q Consensus 409 ~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~-~~p~~~~~l-~~l~~~L~ls~N--~l~~~-~p~~~~~l~~L~~L~l 480 (988)
++ .++.. +...+..+++|++|+++++ .++. .+...+... +.+ +.|+++++ .++.. +...+..+++|+.||+
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L-~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L 182 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI-TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC-CEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhccccccc-chhhhccccccccccccccccccccccccccc
Confidence 85 55422 2233456788999999885 4442 122334444 344 88888864 33321 2333456788999999
Q ss_pred CCc-ccccccCcccccCCCCcEEEecCc-cccccCCccccCccccCeeecCCCcccCcCccc-ccCCCCcEEeCCCCcCc
Q 001974 481 SSN-NLSGEIPSQLGLCSYLEEIYMRGN-FFHGSIPSSLSSLRAVLAIDLSRNNLSGLIPKF-LEDLSLEYLNLSFNDLE 557 (988)
Q Consensus 481 s~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~L~~l~l~~N~l~ 557 (988)
++| .+++.....++.+++|++|+|+++ .++......++++++|+.|+++++--.+.++.. .. +..|.+..++++
T Consensus 183 ~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~---lp~L~i~~~~ls 259 (284)
T d2astb2 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LPHLQINCSHFT 259 (284)
T ss_dssp TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHH---STTSEESCCCSC
T ss_pred ccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHh---CccccccCccCC
Confidence 886 578777888888999999999984 677666677888889999999887222222222 22 333445667776
Q ss_pred ccCC
Q 001974 558 GEVP 561 (988)
Q Consensus 558 ~~~p 561 (988)
+..+
T Consensus 260 ~~~~ 263 (284)
T d2astb2 260 TIAR 263 (284)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 5443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=1.7e-14 Score=130.39 Aligned_cols=102 Identities=26% Similarity=0.296 Sum_probs=76.4
Q ss_pred cEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCCccceeecccc
Q 001974 83 EALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAAN 162 (988)
Q Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (988)
+.|+|++|+|+ .++ .++.+.+|++|+|++|+|+ .+|..|..+++|++|++++|.|+. +| .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46888888888 555 3788888888888888887 566678888888888888888874 33 4777888888888888
Q ss_pred ccCCCC-CccccCccccccccccccccc
Q 001974 163 AFGGNI-PNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 163 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 189 (988)
+|+... ...+..+++|+.|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 887443 245777777777777777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.9e-15 Score=157.97 Aligned_cols=57 Identities=18% Similarity=0.172 Sum_probs=23.4
Q ss_pred CCceeecCcccccCC-CcccccCcccccccccccccccCCCCCcccCCCccceeeccc
Q 001974 105 RLTILFLGRNKLMGS-IPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLTSLESISLAA 161 (988)
Q Consensus 105 ~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 161 (988)
+|++|||+++.+... +...+.++++|++|+|++|.+++..+..+..+++|++|++++
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 444444444443311 122233444444444444444333333344444444444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=4.2e-15 Score=162.08 Aligned_cols=135 Identities=13% Similarity=0.137 Sum_probs=82.5
Q ss_pred ccccceeecCCCCCCcc----CchhhhhhcccccceecccccccCC-----CccccccccccceeecCCcccccc----c
Q 001974 423 LKQLAILHLFENGLNGT----IPEEIFNLTYLSNSLNLARNHLVGS-----IPTKIGNLKYLRVFNVSSNNLSGE----I 489 (988)
Q Consensus 423 l~~L~~L~l~~N~l~~~----~p~~~~~l~~l~~~L~ls~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~----~ 489 (988)
.+.|+.+++++|+++.. +...+...+.+ +.|+|++|+++.. +...+..+++|+.|+|++|.++.. +
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L-~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhh-cccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 34566666666665421 12222334444 6666666665421 234456677788888888887633 4
Q ss_pred CcccccCCCCcEEEecCccccccCCccc----c--CccccCeeecCCCcccCcC----ccc--ccCCCCcEEeCCCCcCc
Q 001974 490 PSQLGLCSYLEEIYMRGNFFHGSIPSSL----S--SLRAVLAIDLSRNNLSGLI----PKF--LEDLSLEYLNLSFNDLE 557 (988)
Q Consensus 490 p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~--~l~~L~~L~ls~N~l~~~~----p~~--~~~~~L~~l~l~~N~l~ 557 (988)
...+..+++|++|+|++|.|++.-...+ . ..+.|+.|||++|+|+..- ... ...++|+.|+|++|.+.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 4556678888888888888875433333 2 2356888888888876422 111 13557888899888885
Q ss_pred c
Q 001974 558 G 558 (988)
Q Consensus 558 ~ 558 (988)
.
T Consensus 316 ~ 316 (344)
T d2ca6a1 316 E 316 (344)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=1.7e-15 Score=165.33 Aligned_cols=115 Identities=17% Similarity=0.200 Sum_probs=62.3
Q ss_pred cccccceeecCCCCCCcc-----CchhhhhhcccccceecccccccCC----CccccccccccceeecCCcccccccCcc
Q 001974 422 SLKQLAILHLFENGLNGT-----IPEEIFNLTYLSNSLNLARNHLVGS----IPTKIGNLKYLRVFNVSSNNLSGEIPSQ 492 (988)
Q Consensus 422 ~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~l~~~L~ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 492 (988)
..++|+.|+|++|++... +...+...+.+ +.|+|++|.++.. +...+...++|+.|+|++|.|++.-...
T Consensus 184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L-~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL-KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC-CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhcccccccccccccccccchhhhhcchhhh-cccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 344455555555554411 11122333344 4555555554321 2334555667777777777776542222
Q ss_pred c----cc--CCCCcEEEecCcccccc----CCcccc-CccccCeeecCCCcccCcC
Q 001974 493 L----GL--CSYLEEIYMRGNFFHGS----IPSSLS-SLRAVLAIDLSRNNLSGLI 537 (988)
Q Consensus 493 ~----~~--l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~~~ 537 (988)
+ .. ...|++|++++|.++.. +...+. +++.|+.|+|++|++....
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 2 22 35688888888877643 222332 4567888888888886543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=3.4e-15 Score=147.63 Aligned_cols=112 Identities=27% Similarity=0.270 Sum_probs=50.5
Q ss_pred CcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccccccccccCCCCCcccCCC
Q 001974 73 PREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLAMQRNNLTGGIPPFIGNLT 152 (988)
Q Consensus 73 p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 152 (988)
|.+|..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++. + +.+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHH
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccc
Confidence 344444555555555555554 222 2444555555555555554 333333334445555555554442 1 1244444
Q ss_pred ccceeeccccccCCCCC-ccccCccccccccccccccc
Q 001974 153 SLESISLAANAFGGNIP-NSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 153 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 189 (988)
+|++|++++|+|+.... ..|..+++|+.|+|++|.+.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccc
Confidence 45555555554442111 23444445555555555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=1.2e-14 Score=143.62 Aligned_cols=112 Identities=25% Similarity=0.333 Sum_probs=61.0
Q ss_pred CCCCCCCCCEEEccccccccccccccccccccceeecCCCCCCccCchhhhhhcccccceecccccccCCCccccccccc
Q 001974 395 SLGNLSILSELLLNNNSLSGVIPSCLGSLKQLAILHLFENGLNGTIPEEIFNLTYLSNSLNLARNHLVGSIPTKIGNLKY 474 (988)
Q Consensus 395 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~L~ls~N~l~~~~p~~~~~l~~ 474 (988)
.+..+++|+.|+|++|+|+. ++ .+..+++|+.|+|++|+++ .+|.....++.| +.|++++|+++. ++ .+..+++
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L-~~L~l~~N~i~~-l~-~~~~l~~ 116 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL-EELWISYNQIAS-LS-GIEKLVN 116 (198)
T ss_dssp HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHC-CEEECSEEECCC-HH-HHHHHHH
T ss_pred HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccc-cccccccccccc-cc-ccccccc
Confidence 34445555555555555552 22 2555555555555555554 444433334444 555666665552 22 3555666
Q ss_pred cceeecCCcccccccC--cccccCCCCcEEEecCccccccC
Q 001974 475 LRVFNVSSNNLSGEIP--SQLGLCSYLEEIYMRGNFFHGSI 513 (988)
Q Consensus 475 L~~L~ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~ 513 (988)
|+.|++++|+|+. ++ ..+..+++|+.|+|++|++....
T Consensus 117 L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 156 (198)
T d1m9la_ 117 LRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDY 156 (198)
T ss_dssp SSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred ccccccccchhcc-ccccccccCCCccceeecCCCccccCc
Confidence 6666666666663 33 34666667777777777665433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=6.1e-13 Score=125.51 Aligned_cols=100 Identities=22% Similarity=0.179 Sum_probs=68.1
Q ss_pred CCCCCcccccccccCCCCCCEEEcCCC-cccccCCcccCCCCCCcEEECCCCCCCCcCCcccccCCCCceeecCcccccC
Q 001974 40 RSKGLSGSLSPYIGNLSFLREINLMNN-SIQGEIPREFGRLFRLEALFLSDNDLVGEIPANLSYCSRLTILFLGRNKLMG 118 (988)
Q Consensus 40 ~~~~~~~~~~~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~N~i~~ 118 (988)
.++++. ..|..+..+++|++|+|++| .|+.+.+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+|+.
T Consensus 16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence 344544 45666777777888888655 4776666677777788888888887776667777777777777777777774
Q ss_pred CCcccccCccccccccccccccc
Q 001974 119 SIPFEFFSLYKLKQLAMQRNNLT 141 (988)
Q Consensus 119 ~~~~~~~~l~~L~~L~L~~N~l~ 141 (988)
..++.|..+ +|++|+|++|.+.
T Consensus 95 l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 95 LSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSTTTCSC-CCCEEECCSSCCC
T ss_pred cChhhhccc-cccccccCCCccc
Confidence 444444433 5666777666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.33 E-value=8.6e-13 Score=124.43 Aligned_cols=144 Identities=15% Similarity=0.068 Sum_probs=111.1
Q ss_pred CCCCEEEcCCCcccccCCcccCCCCCCcEEECCCC-CCCCcCCcccccCCCCceeecCcccccCCCcccccCcccccccc
Q 001974 56 SFLREINLMNNSIQGEIPREFGRLFRLEALFLSDN-DLVGEIPANLSYCSRLTILFLGRNKLMGSIPFEFFSLYKLKQLA 134 (988)
Q Consensus 56 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 134 (988)
.....++.++++++ ..|..+.++++|++|++++| .|+...+.+|.++++|+.|+|++|+|+.+.+.+|.++++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34567899999998 67888999999999999766 58877778899999999999999999988899999999999999
Q ss_pred cccccccCCCCCcccCCCccceeeccccccCC-CCCccccCcccccccccccccccCccchhhccccC
Q 001974 135 MQRNNLTGGIPPFIGNLTSLESISLAANAFGG-NIPNSLGQLKELKSLGLGANNLSGIIPPSIYNLSL 201 (988)
Q Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 201 (988)
|++|+|+...++.|..+ +|++|+|++|.+.= -....|..........+..++++...|..+.+++.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p~ 153 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPN 153 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCCc
Confidence 99999996555666555 79999999999851 11112323233344555567777667766666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=7e-09 Score=97.81 Aligned_cols=41 Identities=17% Similarity=0.212 Sum_probs=16.9
Q ss_pred cCcccccccccccccccCCC--CCcccCCCccceeeccccccC
Q 001974 125 FSLYKLKQLAMQRNNLTGGI--PPFIGNLTSLESISLAANAFG 165 (988)
Q Consensus 125 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~ 165 (988)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 34444444444444444221 122333444444444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=4.5e-09 Score=99.20 Aligned_cols=41 Identities=27% Similarity=0.293 Sum_probs=18.5
Q ss_pred cCCCccceeeccccccCCCC--CccccCccccccccccccccc
Q 001974 149 GNLTSLESISLAANAFGGNI--PNSLGQLKELKSLGLGANNLS 189 (988)
Q Consensus 149 ~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~ 189 (988)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 34445555555555554321 223334444444444444444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=3.1e-07 Score=94.27 Aligned_cols=149 Identities=15% Similarity=0.087 Sum_probs=101.0
Q ss_pred HHHHhhCCCCCCceeccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC-CCCceEEEeeccccccc
Q 001974 657 SLFKATDGFSSTHLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR-HRNLVKVITSCSSIDFQ 735 (988)
Q Consensus 657 ~l~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 735 (988)
++..-.+.|+.++..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.++++++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----- 80 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence 3444556677666655555578998864 66678889886554444556788888887773 333566666532
Q ss_pred CCCceEEEEeeccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcCC-------------------
Q 001974 736 GNDFKALVYEFMTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHHC------------------- 796 (988)
Q Consensus 736 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------- 796 (988)
.++..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~~----------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDEQ----------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTCS----------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred cCCceEEEEEecccccccccccccc----------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 3467899999999988876543221 12234556666666666431
Q ss_pred -------------------------------------CCCeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 797 -------------------------------------QEPVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 797 -------------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876677999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=1.2e-05 Score=81.63 Aligned_cols=130 Identities=15% Similarity=0.063 Sum_probs=83.6
Q ss_pred eeccccc-eeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcC--CCCceEEEeecccccccCCCceEEEEee
Q 001974 670 LIGMGSF-GSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIR--HRNLVKVITSCSSIDFQGNDFKALVYEF 746 (988)
Q Consensus 670 ~lg~G~~-g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~ 746 (988)
.+..|.. +.||+.... ++..+++|...... ...+..|+..++.+. .-.+.++++++. +++..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence 4455554 678998874 67778889865332 345677888887773 233566676633 34678999999
Q ss_pred ccccchhhhcCCCCCCCchhhhHhhcCCHHHHHHHHHHHHHHHHHHHcC-------------------------------
Q 001974 747 MTNGSLENWLHPDAVPQKDVEIEIQKLTLLQRINIAIDVASAIDYLHHH------------------------------- 795 (988)
Q Consensus 747 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------- 795 (988)
++|.++.+... .. ...+.++++.++-||+.
T Consensus 88 i~G~~~~~~~~----------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (255)
T d1nd4a_ 88 VPGQDLLSSHL----------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 148 (255)
T ss_dssp CSSEETTTSCC----------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred eeccccccccc----------------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhcccc
Confidence 98877654211 00 11223334444444421
Q ss_pred ------------------------CCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 796 ------------------------CQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 796 ------------------------~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 149 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02247999999999999987667899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=6.7e-05 Score=80.91 Aligned_cols=78 Identities=18% Similarity=0.101 Sum_probs=50.5
Q ss_pred CceeccccceeEEEEEECCCCeEEEEEEeecc----c---cchhHHHHHHHHHHHhc-CC--CCceEEEeecccccccCC
Q 001974 668 THLIGMGSFGSVYKGAFDQDGTIVAIKVFNLQ----R---HGASKSFLAECKALKNI-RH--RNLVKVITSCSSIDFQGN 737 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l-~h--~niv~~~~~~~~~~~~~~ 737 (988)
.+.||.|....||++....+++.|+||.-... . .....+...|++.++.+ .+ ..+.+++.+. +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 45789999999999988767889999975421 1 11234566788888776 22 3566677652 2
Q ss_pred CceEEEEeeccccch
Q 001974 738 DFKALVYEFMTNGSL 752 (988)
Q Consensus 738 ~~~~lv~e~~~~gsL 752 (988)
+..++|||++++..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEeccCCccc
Confidence 456799999976543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=8.9e-06 Score=76.28 Aligned_cols=39 Identities=8% Similarity=0.074 Sum_probs=18.2
Q ss_pred CCCCcEEECCCC-CCCCc----CCcccccCCCCceeecCccccc
Q 001974 79 LFRLEALFLSDN-DLVGE----IPANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 79 l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~N~i~ 117 (988)
.++|++|+|+++ .++.. +-..+...++|++|+|++|.+.
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 455666666653 34321 1223334444555555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.28 E-value=6.4e-05 Score=70.19 Aligned_cols=17 Identities=12% Similarity=0.217 Sum_probs=8.0
Q ss_pred ccccccceeecCCCCCC
Q 001974 421 GSLKQLAILHLFENGLN 437 (988)
Q Consensus 421 ~~l~~L~~L~l~~N~l~ 437 (988)
...++|+.|+|++|.+.
T Consensus 41 ~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TTCSCCCEEECTTSCCB
T ss_pred hhCCccceeeccccccc
Confidence 33344555555555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.00054 Score=71.52 Aligned_cols=149 Identities=14% Similarity=0.134 Sum_probs=80.6
Q ss_pred ceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC--ceEEEeecccccccCCCceEEEEeeccccchh
Q 001974 676 FGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN--LVKVITSCSSIDFQGNDFKALVYEFMTNGSLE 753 (988)
Q Consensus 676 ~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 753 (988)
--.||+++.. +|+.|++|+.+.... ..+++..|.+.+..+.... ++..+.......+..++..+.|+++++|..+.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4589999885 888999999875533 3466778888888874222 22222222222233456678899999764432
Q ss_pred hh------------------cCCCCCCCc---hhh---h-------HhhcCCHHH---HHHHHHHHHHHHHHHH-cCCCC
Q 001974 754 NW------------------LHPDAVPQK---DVE---I-------EIQKLTLLQ---RINIAIDVASAIDYLH-HHCQE 798 (988)
Q Consensus 754 ~~------------------l~~~~~~~~---~~~---~-------~~~~l~~~~---~~~i~~~i~~~L~~LH-~~~~~ 798 (988)
.. ........+ +.. . ....++... ....+.++...+.-.- +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 011110000 000 0 000111111 2222333333332221 22245
Q ss_pred CeEeccCCCCCeeeCCCCcEEEeeeccccc
Q 001974 799 PVLHCDLKPGNVLLDNDMIAHVGDFGLARV 828 (988)
Q Consensus 799 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 828 (988)
++||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.84 E-value=2.9e-05 Score=72.64 Aligned_cols=70 Identities=17% Similarity=0.086 Sum_probs=43.8
Q ss_pred ccccccCCCCCCEEEcCC-Ccccc----cCCcccCCCCCCcEEECCCCCCCCc----CCcccccCCCCceeecCccccc
Q 001974 48 LSPYIGNLSFLREINLMN-NSIQG----EIPREFGRLFRLEALFLSDNDLVGE----IPANLSYCSRLTILFLGRNKLM 117 (988)
Q Consensus 48 ~~~~l~~l~~L~~L~L~~-n~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~L~~N~i~ 117 (988)
+.....+.+.|++|+|++ +.|+. .+-.++...++|++|+|++|.+... +-..+...++++.|++++|.+.
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344445667888888887 45652 2334556777888888888877643 2233445566777777766654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.54 E-value=9.9e-05 Score=68.88 Aligned_cols=61 Identities=18% Similarity=0.219 Sum_probs=27.7
Q ss_pred CCccceeeccccccCCC----CCccccCcccccc--cccccccccC----ccchhhccccCccEEEeccCC
Q 001974 151 LTSLESISLAANAFGGN----IPNSLGQLKELKS--LGLGANNLSG----IIPPSIYNLSLLANFSVPRNQ 211 (988)
Q Consensus 151 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~--L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~ 211 (988)
.++++.|++++|.++.. +..++...++|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 34445555555444321 1233444455554 3334455542 233444555666666655443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.43 E-value=0.004 Score=66.60 Aligned_cols=75 Identities=13% Similarity=0.132 Sum_probs=52.0
Q ss_pred CceeccccceeEEEEEECC-------CCeEEEEEEeeccccchhHHHHHHHHHHHhc-CCCCceEEEeecccccccCCCc
Q 001974 668 THLIGMGSFGSVYKGAFDQ-------DGTIVAIKVFNLQRHGASKSFLAECKALKNI-RHRNLVKVITSCSSIDFQGNDF 739 (988)
Q Consensus 668 ~~~lg~G~~g~Vy~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 739 (988)
++.|+.|-.-.+|++.... ..+.|++++... .....+..+|..+++.+ .+.-..++++++.
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--------- 115 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFS--------- 115 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence 4678888899999998752 235688887752 22334567899999888 4444557787742
Q ss_pred eEEEEeeccccchh
Q 001974 740 KALVYEFMTNGSLE 753 (988)
Q Consensus 740 ~~lv~e~~~~gsL~ 753 (988)
-.+|+||++|..+.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 15899999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.27 E-value=0.013 Score=60.23 Aligned_cols=172 Identities=10% Similarity=0.002 Sum_probs=84.7
Q ss_pred ccCHHHHHHhhCCCCCCcee-----ccccceeEEEEEECCCCeEEEEEEeeccccchhHHHHHHHHHHHhcCCCC--ceE
Q 001974 652 KVSYESLFKATDGFSSTHLI-----GMGSFGSVYKGAFDQDGTIVAIKVFNLQRHGASKSFLAECKALKNIRHRN--LVK 724 (988)
Q Consensus 652 ~~~~~~l~~~~~~y~~~~~l-----g~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 724 (988)
.++.+++.....+|.+.+.. ..|---+.|+.+.. .| .+++|++.... ..+++..|++++..+.... +..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 35667777777788775443 45666788998874 44 58899985432 2345566777777763222 222
Q ss_pred EEeecccc-cccCCCceEEEEeeccccchhhhc------------------CCCCCCCc---hhhh------H---hhcC
Q 001974 725 VITSCSSI-DFQGNDFKALVYEFMTNGSLENWL------------------HPDAVPQK---DVEI------E---IQKL 773 (988)
Q Consensus 725 ~~~~~~~~-~~~~~~~~~lv~e~~~~gsL~~~l------------------~~~~~~~~---~~~~------~---~~~l 773 (988)
.+...... ...-......++.+..+......- ........ .... . ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 11110000 011123445666666553332100 00000000 0000 0 0001
Q ss_pred CHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCCeeeCCCCcEEEeeecccc
Q 001974 774 TLLQRINIAIDVASAIDYLHH-HCQEPVLHCDLKPGNVLLDNDMIAHVGDFGLAR 827 (988)
Q Consensus 774 ~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 827 (988)
........+..+...+...+. .-..++||+|+.++||+++.+...-+.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222333333333332 124589999999999999988777899999885
|